--
-- PostgreSQL database dump
--

-- Dumped from database version 9.5.2
-- Dumped by pg_dump version 9.5.3

SET statement_timeout = 0;
SET lock_timeout = 0;
SET client_encoding = 'UTF8';
SET standard_conforming_strings = on;
SET check_function_bodies = false;
SET client_min_messages = warning;
SET row_security = off;

SET search_path = public, pg_catalog;

--
-- Data for Name: amino_acids; Type: TABLE DATA; Schema: public; Owner: acoffman
--

COPY amino_acids (id, name) FROM stdin;
1	p.Q61H
2	p.Q61L
3	p.Q61E
4	p.Q61K
5	p.G13V
6	p.G13A
7	p.G13D
8	p.G13C
9	p.G13R
10	p.G12V
11	p.G12A
12	p.G12D
13	p.G12C
14	p.G12R
15	p.G12S
16	p.S768R
17	p.M918T
18	p.R130G
19	p.R130*
20	p.R130Q
21	p.R159S
22	p.R233*
23	p.K267X
24	p.Q61R
25	p.A146V
26	p.A146P
27	p.A146T
28	p.K117N
29	p.Q61P
30	p.G13S
31	p.I836M
32	p.I836L
33	p.D835E
34	p.D835V
35	p.D835A
36	p.D835Y
37	p.D835H
38	p.D835N
39	p.E17K
40	p.D759X
41	p.L755S
42	p.A309G
43	p.F53L
44	p.Q56P
45	p.K57N
46	p.D67N
47	p.I111S
48	p.C121S
49	p.P124S
50	p.P124L
51	p.E203K
52	p.P264S
53	p.N382H
54	p.R172S
55	p.R172M
56	p.R172K
57	p.R140L
58	p.R140Q
59	p.R140W
60	p.G309A
61	p.L755X
62	p.D769H
63	p.D769Y
64	p.V777L
65	p.G778GSPX
66	p.V842I
67	p.R896C
68	p.E330A
69	p.D351N
70	p.D351H
71	p.D355E
72	p.R361S
73	p.R361C
74	p.R361H
75	p.D537Y
76	p.Q209P
77	p.Q209L
78	p.R132L
79	p.R132P
80	p.R132H
81	p.R132C
82	p.R132G
83	p.R132S
84	p.R882L
85	p.R882P
86	p.R882H
87	p.R882C
88	p.R882G
89	p.R882S
90	p.Y1278S
91	p.R1275Q
92	p.F1245L
93	p.F1245C
94	p.F1245V
95	p.D1225N
96	p.F1174L
97	p.F1174C
98	p.F1174V
99	p.F1174I
100	p.I1171N
101	p.T1151M
102	p.D1091N
103	p.E542K
104	p.E545K
105	p.E545Q
106	p.E545A
107	p.E545G
108	p.E545V
109	p.Q546K
110	p.Q546E
111	p.Q546P
112	p.Q546R
113	p.Q546L
114	p.D549N
115	p.H1047R
116	p.H1047L
117	p.S37Y
118	p.S37F
119	p.S45P
120	p.S45Y
121	p.S45F
122	p.V561D
123	p.N659K
124	p.D842V
125	p.E490K
126	p.F504L
127	p.K550N
128	p.Y553N
129	p.E554X
130	p.Q556LX
131	p.W557R
132	p.K558N
133	p.V559-
134	p.V559D
135	p.V559A
136	p.V559G
137	p.V560X
138	p.V560D
139	p.V560A
140	p.V560G
141	p.G565V
142	p.N566D
143	p.NNYVYI566-
144	p.NNYVYIDPT566-
145	p.V569G
146	p.Q575PEX
147	p.L576P
148	p.P577X
149	p.D579-
150	p.R634W
151	p.K642E
152	p.V654A
153	p.N655S
154	p.N655K
155	p.H697Y
156	p.D816H
157	p.D816Y
158	p.D816I
159	p.D816V
160	p.D820H
161	p.D820Y
162	p.D820V
163	p.D820E
164	p.N822Y
165	p.N822I
166	p.N822K
167	p.Y823D
168	p.A829P
169	p.I841V
170	p.S864F
171	p.A68V
172	p.R199W
173	p.T349I
174	p.D473H
175	p.FR484FW
176	p.SL514SF
177	p.W535L
178	p.R562Q
179	p.A652V
180	p.P755F
181	p.K601E
182	p.V600D
183	p.V600G
184	p.V600E
185	p.V600R
186	p.V600K
187	p.L597R
188	p.D594E
189	p.D594V
190	p.D594G
191	p.D594H
192	p.D594N
193	p.GD593GN
194	p.Y472C
195	p.G77V
196	p.G469A
197	p.G469E
198	p.G77L
199	p.G466V
200	p.G719S
201	p.G719C
202	p.G719A
203	p.T790M
204	p.L858R
205	p.L861Q
206	p.R683G
207	p.R683T
208	p.R683S
209	p.Q209R
210	p.F232C
211	p.T618I
212	p.S381LYG
213	p.D839G
214	p.R273H
215	p.R273C
216	p.R249T
217	p.R249W
218	p.R248Q
219	p.Y220C
220	p.V173G
221	p.V173A
222	p.K700E
223	p.K666N
224	p.R201*
225	p.R162S
226	p.R162K
227	p.R162G
228	p.Q157R
229	p.Q157P
230	p.S34F
231	p.S34Y
232	p.R398W
233	p.T354M
234	p.W288HX
235	p.W288PX
236	p.W288SX
237	p.V617F
238	p.Q61*
239	p.K700N
240	p.K700I
241	p.K700R
242	p.K700T
243	p.K700*
244	p.K700Q
245	p.K666R
246	p.K666T
247	p.K666E
248	p.V654E
249	p.D594A
250	p.D594Y
251	p.T334I
252	p.S185C
253	p.S646F
254	p.S492G
255	p.V559I
256	p.T670I
257	p.Y842C
258	p.Y842H
259	p.D835F
260	p.F691L
261	p.I687F
262	p.N676K
263	p.N676D
264	p.D651G
265	p.G619C
266	p.R657Q
267	p.Q501H
268	p.I87T
269	p.E255K
270	p.Y272H
271	p.V318L
272	p.T334A
273	p.F336I
274	p.F336V
275	p.F336C
276	p.F336L
277	p.F378I
278	p.F378L
279	p.F378C
280	p.T615A
281	p.H1112R
282	p.M1268T
283	p.R2505P
284	p.Q2223K
285	p.S2215Y
286	p.L1460P
287	p.E2419K
288	p.E2014K
289	p.G1269A
290	p.S1206Y
291	p.G1202R
292	p.L1196M
293	p.L1152R
294	p.S214C
295	p.G309E
296	p.G2032R
297	p.L63V
298	p.L239R
299	p.G253C
300	p.G505S
301	p.I638F
302	p.G774V
303	p.G719D
304	p.L747S
305	p.S768I
306	p.L861P
307	p.L861R
308	p.G391R
309	p.S320C
310	p.W290C
311	p.N535K
312	p.V550E
313	p.E690K
314	p.K660E
315	p.L618M
316	p.E566G
317	p.V565I
318	p.N550K
319	p.N550H
320	p.I548V
321	p.M538I
322	p.M536I
323	p.S252W
324	p.N561D
325	p.Y371H
326	p.C384R
327	p.Y571D
328	p.W515L
329	p.G284R
330	p.Q79K
331	p.K601R
332	p.L597Q
333	p.L597S
334	p.L597V
335	p.E872K
336	p.R544W
337	p.E452K
338	p.R393W
339	p.E317K
340	p.K57E
341	p.G128D
342	p.F129L
343	p.N126D
344	p.C125S
345	p.Q60P
346	p.L46F
347	p.V35M
348	p.P577S
349	p.V658A
350	p.R841K
351	p.H845Y
352	p.G853D
353	p.W388S
354	p.S257P
355	p.D194E
356	p.C634W
357	p.S310Y
358	p.S310F
359	p.P262H
360	p.Q809R
361	p.R202C
362	p.R202H
363	p.R202L
364	p.I99T
365	p.I103N
366	p.I111N
367	p.H119P
368	p.E120D
369	p.V211D
370	p.L215P
371	p.R988C
372	p.T1010I
373	p.V1110I
374	p.Y1248C
375	p.Y1253D
376	p.M1268I
377	p.C481S
378	p.E380Q
379	p.R1192P
380	p.G1128A
381	p.R108K
382	p.T263P
383	p.A289V
384	p.G598V
385	p.P546S
386	p.P753S
387	p.V843I
388	p.P253R
389	p.R665W
390	p.L845F
391	p.Y646H
392	p.Y646N
393	p.Y646F
394	p.Y646S
395	p.A682G
396	p.L273P
397	p.R876*
398	p.R1114*
399	p.E1306*
400	p.Q1338*
401	p.Q1367*
402	p.Q1378*
403	p.E1379*
404	p.Q1429*
405	p.R1450*
406	p.M263V
407	p.L267V
408	p.G269E
409	p.Q271H
410	p.Y272F
411	p.E274K
412	p.E274V
413	p.F302V
414	p.M370T
415	p.E374G
416	p.F378V
417	p.H415R
418	p.R368S
419	p.G466R
420	p.G464V
421	p.G464E
422	p.S302G
423	p.KIGT1310X
424	p.KIGTRSA1310X
425	p.GP1466X
426	p.IDS1557X
427	p.R444W
428	p.G464R
429	p.G466A
430	p.G466E
431	p.G469R
432	p.G469S
433	p.V471F
434	p.N581S
435	p.E586K
436	p.D587A
437	p.D587E
438	p.I592M
439	p.I592V
440	p.F595L
441	p.F203L
442	p.F595S
443	p.G596R
444	p.T207I
445	p.V600A
446	p.V600L
447	p.V600M
448	p.K601-
449	p.K601N
450	p.S605F
451	p.S605N
452	p.R24H
453	p.R58*
454	p.E61*
455	p.E69*
456	p.R80*
457	p.A138V
458	p.R139L
459	p.E88*
460	p.R163L
461	p.W110*
462	p.P114L
463	p.L301S
464	p.L301*
465	p.Y969C
466	p.Y969F
467	p.Y969H
468	p.Y969*
469	p.A13T
470	p.A21T
471	p.V22A
472	p.VSHWQQQSYLDSGIHSG22-
473	p.WQQQSYLD25-
474	p.D32A
475	p.D32G
476	p.D32H
477	p.D32N
478	p.D32V
479	p.D32Y
480	p.S33C
481	p.S33Y
482	p.G34E
483	p.G34R
484	p.G34V
485	p.S37A
486	p.S37C
487	p.S37P
488	p.T40A
489	p.T40I
490	p.T40P
491	p.T40S
492	p.S45A
493	p.W731*
494	p.P733L
495	p.E734K
496	p.G735S
497	p.V742A
498	p.K745R
499	p.E746K
500	p.A750P
501	p.S752Y
502	p.D761N
503	p.D761Y
504	p.H773R
505	p.G810D
506	p.G810S
507	p.L858M
508	p.L858Q
509	p.L785P
510	p.G776S
511	p.G776CX
512	p.S158L
513	p.P283T
514	p.K310R
515	p.S373C
516	p.Y376C
517	p.Y382H
518	p.N639K
519	p.R248C
520	p.S249C
521	p.G372C
522	p.Y375C
523	p.K652Q
524	p.G699C
525	p.Y572C
526	p.D835-
527	p.I836-
528	p.Q228L
529	p.P132T
530	p.A572V
531	p.V722I
532	p.D52N
533	p.V825A
534	p.E839K
535	p.L19F
536	p.Q22K
537	p.A59T
538	p.H1112Y
539	p.Y1248H
540	p.V384D
541	p.P57S
542	p.A59V
543	p.T73I
544	p.S77F
545	p.N101T
546	p.P260A
547	p.A18T
548	p.RD841-
549	p.D842I
550	p.D842Y
551	p.DIM842-
552	p.DIMH842-
553	p.IMHD843-
554	p.D846Y
555	p.R88Q
556	p.N345K
557	p.C420R
558	p.P539R
559	p.E542Q
560	p.E545D
561	p.H701P
562	p.Y1021C
563	p.M1043I
564	p.G1049S
565	p.G376R
566	p.E439X
567	p.R461*
568	p.D560Y
569	p.DKRMNS560-
570	p.N564D
571	p.N564K
572	p.T576-
573	p.W583X
574	p.R173C
575	p.R173H
576	p.R234W
577	p.R335*
578	p.E137*
579	p.L199*
580	p.R320*
581	p.R358*
582	p.R455*
583	p.R552*
584	p.R556*
585	p.R579*
586	p.C706F
587	p.E748*
588	p.FPEEEKCFC612-
589	p.D631G
590	p.EL632-
591	p.C634R
592	p.C634Y
593	p.E768D
594	p.A883F
595	p.DVYE898-
596	p.Q537*
597	p.Q37*
598	p.Q170*
599	p.D194N
600	p.D194V
601	p.G196V
602	p.E199K
603	p.E199*
604	p.P281L
605	p.W332*
606	p.R175H
607	p.G245S
608	p.R248W
609	p.R306*
610	p.P81S
611	p.L85P
612	p.L89H
613	p.L158Q
614	p.R161*
615	p.R167W
\.


--
-- Name: amino_acids_id_seq; Type: SEQUENCE SET; Schema: public; Owner: acoffman
--

SELECT pg_catalog.setval('amino_acids_id_seq', 615, true);


--
-- Data for Name: batches; Type: TABLE DATA; Schema: public; Owner: acoffman
--

COPY batches (id, name, submitter_name, submitter_email, submitter_affiliation, reason_for_inclusion, file, url_slug, created_at, updated_at, reference_sequence_version, tags, reference_url) FROM stdin;
1	My Cancer Genome	Ben Ainscough	bainscou@genome.wustl.edu	McDonnell Genome Institute, Washington University School of Medicine	My Cancer Genome outlines variants that drive tumorigenesis and/or that have therapeutic implications. Upon review of the publications that My Cancer Genome cites, the majority of variants appear to be pathogenic. Few variants are diagnostic or prognostic. My Cancer Genome also identifies relevant clinical trials for variants. The variants outlined in My Cancer Genome are well supported with a detailed write up outlining each variant’s role in a particular cancer type. Links to these pages were included in DoCM to allow for access to these summaries for additional information about these variants. A representative transcript was chosen such that the amino acid change would resemble the variant outlined in the paper. In the event that there were multiple transcripts that included this variant, the longest transcript was chosen. Variants without literature support were not included in DoCM.	mcg.tsv	3566d868-ab6e-436d-88e5-3a5300e710e8-my-cancer-genome-ben	2016-05-18 19:52:57.980403	2016-05-18 19:52:57.980403	\N	Pathogenic	https://www.mycancergenome.org/about/what-is-my-cancer-genome/
2	WashU hematologic malignancy mutation list	Ben Ainscough	bainscou@genome.wustl.edu	McDonnell Genome Institute, Washington University School of Medicine	The WashU hematologic malignancy mutation list represents variants outlined for their importance in leukemias by investigators at Washington University that study hematologic malignancies. Many of these variants have established effects on tumor growth in leukemias with some having clinical trials performed. The variants were provided by domain experts in the genomics of hematologic malignancies and further curated against the biomedical literature. The transcript was chosen such that the amino acid change resembles the variant outlined in the cited paper. In the event that there were multiple transcripts that included this variant, the longest transcript was chosen.	tl.tsv	fb4d49d4-6925-4c22-8e66-8119056d3014-washu-hematologic-malignancy	2016-05-18 20:26:10.46571	2016-05-18 20:26:10.46571	\N	Likely Pathogenic	
3	Literature	Ben Ainscough	bainscou@genome.wustl.edu	McDonnell Genome Institute, Washington University School of Medicine	This is a list of variants curated from the literature in the original release of DoCM.	literature.tsv	ac995c00-fb09-4cda-a2c5-ee64b7c61663-literature-ben-ainscough	2016-05-18 20:32:54.138008	2016-05-18 20:32:54.138008	\N		
4	Drug Gene Knowledge Database	Jason Kunisaki, Ben Ainscough	bainscou@genome.wustl.edu	McDonnell Genome Institute, Washington University School of Medicine	The Drug Gene Knowledge Database by Dienstmann et al. [Cancer Discov; 5(2); 118-23] is an open resource that outlines the “prevalence of mutations and copy-number alterations with predictive associations across solid tumors.” This resource outlines the importance of individual variants in cancer along with a PubMed reference including the drugs that target a particular mutation. Only variants with a PubMed reference were included in DoCM. Since this database is open, high quality and freely available, useful metadata, like drug sensitivity information, was included in DoCM. The transcript was chosen such that the amino acid change resembles the variant outlined in the paper. In the event that there were multiple transcripts that included this variant, the longest transcript was chosen.	dienstmann.tsv	7b2c6957-0308-49aa-9b6b-57831e3436e4-drug-gene-knowledge-database	2016-05-18 20:50:21.655622	2016-05-18 20:50:21.655622	\N	Likely Pathogenic	http://cancerdiscovery.aacrjournals.org/content/5/2/118.full.pdf 
5	Oncomap variants	Mayank Choudhary, Ben Ainscough	bainscou@genome.wustl.edu	McDonnell Genome Institute, Washington University School of Medicine	Oncomap is a listing of 471 variants with known and established importance in cancer, many of which are known to predict response or resistance to targeted therapies. The panel is used as a diagnostic test to identify tumorigenic mutations in clinical cases by MacConnaill et al. in their manuscript in the Journal of Molecular Diagnostics. Many of these mutations overlap with mutations already existing in DoCM and this panel adds further credibility to their importance. As only the gene and amino acid were listed in the publication, many fields were filled in by manual curation. The transcript was chosen such that the amino acid change resembles the variant outlined in the cited paper. In the event that there were multiple transcripts that included this variant, the longest transcript was chosen. Associated diseases and other relevant sources were identified by searching PubMed for the gene and amino acid change.	oncomap.tsv	4816605b-9ef2-466e-9402-2cfed05c84fd-oncomap-variants-mayank	2016-05-18 21:06:38.924503	2016-05-18 21:06:38.924503	\N	Likely Pathogenic	http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0007887
\.


--
-- Name: batches_id_seq; Type: SEQUENCE SET; Schema: public; Owner: acoffman
--

SELECT pg_catalog.setval('batches_id_seq', 5, true);


--
-- Data for Name: data_versions; Type: TABLE DATA; Schema: public; Owner: acoffman
--

COPY data_versions (id, version) FROM stdin;
\.


--
-- Name: data_versions_id_seq; Type: SEQUENCE SET; Schema: public; Owner: acoffman
--

SELECT pg_catalog.setval('data_versions_id_seq', 1, false);


--
-- Data for Name: delayed_jobs; Type: TABLE DATA; Schema: public; Owner: acoffman
--

COPY delayed_jobs (id, priority, attempts, handler, last_error, run_at, locked_at, failed_at, locked_by, queue, created_at, updated_at) FROM stdin;
\.


--
-- Name: delayed_jobs_id_seq; Type: SEQUENCE SET; Schema: public; Owner: acoffman
--

SELECT pg_catalog.setval('delayed_jobs_id_seq', 7, true);


--
-- Data for Name: diseases; Type: TABLE DATA; Schema: public; Owner: acoffman
--

COPY diseases (id, name, doid, external_id, external_name) FROM stdin;
1	melanoma	1909	D008545	MeSH
2	non-small cell lung carcinoma	3908	D002289	MeSH
3	thyroid cancer	1781	D013964	MeSH
4	colorectal cancer	9256	D015179	MeSH
5	squamous cell carcinoma	1749	D002294	MeSH
6	ovarian cancer	2394	D010051	MeSH
7	breast cancer	1612	D001943	MeSH
8	acute myeloid leukemia	9119	D015470	MeSH
9	neuroblastoma	769	D009447	MeSH
10	rhabdomyosarcoma	3247	D012208	MeSH
11	gastrointestinal stromal tumor	9253	D046152	MeSH
12	thymic carcinoma	3284	D013945	MeSH
13	progesterone-receptor positive breast cancer	0060077	\N	\N
14	basal cell carcinoma	2513	D002280	MeSH
15	lung cancer	1324	211980	OMIM
16	lymphoblastic leukemia	1037	D007945	MeSH
17	acute lymphocytic leukemia	9952	247640	OMIM
18	megakaryocytic leukemia	8761	D007947	MeSH
19	chronic myeloid leukemia	8552	D015464	MeSH
20	myelofibrosis	4971	D055728	MeSH
21	renal carcinoma	4451	C1378703	UMLS
22	urinary bladder urothelial carcinoma	4006	C0279680	UMLS
23	lung adenocarcinoma	3910	C538231	MeSH
24	lung squamous cell carcinoma	3907	C0149782	UMLS
25	systemic mastocytosis	349	D034721	MeSH
26	endometrial adenocarcinoma	2870	C0279763	UMLS
27	hematologic cancer	2531	D019337	MeSH
28	colon cancer	219	D003110	MeSH
29	pancreatic cancer	1793	D010190	MeSH
30	cancer	162	D009369	MeSH
31	brain cancer	1319	D001932	MeSH
32	head and neck cancer	11934	D006258	MeSH
33	stomach cancer	10534	D013274	MeSH
34	chronic lymphocytic leukemia	1040	D015451	MeSH
35	myeloma	0070004	\N	\N
36	lymphoma	0060058	D008223	MeSH
37	medulloblastoma	0050902	D008527	MeSH
38	lung small cell carcinoma	5409	D055752	MeSH
39	meningioma	3565	D008577	MeSH
40	osteosarcoma	3347	D012516	MeSH
41	prostate cancer	10283	D011471	MeSH
42	esophagus squamous cell carcinoma	3748	C562729	MeSH
43	endometrial carcinoma	2871	D016889	MeSH
44	craniopharyngioma	3840	D003397	MeSH
45	parathyroid carcinoma	1540	D010282	MeSH
46	hepatocellular carcinoma	684	114550	OMIM
47	pilomatrixoma	5374	D018296	MeSH
48	adrenal cortical adenoma	0050891	\N	\N
49	head and neck squamous cell carcinoma	5520	C535575	MeSH
50	esophageal carcinoma	1107	C0152018	UMLS
51	tongue squamous cell carcinoma	0050865	D002294	MeSH
52	bladder carcinoma	4007	C0699885	UMLS
53	uveal melanoma	6039	C536494	MeSH
54	skin squamous cell carcinoma	3151	C0553723	UMLS
55	astrocytoma	3069	D001254	MeSH
56	chronic myeloproliferative disease	2226	C1292778	UMLS
57	mast-cell leukemia	9254	D007946	MeSH
58	angiosarcoma	0001816	D006394	MeSH
59	gastric adenocarcinoma	3717	C0278701	UMLS
60	oral squamous cell carcinoma	0050866	\N	\N
61	retinoblastoma	768	D012175	MeSH
62	thyroid medullary carcinoma	3973	C536914	MeSH
63	renal clear cell carcinoma	4467	D002292	MeSH
\.


--
-- Data for Name: genes; Type: TABLE DATA; Schema: public; Owner: acoffman
--

COPY genes (id, name, ensembl_id, entrez_id) FROM stdin;
1	NRAS	ENSG00000213281	\N
2	DDR2	ENSG00000162733	\N
3	RET	ENSG00000165731	\N
4	PTEN	ENSG00000171862	\N
5	HRAS	ENSG00000174775	\N
6	KRAS	ENSG00000133703	\N
7	FLT3	ENSG00000122025	\N
8	AKT1	ENSG00000142208	\N
9	HERC2	ENSG00000128731	\N
10	MAP2K1	ENSG00000169032	\N
11	IDH2	ENSG00000182054	\N
12	ERBB2	ENSG00000141736	\N
13	SMAD4	ENSG00000141646	\N
14	GNA11	ENSG00000088256	\N
15	IDH1	ENSG00000138413	\N
16	DNMT3A	ENSG00000119772	\N
17	ALK	ENSG00000171094	\N
18	PIK3CA	ENSG00000121879	\N
19	CTNNB1	ENSG00000168036	\N
20	PDGFRA	ENSG00000134853	\N
21	KIT	ENSG00000157404	\N
22	SMO	ENSG00000128602	\N
23	BRAF	ENSG00000157764	\N
24	EGFR	ENSG00000146648	\N
25	JAK2	ENSG00000096968	\N
26	GNAQ	ENSG00000156052	\N
27	CRLF2	ENSG00000205755	\N
28	CSF3R	ENSG00000119535	\N
29	WT1	ENSG00000184937	\N
30	TP53	ENSG00000141510	\N
31	SF3B1	ENSG00000115524	\N
32	RUNX1	ENSG00000159216	\N
33	U2AF1	ENSG00000160201	\N
34	GATA2	ENSG00000179348	\N
35	NPM1	ENSG00000181163	\N
36	ABL1	ENSG00000097007	\N
37	IL7R	ENSG00000168685	\N
38	JAK1	ENSG00000162434	\N
39	JAK3	ENSG00000105639	\N
40	MET	ENSG00000105976	\N
41	MTOR	ENSG00000198793	\N
42	ARAF	ENSG00000078061	\N
43	ROS1	ENSG00000047936	\N
44	EPHA2	ENSG00000142627	\N
45	FGFR2	ENSG00000066468	\N
46	FGFR4	ENSG00000160867	\N
47	PIK3R2	ENSG00000105647	\N
48	CBL	ENSG00000110395	\N
49	CSF1R	ENSG00000182578	\N
50	MPL	ENSG00000117400	\N
51	ERBB3	ENSG00000065361	\N
52	ERBB4	ENSG00000178568	\N
53	MAP2K2	ENSG00000126934	\N
54	RAF1	ENSG00000132155	\N
55	STK11	ENSG00000118046	\N
56	GNAS	ENSG00000087460	\N
57	BTK	ENSG00000010671	\N
58	ESR1	ENSG00000091831	\N
59	PLCG2	ENSG00000197943	\N
60	EZH2	ENSG00000106462	\N
61	MYD88	ENSG00000172936	\N
62	APC	ENSG00000134982	\N
63	AKT2	ENSG00000105221	\N
64	CDK4	ENSG00000135446	\N
65	CDKN2A	ENSG00000147889	\N
66	FGFR1	ENSG00000077782	\N
67	FGFR3	ENSG00000068078	\N
68	MLH1	ENSG00000076242	\N
69	MYC	ENSG00000136997	\N
70	PIK3R1	ENSG00000145675	\N
71	RB1	ENSG00000139687	\N
72	SRC	ENSG00000197122	\N
73	VHL	ENSG00000134086	\N
\.


--
-- Data for Name: locations; Type: TABLE DATA; Schema: public; Owner: acoffman
--

COPY locations (id, chromosome, reference_build, reference_read, start, stop, previous_reference_base, reference_sequence_version) FROM stdin;
1	1	\N	T	115256528	115256528	\N	GRCh37
2	1	\N	T	115256529	115256529	\N	GRCh37
3	1	\N	G	115256530	115256530	\N	GRCh37
4	1	\N	C	115258744	115258744	\N	GRCh37
5	1	\N	C	115258745	115258745	\N	GRCh37
6	1	\N	C	115258747	115258747	\N	GRCh37
7	1	\N	C	115258748	115258748	\N	GRCh37
8	1	\N	T	162748390	162748390	\N	GRCh37
9	10	\N	T	43617416	43617416	\N	GRCh37
10	10	\N	C	89692904	89692904	\N	GRCh37
11	10	\N	G	89692905	89692905	\N	GRCh37
12	10	\N	G	89692993	89692993	\N	GRCh37
13	10	\N	C	89717672	89717672	\N	GRCh37
14	10	\N	A	89717775	89717775	\N	GRCh37
15	11	\N	T	533874	533874	\N	GRCh37
16	11	\N	C	534286	534286	\N	GRCh37
17	11	\N	C	534288	534288	\N	GRCh37
18	11	\N	C	534289	534289	\N	GRCh37
19	12	\N	G	25378561	25378561	\N	GRCh37
20	12	\N	C	25378562	25378562	\N	GRCh37
21	12	\N	T	25378647	25378647	\N	GRCh37
22	12	\N	T	25380275	25380275	\N	GRCh37
23	12	\N	T	25380276	25380276	\N	GRCh37
24	12	\N	G	25380277	25380277	\N	GRCh37
25	12	\N	C	25398281	25398281	\N	GRCh37
26	12	\N	C	25398282	25398282	\N	GRCh37
27	12	\N	C	25398284	25398284	\N	GRCh37
28	12	\N	C	25398285	25398285	\N	GRCh37
29	13	\N	G	28592637	28592637	\N	GRCh37
30	13	\N	T	28592639	28592639	\N	GRCh37
31	13	\N	A	28592640	28592640	\N	GRCh37
32	13	\N	T	28592641	28592641	\N	GRCh37
33	13	\N	C	28592642	28592642	\N	GRCh37
34	14	\N	C	105246551	105246551	\N	GRCh37
35	15	\N	CAGGTCAGGACCGTT	28505962	28505962	\N	GRCh37
36	15	\N	A	28505975	28505975	\N	GRCh37
37	15	\N	G	28517518	28517518	\N	GRCh37
38	15	\N	T	66727441	66727441	\N	GRCh37
39	15	\N	A	66727451	66727451	\N	GRCh37
40	15	\N	G	66727455	66727455	\N	GRCh37
41	15	\N	G	66727483	66727483	\N	GRCh37
42	15	\N	T	66729124	66729124	\N	GRCh37
43	15	\N	G	66729154	66729154	\N	GRCh37
44	15	\N	C	66729162	66729162	\N	GRCh37
45	15	\N	C	66729163	66729163	\N	GRCh37
46	15	\N	G	66774131	66774131	\N	GRCh37
47	15	\N	C	66777424	66777424	\N	GRCh37
48	15	\N	A	66782915	66782915	\N	GRCh37
49	15	\N	C	90631837	90631837	\N	GRCh37
50	15	\N	C	90631838	90631838	\N	GRCh37
51	15	\N	C	90631934	90631934	\N	GRCh37
52	15	\N	G	90631935	90631935	\N	GRCh37
53	17	\N	G	37868205	37868205	\N	GRCh37
54	17	\N	TTGAGGGAAAACACA	37880219	37880219	\N	GRCh37
55	17	\N	T	37880220	37880220	\N	GRCh37
56	17	\N	G	37880261	37880261	\N	GRCh37
57	17	\N	G	37881000	37881000	\N	GRCh37
58	17	\N	-	37881003	37881004	\N	GRCh37
59	17	\N	G	37881332	37881332	\N	GRCh37
60	17	\N	C	37881616	37881616	\N	GRCh37
61	18	\N	A	48591826	48591826	\N	GRCh37
62	18	\N	G	48591888	48591888	\N	GRCh37
63	18	\N	C	48591902	48591902	\N	GRCh37
64	18	\N	C	48591918	48591918	\N	GRCh37
65	18	\N	G	48591919	48591919	\N	GRCh37
66	18	\N	G	48604787	48604787	\N	GRCh37
67	19	\N	A	3118942	3118942	\N	GRCh37
68	2	\N	C	209113112	209113112	\N	GRCh37
69	2	\N	G	209113113	209113113	\N	GRCh37
70	2	\N	C	25457242	25457242	\N	GRCh37
71	2	\N	G	25457243	25457243	\N	GRCh37
72	2	\N	T	29432655	29432655	\N	GRCh37
73	2	\N	C	29432664	29432664	\N	GRCh37
74	2	\N	G	29436858	29436858	\N	GRCh37
75	2	\N	A	29436859	29436859	\N	GRCh37
76	2	\N	A	29436860	29436860	\N	GRCh37
77	2	\N	C	29436920	29436920	\N	GRCh37
78	2	\N	G	29443695	29443695	\N	GRCh37
79	2	\N	A	29443696	29443696	\N	GRCh37
80	2	\N	A	29443697	29443697	\N	GRCh37
81	2	\N	A	29445213	29445213	\N	GRCh37
82	2	\N	G	29445273	29445273	\N	GRCh37
83	2	\N	C	29446296	29446296	\N	GRCh37
84	3	\N	G	178936082	178936082	\N	GRCh37
85	3	\N	G	178936091	178936091	\N	GRCh37
86	3	\N	A	178936092	178936092	\N	GRCh37
87	3	\N	C	178936094	178936094	\N	GRCh37
88	3	\N	A	178936095	178936095	\N	GRCh37
89	3	\N	G	178936103	178936103	\N	GRCh37
90	3	\N	A	178952085	178952085	\N	GRCh37
91	3	\N	C	41266113	41266113	\N	GRCh37
92	3	\N	T	41266136	41266136	\N	GRCh37
93	3	\N	C	41266137	41266137	\N	GRCh37
94	4	\N	T	55141036	55141036	\N	GRCh37
95	4	\N	C	55144148	55144148	\N	GRCh37
96	4	\N	A	55152093	55152093	\N	GRCh37
97	4	\N	G	55592144	55592144	\N	GRCh37
98	4	\N	T	55592186	55592186	\N	GRCh37
99	4	\N	A	55593584	55593584	\N	GRCh37
100	4	\N	T	55593591	55593591	\N	GRCh37
101	4	\N	GAAGTACAGTGGAAG	55593594	55593594	\N	GRCh37
102	4	\N	GAAGTACAGTGGAAGGTT	55593594	55593594	\N	GRCh37
103	4	\N	-	55593600	55593601	\N	GRCh37
104	4	\N	T	55593603	55593603	\N	GRCh37
105	4	\N	G	55593608	55593608	\N	GRCh37
106	4	\N	GTT	55593609	55593611	\N	GRCh37
107	4	\N	T	55593610	55593610	\N	GRCh37
108	4	\N	GTT	55593612	55593612	\N	GRCh37
109	4	\N	T	55593613	55593613	\N	GRCh37
110	4	\N	G	55593628	55593628	\N	GRCh37
111	4	\N	A	55593630	55593630	\N	GRCh37
112	4	\N	AACAATTATGTTACAGAC	55593630	55593647	\N	GRCh37
113	4	\N	AACAATTATGTTACAGACCCAACA	55593630	55593656	\N	GRCh37
114	4	\N	T	55593640	55593640	\N	GRCh37
115	4	\N	-	55593657	55593658	\N	GRCh37
116	4	\N	T	55593661	55593661	\N	GRCh37
117	4	\N	CTTATGATC	55593664	55593664	\N	GRCh37
118	4	\N	GAT	55593669	55593671	\N	GRCh37
119	4	\N	C	55594197	55594197	\N	GRCh37
120	4	\N	A	55594221	55594221	\N	GRCh37
121	4	\N	T	55594258	55594258	\N	GRCh37
122	4	\N	A	55594261	55594261	\N	GRCh37
123	4	\N	T	55594262	55594262	\N	GRCh37
124	4	\N	C	55595599	55595599	\N	GRCh37
125	4	\N	G	55599320	55599320	\N	GRCh37
126	4	\N	GA	55599320	55599321	\N	GRCh37
127	4	\N	A	55599321	55599321	\N	GRCh37
128	4	\N	G	55599332	55599332	\N	GRCh37
129	4	\N	A	55599333	55599333	\N	GRCh37
130	4	\N	T	55599334	55599334	\N	GRCh37
131	4	\N	A	55599338	55599338	\N	GRCh37
132	4	\N	A	55599339	55599339	\N	GRCh37
133	4	\N	T	55599340	55599340	\N	GRCh37
134	4	\N	T	55599341	55599341	\N	GRCh37
135	4	\N	G	55602664	55602664	\N	GRCh37
136	4	\N	A	55602700	55602700	\N	GRCh37
137	4	\N	C	55602770	55602770	\N	GRCh37
138	7	\N	CC	128829195	128829196	\N	GRCh37
139	7	\N	C	128845101	128845101	\N	GRCh37
140	7	\N	CC	128846116	128846117	\N	GRCh37
141	7	\N	G	128849189	128849189	\N	GRCh37
142	7	\N	CC	128849224	128849225	\N	GRCh37
143	7	\N	CC	128850279	128850280	\N	GRCh37
144	7	\N	G	128850341	128850341	\N	GRCh37
145	7	\N	G	128850838	128850838	\N	GRCh37
146	7	\N	C	128851883	128851883	\N	GRCh37
147	7	\N	CC	128852191	128852192	\N	GRCh37
148	7	\N	T	140453134	140453134	\N	GRCh37
149	7	\N	CA	140453135	140453136	\N	GRCh37
150	7	\N	A	140453136	140453136	\N	GRCh37
151	7	\N	AC	140453136	140453137	\N	GRCh37
152	7	\N	A	140453145	140453145	\N	GRCh37
153	7	\N	A	140453153	140453153	\N	GRCh37
154	7	\N	T	140453154	140453154	\N	GRCh37
155	7	\N	C	140453155	140453155	\N	GRCh37
156	7	\N	CA	140453155	140453156	\N	GRCh37
157	7	\N	T	140481393	140481393	\N	GRCh37
158	7	\N	C	140481402	140481402	\N	GRCh37
159	7	\N	CC	140481402	140481403	\N	GRCh37
160	7	\N	C	140481411	140481411	\N	GRCh37
161	7	\N	G	55241707	55241707	\N	GRCh37
162	7	\N	G	55241708	55241708	\N	GRCh37
163	7	\N	C	55249071	55249071	\N	GRCh37
164	7	\N	T	55259515	55259515	\N	GRCh37
165	7	\N	T	55259524	55259524	\N	GRCh37
166	9	\N	A	5078360	5078360	\N	GRCh37
167	9	\N	G	5078361	5078361	\N	GRCh37
168	9	\N	A	5078362	5078362	\N	GRCh37
169	9	\N	T	80409488	80409488	\N	GRCh37
170	X	\N	A	1314966	1314966	\N	GRCh37
171	1	\N	G	36933434	36933434	\N	GRCh37
172	11	\N	-	32417909	32417910	\N	GRCh37
173	13	\N	T	28592629	28592629	\N	GRCh37
174	17	\N	C	7577120	7577120	\N	GRCh37
175	17	\N	G	7577121	7577121	\N	GRCh37
176	17	\N	C	7577535	7577535	\N	GRCh37
177	17	\N	T	7577536	7577536	\N	GRCh37
178	17	\N	C	7577538	7577538	\N	GRCh37
179	17	\N	T	7578190	7578190	\N	GRCh37
180	17	\N	A	7578412	7578412	\N	GRCh37
181	2	\N	T	198266834	198266834	\N	GRCh37
182	2	\N	C	198267359	198267359	\N	GRCh37
183	21	\N	G	36231783	36231783	\N	GRCh37
184	21	\N	C	36252876	36252876	\N	GRCh37
185	21	\N	C	36252877	36252877	\N	GRCh37
186	21	\N	T	36252878	36252878	\N	GRCh37
187	21	\N	T	44514777	44514777	\N	GRCh37
188	21	\N	G	44524456	44524456	\N	GRCh37
189	3	\N	G	128200113	128200113	\N	GRCh37
190	3	\N	G	128200744	128200744	\N	GRCh37
191	5	\N	-	170837546	170837547	\N	GRCh37
192	9	\N	G	5073770	5073770	\N	GRCh37
193	2	\N	T	198266832	198266832	\N	GRCh37
194	2	\N	T	198266833	198266833	\N	GRCh37
195	2	\N	T	198267360	198267360	\N	GRCh37
196	2	\N	T	198267361	198267361	\N	GRCh37
197	9	\N	C	133748283	133748283	\N	GRCh37
198	5	\N	A	35873597	35873597	\N	GRCh37
199	1	\N	G	65312382	65312382	\N	GRCh37
200	7	\N	A	55228007	55228007	\N	GRCh37
201	4	\N	G	55593609	55593609	\N	GRCh37
202	4	\N	C	55595519	55595519	\N	GRCh37
203	13	\N	T	28592620	28592620	\N	GRCh37
204	13	\N	A	28592621	28592621	\N	GRCh37
205	13	\N	TC	28592641	28592642	\N	GRCh37
206	13	\N	A	28601359	28601359	\N	GRCh37
207	13	\N	T	28601373	28601373	\N	GRCh37
208	13	\N	G	28602340	28602340	\N	GRCh37
209	13	\N	T	28602342	28602342	\N	GRCh37
210	13	\N	T	28602416	28602416	\N	GRCh37
211	13	\N	C	28608111	28608111	\N	GRCh37
212	19	\N	C	17945969	17945969	\N	GRCh37
213	19	\N	C	17949138	17949138	\N	GRCh37
214	19	\N	A	17954634	17954634	\N	GRCh37
215	9	\N	G	133738306	133738306	\N	GRCh37
216	9	\N	T	133738357	133738357	\N	GRCh37
217	9	\N	G	133747588	133747588	\N	GRCh37
218	9	\N	A	133748282	133748282	\N	GRCh37
219	9	\N	T	133748288	133748288	\N	GRCh37
220	9	\N	T	133748289	133748289	\N	GRCh37
221	9	\N	C	133748290	133748290	\N	GRCh37
222	9	\N	T	133748414	133748414	\N	GRCh37
223	9	\N	T	133748415	133748415	\N	GRCh37
224	1	\N	T	36933444	36933444	\N	GRCh37
225	7	\N	A	116417464	116417464	\N	GRCh37
226	7	\N	T	116423474	116423474	\N	GRCh37
227	1	\N	C	11169361	11169361	\N	GRCh37
228	1	\N	G	11182179	11182179	\N	GRCh37
229	1	\N	G	11184573	11184573	\N	GRCh37
230	1	\N	A	11217299	11217299	\N	GRCh37
231	1	\N	C	11174420	11174420	\N	GRCh37
232	1	\N	C	11187857	11187857	\N	GRCh37
233	2	\N	C	29432682	29432682	\N	GRCh37
234	2	\N	G	29443600	29443600	\N	GRCh37
235	2	\N	C	29443613	29443613	\N	GRCh37
236	2	\N	G	29443631	29443631	\N	GRCh37
237	2	\N	A	29445270	29445270	\N	GRCh37
238	X	\N	C	47426121	47426121	\N	GRCh37
239	6	\N	C	117638347	117638347	\N	GRCh37
240	1	\N	C	162724415	162724415	\N	GRCh37
241	1	\N	T	162729630	162729630	\N	GRCh37
242	1	\N	G	162729671	162729671	\N	GRCh37
243	1	\N	G	162741822	162741822	\N	GRCh37
244	1	\N	A	162745497	162745497	\N	GRCh37
245	1	\N	G	162748407	162748407	\N	GRCh37
246	7	\N	T	55242470	55242470	\N	GRCh37
247	7	\N	G	55249005	55249005	\N	GRCh37
248	1	\N	C	16464489	16464489	\N	GRCh37
249	10	\N	G	123278324	123278324	\N	GRCh37
250	10	\N	C	123279562	123279562	\N	GRCh37
251	5	\N	C	176522416	176522416	\N	GRCh37
252	5	\N	T	176522552	176522552	\N	GRCh37
253	7	\N	G	55241620	55241620	\N	GRCh37
254	10	\N	T	123247516	123247516	\N	GRCh37
255	10	\N	A	123256060	123256060	\N	GRCh37
256	10	\N	T	123256215	123256215	\N	GRCh37
257	10	\N	C	123256219	123256219	\N	GRCh37
258	10	\N	A	123258034	123258034	\N	GRCh37
259	10	\N	T	123258036	123258036	\N	GRCh37
260	10	\N	T	123258042	123258042	\N	GRCh37
261	10	\N	C	123258070	123258070	\N	GRCh37
262	10	\N	C	123258076	123258076	\N	GRCh37
263	10	\N	G	123279677	123279677	\N	GRCh37
264	19	\N	A	18278061	18278061	\N	GRCh37
265	11	\N	T	119148891	119148891	\N	GRCh37
266	11	\N	T	119148930	119148930	\N	GRCh37
267	5	\N	A	149441328	149441328	\N	GRCh37
268	1	\N	G	43815009	43815009	\N	GRCh37
269	12	\N	G	56481922	56481922	\N	GRCh37
270	14	\N	G	105243048	105243048	\N	GRCh37
271	7	\N	T	140453133	140453133	\N	GRCh37
272	7	\N	AG	140453145	140453146	\N	GRCh37
273	7	\N	G	140453146	140453146	\N	GRCh37
274	2	\N	C	212295699	212295699	\N	GRCh37
275	2	\N	G	212537975	212537975	\N	GRCh37
276	2	\N	C	212537981	212537981	\N	GRCh37
277	2	\N	C	212566827	212566827	\N	GRCh37
278	2	\N	G	212570064	212570064	\N	GRCh37
279	2	\N	C	212578308	212578308	\N	GRCh37
280	15	\N	A	66727453	66727453	\N	GRCh37
281	15	\N	G	66729175	66729175	\N	GRCh37
282	15	\N	T	66729177	66729177	\N	GRCh37
283	19	\N	T	4110581	4110581	\N	GRCh37
284	19	\N	A	4110584	4110584	\N	GRCh37
285	19	\N	T	4117541	4117541	\N	GRCh37
286	19	\N	G	4117584	4117584	\N	GRCh37
287	19	\N	C	4117617	4117617	\N	GRCh37
288	1	\N	TT	115256528	115256529	\N	GRCh37
289	4	\N	C	55141083	55141083	\N	GRCh37
290	4	\N	T	55144144	55144144	\N	GRCh37
291	4	\N	G	55152090	55152090	\N	GRCh37
292	4	\N	C	55152101	55152101	\N	GRCh37
293	4	\N	G	55152126	55152126	\N	GRCh37
294	3	\N	C	12641195	12641195	\N	GRCh37
295	3	\N	A	12645700	12645700	\N	GRCh37
296	19	\N	C	1220489	1220489	\N	GRCh37
297	10	\N	C	43609950	43609950	\N	GRCh37
298	17	\N	C	37868208	37868208	\N	GRCh37
299	12	\N	C	56481857	56481857	\N	GRCh37
300	12	\N	A	56490980	56490980	\N	GRCh37
301	20	\N	C	57484420	57484420	\N	GRCh37
302	20	\N	G	57484421	57484421	\N	GRCh37
303	15	\N	T	66729088	66729088	\N	GRCh37
304	15	\N	T	66729100	66729100	\N	GRCh37
305	15	\N	A	66729148	66729148	\N	GRCh37
306	15	\N	G	66729152	66729152	\N	GRCh37
307	15	\N	T	66774156	66774156	\N	GRCh37
308	15	\N	T	66774168	66774168	\N	GRCh37
309	7	\N	C	116411923	116411923	\N	GRCh37
310	7	\N	C	116411990	116411990	\N	GRCh37
311	7	\N	G	116417457	116417457	\N	GRCh37
312	7	\N	A	116423414	116423414	\N	GRCh37
313	7	\N	T	116423428	116423428	\N	GRCh37
314	7	\N	G	116423475	116423475	\N	GRCh37
315	X	\N	C	100611164	100611164	\N	GRCh37
316	X	\N	A	100611165	100611165	\N	GRCh37
317	6	\N	G	152332832	152332832	\N	GRCh37
318	2	\N	C	29443642	29443642	\N	GRCh37
319	2	\N	C	29445450	29445450	\N	GRCh37
320	7	\N	G	55211080	55211080	\N	GRCh37
321	7	\N	A	55221743	55221743	\N	GRCh37
322	7	\N	C	55221822	55221822	\N	GRCh37
323	7	\N	G	55233043	55233043	\N	GRCh37
324	7	\N	C	55231430	55231430	\N	GRCh37
325	7	\N	C	55242487	55242487	\N	GRCh37
326	7	\N	G	55259469	55259469	\N	GRCh37
327	10	\N	G	123279674	123279674	\N	GRCh37
328	16	\N	C	81946260	81946260	\N	GRCh37
329	16	\N	A	81962183	81962183	\N	GRCh37
330	7	\N	A	148508728	148508728	\N	GRCh37
331	7	\N	T	148508727	148508727	\N	GRCh37
332	7	\N	G	148506467	148506467	\N	GRCh37
333	3	\N	T	38182641	38182641	\N	GRCh37
334	5	\N	C	112173917	112173917	\N	GRCh37
335	5	\N	C	112174631	112174631	\N	GRCh37
336	5	\N	G	112175207	112175207	\N	GRCh37
337	5	\N	C	112175303	112175303	\N	GRCh37
338	5	\N	C	112175390	112175390	\N	GRCh37
339	5	\N	C	112175423	112175423	\N	GRCh37
340	5	\N	G	112175426	112175426	\N	GRCh37
341	5	\N	C	112175576	112175576	\N	GRCh37
342	5	\N	C	112175639	112175639	\N	GRCh37
343	9	\N	A	133738330	133738330	\N	GRCh37
344	9	\N	C	133738342	133738342	\N	GRCh37
345	9	\N	G	133738349	133738349	\N	GRCh37
346	9	\N	G	133738356	133738356	\N	GRCh37
347	9	\N	A	133738358	133738358	\N	GRCh37
348	9	\N	G	133738363	133738363	\N	GRCh37
349	9	\N	A	133738364	133738364	\N	GRCh37
350	9	\N	A	133747540	133747540	\N	GRCh37
351	9	\N	T	133748391	133748391	\N	GRCh37
352	9	\N	A	133748403	133748403	\N	GRCh37
353	9	\N	A	133750356	133750356	\N	GRCh37
354	19	\N	C	40741870	40741870	\N	GRCh37
355	7	\N	C	140481412	140481412	\N	GRCh37
356	7	\N	C	140481417	140481417	\N	GRCh37
357	19	\N	T	40742220	40742220	\N	GRCh37
358	5	\N	AAGATTGGAAC	112175219	112175229	\N	GRCh37
359	5	\N	AAGATTGGAACTAGGTCAGC	112175219	112175238	\N	GRCh37
360	5	\N	GGACC	112175687	112175691	\N	GRCh37
361	5	\N	ATTGATTC	112175960	112175967	\N	GRCh37
362	7	\N	G	140481478	140481478	\N	GRCh37
363	7	\N	C	140481418	140481418	\N	GRCh37
364	7	\N	C	140481403	140481403	\N	GRCh37
365	7	\N	C	140481397	140481397	\N	GRCh37
366	7	\N	T	140453193	140453193	\N	GRCh37
367	7	\N	C	140453179	140453179	\N	GRCh37
368	7	\N	T	140453175	140453175	\N	GRCh37
369	7	\N	G	140453174	140453174	\N	GRCh37
370	7	\N	T	140453159	140453159	\N	GRCh37
371	7	\N	T	140453161	140453161	\N	GRCh37
372	7	\N	A	140453152	140453152	\N	GRCh37
373	7	\N	A	140453150	140453150	\N	GRCh37
374	7	\N	A	140453151	140453151	\N	GRCh37
375	7	\N	C	140453149	140453149	\N	GRCh37
376	7	\N	G	140453139	140453139	\N	GRCh37
377	7	\N	C	140453137	140453137	\N	GRCh37
378	7	\N	TTT	140453132	140453134	\N	GRCh37
379	7	\N	T	140453132	140453132	\N	GRCh37
380	7	\N	CT	140453121	140453122	\N	GRCh37
381	7	\N	C	140453121	140453121	\N	GRCh37
382	12	\N	C	58145430	58145430	\N	GRCh37
383	9	\N	G	21971186	21971186	\N	GRCh37
384	9	\N	C	21971177	21971177	\N	GRCh37
385	9	\N	C	21971153	21971153	\N	GRCh37
386	9	\N	G	21971120	21971120	\N	GRCh37
387	9	\N	G	21971111	21971111	\N	GRCh37
388	9	\N	C	21971108	21971108	\N	GRCh37
389	9	\N	C	21971096	21971096	\N	GRCh37
390	9	\N	C	21971036	21971036	\N	GRCh37
391	9	\N	C	21971029	21971029	\N	GRCh37
392	9	\N	C	21971028	21971028	\N	GRCh37
393	9	\N	G	21971017	21971017	\N	GRCh37
394	5	\N	A	149453044	149453044	\N	GRCh37
395	5	\N	T	149433645	149433645	\N	GRCh37
396	5	\N	A	149433646	149433646	\N	GRCh37
397	5	\N	A	149433644	149433644	\N	GRCh37
398	3	\N	G	41266040	41266040	\N	GRCh37
399	3	\N	G	41266064	41266064	\N	GRCh37
400	3	\N	T	41266068	41266068	\N	GRCh37
401	3	\N	GTTAGTCACTGGCAGCAACAGTCTTACCTGGACTCTGGAATCCATTCTGGT	41266067	41266117	\N	GRCh37
402	3	\N	TGGCAGCAACAGTCTTACCTGGAC	41266076	41266099	\N	GRCh37
403	3	\N	A	41266098	41266098	\N	GRCh37
404	3	\N	G	41266097	41266097	\N	GRCh37
405	3	\N	C	41266101	41266101	\N	GRCh37
406	3	\N	G	41266104	41266104	\N	GRCh37
407	3	\N	G	41266103	41266103	\N	GRCh37
408	3	\N	T	41266112	41266112	\N	GRCh37
409	3	\N	A	41266121	41266121	\N	GRCh37
410	3	\N	C	41266122	41266122	\N	GRCh37
411	7	\N	G	55242423	55242423	\N	GRCh37
412	7	\N	C	55242428	55242428	\N	GRCh37
413	7	\N	G	55242430	55242430	\N	GRCh37
414	7	\N	G	55242433	55242433	\N	GRCh37
415	7	\N	T	55242455	55242455	\N	GRCh37
416	7	\N	A	55242464	55242464	\N	GRCh37
417	7	\N	G	55242466	55242466	\N	GRCh37
418	7	\N	G	55242478	55242478	\N	GRCh37
419	7	\N	C	55242485	55242485	\N	GRCh37
420	7	\N	G	55242511	55242511	\N	GRCh37
421	7	\N	A	55249020	55249020	\N	GRCh37
422	7	\N	G	55249131	55249131	\N	GRCh37
423	7	\N	G	55249130	55249130	\N	GRCh37
424	7	\N	C	55259514	55259514	\N	GRCh37
425	7	\N	TG	55259515	55259516	\N	GRCh37
426	7	\N	CT	55259514	55259515	\N	GRCh37
427	17	\N	T	37881025	37881025	\N	GRCh37
428	17	\N	G	37880997	37880997	\N	GRCh37
429	17	\N	-	37880997	37880998	\N	GRCh37
430	8	\N	G	38285938	38285938	\N	GRCh37
431	8	\N	G	38282209	38282209	\N	GRCh37
432	10	\N	T	123279503	123279503	\N	GRCh37
433	10	\N	G	123274803	123274803	\N	GRCh37
434	10	\N	T	123274794	123274794	\N	GRCh37
435	10	\N	A	123274777	123274777	\N	GRCh37
436	10	\N	A	123247577	123247577	\N	GRCh37
437	4	\N	C	1803564	1803564	\N	GRCh37
438	4	\N	C	1803568	1803568	\N	GRCh37
439	4	\N	G	1806089	1806089	\N	GRCh37
440	4	\N	A	1806092	1806092	\N	GRCh37
441	4	\N	A	1806099	1806099	\N	GRCh37
442	4	\N	A	1807889	1807889	\N	GRCh37
443	4	\N	G	1808331	1808331	\N	GRCh37
444	13	\N	T	28608341	28608341	\N	GRCh37
445	13	\N	ATC	28592640	28592642	\N	GRCh37
446	13	\N	GAT	28592637	28592639	\N	GRCh37
447	9	\N	TG	80409488	80409489	\N	GRCh37
448	20	\N	A	57484596	57484596	\N	GRCh37
449	11	\N	C	534285	534285	\N	GRCh37
450	11	\N	C	533873	533873	\N	GRCh37
451	11	\N	G	533875	533875	\N	GRCh37
452	11	\N	CT	533873	533874	\N	GRCh37
453	19	\N	G	17954215	17954215	\N	GRCh37
454	19	\N	G	17948009	17948009	\N	GRCh37
455	19	\N	C	17945696	17945696	\N	GRCh37
456	4	\N	G	55561764	55561764	\N	GRCh37
457	4	\N	G	55593603	55593603	\N	GRCh37
458	4	\N	T	55599348	55599348	\N	GRCh37
459	4	\N	G	55602694	55602694	\N	GRCh37
460	12	\N	C	25398262	25398262	\N	GRCh37
461	12	\N	G	25398255	25398255	\N	GRCh37
462	12	\N	C	25380283	25380283	\N	GRCh37
463	15	\N	T	66729153	66729153	\N	GRCh37
464	7	\N	C	116417463	116417463	\N	GRCh37
465	7	\N	T	116423413	116423413	\N	GRCh37
466	3	\N	T	37067240	37067240	\N	GRCh37
467	8	\N	C	128750632	128750632	\N	GRCh37
468	8	\N	C	128750639	128750639	\N	GRCh37
469	8	\N	C	128750681	128750681	\N	GRCh37
470	8	\N	C	128750693	128750693	\N	GRCh37
471	8	\N	A	128750765	128750765	\N	GRCh37
472	8	\N	C	128751241	128751241	\N	GRCh37
473	1	\N	C	115258730	115258730	\N	GRCh37
474	1	\N	TG	115256529	115256530	\N	GRCh37
475	4	\N	AGAGAC	55152089	55152094	\N	GRCh37
476	4	\N	GA	55152092	55152093	\N	GRCh37
477	4	\N	G	55152092	55152092	\N	GRCh37
478	4	\N	GACATCATG	55152092	55152100	\N	GRCh37
479	4	\N	GACATCATGCAT	55152092	55152103	\N	GRCh37
480	4	\N	ATCATGCATGAT	55152095	55152106	\N	GRCh37
481	4	\N	G	55152104	55152104	\N	GRCh37
482	3	\N	G	178916876	178916876	\N	GRCh37
483	3	\N	T	178921553	178921553	\N	GRCh37
484	3	\N	T	178927980	178927980	\N	GRCh37
485	3	\N	C	178936074	178936074	\N	GRCh37
486	3	\N	G	178936093	178936093	\N	GRCh37
487	3	\N	A	178938860	178938860	\N	GRCh37
488	3	\N	A	178952007	178952007	\N	GRCh37
489	3	\N	G	178952074	178952074	\N	GRCh37
490	3	\N	G	178952090	178952090	\N	GRCh37
491	5	\N	G	67589138	67589138	\N	GRCh37
492	5	\N	GAA	67589552	67589552	\N	GRCh37
493	5	\N	C	67589618	67589618	\N	GRCh37
494	5	\N	G	67591085	67591085	\N	GRCh37
495	5	\N	GACAAACGTATGAACAGC	67591085	67591102	\N	GRCh37
496	5	\N	A	67591097	67591097	\N	GRCh37
497	5	\N	C	67591099	67591099	\N	GRCh37
498	5	\N	ACG	67591133	67591135	\N	GRCh37
499	5	\N	TGG	67591249	67591249	\N	GRCh37
500	10	\N	C	89711899	89711899	\N	GRCh37
501	10	\N	G	89711900	89711900	\N	GRCh37
502	10	\N	C	89717675	89717675	\N	GRCh37
503	10	\N	C	89720852	89720852	\N	GRCh37
504	13	\N	G	48919244	48919244	\N	GRCh37
505	13	\N	T	48923148	48923148	\N	GRCh37
506	13	\N	C	48941648	48941648	\N	GRCh37
507	13	\N	C	48942685	48942685	\N	GRCh37
508	13	\N	C	48953760	48953760	\N	GRCh37
509	13	\N	C	48955538	48955538	\N	GRCh37
510	13	\N	C	48955550	48955550	\N	GRCh37
511	13	\N	C	49027168	49027168	\N	GRCh37
512	13	\N	G	49037877	49037877	\N	GRCh37
513	13	\N	G	49039164	49039164	\N	GRCh37
514	10	\N	TTCCCTGAGGAGGAGAAGTGCTTCTGC	43609078	43609104	\N	GRCh37
515	10	\N	A	43609940	43609940	\N	GRCh37
516	10	\N	GAGCTG	43609942	43609947	\N	GRCh37
517	10	\N	T	43609948	43609948	\N	GRCh37
518	10	\N	G	43609949	43609949	\N	GRCh37
519	10	\N	G	43613840	43613840	\N	GRCh37
520	10	\N	GC	43615568	43615569	\N	GRCh37
521	10	\N	GATGTTTATGAA	43615613	43615624	\N	GRCh37
522	20	\N	C	36031762	36031762	\N	GRCh37
523	19	\N	C	1207021	1207021	\N	GRCh37
524	19	\N	C	1220415	1220415	\N	GRCh37
525	19	\N	G	1220487	1220487	\N	GRCh37
526	19	\N	A	1220488	1220488	\N	GRCh37
527	19	\N	G	1220494	1220494	\N	GRCh37
528	19	\N	G	1220502	1220502	\N	GRCh37
529	19	\N	C	1221319	1221319	\N	GRCh37
530	19	\N	G	1223059	1223059	\N	GRCh37
531	17	\N	C	7578406	7578406	\N	GRCh37
532	17	\N	C	7577548	7577548	\N	GRCh37
533	17	\N	G	7577539	7577539	\N	GRCh37
534	17	\N	G	7577022	7577022	\N	GRCh37
535	3	\N	C	10183772	10183772	\N	GRCh37
536	3	\N	T	10183785	10183785	\N	GRCh37
537	3	\N	T	10183797	10183797	\N	GRCh37
538	3	\N	T	10191480	10191480	\N	GRCh37
539	3	\N	C	10191488	10191488	\N	GRCh37
540	3	\N	C	10191506	10191506	\N	GRCh37
\.


--
-- Data for Name: mutation_types; Type: TABLE DATA; Schema: public; Owner: acoffman
--

COPY mutation_types (id, name) FROM stdin;
1	missense
2	stop
3	frameshift
4	inframe
5	protein
\.


--
-- Data for Name: sources; Type: TABLE DATA; Schema: public; Owner: acoffman
--

COPY sources (id, name, pubmed_id, citation) FROM stdin;
1	\N	18615627	Jones et al., 2008, Cancer
2	\N	11853795	von Bubnoff et al., 2002, Lancet
3	\N	25157968	MacConaill et al., 2014, J Mol Diagn
4	\N	\N	
5	\N	22772060	Giles et al., 2013, Leukemia
6	\N	22897847	Roberts et al., 2012, Cancer Cell
7	\N	22955920	Maude et al., 2012, Blood
8	\N	21680795	Zhang et al., 2011, Blood
9	\N	19470474	Mullighan et al., 2009, Proc. Natl. Acad. Sci. U.S.A.
10	\N	19838194	Mullighan et al., 2009, Nat. Genet.
11	\N	19139102	Hornakova et al., 2009, J. Biol. Chem.
12	\N	22368270	Man et al., 2012, Blood
13	\N	18805579	Bercovich et al., 2008, Lancet
14	\N	24651453	Drew et al., 2014, Mol. Cancer Res.
15	\N	8187091	Miyaki et al., 1994, Cancer Res.
16	\N	1528264	Powell et al., 1992, Nature
17	\N	23700467	Han et al., 2013, PLoS ONE
18	\N	2281069	Steinbrugger et al., 1990, Pneumologie
19	\N	21901162	Vasovcak et al., 2011, PLoS ONE
20	\N	24861525	Palacio-Rúa et al., Rev Gastroenterol Mex
21	\N	22810696	2012, Nature
22	\N	23204322	Nikolaev et al., 2012, Cancer Res.
23	\N	1338904	Miyoshi et al., 1992, Hum. Mol. Genet.
24	\N	10737795	Rowan et al., 2000, Proc. Natl. Acad. Sci. U.S.A.
25	\N	24518971	Hasanpour et al., 2014, Cell J
26	\N	17704924	Jeon et al., 2008, Int J Colorectal Dis
27	\N	18992635	Bougatef et al., 2008, Cancer Genet. Cytogenet.
28	\N	22848674	Voorham et al., 2012, PLoS ONE
29	\N	12374230	De Filippo et al., 2002, Scand. J. Gastroenterol.
30	\N	17611497	Carpten et al., 2007, Nature
31	\N	20233444	Fumagalli et al., 2010, BMC Cancer
32	\N	18392055	Kim et al., 2008, Br. J. Cancer
33	\N	19537845	De Roock et al., 2009, Mol Diagn Ther
34	\N	21129611	Rizzo et al., 2010, Cancer Treat. Rev.
35	\N	20350999	Tejpar et al., 2010, Oncologist
36	\N	12068308	Davies et al., 2002, Nature
37	\N	21163703	De Roock et al., 2011, Lancet Oncol.
38	\N	20857202	Mao et al., 2011, Mol. Biol. Rep.
39	\N	20413299	Tol et al., 2010, Eur. J. Cancer
40	\N	21426297	Dienstmann et al., 2011, Anticancer Agents Med Chem
41	\N	22281684	Prahallad et al., 2012, Nature
42	\N	22448344	Corcoran et al., 2012, Cancer Discov
43	\N	22180495	Yang et al., 2012, Cancer Res.
44	\N	20619739	De Roock et al., 2010, Lancet Oncol.
45	\N	23325582	Peeters et al., 2013, Clin. Cancer Res.
46	\N	22608338	Falchook et al., 2012, Lancet
47	\N	23251002	Mao et al., 2013, Clin. Cancer Res.
48	\N	23549875	Coffee et al., 2013, Clin. Cancer Res.
49	\N	24107445	Zecchin et al., 2013, Mol. Cancer Ther.
50	\N	24163374	Faber et al., 2014, Cancer Discov
51	\N	22310681	Bardelli et al., 2012, Nat. Med.
52	\N	14678966	Ikenoue et al., 2003, Cancer Res.
53	\N	15035987	Wan et al., 2004, Cell
54	\N	12438234	Yuen et al., 2002, Cancer Res.
55	\N	18186519	Bentivegna et al., 2008, Hum. Mutat.
56	\N	22270724	Montagut et al., 2012, Nat. Med.
57	\N	18316791	Amado et al., 2008, J. Clin. Oncol.
58	\N	19679400	Neumann et al., 2009, Pathol. Res. Pract.
59	\N	16361624	Rothenberg et al., 2005, J. Clin. Oncol.
60	\N	19114683	Bokemeyer et al., 2009, J. Clin. Oncol.
61	\N	21228335	Bokemeyer et al., 2011, Ann. Oncol.
62	\N	20921465	Douillard et al., 2010, J. Clin. Oncol.
63	\N	16618717	Lièvre et al., 2006, Cancer Res.
64	\N	20921462	Peeters et al., 2010, J. Clin. Oncol.
65	\N	22734028	Tejpar et al., 2012, J. Clin. Oncol.
66	\N	20978259	De Roock et al., 2010, JAMA
67	\N	22392911	Migliardi et al., 2012, Clin. Cancer Res.
68	\N	20736745	Irahara et al., 2010, Diagn. Mol. Pathol.
69	\N	21829508	Janku et al., 2011, PLoS ONE
70	\N	21305640	Vaughn et al., 2011, Genes Chromosomes Cancer
71	\N	21729679	De Mattos-Arruda et al., 2011, Clin Colorectal Cancer
72	\N	17699718	Davies et al., 2007, Mol. Cancer Ther.
73	\N	16273091	Solit et al., 2006, Nature
74	\N	15016963	Samuels et al., 2004, Science
75	\N	15647370	Kang et al., 2005, Proc. Natl. Acad. Sci. U.S.A.
76	\N	15254419	Bachman et al., 2004, Cancer Biol. Ther.
77	\N	20453058	O'Brien et al., 2010, Clin. Cancer Res.
78	\N	18725974	She et al., 2008, PLoS ONE
79	\N	22162589	Bendell et al., 2012, J. Clin. Oncol.
80	\N	22162582	Clarke et al., 2012, J. Clin. Oncol.
81	\N	19903786	He et al., 2009, Clin. Cancer Res.
82	\N	19366826	Prenen et al., 2009, Clin. Cancer Res.
83	\N	14715079	De Bosscher et al., 2004, Biochem. J.
84	\N	10479724	Koyama et al., 1999, Mutat. Res.
85	\N	12821112	Miyaki et al., 2003, Biochem. Biophys. Res. Commun.
86	\N	8898652	Takagi et al., 1996, Gastroenterology
87	\N	9679244	Hata et al., 1998, Mol Med Today
88	\N	17994767	Prokova et al., 2007, Biochemistry
89	\N	10775259	Massagué et al., 2000, EMBO J.
90	\N	23582185	Todd et al., 2013, Pigment Cell Melanoma Res
91	\N	21689725	Wasag et al., 2011, Exp. Hematol.
92	\N	17259998	Nakagomi et al., 2007, Lab. Invest.
93	\N	16751810	Tamborini et al., 2006, Oncogene
94	\N	24687822	Serrano et al., 2015, J. Clin. Oncol.
95	\N	19164557	Gajiwala et al., 2009, Proc. Natl. Acad. Sci. U.S.A.
96	\N	14645423	Heinrich et al., 2003, J. Clin. Oncol.
97	\N	15928335	Corless et al., 2005, J. Clin. Oncol.
98	\N	22718859	Cassier et al., 2012, Clin. Cancer Res.
99	\N	16638875	Prenen et al., 2006, Clin. Cancer Res.
100	\N	18794084	Dewaele et al., 2008, Clin. Cancer Res.
101	\N	22745105	Heinrich et al., 2012, Clin. Cancer Res.
102	\N	22160010	Döhner et al., 2011, Hematology Am Soc Hematol Educ Program
103	\N	22898540	McCarthy, 2012, Nat. Rev. Cancer
104	\N	21067377	Ley et al., 2010, N. Engl. J. Med.
105	\N	22898541	Vogt, 2012, Nat. Rev. Cancer
106	\N	22898539	Shih et al., 2012, Nat. Rev. Cancer
107	\N	24656771	Russler-Germain et al., 2014, Cancer Cell
108	\N	24606448	Ahmad et al., 2014, Asian Pac. J. Cancer Prev.
109	\N	22744846	Li et al., 2012, Int. J. Hematol.
110	\N	21518476	Qiao et al., 2011, Zhongguo Shi Yan Xue Ye Xue Za Zhi
111	\N	22504184	Smith et al., 2012, Nature
112	\N	23430109	Smith et al., 2013, Blood
113	\N	24619500	Zhang et al., 2014, Clin. Cancer Res.
114	\N	15667533	Smith et al., 2005, Br. J. Haematol.
115	\N	23261068	Martelli et al., 2013, Blood Rev.
116	\N	23783394	Allen et al., 2013, Leukemia
117	\N	23321257	Jourdan et al., 2013, Blood
118	\N	23714533	Smith et al., 2013, Am Soc Clin Oncol Educ Book
119	\N	22504186	Connors et al., 2012, Ann. Surg.
120	\N	22504183	Eisenhoffer et al., 2012, Nature
121	\N	15256420	Clark et al., 2004, Blood
122	\N	11290608	Yamamoto et al., 2001, Blood
123	\N	19657110	Mardis et al., 2009, N. Engl. J. Med.
124	\N	20733134	Fischer et al., 2010, J. Clin. Oncol.
125	\N	16857985	Knapper et al., 2006, Blood
126	\N	22504185	Wang et al., 2012, Gastroenterology
127	\N	23878140	Opatz et al., 2013, Blood
128	\N	22147895	Kazenwadel et al., 2012, Blood
129	\N	21765025	Dickinson et al., 2011, Blood
130	\N	22417203	Patel et al., 2012, N. Engl. J. Med.
131	\N	22397365	Chotirat et al., 2012, J Hematol Oncol
132	\N	20946881	Zou et al., 2010, Biochem. Biophys. Res. Commun.
133	\N	23949315	Ashraf et al., 2013, Ann. Hematol.
134	\N	23815907	Shang et al., 2013, Zhongguo Shi Yan Xue Ye Xue Za Zhi
135	\N	21436584	Wartman et al., 2011, J. Clin. Invest.
136	\N	24404189	Nagao et al., 2014, PLoS ONE
137	\N	23115274	Paschka et al., 2013, Blood
138	\N	22829971	Novotny-Diermayr et al., 2012, Blood Cancer J
139	\N	22818858	Malak et al., Blood Cells Mol. Dis.
140	\N	22571758	Ismael et al., 2012, Br. J. Haematol.
141	\N	22041374	Yoshiki et al., 2011, Intern. Med.
142	\N	21689158	Roug et al., 2011, Eur. J. Haematol.
143	\N	21120162	Jekarl et al., 2010, Korean J Hematol
144	\N	20339092	Wang et al., 2010, Blood
145	\N	20631743	Passamonti et al., 2010, Leukemia
146	\N	22422826	Eghtedar et al., 2012, Blood
147	\N	24045550	Johnson et al., 2013, Am. J. Clin. Pathol.
148	\N	18986703	Ustun et al., 2009, Leuk. Res.
149	\N	23149070	Mpakou et al., 2013, Leuk. Res.
150	\N	22407852	Sano et al., 2012, Int. J. Hematol.
151	\N	19075190	Tyner et al., 2009, Blood
152	\N	16434492	Bacher et al., 2006, Blood
153	\N	2278970	Vogelstein et al., 1990, Genes Chromosomes Cancer
154	\N	3122217	Janssen et al., 1987, Proc. Natl. Acad. Sci. U.S.A.
155	\N	10508512	Song et al., 1999, Nat. Genet.
156	\N	24659740	Renneville et al., 2014, Oncotarget
157	\N	24616160	Duployez et al., 2014, Am. J. Hematol.
158	\N	24374719	Ismael et al., 2014, Int. J. Hematol.
159	\N	23634996	2013, N. Engl. J. Med.
160	\N	24641375	Zeichner et al., 2014, Asian Pac. J. Cancer Prev.
161	\N	24487413	Kihara et al., 2014, Leukemia
162	\N	24381225	Stoddart et al., 2014, Blood
163	\N	22158538	Graubert et al., 2012, Nat. Genet.
164	\N	24498085	Brooks et al., 2014, PLoS ONE
165	\N	24671364	Christopeit et al., 2014, Ann. Hematol.
166	\N	24667279	Lyu et al., 2014, PLoS ONE
167	\N	24521058	Rein et al., 2014, Expert Opin Investig Drugs
168	\N	24422723	Uttenthal et al., 2014, Br. J. Haematol.
169	\N	24374862	Ujj et al., 2014, Pathol. Oncol. Res.
170	\N	16239216	Staerk et al., 2005, J. Biol. Chem.
171	\N	18397343	Sato et al., 2008, Br. J. Haematol.
172	\N	23676790	Chahardouli et al., 2013, Hematology
173	\N	21895409	Strhakova et al., 2011, Neoplasma
174	\N	21888027	Bagadi et al., 2011, Clin. Lab.
175	\N	20367437	Sharma et al., 2010, Leuk. Lymphoma
176	\N	18223278	Ernst et al., 2008, Haematologica
177	\N	12623848	Branford et al., 2003, Blood
178	\N	12576318	Corbin et al., 2003, Blood
179	\N	12399961	Hochhaus et al., 2002, Leukemia
180	\N	17008892	Gruber et al., 2006, Leukemia
181	\N	21221851	Gruber et al., 2012, Med. Oncol.
182	\N	18354488	Sherbenou et al., 2008, Leukemia
183	\N	21505103	Eide et al., 2011, Cancer Res.
184	\N	11964322	Branford et al., 2002, Blood
185	\N	22870928	Ferri et al., 2013, Leuk. Lymphoma
186	\N	15256422	O'Hare et al., 2004, Blood
187	\N	24109527	McCarron et al., 2013, Case Rep Hematol
188	\N	14745431	Al-Ali et al., 2004, Hematol. J.
189	\N	21562040	Soverini et al., 2011, Blood
190	\N	25152116	Gao et al., 2014, Zhonghua Xue Ye Xue Za Zhi
191	\N	19768693	Kim et al., 2010, Hematol Oncol
192	\N	23575252	Cho et al., 2013, Int J Lab Hematol
193	\N	21489624	Oyekunle et al., 2011, Leuk. Res.
194	\N	19811824	Faber et al., 2010, Leuk. Res.
195	\N	23656643	Maxson et al., 2013, N. Engl. J. Med.
196	\N	22072639	Bresler et al., 2011, Sci Transl Med
197	\N	21838707	Schönherr et al., 2011, Biochem. J.
198	\N	24657128	Wakuda et al., 2014, Lung Cancer
199	\N	24986690	Rumi et al., 2014, Blood
200	\N	20151976	Boyd et al., 2010, Br. J. Haematol.
201	\N	18528423	Chaligné et al., 2008, Leukemia
202	\N	23213094	Choueiri et al., 2013, J. Clin. Oncol.
203	\N	23610116	Diamond et al., 2013, J. Clin. Oncol.
204	\N	24631838	Grabiner et al., 2014, Cancer Discov
205	\N	24622468	Voss et al., 2014, Clin. Cancer Res.
206	\N	24625776	Wagle et al., 2014, Cancer Discov
207	\N	22980975	Imielinski et al., 2012, Cell
208	\N	18948947	Ding et al., 2008, Nature
209	\N	22277784	Katayama et al., 2012, Sci Transl Med
210	\N	24670165	Shaw et al., 2014, N. Engl. J. Med.
211	\N	24327273	Chen et al., 2014, Clin. Cancer Res.
212	\N	24569458	Imielinski et al., 2014, J. Clin. Invest.
213	\N	22773810	Ohashi et al., 2012, Proc. Natl. Acad. Sci. U.S.A.
214	\N	22908275	Greulich et al., 2012, Proc. Natl. Acad. Sci. U.S.A.
215	\N	23724914	Awad et al., 2013, N. Engl. J. Med.
216	\N	23728071	Trigka et al., 2013, Oncol. Rep.
217	\N	21479466	Sasaki et al., Mol Med Rep
218	\N	18504432	Bleeker et al., 2008, Oncogene
219	\N	18611285	Do et al., 2008, BMC Res Notes
220	\N	18256540	Malanga et al., 2008, Cell Cycle
221	\N	15118073	Lynch et al., 2004, N. Engl. J. Med.
222	\N	15118125	Paez et al., 2004, Science
223	\N	15329413	Pao et al., 2004, Proc. Natl. Acad. Sci. U.S.A.
224	\N	19922469	Mitsudomi et al., 2010, FEBS J.
225	\N	15710947	Han et al., 2005, J. Clin. Oncol.
226	\N	16011858	Rosell et al., 2005, Lung Cancer
227	\N	16115929	Taron et al., 2005, Clin. Cancer Res.
228	\N	20479403	Sequist et al., 2010, J. Clin. Oncol.
229	\N	22753918	Ramalingam et al., 2012, J. Clin. Oncol.
230	\N	23102728	Huang et al., 2013, Mol Oncol
231	\N	16912157	Inukai et al., 2006, Cancer Res.
232	\N	15728811	Kobayashi et al., 2005, N. Engl. J. Med.
233	\N	15737014	Pao et al., 2005, PLoS Med.
234	\N	21430269	Sequist et al., 2011, Sci Transl Med
235	\N	21194487	Watanabe et al., 2011, BMC Cancer
236	\N	21531810	Wu et al., 2011, Clin. Cancer Res.
237	\N	20068085	Girard et al., 2010, Clin. Cancer Res.
238	\N	16258541	Bell et al., 2005, Nat. Genet.
239	\N	22588155	Oxnard et al., 2012, J Thorac Oncol
240	\N	22452896	Miller et al., 2012, Lancet Oncol.
241	\N	23816963	Katakami et al., 2013, J. Clin. Oncol.
242	\N	24729716	Li et al., 2014, Onco Targets Ther
243	\N	21670455	Fukuoka et al., 2011, J. Clin. Oncol.
244	\N	20573926	Maemondo et al., 2010, N. Engl. J. Med.
245	\N	20022809	Mitsudomi et al., 2010, Lancet Oncol.
246	\N	19692680	Mok et al., 2009, N. Engl. J. Med.
247	\N	19692684	Rosell et al., 2009, N. Engl. J. Med.
248	\N	22285168	Rosell et al., 2012, Lancet Oncol.
249	\N	23816960	Sequist et al., 2013, J. Clin. Oncol.
250	\N	22452895	Yang et al., 2012, Lancet Oncol.
251	\N	21783417	Zhou et al., 2011, Lancet Oncol.
252	\N	19096302	Kosaka et al., 2009, J Thorac Oncol
253	\N	18303429	Marks et al., 2008, J Thorac Oncol
254	\N	23948351	Shi et al., 2013, Lancet Oncol.
255	\N	12460918	Brose et al., 2002, Cancer Res.
256	\N	18794081	Riely et al., 2008, Clin. Cancer Res.
257	\N	18632602	Marks et al., 2008, Cancer Res.
258	\N	7651428	Bottorff et al., 1995, Mol. Cell. Biol.
259	\N	18060073	Estep et al., 2007, PLoS ONE
260	\N	23515407	Ohashi et al., 2013, Clin. Cancer Res.
261	\N	24370118	Bar et al., 2014, Clin Lung Cancer
262	\N	16930767	Kawano et al., 2006, Lung Cancer
263	\N	19513541	Zou et al., 2009, Int. J. Mol. Med.
264	\N	19029981	Engelman et al., 2008, Nat. Med.
265	\N	16906227	Engelman et al., 2006, J. Clin. Invest.
266	\N	20018398	Jin et al., 2010, Lung Cancer
267	\N	9598803	Kohno et al., 1998, Genes Chromosomes Cancer
268	\N	20881644	Lee et al., 2010, J Thorac Oncol
269	\N	10555148	Lee et al., 1999, Cell
270	\N	20085938	Courtney et al., 2010, J. Clin. Oncol.
271	\N	11504908	Neshat et al., 2001, Proc. Natl. Acad. Sci. U.S.A.
272	\N	19351834	Sos et al., 2009, Cancer Res.
273	\N	22328973	Hammerman et al., 2011, Cancer Discov
274	\N	20360610	Faoro et al., 2010, J. Biol. Chem.
275	\N	23786770	Liao et al., 2013, Cancer Res.
276	\N	23348505	Clark et al., 2013, Science
277	\N	18559612	Verstovsek et al., 2008, Clin. Cancer Res.
278	\N	24190505	Joseph et al., 2014, Genes Chromosomes Cancer
279	\N	22357254	Schirosi et al., 2012, Ann. Oncol.
280	\N	21325067	Kong et al., 2011, Clin. Cancer Res.
281	\N	21969494	Buti et al., 2011, J. Clin. Oncol.
282	\N	23375402	Rossi et al., 2013, Lung Cancer
283	\N	12960119	Antonescu et al., 2003, Clin. Cancer Res.
284	\N	20736294	Rossi et al., 2010, Mol. Cancer Res.
285	\N	19861435	Girard et al., 2009, Clin. Cancer Res.
286	\N	15201427	Ströbel et al., 2004, N. Engl. J. Med.
287	\N	17372901	Antonescu et al., 2007, Int. J. Cancer
288	\N	15930355	Antonescu et al., 2005, Clin. Cancer Res.
289	\N	22184391	van Gaal et al., 2012, J. Clin. Oncol.
290	\N	24124571	Li et al., 2013, PLoS ONE
291	\N	19853286	Cohen et al., 2010, Gynecol. Oncol.
292	\N	22885469	Leslie et al., 2012, Gynecol. Oncol.
293	\N	23908597	Byron et al., 2013, Neoplasia
294	\N	18552176	Dutt et al., 2008, Proc. Natl. Acad. Sci. U.S.A.
295	\N	22238366	Gozgit et al., 2012, Mol. Cancer Ther.
296	\N	23002168	Guagnano et al., 2012, Cancer Discov
297	\N	21984976	Cheung et al., 2011, Cancer Discov
298	\N	23696637	Javadi et al., 2013, J. Biol. Chem.
299	\N	18971950	Chase et al., 2009, Leukemia
300	\N	16834459	Pikman et al., 2006, PLoS Med.
301	\N	19726788	Yauch et al., 2009, Science
302	\N	22679179	Rudin, 2012, Clin. Cancer Res.
303	\N	21683865	Kurman et al., 2011, Hum. Pathol.
304	\N	21975775	Haldar et al., 2011, Cochrane Database Syst Rev
305	\N	20818844	Flaherty et al., 2010, N. Engl. J. Med.
306	\N	21639808	Chapman et al., 2011, N. Engl. J. Med.
307	\N	19018267	Nakayama et al., 2008, Br. J. Cancer
308	\N	22798288	Dahlman et al., 2012, Cancer Discov
309	\N	22271473	Janku et al., 2012, J. Clin. Oncol.
310	\N	18767981	Chalhoub et al., 2009, Annu Rev Pathol
311	\N	18451306	Beer et al., 2008, Blood
312	\N	23970983	Morrell et al., 2013, Case Rep Hematol
313	\N	21228032	Pietra et al., 2011, Haematologica
314	\N	19608689	Liu et al., 2009, Haematologica
315	\N	24265152	Shi et al., 2014, Cancer Discov
316	\N	23248257	Kim et al., 2013, J. Clin. Oncol.
317	\N	14679157	Maldonado et al., 2003, J. Natl. Cancer Inst.
318	\N	22356324	Sosman et al., 2012, N. Engl. J. Med.
319	\N	22663011	Flaherty et al., 2012, N. Engl. J. Med.
320	\N	22805292	Falchook et al., 2012, Lancet Oncol.
321	\N	22048237	Kirkwood et al., 2012, Clin. Cancer Res.
322	\N	22972589	Patel et al., 2013, Cancer
323	\N	20630094	Rubinstein et al., 2010, J Transl Med
324	\N	23020132	Flaherty et al., 2012, N. Engl. J. Med.
325	\N	22735384	Hauschild et al., 2012, Lancet
326	\N	20551065	Yang et al., 2010, Cancer Res.
327	\N	22536370	Lovly et al., 2012, PLoS ONE
328	\N	19404918	Boulalas et al., Int. J. Biol. Markers
329	\N	22389471	Greger et al., 2012, Mol. Cancer Ther.
330	\N	21156289	Villanueva et al., 2010, Cancer Cell
331	\N	22351686	Paraiso et al., 2012, Clin. Cancer Res.
332	\N	22997239	Jalili et al., 2012, J. Natl. Cancer Inst.
333	\N	23614898	Morris et al., 2013, Cancer Discov
334	\N	23237741	Klein et al., 2013, Eur. J. Cancer
335	\N	11861307	Hofmann et al., 2002, Blood
336	\N	23934607	Neumann et al., 2013, Virchows Arch.
337	\N	19561230	Agaimy et al., 2009, J. Clin. Pathol.
338	\N	23470635	Falchook et al., 2013, Oncotarget
339	\N	23395771	Yang et al., 2013, Clin. Biochem.
340	\N	19652056	Hughes et al., 2009, J. Clin. Oncol.
341	\N	19466505	Doi et al., 2009, Int. J. Hematol.
342	\N	15381060	Sorel et al., 2004, Biochem. Biophys. Res. Commun.
343	\N	14559829	von Bubnoff et al., 2003, Cancer Res.
344	\N	24456693	Elias et al., 2014, Leuk. Res.
345	\N	20697894	Qin et al., 2011, Ann. Hematol.
346	\N	22210874	Parker et al., 2012, Blood
347	\N	24236021	Tanneeru et al., 2013, PLoS ONE
348	\N	22912393	Cai et al., 2012, Clin. Cancer Res.
349	\N	15194504	Yamamoto et al., 2004, Biochem. Biophys. Res. Commun.
350	\N	11423618	Gorre et al., 2001, Science
351	\N	11567109	Barthe et al., 2001, Science
352	\N	21509757	Jabbour et al., 2011, Cancer
353	\N	18757400	Cramer et al., 2008, Cancer Res.
354	\N	11569495	Hochhaus et al., 2001, Science
355	\N	19264234	Park et al., 2009, Cancer Genet. Cytogenet.
356	\N	19164531	Iacob et al., 2009, Proc. Natl. Acad. Sci. U.S.A.
357	\N	15510211	Piazza et al., 2005, Leukemia
358	\N	23540562	Chahardouli et al., 2013, Hematology
359	\N	23355941	Elias et al., 2012, Hematol Rep
360	\N	22306673	Yin et al., 2012, Diagn. Mol. Pathol.
361	\N	21762985	Soverini et al., 2011, Leuk. Res.
362	\N	20512393	Manrique Arechavaleta et al., 2011, Clin. Exp. Med.
363	\N	20963643	Minami et al., 2010, Int. J. Hematol.
364	\N	12130516	Roche-Lestienne et al., 2002, Blood
365	\N	21872826	Paquette et al., 2011, Cancer Genet
366	\N	17114651	Soverini et al., 2006, J. Clin. Oncol.
367	\N	18828913	Cang et al., 2008, J Hematol Oncol
368	\N	21605905	Eskazan et al., 2011, Leuk. Res.
369	\N	19557636	Mascarenhas et al., 2009, Leuk. Lymphoma
370	\N	20607847	Schnittger et al., 2010, Genes Chromosomes Cancer
371	\N	20557306	Yin et al., 2010, Cancer Sci.
372	\N	12783380	Roche-Lestienne et al., 2003, Semin. Hematol.
373	\N	17189410	Soverini et al., 2006, Clin. Cancer Res.
374	\N	20702476	Bennour et al., 2010, J. Clin. Pathol.
375	\N	20010464	Lewandowski et al., 2009, Pol. Arch. Med. Wewn.
376	\N	18448188	Yoh et al., 2008, Lung Cancer
377	\N	20970876	Dişel et al., 2011, Lung Cancer
378	\N	19461405	Bisagni et al., 2009, J Thorac Oncol
379	\N	17699867	Guo et al., 2007, Clin. Cancer Res.
380	\N	23680147	Jaiswal et al., 2013, Cancer Cell
381	\N	19907440	Chapiro et al., 2010, Leukemia
382	\N	19965641	Hertzberg et al., 2010, Blood
383	\N	20018760	Yoda et al., 2010, Proc. Natl. Acad. Sci. U.S.A.
384	\N	22368272	Chen et al., 2012, Blood
385	\N	19357396	Preudhomme et al., 2009, Blood
386	\N	23833300	Cardarella et al., 2013, Clin. Cancer Res.
387	\N	12460919	Naoki et al., 2002, Cancer Res.
388	\N	21483012	Paik et al., 2011, J. Clin. Oncol.
389	\N	19010912	Pratilas et al., 2008, Cancer Res.
390	\N	22649091	Sen et al., 2012, Sci Transl Med
391	\N	19238210	Gandhi et al., 2009, PLoS ONE
392	\N	23715574	Bahadoran et al., 2013, J. Clin. Oncol.
393	\N	18794803	Smalley et al., 2009, Oncogene
394	\N	19718025	Prickett et al., 2009, Nat. Genet.
395	\N	21083380	Van Raamsdonk et al., 2010, N. Engl. J. Med.
396	\N	2549426	Landis et al., 1989, Nature
397	\N	1328859	Kalinec et al., 1992, Mol. Cell. Biol.
398	\N	22733540	Khalili et al., 2012, Clin. Cancer Res.
399	\N	22808163	Ho et al., 2012, PLoS ONE
400	\N	18719078	Onken et al., 2008, Invest. Ophthalmol. Vis. Sci.
401	\N	19078957	Van Raamsdonk et al., 2009, Nature
402	\N	22653968	Wu et al., 2012, Mol. Cancer Ther.
403	\N	22253748	Wu et al., 2012, PLoS ONE
404	\N	20088873	Handolias et al., 2010, Pigment Cell Melanoma Res
405	\N	21642685	Carvajal et al., 2011, JAMA
406	\N	23775962	Hodi et al., 2013, J. Clin. Oncol.
407	\N	23569304	Trunzer et al., 2013, J. Clin. Oncol.
408	\N	19915144	Emery et al., 2009, Proc. Natl. Acad. Sci. U.S.A.
409	\N	23444215	Catalanotti et al., 2013, Clin. Cancer Res.
410	\N	22197931	Nikolaev et al., 2012, Nat. Genet.
411	\N	22588879	Shi et al., 2012, Cancer Discov
412	\N	21383288	Wagle et al., 2011, J. Clin. Oncol.
413	\N	24448821	Narita et al., 2014, Mol. Cancer Ther.
414	\N	21107320	Johannessen et al., 2010, Nature
415	\N	24265153	Van Allen et al., 2014, Cancer Discov
416	\N	24265154	Wagle et al., 2014, Cancer Discov
417	\N	8120410	Ball et al., 1994, J. Invest. Dermatol.
418	\N	16291983	Curtin et al., 2005, N. Engl. J. Med.
419	\N	2674680	van 't Veer et al., 1989, Mol. Cell. Biol.
420	\N	20130576	Hatzivassiliou et al., 2010, Nature
421	\N	20179705	Poulikakos et al., 2010, Nature
422	\N	23414587	Ascierto et al., 2013, Lancet Oncol.
423	\N	18390968	Adjei et al., 2008, J. Clin. Oncol.
424	\N	22761467	Martinez-Garcia et al., 2012, Clin. Cancer Res.
425	\N	23538902	Haarberg et al., 2013, Mol. Cancer Ther.
426	\N	21107323	Nazarian et al., 2010, Nature
427	\N	24132921	Dai et al., 2013, Clin. Cancer Res.
428	\N	23737487	Antony et al., 2013, Cancer Res.
429	\N	21189378	Klümpen et al., 2011, J. Clin. Oncol.
430	\N	19255327	Kloos et al., 2009, J. Clin. Oncol.
431	\N	19773371	Hoftijzer et al., 2009, Eur. J. Endocrinol.
432	\N	18541894	Gupta-Abramson et al., 2008, J. Clin. Oncol.
433	\N	20368568	Lam et al., 2010, J. Clin. Oncol.
434	\N	23489023	Kim et al., 2013, Thyroid
435	\N	22241789	Hayes et al., 2012, Clin. Cancer Res.
436	\N	23406027	Ho et al., 2013, N. Engl. J. Med.
437	\N	20065189	Wells et al., 2010, J. Clin. Oncol.
438	\N	22025146	Wells et al., 2012, J. Clin. Oncol.
439	\N	21470995	Verbeek et al., 2011, J. Clin. Endocrinol. Metab.
440	\N	23056499	Couto et al., 2012, PLoS ONE
441	\N	9681850	Santoro et al., 1998, J. Intern. Med.
442	\N	20847059	Carr et al., 2010, Clin. Cancer Res.
443	\N	21455200	Sherman, 2011, Mod. Pathol.
444	\N	23932362	Pitini et al., 2013, Lung Cancer
445	\N	18938156	Day et al., 2008, Eur. J. Pharmacol.
446	\N	21835143	Nault et al., 2012, J. Hepatol.
447	\N	17483355	Zou et al., 2007, Cancer Res.
448	\N	21464312	Jo et al., 2011, Proc. Natl. Acad. Sci. U.S.A.
449	\N	24869598	Woyach et al., 2014, N. Engl. J. Med.
450	\N	23220880	Bose et al., 2013, Cancer Discov
451	\N	16397024	Lee et al., 2006, Clin. Cancer Res.
452	\N	24185512	Toy et al., 2013, Nat. Genet.
453	\N	24185510	Robinson et al., 2013, Nat. Genet.
454	\N	24398047	Jeselsohn et al., 2014, Clin. Cancer Res.
455	\N	22743296	Gautschi et al., 2012, J Thorac Oncol
456	\N	23524406	Rudin et al., 2013, J Thorac Oncol
457	\N	22038996	Nicolaides et al., 2011, Clin. Cancer Res.
458	\N	22586120	Huillard et al., 2012, Proc. Natl. Acad. Sci. U.S.A.
459	\N	17177598	Lee et al., 2006, PLoS Med.
460	\N	23558169	Rohle et al., 2013, Science
461	\N	23578570	Bahassi et al., 2013, Eur. J. Cancer
462	\N	24934779	Ganesan et al., 2016, J. Clin. Oncol.
463	\N	21274259	Murray et al., 2010, J Oncol
464	\N	23612012	Andrulis et al., 2013, Cancer Discov
465	\N	19331127	Guan et al., 2009, Anticancer Res.
466	\N	21273588	Otsuka et al., 2011, Anticancer Res.
467	\N	22869148	Chell et al., 2013, Oncogene
468	\N	23023262	Knutson et al., 2012, Nat. Chem. Biol.
469	\N	24563539	Knutson et al., 2014, Mol. Cancer Ther.
470	\N	21179087	Ngo et al., 2011, Nature
471	\N	22538770	Santarpia et al., 2012, Breast Cancer Res. Treat.
472	\N	22722201	Stephens et al., 2012, Nature
473	\N	21512767	Boyault et al., 2012, Breast Cancer Res. Treat.
474	\N	19487299	Ricarte-Filho et al., 2009, Cancer Res.
475	\N	19418217	Dunlap et al., 2010, Breast Cancer Res. Treat.
476	\N	23237847	Yi et al., 2013, Oncotarget
477	\N	22722839	Grasso et al., 2012, Nature
478	\N	22610119	Barbieri et al., 2012, Nat. Genet.
479	\N	16094359	Parsons et al., 2005, Nature
480	\N	24918823	Carlino et al., 2014, Br. J. Cancer
481	\N	23273605	Greaves et al., 2013, J Mol Diagn
482	\N	16096377	Libra et al., 2005, Cell Cycle
483	\N	24446311	Zhang et al., 2014, Am. J. Hematol.
484	\N	24926260	Shackelford et al., 2014, Case Rep Oncol
485	\N	24710085	Chiappetta et al., 2015, Appl. Immunohistochem. Mol. Morphol.
486	\N	24345920	Hutchinson et al., 2013, Clin. Cancer Res.
487	\N	2493360	Müller-Gärtner et al., 1989, Chirurg
488	\N	23317446	Gentilcore et al., 2013, BMC Cancer
489	\N	23918947	Ascierto et al., 2013, J. Clin. Oncol.
490	\N	24508103	McArthur et al., 2014, Lancet Oncol.
491	\N	23031422	Ponti et al., 2012, J Hematol Oncol
492	\N	21609436	Niehr et al., 2011, J Transl Med
493	\N	19234609	Halaban et al., 2009, PLoS ONE
494	\N	24788118	Hamada et al., 2014, PLoS ONE
495	\N	2302402	Schick et al., 1990, Biochim. Biophys. Acta
496	\N	23242437	Kobayashi et al., 2013, J Thorac Oncol
497	\N	18458038	Sequist et al., 2008, J. Clin. Oncol.
498	\N	18199554	Gilmer et al., 2008, Cancer Res.
499	\N	19671738	Tam et al., 2009, Mol. Cancer Ther.
500	\N	23945392	Berge et al., 2013, J Thorac Oncol
501	\N	16204070	Jiang et al., 2005, Cancer Res.
502	\N	16187797	Greulich et al., 2005, PLoS Med.
503	\N	23485129	Massarelli et al., 2013, Lung Cancer
504	\N	19455431	Rajasekaran et al., 2010, Appl. Biochem. Biotechnol.
505	\N	19147750	Kancha et al., 2009, Clin. Cancer Res.
506	\N	21531084	Uribe et al., 2011, Pathol. Res. Pract.
507	\N	20415598	Cassell et al., 2010, Expert Opin Investig Drugs
508	\N	22622260	Lee et al., 2012, Lung Cancer
509	\N	18089823	Engelman et al., 2007, Cancer Res.
510	\N	23800712	Wheler et al., 2013, Oncotarget
511	\N	17545553	Toyooka et al., 2007, Clin. Cancer Res.
512	\N	16730855	Tokumo et al., 2006, Lung Cancer
513	\N	16707764	Guo et al., 2006, N. Engl. J. Med.
514	\N	17653080	Fu et al., 2008, Oncogene
515	\N	18628075	González Manzano et al., 2008, Clin Transl Oncol
516	\N	20033049	Zhou et al., 2009, Nature
517	\N	22215752	Su et al., 2012, J. Clin. Oncol.
518	\N	21233402	Rosell et al., 2011, Clin. Cancer Res.
519	\N	21718596	Chen et al., 2011, Chin J Cancer
520	\N	22046346	Kancha et al., 2011, PLoS ONE
521	\N	18413839	Trowe et al., 2008, Clin. Cancer Res.
522	\N	24516025	Ali et al., 2014, J. Clin. Oncol.
523	\N	21367659	Greulich et al., 2011, Trends Mol Med
524	\N	19381019	Qing et al., 2009, J. Clin. Invest.
525	\N	15374878	Brown et al., 2005, Blood
526	\N	14604974	Bagrintseva et al., 2004, Blood
527	\N	17047150	Piloto et al., 2007, Blood
528	\N	24046014	Zimmerman et al., 2013, Blood
529	\N	17606455	Mathews et al., 2007, Haematologica
530	\N	17889720	Kancha et al., 2007, Exp. Hematol.
531	\N	24141786	Chen et al., 2014, Oncogene
532	\N	21444680	Patel et al., 2011, Clin. Cancer Res.
533	\N	16478791	Park et al., 2006, J. Cell. Sci.
534	\N	20859122	Girard, 2010, J Thorac Oncol
535	\N	22256804	Su et al., 2012, N. Engl. J. Med.
536	\N	22726224	Anforth et al., 2012, Pigment Cell Melanoma Res
537	\N	19798509	Capper et al., 2009, Acta Neuropathol.
538	\N	19818334	Kato et al., 2009, Biochem. Biophys. Res. Commun.
539	\N	21352804	Kaneko et al., 2011, Biochem. Biophys. Res. Commun.
540	\N	23558173	Wang et al., 2013, Science
541	\N	21250968	Pichler et al., 2011, Br. J. Haematol.
542	\N	16293597	Campbell et al., 2006, Blood
543	\N	20372971	Quintás-Cardama et al., 2011, Invest New Drugs
544	\N	22271575	Weigert et al., 2012, J. Exp. Med.
545	\N	20385788	Tyner et al., 2010, Blood
546	\N	19812602	Terheyden et al., 2010, J. Invest. Dermatol.
547	\N	21159146	McDonnell et al., 2011, Pigment Cell Melanoma Res
548	\N	16046538	Carter et al., 2005, Proc. Natl. Acad. Sci. U.S.A.
549	\N	16624552	Debiec-Rychter et al., 2006, Eur. J. Cancer
550	\N	19175693	Tefferi, 2009, J. Cell. Mol. Med.
551	\N	19671763	Woodman et al., 2009, Mol. Cancer Ther.
552	\N	16397263	Schittenhelm et al., 2006, Cancer Res.
553	\N	19737976	Bougherara et al., 2009, Mol. Cancer Res.
554	\N	17824795	Graham et al., 2007, Arch. Pathol. Lab. Med.
555	\N	11526490	Tuveson et al., 2001, Oncogene
556	\N	15685537	Debiec-Rychter et al., 2005, Gastroenterology
557	\N	17363509	Roberts et al., 2007, Mol. Cancer Ther.
558	\N	15236194	Tamborini et al., 2004, Gastroenterology
559	\N	20147452	DiNitto et al., 2010, J. Biochem.
560	\N	15972446	Gotlib et al., 2005, Blood
561	\N	18024392	Gleixner et al., 2007, Haematologica
562	\N	16912224	Pan et al., 2007, Blood
563	\N	15790786	Growney et al., 2005, Blood
564	\N	22282465	Miranda et al., 2012, Clin. Cancer Res.
565	\N	23182985	Peeters et al., 2013, J. Clin. Oncol.
566	\N	25044103	Chaft et al., 2014, Clin Lung Cancer
567	\N	22722830	Misale et al., 2012, Nature
568	\N	18594010	Koivunen et al., 2008, Clin. Cancer Res.
569	\N	22897852	Maraver et al., 2012, Cancer Cell
570	\N	22235099	Doebele et al., 2012, Clin. Cancer Res.
571	\N	21398618	Lee et al., 2011, J. Natl. Cancer Inst.
572	\N	19881948	Oikonomou et al., 2009, Neoplasia
573	\N	24558511	Kumar et al., 2014, Gastrointest Cancer Res
574	\N	24628546	Isham et al., 2014, J. Clin. Endocrinol. Metab.
575	\N	24740626	Jeng et al., 2014, Pediatr Blood Cancer
576	\N	18829470	Toschi et al., 2008, Clin. Cancer Res.
577	\N	11750879	Maulik et al., 2002, Cytokine Growth Factor Rev.
578	\N	24121490	Miyajima et al., 2013, Cancer Res.
579	\N	25823662	Chiu et al., 2015, Oncotarget
580	\N	24553387	Misale et al., 2014, Sci Transl Med
581	\N	22144181	Xu et al., 2012, Blood
582	\N	23134356	Callahan et al., 2012, N. Engl. J. Med.
583	\N	23431193	Posch et al., 2013, Proc. Natl. Acad. Sci. U.S.A.
584	\N	22962325	Wilmott et al., 2012, Mol. Cancer Ther.
585	\N	23076151	Kaplan et al., 2012, J. Biol. Chem.
586	\N	20406486	Søndergaard et al., 2010, J Transl Med
587	\N	20149136	Halaban et al., 2010, Pigment Cell Melanoma Res
588	\N	16954519	Heinrich et al., 2006, J. Clin. Oncol.
589	\N	17087936	Weisberg et al., 2006, Gastroenterology
590	\N	23066039	Janku et al., 2013, Cancer Res.
591	\N	24265155	Shi et al., 2014, Cancer Discov
592	\N	23408298	Fury et al., 2013, Cancer
593	\N	15805248	Saal et al., 2005, Cancer Res.
594	\N	15930273	Ikenoue et al., 2005, Cancer Res.
595	\N	21824802	Cohen et al., 2011, Oral Oncol.
596	\N	19962457	Gabelli et al., 2010, Biochim. Biophys. Acta
597	\N	24459181	Liu et al., 2014, Cancer Res.
598	\N	11274365	Wen et al., 2001, Proc. Natl. Acad. Sci. U.S.A.
599	\N	24721394	Xu et al., 2014, Transl Oncol
600	\N	25754945	Sagi et al., 2015, Fam. Cancer
601	\N	15184865	Carlomagno et al., 2004, Oncogene
602	\N	20943719	Vitagliano et al., 2011, Endocr. Relat. Cancer
603	\N	11351254	Frisk et al., 2001, Int. J. Oncol.
604	\N	11101847	Stiewe et al., 2000, Nat. Genet.
605	\N	18391940	Kawauchi et al., 2008, Nat. Cell Biol.
606	\N	17015838	Joerger et al., 2006, Proc. Natl. Acad. Sci. U.S.A.
607	\N	24651012	Muller et al., 2014, Cancer Cell
608	\N	15004724	Chan et al., 2004, Cancer Chemother. Pharmacol.
609	\N	20013323	Ikezoe et al., 2010, Int. J. Hematol.
610	\N	11921283	Kondo et al., 2002, Genes Chromosomes Cancer
611	\N	7660122	Duan et al., 1995, Science
\.


--
-- Data for Name: transcripts; Type: TABLE DATA; Schema: public; Owner: acoffman
--

COPY transcripts (id, name, source, version) FROM stdin;
1	ENST00000369535	ensembl	74_37
2	ENST00000367921	ensembl	74_37
3	ENST00000355710	ensembl	74_37
4	ENST00000371953	ensembl	74_37
5	ENST00000311189	ensembl	74_37
6	ENST00000256078	ensembl	74_37
7	ENST00000380982	ensembl	74_37
8	ENST00000349310	ensembl	74_37
9	ENST00000261609	ensembl	74_37
10	ENST00000307102	ensembl	74_37
11	ENST00000330062	ensembl	74_37
12	ENST00000269571	ensembl	74_37
13	ENST00000342988	ensembl	74_37
14	ENST00000078429	ensembl	74_37
15	ENST00000345146	ensembl	74_37
16	ENST00000264709	ensembl	74_37
17	ENST00000389048	ensembl	74_37
18	ENST00000263967	ensembl	74_37
19	ENST00000349496	ensembl	74_37
20	ENST00000257290	ensembl	74_37
21	ENST00000288135	ensembl	74_37
22	ENST00000249373	ensembl	74_37
23	ENST00000288602	ensembl	74_37
24	ENST00000496384	ensembl	74_37
25	ENST00000275493	ensembl	74_37
26	ENST00000381652	ensembl	74_37
27	ENST00000286548	ensembl	74_37
28	ENST00000381567	ensembl	74_37
29	ENST00000373103	ensembl	74_37
30	ENST00000332351	ensembl	74_37
31	ENST00000269305	ensembl	74_37
32	ENST00000335508	ensembl	74_37
33	ENST00000300305	ensembl	74_37
34	ENST00000291552	ensembl	74_37
35	ENST00000341105	ensembl	74_37
36	ENST00000296930	ensembl	74_37
37	ENST00000372348	ensembl	74_37
38	ENST00000303115	ensembl	74_37
39	ENST00000342505	ensembl	74_37
40	ENST00000458235	ensembl	74_37
41	ENST00000318493	ensembl	74_37
42	ENST00000361445	ensembl	74_37
43	ENST00000377045	ensembl	74_37
44	ENST00000368508	ensembl	74_37
45	ENST00000358432	ensembl	74_37
46	ENST00000457416	ensembl	74_37
47	ENST00000292408	ensembl	74_37
48	ENST00000222254	ensembl	74_37
49	ENST00000264033	ensembl	74_37
50	ENST00000286301	ensembl	74_37
51	ENST00000372470	ensembl	74_37
52	ENST00000267101	ensembl	74_37
53	ENST00000342788	ensembl	74_37
54	ENST00000262948	ensembl	74_37
55	ENST00000442415	ensembl	74_37
56	ENST00000326873	ensembl	74_37
57	ENST00000354359	ensembl	74_37
58	ENST00000308731	ensembl	74_37
59	ENST00000206249	ensembl	74_37
60	ENST00000359376	ensembl	74_37
61	ENST00000320356	ensembl	74_37
62	ENST00000417037	ensembl	74_37
63	ENST00000257430	ensembl	74_37
64	ENST00000392038	ensembl	74_37
65	ENST00000257904	ensembl	74_37
66	ENST00000446177	ensembl	74_37
67	ENST00000361570	ensembl	74_37
68	ENST00000425967	ensembl	74_37
69	ENST00000340107	ensembl	74_37
70	ENST00000231790	ensembl	74_37
71	ENST00000377970	ensembl	74_37
72	ENST00000396611	ensembl	74_37
73	ENST00000267163	ensembl	74_37
74	ENST00000360723	ensembl	74_37
75	ENST00000256474	ensembl	74_37
\.


--
-- Data for Name: variant_types; Type: TABLE DATA; Schema: public; Owner: acoffman
--

COPY variant_types (id, name) FROM stdin;
1	SNP
2	DEL
3	INS
4	DNP
\.


--
-- Data for Name: variants; Type: TABLE DATA; Schema: public; Owner: acoffman
--

COPY variants (id, cdna_change, variant, strand, location_id, variant_type_id, amino_acid_id, gene_id, mutation_type_id, hgvs, transcript_id, batch_id, civic_url) FROM stdin;
1	c.183	A	-1	1	1	1	1	1	ENST00000369535:c.183A>T	1	1	\N
2	c.182	A	-1	2	1	2	1	1	ENST00000369535:c.182A>T	1	1	\N
3	c.181	C	-1	3	1	3	1	1	ENST00000369535:c.181C>G	1	1	\N
4	c.181	T	-1	3	1	4	1	1	ENST00000369535:c.181C>A	1	1	\N
5	c.38	A	-1	4	1	5	1	1	ENST00000369535:c.38G>T	1	1	\N
6	c.38	G	-1	4	1	6	1	1	ENST00000369535:c.38G>C	1	1	\N
7	c.38	T	-1	4	1	7	1	1	ENST00000369535:c.38G>A	1	1	\N
8	c.37	A	-1	5	1	8	1	1	ENST00000369535:c.37G>T	1	1	\N
9	c.37	G	-1	5	1	9	1	1	ENST00000369535:c.37G>C	1	1	\N
10	c.35	A	-1	6	1	10	1	1	ENST00000369535:c.35G>T	1	1	\N
11	c.35	G	-1	6	1	11	1	1	ENST00000369535:c.35G>C	1	1	\N
12	c.35	T	-1	6	1	12	1	1	ENST00000369535:c.35G>A	1	1	\N
13	c.34	A	-1	7	1	13	1	1	ENST00000369535:c.34G>T	1	1	\N
14	c.34	G	-1	7	1	14	1	1	ENST00000369535:c.34G>C	1	1	\N
15	c.34	T	-1	7	1	15	1	1	ENST00000369535:c.34G>A	1	1	\N
16	c.2304	A	1	8	1	16	2	1	ENST00000367921:c.2304T>A	2	1	\N
17	c.2753	C	1	9	1	17	3	1	ENST00000355710:c.2753T>C	3	1	\N
18	c.388	G	1	10	1	18	4	1	ENST00000371953:c.388C>G	4	1	\N
19	c.388	T	1	10	1	19	4	2	ENST00000371953:c.388C>T	4	1	\N
20	c.389	A	1	11	1	20	4	1	ENST00000371953:c.389G>A	4	1	\N
21	c.477	T	1	12	1	21	4	1	ENST00000371953:c.477G>T	4	1	\N
22	c.697	T	1	13	1	22	4	2	ENST00000371953:c.697C>T	4	1	\N
23	c.800	-	1	14	2	23	4	3	ENST00000371953:c.800delA	4	1	\N
24	c.182	C	-1	15	1	24	5	1	ENST00000311189:c.182A>G	5	1	\N
25	c.37	A	-1	16	1	8	5	1	ENST00000311189:c.37G>T	5	1	\N
26	c.37	G	-1	16	1	9	5	1	ENST00000311189:c.37G>C	5	1	\N
27	c.35	A	-1	17	1	10	5	1	ENST00000311189:c.35G>T	5	1	\N
28	c.34	G	-1	18	1	14	5	1	ENST00000311189:c.34G>C	5	1	\N
29	c.437	A	-1	19	1	25	6	1	ENST00000256078:c.437C>T	6	1	\N
30	c.436	G	-1	20	1	26	6	1	ENST00000256078:c.436G>C	6	1	\N
31	c.436	T	-1	20	1	27	6	1	ENST00000256078:c.436G>A	6	1	\N
32	c.351	A	-1	21	1	28	6	1	ENST00000256078:c.351A>T	6	1	\N
33	c.351	G	-1	21	1	28	6	1	ENST00000256078:c.351A>C	6	1	\N
34	c.183	A	-1	22	1	1	6	1	ENST00000256078:c.183A>T	6	1	\N
35	c.183	G	-1	22	1	1	6	1	ENST00000256078:c.183A>C	6	1	\N
36	c.182	A	-1	23	1	2	6	1	ENST00000256078:c.182A>T	6	1	\N
37	c.182	C	-1	23	1	24	6	1	ENST00000256078:c.182A>G	6	1	\N
38	c.182	G	-1	23	1	29	6	1	ENST00000256078:c.182A>C	6	1	\N
39	c.181	T	-1	24	1	4	6	1	ENST00000256078:c.181C>A	6	1	\N
40	c.38	A	-1	25	1	5	6	1	ENST00000256078:c.38G>T	6	1	\N
41	c.38	G	-1	25	1	6	6	1	ENST00000256078:c.38G>C	6	1	\N
42	c.38	T	-1	25	1	7	6	1	ENST00000256078:c.38G>A	6	1	\N
43	c.37	A	-1	26	1	8	6	1	ENST00000256078:c.37G>T	6	1	\N
44	c.37	G	-1	26	1	9	6	1	ENST00000256078:c.37G>C	6	1	\N
45	c.37	T	-1	26	1	30	6	1	ENST00000256078:c.37G>A	6	1	\N
46	c.35	A	-1	27	1	10	6	1	ENST00000256078:c.35G>T	6	1	\N
47	c.35	G	-1	27	1	11	6	1	ENST00000256078:c.35G>C	6	1	\N
48	c.35	T	-1	27	1	12	6	1	ENST00000256078:c.35G>A	6	1	\N
49	c.34	A	-1	28	1	13	6	1	ENST00000256078:c.34G>T	6	1	\N
50	c.34	G	-1	28	1	14	6	1	ENST00000256078:c.34G>C	6	1	\N
51	c.34	T	-1	28	1	15	6	1	ENST00000256078:c.34G>A	6	1	\N
52	c.2508	C	-1	29	1	31	7	1	ENST00000380982:c.2508C>G	7	1	\N
53	c.2506	G	-1	30	1	32	7	1	ENST00000380982:c.2506A>C	7	1	\N
54	c.2505	C	-1	31	1	33	7	1	ENST00000380982:c.2505T>G	7	1	\N
55	c.2505	T	-1	31	1	33	7	1	ENST00000380982:c.2505T>A	7	1	\N
56	c.2504	A	-1	32	1	34	7	1	ENST00000380982:c.2504A>T	7	1	\N
57	c.2504	G	-1	32	1	35	7	1	ENST00000380982:c.2504A>C	7	1	\N
58	c.2503	A	-1	33	1	36	7	1	ENST00000380982:c.2503G>T	7	1	\N
59	c.2503	G	-1	33	1	37	7	1	ENST00000380982:c.2503G>C	7	1	\N
60	c.2503	T	-1	33	1	38	7	1	ENST00000380982:c.2503G>A	7	1	\N
61	c.49	T	-1	34	1	39	8	1	ENST00000349310:c.49G>A	8	1	\N
62	c.2277	-	-1	35	2	40	9	3	ENST00000261609:c.2277delAACGGTCCTGACCTG	9	1	\N
63	c.2264	G	-1	36	1	41	9	1	ENST00000261609:c.2264T>C	9	1	\N
64	c.926	C	-1	37	1	42	9	1	ENST00000261609:c.926C>G	9	1	\N
65	c.157	C	1	38	1	43	10	1	ENST00000307102:c.157T>C	10	1	\N
66	c.167	C	1	39	1	44	10	1	ENST00000307102:c.167A>C	10	1	\N
67	c.171	T	1	40	1	45	10	1	ENST00000307102:c.171G>T	10	1	\N
68	c.199	A	1	41	1	46	10	1	ENST00000307102:c.199G>A	10	1	\N
69	c.332	G	1	42	1	47	10	1	ENST00000307102:c.332T>G	10	1	\N
70	c.362	C	1	43	1	48	10	1	ENST00000307102:c.362G>C	10	1	\N
71	c.370	T	1	44	1	49	10	1	ENST00000307102:c.370C>T	10	1	\N
72	c.371	T	1	45	1	50	10	1	ENST00000307102:c.371C>T	10	1	\N
73	c.607	A	1	46	1	51	10	1	ENST00000307102:c.607G>A	10	1	\N
74	c.790	T	1	47	1	52	10	1	ENST00000307102:c.790C>T	10	1	\N
75	c.1144	C	1	48	1	53	10	1	ENST00000307102:c.1144A>C	10	1	\N
76	c.516	G	-1	49	1	54	11	1	ENST00000330062:c.516G>C	11	1	\N
77	c.515	A	-1	50	1	55	11	1	ENST00000330062:c.515G>T	11	1	\N
78	c.515	T	-1	50	1	56	11	1	ENST00000330062:c.515G>A	11	1	\N
79	c.419	A	-1	51	1	57	11	1	ENST00000330062:c.419G>T	11	1	\N
80	c.419	T	-1	51	1	58	11	1	ENST00000330062:c.419G>A	11	1	\N
81	c.418	A	-1	52	1	59	11	1	ENST00000330062:c.418C>T	11	1	\N
82	c.926	C	1	53	1	60	12	1	ENST00000269571:c.926G>C	12	1	\N
83	c.2263	-	1	54	2	61	12	3	ENST00000269571:c.2263delTTGAGGGAAAACACA	12	1	\N
84	c.2264	C	1	55	1	41	12	1	ENST00000269571:c.2264T>C	12	1	\N
85	c.2305	C	1	56	1	62	12	1	ENST00000269571:c.2305G>C	12	1	\N
86	c.2305	T	1	56	1	63	12	1	ENST00000269571:c.2305G>T	12	1	\N
87	c.2329	T	1	57	1	64	12	1	ENST00000269571:c.2329G>T	12	1	\N
88	c.2332	GGCTCCCCA	1	58	3	65	12	3	ENST00000269571:c.2332insGGCTCCCCA	12	1	\N
89	c.2524	A	1	59	1	66	12	1	ENST00000269571:c.2524G>A	12	1	\N
90	c.2686	T	1	60	1	67	12	1	ENST00000269571:c.2686C>T	12	1	\N
91	c.989	C	1	61	1	68	13	1	ENST00000342988:c.989A>C	13	1	\N
92	c.1051	A	1	62	1	69	13	1	ENST00000342988:c.1051G>A	13	1	\N
93	c.1051	C	1	62	1	70	13	1	ENST00000342988:c.1051G>C	13	1	\N
94	c.1065	A	1	63	1	71	13	1	ENST00000342988:c.1065C>A	13	1	\N
95	c.1081	A	1	64	1	72	13	1	ENST00000342988:c.1081C>A	13	1	\N
96	c.1081	T	1	64	1	73	13	1	ENST00000342988:c.1081C>T	13	1	\N
97	c.1082	A	1	65	1	74	13	1	ENST00000342988:c.1082G>A	13	1	\N
98	c.1609	T	1	66	1	75	13	1	ENST00000342988:c.1609G>T	13	1	\N
99	c.626	C	1	67	1	76	14	1	ENST00000078429:c.626A>C	14	1	\N
100	c.626	T	1	67	1	77	14	1	ENST00000078429:c.626A>T	14	1	\N
101	c.395	A	-1	68	1	78	15	1	ENST00000345146:c.395G>T	15	1	\N
102	c.395	G	-1	68	1	79	15	1	ENST00000345146:c.395G>C	15	1	\N
103	c.395	T	-1	68	1	80	15	1	ENST00000345146:c.395G>A	15	1	\N
104	c.394	A	-1	69	1	81	15	1	ENST00000345146:c.394C>T	15	1	\N
105	c.394	C	-1	69	1	82	15	1	ENST00000345146:c.394C>G	15	1	\N
106	c.394	T	-1	69	1	83	15	1	ENST00000345146:c.394C>A	15	1	\N
107	c.2645	A	-1	70	1	84	16	1	ENST00000264709:c.2645G>T	16	1	\N
108	c.2645	G	-1	70	1	85	16	1	ENST00000264709:c.2645G>C	16	1	\N
109	c.2645	T	-1	70	1	86	16	1	ENST00000264709:c.2645G>A	16	1	\N
110	c.2644	A	-1	71	1	87	16	1	ENST00000264709:c.2644C>T	16	1	\N
111	c.2644	C	-1	71	1	88	16	1	ENST00000264709:c.2644C>G	16	1	\N
112	c.2644	T	-1	71	1	89	16	1	ENST00000264709:c.2644C>A	16	1	\N
113	c.3833	G	-1	72	1	90	17	1	ENST00000389048:c.3833A>C	17	1	\N
114	c.3824	T	-1	73	1	91	17	1	ENST00000389048:c.3824G>A	17	1	\N
115	c.3735	C	-1	74	1	92	17	1	ENST00000389048:c.3735C>G	17	1	\N
116	c.3734	C	-1	75	1	93	17	1	ENST00000389048:c.3734T>G	17	1	\N
117	c.3733	C	-1	76	1	94	17	1	ENST00000389048:c.3733T>G	17	1	\N
118	c.3673	T	-1	77	1	95	17	1	ENST00000389048:c.3673G>A	17	1	\N
119	c.3522	T	-1	78	1	96	17	1	ENST00000389048:c.3522C>A	17	1	\N
120	c.3521	C	-1	79	1	97	17	1	ENST00000389048:c.3521T>G	17	1	\N
121	c.3520	C	-1	80	1	98	17	1	ENST00000389048:c.3520T>G	17	1	\N
122	c.3520	T	-1	80	1	99	17	1	ENST00000389048:c.3520T>A	17	1	\N
123	c.3512	T	-1	81	1	100	17	1	ENST00000389048:c.3512T>A	17	1	\N
124	c.3452	A	-1	82	1	101	17	1	ENST00000389048:c.3452C>T	17	1	\N
125	c.3271	T	-1	83	1	102	17	1	ENST00000389048:c.3271G>A	17	1	\N
126	c.1624	A	1	84	1	103	18	1	ENST00000263967:c.1624G>A	18	1	\N
127	c.1633	A	1	85	1	104	18	1	ENST00000263967:c.1633G>A	18	1	\N
128	c.1633	C	1	85	1	105	18	1	ENST00000263967:c.1633G>C	18	1	\N
129	c.1634	C	1	86	1	106	18	1	ENST00000263967:c.1634A>C	18	1	\N
130	c.1634	G	1	86	1	107	18	1	ENST00000263967:c.1634A>G	18	1	\N
131	c.1634	T	1	86	1	108	18	1	ENST00000263967:c.1634A>T	18	1	\N
132	c.1636	A	1	87	1	109	18	1	ENST00000263967:c.1636C>A	18	1	\N
133	c.1636	G	1	87	1	110	18	1	ENST00000263967:c.1636C>G	18	1	\N
134	c.1637	C	1	88	1	111	18	1	ENST00000263967:c.1637A>C	18	1	\N
135	c.1637	G	1	88	1	112	18	1	ENST00000263967:c.1637A>G	18	1	\N
136	c.1637	T	1	88	1	113	18	1	ENST00000263967:c.1637A>T	18	1	\N
137	c.1645	A	1	89	1	114	18	1	ENST00000263967:c.1645G>A	18	1	\N
138	c.3140	G	1	90	1	115	18	1	ENST00000263967:c.3140A>G	18	1	\N
139	c.3140	T	1	90	1	116	18	1	ENST00000263967:c.3140A>T	18	1	\N
140	c.110	A	1	91	1	117	19	1	ENST00000349496:c.110C>A	19	1	\N
141	c.110	T	1	91	1	118	19	1	ENST00000349496:c.110C>T	19	1	\N
142	c.133	C	1	92	1	119	19	1	ENST00000349496:c.133T>C	19	1	\N
143	c.134	A	1	93	1	120	19	1	ENST00000349496:c.134C>A	19	1	\N
144	c.134	T	1	93	1	121	19	1	ENST00000349496:c.134C>T	19	1	\N
145	c.1682	A	1	94	1	122	20	1	ENST00000257290:c.1682T>A	20	1	\N
146	c.1977	A	1	95	1	123	20	1	ENST00000257290:c.1977C>A	20	1	\N
147	c.1977	G	1	95	1	123	20	1	ENST00000257290:c.1977C>G	20	1	\N
148	c.2525	T	1	96	1	124	20	1	ENST00000257290:c.2525A>T	20	1	\N
149	c.1468	A	1	97	1	125	21	1	ENST00000288135:c.1468G>A	21	1	\N
150	c.1510	C	1	98	1	126	21	1	ENST00000288135:c.1510T>C	21	1	\N
151	c.1650	C	1	99	1	127	21	1	ENST00000288135:c.1650A>C	21	1	\N
152	c.1650	T	1	99	1	127	21	1	ENST00000288135:c.1650A>T	21	1	\N
153	c.1657	A	1	100	1	128	21	1	ENST00000288135:c.1657T>A	21	1	\N
154	c.1660	-	1	101	2	129	21	3	ENST00000288135:c.1660delGAAGTACAGTGGAAG	21	1	\N
155	c.1660	-	1	102	2	129	21	3	ENST00000288135:c.1660delGAAGTACAGTGGAAGGTT	21	1	\N
156	c.1666	CTA	1	103	3	130	21	3	ENST00000288135:c.1666insCTA	21	1	\N
157	c.1666	CTC	1	103	3	130	21	3	ENST00000288135:c.1666insCTC	21	1	\N
158	c.1666	CTG	1	103	3	130	21	3	ENST00000288135:c.1666insCTG	21	1	\N
159	c.1666	CTT	1	103	3	130	21	3	ENST00000288135:c.1666insCTT	21	1	\N
160	c.1666	TTA	1	103	3	130	21	3	ENST00000288135:c.1666insTTA	21	1	\N
161	c.1666	TTG	1	103	3	130	21	3	ENST00000288135:c.1666insTTG	21	1	\N
162	c.1669	A	1	104	1	131	21	1	ENST00000288135:c.1669T>A	21	1	\N
163	c.1669	C	1	104	1	131	21	1	ENST00000288135:c.1669T>C	21	1	\N
164	c.1674	C	1	105	1	132	21	1	ENST00000288135:c.1674G>C	21	1	\N
165	c.1674	T	1	105	1	132	21	1	ENST00000288135:c.1674G>T	21	1	\N
166	c.1675	-	1	106	2	133	21	4	ENST00000288135:c.1675delGTT	21	1	\N
167	c.1676	A	1	107	1	134	21	1	ENST00000288135:c.1676T>A	21	1	\N
168	c.1676	C	1	107	1	135	21	1	ENST00000288135:c.1676T>C	21	1	\N
169	c.1676	G	1	107	1	136	21	1	ENST00000288135:c.1676T>G	21	1	\N
170	c.1678	-	1	108	2	137	21	3	ENST00000288135:c.1678delGTT	21	1	\N
171	c.1679	A	1	109	1	138	21	1	ENST00000288135:c.1679T>A	21	1	\N
172	c.1679	C	1	109	1	139	21	1	ENST00000288135:c.1679T>C	21	1	\N
173	c.1679	G	1	109	1	140	21	1	ENST00000288135:c.1679T>G	21	1	\N
174	c.1694	T	1	110	1	141	21	1	ENST00000288135:c.1694G>T	21	1	\N
175	c.1696	G	1	111	1	142	21	1	ENST00000288135:c.1696A>G	21	1	\N
176	c.1696	-	1	112	2	143	21	4	ENST00000288135:c.1696delAACAATTATGTTACAGAC	21	1	\N
177	c.1696	-	1	113	2	144	21	4	ENST00000288135:c.1696delAACAATTATGTTACAGACCCAACA	21	1	\N
178	c.1706	G	1	114	1	145	21	1	ENST00000288135:c.1706T>G	21	1	\N
179	c.1723	CCAGAA	1	115	3	146	21	3	ENST00000288135:c.1723insCCAGAA	21	1	\N
180	c.1723	CCAGAG	1	115	3	146	21	3	ENST00000288135:c.1723insCCAGAG	21	1	\N
181	c.1723	CCCGAA	1	115	3	146	21	3	ENST00000288135:c.1723insCCCGAA	21	1	\N
182	c.1723	CCCGAG	1	115	3	146	21	3	ENST00000288135:c.1723insCCCGAG	21	1	\N
183	c.1723	CCGGAA	1	115	3	146	21	3	ENST00000288135:c.1723insCCGGAA	21	1	\N
184	c.1723	CCGGAG	1	115	3	146	21	3	ENST00000288135:c.1723insCCGGAG	21	1	\N
185	c.1723	CCTGAA	1	115	3	146	21	3	ENST00000288135:c.1723insCCTGAA	21	1	\N
186	c.1723	CCTGAG	1	115	3	146	21	3	ENST00000288135:c.1723insCCTGAG	21	1	\N
187	c.1727	C	1	116	1	147	21	1	ENST00000288135:c.1727T>C	21	1	\N
188	c.1730	-	1	117	2	148	21	3	ENST00000288135:c.1730delCTTATGATC	21	1	\N
189	c.1735	-	1	118	2	149	21	4	ENST00000288135:c.1735delGAT	21	1	\N
190	c.1900	T	1	119	1	150	21	1	ENST00000288135:c.1900C>T	21	1	\N
191	c.1924	G	1	120	1	151	21	1	ENST00000288135:c.1924A>G	21	1	\N
192	c.1961	C	1	121	1	152	21	1	ENST00000288135:c.1961T>C	21	1	\N
193	c.1964	G	1	122	1	153	21	1	ENST00000288135:c.1964A>G	21	1	\N
194	c.1965	A	1	123	1	154	21	1	ENST00000288135:c.1965T>A	21	1	\N
195	c.1965	G	1	123	1	154	21	1	ENST00000288135:c.1965T>G	21	1	\N
196	c.2089	T	1	124	1	155	21	1	ENST00000288135:c.2089C>T	21	1	\N
197	c.2446	C	1	125	1	156	21	1	ENST00000288135:c.2446G>C	21	1	\N
198	c.2446	T	1	125	1	157	21	1	ENST00000288135:c.2446G>T	21	1	\N
199	c.2446	AT	1	126	4	158	21	1	ENST00000288135:c.2446GA>AT	21	1	\N
200	c.2447	T	1	127	1	159	21	1	ENST00000288135:c.2447A>T	21	1	\N
201	c.2458	C	1	128	1	160	21	1	ENST00000288135:c.2458G>C	21	1	\N
202	c.2458	T	1	128	1	161	21	1	ENST00000288135:c.2458G>T	21	1	\N
203	c.2459	T	1	129	1	162	21	1	ENST00000288135:c.2459A>T	21	1	\N
204	c.2460	A	1	130	1	163	21	1	ENST00000288135:c.2460T>A	21	1	\N
205	c.2464	T	1	131	1	164	21	1	ENST00000288135:c.2464A>T	21	1	\N
206	c.2465	T	1	132	1	165	21	1	ENST00000288135:c.2465A>T	21	1	\N
207	c.2466	A	1	133	1	166	21	1	ENST00000288135:c.2466T>A	21	1	\N
208	c.2466	G	1	133	1	166	21	1	ENST00000288135:c.2466T>G	21	1	\N
209	c.2467	G	1	134	1	167	21	1	ENST00000288135:c.2467T>G	21	1	\N
210	c.2485	C	1	135	1	168	21	1	ENST00000288135:c.2485G>C	21	1	\N
211	c.2521	G	1	136	1	169	21	1	ENST00000288135:c.2521A>G	21	1	\N
212	c.2591	T	1	137	1	170	21	1	ENST00000288135:c.2591C>T	21	1	\N
213	c.203	TT	1	138	4	171	22	1	ENST00000249373:c.203CC>TT	22	1	\N
214	c.595	T	1	139	1	172	22	1	ENST00000249373:c.595C>T	22	1	\N
215	c.1046	TT	1	140	4	173	22	1	ENST00000249373:c.1046CC>TT	22	1	\N
216	c.1417	C	1	141	1	174	22	1	ENST00000249373:c.1417G>C	22	1	\N
217	c.1452	TT	1	142	4	175	22	1	ENST00000249373:c.1452CC>TT	22	1	\N
218	c.1542	TT	1	143	4	176	22	1	ENST00000249373:c.1542CC>TT	22	1	\N
219	c.1604	T	1	144	1	177	22	1	ENST00000249373:c.1604G>T	22	1	\N
220	c.1685	A	1	145	1	178	22	1	ENST00000249373:c.1685G>A	22	1	\N
221	c.1955	T	1	146	1	179	22	1	ENST00000249373:c.1955C>T	22	1	\N
222	c.2263	TT	1	147	4	180	22	1	ENST00000249373:c.2263CC>TT	22	1	\N
223	c.1801	C	-1	148	1	181	23	1	ENST00000288602:c.1801A>G	23	1	\N
224	c.1799	AT	-1	149	4	182	23	1	ENST00000288602:c.1799TG>AT	23	1	\N
225	c.1799	C	-1	150	1	183	23	1	ENST00000288602:c.1799T>G	23	1	\N
226	c.1799	T	-1	150	1	184	23	1	ENST00000288602:c.1799T>A	23	1	\N
227	c.1798	CT	-1	151	4	185	23	1	ENST00000288602:c.1798GT>AG	23	1	\N
228	c.1798	TT	-1	151	4	186	23	1	ENST00000288602:c.1798GT>AA	23	1	\N
229	c.1790	C	-1	152	1	187	23	1	ENST00000288602:c.1790T>G	23	1	\N
230	c.1782	T	-1	153	1	188	23	1	ENST00000288602:c.1782T>A	23	1	\N
231	c.1781	A	-1	154	1	189	23	1	ENST00000288602:c.1781A>T	23	1	\N
232	c.1781	C	-1	154	1	190	23	1	ENST00000288602:c.1781A>G	23	1	\N
233	c.1780	G	-1	155	1	191	23	1	ENST00000288602:c.1780G>C	23	1	\N
234	c.1780	T	-1	155	1	192	23	1	ENST00000288602:c.1780G>A	23	1	\N
235	c.1779	TC	-1	156	4	193	23	1	ENST00000288602:c.1779TG>GA	23	1	\N
236	c.1415	C	-1	157	1	194	23	1	ENST00000288602:c.1415A>G	23	1	\N
237	c.230	A	-1	158	1	195	23	1	ENST00000496384:c.230G>T	24	1	\N
238	c.1406	G	-1	158	1	196	23	1	ENST00000288602:c.1406G>C	23	1	\N
239	c.1406	T	-1	158	1	197	23	1	ENST00000288602:c.1406G>A	23	1	\N
240	c.229	AA	-1	159	4	198	23	1	ENST00000496384:c.229GG>TT	24	1	\N
241	c.1397	A	-1	160	1	199	23	1	ENST00000288602:c.1397G>T	23	1	\N
242	c.2155	A	1	161	1	200	24	1	ENST00000275493:c.2155G>A	25	1	\N
243	c.2155	T	1	161	1	201	24	1	ENST00000275493:c.2155G>T	25	1	\N
244	c.2156	C	1	162	1	202	24	1	ENST00000275493:c.2156G>C	25	1	\N
245	c.2369	T	1	163	1	203	24	1	ENST00000275493:c.2369C>T	25	1	\N
246	c.2573	G	1	164	1	204	24	1	ENST00000275493:c.2573T>G	25	1	\N
247	c.2582	A	1	165	1	205	24	1	ENST00000275493:c.2582T>A	25	1	\N
248	c.2047	G	1	166	1	206	25	1	ENST00000381652:c.2047A>G	26	1	\N
249	c.2048	C	1	167	1	207	25	1	ENST00000381652:c.2048G>C	26	1	\N
250	c.2049	C	1	168	1	208	25	1	ENST00000381652:c.2049A>C	26	1	\N
251	c.2049	T	1	168	1	208	25	1	ENST00000381652:c.2049A>T	26	1	\N
252	c.626	A	-1	169	1	77	26	1	ENST00000286548:c.626A>T	27	1	\N
253	c.626	C	-1	169	1	209	26	1	ENST00000286548:c.626A>G	27	1	\N
254	c.626	G	-1	169	1	76	26	1	ENST00000286548:c.626A>C	27	1	\N
255	c.695	C	-1	170	1	210	27	1	ENST00000381567:c.695T>G	28	1	\N
256	c.1853	A	-1	171	1	211	28	1	ENST00000373103:c.1853C>T	29	2	\N
257	c.1142	ACCGTACA	-1	172	3	212	29	5	ENST00000332351:c.1142insTGTACGGT	30	2	\N
258	c.2516	C	-1	173	1	213	7	1	ENST00000380982:c.2516A>G	7	2	\N
259	c.818	T	-1	174	1	214	30	1	ENST00000269305:c.818G>A	31	2	\N
260	c.817	A	-1	175	1	215	30	1	ENST00000269305:c.817C>T	31	2	\N
261	c.746	G	-1	176	1	216	30	1	ENST00000269305:c.746G>C	31	2	\N
262	c.745	A	-1	177	1	217	30	1	ENST00000269305:c.745A>T	31	2	\N
263	c.743	T	-1	178	1	218	30	1	ENST00000269305:c.743G>A	31	2	\N
264	c.659	C	-1	179	1	219	30	1	ENST00000269305:c.659A>G	31	2	\N
265	c.518	C	-1	180	1	220	30	1	ENST00000269305:c.518T>G	31	2	\N
266	c.518	G	-1	180	1	221	30	1	ENST00000269305:c.518T>C	31	2	\N
267	c.2098	C	-1	181	1	222	31	1	ENST00000335508:c.2098A>G	32	2	\N
268	c.1998	A	-1	182	1	223	31	1	ENST00000335508:c.1998G>T	32	2	\N
269	c.1998	G	-1	182	1	223	31	1	ENST00000335508:c.1998G>C	32	2	\N
270	c.601	A	-1	183	1	224	32	2	ENST00000300305:c.601C>T	33	2	\N
271	c.486	A	-1	184	1	225	32	1	ENST00000300305:c.486G>T	33	2	\N
272	c.486	G	-1	184	1	225	32	1	ENST00000300305:c.486G>C	33	2	\N
273	c.485	T	-1	185	1	226	32	1	ENST00000300305:c.485G>A	33	2	\N
274	c.484	C	-1	186	1	227	32	1	ENST00000300305:c.484A>G	33	2	\N
275	c.470	C	-1	187	1	228	33	1	ENST00000291552:c.470A>G	34	2	\N
276	c.470	G	-1	187	1	229	33	1	ENST00000291552:c.470A>C	34	2	\N
277	c.101	A	-1	188	1	230	33	1	ENST00000291552:c.101C>T	34	2	\N
278	c.101	T	-1	188	1	231	33	1	ENST00000291552:c.101C>A	34	2	\N
279	c.1192	A	-1	189	1	232	34	1	ENST00000341105:c.1192C>T	35	2	\N
280	c.1061	A	-1	190	1	233	34	1	ENST00000341105:c.1061C>T	35	2	\N
281	c.862	CATG	1	191	3	234	35	3	ENST00000296930:c.862insCATG	36	2	\N
282	c.862	CCTG	1	191	3	235	35	3	ENST00000296930:c.862insCCTG	36	2	\N
283	c.862	TCAG	1	191	3	236	35	3	ENST00000296930:c.862insTCAG	36	2	\N
284	c.862	TCTG	1	191	3	236	35	3	ENST00000296930:c.862insTCTG	36	2	\N
285	c.1849	T	1	192	1	237	25	1	ENST00000381652:c.1849G>T	26	2	\N
286	c.181	A	-1	3	1	238	1	2	ENST00000369535:c.181C>T	1	3	\N
287	c.2100	A	-1	193	1	239	31	1	ENST00000335508:c.2100A>T	32	3	\N
288	c.2100	G	-1	193	1	239	31	1	ENST00000335508:c.2100A>C	32	3	\N
289	c.2099	A	-1	194	1	240	31	1	ENST00000335508:c.2099A>T	32	3	\N
290	c.2099	C	-1	194	1	241	31	1	ENST00000335508:c.2099A>G	32	3	\N
291	c.2099	G	-1	194	1	242	31	1	ENST00000335508:c.2099A>C	32	3	\N
292	c.2098	A	-1	181	1	243	31	2	ENST00000335508:c.2098A>T	32	3	\N
293	c.2098	G	-1	181	1	244	31	1	ENST00000335508:c.2098A>C	32	3	\N
294	c.1997	C	-1	195	1	245	31	1	ENST00000335508:c.1997A>G	32	3	\N
295	c.1997	G	-1	195	1	246	31	1	ENST00000335508:c.1997A>C	32	3	\N
296	c.1996	C	-1	196	1	247	31	1	ENST00000335508:c.1996A>G	32	3	\N
297	c.1961	A	1	121	1	248	21	1	ENST00000288135:c.1961T>A	21	3	\N
298	c.1781	G	-1	154	1	249	23	1	ENST00000288602:c.1781A>C	23	3	\N
299	c.1780	A	-1	155	1	250	23	1	ENST00000288602:c.1780G>T	23	3	\N
300	c.1001	T	1	197	1	251	36	1	ENST00000372348:c.1001C>T	37	4	\N
301	c.553	T	1	198	1	252	37	1	ENST00000303115:c.553A>T	38	4	\N
302	c.1937	A	-1	199	1	253	38	1	ENST00000342505:c.1937C>T	39	4	\N
303	c.1474	G	1	200	1	254	24	1	ENST00000275493:c.1474A>G	25	4	\N
304	c.1675	A	1	201	1	255	21	1	ENST00000288135:c.1675G>A	21	4	\N
305	c.2009	T	1	202	1	256	21	1	ENST00000288135:c.2009C>T	21	4	\N
306	c.2525	C	-1	203	1	257	7	1	ENST00000380982:c.2525A>G	7	4	\N
307	c.2524	G	-1	204	1	258	7	1	ENST00000380982:c.2524T>C	7	4	\N
308	c.2503	AA	-1	205	4	259	7	1	ENST00000380982:c.2503GA>TT	7	4	\N
309	c.2073	C	-1	206	1	260	7	1	ENST00000380982:c.2073T>G	7	4	\N
310	c.2073	T	-1	206	1	260	7	1	ENST00000380982:c.2073T>A	7	4	\N
311	c.2059	A	-1	207	1	261	7	1	ENST00000380982:c.2059A>T	7	4	\N
312	c.2028	C	-1	208	1	262	7	1	ENST00000380982:c.2028C>G	7	4	\N
313	c.2028	T	-1	208	1	262	7	1	ENST00000380982:c.2028C>A	7	4	\N
314	c.2026	C	-1	209	1	263	7	1	ENST00000380982:c.2026A>G	7	4	\N
315	c.1952	C	-1	210	1	264	7	1	ENST00000380982:c.1952A>G	7	4	\N
316	c.1855	A	-1	211	1	265	7	1	ENST00000380982:c.1855G>T	7	4	\N
317	c.1970	T	-1	212	1	266	39	1	ENST00000458235:c.1970G>A	40	4	\N
318	c.1503	A	-1	213	1	267	39	1	ENST00000458235:c.1503G>T	40	4	\N
319	c.1503	G	-1	213	1	267	39	1	ENST00000458235:c.1503G>C	40	4	\N
320	c.260	G	-1	214	1	268	39	1	ENST00000458235:c.260T>C	40	4	\N
321	c.763	A	1	215	1	269	36	1	ENST00000372348:c.763G>A	37	4	\N
322	c.814	C	1	216	1	270	36	1	ENST00000372348:c.814T>C	37	4	\N
323	c.952	C	1	217	1	271	36	1	ENST00000372348:c.952G>C	37	4	\N
324	c.1000	G	1	218	1	272	36	1	ENST00000372348:c.1000A>G	37	4	\N
325	c.1006	A	1	219	1	273	36	1	ENST00000372348:c.1006T>A	37	4	\N
326	c.1006	G	1	219	1	274	36	1	ENST00000372348:c.1006T>G	37	4	\N
327	c.1007	G	1	220	1	275	36	1	ENST00000372348:c.1007T>G	37	4	\N
328	c.1008	A	1	221	1	276	36	1	ENST00000372348:c.1008C>A	37	4	\N
329	c.1008	G	1	221	1	276	36	1	ENST00000372348:c.1008C>G	37	4	\N
330	c.1132	A	1	222	1	277	36	1	ENST00000372348:c.1132T>A	37	4	\N
331	c.1132	C	1	222	1	278	36	1	ENST00000372348:c.1132T>C	37	4	\N
332	c.1133	G	1	223	1	279	36	1	ENST00000372348:c.1133T>G	37	4	\N
333	c.1843	C	-1	224	1	280	28	1	ENST00000373103:c.1843A>G	29	4	\N
334	c.3335	G	1	225	1	281	40	1	ENST00000318493:c.3335A>G	41	4	\N
335	c.3803	C	1	226	1	282	40	1	ENST00000318493:c.3803T>C	41	4	\N
336	c.7514	G	-1	227	1	283	41	1	ENST00000361445:c.7514G>C	42	4	\N
337	c.6667	T	-1	228	1	284	41	1	ENST00000361445:c.6667C>A	42	4	\N
338	c.6644	T	-1	229	1	285	41	1	ENST00000361445:c.6644C>A	42	4	\N
339	c.4379	G	-1	230	1	286	41	1	ENST00000361445:c.4379T>C	42	4	\N
340	c.7255	T	-1	231	1	287	41	1	ENST00000361445:c.7255G>A	42	4	\N
341	c.6040	T	-1	232	1	288	41	1	ENST00000361445:c.6040G>A	42	4	\N
342	c.3806	G	-1	233	1	289	17	1	ENST00000389048:c.3806G>C	17	4	\N
343	c.3617	T	-1	234	1	290	17	1	ENST00000389048:c.3617C>A	17	4	\N
344	c.3604	T	-1	235	1	291	17	1	ENST00000389048:c.3604G>A	17	4	\N
345	c.3586	T	-1	236	1	292	17	1	ENST00000389048:c.3586C>A	17	4	\N
346	c.3522	C	-1	78	1	96	17	1	ENST00000389048:c.3522C>G	17	4	\N
347	c.3455	C	-1	237	1	293	17	1	ENST00000389048:c.3455T>G	17	4	\N
348	c.641	G	1	238	1	294	42	1	ENST00000377045:c.641C>G	43	4	\N
349	c.926	A	1	53	1	295	12	1	ENST00000269571:c.926G>A	12	4	\N
350	c.6094	T	-1	239	1	296	43	1	ENST00000368508:c.6094G>A	44	4	\N
351	c.187	G	1	240	1	297	2	1	ENST00000367921:c.187C>G	2	4	\N
352	c.716	G	1	241	1	298	2	1	ENST00000367921:c.716T>G	2	4	\N
353	c.757	T	1	242	1	299	2	1	ENST00000367921:c.757G>T	2	4	\N
354	c.1513	A	1	243	1	300	2	1	ENST00000367921:c.1513G>A	2	4	\N
355	c.1912	T	1	244	1	301	2	1	ENST00000367921:c.1912A>T	2	4	\N
356	c.2321	T	1	245	1	302	2	1	ENST00000367921:c.2321G>T	2	4	\N
357	c.2156	A	1	162	1	303	24	1	ENST00000275493:c.2156G>A	25	4	\N
358	c.2240	C	1	246	1	304	24	1	ENST00000275493:c.2240T>C	25	4	\N
359	c.2303	T	1	247	1	305	24	1	ENST00000275493:c.2303G>T	25	4	\N
360	c.2582	C	1	165	1	306	24	1	ENST00000275493:c.2582T>C	25	4	\N
361	c.2582	G	1	165	1	307	24	1	ENST00000275493:c.2582T>G	25	4	\N
362	c.1171	G	-1	248	1	308	44	1	ENST00000358432:c.1171G>C	45	4	\N
363	c.1171	T	-1	248	1	308	44	1	ENST00000358432:c.1171G>A	45	4	\N
364	c.959	C	-1	249	1	309	45	1	ENST00000457416:c.959C>G	46	4	\N
365	c.870	G	-1	250	1	310	45	1	ENST00000457416:c.870G>C	46	4	\N
366	c.1605	A	1	251	1	311	46	1	ENST00000292408:c.1605C>A	47	4	\N
367	c.1605	G	1	251	1	311	46	1	ENST00000292408:c.1605C>G	47	4	\N
368	c.1649	A	1	252	1	312	46	1	ENST00000292408:c.1649T>A	47	4	\N
369	c.2068	A	1	253	1	313	24	1	ENST00000275493:c.2068G>A	25	4	\N
370	c.1978	C	-1	254	1	314	45	1	ENST00000457416:c.1978A>G	46	4	\N
371	c.1852	T	-1	255	1	315	45	1	ENST00000457416:c.1852T>A	46	4	\N
372	c.1697	C	-1	256	1	316	45	1	ENST00000457416:c.1697A>G	46	4	\N
373	c.1693	T	-1	257	1	317	45	1	ENST00000457416:c.1693G>A	46	4	\N
374	c.1650	C	-1	258	1	318	45	1	ENST00000457416:c.1650T>G	46	4	\N
375	c.1650	T	-1	258	1	318	45	1	ENST00000457416:c.1650T>A	46	4	\N
376	c.1648	G	-1	259	1	319	45	1	ENST00000457416:c.1648A>C	46	4	\N
377	c.1642	C	-1	260	1	320	45	1	ENST00000457416:c.1642A>G	46	4	\N
378	c.1614	A	-1	261	1	321	45	1	ENST00000457416:c.1614G>T	46	4	\N
379	c.1614	G	-1	261	1	321	45	1	ENST00000457416:c.1614G>C	46	4	\N
380	c.1614	T	-1	261	1	321	45	1	ENST00000457416:c.1614G>A	46	4	\N
381	c.1608	A	-1	262	1	322	45	1	ENST00000457416:c.1608G>T	46	4	\N
382	c.1608	G	-1	262	1	322	45	1	ENST00000457416:c.1608G>C	46	4	\N
383	c.1608	T	-1	262	1	322	45	1	ENST00000457416:c.1608G>A	46	4	\N
384	c.755	C	-1	263	1	323	45	1	ENST00000457416:c.755C>G	46	4	\N
385	c.1681	G	1	264	1	324	47	1	ENST00000222254:c.1681A>G	48	4	\N
386	c.1111	C	1	265	1	325	48	1	ENST00000264033:c.1111T>C	49	4	\N
387	c.1150	C	1	266	1	326	48	1	ENST00000264033:c.1150T>C	49	4	\N
388	c.1711	C	-1	267	1	327	49	1	ENST00000286301:c.1711T>G	50	4	\N
389	c.1544	T	1	268	1	328	50	1	ENST00000372470:c.1544G>T	51	4	\N
390	c.850	A	1	269	1	329	51	1	ENST00000267101:c.850G>A	52	4	\N
391	c.235	T	-1	270	1	330	8	1	ENST00000349310:c.235C>A	8	4	\N
392	c.1802	C	-1	271	1	331	23	1	ENST00000288602:c.1802A>G	23	4	\N
393	c.1790	T	-1	152	1	332	23	1	ENST00000288602:c.1790T>A	23	4	\N
394	c.1789	GA	-1	272	4	333	23	1	ENST00000288602:c.1789CT>TC	23	4	\N
395	c.1789	C	-1	273	1	334	23	1	ENST00000288602:c.1789C>G	23	4	\N
396	c.2614	T	-1	274	1	335	52	1	ENST00000342788:c.2614G>A	53	4	\N
397	c.1630	A	-1	275	1	336	52	1	ENST00000342788:c.1630C>T	53	4	\N
398	c.1624	T	-1	276	1	103	52	1	ENST00000342788:c.1624G>A	53	4	\N
399	c.1354	T	-1	277	1	337	52	1	ENST00000342788:c.1354G>A	53	4	\N
400	c.1177	A	-1	278	1	338	52	1	ENST00000342788:c.1177C>T	53	4	\N
401	c.949	T	-1	279	1	339	52	1	ENST00000342788:c.949G>A	53	4	\N
402	c.169	G	1	280	1	340	10	1	ENST00000307102:c.169A>G	10	4	\N
403	c.171	C	1	40	1	45	10	1	ENST00000307102:c.171G>C	10	4	\N
404	c.383	A	1	281	1	341	10	1	ENST00000307102:c.383G>A	10	4	\N
405	c.385	C	1	282	1	342	10	1	ENST00000307102:c.385T>C	10	4	\N
406	c.376	C	-1	283	1	343	53	1	ENST00000262948:c.376A>G	54	4	\N
407	c.373	T	-1	284	1	344	53	1	ENST00000262948:c.373T>A	54	4	\N
408	c.179	G	-1	285	1	345	53	1	ENST00000262948:c.179A>C	54	4	\N
409	c.136	A	-1	286	1	346	53	1	ENST00000262948:c.136C>T	54	4	\N
410	c.103	T	-1	287	1	347	53	1	ENST00000262948:c.103G>A	54	4	\N
411	c.183	G	-1	1	1	1	1	1	ENST00000369535:c.183A>C	1	4	\N
412	c.182	CA	-1	288	4	2	1	1	ENST00000369535:c.182AA>TG	1	4	\N
413	c.182	CC	-1	288	4	24	1	1	ENST00000369535:c.182AA>GG	1	4	\N
414	c.182	C	-1	2	1	24	1	1	ENST00000369535:c.182A>G	1	4	\N
415	c.182	G	-1	2	1	29	1	1	ENST00000369535:c.182A>C	1	4	\N
416	c.1729	T	1	289	1	348	20	1	ENST00000257290:c.1729C>T	20	4	\N
417	c.1973	C	1	290	1	349	20	1	ENST00000257290:c.1973T>C	20	4	\N
418	c.2522	A	1	291	1	350	20	1	ENST00000257290:c.2522G>A	20	4	\N
419	c.2533	T	1	292	1	351	20	1	ENST00000257290:c.2533C>T	20	4	\N
420	c.2558	A	1	293	1	352	20	1	ENST00000257290:c.2558G>A	20	4	\N
421	c.1163	G	-1	294	1	353	54	1	ENST00000442415:c.1163G>C	55	4	\N
422	c.769	G	-1	295	1	354	54	1	ENST00000442415:c.769T>C	55	4	\N
423	c.582	A	1	296	1	355	55	1	ENST00000326873:c.582C>A	56	4	\N
424	c.582	G	1	296	1	355	55	1	ENST00000326873:c.582C>G	56	4	\N
425	c.1902	G	1	297	1	356	3	1	ENST00000355710:c.1902C>G	3	4	\N
426	c.929	A	1	298	1	357	12	1	ENST00000269571:c.929C>A	12	4	\N
427	c.929	T	1	298	1	358	12	1	ENST00000269571:c.929C>T	12	4	\N
428	c.785	A	1	299	1	359	51	1	ENST00000267101:c.785C>A	52	4	\N
429	c.2426	G	1	300	1	360	51	1	ENST00000267101:c.2426A>G	52	4	\N
430	c.604	T	1	301	1	361	56	1	ENST00000354359:c.604C>T	57	4	\N
431	c.605	A	1	302	1	362	56	1	ENST00000354359:c.605G>A	57	4	\N
432	c.605	T	1	302	1	363	56	1	ENST00000354359:c.605G>T	57	4	\N
433	c.296	C	1	303	1	364	10	1	ENST00000307102:c.296T>C	10	4	\N
434	c.308	A	1	304	1	365	10	1	ENST00000307102:c.308T>A	10	4	\N
435	c.332	A	1	42	1	366	10	1	ENST00000307102:c.332T>A	10	4	\N
436	c.356	C	1	305	1	367	10	1	ENST00000307102:c.356A>C	10	4	\N
437	c.360	C	1	306	1	368	10	1	ENST00000307102:c.360G>C	10	4	\N
438	c.360	T	1	306	1	368	10	1	ENST00000307102:c.360G>T	10	4	\N
439	c.632	A	1	307	1	369	10	1	ENST00000307102:c.632T>A	10	4	\N
440	c.644	C	1	308	1	370	10	1	ENST00000307102:c.644T>C	10	4	\N
441	c.2962	T	1	309	1	371	40	1	ENST00000318493:c.2962C>T	41	4	\N
442	c.3029	T	1	310	1	372	40	1	ENST00000318493:c.3029C>T	41	4	\N
443	c.3328	A	1	311	1	373	40	1	ENST00000318493:c.3328G>A	41	4	\N
444	c.3743	G	1	312	1	374	40	1	ENST00000318493:c.3743A>G	41	4	\N
445	c.3757	G	1	313	1	375	40	1	ENST00000318493:c.3757T>G	41	4	\N
446	c.3804	A	1	314	1	376	40	1	ENST00000318493:c.3804G>A	41	4	\N
447	c.3804	C	1	314	1	376	40	1	ENST00000318493:c.3804G>C	41	4	\N
448	c.3804	T	1	314	1	376	40	1	ENST00000318493:c.3804G>T	41	4	\N
449	c.1442	G	-1	315	1	377	57	1	ENST00000308731:c.1442G>C	58	4	\N
450	c.1441	T	-1	316	1	377	57	1	ENST00000308731:c.1441T>A	58	4	\N
451	c.1138	C	1	317	1	378	58	1	ENST00000206249:c.1138G>C	59	4	\N
452	c.3575	G	-1	318	1	379	17	1	ENST00000389048:c.3575G>C	17	4	\N
453	c.3383	G	-1	319	1	380	17	1	ENST00000389048:c.3383G>C	17	4	\N
454	c.323	A	1	320	1	381	24	1	ENST00000275493:c.323G>A	25	4	\N
455	c.787	C	1	321	1	382	24	1	ENST00000275493:c.787A>C	25	4	\N
456	c.866	T	1	322	1	383	24	1	ENST00000275493:c.866C>T	25	4	\N
457	c.1793	T	1	323	1	384	24	1	ENST00000275493:c.1793G>T	25	4	\N
458	c.1636	T	1	324	1	385	24	1	ENST00000275493:c.1636C>T	25	4	\N
459	c.2257	T	1	325	1	386	24	1	ENST00000275493:c.2257C>T	25	4	\N
460	c.2527	A	1	326	1	387	24	1	ENST00000275493:c.2527G>A	25	4	\N
461	c.758	C	-1	327	1	388	45	1	ENST00000457416:c.758C>G	46	4	\N
462	c.1993	T	1	328	1	389	59	1	ENST00000359376:c.1993C>T	60	4	\N
463	c.2535	C	1	329	1	390	59	1	ENST00000359376:c.2535A>C	60	4	\N
464	c.2535	T	1	329	1	390	59	1	ENST00000359376:c.2535A>T	60	4	\N
465	c.1936	G	-1	330	1	391	60	1	ENST00000320356:c.1936T>C	61	4	\N
466	c.1936	T	-1	330	1	392	60	1	ENST00000320356:c.1936T>A	61	4	\N
467	c.1937	A	-1	331	1	393	60	1	ENST00000320356:c.1937A>T	61	4	\N
468	c.1937	G	-1	331	1	394	60	1	ENST00000320356:c.1937A>C	61	4	\N
469	c.2045	C	-1	332	1	395	60	1	ENST00000320356:c.2045C>G	61	4	\N
470	c.818	C	1	333	1	396	61	1	ENST00000417037:c.818T>C	62	4	\N
471	c.2626	T	1	334	1	397	62	2	ENST00000257430:c.2626C>T	63	5	\N
472	c.3340	T	1	335	1	398	62	2	ENST00000257430:c.3340C>T	63	5	\N
473	c.3916	T	1	336	1	399	62	2	ENST00000257430:c.3916G>T	63	5	\N
474	c.4012	T	1	337	1	400	62	2	ENST00000257430:c.4012C>T	63	5	\N
475	c.4099	T	1	338	1	401	62	2	ENST00000257430:c.4099C>T	63	5	\N
476	c.4132	T	1	339	1	402	62	2	ENST00000257430:c.4132C>T	63	5	\N
477	c.4135	T	1	340	1	403	62	2	ENST00000257430:c.4135G>T	63	5	\N
478	c.4285	T	1	341	1	404	62	2	ENST00000257430:c.4285C>T	63	5	\N
479	c.4348	T	1	342	1	405	62	2	ENST00000257430:c.4348C>T	63	5	\N
480	c.787	G	1	343	1	406	36	1	ENST00000372348:c.787A>G	37	5	\N
481	c.799	G	1	344	1	407	36	1	ENST00000372348:c.799C>G	37	5	\N
482	c.806	A	1	345	1	408	36	1	ENST00000372348:c.806G>A	37	5	\N
483	c.813	C	1	346	1	409	36	1	ENST00000372348:c.813G>C	37	5	\N
484	c.813	T	1	346	1	409	36	1	ENST00000372348:c.813G>T	37	5	\N
485	c.815	T	1	347	1	410	36	1	ENST00000372348:c.815A>T	37	5	\N
486	c.820	A	1	348	1	411	36	1	ENST00000372348:c.820G>A	37	5	\N
487	c.821	T	1	349	1	412	36	1	ENST00000372348:c.821A>T	37	5	\N
488	c.904	G	1	350	1	413	36	1	ENST00000372348:c.904A>G	37	5	\N
489	c.1109	C	1	351	1	414	36	1	ENST00000372348:c.1109T>C	37	5	\N
490	c.1121	G	1	352	1	415	36	1	ENST00000372348:c.1121A>G	37	5	\N
491	c.1132	G	1	222	1	416	36	1	ENST00000372348:c.1132T>G	37	5	\N
492	c.1244	G	1	353	1	417	36	1	ENST00000372348:c.1244A>G	37	5	\N
493	c.1102	T	-1	354	1	418	63	1	ENST00000392038:c.1102G>A	64	5	\N
494	c.1396	T	-1	355	1	419	23	1	ENST00000288602:c.1396G>A	23	5	\N
495	c.1391	A	-1	356	1	420	23	1	ENST00000288602:c.1391G>T	23	5	\N
496	c.1391	T	-1	356	1	421	23	1	ENST00000288602:c.1391G>A	23	5	\N
497	c.904	C	-1	357	1	422	63	1	ENST00000392038:c.904A>G	64	5	\N
498	c.3928	-	1	358	2	423	62	3	ENST00000257430:c.3928delAAGATTGGAAC	63	5	\N
499	c.3928	-	1	359	2	424	62	3	ENST00000257430:c.3928delAAGATTGGAACTAGGTCAGC	63	5	\N
500	c.4396	-	1	360	2	425	62	3	ENST00000257430:c.4396delGGACC	63	5	\N
501	c.4669	-	1	361	2	426	62	3	ENST00000257430:c.4669delATTGATTC	63	5	\N
502	c.1330	A	-1	362	1	427	23	1	ENST00000288602:c.1330C>T	23	5	\N
503	c.1390	T	-1	363	1	428	23	1	ENST00000288602:c.1390G>A	23	5	\N
504	c.1397	G	-1	160	1	429	23	1	ENST00000288602:c.1397G>C	23	5	\N
505	c.1397	T	-1	160	1	430	23	1	ENST00000288602:c.1397G>A	23	5	\N
506	c.1405	T	-1	364	1	431	23	1	ENST00000288602:c.1405G>A	23	5	\N
507	c.1405	G	-1	364	1	431	23	1	ENST00000288602:c.1405G>C	23	5	\N
508	c.1405	GA	-1	159	4	432	23	1	ENST00000288602:c.1405GG>TC	23	5	\N
509	c.1411	A	-1	365	1	433	23	1	ENST00000288602:c.1411G>T	23	5	\N
510	c.1742	C	-1	366	1	434	23	1	ENST00000288602:c.1742A>G	23	5	\N
511	c.1756	T	-1	367	1	435	23	1	ENST00000288602:c.1756G>A	23	5	\N
512	c.1760	G	-1	368	1	436	23	1	ENST00000288602:c.1760A>C	23	5	\N
513	c.1761	T	-1	369	1	437	23	1	ENST00000288602:c.1761C>A	23	5	\N
514	c.1761	C	-1	369	1	437	23	1	ENST00000288602:c.1761C>G	23	5	\N
515	c.1776	C	-1	370	1	438	23	1	ENST00000288602:c.1776A>G	23	5	\N
516	c.1774	C	-1	371	1	439	23	1	ENST00000288602:c.1774A>G	23	5	\N
517	c.1783	G	-1	372	1	440	23	1	ENST00000288602:c.1783T>C	23	5	\N
518	c.609	T	-1	373	1	441	23	1	ENST00000496384:c.609T>A	24	5	\N
519	c.1785	C	-1	373	1	440	23	1	ENST00000288602:c.1785T>G	23	5	\N
520	c.1784	G	-1	374	1	442	23	1	ENST00000288602:c.1784T>C	23	5	\N
521	c.1786	G	-1	375	1	443	23	1	ENST00000288602:c.1786G>C	23	5	\N
522	c.620	A	-1	376	1	444	23	1	ENST00000496384:c.620C>T	24	5	\N
523	c.1799	G	-1	150	1	445	23	1	ENST00000288602:c.1799T>C	23	5	\N
524	c.1799	TT	-1	149	4	184	23	1	ENST00000288602:c.1799TG>AA	23	5	\N
525	c.1798	G	-1	377	1	446	23	1	ENST00000288602:c.1798G>C	23	5	\N
526	c.1798	A	-1	377	1	446	23	1	ENST00000288602:c.1798G>T	23	5	\N
527	c.1798	T	-1	377	1	447	23	1	ENST00000288602:c.1798G>A	23	5	\N
528	c.1801	-	-1	378	2	448	23	4	ENST00000288602:c.1801delAAA	23	5	\N
529	c.1803	A	-1	379	1	449	23	1	ENST00000288602:c.1803A>T	23	5	\N
530	c.1803	G	-1	379	1	449	23	1	ENST00000288602:c.1803A>C	23	5	\N
531	c.1813	AA	-1	380	4	450	23	1	ENST00000288602:c.1813AG>TT	23	5	\N
532	c.1814	T	-1	381	1	451	23	1	ENST00000288602:c.1814G>A	23	5	\N
533	c.71	T	-1	382	1	452	64	1	ENST00000257904:c.71G>A	65	5	\N
534	c.172	A	-1	383	1	453	65	2	ENST00000446177:c.172C>T	66	5	\N
535	c.181	A	-1	384	1	454	65	2	ENST00000446177:c.181G>T	66	5	\N
536	c.205	A	-1	385	1	455	65	2	ENST00000446177:c.205G>T	66	5	\N
537	c.238	A	-1	386	1	456	65	2	ENST00000446177:c.238C>T	66	5	\N
538	c.413	A	-1	387	1	457	65	1	ENST00000361570:c.413C>T	67	5	\N
539	c.416	A	-1	388	1	458	65	1	ENST00000361570:c.416G>T	67	5	\N
540	c.262	A	-1	389	1	459	65	2	ENST00000446177:c.262G>T	66	5	\N
541	c.488	A	-1	390	1	460	65	1	ENST00000361570:c.488G>T	67	5	\N
542	c.329	T	-1	391	1	461	65	2	ENST00000446177:c.329G>A	66	5	\N
543	c.330	T	-1	392	1	461	65	2	ENST00000446177:c.330G>A	66	5	\N
544	c.341	A	-1	393	1	462	65	1	ENST00000446177:c.341C>T	66	5	\N
545	c.902	G	-1	394	1	463	49	1	ENST00000286301:c.902T>C	50	5	\N
546	c.902	T	-1	394	1	464	49	2	ENST00000286301:c.902T>A	50	5	\N
547	c.2906	C	-1	395	1	465	49	1	ENST00000286301:c.2906A>G	50	5	\N
548	c.2906	A	-1	395	1	466	49	1	ENST00000286301:c.2906A>T	50	5	\N
549	c.2905	G	-1	396	1	467	49	1	ENST00000286301:c.2905T>C	50	5	\N
550	c.2907	T	-1	397	1	468	49	2	ENST00000286301:c.2907T>A	50	5	\N
551	c.2907	C	-1	397	1	468	49	2	ENST00000286301:c.2907T>G	50	5	\N
552	c.37	A	1	398	1	469	19	1	ENST00000349496:c.37G>A	19	5	\N
553	c.61	A	1	399	1	470	19	1	ENST00000349496:c.61G>A	19	5	\N
554	c.65	C	1	400	1	471	19	1	ENST00000349496:c.65T>C	19	5	\N
555	c.64	-	1	401	2	472	19	4	ENST00000349496:c.64delGTTAGTCACTGGCAGCAACAGTCTTACCTGGACTCTGGAATCCATTCTGGT	19	5	\N
556	c.73	-	1	402	2	473	19	4	ENST00000349496:c.73delTGGCAGCAACAGTCTTACCTGGAC	19	5	\N
557	c.95	C	1	403	1	474	19	1	ENST00000349496:c.95A>C	19	5	\N
558	c.95	G	1	403	1	475	19	1	ENST00000349496:c.95A>G	19	5	\N
559	c.94	C	1	404	1	476	19	1	ENST00000349496:c.94G>C	19	5	\N
560	c.94	A	1	404	1	477	19	1	ENST00000349496:c.94G>A	19	5	\N
561	c.95	T	1	403	1	478	19	1	ENST00000349496:c.95A>T	19	5	\N
562	c.94	T	1	404	1	479	19	1	ENST00000349496:c.94G>T	19	5	\N
563	c.98	G	1	405	1	480	19	1	ENST00000349496:c.98C>G	19	5	\N
564	c.98	A	1	405	1	481	19	1	ENST00000349496:c.98C>A	19	5	\N
565	c.101	A	1	406	1	482	19	1	ENST00000349496:c.101G>A	19	5	\N
566	c.100	A	1	407	1	483	19	1	ENST00000349496:c.100G>A	19	5	\N
567	c.100	C	1	407	1	483	19	1	ENST00000349496:c.100G>C	19	5	\N
568	c.101	T	1	406	1	484	19	1	ENST00000349496:c.101G>T	19	5	\N
569	c.109	G	1	408	1	485	19	1	ENST00000349496:c.109T>G	19	5	\N
570	c.110	G	1	91	1	486	19	1	ENST00000349496:c.110C>G	19	5	\N
571	c.109	C	1	408	1	487	19	1	ENST00000349496:c.109T>C	19	5	\N
572	c.118	G	1	409	1	488	19	1	ENST00000349496:c.118A>G	19	5	\N
573	c.119	T	1	410	1	489	19	1	ENST00000349496:c.119C>T	19	5	\N
574	c.118	C	1	409	1	490	19	1	ENST00000349496:c.118A>C	19	5	\N
575	c.118	T	1	409	1	491	19	1	ENST00000349496:c.118A>T	19	5	\N
576	c.119	G	1	410	1	491	19	1	ENST00000349496:c.119C>G	19	5	\N
577	c.133	G	1	92	1	492	19	1	ENST00000349496:c.133T>G	19	5	\N
578	c.2193	A	1	411	1	493	24	2	ENST00000275493:c.2193G>A	25	5	\N
579	c.2198	T	1	412	1	494	24	1	ENST00000275493:c.2198C>T	25	5	\N
580	c.2200	A	1	413	1	495	24	1	ENST00000275493:c.2200G>A	25	5	\N
581	c.2203	A	1	414	1	496	24	1	ENST00000275493:c.2203G>A	25	5	\N
582	c.2225	C	1	415	1	497	24	1	ENST00000275493:c.2225T>C	25	5	\N
583	c.2234	G	1	416	1	498	24	1	ENST00000275493:c.2234A>G	25	5	\N
584	c.2236	A	1	417	1	499	24	1	ENST00000275493:c.2236G>A	25	5	\N
585	c.2248	C	1	418	1	500	24	1	ENST00000275493:c.2248G>C	25	5	\N
586	c.2255	A	1	419	1	501	24	1	ENST00000275493:c.2255C>A	25	5	\N
587	c.2281	A	1	420	1	502	24	1	ENST00000275493:c.2281G>A	25	5	\N
588	c.2281	T	1	420	1	503	24	1	ENST00000275493:c.2281G>T	25	5	\N
589	c.2318	G	1	421	1	504	24	1	ENST00000275493:c.2318A>G	25	5	\N
590	c.2429	A	1	422	1	505	24	1	ENST00000275493:c.2429G>A	25	5	\N
591	c.2428	A	1	423	1	506	24	1	ENST00000275493:c.2428G>A	25	5	\N
592	c.2572	A	1	424	1	507	24	1	ENST00000275493:c.2572C>A	25	5	\N
593	c.2573	GT	1	425	4	204	24	1	ENST00000275493:c.2573TG>GT	25	5	\N
594	c.2572	AG	1	426	4	204	24	1	ENST00000275493:c.2572CT>AG	25	5	\N
595	c.2573	A	1	164	1	508	24	1	ENST00000275493:c.2573T>A	25	5	\N
596	c.2354	C	1	427	1	509	12	1	ENST00000269571:c.2354T>C	12	5	\N
597	c.2326	A	1	428	1	510	12	1	ENST00000269571:c.2326G>A	12	5	\N
598	c.2326	TGT	1	429	3	511	12	3	ENST00000269571:c.2326insTGT	12	5	\N
599	c.2329	C	1	57	1	64	12	1	ENST00000269571:c.2329G>C	12	5	\N
600	c.473	A	-1	430	1	512	66	1	ENST00000425967:c.473C>T	68	5	\N
601	c.847	T	-1	431	1	513	66	1	ENST00000425967:c.847C>A	68	5	\N
602	c.929	C	-1	432	1	514	45	1	ENST00000457416:c.929A>G	46	5	\N
603	c.1118	C	-1	433	1	515	45	1	ENST00000457416:c.1118C>G	46	5	\N
604	c.1127	C	-1	434	1	516	45	1	ENST00000457416:c.1127A>G	46	5	\N
605	c.1144	G	-1	435	1	517	45	1	ENST00000457416:c.1144T>C	46	5	\N
606	c.1917	T	-1	436	1	518	45	1	ENST00000457416:c.1917T>A	46	5	\N
607	c.742	T	1	437	1	519	67	1	ENST00000340107:c.742C>T	69	5	\N
608	c.746	G	1	438	1	520	67	1	ENST00000340107:c.746C>G	69	5	\N
609	c.1114	T	1	439	1	521	67	1	ENST00000340107:c.1114G>T	69	5	\N
610	c.1117	T	1	440	1	515	67	1	ENST00000340107:c.1117A>T	69	5	\N
611	c.1124	G	1	441	1	522	67	1	ENST00000340107:c.1124A>G	69	5	\N
612	c.1954	C	1	442	1	523	67	1	ENST00000340107:c.1954A>C	69	5	\N
613	c.2095	T	1	443	1	524	67	1	ENST00000340107:c.2095G>T	69	5	\N
614	c.1715	C	-1	444	1	525	7	1	ENST00000380982:c.1715A>G	7	5	\N
615	c.2503	-	-1	445	2	526	7	4	ENST00000380982:c.2503delGAT	7	5	\N
616	c.2506	-	-1	446	2	527	7	4	ENST00000380982:c.2506delATC	7	5	\N
617	c.625	AA	-1	447	4	77	26	1	ENST00000286548:c.625CA>TT	27	5	\N
618	c.683	T	1	448	1	528	56	1	ENST00000354359:c.683A>T	57	5	\N
619	c.34	A	-1	18	1	13	5	1	ENST00000311189:c.34G>T	5	5	\N
620	c.35	T	-1	17	1	12	5	1	ENST00000311189:c.35G>A	5	5	\N
621	c.37	T	-1	16	1	30	5	1	ENST00000311189:c.37G>A	5	5	\N
622	c.38	A	-1	449	1	5	5	1	ENST00000311189:c.38G>T	5	5	\N
623	c.183	G	-1	450	1	1	5	1	ENST00000311189:c.183G>C	5	5	\N
624	c.183	A	-1	450	1	1	5	1	ENST00000311189:c.183G>T	5	5	\N
625	c.181	T	-1	451	1	4	5	1	ENST00000311189:c.181C>A	5	5	\N
626	c.182	A	-1	15	1	2	5	1	ENST00000311189:c.182A>T	5	5	\N
627	c.182	G	-1	15	1	29	5	1	ENST00000311189:c.182A>C	5	5	\N
628	c.182	TC	-1	452	4	24	5	1	ENST00000311189:c.182AG>GA	5	5	\N
629	c.182	AC	-1	452	4	24	5	1	ENST00000311189:c.182AG>GT	5	5	\N
630	c.394	T	-1	453	1	529	39	1	ENST00000458235:c.394C>A	40	5	\N
631	c.1715	A	-1	454	1	530	39	1	ENST00000458235:c.1715C>T	40	5	\N
632	c.2164	T	-1	455	1	531	39	1	ENST00000458235:c.2164G>A	40	5	\N
633	c.154	A	1	456	1	532	21	1	ENST00000288135:c.154G>A	21	5	\N
634	c.1669	A	1	457	1	131	21	1	ENST00000288135:c.1669G>A	21	5	\N
635	c.1669	C	1	457	1	131	21	1	ENST00000288135:c.1669G>C	21	5	\N
636	c.2474	C	1	458	1	533	21	1	ENST00000288135:c.2474T>C	21	5	\N
637	c.2515	A	1	459	1	534	21	1	ENST00000288135:c.2515G>A	21	5	\N
638	c.57	A	-1	460	1	535	6	1	ENST00000256078:c.57G>T	6	5	\N
639	c.57	G	-1	460	1	535	6	1	ENST00000256078:c.57G>C	6	5	\N
640	c.64	T	-1	461	1	536	6	1	ENST00000256078:c.64C>A	6	5	\N
641	c.175	T	-1	462	1	537	6	1	ENST00000256078:c.175G>A	6	5	\N
642	c.181	C	-1	24	1	3	6	1	ENST00000256078:c.181C>G	6	5	\N
643	c.361	A	1	463	1	48	10	1	ENST00000307102:c.361T>A	10	5	\N
644	c.3334	T	1	464	1	538	40	1	ENST00000318493:c.3334C>T	41	5	\N
645	c.3742	C	1	465	1	539	40	1	ENST00000318493:c.3742T>C	41	5	\N
646	c.1151	A	1	466	1	540	68	1	ENST00000231790:c.1151T>A	70	5	\N
647	c.169	T	1	467	1	541	69	1	ENST00000377970:c.169C>T	71	5	\N
648	c.176	T	1	468	1	542	69	1	ENST00000377970:c.176C>T	71	5	\N
649	c.218	T	1	469	1	543	69	1	ENST00000377970:c.218C>T	71	5	\N
650	c.230	T	1	470	1	544	69	1	ENST00000377970:c.230C>T	71	5	\N
651	c.302	C	1	471	1	545	69	1	ENST00000377970:c.302A>C	71	5	\N
652	c.778	G	1	472	1	546	69	1	ENST00000377970:c.778C>G	71	5	\N
653	c.37	T	-1	5	1	30	1	1	ENST00000369535:c.37G>A	1	5	\N
654	c.52	T	-1	473	1	547	1	1	ENST00000369535:c.52G>A	1	5	\N
655	c.181	CT	-1	474	4	24	1	1	ENST00000369535:c.181CA>AG	1	5	\N
656	c.2521	-	1	475	2	548	20	4	ENST00000257290:c.2521delAGAGAC	20	5	\N
657	c.2524	AT	1	476	4	549	20	1	ENST00000257290:c.2524GA>AT	20	5	\N
658	c.2524	T	1	477	1	550	20	1	ENST00000257290:c.2524G>T	20	5	\N
659	c.2524	-	1	478	2	551	20	4	ENST00000257290:c.2524delGACATCATG	20	5	\N
660	c.2524	-	1	479	2	552	20	4	ENST00000257290:c.2524delGACATCATGCAT	20	5	\N
661	c.2527	-	1	480	2	553	20	4	ENST00000257290:c.2527delATCATGCATGAT	20	5	\N
662	c.2536	T	1	481	1	554	20	1	ENST00000257290:c.2536G>T	20	5	\N
663	c.263	A	1	482	1	555	18	1	ENST00000263967:c.263G>A	18	5	\N
664	c.1035	A	1	483	1	556	18	1	ENST00000263967:c.1035T>A	18	5	\N
665	c.1035	G	1	483	1	556	18	1	ENST00000263967:c.1035T>G	18	5	\N
666	c.1258	C	1	484	1	557	18	1	ENST00000263967:c.1258T>C	18	5	\N
667	c.1616	G	1	485	1	558	18	1	ENST00000263967:c.1616C>G	18	5	\N
668	c.1624	C	1	84	1	559	18	1	ENST00000263967:c.1624G>C	18	5	\N
669	c.1635	T	1	486	1	560	18	1	ENST00000263967:c.1635G>T	18	5	\N
670	c.1635	C	1	486	1	560	18	1	ENST00000263967:c.1635G>C	18	5	\N
671	c.2102	C	1	487	1	561	18	1	ENST00000263967:c.2102A>C	18	5	\N
672	c.3062	G	1	488	1	562	18	1	ENST00000263967:c.3062A>G	18	5	\N
673	c.3129	T	1	489	1	563	18	1	ENST00000263967:c.3129G>T	18	5	\N
674	c.3129	A	1	489	1	563	18	1	ENST00000263967:c.3129G>A	18	5	\N
675	c.3145	A	1	490	1	564	18	1	ENST00000263967:c.3145G>A	18	5	\N
676	c.1126	A	1	491	1	565	70	1	ENST00000396611:c.1126G>A	72	5	\N
677	c.1126	C	1	491	1	565	70	1	ENST00000396611:c.1126G>C	72	5	\N
678	c.1315	-	1	492	2	566	70	3	ENST00000396611:c.1315delGAA	72	5	\N
679	c.1381	T	1	493	1	567	70	2	ENST00000396611:c.1381C>T	72	5	\N
680	c.1678	T	1	494	1	568	70	1	ENST00000396611:c.1678G>T	72	5	\N
681	c.1678	-	1	495	2	569	70	4	ENST00000396611:c.1678delGACAAACGTATGAACAGC	72	5	\N
682	c.1690	G	1	496	1	570	70	1	ENST00000396611:c.1690A>G	72	5	\N
683	c.1692	A	1	497	1	571	70	1	ENST00000396611:c.1692C>A	72	5	\N
684	c.1692	G	1	497	1	571	70	1	ENST00000396611:c.1692C>G	72	5	\N
685	c.1726	-	1	498	2	572	70	4	ENST00000396611:c.1726delACG	72	5	\N
686	c.1747	-	1	499	2	573	70	3	ENST00000396611:c.1747delTGG	72	5	\N
687	c.517	T	1	500	1	574	4	1	ENST00000371953:c.517C>T	4	5	\N
688	c.518	A	1	501	1	575	4	1	ENST00000371953:c.518G>A	4	5	\N
689	c.700	T	1	502	1	576	4	1	ENST00000371953:c.700C>T	4	5	\N
690	c.1003	T	1	503	1	577	4	2	ENST00000371953:c.1003C>T	4	5	\N
691	c.409	T	1	504	1	578	71	2	ENST00000267163:c.409G>T	73	5	\N
692	c.596	A	1	505	1	579	71	2	ENST00000267163:c.596T>A	73	5	\N
693	c.958	T	1	506	1	580	71	2	ENST00000267163:c.958C>T	73	5	\N
694	c.1072	T	1	507	1	581	71	2	ENST00000267163:c.1072C>T	73	5	\N
695	c.1363	T	1	508	1	582	71	2	ENST00000267163:c.1363C>T	73	5	\N
696	c.1654	T	1	509	1	583	71	2	ENST00000267163:c.1654C>T	73	5	\N
697	c.1666	T	1	510	1	584	71	2	ENST00000267163:c.1666C>T	73	5	\N
698	c.1735	T	1	511	1	585	71	2	ENST00000267163:c.1735C>T	73	5	\N
699	c.2117	T	1	512	1	586	71	1	ENST00000267163:c.2117G>T	73	5	\N
700	c.2242	T	1	513	1	587	71	2	ENST00000267163:c.2242G>T	73	5	\N
701	c.1834	-	1	514	2	588	3	4	ENST00000355710:c.1834delTTCCCTGAGGAGGAGAAGTGCTTCTGC	3	5	\N
702	c.1892	G	1	515	1	589	3	1	ENST00000355710:c.1892A>G	3	5	\N
703	c.1894	-	1	516	2	590	3	4	ENST00000355710:c.1894delGAGCTG	3	5	\N
704	c.1900	C	1	517	1	591	3	1	ENST00000355710:c.1900T>C	3	5	\N
705	c.1901	A	1	518	1	592	3	1	ENST00000355710:c.1901G>A	3	5	\N
706	c.2304	C	1	519	1	593	3	1	ENST00000355710:c.2304G>C	3	5	\N
707	c.2647	TT	1	520	4	594	3	1	ENST00000355710:c.2647GC>TT	3	5	\N
708	c.2692	-	1	521	2	595	3	4	ENST00000355710:c.2692delGATGTTTATGAA	3	5	\N
709	c.1609	T	1	522	1	596	72	2	ENST00000360723:c.1609C>T	74	5	\N
710	c.109	T	1	523	1	597	55	2	ENST00000326873:c.109C>T	56	5	\N
711	c.508	T	1	524	1	598	55	2	ENST00000326873:c.508C>T	56	5	\N
712	c.580	A	1	525	1	599	55	1	ENST00000326873:c.580G>A	56	5	\N
713	c.581	T	1	526	1	600	55	1	ENST00000326873:c.581A>T	56	5	\N
714	c.587	T	1	527	1	601	55	1	ENST00000326873:c.587G>T	56	5	\N
715	c.595	A	1	528	1	602	55	1	ENST00000326873:c.595G>A	56	5	\N
716	c.595	T	1	528	1	603	55	2	ENST00000326873:c.595G>T	56	5	\N
717	c.842	T	1	529	1	604	55	1	ENST00000326873:c.842C>T	56	5	\N
718	c.996	A	1	530	1	605	55	2	ENST00000326873:c.996G>A	56	5	\N
719	c.524	T	-1	531	1	606	30	1	ENST00000269305:c.524G>A	31	5	\N
720	c.733	T	-1	532	1	607	30	1	ENST00000269305:c.733G>A	31	5	\N
721	c.742	A	-1	533	1	608	30	1	ENST00000269305:c.742C>T	31	5	\N
722	c.916	A	-1	534	1	609	30	2	ENST00000269305:c.916C>T	31	5	\N
723	c.241	T	1	535	1	610	73	1	ENST00000256474:c.241C>T	75	5	\N
724	c.254	C	1	536	1	611	73	1	ENST00000256474:c.254T>C	75	5	\N
725	c.266	A	1	537	1	612	73	1	ENST00000256474:c.266T>A	75	5	\N
726	c.473	A	1	538	1	613	73	1	ENST00000256474:c.473T>A	75	5	\N
727	c.481	T	1	539	1	614	73	2	ENST00000256474:c.481C>T	75	5	\N
728	c.499	T	1	540	1	615	73	1	ENST00000256474:c.499C>T	75	5	\N
\.


--
-- Data for Name: versions; Type: TABLE DATA; Schema: public; Owner: acoffman
--

COPY versions (id, name, sort_order, is_current, import_date, created_at, updated_at) FROM stdin;
1	0	\N	f	\N	2016-05-18 20:38:34.148828	2016-05-18 20:38:34.165979
2	1	\N	f	\N	2016-05-18 20:38:34.169673	2016-05-18 21:26:07.211381
3	2	\N	t	\N	2016-05-18 21:26:07.21473	2016-05-18 21:26:07.21473
\.


--
-- Data for Name: disease_source_variants; Type: TABLE DATA; Schema: public; Owner: acoffman
--

COPY disease_source_variants (id, disease_id, source_id, variant_id, my_cancer_genome_url, civic_url, version_id, meta, batch_id, created_at, updated_at) FROM stdin;
1	1	1	1	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/nras/81"}}}	1	2016-05-18 20:38:34.636988	2016-05-18 20:38:34.677118
2	1	2	1	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/nras/81"}}}	1	2016-05-18 20:38:34.714365	2016-05-18 20:38:34.728101
3	1	3	1	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/nras/81"}}}	1	2016-05-18 20:38:34.768998	2016-05-18 20:38:34.781136
4	1	5	2	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/nras/76"}}}	1	2016-05-18 20:38:34.832926	2016-05-18 20:38:34.842925
5	1	6	3	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/nras/97"}}}	1	2016-05-18 20:38:34.898235	2016-05-18 20:38:34.90894
6	1	7	3	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/nras/97"}}}	1	2016-05-18 20:38:34.944503	2016-05-18 20:38:34.959617
7	3	7	4	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/nras/75"}}}	1	2016-05-18 20:38:35.010199	2016-05-18 20:38:35.021852
8	1	8	4	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/nras/75"}}}	1	2016-05-18 20:38:35.054098	2016-05-18 20:38:35.071241
9	1	9	4	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/nras/75"}}}	1	2016-05-18 20:38:35.108033	2016-05-18 20:38:35.118558
10	1	10	4	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/nras/75"}}}	1	2016-05-18 20:38:35.152034	2016-05-18 20:38:35.171641
11	1	11	4	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/nras/75"}}}	1	2016-05-18 20:38:35.207661	2016-05-18 20:38:35.219032
12	2	9	4	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/nras/75"}}}	1	2016-05-18 20:38:35.252204	2016-05-18 20:38:35.270445
13	2	12	4	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/nras/75"}}}	1	2016-05-18 20:38:35.30908	2016-05-18 20:38:35.31981
14	2	13	4	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/nras/75"}}}	1	2016-05-18 20:38:35.352953	2016-05-18 20:38:35.370776
15	2	7	4	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/nras/75"}}}	1	2016-05-18 20:38:35.409992	2016-05-18 20:38:35.421086
16	4	9	4	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/75"}}}	1	2016-05-18 20:38:35.454106	2016-05-18 20:38:35.472805
17	4	12	4	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/75"}}}	1	2016-05-18 20:38:35.505435	2016-05-18 20:38:35.516385
18	4	13	4	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/75"}}}	1	2016-05-18 20:38:35.546044	2016-05-18 20:38:35.557522
19	4	7	4	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/75"}}}	1	2016-05-18 20:38:35.604153	2016-05-18 20:38:35.614098
20	1	9	5	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/nras/94"}}}	1	2016-05-18 20:38:35.673783	2016-05-18 20:38:35.685124
21	1	12	5	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/nras/94"}}}	1	2016-05-18 20:38:35.717207	2016-05-18 20:38:35.72907
22	1	13	5	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/nras/94"}}}	1	2016-05-18 20:38:35.778856	2016-05-18 20:38:35.790193
23	1	7	5	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/nras/94"}}}	1	2016-05-18 20:38:35.821735	2016-05-18 20:38:35.836089
24	1	14	6	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/nras/91"}}}	1	2016-05-18 20:38:35.885691	2016-05-18 20:38:35.897154
25	1	15	6	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/nras/91"}}}	1	2016-05-18 20:38:35.941914	2016-05-18 20:38:35.951999
26	1	16	6	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/nras/91"}}}	1	2016-05-18 20:38:36.005737	2016-05-18 20:38:36.016005
27	1	3	6	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/nras/91"}}}	1	2016-05-18 20:38:36.048015	2016-05-18 20:38:36.059707
28	1	17	7	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/nras/92"}}}	1	2016-05-18 20:38:36.114898	2016-05-18 20:38:36.126093
1662	1	1	1	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/nras/81"}}}	1	2016-05-18 21:26:07.340281	2016-05-18 21:26:07.340281
1663	1	2	1	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/nras/81"}}}	1	2016-05-18 21:26:07.364481	2016-05-18 21:26:07.364481
1664	1	3	1	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/nras/81"}}}	1	2016-05-18 21:26:07.382401	2016-05-18 21:26:07.382401
1665	1	5	2	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/nras/76"}}}	1	2016-05-18 21:26:07.396962	2016-05-18 21:26:07.396962
1666	1	6	3	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/nras/97"}}}	1	2016-05-18 21:26:07.413767	2016-05-18 21:26:07.413767
1667	1	7	3	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/nras/97"}}}	1	2016-05-18 21:26:07.431252	2016-05-18 21:26:07.431252
1668	3	7	4	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/nras/75"}}}	1	2016-05-18 21:26:07.450129	2016-05-18 21:26:07.450129
1669	1	8	4	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/nras/75"}}}	1	2016-05-18 21:26:07.467452	2016-05-18 21:26:07.467452
1670	1	9	4	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/nras/75"}}}	1	2016-05-18 21:26:07.484403	2016-05-18 21:26:07.484403
3100	8	74	34	\N	\N	3	\N	2	2016-05-18 21:26:44.096776	2016-05-18 21:26:44.096776
3101	8	75	34	\N	\N	3	\N	2	2016-05-18 21:26:44.115763	2016-05-18 21:26:44.115763
29	1	18	7	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/nras/92"}}}	1	2016-05-18 20:38:36.1709	2016-05-18 20:38:36.18339
30	1	19	7	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/nras/92"}}}	1	2016-05-18 20:38:36.213978	2016-05-18 20:38:36.224588
31	1	15	7	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/nras/92"}}}	1	2016-05-18 20:38:36.257179	2016-05-18 20:38:36.282519
32	1	3	7	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/nras/92"}}}	1	2016-05-18 20:38:36.313614	2016-05-18 20:38:36.324104
33	1	15	8	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/nras/297"}}}	1	2016-05-18 20:38:36.38466	2016-05-18 20:38:36.39694
34	1	16	8	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/nras/297"}}}	1	2016-05-18 20:38:36.445584	2016-05-18 20:38:36.456165
35	1	20	8	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/nras/297"}}}	1	2016-05-18 20:38:36.503229	2016-05-18 20:38:36.514942
36	1	21	8	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/nras/297"}}}	1	2016-05-18 20:38:36.555069	2016-05-18 20:38:36.566132
37	1	22	8	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/nras/297"}}}	1	2016-05-18 20:38:36.599434	2016-05-18 20:38:36.611991
38	1	23	8	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/nras/297"}}}	1	2016-05-18 20:38:36.651697	2016-05-18 20:38:36.661665
39	1	24	8	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/nras/297"}}}	1	2016-05-18 20:38:36.695753	2016-05-18 20:38:36.708838
40	1	3	8	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/nras/297"}}}	1	2016-05-18 20:38:36.751362	2016-05-18 20:38:36.762358
41	1	16	9	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/nras/93"}}}	1	2016-05-18 20:38:36.819607	2016-05-18 20:38:36.830164
42	1	20	9	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/nras/93"}}}	1	2016-05-18 20:38:36.861385	2016-05-18 20:38:36.881111
43	1	25	9	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/nras/93"}}}	1	2016-05-18 20:38:36.907948	2016-05-18 20:38:36.923922
44	1	23	9	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/nras/93"}}}	1	2016-05-18 20:38:36.955238	2016-05-18 20:38:36.966417
45	1	24	9	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/nras/93"}}}	1	2016-05-18 20:38:36.99677	2016-05-18 20:38:37.02218
46	1	21	9	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/nras/93"}}}	1	2016-05-18 20:38:37.054194	2016-05-18 20:38:37.065343
47	1	3	9	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/nras/93"}}}	1	2016-05-18 20:38:37.103001	2016-05-18 20:38:37.120988
48	1	15	10	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/nras/90"}}}	1	2016-05-18 20:38:37.165899	2016-05-18 20:38:37.189002
49	1	17	10	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/nras/90"}}}	1	2016-05-18 20:38:37.220392	2016-05-18 20:38:37.231933
50	1	26	10	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/nras/90"}}}	1	2016-05-18 20:38:37.26624	2016-05-18 20:38:37.291756
51	1	27	10	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/nras/90"}}}	1	2016-05-18 20:38:37.325724	2016-05-18 20:38:37.336069
52	1	3	10	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/nras/90"}}}	1	2016-05-18 20:38:37.386133	2016-05-18 20:38:37.397389
53	4	15	10	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/90"}}}	1	2016-05-18 20:38:37.429162	2016-05-18 20:38:37.44241
54	4	16	10	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/90"}}}	1	2016-05-18 20:38:37.485841	2016-05-18 20:38:37.496882
55	4	21	10	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/90"}}}	1	2016-05-18 20:38:37.528042	2016-05-18 20:38:37.539922
56	4	28	10	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/90"}}}	1	2016-05-18 20:38:37.585854	2016-05-18 20:38:37.596574
1671	1	10	4	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/nras/75"}}}	1	2016-05-18 21:26:07.50607	2016-05-18 21:26:07.50607
1672	1	11	4	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/nras/75"}}}	1	2016-05-18 21:26:07.527983	2016-05-18 21:26:07.527983
1673	2	9	4	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/nras/75"}}}	1	2016-05-18 21:26:07.543985	2016-05-18 21:26:07.543985
1674	2	12	4	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/nras/75"}}}	1	2016-05-18 21:26:07.56077	2016-05-18 21:26:07.56077
1675	2	13	4	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/nras/75"}}}	1	2016-05-18 21:26:07.578729	2016-05-18 21:26:07.578729
1676	2	7	4	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/nras/75"}}}	1	2016-05-18 21:26:07.598068	2016-05-18 21:26:07.598068
1677	4	9	4	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/75"}}}	1	2016-05-18 21:26:07.614796	2016-05-18 21:26:07.614796
1678	4	12	4	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/75"}}}	1	2016-05-18 21:26:07.632671	2016-05-18 21:26:07.632671
1679	4	13	4	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/75"}}}	1	2016-05-18 21:26:07.650444	2016-05-18 21:26:07.650444
3102	8	76	34	\N	\N	3	\N	2	2016-05-18 21:26:44.133447	2016-05-18 21:26:44.133447
3103	8	77	34	\N	\N	3	\N	2	2016-05-18 21:26:44.148568	2016-05-18 21:26:44.148568
57	4	29	10	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/90"}}}	1	2016-05-18 20:38:37.627979	2016-05-18 20:38:37.640492
58	4	24	10	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/90"}}}	1	2016-05-18 20:38:37.668863	2016-05-18 20:38:37.694769
59	4	3	10	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/90"}}}	1	2016-05-18 20:38:37.728001	2016-05-18 20:38:37.740273
60	1	15	11	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/nras/85"}}}	1	2016-05-18 20:38:37.795263	2016-05-18 20:38:37.806148
61	1	16	11	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/nras/85"}}}	1	2016-05-18 20:38:37.835572	2016-05-18 20:38:37.847943
62	1	20	11	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/nras/85"}}}	1	2016-05-18 20:38:37.880013	2016-05-18 20:38:37.891361
63	1	21	11	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/nras/85"}}}	1	2016-05-18 20:38:37.92337	2016-05-18 20:38:37.935556
64	1	22	11	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/nras/85"}}}	1	2016-05-18 20:38:37.970154	2016-05-18 20:38:37.981313
65	1	19	11	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/nras/85"}}}	1	2016-05-18 20:38:38.013589	2016-05-18 20:38:38.02756
66	1	23	11	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/nras/85"}}}	1	2016-05-18 20:38:38.056648	2016-05-18 20:38:38.067637
67	1	24	11	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/nras/85"}}}	1	2016-05-18 20:38:38.097255	2016-05-18 20:38:38.10908
68	1	27	11	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/nras/85"}}}	1	2016-05-18 20:38:38.137848	2016-05-18 20:38:38.148498
69	1	29	11	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/nras/85"}}}	1	2016-05-18 20:38:38.178741	2016-05-18 20:38:38.195664
70	1	17	11	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/nras/85"}}}	1	2016-05-18 20:38:38.225274	2016-05-18 20:38:38.236229
71	1	3	11	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/nras/85"}}}	1	2016-05-18 20:38:38.265482	2016-05-18 20:38:38.276486
72	2	30	11	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/nras/85"}}}	1	2016-05-18 20:38:38.307637	2016-05-18 20:38:38.321255
73	2	31	11	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/nras/85"}}}	1	2016-05-18 20:38:38.349088	2016-05-18 20:38:38.359904
74	2	32	11	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/nras/85"}}}	1	2016-05-18 20:38:38.393236	2016-05-18 20:38:38.403606
75	4	33	11	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/85"}}}	1	2016-05-18 20:38:38.433346	2016-05-18 20:38:38.445374
76	4	34	11	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/85"}}}	1	2016-05-18 20:38:38.476767	2016-05-18 20:38:38.488818
77	4	35	11	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/85"}}}	1	2016-05-18 20:38:38.52589	2016-05-18 20:38:38.535572
78	4	36	11	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/85"}}}	1	2016-05-18 20:38:38.572122	2016-05-18 20:38:38.58358
79	4	37	11	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/85"}}}	1	2016-05-18 20:38:38.626384	2016-05-18 20:38:38.635716
80	4	38	11	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/85"}}}	1	2016-05-18 20:38:38.666853	2016-05-18 20:38:38.677152
81	4	39	11	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/85"}}}	1	2016-05-18 20:38:38.726044	2016-05-18 20:38:38.735304
82	4	40	11	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/85"}}}	1	2016-05-18 20:38:38.772144	2016-05-18 20:38:38.783812
83	4	41	11	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/85"}}}	1	2016-05-18 20:38:38.82654	2016-05-18 20:38:38.835941
84	4	42	11	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/85"}}}	1	2016-05-18 20:38:38.873349	2016-05-18 20:38:38.884526
1680	4	7	4	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/75"}}}	1	2016-05-18 21:26:07.669583	2016-05-18 21:26:07.669583
1681	1	9	5	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/nras/94"}}}	1	2016-05-18 21:26:07.691924	2016-05-18 21:26:07.691924
1682	1	12	5	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/nras/94"}}}	1	2016-05-18 21:26:07.712222	2016-05-18 21:26:07.712222
1683	1	13	5	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/nras/94"}}}	1	2016-05-18 21:26:07.7281	2016-05-18 21:26:07.7281
1684	1	7	5	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/nras/94"}}}	1	2016-05-18 21:26:07.745847	2016-05-18 21:26:07.745847
1685	1	14	6	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/nras/91"}}}	1	2016-05-18 21:26:07.767034	2016-05-18 21:26:07.767034
1686	1	15	6	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/nras/91"}}}	1	2016-05-18 21:26:07.782652	2016-05-18 21:26:07.782652
1687	1	16	6	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/nras/91"}}}	1	2016-05-18 21:26:07.804345	2016-05-18 21:26:07.804345
1688	1	3	6	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/nras/91"}}}	1	2016-05-18 21:26:07.820842	2016-05-18 21:26:07.820842
3104	8	78	34	\N	\N	3	\N	2	2016-05-18 21:26:44.166526	2016-05-18 21:26:44.166526
85	4	43	11	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/85"}}}	1	2016-05-18 20:38:38.926921	2016-05-18 20:38:38.936945
86	4	44	11	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/85"}}}	1	2016-05-18 20:38:38.975193	2016-05-18 20:38:38.989312
87	4	45	11	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/85"}}}	1	2016-05-18 20:38:39.018281	2016-05-18 20:38:39.034977
88	4	46	11	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/85"}}}	1	2016-05-18 20:38:39.078033	2016-05-18 20:38:39.091621
89	4	47	11	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/85"}}}	1	2016-05-18 20:38:39.127634	2016-05-18 20:38:39.136515
90	4	48	11	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/85"}}}	1	2016-05-18 20:38:39.175246	2016-05-18 20:38:39.187872
91	4	49	11	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/85"}}}	1	2016-05-18 20:38:39.229171	2016-05-18 20:38:39.238594
92	4	50	11	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/85"}}}	1	2016-05-18 20:38:39.278982	2016-05-18 20:38:39.290546
93	1	33	12	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/nras/87"}}}	1	2016-05-18 20:38:39.337783	2016-05-18 20:38:39.349804
94	1	34	12	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/nras/87"}}}	1	2016-05-18 20:38:39.379204	2016-05-18 20:38:39.408951
95	1	35	12	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/nras/87"}}}	1	2016-05-18 20:38:39.438834	2016-05-18 20:38:39.450073
96	1	36	12	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/nras/87"}}}	1	2016-05-18 20:38:39.488837	2016-05-18 20:38:39.503456
97	1	51	12	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/nras/87"}}}	1	2016-05-18 20:38:39.539731	2016-05-18 20:38:39.550086
98	2	33	12	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/nras/87"}}}	1	2016-05-18 20:38:39.583181	2016-05-18 20:38:39.610719
99	2	34	12	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/nras/87"}}}	1	2016-05-18 20:38:39.643445	2016-05-18 20:38:39.655859
100	2	35	12	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/nras/87"}}}	1	2016-05-18 20:38:39.701865	2016-05-18 20:38:39.711889
101	2	36	12	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/nras/87"}}}	1	2016-05-18 20:38:39.741979	2016-05-18 20:38:39.753773
102	2	52	12	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/nras/87"}}}	1	2016-05-18 20:38:39.783028	2016-05-18 20:38:39.811156
103	2	53	12	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/nras/87"}}}	1	2016-05-18 20:38:39.841809	2016-05-18 20:38:39.854219
104	2	54	12	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/nras/87"}}}	1	2016-05-18 20:38:39.891741	2016-05-18 20:38:39.9108
105	2	51	12	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/nras/87"}}}	1	2016-05-18 20:38:39.940644	2016-05-18 20:38:39.951513
106	4	33	12	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/87"}}}	1	2016-05-18 20:38:39.989924	2016-05-18 20:38:40.010205
107	4	34	12	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/87"}}}	1	2016-05-18 20:38:40.040905	2016-05-18 20:38:40.051176
108	4	35	12	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/87"}}}	1	2016-05-18 20:38:40.083944	2016-05-18 20:38:40.104605
109	4	55	12	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/87"}}}	1	2016-05-18 20:38:40.144464	2016-05-18 20:38:40.155986
110	4	36	12	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/87"}}}	1	2016-05-18 20:38:40.187078	2016-05-18 20:38:40.207002
111	4	51	12	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/87"}}}	1	2016-05-18 20:38:40.244463	2016-05-18 20:38:40.255718
1689	1	17	7	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/nras/92"}}}	1	2016-05-18 21:26:07.839595	2016-05-18 21:26:07.839595
1690	1	18	7	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/nras/92"}}}	1	2016-05-18 21:26:07.857408	2016-05-18 21:26:07.857408
1691	1	19	7	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/nras/92"}}}	1	2016-05-18 21:26:07.873691	2016-05-18 21:26:07.873691
1692	1	15	7	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/nras/92"}}}	1	2016-05-18 21:26:07.89054	2016-05-18 21:26:07.89054
1693	1	3	7	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/nras/92"}}}	1	2016-05-18 21:26:07.907081	2016-05-18 21:26:07.907081
1694	1	15	8	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/nras/297"}}}	1	2016-05-18 21:26:07.925999	2016-05-18 21:26:07.925999
1695	1	16	8	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/nras/297"}}}	1	2016-05-18 21:26:07.943555	2016-05-18 21:26:07.943555
1696	1	20	8	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/nras/297"}}}	1	2016-05-18 21:26:07.965143	2016-05-18 21:26:07.965143
1697	1	21	8	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/nras/297"}}}	1	2016-05-18 21:26:07.97986	2016-05-18 21:26:07.97986
1698	1	22	8	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/nras/297"}}}	1	2016-05-18 21:26:07.999671	2016-05-18 21:26:07.999671
3105	8	79	34	\N	\N	3	\N	2	2016-05-18 21:26:44.181716	2016-05-18 21:26:44.181716
112	1	33	13	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/nras/86"}}}	1	2016-05-18 20:38:40.308812	2016-05-18 20:38:40.319089
113	1	34	13	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/nras/86"}}}	1	2016-05-18 20:38:40.357052	2016-05-18 20:38:40.375214
114	1	35	13	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/nras/86"}}}	1	2016-05-18 20:38:40.411267	2016-05-18 20:38:40.422029
115	1	55	13	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/nras/86"}}}	1	2016-05-18 20:38:40.452992	2016-05-18 20:38:40.468136
116	1	36	13	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/nras/86"}}}	1	2016-05-18 20:38:40.509639	2016-05-18 20:38:40.520508
117	1	51	13	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/nras/86"}}}	1	2016-05-18 20:38:40.556278	2016-05-18 20:38:40.569606
118	2	33	13	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/nras/86"}}}	1	2016-05-18 20:38:40.611533	2016-05-18 20:38:40.622565
119	2	34	13	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/nras/86"}}}	1	2016-05-18 20:38:40.653152	2016-05-18 20:38:40.66745
120	2	35	13	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/nras/86"}}}	1	2016-05-18 20:38:40.71503	2016-05-18 20:38:40.72511
121	2	55	13	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/nras/86"}}}	1	2016-05-18 20:38:40.759904	2016-05-18 20:38:40.77804
122	2	36	13	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/nras/86"}}}	1	2016-05-18 20:38:40.817865	2016-05-18 20:38:40.828296
123	2	51	13	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/nras/86"}}}	1	2016-05-18 20:38:40.859017	2016-05-18 20:38:40.878805
124	4	56	13	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/86"}}}	1	2016-05-18 20:38:40.91315	2016-05-18 20:38:40.924487
125	1	57	14	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/nras/88"}}}	1	2016-05-18 20:38:40.980842	2016-05-18 20:38:40.991596
126	1	58	14	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/nras/88"}}}	1	2016-05-18 20:38:41.024792	2016-05-18 20:38:41.038847
127	1	59	14	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/nras/88"}}}	1	2016-05-18 20:38:41.083849	2016-05-18 20:38:41.094888
128	1	60	14	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/nras/88"}}}	1	2016-05-18 20:38:41.127526	2016-05-18 20:38:41.141519
129	1	61	14	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/nras/88"}}}	1	2016-05-18 20:38:41.179618	2016-05-18 20:38:41.18941
130	1	62	14	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/nras/88"}}}	1	2016-05-18 20:38:41.220308	2016-05-18 20:38:41.231746
131	1	63	14	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/nras/88"}}}	1	2016-05-18 20:38:41.281246	2016-05-18 20:38:41.291554
132	1	64	14	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/nras/88"}}}	1	2016-05-18 20:38:41.325637	2016-05-18 20:38:41.343883
133	2	57	14	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/nras/88"}}}	1	2016-05-18 20:38:41.387875	2016-05-18 20:38:41.398697
134	2	58	14	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/nras/88"}}}	1	2016-05-18 20:38:41.430179	2016-05-18 20:38:41.449607
135	2	59	14	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/nras/88"}}}	1	2016-05-18 20:38:41.489343	2016-05-18 20:38:41.501024
136	2	60	14	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/nras/88"}}}	1	2016-05-18 20:38:41.531268	2016-05-18 20:38:41.550892
137	2	61	14	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/nras/88"}}}	1	2016-05-18 20:38:41.591864	2016-05-18 20:38:41.603305
138	2	62	14	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/nras/88"}}}	1	2016-05-18 20:38:41.634312	2016-05-18 20:38:41.652366
139	2	63	14	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/nras/88"}}}	1	2016-05-18 20:38:41.695467	2016-05-18 20:38:41.707168
1699	1	23	8	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/nras/297"}}}	1	2016-05-18 21:26:08.018085	2016-05-18 21:26:08.018085
1700	1	24	8	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/nras/297"}}}	1	2016-05-18 21:26:08.039227	2016-05-18 21:26:08.039227
1701	1	3	8	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/nras/297"}}}	1	2016-05-18 21:26:08.057033	2016-05-18 21:26:08.057033
1702	1	16	9	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/nras/93"}}}	1	2016-05-18 21:26:08.081576	2016-05-18 21:26:08.081576
1703	1	20	9	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/nras/93"}}}	1	2016-05-18 21:26:08.098715	2016-05-18 21:26:08.098715
1704	1	25	9	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/nras/93"}}}	1	2016-05-18 21:26:08.119102	2016-05-18 21:26:08.119102
1705	1	23	9	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/nras/93"}}}	1	2016-05-18 21:26:08.139261	2016-05-18 21:26:08.139261
1706	1	24	9	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/nras/93"}}}	1	2016-05-18 21:26:08.156284	2016-05-18 21:26:08.156284
1707	1	21	9	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/nras/93"}}}	1	2016-05-18 21:26:08.17338	2016-05-18 21:26:08.17338
3106	8	80	34	\N	\N	3	\N	2	2016-05-18 21:26:44.204394	2016-05-18 21:26:44.204394
3107	8	81	34	\N	\N	3	\N	2	2016-05-18 21:26:44.2203	2016-05-18 21:26:44.2203
140	2	64	14	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/nras/88"}}}	1	2016-05-18 20:38:41.748262	2016-05-18 20:38:41.757975
141	1	57	15	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/nras/89"}}}	1	2016-05-18 20:38:41.799973	2016-05-18 20:38:41.819262
142	1	58	15	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/nras/89"}}}	1	2016-05-18 20:38:41.850429	2016-05-18 20:38:41.860363
143	1	59	15	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/nras/89"}}}	1	2016-05-18 20:38:41.892757	2016-05-18 20:38:41.904767
144	1	60	15	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/nras/89"}}}	1	2016-05-18 20:38:41.953988	2016-05-18 20:38:41.964285
145	1	61	15	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/nras/89"}}}	1	2016-05-18 20:38:41.995614	2016-05-18 20:38:42.008121
146	1	62	15	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/nras/89"}}}	1	2016-05-18 20:38:42.051696	2016-05-18 20:38:42.06239
147	1	63	15	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/nras/89"}}}	1	2016-05-18 20:38:42.093924	2016-05-18 20:38:42.106037
148	1	64	15	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/nras/89"}}}	1	2016-05-18 20:38:42.151286	2016-05-18 20:38:42.161057
149	2	57	15	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/kras/41"}}}	1	2016-05-18 20:38:42.193047	2016-05-18 20:38:42.204004
150	2	58	15	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/kras/41"}}}	1	2016-05-18 20:38:42.250448	2016-05-18 20:38:42.26122
151	2	59	15	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/kras/41"}}}	1	2016-05-18 20:38:42.290158	2016-05-18 20:38:42.301052
152	2	60	15	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/kras/41"}}}	1	2016-05-18 20:38:42.3311	2016-05-18 20:38:42.343432
153	2	61	15	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/kras/41"}}}	1	2016-05-18 20:38:42.375359	2016-05-18 20:38:42.387786
154	2	62	15	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/kras/41"}}}	1	2016-05-18 20:38:42.418264	2016-05-18 20:38:42.434526
155	2	63	15	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/kras/41"}}}	1	2016-05-18 20:38:42.464631	2016-05-18 20:38:42.475207
156	2	64	15	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/kras/41"}}}	1	2016-05-18 20:38:42.504303	2016-05-18 20:38:42.517329
157	4	57	15	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/89"}}}	1	2016-05-18 20:38:42.545245	2016-05-18 20:38:42.557079
158	4	58	15	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/89"}}}	1	2016-05-18 20:38:42.58755	2016-05-18 20:38:42.597763
159	4	59	15	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/89"}}}	1	2016-05-18 20:38:42.627867	2016-05-18 20:38:42.638135
160	4	60	15	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/89"}}}	1	2016-05-18 20:38:42.667049	2016-05-18 20:38:42.681547
161	4	61	15	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/89"}}}	1	2016-05-18 20:38:42.710301	2016-05-18 20:38:42.722636
162	4	62	15	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/89"}}}	1	2016-05-18 20:38:42.752771	2016-05-18 20:38:42.762281
163	4	63	15	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/89"}}}	1	2016-05-18 20:38:42.789839	2016-05-18 20:38:42.798696
164	4	64	15	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/89"}}}	1	2016-05-18 20:38:42.8232	2016-05-18 20:38:42.831953
165	5	57	16	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/ddr2/78"}}}	1	2016-05-18 20:38:42.87543	2016-05-18 20:38:42.884417
166	5	58	16	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/ddr2/78"}}}	1	2016-05-18 20:38:42.924355	2016-05-18 20:38:42.933573
167	5	59	16	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/ddr2/78"}}}	1	2016-05-18 20:38:42.96427	2016-05-18 20:38:42.974689
1708	1	3	9	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/nras/93"}}}	1	2016-05-18 21:26:08.189695	2016-05-18 21:26:08.189695
1709	1	15	10	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/nras/90"}}}	1	2016-05-18 21:26:08.207638	2016-05-18 21:26:08.207638
1710	1	17	10	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/nras/90"}}}	1	2016-05-18 21:26:08.226158	2016-05-18 21:26:08.226158
1711	1	26	10	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/nras/90"}}}	1	2016-05-18 21:26:08.244571	2016-05-18 21:26:08.244571
1712	1	27	10	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/nras/90"}}}	1	2016-05-18 21:26:08.261708	2016-05-18 21:26:08.261708
1713	1	3	10	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/nras/90"}}}	1	2016-05-18 21:26:08.280532	2016-05-18 21:26:08.280532
1714	4	15	10	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/90"}}}	1	2016-05-18 21:26:08.296134	2016-05-18 21:26:08.296134
1715	4	16	10	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/90"}}}	1	2016-05-18 21:26:08.31365	2016-05-18 21:26:08.31365
1716	4	21	10	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/90"}}}	1	2016-05-18 21:26:08.330474	2016-05-18 21:26:08.330474
3108	8	44	34	\N	\N	3	\N	2	2016-05-18 21:26:44.251982	2016-05-18 21:26:44.251982
168	5	60	16	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/ddr2/78"}}}	1	2016-05-18 20:38:43.003368	2016-05-18 20:38:43.015581
169	5	61	16	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/ddr2/78"}}}	1	2016-05-18 20:38:43.058642	2016-05-18 20:38:43.068297
170	5	62	16	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/ddr2/78"}}}	1	2016-05-18 20:38:43.10042	2016-05-18 20:38:43.111906
171	5	63	16	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/ddr2/78"}}}	1	2016-05-18 20:38:43.158088	2016-05-18 20:38:43.167375
172	5	64	16	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/ddr2/78"}}}	1	2016-05-18 20:38:43.20261	2016-05-18 20:38:43.214677
173	3	57	17	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/ret/128"}}}	1	2016-05-18 20:38:43.276752	2016-05-18 20:38:43.288727
174	3	58	17	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/ret/128"}}}	1	2016-05-18 20:38:43.321305	2016-05-18 20:38:43.332599
175	3	59	17	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/ret/128"}}}	1	2016-05-18 20:38:43.362682	2016-05-18 20:38:43.372243
176	3	60	17	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/ret/128"}}}	1	2016-05-18 20:38:43.398412	2016-05-18 20:38:43.408109
177	3	61	17	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/ret/128"}}}	1	2016-05-18 20:38:43.440025	2016-05-18 20:38:43.451525
178	3	62	17	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/ret/128"}}}	1	2016-05-18 20:38:43.49696	2016-05-18 20:38:43.51618
179	3	63	17	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/ret/128"}}}	1	2016-05-18 20:38:43.544627	2016-05-18 20:38:43.555499
180	3	64	17	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/ret/128"}}}	1	2016-05-18 20:38:43.59761	2016-05-18 20:38:43.607799
181	6	57	18	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/ovarian-cancer/pten/145"}}}	1	2016-05-18 20:38:43.669039	2016-05-18 20:38:43.680708
182	6	58	18	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/ovarian-cancer/pten/145"}}}	1	2016-05-18 20:38:43.712341	2016-05-18 20:38:43.741029
183	6	59	18	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/ovarian-cancer/pten/145"}}}	1	2016-05-18 20:38:43.771895	2016-05-18 20:38:43.783766
184	6	60	18	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/ovarian-cancer/pten/145"}}}	1	2016-05-18 20:38:43.83055	2016-05-18 20:38:43.840498
185	6	61	18	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/ovarian-cancer/pten/145"}}}	1	2016-05-18 20:38:43.871181	2016-05-18 20:38:43.881373
186	6	62	18	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/ovarian-cancer/pten/145"}}}	1	2016-05-18 20:38:43.932799	2016-05-18 20:38:43.942496
187	6	63	18	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/ovarian-cancer/pten/145"}}}	1	2016-05-18 20:38:43.973088	2016-05-18 20:38:43.983945
188	6	64	18	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/ovarian-cancer/pten/145"}}}	1	2016-05-18 20:38:44.014901	2016-05-18 20:38:44.042723
189	6	57	19	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/ovarian-cancer/pten/137"}}}	1	2016-05-18 20:38:44.101558	2016-05-18 20:38:44.112023
190	6	58	19	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/ovarian-cancer/pten/137"}}}	1	2016-05-18 20:38:44.142714	2016-05-18 20:38:44.155418
191	6	59	19	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/ovarian-cancer/pten/137"}}}	1	2016-05-18 20:38:44.201545	2016-05-18 20:38:44.211867
192	6	60	19	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/ovarian-cancer/pten/137"}}}	1	2016-05-18 20:38:44.243524	2016-05-18 20:38:44.255849
193	6	61	19	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/ovarian-cancer/pten/137"}}}	1	2016-05-18 20:38:44.301224	2016-05-18 20:38:44.311855
194	6	62	19	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/ovarian-cancer/pten/137"}}}	1	2016-05-18 20:38:44.343276	2016-05-18 20:38:44.355993
1717	4	28	10	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/90"}}}	1	2016-05-18 21:26:08.349863	2016-05-18 21:26:08.349863
1718	4	29	10	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/90"}}}	1	2016-05-18 21:26:08.366144	2016-05-18 21:26:08.366144
1719	4	24	10	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/90"}}}	1	2016-05-18 21:26:08.384068	2016-05-18 21:26:08.384068
1720	4	3	10	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/90"}}}	1	2016-05-18 21:26:08.405164	2016-05-18 21:26:08.405164
1721	1	15	11	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/nras/85"}}}	1	2016-05-18 21:26:08.421739	2016-05-18 21:26:08.421739
1722	1	16	11	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/nras/85"}}}	1	2016-05-18 21:26:08.440856	2016-05-18 21:26:08.440856
1723	1	20	11	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/nras/85"}}}	1	2016-05-18 21:26:08.457361	2016-05-18 21:26:08.457361
1724	1	21	11	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/nras/85"}}}	1	2016-05-18 21:26:08.477337	2016-05-18 21:26:08.477337
1725	1	22	11	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/nras/85"}}}	1	2016-05-18 21:26:08.494423	2016-05-18 21:26:08.494423
1726	1	19	11	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/nras/85"}}}	1	2016-05-18 21:26:08.511689	2016-05-18 21:26:08.511689
195	6	63	19	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/ovarian-cancer/pten/137"}}}	1	2016-05-18 20:38:44.400448	2016-05-18 20:38:44.409656
196	6	64	19	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/ovarian-cancer/pten/137"}}}	1	2016-05-18 20:38:44.446041	2016-05-18 20:38:44.45757
197	6	57	20	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/ovarian-cancer/pten/144"}}}	1	2016-05-18 20:38:44.510357	2016-05-18 20:38:44.521624
198	6	58	20	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/ovarian-cancer/pten/144"}}}	1	2016-05-18 20:38:44.56535	2016-05-18 20:38:44.574172
199	6	59	20	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/ovarian-cancer/pten/144"}}}	1	2016-05-18 20:38:44.615848	2016-05-18 20:38:44.626702
200	6	60	20	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/ovarian-cancer/pten/144"}}}	1	2016-05-18 20:38:44.670849	2016-05-18 20:38:44.681357
201	6	61	20	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/ovarian-cancer/pten/144"}}}	1	2016-05-18 20:38:44.712495	2016-05-18 20:38:44.723876
202	6	62	20	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/ovarian-cancer/pten/144"}}}	1	2016-05-18 20:38:44.772681	2016-05-18 20:38:44.786247
203	6	63	20	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/ovarian-cancer/pten/144"}}}	1	2016-05-18 20:38:44.815624	2016-05-18 20:38:44.827537
204	6	64	20	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/ovarian-cancer/pten/144"}}}	1	2016-05-18 20:38:44.874371	2016-05-18 20:38:44.884961
205	7	57	21	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/breast-cancer/pten/24"}}}	1	2016-05-18 20:38:44.944817	2016-05-18 20:38:44.955979
206	7	58	21	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/breast-cancer/pten/24"}}}	1	2016-05-18 20:38:44.993089	2016-05-18 20:38:45.012139
207	7	59	21	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/breast-cancer/pten/24"}}}	1	2016-05-18 20:38:45.045162	2016-05-18 20:38:45.054972
208	7	60	21	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/breast-cancer/pten/24"}}}	1	2016-05-18 20:38:45.086403	2016-05-18 20:38:45.114346
209	7	61	21	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/breast-cancer/pten/24"}}}	1	2016-05-18 20:38:45.146834	2016-05-18 20:38:45.156999
210	7	62	21	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/breast-cancer/pten/24"}}}	1	2016-05-18 20:38:45.190493	2016-05-18 20:38:45.210976
211	7	63	21	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/breast-cancer/pten/24"}}}	1	2016-05-18 20:38:45.251397	2016-05-18 20:38:45.264234
212	7	64	21	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/breast-cancer/pten/24"}}}	1	2016-05-18 20:38:45.305764	2016-05-18 20:38:45.314699
213	7	65	21	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/breast-cancer/pten/24"}}}	1	2016-05-18 20:38:45.352876	2016-05-18 20:38:45.365849
214	7	66	21	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/breast-cancer/pten/24"}}}	1	2016-05-18 20:38:45.397887	2016-05-18 20:38:45.410979
215	7	67	21	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/breast-cancer/pten/24"}}}	1	2016-05-18 20:38:45.449654	2016-05-18 20:38:45.461348
216	4	57	21	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/pten/24"}}}	1	2016-05-18 20:38:45.494551	2016-05-18 20:38:45.513677
217	4	58	21	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/pten/24"}}}	1	2016-05-18 20:38:45.550347	2016-05-18 20:38:45.561166
218	4	59	21	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/pten/24"}}}	1	2016-05-18 20:38:45.593408	2016-05-18 20:38:45.614348
219	4	60	21	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/pten/24"}}}	1	2016-05-18 20:38:45.654703	2016-05-18 20:38:45.667289
220	4	61	21	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/pten/24"}}}	1	2016-05-18 20:38:45.709571	2016-05-18 20:38:45.719376
221	4	62	21	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/pten/24"}}}	1	2016-05-18 20:38:45.757867	2016-05-18 20:38:45.772506
1727	1	23	11	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/nras/85"}}}	1	2016-05-18 21:26:08.529516	2016-05-18 21:26:08.529516
1728	1	24	11	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/nras/85"}}}	1	2016-05-18 21:26:08.547482	2016-05-18 21:26:08.547482
1729	1	27	11	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/nras/85"}}}	1	2016-05-18 21:26:08.562461	2016-05-18 21:26:08.562461
1730	1	29	11	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/nras/85"}}}	1	2016-05-18 21:26:08.578595	2016-05-18 21:26:08.578595
1731	1	17	11	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/nras/85"}}}	1	2016-05-18 21:26:08.594712	2016-05-18 21:26:08.594712
1732	1	3	11	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/nras/85"}}}	1	2016-05-18 21:26:08.611569	2016-05-18 21:26:08.611569
1733	2	30	11	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/nras/85"}}}	1	2016-05-18 21:26:08.628251	2016-05-18 21:26:08.628251
1734	2	31	11	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/nras/85"}}}	1	2016-05-18 21:26:08.645358	2016-05-18 21:26:08.645358
1735	2	32	11	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/nras/85"}}}	1	2016-05-18 21:26:08.661921	2016-05-18 21:26:08.661921
3109	8	82	34	\N	\N	3	\N	2	2016-05-18 21:26:44.273399	2016-05-18 21:26:44.273399
3110	8	74	35	\N	\N	3	\N	2	2016-05-18 21:26:44.291095	2016-05-18 21:26:44.291095
222	4	63	21	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/pten/24"}}}	1	2016-05-18 20:38:45.819056	2016-05-18 20:38:45.829953
223	4	64	21	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/pten/24"}}}	1	2016-05-18 20:38:45.862211	2016-05-18 20:38:45.883745
224	7	57	22	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/breast-cancer/pten/25"}}}	1	2016-05-18 20:38:45.936212	2016-05-18 20:38:45.950869
225	7	58	22	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/breast-cancer/pten/25"}}}	1	2016-05-18 20:38:45.987171	2016-05-18 20:38:45.999503
226	7	59	22	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/breast-cancer/pten/25"}}}	1	2016-05-18 20:38:46.046198	2016-05-18 20:38:46.056431
227	7	60	22	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/breast-cancer/pten/25"}}}	1	2016-05-18 20:38:46.089068	2016-05-18 20:38:46.100707
228	7	61	22	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/breast-cancer/pten/25"}}}	1	2016-05-18 20:38:46.130473	2016-05-18 20:38:46.157335
229	7	62	22	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/breast-cancer/pten/25"}}}	1	2016-05-18 20:38:46.188825	2016-05-18 20:38:46.2016
230	7	63	22	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/breast-cancer/pten/25"}}}	1	2016-05-18 20:38:46.240222	2016-05-18 20:38:46.282216
231	7	64	22	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/breast-cancer/pten/25"}}}	1	2016-05-18 20:38:46.318016	2016-05-18 20:38:46.331012
232	2	57	22	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/pten/25"}}}	1	2016-05-18 20:38:46.370967	2016-05-18 20:38:46.398468
233	2	58	22	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/pten/25"}}}	1	2016-05-18 20:38:46.435779	2016-05-18 20:38:46.448605
234	2	59	22	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/pten/25"}}}	1	2016-05-18 20:38:46.500864	2016-05-18 20:38:46.523815
235	2	60	22	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/pten/25"}}}	1	2016-05-18 20:38:46.562084	2016-05-18 20:38:46.574352
236	2	61	22	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/pten/25"}}}	1	2016-05-18 20:38:46.611092	2016-05-18 20:38:46.631742
237	2	62	22	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/pten/25"}}}	1	2016-05-18 20:38:46.670667	2016-05-18 20:38:46.682422
238	2	63	22	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/pten/25"}}}	1	2016-05-18 20:38:46.719205	2016-05-18 20:38:46.743429
239	2	64	22	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/pten/25"}}}	1	2016-05-18 20:38:46.796692	2016-05-18 20:38:46.807154
240	4	57	22	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/pten/25"}}}	1	2016-05-18 20:38:46.841958	2016-05-18 20:38:46.853081
241	4	58	22	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/pten/25"}}}	1	2016-05-18 20:38:46.889999	2016-05-18 20:38:46.903206
242	4	59	22	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/pten/25"}}}	1	2016-05-18 20:38:46.944358	2016-05-18 20:38:46.968515
243	4	60	22	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/pten/25"}}}	1	2016-05-18 20:38:47.009557	2016-05-18 20:38:47.023525
244	4	61	22	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/pten/25"}}}	1	2016-05-18 20:38:47.065337	2016-05-18 20:38:47.088178
245	4	62	22	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/pten/25"}}}	1	2016-05-18 20:38:47.131817	2016-05-18 20:38:47.143061
246	4	63	22	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/pten/25"}}}	1	2016-05-18 20:38:47.211802	2016-05-18 20:38:47.221398
247	4	64	22	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/pten/25"}}}	1	2016-05-18 20:38:47.262416	2016-05-18 20:38:47.275733
248	7	57	23	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/breast-cancer/pten/26"}}}	1	2016-05-18 20:38:47.347076	2016-05-18 20:38:47.380146
249	7	58	23	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/breast-cancer/pten/26"}}}	1	2016-05-18 20:38:47.451042	2016-05-18 20:38:47.47404
1736	4	33	11	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/85"}}}	1	2016-05-18 21:26:08.679324	2016-05-18 21:26:08.679324
1737	4	34	11	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/85"}}}	1	2016-05-18 21:26:08.697748	2016-05-18 21:26:08.697748
1738	4	35	11	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/85"}}}	1	2016-05-18 21:26:08.71543	2016-05-18 21:26:08.71543
1739	4	36	11	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/85"}}}	1	2016-05-18 21:26:08.737077	2016-05-18 21:26:08.737077
1740	4	37	11	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/85"}}}	1	2016-05-18 21:26:08.753532	2016-05-18 21:26:08.753532
1741	4	38	11	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/85"}}}	1	2016-05-18 21:26:08.768849	2016-05-18 21:26:08.768849
1742	4	39	11	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/85"}}}	1	2016-05-18 21:26:08.787253	2016-05-18 21:26:08.787253
1743	4	40	11	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/85"}}}	1	2016-05-18 21:26:08.80746	2016-05-18 21:26:08.80746
3111	8	75	35	\N	\N	3	\N	2	2016-05-18 21:26:44.306179	2016-05-18 21:26:44.306179
3112	8	76	35	\N	\N	3	\N	2	2016-05-18 21:26:44.3215	2016-05-18 21:26:44.3215
250	7	59	23	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/breast-cancer/pten/26"}}}	1	2016-05-18 20:38:47.536468	2016-05-18 20:38:47.556495
251	7	60	23	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/breast-cancer/pten/26"}}}	1	2016-05-18 20:38:47.635984	2016-05-18 20:38:47.662417
252	7	61	23	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/breast-cancer/pten/26"}}}	1	2016-05-18 20:38:47.714932	2016-05-18 20:38:47.74225
253	7	62	23	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/breast-cancer/pten/26"}}}	1	2016-05-18 20:38:47.79254	2016-05-18 20:38:47.806852
254	7	63	23	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/breast-cancer/pten/26"}}}	1	2016-05-18 20:38:47.850988	2016-05-18 20:38:47.882171
255	7	64	23	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/breast-cancer/pten/26"}}}	1	2016-05-18 20:38:47.945839	2016-05-18 20:38:47.964589
256	4	57	23	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/pten/26"}}}	1	2016-05-18 20:38:48.0228	2016-05-18 20:38:48.035649
257	4	58	23	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/pten/26"}}}	1	2016-05-18 20:38:48.077032	2016-05-18 20:38:48.089427
258	4	59	23	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/pten/26"}}}	1	2016-05-18 20:38:48.163026	2016-05-18 20:38:48.176716
259	4	60	23	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/pten/26"}}}	1	2016-05-18 20:38:48.292175	2016-05-18 20:38:48.306192
260	4	61	23	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/pten/26"}}}	1	2016-05-18 20:38:48.343176	2016-05-18 20:38:48.36012
261	4	62	23	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/pten/26"}}}	1	2016-05-18 20:38:48.401667	2016-05-18 20:38:48.447283
262	4	63	23	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/pten/26"}}}	1	2016-05-18 20:38:48.525511	2016-05-18 20:38:48.543999
263	4	64	23	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/pten/26"}}}	1	2016-05-18 20:38:48.599717	2016-05-18 20:38:48.62769
264	3	57	24	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/307"}}}	1	2016-05-18 20:38:48.742199	2016-05-18 20:38:48.756849
265	3	58	24	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/307"}}}	1	2016-05-18 20:38:48.809178	2016-05-18 20:38:48.820745
266	3	59	24	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/307"}}}	1	2016-05-18 20:38:48.879604	2016-05-18 20:38:48.89831
267	3	60	24	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/307"}}}	1	2016-05-18 20:38:48.943229	2016-05-18 20:38:48.953198
268	3	61	24	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/307"}}}	1	2016-05-18 20:38:49.010189	2016-05-18 20:38:49.02193
269	3	62	24	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/307"}}}	1	2016-05-18 20:38:49.074087	2016-05-18 20:38:49.094295
270	3	63	24	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/307"}}}	1	2016-05-18 20:38:49.150944	2016-05-18 20:38:49.163342
271	3	64	24	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/307"}}}	1	2016-05-18 20:38:49.232952	2016-05-18 20:38:49.247253
272	3	57	25	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/305"}}}	1	2016-05-18 20:38:49.323951	2016-05-18 20:38:49.337206
273	3	58	25	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/305"}}}	1	2016-05-18 20:38:49.409131	2016-05-18 20:38:49.424174
274	3	59	25	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/305"}}}	1	2016-05-18 20:38:49.504108	2016-05-18 20:38:49.520482
275	3	60	25	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/305"}}}	1	2016-05-18 20:38:49.565051	2016-05-18 20:38:49.579306
276	3	61	25	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/305"}}}	1	2016-05-18 20:38:49.619624	2016-05-18 20:38:49.647746
1744	4	41	11	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/85"}}}	1	2016-05-18 21:26:08.822798	2016-05-18 21:26:08.822798
1745	4	42	11	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/85"}}}	1	2016-05-18 21:26:08.843143	2016-05-18 21:26:08.843143
1746	4	43	11	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/85"}}}	1	2016-05-18 21:26:08.861569	2016-05-18 21:26:08.861569
1747	4	44	11	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/85"}}}	1	2016-05-18 21:26:08.885754	2016-05-18 21:26:08.885754
1748	4	45	11	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/85"}}}	1	2016-05-18 21:26:08.902935	2016-05-18 21:26:08.902935
1749	4	46	11	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/85"}}}	1	2016-05-18 21:26:08.921159	2016-05-18 21:26:08.921159
1750	4	47	11	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/85"}}}	1	2016-05-18 21:26:08.942108	2016-05-18 21:26:08.942108
1751	4	48	11	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/85"}}}	1	2016-05-18 21:26:08.960388	2016-05-18 21:26:08.960388
1752	4	49	11	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/85"}}}	1	2016-05-18 21:26:08.980105	2016-05-18 21:26:08.980105
3113	8	77	35	\N	\N	3	\N	2	2016-05-18 21:26:44.334533	2016-05-18 21:26:44.334533
277	3	62	25	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/305"}}}	1	2016-05-18 20:38:49.688059	2016-05-18 20:38:49.700594
278	3	63	25	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/305"}}}	1	2016-05-18 20:38:49.740396	2016-05-18 20:38:49.754022
279	3	64	25	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/305"}}}	1	2016-05-18 20:38:49.791508	2016-05-18 20:38:49.816851
280	3	44	26	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/306"}}}	1	2016-05-18 20:38:49.898953	2016-05-18 20:38:49.913836
281	3	68	26	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/306"}}}	1	2016-05-18 20:38:49.96649	2016-05-18 20:38:49.976349
282	3	69	26	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/306"}}}	1	2016-05-18 20:38:50.032753	2016-05-18 20:38:50.053638
283	3	70	26	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/306"}}}	1	2016-05-18 20:38:50.127695	2016-05-18 20:38:50.141439
284	3	71	26	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/306"}}}	1	2016-05-18 20:38:50.21233	2016-05-18 20:38:50.252736
285	3	72	26	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/306"}}}	1	2016-05-18 20:38:50.306902	2016-05-18 20:38:50.316703
286	3	73	26	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/306"}}}	1	2016-05-18 20:38:50.353975	2016-05-18 20:38:50.370126
287	3	44	27	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/304"}}}	1	2016-05-18 20:38:50.435617	2016-05-18 20:38:50.451017
288	3	68	27	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/304"}}}	1	2016-05-18 20:38:50.492835	2016-05-18 20:38:50.531879
289	3	69	27	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/304"}}}	1	2016-05-18 20:38:50.571357	2016-05-18 20:38:50.583512
290	3	70	27	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/304"}}}	1	2016-05-18 20:38:50.6365	2016-05-18 20:38:50.66143
291	3	71	27	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/304"}}}	1	2016-05-18 20:38:50.70087	2016-05-18 20:38:50.717306
292	3	72	27	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/304"}}}	1	2016-05-18 20:38:50.758557	2016-05-18 20:38:50.788623
293	3	73	27	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/304"}}}	1	2016-05-18 20:38:50.827361	2016-05-18 20:38:50.840424
294	3	44	28	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/303"}}}	1	2016-05-18 20:38:50.906854	2016-05-18 20:38:50.926791
295	3	68	28	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/303"}}}	1	2016-05-18 20:38:50.963516	2016-05-18 20:38:50.987043
296	3	69	28	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/303"}}}	1	2016-05-18 20:38:51.039793	2016-05-18 20:38:51.052967
297	3	70	28	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/303"}}}	1	2016-05-18 20:38:51.109489	2016-05-18 20:38:51.133703
298	3	71	28	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/303"}}}	1	2016-05-18 20:38:51.168703	2016-05-18 20:38:51.180378
299	3	72	28	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/303"}}}	1	2016-05-18 20:38:51.223692	2016-05-18 20:38:51.245075
300	3	73	28	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/303"}}}	1	2016-05-18 20:38:51.28615	2016-05-18 20:38:51.316279
301	3	44	29	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/29"}}}	1	2016-05-18 20:38:51.41527	2016-05-18 20:38:51.428265
302	3	68	29	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/29"}}}	1	2016-05-18 20:38:51.464581	2016-05-18 20:38:51.501137
303	3	69	29	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/29"}}}	1	2016-05-18 20:38:51.55284	2016-05-18 20:38:51.56332
1753	4	50	11	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/85"}}}	1	2016-05-18 21:26:08.996944	2016-05-18 21:26:08.996944
1754	1	33	12	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/nras/87"}}}	1	2016-05-18 21:26:09.018452	2016-05-18 21:26:09.018452
1755	1	34	12	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/nras/87"}}}	1	2016-05-18 21:26:09.042248	2016-05-18 21:26:09.042248
1756	1	35	12	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/nras/87"}}}	1	2016-05-18 21:26:09.069212	2016-05-18 21:26:09.069212
1757	1	36	12	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/nras/87"}}}	1	2016-05-18 21:26:09.132727	2016-05-18 21:26:09.132727
1758	1	51	12	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/nras/87"}}}	1	2016-05-18 21:26:09.149402	2016-05-18 21:26:09.149402
1759	2	33	12	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/nras/87"}}}	1	2016-05-18 21:26:09.166729	2016-05-18 21:26:09.166729
1760	2	34	12	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/nras/87"}}}	1	2016-05-18 21:26:09.181746	2016-05-18 21:26:09.181746
1761	2	35	12	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/nras/87"}}}	1	2016-05-18 21:26:09.198219	2016-05-18 21:26:09.198219
3114	8	78	35	\N	\N	3	\N	2	2016-05-18 21:26:44.351343	2016-05-18 21:26:44.351343
3115	8	79	35	\N	\N	3	\N	2	2016-05-18 21:26:44.364866	2016-05-18 21:26:44.364866
304	3	70	29	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/29"}}}	1	2016-05-18 20:38:51.640963	2016-05-18 20:38:51.655822
305	3	71	29	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/29"}}}	1	2016-05-18 20:38:51.701018	2016-05-18 20:38:51.715451
306	3	72	29	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/29"}}}	1	2016-05-18 20:38:51.773959	2016-05-18 20:38:51.787635
307	3	73	29	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/29"}}}	1	2016-05-18 20:38:51.836125	2016-05-18 20:38:51.845999
308	4	44	29	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/29"}}}	1	2016-05-18 20:38:51.898377	2016-05-18 20:38:51.911199
309	4	68	29	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/29"}}}	1	2016-05-18 20:38:51.94042	2016-05-18 20:38:51.98351
310	4	69	29	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/29"}}}	1	2016-05-18 20:38:52.020541	2016-05-18 20:38:52.032911
311	4	70	29	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/29"}}}	1	2016-05-18 20:38:52.072394	2016-05-18 20:38:52.100022
312	4	71	29	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/29"}}}	1	2016-05-18 20:38:52.155902	2016-05-18 20:38:52.165999
313	4	72	29	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/29"}}}	1	2016-05-18 20:38:52.211415	2016-05-18 20:38:52.268567
314	4	73	29	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/29"}}}	1	2016-05-18 20:38:52.314556	2016-05-18 20:38:52.32638
315	4	44	30	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/27"}}}	1	2016-05-18 20:38:52.393317	2016-05-18 20:38:52.405572
316	4	68	30	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/27"}}}	1	2016-05-18 20:38:52.446925	2016-05-18 20:38:52.465483
317	4	69	30	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/27"}}}	1	2016-05-18 20:38:52.504712	2016-05-18 20:38:52.518485
318	4	70	30	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/27"}}}	1	2016-05-18 20:38:52.561005	2016-05-18 20:38:52.572994
319	4	71	30	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/27"}}}	1	2016-05-18 20:38:52.608211	2016-05-18 20:38:52.622902
320	4	72	30	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/27"}}}	1	2016-05-18 20:38:52.674508	2016-05-18 20:38:52.684885
321	4	73	30	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/27"}}}	1	2016-05-18 20:38:52.729194	2016-05-18 20:38:52.75484
322	4	44	31	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/28"}}}	1	2016-05-18 20:38:52.824724	2016-05-18 20:38:52.837847
323	4	68	31	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/28"}}}	1	2016-05-18 20:38:52.887106	2016-05-18 20:38:52.901335
324	4	69	31	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/28"}}}	1	2016-05-18 20:38:52.965135	2016-05-18 20:38:52.979409
325	4	70	31	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/28"}}}	1	2016-05-18 20:38:53.016548	2016-05-18 20:38:53.028733
326	4	71	31	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/28"}}}	1	2016-05-18 20:38:53.065129	2016-05-18 20:38:53.087053
327	4	72	31	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/28"}}}	1	2016-05-18 20:38:53.123644	2016-05-18 20:38:53.135921
328	4	73	31	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/28"}}}	1	2016-05-18 20:38:53.179779	2016-05-18 20:38:53.189172
329	4	74	32	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/161"}}}	1	2016-05-18 20:38:53.251622	2016-05-18 20:38:53.261959
330	4	75	32	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/161"}}}	1	2016-05-18 20:38:53.293724	2016-05-18 20:38:53.305795
1762	2	36	12	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/nras/87"}}}	1	2016-05-18 21:26:09.216598	2016-05-18 21:26:09.216598
1763	2	52	12	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/nras/87"}}}	1	2016-05-18 21:26:09.234131	2016-05-18 21:26:09.234131
1764	2	53	12	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/nras/87"}}}	1	2016-05-18 21:26:09.25079	2016-05-18 21:26:09.25079
1765	2	54	12	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/nras/87"}}}	1	2016-05-18 21:26:09.268385	2016-05-18 21:26:09.268385
1766	2	51	12	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/nras/87"}}}	1	2016-05-18 21:26:09.285741	2016-05-18 21:26:09.285741
1767	4	33	12	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/87"}}}	1	2016-05-18 21:26:09.302262	2016-05-18 21:26:09.302262
1768	4	34	12	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/87"}}}	1	2016-05-18 21:26:09.319122	2016-05-18 21:26:09.319122
1769	4	35	12	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/87"}}}	1	2016-05-18 21:26:09.337228	2016-05-18 21:26:09.337228
1770	4	55	12	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/87"}}}	1	2016-05-18 21:26:09.354873	2016-05-18 21:26:09.354873
3116	8	80	35	\N	\N	3	\N	2	2016-05-18 21:26:44.384285	2016-05-18 21:26:44.384285
3117	8	81	35	\N	\N	3	\N	2	2016-05-18 21:26:44.400061	2016-05-18 21:26:44.400061
331	4	76	32	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/161"}}}	1	2016-05-18 20:38:53.347312	2016-05-18 20:38:53.360086
332	4	77	32	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/161"}}}	1	2016-05-18 20:38:53.396779	2016-05-18 20:38:53.40707
333	4	78	32	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/161"}}}	1	2016-05-18 20:38:53.438197	2016-05-18 20:38:53.450844
334	4	79	32	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/161"}}}	1	2016-05-18 20:38:53.47955	2016-05-18 20:38:53.493952
335	4	80	32	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/161"}}}	1	2016-05-18 20:38:53.528095	2016-05-18 20:38:53.53784
336	4	81	32	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/161"}}}	1	2016-05-18 20:38:53.577599	2016-05-18 20:38:53.589959
337	4	44	32	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/161"}}}	1	2016-05-18 20:38:53.639287	2016-05-18 20:38:53.654309
338	4	82	32	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/161"}}}	1	2016-05-18 20:38:53.689213	2016-05-18 20:38:53.7077
339	4	74	33	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/160"}}}	1	2016-05-18 20:38:53.760197	2016-05-18 20:38:53.772057
340	4	75	33	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/160"}}}	1	2016-05-18 20:38:53.824652	2016-05-18 20:38:53.837575
341	4	76	33	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/160"}}}	1	2016-05-18 20:38:53.873902	2016-05-18 20:38:53.886126
342	4	77	33	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/160"}}}	1	2016-05-18 20:38:53.918079	2016-05-18 20:38:53.934384
343	4	78	33	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/160"}}}	1	2016-05-18 20:38:53.966091	2016-05-18 20:38:53.976592
344	4	79	33	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/160"}}}	1	2016-05-18 20:38:54.00033	2016-05-18 20:38:54.013096
345	4	80	33	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/160"}}}	1	2016-05-18 20:38:54.038667	2016-05-18 20:38:54.052557
346	4	81	33	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/160"}}}	1	2016-05-18 20:38:54.086304	2016-05-18 20:38:54.100509
347	4	44	33	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/160"}}}	1	2016-05-18 20:38:54.124983	2016-05-18 20:38:54.133538
348	4	82	33	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/160"}}}	1	2016-05-18 20:38:54.160441	2016-05-18 20:38:54.170333
349	2	74	34	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/kras/31"}}}	1	2016-05-18 20:38:54.214425	2016-05-18 20:38:54.238554
350	2	75	34	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/kras/31"}}}	1	2016-05-18 20:38:54.275393	2016-05-18 20:38:54.285449
351	2	76	34	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/kras/31"}}}	1	2016-05-18 20:38:54.327981	2016-05-18 20:38:54.344729
352	2	77	34	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/kras/31"}}}	1	2016-05-18 20:38:54.386363	2016-05-18 20:38:54.399121
353	2	78	34	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/kras/31"}}}	1	2016-05-18 20:38:54.462919	2016-05-18 20:38:54.481859
354	2	79	34	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/kras/31"}}}	1	2016-05-18 20:38:54.512985	2016-05-18 20:38:54.523604
355	2	80	34	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/kras/31"}}}	1	2016-05-18 20:38:54.555501	2016-05-18 20:38:54.589608
356	2	81	34	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/kras/31"}}}	1	2016-05-18 20:38:54.624892	2016-05-18 20:38:54.638106
357	2	44	34	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/kras/31"}}}	1	2016-05-18 20:38:54.671593	2016-05-18 20:38:54.690284
358	2	82	34	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/kras/31"}}}	1	2016-05-18 20:38:54.723068	2016-05-18 20:38:54.736414
1771	4	36	12	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/87"}}}	1	2016-05-18 21:26:09.371026	2016-05-18 21:26:09.371026
1772	4	51	12	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/87"}}}	1	2016-05-18 21:26:09.389721	2016-05-18 21:26:09.389721
1773	1	33	13	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/nras/86"}}}	1	2016-05-18 21:26:09.405657	2016-05-18 21:26:09.405657
1774	1	34	13	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/nras/86"}}}	1	2016-05-18 21:26:09.424767	2016-05-18 21:26:09.424767
1775	1	35	13	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/nras/86"}}}	1	2016-05-18 21:26:09.445693	2016-05-18 21:26:09.445693
1776	1	55	13	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/nras/86"}}}	1	2016-05-18 21:26:09.462561	2016-05-18 21:26:09.462561
1777	1	36	13	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/nras/86"}}}	1	2016-05-18 21:26:09.48213	2016-05-18 21:26:09.48213
1778	1	51	13	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/nras/86"}}}	1	2016-05-18 21:26:09.498164	2016-05-18 21:26:09.498164
1779	2	33	13	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/nras/86"}}}	1	2016-05-18 21:26:09.514652	2016-05-18 21:26:09.514652
359	4	74	34	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/31"}}}	1	2016-05-18 20:38:54.791194	2016-05-18 20:38:54.817803
360	4	75	34	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/31"}}}	1	2016-05-18 20:38:54.856382	2016-05-18 20:38:54.869409
361	4	76	34	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/31"}}}	1	2016-05-18 20:38:54.922576	2016-05-18 20:38:54.936602
362	4	77	34	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/31"}}}	1	2016-05-18 20:38:54.970561	2016-05-18 20:38:54.984056
363	4	78	34	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/31"}}}	1	2016-05-18 20:38:55.013959	2016-05-18 20:38:55.028691
364	4	79	34	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/31"}}}	1	2016-05-18 20:38:55.059664	2016-05-18 20:38:55.070132
365	4	80	34	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/31"}}}	1	2016-05-18 20:38:55.099539	2016-05-18 20:38:55.109586
366	4	81	34	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/31"}}}	1	2016-05-18 20:38:55.144047	2016-05-18 20:38:55.15466
367	4	44	34	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/31"}}}	1	2016-05-18 20:38:55.198452	2016-05-18 20:38:55.2089
368	4	82	34	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/31"}}}	1	2016-05-18 20:38:55.239844	2016-05-18 20:38:55.252695
369	2	74	35	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/kras/30"}}}	1	2016-05-18 20:38:55.303036	2016-05-18 20:38:55.315254
370	2	75	35	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/kras/30"}}}	1	2016-05-18 20:38:55.348103	2016-05-18 20:38:55.377563
371	2	76	35	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/kras/30"}}}	1	2016-05-18 20:38:55.413259	2016-05-18 20:38:55.425424
372	2	77	35	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/kras/30"}}}	1	2016-05-18 20:38:55.457023	2016-05-18 20:38:55.474241
373	2	78	35	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/kras/30"}}}	1	2016-05-18 20:38:55.508643	2016-05-18 20:38:55.521437
374	2	79	35	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/kras/30"}}}	1	2016-05-18 20:38:55.553158	2016-05-18 20:38:55.569922
375	2	80	35	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/kras/30"}}}	1	2016-05-18 20:38:55.607577	2016-05-18 20:38:55.619937
376	2	81	35	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/kras/30"}}}	1	2016-05-18 20:38:55.666203	2016-05-18 20:38:55.676422
377	2	44	35	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/kras/30"}}}	1	2016-05-18 20:38:55.707472	2016-05-18 20:38:55.718826
378	2	82	35	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/kras/30"}}}	1	2016-05-18 20:38:55.769378	2016-05-18 20:38:55.779545
379	4	74	35	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/30"}}}	1	2016-05-18 20:38:55.81598	2016-05-18 20:38:55.835842
380	4	75	35	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/30"}}}	1	2016-05-18 20:38:55.871199	2016-05-18 20:38:55.881843
381	4	76	35	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/30"}}}	1	2016-05-18 20:38:55.92039	2016-05-18 20:38:55.947398
382	4	77	35	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/30"}}}	1	2016-05-18 20:38:55.976533	2016-05-18 20:38:55.987934
383	4	78	35	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/30"}}}	1	2016-05-18 20:38:56.024668	2016-05-18 20:38:56.043962
384	4	79	35	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/30"}}}	1	2016-05-18 20:38:56.07911	2016-05-18 20:38:56.091552
385	4	80	35	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/30"}}}	1	2016-05-18 20:38:56.121489	2016-05-18 20:38:56.141931
386	4	81	35	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/30"}}}	1	2016-05-18 20:38:56.177468	2016-05-18 20:38:56.18882
1780	2	34	13	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/nras/86"}}}	1	2016-05-18 21:26:09.530516	2016-05-18 21:26:09.530516
1781	2	35	13	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/nras/86"}}}	1	2016-05-18 21:26:09.549639	2016-05-18 21:26:09.549639
1782	2	55	13	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/nras/86"}}}	1	2016-05-18 21:26:09.564017	2016-05-18 21:26:09.564017
1783	2	36	13	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/nras/86"}}}	1	2016-05-18 21:26:09.582333	2016-05-18 21:26:09.582333
1784	2	51	13	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/nras/86"}}}	1	2016-05-18 21:26:09.59925	2016-05-18 21:26:09.59925
1785	4	56	13	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/86"}}}	1	2016-05-18 21:26:09.616265	2016-05-18 21:26:09.616265
1786	1	57	14	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/nras/88"}}}	1	2016-05-18 21:26:09.633163	2016-05-18 21:26:09.633163
1787	1	58	14	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/nras/88"}}}	1	2016-05-18 21:26:09.652024	2016-05-18 21:26:09.652024
1788	1	59	14	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/nras/88"}}}	1	2016-05-18 21:26:09.66869	2016-05-18 21:26:09.66869
387	4	44	35	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/30"}}}	1	2016-05-18 20:38:56.220832	2016-05-18 20:38:56.236479
388	4	82	35	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/30"}}}	1	2016-05-18 20:38:56.273095	2016-05-18 20:38:56.283045
389	3	74	36	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/42"}}}	1	2016-05-18 20:38:56.342731	2016-05-18 20:38:56.353955
390	3	75	36	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/42"}}}	1	2016-05-18 20:38:56.387456	2016-05-18 20:38:56.399213
391	3	76	36	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/42"}}}	1	2016-05-18 20:38:56.440464	2016-05-18 20:38:56.450682
392	3	77	36	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/42"}}}	1	2016-05-18 20:38:56.4839	2016-05-18 20:38:56.498111
393	3	78	36	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/42"}}}	1	2016-05-18 20:38:56.542448	2016-05-18 20:38:56.55383
394	3	79	36	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/42"}}}	1	2016-05-18 20:38:56.58554	2016-05-18 20:38:56.601974
395	3	80	36	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/42"}}}	1	2016-05-18 20:38:56.638935	2016-05-18 20:38:56.648892
396	3	81	36	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/42"}}}	1	2016-05-18 20:38:56.688053	2016-05-18 20:38:56.699218
397	3	44	36	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/42"}}}	1	2016-05-18 20:38:56.742292	2016-05-18 20:38:56.756955
398	3	82	36	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/42"}}}	1	2016-05-18 20:38:56.792889	2016-05-18 20:38:56.811457
399	2	74	36	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/kras/42"}}}	1	2016-05-18 20:38:56.850474	2016-05-18 20:38:56.862281
400	2	75	36	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/kras/42"}}}	1	2016-05-18 20:38:56.894262	2016-05-18 20:38:56.912387
401	2	76	36	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/kras/42"}}}	1	2016-05-18 20:38:56.947756	2016-05-18 20:38:56.961537
402	2	77	36	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/kras/42"}}}	1	2016-05-18 20:38:57.00298	2016-05-18 20:38:57.018536
403	2	78	36	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/kras/42"}}}	1	2016-05-18 20:38:57.063181	2016-05-18 20:38:57.074421
404	2	79	36	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/kras/42"}}}	1	2016-05-18 20:38:57.108803	2016-05-18 20:38:57.129541
405	2	80	36	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/kras/42"}}}	1	2016-05-18 20:38:57.167047	2016-05-18 20:38:57.179196
406	2	81	36	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/kras/42"}}}	1	2016-05-18 20:38:57.21208	2016-05-18 20:38:57.236726
407	2	44	36	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/kras/42"}}}	1	2016-05-18 20:38:57.271743	2016-05-18 20:38:57.285198
408	2	82	36	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/kras/42"}}}	1	2016-05-18 20:38:57.321343	2016-05-18 20:38:57.340338
409	4	74	36	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/42"}}}	1	2016-05-18 20:38:57.373025	2016-05-18 20:38:57.384291
410	4	75	36	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/42"}}}	1	2016-05-18 20:38:57.421081	2016-05-18 20:38:57.443402
411	4	76	36	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/42"}}}	1	2016-05-18 20:38:57.497044	2016-05-18 20:38:57.507895
412	4	77	36	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/42"}}}	1	2016-05-18 20:38:57.537272	2016-05-18 20:38:57.546829
413	4	78	36	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/42"}}}	1	2016-05-18 20:38:57.576574	2016-05-18 20:38:57.588583
414	4	79	36	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/42"}}}	1	2016-05-18 20:38:57.622508	2016-05-18 20:38:57.644527
1789	1	60	14	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/nras/88"}}}	1	2016-05-18 21:26:09.684436	2016-05-18 21:26:09.684436
1790	1	61	14	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/nras/88"}}}	1	2016-05-18 21:26:09.700044	2016-05-18 21:26:09.700044
1791	1	62	14	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/nras/88"}}}	1	2016-05-18 21:26:09.718741	2016-05-18 21:26:09.718741
1792	1	63	14	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/nras/88"}}}	1	2016-05-18 21:26:09.734411	2016-05-18 21:26:09.734411
1793	1	64	14	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/nras/88"}}}	1	2016-05-18 21:26:09.750262	2016-05-18 21:26:09.750262
1794	2	57	14	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/nras/88"}}}	1	2016-05-18 21:26:09.76431	2016-05-18 21:26:09.76431
1795	2	58	14	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/nras/88"}}}	1	2016-05-18 21:26:09.782026	2016-05-18 21:26:09.782026
1796	2	59	14	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/nras/88"}}}	1	2016-05-18 21:26:09.797683	2016-05-18 21:26:09.797683
1797	2	60	14	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/nras/88"}}}	1	2016-05-18 21:26:09.815295	2016-05-18 21:26:09.815295
415	4	80	36	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/42"}}}	1	2016-05-18 20:38:57.678307	2016-05-18 20:38:57.691301
416	4	81	36	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/42"}}}	1	2016-05-18 20:38:57.723663	2016-05-18 20:38:57.743287
417	4	44	36	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/42"}}}	1	2016-05-18 20:38:57.77942	2016-05-18 20:38:57.793938
418	4	82	36	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/42"}}}	1	2016-05-18 20:38:57.831073	2016-05-18 20:38:57.840432
419	3	74	37	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/43"}}}	1	2016-05-18 20:38:57.888705	2016-05-18 20:38:57.903718
420	3	75	37	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/43"}}}	1	2016-05-18 20:38:57.939916	2016-05-18 20:38:57.955263
421	3	76	37	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/43"}}}	1	2016-05-18 20:38:57.99172	2016-05-18 20:38:58.012594
422	3	77	37	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/43"}}}	1	2016-05-18 20:38:58.047924	2016-05-18 20:38:58.062237
423	3	78	37	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/43"}}}	1	2016-05-18 20:38:58.098353	2016-05-18 20:38:58.127811
424	3	79	37	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/43"}}}	1	2016-05-18 20:38:58.163876	2016-05-18 20:38:58.177543
425	3	80	37	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/43"}}}	1	2016-05-18 20:38:58.230163	2016-05-18 20:38:58.242509
426	3	81	37	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/43"}}}	1	2016-05-18 20:38:58.277784	2016-05-18 20:38:58.290346
427	3	44	37	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/43"}}}	1	2016-05-18 20:38:58.32997	2016-05-18 20:38:58.341276
428	3	82	37	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/43"}}}	1	2016-05-18 20:38:58.370729	2016-05-18 20:38:58.385721
429	2	74	37	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/kras/43"}}}	1	2016-05-18 20:38:58.418417	2016-05-18 20:38:58.431363
430	2	75	37	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/kras/43"}}}	1	2016-05-18 20:38:58.477746	2016-05-18 20:38:58.489343
431	2	76	37	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/kras/43"}}}	1	2016-05-18 20:38:58.528348	2016-05-18 20:38:58.540017
432	2	77	37	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/kras/43"}}}	1	2016-05-18 20:38:58.583627	2016-05-18 20:38:58.596587
433	2	78	37	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/kras/43"}}}	1	2016-05-18 20:38:58.632785	2016-05-18 20:38:58.645292
434	2	79	37	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/kras/43"}}}	1	2016-05-18 20:38:58.701108	2016-05-18 20:38:58.713298
435	2	80	37	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/kras/43"}}}	1	2016-05-18 20:38:58.743612	2016-05-18 20:38:58.763654
436	2	81	37	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/kras/43"}}}	1	2016-05-18 20:38:58.799319	2016-05-18 20:38:58.813144
437	2	44	37	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/kras/43"}}}	1	2016-05-18 20:38:58.847186	2016-05-18 20:38:58.865771
438	2	82	37	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/kras/43"}}}	1	2016-05-18 20:38:58.901386	2016-05-18 20:38:58.915161
439	4	74	37	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/43"}}}	1	2016-05-18 20:38:58.958612	2016-05-18 20:38:58.970912
440	4	75	37	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/43"}}}	1	2016-05-18 20:38:59.009716	2016-05-18 20:38:59.023254
441	4	76	37	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/43"}}}	1	2016-05-18 20:38:59.068024	2016-05-18 20:38:59.081579
442	4	77	37	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/43"}}}	1	2016-05-18 20:38:59.115546	2016-05-18 20:38:59.142175
1798	2	61	14	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/nras/88"}}}	1	2016-05-18 21:26:09.828585	2016-05-18 21:26:09.828585
1799	2	62	14	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/nras/88"}}}	1	2016-05-18 21:26:09.8428	2016-05-18 21:26:09.8428
1800	2	63	14	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/nras/88"}}}	1	2016-05-18 21:26:09.859759	2016-05-18 21:26:09.859759
1801	2	64	14	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/nras/88"}}}	1	2016-05-18 21:26:09.877965	2016-05-18 21:26:09.877965
1802	1	57	15	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/nras/89"}}}	1	2016-05-18 21:26:09.8919	2016-05-18 21:26:09.8919
1803	1	58	15	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/nras/89"}}}	1	2016-05-18 21:26:09.908361	2016-05-18 21:26:09.908361
1804	1	59	15	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/nras/89"}}}	1	2016-05-18 21:26:09.924218	2016-05-18 21:26:09.924218
1805	1	60	15	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/nras/89"}}}	1	2016-05-18 21:26:09.940094	2016-05-18 21:26:09.940094
1806	1	61	15	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/nras/89"}}}	1	2016-05-18 21:26:09.956883	2016-05-18 21:26:09.956883
443	4	78	37	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/43"}}}	1	2016-05-18 20:38:59.26582	2016-05-18 20:38:59.286128
444	4	79	37	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/43"}}}	1	2016-05-18 20:38:59.357388	2016-05-18 20:38:59.384984
445	4	80	37	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/43"}}}	1	2016-05-18 20:38:59.454625	2016-05-18 20:38:59.471716
446	4	81	37	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/43"}}}	1	2016-05-18 20:38:59.514809	2016-05-18 20:38:59.531397
447	4	44	37	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/43"}}}	1	2016-05-18 20:38:59.580004	2016-05-18 20:38:59.592246
448	4	82	37	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/43"}}}	1	2016-05-18 20:38:59.626068	2016-05-18 20:38:59.656044
449	3	74	38	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/308"}}}	1	2016-05-18 20:38:59.703303	2016-05-18 20:38:59.716101
450	3	75	38	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/308"}}}	1	2016-05-18 20:38:59.756974	2016-05-18 20:38:59.768863
451	3	76	38	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/308"}}}	1	2016-05-18 20:38:59.802125	2016-05-18 20:38:59.815292
452	3	77	38	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/308"}}}	1	2016-05-18 20:38:59.842872	2016-05-18 20:38:59.851714
453	3	78	38	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/308"}}}	1	2016-05-18 20:38:59.887829	2016-05-18 20:38:59.908342
454	3	79	38	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/308"}}}	1	2016-05-18 20:38:59.941172	2016-05-18 20:38:59.952971
455	3	80	38	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/308"}}}	1	2016-05-18 20:39:00.004778	2016-05-18 20:39:00.017845
456	3	81	38	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/308"}}}	1	2016-05-18 20:39:00.052472	2016-05-18 20:39:00.065679
457	3	44	38	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/308"}}}	1	2016-05-18 20:39:00.106195	2016-05-18 20:39:00.116669
458	3	82	38	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/308"}}}	1	2016-05-18 20:39:00.149989	2016-05-18 20:39:00.160859
459	3	74	39	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/41"}}}	1	2016-05-18 20:39:00.240189	2016-05-18 20:39:00.259642
460	3	75	39	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/41"}}}	1	2016-05-18 20:39:00.335322	2016-05-18 20:39:00.34757
461	3	76	39	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/41"}}}	1	2016-05-18 20:39:00.391175	2016-05-18 20:39:00.405056
462	3	77	39	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/41"}}}	1	2016-05-18 20:39:00.479335	2016-05-18 20:39:00.489192
463	3	78	39	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/41"}}}	1	2016-05-18 20:39:00.521989	2016-05-18 20:39:00.532541
464	3	79	39	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/41"}}}	1	2016-05-18 20:39:00.573895	2016-05-18 20:39:00.58689
465	3	80	39	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/41"}}}	1	2016-05-18 20:39:00.619545	2016-05-18 20:39:00.630999
466	3	81	39	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/41"}}}	1	2016-05-18 20:39:00.678199	2016-05-18 20:39:00.689847
467	3	44	39	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/41"}}}	1	2016-05-18 20:39:00.725	2016-05-18 20:39:00.746076
468	3	82	39	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/41"}}}	1	2016-05-18 20:39:00.781822	2016-05-18 20:39:00.79501
469	2	83	39	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/kras/41"}}}	1	2016-05-18 20:39:00.826995	2016-05-18 20:39:00.848334
1807	1	62	15	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/nras/89"}}}	1	2016-05-18 21:26:09.974437	2016-05-18 21:26:09.974437
1808	1	63	15	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/nras/89"}}}	1	2016-05-18 21:26:09.991044	2016-05-18 21:26:09.991044
1809	1	64	15	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/nras/89"}}}	1	2016-05-18 21:26:10.00848	2016-05-18 21:26:10.00848
1810	2	57	15	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/kras/41"}}}	1	2016-05-18 21:26:10.02522	2016-05-18 21:26:10.02522
1811	2	58	15	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/kras/41"}}}	1	2016-05-18 21:26:10.041561	2016-05-18 21:26:10.041561
1812	2	59	15	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/kras/41"}}}	1	2016-05-18 21:26:10.05717	2016-05-18 21:26:10.05717
1813	2	60	15	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/kras/41"}}}	1	2016-05-18 21:26:10.07257	2016-05-18 21:26:10.07257
1814	2	61	15	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/kras/41"}}}	1	2016-05-18 21:26:10.087964	2016-05-18 21:26:10.087964
1815	2	62	15	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/kras/41"}}}	1	2016-05-18 21:26:10.102192	2016-05-18 21:26:10.102192
1816	2	63	15	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/kras/41"}}}	1	2016-05-18 21:26:10.1209	2016-05-18 21:26:10.1209
470	2	84	39	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/kras/41"}}}	1	2016-05-18 20:39:00.883231	2016-05-18 20:39:00.895145
471	2	85	39	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/kras/41"}}}	1	2016-05-18 20:39:00.931202	2016-05-18 20:39:00.958301
472	2	86	39	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/kras/41"}}}	1	2016-05-18 20:39:00.998482	2016-05-18 20:39:01.012682
473	2	87	39	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/kras/41"}}}	1	2016-05-18 20:39:01.058028	2016-05-18 20:39:01.069351
474	2	88	39	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/kras/41"}}}	1	2016-05-18 20:39:01.108642	2016-05-18 20:39:01.120918
475	2	89	39	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/kras/41"}}}	1	2016-05-18 20:39:01.170571	2016-05-18 20:39:01.18267
476	4	83	39	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/41"}}}	1	2016-05-18 20:39:01.21728	2016-05-18 20:39:01.232755
477	4	84	39	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/41"}}}	1	2016-05-18 20:39:01.288596	2016-05-18 20:39:01.312951
478	4	85	39	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/41"}}}	1	2016-05-18 20:39:01.362517	2016-05-18 20:39:01.380552
479	4	86	39	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/41"}}}	1	2016-05-18 20:39:01.426105	2016-05-18 20:39:01.439144
480	4	87	39	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/41"}}}	1	2016-05-18 20:39:01.520222	2016-05-18 20:39:01.530658
481	4	88	39	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/41"}}}	1	2016-05-18 20:39:01.569511	2016-05-18 20:39:01.585955
482	4	89	39	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/41"}}}	1	2016-05-18 20:39:01.619106	2016-05-18 20:39:01.630131
483	4	83	40	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/159"}}}	1	2016-05-18 20:39:01.683045	2016-05-18 20:39:01.696507
484	4	84	40	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/159"}}}	1	2016-05-18 20:39:01.740828	2016-05-18 20:39:01.754873
485	4	85	40	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/159"}}}	1	2016-05-18 20:39:01.800922	2016-05-18 20:39:01.815932
486	4	86	40	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/159"}}}	1	2016-05-18 20:39:01.856425	2016-05-18 20:39:01.86986
487	4	87	40	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/159"}}}	1	2016-05-18 20:39:01.916372	2016-05-18 20:39:01.929038
488	4	88	40	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/159"}}}	1	2016-05-18 20:39:01.969242	2016-05-18 20:39:01.980016
489	4	89	40	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/159"}}}	1	2016-05-18 20:39:02.021745	2016-05-18 20:39:02.057536
490	2	83	41	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/kras/68"}}}	1	2016-05-18 20:39:02.102374	2016-05-18 20:39:02.112528
491	2	84	41	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/kras/68"}}}	1	2016-05-18 20:39:02.169386	2016-05-18 20:39:02.180747
492	2	85	41	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/kras/68"}}}	1	2016-05-18 20:39:02.211866	2016-05-18 20:39:02.223456
493	2	86	41	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/kras/68"}}}	1	2016-05-18 20:39:02.293756	2016-05-18 20:39:02.304983
494	2	87	41	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/kras/68"}}}	1	2016-05-18 20:39:02.340747	2016-05-18 20:39:02.355812
495	2	88	41	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/kras/68"}}}	1	2016-05-18 20:39:02.419273	2016-05-18 20:39:02.430798
496	2	89	41	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/kras/68"}}}	1	2016-05-18 20:39:02.466175	2016-05-18 20:39:02.47814
497	4	83	41	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/68"}}}	1	2016-05-18 20:39:02.531331	2016-05-18 20:39:02.544703
1817	2	64	15	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/kras/41"}}}	1	2016-05-18 21:26:10.134428	2016-05-18 21:26:10.134428
1818	4	57	15	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/89"}}}	1	2016-05-18 21:26:10.150704	2016-05-18 21:26:10.150704
1819	4	58	15	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/89"}}}	1	2016-05-18 21:26:10.166136	2016-05-18 21:26:10.166136
1820	4	59	15	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/89"}}}	1	2016-05-18 21:26:10.184201	2016-05-18 21:26:10.184201
1821	4	60	15	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/89"}}}	1	2016-05-18 21:26:10.199492	2016-05-18 21:26:10.199492
1822	4	61	15	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/89"}}}	1	2016-05-18 21:26:10.214073	2016-05-18 21:26:10.214073
1823	4	62	15	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/89"}}}	1	2016-05-18 21:26:10.232601	2016-05-18 21:26:10.232601
1824	4	63	15	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/89"}}}	1	2016-05-18 21:26:10.2512	2016-05-18 21:26:10.2512
1825	4	64	15	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/89"}}}	1	2016-05-18 21:26:10.266019	2016-05-18 21:26:10.266019
498	4	84	41	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/68"}}}	1	2016-05-18 20:39:02.582887	2016-05-18 20:39:02.595487
499	4	85	41	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/68"}}}	1	2016-05-18 20:39:02.642321	2016-05-18 20:39:02.655548
500	4	86	41	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/68"}}}	1	2016-05-18 20:39:02.693011	2016-05-18 20:39:02.703925
501	4	87	41	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/68"}}}	1	2016-05-18 20:39:02.736097	2016-05-18 20:39:02.74694
502	4	88	41	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/68"}}}	1	2016-05-18 20:39:02.792432	2016-05-18 20:39:02.80955
503	4	89	41	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/68"}}}	1	2016-05-18 20:39:02.850489	2016-05-18 20:39:02.86257
504	3	83	42	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/39"}}}	1	2016-05-18 20:39:02.918545	2016-05-18 20:39:02.932854
505	3	84	42	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/39"}}}	1	2016-05-18 20:39:02.987166	2016-05-18 20:39:03.000786
506	3	85	42	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/39"}}}	1	2016-05-18 20:39:03.033708	2016-05-18 20:39:03.04875
507	3	86	42	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/39"}}}	1	2016-05-18 20:39:03.09576	2016-05-18 20:39:03.11173
508	3	87	42	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/39"}}}	1	2016-05-18 20:39:03.155091	2016-05-18 20:39:03.180032
509	3	88	42	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/39"}}}	1	2016-05-18 20:39:03.217719	2016-05-18 20:39:03.231174
510	3	89	42	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/39"}}}	1	2016-05-18 20:39:03.281484	2016-05-18 20:39:03.299729
511	6	83	42	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/ovarian-cancer/kras/39"}}}	1	2016-05-18 20:39:03.332172	2016-05-18 20:39:03.348837
512	6	84	42	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/ovarian-cancer/kras/39"}}}	1	2016-05-18 20:39:03.40594	2016-05-18 20:39:03.428399
513	6	85	42	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/ovarian-cancer/kras/39"}}}	1	2016-05-18 20:39:03.461201	2016-05-18 20:39:03.484331
514	6	86	42	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/ovarian-cancer/kras/39"}}}	1	2016-05-18 20:39:03.53109	2016-05-18 20:39:03.542225
515	6	87	42	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/ovarian-cancer/kras/39"}}}	1	2016-05-18 20:39:03.589028	2016-05-18 20:39:03.599079
516	6	88	42	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/ovarian-cancer/kras/39"}}}	1	2016-05-18 20:39:03.635019	2016-05-18 20:39:03.648733
517	6	89	42	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/ovarian-cancer/kras/39"}}}	1	2016-05-18 20:39:03.708414	2016-05-18 20:39:03.721942
518	2	83	42	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/kras/39"}}}	1	2016-05-18 20:39:03.755773	2016-05-18 20:39:03.768646
519	2	84	42	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/kras/39"}}}	1	2016-05-18 20:39:03.81789	2016-05-18 20:39:03.830077
520	2	85	42	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/kras/39"}}}	1	2016-05-18 20:39:03.868208	2016-05-18 20:39:03.877355
521	2	86	42	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/kras/39"}}}	1	2016-05-18 20:39:03.923327	2016-05-18 20:39:03.93558
522	2	87	42	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/kras/39"}}}	1	2016-05-18 20:39:03.968707	2016-05-18 20:39:03.980246
523	2	88	42	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/kras/39"}}}	1	2016-05-18 20:39:04.02019	2016-05-18 20:39:04.034828
524	2	89	42	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/kras/39"}}}	1	2016-05-18 20:39:04.071124	2016-05-18 20:39:04.08432
525	4	90	42	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/39"}}}	1	2016-05-18 20:39:04.12811	2016-05-18 20:39:04.139842
1826	5	57	16	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/ddr2/78"}}}	1	2016-05-18 21:26:10.282601	2016-05-18 21:26:10.282601
1827	5	58	16	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/ddr2/78"}}}	1	2016-05-18 21:26:10.29929	2016-05-18 21:26:10.29929
1828	5	59	16	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/ddr2/78"}}}	1	2016-05-18 21:26:10.316378	2016-05-18 21:26:10.316378
1829	5	60	16	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/ddr2/78"}}}	1	2016-05-18 21:26:10.3342	2016-05-18 21:26:10.3342
1830	5	61	16	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/ddr2/78"}}}	1	2016-05-18 21:26:10.351385	2016-05-18 21:26:10.351385
1831	5	62	16	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/ddr2/78"}}}	1	2016-05-18 21:26:10.365765	2016-05-18 21:26:10.365765
1832	5	63	16	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/ddr2/78"}}}	1	2016-05-18 21:26:10.38473	2016-05-18 21:26:10.38473
1833	5	64	16	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/ddr2/78"}}}	1	2016-05-18 21:26:10.39895	2016-05-18 21:26:10.39895
1834	3	57	17	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/ret/128"}}}	1	2016-05-18 21:26:10.417253	2016-05-18 21:26:10.417253
526	4	91	42	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/39"}}}	1	2016-05-18 20:39:04.170869	2016-05-18 20:39:04.186424
527	4	92	42	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/39"}}}	1	2016-05-18 20:39:04.232215	2016-05-18 20:39:04.243307
528	2	90	43	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/kras/38"}}}	1	2016-05-18 20:39:04.293882	2016-05-18 20:39:04.310203
529	2	91	43	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/kras/38"}}}	1	2016-05-18 20:39:04.35026	2016-05-18 20:39:04.361352
530	2	92	43	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/kras/38"}}}	1	2016-05-18 20:39:04.425575	2016-05-18 20:39:04.434473
531	4	90	43	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/38"}}}	1	2016-05-18 20:39:04.461307	2016-05-18 20:39:04.471448
532	4	91	43	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/38"}}}	1	2016-05-18 20:39:04.518555	2016-05-18 20:39:04.527684
533	4	92	43	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/38"}}}	1	2016-05-18 20:39:04.556857	2016-05-18 20:39:04.569865
534	3	90	44	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/40"}}}	1	2016-05-18 20:39:04.618107	2016-05-18 20:39:04.63186
535	3	91	44	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/40"}}}	1	2016-05-18 20:39:04.66962	2016-05-18 20:39:04.695318
536	3	92	44	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/40"}}}	1	2016-05-18 20:39:04.730282	2016-05-18 20:39:04.743339
537	2	93	44	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/kras/40"}}}	1	2016-05-18 20:39:04.781903	2016-05-18 20:39:04.792559
538	4	94	44	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/40"}}}	1	2016-05-18 20:39:04.828156	2016-05-18 20:39:04.840601
539	3	90	45	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/69"}}}	1	2016-05-18 20:39:04.890291	2016-05-18 20:39:04.900434
540	3	91	45	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/69"}}}	1	2016-05-18 20:39:04.928517	2016-05-18 20:39:04.941562
541	3	92	45	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/69"}}}	1	2016-05-18 20:39:04.973016	2016-05-18 20:39:04.994206
542	2	95	45	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/kras/69"}}}	1	2016-05-18 20:39:05.035396	2016-05-18 20:39:05.047145
543	4	95	45	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/69"}}}	1	2016-05-18 20:39:05.083067	2016-05-18 20:39:05.097033
544	3	95	46	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/37"}}}	1	2016-05-18 20:39:05.156615	2016-05-18 20:39:05.169279
545	6	90	46	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/ovarian-cancer/kras/37"}}}	1	2016-05-18 20:39:05.214686	2016-05-18 20:39:05.227129
546	6	91	46	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/ovarian-cancer/kras/37"}}}	1	2016-05-18 20:39:05.263492	2016-05-18 20:39:05.284936
547	6	92	46	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/ovarian-cancer/kras/37"}}}	1	2016-05-18 20:39:05.323077	2016-05-18 20:39:05.335029
548	4	90	46	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/37"}}}	1	2016-05-18 20:39:05.399804	2016-05-18 20:39:05.409484
549	4	91	46	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/37"}}}	1	2016-05-18 20:39:05.444988	2016-05-18 20:39:05.455188
550	4	92	46	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/37"}}}	1	2016-05-18 20:39:05.511024	2016-05-18 20:39:05.522292
551	6	90	47	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/ovarian-cancer/kras/32"}}}	1	2016-05-18 20:39:05.563083	2016-05-18 20:39:05.576998
552	6	91	47	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/ovarian-cancer/kras/32"}}}	1	2016-05-18 20:39:05.61059	2016-05-18 20:39:05.621922
1835	3	58	17	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/ret/128"}}}	1	2016-05-18 21:26:10.430895	2016-05-18 21:26:10.430895
1836	3	59	17	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/ret/128"}}}	1	2016-05-18 21:26:10.448934	2016-05-18 21:26:10.448934
1397	8	3	7	\N	\N	2	\N	2	2016-05-18 20:39:57.709833	2016-05-18 20:39:57.709833
1837	3	60	17	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/ret/128"}}}	1	2016-05-18 21:26:10.461829	2016-05-18 21:26:10.461829
1838	3	61	17	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/ret/128"}}}	1	2016-05-18 21:26:10.47889	2016-05-18 21:26:10.47889
1839	3	62	17	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/ret/128"}}}	1	2016-05-18 21:26:10.49438	2016-05-18 21:26:10.49438
1840	3	63	17	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/ret/128"}}}	1	2016-05-18 21:26:10.508704	2016-05-18 21:26:10.508704
1841	3	64	17	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/ret/128"}}}	1	2016-05-18 21:26:10.524154	2016-05-18 21:26:10.524154
1842	6	57	18	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/ovarian-cancer/pten/145"}}}	1	2016-05-18 21:26:10.539796	2016-05-18 21:26:10.539796
1843	6	58	18	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/ovarian-cancer/pten/145"}}}	1	2016-05-18 21:26:10.55585	2016-05-18 21:26:10.55585
3118	8	44	35	\N	\N	3	\N	2	2016-05-18 21:26:44.41753	2016-05-18 21:26:44.41753
553	6	92	47	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/ovarian-cancer/kras/32"}}}	1	2016-05-18 20:39:05.655316	2016-05-18 20:39:05.667237
554	2	90	47	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/kras/32"}}}	1	2016-05-18 20:39:05.711683	2016-05-18 20:39:05.722541
555	2	91	47	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/kras/32"}}}	1	2016-05-18 20:39:05.755532	2016-05-18 20:39:05.770205
556	2	92	47	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/kras/32"}}}	1	2016-05-18 20:39:05.813139	2016-05-18 20:39:05.824714
557	4	96	47	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/32"}}}	1	2016-05-18 20:39:05.856836	2016-05-18 20:39:05.869873
558	4	97	47	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/32"}}}	1	2016-05-18 20:39:05.915569	2016-05-18 20:39:05.92708
559	3	96	48	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/34"}}}	1	2016-05-18 20:39:05.972915	2016-05-18 20:39:05.987745
560	3	97	48	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/34"}}}	1	2016-05-18 20:39:06.030655	2016-05-18 20:39:06.042016
561	6	96	48	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/ovarian-cancer/kras/34"}}}	1	2016-05-18 20:39:06.099749	2016-05-18 20:39:06.110534
562	6	97	48	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/ovarian-cancer/kras/34"}}}	1	2016-05-18 20:39:06.146946	2016-05-18 20:39:06.160771
563	2	96	48	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/kras/34"}}}	1	2016-05-18 20:39:06.199297	2016-05-18 20:39:06.210857
564	2	97	48	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/kras/34"}}}	1	2016-05-18 20:39:06.2494	2016-05-18 20:39:06.26299
565	2	98	48	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/kras/34"}}}	1	2016-05-18 20:39:06.296851	2016-05-18 20:39:06.310877
566	2	99	48	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/kras/34"}}}	1	2016-05-18 20:39:06.365767	2016-05-18 20:39:06.376871
567	2	100	48	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/kras/34"}}}	1	2016-05-18 20:39:06.427476	2016-05-18 20:39:06.449908
568	2	101	48	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/kras/34"}}}	1	2016-05-18 20:39:06.498501	2016-05-18 20:39:06.508127
569	4	102	48	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/34"}}}	1	2016-05-18 20:39:06.536955	2016-05-18 20:39:06.546476
570	4	103	48	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/34"}}}	1	2016-05-18 20:39:06.57806	2016-05-18 20:39:06.592646
571	3	104	49	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/33"}}}	1	2016-05-18 20:39:06.652587	2016-05-18 20:39:06.662102
572	3	102	49	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/33"}}}	1	2016-05-18 20:39:06.688232	2016-05-18 20:39:06.701103
573	3	105	49	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/33"}}}	1	2016-05-18 20:39:06.740898	2016-05-18 20:39:06.754026
574	6	104	49	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/ovarian-cancer/kras/33"}}}	1	2016-05-18 20:39:06.789281	2016-05-18 20:39:06.809502
575	6	102	49	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/ovarian-cancer/kras/33"}}}	1	2016-05-18 20:39:06.847916	2016-05-18 20:39:06.860655
576	6	106	49	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/ovarian-cancer/kras/33"}}}	1	2016-05-18 20:39:06.907574	2016-05-18 20:39:06.919765
577	6	107	49	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/ovarian-cancer/kras/33"}}}	1	2016-05-18 20:39:06.9558	2016-05-18 20:39:06.96693
578	6	108	49	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/ovarian-cancer/kras/33"}}}	1	2016-05-18 20:39:07.00413	2016-05-18 20:39:07.013373
579	6	109	49	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/ovarian-cancer/kras/33"}}}	1	2016-05-18 20:39:07.054041	2016-05-18 20:39:07.066916
580	6	110	49	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/ovarian-cancer/kras/33"}}}	1	2016-05-18 20:39:07.097728	2016-05-18 20:39:07.109356
1844	6	59	18	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/ovarian-cancer/pten/145"}}}	1	2016-05-18 21:26:10.570372	2016-05-18 21:26:10.570372
1845	6	60	18	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/ovarian-cancer/pten/145"}}}	1	2016-05-18 21:26:10.587094	2016-05-18 21:26:10.587094
1846	6	61	18	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/ovarian-cancer/pten/145"}}}	1	2016-05-18 21:26:10.601561	2016-05-18 21:26:10.601561
1847	6	62	18	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/ovarian-cancer/pten/145"}}}	1	2016-05-18 21:26:10.615823	2016-05-18 21:26:10.615823
1848	6	63	18	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/ovarian-cancer/pten/145"}}}	1	2016-05-18 21:26:10.63197	2016-05-18 21:26:10.63197
1849	6	64	18	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/ovarian-cancer/pten/145"}}}	1	2016-05-18 21:26:10.646984	2016-05-18 21:26:10.646984
1850	6	57	19	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/ovarian-cancer/pten/137"}}}	1	2016-05-18 21:26:10.663831	2016-05-18 21:26:10.663831
1851	6	58	19	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/ovarian-cancer/pten/137"}}}	1	2016-05-18 21:26:10.680201	2016-05-18 21:26:10.680201
3119	8	82	35	\N	\N	3	\N	2	2016-05-18 21:26:44.430577	2016-05-18 21:26:44.430577
3120	8	337	42	\N	\N	3	\N	2	2016-05-18 21:26:44.452361	2016-05-18 21:26:44.452361
581	2	104	49	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/kras/33"}}}	1	2016-05-18 20:39:07.141201	2016-05-18 20:39:07.153948
582	2	102	49	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/kras/33"}}}	1	2016-05-18 20:39:07.187754	2016-05-18 20:39:07.201796
583	2	106	49	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/kras/33"}}}	1	2016-05-18 20:39:07.234728	2016-05-18 20:39:07.246243
584	2	108	49	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/kras/33"}}}	1	2016-05-18 20:39:07.282269	2016-05-18 20:39:07.319036
585	2	109	49	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/kras/33"}}}	1	2016-05-18 20:39:07.348796	2016-05-18 20:39:07.360157
586	2	110	49	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/kras/33"}}}	1	2016-05-18 20:39:07.409496	2016-05-18 20:39:07.431691
587	4	102	49	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/33"}}}	1	2016-05-18 20:39:07.463671	2016-05-18 20:39:07.474838
588	4	106	49	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/33"}}}	1	2016-05-18 20:39:07.510902	2016-05-18 20:39:07.523654
589	3	104	50	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/35"}}}	1	2016-05-18 20:39:07.571956	2016-05-18 20:39:07.584621
590	3	102	50	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/35"}}}	1	2016-05-18 20:39:07.63611	2016-05-18 20:39:07.647649
591	3	103	50	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/35"}}}	1	2016-05-18 20:39:07.682012	2016-05-18 20:39:07.692949
592	3	109	50	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/35"}}}	1	2016-05-18 20:39:07.724884	2016-05-18 20:39:07.739176
593	3	110	50	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/35"}}}	1	2016-05-18 20:39:07.774177	2016-05-18 20:39:07.788283
594	6	111	50	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/ovarian-cancer/kras/35"}}}	1	2016-05-18 20:39:07.823239	2016-05-18 20:39:07.843768
595	6	112	50	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/ovarian-cancer/kras/35"}}}	1	2016-05-18 20:39:07.880115	2016-05-18 20:39:07.895068
596	6	113	50	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/ovarian-cancer/kras/35"}}}	1	2016-05-18 20:39:07.945264	2016-05-18 20:39:07.959645
597	2	111	50	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/kras/35"}}}	1	2016-05-18 20:39:07.996227	2016-05-18 20:39:08.009834
598	2	112	50	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/kras/35"}}}	1	2016-05-18 20:39:08.054454	2016-05-18 20:39:08.067138
599	2	113	50	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/kras/35"}}}	1	2016-05-18 20:39:08.102938	2016-05-18 20:39:08.117765
600	4	114	50	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/35"}}}	1	2016-05-18 20:39:08.154444	2016-05-18 20:39:08.166957
601	3	115	51	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/36"}}}	1	2016-05-18 20:39:08.219242	2016-05-18 20:39:08.233204
602	3	116	51	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/36"}}}	1	2016-05-18 20:39:08.270454	2016-05-18 20:39:08.285288
603	3	117	51	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/36"}}}	1	2016-05-18 20:39:08.342017	2016-05-18 20:39:08.351076
604	3	12	51	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/36"}}}	1	2016-05-18 20:39:08.385589	2016-05-18 20:39:08.405384
605	3	118	51	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/36"}}}	1	2016-05-18 20:39:08.443601	2016-05-18 20:39:08.46244
606	3	119	51	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/36"}}}	1	2016-05-18 20:39:08.508196	2016-05-18 20:39:08.523052
607	2	115	51	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/kras/36"}}}	1	2016-05-18 20:39:08.56944	2016-05-18 20:39:08.585598
608	2	116	51	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/kras/36"}}}	1	2016-05-18 20:39:08.629652	2016-05-18 20:39:08.649179
1852	6	59	19	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/ovarian-cancer/pten/137"}}}	1	2016-05-18 21:26:10.695838	2016-05-18 21:26:10.695838
1853	6	60	19	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/ovarian-cancer/pten/137"}}}	1	2016-05-18 21:26:10.715712	2016-05-18 21:26:10.715712
1854	6	61	19	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/ovarian-cancer/pten/137"}}}	1	2016-05-18 21:26:10.728387	2016-05-18 21:26:10.728387
1855	6	62	19	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/ovarian-cancer/pten/137"}}}	1	2016-05-18 21:26:10.743956	2016-05-18 21:26:10.743956
1856	6	63	19	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/ovarian-cancer/pten/137"}}}	1	2016-05-18 21:26:10.758381	2016-05-18 21:26:10.758381
1857	6	64	19	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/ovarian-cancer/pten/137"}}}	1	2016-05-18 21:26:10.774319	2016-05-18 21:26:10.774319
1858	6	57	20	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/ovarian-cancer/pten/144"}}}	1	2016-05-18 21:26:10.790592	2016-05-18 21:26:10.790592
1859	6	58	20	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/ovarian-cancer/pten/144"}}}	1	2016-05-18 21:26:10.803727	2016-05-18 21:26:10.803727
1860	6	59	20	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/ovarian-cancer/pten/144"}}}	1	2016-05-18 21:26:10.822381	2016-05-18 21:26:10.822381
609	2	117	51	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/kras/36"}}}	1	2016-05-18 20:39:08.690061	2016-05-18 20:39:08.708349
610	2	12	51	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/kras/36"}}}	1	2016-05-18 20:39:08.748248	2016-05-18 20:39:08.762652
611	2	118	51	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/kras/36"}}}	1	2016-05-18 20:39:08.803229	2016-05-18 20:39:08.818647
612	2	119	51	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/kras/36"}}}	1	2016-05-18 20:39:08.859898	2016-05-18 20:39:08.898504
613	4	115	51	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/36"}}}	1	2016-05-18 20:39:08.931826	2016-05-18 20:39:08.944237
614	4	116	51	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/36"}}}	1	2016-05-18 20:39:09.002019	2016-05-18 20:39:09.015691
615	4	117	51	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/36"}}}	1	2016-05-18 20:39:09.060244	2016-05-18 20:39:09.071339
616	4	12	51	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/36"}}}	1	2016-05-18 20:39:09.117157	2016-05-18 20:39:09.12792
617	4	118	51	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/36"}}}	1	2016-05-18 20:39:09.161655	2016-05-18 20:39:09.173478
618	4	120	51	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/36"}}}	1	2016-05-18 20:39:09.2147	2016-05-18 20:39:09.236573
619	4	121	51	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/36"}}}	1	2016-05-18 20:39:09.274751	2016-05-18 20:39:09.28863
620	4	122	51	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/36"}}}	1	2016-05-18 20:39:09.342113	2016-05-18 20:39:09.357199
621	4	123	51	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/36"}}}	1	2016-05-18 20:39:09.403056	2016-05-18 20:39:09.4117
622	4	111	51	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/36"}}}	1	2016-05-18 20:39:09.453982	2016-05-18 20:39:09.465725
623	4	112	51	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/36"}}}	1	2016-05-18 20:39:09.505651	2016-05-18 20:39:09.518806
624	4	124	51	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/36"}}}	1	2016-05-18 20:39:09.554675	2016-05-18 20:39:09.578603
625	4	125	51	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/36"}}}	1	2016-05-18 20:39:09.619044	2016-05-18 20:39:09.632345
626	8	115	52	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/290"}}}	1	2016-05-18 20:39:09.712245	2016-05-18 20:39:09.722793
627	8	116	52	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/290"}}}	1	2016-05-18 20:39:09.762798	2016-05-18 20:39:09.772966
628	8	117	52	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/290"}}}	1	2016-05-18 20:39:09.822775	2016-05-18 20:39:09.837723
629	8	12	52	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/290"}}}	1	2016-05-18 20:39:09.872681	2016-05-18 20:39:09.885265
630	8	118	52	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/290"}}}	1	2016-05-18 20:39:09.950016	2016-05-18 20:39:09.963772
631	8	120	52	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/290"}}}	1	2016-05-18 20:39:10.003265	2016-05-18 20:39:10.016305
632	8	121	52	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/290"}}}	1	2016-05-18 20:39:10.10068	2016-05-18 20:39:10.111194
633	8	122	52	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/290"}}}	1	2016-05-18 20:39:10.158374	2016-05-18 20:39:10.168053
634	8	123	52	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/290"}}}	1	2016-05-18 20:39:10.219739	2016-05-18 20:39:10.231816
635	8	111	52	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/290"}}}	1	2016-05-18 20:39:10.268524	2016-05-18 20:39:10.280015
1861	6	60	20	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/ovarian-cancer/pten/144"}}}	1	2016-05-18 21:26:10.83667	2016-05-18 21:26:10.83667
1398	8	15	10	\N	\N	2	\N	2	2016-05-18 20:39:57.760954	2016-05-18 20:39:57.760954
1862	6	61	20	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/ovarian-cancer/pten/144"}}}	1	2016-05-18 21:26:10.85073	2016-05-18 21:26:10.85073
1863	6	62	20	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/ovarian-cancer/pten/144"}}}	1	2016-05-18 21:26:10.865651	2016-05-18 21:26:10.865651
1864	6	63	20	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/ovarian-cancer/pten/144"}}}	1	2016-05-18 21:26:10.879595	2016-05-18 21:26:10.879595
1865	6	64	20	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/ovarian-cancer/pten/144"}}}	1	2016-05-18 21:26:10.891392	2016-05-18 21:26:10.891392
1866	7	57	21	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/breast-cancer/pten/24"}}}	1	2016-05-18 21:26:10.903744	2016-05-18 21:26:10.903744
1867	7	58	21	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/breast-cancer/pten/24"}}}	1	2016-05-18 21:26:10.918522	2016-05-18 21:26:10.918522
1868	7	59	21	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/breast-cancer/pten/24"}}}	1	2016-05-18 21:26:10.93252	2016-05-18 21:26:10.93252
1869	7	60	21	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/breast-cancer/pten/24"}}}	1	2016-05-18 21:26:10.945025	2016-05-18 21:26:10.945025
636	8	112	52	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/290"}}}	1	2016-05-18 20:39:10.326174	2016-05-18 20:39:10.33984
637	8	124	52	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/290"}}}	1	2016-05-18 20:39:10.377523	2016-05-18 20:39:10.388879
638	8	125	52	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/290"}}}	1	2016-05-18 20:39:10.424467	2016-05-18 20:39:10.435766
639	8	111	53	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/284"}}}	1	2016-05-18 20:39:10.509251	2016-05-18 20:39:10.519838
640	8	115	54	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/283"}}}	1	2016-05-18 20:39:10.586246	2016-05-18 20:39:10.596907
641	8	116	54	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/283"}}}	1	2016-05-18 20:39:10.635659	2016-05-18 20:39:10.6683
642	8	117	54	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/283"}}}	1	2016-05-18 20:39:10.698905	2016-05-18 20:39:10.710711
643	8	12	54	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/283"}}}	1	2016-05-18 20:39:10.742451	2016-05-18 20:39:10.756775
644	8	118	54	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/283"}}}	1	2016-05-18 20:39:10.806629	2016-05-18 20:39:10.818796
645	8	120	54	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/283"}}}	1	2016-05-18 20:39:10.862972	2016-05-18 20:39:10.883266
646	8	111	54	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/283"}}}	1	2016-05-18 20:39:10.916873	2016-05-18 20:39:10.929906
647	8	112	54	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/283"}}}	1	2016-05-18 20:39:10.971946	2016-05-18 20:39:11.015012
648	8	124	54	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/283"}}}	1	2016-05-18 20:39:11.045809	2016-05-18 20:39:11.058109
649	8	125	54	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/283"}}}	1	2016-05-18 20:39:11.097865	2016-05-18 20:39:11.117234
650	8	111	55	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/288"}}}	1	2016-05-18 20:39:11.161805	2016-05-18 20:39:11.181291
651	8	115	56	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/282"}}}	1	2016-05-18 20:39:11.234024	2016-05-18 20:39:11.253601
652	8	116	56	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/282"}}}	1	2016-05-18 20:39:11.342705	2016-05-18 20:39:11.351489
653	8	117	56	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/282"}}}	1	2016-05-18 20:39:11.3856	2016-05-18 20:39:11.3987
654	8	12	56	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/282"}}}	1	2016-05-18 20:39:11.439925	2016-05-18 20:39:11.453528
655	8	118	56	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/282"}}}	1	2016-05-18 20:39:11.501019	2016-05-18 20:39:11.519456
656	8	120	56	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/282"}}}	1	2016-05-18 20:39:11.551581	2016-05-18 20:39:11.562672
657	8	121	56	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/282"}}}	1	2016-05-18 20:39:11.632223	2016-05-18 20:39:11.644486
658	8	122	56	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/282"}}}	1	2016-05-18 20:39:11.69143	2016-05-18 20:39:11.702104
659	8	123	56	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/282"}}}	1	2016-05-18 20:39:11.751432	2016-05-18 20:39:11.763288
660	8	111	56	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/282"}}}	1	2016-05-18 20:39:11.806221	2016-05-18 20:39:11.825952
661	8	112	56	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/282"}}}	1	2016-05-18 20:39:11.864095	2016-05-18 20:39:11.877894
662	8	124	56	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/282"}}}	1	2016-05-18 20:39:11.914308	2016-05-18 20:39:11.93411
1870	7	61	21	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/breast-cancer/pten/24"}}}	1	2016-05-18 21:26:10.960166	2016-05-18 21:26:10.960166
1871	7	62	21	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/breast-cancer/pten/24"}}}	1	2016-05-18 21:26:10.975485	2016-05-18 21:26:10.975485
1872	7	63	21	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/breast-cancer/pten/24"}}}	1	2016-05-18 21:26:10.992243	2016-05-18 21:26:10.992243
1873	7	64	21	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/breast-cancer/pten/24"}}}	1	2016-05-18 21:26:11.006633	2016-05-18 21:26:11.006633
1874	7	65	21	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/breast-cancer/pten/24"}}}	1	2016-05-18 21:26:11.026564	2016-05-18 21:26:11.026564
1875	7	66	21	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/breast-cancer/pten/24"}}}	1	2016-05-18 21:26:11.04069	2016-05-18 21:26:11.04069
1876	7	67	21	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/breast-cancer/pten/24"}}}	1	2016-05-18 21:26:11.059349	2016-05-18 21:26:11.059349
1877	4	57	21	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/pten/24"}}}	1	2016-05-18 21:26:11.073007	2016-05-18 21:26:11.073007
3121	8	36	42	\N	\N	3	\N	2	2016-05-18 21:26:44.467512	2016-05-18 21:26:44.467512
663	8	125	56	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/282"}}}	1	2016-05-18 20:39:11.974801	2016-05-18 20:39:11.988683
664	8	111	57	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/281"}}}	1	2016-05-18 20:39:12.044773	2016-05-18 20:39:12.056167
665	8	115	58	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/280"}}}	1	2016-05-18 20:39:12.112441	2016-05-18 20:39:12.124787
666	8	116	58	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/280"}}}	1	2016-05-18 20:39:12.157591	2016-05-18 20:39:12.168801
667	8	117	58	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/280"}}}	1	2016-05-18 20:39:12.21775	2016-05-18 20:39:12.227926
668	8	12	58	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/280"}}}	1	2016-05-18 20:39:12.264341	2016-05-18 20:39:12.27779
669	8	118	58	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/280"}}}	1	2016-05-18 20:39:12.325753	2016-05-18 20:39:12.336516
670	8	111	58	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/280"}}}	1	2016-05-18 20:39:12.374919	2016-05-18 20:39:12.387022
671	8	121	58	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/280"}}}	1	2016-05-18 20:39:12.452235	2016-05-18 20:39:12.461394
672	8	122	58	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/280"}}}	1	2016-05-18 20:39:12.495821	2016-05-18 20:39:12.507716
673	8	112	58	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/280"}}}	1	2016-05-18 20:39:12.571154	2016-05-18 20:39:12.581159
674	8	124	58	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/280"}}}	1	2016-05-18 20:39:12.619451	2016-05-18 20:39:12.630623
675	8	125	58	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/280"}}}	1	2016-05-18 20:39:12.836198	2016-05-18 20:39:12.846431
676	8	115	59	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/278"}}}	1	2016-05-18 20:39:12.891728	2016-05-18 20:39:12.907942
677	8	116	59	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/278"}}}	1	2016-05-18 20:39:12.943087	2016-05-18 20:39:12.960562
678	8	117	59	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/278"}}}	1	2016-05-18 20:39:13.006107	2016-05-18 20:39:13.020462
679	8	12	59	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/278"}}}	1	2016-05-18 20:39:13.055689	2016-05-18 20:39:13.096145
680	8	118	59	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/278"}}}	1	2016-05-18 20:39:13.127574	2016-05-18 20:39:13.138597
681	8	126	59	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/278"}}}	1	2016-05-18 20:39:13.168393	2016-05-18 20:39:13.179949
682	8	121	59	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/278"}}}	1	2016-05-18 20:39:13.218976	2016-05-18 20:39:13.234235
683	8	122	59	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/278"}}}	1	2016-05-18 20:39:13.281308	2016-05-18 20:39:13.291774
684	8	111	59	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/278"}}}	1	2016-05-18 20:39:13.329006	2016-05-18 20:39:13.343425
685	8	112	59	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/278"}}}	1	2016-05-18 20:39:13.438479	2016-05-18 20:39:13.448283
686	8	124	59	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/278"}}}	1	2016-05-18 20:39:13.475084	2016-05-18 20:39:13.487582
687	8	125	59	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/278"}}}	1	2016-05-18 20:39:13.543422	2016-05-18 20:39:13.556417
688	8	111	60	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/279"}}}	1	2016-05-18 20:39:13.630066	2016-05-18 20:39:13.640256
689	7	111	61	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/breast-cancer/akt1/23"}}}	1	2016-05-18 20:39:13.70876	2016-05-18 20:39:13.721211
1878	4	58	21	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/pten/24"}}}	1	2016-05-18 21:26:11.088583	2016-05-18 21:26:11.088583
1879	4	59	21	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/pten/24"}}}	1	2016-05-18 21:26:11.103413	2016-05-18 21:26:11.103413
1880	4	60	21	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/pten/24"}}}	1	2016-05-18 21:26:11.122423	2016-05-18 21:26:11.122423
1881	4	61	21	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/pten/24"}}}	1	2016-05-18 21:26:11.1374	2016-05-18 21:26:11.1374
1882	4	62	21	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/pten/24"}}}	1	2016-05-18 21:26:11.169044	2016-05-18 21:26:11.169044
1883	4	63	21	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/pten/24"}}}	1	2016-05-18 21:26:11.187041	2016-05-18 21:26:11.187041
1884	4	64	21	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/pten/24"}}}	1	2016-05-18 21:26:11.2007	2016-05-18 21:26:11.2007
1885	7	57	22	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/breast-cancer/pten/25"}}}	1	2016-05-18 21:26:11.217279	2016-05-18 21:26:11.217279
3122	8	305	42	\N	\N	3	\N	2	2016-05-18 21:26:44.485866	2016-05-18 21:26:44.485866
3123	8	306	42	\N	\N	3	\N	2	2016-05-18 21:26:44.500957	2016-05-18 21:26:44.500957
690	2	111	61	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/akt1/23"}}}	1	2016-05-18 20:39:13.776645	2016-05-18 20:39:13.795231
691	2	112	61	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/akt1/23"}}}	1	2016-05-18 20:39:13.823852	2016-05-18 20:39:13.83322
692	2	113	61	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/akt1/23"}}}	1	2016-05-18 20:39:13.915763	2016-05-18 20:39:13.926976
693	4	127	61	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/akt1/23"}}}	1	2016-05-18 20:39:13.956862	2016-05-18 20:39:13.970819
694	4	113	61	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/akt1/23"}}}	1	2016-05-18 20:39:14.025723	2016-05-18 20:39:14.038658
695	7	127	62	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/breast-cancer/her2/242"}}}	1	2016-05-18 20:39:14.163065	2016-05-18 20:39:14.186046
696	7	113	62	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/breast-cancer/her2/242"}}}	1	2016-05-18 20:39:14.237498	2016-05-18 20:39:14.249936
697	7	111	63	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/breast-cancer/her2/246"}}}	1	2016-05-18 20:39:14.33294	2016-05-18 20:39:14.345996
698	7	112	63	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/breast-cancer/her2/246"}}}	1	2016-05-18 20:39:14.378069	2016-05-18 20:39:14.389031
699	7	113	63	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/breast-cancer/her2/246"}}}	1	2016-05-18 20:39:14.433953	2016-05-18 20:39:14.447562
700	7	111	64	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/breast-cancer/her2/239"}}}	1	2016-05-18 20:39:14.503191	2016-05-18 20:39:14.516115
701	7	112	64	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/breast-cancer/her2/239"}}}	1	2016-05-18 20:39:14.551593	2016-05-18 20:39:14.571128
702	7	113	64	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/breast-cancer/her2/239"}}}	1	2016-05-18 20:39:14.604011	2016-05-18 20:39:14.616693
703	1	111	65	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/mek1/210"}}}	1	2016-05-18 20:39:14.677163	2016-05-18 20:39:14.691182
704	1	112	65	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/mek1/210"}}}	1	2016-05-18 20:39:14.727988	2016-05-18 20:39:14.744732
705	1	113	65	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/mek1/210"}}}	1	2016-05-18 20:39:14.778684	2016-05-18 20:39:14.791227
706	2	128	66	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/mek1/74"}}}	1	2016-05-18 20:39:14.850835	2016-05-18 20:39:14.861889
707	2	129	66	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/mek1/74"}}}	1	2016-05-18 20:39:14.894247	2016-05-18 20:39:14.917306
708	2	128	67	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/mek1/72"}}}	1	2016-05-18 20:39:14.969864	2016-05-18 20:39:14.982068
709	2	129	67	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/mek1/72"}}}	1	2016-05-18 20:39:15.021439	2016-05-18 20:39:15.032742
710	2	102	68	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/mek1/60"}}}	1	2016-05-18 20:39:15.089689	2016-05-18 20:39:15.099795
711	2	106	68	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/mek1/60"}}}	1	2016-05-18 20:39:15.141085	2016-05-18 20:39:15.152849
712	2	130	68	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/mek1/60"}}}	1	2016-05-18 20:39:15.184933	2016-05-18 20:39:15.199709
713	2	131	68	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/mek1/60"}}}	1	2016-05-18 20:39:15.245454	2016-05-18 20:39:15.256609
714	1	102	69	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/mek1/211"}}}	1	2016-05-18 20:39:15.314833	2016-05-18 20:39:15.325849
715	1	106	69	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/mek1/211"}}}	1	2016-05-18 20:39:15.359138	2016-05-18 20:39:15.368937
716	1	130	69	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/mek1/211"}}}	1	2016-05-18 20:39:15.414822	2016-05-18 20:39:15.427822
717	1	123	70	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/mek1/212"}}}	1	2016-05-18 20:39:15.48217	2016-05-18 20:39:15.491445
1886	7	58	22	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/breast-cancer/pten/25"}}}	1	2016-05-18 21:26:11.232599	2016-05-18 21:26:11.232599
1887	7	59	22	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/breast-cancer/pten/25"}}}	1	2016-05-18 21:26:11.249914	2016-05-18 21:26:11.249914
1888	7	60	22	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/breast-cancer/pten/25"}}}	1	2016-05-18 21:26:11.265803	2016-05-18 21:26:11.265803
1889	7	61	22	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/breast-cancer/pten/25"}}}	1	2016-05-18 21:26:11.281761	2016-05-18 21:26:11.281761
1890	7	62	22	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/breast-cancer/pten/25"}}}	1	2016-05-18 21:26:11.297106	2016-05-18 21:26:11.297106
1891	7	63	22	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/breast-cancer/pten/25"}}}	1	2016-05-18 21:26:11.311249	2016-05-18 21:26:11.311249
1892	7	64	22	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/breast-cancer/pten/25"}}}	1	2016-05-18 21:26:11.328899	2016-05-18 21:26:11.328899
1893	2	57	22	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/pten/25"}}}	1	2016-05-18 21:26:11.34272	2016-05-18 21:26:11.34272
1894	2	58	22	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/pten/25"}}}	1	2016-05-18 21:26:11.36093	2016-05-18 21:26:11.36093
718	1	102	70	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/mek1/212"}}}	1	2016-05-18 20:39:15.526807	2016-05-18 20:39:15.547198
719	1	106	70	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/mek1/212"}}}	1	2016-05-18 20:39:15.5802	2016-05-18 20:39:15.589705
720	1	130	70	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/mek1/212"}}}	1	2016-05-18 20:39:15.620973	2016-05-18 20:39:15.639419
721	1	108	70	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/mek1/212"}}}	1	2016-05-18 20:39:15.671746	2016-05-18 20:39:15.684134
722	1	131	70	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/mek1/212"}}}	1	2016-05-18 20:39:15.731539	2016-05-18 20:39:15.744368
723	1	123	71	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/mek1/214"}}}	1	2016-05-18 20:39:15.798554	2016-05-18 20:39:15.813097
724	1	102	71	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/mek1/214"}}}	1	2016-05-18 20:39:15.845971	2016-05-18 20:39:15.856495
725	1	106	71	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/mek1/214"}}}	1	2016-05-18 20:39:15.902614	2016-05-18 20:39:15.916191
726	1	130	71	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/mek1/214"}}}	1	2016-05-18 20:39:15.950968	2016-05-18 20:39:15.963027
727	1	131	71	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/mek1/214"}}}	1	2016-05-18 20:39:16.00821	2016-05-18 20:39:16.020509
728	1	132	71	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/mek1/214"}}}	1	2016-05-18 20:39:16.053752	2016-05-18 20:39:16.065983
729	1	102	72	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/mek1/213"}}}	1	2016-05-18 20:39:16.117133	2016-05-18 20:39:16.129436
730	1	106	72	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/mek1/213"}}}	1	2016-05-18 20:39:16.171683	2016-05-18 20:39:16.18441
731	1	130	72	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/mek1/213"}}}	1	2016-05-18 20:39:16.218848	2016-05-18 20:39:16.242068
732	1	131	72	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/mek1/213"}}}	1	2016-05-18 20:39:16.27705	2016-05-18 20:39:16.287828
733	1	132	72	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/mek1/213"}}}	1	2016-05-18 20:39:16.321355	2016-05-18 20:39:16.335401
734	1	123	73	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/mek1/215"}}}	1	2016-05-18 20:39:16.385339	2016-05-18 20:39:16.398906
735	1	102	73	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/mek1/215"}}}	1	2016-05-18 20:39:16.441118	2016-05-18 20:39:16.451321
736	1	106	73	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/mek1/215"}}}	1	2016-05-18 20:39:16.483832	2016-05-18 20:39:16.50608
737	1	130	73	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/mek1/215"}}}	1	2016-05-18 20:39:16.544484	2016-05-18 20:39:16.553382
738	1	102	74	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/mek1/216"}}}	1	2016-05-18 20:39:16.61124	2016-05-18 20:39:16.61977
739	1	106	74	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/mek1/216"}}}	1	2016-05-18 20:39:16.670754	2016-05-18 20:39:16.679452
740	1	130	74	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/mek1/216"}}}	1	2016-05-18 20:39:16.706456	2016-05-18 20:39:16.717373
741	1	108	74	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/mek1/216"}}}	1	2016-05-18 20:39:16.76906	2016-05-18 20:39:16.780862
742	1	102	75	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/mek1/217"}}}	1	2016-05-18 20:39:16.831791	2016-05-18 20:39:16.84287
743	1	106	75	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/mek1/217"}}}	1	2016-05-18 20:39:16.877368	2016-05-18 20:39:16.8886
744	1	130	75	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/mek1/217"}}}	1	2016-05-18 20:39:16.932834	2016-05-18 20:39:16.943498
745	8	102	76	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh2/272"}}}	1	2016-05-18 20:39:17.009357	2016-05-18 20:39:17.022133
1895	2	59	22	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/pten/25"}}}	1	2016-05-18 21:26:11.377026	2016-05-18 21:26:11.377026
1896	2	60	22	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/pten/25"}}}	1	2016-05-18 21:26:11.394501	2016-05-18 21:26:11.394501
1897	2	61	22	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/pten/25"}}}	1	2016-05-18 21:26:11.410114	2016-05-18 21:26:11.410114
1898	2	62	22	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/pten/25"}}}	1	2016-05-18 21:26:11.425809	2016-05-18 21:26:11.425809
1899	2	63	22	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/pten/25"}}}	1	2016-05-18 21:26:11.440777	2016-05-18 21:26:11.440777
1900	2	64	22	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/pten/25"}}}	1	2016-05-18 21:26:11.455793	2016-05-18 21:26:11.455793
1901	4	57	22	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/pten/25"}}}	1	2016-05-18 21:26:11.472614	2016-05-18 21:26:11.472614
1902	4	58	22	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/pten/25"}}}	1	2016-05-18 21:26:11.491531	2016-05-18 21:26:11.491531
1903	4	59	22	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/pten/25"}}}	1	2016-05-18 21:26:11.505788	2016-05-18 21:26:11.505788
3124	8	338	42	\N	\N	3	\N	2	2016-05-18 21:26:44.518096	2016-05-18 21:26:44.518096
3125	8	46	42	\N	\N	3	\N	2	2016-05-18 21:26:44.533996	2016-05-18 21:26:44.533996
746	8	130	76	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh2/272"}}}	1	2016-05-18 20:39:17.057553	2016-05-18 20:39:17.068438
747	8	108	76	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh2/272"}}}	1	2016-05-18 20:39:17.117217	2016-05-18 20:39:17.126948
748	8	133	76	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh2/272"}}}	1	2016-05-18 20:39:17.153653	2016-05-18 20:39:17.16281
749	8	131	76	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh2/272"}}}	1	2016-05-18 20:39:17.188224	2016-05-18 20:39:17.204039
750	8	132	76	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh2/272"}}}	1	2016-05-18 20:39:17.241573	2016-05-18 20:39:17.25099
751	8	102	77	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh2/271"}}}	1	2016-05-18 20:39:17.300337	2016-05-18 20:39:17.311464
752	8	130	77	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh2/271"}}}	1	2016-05-18 20:39:17.342237	2016-05-18 20:39:17.374091
753	8	102	78	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh2/270"}}}	1	2016-05-18 20:39:17.417819	2016-05-18 20:39:17.447502
754	8	108	78	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh2/270"}}}	1	2016-05-18 20:39:17.494997	2016-05-18 20:39:17.509211
755	8	133	78	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh2/270"}}}	1	2016-05-18 20:39:17.540556	2016-05-18 20:39:17.56133
756	8	134	78	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh2/270"}}}	1	2016-05-18 20:39:17.61086	2016-05-18 20:39:17.624438
757	8	131	78	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh2/270"}}}	1	2016-05-18 20:39:17.671122	2016-05-18 20:39:17.68984
758	8	132	78	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh2/270"}}}	1	2016-05-18 20:39:17.726738	2016-05-18 20:39:17.743474
759	8	102	79	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh2/268"}}}	1	2016-05-18 20:39:17.810114	2016-05-18 20:39:17.823426
760	8	106	79	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh2/268"}}}	1	2016-05-18 20:39:17.865674	2016-05-18 20:39:17.874623
761	8	130	79	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh2/268"}}}	1	2016-05-18 20:39:17.93783	2016-05-18 20:39:17.963422
762	8	8	80	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh2/266"}}}	1	2016-05-18 20:39:18.027024	2016-05-18 20:39:18.042634
763	8	135	80	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh2/266"}}}	1	2016-05-18 20:39:18.090682	2016-05-18 20:39:18.102752
764	8	136	81	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh2/267"}}}	1	2016-05-18 20:39:18.188365	2016-05-18 20:39:18.206537
765	8	137	81	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh2/267"}}}	1	2016-05-18 20:39:18.266336	2016-05-18 20:39:18.282369
766	8	138	81	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh2/267"}}}	1	2016-05-18 20:39:18.330275	2016-05-18 20:39:18.365727
767	8	139	81	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh2/267"}}}	1	2016-05-18 20:39:18.406841	2016-05-18 20:39:18.418973
768	8	140	81	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh2/267"}}}	1	2016-05-18 20:39:18.458701	2016-05-18 20:39:18.493999
769	8	141	81	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh2/267"}}}	1	2016-05-18 20:39:18.531299	2016-05-18 20:39:18.542077
770	8	142	81	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh2/267"}}}	1	2016-05-18 20:39:18.575601	2016-05-18 20:39:18.587953
771	8	143	81	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh2/267"}}}	1	2016-05-18 20:39:18.64595	2016-05-18 20:39:18.655778
772	8	144	81	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh2/267"}}}	1	2016-05-18 20:39:18.696805	2016-05-18 20:39:18.707635
1904	4	60	22	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/pten/25"}}}	1	2016-05-18 21:26:11.524376	2016-05-18 21:26:11.524376
1905	4	61	22	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/pten/25"}}}	1	2016-05-18 21:26:11.539132	2016-05-18 21:26:11.539132
1906	4	62	22	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/pten/25"}}}	1	2016-05-18 21:26:11.553665	2016-05-18 21:26:11.553665
1907	4	63	22	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/pten/25"}}}	1	2016-05-18 21:26:11.569542	2016-05-18 21:26:11.569542
1908	4	64	22	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/pten/25"}}}	1	2016-05-18 21:26:11.585313	2016-05-18 21:26:11.585313
1909	7	57	23	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/breast-cancer/pten/26"}}}	1	2016-05-18 21:26:11.601636	2016-05-18 21:26:11.601636
1910	7	58	23	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/breast-cancer/pten/26"}}}	1	2016-05-18 21:26:11.617564	2016-05-18 21:26:11.617564
1911	7	59	23	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/breast-cancer/pten/26"}}}	1	2016-05-18 21:26:11.632703	2016-05-18 21:26:11.632703
3126	8	90	46	\N	\N	3	\N	2	2016-05-18 21:26:44.5492	2016-05-18 21:26:44.5492
773	8	145	81	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh2/267"}}}	1	2016-05-18 20:39:18.755426	2016-05-18 20:39:18.767285
774	8	146	81	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh2/267"}}}	1	2016-05-18 20:39:18.802954	2016-05-18 20:39:18.814107
775	7	95	82	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/breast-cancer/her2/239/"}}}	1	2016-05-18 20:39:18.87754	2016-05-18 20:39:18.886846
776	7	118	82	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/breast-cancer/her2/239/"}}}	1	2016-05-18 20:39:18.925913	2016-05-18 20:39:18.96071
777	7	118	83	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/breast-cancer/her2/242/"}}}	1	2016-05-18 20:39:19.017293	2016-05-18 20:39:19.035992
778	7	95	83	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/breast-cancer/her2/242/"}}}	1	2016-05-18 20:39:19.069067	2016-05-18 20:39:19.079049
779	7	95	84	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/breast-cancer/her2/246/"}}}	1	2016-05-18 20:39:19.131429	2016-05-18 20:39:19.143429
780	7	118	84	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/breast-cancer/her2/246/"}}}	1	2016-05-18 20:39:19.177119	2016-05-18 20:39:19.199872
781	7	147	84	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/breast-cancer/her2/246/"}}}	1	2016-05-18 20:39:19.230254	2016-05-18 20:39:19.239344
782	7	148	84	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/breast-cancer/her2/246/"}}}	1	2016-05-18 20:39:19.272283	2016-05-18 20:39:19.287085
783	7	111	85	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/breast-cancer/her2/240"}}}	1	2016-05-18 20:39:19.381885	2016-05-18 20:39:19.394498
784	7	149	86	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/breast-cancer/her2/241"}}}	1	2016-05-18 20:39:19.442999	2016-05-18 20:39:19.455436
785	7	149	87	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/breast-cancer/her2/247"}}}	1	2016-05-18 20:39:19.511666	2016-05-18 20:39:19.524673
786	7	150	88	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/breast-cancer/her2/243/"}}}	1	2016-05-18 20:39:19.58596	2016-05-18 20:39:19.596366
787	7	151	88	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/breast-cancer/her2/243/"}}}	1	2016-05-18 20:39:19.635195	2016-05-18 20:39:19.645317
788	7	152	88	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/breast-cancer/her2/243/"}}}	1	2016-05-18 20:39:19.717315	2016-05-18 20:39:19.72948
789	7	153	88	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/breast-cancer/her2/243/"}}}	1	2016-05-18 20:39:19.771665	2016-05-18 20:39:19.784373
790	7	154	88	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/breast-cancer/her2/243/"}}}	1	2016-05-18 20:39:19.849859	2016-05-18 20:39:19.862243
791	7	150	89	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/breast-cancer/her2/244"}}}	1	2016-05-18 20:39:19.920572	2016-05-18 20:39:19.943347
792	7	151	89	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/breast-cancer/her2/244"}}}	1	2016-05-18 20:39:19.980392	2016-05-18 20:39:19.993002
793	7	152	89	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/breast-cancer/her2/244"}}}	1	2016-05-18 20:39:20.028441	2016-05-18 20:39:20.046849
794	7	153	89	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/breast-cancer/her2/244"}}}	1	2016-05-18 20:39:20.079129	2016-05-18 20:39:20.090837
795	7	154	89	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/breast-cancer/her2/244"}}}	1	2016-05-18 20:39:20.139683	2016-05-18 20:39:20.152005
796	7	150	90	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/breast-cancer/her2/245"}}}	1	2016-05-18 20:39:20.213183	2016-05-18 20:39:20.22657
797	7	151	90	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/breast-cancer/her2/245"}}}	1	2016-05-18 20:39:20.263407	2016-05-18 20:39:20.274176
798	7	152	90	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/breast-cancer/her2/245"}}}	1	2016-05-18 20:39:20.316837	2016-05-18 20:39:20.329916
799	7	153	90	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/breast-cancer/her2/245"}}}	1	2016-05-18 20:39:20.364085	2016-05-18 20:39:20.377132
1912	7	60	23	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/breast-cancer/pten/26"}}}	1	2016-05-18 21:26:11.649655	2016-05-18 21:26:11.649655
1399	8	16	10	\N	\N	2	\N	2	2016-05-18 20:39:57.809006	2016-05-18 20:39:57.809006
1400	8	20	10	\N	\N	2	\N	2	2016-05-18 20:39:57.849679	2016-05-18 20:39:57.849679
1913	7	61	23	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/breast-cancer/pten/26"}}}	1	2016-05-18 21:26:11.667232	2016-05-18 21:26:11.667232
1914	7	62	23	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/breast-cancer/pten/26"}}}	1	2016-05-18 21:26:11.683822	2016-05-18 21:26:11.683822
1915	7	63	23	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/breast-cancer/pten/26"}}}	1	2016-05-18 21:26:11.699988	2016-05-18 21:26:11.699988
1916	7	64	23	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/breast-cancer/pten/26"}}}	1	2016-05-18 21:26:11.714492	2016-05-18 21:26:11.714492
1917	4	57	23	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/pten/26"}}}	1	2016-05-18 21:26:11.732435	2016-05-18 21:26:11.732435
1918	4	58	23	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/pten/26"}}}	1	2016-05-18 21:26:11.745808	2016-05-18 21:26:11.745808
1919	4	59	23	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/pten/26"}}}	1	2016-05-18 21:26:11.762293	2016-05-18 21:26:11.762293
3127	8	91	46	\N	\N	3	\N	2	2016-05-18 21:26:44.565011	2016-05-18 21:26:44.565011
3128	8	92	46	\N	\N	3	\N	2	2016-05-18 21:26:44.581066	2016-05-18 21:26:44.581066
800	7	154	90	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/breast-cancer/her2/245"}}}	1	2016-05-18 20:39:20.421168	2016-05-18 20:39:20.434271
801	4	150	91	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/151"}}}	1	2016-05-18 20:39:20.499983	2016-05-18 20:39:20.513155
802	4	151	91	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/151"}}}	1	2016-05-18 20:39:20.545293	2016-05-18 20:39:20.566004
803	4	152	91	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/151"}}}	1	2016-05-18 20:39:20.598079	2016-05-18 20:39:20.607771
804	4	153	91	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/151"}}}	1	2016-05-18 20:39:20.634779	2016-05-18 20:39:20.647805
805	4	154	91	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/151"}}}	1	2016-05-18 20:39:20.696355	2016-05-18 20:39:20.706586
806	4	123	92	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/154"}}}	1	2016-05-18 20:39:20.762229	2016-05-18 20:39:20.772605
807	4	123	93	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/152"}}}	1	2016-05-18 20:39:20.834522	2016-05-18 20:39:20.843243
808	4	123	94	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/155"}}}	1	2016-05-18 20:39:20.902075	2016-05-18 20:39:20.910638
809	4	123	95	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/156"}}}	1	2016-05-18 20:39:20.967487	2016-05-18 20:39:20.976617
810	4	123	96	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/157"}}}	1	2016-05-18 20:39:21.033512	2016-05-18 20:39:21.046963
811	4	150	96	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/157"}}}	1	2016-05-18 20:39:21.082626	2016-05-18 20:39:21.092102
812	4	151	96	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/157"}}}	1	2016-05-18 20:39:21.132375	2016-05-18 20:39:21.141392
813	4	152	96	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/157"}}}	1	2016-05-18 20:39:21.220265	2016-05-18 20:39:21.230009
814	4	153	96	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/157"}}}	1	2016-05-18 20:39:21.264134	2016-05-18 20:39:21.27317
815	4	154	96	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/157"}}}	1	2016-05-18 20:39:21.322214	2016-05-18 20:39:21.337787
816	4	123	97	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/158"}}}	1	2016-05-18 20:39:21.400168	2016-05-18 20:39:21.413269
817	4	150	97	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/158"}}}	1	2016-05-18 20:39:21.451929	2016-05-18 20:39:21.466395
818	4	151	97	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/158"}}}	1	2016-05-18 20:39:21.519263	2016-05-18 20:39:21.533265
819	4	152	97	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/158"}}}	1	2016-05-18 20:39:21.570877	2016-05-18 20:39:21.591985
820	4	153	97	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/158"}}}	1	2016-05-18 20:39:21.626814	2016-05-18 20:39:21.639739
821	4	154	97	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/158"}}}	1	2016-05-18 20:39:21.672211	2016-05-18 20:39:21.681425
822	4	123	98	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/153"}}}	1	2016-05-18 20:39:21.742358	2016-05-18 20:39:21.752794
823	1	155	99	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/gna11/101"}}}	1	2016-05-18 20:39:21.812454	2016-05-18 20:39:21.829893
824	1	156	100	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/gna11/99"}}}	1	2016-05-18 20:39:21.876527	2016-05-18 20:39:21.88869
825	1	157	100	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/gna11/99"}}}	1	2016-05-18 20:39:21.927155	2016-05-18 20:39:21.941976
826	1	158	100	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/gna11/99"}}}	1	2016-05-18 20:39:21.981272	2016-05-18 20:39:21.99741
1920	4	60	23	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/pten/26"}}}	1	2016-05-18 21:26:11.777281	2016-05-18 21:26:11.777281
1401	8	21	10	\N	\N	2	\N	2	2016-05-18 20:39:57.887012	2016-05-18 20:39:57.887012
1402	8	3	10	\N	\N	2	\N	2	2016-05-18 20:39:57.937248	2016-05-18 20:39:57.937248
1921	4	61	23	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/pten/26"}}}	1	2016-05-18 21:26:11.7955	2016-05-18 21:26:11.7955
1922	4	62	23	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/pten/26"}}}	1	2016-05-18 21:26:11.808889	2016-05-18 21:26:11.808889
1923	4	63	23	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/pten/26"}}}	1	2016-05-18 21:26:11.823697	2016-05-18 21:26:11.823697
1924	4	64	23	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/pten/26"}}}	1	2016-05-18 21:26:11.840371	2016-05-18 21:26:11.840371
1925	3	57	24	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/307"}}}	1	2016-05-18 21:26:11.859377	2016-05-18 21:26:11.859377
1926	3	58	24	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/307"}}}	1	2016-05-18 21:26:11.87372	2016-05-18 21:26:11.87372
1927	3	59	24	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/307"}}}	1	2016-05-18 21:26:11.889101	2016-05-18 21:26:11.889101
1928	3	60	24	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/307"}}}	1	2016-05-18 21:26:11.905266	2016-05-18 21:26:11.905266
827	8	159	101	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh1/264"}}}	1	2016-05-18 20:39:22.073076	2016-05-18 20:39:22.096008
828	8	159	102	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh1/265"}}}	1	2016-05-18 20:39:22.157323	2016-05-18 20:39:22.174252
829	8	159	103	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh1/263"}}}	1	2016-05-18 20:39:22.220785	2016-05-18 20:39:22.233461
830	8	160	104	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh1/260"}}}	1	2016-05-18 20:39:22.284707	2016-05-18 20:39:22.297261
831	8	161	104	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh1/260"}}}	1	2016-05-18 20:39:22.334488	2016-05-18 20:39:22.347055
832	8	162	104	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh1/260"}}}	1	2016-05-18 20:39:22.382036	2016-05-18 20:39:22.394233
833	8	160	105	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh1/261"}}}	1	2016-05-18 20:39:22.449341	2016-05-18 20:39:22.46168
834	8	161	105	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh1/261"}}}	1	2016-05-18 20:39:22.498003	2016-05-18 20:39:22.521035
835	8	162	105	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh1/261"}}}	1	2016-05-18 20:39:22.558165	2016-05-18 20:39:22.569471
836	8	160	106	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh1/262"}}}	1	2016-05-18 20:39:22.622161	2016-05-18 20:39:22.633398
837	8	161	106	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh1/262"}}}	1	2016-05-18 20:39:22.666426	2016-05-18 20:39:22.678305
838	8	162	106	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh1/262"}}}	1	2016-05-18 20:39:22.711608	2016-05-18 20:39:22.732455
839	8	160	107	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/dnmt3a/296"}}}	1	2016-05-18 20:39:22.782598	2016-05-18 20:39:22.796426
840	8	161	107	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/dnmt3a/296"}}}	1	2016-05-18 20:39:22.83091	2016-05-18 20:39:22.843499
841	8	162	107	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/dnmt3a/296"}}}	1	2016-05-18 20:39:22.879939	2016-05-18 20:39:22.901321
842	8	160	108	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/dnmt3a/294"}}}	1	2016-05-18 20:39:22.948537	2016-05-18 20:39:22.967733
843	8	161	108	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/dnmt3a/294"}}}	1	2016-05-18 20:39:23.008661	2016-05-18 20:39:23.019952
844	8	162	108	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/dnmt3a/294"}}}	1	2016-05-18 20:39:23.062211	2016-05-18 20:39:23.072578
845	8	160	109	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/dnmt3a/293"}}}	1	2016-05-18 20:39:23.121825	2016-05-18 20:39:23.134608
846	8	161	109	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/dnmt3a/293"}}}	1	2016-05-18 20:39:23.167885	2016-05-18 20:39:23.180859
847	8	162	109	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/dnmt3a/293"}}}	1	2016-05-18 20:39:23.218086	2016-05-18 20:39:23.237632
848	8	160	110	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/dnmt3a/291"}}}	1	2016-05-18 20:39:23.288698	2016-05-18 20:39:23.304027
849	8	161	110	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/dnmt3a/291"}}}	1	2016-05-18 20:39:23.337042	2016-05-18 20:39:23.349491
850	8	162	110	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/dnmt3a/291"}}}	1	2016-05-18 20:39:23.383191	2016-05-18 20:39:23.404536
851	8	160	111	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/dnmt3a/295"}}}	1	2016-05-18 20:39:23.453038	2016-05-18 20:39:23.466341
852	8	161	111	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/dnmt3a/295"}}}	1	2016-05-18 20:39:23.500294	2016-05-18 20:39:23.5136
853	8	162	111	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/dnmt3a/295"}}}	1	2016-05-18 20:39:23.550397	2016-05-18 20:39:23.561812
1929	3	61	24	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/307"}}}	1	2016-05-18 21:26:11.92159	2016-05-18 21:26:11.92159
1930	3	62	24	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/307"}}}	1	2016-05-18 21:26:11.936234	2016-05-18 21:26:11.936234
1931	3	63	24	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/307"}}}	1	2016-05-18 21:26:11.953498	2016-05-18 21:26:11.953498
1932	3	64	24	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/307"}}}	1	2016-05-18 21:26:11.970938	2016-05-18 21:26:11.970938
1933	3	57	25	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/305"}}}	1	2016-05-18 21:26:11.987009	2016-05-18 21:26:11.987009
1934	3	58	25	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/305"}}}	1	2016-05-18 21:26:12.005267	2016-05-18 21:26:12.005267
1935	3	59	25	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/305"}}}	1	2016-05-18 21:26:12.02174	2016-05-18 21:26:12.02174
1936	3	60	25	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/305"}}}	1	2016-05-18 21:26:12.037857	2016-05-18 21:26:12.037857
3129	8	159	48	\N	\N	3	\N	2	2016-05-18 21:26:44.599782	2016-05-18 21:26:44.599782
854	8	163	112	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/dnmt3a/292"}}}	1	2016-05-18 20:39:23.625686	2016-05-18 20:39:23.638776
855	9	163	113	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/neuroblastoma/alk/184"}}}	1	2016-05-18 20:39:23.705893	2016-05-18 20:39:23.716712
856	9	163	114	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/neuroblastoma/alk/183"}}}	1	2016-05-18 20:39:23.772039	2016-05-18 20:39:23.782497
857	9	164	114	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/neuroblastoma/alk/183"}}}	1	2016-05-18 20:39:23.825561	2016-05-18 20:39:23.839478
858	9	163	115	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/neuroblastoma/alk/181"}}}	1	2016-05-18 20:39:23.895528	2016-05-18 20:39:23.908252
859	9	164	115	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/neuroblastoma/alk/181"}}}	1	2016-05-18 20:39:23.946683	2016-05-18 20:39:23.964334
860	9	156	116	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/neuroblastoma/alk/180"}}}	1	2016-05-18 20:39:24.020257	2016-05-18 20:39:24.031555
861	9	165	116	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/neuroblastoma/alk/180"}}}	1	2016-05-18 20:39:24.075018	2016-05-18 20:39:24.087104
862	9	166	116	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/neuroblastoma/alk/180"}}}	1	2016-05-18 20:39:24.122329	2016-05-18 20:39:24.133211
863	9	167	116	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/neuroblastoma/alk/180"}}}	1	2016-05-18 20:39:24.178613	2016-05-18 20:39:24.191237
864	9	168	116	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/neuroblastoma/alk/180"}}}	1	2016-05-18 20:39:24.225047	2016-05-18 20:39:24.238681
865	9	169	116	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/neuroblastoma/alk/180"}}}	1	2016-05-18 20:39:24.284215	2016-05-18 20:39:24.297085
866	9	170	117	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/neuroblastoma/alk/182"}}}	1	2016-05-18 20:39:24.36359	2016-05-18 20:39:24.374124
867	10	171	118	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/rhabdomyosarcoma/alk/187"}}}	1	2016-05-18 20:39:24.431118	2016-05-18 20:39:24.444005
868	9	171	119	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/neuroblastoma/alk/178"}}}	1	2016-05-18 20:39:24.49871	2016-05-18 20:39:24.511103
869	9	171	120	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/neuroblastoma/alk/176"}}}	1	2016-05-18 20:39:24.566307	2016-05-18 20:39:24.579011
870	9	171	121	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/neuroblastoma/alk/179"}}}	1	2016-05-18 20:39:24.634226	2016-05-18 20:39:24.646273
871	9	172	122	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/neuroblastoma/alk/177"}}}	1	2016-05-18 20:39:24.712638	2016-05-18 20:39:24.724948
872	9	173	122	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/neuroblastoma/alk/177"}}}	1	2016-05-18 20:39:24.763911	2016-05-18 20:39:24.783633
873	9	174	122	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/neuroblastoma/alk/177"}}}	1	2016-05-18 20:39:24.823108	2016-05-18 20:39:24.836675
874	9	175	122	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/neuroblastoma/alk/177"}}}	1	2016-05-18 20:39:24.87595	2016-05-18 20:39:24.896038
875	9	176	122	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/neuroblastoma/alk/177"}}}	1	2016-05-18 20:39:24.932161	2016-05-18 20:39:24.945517
876	9	177	122	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/neuroblastoma/alk/177"}}}	1	2016-05-18 20:39:24.981267	2016-05-18 20:39:24.99207
877	9	178	122	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/neuroblastoma/alk/177"}}}	1	2016-05-18 20:39:25.040542	2016-05-18 20:39:25.052943
878	9	179	122	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/neuroblastoma/alk/177"}}}	1	2016-05-18 20:39:25.08763	2016-05-18 20:39:25.10017
879	9	3	122	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/neuroblastoma/alk/177"}}}	1	2016-05-18 20:39:25.139603	2016-05-18 20:39:25.153067
880	9	180	123	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/neuroblastoma/alk/175"}}}	1	2016-05-18 20:39:25.209821	2016-05-18 20:39:25.224954
1937	3	61	25	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/305"}}}	1	2016-05-18 21:26:12.053543	2016-05-18 21:26:12.053543
1403	8	33	12	\N	\N	2	\N	2	2016-05-18 20:39:57.976859	2016-05-18 20:39:57.976859
1404	8	34	12	\N	\N	2	\N	2	2016-05-18 20:39:58.02288	2016-05-18 20:39:58.02288
1938	3	62	25	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/305"}}}	1	2016-05-18 21:26:12.068796	2016-05-18 21:26:12.068796
1939	3	63	25	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/305"}}}	1	2016-05-18 21:26:12.084762	2016-05-18 21:26:12.084762
1940	3	64	25	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/305"}}}	1	2016-05-18 21:26:12.102229	2016-05-18 21:26:12.102229
1941	3	44	26	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/306"}}}	1	2016-05-18 21:26:12.116361	2016-05-18 21:26:12.116361
1942	3	68	26	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/306"}}}	1	2016-05-18 21:26:12.132249	2016-05-18 21:26:12.132249
1943	3	69	26	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/306"}}}	1	2016-05-18 21:26:12.146796	2016-05-18 21:26:12.146796
1944	3	70	26	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/306"}}}	1	2016-05-18 21:26:12.161111	2016-05-18 21:26:12.161111
3130	8	115	258	\N	\N	3	\N	2	2016-05-18 21:26:44.619172	2016-05-18 21:26:44.619172
3131	8	116	258	\N	\N	3	\N	2	2016-05-18 21:26:44.638504	2016-05-18 21:26:44.638504
881	9	181	123	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/neuroblastoma/alk/175"}}}	1	2016-05-18 20:39:25.27508	2016-05-18 20:39:25.287359
882	9	182	123	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/neuroblastoma/alk/175"}}}	1	2016-05-18 20:39:25.333465	2016-05-18 20:39:25.360028
883	9	177	123	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/neuroblastoma/alk/175"}}}	1	2016-05-18 20:39:25.406028	2016-05-18 20:39:25.420595
884	9	175	123	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/neuroblastoma/alk/175"}}}	1	2016-05-18 20:39:25.469039	2016-05-18 20:39:25.491056
885	9	3	123	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/neuroblastoma/alk/175"}}}	1	2016-05-18 20:39:25.541356	2016-05-18 20:39:25.553705
886	9	183	124	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/neuroblastoma/alk/174"}}}	1	2016-05-18 20:39:25.615493	2016-05-18 20:39:25.625589
887	9	184	124	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/neuroblastoma/alk/174"}}}	1	2016-05-18 20:39:25.66108	2016-05-18 20:39:25.688435
888	9	177	124	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/neuroblastoma/alk/174"}}}	1	2016-05-18 20:39:25.72692	2016-05-18 20:39:25.738177
889	9	175	124	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/neuroblastoma/alk/174"}}}	1	2016-05-18 20:39:25.772736	2016-05-18 20:39:25.783023
890	9	173	124	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/neuroblastoma/alk/174"}}}	1	2016-05-18 20:39:25.819632	2016-05-18 20:39:25.844116
891	9	185	124	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/neuroblastoma/alk/174"}}}	1	2016-05-18 20:39:25.88203	2016-05-18 20:39:25.893761
892	9	172	124	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/neuroblastoma/alk/174"}}}	1	2016-05-18 20:39:25.932661	2016-05-18 20:39:25.963238
893	9	3	124	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/neuroblastoma/alk/174"}}}	1	2016-05-18 20:39:26.014554	2016-05-18 20:39:26.027872
894	9	186	125	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/neuroblastoma/alk/173"}}}	1	2016-05-18 20:39:26.107007	2016-05-18 20:39:26.120601
895	9	187	125	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/neuroblastoma/alk/173"}}}	1	2016-05-18 20:39:26.158963	2016-05-18 20:39:26.184256
896	9	175	125	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/neuroblastoma/alk/173"}}}	1	2016-05-18 20:39:26.222487	2016-05-18 20:39:26.234536
897	9	177	125	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/neuroblastoma/alk/173"}}}	1	2016-05-18 20:39:26.272626	2016-05-18 20:39:26.299271
898	9	179	125	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/neuroblastoma/alk/173"}}}	1	2016-05-18 20:39:26.338478	2016-05-18 20:39:26.350128
899	9	3	125	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/neuroblastoma/alk/173"}}}	1	2016-05-18 20:39:26.38548	2016-05-18 20:39:26.396279
900	7	172	126	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/7"}}}	1	2016-05-18 20:39:26.467429	2016-05-18 20:39:26.500416
901	7	177	126	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/7"}}}	1	2016-05-18 20:39:26.548655	2016-05-18 20:39:26.563774
902	7	173	126	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/7"}}}	1	2016-05-18 20:39:26.620388	2016-05-18 20:39:26.645567
903	7	175	126	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/7"}}}	1	2016-05-18 20:39:26.714587	2016-05-18 20:39:26.728094
904	7	188	126	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/7"}}}	1	2016-05-18 20:39:26.798143	2016-05-18 20:39:26.811316
905	7	189	126	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/7"}}}	1	2016-05-18 20:39:26.863144	2016-05-18 20:39:26.876295
906	7	190	126	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/7"}}}	1	2016-05-18 20:39:26.946597	2016-05-18 20:39:26.959858
907	7	191	126	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/7"}}}	1	2016-05-18 20:39:27.018431	2016-05-18 20:39:27.049135
1945	3	71	26	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/306"}}}	1	2016-05-18 21:26:12.178152	2016-05-18 21:26:12.178152
1405	8	35	12	\N	\N	2	\N	2	2016-05-18 20:39:58.072528	2016-05-18 20:39:58.072528
1406	8	36	12	\N	\N	2	\N	2	2016-05-18 20:39:58.122698	2016-05-18 20:39:58.122698
1946	3	72	26	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/306"}}}	1	2016-05-18 21:26:12.197513	2016-05-18 21:26:12.197513
1947	3	73	26	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/306"}}}	1	2016-05-18 21:26:12.210693	2016-05-18 21:26:12.210693
1948	3	44	27	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/304"}}}	1	2016-05-18 21:26:12.226684	2016-05-18 21:26:12.226684
1949	3	68	27	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/304"}}}	1	2016-05-18 21:26:12.243332	2016-05-18 21:26:12.243332
1950	3	69	27	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/304"}}}	1	2016-05-18 21:26:12.259706	2016-05-18 21:26:12.259706
1951	3	70	27	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/304"}}}	1	2016-05-18 21:26:12.277264	2016-05-18 21:26:12.277264
1952	3	71	27	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/304"}}}	1	2016-05-18 21:26:12.295893	2016-05-18 21:26:12.295893
3132	8	117	258	\N	\N	3	\N	2	2016-05-18 21:26:44.653789	2016-05-18 21:26:44.653789
3133	8	12	258	\N	\N	3	\N	2	2016-05-18 21:26:44.671001	2016-05-18 21:26:44.671001
908	7	192	126	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/7"}}}	1	2016-05-18 20:39:27.113759	2016-05-18 20:39:27.130733
909	7	3	126	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/7"}}}	1	2016-05-18 20:39:27.180565	2016-05-18 20:39:27.192256
910	6	193	126	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/ovarian-cancer/pik3ca/7"}}}	1	2016-05-18 20:39:27.238997	2016-05-18 20:39:27.262993
911	6	172	126	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/ovarian-cancer/pik3ca/7"}}}	1	2016-05-18 20:39:27.313707	2016-05-18 20:39:27.327224
912	6	194	126	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/ovarian-cancer/pik3ca/7"}}}	1	2016-05-18 20:39:27.373437	2016-05-18 20:39:27.387521
913	6	188	126	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/ovarian-cancer/pik3ca/7"}}}	1	2016-05-18 20:39:27.453397	2016-05-18 20:39:27.465208
914	6	177	126	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/ovarian-cancer/pik3ca/7"}}}	1	2016-05-18 20:39:27.508281	2016-05-18 20:39:27.521136
915	6	179	126	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/ovarian-cancer/pik3ca/7"}}}	1	2016-05-18 20:39:27.579718	2016-05-18 20:39:27.590359
916	6	3	126	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/ovarian-cancer/pik3ca/7"}}}	1	2016-05-18 20:39:27.626591	2016-05-18 20:39:27.653165
917	2	189	126	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/pik3ca/7"}}}	1	2016-05-18 20:39:27.693357	2016-05-18 20:39:27.703934
918	4	189	126	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/7"}}}	1	2016-05-18 20:39:27.747676	2016-05-18 20:39:27.76662
919	7	189	127	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/8"}}}	1	2016-05-18 20:39:27.821835	2016-05-18 20:39:27.836317
920	6	189	127	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/ovarian-cancer/pik3ca/8"}}}	1	2016-05-18 20:39:27.875803	2016-05-18 20:39:27.890234
921	2	189	127	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/pik3ca/8"}}}	1	2016-05-18 20:39:27.926274	2016-05-18 20:39:27.938333
922	4	189	127	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/8"}}}	1	2016-05-18 20:39:27.993285	2016-05-18 20:39:28.006492
923	7	189	128	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/9"}}}	1	2016-05-18 20:39:28.057413	2016-05-18 20:39:28.070396
924	2	189	128	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/pik3ca/9"}}}	1	2016-05-18 20:39:28.105763	2016-05-18 20:39:28.116397
925	4	189	128	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/9"}}}	1	2016-05-18 20:39:28.151671	2016-05-18 20:39:28.181879
926	7	189	129	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/12"}}}	1	2016-05-18 20:39:28.242512	2016-05-18 20:39:28.26808
927	6	189	129	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/ovarian-cancer/pik3ca/12"}}}	1	2016-05-18 20:39:28.319875	2016-05-18 20:39:28.333221
928	4	189	129	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/12"}}}	1	2016-05-18 20:39:28.37244	2016-05-18 20:39:28.397389
929	7	189	130	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/13"}}}	1	2016-05-18 20:39:28.45761	2016-05-18 20:39:28.472739
930	4	195	130	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/13"}}}	1	2016-05-18 20:39:28.500667	2016-05-18 20:39:28.524189
931	7	195	131	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/14"}}}	1	2016-05-18 20:39:28.587423	2016-05-18 20:39:28.6004
932	4	196	131	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/14"}}}	1	2016-05-18 20:39:28.63535	2016-05-18 20:39:28.644967
933	4	197	131	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/14"}}}	1	2016-05-18 20:39:28.677873	2016-05-18 20:39:28.692562
934	7	196	132	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/16"}}}	1	2016-05-18 20:39:28.744948	2016-05-18 20:39:28.757639
1953	3	72	27	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/304"}}}	1	2016-05-18 21:26:12.310171	2016-05-18 21:26:12.310171
1407	8	51	12	\N	\N	2	\N	2	2016-05-18 20:39:58.172594	2016-05-18 20:39:58.172594
1408	8	44	12	\N	\N	2	\N	2	2016-05-18 20:39:58.252013	2016-05-18 20:39:58.252013
1954	3	73	27	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/304"}}}	1	2016-05-18 21:26:12.325815	2016-05-18 21:26:12.325815
1955	3	44	28	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/303"}}}	1	2016-05-18 21:26:12.341321	2016-05-18 21:26:12.341321
1956	3	68	28	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/303"}}}	1	2016-05-18 21:26:12.357205	2016-05-18 21:26:12.357205
1957	3	69	28	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/303"}}}	1	2016-05-18 21:26:12.372969	2016-05-18 21:26:12.372969
1958	3	70	28	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/303"}}}	1	2016-05-18 21:26:12.389965	2016-05-18 21:26:12.389965
1959	3	71	28	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/303"}}}	1	2016-05-18 21:26:12.404797	2016-05-18 21:26:12.404797
1960	3	72	28	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/303"}}}	1	2016-05-18 21:26:12.420667	2016-05-18 21:26:12.420667
3134	8	118	258	\N	\N	3	\N	2	2016-05-18 21:26:44.685503	2016-05-18 21:26:44.685503
3135	8	120	258	\N	\N	3	\N	2	2016-05-18 21:26:44.70181	2016-05-18 21:26:44.70181
935	7	197	132	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/16"}}}	1	2016-05-18 20:39:28.795389	2016-05-18 20:39:28.80829
936	6	196	132	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/ovarian-cancer/pik3ca/16"}}}	1	2016-05-18 20:39:28.84285	2016-05-18 20:39:28.867056
937	6	197	132	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/ovarian-cancer/pik3ca/16"}}}	1	2016-05-18 20:39:28.898656	2016-05-18 20:39:28.908897
938	4	197	132	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/16"}}}	1	2016-05-18 20:39:28.943789	2016-05-18 20:39:28.959466
939	4	196	132	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/16"}}}	1	2016-05-18 20:39:28.991836	2016-05-18 20:39:29.004332
940	7	196	133	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/15"}}}	1	2016-05-18 20:39:29.047634	2016-05-18 20:39:29.06106
941	7	197	133	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/15"}}}	1	2016-05-18 20:39:29.09441	2016-05-18 20:39:29.107249
942	4	196	133	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/15"}}}	1	2016-05-18 20:39:29.140675	2016-05-18 20:39:29.153405
943	4	197	133	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/15"}}}	1	2016-05-18 20:39:29.185397	2016-05-18 20:39:29.195632
944	7	196	134	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/18"}}}	1	2016-05-18 20:39:29.247819	2016-05-18 20:39:29.26465
945	7	197	134	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/18"}}}	1	2016-05-18 20:39:29.312143	2016-05-18 20:39:29.326564
946	4	196	134	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/18"}}}	1	2016-05-18 20:39:29.359811	2016-05-18 20:39:29.382926
947	4	197	134	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/18"}}}	1	2016-05-18 20:39:29.415901	2016-05-18 20:39:29.427742
948	7	196	135	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/19"}}}	1	2016-05-18 20:39:29.485436	2016-05-18 20:39:29.498831
949	7	197	135	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/19"}}}	1	2016-05-18 20:39:29.530963	2016-05-18 20:39:29.551816
950	4	197	135	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/19"}}}	1	2016-05-18 20:39:29.59428	2016-05-18 20:39:29.606131
951	4	196	135	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/19"}}}	1	2016-05-18 20:39:29.649393	2016-05-18 20:39:29.668816
952	7	196	136	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/17"}}}	1	2016-05-18 20:39:29.715133	2016-05-18 20:39:29.732961
953	7	197	136	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/17"}}}	1	2016-05-18 20:39:29.766854	2016-05-18 20:39:29.778796
954	7	196	137	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/20"}}}	1	2016-05-18 20:39:29.840845	2016-05-18 20:39:29.850236
955	7	197	137	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/20"}}}	1	2016-05-18 20:39:29.881112	2016-05-18 20:39:29.896368
956	4	198	137	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/20"}}}	1	2016-05-18 20:39:29.92285	2016-05-18 20:39:29.935207
957	4	3	137	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/20"}}}	1	2016-05-18 20:39:29.977766	2016-05-18 20:39:29.987278
958	7	199	138	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/11"}}}	1	2016-05-18 20:39:30.037965	2016-05-18 20:39:30.049175
959	6	200	138	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/ovarian-cancer/pik3ca/11"}}}	1	2016-05-18 20:39:30.096305	2016-05-18 20:39:30.107649
960	6	201	138	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/ovarian-cancer/pik3ca/11"}}}	1	2016-05-18 20:39:30.139604	2016-05-18 20:39:30.151972
961	2	202	138	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/pik3ca/11"}}}	1	2016-05-18 20:39:30.193227	2016-05-18 20:39:30.206288
1961	3	73	28	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/303"}}}	1	2016-05-18 21:26:12.438505	2016-05-18 21:26:12.438505
1409	8	33	13	\N	\N	2	\N	2	2016-05-18 20:39:58.30648	2016-05-18 20:39:58.30648
1410	8	34	13	\N	\N	2	\N	2	2016-05-18 20:39:58.359027	2016-05-18 20:39:58.359027
1962	3	44	29	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/29"}}}	1	2016-05-18 21:26:12.454789	2016-05-18 21:26:12.454789
1963	3	68	29	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/29"}}}	1	2016-05-18 21:26:12.472405	2016-05-18 21:26:12.472405
1964	3	69	29	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/29"}}}	1	2016-05-18 21:26:12.489257	2016-05-18 21:26:12.489257
1965	3	70	29	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/29"}}}	1	2016-05-18 21:26:12.505797	2016-05-18 21:26:12.505797
1966	3	71	29	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/29"}}}	1	2016-05-18 21:26:12.519811	2016-05-18 21:26:12.519811
1967	3	72	29	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/29"}}}	1	2016-05-18 21:26:12.538084	2016-05-18 21:26:12.538084
1968	3	73	29	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/29"}}}	1	2016-05-18 21:26:12.551941	2016-05-18 21:26:12.551941
3136	8	121	258	\N	\N	3	\N	2	2016-05-18 21:26:44.716174	2016-05-18 21:26:44.716174
3137	8	122	258	\N	\N	3	\N	2	2016-05-18 21:26:44.73276	2016-05-18 21:26:44.73276
962	4	203	138	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/10"}}}	1	2016-05-18 20:39:30.239469	2016-05-18 20:39:30.251315
963	7	204	139	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/10"}}}	1	2016-05-18 20:39:30.314257	2016-05-18 20:39:30.324089
964	6	205	139	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/ovarian-cancer/pik3ca/10"}}}	1	2016-05-18 20:39:30.358265	2016-05-18 20:39:30.381553
965	2	204	139	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/pik3ca/10"}}}	1	2016-05-18 20:39:30.418484	2016-05-18 20:39:30.428204
966	4	204	139	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/10"}}}	1	2016-05-18 20:39:30.469095	2016-05-18 20:39:30.480318
967	1	206	140	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/ctnnb1/105"}}}	1	2016-05-18 20:39:30.542456	2016-05-18 20:39:30.554314
968	1	206	141	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/ctnnb1/104"}}}	1	2016-05-18 20:39:30.6053	2016-05-18 20:39:30.617564
969	1	207	142	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/ctnnb1/107"}}}	1	2016-05-18 20:39:30.67921	2016-05-18 20:39:30.693484
970	1	3	142	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/ctnnb1/107"}}}	1	2016-05-18 20:39:30.72728	2016-05-18 20:39:30.740095
971	1	208	143	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/ctnnb1/108"}}}	1	2016-05-18 20:39:30.794951	2016-05-18 20:39:30.806588
972	1	3	143	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/ctnnb1/108"}}}	1	2016-05-18 20:39:30.859612	2016-05-18 20:39:30.872216
973	1	209	144	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/ctnnb1/106"}}}	1	2016-05-18 20:39:30.920136	2016-05-18 20:39:30.938579
974	1	210	144	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/ctnnb1/106"}}}	1	2016-05-18 20:39:30.975175	2016-05-18 20:39:30.986322
975	11	209	145	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/gist/pdgfra/48"}}}	1	2016-05-18 20:39:31.049635	2016-05-18 20:39:31.060389
976	11	210	145	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/gist/pdgfra/48"}}}	1	2016-05-18 20:39:31.098152	2016-05-18 20:39:31.117609
977	11	209	146	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/gist/pdgfra/51"}}}	1	2016-05-18 20:39:31.167982	2016-05-18 20:39:31.182495
978	11	209	147	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/gist/pdgfra/51"}}}	1	2016-05-18 20:39:31.225673	2016-05-18 20:39:31.23897
979	11	210	147	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/gist/pdgfra/51"}}}	1	2016-05-18 20:39:31.276098	2016-05-18 20:39:31.288376
980	11	211	147	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/gist/pdgfra/51"}}}	1	2016-05-18 20:39:31.324365	2016-05-18 20:39:31.338353
981	11	209	148	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/gist/pdgfra/45"}}}	1	2016-05-18 20:39:31.393034	2016-05-18 20:39:31.406938
982	11	211	148	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/gist/pdgfra/45"}}}	1	2016-05-18 20:39:31.443099	2016-05-18 20:39:31.456577
983	12	209	149	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thymic-carcinoma/kit/218"}}}	1	2016-05-18 20:39:31.523445	2016-05-18 20:39:31.534522
984	12	211	149	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thymic-carcinoma/kit/218"}}}	1	2016-05-18 20:39:31.578344	2016-05-18 20:39:31.591724
985	1	209	150	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 20:39:31.655147	2016-05-18 20:39:31.672172
986	1	212	151	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 20:39:31.738502	2016-05-18 20:39:31.759994
987	1	213	152	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 20:39:31.8133	2016-05-18 20:39:31.82642
988	1	214	153	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 20:39:31.904317	2016-05-18 20:39:31.918918
989	12	215	153	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thymic-carcinoma/kit/124"}}}	1	2016-05-18 20:39:31.95815	2016-05-18 20:39:31.984984
1969	4	44	29	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/29"}}}	1	2016-05-18 21:26:12.568647	2016-05-18 21:26:12.568647
1970	4	68	29	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/29"}}}	1	2016-05-18 21:26:12.58446	2016-05-18 21:26:12.58446
1971	4	69	29	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/29"}}}	1	2016-05-18 21:26:12.60384	2016-05-18 21:26:12.60384
1972	4	70	29	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/29"}}}	1	2016-05-18 21:26:12.61828	2016-05-18 21:26:12.61828
1973	4	71	29	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/29"}}}	1	2016-05-18 21:26:12.634553	2016-05-18 21:26:12.634553
1974	4	72	29	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/29"}}}	1	2016-05-18 21:26:12.648075	2016-05-18 21:26:12.648075
1975	4	73	29	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/29"}}}	1	2016-05-18 21:26:12.666478	2016-05-18 21:26:12.666478
1976	4	44	30	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/27"}}}	1	2016-05-18 21:26:12.683211	2016-05-18 21:26:12.683211
1977	4	68	30	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/27"}}}	1	2016-05-18 21:26:12.699838	2016-05-18 21:26:12.699838
990	1	30	154	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 20:39:32.039178	2016-05-18 20:39:32.053172
991	1	3	154	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 20:39:32.08562	2016-05-18 20:39:32.099114
992	1	216	155	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 20:39:32.152485	2016-05-18 20:39:32.167344
993	1	3	155	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 20:39:32.201769	2016-05-18 20:39:32.216509
994	1	217	156	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 20:39:32.287354	2016-05-18 20:39:32.30187
995	1	3	156	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 20:39:32.343762	2016-05-18 20:39:32.356726
996	1	218	157	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 20:39:32.422247	2016-05-18 20:39:32.435194
997	1	219	157	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 20:39:32.488276	2016-05-18 20:39:32.505989
998	1	220	157	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 20:39:32.541994	2016-05-18 20:39:32.554774
999	1	30	157	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 20:39:32.596787	2016-05-18 20:39:32.608613
1000	1	221	158	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 20:39:32.656472	2016-05-18 20:39:32.673317
1001	1	222	158	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 20:39:32.743869	2016-05-18 20:39:32.758299
1002	1	223	158	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 20:39:32.803321	2016-05-18 20:39:32.818781
1003	1	224	158	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 20:39:32.912745	2016-05-18 20:39:33.006827
1004	1	225	158	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 20:39:33.053276	2016-05-18 20:39:33.067245
1005	1	226	158	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 20:39:33.117467	2016-05-18 20:39:33.130158
1006	1	227	158	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 20:39:33.169595	2016-05-18 20:39:33.193538
1007	1	228	158	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 20:39:33.241539	2016-05-18 20:39:33.252685
1008	1	229	158	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 20:39:33.298505	2016-05-18 20:39:33.326434
1009	1	230	158	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 20:39:33.385139	2016-05-18 20:39:33.399572
1010	1	221	159	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 20:39:33.483832	2016-05-18 20:39:33.496019
1011	1	222	159	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 20:39:33.544008	2016-05-18 20:39:33.577416
1012	1	223	159	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 20:39:33.62497	2016-05-18 20:39:33.642157
1013	1	224	159	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 20:39:33.689104	2016-05-18 20:39:33.72638
1014	1	225	159	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 20:39:33.817825	2016-05-18 20:39:33.849601
1015	1	226	159	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 20:39:33.901228	2016-05-18 20:39:33.921234
1016	1	227	159	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 20:39:33.988192	2016-05-18 20:39:34.011302
1017	1	228	159	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 20:39:34.059059	2016-05-18 20:39:34.09814
1978	4	69	30	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/27"}}}	1	2016-05-18 21:26:12.715104	2016-05-18 21:26:12.715104
1411	8	35	13	\N	\N	2	\N	2	2016-05-18 20:39:58.418973	2016-05-18 20:39:58.418973
1979	4	70	30	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/27"}}}	1	2016-05-18 21:26:12.734217	2016-05-18 21:26:12.734217
1980	4	71	30	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/27"}}}	1	2016-05-18 21:26:12.747504	2016-05-18 21:26:12.747504
1981	4	72	30	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/27"}}}	1	2016-05-18 21:26:12.763052	2016-05-18 21:26:12.763052
1982	4	73	30	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/27"}}}	1	2016-05-18 21:26:12.780964	2016-05-18 21:26:12.780964
1983	4	44	31	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/28"}}}	1	2016-05-18 21:26:12.799828	2016-05-18 21:26:12.799828
1984	4	68	31	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/28"}}}	1	2016-05-18 21:26:12.813678	2016-05-18 21:26:12.813678
1985	4	69	31	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/28"}}}	1	2016-05-18 21:26:12.828687	2016-05-18 21:26:12.828687
1986	4	70	31	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/28"}}}	1	2016-05-18 21:26:12.843979	2016-05-18 21:26:12.843979
1018	1	229	159	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 20:39:34.148769	2016-05-18 20:39:34.174458
1019	1	230	159	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 20:39:34.224854	2016-05-18 20:39:34.242197
1020	1	221	160	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 20:39:34.310645	2016-05-18 20:39:34.32405
1021	1	222	160	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 20:39:34.39756	2016-05-18 20:39:34.411196
1022	1	223	160	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 20:39:34.465709	2016-05-18 20:39:34.478674
1023	1	224	160	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 20:39:34.549189	2016-05-18 20:39:34.561598
1024	1	225	160	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 20:39:34.613008	2016-05-18 20:39:34.625436
1025	1	226	160	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 20:39:34.679644	2016-05-18 20:39:34.702036
1026	1	227	160	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 20:39:34.750478	2016-05-18 20:39:34.766847
1027	1	228	160	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 20:39:34.822812	2016-05-18 20:39:34.835036
1028	1	229	160	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 20:39:34.881973	2016-05-18 20:39:34.895156
1029	1	230	160	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 20:39:34.953295	2016-05-18 20:39:34.967727
1030	1	221	161	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 20:39:35.048415	2016-05-18 20:39:35.069944
1031	1	222	161	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 20:39:35.143963	2016-05-18 20:39:35.159377
1032	1	223	161	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 20:39:35.224352	2016-05-18 20:39:35.256987
1033	1	231	161	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 20:39:35.329434	2016-05-18 20:39:35.352593
1034	1	232	161	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 20:39:35.400936	2016-05-18 20:39:35.415104
1035	1	233	161	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 20:39:35.463174	2016-05-18 20:39:35.492082
1036	1	234	161	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 20:39:35.541096	2016-05-18 20:39:35.554482
1037	1	235	161	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 20:39:35.595278	2016-05-18 20:39:35.631525
1038	1	236	161	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 20:39:35.672965	2016-05-18 20:39:35.6856
1039	1	237	161	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 20:39:35.726535	2016-05-18 20:39:35.737449
1040	1	238	161	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 20:39:35.782297	2016-05-18 20:39:35.79327
1041	1	239	161	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 20:39:35.853021	2016-05-18 20:39:35.868387
1042	1	240	161	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 20:39:35.912298	2016-05-18 20:39:35.924316
1043	1	241	161	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 20:39:36.001819	2016-05-18 20:39:36.021089
1044	1	242	161	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 20:39:36.071825	2016-05-18 20:39:36.106026
1045	1	230	161	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 20:39:36.145487	2016-05-18 20:39:36.159096
1987	4	71	31	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/28"}}}	1	2016-05-18 21:26:12.860198	2016-05-18 21:26:12.860198
1412	8	55	13	\N	\N	2	\N	2	2016-05-18 20:39:58.463194	2016-05-18 20:39:58.463194
1988	4	72	31	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/28"}}}	1	2016-05-18 21:26:12.876148	2016-05-18 21:26:12.876148
1989	4	73	31	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/28"}}}	1	2016-05-18 21:26:12.892594	2016-05-18 21:26:12.892594
1990	4	74	32	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/161"}}}	1	2016-05-18 21:26:12.90901	2016-05-18 21:26:12.90901
1991	4	75	32	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/161"}}}	1	2016-05-18 21:26:12.92746	2016-05-18 21:26:12.92746
1992	4	76	32	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/161"}}}	1	2016-05-18 21:26:12.942769	2016-05-18 21:26:12.942769
1993	4	77	32	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/161"}}}	1	2016-05-18 21:26:12.957085	2016-05-18 21:26:12.957085
1994	4	78	32	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/161"}}}	1	2016-05-18 21:26:12.973805	2016-05-18 21:26:12.973805
1995	4	79	32	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/161"}}}	1	2016-05-18 21:26:12.989961	2016-05-18 21:26:12.989961
1046	1	221	162	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 20:39:36.240448	2016-05-18 20:39:36.252514
1047	1	222	162	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 20:39:36.303267	2016-05-18 20:39:36.335602
1048	1	223	162	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 20:39:36.380853	2016-05-18 20:39:36.393225
1049	1	224	162	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 20:39:36.434576	2016-05-18 20:39:36.446053
1050	1	243	162	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 20:39:36.504042	2016-05-18 20:39:36.521512
1051	1	244	162	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 20:39:36.567601	2016-05-18 20:39:36.577116
1052	1	245	162	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 20:39:36.682446	2016-05-18 20:39:36.699497
1053	1	246	162	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 20:39:36.733415	2016-05-18 20:39:36.754357
1054	1	247	162	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 20:39:36.840382	2016-05-18 20:39:36.85404
1055	1	248	162	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 20:39:36.905978	2016-05-18 20:39:36.921235
1056	1	249	162	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 20:39:36.985796	2016-05-18 20:39:37.005104
1057	1	250	162	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 20:39:37.04925	2016-05-18 20:39:37.071702
1058	1	251	162	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 20:39:37.105989	2016-05-18 20:39:37.121942
1059	1	252	162	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 20:39:37.15741	2016-05-18 20:39:37.167377
1060	1	253	162	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 20:39:37.212806	2016-05-18 20:39:37.225427
1061	1	254	162	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 20:39:37.262959	2016-05-18 20:39:37.273154
1062	1	229	162	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 20:39:37.308602	2016-05-18 20:39:37.31875
1063	1	228	162	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 20:39:37.350788	2016-05-18 20:39:37.360996
1064	1	230	162	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 20:39:37.414198	2016-05-18 20:39:37.423972
1065	1	221	163	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 20:39:37.485244	2016-05-18 20:39:37.497047
1066	1	222	163	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 20:39:37.532249	2016-05-18 20:39:37.543933
1067	1	223	163	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 20:39:37.604367	2016-05-18 20:39:37.619967
1068	1	224	163	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 20:39:37.679805	2016-05-18 20:39:37.69964
1069	1	229	163	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 20:39:37.756325	2016-05-18 20:39:37.768492
1070	1	230	163	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 20:39:37.86874	2016-05-18 20:39:37.882197
1071	12	255	163	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thymic-carcinoma/kit/110"}}}	1	2016-05-18 20:39:37.945607	2016-05-18 20:39:37.958821
1072	12	256	163	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thymic-carcinoma/kit/110"}}}	1	2016-05-18 20:39:37.99195	2016-05-18 20:39:38.001641
1073	1	255	164	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 20:39:38.070181	2016-05-18 20:39:38.079525
1996	4	80	32	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/161"}}}	1	2016-05-18 21:26:13.009705	2016-05-18 21:26:13.009705
1997	4	81	32	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/161"}}}	1	2016-05-18 21:26:13.027506	2016-05-18 21:26:13.027506
1998	4	44	32	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/161"}}}	1	2016-05-18 21:26:13.043522	2016-05-18 21:26:13.043522
1999	4	82	32	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/161"}}}	1	2016-05-18 21:26:13.059367	2016-05-18 21:26:13.059367
2000	4	74	33	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/160"}}}	1	2016-05-18 21:26:13.07474	2016-05-18 21:26:13.07474
2001	4	75	33	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/160"}}}	1	2016-05-18 21:26:13.090168	2016-05-18 21:26:13.090168
2002	4	76	33	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/160"}}}	1	2016-05-18 21:26:13.108524	2016-05-18 21:26:13.108524
2003	4	77	33	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/160"}}}	1	2016-05-18 21:26:13.121737	2016-05-18 21:26:13.121737
2004	4	78	33	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/160"}}}	1	2016-05-18 21:26:13.139986	2016-05-18 21:26:13.139986
3138	8	123	258	\N	\N	3	\N	2	2016-05-18 21:26:44.745169	2016-05-18 21:26:44.745169
1074	1	256	164	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 20:39:38.12257	2016-05-18 20:39:38.13582
1075	1	255	165	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 20:39:38.176937	2016-05-18 20:39:38.192559
1076	1	256	165	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 20:39:38.227323	2016-05-18 20:39:38.239439
1077	1	255	166	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 20:39:38.286713	2016-05-18 20:39:38.29657
1078	1	256	166	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 20:39:38.328762	2016-05-18 20:39:38.341008
1079	1	255	167	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 20:39:38.395233	2016-05-18 20:39:38.405662
1080	1	256	167	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 20:39:38.435987	2016-05-18 20:39:38.449523
1081	12	255	168	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thymic-carcinoma/kit/112"}}}	1	2016-05-18 20:39:38.504923	2016-05-18 20:39:38.517933
1082	12	256	168	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thymic-carcinoma/kit/112"}}}	1	2016-05-18 20:39:38.568102	2016-05-18 20:39:38.581474
1083	1	255	169	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 20:39:38.643106	2016-05-18 20:39:38.677454
1084	1	256	169	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 20:39:38.727554	2016-05-18 20:39:38.740449
1085	12	255	170	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thymic-carcinoma/kit/123"}}}	1	2016-05-18 20:39:38.804258	2016-05-18 20:39:38.817736
1086	12	256	170	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thymic-carcinoma/kit/123"}}}	1	2016-05-18 20:39:38.853973	2016-05-18 20:39:38.875196
1087	1	255	171	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 20:39:38.930365	2016-05-18 20:39:38.955588
1088	1	256	171	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 20:39:38.986478	2016-05-18 20:39:39.000311
1089	1	255	172	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 20:39:39.053955	2016-05-18 20:39:39.067572
1090	1	256	172	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 20:39:39.102162	2016-05-18 20:39:39.121471
1091	1	255	173	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 20:39:39.169103	2016-05-18 20:39:39.184965
1092	1	256	173	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 20:39:39.23123	2016-05-18 20:39:39.246594
1093	1	255	174	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 20:39:39.31072	2016-05-18 20:39:39.323325
1094	1	256	174	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 20:39:39.366509	2016-05-18 20:39:39.379167
1095	1	255	175	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 20:39:39.471749	2016-05-18 20:39:39.495176
1096	1	256	175	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 20:39:39.546449	2016-05-18 20:39:39.558646
1097	1	255	176	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 20:39:39.629095	2016-05-18 20:39:39.639299
1098	1	256	176	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 20:39:39.694471	2016-05-18 20:39:39.704879
1099	1	257	177	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 20:39:39.76075	2016-05-18 20:39:39.775262
1100	1	258	177	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 20:39:39.813166	2016-05-18 20:39:39.829263
1101	1	257	178	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 20:39:39.906229	2016-05-18 20:39:39.925915
2005	4	79	33	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/160"}}}	1	2016-05-18 21:26:13.155552	2016-05-18 21:26:13.155552
2006	4	80	33	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/160"}}}	1	2016-05-18 21:26:13.189705	2016-05-18 21:26:13.189705
2007	4	81	33	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/160"}}}	1	2016-05-18 21:26:13.207636	2016-05-18 21:26:13.207636
2008	4	44	33	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/160"}}}	1	2016-05-18 21:26:13.220383	2016-05-18 21:26:13.220383
2009	4	82	33	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/160"}}}	1	2016-05-18 21:26:13.235305	2016-05-18 21:26:13.235305
2010	2	74	34	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/kras/31"}}}	1	2016-05-18 21:26:13.25297	2016-05-18 21:26:13.25297
2011	2	75	34	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/kras/31"}}}	1	2016-05-18 21:26:13.27147	2016-05-18 21:26:13.27147
2012	2	76	34	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/kras/31"}}}	1	2016-05-18 21:26:13.284934	2016-05-18 21:26:13.284934
2013	2	77	34	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/kras/31"}}}	1	2016-05-18 21:26:13.300813	2016-05-18 21:26:13.300813
3139	8	111	258	\N	\N	3	\N	2	2016-05-18 21:26:44.761024	2016-05-18 21:26:44.761024
1102	1	259	179	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 20:39:39.984526	2016-05-18 20:39:39.999127
1103	1	257	179	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 20:39:40.055275	2016-05-18 20:39:40.078086
1104	1	255	180	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 20:39:40.135333	2016-05-18 20:39:40.157913
1105	1	208	180	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 20:39:40.199865	2016-05-18 20:39:40.211318
1106	1	260	180	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 20:39:40.250484	2016-05-18 20:39:40.275364
1107	1	255	181	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 20:39:40.31862	2016-05-18 20:39:40.330445
1108	1	208	181	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 20:39:40.374077	2016-05-18 20:39:40.38512
1109	1	260	181	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 20:39:40.41603	2016-05-18 20:39:40.425497
1110	1	255	182	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 20:39:40.481755	2016-05-18 20:39:40.490813
1111	1	208	182	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 20:39:40.524887	2016-05-18 20:39:40.545909
1112	1	260	182	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 20:39:40.578098	2016-05-18 20:39:40.589444
1113	1	261	183	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 20:39:40.636482	2016-05-18 20:39:40.646754
1114	1	260	183	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 20:39:40.680615	2016-05-18 20:39:40.690692
1115	1	260	184	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 20:39:40.727975	2016-05-18 20:39:40.745236
1116	1	255	185	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 20:39:40.790516	2016-05-18 20:39:40.811138
1117	1	208	185	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 20:39:40.840938	2016-05-18 20:39:40.849936
1118	1	260	185	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 20:39:40.880909	2016-05-18 20:39:40.898162
1119	1	255	186	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 20:39:40.935963	2016-05-18 20:39:40.94475
1120	1	208	186	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 20:39:40.97383	2016-05-18 20:39:40.985747
1121	1	260	186	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 20:39:41.034148	2016-05-18 20:39:41.042858
1122	1	255	187	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/96"}}}	1	2016-05-18 20:39:41.091367	2016-05-18 20:39:41.103591
1123	1	208	187	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/96"}}}	1	2016-05-18 20:39:41.142299	2016-05-18 20:39:41.154342
1124	1	260	187	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/96"}}}	1	2016-05-18 20:39:41.193566	2016-05-18 20:39:41.203305
1125	12	255	187	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thymic-carcinoma/kit/96"}}}	1	2016-05-18 20:39:41.241614	2016-05-18 20:39:41.251452
1126	12	208	187	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thymic-carcinoma/kit/96"}}}	1	2016-05-18 20:39:41.313039	2016-05-18 20:39:41.323987
1127	12	260	187	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thymic-carcinoma/kit/96"}}}	1	2016-05-18 20:39:41.372169	2016-05-18 20:39:41.385754
1128	12	255	188	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thymic-carcinoma/kit/122"}}}	1	2016-05-18 20:39:41.437883	2016-05-18 20:39:41.451201
1129	12	208	188	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thymic-carcinoma/kit/122"}}}	1	2016-05-18 20:39:41.492627	2016-05-18 20:39:41.51997
2014	2	78	34	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/kras/31"}}}	1	2016-05-18 21:26:13.317163	2016-05-18 21:26:13.317163
2015	2	79	34	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/kras/31"}}}	1	2016-05-18 21:26:13.332849	2016-05-18 21:26:13.332849
2016	2	80	34	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/kras/31"}}}	1	2016-05-18 21:26:13.349606	2016-05-18 21:26:13.349606
2017	2	81	34	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/kras/31"}}}	1	2016-05-18 21:26:13.368939	2016-05-18 21:26:13.368939
2018	2	44	34	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/kras/31"}}}	1	2016-05-18 21:26:13.383065	2016-05-18 21:26:13.383065
2019	2	82	34	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/kras/31"}}}	1	2016-05-18 21:26:13.399351	2016-05-18 21:26:13.399351
2020	4	74	34	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/31"}}}	1	2016-05-18 21:26:13.41497	2016-05-18 21:26:13.41497
2021	4	75	34	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/31"}}}	1	2016-05-18 21:26:13.430389	2016-05-18 21:26:13.430389
2022	4	76	34	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/31"}}}	1	2016-05-18 21:26:13.445775	2016-05-18 21:26:13.445775
3140	8	112	258	\N	\N	3	\N	2	2016-05-18 21:26:44.773245	2016-05-18 21:26:44.773245
3141	8	124	258	\N	\N	3	\N	2	2016-05-18 21:26:44.786892	2016-05-18 21:26:44.786892
1130	12	260	188	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thymic-carcinoma/kit/122"}}}	1	2016-05-18 20:39:41.557799	2016-05-18 20:39:41.570804
1131	1	255	189	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 20:39:41.643825	2016-05-18 20:39:41.654277
1132	1	256	189	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 20:39:41.696996	2016-05-18 20:39:41.706705
1133	1	262	190	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 20:39:41.758733	2016-05-18 20:39:41.774034
1134	1	74	190	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 20:39:41.8084	2016-05-18 20:39:41.820839
1135	1	75	190	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 20:39:41.853636	2016-05-18 20:39:41.874086
1136	1	76	190	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 20:39:41.912327	2016-05-18 20:39:41.926182
1137	1	77	190	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 20:39:41.97611	2016-05-18 20:39:42.008291
1138	1	78	190	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 20:39:42.05665	2016-05-18 20:39:42.070888
1139	1	79	190	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 20:39:42.118114	2016-05-18 20:39:42.133368
1140	1	263	190	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 20:39:42.194093	2016-05-18 20:39:42.208388
1141	1	264	190	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 20:39:42.252765	2016-05-18 20:39:42.264419
1142	1	265	190	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 20:39:42.313863	2016-05-18 20:39:42.327316
1143	1	234	190	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 20:39:42.374128	2016-05-18 20:39:42.385657
1144	1	262	191	\N	\N	2	\N	1	2016-05-18 20:39:42.442654	2016-05-18 20:39:42.442654
1145	1	74	191	\N	\N	2	\N	1	2016-05-18 20:39:42.485764	2016-05-18 20:39:42.485764
1146	1	75	191	\N	\N	2	\N	1	2016-05-18 20:39:42.54588	2016-05-18 20:39:42.54588
1147	1	76	191	\N	\N	2	\N	1	2016-05-18 20:39:42.586068	2016-05-18 20:39:42.586068
1148	1	77	191	\N	\N	2	\N	1	2016-05-18 20:39:42.644338	2016-05-18 20:39:42.644338
1149	1	78	191	\N	\N	2	\N	1	2016-05-18 20:39:42.682172	2016-05-18 20:39:42.682172
1150	1	79	191	\N	\N	2	\N	1	2016-05-18 20:39:42.721926	2016-05-18 20:39:42.721926
1151	1	263	191	\N	\N	2	\N	1	2016-05-18 20:39:42.786725	2016-05-18 20:39:42.786725
1152	1	264	191	\N	\N	2	\N	1	2016-05-18 20:39:42.829223	2016-05-18 20:39:42.829223
1153	1	265	191	\N	\N	2	\N	1	2016-05-18 20:39:42.867585	2016-05-18 20:39:42.867585
1154	1	234	191	\N	\N	2	\N	1	2016-05-18 20:39:42.922535	2016-05-18 20:39:42.922535
1155	1	262	192	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 20:39:42.990357	2016-05-18 20:39:43.002538
1156	1	74	192	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 20:39:43.034227	2016-05-18 20:39:43.04532
1157	1	75	192	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 20:39:43.098135	2016-05-18 20:39:43.111103
1158	1	76	192	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 20:39:43.143562	2016-05-18 20:39:43.1559
1159	1	77	192	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 20:39:43.194373	2016-05-18 20:39:43.208052
1160	1	78	192	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 20:39:43.247238	2016-05-18 20:39:43.257782
1161	1	79	192	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 20:39:43.302527	2016-05-18 20:39:43.31416
1162	1	263	192	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 20:39:43.354921	2016-05-18 20:39:43.36669
1163	1	264	192	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 20:39:43.412063	2016-05-18 20:39:43.424335
1164	1	265	192	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 20:39:43.456652	2016-05-18 20:39:43.466733
1165	1	234	192	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 20:39:43.525813	2016-05-18 20:39:43.541701
2023	4	77	34	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/31"}}}	1	2016-05-18 21:26:13.461578	2016-05-18 21:26:13.461578
1413	8	36	13	\N	\N	2	\N	2	2016-05-18 20:39:58.523073	2016-05-18 20:39:58.523073
2024	4	78	34	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/31"}}}	1	2016-05-18 21:26:13.479615	2016-05-18 21:26:13.479615
2025	4	79	34	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/31"}}}	1	2016-05-18 21:26:13.497101	2016-05-18 21:26:13.497101
2026	4	80	34	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/31"}}}	1	2016-05-18 21:26:13.512444	2016-05-18 21:26:13.512444
2027	4	81	34	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/31"}}}	1	2016-05-18 21:26:13.527906	2016-05-18 21:26:13.527906
2028	4	44	34	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/31"}}}	1	2016-05-18 21:26:13.54479	2016-05-18 21:26:13.54479
2029	4	82	34	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/31"}}}	1	2016-05-18 21:26:13.562472	2016-05-18 21:26:13.562472
2030	2	74	35	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/kras/30"}}}	1	2016-05-18 21:26:13.578194	2016-05-18 21:26:13.578194
3142	8	125	258	\N	\N	3	\N	2	2016-05-18 21:26:44.800958	2016-05-18 21:26:44.800958
1166	1	262	193	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 20:39:43.588838	2016-05-18 20:39:43.609142
1167	1	74	193	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 20:39:43.644011	2016-05-18 20:39:43.656224
1168	1	75	193	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 20:39:43.700439	2016-05-18 20:39:43.724132
1169	1	76	193	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 20:39:43.755816	2016-05-18 20:39:43.768578
1170	1	77	193	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 20:39:43.812498	2016-05-18 20:39:43.845941
1171	1	78	193	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 20:39:43.895588	2016-05-18 20:39:43.906174
1172	1	79	193	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 20:39:43.95106	2016-05-18 20:39:43.966532
1173	1	263	193	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 20:39:43.999328	2016-05-18 20:39:44.011347
1174	1	264	193	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 20:39:44.037114	2016-05-18 20:39:44.050434
1175	1	265	193	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 20:39:44.081792	2016-05-18 20:39:44.097092
1176	1	234	193	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 20:39:44.131369	2016-05-18 20:39:44.141787
1177	1	266	194	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 20:39:44.20157	2016-05-18 20:39:44.212158
1178	1	267	194	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 20:39:44.264816	2016-05-18 20:39:44.281908
1179	1	268	194	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 20:39:44.32299	2016-05-18 20:39:44.337752
1180	1	269	194	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 20:39:44.40422	2016-05-18 20:39:44.418544
1181	1	270	194	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 20:39:44.46589	2016-05-18 20:39:44.477948
1182	1	271	194	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 20:39:44.525702	2016-05-18 20:39:44.539762
1183	1	272	194	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 20:39:44.575802	2016-05-18 20:39:44.596636
1184	1	273	195	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 20:39:44.657467	2016-05-18 20:39:44.682604
1185	12	273	196	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thymic-carcinoma/kit/121"}}}	1	2016-05-18 20:39:44.730222	2016-05-18 20:39:44.750329
1186	1	273	197	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/84"}}}	1	2016-05-18 20:39:44.796836	2016-05-18 20:39:44.812621
1187	8	273	198	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/kit/274"}}}	1	2016-05-18 20:39:44.862642	2016-05-18 20:39:44.881053
1188	8	229	199	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/kit/276"}}}	1	2016-05-18 20:39:44.945534	2016-05-18 20:39:44.959238
1189	8	230	199	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/kit/276"}}}	1	2016-05-18 20:39:44.995534	2016-05-18 20:39:45.010749
1190	1	229	200	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 20:39:45.082975	2016-05-18 20:39:45.099063
1191	1	230	200	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 20:39:45.156522	2016-05-18 20:39:45.196204
1192	8	229	200	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/kit/275"}}}	1	2016-05-18 20:39:45.242106	2016-05-18 20:39:45.258306
1193	8	230	200	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/kit/275"}}}	1	2016-05-18 20:39:45.307108	2016-05-18 20:39:45.331216
2031	2	75	35	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/kras/30"}}}	1	2016-05-18 21:26:13.594827	2016-05-18 21:26:13.594827
2032	2	76	35	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/kras/30"}}}	1	2016-05-18 21:26:13.613156	2016-05-18 21:26:13.613156
2033	2	77	35	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/kras/30"}}}	1	2016-05-18 21:26:13.627277	2016-05-18 21:26:13.627277
2034	2	78	35	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/kras/30"}}}	1	2016-05-18 21:26:13.644396	2016-05-18 21:26:13.644396
2035	2	79	35	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/kras/30"}}}	1	2016-05-18 21:26:13.659723	2016-05-18 21:26:13.659723
2036	2	80	35	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/kras/30"}}}	1	2016-05-18 21:26:13.677124	2016-05-18 21:26:13.677124
2037	2	81	35	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/kras/30"}}}	1	2016-05-18 21:26:13.693707	2016-05-18 21:26:13.693707
2038	2	44	35	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/kras/30"}}}	1	2016-05-18 21:26:13.712569	2016-05-18 21:26:13.712569
2039	2	82	35	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/kras/30"}}}	1	2016-05-18 21:26:13.725598	2016-05-18 21:26:13.725598
3143	8	150	259	\N	\N	3	\N	2	2016-05-18 21:26:44.812552	2016-05-18 21:26:44.812552
1194	1	274	201	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/84"}}}	1	2016-05-18 20:39:45.377136	2016-05-18 20:39:45.388594
1195	1	274	202	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 20:39:45.437434	2016-05-18 20:39:45.44899
1196	1	275	203	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 20:39:45.502457	2016-05-18 20:39:45.515348
1197	12	275	204	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thymic-carcinoma/kit/120"}}}	1	2016-05-18 20:39:45.56891	2016-05-18 20:39:45.581339
1198	1	276	205	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 20:39:45.637217	2016-05-18 20:39:45.646839
1199	1	3	205	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 20:39:45.677891	2016-05-18 20:39:45.692079
1200	1	277	206	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 20:39:45.746668	2016-05-18 20:39:45.762392
1201	1	278	207	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 20:39:45.826008	2016-05-18 20:39:45.846789
1202	1	3	207	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 20:39:45.892877	2016-05-18 20:39:45.90953
1203	1	279	208	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 20:39:46.012252	2016-05-18 20:39:46.030724
1204	1	280	208	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 20:39:46.084873	2016-05-18 20:39:46.099877
1205	1	281	209	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 20:39:46.18643	2016-05-18 20:39:46.198869
1206	1	279	209	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 20:39:46.234302	2016-05-18 20:39:46.248239
1207	1	282	209	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 20:39:46.291271	2016-05-18 20:39:46.303914
1208	1	283	210	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 20:39:46.355219	2016-05-18 20:39:46.374814
1209	1	279	210	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 20:39:46.41186	2016-05-18 20:39:46.426701
1210	1	284	211	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 20:39:46.494717	2016-05-18 20:39:46.511435
1211	1	283	211	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 20:39:46.563815	2016-05-18 20:39:46.577637
1212	1	279	211	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 20:39:46.613582	2016-05-18 20:39:46.62619
1213	1	285	212	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 20:39:46.685392	2016-05-18 20:39:46.702589
1214	1	286	212	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 20:39:46.737074	2016-05-18 20:39:46.747253
1215	1	287	212	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 20:39:46.785809	2016-05-18 20:39:46.802959
1216	1	288	212	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 20:39:46.838531	2016-05-18 20:39:46.849937
1217	14	293	213	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/basal-cell-carcinoma/smo/164"}}}	1	2016-05-18 20:39:46.907476	2016-05-18 20:39:46.916798
1218	14	293	214	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/basal-cell-carcinoma/smo/165"}}}	1	2016-05-18 20:39:46.974614	2016-05-18 20:39:46.984186
1219	14	294	215	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/basal-cell-carcinoma/smo/166"}}}	1	2016-05-18 20:39:47.036475	2016-05-18 20:39:47.046749
1220	14	295	215	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/basal-cell-carcinoma/smo/166"}}}	1	2016-05-18 20:39:47.094794	2016-05-18 20:39:47.108597
1221	14	296	215	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/basal-cell-carcinoma/smo/166"}}}	1	2016-05-18 20:39:47.139602	2016-05-18 20:39:47.149341
2040	4	74	35	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/30"}}}	1	2016-05-18 21:26:13.743052	2016-05-18 21:26:13.743052
2041	4	75	35	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/30"}}}	1	2016-05-18 21:26:13.758647	2016-05-18 21:26:13.758647
2042	4	76	35	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/30"}}}	1	2016-05-18 21:26:13.776221	2016-05-18 21:26:13.776221
2043	4	77	35	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/30"}}}	1	2016-05-18 21:26:13.790887	2016-05-18 21:26:13.790887
2044	4	78	35	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/30"}}}	1	2016-05-18 21:26:13.808263	2016-05-18 21:26:13.808263
2045	4	79	35	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/30"}}}	1	2016-05-18 21:26:13.822608	2016-05-18 21:26:13.822608
2046	4	80	35	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/30"}}}	1	2016-05-18 21:26:13.842505	2016-05-18 21:26:13.842505
2047	4	81	35	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/30"}}}	1	2016-05-18 21:26:13.85592	2016-05-18 21:26:13.85592
2048	4	44	35	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/30"}}}	1	2016-05-18 21:26:13.872798	2016-05-18 21:26:13.872798
1222	14	293	216	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/basal-cell-carcinoma/smo/163"}}}	1	2016-05-18 20:39:47.208463	2016-05-18 20:39:47.220253
1223	14	293	217	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/basal-cell-carcinoma/smo/167"}}}	1	2016-05-18 20:39:47.265292	2016-05-18 20:39:47.276394
1224	14	293	218	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/basal-cell-carcinoma/smo/168"}}}	1	2016-05-18 20:39:47.324778	2016-05-18 20:39:47.335119
1225	14	293	219	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/basal-cell-carcinoma/smo/169"}}}	1	2016-05-18 20:39:47.379093	2016-05-18 20:39:47.391555
1226	14	293	220	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/basal-cell-carcinoma/smo/170"}}}	1	2016-05-18 20:39:47.445497	2016-05-18 20:39:47.46027
1227	14	293	221	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/basal-cell-carcinoma/smo/171"}}}	1	2016-05-18 20:39:47.524816	2016-05-18 20:39:47.543107
1228	14	293	222	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/basal-cell-carcinoma/smo/172"}}}	1	2016-05-18 20:39:47.606663	2016-05-18 20:39:47.625217
1229	1	293	223	\N	\N	2	\N	1	2016-05-18 20:39:47.707109	2016-05-18 20:39:47.707109
1230	1	293	224	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/braf/114"}}}	1	2016-05-18 20:39:47.793397	2016-05-18 20:39:47.817611
1231	1	293	225	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/braf/115"}}}	1	2016-05-18 20:39:47.906424	2016-05-18 20:39:47.927419
1232	15	293	226	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/braf/54"}}}	1	2016-05-18 20:39:48.047365	2016-05-18 20:39:48.083458
1233	3	294	226	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/braf/54"}}}	1	2016-05-18 20:39:48.149897	2016-05-18 20:39:48.176395
1234	3	295	226	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/braf/54"}}}	1	2016-05-18 20:39:48.247954	2016-05-18 20:39:48.264663
1235	3	296	226	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/braf/54"}}}	1	2016-05-18 20:39:48.321398	2016-05-18 20:39:48.344261
1236	6	297	226	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/ovarian-cancer/braf/54"}}}	1	2016-05-18 20:39:48.386017	2016-05-18 20:39:48.397442
1237	11	298	226	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/gist/braf/54"}}}	1	2016-05-18 20:39:48.440675	2016-05-18 20:39:48.469926
1238	4	298	226	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/54"}}}	1	2016-05-18 20:39:48.509307	2016-05-18 20:39:48.522098
1239	1	299	227	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/braf/118"}}}	1	2016-05-18 20:39:48.599689	2016-05-18 20:39:48.616624
1240	1	300	228	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/braf/116"}}}	1	2016-05-18 20:39:48.684662	2016-05-18 20:39:48.698861
1241	6	301	229	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/ovarian-cancer/braf/138"}}}	1	2016-05-18 20:39:48.767785	2016-05-18 20:39:48.78336
1242	6	302	229	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/ovarian-cancer/braf/138"}}}	1	2016-05-18 20:39:48.83002	2016-05-18 20:39:48.858213
1243	1	3	230	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/braf/301"}}}	1	2016-05-18 20:39:48.923315	2016-05-18 20:39:48.936584
1244	4	303	231	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/149"}}}	1	2016-05-18 20:39:48.985057	2016-05-18 20:39:49.00368
1245	4	304	231	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/149"}}}	1	2016-05-18 20:39:49.035736	2016-05-18 20:39:49.046773
1246	4	36	231	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/149"}}}	1	2016-05-18 20:39:49.079881	2016-05-18 20:39:49.101361
1247	4	305	231	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/149"}}}	1	2016-05-18 20:39:49.137809	2016-05-18 20:39:49.147895
1248	4	306	231	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/149"}}}	1	2016-05-18 20:39:49.187209	2016-05-18 20:39:49.216124
1249	4	46	231	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/149"}}}	1	2016-05-18 20:39:49.257113	2016-05-18 20:39:49.273202
2049	4	82	35	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/30"}}}	1	2016-05-18 21:26:13.891827	2016-05-18 21:26:13.891827
1414	8	51	13	\N	\N	2	\N	2	2016-05-18 20:39:58.570616	2016-05-18 20:39:58.570616
2050	3	74	36	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/42"}}}	1	2016-05-18 21:26:13.911598	2016-05-18 21:26:13.911598
2051	3	75	36	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/42"}}}	1	2016-05-18 21:26:13.92756	2016-05-18 21:26:13.92756
2052	3	76	36	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/42"}}}	1	2016-05-18 21:26:13.94656	2016-05-18 21:26:13.94656
2053	3	77	36	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/42"}}}	1	2016-05-18 21:26:13.969738	2016-05-18 21:26:13.969738
2054	3	78	36	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/42"}}}	1	2016-05-18 21:26:13.995821	2016-05-18 21:26:13.995821
2055	3	79	36	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/42"}}}	1	2016-05-18 21:26:14.027283	2016-05-18 21:26:14.027283
2056	3	80	36	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/42"}}}	1	2016-05-18 21:26:14.056037	2016-05-18 21:26:14.056037
2057	3	81	36	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/42"}}}	1	2016-05-18 21:26:14.076477	2016-05-18 21:26:14.076477
1250	4	307	231	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/149"}}}	1	2016-05-18 20:39:49.324349	2016-05-18 20:39:49.34333
1251	1	303	232	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/braf/148"}}}	1	2016-05-18 20:39:49.421757	2016-05-18 20:39:49.448517
1252	1	304	232	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/braf/148"}}}	1	2016-05-18 20:39:49.493637	2016-05-18 20:39:49.506134
1253	1	36	232	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/braf/148"}}}	1	2016-05-18 20:39:49.54231	2016-05-18 20:39:49.566232
1254	1	305	232	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/braf/148"}}}	1	2016-05-18 20:39:49.597968	2016-05-18 20:39:49.609372
1255	1	306	232	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/braf/148"}}}	1	2016-05-18 20:39:49.643559	2016-05-18 20:39:49.658327
1256	1	46	232	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/braf/148"}}}	1	2016-05-18 20:39:49.712863	2016-05-18 20:39:49.725405
1257	4	303	232	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/148"}}}	1	2016-05-18 20:39:49.761851	2016-05-18 20:39:49.780815
1258	4	304	232	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/148"}}}	1	2016-05-18 20:39:49.815368	2016-05-18 20:39:49.827374
1259	4	36	232	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/148"}}}	1	2016-05-18 20:39:49.860414	2016-05-18 20:39:49.88033
1260	4	308	232	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/148"}}}	1	2016-05-18 20:39:49.911712	2016-05-18 20:39:49.923578
1261	1	304	233	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/braf/300"}}}	1	2016-05-18 20:39:49.972257	2016-05-18 20:39:49.995543
1262	1	307	233	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/braf/300"}}}	1	2016-05-18 20:39:50.030821	2016-05-18 20:39:50.042264
1263	1	304	234	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/braf/298"}}}	1	2016-05-18 20:39:50.08392	2016-05-18 20:39:50.095012
1264	1	307	234	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/braf/298"}}}	1	2016-05-18 20:39:50.12341	2016-05-18 20:39:50.146239
1265	1	304	235	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/braf/299"}}}	1	2016-05-18 20:39:50.205216	2016-05-18 20:39:50.215019
1266	1	307	235	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/braf/299"}}}	1	2016-05-18 20:39:50.250949	2016-05-18 20:39:50.266291
1267	15	304	236	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/braf/209"}}}	1	2016-05-18 20:39:50.325383	2016-05-18 20:39:50.335063
1268	15	307	236	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/braf/209"}}}	1	2016-05-18 20:39:50.371227	2016-05-18 20:39:50.401287
1269	4	75	237	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/147"}}}	1	2016-05-18 20:39:50.465813	2016-05-18 20:39:50.480406
1270	4	309	237	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/147"}}}	1	2016-05-18 20:39:50.522777	2016-05-18 20:39:50.55196
1271	15	75	238	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/braf/71"}}}	1	2016-05-18 20:39:50.618704	2016-05-18 20:39:50.644792
1272	15	309	238	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/braf/71"}}}	1	2016-05-18 20:39:50.70198	2016-05-18 20:39:50.716335
1273	4	75	238	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/71"}}}	1	2016-05-18 20:39:50.768232	2016-05-18 20:39:50.78143
1274	4	309	238	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/71"}}}	1	2016-05-18 20:39:50.83287	2016-05-18 20:39:50.846192
1275	4	75	239	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/146"}}}	1	2016-05-18 20:39:50.908093	2016-05-18 20:39:50.924328
1276	4	309	239	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/146"}}}	1	2016-05-18 20:39:50.958871	2016-05-18 20:39:50.969808
1277	15	75	240	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/braf/310"}}}	1	2016-05-18 20:39:51.028713	2016-05-18 20:39:51.037029
2058	3	44	36	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/42"}}}	1	2016-05-18 21:26:14.092522	2016-05-18 21:26:14.092522
2059	3	82	36	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/42"}}}	1	2016-05-18 21:26:14.114509	2016-05-18 21:26:14.114509
2060	2	74	36	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/kras/42"}}}	1	2016-05-18 21:26:14.129361	2016-05-18 21:26:14.129361
2061	2	75	36	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/kras/42"}}}	1	2016-05-18 21:26:14.145522	2016-05-18 21:26:14.145522
2062	2	76	36	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/kras/42"}}}	1	2016-05-18 21:26:14.171282	2016-05-18 21:26:14.171282
2063	2	77	36	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/kras/42"}}}	1	2016-05-18 21:26:14.191622	2016-05-18 21:26:14.191622
2064	2	78	36	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/kras/42"}}}	1	2016-05-18 21:26:14.21203	2016-05-18 21:26:14.21203
2065	2	79	36	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/kras/42"}}}	1	2016-05-18 21:26:14.229328	2016-05-18 21:26:14.229328
2066	2	80	36	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/kras/42"}}}	1	2016-05-18 21:26:14.247724	2016-05-18 21:26:14.247724
1278	15	309	240	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/braf/310"}}}	1	2016-05-18 20:39:51.070334	2016-05-18 20:39:51.079769
1279	15	75	241	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/braf/70"}}}	1	2016-05-18 20:39:51.128965	2016-05-18 20:39:51.141076
1280	15	309	241	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/braf/70"}}}	1	2016-05-18 20:39:51.171758	2016-05-18 20:39:51.184244
1281	4	310	241	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/70"}}}	1	2016-05-18 20:39:51.219258	2016-05-18 20:39:51.230617
1282	4	270	241	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/70"}}}	1	2016-05-18 20:39:51.257589	2016-05-18 20:39:51.267807
1283	4	271	241	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/70"}}}	1	2016-05-18 20:39:51.300694	2016-05-18 20:39:51.309582
1284	2	310	242	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/egfr/3"}}}	1	2016-05-18 20:39:51.370399	2016-05-18 20:39:51.380315
1285	2	270	242	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/egfr/3"}}}	1	2016-05-18 20:39:51.411141	2016-05-18 20:39:51.424967
1286	2	271	242	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/egfr/3"}}}	1	2016-05-18 20:39:51.452621	2016-05-18 20:39:51.46382
1287	2	310	243	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/egfr/2"}}}	1	2016-05-18 20:39:51.513785	2016-05-18 20:39:51.523791
1288	2	270	243	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/egfr/2"}}}	1	2016-05-18 20:39:51.574359	2016-05-18 20:39:51.583943
1289	2	271	243	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/egfr/2"}}}	1	2016-05-18 20:39:51.614709	2016-05-18 20:39:51.625034
1290	2	201	244	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/egfr/1"}}}	1	2016-05-18 20:39:51.699683	2016-05-18 20:39:51.714134
1291	2	311	244	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/egfr/1"}}}	1	2016-05-18 20:39:51.750498	2016-05-18 20:39:51.760879
1292	2	312	244	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/egfr/1"}}}	1	2016-05-18 20:39:51.795273	2016-05-18 20:39:51.807499
1293	2	313	245	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/egfr/4"}}}	1	2016-05-18 20:39:51.867407	2016-05-18 20:39:51.876864
1294	2	200	246	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/egfr/5"}}}	1	2016-05-18 20:39:51.924549	2016-05-18 20:39:51.938046
1295	2	311	246	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/egfr/5"}}}	1	2016-05-18 20:39:51.98515	2016-05-18 20:39:51.996273
1296	2	201	246	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/egfr/5"}}}	1	2016-05-18 20:39:52.050906	2016-05-18 20:39:52.06519
1297	2	314	247	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/egfr/6"}}}	1	2016-05-18 20:39:52.128822	2016-05-18 20:39:52.145813
1298	16	315	248	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/jak2/200"}}}	1	2016-05-18 20:39:52.212827	2016-05-18 20:39:52.224464
1299	16	316	249	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/jak2/203"}}}	1	2016-05-18 20:39:52.294567	2016-05-18 20:39:52.306323
1300	16	317	250	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/jak2/202"}}}	1	2016-05-18 20:39:52.386078	2016-05-18 20:39:52.409103
1301	16	36	250	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/jak2/202"}}}	1	2016-05-18 20:39:52.464342	2016-05-18 20:39:52.47499
1302	16	308	250	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/jak2/202"}}}	1	2016-05-18 20:39:52.516623	2016-05-18 20:39:52.529084
1303	16	305	250	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/jak2/202"}}}	1	2016-05-18 20:39:52.603387	2016-05-18 20:39:52.61424
1304	16	306	250	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/jak2/202"}}}	1	2016-05-18 20:39:52.659685	2016-05-18 20:39:52.670792
2067	2	81	36	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/kras/42"}}}	1	2016-05-18 21:26:14.267322	2016-05-18 21:26:14.267322
1415	8	57	15	\N	\N	2	\N	2	2016-05-18 20:39:58.611712	2016-05-18 20:39:58.611712
1416	8	58	15	\N	\N	2	\N	2	2016-05-18 20:39:58.651408	2016-05-18 20:39:58.651408
2068	2	44	36	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/kras/42"}}}	1	2016-05-18 21:26:14.285733	2016-05-18 21:26:14.285733
2069	2	82	36	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/kras/42"}}}	1	2016-05-18 21:26:14.305417	2016-05-18 21:26:14.305417
2070	4	74	36	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/42"}}}	1	2016-05-18 21:26:14.323487	2016-05-18 21:26:14.323487
2071	4	75	36	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/42"}}}	1	2016-05-18 21:26:14.343531	2016-05-18 21:26:14.343531
2072	4	76	36	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/42"}}}	1	2016-05-18 21:26:14.361183	2016-05-18 21:26:14.361183
2073	4	77	36	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/42"}}}	1	2016-05-18 21:26:14.379623	2016-05-18 21:26:14.379623
2074	4	78	36	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/42"}}}	1	2016-05-18 21:26:14.399489	2016-05-18 21:26:14.399489
2075	4	79	36	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/42"}}}	1	2016-05-18 21:26:14.418178	2016-05-18 21:26:14.418178
1305	16	318	250	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/jak2/202"}}}	1	2016-05-18 20:39:52.730467	2016-05-18 20:39:52.74114
1306	16	319	250	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/jak2/202"}}}	1	2016-05-18 20:39:52.773621	2016-05-18 20:39:52.786896
1307	16	320	250	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/jak2/202"}}}	1	2016-05-18 20:39:52.815306	2016-05-18 20:39:52.83959
1308	16	321	250	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/jak2/202"}}}	1	2016-05-18 20:39:52.867406	2016-05-18 20:39:52.8796
1309	16	322	250	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/jak2/202"}}}	1	2016-05-18 20:39:52.912202	2016-05-18 20:39:52.934759
1310	16	36	251	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/jak2/201"}}}	1	2016-05-18 20:39:52.975238	2016-05-18 20:39:52.990486
1311	16	317	251	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/jak2/201"}}}	1	2016-05-18 20:39:53.025018	2016-05-18 20:39:53.037609
1312	16	321	251	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/jak2/201"}}}	1	2016-05-18 20:39:53.072085	2016-05-18 20:39:53.082329
1313	16	322	251	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/jak2/201"}}}	1	2016-05-18 20:39:53.135915	2016-05-18 20:39:53.145888
1314	16	319	251	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/jak2/201"}}}	1	2016-05-18 20:39:53.177197	2016-05-18 20:39:53.188011
1315	16	320	251	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/jak2/201"}}}	1	2016-05-18 20:39:53.231779	2016-05-18 20:39:53.241697
1316	16	323	251	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/jak2/201"}}}	1	2016-05-18 20:39:53.280955	2016-05-18 20:39:53.293432
1317	16	306	251	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/jak2/201"}}}	1	2016-05-18 20:39:53.334046	2016-05-18 20:39:53.34406
1318	16	46	251	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/jak2/201"}}}	1	2016-05-18 20:39:53.379239	2016-05-18 20:39:53.391186
1319	16	324	251	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/jak2/201"}}}	1	2016-05-18 20:39:53.43041	2016-05-18 20:39:53.441324
1320	16	305	251	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/jak2/201"}}}	1	2016-05-18 20:39:53.476325	2016-05-18 20:39:53.496399
1321	16	325	251	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/jak2/201"}}}	1	2016-05-18 20:39:53.529057	2016-05-18 20:39:53.540566
1322	16	318	251	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/jak2/201"}}}	1	2016-05-18 20:39:53.572267	2016-05-18 20:39:53.584964
1323	16	326	251	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/jak2/201"}}}	1	2016-05-18 20:39:53.614265	2016-05-18 20:39:53.624089
1324	1	36	252	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/gnaq/100"}}}	1	2016-05-18 20:39:53.67195	2016-05-18 20:39:53.684128
1325	1	317	252	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/gnaq/100"}}}	1	2016-05-18 20:39:53.713005	2016-05-18 20:39:53.723777
1326	1	306	252	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/gnaq/100"}}}	1	2016-05-18 20:39:53.754802	2016-05-18 20:39:53.76447
1327	1	46	252	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/gnaq/100"}}}	1	2016-05-18 20:39:53.796195	2016-05-18 20:39:53.807666
1328	1	324	252	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/gnaq/100"}}}	1	2016-05-18 20:39:53.838538	2016-05-18 20:39:53.850742
1329	1	305	252	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/gnaq/100"}}}	1	2016-05-18 20:39:53.88156	2016-05-18 20:39:53.893196
1330	1	325	252	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/gnaq/100"}}}	1	2016-05-18 20:39:53.921171	2016-05-18 20:39:53.930685
1331	1	318	252	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/gnaq/100"}}}	1	2016-05-18 20:39:53.960381	2016-05-18 20:39:53.973158
2076	4	80	36	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/42"}}}	1	2016-05-18 21:26:14.435945	2016-05-18 21:26:14.435945
2077	4	81	36	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/42"}}}	1	2016-05-18 21:26:14.464021	2016-05-18 21:26:14.464021
2078	4	44	36	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/42"}}}	1	2016-05-18 21:26:14.484848	2016-05-18 21:26:14.484848
2079	4	82	36	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/42"}}}	1	2016-05-18 21:26:14.503412	2016-05-18 21:26:14.503412
2080	3	74	37	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/43"}}}	1	2016-05-18 21:26:14.519233	2016-05-18 21:26:14.519233
2081	3	75	37	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/43"}}}	1	2016-05-18 21:26:14.540066	2016-05-18 21:26:14.540066
2082	3	76	37	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/43"}}}	1	2016-05-18 21:26:14.556339	2016-05-18 21:26:14.556339
2083	3	77	37	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/43"}}}	1	2016-05-18 21:26:14.577059	2016-05-18 21:26:14.577059
3144	8	151	259	\N	\N	3	\N	2	2016-05-18 21:26:44.828539	2016-05-18 21:26:44.828539
1332	1	319	252	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/gnaq/100"}}}	1	2016-05-18 20:39:54.003785	2016-05-18 20:39:54.013864
1333	1	320	252	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/gnaq/100"}}}	1	2016-05-18 20:39:54.046565	2016-05-18 20:39:54.059797
1334	1	321	252	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/gnaq/100"}}}	1	2016-05-18 20:39:54.091727	2016-05-18 20:39:54.101535
1335	1	322	252	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/gnaq/100"}}}	1	2016-05-18 20:39:54.131052	2016-05-18 20:39:54.142522
1336	1	36	253	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/gnaq/103"}}}	1	2016-05-18 20:39:54.20039	2016-05-18 20:39:54.209742
1337	1	317	253	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/gnaq/103"}}}	1	2016-05-18 20:39:54.241553	2016-05-18 20:39:54.254174
1338	1	327	253	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/gnaq/103"}}}	1	2016-05-18 20:39:54.301082	2016-05-18 20:39:54.310537
1339	1	323	253	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/gnaq/103"}}}	1	2016-05-18 20:39:54.342204	2016-05-18 20:39:54.354896
1340	1	306	253	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/gnaq/103"}}}	1	2016-05-18 20:39:54.397416	2016-05-18 20:39:54.408565
1341	1	46	253	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/gnaq/103"}}}	1	2016-05-18 20:39:54.445062	2016-05-18 20:39:54.458067
1342	1	324	253	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/gnaq/103"}}}	1	2016-05-18 20:39:54.497216	2016-05-18 20:39:54.509268
1343	1	305	253	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/gnaq/103"}}}	1	2016-05-18 20:39:54.542955	2016-05-18 20:39:54.554923
1344	1	325	253	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/gnaq/103"}}}	1	2016-05-18 20:39:54.597823	2016-05-18 20:39:54.60833
1345	1	318	253	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/gnaq/103"}}}	1	2016-05-18 20:39:54.640763	2016-05-18 20:39:54.650227
1346	1	319	253	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/gnaq/103"}}}	1	2016-05-18 20:39:54.697615	2016-05-18 20:39:54.708523
1347	1	320	253	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/gnaq/103"}}}	1	2016-05-18 20:39:54.742599	2016-05-18 20:39:54.766294
1348	1	321	253	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/gnaq/103"}}}	1	2016-05-18 20:39:54.798252	2016-05-18 20:39:54.80718
1349	1	322	253	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/gnaq/103"}}}	1	2016-05-18 20:39:54.839064	2016-05-18 20:39:54.851776
1350	1	328	253	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/gnaq/103"}}}	1	2016-05-18 20:39:54.901821	2016-05-18 20:39:54.911846
1351	1	329	253	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/gnaq/103"}}}	1	2016-05-18 20:39:54.945197	2016-05-18 20:39:54.966865
1352	1	330	253	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/gnaq/103"}}}	1	2016-05-18 20:39:55.001455	2016-05-18 20:39:55.014355
1353	1	331	253	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/gnaq/103"}}}	1	2016-05-18 20:39:55.05188	2016-05-18 20:39:55.066038
1354	1	332	253	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/gnaq/103"}}}	1	2016-05-18 20:39:55.12349	2016-05-18 20:39:55.137418
1355	1	333	253	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/gnaq/103"}}}	1	2016-05-18 20:39:55.184108	2016-05-18 20:39:55.217466
1356	1	36	254	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/gnaq/102"}}}	1	2016-05-18 20:39:55.283417	2016-05-18 20:39:55.303989
1357	1	317	254	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/gnaq/102"}}}	1	2016-05-18 20:39:55.352758	2016-05-18 20:39:55.366796
1358	1	334	254	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/gnaq/102"}}}	1	2016-05-18 20:39:55.415625	2016-05-18 20:39:55.440235
1359	1	326	254	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/gnaq/102"}}}	1	2016-05-18 20:39:55.479069	2016-05-18 20:39:55.489021
2084	3	78	37	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/43"}}}	1	2016-05-18 21:26:14.599641	2016-05-18 21:26:14.599641
1417	8	59	15	\N	\N	2	\N	2	2016-05-18 20:39:58.716465	2016-05-18 20:39:58.716465
2085	3	79	37	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/43"}}}	1	2016-05-18 21:26:14.626757	2016-05-18 21:26:14.626757
2086	3	80	37	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/43"}}}	1	2016-05-18 21:26:14.643225	2016-05-18 21:26:14.643225
2087	3	81	37	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/43"}}}	1	2016-05-18 21:26:14.658764	2016-05-18 21:26:14.658764
2088	3	44	37	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/43"}}}	1	2016-05-18 21:26:14.674426	2016-05-18 21:26:14.674426
2089	3	82	37	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/43"}}}	1	2016-05-18 21:26:14.690487	2016-05-18 21:26:14.690487
2090	2	74	37	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/kras/43"}}}	1	2016-05-18 21:26:14.707527	2016-05-18 21:26:14.707527
2091	2	75	37	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/kras/43"}}}	1	2016-05-18 21:26:14.725959	2016-05-18 21:26:14.725959
2092	2	76	37	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/kras/43"}}}	1	2016-05-18 21:26:14.750536	2016-05-18 21:26:14.750536
1360	1	306	254	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/gnaq/102"}}}	1	2016-05-18 20:39:55.539912	2016-05-18 20:39:55.551644
1361	1	46	254	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/gnaq/102"}}}	1	2016-05-18 20:39:55.58678	2016-05-18 20:39:55.596758
1362	1	324	254	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/gnaq/102"}}}	1	2016-05-18 20:39:55.643435	2016-05-18 20:39:55.658064
1363	1	305	254	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/gnaq/102"}}}	1	2016-05-18 20:39:55.694994	2016-05-18 20:39:55.705322
1364	1	325	254	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/gnaq/102"}}}	1	2016-05-18 20:39:55.765362	2016-05-18 20:39:55.789337
1365	1	318	254	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/gnaq/102"}}}	1	2016-05-18 20:39:55.834864	2016-05-18 20:39:55.861218
1366	1	319	254	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/gnaq/102"}}}	1	2016-05-18 20:39:55.90693	2016-05-18 20:39:55.922988
1367	1	320	254	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/gnaq/102"}}}	1	2016-05-18 20:39:56.011004	2016-05-18 20:39:56.0269
1368	1	321	254	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/gnaq/102"}}}	1	2016-05-18 20:39:56.065152	2016-05-18 20:39:56.077834
1369	1	322	254	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/gnaq/102"}}}	1	2016-05-18 20:39:56.123975	2016-05-18 20:39:56.137382
1370	1	316	254	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/gnaq/102"}}}	1	2016-05-18 20:39:56.17461	2016-05-18 20:39:56.185406
1371	16	36	255	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/crlf2/199"}}}	1	2016-05-18 20:39:56.255064	2016-05-18 20:39:56.271284
1372	16	317	255	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/crlf2/199"}}}	1	2016-05-18 20:39:56.305813	2016-05-18 20:39:56.317078
1373	16	327	255	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/crlf2/199"}}}	1	2016-05-18 20:39:56.378267	2016-05-18 20:39:56.393602
1374	16	323	255	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/crlf2/199"}}}	1	2016-05-18 20:39:56.436634	2016-05-18 20:39:56.448472
1375	16	46	255	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/crlf2/199"}}}	1	2016-05-18 20:39:56.493013	2016-05-18 20:39:56.522509
1376	16	305	255	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/crlf2/199"}}}	1	2016-05-18 20:39:56.568288	2016-05-18 20:39:56.581468
1377	16	325	255	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/crlf2/199"}}}	1	2016-05-18 20:39:56.624747	2016-05-18 20:39:56.65342
1378	16	318	255	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/crlf2/199"}}}	1	2016-05-18 20:39:56.69913	2016-05-18 20:39:56.713928
1379	16	306	255	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/crlf2/199"}}}	1	2016-05-18 20:39:56.75472	2016-05-18 20:39:56.785892
1380	16	319	255	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/crlf2/199"}}}	1	2016-05-18 20:39:56.821635	2016-05-18 20:39:56.834016
1381	16	320	255	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/crlf2/199"}}}	1	2016-05-18 20:39:56.88028	2016-05-18 20:39:56.893043
1382	16	322	255	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/crlf2/199"}}}	1	2016-05-18 20:39:56.927337	2016-05-18 20:39:56.938028
1383	16	321	255	\N	\N	2	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/crlf2/199"}}}	1	2016-05-18 20:39:56.987349	2016-05-18 20:39:57.0034
1384	8	335	1	\N	\N	2	\N	2	2016-05-18 20:39:57.048781	2016-05-18 20:39:57.048781
1385	8	3	1	\N	\N	2	\N	2	2016-05-18 20:39:57.104011	2016-05-18 20:39:57.104011
1386	8	9	4	\N	\N	2	\N	2	2016-05-18 20:39:57.146609	2016-05-18 20:39:57.146609
1387	8	12	4	\N	\N	2	\N	2	2016-05-18 20:39:57.197491	2016-05-18 20:39:57.197491
1388	8	13	4	\N	\N	2	\N	2	2016-05-18 20:39:57.265422	2016-05-18 20:39:57.265422
1389	8	7	4	\N	\N	2	\N	2	2016-05-18 20:39:57.316962	2016-05-18 20:39:57.316962
1390	8	17	5	\N	\N	2	\N	2	2016-05-18 20:39:57.371873	2016-05-18 20:39:57.371873
1391	8	336	5	\N	\N	2	\N	2	2016-05-18 20:39:57.42855	2016-05-18 20:39:57.42855
1392	8	30	5	\N	\N	2	\N	2	2016-05-18 20:39:57.475386	2016-05-18 20:39:57.475386
1393	8	3	5	\N	\N	2	\N	2	2016-05-18 20:39:57.513996	2016-05-18 20:39:57.513996
1394	8	15	7	\N	\N	2	\N	2	2016-05-18 20:39:57.570102	2016-05-18 20:39:57.570102
1395	8	16	7	\N	\N	2	\N	2	2016-05-18 20:39:57.611248	2016-05-18 20:39:57.611248
1396	8	20	7	\N	\N	2	\N	2	2016-05-18 20:39:57.667973	2016-05-18 20:39:57.667973
2093	2	77	37	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/kras/43"}}}	1	2016-05-18 21:26:14.766399	2016-05-18 21:26:14.766399
2094	2	78	37	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/kras/43"}}}	1	2016-05-18 21:26:14.785134	2016-05-18 21:26:14.785134
2095	2	79	37	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/kras/43"}}}	1	2016-05-18 21:26:14.802731	2016-05-18 21:26:14.802731
2096	2	80	37	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/kras/43"}}}	1	2016-05-18 21:26:14.816657	2016-05-18 21:26:14.816657
2097	2	81	37	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/kras/43"}}}	1	2016-05-18 21:26:14.835636	2016-05-18 21:26:14.835636
2098	2	44	37	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/kras/43"}}}	1	2016-05-18 21:26:14.848654	2016-05-18 21:26:14.848654
2099	2	82	37	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/kras/43"}}}	1	2016-05-18 21:26:14.867284	2016-05-18 21:26:14.867284
3145	8	152	259	\N	\N	3	\N	2	2016-05-18 21:26:44.840603	2016-05-18 21:26:44.840603
3146	8	153	259	\N	\N	3	\N	2	2016-05-18 21:26:44.866842	2016-05-18 21:26:44.866842
1418	8	60	15	\N	\N	2	\N	2	2016-05-18 20:39:58.762281	2016-05-18 20:39:58.762281
1419	8	61	15	\N	\N	2	\N	2	2016-05-18 20:39:58.811558	2016-05-18 20:39:58.811558
1420	8	62	15	\N	\N	2	\N	2	2016-05-18 20:39:58.862451	2016-05-18 20:39:58.862451
1421	8	63	15	\N	\N	2	\N	2	2016-05-18 20:39:58.907465	2016-05-18 20:39:58.907465
1422	8	64	15	\N	\N	2	\N	2	2016-05-18 20:39:58.966541	2016-05-18 20:39:58.966541
1423	8	57	256	\N	\N	2	\N	2	2016-05-18 20:39:59.045358	2016-05-18 20:39:59.045358
1424	8	58	256	\N	\N	2	\N	2	2016-05-18 20:39:59.087293	2016-05-18 20:39:59.087293
1425	8	59	256	\N	\N	2	\N	2	2016-05-18 20:39:59.129191	2016-05-18 20:39:59.129191
1426	8	60	256	\N	\N	2	\N	2	2016-05-18 20:39:59.1868	2016-05-18 20:39:59.1868
1427	8	61	256	\N	\N	2	\N	2	2016-05-18 20:39:59.229023	2016-05-18 20:39:59.229023
1428	8	62	256	\N	\N	2	\N	2	2016-05-18 20:39:59.271785	2016-05-18 20:39:59.271785
1429	8	63	256	\N	\N	2	\N	2	2016-05-18 20:39:59.330175	2016-05-18 20:39:59.330175
1430	8	64	256	\N	\N	2	\N	2	2016-05-18 20:39:59.375171	2016-05-18 20:39:59.375171
1431	8	57	257	\N	\N	2	\N	2	2016-05-18 20:39:59.45633	2016-05-18 20:39:59.45633
1432	8	58	257	\N	\N	2	\N	2	2016-05-18 20:39:59.507761	2016-05-18 20:39:59.507761
1433	8	59	257	\N	\N	2	\N	2	2016-05-18 20:39:59.551531	2016-05-18 20:39:59.551531
1434	8	60	257	\N	\N	2	\N	2	2016-05-18 20:39:59.597929	2016-05-18 20:39:59.597929
1435	8	61	257	\N	\N	2	\N	2	2016-05-18 20:39:59.650022	2016-05-18 20:39:59.650022
1436	8	62	257	\N	\N	2	\N	2	2016-05-18 20:39:59.696705	2016-05-18 20:39:59.696705
1437	8	63	257	\N	\N	2	\N	2	2016-05-18 20:39:59.752162	2016-05-18 20:39:59.752162
1438	8	64	257	\N	\N	2	\N	2	2016-05-18 20:39:59.8075	2016-05-18 20:39:59.8075
1439	8	74	34	\N	\N	2	\N	2	2016-05-18 20:39:59.849285	2016-05-18 20:39:59.849285
1440	8	75	34	\N	\N	2	\N	2	2016-05-18 20:39:59.891225	2016-05-18 20:39:59.891225
1441	8	76	34	\N	\N	2	\N	2	2016-05-18 20:39:59.947616	2016-05-18 20:39:59.947616
1442	8	77	34	\N	\N	2	\N	2	2016-05-18 20:39:59.981479	2016-05-18 20:39:59.981479
1443	8	78	34	\N	\N	2	\N	2	2016-05-18 20:40:00.026023	2016-05-18 20:40:00.026023
1444	8	79	34	\N	\N	2	\N	2	2016-05-18 20:40:00.068	2016-05-18 20:40:00.068
1445	8	80	34	\N	\N	2	\N	2	2016-05-18 20:40:00.105403	2016-05-18 20:40:00.105403
1446	8	81	34	\N	\N	2	\N	2	2016-05-18 20:40:00.161147	2016-05-18 20:40:00.161147
1447	8	44	34	\N	\N	2	\N	2	2016-05-18 20:40:00.22269	2016-05-18 20:40:00.22269
1448	8	82	34	\N	\N	2	\N	2	2016-05-18 20:40:00.272239	2016-05-18 20:40:00.272239
1449	8	74	35	\N	\N	2	\N	2	2016-05-18 20:40:00.311853	2016-05-18 20:40:00.311853
1450	8	75	35	\N	\N	2	\N	2	2016-05-18 20:40:00.364731	2016-05-18 20:40:00.364731
1451	8	76	35	\N	\N	2	\N	2	2016-05-18 20:40:00.41852	2016-05-18 20:40:00.41852
1452	8	77	35	\N	\N	2	\N	2	2016-05-18 20:40:00.4576	2016-05-18 20:40:00.4576
1453	8	78	35	\N	\N	2	\N	2	2016-05-18 20:40:00.534144	2016-05-18 20:40:00.534144
1454	8	79	35	\N	\N	2	\N	2	2016-05-18 20:40:00.57283	2016-05-18 20:40:00.57283
1455	8	80	35	\N	\N	2	\N	2	2016-05-18 20:40:00.626442	2016-05-18 20:40:00.626442
1456	8	81	35	\N	\N	2	\N	2	2016-05-18 20:40:00.666521	2016-05-18 20:40:00.666521
1457	8	44	35	\N	\N	2	\N	2	2016-05-18 20:40:00.704814	2016-05-18 20:40:00.704814
1458	8	82	35	\N	\N	2	\N	2	2016-05-18 20:40:00.745436	2016-05-18 20:40:00.745436
1459	8	337	42	\N	\N	2	\N	2	2016-05-18 20:40:00.792109	2016-05-18 20:40:00.792109
1460	8	36	42	\N	\N	2	\N	2	2016-05-18 20:40:00.838807	2016-05-18 20:40:00.838807
1461	8	305	42	\N	\N	2	\N	2	2016-05-18 20:40:00.880995	2016-05-18 20:40:00.880995
1462	8	306	42	\N	\N	2	\N	2	2016-05-18 20:40:00.930335	2016-05-18 20:40:00.930335
1463	8	338	42	\N	\N	2	\N	2	2016-05-18 20:40:00.970893	2016-05-18 20:40:00.970893
1464	8	46	42	\N	\N	2	\N	2	2016-05-18 20:40:01.010898	2016-05-18 20:40:01.010898
1465	8	90	46	\N	\N	2	\N	2	2016-05-18 20:40:01.062344	2016-05-18 20:40:01.062344
1466	8	91	46	\N	\N	2	\N	2	2016-05-18 20:40:01.103621	2016-05-18 20:40:01.103621
1467	8	92	46	\N	\N	2	\N	2	2016-05-18 20:40:01.144194	2016-05-18 20:40:01.144194
1468	8	159	48	\N	\N	2	\N	2	2016-05-18 20:40:01.201181	2016-05-18 20:40:01.201181
1469	8	115	258	\N	\N	2	\N	2	2016-05-18 20:40:01.255067	2016-05-18 20:40:01.255067
1470	8	116	258	\N	\N	2	\N	2	2016-05-18 20:40:01.291428	2016-05-18 20:40:01.291428
1471	8	117	258	\N	\N	2	\N	2	2016-05-18 20:40:01.334849	2016-05-18 20:40:01.334849
1472	8	12	258	\N	\N	2	\N	2	2016-05-18 20:40:01.374434	2016-05-18 20:40:01.374434
1473	8	118	258	\N	\N	2	\N	2	2016-05-18 20:40:01.416572	2016-05-18 20:40:01.416572
1474	8	120	258	\N	\N	2	\N	2	2016-05-18 20:40:01.463278	2016-05-18 20:40:01.463278
1475	8	121	258	\N	\N	2	\N	2	2016-05-18 20:40:01.50582	2016-05-18 20:40:01.50582
1476	8	122	258	\N	\N	2	\N	2	2016-05-18 20:40:01.562177	2016-05-18 20:40:01.562177
1477	8	123	258	\N	\N	2	\N	2	2016-05-18 20:40:01.60576	2016-05-18 20:40:01.60576
1478	8	111	258	\N	\N	2	\N	2	2016-05-18 20:40:01.643024	2016-05-18 20:40:01.643024
1479	8	112	258	\N	\N	2	\N	2	2016-05-18 20:40:01.696101	2016-05-18 20:40:01.696101
1480	8	124	258	\N	\N	2	\N	2	2016-05-18 20:40:01.737162	2016-05-18 20:40:01.737162
1481	8	125	258	\N	\N	2	\N	2	2016-05-18 20:40:01.775276	2016-05-18 20:40:01.775276
1482	8	150	259	\N	\N	2	\N	2	2016-05-18 20:40:01.835512	2016-05-18 20:40:01.835512
1483	8	151	259	\N	\N	2	\N	2	2016-05-18 20:40:01.87124	2016-05-18 20:40:01.87124
1484	8	152	259	\N	\N	2	\N	2	2016-05-18 20:40:01.906642	2016-05-18 20:40:01.906642
1485	8	153	259	\N	\N	2	\N	2	2016-05-18 20:40:01.941837	2016-05-18 20:40:01.941837
1486	8	154	259	\N	\N	2	\N	2	2016-05-18 20:40:01.98025	2016-05-18 20:40:01.98025
1487	8	150	260	\N	\N	2	\N	2	2016-05-18 20:40:02.043603	2016-05-18 20:40:02.043603
1488	8	151	260	\N	\N	2	\N	2	2016-05-18 20:40:02.07924	2016-05-18 20:40:02.07924
1489	8	152	260	\N	\N	2	\N	2	2016-05-18 20:40:02.120713	2016-05-18 20:40:02.120713
1490	8	153	260	\N	\N	2	\N	2	2016-05-18 20:40:02.166018	2016-05-18 20:40:02.166018
1491	8	154	260	\N	\N	2	\N	2	2016-05-18 20:40:02.204365	2016-05-18 20:40:02.204365
1492	8	123	261	\N	\N	2	\N	2	2016-05-18 20:40:02.265897	2016-05-18 20:40:02.265897
1493	8	123	262	\N	\N	2	\N	2	2016-05-18 20:40:02.319	2016-05-18 20:40:02.319
1494	8	123	263	\N	\N	2	\N	2	2016-05-18 20:40:02.373909	2016-05-18 20:40:02.373909
1495	8	123	264	\N	\N	2	\N	2	2016-05-18 20:40:02.428847	2016-05-18 20:40:02.428847
1496	8	123	265	\N	\N	2	\N	2	2016-05-18 20:40:02.483636	2016-05-18 20:40:02.483636
1497	8	123	266	\N	\N	2	\N	2	2016-05-18 20:40:02.53529	2016-05-18 20:40:02.53529
1498	8	339	267	\N	\N	2	\N	2	2016-05-18 20:40:02.5942	2016-05-18 20:40:02.5942
1499	8	339	268	\N	\N	2	\N	2	2016-05-18 20:40:02.648797	2016-05-18 20:40:02.648797
1500	8	339	269	\N	\N	2	\N	2	2016-05-18 20:40:02.692921	2016-05-18 20:40:02.692921
1501	8	177	270	\N	\N	2	\N	2	2016-05-18 20:40:02.750376	2016-05-18 20:40:02.750376
1502	8	186	270	\N	\N	2	\N	2	2016-05-18 20:40:02.787787	2016-05-18 20:40:02.787787
1503	8	3	270	\N	\N	2	\N	2	2016-05-18 20:40:02.823798	2016-05-18 20:40:02.823798
1504	8	175	271	\N	\N	2	\N	2	2016-05-18 20:40:02.873798	2016-05-18 20:40:02.873798
1505	8	177	271	\N	\N	2	\N	2	2016-05-18 20:40:02.912522	2016-05-18 20:40:02.912522
1506	8	179	271	\N	\N	2	\N	2	2016-05-18 20:40:02.947845	2016-05-18 20:40:02.947845
1507	8	3	271	\N	\N	2	\N	2	2016-05-18 20:40:02.987091	2016-05-18 20:40:02.987091
1508	8	172	272	\N	\N	2	\N	2	2016-05-18 20:40:03.032188	2016-05-18 20:40:03.032188
1509	8	173	272	\N	\N	2	\N	2	2016-05-18 20:40:03.072806	2016-05-18 20:40:03.072806
1510	8	183	272	\N	\N	2	\N	2	2016-05-18 20:40:03.110502	2016-05-18 20:40:03.110502
1511	8	175	272	\N	\N	2	\N	2	2016-05-18 20:40:03.148032	2016-05-18 20:40:03.148032
1512	8	340	272	\N	\N	2	\N	2	2016-05-18 20:40:03.191756	2016-05-18 20:40:03.191756
1513	8	341	272	\N	\N	2	\N	2	2016-05-18 20:40:03.227046	2016-05-18 20:40:03.227046
1514	8	342	272	\N	\N	2	\N	2	2016-05-18 20:40:03.271303	2016-05-18 20:40:03.271303
1515	8	186	272	\N	\N	2	\N	2	2016-05-18 20:40:03.308426	2016-05-18 20:40:03.308426
1516	8	188	272	\N	\N	2	\N	2	2016-05-18 20:40:03.36355	2016-05-18 20:40:03.36355
1517	8	343	272	\N	\N	2	\N	2	2016-05-18 20:40:03.399737	2016-05-18 20:40:03.399737
1518	8	179	272	\N	\N	2	\N	2	2016-05-18 20:40:03.437175	2016-05-18 20:40:03.437175
1519	8	184	272	\N	\N	2	\N	2	2016-05-18 20:40:03.472333	2016-05-18 20:40:03.472333
1520	8	344	272	\N	\N	2	\N	2	2016-05-18 20:40:03.507971	2016-05-18 20:40:03.507971
1521	8	345	272	\N	\N	2	\N	2	2016-05-18 20:40:03.544882	2016-05-18 20:40:03.544882
1522	8	3	272	\N	\N	2	\N	2	2016-05-18 20:40:03.592249	2016-05-18 20:40:03.592249
1523	8	346	273	\N	\N	2	\N	2	2016-05-18 20:40:03.643133	2016-05-18 20:40:03.643133
1524	8	347	273	\N	\N	2	\N	2	2016-05-18 20:40:03.682302	2016-05-18 20:40:03.682302
1525	8	348	273	\N	\N	2	\N	2	2016-05-18 20:40:03.741879	2016-05-18 20:40:03.741879
1526	8	349	273	\N	\N	2	\N	2	2016-05-18 20:40:03.784886	2016-05-18 20:40:03.784886
1527	8	189	273	\N	\N	2	\N	2	2016-05-18 20:40:03.836048	2016-05-18 20:40:03.836048
1528	8	350	273	\N	\N	2	\N	2	2016-05-18 20:40:03.878551	2016-05-18 20:40:03.878551
1529	8	188	273	\N	\N	2	\N	2	2016-05-18 20:40:03.919739	2016-05-18 20:40:03.919739
1530	8	177	273	\N	\N	2	\N	2	2016-05-18 20:40:03.972197	2016-05-18 20:40:03.972197
1531	8	184	273	\N	\N	2	\N	2	2016-05-18 20:40:04.012705	2016-05-18 20:40:04.012705
1532	8	179	273	\N	\N	2	\N	2	2016-05-18 20:40:04.067027	2016-05-18 20:40:04.067027
1533	8	335	273	\N	\N	2	\N	2	2016-05-18 20:40:04.110272	2016-05-18 20:40:04.110272
1534	8	2	273	\N	\N	2	\N	2	2016-05-18 20:40:04.168934	2016-05-18 20:40:04.168934
1535	8	172	273	\N	\N	2	\N	2	2016-05-18 20:40:04.21102	2016-05-18 20:40:04.21102
1536	8	351	273	\N	\N	2	\N	2	2016-05-18 20:40:04.249326	2016-05-18 20:40:04.249326
1537	8	352	273	\N	\N	2	\N	2	2016-05-18 20:40:04.299245	2016-05-18 20:40:04.299245
1538	8	353	273	\N	\N	2	\N	2	2016-05-18 20:40:04.341002	2016-05-18 20:40:04.341002
1539	8	3	273	\N	\N	2	\N	2	2016-05-18 20:40:04.383879	2016-05-18 20:40:04.383879
1540	8	172	274	\N	\N	2	\N	2	2016-05-18 20:40:04.434702	2016-05-18 20:40:04.434702
1541	8	188	274	\N	\N	2	\N	2	2016-05-18 20:40:04.472849	2016-05-18 20:40:04.472849
1542	8	177	274	\N	\N	2	\N	2	2016-05-18 20:40:04.51863	2016-05-18 20:40:04.51863
1543	8	179	274	\N	\N	2	\N	2	2016-05-18 20:40:04.58573	2016-05-18 20:40:04.58573
1544	8	2	274	\N	\N	2	\N	2	2016-05-18 20:40:04.636326	2016-05-18 20:40:04.636326
1545	8	354	274	\N	\N	2	\N	2	2016-05-18 20:40:04.703083	2016-05-18 20:40:04.703083
1546	8	347	274	\N	\N	2	\N	2	2016-05-18 20:40:04.759711	2016-05-18 20:40:04.759711
1547	8	355	274	\N	\N	2	\N	2	2016-05-18 20:40:04.807788	2016-05-18 20:40:04.807788
1548	8	356	274	\N	\N	2	\N	2	2016-05-18 20:40:04.85263	2016-05-18 20:40:04.85263
1549	8	3	274	\N	\N	2	\N	2	2016-05-18 20:40:04.889655	2016-05-18 20:40:04.889655
1550	8	173	275	\N	\N	2	\N	2	2016-05-18 20:40:04.951009	2016-05-18 20:40:04.951009
1551	8	188	275	\N	\N	2	\N	2	2016-05-18 20:40:04.988098	2016-05-18 20:40:04.988098
1552	8	344	275	\N	\N	2	\N	2	2016-05-18 20:40:05.027305	2016-05-18 20:40:05.027305
1553	8	357	275	\N	\N	2	\N	2	2016-05-18 20:40:05.068356	2016-05-18 20:40:05.068356
1554	8	3	275	\N	\N	2	\N	2	2016-05-18 20:40:05.112113	2016-05-18 20:40:05.112113
1555	8	358	276	\N	\N	2	\N	2	2016-05-18 20:40:05.180521	2016-05-18 20:40:05.180521
1556	8	359	276	\N	\N	2	\N	2	2016-05-18 20:40:05.239588	2016-05-18 20:40:05.239588
1557	8	185	276	\N	\N	2	\N	2	2016-05-18 20:40:05.297758	2016-05-18 20:40:05.297758
1558	8	360	276	\N	\N	2	\N	2	2016-05-18 20:40:05.350526	2016-05-18 20:40:05.350526
1559	8	361	276	\N	\N	2	\N	2	2016-05-18 20:40:05.423655	2016-05-18 20:40:05.423655
1560	8	173	276	\N	\N	2	\N	2	2016-05-18 20:40:05.482405	2016-05-18 20:40:05.482405
1561	8	362	276	\N	\N	2	\N	2	2016-05-18 20:40:05.53077	2016-05-18 20:40:05.53077
1562	8	363	276	\N	\N	2	\N	2	2016-05-18 20:40:05.61446	2016-05-18 20:40:05.61446
1563	8	175	276	\N	\N	2	\N	2	2016-05-18 20:40:05.670846	2016-05-18 20:40:05.670846
1564	8	172	276	\N	\N	2	\N	2	2016-05-18 20:40:05.726525	2016-05-18 20:40:05.726525
1565	8	188	276	\N	\N	2	\N	2	2016-05-18 20:40:05.798575	2016-05-18 20:40:05.798575
1566	8	177	276	\N	\N	2	\N	2	2016-05-18 20:40:05.841671	2016-05-18 20:40:05.841671
1567	8	179	276	\N	\N	2	\N	2	2016-05-18 20:40:05.879669	2016-05-18 20:40:05.879669
1568	8	2	276	\N	\N	2	\N	2	2016-05-18 20:40:05.925519	2016-05-18 20:40:05.925519
1569	8	347	276	\N	\N	2	\N	2	2016-05-18 20:40:05.969488	2016-05-18 20:40:05.969488
1570	8	184	276	\N	\N	2	\N	2	2016-05-18 20:40:06.011318	2016-05-18 20:40:06.011318
1571	8	364	276	\N	\N	2	\N	2	2016-05-18 20:40:06.066783	2016-05-18 20:40:06.066783
1572	8	350	276	\N	\N	2	\N	2	2016-05-18 20:40:06.111855	2016-05-18 20:40:06.111855
1573	8	365	276	\N	\N	2	\N	2	2016-05-18 20:40:06.171186	2016-05-18 20:40:06.171186
1574	8	3	276	\N	\N	2	\N	2	2016-05-18 20:40:06.210566	2016-05-18 20:40:06.210566
1575	8	173	277	\N	\N	2	\N	2	2016-05-18 20:40:06.272719	2016-05-18 20:40:06.272719
1576	8	193	277	\N	\N	2	\N	2	2016-05-18 20:40:06.312082	2016-05-18 20:40:06.312082
1577	8	366	277	\N	\N	2	\N	2	2016-05-18 20:40:06.350627	2016-05-18 20:40:06.350627
1578	8	367	277	\N	\N	2	\N	2	2016-05-18 20:40:06.385689	2016-05-18 20:40:06.385689
1579	8	177	277	\N	\N	2	\N	2	2016-05-18 20:40:06.43406	2016-05-18 20:40:06.43406
1580	8	175	277	\N	\N	2	\N	2	2016-05-18 20:40:06.471522	2016-05-18 20:40:06.471522
1581	8	3	277	\N	\N	2	\N	2	2016-05-18 20:40:06.510763	2016-05-18 20:40:06.510763
1582	8	172	278	\N	\N	2	\N	2	2016-05-18 20:40:06.564765	2016-05-18 20:40:06.564765
1583	8	368	278	\N	\N	2	\N	2	2016-05-18 20:40:06.617059	2016-05-18 20:40:06.617059
1584	8	193	278	\N	\N	2	\N	2	2016-05-18 20:40:06.68513	2016-05-18 20:40:06.68513
1585	8	175	278	\N	\N	2	\N	2	2016-05-18 20:40:06.744813	2016-05-18 20:40:06.744813
1586	8	177	278	\N	\N	2	\N	2	2016-05-18 20:40:06.794313	2016-05-18 20:40:06.794313
1587	8	184	278	\N	\N	2	\N	2	2016-05-18 20:40:06.863614	2016-05-18 20:40:06.863614
1588	8	3	278	\N	\N	2	\N	2	2016-05-18 20:40:06.930632	2016-05-18 20:40:06.930632
1589	8	172	279	\N	\N	2	\N	2	2016-05-18 20:40:07.032863	2016-05-18 20:40:07.032863
1590	8	359	279	\N	\N	2	\N	2	2016-05-18 20:40:07.097323	2016-05-18 20:40:07.097323
1591	8	188	279	\N	\N	2	\N	2	2016-05-18 20:40:07.155403	2016-05-18 20:40:07.155403
1592	8	177	279	\N	\N	2	\N	2	2016-05-18 20:40:07.211958	2016-05-18 20:40:07.211958
1593	8	184	279	\N	\N	2	\N	2	2016-05-18 20:40:07.269042	2016-05-18 20:40:07.269042
1594	8	179	279	\N	\N	2	\N	2	2016-05-18 20:40:07.3111	2016-05-18 20:40:07.3111
1595	8	364	279	\N	\N	2	\N	2	2016-05-18 20:40:07.366749	2016-05-18 20:40:07.366749
1596	8	191	279	\N	\N	2	\N	2	2016-05-18 20:40:07.410055	2016-05-18 20:40:07.410055
1597	8	369	279	\N	\N	2	\N	2	2016-05-18 20:40:07.451901	2016-05-18 20:40:07.451901
1598	8	370	279	\N	\N	2	\N	2	2016-05-18 20:40:07.511426	2016-05-18 20:40:07.511426
1599	8	371	279	\N	\N	2	\N	2	2016-05-18 20:40:07.550204	2016-05-18 20:40:07.550204
1600	8	372	279	\N	\N	2	\N	2	2016-05-18 20:40:07.604041	2016-05-18 20:40:07.604041
1601	8	342	279	\N	\N	2	\N	2	2016-05-18 20:40:07.644824	2016-05-18 20:40:07.644824
1602	8	373	279	\N	\N	2	\N	2	2016-05-18 20:40:07.692822	2016-05-18 20:40:07.692822
1603	8	3	279	\N	\N	2	\N	2	2016-05-18 20:40:07.760418	2016-05-18 20:40:07.760418
1604	8	172	280	\N	\N	2	\N	2	2016-05-18 20:40:07.842148	2016-05-18 20:40:07.842148
1605	8	177	280	\N	\N	2	\N	2	2016-05-18 20:40:07.896542	2016-05-18 20:40:07.896542
1606	8	179	280	\N	\N	2	\N	2	2016-05-18 20:40:07.961485	2016-05-18 20:40:07.961485
1607	8	344	280	\N	\N	2	\N	2	2016-05-18 20:40:08.028159	2016-05-18 20:40:08.028159
1608	8	374	280	\N	\N	2	\N	2	2016-05-18 20:40:08.079792	2016-05-18 20:40:08.079792
1609	8	375	280	\N	\N	2	\N	2	2016-05-18 20:40:08.129503	2016-05-18 20:40:08.129503
1610	8	372	280	\N	\N	2	\N	2	2016-05-18 20:40:08.182979	2016-05-18 20:40:08.182979
1611	8	3	280	\N	\N	2	\N	2	2016-05-18 20:40:08.228199	2016-05-18 20:40:08.228199
1612	8	279	281	\N	\N	2	\N	2	2016-05-18 20:40:08.295144	2016-05-18 20:40:08.295144
1613	8	287	281	\N	\N	2	\N	2	2016-05-18 20:40:08.354031	2016-05-18 20:40:08.354031
1614	8	376	281	\N	\N	2	\N	2	2016-05-18 20:40:08.396311	2016-05-18 20:40:08.396311
1615	8	377	282	\N	\N	2	\N	2	2016-05-18 20:40:08.477776	2016-05-18 20:40:08.477776
1616	8	285	283	\N	\N	2	\N	2	2016-05-18 20:40:08.545702	2016-05-18 20:40:08.545702
1617	8	378	284	\N	\N	2	\N	2	2016-05-18 20:40:08.618192	2016-05-18 20:40:08.618192
1618	8	279	284	\N	\N	2	\N	2	2016-05-18 20:40:08.674799	2016-05-18 20:40:08.674799
1619	8	379	284	\N	\N	2	\N	2	2016-05-18 20:40:08.734376	2016-05-18 20:40:08.734376
1620	8	380	285	\N	\N	2	\N	2	2016-05-18 20:40:08.80761	2016-05-18 20:40:08.80761
1621	2	381	286	\N	\N	2	\N	3	2016-05-18 20:40:08.870795	2016-05-18 20:40:08.870795
1622	2	382	286	\N	\N	2	\N	3	2016-05-18 20:40:08.926104	2016-05-18 20:40:08.926104
1623	2	383	286	\N	\N	2	\N	3	2016-05-18 20:40:08.99105	2016-05-18 20:40:08.99105
1624	2	384	286	\N	\N	2	\N	3	2016-05-18 20:40:09.056657	2016-05-18 20:40:09.056657
1625	8	156	287	\N	\N	2	\N	3	2016-05-18 20:40:09.11662	2016-05-18 20:40:09.11662
1626	8	157	287	\N	\N	2	\N	3	2016-05-18 20:40:09.169206	2016-05-18 20:40:09.169206
1627	8	158	287	\N	\N	2	\N	3	2016-05-18 20:40:09.225635	2016-05-18 20:40:09.225635
1628	8	156	288	\N	\N	2	\N	3	2016-05-18 20:40:09.277774	2016-05-18 20:40:09.277774
1629	8	385	288	\N	\N	2	\N	3	2016-05-18 20:40:09.315693	2016-05-18 20:40:09.315693
1630	8	156	289	\N	\N	2	\N	3	2016-05-18 20:40:09.379909	2016-05-18 20:40:09.379909
1631	8	385	289	\N	\N	2	\N	3	2016-05-18 20:40:09.420397	2016-05-18 20:40:09.420397
1632	8	339	290	\N	\N	2	\N	3	2016-05-18 20:40:09.482416	2016-05-18 20:40:09.482416
1633	8	339	291	\N	\N	2	\N	3	2016-05-18 20:40:09.546704	2016-05-18 20:40:09.546704
1634	8	339	292	\N	\N	2	\N	3	2016-05-18 20:40:09.597439	2016-05-18 20:40:09.597439
1635	8	339	293	\N	\N	2	\N	3	2016-05-18 20:40:09.644409	2016-05-18 20:40:09.644409
1636	8	339	294	\N	\N	2	\N	3	2016-05-18 20:40:09.704246	2016-05-18 20:40:09.704246
1637	8	339	295	\N	\N	2	\N	3	2016-05-18 20:40:09.750744	2016-05-18 20:40:09.750744
1638	8	339	296	\N	\N	2	\N	3	2016-05-18 20:40:09.8176	2016-05-18 20:40:09.8176
1639	1	255	168	\N	\N	2	\N	3	2016-05-18 20:40:09.859517	2016-05-18 20:40:09.859517
1640	1	256	168	\N	\N	2	\N	3	2016-05-18 20:40:09.923214	2016-05-18 20:40:09.923214
1641	1	262	297	\N	\N	2	\N	3	2016-05-18 20:40:09.993943	2016-05-18 20:40:09.993943
1642	1	74	297	\N	\N	2	\N	3	2016-05-18 20:40:10.048343	2016-05-18 20:40:10.048343
1643	1	75	297	\N	\N	2	\N	3	2016-05-18 20:40:10.088048	2016-05-18 20:40:10.088048
1644	1	76	297	\N	\N	2	\N	3	2016-05-18 20:40:10.127703	2016-05-18 20:40:10.127703
1645	1	77	297	\N	\N	2	\N	3	2016-05-18 20:40:10.159204	2016-05-18 20:40:10.159204
1646	1	78	297	\N	\N	2	\N	3	2016-05-18 20:40:10.193899	2016-05-18 20:40:10.193899
1647	1	79	297	\N	\N	2	\N	3	2016-05-18 20:40:10.225064	2016-05-18 20:40:10.225064
1648	1	263	297	\N	\N	2	\N	3	2016-05-18 20:40:10.259059	2016-05-18 20:40:10.259059
1649	1	264	297	\N	\N	2	\N	3	2016-05-18 20:40:10.290493	2016-05-18 20:40:10.290493
1650	1	265	297	\N	\N	2	\N	3	2016-05-18 20:40:10.325331	2016-05-18 20:40:10.325331
1651	1	234	297	\N	\N	2	\N	3	2016-05-18 20:40:10.356076	2016-05-18 20:40:10.356076
1652	8	273	197	\N	\N	2	\N	3	2016-05-18 20:40:10.392181	2016-05-18 20:40:10.392181
1653	1	273	198	\N	\N	2	\N	3	2016-05-18 20:40:10.425816	2016-05-18 20:40:10.425816
1654	11	229	198	\N	\N	2	\N	3	2016-05-18 20:40:10.461633	2016-05-18 20:40:10.461633
1655	11	230	198	\N	\N	2	\N	3	2016-05-18 20:40:10.497941	2016-05-18 20:40:10.497941
1656	11	229	200	\N	\N	2	\N	3	2016-05-18 20:40:10.528431	2016-05-18 20:40:10.528431
1657	11	230	200	\N	\N	2	\N	3	2016-05-18 20:40:10.565793	2016-05-18 20:40:10.565793
1658	1	304	298	\N	\N	2	\N	3	2016-05-18 20:40:10.614902	2016-05-18 20:40:10.614902
1659	1	307	298	\N	\N	2	\N	3	2016-05-18 20:40:10.653306	2016-05-18 20:40:10.653306
1660	1	304	299	\N	\N	2	\N	3	2016-05-18 20:40:10.706857	2016-05-18 20:40:10.706857
1661	1	307	299	\N	\N	2	\N	3	2016-05-18 20:40:10.742495	2016-05-18 20:40:10.742495
2100	4	74	37	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/43"}}}	1	2016-05-18 21:26:14.885085	2016-05-18 21:26:14.885085
2101	4	75	37	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/43"}}}	1	2016-05-18 21:26:14.905483	2016-05-18 21:26:14.905483
2102	4	76	37	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/43"}}}	1	2016-05-18 21:26:14.919943	2016-05-18 21:26:14.919943
2103	4	77	37	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/43"}}}	1	2016-05-18 21:26:14.93829	2016-05-18 21:26:14.93829
2104	4	78	37	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/43"}}}	1	2016-05-18 21:26:14.953821	2016-05-18 21:26:14.953821
2105	4	79	37	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/43"}}}	1	2016-05-18 21:26:14.97194	2016-05-18 21:26:14.97194
2106	4	80	37	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/43"}}}	1	2016-05-18 21:26:14.986203	2016-05-18 21:26:14.986203
2107	4	81	37	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/43"}}}	1	2016-05-18 21:26:15.005397	2016-05-18 21:26:15.005397
2108	4	44	37	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/43"}}}	1	2016-05-18 21:26:15.026365	2016-05-18 21:26:15.026365
2109	4	82	37	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/43"}}}	1	2016-05-18 21:26:15.045568	2016-05-18 21:26:15.045568
2110	3	74	38	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/308"}}}	1	2016-05-18 21:26:15.064079	2016-05-18 21:26:15.064079
2111	3	75	38	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/308"}}}	1	2016-05-18 21:26:15.0812	2016-05-18 21:26:15.0812
2112	3	76	38	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/308"}}}	1	2016-05-18 21:26:15.098638	2016-05-18 21:26:15.098638
2113	3	77	38	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/308"}}}	1	2016-05-18 21:26:15.11316	2016-05-18 21:26:15.11316
2114	3	78	38	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/308"}}}	1	2016-05-18 21:26:15.129209	2016-05-18 21:26:15.129209
2115	3	79	38	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/308"}}}	1	2016-05-18 21:26:15.146008	2016-05-18 21:26:15.146008
2116	3	80	38	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/308"}}}	1	2016-05-18 21:26:15.166311	2016-05-18 21:26:15.166311
2117	3	81	38	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/308"}}}	1	2016-05-18 21:26:15.188745	2016-05-18 21:26:15.188745
2118	3	44	38	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/308"}}}	1	2016-05-18 21:26:15.207732	2016-05-18 21:26:15.207732
2119	3	82	38	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/308"}}}	1	2016-05-18 21:26:15.224332	2016-05-18 21:26:15.224332
2120	3	74	39	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/41"}}}	1	2016-05-18 21:26:15.242776	2016-05-18 21:26:15.242776
2121	3	75	39	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/41"}}}	1	2016-05-18 21:26:15.260595	2016-05-18 21:26:15.260595
2122	3	76	39	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/41"}}}	1	2016-05-18 21:26:15.276578	2016-05-18 21:26:15.276578
2123	3	77	39	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/41"}}}	1	2016-05-18 21:26:15.292248	2016-05-18 21:26:15.292248
2124	3	78	39	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/41"}}}	1	2016-05-18 21:26:15.314869	2016-05-18 21:26:15.314869
2125	3	79	39	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/41"}}}	1	2016-05-18 21:26:15.332678	2016-05-18 21:26:15.332678
3147	8	154	259	\N	\N	3	\N	2	2016-05-18 21:26:44.881043	2016-05-18 21:26:44.881043
3148	8	150	260	\N	\N	3	\N	2	2016-05-18 21:26:44.894	2016-05-18 21:26:44.894
2126	3	80	39	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/41"}}}	1	2016-05-18 21:26:15.350476	2016-05-18 21:26:15.350476
2127	3	81	39	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/41"}}}	1	2016-05-18 21:26:15.370784	2016-05-18 21:26:15.370784
2128	3	44	39	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/41"}}}	1	2016-05-18 21:26:15.394019	2016-05-18 21:26:15.394019
2129	3	82	39	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/41"}}}	1	2016-05-18 21:26:15.409924	2016-05-18 21:26:15.409924
2130	2	83	39	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/kras/41"}}}	1	2016-05-18 21:26:15.423904	2016-05-18 21:26:15.423904
2131	2	84	39	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/kras/41"}}}	1	2016-05-18 21:26:15.444059	2016-05-18 21:26:15.444059
2132	2	85	39	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/kras/41"}}}	1	2016-05-18 21:26:15.46469	2016-05-18 21:26:15.46469
2133	2	86	39	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/kras/41"}}}	1	2016-05-18 21:26:15.485216	2016-05-18 21:26:15.485216
2134	2	87	39	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/kras/41"}}}	1	2016-05-18 21:26:15.504962	2016-05-18 21:26:15.504962
2135	2	88	39	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/kras/41"}}}	1	2016-05-18 21:26:15.519159	2016-05-18 21:26:15.519159
2136	2	89	39	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/kras/41"}}}	1	2016-05-18 21:26:15.540124	2016-05-18 21:26:15.540124
2137	4	83	39	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/41"}}}	1	2016-05-18 21:26:15.556262	2016-05-18 21:26:15.556262
2138	4	84	39	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/41"}}}	1	2016-05-18 21:26:15.573272	2016-05-18 21:26:15.573272
2139	4	85	39	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/41"}}}	1	2016-05-18 21:26:15.591581	2016-05-18 21:26:15.591581
2140	4	86	39	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/41"}}}	1	2016-05-18 21:26:15.608781	2016-05-18 21:26:15.608781
2141	4	87	39	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/41"}}}	1	2016-05-18 21:26:15.625418	2016-05-18 21:26:15.625418
2142	4	88	39	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/41"}}}	1	2016-05-18 21:26:15.645439	2016-05-18 21:26:15.645439
2143	4	89	39	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/41"}}}	1	2016-05-18 21:26:15.661703	2016-05-18 21:26:15.661703
2144	4	83	40	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/159"}}}	1	2016-05-18 21:26:15.677174	2016-05-18 21:26:15.677174
2145	4	84	40	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/159"}}}	1	2016-05-18 21:26:15.6934	2016-05-18 21:26:15.6934
2146	4	85	40	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/159"}}}	1	2016-05-18 21:26:15.709499	2016-05-18 21:26:15.709499
2147	4	86	40	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/159"}}}	1	2016-05-18 21:26:15.73616	2016-05-18 21:26:15.73616
2148	4	87	40	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/159"}}}	1	2016-05-18 21:26:15.755389	2016-05-18 21:26:15.755389
2149	4	88	40	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/159"}}}	1	2016-05-18 21:26:15.767516	2016-05-18 21:26:15.767516
2150	4	89	40	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/159"}}}	1	2016-05-18 21:26:15.781636	2016-05-18 21:26:15.781636
2151	2	83	41	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/kras/68"}}}	1	2016-05-18 21:26:15.7945	2016-05-18 21:26:15.7945
2152	2	84	41	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/kras/68"}}}	1	2016-05-18 21:26:15.806399	2016-05-18 21:26:15.806399
2153	2	85	41	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/kras/68"}}}	1	2016-05-18 21:26:15.822619	2016-05-18 21:26:15.822619
2154	2	86	41	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/kras/68"}}}	1	2016-05-18 21:26:15.837154	2016-05-18 21:26:15.837154
2155	2	87	41	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/kras/68"}}}	1	2016-05-18 21:26:15.849233	2016-05-18 21:26:15.849233
2156	2	88	41	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/kras/68"}}}	1	2016-05-18 21:26:15.868059	2016-05-18 21:26:15.868059
2157	2	89	41	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/kras/68"}}}	1	2016-05-18 21:26:15.886988	2016-05-18 21:26:15.886988
2158	4	83	41	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/68"}}}	1	2016-05-18 21:26:15.904696	2016-05-18 21:26:15.904696
2159	4	84	41	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/68"}}}	1	2016-05-18 21:26:15.92258	2016-05-18 21:26:15.92258
2160	4	85	41	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/68"}}}	1	2016-05-18 21:26:15.937135	2016-05-18 21:26:15.937135
2161	4	86	41	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/68"}}}	1	2016-05-18 21:26:15.952792	2016-05-18 21:26:15.952792
2162	4	87	41	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/68"}}}	1	2016-05-18 21:26:15.970056	2016-05-18 21:26:15.970056
3081	8	62	15	\N	\N	3	\N	2	2016-05-18 21:26:43.780299	2016-05-18 21:26:43.780299
2163	4	88	41	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/68"}}}	1	2016-05-18 21:26:15.98508	2016-05-18 21:26:15.98508
2164	4	89	41	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/68"}}}	1	2016-05-18 21:26:16.008175	2016-05-18 21:26:16.008175
2165	3	83	42	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/39"}}}	1	2016-05-18 21:26:16.031659	2016-05-18 21:26:16.031659
2166	3	84	42	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/39"}}}	1	2016-05-18 21:26:16.048707	2016-05-18 21:26:16.048707
2167	3	85	42	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/39"}}}	1	2016-05-18 21:26:16.066228	2016-05-18 21:26:16.066228
2168	3	86	42	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/39"}}}	1	2016-05-18 21:26:16.081347	2016-05-18 21:26:16.081347
2169	3	87	42	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/39"}}}	1	2016-05-18 21:26:16.097949	2016-05-18 21:26:16.097949
2170	3	88	42	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/39"}}}	1	2016-05-18 21:26:16.114464	2016-05-18 21:26:16.114464
2171	3	89	42	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/39"}}}	1	2016-05-18 21:26:16.131712	2016-05-18 21:26:16.131712
2172	6	83	42	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/ovarian-cancer/kras/39"}}}	1	2016-05-18 21:26:16.150528	2016-05-18 21:26:16.150528
2173	6	84	42	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/ovarian-cancer/kras/39"}}}	1	2016-05-18 21:26:16.173149	2016-05-18 21:26:16.173149
2174	6	85	42	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/ovarian-cancer/kras/39"}}}	1	2016-05-18 21:26:16.204057	2016-05-18 21:26:16.204057
2175	6	86	42	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/ovarian-cancer/kras/39"}}}	1	2016-05-18 21:26:16.21824	2016-05-18 21:26:16.21824
2176	6	87	42	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/ovarian-cancer/kras/39"}}}	1	2016-05-18 21:26:16.234216	2016-05-18 21:26:16.234216
2177	6	88	42	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/ovarian-cancer/kras/39"}}}	1	2016-05-18 21:26:16.249822	2016-05-18 21:26:16.249822
2178	6	89	42	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/ovarian-cancer/kras/39"}}}	1	2016-05-18 21:26:16.26558	2016-05-18 21:26:16.26558
2179	2	83	42	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/kras/39"}}}	1	2016-05-18 21:26:16.283425	2016-05-18 21:26:16.283425
2180	2	84	42	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/kras/39"}}}	1	2016-05-18 21:26:16.298994	2016-05-18 21:26:16.298994
2181	2	85	42	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/kras/39"}}}	1	2016-05-18 21:26:16.319588	2016-05-18 21:26:16.319588
2182	2	86	42	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/kras/39"}}}	1	2016-05-18 21:26:16.340974	2016-05-18 21:26:16.340974
2183	2	87	42	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/kras/39"}}}	1	2016-05-18 21:26:16.361003	2016-05-18 21:26:16.361003
2184	2	88	42	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/kras/39"}}}	1	2016-05-18 21:26:16.376408	2016-05-18 21:26:16.376408
2185	2	89	42	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/kras/39"}}}	1	2016-05-18 21:26:16.3916	2016-05-18 21:26:16.3916
2186	4	90	42	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/39"}}}	1	2016-05-18 21:26:16.405382	2016-05-18 21:26:16.405382
2187	4	91	42	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/39"}}}	1	2016-05-18 21:26:16.418144	2016-05-18 21:26:16.418144
2188	4	92	42	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/39"}}}	1	2016-05-18 21:26:16.433399	2016-05-18 21:26:16.433399
2189	2	90	43	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/kras/38"}}}	1	2016-05-18 21:26:16.447241	2016-05-18 21:26:16.447241
2190	2	91	43	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/kras/38"}}}	1	2016-05-18 21:26:16.468241	2016-05-18 21:26:16.468241
2191	2	92	43	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/kras/38"}}}	1	2016-05-18 21:26:16.487687	2016-05-18 21:26:16.487687
2192	4	90	43	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/38"}}}	1	2016-05-18 21:26:16.510697	2016-05-18 21:26:16.510697
2193	4	91	43	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/38"}}}	1	2016-05-18 21:26:16.526523	2016-05-18 21:26:16.526523
2194	4	92	43	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/38"}}}	1	2016-05-18 21:26:16.544393	2016-05-18 21:26:16.544393
2195	3	90	44	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/40"}}}	1	2016-05-18 21:26:16.564365	2016-05-18 21:26:16.564365
2196	3	91	44	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/40"}}}	1	2016-05-18 21:26:16.579866	2016-05-18 21:26:16.579866
2197	3	92	44	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/40"}}}	1	2016-05-18 21:26:16.597179	2016-05-18 21:26:16.597179
2198	2	93	44	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/kras/40"}}}	1	2016-05-18 21:26:16.629284	2016-05-18 21:26:16.629284
2199	4	94	44	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/40"}}}	1	2016-05-18 21:26:16.660356	2016-05-18 21:26:16.660356
3082	8	63	15	\N	\N	3	\N	2	2016-05-18 21:26:43.799099	2016-05-18 21:26:43.799099
2200	3	90	45	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/69"}}}	1	2016-05-18 21:26:16.681848	2016-05-18 21:26:16.681848
2201	3	91	45	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/69"}}}	1	2016-05-18 21:26:16.700343	2016-05-18 21:26:16.700343
2202	3	92	45	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/69"}}}	1	2016-05-18 21:26:16.718034	2016-05-18 21:26:16.718034
2203	2	95	45	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/kras/69"}}}	1	2016-05-18 21:26:16.732995	2016-05-18 21:26:16.732995
2204	4	95	45	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/69"}}}	1	2016-05-18 21:26:16.751285	2016-05-18 21:26:16.751285
2205	3	95	46	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/37"}}}	1	2016-05-18 21:26:16.764384	2016-05-18 21:26:16.764384
2206	6	90	46	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/ovarian-cancer/kras/37"}}}	1	2016-05-18 21:26:16.784523	2016-05-18 21:26:16.784523
2207	6	91	46	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/ovarian-cancer/kras/37"}}}	1	2016-05-18 21:26:16.800255	2016-05-18 21:26:16.800255
2208	6	92	46	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/ovarian-cancer/kras/37"}}}	1	2016-05-18 21:26:16.818627	2016-05-18 21:26:16.818627
2209	4	90	46	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/37"}}}	1	2016-05-18 21:26:16.831742	2016-05-18 21:26:16.831742
2210	4	91	46	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/37"}}}	1	2016-05-18 21:26:16.848863	2016-05-18 21:26:16.848863
2211	4	92	46	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/37"}}}	1	2016-05-18 21:26:16.864347	2016-05-18 21:26:16.864347
2212	6	90	47	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/ovarian-cancer/kras/32"}}}	1	2016-05-18 21:26:16.882043	2016-05-18 21:26:16.882043
2213	6	91	47	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/ovarian-cancer/kras/32"}}}	1	2016-05-18 21:26:16.896412	2016-05-18 21:26:16.896412
2214	6	92	47	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/ovarian-cancer/kras/32"}}}	1	2016-05-18 21:26:16.915265	2016-05-18 21:26:16.915265
2215	2	90	47	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/kras/32"}}}	1	2016-05-18 21:26:16.930189	2016-05-18 21:26:16.930189
2216	2	91	47	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/kras/32"}}}	1	2016-05-18 21:26:16.944761	2016-05-18 21:26:16.944761
2217	2	92	47	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/kras/32"}}}	1	2016-05-18 21:26:16.96204	2016-05-18 21:26:16.96204
2218	4	96	47	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/32"}}}	1	2016-05-18 21:26:16.981949	2016-05-18 21:26:16.981949
2219	4	97	47	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/32"}}}	1	2016-05-18 21:26:16.996032	2016-05-18 21:26:16.996032
2220	3	96	48	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/34"}}}	1	2016-05-18 21:26:17.017259	2016-05-18 21:26:17.017259
2221	3	97	48	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/34"}}}	1	2016-05-18 21:26:17.033674	2016-05-18 21:26:17.033674
2222	6	96	48	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/ovarian-cancer/kras/34"}}}	1	2016-05-18 21:26:17.051434	2016-05-18 21:26:17.051434
2223	6	97	48	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/ovarian-cancer/kras/34"}}}	1	2016-05-18 21:26:17.066674	2016-05-18 21:26:17.066674
2224	2	96	48	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/kras/34"}}}	1	2016-05-18 21:26:17.084932	2016-05-18 21:26:17.084932
2225	2	97	48	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/kras/34"}}}	1	2016-05-18 21:26:17.100298	2016-05-18 21:26:17.100298
2226	2	98	48	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/kras/34"}}}	1	2016-05-18 21:26:17.118451	2016-05-18 21:26:17.118451
2227	2	99	48	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/kras/34"}}}	1	2016-05-18 21:26:17.133639	2016-05-18 21:26:17.133639
2228	2	100	48	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/kras/34"}}}	1	2016-05-18 21:26:17.150623	2016-05-18 21:26:17.150623
2229	2	101	48	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/kras/34"}}}	1	2016-05-18 21:26:17.165524	2016-05-18 21:26:17.165524
2230	4	102	48	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/34"}}}	1	2016-05-18 21:26:17.182792	2016-05-18 21:26:17.182792
2231	4	103	48	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/34"}}}	1	2016-05-18 21:26:17.196366	2016-05-18 21:26:17.196366
2232	3	104	49	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/33"}}}	1	2016-05-18 21:26:17.215528	2016-05-18 21:26:17.215528
2233	3	102	49	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/33"}}}	1	2016-05-18 21:26:17.229564	2016-05-18 21:26:17.229564
2234	3	105	49	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/33"}}}	1	2016-05-18 21:26:17.244908	2016-05-18 21:26:17.244908
2235	6	104	49	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/ovarian-cancer/kras/33"}}}	1	2016-05-18 21:26:17.260452	2016-05-18 21:26:17.260452
2236	6	102	49	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/ovarian-cancer/kras/33"}}}	1	2016-05-18 21:26:17.277558	2016-05-18 21:26:17.277558
3083	8	64	15	\N	\N	3	\N	2	2016-05-18 21:26:43.819708	2016-05-18 21:26:43.819708
2237	6	106	49	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/ovarian-cancer/kras/33"}}}	1	2016-05-18 21:26:17.293197	2016-05-18 21:26:17.293197
2238	6	107	49	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/ovarian-cancer/kras/33"}}}	1	2016-05-18 21:26:17.310112	2016-05-18 21:26:17.310112
2239	6	108	49	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/ovarian-cancer/kras/33"}}}	1	2016-05-18 21:26:17.332052	2016-05-18 21:26:17.332052
2240	6	109	49	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/ovarian-cancer/kras/33"}}}	1	2016-05-18 21:26:17.349952	2016-05-18 21:26:17.349952
2241	6	110	49	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/ovarian-cancer/kras/33"}}}	1	2016-05-18 21:26:17.369532	2016-05-18 21:26:17.369532
2242	2	104	49	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/kras/33"}}}	1	2016-05-18 21:26:17.384026	2016-05-18 21:26:17.384026
2243	2	102	49	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/kras/33"}}}	1	2016-05-18 21:26:17.396877	2016-05-18 21:26:17.396877
2244	2	106	49	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/kras/33"}}}	1	2016-05-18 21:26:17.413972	2016-05-18 21:26:17.413972
2245	2	108	49	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/kras/33"}}}	1	2016-05-18 21:26:17.430832	2016-05-18 21:26:17.430832
2246	2	109	49	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/kras/33"}}}	1	2016-05-18 21:26:17.44974	2016-05-18 21:26:17.44974
2247	2	110	49	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/kras/33"}}}	1	2016-05-18 21:26:17.477373	2016-05-18 21:26:17.477373
2248	4	102	49	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/33"}}}	1	2016-05-18 21:26:17.494971	2016-05-18 21:26:17.494971
2249	4	106	49	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/33"}}}	1	2016-05-18 21:26:17.511063	2016-05-18 21:26:17.511063
2250	3	104	50	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/35"}}}	1	2016-05-18 21:26:17.528883	2016-05-18 21:26:17.528883
2251	3	102	50	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/35"}}}	1	2016-05-18 21:26:17.54695	2016-05-18 21:26:17.54695
2252	3	103	50	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/35"}}}	1	2016-05-18 21:26:17.562037	2016-05-18 21:26:17.562037
2253	3	109	50	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/35"}}}	1	2016-05-18 21:26:17.577437	2016-05-18 21:26:17.577437
2254	3	110	50	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/35"}}}	1	2016-05-18 21:26:17.5947	2016-05-18 21:26:17.5947
2255	6	111	50	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/ovarian-cancer/kras/35"}}}	1	2016-05-18 21:26:17.613794	2016-05-18 21:26:17.613794
2256	6	112	50	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/ovarian-cancer/kras/35"}}}	1	2016-05-18 21:26:17.627601	2016-05-18 21:26:17.627601
2257	6	113	50	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/ovarian-cancer/kras/35"}}}	1	2016-05-18 21:26:17.64901	2016-05-18 21:26:17.64901
2258	2	111	50	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/kras/35"}}}	1	2016-05-18 21:26:17.665555	2016-05-18 21:26:17.665555
2259	2	112	50	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/kras/35"}}}	1	2016-05-18 21:26:17.677259	2016-05-18 21:26:17.677259
2260	2	113	50	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/kras/35"}}}	1	2016-05-18 21:26:17.688921	2016-05-18 21:26:17.688921
2261	4	114	50	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/35"}}}	1	2016-05-18 21:26:17.701866	2016-05-18 21:26:17.701866
2262	3	115	51	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/36"}}}	1	2016-05-18 21:26:17.715553	2016-05-18 21:26:17.715553
2263	3	116	51	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/36"}}}	1	2016-05-18 21:26:17.736194	2016-05-18 21:26:17.736194
2264	3	117	51	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/36"}}}	1	2016-05-18 21:26:17.752432	2016-05-18 21:26:17.752432
2265	3	12	51	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/36"}}}	1	2016-05-18 21:26:17.767759	2016-05-18 21:26:17.767759
2266	3	118	51	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/36"}}}	1	2016-05-18 21:26:17.783533	2016-05-18 21:26:17.783533
2267	3	119	51	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/36"}}}	1	2016-05-18 21:26:17.803463	2016-05-18 21:26:17.803463
2268	2	115	51	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/kras/36"}}}	1	2016-05-18 21:26:17.822538	2016-05-18 21:26:17.822538
2269	2	116	51	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/kras/36"}}}	1	2016-05-18 21:26:17.83438	2016-05-18 21:26:17.83438
2270	2	117	51	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/kras/36"}}}	1	2016-05-18 21:26:17.857123	2016-05-18 21:26:17.857123
2271	2	12	51	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/kras/36"}}}	1	2016-05-18 21:26:17.872591	2016-05-18 21:26:17.872591
2272	2	118	51	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/kras/36"}}}	1	2016-05-18 21:26:17.895208	2016-05-18 21:26:17.895208
2273	2	119	51	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/kras/36"}}}	1	2016-05-18 21:26:17.937169	2016-05-18 21:26:17.937169
3084	8	57	256	\N	\N	3	\N	2	2016-05-18 21:26:43.833934	2016-05-18 21:26:43.833934
2274	4	115	51	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/36"}}}	1	2016-05-18 21:26:17.953016	2016-05-18 21:26:17.953016
2275	4	116	51	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/36"}}}	1	2016-05-18 21:26:17.97221	2016-05-18 21:26:17.97221
2276	4	117	51	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/36"}}}	1	2016-05-18 21:26:17.996692	2016-05-18 21:26:17.996692
2277	4	12	51	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/36"}}}	1	2016-05-18 21:26:18.017697	2016-05-18 21:26:18.017697
2278	4	118	51	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/36"}}}	1	2016-05-18 21:26:18.038591	2016-05-18 21:26:18.038591
2279	4	120	51	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/36"}}}	1	2016-05-18 21:26:18.064355	2016-05-18 21:26:18.064355
2280	4	121	51	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/36"}}}	1	2016-05-18 21:26:18.083965	2016-05-18 21:26:18.083965
2281	4	122	51	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/36"}}}	1	2016-05-18 21:26:18.102437	2016-05-18 21:26:18.102437
2282	4	123	51	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/36"}}}	1	2016-05-18 21:26:18.133337	2016-05-18 21:26:18.133337
2283	4	111	51	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/36"}}}	1	2016-05-18 21:26:18.15145	2016-05-18 21:26:18.15145
2284	4	112	51	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/36"}}}	1	2016-05-18 21:26:18.16921	2016-05-18 21:26:18.16921
2285	4	124	51	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/36"}}}	1	2016-05-18 21:26:18.185759	2016-05-18 21:26:18.185759
2286	4	125	51	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/36"}}}	1	2016-05-18 21:26:18.198964	2016-05-18 21:26:18.198964
2287	8	115	52	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/290"}}}	1	2016-05-18 21:26:18.221877	2016-05-18 21:26:18.221877
2288	8	116	52	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/290"}}}	1	2016-05-18 21:26:18.25577	2016-05-18 21:26:18.25577
2289	8	117	52	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/290"}}}	1	2016-05-18 21:26:18.26973	2016-05-18 21:26:18.26973
2290	8	12	52	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/290"}}}	1	2016-05-18 21:26:18.283414	2016-05-18 21:26:18.283414
2291	8	118	52	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/290"}}}	1	2016-05-18 21:26:18.301115	2016-05-18 21:26:18.301115
2292	8	120	52	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/290"}}}	1	2016-05-18 21:26:18.317213	2016-05-18 21:26:18.317213
2293	8	121	52	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/290"}}}	1	2016-05-18 21:26:18.334752	2016-05-18 21:26:18.334752
2294	8	122	52	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/290"}}}	1	2016-05-18 21:26:18.354777	2016-05-18 21:26:18.354777
2295	8	123	52	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/290"}}}	1	2016-05-18 21:26:20.106791	2016-05-18 21:26:20.106791
2296	8	111	52	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/290"}}}	1	2016-05-18 21:26:20.117837	2016-05-18 21:26:20.117837
2297	8	112	52	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/290"}}}	1	2016-05-18 21:26:20.130484	2016-05-18 21:26:20.130484
2298	8	124	52	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/290"}}}	1	2016-05-18 21:26:20.144607	2016-05-18 21:26:20.144607
2299	8	125	52	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/290"}}}	1	2016-05-18 21:26:20.157813	2016-05-18 21:26:20.157813
2300	8	111	53	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/284"}}}	1	2016-05-18 21:26:20.171803	2016-05-18 21:26:20.171803
2342	8	126	59	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/278"}}}	1	2016-05-18 21:26:20.844461	2016-05-18 21:26:20.844461
3085	8	58	256	\N	\N	3	\N	2	2016-05-18 21:26:43.852931	2016-05-18 21:26:43.852931
3086	8	59	256	\N	\N	3	\N	2	2016-05-18 21:26:43.867298	2016-05-18 21:26:43.867298
2350	7	111	61	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/breast-cancer/akt1/23"}}}	1	2016-05-18 21:26:20.975422	2016-05-18 21:26:20.975422
2351	2	111	61	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/akt1/23"}}}	1	2016-05-18 21:26:20.99575	2016-05-18 21:26:20.99575
2352	2	112	61	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/akt1/23"}}}	1	2016-05-18 21:26:21.011279	2016-05-18 21:26:21.011279
2353	2	113	61	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/akt1/23"}}}	1	2016-05-18 21:26:21.032105	2016-05-18 21:26:21.032105
2354	4	127	61	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/akt1/23"}}}	1	2016-05-18 21:26:21.046672	2016-05-18 21:26:21.046672
2355	4	113	61	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/akt1/23"}}}	1	2016-05-18 21:26:21.064796	2016-05-18 21:26:21.064796
2356	7	127	62	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/breast-cancer/her2/242"}}}	1	2016-05-18 21:26:21.078517	2016-05-18 21:26:21.078517
2357	7	113	62	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/breast-cancer/her2/242"}}}	1	2016-05-18 21:26:21.098826	2016-05-18 21:26:21.098826
2358	7	111	63	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/breast-cancer/her2/246"}}}	1	2016-05-18 21:26:21.113761	2016-05-18 21:26:21.113761
2359	7	112	63	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/breast-cancer/her2/246"}}}	1	2016-05-18 21:26:21.131011	2016-05-18 21:26:21.131011
2360	7	113	63	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/breast-cancer/her2/246"}}}	1	2016-05-18 21:26:21.146119	2016-05-18 21:26:21.146119
2361	7	111	64	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/breast-cancer/her2/239"}}}	1	2016-05-18 21:26:21.165363	2016-05-18 21:26:21.165363
2362	7	112	64	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/breast-cancer/her2/239"}}}	1	2016-05-18 21:26:21.18045	2016-05-18 21:26:21.18045
2363	7	113	64	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/breast-cancer/her2/239"}}}	1	2016-05-18 21:26:21.197323	2016-05-18 21:26:21.197323
2364	1	111	65	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/mek1/210"}}}	1	2016-05-18 21:26:21.213547	2016-05-18 21:26:21.213547
2365	1	112	65	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/mek1/210"}}}	1	2016-05-18 21:26:21.240083	2016-05-18 21:26:21.240083
2366	1	113	65	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/mek1/210"}}}	1	2016-05-18 21:26:21.254991	2016-05-18 21:26:21.254991
2367	2	128	66	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/mek1/74"}}}	1	2016-05-18 21:26:21.270532	2016-05-18 21:26:21.270532
2368	2	129	66	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/mek1/74"}}}	1	2016-05-18 21:26:21.287024	2016-05-18 21:26:21.287024
2369	2	128	67	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/mek1/72"}}}	1	2016-05-18 21:26:21.303825	2016-05-18 21:26:21.303825
2370	2	129	67	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/mek1/72"}}}	1	2016-05-18 21:26:21.320106	2016-05-18 21:26:21.320106
2371	2	102	68	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/mek1/60"}}}	1	2016-05-18 21:26:21.33636	2016-05-18 21:26:21.33636
2372	2	106	68	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/mek1/60"}}}	1	2016-05-18 21:26:21.351662	2016-05-18 21:26:21.351662
2373	2	130	68	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/mek1/60"}}}	1	2016-05-18 21:26:21.369108	2016-05-18 21:26:21.369108
2374	2	131	68	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/mek1/60"}}}	1	2016-05-18 21:26:21.384963	2016-05-18 21:26:21.384963
2375	1	102	69	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/mek1/211"}}}	1	2016-05-18 21:26:21.401973	2016-05-18 21:26:21.401973
2376	1	106	69	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/mek1/211"}}}	1	2016-05-18 21:26:21.417716	2016-05-18 21:26:21.417716
2377	1	130	69	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/mek1/211"}}}	1	2016-05-18 21:26:21.434227	2016-05-18 21:26:21.434227
2378	1	123	70	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/mek1/212"}}}	1	2016-05-18 21:26:21.44914	2016-05-18 21:26:21.44914
2379	1	102	70	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/mek1/212"}}}	1	2016-05-18 21:26:21.46717	2016-05-18 21:26:21.46717
2380	1	106	70	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/mek1/212"}}}	1	2016-05-18 21:26:21.519535	2016-05-18 21:26:21.519535
2381	1	130	70	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/mek1/212"}}}	1	2016-05-18 21:26:21.536605	2016-05-18 21:26:21.536605
3087	8	60	256	\N	\N	3	\N	2	2016-05-18 21:26:43.886345	2016-05-18 21:26:43.886345
3088	8	61	256	\N	\N	3	\N	2	2016-05-18 21:26:43.901619	2016-05-18 21:26:43.901619
2382	1	108	70	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/mek1/212"}}}	1	2016-05-18 21:26:21.55164	2016-05-18 21:26:21.55164
2383	1	131	70	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/mek1/212"}}}	1	2016-05-18 21:26:21.574898	2016-05-18 21:26:21.574898
2384	1	123	71	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/mek1/214"}}}	1	2016-05-18 21:26:21.591356	2016-05-18 21:26:21.591356
2385	1	102	71	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/mek1/214"}}}	1	2016-05-18 21:26:21.60688	2016-05-18 21:26:21.60688
2386	1	106	71	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/mek1/214"}}}	1	2016-05-18 21:26:21.624704	2016-05-18 21:26:21.624704
2387	1	130	71	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/mek1/214"}}}	1	2016-05-18 21:26:21.640813	2016-05-18 21:26:21.640813
2388	1	131	71	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/mek1/214"}}}	1	2016-05-18 21:26:21.683601	2016-05-18 21:26:21.683601
2389	1	132	71	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/mek1/214"}}}	1	2016-05-18 21:26:21.703464	2016-05-18 21:26:21.703464
2390	1	102	72	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/mek1/213"}}}	1	2016-05-18 21:26:21.718515	2016-05-18 21:26:21.718515
2391	1	106	72	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/mek1/213"}}}	1	2016-05-18 21:26:21.737107	2016-05-18 21:26:21.737107
2392	1	130	72	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/mek1/213"}}}	1	2016-05-18 21:26:21.750182	2016-05-18 21:26:21.750182
2393	1	131	72	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/mek1/213"}}}	1	2016-05-18 21:26:21.769737	2016-05-18 21:26:21.769737
2394	1	132	72	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/mek1/213"}}}	1	2016-05-18 21:26:21.783668	2016-05-18 21:26:21.783668
2395	1	123	73	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/mek1/215"}}}	1	2016-05-18 21:26:21.80281	2016-05-18 21:26:21.80281
2396	1	102	73	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/mek1/215"}}}	1	2016-05-18 21:26:21.817945	2016-05-18 21:26:21.817945
2397	1	106	73	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/mek1/215"}}}	1	2016-05-18 21:26:21.835456	2016-05-18 21:26:21.835456
2398	1	130	73	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/mek1/215"}}}	1	2016-05-18 21:26:21.850561	2016-05-18 21:26:21.850561
2399	1	102	74	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/mek1/216"}}}	1	2016-05-18 21:26:21.87026	2016-05-18 21:26:21.87026
2400	1	106	74	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/mek1/216"}}}	1	2016-05-18 21:26:21.88434	2016-05-18 21:26:21.88434
2401	1	130	74	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/mek1/216"}}}	1	2016-05-18 21:26:21.898356	2016-05-18 21:26:21.898356
2402	1	108	74	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/mek1/216"}}}	1	2016-05-18 21:26:21.915534	2016-05-18 21:26:21.915534
2403	1	102	75	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/mek1/217"}}}	1	2016-05-18 21:26:21.935201	2016-05-18 21:26:21.935201
2404	1	106	75	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/mek1/217"}}}	1	2016-05-18 21:26:21.948666	2016-05-18 21:26:21.948666
2405	1	130	75	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/mek1/217"}}}	1	2016-05-18 21:26:21.964957	2016-05-18 21:26:21.964957
2406	8	102	76	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh2/272"}}}	1	2016-05-18 21:26:21.981621	2016-05-18 21:26:21.981621
2407	8	130	76	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh2/272"}}}	1	2016-05-18 21:26:22.001179	2016-05-18 21:26:22.001179
2408	8	108	76	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh2/272"}}}	1	2016-05-18 21:26:22.015884	2016-05-18 21:26:22.015884
2409	8	133	76	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh2/272"}}}	1	2016-05-18 21:26:22.035582	2016-05-18 21:26:22.035582
2410	8	131	76	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh2/272"}}}	1	2016-05-18 21:26:22.048759	2016-05-18 21:26:22.048759
2411	8	132	76	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh2/272"}}}	1	2016-05-18 21:26:22.064797	2016-05-18 21:26:22.064797
2412	8	102	77	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh2/271"}}}	1	2016-05-18 21:26:22.082115	2016-05-18 21:26:22.082115
2413	8	130	77	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh2/271"}}}	1	2016-05-18 21:26:22.100537	2016-05-18 21:26:22.100537
2417	8	134	78	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh2/270"}}}	1	2016-05-18 21:26:22.163811	2016-05-18 21:26:22.163811
3089	8	62	256	\N	\N	3	\N	2	2016-05-18 21:26:43.915885	2016-05-18 21:26:43.915885
2420	8	102	79	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh2/268"}}}	1	2016-05-18 21:26:22.214347	2016-05-18 21:26:22.214347
2421	8	106	79	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh2/268"}}}	1	2016-05-18 21:26:22.234444	2016-05-18 21:26:22.234444
2422	8	130	79	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh2/268"}}}	1	2016-05-18 21:26:22.249516	2016-05-18 21:26:22.249516
2423	8	8	80	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh2/266"}}}	1	2016-05-18 21:26:22.26564	2016-05-18 21:26:22.26564
2424	8	135	80	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh2/266"}}}	1	2016-05-18 21:26:22.282613	2016-05-18 21:26:22.282613
2425	8	136	81	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh2/267"}}}	1	2016-05-18 21:26:22.302975	2016-05-18 21:26:22.302975
2426	8	137	81	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh2/267"}}}	1	2016-05-18 21:26:22.317315	2016-05-18 21:26:22.317315
2427	8	138	81	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh2/267"}}}	1	2016-05-18 21:26:22.334095	2016-05-18 21:26:22.334095
2428	8	139	81	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh2/267"}}}	1	2016-05-18 21:26:22.351226	2016-05-18 21:26:22.351226
2429	8	140	81	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh2/267"}}}	1	2016-05-18 21:26:22.371471	2016-05-18 21:26:22.371471
2430	8	141	81	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh2/267"}}}	1	2016-05-18 21:26:22.388653	2016-05-18 21:26:22.388653
2431	8	142	81	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh2/267"}}}	1	2016-05-18 21:26:22.405998	2016-05-18 21:26:22.405998
2432	8	143	81	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh2/267"}}}	1	2016-05-18 21:26:22.42077	2016-05-18 21:26:22.42077
2433	8	144	81	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh2/267"}}}	1	2016-05-18 21:26:22.441956	2016-05-18 21:26:22.441956
2434	8	145	81	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh2/267"}}}	1	2016-05-18 21:26:22.457535	2016-05-18 21:26:22.457535
2435	8	146	81	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh2/267"}}}	1	2016-05-18 21:26:22.475325	2016-05-18 21:26:22.475325
2436	7	95	82	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/breast-cancer/her2/239/"}}}	1	2016-05-18 21:26:22.490591	2016-05-18 21:26:22.490591
2437	7	118	82	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/breast-cancer/her2/239/"}}}	1	2016-05-18 21:26:22.510142	2016-05-18 21:26:22.510142
2438	7	118	83	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/breast-cancer/her2/242/"}}}	1	2016-05-18 21:26:22.524692	2016-05-18 21:26:22.524692
2439	7	95	83	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/breast-cancer/her2/242/"}}}	1	2016-05-18 21:26:22.542078	2016-05-18 21:26:22.542078
2440	7	95	84	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/breast-cancer/her2/246/"}}}	1	2016-05-18 21:26:22.558017	2016-05-18 21:26:22.558017
2441	7	118	84	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/breast-cancer/her2/246/"}}}	1	2016-05-18 21:26:22.577926	2016-05-18 21:26:22.577926
2442	7	147	84	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/breast-cancer/her2/246/"}}}	1	2016-05-18 21:26:22.591991	2016-05-18 21:26:22.591991
2443	7	148	84	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/breast-cancer/her2/246/"}}}	1	2016-05-18 21:26:22.609766	2016-05-18 21:26:22.609766
2444	7	111	85	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/breast-cancer/her2/240"}}}	1	2016-05-18 21:26:22.623763	2016-05-18 21:26:22.623763
2445	7	149	86	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/breast-cancer/her2/241"}}}	1	2016-05-18 21:26:22.643682	2016-05-18 21:26:22.643682
2446	7	149	87	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/breast-cancer/her2/247"}}}	1	2016-05-18 21:26:22.6585	2016-05-18 21:26:22.6585
2447	7	150	88	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/breast-cancer/her2/243/"}}}	1	2016-05-18 21:26:22.674564	2016-05-18 21:26:22.674564
2448	7	151	88	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/breast-cancer/her2/243/"}}}	1	2016-05-18 21:26:22.690267	2016-05-18 21:26:22.690267
2449	7	152	88	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/breast-cancer/her2/243/"}}}	1	2016-05-18 21:26:22.708352	2016-05-18 21:26:22.708352
2450	7	153	88	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/breast-cancer/her2/243/"}}}	1	2016-05-18 21:26:22.722066	2016-05-18 21:26:22.722066
2451	7	154	88	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/breast-cancer/her2/243/"}}}	1	2016-05-18 21:26:22.737154	2016-05-18 21:26:22.737154
2452	7	150	89	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/breast-cancer/her2/244"}}}	1	2016-05-18 21:26:22.754861	2016-05-18 21:26:22.754861
2453	7	151	89	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/breast-cancer/her2/244"}}}	1	2016-05-18 21:26:22.773551	2016-05-18 21:26:22.773551
2454	7	152	89	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/breast-cancer/her2/244"}}}	1	2016-05-18 21:26:22.78816	2016-05-18 21:26:22.78816
3090	8	63	256	\N	\N	3	\N	2	2016-05-18 21:26:43.930771	2016-05-18 21:26:43.930771
2455	7	153	89	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/breast-cancer/her2/244"}}}	1	2016-05-18 21:26:22.802576	2016-05-18 21:26:22.802576
2456	7	154	89	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/breast-cancer/her2/244"}}}	1	2016-05-18 21:26:22.821579	2016-05-18 21:26:22.821579
2457	7	150	90	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/breast-cancer/her2/245"}}}	1	2016-05-18 21:26:22.842531	2016-05-18 21:26:22.842531
2458	7	151	90	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/breast-cancer/her2/245"}}}	1	2016-05-18 21:26:22.866153	2016-05-18 21:26:22.866153
2459	7	152	90	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/breast-cancer/her2/245"}}}	1	2016-05-18 21:26:22.88057	2016-05-18 21:26:22.88057
2460	7	153	90	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/breast-cancer/her2/245"}}}	1	2016-05-18 21:26:22.897896	2016-05-18 21:26:22.897896
2461	7	154	90	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/breast-cancer/her2/245"}}}	1	2016-05-18 21:26:22.914772	2016-05-18 21:26:22.914772
2462	4	150	91	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/151"}}}	1	2016-05-18 21:26:22.928277	2016-05-18 21:26:22.928277
2463	4	151	91	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/151"}}}	1	2016-05-18 21:26:22.942622	2016-05-18 21:26:22.942622
2464	4	152	91	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/151"}}}	1	2016-05-18 21:26:22.9545	2016-05-18 21:26:22.9545
2465	4	153	91	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/151"}}}	1	2016-05-18 21:26:22.973317	2016-05-18 21:26:22.973317
2466	4	154	91	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/151"}}}	1	2016-05-18 21:26:22.994675	2016-05-18 21:26:22.994675
2467	4	123	92	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/154"}}}	1	2016-05-18 21:26:23.016762	2016-05-18 21:26:23.016762
2468	4	123	93	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/152"}}}	1	2016-05-18 21:26:23.033766	2016-05-18 21:26:23.033766
2469	4	123	94	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/155"}}}	1	2016-05-18 21:26:23.048912	2016-05-18 21:26:23.048912
2470	4	123	95	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/156"}}}	1	2016-05-18 21:26:23.065782	2016-05-18 21:26:23.065782
2471	4	123	96	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/157"}}}	1	2016-05-18 21:26:23.083458	2016-05-18 21:26:23.083458
2472	4	150	96	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/157"}}}	1	2016-05-18 21:26:23.100578	2016-05-18 21:26:23.100578
2473	4	151	96	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/157"}}}	1	2016-05-18 21:26:23.118291	2016-05-18 21:26:23.118291
2474	4	152	96	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/157"}}}	1	2016-05-18 21:26:23.137393	2016-05-18 21:26:23.137393
2475	4	153	96	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/157"}}}	1	2016-05-18 21:26:23.156357	2016-05-18 21:26:23.156357
2476	4	154	96	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/157"}}}	1	2016-05-18 21:26:23.174382	2016-05-18 21:26:23.174382
2477	4	123	97	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/158"}}}	1	2016-05-18 21:26:23.18979	2016-05-18 21:26:23.18979
2478	4	150	97	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/158"}}}	1	2016-05-18 21:26:23.206152	2016-05-18 21:26:23.206152
2479	4	151	97	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/158"}}}	1	2016-05-18 21:26:23.225997	2016-05-18 21:26:23.225997
2480	4	152	97	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/158"}}}	1	2016-05-18 21:26:23.241327	2016-05-18 21:26:23.241327
2481	4	153	97	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/158"}}}	1	2016-05-18 21:26:23.269832	2016-05-18 21:26:23.269832
2482	4	154	97	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/158"}}}	1	2016-05-18 21:26:23.288422	2016-05-18 21:26:23.288422
2483	4	123	98	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/153"}}}	1	2016-05-18 21:26:23.306997	2016-05-18 21:26:23.306997
2484	1	155	99	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/gna11/101"}}}	1	2016-05-18 21:26:23.323986	2016-05-18 21:26:23.323986
2485	1	156	100	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/gna11/99"}}}	1	2016-05-18 21:26:23.341437	2016-05-18 21:26:23.341437
2486	1	157	100	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/gna11/99"}}}	1	2016-05-18 21:26:23.356463	2016-05-18 21:26:23.356463
2487	1	158	100	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/gna11/99"}}}	1	2016-05-18 21:26:23.372285	2016-05-18 21:26:23.372285
2488	8	159	101	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh1/264"}}}	1	2016-05-18 21:26:23.387969	2016-05-18 21:26:23.387969
2489	8	159	102	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh1/265"}}}	1	2016-05-18 21:26:23.407002	2016-05-18 21:26:23.407002
2490	8	159	103	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh1/263"}}}	1	2016-05-18 21:26:23.424269	2016-05-18 21:26:23.424269
2491	8	160	104	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh1/260"}}}	1	2016-05-18 21:26:23.444091	2016-05-18 21:26:23.444091
2492	8	161	104	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh1/260"}}}	1	2016-05-18 21:26:23.460072	2016-05-18 21:26:23.460072
2493	8	162	104	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh1/260"}}}	1	2016-05-18 21:26:23.47857	2016-05-18 21:26:23.47857
2494	8	160	105	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh1/261"}}}	1	2016-05-18 21:26:23.497309	2016-05-18 21:26:23.497309
2495	8	161	105	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh1/261"}}}	1	2016-05-18 21:26:23.51286	2016-05-18 21:26:23.51286
2496	8	162	105	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh1/261"}}}	1	2016-05-18 21:26:23.530733	2016-05-18 21:26:23.530733
2497	8	160	106	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh1/262"}}}	1	2016-05-18 21:26:23.547314	2016-05-18 21:26:23.547314
2498	8	161	106	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh1/262"}}}	1	2016-05-18 21:26:23.568744	2016-05-18 21:26:23.568744
2499	8	162	106	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh1/262"}}}	1	2016-05-18 21:26:23.587151	2016-05-18 21:26:23.587151
2500	8	160	107	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/dnmt3a/296"}}}	1	2016-05-18 21:26:23.605148	2016-05-18 21:26:23.605148
2501	8	161	107	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/dnmt3a/296"}}}	1	2016-05-18 21:26:23.621841	2016-05-18 21:26:23.621841
2502	8	162	107	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/dnmt3a/296"}}}	1	2016-05-18 21:26:23.638414	2016-05-18 21:26:23.638414
2503	8	160	108	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/dnmt3a/294"}}}	1	2016-05-18 21:26:23.654632	2016-05-18 21:26:23.654632
2504	8	161	108	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/dnmt3a/294"}}}	1	2016-05-18 21:26:23.669724	2016-05-18 21:26:23.669724
2505	8	162	108	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/dnmt3a/294"}}}	1	2016-05-18 21:26:23.686739	2016-05-18 21:26:23.686739
2506	8	160	109	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/dnmt3a/293"}}}	1	2016-05-18 21:26:23.708193	2016-05-18 21:26:23.708193
2507	8	161	109	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/dnmt3a/293"}}}	1	2016-05-18 21:26:23.726448	2016-05-18 21:26:23.726448
2508	8	162	109	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/dnmt3a/293"}}}	1	2016-05-18 21:26:23.745099	2016-05-18 21:26:23.745099
2509	8	160	110	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/dnmt3a/291"}}}	1	2016-05-18 21:26:23.76181	2016-05-18 21:26:23.76181
2510	8	161	110	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/dnmt3a/291"}}}	1	2016-05-18 21:26:23.779712	2016-05-18 21:26:23.779712
2511	8	162	110	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/dnmt3a/291"}}}	1	2016-05-18 21:26:23.797801	2016-05-18 21:26:23.797801
2512	8	160	111	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/dnmt3a/295"}}}	1	2016-05-18 21:26:23.811444	2016-05-18 21:26:23.811444
2513	8	161	111	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/dnmt3a/295"}}}	1	2016-05-18 21:26:23.827899	2016-05-18 21:26:23.827899
2514	8	162	111	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/dnmt3a/295"}}}	1	2016-05-18 21:26:23.85226	2016-05-18 21:26:23.85226
2515	8	163	112	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/dnmt3a/292"}}}	1	2016-05-18 21:26:23.87105	2016-05-18 21:26:23.87105
2516	9	163	113	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/neuroblastoma/alk/184"}}}	1	2016-05-18 21:26:23.887195	2016-05-18 21:26:23.887195
2517	9	163	114	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/neuroblastoma/alk/183"}}}	1	2016-05-18 21:26:23.905091	2016-05-18 21:26:23.905091
2518	9	164	114	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/neuroblastoma/alk/183"}}}	1	2016-05-18 21:26:23.919683	2016-05-18 21:26:23.919683
2519	9	163	115	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/neuroblastoma/alk/181"}}}	1	2016-05-18 21:26:23.936122	2016-05-18 21:26:23.936122
2520	9	164	115	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/neuroblastoma/alk/181"}}}	1	2016-05-18 21:26:23.954762	2016-05-18 21:26:23.954762
2521	9	156	116	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/neuroblastoma/alk/180"}}}	1	2016-05-18 21:26:23.973025	2016-05-18 21:26:23.973025
2522	9	165	116	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/neuroblastoma/alk/180"}}}	1	2016-05-18 21:26:23.992802	2016-05-18 21:26:23.992802
2523	9	166	116	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/neuroblastoma/alk/180"}}}	1	2016-05-18 21:26:24.012779	2016-05-18 21:26:24.012779
2524	9	167	116	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/neuroblastoma/alk/180"}}}	1	2016-05-18 21:26:24.031074	2016-05-18 21:26:24.031074
2525	9	168	116	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/neuroblastoma/alk/180"}}}	1	2016-05-18 21:26:24.046737	2016-05-18 21:26:24.046737
2526	9	169	116	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/neuroblastoma/alk/180"}}}	1	2016-05-18 21:26:24.069717	2016-05-18 21:26:24.069717
2527	9	170	117	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/neuroblastoma/alk/182"}}}	1	2016-05-18 21:26:24.084658	2016-05-18 21:26:24.084658
2528	10	171	118	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/rhabdomyosarcoma/alk/187"}}}	1	2016-05-18 21:26:24.101369	2016-05-18 21:26:24.101369
2529	9	171	119	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/neuroblastoma/alk/178"}}}	1	2016-05-18 21:26:24.122215	2016-05-18 21:26:24.122215
2530	9	171	120	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/neuroblastoma/alk/176"}}}	1	2016-05-18 21:26:24.143078	2016-05-18 21:26:24.143078
2531	9	171	121	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/neuroblastoma/alk/179"}}}	1	2016-05-18 21:26:24.159734	2016-05-18 21:26:24.159734
2532	9	172	122	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/neuroblastoma/alk/177"}}}	1	2016-05-18 21:26:24.178135	2016-05-18 21:26:24.178135
2533	9	173	122	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/neuroblastoma/alk/177"}}}	1	2016-05-18 21:26:24.194769	2016-05-18 21:26:24.194769
2534	9	174	122	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/neuroblastoma/alk/177"}}}	1	2016-05-18 21:26:24.212686	2016-05-18 21:26:24.212686
2535	9	175	122	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/neuroblastoma/alk/177"}}}	1	2016-05-18 21:26:24.229641	2016-05-18 21:26:24.229641
2536	9	176	122	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/neuroblastoma/alk/177"}}}	1	2016-05-18 21:26:24.246476	2016-05-18 21:26:24.246476
2537	9	177	122	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/neuroblastoma/alk/177"}}}	1	2016-05-18 21:26:24.263478	2016-05-18 21:26:24.263478
2538	9	178	122	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/neuroblastoma/alk/177"}}}	1	2016-05-18 21:26:24.284212	2016-05-18 21:26:24.284212
2539	9	179	122	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/neuroblastoma/alk/177"}}}	1	2016-05-18 21:26:24.303316	2016-05-18 21:26:24.303316
2540	9	3	122	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/neuroblastoma/alk/177"}}}	1	2016-05-18 21:26:24.318489	2016-05-18 21:26:24.318489
2541	9	180	123	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/neuroblastoma/alk/175"}}}	1	2016-05-18 21:26:24.337174	2016-05-18 21:26:24.337174
2542	9	181	123	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/neuroblastoma/alk/175"}}}	1	2016-05-18 21:26:24.352055	2016-05-18 21:26:24.352055
2543	9	182	123	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/neuroblastoma/alk/175"}}}	1	2016-05-18 21:26:24.366805	2016-05-18 21:26:24.366805
2544	9	177	123	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/neuroblastoma/alk/175"}}}	1	2016-05-18 21:26:24.384978	2016-05-18 21:26:24.384978
2545	9	175	123	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/neuroblastoma/alk/175"}}}	1	2016-05-18 21:26:24.405049	2016-05-18 21:26:24.405049
2546	9	3	123	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/neuroblastoma/alk/175"}}}	1	2016-05-18 21:26:24.423445	2016-05-18 21:26:24.423445
2547	9	183	124	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/neuroblastoma/alk/174"}}}	1	2016-05-18 21:26:24.44247	2016-05-18 21:26:24.44247
2548	9	184	124	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/neuroblastoma/alk/174"}}}	1	2016-05-18 21:26:24.460888	2016-05-18 21:26:24.460888
2549	9	177	124	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/neuroblastoma/alk/174"}}}	1	2016-05-18 21:26:24.47846	2016-05-18 21:26:24.47846
2550	9	175	124	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/neuroblastoma/alk/174"}}}	1	2016-05-18 21:26:24.49438	2016-05-18 21:26:24.49438
2551	9	173	124	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/neuroblastoma/alk/174"}}}	1	2016-05-18 21:26:24.513326	2016-05-18 21:26:24.513326
2552	9	185	124	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/neuroblastoma/alk/174"}}}	1	2016-05-18 21:26:24.532504	2016-05-18 21:26:24.532504
2553	9	172	124	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/neuroblastoma/alk/174"}}}	1	2016-05-18 21:26:24.554467	2016-05-18 21:26:24.554467
2554	9	3	124	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/neuroblastoma/alk/174"}}}	1	2016-05-18 21:26:24.576408	2016-05-18 21:26:24.576408
2555	9	186	125	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/neuroblastoma/alk/173"}}}	1	2016-05-18 21:26:24.59578	2016-05-18 21:26:24.59578
2556	9	187	125	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/neuroblastoma/alk/173"}}}	1	2016-05-18 21:26:24.612705	2016-05-18 21:26:24.612705
2557	9	175	125	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/neuroblastoma/alk/173"}}}	1	2016-05-18 21:26:24.628367	2016-05-18 21:26:24.628367
2558	9	177	125	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/neuroblastoma/alk/173"}}}	1	2016-05-18 21:26:24.645093	2016-05-18 21:26:24.645093
2559	9	179	125	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/neuroblastoma/alk/173"}}}	1	2016-05-18 21:26:24.661862	2016-05-18 21:26:24.661862
2560	9	3	125	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/neuroblastoma/alk/173"}}}	1	2016-05-18 21:26:24.678209	2016-05-18 21:26:24.678209
2561	7	172	126	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/7"}}}	1	2016-05-18 21:26:24.697516	2016-05-18 21:26:24.697516
2562	7	177	126	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/7"}}}	1	2016-05-18 21:26:24.715982	2016-05-18 21:26:24.715982
2563	7	173	126	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/7"}}}	1	2016-05-18 21:26:24.734328	2016-05-18 21:26:24.734328
2564	7	175	126	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/7"}}}	1	2016-05-18 21:26:24.751514	2016-05-18 21:26:24.751514
2565	7	188	126	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/7"}}}	1	2016-05-18 21:26:24.765237	2016-05-18 21:26:24.765237
2566	7	189	126	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/7"}}}	1	2016-05-18 21:26:24.779811	2016-05-18 21:26:24.779811
2567	7	190	126	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/7"}}}	1	2016-05-18 21:26:24.795588	2016-05-18 21:26:24.795588
2568	7	191	126	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/7"}}}	1	2016-05-18 21:26:24.812997	2016-05-18 21:26:24.812997
2569	7	192	126	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/7"}}}	1	2016-05-18 21:26:24.830001	2016-05-18 21:26:24.830001
2570	7	3	126	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/7"}}}	1	2016-05-18 21:26:24.848535	2016-05-18 21:26:24.848535
2571	6	193	126	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/ovarian-cancer/pik3ca/7"}}}	1	2016-05-18 21:26:24.873652	2016-05-18 21:26:24.873652
2572	6	172	126	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/ovarian-cancer/pik3ca/7"}}}	1	2016-05-18 21:26:24.891131	2016-05-18 21:26:24.891131
2573	6	194	126	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/ovarian-cancer/pik3ca/7"}}}	1	2016-05-18 21:26:24.909195	2016-05-18 21:26:24.909195
2574	6	188	126	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/ovarian-cancer/pik3ca/7"}}}	1	2016-05-18 21:26:24.926893	2016-05-18 21:26:24.926893
2575	6	177	126	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/ovarian-cancer/pik3ca/7"}}}	1	2016-05-18 21:26:24.943686	2016-05-18 21:26:24.943686
2576	6	179	126	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/ovarian-cancer/pik3ca/7"}}}	1	2016-05-18 21:26:24.957762	2016-05-18 21:26:24.957762
2577	6	3	126	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/ovarian-cancer/pik3ca/7"}}}	1	2016-05-18 21:26:24.975438	2016-05-18 21:26:24.975438
2578	2	189	126	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/pik3ca/7"}}}	1	2016-05-18 21:26:24.992472	2016-05-18 21:26:24.992472
2579	4	189	126	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/7"}}}	1	2016-05-18 21:26:25.01262	2016-05-18 21:26:25.01262
2580	7	189	127	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/8"}}}	1	2016-05-18 21:26:25.02751	2016-05-18 21:26:25.02751
2581	6	189	127	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/ovarian-cancer/pik3ca/8"}}}	1	2016-05-18 21:26:25.045049	2016-05-18 21:26:25.045049
2582	2	189	127	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/pik3ca/8"}}}	1	2016-05-18 21:26:25.059551	2016-05-18 21:26:25.059551
2583	4	189	127	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/8"}}}	1	2016-05-18 21:26:25.079997	2016-05-18 21:26:25.079997
2584	7	189	128	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/9"}}}	1	2016-05-18 21:26:25.095535	2016-05-18 21:26:25.095535
2585	2	189	128	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/pik3ca/9"}}}	1	2016-05-18 21:26:25.111645	2016-05-18 21:26:25.111645
2586	4	189	128	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/9"}}}	1	2016-05-18 21:26:25.12612	2016-05-18 21:26:25.12612
2587	7	189	129	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/12"}}}	1	2016-05-18 21:26:25.14493	2016-05-18 21:26:25.14493
2588	6	189	129	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/ovarian-cancer/pik3ca/12"}}}	1	2016-05-18 21:26:25.160461	2016-05-18 21:26:25.160461
2589	4	189	129	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/12"}}}	1	2016-05-18 21:26:25.178178	2016-05-18 21:26:25.178178
2590	7	189	130	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/13"}}}	1	2016-05-18 21:26:25.196175	2016-05-18 21:26:25.196175
2591	4	195	130	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/13"}}}	1	2016-05-18 21:26:25.213919	2016-05-18 21:26:25.213919
2592	7	195	131	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/14"}}}	1	2016-05-18 21:26:25.228839	2016-05-18 21:26:25.228839
2593	4	196	131	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/14"}}}	1	2016-05-18 21:26:25.246531	2016-05-18 21:26:25.246531
2594	4	197	131	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/14"}}}	1	2016-05-18 21:26:25.26488	2016-05-18 21:26:25.26488
2595	7	196	132	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/16"}}}	1	2016-05-18 21:26:25.290794	2016-05-18 21:26:25.290794
2596	7	197	132	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/16"}}}	1	2016-05-18 21:26:25.305819	2016-05-18 21:26:25.305819
2597	6	196	132	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/ovarian-cancer/pik3ca/16"}}}	1	2016-05-18 21:26:25.323241	2016-05-18 21:26:25.323241
2598	6	197	132	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/ovarian-cancer/pik3ca/16"}}}	1	2016-05-18 21:26:25.339389	2016-05-18 21:26:25.339389
2599	4	197	132	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/16"}}}	1	2016-05-18 21:26:25.357285	2016-05-18 21:26:25.357285
2600	4	196	132	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/16"}}}	1	2016-05-18 21:26:25.383656	2016-05-18 21:26:25.383656
2601	7	196	133	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/15"}}}	1	2016-05-18 21:26:25.40438	2016-05-18 21:26:25.40438
2602	7	197	133	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/15"}}}	1	2016-05-18 21:26:25.426111	2016-05-18 21:26:25.426111
2603	4	196	133	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/15"}}}	1	2016-05-18 21:26:25.443774	2016-05-18 21:26:25.443774
2604	4	197	133	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/15"}}}	1	2016-05-18 21:26:25.458579	2016-05-18 21:26:25.458579
2605	7	196	134	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/18"}}}	1	2016-05-18 21:26:25.476334	2016-05-18 21:26:25.476334
2606	7	197	134	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/18"}}}	1	2016-05-18 21:26:25.495218	2016-05-18 21:26:25.495218
2607	4	196	134	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/18"}}}	1	2016-05-18 21:26:25.509842	2016-05-18 21:26:25.509842
2608	4	197	134	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/18"}}}	1	2016-05-18 21:26:25.529656	2016-05-18 21:26:25.529656
2609	7	196	135	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/19"}}}	1	2016-05-18 21:26:25.544484	2016-05-18 21:26:25.544484
2610	7	197	135	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/19"}}}	1	2016-05-18 21:26:25.559143	2016-05-18 21:26:25.559143
2611	4	197	135	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/19"}}}	1	2016-05-18 21:26:25.576989	2016-05-18 21:26:25.576989
2612	4	196	135	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/19"}}}	1	2016-05-18 21:26:25.595707	2016-05-18 21:26:25.595707
2613	7	196	136	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/17"}}}	1	2016-05-18 21:26:25.609539	2016-05-18 21:26:25.609539
2614	7	197	136	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/17"}}}	1	2016-05-18 21:26:25.624548	2016-05-18 21:26:25.624548
2615	7	196	137	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/20"}}}	1	2016-05-18 21:26:25.641489	2016-05-18 21:26:25.641489
2616	7	197	137	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/20"}}}	1	2016-05-18 21:26:25.657463	2016-05-18 21:26:25.657463
2617	4	198	137	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/20"}}}	1	2016-05-18 21:26:25.673467	2016-05-18 21:26:25.673467
2618	4	3	137	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/20"}}}	1	2016-05-18 21:26:25.689056	2016-05-18 21:26:25.689056
2619	7	199	138	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/11"}}}	1	2016-05-18 21:26:25.70582	2016-05-18 21:26:25.70582
2620	6	200	138	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/ovarian-cancer/pik3ca/11"}}}	1	2016-05-18 21:26:25.724671	2016-05-18 21:26:25.724671
2621	6	201	138	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/ovarian-cancer/pik3ca/11"}}}	1	2016-05-18 21:26:25.742189	2016-05-18 21:26:25.742189
2622	2	202	138	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/pik3ca/11"}}}	1	2016-05-18 21:26:25.757731	2016-05-18 21:26:25.757731
2623	4	203	138	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/10"}}}	1	2016-05-18 21:26:25.774954	2016-05-18 21:26:25.774954
2624	7	204	139	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/10"}}}	1	2016-05-18 21:26:25.79135	2016-05-18 21:26:25.79135
2625	6	205	139	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/ovarian-cancer/pik3ca/10"}}}	1	2016-05-18 21:26:25.807831	2016-05-18 21:26:25.807831
2626	2	204	139	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/pik3ca/10"}}}	1	2016-05-18 21:26:25.823563	2016-05-18 21:26:25.823563
2627	4	204	139	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/10"}}}	1	2016-05-18 21:26:25.839989	2016-05-18 21:26:25.839989
2628	1	206	140	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/ctnnb1/105"}}}	1	2016-05-18 21:26:25.857568	2016-05-18 21:26:25.857568
2629	1	206	141	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/ctnnb1/104"}}}	1	2016-05-18 21:26:25.875495	2016-05-18 21:26:25.875495
2630	1	207	142	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/ctnnb1/107"}}}	1	2016-05-18 21:26:25.892156	2016-05-18 21:26:25.892156
2631	1	3	142	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/ctnnb1/107"}}}	1	2016-05-18 21:26:25.909454	2016-05-18 21:26:25.909454
2632	1	208	143	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/ctnnb1/108"}}}	1	2016-05-18 21:26:25.927971	2016-05-18 21:26:25.927971
2633	1	3	143	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/ctnnb1/108"}}}	1	2016-05-18 21:26:25.942128	2016-05-18 21:26:25.942128
2634	1	209	144	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/ctnnb1/106"}}}	1	2016-05-18 21:26:25.95748	2016-05-18 21:26:25.95748
2635	1	210	144	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/ctnnb1/106"}}}	1	2016-05-18 21:26:25.973279	2016-05-18 21:26:25.973279
2636	11	209	145	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/gist/pdgfra/48"}}}	1	2016-05-18 21:26:25.989287	2016-05-18 21:26:25.989287
2637	11	210	145	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/gist/pdgfra/48"}}}	1	2016-05-18 21:26:26.010712	2016-05-18 21:26:26.010712
2638	11	209	146	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/gist/pdgfra/51"}}}	1	2016-05-18 21:26:26.02719	2016-05-18 21:26:26.02719
3091	8	64	256	\N	\N	3	\N	2	2016-05-18 21:26:43.947162	2016-05-18 21:26:43.947162
2639	11	209	147	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/gist/pdgfra/51"}}}	1	2016-05-18 21:26:26.044902	2016-05-18 21:26:26.044902
2640	11	210	147	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/gist/pdgfra/51"}}}	1	2016-05-18 21:26:26.064295	2016-05-18 21:26:26.064295
2641	11	211	147	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/gist/pdgfra/51"}}}	1	2016-05-18 21:26:26.079738	2016-05-18 21:26:26.079738
2642	11	209	148	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/gist/pdgfra/45"}}}	1	2016-05-18 21:26:26.099274	2016-05-18 21:26:26.099274
2643	11	211	148	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/gist/pdgfra/45"}}}	1	2016-05-18 21:26:26.112715	2016-05-18 21:26:26.112715
2644	12	209	149	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thymic-carcinoma/kit/218"}}}	1	2016-05-18 21:26:26.128394	2016-05-18 21:26:26.128394
2645	12	211	149	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thymic-carcinoma/kit/218"}}}	1	2016-05-18 21:26:26.146111	2016-05-18 21:26:26.146111
2646	1	209	150	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 21:26:26.161048	2016-05-18 21:26:26.161048
2647	1	212	151	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 21:26:26.177756	2016-05-18 21:26:26.177756
2648	1	213	152	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 21:26:26.196892	2016-05-18 21:26:26.196892
2649	1	214	153	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 21:26:26.210893	2016-05-18 21:26:26.210893
2650	12	215	153	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thymic-carcinoma/kit/124"}}}	1	2016-05-18 21:26:26.227396	2016-05-18 21:26:26.227396
2651	1	30	154	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 21:26:26.244801	2016-05-18 21:26:26.244801
2652	1	3	154	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 21:26:26.261397	2016-05-18 21:26:26.261397
2653	1	216	155	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 21:26:26.278532	2016-05-18 21:26:26.278532
2654	1	3	155	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 21:26:26.296699	2016-05-18 21:26:26.296699
2655	1	217	156	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 21:26:26.311427	2016-05-18 21:26:26.311427
2656	1	3	156	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 21:26:26.328103	2016-05-18 21:26:26.328103
2657	1	218	157	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 21:26:26.344366	2016-05-18 21:26:26.344366
2658	1	219	157	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 21:26:26.36042	2016-05-18 21:26:26.36042
2659	1	220	157	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 21:26:26.376873	2016-05-18 21:26:26.376873
2660	1	30	157	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 21:26:26.393958	2016-05-18 21:26:26.393958
2661	1	221	158	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 21:26:26.410157	2016-05-18 21:26:26.410157
2662	1	222	158	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 21:26:26.465703	2016-05-18 21:26:26.465703
2663	1	223	158	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 21:26:26.482484	2016-05-18 21:26:26.482484
2664	1	224	158	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 21:26:26.501386	2016-05-18 21:26:26.501386
2665	1	225	158	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 21:26:26.515322	2016-05-18 21:26:26.515322
2666	1	226	158	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 21:26:26.531219	2016-05-18 21:26:26.531219
2667	1	227	158	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 21:26:26.548454	2016-05-18 21:26:26.548454
2668	1	228	158	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 21:26:26.564997	2016-05-18 21:26:26.564997
2669	1	229	158	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 21:26:26.58341	2016-05-18 21:26:26.58341
2670	1	230	158	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 21:26:26.598459	2016-05-18 21:26:26.598459
2671	1	221	159	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 21:26:26.615142	2016-05-18 21:26:26.615142
2672	1	222	159	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 21:26:26.634577	2016-05-18 21:26:26.634577
2673	1	223	159	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 21:26:26.649394	2016-05-18 21:26:26.649394
2674	1	224	159	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 21:26:26.66465	2016-05-18 21:26:26.66465
2675	1	225	159	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 21:26:26.681224	2016-05-18 21:26:26.681224
2676	1	226	159	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 21:26:26.697565	2016-05-18 21:26:26.697565
2677	1	227	159	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 21:26:26.714891	2016-05-18 21:26:26.714891
2678	1	228	159	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 21:26:26.735035	2016-05-18 21:26:26.735035
2679	1	229	159	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 21:26:26.750327	2016-05-18 21:26:26.750327
2680	1	230	159	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 21:26:26.764917	2016-05-18 21:26:26.764917
2681	1	221	160	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 21:26:26.780785	2016-05-18 21:26:26.780785
2682	1	222	160	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 21:26:26.797202	2016-05-18 21:26:26.797202
2683	1	223	160	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 21:26:26.813026	2016-05-18 21:26:26.813026
2684	1	224	160	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 21:26:26.828865	2016-05-18 21:26:26.828865
2685	1	225	160	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 21:26:26.844343	2016-05-18 21:26:26.844343
2686	1	226	160	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 21:26:26.861475	2016-05-18 21:26:26.861475
2687	1	227	160	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 21:26:26.878723	2016-05-18 21:26:26.878723
2688	1	228	160	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 21:26:26.896915	2016-05-18 21:26:26.896915
2689	1	229	160	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 21:26:26.919516	2016-05-18 21:26:26.919516
2690	1	230	160	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 21:26:26.942418	2016-05-18 21:26:26.942418
2691	1	221	161	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 21:26:26.962849	2016-05-18 21:26:26.962849
2692	1	222	161	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 21:26:26.979392	2016-05-18 21:26:26.979392
2693	1	223	161	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 21:26:26.99755	2016-05-18 21:26:26.99755
2694	1	231	161	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 21:26:27.016401	2016-05-18 21:26:27.016401
2695	1	232	161	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 21:26:27.035898	2016-05-18 21:26:27.035898
2696	1	233	161	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 21:26:27.050103	2016-05-18 21:26:27.050103
2697	1	234	161	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 21:26:27.066479	2016-05-18 21:26:27.066479
2698	1	235	161	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 21:26:27.083383	2016-05-18 21:26:27.083383
2699	1	236	161	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 21:26:27.100219	2016-05-18 21:26:27.100219
2700	1	237	161	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 21:26:27.120844	2016-05-18 21:26:27.120844
2701	1	238	161	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 21:26:27.139726	2016-05-18 21:26:27.139726
2702	1	239	161	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 21:26:27.153604	2016-05-18 21:26:27.153604
2703	1	240	161	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 21:26:27.169685	2016-05-18 21:26:27.169685
2704	1	241	161	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 21:26:27.199533	2016-05-18 21:26:27.199533
2705	1	242	161	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 21:26:27.21479	2016-05-18 21:26:27.21479
2706	1	230	161	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 21:26:27.231284	2016-05-18 21:26:27.231284
2707	1	221	162	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 21:26:27.247096	2016-05-18 21:26:27.247096
2708	1	222	162	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 21:26:27.262659	2016-05-18 21:26:27.262659
2709	1	223	162	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 21:26:27.278612	2016-05-18 21:26:27.278612
2710	1	224	162	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 21:26:27.319383	2016-05-18 21:26:27.319383
2711	1	243	162	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 21:26:27.335838	2016-05-18 21:26:27.335838
2712	1	244	162	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 21:26:27.353261	2016-05-18 21:26:27.353261
2713	1	245	162	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 21:26:27.372594	2016-05-18 21:26:27.372594
2714	1	246	162	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 21:26:27.38784	2016-05-18 21:26:27.38784
3092	8	57	257	\N	\N	3	\N	2	2016-05-18 21:26:43.965754	2016-05-18 21:26:43.965754
2715	1	247	162	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 21:26:27.406924	2016-05-18 21:26:27.406924
2716	1	248	162	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 21:26:27.422558	2016-05-18 21:26:27.422558
2717	1	249	162	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 21:26:37.60693	2016-05-18 21:26:37.60693
2718	1	250	162	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 21:26:37.617603	2016-05-18 21:26:37.617603
2719	1	251	162	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 21:26:37.630335	2016-05-18 21:26:37.630335
2720	1	252	162	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 21:26:37.645078	2016-05-18 21:26:37.645078
2721	1	253	162	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 21:26:37.658702	2016-05-18 21:26:37.658702
2722	1	254	162	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 21:26:37.672487	2016-05-18 21:26:37.672487
2723	1	229	162	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 21:26:37.687266	2016-05-18 21:26:37.687266
2724	1	228	162	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 21:26:37.702692	2016-05-18 21:26:37.702692
2725	1	230	162	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 21:26:37.720443	2016-05-18 21:26:37.720443
2726	1	221	163	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 21:26:37.735245	2016-05-18 21:26:37.735245
2727	1	222	163	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 21:26:37.753171	2016-05-18 21:26:37.753171
2728	1	223	163	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 21:26:37.768936	2016-05-18 21:26:37.768936
2729	1	224	163	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 21:26:37.786092	2016-05-18 21:26:37.786092
2730	1	229	163	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 21:26:37.802635	2016-05-18 21:26:37.802635
2731	1	230	163	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 21:26:37.819502	2016-05-18 21:26:37.819502
2732	12	255	163	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thymic-carcinoma/kit/110"}}}	1	2016-05-18 21:26:37.834468	2016-05-18 21:26:37.834468
2733	12	256	163	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thymic-carcinoma/kit/110"}}}	1	2016-05-18 21:26:37.85057	2016-05-18 21:26:37.85057
2734	1	255	164	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 21:26:37.864159	2016-05-18 21:26:37.864159
2735	1	256	164	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 21:26:37.880101	2016-05-18 21:26:37.880101
2736	1	255	165	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 21:26:37.896352	2016-05-18 21:26:37.896352
2737	1	256	165	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 21:26:37.911964	2016-05-18 21:26:37.911964
2738	1	255	166	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 21:26:37.927711	2016-05-18 21:26:37.927711
2739	1	256	166	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 21:26:37.943903	2016-05-18 21:26:37.943903
2740	1	255	167	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 21:26:37.960136	2016-05-18 21:26:37.960136
2741	1	256	167	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 21:26:37.975101	2016-05-18 21:26:37.975101
2742	12	255	168	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thymic-carcinoma/kit/112"}}}	1	2016-05-18 21:26:37.990636	2016-05-18 21:26:37.990636
2743	12	256	168	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thymic-carcinoma/kit/112"}}}	1	2016-05-18 21:26:38.007751	2016-05-18 21:26:38.007751
2744	1	255	169	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 21:26:38.025177	2016-05-18 21:26:38.025177
2745	1	256	169	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 21:26:38.04227	2016-05-18 21:26:38.04227
2746	12	255	170	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thymic-carcinoma/kit/123"}}}	1	2016-05-18 21:26:38.058237	2016-05-18 21:26:38.058237
2747	12	256	170	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thymic-carcinoma/kit/123"}}}	1	2016-05-18 21:26:38.075858	2016-05-18 21:26:38.075858
2748	1	255	171	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 21:26:38.096485	2016-05-18 21:26:38.096485
2749	1	256	171	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 21:26:38.113259	2016-05-18 21:26:38.113259
2750	1	255	172	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 21:26:38.128634	2016-05-18 21:26:38.128634
2751	1	256	172	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 21:26:38.143816	2016-05-18 21:26:38.143816
2752	1	255	173	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 21:26:38.158949	2016-05-18 21:26:38.158949
2753	1	256	173	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 21:26:38.176208	2016-05-18 21:26:38.176208
2754	1	255	174	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 21:26:38.194049	2016-05-18 21:26:38.194049
2755	1	256	174	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 21:26:38.210119	2016-05-18 21:26:38.210119
2756	1	255	175	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 21:26:38.225094	2016-05-18 21:26:38.225094
2757	1	256	175	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 21:26:38.240004	2016-05-18 21:26:38.240004
2758	1	255	176	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 21:26:38.257037	2016-05-18 21:26:38.257037
2759	1	256	176	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 21:26:38.272429	2016-05-18 21:26:38.272429
2760	1	257	177	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 21:26:38.289612	2016-05-18 21:26:38.289612
2761	1	258	177	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 21:26:38.304627	2016-05-18 21:26:38.304627
2762	1	257	178	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 21:26:38.321765	2016-05-18 21:26:38.321765
2763	1	259	179	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 21:26:38.336606	2016-05-18 21:26:38.336606
2764	1	257	179	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 21:26:38.356622	2016-05-18 21:26:38.356622
2765	1	255	180	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 21:26:38.373044	2016-05-18 21:26:38.373044
2766	1	208	180	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 21:26:38.389267	2016-05-18 21:26:38.389267
2767	1	260	180	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 21:26:38.403653	2016-05-18 21:26:38.403653
2768	1	255	181	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 21:26:38.418623	2016-05-18 21:26:38.418623
2769	1	208	181	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 21:26:38.436001	2016-05-18 21:26:38.436001
2770	1	260	181	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 21:26:38.451288	2016-05-18 21:26:38.451288
2771	1	255	182	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 21:26:38.468596	2016-05-18 21:26:38.468596
2772	1	208	182	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 21:26:38.487347	2016-05-18 21:26:38.487347
2773	1	260	182	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 21:26:38.501672	2016-05-18 21:26:38.501672
2774	1	261	183	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 21:26:38.517533	2016-05-18 21:26:38.517533
2775	1	260	183	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 21:26:38.534218	2016-05-18 21:26:38.534218
2776	1	260	184	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 21:26:38.549833	2016-05-18 21:26:38.549833
2777	1	255	185	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 21:26:38.565373	2016-05-18 21:26:38.565373
2778	1	208	185	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 21:26:38.580762	2016-05-18 21:26:38.580762
2779	1	260	185	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 21:26:38.596888	2016-05-18 21:26:38.596888
2780	1	255	186	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 21:26:38.6152	2016-05-18 21:26:38.6152
2781	1	208	186	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 21:26:38.672736	2016-05-18 21:26:38.672736
2782	1	260	186	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 21:26:38.686458	2016-05-18 21:26:38.686458
2783	1	255	187	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/96"}}}	1	2016-05-18 21:26:38.702892	2016-05-18 21:26:38.702892
2784	1	208	187	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/96"}}}	1	2016-05-18 21:26:38.718185	2016-05-18 21:26:38.718185
2785	1	260	187	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/96"}}}	1	2016-05-18 21:26:38.735204	2016-05-18 21:26:38.735204
2786	12	255	187	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thymic-carcinoma/kit/96"}}}	1	2016-05-18 21:26:38.751836	2016-05-18 21:26:38.751836
2787	12	208	187	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thymic-carcinoma/kit/96"}}}	1	2016-05-18 21:26:38.76765	2016-05-18 21:26:38.76765
2788	12	260	187	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thymic-carcinoma/kit/96"}}}	1	2016-05-18 21:26:38.782759	2016-05-18 21:26:38.782759
2789	12	255	188	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thymic-carcinoma/kit/122"}}}	1	2016-05-18 21:26:38.79977	2016-05-18 21:26:38.79977
2790	12	208	188	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thymic-carcinoma/kit/122"}}}	1	2016-05-18 21:26:38.814612	2016-05-18 21:26:38.814612
2791	12	260	188	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thymic-carcinoma/kit/122"}}}	1	2016-05-18 21:26:38.830364	2016-05-18 21:26:38.830364
2792	1	255	189	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 21:26:38.846835	2016-05-18 21:26:38.846835
2793	1	256	189	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 21:26:38.865185	2016-05-18 21:26:38.865185
2794	1	262	190	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 21:26:38.881651	2016-05-18 21:26:38.881651
2795	1	74	190	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 21:26:38.898205	2016-05-18 21:26:38.898205
2796	1	75	190	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 21:26:38.913234	2016-05-18 21:26:38.913234
2797	1	76	190	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 21:26:38.931095	2016-05-18 21:26:38.931095
2798	1	77	190	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 21:26:38.945543	2016-05-18 21:26:38.945543
2799	1	78	190	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 21:26:38.962358	2016-05-18 21:26:38.962358
2800	1	79	190	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 21:26:38.978205	2016-05-18 21:26:38.978205
2801	1	263	190	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 21:26:38.998132	2016-05-18 21:26:38.998132
2802	1	264	190	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 21:26:39.012586	2016-05-18 21:26:39.012586
2803	1	265	190	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 21:26:39.03036	2016-05-18 21:26:39.03036
2804	1	234	190	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 21:26:39.046318	2016-05-18 21:26:39.046318
2805	1	262	191	\N	\N	3	\N	1	2016-05-18 21:26:39.067623	2016-05-18 21:26:39.067623
2806	1	74	191	\N	\N	3	\N	1	2016-05-18 21:26:39.133083	2016-05-18 21:26:39.133083
2807	1	75	191	\N	\N	3	\N	1	2016-05-18 21:26:39.146559	2016-05-18 21:26:39.146559
2808	1	76	191	\N	\N	3	\N	1	2016-05-18 21:26:39.159422	2016-05-18 21:26:39.159422
2809	1	77	191	\N	\N	3	\N	1	2016-05-18 21:26:39.172968	2016-05-18 21:26:39.172968
2810	1	78	191	\N	\N	3	\N	1	2016-05-18 21:26:39.184052	2016-05-18 21:26:39.184052
2811	1	79	191	\N	\N	3	\N	1	2016-05-18 21:26:39.199095	2016-05-18 21:26:39.199095
2812	1	263	191	\N	\N	3	\N	1	2016-05-18 21:26:39.214667	2016-05-18 21:26:39.214667
2813	1	264	191	\N	\N	3	\N	1	2016-05-18 21:26:39.281734	2016-05-18 21:26:39.281734
2814	1	265	191	\N	\N	3	\N	1	2016-05-18 21:26:39.351101	2016-05-18 21:26:39.351101
2815	1	234	191	\N	\N	3	\N	1	2016-05-18 21:26:39.36619	2016-05-18 21:26:39.36619
2816	1	262	192	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 21:26:39.380446	2016-05-18 21:26:39.380446
2817	1	74	192	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 21:26:39.393856	2016-05-18 21:26:39.393856
2818	1	75	192	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 21:26:39.406554	2016-05-18 21:26:39.406554
2819	1	76	192	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 21:26:39.423313	2016-05-18 21:26:39.423313
2820	1	77	192	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 21:26:39.4387	2016-05-18 21:26:39.4387
2821	1	78	192	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 21:26:39.454341	2016-05-18 21:26:39.454341
2822	1	79	192	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 21:26:39.468476	2016-05-18 21:26:39.468476
2823	1	263	192	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 21:26:39.483764	2016-05-18 21:26:39.483764
2824	1	264	192	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 21:26:39.498206	2016-05-18 21:26:39.498206
2825	1	265	192	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 21:26:39.510351	2016-05-18 21:26:39.510351
2826	1	234	192	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 21:26:39.525927	2016-05-18 21:26:39.525927
2827	1	262	193	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 21:26:39.539524	2016-05-18 21:26:39.539524
2828	1	74	193	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 21:26:39.554385	2016-05-18 21:26:39.554385
2829	1	75	193	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 21:26:39.568989	2016-05-18 21:26:39.568989
2830	1	76	193	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 21:26:39.58395	2016-05-18 21:26:39.58395
2831	1	77	193	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 21:26:39.598711	2016-05-18 21:26:39.598711
2832	1	78	193	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 21:26:39.610861	2016-05-18 21:26:39.610861
2833	1	79	193	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 21:26:39.627229	2016-05-18 21:26:39.627229
2834	1	263	193	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 21:26:39.640308	2016-05-18 21:26:39.640308
2835	1	264	193	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 21:26:39.654956	2016-05-18 21:26:39.654956
3093	8	58	257	\N	\N	3	\N	2	2016-05-18 21:26:43.979645	2016-05-18 21:26:43.979645
2836	1	265	193	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 21:26:39.671139	2016-05-18 21:26:39.671139
2837	1	234	193	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 21:26:39.685935	2016-05-18 21:26:39.685935
2838	1	266	194	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 21:26:39.700329	2016-05-18 21:26:39.700329
2839	1	267	194	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 21:26:39.714622	2016-05-18 21:26:39.714622
2840	1	268	194	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 21:26:39.729912	2016-05-18 21:26:39.729912
2841	1	269	194	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 21:26:39.744975	2016-05-18 21:26:39.744975
2842	1	270	194	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 21:26:39.758311	2016-05-18 21:26:39.758311
2843	1	271	194	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 21:26:39.773096	2016-05-18 21:26:39.773096
2844	1	272	194	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 21:26:39.787594	2016-05-18 21:26:39.787594
2845	1	273	195	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 21:26:39.803286	2016-05-18 21:26:39.803286
2846	12	273	196	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thymic-carcinoma/kit/121"}}}	1	2016-05-18 21:26:39.81734	2016-05-18 21:26:39.81734
2847	1	273	197	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/84"}}}	1	2016-05-18 21:26:39.834353	2016-05-18 21:26:39.834353
2848	8	273	198	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/kit/274"}}}	1	2016-05-18 21:26:39.848676	2016-05-18 21:26:39.848676
2849	8	229	199	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/kit/276"}}}	1	2016-05-18 21:26:39.862283	2016-05-18 21:26:39.862283
2850	8	230	199	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/kit/276"}}}	1	2016-05-18 21:26:39.878103	2016-05-18 21:26:39.878103
2851	1	229	200	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 21:26:39.89052	2016-05-18 21:26:39.89052
2852	1	230	200	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 21:26:39.906012	2016-05-18 21:26:39.906012
2853	8	229	200	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/kit/275"}}}	1	2016-05-18 21:26:39.919973	2016-05-18 21:26:39.919973
2854	8	230	200	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/kit/275"}}}	1	2016-05-18 21:26:39.936115	2016-05-18 21:26:39.936115
2855	1	274	201	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/84"}}}	1	2016-05-18 21:26:39.950761	2016-05-18 21:26:39.950761
2856	1	274	202	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 21:26:39.966536	2016-05-18 21:26:39.966536
2857	1	275	203	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 21:26:39.981102	2016-05-18 21:26:39.981102
2858	12	275	204	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thymic-carcinoma/kit/120"}}}	1	2016-05-18 21:26:39.994884	2016-05-18 21:26:39.994884
2859	1	276	205	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 21:26:40.010467	2016-05-18 21:26:40.010467
2860	1	3	205	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 21:26:40.025502	2016-05-18 21:26:40.025502
2861	1	277	206	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 21:26:40.04045	2016-05-18 21:26:40.04045
2862	1	278	207	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 21:26:40.054745	2016-05-18 21:26:40.054745
2863	1	3	207	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 21:26:40.070394	2016-05-18 21:26:40.070394
2864	1	279	208	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 21:26:40.084757	2016-05-18 21:26:40.084757
2865	1	280	208	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 21:26:40.10101	2016-05-18 21:26:40.10101
2866	1	281	209	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 21:26:40.115492	2016-05-18 21:26:40.115492
2867	1	279	209	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 21:26:40.129308	2016-05-18 21:26:40.129308
2868	1	282	209	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 21:26:40.147156	2016-05-18 21:26:40.147156
2869	1	283	210	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 21:26:40.159638	2016-05-18 21:26:40.159638
2870	1	279	210	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 21:26:40.17454	2016-05-18 21:26:40.17454
2871	1	284	211	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 21:26:40.188426	2016-05-18 21:26:40.188426
2872	1	283	211	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 21:26:40.204074	2016-05-18 21:26:40.204074
2873	1	279	211	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 21:26:40.218924	2016-05-18 21:26:40.218924
2874	1	285	212	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 21:26:40.23533	2016-05-18 21:26:40.23533
2875	1	286	212	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 21:26:40.250535	2016-05-18 21:26:40.250535
2876	1	287	212	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 21:26:40.26636	2016-05-18 21:26:40.26636
2877	1	288	212	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/kit/132"}}}	1	2016-05-18 21:26:40.282225	2016-05-18 21:26:40.282225
2878	14	293	213	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/basal-cell-carcinoma/smo/164"}}}	1	2016-05-18 21:26:40.295094	2016-05-18 21:26:40.295094
2879	14	293	214	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/basal-cell-carcinoma/smo/165"}}}	1	2016-05-18 21:26:40.312378	2016-05-18 21:26:40.312378
2880	14	294	215	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/basal-cell-carcinoma/smo/166"}}}	1	2016-05-18 21:26:40.32767	2016-05-18 21:26:40.32767
2881	14	295	215	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/basal-cell-carcinoma/smo/166"}}}	1	2016-05-18 21:26:40.339912	2016-05-18 21:26:40.339912
2882	14	296	215	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/basal-cell-carcinoma/smo/166"}}}	1	2016-05-18 21:26:40.356181	2016-05-18 21:26:40.356181
2883	14	293	216	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/basal-cell-carcinoma/smo/163"}}}	1	2016-05-18 21:26:40.369174	2016-05-18 21:26:40.369174
2884	14	293	217	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/basal-cell-carcinoma/smo/167"}}}	1	2016-05-18 21:26:40.385779	2016-05-18 21:26:40.385779
2885	14	293	218	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/basal-cell-carcinoma/smo/168"}}}	1	2016-05-18 21:26:40.399521	2016-05-18 21:26:40.399521
2886	14	293	219	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/basal-cell-carcinoma/smo/169"}}}	1	2016-05-18 21:26:40.41375	2016-05-18 21:26:40.41375
2887	14	293	220	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/basal-cell-carcinoma/smo/170"}}}	1	2016-05-18 21:26:40.428077	2016-05-18 21:26:40.428077
2888	14	293	221	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/basal-cell-carcinoma/smo/171"}}}	1	2016-05-18 21:26:40.439999	2016-05-18 21:26:40.439999
2889	14	293	222	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/basal-cell-carcinoma/smo/172"}}}	1	2016-05-18 21:26:40.45605	2016-05-18 21:26:40.45605
2890	1	293	223	\N	\N	3	\N	1	2016-05-18 21:26:40.469008	2016-05-18 21:26:40.469008
2891	1	293	224	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/braf/114"}}}	1	2016-05-18 21:26:40.483275	2016-05-18 21:26:40.483275
2892	1	293	225	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/braf/115"}}}	1	2016-05-18 21:26:40.49811	2016-05-18 21:26:40.49811
2893	15	293	226	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/braf/54"}}}	1	2016-05-18 21:26:40.512416	2016-05-18 21:26:40.512416
2894	3	294	226	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/braf/54"}}}	1	2016-05-18 21:26:40.526143	2016-05-18 21:26:40.526143
2895	3	295	226	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/braf/54"}}}	1	2016-05-18 21:26:40.539024	2016-05-18 21:26:40.539024
2896	3	296	226	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/thyroid-cancer/braf/54"}}}	1	2016-05-18 21:26:40.555118	2016-05-18 21:26:40.555118
2897	6	297	226	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/ovarian-cancer/braf/54"}}}	1	2016-05-18 21:26:40.568536	2016-05-18 21:26:40.568536
2898	11	298	226	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/gist/braf/54"}}}	1	2016-05-18 21:26:40.583299	2016-05-18 21:26:40.583299
2899	4	298	226	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/54"}}}	1	2016-05-18 21:26:40.598312	2016-05-18 21:26:40.598312
2900	1	299	227	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/braf/118"}}}	1	2016-05-18 21:26:40.610454	2016-05-18 21:26:40.610454
2901	1	300	228	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/braf/116"}}}	1	2016-05-18 21:26:40.626607	2016-05-18 21:26:40.626607
2902	6	301	229	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/ovarian-cancer/braf/138"}}}	1	2016-05-18 21:26:40.639551	2016-05-18 21:26:40.639551
2903	6	302	229	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/ovarian-cancer/braf/138"}}}	1	2016-05-18 21:26:40.65587	2016-05-18 21:26:40.65587
2904	1	3	230	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/braf/301"}}}	1	2016-05-18 21:26:40.669517	2016-05-18 21:26:40.669517
2905	4	303	231	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/149"}}}	1	2016-05-18 21:26:40.683917	2016-05-18 21:26:40.683917
2906	4	304	231	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/149"}}}	1	2016-05-18 21:26:40.698196	2016-05-18 21:26:40.698196
2907	4	36	231	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/149"}}}	1	2016-05-18 21:26:40.711557	2016-05-18 21:26:40.711557
2908	4	305	231	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/149"}}}	1	2016-05-18 21:26:40.729013	2016-05-18 21:26:40.729013
2909	4	306	231	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/149"}}}	1	2016-05-18 21:26:40.742127	2016-05-18 21:26:40.742127
2910	4	46	231	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/149"}}}	1	2016-05-18 21:26:40.759618	2016-05-18 21:26:40.759618
3094	8	59	257	\N	\N	3	\N	2	2016-05-18 21:26:43.994753	2016-05-18 21:26:43.994753
3095	8	60	257	\N	\N	3	\N	2	2016-05-18 21:26:44.00922	2016-05-18 21:26:44.00922
2911	4	307	231	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/149"}}}	1	2016-05-18 21:26:40.77402	2016-05-18 21:26:40.77402
2912	1	303	232	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/braf/148"}}}	1	2016-05-18 21:26:40.789903	2016-05-18 21:26:40.789903
2913	1	304	232	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/braf/148"}}}	1	2016-05-18 21:26:40.807876	2016-05-18 21:26:40.807876
2915	1	305	232	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/braf/148"}}}	1	2016-05-18 21:26:40.838937	2016-05-18 21:26:40.838937
2916	1	306	232	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/braf/148"}}}	1	2016-05-18 21:26:40.855747	2016-05-18 21:26:40.855747
2917	1	46	232	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/braf/148"}}}	1	2016-05-18 21:26:40.869418	2016-05-18 21:26:40.869418
2918	4	303	232	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/148"}}}	1	2016-05-18 21:26:40.884821	2016-05-18 21:26:40.884821
2919	4	304	232	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/148"}}}	1	2016-05-18 21:26:40.913543	2016-05-18 21:26:40.913543
2920	4	36	232	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/148"}}}	1	2016-05-18 21:26:40.928597	2016-05-18 21:26:40.928597
2921	4	308	232	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/148"}}}	1	2016-05-18 21:26:40.941488	2016-05-18 21:26:40.941488
2922	1	304	233	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/braf/300"}}}	1	2016-05-18 21:26:40.958049	2016-05-18 21:26:40.958049
2923	1	307	233	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/braf/300"}}}	1	2016-05-18 21:26:40.971502	2016-05-18 21:26:40.971502
2924	1	304	234	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/braf/298"}}}	1	2016-05-18 21:26:40.987854	2016-05-18 21:26:40.987854
2925	1	307	234	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/braf/298"}}}	1	2016-05-18 21:26:41.00332	2016-05-18 21:26:41.00332
2926	1	304	235	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/braf/299"}}}	1	2016-05-18 21:26:41.018999	2016-05-18 21:26:41.018999
2927	1	307	235	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/braf/299"}}}	1	2016-05-18 21:26:41.035795	2016-05-18 21:26:41.035795
2928	15	304	236	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/braf/209"}}}	1	2016-05-18 21:26:41.052017	2016-05-18 21:26:41.052017
2929	15	307	236	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/braf/209"}}}	1	2016-05-18 21:26:41.068043	2016-05-18 21:26:41.068043
2930	4	75	237	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/147"}}}	1	2016-05-18 21:26:41.082244	2016-05-18 21:26:41.082244
2931	4	309	237	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/147"}}}	1	2016-05-18 21:26:41.100741	2016-05-18 21:26:41.100741
2932	15	75	238	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/braf/71"}}}	1	2016-05-18 21:26:41.116277	2016-05-18 21:26:41.116277
2933	15	309	238	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/braf/71"}}}	1	2016-05-18 21:26:41.131678	2016-05-18 21:26:41.131678
2934	4	75	238	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/71"}}}	1	2016-05-18 21:26:41.144494	2016-05-18 21:26:41.144494
2935	4	309	238	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/71"}}}	1	2016-05-18 21:26:41.162483	2016-05-18 21:26:41.162483
2936	4	75	239	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/146"}}}	1	2016-05-18 21:26:41.175738	2016-05-18 21:26:41.175738
2937	4	309	239	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/146"}}}	1	2016-05-18 21:26:41.19117	2016-05-18 21:26:41.19117
2938	15	75	240	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/braf/310"}}}	1	2016-05-18 21:26:41.205717	2016-05-18 21:26:41.205717
2939	15	309	240	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/braf/310"}}}	1	2016-05-18 21:26:41.221263	2016-05-18 21:26:41.221263
2940	15	75	241	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/braf/70"}}}	1	2016-05-18 21:26:41.237346	2016-05-18 21:26:41.237346
2941	15	309	241	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/braf/70"}}}	1	2016-05-18 21:26:41.252664	2016-05-18 21:26:41.252664
2942	4	310	241	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/70"}}}	1	2016-05-18 21:26:41.267486	2016-05-18 21:26:41.267486
2943	4	270	241	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/70"}}}	1	2016-05-18 21:26:41.279756	2016-05-18 21:26:41.279756
2944	4	271	241	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/70"}}}	1	2016-05-18 21:26:41.297186	2016-05-18 21:26:41.297186
2945	2	310	242	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/egfr/3"}}}	1	2016-05-18 21:26:41.310488	2016-05-18 21:26:41.310488
2946	2	270	242	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/egfr/3"}}}	1	2016-05-18 21:26:41.326988	2016-05-18 21:26:41.326988
2947	2	271	242	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/egfr/3"}}}	1	2016-05-18 21:26:41.340058	2016-05-18 21:26:41.340058
3096	8	61	257	\N	\N	3	\N	2	2016-05-18 21:26:44.026649	2016-05-18 21:26:44.026649
3097	8	62	257	\N	\N	3	\N	2	2016-05-18 21:26:44.039665	2016-05-18 21:26:44.039665
2948	2	310	243	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/egfr/2"}}}	1	2016-05-18 21:26:41.357493	2016-05-18 21:26:41.357493
2949	2	270	243	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/egfr/2"}}}	1	2016-05-18 21:26:41.372018	2016-05-18 21:26:41.372018
2950	2	271	243	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/egfr/2"}}}	1	2016-05-18 21:26:41.386795	2016-05-18 21:26:41.386795
2951	2	201	244	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/egfr/1"}}}	1	2016-05-18 21:26:41.404305	2016-05-18 21:26:41.404305
2952	2	311	244	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/egfr/1"}}}	1	2016-05-18 21:26:41.419624	2016-05-18 21:26:41.419624
2953	2	312	244	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/egfr/1"}}}	1	2016-05-18 21:26:41.435112	2016-05-18 21:26:41.435112
2954	2	313	245	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/egfr/4"}}}	1	2016-05-18 21:26:41.447263	2016-05-18 21:26:41.447263
2955	2	200	246	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/egfr/5"}}}	1	2016-05-18 21:26:41.464508	2016-05-18 21:26:41.464508
2956	2	311	246	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/egfr/5"}}}	1	2016-05-18 21:26:41.477374	2016-05-18 21:26:41.477374
2957	2	201	246	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/egfr/5"}}}	1	2016-05-18 21:26:41.492264	2016-05-18 21:26:41.492264
2958	2	314	247	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/lung-cancer/egfr/6"}}}	1	2016-05-18 21:26:41.505457	2016-05-18 21:26:41.505457
2959	16	315	248	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/jak2/200"}}}	1	2016-05-18 21:26:41.520649	2016-05-18 21:26:41.520649
2960	16	316	249	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/jak2/203"}}}	1	2016-05-18 21:26:41.536047	2016-05-18 21:26:41.536047
2961	16	317	250	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/jak2/202"}}}	1	2016-05-18 21:26:41.54837	2016-05-18 21:26:41.54837
2962	16	36	250	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/jak2/202"}}}	1	2016-05-18 21:26:41.565614	2016-05-18 21:26:41.565614
2963	16	308	250	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/jak2/202"}}}	1	2016-05-18 21:26:41.578754	2016-05-18 21:26:41.578754
2964	16	305	250	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/jak2/202"}}}	1	2016-05-18 21:26:41.595713	2016-05-18 21:26:41.595713
2965	16	306	250	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/jak2/202"}}}	1	2016-05-18 21:26:41.610647	2016-05-18 21:26:41.610647
2966	16	318	250	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/jak2/202"}}}	1	2016-05-18 21:26:41.640879	2016-05-18 21:26:41.640879
2967	16	319	250	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/jak2/202"}}}	1	2016-05-18 21:26:41.652244	2016-05-18 21:26:41.652244
2968	16	320	250	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/jak2/202"}}}	1	2016-05-18 21:26:41.665636	2016-05-18 21:26:41.665636
2969	16	321	250	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/jak2/202"}}}	1	2016-05-18 21:26:41.680273	2016-05-18 21:26:41.680273
2970	16	322	250	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/jak2/202"}}}	1	2016-05-18 21:26:41.696536	2016-05-18 21:26:41.696536
2971	16	36	251	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/jak2/201"}}}	1	2016-05-18 21:26:41.708464	2016-05-18 21:26:41.708464
2972	16	317	251	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/jak2/201"}}}	1	2016-05-18 21:26:41.725693	2016-05-18 21:26:41.725693
2973	16	321	251	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/jak2/201"}}}	1	2016-05-18 21:26:41.738791	2016-05-18 21:26:41.738791
2974	16	322	251	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/jak2/201"}}}	1	2016-05-18 21:26:41.756511	2016-05-18 21:26:41.756511
2975	16	319	251	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/jak2/201"}}}	1	2016-05-18 21:26:41.771183	2016-05-18 21:26:41.771183
2976	16	320	251	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/jak2/201"}}}	1	2016-05-18 21:26:41.788749	2016-05-18 21:26:41.788749
2977	16	323	251	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/jak2/201"}}}	1	2016-05-18 21:26:41.809857	2016-05-18 21:26:41.809857
2978	16	306	251	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/jak2/201"}}}	1	2016-05-18 21:26:41.826745	2016-05-18 21:26:41.826745
2979	16	46	251	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/jak2/201"}}}	1	2016-05-18 21:26:41.850156	2016-05-18 21:26:41.850156
2980	16	324	251	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/jak2/201"}}}	1	2016-05-18 21:26:41.865395	2016-05-18 21:26:41.865395
2981	16	305	251	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/jak2/201"}}}	1	2016-05-18 21:26:41.889484	2016-05-18 21:26:41.889484
2982	16	325	251	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/jak2/201"}}}	1	2016-05-18 21:26:41.910509	2016-05-18 21:26:41.910509
3098	8	63	257	\N	\N	3	\N	2	2016-05-18 21:26:44.056752	2016-05-18 21:26:44.056752
3099	8	64	257	\N	\N	3	\N	2	2016-05-18 21:26:44.074982	2016-05-18 21:26:44.074982
2983	16	318	251	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/jak2/201"}}}	1	2016-05-18 21:26:41.926518	2016-05-18 21:26:41.926518
2984	16	326	251	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/jak2/201"}}}	1	2016-05-18 21:26:41.949459	2016-05-18 21:26:41.949459
2985	1	36	252	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/gnaq/100"}}}	1	2016-05-18 21:26:41.968073	2016-05-18 21:26:41.968073
2986	1	317	252	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/gnaq/100"}}}	1	2016-05-18 21:26:41.990791	2016-05-18 21:26:41.990791
2987	1	306	252	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/gnaq/100"}}}	1	2016-05-18 21:26:42.011301	2016-05-18 21:26:42.011301
2988	1	46	252	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/gnaq/100"}}}	1	2016-05-18 21:26:42.036509	2016-05-18 21:26:42.036509
2989	1	324	252	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/gnaq/100"}}}	1	2016-05-18 21:26:42.059002	2016-05-18 21:26:42.059002
2990	1	305	252	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/gnaq/100"}}}	1	2016-05-18 21:26:42.080162	2016-05-18 21:26:42.080162
2991	1	325	252	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/gnaq/100"}}}	1	2016-05-18 21:26:42.099869	2016-05-18 21:26:42.099869
2992	1	318	252	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/gnaq/100"}}}	1	2016-05-18 21:26:42.11606	2016-05-18 21:26:42.11606
2993	1	319	252	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/gnaq/100"}}}	1	2016-05-18 21:26:42.134826	2016-05-18 21:26:42.134826
2994	1	320	252	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/gnaq/100"}}}	1	2016-05-18 21:26:42.148777	2016-05-18 21:26:42.148777
2995	1	321	252	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/gnaq/100"}}}	1	2016-05-18 21:26:42.161644	2016-05-18 21:26:42.161644
2996	1	322	252	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/gnaq/100"}}}	1	2016-05-18 21:26:42.174415	2016-05-18 21:26:42.174415
2997	1	36	253	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/gnaq/103"}}}	1	2016-05-18 21:26:42.18985	2016-05-18 21:26:42.18985
2998	1	317	253	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/gnaq/103"}}}	1	2016-05-18 21:26:42.20395	2016-05-18 21:26:42.20395
2999	1	327	253	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/gnaq/103"}}}	1	2016-05-18 21:26:42.218291	2016-05-18 21:26:42.218291
3000	1	323	253	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/gnaq/103"}}}	1	2016-05-18 21:26:42.234066	2016-05-18 21:26:42.234066
3001	1	306	253	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/gnaq/103"}}}	1	2016-05-18 21:26:42.248763	2016-05-18 21:26:42.248763
3002	1	46	253	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/gnaq/103"}}}	1	2016-05-18 21:26:42.264349	2016-05-18 21:26:42.264349
3003	1	324	253	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/gnaq/103"}}}	1	2016-05-18 21:26:42.279133	2016-05-18 21:26:42.279133
3004	1	305	253	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/gnaq/103"}}}	1	2016-05-18 21:26:42.293296	2016-05-18 21:26:42.293296
3005	1	325	253	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/gnaq/103"}}}	1	2016-05-18 21:26:42.306847	2016-05-18 21:26:42.306847
3006	1	318	253	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/gnaq/103"}}}	1	2016-05-18 21:26:42.323317	2016-05-18 21:26:42.323317
3007	1	319	253	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/gnaq/103"}}}	1	2016-05-18 21:26:42.339127	2016-05-18 21:26:42.339127
3008	1	320	253	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/gnaq/103"}}}	1	2016-05-18 21:26:42.355715	2016-05-18 21:26:42.355715
3009	1	321	253	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/gnaq/103"}}}	1	2016-05-18 21:26:42.370322	2016-05-18 21:26:42.370322
3010	1	322	253	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/gnaq/103"}}}	1	2016-05-18 21:26:42.384339	2016-05-18 21:26:42.384339
3011	1	328	253	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/gnaq/103"}}}	1	2016-05-18 21:26:42.399994	2016-05-18 21:26:42.399994
3012	1	329	253	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/gnaq/103"}}}	1	2016-05-18 21:26:42.417293	2016-05-18 21:26:42.417293
3013	1	330	253	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/gnaq/103"}}}	1	2016-05-18 21:26:42.435642	2016-05-18 21:26:42.435642
3014	1	331	253	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/gnaq/103"}}}	1	2016-05-18 21:26:42.448838	2016-05-18 21:26:42.448838
3015	1	332	253	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/gnaq/103"}}}	1	2016-05-18 21:26:42.468111	2016-05-18 21:26:42.468111
3016	1	333	253	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/gnaq/103"}}}	1	2016-05-18 21:26:42.481856	2016-05-18 21:26:42.481856
3017	1	36	254	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/gnaq/102"}}}	1	2016-05-18 21:26:42.496337	2016-05-18 21:26:42.496337
3018	1	317	254	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/gnaq/102"}}}	1	2016-05-18 21:26:42.51007	2016-05-18 21:26:42.51007
3019	1	334	254	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/gnaq/102"}}}	1	2016-05-18 21:26:42.531915	2016-05-18 21:26:42.531915
3020	1	326	254	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/gnaq/102"}}}	1	2016-05-18 21:26:42.546413	2016-05-18 21:26:42.546413
3021	1	306	254	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/gnaq/102"}}}	1	2016-05-18 21:26:42.563252	2016-05-18 21:26:42.563252
3022	1	46	254	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/gnaq/102"}}}	1	2016-05-18 21:26:42.580818	2016-05-18 21:26:42.580818
3023	1	324	254	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/gnaq/102"}}}	1	2016-05-18 21:26:42.613884	2016-05-18 21:26:42.613884
3024	1	305	254	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/gnaq/102"}}}	1	2016-05-18 21:26:42.722187	2016-05-18 21:26:42.722187
3025	1	325	254	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/gnaq/102"}}}	1	2016-05-18 21:26:42.743668	2016-05-18 21:26:42.743668
3026	1	318	254	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/gnaq/102"}}}	1	2016-05-18 21:26:42.761269	2016-05-18 21:26:42.761269
3027	1	319	254	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/gnaq/102"}}}	1	2016-05-18 21:26:42.780185	2016-05-18 21:26:42.780185
3028	1	320	254	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/gnaq/102"}}}	1	2016-05-18 21:26:42.820216	2016-05-18 21:26:42.820216
3029	1	321	254	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/gnaq/102"}}}	1	2016-05-18 21:26:42.83754	2016-05-18 21:26:42.83754
3030	1	322	254	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/gnaq/102"}}}	1	2016-05-18 21:26:42.856274	2016-05-18 21:26:42.856274
3031	1	316	254	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/melanoma/gnaq/102"}}}	1	2016-05-18 21:26:42.875692	2016-05-18 21:26:42.875692
3032	16	36	255	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/crlf2/199"}}}	1	2016-05-18 21:26:42.896233	2016-05-18 21:26:42.896233
3033	16	317	255	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/crlf2/199"}}}	1	2016-05-18 21:26:42.922058	2016-05-18 21:26:42.922058
3034	16	327	255	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/crlf2/199"}}}	1	2016-05-18 21:26:42.940498	2016-05-18 21:26:42.940498
3035	16	323	255	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/crlf2/199"}}}	1	2016-05-18 21:26:42.961386	2016-05-18 21:26:42.961386
3036	16	46	255	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/crlf2/199"}}}	1	2016-05-18 21:26:42.98046	2016-05-18 21:26:42.98046
3037	16	305	255	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/crlf2/199"}}}	1	2016-05-18 21:26:43.007218	2016-05-18 21:26:43.007218
3038	16	325	255	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/crlf2/199"}}}	1	2016-05-18 21:26:43.031397	2016-05-18 21:26:43.031397
3039	16	318	255	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/crlf2/199"}}}	1	2016-05-18 21:26:43.050195	2016-05-18 21:26:43.050195
3040	16	306	255	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/crlf2/199"}}}	1	2016-05-18 21:26:43.073095	2016-05-18 21:26:43.073095
3041	16	319	255	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/crlf2/199"}}}	1	2016-05-18 21:26:43.092877	2016-05-18 21:26:43.092877
3042	16	320	255	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/crlf2/199"}}}	1	2016-05-18 21:26:43.113714	2016-05-18 21:26:43.113714
3043	16	322	255	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/crlf2/199"}}}	1	2016-05-18 21:26:43.13257	2016-05-18 21:26:43.13257
3044	16	321	255	\N	\N	3	{"My Cancer Genome":{"urls":{"name":"My Cancer Genome","path":"http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/crlf2/199"}}}	1	2016-05-18 21:26:43.152305	2016-05-18 21:26:43.152305
3045	8	335	1	\N	\N	3	\N	2	2016-05-18 21:26:43.175576	2016-05-18 21:26:43.175576
3046	8	3	1	\N	\N	3	\N	2	2016-05-18 21:26:43.194221	2016-05-18 21:26:43.194221
3047	8	9	4	\N	\N	3	\N	2	2016-05-18 21:26:43.214413	2016-05-18 21:26:43.214413
3048	8	12	4	\N	\N	3	\N	2	2016-05-18 21:26:43.232727	2016-05-18 21:26:43.232727
3049	8	13	4	\N	\N	3	\N	2	2016-05-18 21:26:43.251639	2016-05-18 21:26:43.251639
3050	8	7	4	\N	\N	3	\N	2	2016-05-18 21:26:43.265633	2016-05-18 21:26:43.265633
3051	8	17	5	\N	\N	3	\N	2	2016-05-18 21:26:43.28109	2016-05-18 21:26:43.28109
3052	8	336	5	\N	\N	3	\N	2	2016-05-18 21:26:43.294531	2016-05-18 21:26:43.294531
3053	8	30	5	\N	\N	3	\N	2	2016-05-18 21:26:43.312134	2016-05-18 21:26:43.312134
3054	8	3	5	\N	\N	3	\N	2	2016-05-18 21:26:43.324117	2016-05-18 21:26:43.324117
3055	8	15	7	\N	\N	3	\N	2	2016-05-18 21:26:43.342522	2016-05-18 21:26:43.342522
3056	8	16	7	\N	\N	3	\N	2	2016-05-18 21:26:43.354635	2016-05-18 21:26:43.354635
3057	8	20	7	\N	\N	3	\N	2	2016-05-18 21:26:43.374895	2016-05-18 21:26:43.374895
3058	8	3	7	\N	\N	3	\N	2	2016-05-18 21:26:43.388188	2016-05-18 21:26:43.388188
3059	8	15	10	\N	\N	3	\N	2	2016-05-18 21:26:43.410085	2016-05-18 21:26:43.410085
3060	8	16	10	\N	\N	3	\N	2	2016-05-18 21:26:43.423806	2016-05-18 21:26:43.423806
3061	8	20	10	\N	\N	3	\N	2	2016-05-18 21:26:43.447395	2016-05-18 21:26:43.447395
3062	8	21	10	\N	\N	3	\N	2	2016-05-18 21:26:43.4654	2016-05-18 21:26:43.4654
3063	8	3	10	\N	\N	3	\N	2	2016-05-18 21:26:43.486042	2016-05-18 21:26:43.486042
3064	8	33	12	\N	\N	3	\N	2	2016-05-18 21:26:43.500408	2016-05-18 21:26:43.500408
3065	8	34	12	\N	\N	3	\N	2	2016-05-18 21:26:43.516494	2016-05-18 21:26:43.516494
3066	8	35	12	\N	\N	3	\N	2	2016-05-18 21:26:43.534204	2016-05-18 21:26:43.534204
3067	8	36	12	\N	\N	3	\N	2	2016-05-18 21:26:43.548598	2016-05-18 21:26:43.548598
3068	8	51	12	\N	\N	3	\N	2	2016-05-18 21:26:43.560647	2016-05-18 21:26:43.560647
3069	8	44	12	\N	\N	3	\N	2	2016-05-18 21:26:43.576074	2016-05-18 21:26:43.576074
3070	8	33	13	\N	\N	3	\N	2	2016-05-18 21:26:43.593847	2016-05-18 21:26:43.593847
3071	8	34	13	\N	\N	3	\N	2	2016-05-18 21:26:43.614534	2016-05-18 21:26:43.614534
3072	8	35	13	\N	\N	3	\N	2	2016-05-18 21:26:43.626038	2016-05-18 21:26:43.626038
3073	8	55	13	\N	\N	3	\N	2	2016-05-18 21:26:43.646583	2016-05-18 21:26:43.646583
3074	8	36	13	\N	\N	3	\N	2	2016-05-18 21:26:43.661902	2016-05-18 21:26:43.661902
3075	8	51	13	\N	\N	3	\N	2	2016-05-18 21:26:43.682364	2016-05-18 21:26:43.682364
3076	8	57	15	\N	\N	3	\N	2	2016-05-18 21:26:43.695956	2016-05-18 21:26:43.695956
3077	8	58	15	\N	\N	3	\N	2	2016-05-18 21:26:43.716763	2016-05-18 21:26:43.716763
3078	8	59	15	\N	\N	3	\N	2	2016-05-18 21:26:43.72873	2016-05-18 21:26:43.72873
3079	8	60	15	\N	\N	3	\N	2	2016-05-18 21:26:43.750311	2016-05-18 21:26:43.750311
3080	8	61	15	\N	\N	3	\N	2	2016-05-18 21:26:43.762439	2016-05-18 21:26:43.762439
3149	8	151	260	\N	\N	3	\N	2	2016-05-18 21:26:44.906332	2016-05-18 21:26:44.906332
3150	8	152	260	\N	\N	3	\N	2	2016-05-18 21:26:44.920235	2016-05-18 21:26:44.920235
3151	8	153	260	\N	\N	3	\N	2	2016-05-18 21:26:44.935773	2016-05-18 21:26:44.935773
3152	8	154	260	\N	\N	3	\N	2	2016-05-18 21:26:44.949187	2016-05-18 21:26:44.949187
3153	8	123	261	\N	\N	3	\N	2	2016-05-18 21:26:44.96237	2016-05-18 21:26:44.96237
3154	8	123	262	\N	\N	3	\N	2	2016-05-18 21:26:44.974382	2016-05-18 21:26:44.974382
3155	8	123	263	\N	\N	3	\N	2	2016-05-18 21:26:44.987237	2016-05-18 21:26:44.987237
3156	8	123	264	\N	\N	3	\N	2	2016-05-18 21:26:45.001546	2016-05-18 21:26:45.001546
3157	8	123	265	\N	\N	3	\N	2	2016-05-18 21:26:45.01681	2016-05-18 21:26:45.01681
3158	8	123	266	\N	\N	3	\N	2	2016-05-18 21:26:45.031836	2016-05-18 21:26:45.031836
3159	8	339	267	\N	\N	3	\N	2	2016-05-18 21:26:45.045932	2016-05-18 21:26:45.045932
3160	8	339	268	\N	\N	3	\N	2	2016-05-18 21:26:45.059737	2016-05-18 21:26:45.059737
3161	8	339	269	\N	\N	3	\N	2	2016-05-18 21:26:45.070881	2016-05-18 21:26:45.070881
3162	8	177	270	\N	\N	3	\N	2	2016-05-18 21:26:45.085677	2016-05-18 21:26:45.085677
3163	8	186	270	\N	\N	3	\N	2	2016-05-18 21:26:45.0979	2016-05-18 21:26:45.0979
3164	8	3	270	\N	\N	3	\N	2	2016-05-18 21:26:45.111405	2016-05-18 21:26:45.111405
3165	8	175	271	\N	\N	3	\N	2	2016-05-18 21:26:45.125307	2016-05-18 21:26:45.125307
3166	8	177	271	\N	\N	3	\N	2	2016-05-18 21:26:45.136564	2016-05-18 21:26:45.136564
3167	8	179	271	\N	\N	3	\N	2	2016-05-18 21:26:45.151303	2016-05-18 21:26:45.151303
3168	8	3	271	\N	\N	3	\N	2	2016-05-18 21:26:45.164117	2016-05-18 21:26:45.164117
3169	8	172	272	\N	\N	3	\N	2	2016-05-18 21:26:45.177081	2016-05-18 21:26:45.177081
3170	8	173	272	\N	\N	3	\N	2	2016-05-18 21:26:45.191927	2016-05-18 21:26:45.191927
3171	8	183	272	\N	\N	3	\N	2	2016-05-18 21:26:45.204805	2016-05-18 21:26:45.204805
3172	8	175	272	\N	\N	3	\N	2	2016-05-18 21:26:45.218926	2016-05-18 21:26:45.218926
3173	8	340	272	\N	\N	3	\N	2	2016-05-18 21:26:45.233254	2016-05-18 21:26:45.233254
3174	8	341	272	\N	\N	3	\N	2	2016-05-18 21:26:45.247626	2016-05-18 21:26:45.247626
3175	8	342	272	\N	\N	3	\N	2	2016-05-18 21:26:45.263894	2016-05-18 21:26:45.263894
3176	8	186	272	\N	\N	3	\N	2	2016-05-18 21:26:45.274784	2016-05-18 21:26:45.274784
3177	8	188	272	\N	\N	3	\N	2	2016-05-18 21:26:45.290464	2016-05-18 21:26:45.290464
3178	8	343	272	\N	\N	3	\N	2	2016-05-18 21:26:45.302415	2016-05-18 21:26:45.302415
3179	8	179	272	\N	\N	3	\N	2	2016-05-18 21:26:45.316648	2016-05-18 21:26:45.316648
3180	8	184	272	\N	\N	3	\N	2	2016-05-18 21:26:45.33028	2016-05-18 21:26:45.33028
3181	8	344	272	\N	\N	3	\N	2	2016-05-18 21:26:45.341299	2016-05-18 21:26:45.341299
3182	8	345	272	\N	\N	3	\N	2	2016-05-18 21:26:45.356038	2016-05-18 21:26:45.356038
3183	8	3	272	\N	\N	3	\N	2	2016-05-18 21:26:45.36817	2016-05-18 21:26:45.36817
3184	8	346	273	\N	\N	3	\N	2	2016-05-18 21:26:45.381357	2016-05-18 21:26:45.381357
3185	8	347	273	\N	\N	3	\N	2	2016-05-18 21:26:45.395101	2016-05-18 21:26:45.395101
3186	8	348	273	\N	\N	3	\N	2	2016-05-18 21:26:45.40607	2016-05-18 21:26:45.40607
3187	8	349	273	\N	\N	3	\N	2	2016-05-18 21:26:45.421801	2016-05-18 21:26:45.421801
3188	8	189	273	\N	\N	3	\N	2	2016-05-18 21:26:45.433772	2016-05-18 21:26:45.433772
3189	8	350	273	\N	\N	3	\N	2	2016-05-18 21:26:45.447141	2016-05-18 21:26:45.447141
3190	8	188	273	\N	\N	3	\N	2	2016-05-18 21:26:45.460904	2016-05-18 21:26:45.460904
3191	8	177	273	\N	\N	3	\N	2	2016-05-18 21:26:45.472478	2016-05-18 21:26:45.472478
3192	8	184	273	\N	\N	3	\N	2	2016-05-18 21:26:45.486533	2016-05-18 21:26:45.486533
3193	8	179	273	\N	\N	3	\N	2	2016-05-18 21:26:45.499595	2016-05-18 21:26:45.499595
3194	8	335	273	\N	\N	3	\N	2	2016-05-18 21:26:45.510776	2016-05-18 21:26:45.510776
3195	8	2	273	\N	\N	3	\N	2	2016-05-18 21:26:45.526574	2016-05-18 21:26:45.526574
3196	8	172	273	\N	\N	3	\N	2	2016-05-18 21:26:45.538211	2016-05-18 21:26:45.538211
3197	8	351	273	\N	\N	3	\N	2	2016-05-18 21:26:45.552457	2016-05-18 21:26:45.552457
3198	8	352	273	\N	\N	3	\N	2	2016-05-18 21:26:45.565782	2016-05-18 21:26:45.565782
3199	8	353	273	\N	\N	3	\N	2	2016-05-18 21:26:45.576643	2016-05-18 21:26:45.576643
3200	8	3	273	\N	\N	3	\N	2	2016-05-18 21:26:45.591534	2016-05-18 21:26:45.591534
3201	8	172	274	\N	\N	3	\N	2	2016-05-18 21:26:45.603499	2016-05-18 21:26:45.603499
3202	8	188	274	\N	\N	3	\N	2	2016-05-18 21:26:45.61705	2016-05-18 21:26:45.61705
3203	8	177	274	\N	\N	3	\N	2	2016-05-18 21:26:45.630637	2016-05-18 21:26:45.630637
3204	8	179	274	\N	\N	3	\N	2	2016-05-18 21:26:45.641776	2016-05-18 21:26:45.641776
3205	8	2	274	\N	\N	3	\N	2	2016-05-18 21:26:45.656879	2016-05-18 21:26:45.656879
3206	8	354	274	\N	\N	3	\N	2	2016-05-18 21:26:45.668997	2016-05-18 21:26:45.668997
3207	8	347	274	\N	\N	3	\N	2	2016-05-18 21:26:45.682515	2016-05-18 21:26:45.682515
3208	8	355	274	\N	\N	3	\N	2	2016-05-18 21:26:45.695844	2016-05-18 21:26:45.695844
3209	8	356	274	\N	\N	3	\N	2	2016-05-18 21:26:45.706818	2016-05-18 21:26:45.706818
3210	8	3	274	\N	\N	3	\N	2	2016-05-18 21:26:45.723669	2016-05-18 21:26:45.723669
3211	8	173	275	\N	\N	3	\N	2	2016-05-18 21:26:45.736519	2016-05-18 21:26:45.736519
3212	8	188	275	\N	\N	3	\N	2	2016-05-18 21:26:45.752064	2016-05-18 21:26:45.752064
3213	8	344	275	\N	\N	3	\N	2	2016-05-18 21:26:45.768692	2016-05-18 21:26:45.768692
3214	8	357	275	\N	\N	3	\N	2	2016-05-18 21:26:45.780001	2016-05-18 21:26:45.780001
3215	8	3	275	\N	\N	3	\N	2	2016-05-18 21:26:45.79718	2016-05-18 21:26:45.79718
3216	8	358	276	\N	\N	3	\N	2	2016-05-18 21:26:45.815993	2016-05-18 21:26:45.815993
3217	8	359	276	\N	\N	3	\N	2	2016-05-18 21:26:45.830818	2016-05-18 21:26:45.830818
3218	8	185	276	\N	\N	3	\N	2	2016-05-18 21:26:45.843426	2016-05-18 21:26:45.843426
3219	8	360	276	\N	\N	3	\N	2	2016-05-18 21:26:45.85875	2016-05-18 21:26:45.85875
3220	8	361	276	\N	\N	3	\N	2	2016-05-18 21:26:45.872639	2016-05-18 21:26:45.872639
3221	8	173	276	\N	\N	3	\N	2	2016-05-18 21:26:45.886145	2016-05-18 21:26:45.886145
3222	8	362	276	\N	\N	3	\N	2	2016-05-18 21:26:45.900695	2016-05-18 21:26:45.900695
3223	8	363	276	\N	\N	3	\N	2	2016-05-18 21:26:45.919782	2016-05-18 21:26:45.919782
3224	8	175	276	\N	\N	3	\N	2	2016-05-18 21:26:45.934731	2016-05-18 21:26:45.934731
3225	8	172	276	\N	\N	3	\N	2	2016-05-18 21:26:45.947361	2016-05-18 21:26:45.947361
3226	8	188	276	\N	\N	3	\N	2	2016-05-18 21:26:45.963814	2016-05-18 21:26:45.963814
3227	8	177	276	\N	\N	3	\N	2	2016-05-18 21:26:45.976988	2016-05-18 21:26:45.976988
3228	8	179	276	\N	\N	3	\N	2	2016-05-18 21:26:45.992316	2016-05-18 21:26:45.992316
3229	8	2	276	\N	\N	3	\N	2	2016-05-18 21:26:46.007843	2016-05-18 21:26:46.007843
3230	8	347	276	\N	\N	3	\N	2	2016-05-18 21:26:46.020201	2016-05-18 21:26:46.020201
3231	8	184	276	\N	\N	3	\N	2	2016-05-18 21:26:46.035236	2016-05-18 21:26:46.035236
3232	8	364	276	\N	\N	3	\N	2	2016-05-18 21:26:46.053858	2016-05-18 21:26:46.053858
3233	8	350	276	\N	\N	3	\N	2	2016-05-18 21:26:46.066573	2016-05-18 21:26:46.066573
3234	8	365	276	\N	\N	3	\N	2	2016-05-18 21:26:46.084759	2016-05-18 21:26:46.084759
3235	8	3	276	\N	\N	3	\N	2	2016-05-18 21:26:46.10029	2016-05-18 21:26:46.10029
3236	8	173	277	\N	\N	3	\N	2	2016-05-18 21:26:46.114005	2016-05-18 21:26:46.114005
3237	8	193	277	\N	\N	3	\N	2	2016-05-18 21:26:46.127616	2016-05-18 21:26:46.127616
3238	8	366	277	\N	\N	3	\N	2	2016-05-18 21:26:46.142276	2016-05-18 21:26:46.142276
3239	8	367	277	\N	\N	3	\N	2	2016-05-18 21:26:46.159117	2016-05-18 21:26:46.159117
3240	8	177	277	\N	\N	3	\N	2	2016-05-18 21:26:46.174878	2016-05-18 21:26:46.174878
3241	8	175	277	\N	\N	3	\N	2	2016-05-18 21:26:46.186257	2016-05-18 21:26:46.186257
3242	8	3	277	\N	\N	3	\N	2	2016-05-18 21:26:46.200226	2016-05-18 21:26:46.200226
3243	8	172	278	\N	\N	3	\N	2	2016-05-18 21:26:46.214774	2016-05-18 21:26:46.214774
3244	8	368	278	\N	\N	3	\N	2	2016-05-18 21:26:46.231037	2016-05-18 21:26:46.231037
3245	8	193	278	\N	\N	3	\N	2	2016-05-18 21:26:46.243297	2016-05-18 21:26:46.243297
3246	8	175	278	\N	\N	3	\N	2	2016-05-18 21:26:46.259399	2016-05-18 21:26:46.259399
3247	8	177	278	\N	\N	3	\N	2	2016-05-18 21:26:46.273274	2016-05-18 21:26:46.273274
3248	8	184	278	\N	\N	3	\N	2	2016-05-18 21:26:46.287444	2016-05-18 21:26:46.287444
3249	8	3	278	\N	\N	3	\N	2	2016-05-18 21:26:46.302219	2016-05-18 21:26:46.302219
3250	8	172	279	\N	\N	3	\N	2	2016-05-18 21:26:46.31347	2016-05-18 21:26:46.31347
3251	8	359	279	\N	\N	3	\N	2	2016-05-18 21:26:46.334176	2016-05-18 21:26:46.334176
3252	8	188	279	\N	\N	3	\N	2	2016-05-18 21:26:46.345904	2016-05-18 21:26:46.345904
3253	8	177	279	\N	\N	3	\N	2	2016-05-18 21:26:46.362753	2016-05-18 21:26:46.362753
3254	8	184	279	\N	\N	3	\N	2	2016-05-18 21:26:46.375803	2016-05-18 21:26:46.375803
3255	8	179	279	\N	\N	3	\N	2	2016-05-18 21:26:46.390015	2016-05-18 21:26:46.390015
3256	8	364	279	\N	\N	3	\N	2	2016-05-18 21:26:46.404699	2016-05-18 21:26:46.404699
3257	8	191	279	\N	\N	3	\N	2	2016-05-18 21:26:46.419088	2016-05-18 21:26:46.419088
3258	8	369	279	\N	\N	3	\N	2	2016-05-18 21:26:46.434918	2016-05-18 21:26:46.434918
3259	8	370	279	\N	\N	3	\N	2	2016-05-18 21:26:46.449064	2016-05-18 21:26:46.449064
3260	8	371	279	\N	\N	3	\N	2	2016-05-18 21:26:46.463323	2016-05-18 21:26:46.463323
3261	8	372	279	\N	\N	3	\N	2	2016-05-18 21:26:46.477004	2016-05-18 21:26:46.477004
3262	8	342	279	\N	\N	3	\N	2	2016-05-18 21:26:46.492113	2016-05-18 21:26:46.492113
3263	8	373	279	\N	\N	3	\N	2	2016-05-18 21:26:46.507727	2016-05-18 21:26:46.507727
3264	8	3	279	\N	\N	3	\N	2	2016-05-18 21:26:46.521776	2016-05-18 21:26:46.521776
3265	8	172	280	\N	\N	3	\N	2	2016-05-18 21:26:46.537992	2016-05-18 21:26:46.537992
3266	8	177	280	\N	\N	3	\N	2	2016-05-18 21:26:46.552146	2016-05-18 21:26:46.552146
3267	8	179	280	\N	\N	3	\N	2	2016-05-18 21:26:46.566539	2016-05-18 21:26:46.566539
3268	8	344	280	\N	\N	3	\N	2	2016-05-18 21:26:46.580028	2016-05-18 21:26:46.580028
3269	8	374	280	\N	\N	3	\N	2	2016-05-18 21:26:46.592217	2016-05-18 21:26:46.592217
3270	8	375	280	\N	\N	3	\N	2	2016-05-18 21:26:46.605549	2016-05-18 21:26:46.605549
3271	8	372	280	\N	\N	3	\N	2	2016-05-18 21:26:46.619556	2016-05-18 21:26:46.619556
3272	8	3	280	\N	\N	3	\N	2	2016-05-18 21:26:46.643702	2016-05-18 21:26:46.643702
3273	8	279	281	\N	\N	3	\N	2	2016-05-18 21:26:46.661111	2016-05-18 21:26:46.661111
3274	8	287	281	\N	\N	3	\N	2	2016-05-18 21:26:46.676537	2016-05-18 21:26:46.676537
3275	8	376	281	\N	\N	3	\N	2	2016-05-18 21:26:46.695884	2016-05-18 21:26:46.695884
3276	8	377	282	\N	\N	3	\N	2	2016-05-18 21:26:46.711035	2016-05-18 21:26:46.711035
3277	8	285	283	\N	\N	3	\N	2	2016-05-18 21:26:46.730692	2016-05-18 21:26:46.730692
3278	8	378	284	\N	\N	3	\N	2	2016-05-18 21:26:46.746034	2016-05-18 21:26:46.746034
3279	8	279	284	\N	\N	3	\N	2	2016-05-18 21:26:46.767377	2016-05-18 21:26:46.767377
3280	8	379	284	\N	\N	3	\N	2	2016-05-18 21:26:46.787989	2016-05-18 21:26:46.787989
3281	8	380	285	\N	\N	3	\N	2	2016-05-18 21:26:46.805328	2016-05-18 21:26:46.805328
3282	2	381	286	\N	\N	3	\N	3	2016-05-18 21:26:46.819068	2016-05-18 21:26:46.819068
3283	2	382	286	\N	\N	3	\N	3	2016-05-18 21:26:46.826305	2016-05-18 21:26:46.826305
3284	2	383	286	\N	\N	3	\N	3	2016-05-18 21:26:46.834172	2016-05-18 21:26:46.834172
3285	2	384	286	\N	\N	3	\N	3	2016-05-18 21:26:46.840356	2016-05-18 21:26:46.840356
3286	8	156	287	\N	\N	3	\N	3	2016-05-18 21:26:46.848723	2016-05-18 21:26:46.848723
3287	8	157	287	\N	\N	3	\N	3	2016-05-18 21:26:46.855818	2016-05-18 21:26:46.855818
3288	8	158	287	\N	\N	3	\N	3	2016-05-18 21:26:46.862327	2016-05-18 21:26:46.862327
3289	8	156	288	\N	\N	3	\N	3	2016-05-18 21:26:46.868036	2016-05-18 21:26:46.868036
3290	8	385	288	\N	\N	3	\N	3	2016-05-18 21:26:46.873608	2016-05-18 21:26:46.873608
3291	8	156	289	\N	\N	3	\N	3	2016-05-18 21:26:46.88198	2016-05-18 21:26:46.88198
3292	8	385	289	\N	\N	3	\N	3	2016-05-18 21:26:46.889507	2016-05-18 21:26:46.889507
3293	8	339	290	\N	\N	3	\N	3	2016-05-18 21:26:46.896139	2016-05-18 21:26:46.896139
3294	8	339	291	\N	\N	3	\N	3	2016-05-18 21:26:46.901606	2016-05-18 21:26:46.901606
3295	8	339	292	\N	\N	3	\N	3	2016-05-18 21:26:46.907066	2016-05-18 21:26:46.907066
3296	8	339	293	\N	\N	3	\N	3	2016-05-18 21:26:46.914737	2016-05-18 21:26:46.914737
3297	8	339	294	\N	\N	3	\N	3	2016-05-18 21:26:46.92224	2016-05-18 21:26:46.92224
3298	8	339	295	\N	\N	3	\N	3	2016-05-18 21:26:46.928872	2016-05-18 21:26:46.928872
3299	8	339	296	\N	\N	3	\N	3	2016-05-18 21:26:46.93472	2016-05-18 21:26:46.93472
3300	1	255	168	\N	\N	3	\N	3	2016-05-18 21:26:46.9403	2016-05-18 21:26:46.9403
3301	1	256	168	\N	\N	3	\N	3	2016-05-18 21:26:46.948353	2016-05-18 21:26:46.948353
3302	1	262	297	\N	\N	3	\N	3	2016-05-18 21:26:46.955773	2016-05-18 21:26:46.955773
3303	1	74	297	\N	\N	3	\N	3	2016-05-18 21:26:46.962522	2016-05-18 21:26:46.962522
3304	1	75	297	\N	\N	3	\N	3	2016-05-18 21:26:46.968107	2016-05-18 21:26:46.968107
3305	1	76	297	\N	\N	3	\N	3	2016-05-18 21:26:46.973576	2016-05-18 21:26:46.973576
3306	1	77	297	\N	\N	3	\N	3	2016-05-18 21:26:46.981566	2016-05-18 21:26:46.981566
3307	1	78	297	\N	\N	3	\N	3	2016-05-18 21:26:46.988567	2016-05-18 21:26:46.988567
3308	1	79	297	\N	\N	3	\N	3	2016-05-18 21:26:46.995502	2016-05-18 21:26:46.995502
3309	1	263	297	\N	\N	3	\N	3	2016-05-18 21:26:47.001036	2016-05-18 21:26:47.001036
3310	1	264	297	\N	\N	3	\N	3	2016-05-18 21:26:47.007508	2016-05-18 21:26:47.007508
3311	1	265	297	\N	\N	3	\N	3	2016-05-18 21:26:47.015399	2016-05-18 21:26:47.015399
3312	1	234	297	\N	\N	3	\N	3	2016-05-18 21:26:47.021418	2016-05-18 21:26:47.021418
3313	8	273	197	\N	\N	3	\N	3	2016-05-18 21:26:47.027817	2016-05-18 21:26:47.027817
3314	1	273	198	\N	\N	3	\N	3	2016-05-18 21:26:47.035419	2016-05-18 21:26:47.035419
3315	11	229	198	\N	\N	3	\N	3	2016-05-18 21:26:47.042346	2016-05-18 21:26:47.042346
3316	11	230	198	\N	\N	3	\N	3	2016-05-18 21:26:47.050786	2016-05-18 21:26:47.050786
3317	11	229	200	\N	\N	3	\N	3	2016-05-18 21:26:47.059152	2016-05-18 21:26:47.059152
3318	11	230	200	\N	\N	3	\N	3	2016-05-18 21:26:47.066397	2016-05-18 21:26:47.066397
3319	1	304	298	\N	\N	3	\N	3	2016-05-18 21:26:47.07209	2016-05-18 21:26:47.07209
3320	1	307	298	\N	\N	3	\N	3	2016-05-18 21:26:47.077838	2016-05-18 21:26:47.077838
3321	1	304	299	\N	\N	3	\N	3	2016-05-18 21:26:47.0863	2016-05-18 21:26:47.0863
3322	1	307	299	\N	\N	3	\N	3	2016-05-18 21:26:47.092809	2016-05-18 21:26:47.092809
3324	17	6	301	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"ruxolitinib (in SH2B3 deleted)","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"22897847, 22955920","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"mTOR inhibitors  (in SH2B3 deleted)","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"22955920","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:26:47.276083	2016-05-18 21:41:43.245557
3325	17	7	301	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"ruxolitinib (in SH2B3 deleted)","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"22897847, 22955920","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"mTOR inhibitors  (in SH2B3 deleted)","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"22955920","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:26:47.33369	2016-05-18 21:41:43.253409
3326	17	7	302	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"ruxolitinib","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"22955920","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:26:47.419525	2016-05-18 21:41:43.260034
4190	19	177	483	\N	\N	3	\N	5	2016-05-18 21:28:02.000584	2016-05-18 21:28:02.000584
4191	19	179	483	\N	\N	3	\N	5	2016-05-18 21:28:02.070674	2016-05-18 21:28:02.070674
4192	19	3	483	\N	\N	3	\N	5	2016-05-18 21:28:02.12493	2016-05-18 21:28:02.12493
3329	17	13	248	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"ruxolitinib","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"18805579, 22955920","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:26:47.584731	2016-05-18 21:41:43.285824
3330	17	7	248	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"ruxolitinib","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"18805579, 22955920","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:26:47.656566	2016-05-18 21:41:43.292701
3331	17	9	249	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"ruxolitinib","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"18805579, 22955920","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:26:47.707213	2016-05-18 21:41:43.301459
3332	17	12	249	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"ruxolitinib","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"18805579, 22955920","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:26:47.764636	2016-05-18 21:41:43.308995
3333	17	13	249	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"ruxolitinib","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"18805579, 22955920","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:26:47.828042	2016-05-18 21:41:43.315975
3334	17	7	249	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"ruxolitinib","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"18805579, 22955920","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:26:47.875449	2016-05-18 21:41:43.32414
3335	17	9	250	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"ruxolitinib","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"18805579, 22955920","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:26:47.931307	2016-05-18 21:41:43.332583
3336	17	12	250	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"ruxolitinib","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"18805579, 22955920","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:26:47.995448	2016-05-18 21:41:43.341149
3337	17	13	250	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"ruxolitinib","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"18805579, 22955920","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:26:48.043124	2016-05-18 21:41:43.34848
3338	17	7	250	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"ruxolitinib","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"18805579, 22955920","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:26:48.108858	2016-05-18 21:41:43.35769
3339	17	9	251	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"ruxolitinib","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"18805579, 22955920","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:26:48.161864	2016-05-18 21:41:43.363308
3340	17	12	251	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"ruxolitinib","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"18805579, 22955920","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:26:48.235038	2016-05-18 21:41:43.375071
3341	17	13	251	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"ruxolitinib","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"18805579, 22955920","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:26:48.293087	2016-05-18 21:41:43.382254
4193	19	177	484	\N	\N	3	\N	5	2016-05-18 21:28:02.212811	2016-05-18 21:28:02.212811
3327	17	9	248	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"ruxolitinib","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"18805579, 22955920","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:26:47.468138	2016-05-18 21:41:43.269297
3328	17	12	248	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"ruxolitinib","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"18805579, 22955920","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:26:47.529793	2016-05-18 21:41:43.278645
3344	4	34	226	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"cetuximab, panitumumab","Association":"resistance","Status":"late trials","Evidence":"emerging","Source":"20619739, 21163703, 23325582","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors +/- MEK inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"22608338, J Clin Oncol 2010;28:(suppl; abstr 3534), J Clin Oncol 2012;30:(suppl; abstr 3528)","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors + EGFR inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"22281684","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors + PI3K pathway inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23251002, 23549875","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"proteosome inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"24107445.0","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"preclinical","Association":"mTOR inhibitors + BH3 mimetics","Status":"preclinical","Evidence":"emerging","Source":"24163374","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:26:48.432805	2016-05-18 21:41:43.42115
3345	4	35	226	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"cetuximab, panitumumab","Association":"resistance","Status":"late trials","Evidence":"emerging","Source":"20619739, 21163703, 23325582","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors +/- MEK inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"22608338, J Clin Oncol 2010;28:(suppl; abstr 3534), J Clin Oncol 2012;30:(suppl; abstr 3528)","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors + EGFR inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"22281684","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors + PI3K pathway inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23251002, 23549875","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"proteosome inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"24107445.0","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"preclinical","Association":"mTOR inhibitors + BH3 mimetics","Status":"preclinical","Evidence":"emerging","Source":"24163374","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:26:48.5022	2016-05-18 21:41:43.438022
3346	4	36	226	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"cetuximab, panitumumab","Association":"resistance","Status":"late trials","Evidence":"emerging","Source":"20619739, 21163703, 23325582","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors +/- MEK inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"22608338, J Clin Oncol 2010;28:(suppl; abstr 3534), J Clin Oncol 2012;30:(suppl; abstr 3528)","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors + EGFR inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"22281684","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors + PI3K pathway inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23251002, 23549875","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"proteosome inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"24107445.0","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"preclinical","Association":"mTOR inhibitors + BH3 mimetics","Status":"preclinical","Evidence":"emerging","Source":"24163374","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:26:48.545926	2016-05-18 21:41:43.454655
3366	4	61	42	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"panitumumab","Association":"resistance","Status":"FDA-rejected","Evidence":"consensus","Source":"FDA","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"cetuximab","Association":"response","Status":"late trials","Evidence":"emerging","Source":"22734028, 20978259","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors + PI3K pathway inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"22392911","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:26:49.544235	2016-05-18 21:41:43.471237
3342	17	7	251	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"ruxolitinib","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"18805579, 22955920","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:26:48.337826	2016-05-18 21:41:43.391268
3349	4	39	226	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"cetuximab, panitumumab","Association":"resistance","Status":"late trials","Evidence":"emerging","Source":"20619739, 21163703, 23325582","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors +/- MEK inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"22608338, J Clin Oncol 2010;28:(suppl; abstr 3534), J Clin Oncol 2012;30:(suppl; abstr 3528)","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors + EGFR inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"22281684","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors + PI3K pathway inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23251002, 23549875","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"proteosome inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"24107445.0","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"preclinical","Association":"mTOR inhibitors + BH3 mimetics","Status":"preclinical","Evidence":"emerging","Source":"24163374","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:26:48.690584	2016-05-18 21:41:43.527544
3350	4	40	226	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"cetuximab, panitumumab","Association":"resistance","Status":"late trials","Evidence":"emerging","Source":"20619739, 21163703, 23325582","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors +/- MEK inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"22608338, J Clin Oncol 2010;28:(suppl; abstr 3534), J Clin Oncol 2012;30:(suppl; abstr 3528)","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors + EGFR inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"22281684","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors + PI3K pathway inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23251002, 23549875","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"proteosome inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"24107445.0","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"preclinical","Association":"mTOR inhibitors + BH3 mimetics","Status":"preclinical","Evidence":"emerging","Source":"24163374","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:26:48.73583	2016-05-18 21:41:43.547143
3367	4	62	42	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"panitumumab","Association":"resistance","Status":"FDA-rejected","Evidence":"consensus","Source":"FDA","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"cetuximab","Association":"response","Status":"late trials","Evidence":"emerging","Source":"22734028, 20978259","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors + PI3K pathway inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"22392911","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:26:49.597108	2016-05-18 21:41:43.561034
3348	4	38	226	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"cetuximab, panitumumab","Association":"resistance","Status":"late trials","Evidence":"emerging","Source":"20619739, 21163703, 23325582","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors +/- MEK inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"22608338, J Clin Oncol 2010;28:(suppl; abstr 3534), J Clin Oncol 2012;30:(suppl; abstr 3528)","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors + EGFR inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"22281684","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors + PI3K pathway inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23251002, 23549875","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"proteosome inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"24107445.0","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"preclinical","Association":"mTOR inhibitors + BH3 mimetics","Status":"preclinical","Evidence":"emerging","Source":"24163374","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:26:48.642118	2016-05-18 21:41:43.512935
3384	11	92	167	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"imatinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"23582185, 21689725, 17259998","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:26:50.705677	2016-05-18 21:41:43.575883
3353	4	43	226	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"cetuximab, panitumumab","Association":"resistance","Status":"late trials","Evidence":"emerging","Source":"20619739, 21163703, 23325582","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors +/- MEK inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"22608338, J Clin Oncol 2010;28:(suppl; abstr 3534), J Clin Oncol 2012;30:(suppl; abstr 3528)","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors + EGFR inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"22281684","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors + PI3K pathway inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23251002, 23549875","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"proteosome inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"24107445.0","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"preclinical","Association":"mTOR inhibitors + BH3 mimetics","Status":"preclinical","Evidence":"emerging","Source":"24163374","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:26:48.905684	2016-05-18 21:41:43.62026
3354	4	44	226	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"cetuximab, panitumumab","Association":"resistance","Status":"late trials","Evidence":"emerging","Source":"20619739, 21163703, 23325582","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors +/- MEK inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"22608338, J Clin Oncol 2010;28:(suppl; abstr 3534), J Clin Oncol 2012;30:(suppl; abstr 3528)","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors + EGFR inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"22281684","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors + PI3K pathway inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23251002, 23549875","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"proteosome inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"24107445.0","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"preclinical","Association":"mTOR inhibitors + BH3 mimetics","Status":"preclinical","Evidence":"emerging","Source":"24163374","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:26:48.953941	2016-05-18 21:41:43.638499
3368	4	63	42	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"panitumumab","Association":"resistance","Status":"FDA-rejected","Evidence":"consensus","Source":"FDA","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"cetuximab","Association":"response","Status":"late trials","Evidence":"emerging","Source":"22734028, 20978259","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors + PI3K pathway inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"22392911","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:26:49.652429	2016-05-18 21:41:43.651957
3352	4	42	226	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"cetuximab, panitumumab","Association":"resistance","Status":"late trials","Evidence":"emerging","Source":"20619739, 21163703, 23325582","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors +/- MEK inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"22608338, J Clin Oncol 2010;28:(suppl; abstr 3534), J Clin Oncol 2012;30:(suppl; abstr 3528)","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors + EGFR inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"22281684","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors + PI3K pathway inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23251002, 23549875","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"proteosome inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"24107445.0","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"preclinical","Association":"mTOR inhibitors + BH3 mimetics","Status":"preclinical","Evidence":"emerging","Source":"24163374","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:26:48.853706	2016-05-18 21:41:43.605042
3385	11	90	192	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"imatinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"23582185, 21689725, 17259998","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:26:50.763555	2016-05-18 21:41:43.665209
3357	4	47	226	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"cetuximab, panitumumab","Association":"resistance","Status":"late trials","Evidence":"emerging","Source":"20619739, 21163703, 23325582","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors +/- MEK inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"22608338, J Clin Oncol 2010;28:(suppl; abstr 3534), J Clin Oncol 2012;30:(suppl; abstr 3528)","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors + EGFR inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"22281684","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors + PI3K pathway inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23251002, 23549875","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"proteosome inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"24107445.0","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"preclinical","Association":"mTOR inhibitors + BH3 mimetics","Status":"preclinical","Evidence":"emerging","Source":"24163374","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:26:49.104297	2016-05-18 21:41:43.715899
3358	4	48	226	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"cetuximab, panitumumab","Association":"resistance","Status":"late trials","Evidence":"emerging","Source":"20619739, 21163703, 23325582","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors +/- MEK inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"22608338, J Clin Oncol 2010;28:(suppl; abstr 3534), J Clin Oncol 2012;30:(suppl; abstr 3528)","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors + EGFR inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"22281684","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors + PI3K pathway inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23251002, 23549875","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"proteosome inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"24107445.0","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"preclinical","Association":"mTOR inhibitors + BH3 mimetics","Status":"preclinical","Evidence":"emerging","Source":"24163374","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:26:49.15188	2016-05-18 21:41:43.730393
3369	4	64	42	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"panitumumab","Association":"resistance","Status":"FDA-rejected","Evidence":"consensus","Source":"FDA","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"cetuximab","Association":"response","Status":"late trials","Evidence":"emerging","Source":"22734028, 20978259","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors + PI3K pathway inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"22392911","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:26:49.728648	2016-05-18 21:41:43.748348
3356	4	46	226	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"cetuximab, panitumumab","Association":"resistance","Status":"late trials","Evidence":"emerging","Source":"20619739, 21163703, 23325582","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors +/- MEK inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"22608338, J Clin Oncol 2010;28:(suppl; abstr 3534), J Clin Oncol 2012;30:(suppl; abstr 3528)","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors + EGFR inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"22281684","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors + PI3K pathway inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23251002, 23549875","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"proteosome inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"24107445.0","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"preclinical","Association":"mTOR inhibitors + BH3 mimetics","Status":"preclinical","Evidence":"emerging","Source":"24163374","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:26:49.055336	2016-05-18 21:41:43.69032
3386	11	91	192	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"imatinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"23582185, 21689725, 17259998","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:26:50.824395	2016-05-18 21:41:43.757605
3361	4	56	303	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"cetuximab","Association":"resistance","Status":"case report","Evidence":"emerging","Source":"22270724","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"panitumumab","Association":"response","Status":"case report","Evidence":"emerging","Source":"22270724","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:26:49.318381	2016-05-18 21:41:43.806927
3363	4	58	42	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"panitumumab","Association":"resistance","Status":"FDA-rejected","Evidence":"consensus","Source":"FDA","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"cetuximab","Association":"response","Status":"late trials","Evidence":"emerging","Source":"22734028, 20978259","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors + PI3K pathway inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"22392911","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:26:49.405349	2016-05-18 21:41:43.828615
3364	4	59	42	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"panitumumab","Association":"resistance","Status":"FDA-rejected","Evidence":"consensus","Source":"FDA","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"cetuximab","Association":"response","Status":"late trials","Evidence":"emerging","Source":"22734028, 20978259","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors + PI3K pathway inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"22392911","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:26:49.45126	2016-05-18 21:41:43.840738
3365	4	60	42	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"panitumumab","Association":"resistance","Status":"FDA-rejected","Evidence":"consensus","Source":"FDA","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"cetuximab","Association":"response","Status":"late trials","Evidence":"emerging","Source":"22734028, 20978259","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors + PI3K pathway inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"22392911","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:26:49.501698	2016-05-18 21:41:43.850551
3383	11	91	167	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"imatinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"23582185, 21689725, 17259998","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:26:50.649931	2016-05-18 21:41:43.859554
3360	4	50	226	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"cetuximab, panitumumab","Association":"resistance","Status":"late trials","Evidence":"emerging","Source":"20619739, 21163703, 23325582","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors +/- MEK inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"22608338, J Clin Oncol 2010;28:(suppl; abstr 3534), J Clin Oncol 2012;30:(suppl; abstr 3528)","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors + EGFR inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"22281684","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors + PI3K pathway inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23251002, 23549875","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"proteosome inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"24107445.0","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"preclinical","Association":"mTOR inhibitors + BH3 mimetics","Status":"preclinical","Evidence":"emerging","Source":"24163374","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:26:49.255827	2016-05-18 21:41:43.785113
3362	4	57	42	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"panitumumab","Association":"resistance","Status":"FDA-rejected","Evidence":"consensus","Source":"FDA","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"cetuximab","Association":"response","Status":"late trials","Evidence":"emerging","Source":"22734028, 20978259","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors + PI3K pathway inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"22392911","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:26:49.359176	2016-05-18 21:41:43.81713
3372	4	67	42	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"panitumumab","Association":"resistance","Status":"FDA-rejected","Evidence":"consensus","Source":"FDA","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"cetuximab","Association":"response","Status":"late trials","Evidence":"emerging","Source":"22734028, 20978259","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors + PI3K pathway inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"22392911","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:26:49.894212	2016-05-18 21:41:43.891339
3373	11	337	226	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"dabrafenib","Association":"response","Status":"case report","Evidence":"emerging","Source":"23470635, 22608338","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:26:49.953364	2016-05-18 21:41:43.899347
3374	11	36	226	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"dabrafenib","Association":"response","Status":"case report","Evidence":"emerging","Source":"23470635, 22608338","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:26:50.007958	2016-05-18 21:41:43.909103
3375	11	305	226	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"dabrafenib","Association":"response","Status":"case report","Evidence":"emerging","Source":"23470635, 22608338","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:26:50.053255	2016-05-18 21:41:43.917816
3376	11	306	226	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"dabrafenib","Association":"response","Status":"case report","Evidence":"emerging","Source":"23470635, 22608338","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:26:50.120562	2016-05-18 21:41:43.926589
3377	11	338	226	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"dabrafenib","Association":"response","Status":"case report","Evidence":"emerging","Source":"23470635, 22608338","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:26:50.168906	2016-05-18 21:41:43.937559
3378	11	46	226	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"dabrafenib","Association":"response","Status":"case report","Evidence":"emerging","Source":"23470635, 22608338","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:26:50.25768	2016-05-18 21:41:43.944621
3379	11	90	304	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"imatinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"23582185, 21689725, 17259998","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:26:50.370294	2016-05-18 21:41:43.952474
3380	11	91	304	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"imatinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"23582185, 21689725, 17259998","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:26:50.446085	2016-05-18 21:41:43.960675
3381	11	92	304	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"imatinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"23582185, 21689725, 17259998","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:26:50.524216	2016-05-18 21:41:43.97661
3382	11	90	167	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"imatinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"23582185, 21689725, 17259998","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:26:50.579062	2016-05-18 21:41:43.984684
3370	4	65	42	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"panitumumab","Association":"resistance","Status":"FDA-rejected","Evidence":"consensus","Source":"FDA","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"cetuximab","Association":"response","Status":"late trials","Evidence":"emerging","Source":"22734028, 20978259","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors + PI3K pathway inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"22392911","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:26:49.781216	2016-05-18 21:41:43.866882
3371	4	66	42	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"panitumumab","Association":"resistance","Status":"FDA-rejected","Evidence":"consensus","Source":"FDA","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"cetuximab","Association":"response","Status":"late trials","Evidence":"emerging","Source":"22734028, 20978259","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors + PI3K pathway inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"22392911","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:26:49.838787	2016-05-18 21:41:43.880126
3389	11	94	305	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"imatinib","Association":"resistance","Status":"case report","Evidence":"emerging","Source":"24687822","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:26:51.021842	2016-05-18 21:41:44.02227
3390	11	90	305	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"imatinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"23582185, 21689725, 17259998","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:26:51.083918	2016-05-18 21:41:44.030739
3391	11	91	305	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"imatinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"23582185, 21689725, 17259998","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:26:51.143446	2016-05-18 21:41:44.038877
3392	11	92	305	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"imatinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"23582185, 21689725, 17259998","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:26:51.207539	2016-05-18 21:41:44.046457
3393	11	90	200	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"imatinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"23582185, 21689725, 17259998","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:26:51.267829	2016-05-18 21:41:44.053497
3394	11	91	200	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"imatinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"23582185, 21689725, 17259998","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:26:51.332191	2016-05-18 21:41:44.062502
3395	11	92	200	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"imatinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"23582185, 21689725, 17259998","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:26:51.39313	2016-05-18 21:41:44.072421
3396	11	90	206	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"imatinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"23582185, 21689725, 17259998","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:26:51.468341	2016-05-18 21:41:44.079463
3397	11	91	206	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"imatinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"23582185, 21689725, 17259998","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:26:51.527045	2016-05-18 21:41:44.086986
3398	11	92	206	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"imatinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"23582185, 21689725, 17259998","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:26:51.589502	2016-05-18 21:41:44.095491
3399	11	90	209	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"imatinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"23582185, 21689725, 17259998","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:26:51.664281	2016-05-18 21:41:44.101242
3400	11	91	209	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"imatinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"23582185, 21689725, 17259998","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:26:51.732621	2016-05-18 21:41:44.114465
3401	11	92	209	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"imatinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"23582185, 21689725, 17259998","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:26:51.789132	2016-05-18 21:41:44.122373
3387	11	92	192	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"imatinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"23582185, 21689725, 17259998","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:26:50.888246	2016-05-18 21:41:43.993687
3388	11	93	192	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"imatinib","Association":"decreased sensitivity","Status":"preclinical","Evidence":"emerging","Source":"16751810","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:26:50.943851	2016-05-18 21:41:44.015416
3404	11	92	210	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"imatinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"23582185, 21689725, 17259998","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:26:51.984021	2016-05-18 21:41:44.151735
3406	11	97	148	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"imatinib, sunitinib","Association":"resistance","Status":"late trials, preclinical","Evidence":"emerging","Source":"22718859, 16638875","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"HSP90 inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"18794084","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"crenolanib","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"22745105","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"dasatinib","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"18794084","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:26:52.123317	2016-05-18 21:41:44.173342
3407	11	98	148	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"imatinib, sunitinib","Association":"resistance","Status":"late trials, preclinical","Evidence":"emerging","Source":"22718859, 16638875","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"HSP90 inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"18794084","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"crenolanib","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"22745105","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"dasatinib","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"18794084","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:26:52.200457	2016-05-18 21:41:44.185262
3408	11	99	148	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"imatinib, sunitinib","Association":"resistance","Status":"late trials, preclinical","Evidence":"emerging","Source":"22718859, 16638875","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"HSP90 inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"18794084","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"crenolanib","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"22745105","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"dasatinib","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"18794084","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:26:52.266609	2016-05-18 21:41:44.218446
3409	11	100	148	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"imatinib, sunitinib","Association":"resistance","Status":"late trials, preclinical","Evidence":"emerging","Source":"22718859, 16638875","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"HSP90 inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"18794084","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"crenolanib","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"22745105","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"dasatinib","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"18794084","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:26:52.345858	2016-05-18 21:41:44.230203
3410	11	101	148	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"imatinib, sunitinib","Association":"resistance","Status":"late trials, preclinical","Evidence":"emerging","Source":"22718859, 16638875","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"HSP90 inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"18794084","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"crenolanib","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"22745105","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"dasatinib","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"18794084","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:26:52.418227	2016-05-18 21:41:44.249891
3402	11	90	210	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"imatinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"23582185, 21689725, 17259998","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:26:51.8623	2016-05-18 21:41:44.134778
3403	11	91	210	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"imatinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"23582185, 21689725, 17259998","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:26:51.917723	2016-05-18 21:41:44.141988
3413	8	113	306	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"quizartinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"22504184","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"ponatinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"23430109","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"crenolanib, PKC412","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"24619500","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:26:52.665795	2016-05-18 21:41:44.293073
3414	8	111	307	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"quizartinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"22504184","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"ponatinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"23430109","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"crenolanib, PKC412","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"24619500","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:26:52.747617	2016-05-18 21:41:44.305746
3415	8	112	307	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"quizartinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"22504184","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"ponatinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"23430109","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"crenolanib, PKC412","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"24619500","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:26:52.806778	2016-05-18 21:41:44.318235
3416	8	113	307	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"quizartinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"22504184","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"ponatinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"23430109","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"crenolanib, PKC412","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"24619500","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:26:52.880329	2016-05-18 21:41:44.32938
2301	8	115	54	\N	\N	3	{"My Cancer Genome":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"quizartinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"22504184","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"ponatinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"23430109","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"sorafenib","Association":"resistance","Status":"case report","Evidence":"emerging","Source":"22368270","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"midostaurin","Association":"response","Status":"case report","Evidence":"emerging","Source":"20733134","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"lestaurtinib","Association":"response","Status":"case report","Evidence":"emerging","Source":"16857985.0","Effect":"gain-of-function","Pathway":"activation"}]}]}}	1	2016-05-18 21:26:20.183889	2016-05-18 21:41:44.351443
3412	8	112	306	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"quizartinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"22504184","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"ponatinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"23430109","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"crenolanib, PKC412","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"24619500","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:26:52.606057	2016-05-18 21:41:44.282183
2302	8	116	54	\N	\N	3	{"My Cancer Genome":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"quizartinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"22504184","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"ponatinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"23430109","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"sorafenib","Association":"resistance","Status":"case report","Evidence":"emerging","Source":"22368270","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"midostaurin","Association":"response","Status":"case report","Evidence":"emerging","Source":"20733134","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"lestaurtinib","Association":"response","Status":"case report","Evidence":"emerging","Source":"16857985.0","Effect":"gain-of-function","Pathway":"activation"}]}]}}	1	2016-05-18 21:26:20.198689	2016-05-18 21:41:44.366285
3475	8	108	80	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"IDH inhibitor","Association":"response","Status":"early trials","Evidence":"emerging","Source":"AACR 2014; abstr CT103","Effect":"switch-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:03.34036	2016-05-18 21:41:44.381777
3418	8	122	54	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"quizartinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"22504184","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"ponatinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"23430109","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"sorafenib","Association":"resistance","Status":"case report","Evidence":"emerging","Source":"22368270","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"midostaurin","Association":"response","Status":"case report","Evidence":"emerging","Source":"20733134","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"lestaurtinib","Association":"response","Status":"case report","Evidence":"emerging","Source":"16857985.0","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:26:53.408635	2016-05-18 21:41:44.459128
3461	8	113	312	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"quizartinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"23878140","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"crenolanib, PKC412","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"24619500","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:01.937164	2016-05-18 21:41:44.469479
4194	19	186	484	\N	\N	3	\N	5	2016-05-18 21:28:02.273078	2016-05-18 21:28:02.273078
4195	19	3	484	\N	\N	3	\N	5	2016-05-18 21:28:02.325332	2016-05-18 21:28:02.325332
4196	19	175	485	\N	\N	3	\N	5	2016-05-18 21:28:02.407634	2016-05-18 21:28:02.407634
4197	19	177	485	\N	\N	3	\N	5	2016-05-18 21:28:02.460203	2016-05-18 21:28:02.460203
2304	8	12	54	\N	\N	3	{"My Cancer Genome":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"quizartinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"22504184","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"ponatinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"23430109","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"sorafenib","Association":"resistance","Status":"case report","Evidence":"emerging","Source":"22368270","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"midostaurin","Association":"response","Status":"case report","Evidence":"emerging","Source":"20733134","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"lestaurtinib","Association":"response","Status":"case report","Evidence":"emerging","Source":"16857985.0","Effect":"gain-of-function","Pathway":"activation"}]}]}}	1	2016-05-18 21:26:20.226813	2016-05-18 21:41:44.407335
2305	8	118	54	\N	\N	3	{"My Cancer Genome":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"quizartinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"22504184","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"ponatinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"23430109","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"sorafenib","Association":"resistance","Status":"case report","Evidence":"emerging","Source":"22368270","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"midostaurin","Association":"response","Status":"case report","Evidence":"emerging","Source":"20733134","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"lestaurtinib","Association":"response","Status":"case report","Evidence":"emerging","Source":"16857985.0","Effect":"gain-of-function","Pathway":"activation"}]}]}}	1	2016-05-18 21:26:20.23946	2016-05-18 21:41:44.420224
2306	8	120	54	\N	\N	3	{"My Cancer Genome":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"quizartinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"22504184","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"ponatinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"23430109","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"sorafenib","Association":"resistance","Status":"case report","Evidence":"emerging","Source":"22368270","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"midostaurin","Association":"response","Status":"case report","Evidence":"emerging","Source":"20733134","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"lestaurtinib","Association":"response","Status":"case report","Evidence":"emerging","Source":"16857985.0","Effect":"gain-of-function","Pathway":"activation"}]}]}}	1	2016-05-18 21:26:20.25476	2016-05-18 21:41:44.433583
3417	8	121	54	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"quizartinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"22504184","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"ponatinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"23430109","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"sorafenib","Association":"resistance","Status":"case report","Evidence":"emerging","Source":"22368270","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"midostaurin","Association":"response","Status":"case report","Evidence":"emerging","Source":"20733134","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"lestaurtinib","Association":"response","Status":"case report","Evidence":"emerging","Source":"16857985.0","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:26:53.327062	2016-05-18 21:41:44.446299
3462	8	127	313	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"quizartinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"23878140","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"crenolanib, PKC412","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"24619500","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:02.044727	2016-05-18 21:41:44.559016
4198	19	179	485	\N	\N	3	\N	5	2016-05-18 21:28:02.526155	2016-05-18 21:28:02.526155
4199	19	3	485	\N	\N	3	\N	5	2016-05-18 21:28:02.575182	2016-05-18 21:28:02.575182
4200	19	172	322	\N	\N	3	\N	5	2016-05-18 21:28:02.63037	2016-05-18 21:28:02.63037
4201	19	173	322	\N	\N	3	\N	5	2016-05-18 21:28:02.700983	2016-05-18 21:28:02.700983
4202	19	183	322	\N	\N	3	\N	5	2016-05-18 21:28:02.754808	2016-05-18 21:28:02.754808
2307	8	111	54	\N	\N	3	{"My Cancer Genome":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"quizartinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"22504184","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"ponatinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"23430109","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"sorafenib","Association":"resistance","Status":"case report","Evidence":"emerging","Source":"22368270","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"midostaurin","Association":"response","Status":"case report","Evidence":"emerging","Source":"20733134","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"lestaurtinib","Association":"response","Status":"case report","Evidence":"emerging","Source":"16857985.0","Effect":"gain-of-function","Pathway":"activation"}]}]}}	1	2016-05-18 21:26:20.269079	2016-05-18 21:41:44.495169
2308	8	112	54	\N	\N	3	{"My Cancer Genome":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"quizartinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"22504184","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"ponatinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"23430109","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"sorafenib","Association":"resistance","Status":"case report","Evidence":"emerging","Source":"22368270","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"midostaurin","Association":"response","Status":"case report","Evidence":"emerging","Source":"20733134","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"lestaurtinib","Association":"response","Status":"case report","Evidence":"emerging","Source":"16857985.0","Effect":"gain-of-function","Pathway":"activation"}]}]}}	1	2016-05-18 21:26:20.281658	2016-05-18 21:41:44.510067
2309	8	124	54	\N	\N	3	{"My Cancer Genome":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"quizartinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"22504184","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"ponatinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"23430109","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"sorafenib","Association":"resistance","Status":"case report","Evidence":"emerging","Source":"22368270","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"midostaurin","Association":"response","Status":"case report","Evidence":"emerging","Source":"20733134","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"lestaurtinib","Association":"response","Status":"case report","Evidence":"emerging","Source":"16857985.0","Effect":"gain-of-function","Pathway":"activation"}]}]}}	1	2016-05-18 21:26:20.296854	2016-05-18 21:41:44.52249
2310	8	125	54	\N	\N	3	{"My Cancer Genome":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"quizartinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"22504184","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"ponatinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"23430109","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"sorafenib","Association":"resistance","Status":"case report","Evidence":"emerging","Source":"22368270","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"midostaurin","Association":"response","Status":"case report","Evidence":"emerging","Source":"20733134","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"lestaurtinib","Association":"response","Status":"case report","Evidence":"emerging","Source":"16857985.0","Effect":"gain-of-function","Pathway":"activation"}]}]}}	1	2016-05-18 21:26:20.312362	2016-05-18 21:41:44.535311
3420	8	115	55	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"quizartinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"22504184","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"ponatinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"23430109","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"sorafenib","Association":"resistance","Status":"case report","Evidence":"emerging","Source":"22368270","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"midostaurin","Association":"response","Status":"case report","Evidence":"emerging","Source":"20733134","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"lestaurtinib","Association":"response","Status":"case report","Evidence":"emerging","Source":"16857985.0","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:26:53.927633	2016-05-18 21:41:44.547731
3423	8	12	55	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"quizartinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"22504184","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"ponatinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"23430109","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"sorafenib","Association":"resistance","Status":"case report","Evidence":"emerging","Source":"22368270","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"midostaurin","Association":"response","Status":"case report","Evidence":"emerging","Source":"20733134","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"lestaurtinib","Association":"response","Status":"case report","Evidence":"emerging","Source":"16857985.0","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:26:54.173082	2016-05-18 21:41:44.598355
3424	8	118	55	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"quizartinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"22504184","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"ponatinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"23430109","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"sorafenib","Association":"resistance","Status":"case report","Evidence":"emerging","Source":"22368270","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"midostaurin","Association":"response","Status":"case report","Evidence":"emerging","Source":"20733134","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"lestaurtinib","Association":"response","Status":"case report","Evidence":"emerging","Source":"16857985.0","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:26:54.265546	2016-05-18 21:41:44.611708
3425	8	120	55	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"quizartinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"22504184","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"ponatinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"23430109","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"sorafenib","Association":"resistance","Status":"case report","Evidence":"emerging","Source":"22368270","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"midostaurin","Association":"response","Status":"case report","Evidence":"emerging","Source":"20733134","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"lestaurtinib","Association":"response","Status":"case report","Evidence":"emerging","Source":"16857985.0","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:26:54.34497	2016-05-18 21:41:44.624041
3426	8	121	55	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"quizartinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"22504184","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"ponatinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"23430109","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"sorafenib","Association":"resistance","Status":"case report","Evidence":"emerging","Source":"22368270","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"midostaurin","Association":"response","Status":"case report","Evidence":"emerging","Source":"20733134","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"lestaurtinib","Association":"response","Status":"case report","Evidence":"emerging","Source":"16857985.0","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:26:54.40817	2016-05-18 21:41:44.636964
3463	8	113	313	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"quizartinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"23878140","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"crenolanib, PKC412","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"24619500","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:02.109892	2016-05-18 21:41:44.648135
3422	8	117	55	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"quizartinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"22504184","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"ponatinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"23430109","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"sorafenib","Association":"resistance","Status":"case report","Evidence":"emerging","Source":"22368270","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"midostaurin","Association":"response","Status":"case report","Evidence":"emerging","Source":"20733134","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"lestaurtinib","Association":"response","Status":"case report","Evidence":"emerging","Source":"16857985.0","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:26:54.094208	2016-05-18 21:41:44.583425
2311	8	111	55	\N	\N	3	{"My Cancer Genome":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"quizartinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"22504184","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"ponatinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"23430109","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"sorafenib","Association":"resistance","Status":"case report","Evidence":"emerging","Source":"22368270","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"midostaurin","Association":"response","Status":"case report","Evidence":"emerging","Source":"20733134","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"lestaurtinib","Association":"response","Status":"case report","Evidence":"emerging","Source":"16857985.0","Effect":"gain-of-function","Pathway":"activation"}]}]}}	1	2016-05-18 21:26:20.328731	2016-05-18 21:41:44.686692
3430	8	124	55	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"quizartinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"22504184","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"ponatinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"23430109","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"sorafenib","Association":"resistance","Status":"case report","Evidence":"emerging","Source":"22368270","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"midostaurin","Association":"response","Status":"case report","Evidence":"emerging","Source":"20733134","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"lestaurtinib","Association":"response","Status":"case report","Evidence":"emerging","Source":"16857985.0","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:26:54.823824	2016-05-18 21:41:44.713942
3431	8	125	55	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"quizartinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"22504184","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"ponatinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"23430109","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"sorafenib","Association":"resistance","Status":"case report","Evidence":"emerging","Source":"22368270","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"midostaurin","Association":"response","Status":"case report","Evidence":"emerging","Source":"20733134","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"lestaurtinib","Association":"response","Status":"case report","Evidence":"emerging","Source":"16857985.0","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:26:54.912359	2016-05-18 21:41:44.726868
3464	8	111	314	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"quizartinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"22504184","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"ponatinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"23430109","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"crenolanib, PKC412","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"24619500","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:02.199004	2016-05-18 21:41:44.738066
3428	8	123	55	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"quizartinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"22504184","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"ponatinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"23430109","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"sorafenib","Association":"resistance","Status":"case report","Evidence":"emerging","Source":"22368270","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"midostaurin","Association":"response","Status":"case report","Evidence":"emerging","Source":"20733134","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"lestaurtinib","Association":"response","Status":"case report","Evidence":"emerging","Source":"16857985.0","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:26:54.560226	2016-05-18 21:41:44.671387
3429	8	112	55	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"quizartinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"22504184","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"ponatinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"23430109","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"sorafenib","Association":"resistance","Status":"case report","Evidence":"emerging","Source":"22368270","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"midostaurin","Association":"response","Status":"case report","Evidence":"emerging","Source":"20733134","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"lestaurtinib","Association":"response","Status":"case report","Evidence":"emerging","Source":"16857985.0","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:26:54.741467	2016-05-18 21:41:44.700592
4203	19	175	322	\N	\N	3	\N	5	2016-05-18 21:28:02.805804	2016-05-18 21:28:02.805804
2313	8	116	56	\N	\N	3	{"My Cancer Genome":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"quizartinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"22504184","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"ponatinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"23430109","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"sorafenib","Association":"resistance","Status":"case report","Evidence":"emerging","Source":"22368270","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"midostaurin","Association":"response","Status":"case report","Evidence":"emerging","Source":"20733134","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"lestaurtinib","Association":"response","Status":"case report","Evidence":"emerging","Source":"16857985.0","Effect":"gain-of-function","Pathway":"activation"}]}]}}	1	2016-05-18 21:26:20.361715	2016-05-18 21:41:44.765978
2314	8	117	56	\N	\N	3	{"My Cancer Genome":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"quizartinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"22504184","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"ponatinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"23430109","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"sorafenib","Association":"resistance","Status":"case report","Evidence":"emerging","Source":"22368270","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"midostaurin","Association":"response","Status":"case report","Evidence":"emerging","Source":"20733134","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"lestaurtinib","Association":"response","Status":"case report","Evidence":"emerging","Source":"16857985.0","Effect":"gain-of-function","Pathway":"activation"}]}]}}	1	2016-05-18 21:26:20.375194	2016-05-18 21:41:44.780387
2315	8	12	56	\N	\N	3	{"My Cancer Genome":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"quizartinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"22504184","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"ponatinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"23430109","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"sorafenib","Association":"resistance","Status":"case report","Evidence":"emerging","Source":"22368270","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"midostaurin","Association":"response","Status":"case report","Evidence":"emerging","Source":"20733134","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"lestaurtinib","Association":"response","Status":"case report","Evidence":"emerging","Source":"16857985.0","Effect":"gain-of-function","Pathway":"activation"}]}]}}	1	2016-05-18 21:26:20.391564	2016-05-18 21:41:44.795492
2316	8	118	56	\N	\N	3	{"My Cancer Genome":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"quizartinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"22504184","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"ponatinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"23430109","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"sorafenib","Association":"resistance","Status":"case report","Evidence":"emerging","Source":"22368270","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"midostaurin","Association":"response","Status":"case report","Evidence":"emerging","Source":"20733134","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"lestaurtinib","Association":"response","Status":"case report","Evidence":"emerging","Source":"16857985.0","Effect":"gain-of-function","Pathway":"activation"}]}]}}	1	2016-05-18 21:26:20.407198	2016-05-18 21:41:44.809939
2318	8	121	56	\N	\N	3	{"My Cancer Genome":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"quizartinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"22504184","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"ponatinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"23430109","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"sorafenib","Association":"resistance","Status":"case report","Evidence":"emerging","Source":"22368270","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"midostaurin","Association":"response","Status":"case report","Evidence":"emerging","Source":"20733134","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"lestaurtinib","Association":"response","Status":"case report","Evidence":"emerging","Source":"16857985.0","Effect":"gain-of-function","Pathway":"activation"}]}]}}	1	2016-05-18 21:26:20.440588	2016-05-18 21:41:44.847277
3476	8	133	80	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"IDH inhibitor","Association":"response","Status":"early trials","Evidence":"emerging","Source":"AACR 2014; abstr CT103","Effect":"switch-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:03.415645	2016-05-18 21:41:44.939581
4204	19	340	322	\N	\N	3	\N	5	2016-05-18 21:28:02.871455	2016-05-18 21:28:02.871455
4205	19	341	322	\N	\N	3	\N	5	2016-05-18 21:28:02.918306	2016-05-18 21:28:02.918306
4206	19	342	322	\N	\N	3	\N	5	2016-05-18 21:28:02.958106	2016-05-18 21:28:02.958106
2319	8	122	56	\N	\N	3	{"My Cancer Genome":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"quizartinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"22504184","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"ponatinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"23430109","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"sorafenib","Association":"resistance","Status":"case report","Evidence":"emerging","Source":"22368270","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"midostaurin","Association":"response","Status":"case report","Evidence":"emerging","Source":"20733134","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"lestaurtinib","Association":"response","Status":"case report","Evidence":"emerging","Source":"16857985.0","Effect":"gain-of-function","Pathway":"activation"}]}]}}	1	2016-05-18 21:26:20.45549	2016-05-18 21:41:44.85928
2320	8	123	56	\N	\N	3	{"My Cancer Genome":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"quizartinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"22504184","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"ponatinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"23430109","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"sorafenib","Association":"resistance","Status":"case report","Evidence":"emerging","Source":"22368270","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"midostaurin","Association":"response","Status":"case report","Evidence":"emerging","Source":"20733134","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"lestaurtinib","Association":"response","Status":"case report","Evidence":"emerging","Source":"16857985.0","Effect":"gain-of-function","Pathway":"activation"}]}]}}	1	2016-05-18 21:26:20.474079	2016-05-18 21:41:44.872138
2322	8	112	56	\N	\N	3	{"My Cancer Genome":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"quizartinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"22504184","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"ponatinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"23430109","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"sorafenib","Association":"resistance","Status":"case report","Evidence":"emerging","Source":"22368270","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"midostaurin","Association":"response","Status":"case report","Evidence":"emerging","Source":"20733134","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"lestaurtinib","Association":"response","Status":"case report","Evidence":"emerging","Source":"16857985.0","Effect":"gain-of-function","Pathway":"activation"}]}]}}	1	2016-05-18 21:26:20.508635	2016-05-18 21:41:44.888467
2323	8	124	56	\N	\N	3	{"My Cancer Genome":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"quizartinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"22504184","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"ponatinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"23430109","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"sorafenib","Association":"resistance","Status":"case report","Evidence":"emerging","Source":"22368270","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"midostaurin","Association":"response","Status":"case report","Evidence":"emerging","Source":"20733134","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"lestaurtinib","Association":"response","Status":"case report","Evidence":"emerging","Source":"16857985.0","Effect":"gain-of-function","Pathway":"activation"}]}]}}	1	2016-05-18 21:26:20.52755	2016-05-18 21:41:44.90278
2324	8	125	56	\N	\N	3	{"My Cancer Genome":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"quizartinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"22504184","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"ponatinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"23430109","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"sorafenib","Association":"resistance","Status":"case report","Evidence":"emerging","Source":"22368270","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"midostaurin","Association":"response","Status":"case report","Evidence":"emerging","Source":"20733134","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"lestaurtinib","Association":"response","Status":"case report","Evidence":"emerging","Source":"16857985.0","Effect":"gain-of-function","Pathway":"activation"}]}]}}	1	2016-05-18 21:26:20.542395	2016-05-18 21:41:44.922874
2321	8	111	56	\N	\N	3	{"My Cancer Genome":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"quizartinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"22504184","Effect":"gain-of-function","Pathway":"activation"}]}]}}	1	2016-05-18 21:26:20.494318	2016-05-18 21:41:44.933472
3434	8	117	57	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"quizartinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"22504184","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"ponatinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"23430109","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"sorafenib","Association":"resistance","Status":"case report","Evidence":"emerging","Source":"22368270","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"midostaurin","Association":"response","Status":"case report","Evidence":"emerging","Source":"20733134","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"lestaurtinib","Association":"response","Status":"case report","Evidence":"emerging","Source":"16857985.0","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:26:56.412794	2016-05-18 21:41:44.980927
3435	8	12	57	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"quizartinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"22504184","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"ponatinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"23430109","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"sorafenib","Association":"resistance","Status":"case report","Evidence":"emerging","Source":"22368270","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"midostaurin","Association":"response","Status":"case report","Evidence":"emerging","Source":"20733134","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"lestaurtinib","Association":"response","Status":"case report","Evidence":"emerging","Source":"16857985.0","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:26:56.539547	2016-05-18 21:41:44.992893
3436	8	118	57	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"quizartinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"22504184","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"ponatinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"23430109","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"sorafenib","Association":"resistance","Status":"case report","Evidence":"emerging","Source":"22368270","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"midostaurin","Association":"response","Status":"case report","Evidence":"emerging","Source":"20733134","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"lestaurtinib","Association":"response","Status":"case report","Evidence":"emerging","Source":"16857985.0","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:26:56.655376	2016-05-18 21:41:45.005743
3437	8	120	57	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"quizartinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"22504184","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"ponatinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"23430109","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"sorafenib","Association":"resistance","Status":"case report","Evidence":"emerging","Source":"22368270","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"midostaurin","Association":"response","Status":"case report","Evidence":"emerging","Source":"20733134","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"lestaurtinib","Association":"response","Status":"case report","Evidence":"emerging","Source":"16857985.0","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:26:56.772993	2016-05-18 21:41:45.020489
3477	8	134	80	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"IDH inhibitor","Association":"response","Status":"early trials","Evidence":"emerging","Source":"AACR 2014; abstr CT103","Effect":"switch-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:03.475945	2016-05-18 21:41:45.031166
4207	19	186	322	\N	\N	3	\N	5	2016-05-18 21:28:03.010503	2016-05-18 21:28:03.010503
4208	19	188	322	\N	\N	3	\N	5	2016-05-18 21:28:03.053578	2016-05-18 21:28:03.053578
4209	19	343	322	\N	\N	3	\N	5	2016-05-18 21:28:03.105799	2016-05-18 21:28:03.105799
3433	8	116	57	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"quizartinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"22504184","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"ponatinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"23430109","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"sorafenib","Association":"resistance","Status":"case report","Evidence":"emerging","Source":"22368270","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"midostaurin","Association":"response","Status":"case report","Evidence":"emerging","Source":"20733134","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"lestaurtinib","Association":"response","Status":"case report","Evidence":"emerging","Source":"16857985.0","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:26:56.31732	2016-05-18 21:41:44.967094
3439	8	124	57	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"quizartinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"22504184","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"ponatinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"23430109","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"sorafenib","Association":"resistance","Status":"case report","Evidence":"emerging","Source":"22368270","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"midostaurin","Association":"response","Status":"case report","Evidence":"emerging","Source":"20733134","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"lestaurtinib","Association":"response","Status":"case report","Evidence":"emerging","Source":"16857985.0","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:26:57.098657	2016-05-18 21:41:45.070516
3440	8	125	57	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"quizartinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"22504184","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"ponatinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"23430109","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"sorafenib","Association":"resistance","Status":"case report","Evidence":"emerging","Source":"22368270","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"midostaurin","Association":"response","Status":"case report","Evidence":"emerging","Source":"20733134","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"lestaurtinib","Association":"response","Status":"case report","Evidence":"emerging","Source":"16857985.0","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:26:57.191013	2016-05-18 21:41:45.089518
3441	8	111	308	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"quizartinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"22504184","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:26:57.293871	2016-05-18 21:41:45.10044
2327	8	116	58	\N	\N	3	{"My Cancer Genome":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"quizartinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"22504184","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"ponatinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"23430109","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"sorafenib","Association":"resistance","Status":"case report","Evidence":"emerging","Source":"22368270","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"midostaurin","Association":"response","Status":"case report","Evidence":"emerging","Source":"20733134","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"lestaurtinib","Association":"response","Status":"case report","Evidence":"emerging","Source":"16857985.0","Effect":"gain-of-function","Pathway":"activation"}]}]}}	1	2016-05-18 21:26:20.589515	2016-05-18 21:41:45.126684
3438	8	112	57	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"quizartinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"22504184","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"ponatinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"23430109","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"sorafenib","Association":"resistance","Status":"case report","Evidence":"emerging","Source":"22368270","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"midostaurin","Association":"response","Status":"case report","Evidence":"emerging","Source":"20733134","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"lestaurtinib","Association":"response","Status":"case report","Evidence":"emerging","Source":"16857985.0","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:26:57.008543	2016-05-18 21:41:45.05661
3478	8	131	80	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"IDH inhibitor","Association":"response","Status":"early trials","Evidence":"emerging","Source":"AACR 2014; abstr CT103","Effect":"switch-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:03.546384	2016-05-18 21:41:45.137649
2332	8	121	58	\N	\N	3	{"My Cancer Genome":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"quizartinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"22504184","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"ponatinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"23430109","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"sorafenib","Association":"resistance","Status":"case report","Evidence":"emerging","Source":"22368270","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"midostaurin","Association":"response","Status":"case report","Evidence":"emerging","Source":"20733134","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"lestaurtinib","Association":"response","Status":"case report","Evidence":"emerging","Source":"16857985.0","Effect":"gain-of-function","Pathway":"activation"}]}]}}	1	2016-05-18 21:26:20.675594	2016-05-18 21:41:45.204389
4210	19	179	322	\N	\N	3	\N	5	2016-05-18 21:28:03.149818	2016-05-18 21:28:03.149818
2329	8	12	58	\N	\N	3	{"My Cancer Genome":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"quizartinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"22504184","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"ponatinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"23430109","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"sorafenib","Association":"resistance","Status":"case report","Evidence":"emerging","Source":"22368270","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"midostaurin","Association":"response","Status":"case report","Evidence":"emerging","Source":"20733134","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"lestaurtinib","Association":"response","Status":"case report","Evidence":"emerging","Source":"16857985.0","Effect":"gain-of-function","Pathway":"activation"}]}]}}	1	2016-05-18 21:26:20.626748	2016-05-18 21:41:45.161711
2330	8	118	58	\N	\N	3	{"My Cancer Genome":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"quizartinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"22504184","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"ponatinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"23430109","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"sorafenib","Association":"resistance","Status":"case report","Evidence":"emerging","Source":"22368270","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"midostaurin","Association":"response","Status":"case report","Evidence":"emerging","Source":"20733134","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"lestaurtinib","Association":"response","Status":"case report","Evidence":"emerging","Source":"16857985.0","Effect":"gain-of-function","Pathway":"activation"}]}]}}	1	2016-05-18 21:26:20.64219	2016-05-18 21:41:45.175425
3442	8	120	58	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"quizartinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"22504184","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"ponatinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"23430109","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"sorafenib","Association":"resistance","Status":"case report","Evidence":"emerging","Source":"22368270","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"midostaurin","Association":"response","Status":"case report","Evidence":"emerging","Source":"20733134","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"lestaurtinib","Association":"response","Status":"case report","Evidence":"emerging","Source":"16857985.0","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:26:57.86107	2016-05-18 21:41:45.191303
2333	8	122	58	\N	\N	3	{"My Cancer Genome":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"quizartinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"22504184","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"ponatinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"23430109","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"sorafenib","Association":"resistance","Status":"case report","Evidence":"emerging","Source":"22368270","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"midostaurin","Association":"response","Status":"case report","Evidence":"emerging","Source":"20733134","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"lestaurtinib","Association":"response","Status":"case report","Evidence":"emerging","Source":"16857985.0","Effect":"gain-of-function","Pathway":"activation"}]}]}}	1	2016-05-18 21:26:20.693855	2016-05-18 21:41:45.218259
3465	8	112	314	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"quizartinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"22504184","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"ponatinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"23430109","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"crenolanib, PKC412","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"24619500","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:02.277635	2016-05-18 21:41:45.22882
2337	8	115	59	\N	\N	3	{"My Cancer Genome":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"quizartinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"22504184","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"ponatinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"23430109","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"sorafenib","Association":"resistance","Status":"case report","Evidence":"emerging","Source":"22368270","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"midostaurin","Association":"response","Status":"case report","Evidence":"emerging","Source":"20733134","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"lestaurtinib","Association":"response","Status":"case report","Evidence":"emerging","Source":"16857985.0","Effect":"gain-of-function","Pathway":"activation"}]}]}}	1	2016-05-18 21:26:20.760176	2016-05-18 21:41:45.300917
4211	19	184	322	\N	\N	3	\N	5	2016-05-18 21:28:03.245598	2016-05-18 21:28:03.245598
4212	19	344	322	\N	\N	3	\N	5	2016-05-18 21:28:03.287105	2016-05-18 21:28:03.287105
4213	19	345	322	\N	\N	3	\N	5	2016-05-18 21:28:03.337817	2016-05-18 21:28:03.337817
3443	8	123	58	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"quizartinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"22504184","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"ponatinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"23430109","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"sorafenib","Association":"resistance","Status":"case report","Evidence":"emerging","Source":"22368270","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"midostaurin","Association":"response","Status":"case report","Evidence":"emerging","Source":"20733134","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"lestaurtinib","Association":"response","Status":"case report","Evidence":"emerging","Source":"16857985.0","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:26:58.144539	2016-05-18 21:41:45.24056
2334	8	112	58	\N	\N	3	{"My Cancer Genome":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"quizartinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"22504184","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"ponatinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"23430109","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"sorafenib","Association":"resistance","Status":"case report","Evidence":"emerging","Source":"22368270","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"midostaurin","Association":"response","Status":"case report","Evidence":"emerging","Source":"20733134","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"lestaurtinib","Association":"response","Status":"case report","Evidence":"emerging","Source":"16857985.0","Effect":"gain-of-function","Pathway":"activation"}]}]}}	1	2016-05-18 21:26:20.707886	2016-05-18 21:41:45.255449
2335	8	124	58	\N	\N	3	{"My Cancer Genome":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"quizartinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"22504184","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"ponatinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"23430109","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"sorafenib","Association":"resistance","Status":"case report","Evidence":"emerging","Source":"22368270","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"midostaurin","Association":"response","Status":"case report","Evidence":"emerging","Source":"20733134","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"lestaurtinib","Association":"response","Status":"case report","Evidence":"emerging","Source":"16857985.0","Effect":"gain-of-function","Pathway":"activation"}]}]}}	1	2016-05-18 21:26:20.723209	2016-05-18 21:41:45.268746
2336	8	125	58	\N	\N	3	{"My Cancer Genome":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"quizartinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"22504184","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"ponatinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"23430109","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"sorafenib","Association":"resistance","Status":"case report","Evidence":"emerging","Source":"22368270","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"midostaurin","Association":"response","Status":"case report","Evidence":"emerging","Source":"20733134","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"lestaurtinib","Association":"response","Status":"case report","Evidence":"emerging","Source":"16857985.0","Effect":"gain-of-function","Pathway":"activation"}]}]}}	1	2016-05-18 21:26:20.739863	2016-05-18 21:41:45.282069
2331	8	111	58	\N	\N	3	{"My Cancer Genome":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"quizartinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"22504184","Effect":"gain-of-function","Pathway":"activation"}]}]}}	1	2016-05-18 21:26:20.66073	2016-05-18 21:41:45.291371
3479	8	132	80	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"IDH inhibitor","Association":"response","Status":"early trials","Evidence":"emerging","Source":"AACR 2014; abstr CT103","Effect":"switch-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:03.61039	2016-05-18 21:41:45.309844
4214	19	3	322	\N	\N	3	\N	5	2016-05-18 21:28:03.378651	2016-05-18 21:28:03.378651
2339	8	117	59	\N	\N	3	{"My Cancer Genome":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"quizartinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"22504184","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"ponatinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"23430109","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"sorafenib","Association":"resistance","Status":"case report","Evidence":"emerging","Source":"22368270","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"midostaurin","Association":"response","Status":"case report","Evidence":"emerging","Source":"20733134","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"lestaurtinib","Association":"response","Status":"case report","Evidence":"emerging","Source":"16857985.0","Effect":"gain-of-function","Pathway":"activation"}]}]}}	1	2016-05-18 21:26:20.796261	2016-05-18 21:41:45.336317
2340	8	12	59	\N	\N	3	{"My Cancer Genome":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"quizartinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"22504184","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"ponatinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"23430109","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"sorafenib","Association":"resistance","Status":"case report","Evidence":"emerging","Source":"22368270","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"midostaurin","Association":"response","Status":"case report","Evidence":"emerging","Source":"20733134","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"lestaurtinib","Association":"response","Status":"case report","Evidence":"emerging","Source":"16857985.0","Effect":"gain-of-function","Pathway":"activation"}]}]}}	1	2016-05-18 21:26:20.81147	2016-05-18 21:41:45.349191
2341	8	118	59	\N	\N	3	{"My Cancer Genome":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"quizartinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"22504184","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"ponatinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"23430109","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"sorafenib","Association":"resistance","Status":"case report","Evidence":"emerging","Source":"22368270","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"midostaurin","Association":"response","Status":"case report","Evidence":"emerging","Source":"20733134","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"lestaurtinib","Association":"response","Status":"case report","Evidence":"emerging","Source":"16857985.0","Effect":"gain-of-function","Pathway":"activation"}]}]}}	1	2016-05-18 21:26:20.829675	2016-05-18 21:41:45.362439
2345	8	111	59	\N	\N	3	{"My Cancer Genome":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"quizartinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"22504184","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"ponatinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"23430109","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"sorafenib","Association":"resistance","Status":"case report","Evidence":"emerging","Source":"22368270","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"midostaurin","Association":"response","Status":"case report","Evidence":"emerging","Source":"20733134","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"lestaurtinib","Association":"response","Status":"case report","Evidence":"emerging","Source":"16857985.0","Effect":"gain-of-function","Pathway":"activation"}]}]}}	1	2016-05-18 21:26:20.896239	2016-05-18 21:41:45.379352
2344	8	122	59	\N	\N	3	{"My Cancer Genome":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"quizartinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"22504184","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"ponatinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"23430109","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"sorafenib","Association":"resistance","Status":"case report","Evidence":"emerging","Source":"22368270","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"midostaurin","Association":"response","Status":"case report","Evidence":"emerging","Source":"20733134","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"lestaurtinib","Association":"response","Status":"case report","Evidence":"emerging","Source":"16857985.0","Effect":"gain-of-function","Pathway":"activation"}]}]}}	1	2016-05-18 21:26:20.878663	2016-05-18 21:41:45.426838
3445	8	116	60	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"quizartinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"22504184","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"ponatinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"23430109","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"sorafenib","Association":"resistance","Status":"case report","Evidence":"emerging","Source":"22368270","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"midostaurin","Association":"response","Status":"case report","Evidence":"emerging","Source":"20733134","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"lestaurtinib","Association":"response","Status":"case report","Evidence":"emerging","Source":"16857985.0","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:00.638969	2016-05-18 21:41:45.509214
3446	8	117	60	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"quizartinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"22504184","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"ponatinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"23430109","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"sorafenib","Association":"resistance","Status":"case report","Evidence":"emerging","Source":"22368270","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"midostaurin","Association":"response","Status":"case report","Evidence":"emerging","Source":"20733134","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"lestaurtinib","Association":"response","Status":"case report","Evidence":"emerging","Source":"16857985.0","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:00.714251	2016-05-18 21:41:45.526334
3466	8	113	314	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"quizartinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"22504184","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"ponatinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"23430109","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"crenolanib, PKC412","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"24619500","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:02.330399	2016-05-18 21:41:45.539609
2347	8	124	59	\N	\N	3	{"My Cancer Genome":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"quizartinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"22504184","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"ponatinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"23430109","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"sorafenib","Association":"resistance","Status":"case report","Evidence":"emerging","Source":"22368270","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"midostaurin","Association":"response","Status":"case report","Evidence":"emerging","Source":"20733134","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"lestaurtinib","Association":"response","Status":"case report","Evidence":"emerging","Source":"16857985.0","Effect":"gain-of-function","Pathway":"activation"}]}]}}	1	2016-05-18 21:26:20.930165	2016-05-18 21:41:45.4545
2348	8	125	59	\N	\N	3	{"My Cancer Genome":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"quizartinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"22504184","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"ponatinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"23430109","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"sorafenib","Association":"resistance","Status":"case report","Evidence":"emerging","Source":"22368270","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"midostaurin","Association":"response","Status":"case report","Evidence":"emerging","Source":"20733134","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"lestaurtinib","Association":"response","Status":"case report","Evidence":"emerging","Source":"16857985.0","Effect":"gain-of-function","Pathway":"activation"}]}]}}	1	2016-05-18 21:26:20.944076	2016-05-18 21:41:45.469509
3444	8	115	60	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"quizartinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"22504184","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"ponatinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"23430109","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"sorafenib","Association":"resistance","Status":"case report","Evidence":"emerging","Source":"22368270","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"midostaurin","Association":"response","Status":"case report","Evidence":"emerging","Source":"20733134","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"lestaurtinib","Association":"response","Status":"case report","Evidence":"emerging","Source":"16857985.0","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:00.575633	2016-05-18 21:41:45.494513
3449	8	126	60	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"quizartinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"22504184","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"ponatinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"23430109","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"sorafenib","Association":"resistance","Status":"case report","Evidence":"emerging","Source":"22368270","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"midostaurin","Association":"response","Status":"case report","Evidence":"emerging","Source":"20733134","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"lestaurtinib","Association":"response","Status":"case report","Evidence":"emerging","Source":"16857985.0","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:00.927107	2016-05-18 21:41:45.600696
3450	8	121	60	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"quizartinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"22504184","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"ponatinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"23430109","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"sorafenib","Association":"resistance","Status":"case report","Evidence":"emerging","Source":"22368270","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"midostaurin","Association":"response","Status":"case report","Evidence":"emerging","Source":"20733134","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"lestaurtinib","Association":"response","Status":"case report","Evidence":"emerging","Source":"16857985.0","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:00.986769	2016-05-18 21:41:45.615759
3451	8	122	60	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"quizartinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"22504184","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"ponatinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"23430109","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"sorafenib","Association":"resistance","Status":"case report","Evidence":"emerging","Source":"22368270","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"midostaurin","Association":"response","Status":"case report","Evidence":"emerging","Source":"20733134","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"lestaurtinib","Association":"response","Status":"case report","Evidence":"emerging","Source":"16857985.0","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:01.05985	2016-05-18 21:41:45.632578
2349	8	111	60	\N	\N	3	{"My Cancer Genome":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"quizartinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"22504184","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"ponatinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"23430109","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"sorafenib","Association":"resistance","Status":"case report","Evidence":"emerging","Source":"22368270","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"midostaurin","Association":"response","Status":"case report","Evidence":"emerging","Source":"20733134","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"lestaurtinib","Association":"response","Status":"case report","Evidence":"emerging","Source":"16857985.0","Effect":"gain-of-function","Pathway":"activation"}]}]}}	1	2016-05-18 21:26:20.958892	2016-05-18 21:41:45.648567
4215	19	346	486	\N	\N	3	\N	5	2016-05-18 21:28:03.440901	2016-05-18 21:28:03.440901
4216	19	347	486	\N	\N	3	\N	5	2016-05-18 21:28:03.481621	2016-05-18 21:28:03.481621
4217	19	348	486	\N	\N	3	\N	5	2016-05-18 21:28:03.514001	2016-05-18 21:28:03.514001
3448	8	118	60	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"quizartinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"22504184","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"ponatinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"23430109","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"sorafenib","Association":"resistance","Status":"case report","Evidence":"emerging","Source":"22368270","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"midostaurin","Association":"response","Status":"case report","Evidence":"emerging","Source":"20733134","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"lestaurtinib","Association":"response","Status":"case report","Evidence":"emerging","Source":"16857985.0","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:00.858285	2016-05-18 21:41:45.586216
3474	8	102	80	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"IDH inhibitor","Association":"response","Status":"early trials","Evidence":"emerging","Source":"AACR 2014; abstr CT103","Effect":"switch-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:03.284577	2016-05-18 21:41:45.659405
3454	8	125	60	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"quizartinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"22504184","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"ponatinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"23430109","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"sorafenib","Association":"resistance","Status":"case report","Evidence":"emerging","Source":"22368270","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"midostaurin","Association":"response","Status":"case report","Evidence":"emerging","Source":"20733134","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"lestaurtinib","Association":"response","Status":"case report","Evidence":"emerging","Source":"16857985.0","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:01.363564	2016-05-18 21:41:45.711116
3455	8	111	309	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"quizartinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"22504184","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:01.47335	2016-05-18 21:41:45.725507
3458	8	112	311	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"quizartinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"22504184","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"ponatinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"23430109","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"crenolanib, PKC412","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"24619500","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:01.711731	2016-05-18 21:41:45.761261
3459	8	113	311	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"quizartinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"22504184","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"ponatinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"23430109","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"crenolanib, PKC412","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"24619500","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:01.780402	2016-05-18 21:41:45.772297
3460	8	127	312	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"quizartinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"23878140","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"crenolanib, PKC412","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"24619500","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:01.875823	2016-05-18 21:41:45.783481
3453	8	124	60	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"quizartinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"22504184","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"ponatinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"23430109","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"sorafenib","Association":"resistance","Status":"case report","Evidence":"emerging","Source":"22368270","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"midostaurin","Association":"response","Status":"case report","Evidence":"emerging","Source":"20733134","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"lestaurtinib","Association":"response","Status":"case report","Evidence":"emerging","Source":"16857985.0","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:01.280217	2016-05-18 21:41:45.696955
3456	8	111	310	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"quizartinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"22504184","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:01.549353	2016-05-18 21:41:45.73307
3457	8	111	311	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"quizartinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"22504184","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"ponatinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"23430109","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"crenolanib, PKC412","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"24619500","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:01.637768	2016-05-18 21:41:45.743912
3469	8	113	315	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"quizartinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"22504184","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"ponatinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"23430109","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"crenolanib, PKC412","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"24619500","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:02.580166	2016-05-18 21:41:45.817572
3470	8	111	316	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"quizartinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"22504184","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"ponatinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"23430109","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"crenolanib, PKC412","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"24619500","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:02.67669	2016-05-18 21:41:45.829
3471	8	112	316	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"quizartinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"22504184","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"ponatinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"23430109","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"crenolanib, PKC412","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"24619500","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:02.748954	2016-05-18 21:41:45.841204
3472	8	113	316	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"quizartinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"22504184","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"ponatinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"23430109","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"crenolanib, PKC412","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"24619500","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:02.828474	2016-05-18 21:41:45.852785
2414	8	102	78	\N	\N	3	{"My Cancer Genome":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"IDH inhibitor","Association":"response","Status":"early trials","Evidence":"emerging","Source":"AACR 2014; abstr CT103","Effect":"switch-of-function","Pathway":"activation"}]}]}}	1	2016-05-18 21:26:22.114354	2016-05-18 21:41:45.863578
2415	8	108	78	\N	\N	3	{"My Cancer Genome":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"IDH inhibitor","Association":"response","Status":"early trials","Evidence":"emerging","Source":"AACR 2014; abstr CT103","Effect":"switch-of-function","Pathway":"activation"}]}]}}	1	2016-05-18 21:26:22.130603	2016-05-18 21:41:45.879538
3468	8	112	315	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"quizartinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"22504184","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"ponatinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"23430109","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"crenolanib, PKC412","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"24619500","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:02.520121	2016-05-18 21:41:45.806228
3473	8	130	78	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"IDH inhibitor","Association":"response","Status":"early trials","Evidence":"emerging","Source":"AACR 2014; abstr CT103","Effect":"switch-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:02.964432	2016-05-18 21:41:45.87261
2416	8	133	78	\N	\N	3	{"My Cancer Genome":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"IDH inhibitor","Association":"response","Status":"early trials","Evidence":"emerging","Source":"AACR 2014; abstr CT103","Effect":"switch-of-function","Pathway":"activation"}]}]}}	1	2016-05-18 21:26:22.145757	2016-05-18 21:41:45.890086
2418	8	131	78	\N	\N	3	{"My Cancer Genome":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"IDH inhibitor","Association":"response","Status":"early trials","Evidence":"emerging","Source":"AACR 2014; abstr CT103","Effect":"switch-of-function","Pathway":"activation"}]}]}}	1	2016-05-18 21:26:22.179782	2016-05-18 21:41:45.897906
2419	8	132	78	\N	\N	3	{"My Cancer Genome":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"IDH inhibitor","Association":"response","Status":"early trials","Evidence":"emerging","Source":"AACR 2014; abstr CT103","Effect":"switch-of-function","Pathway":"activation"}]}]}}	1	2016-05-18 21:26:22.196583	2016-05-18 21:41:45.906986
3482	8	138	285	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"ruxolitinib","Association":"response","Status":"early trials","Evidence":"emerging","Source":"22422826","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"JAK inhibitors (alone or in combination)","Association":"response","Status":"preclinical","Evidence":"emerging","Source":"22829971","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:03.825335	2016-05-18 21:41:45.936626
3483	8	139	285	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"ruxolitinib","Association":"response","Status":"early trials","Evidence":"emerging","Source":"22422826","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"JAK inhibitors (alone or in combination)","Association":"response","Status":"preclinical","Evidence":"emerging","Source":"22829971","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:03.895515	2016-05-18 21:41:45.945529
3484	8	140	285	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"ruxolitinib","Association":"response","Status":"early trials","Evidence":"emerging","Source":"22422826","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"JAK inhibitors (alone or in combination)","Association":"response","Status":"preclinical","Evidence":"emerging","Source":"22829971","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:03.954169	2016-05-18 21:41:45.956479
3485	8	141	285	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"ruxolitinib","Association":"response","Status":"early trials","Evidence":"emerging","Source":"22422826","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"JAK inhibitors (alone or in combination)","Association":"response","Status":"preclinical","Evidence":"emerging","Source":"22829971","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:04.037088	2016-05-18 21:41:45.96583
3486	8	142	285	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"ruxolitinib","Association":"response","Status":"early trials","Evidence":"emerging","Source":"22422826","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"JAK inhibitors (alone or in combination)","Association":"response","Status":"preclinical","Evidence":"emerging","Source":"22829971","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:04.118999	2016-05-18 21:41:45.975353
3487	8	143	285	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"ruxolitinib","Association":"response","Status":"early trials","Evidence":"emerging","Source":"22422826","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"JAK inhibitors (alone or in combination)","Association":"response","Status":"preclinical","Evidence":"emerging","Source":"22829971","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:04.18188	2016-05-18 21:41:45.988219
3488	8	144	285	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"ruxolitinib","Association":"response","Status":"early trials","Evidence":"emerging","Source":"22422826","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"JAK inhibitors (alone or in combination)","Association":"response","Status":"preclinical","Evidence":"emerging","Source":"22829971","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:04.254445	2016-05-18 21:41:45.999422
3489	8	145	285	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"ruxolitinib","Association":"response","Status":"early trials","Evidence":"emerging","Source":"22422826","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"JAK inhibitors (alone or in combination)","Association":"response","Status":"preclinical","Evidence":"emerging","Source":"22829971","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:04.333481	2016-05-18 21:41:46.012983
3490	8	146	285	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"ruxolitinib","Association":"response","Status":"early trials","Evidence":"emerging","Source":"22422826","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"JAK inhibitors (alone or in combination)","Association":"response","Status":"preclinical","Evidence":"emerging","Source":"22829971","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:04.389892	2016-05-18 21:41:46.026299
4218	19	349	486	\N	\N	3	\N	5	2016-05-18 21:28:03.569032	2016-05-18 21:28:03.569032
4219	19	189	486	\N	\N	3	\N	5	2016-05-18 21:28:03.608634	2016-05-18 21:28:03.608634
3480	8	136	285	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"ruxolitinib","Association":"response","Status":"early trials","Evidence":"emerging","Source":"22422826","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"JAK inhibitors (alone or in combination)","Association":"response","Status":"preclinical","Evidence":"emerging","Source":"22829971","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:03.689202	2016-05-18 21:41:45.91701
3481	8	137	285	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"ruxolitinib","Association":"response","Status":"early trials","Evidence":"emerging","Source":"22422826","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"JAK inhibitors (alone or in combination)","Association":"response","Status":"preclinical","Evidence":"emerging","Source":"22829971","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:03.761956	2016-05-18 21:41:45.926696
3493	8	147	200	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"dasatinib","Association":"response","Status":"case report","Evidence":"emerging","Source":"18986703","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:04.586066	2016-05-18 21:41:46.055905
3494	8	148	200	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"dasatinib","Association":"response","Status":"case report","Evidence":"emerging","Source":"18986703","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:04.672072	2016-05-18 21:41:46.064808
3495	8	111	200	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"quizartinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"22504184","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:04.725788	2016-05-18 21:41:46.074835
3496	8	149	207	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"dasatinib","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23149070","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:04.800585	2016-05-18 21:41:46.086824
3497	8	149	208	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"dasatinib","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23149070","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:04.858363	2016-05-18 21:41:46.096127
3498	18	171	317	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"JAK inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"18397343","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:04.956472	2016-05-18 21:41:46.105706
3499	18	171	318	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"JAK inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"18397343","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:05.0691	2016-05-18 21:41:46.114244
3500	18	171	319	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"JAK inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"18397343","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:05.189091	2016-05-18 21:41:46.123711
3501	18	171	320	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"JAK inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"18397343","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:05.29042	2016-05-18 21:41:46.133269
3502	19	189	321	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"dasatinib, bosutinib, ponatinib","Association":"response","Status":"NCCN guidelines","Evidence":"consensus","Source":"21562040","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:05.37862	2016-05-18 21:41:46.144286
3503	19	189	322	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"dasatinib, bosutinib, ponatinib","Association":"response","Status":"NCCN guidelines","Evidence":"consensus","Source":"21562040","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:05.464746	2016-05-18 21:41:46.154596
3504	19	189	323	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"nilotinib, ponatinib","Association":"response","Status":"NCCN guidelines","Evidence":"consensus","Source":"21562040","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:05.566033	2016-05-18 21:41:46.162957
3505	19	189	324	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"nilotinib, bosutinib, ponatinib","Association":"response","Status":"NCCN guidelines","Evidence":"consensus","Source":"21562040","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:05.778066	2016-05-18 21:41:46.172272
4220	19	350	486	\N	\N	3	\N	5	2016-05-18 21:28:03.662694	2016-05-18 21:28:03.662694
4221	19	188	486	\N	\N	3	\N	5	2016-05-18 21:28:03.708773	2016-05-18 21:28:03.708773
4222	19	177	486	\N	\N	3	\N	5	2016-05-18 21:28:03.770707	2016-05-18 21:28:03.770707
3491	8	95	200	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"dasatinib","Association":"response","Status":"case report","Evidence":"emerging","Source":"18986703","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:04.472116	2016-05-18 21:41:46.037699
3492	8	118	200	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"dasatinib","Association":"response","Status":"case report","Evidence":"emerging","Source":"18986703","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:04.526467	2016-05-18 21:41:46.046378
3508	19	189	326	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"nilotinib, bosutinib, ponatinib","Association":"response","Status":"NCCN guidelines","Evidence":"consensus","Source":"21562040","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:06.022544	2016-05-18 21:41:46.200673
3509	19	189	327	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"nilotinib, bosutinib, ponatinib","Association":"response","Status":"NCCN guidelines","Evidence":"consensus","Source":"21562040","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:06.120182	2016-05-18 21:41:46.208749
3510	19	189	328	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"nilotinib, bosutinib, ponatinib","Association":"response","Status":"NCCN guidelines","Evidence":"consensus","Source":"21562040","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:06.209148	2016-05-18 21:41:46.21691
3511	19	189	329	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"nilotinib, bosutinib, ponatinib","Association":"response","Status":"NCCN guidelines","Evidence":"consensus","Source":"21562040","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:06.297898	2016-05-18 21:41:46.226505
3512	19	189	330	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"dasatinib, bosutinib, ponatinib","Association":"response","Status":"NCCN guidelines","Evidence":"consensus","Source":"21562040","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:06.38181	2016-05-18 21:41:46.235193
3513	19	189	331	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"dasatinib, bosutinib, ponatinib","Association":"response","Status":"NCCN guidelines","Evidence":"consensus","Source":"21562040","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:06.470506	2016-05-18 21:41:46.24561
3514	19	189	332	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"dasatinib, bosutinib, ponatinib","Association":"response","Status":"NCCN guidelines","Evidence":"consensus","Source":"21562040","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:06.556769	2016-05-18 21:41:46.255883
3515	19	195	256	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"ruxolitinib","Association":"response","Status":"case report","Evidence":"emerging","Source":"23656643","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:06.632011	2016-05-18 21:41:46.265127
3516	19	195	333	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"ruxolitinib","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23656643","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:06.698099	2016-05-18 21:41:46.273799
3517	9	197	116	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"crizotinib","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"22072639","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:06.766736	2016-05-18 21:41:46.281545
3518	9	196	116	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"crizotinib","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"22072639","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:06.824554	2016-05-18 21:41:46.290678
3519	9	196	119	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"crizotinib","Association":"reduced sensitivity","Status":"preclinical","Evidence":"emerging","Source":"22072639","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:06.901381	2016-05-18 21:41:46.29949
3520	9	197	119	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"crizotinib","Association":"reduced sensitivity","Status":"preclinical","Evidence":"emerging","Source":"22072639","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:06.955211	2016-05-18 21:41:46.308727
4223	19	184	486	\N	\N	3	\N	5	2016-05-18 21:28:03.821515	2016-05-18 21:28:03.821515
4224	19	179	486	\N	\N	3	\N	5	2016-05-18 21:28:03.877296	2016-05-18 21:28:03.877296
3506	19	189	300	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"ponatinib","Association":"response","Status":"NCCN guidelines","Evidence":"consensus","Source":"21562040","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:05.830375	2016-05-18 21:41:46.180676
3507	19	189	325	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"nilotinib, bosutinib, ponatinib","Association":"response","Status":"NCCN guidelines","Evidence":"consensus","Source":"21562040","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:05.930898	2016-05-18 21:41:46.191141
3523	20	199	285	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"ruxolitinib","Association":"response","Status":"FDA-approved","Evidence":"consensus","Source":"FDA","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:07.169638	2016-05-18 21:41:46.334312
3524	21	202	334	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"MET inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"23213094","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:07.263048	2016-05-18 21:41:46.344049
3525	21	203	335	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"MET inhibitors","Association":"response","Status":"case report","Evidence":"emerging","Source":"23610116","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:07.354361	2016-05-18 21:41:46.353279
3526	21	204	336	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"rapamycin","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"24631838","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:07.439225	2016-05-18 21:41:46.361443
3527	21	205	337	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"everolimus","Association":"response","Status":"case report","Evidence":"emerging","Source":"24622468","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:07.533893	2016-05-18 21:41:46.370506
3528	21	204	338	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"rapamycin","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"24631838","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:07.628735	2016-05-18 21:41:46.38019
3529	21	204	339	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"rapamycin","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"24631838","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:07.730762	2016-05-18 21:41:46.389862
3530	22	206	340	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"everolimus","Association":"sensitivity","Status":"case report","Evidence":"emerging","Source":"24625776","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:07.819179	2016-05-18 21:41:46.401724
3531	22	206	341	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"everolimus","Association":"sensitivity","Status":"case report","Evidence":"emerging","Source":"24625776","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:07.915801	2016-05-18 21:41:46.410293
3532	23	209	342	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"crizotinib","Association":"resistance","Status":"case report","Evidence":"emerging","Source":"22277784","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"ceritinib","Association":"response","Status":"FDA-approved","Evidence":"consensus","Source":"24670165","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:08.012816	2016-05-18 21:41:46.42097
3533	23	210	342	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"crizotinib","Association":"resistance","Status":"case report","Evidence":"emerging","Source":"22277784","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"ceritinib","Association":"response","Status":"FDA-approved","Evidence":"consensus","Source":"24670165","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:08.071516	2016-05-18 21:41:46.43075
3534	23	209	343	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"crizotinib","Association":"resistance","Status":"case report","Evidence":"emerging","Source":"22277784","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"ceritinib","Association":"response","Status":"FDA-approved","Evidence":"consensus","Source":"24670165","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:08.16304	2016-05-18 21:41:46.442349
4225	19	335	486	\N	\N	3	\N	5	2016-05-18 21:28:03.94885	2016-05-18 21:28:03.94885
4226	19	2	486	\N	\N	3	\N	5	2016-05-18 21:28:03.99315	2016-05-18 21:28:03.99315
4227	19	172	486	\N	\N	3	\N	5	2016-05-18 21:28:04.058333	2016-05-18 21:28:04.058333
4228	19	351	486	\N	\N	3	\N	5	2016-05-18 21:28:04.098972	2016-05-18 21:28:04.098972
3521	9	197	123	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"crizotinib","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"22072639","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:07.032836	2016-05-18 21:41:46.316626
3522	9	196	123	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"crizotinib","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"22072639","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:07.091311	2016-05-18 21:41:46.326246
3537	23	209	345	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"crizotinib","Association":"resistance","Status":"case report","Evidence":"emerging","Source":"22277784","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"ceritinib","Association":"response","Status":"FDA-approved","Evidence":"consensus","Source":"24670165, 24327273","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:08.472999	2016-05-18 21:41:46.474611
3538	23	210	345	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"crizotinib","Association":"resistance","Status":"case report","Evidence":"emerging","Source":"22277784","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"ceritinib","Association":"response","Status":"FDA-approved","Evidence":"consensus","Source":"24670165, 24327273","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:08.552429	2016-05-18 21:41:46.487048
3539	23	211	345	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"crizotinib","Association":"resistance","Status":"case report","Evidence":"emerging","Source":"22277784","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"ceritinib","Association":"response","Status":"FDA-approved","Evidence":"consensus","Source":"24670165, 24327273","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:08.612149	2016-05-18 21:41:46.500178
3540	23	209	346	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"crizotinib","Association":"resistance","Status":"case report","Evidence":"emerging","Source":"22277784","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"novel ALK inhibiors","Association":"response","Status":"preclinical","Evidence":"emerging","Source":"24327273","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:08.699201	2016-05-18 21:41:46.511336
3541	23	211	346	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"crizotinib","Association":"resistance","Status":"case report","Evidence":"emerging","Source":"22277784","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"novel ALK inhibiors","Association":"response","Status":"preclinical","Evidence":"emerging","Source":"24327273","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:08.780893	2016-05-18 21:41:46.523553
3542	23	209	119	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"crizotinib","Association":"resistance","Status":"case report","Evidence":"emerging","Source":"22277784","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"novel ALK inhibiors","Association":"response","Status":"preclinical","Evidence":"emerging","Source":"24327273","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:08.838213	2016-05-18 21:41:46.582291
3543	23	211	119	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"crizotinib","Association":"resistance","Status":"case report","Evidence":"emerging","Source":"22277784","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"novel ALK inhibiors","Association":"response","Status":"preclinical","Evidence":"emerging","Source":"24327273","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:08.906014	2016-05-18 21:41:46.595372
3544	23	209	347	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"crizotinib","Association":"resistance","Status":"case report","Evidence":"emerging","Source":"22277784","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:09.0355	2016-05-18 21:41:46.603081
3545	23	212	348	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"sorafenib","Association":"response","Status":"case report","Evidence":"emerging","Source":"24569458","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:09.132681	2016-05-18 21:41:46.610515
3546	23	213	238	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"EGFR TKIs","Association":"resistance","Status":"case report","Evidence":"emerging","Source":"22773810","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"EGFR TKIs + MEK inhibitors in EGFR mutant","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"22773810","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:09.218436	2016-05-18 21:41:46.617542
4229	19	352	486	\N	\N	3	\N	5	2016-05-18 21:28:04.137607	2016-05-18 21:28:04.137607
4230	19	353	486	\N	\N	3	\N	5	2016-05-18 21:28:04.180834	2016-05-18 21:28:04.180834
4231	19	3	486	\N	\N	3	\N	5	2016-05-18 21:28:04.232238	2016-05-18 21:28:04.232238
3535	23	210	343	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"crizotinib","Association":"resistance","Status":"case report","Evidence":"emerging","Source":"22277784","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"ceritinib","Association":"response","Status":"FDA-approved","Evidence":"consensus","Source":"24670165","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:08.276517	2016-05-18 21:41:46.454163
3536	23	209	344	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"crizotinib","Association":"resistance","Status":"case report","Evidence":"emerging","Source":"22277784","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:08.375631	2016-05-18 21:41:46.464965
3550	2	222	242	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"erlotinib, afatinib","Association":"response","Status":"FDA-approved","Evidence":"consensus","Source":"FDA","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"irreversible EGFR TKIs","Association":"response","Status":"late trials","Evidence":"emerging","Source":"22753918","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"afatinib + cetuximab","Association":"response","Status":"early trials","Evidence":"emerging","Source":"Annals Oncol 2012;23(Suppl 9):1289","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"HSP90 inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"Annals Oncol 2012;23(Suppl 9):4380","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors (alone or in combination)","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23102728.0","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:09.566967	2016-05-18 21:41:46.65874
3551	2	223	242	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"erlotinib, afatinib","Association":"response","Status":"FDA-approved","Evidence":"consensus","Source":"FDA","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"irreversible EGFR TKIs","Association":"response","Status":"late trials","Evidence":"emerging","Source":"22753918","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"afatinib + cetuximab","Association":"response","Status":"early trials","Evidence":"emerging","Source":"Annals Oncol 2012;23(Suppl 9):1289","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"HSP90 inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"Annals Oncol 2012;23(Suppl 9):4380","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors (alone or in combination)","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23102728.0","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:09.651072	2016-05-18 21:41:46.673108
3552	2	224	242	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"erlotinib, afatinib","Association":"response","Status":"FDA-approved","Evidence":"consensus","Source":"FDA","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"irreversible EGFR TKIs","Association":"response","Status":"late trials","Evidence":"emerging","Source":"22753918","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"afatinib + cetuximab","Association":"response","Status":"early trials","Evidence":"emerging","Source":"Annals Oncol 2012;23(Suppl 9):1289","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"HSP90 inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"Annals Oncol 2012;23(Suppl 9):4380","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors (alone or in combination)","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23102728.0","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:09.731008	2016-05-18 21:41:46.686804
3553	2	225	242	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"erlotinib, afatinib","Association":"response","Status":"FDA-approved","Evidence":"consensus","Source":"FDA","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"irreversible EGFR TKIs","Association":"response","Status":"late trials","Evidence":"emerging","Source":"22753918","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"afatinib + cetuximab","Association":"response","Status":"early trials","Evidence":"emerging","Source":"Annals Oncol 2012;23(Suppl 9):1289","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"HSP90 inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"Annals Oncol 2012;23(Suppl 9):4380","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors (alone or in combination)","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23102728.0","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:09.795897	2016-05-18 21:41:46.702193
4232	19	172	487	\N	\N	3	\N	5	2016-05-18 21:28:04.289987	2016-05-18 21:28:04.289987
4233	19	188	487	\N	\N	3	\N	5	2016-05-18 21:28:04.347345	2016-05-18 21:28:04.347345
4234	19	177	487	\N	\N	3	\N	5	2016-05-18 21:28:04.389794	2016-05-18 21:28:04.389794
4235	19	179	487	\N	\N	3	\N	5	2016-05-18 21:28:04.437429	2016-05-18 21:28:04.437429
3547	23	214	349	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"ERBB2 TKIs, trastuzumab","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"22908275","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:09.312454	2016-05-18 21:41:46.626282
3548	23	215	350	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"crizotinib","Association":"resistance","Status":"case report","Evidence":"emerging","Source":"23724914","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:09.414862	2016-05-18 21:41:46.633709
3556	2	228	242	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"erlotinib, afatinib","Association":"response","Status":"FDA-approved","Evidence":"consensus","Source":"FDA","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"irreversible EGFR TKIs","Association":"response","Status":"late trials","Evidence":"emerging","Source":"22753918","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"afatinib + cetuximab","Association":"response","Status":"early trials","Evidence":"emerging","Source":"Annals Oncol 2012;23(Suppl 9):1289","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"HSP90 inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"Annals Oncol 2012;23(Suppl 9):4380","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors (alone or in combination)","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23102728.0","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:10.042177	2016-05-18 21:41:46.742383
3557	2	229	242	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"erlotinib, afatinib","Association":"response","Status":"FDA-approved","Evidence":"consensus","Source":"FDA","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"irreversible EGFR TKIs","Association":"response","Status":"late trials","Evidence":"emerging","Source":"22753918","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"afatinib + cetuximab","Association":"response","Status":"early trials","Evidence":"emerging","Source":"Annals Oncol 2012;23(Suppl 9):1289","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"HSP90 inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"Annals Oncol 2012;23(Suppl 9):4380","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors (alone or in combination)","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23102728.0","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:10.123567	2016-05-18 21:41:46.763138
3558	2	230	242	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"erlotinib, afatinib","Association":"response","Status":"FDA-approved","Evidence":"consensus","Source":"FDA","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"irreversible EGFR TKIs","Association":"response","Status":"late trials","Evidence":"emerging","Source":"22753918","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"afatinib + cetuximab","Association":"response","Status":"early trials","Evidence":"emerging","Source":"Annals Oncol 2012;23(Suppl 9):1289","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"HSP90 inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"Annals Oncol 2012;23(Suppl 9):4380","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors (alone or in combination)","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23102728.0","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:10.211152	2016-05-18 21:41:46.780872
3559	2	221	243	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"erlotinib, afatinib","Association":"response","Status":"FDA-approved","Evidence":"consensus","Source":"FDA","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"irreversible EGFR TKIs","Association":"response","Status":"late trials","Evidence":"emerging","Source":"22753918","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"afatinib + cetuximab","Association":"response","Status":"early trials","Evidence":"emerging","Source":"Annals Oncol 2012;23(Suppl 9):1289","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"HSP90 inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"Annals Oncol 2012;23(Suppl 9):4380","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors (alone or in combination)","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23102728.0","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:10.280992	2016-05-18 21:41:46.811866
3555	2	227	242	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"erlotinib, afatinib","Association":"response","Status":"FDA-approved","Evidence":"consensus","Source":"FDA","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"irreversible EGFR TKIs","Association":"response","Status":"late trials","Evidence":"emerging","Source":"22753918","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"afatinib + cetuximab","Association":"response","Status":"early trials","Evidence":"emerging","Source":"Annals Oncol 2012;23(Suppl 9):1289","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"HSP90 inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"Annals Oncol 2012;23(Suppl 9):4380","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors (alone or in combination)","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23102728.0","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:09.957406	2016-05-18 21:41:46.728798
3562	2	224	243	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"erlotinib, afatinib","Association":"response","Status":"FDA-approved","Evidence":"consensus","Source":"FDA","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"irreversible EGFR TKIs","Association":"response","Status":"late trials","Evidence":"emerging","Source":"22753918","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"afatinib + cetuximab","Association":"response","Status":"early trials","Evidence":"emerging","Source":"Annals Oncol 2012;23(Suppl 9):1289","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"HSP90 inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"Annals Oncol 2012;23(Suppl 9):4380","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors (alone or in combination)","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23102728.0","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:10.53224	2016-05-18 21:41:46.870349
3563	2	225	243	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"erlotinib, afatinib","Association":"response","Status":"FDA-approved","Evidence":"consensus","Source":"FDA","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"irreversible EGFR TKIs","Association":"response","Status":"late trials","Evidence":"emerging","Source":"22753918","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"afatinib + cetuximab","Association":"response","Status":"early trials","Evidence":"emerging","Source":"Annals Oncol 2012;23(Suppl 9):1289","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"HSP90 inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"Annals Oncol 2012;23(Suppl 9):4380","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors (alone or in combination)","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23102728.0","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:10.614458	2016-05-18 21:41:46.888828
3564	2	226	243	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"erlotinib, afatinib","Association":"response","Status":"FDA-approved","Evidence":"consensus","Source":"FDA","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"irreversible EGFR TKIs","Association":"response","Status":"late trials","Evidence":"emerging","Source":"22753918","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"afatinib + cetuximab","Association":"response","Status":"early trials","Evidence":"emerging","Source":"Annals Oncol 2012;23(Suppl 9):1289","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"HSP90 inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"Annals Oncol 2012;23(Suppl 9):4380","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors (alone or in combination)","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23102728.0","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:10.705118	2016-05-18 21:41:46.906381
3565	2	227	243	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"erlotinib, afatinib","Association":"response","Status":"FDA-approved","Evidence":"consensus","Source":"FDA","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"irreversible EGFR TKIs","Association":"response","Status":"late trials","Evidence":"emerging","Source":"22753918","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"afatinib + cetuximab","Association":"response","Status":"early trials","Evidence":"emerging","Source":"Annals Oncol 2012;23(Suppl 9):1289","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"HSP90 inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"Annals Oncol 2012;23(Suppl 9):4380","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors (alone or in combination)","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23102728.0","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:10.794149	2016-05-18 21:41:46.92361
3561	2	223	243	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"erlotinib, afatinib","Association":"response","Status":"FDA-approved","Evidence":"consensus","Source":"FDA","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"irreversible EGFR TKIs","Association":"response","Status":"late trials","Evidence":"emerging","Source":"22753918","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"afatinib + cetuximab","Association":"response","Status":"early trials","Evidence":"emerging","Source":"Annals Oncol 2012;23(Suppl 9):1289","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"HSP90 inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"Annals Oncol 2012;23(Suppl 9):4380","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors (alone or in combination)","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23102728.0","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:10.449503	2016-05-18 21:41:46.850719
3568	2	230	243	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"erlotinib, afatinib","Association":"response","Status":"FDA-approved","Evidence":"consensus","Source":"FDA","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"irreversible EGFR TKIs","Association":"response","Status":"late trials","Evidence":"emerging","Source":"22753918","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"afatinib + cetuximab","Association":"response","Status":"early trials","Evidence":"emerging","Source":"Annals Oncol 2012;23(Suppl 9):1289","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"HSP90 inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"Annals Oncol 2012;23(Suppl 9):4380","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors (alone or in combination)","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23102728.0","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:11.030618	2016-05-18 21:41:46.981989
3569	2	221	244	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"erlotinib, afatinib","Association":"response","Status":"FDA-approved","Evidence":"consensus","Source":"FDA","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"irreversible EGFR TKIs","Association":"response","Status":"late trials","Evidence":"emerging","Source":"22753918","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"afatinib + cetuximab","Association":"response","Status":"early trials","Evidence":"emerging","Source":"Annals Oncol 2012;23(Suppl 9):1289","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"HSP90 inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"Annals Oncol 2012;23(Suppl 9):4380","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors (alone or in combination)","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23102728.0","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:11.121066	2016-05-18 21:41:47.000656
3570	2	222	244	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"erlotinib, afatinib","Association":"response","Status":"FDA-approved","Evidence":"consensus","Source":"FDA","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"irreversible EGFR TKIs","Association":"response","Status":"late trials","Evidence":"emerging","Source":"22753918","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"afatinib + cetuximab","Association":"response","Status":"early trials","Evidence":"emerging","Source":"Annals Oncol 2012;23(Suppl 9):1289","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"HSP90 inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"Annals Oncol 2012;23(Suppl 9):4380","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors (alone or in combination)","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23102728.0","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:11.221664	2016-05-18 21:41:47.019469
3571	2	223	244	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"erlotinib, afatinib","Association":"response","Status":"FDA-approved","Evidence":"consensus","Source":"FDA","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"irreversible EGFR TKIs","Association":"response","Status":"late trials","Evidence":"emerging","Source":"22753918","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"afatinib + cetuximab","Association":"response","Status":"early trials","Evidence":"emerging","Source":"Annals Oncol 2012;23(Suppl 9):1289","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"HSP90 inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"Annals Oncol 2012;23(Suppl 9):4380","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors (alone or in combination)","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23102728.0","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:11.309566	2016-05-18 21:41:47.036689
3567	2	229	243	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"erlotinib, afatinib","Association":"response","Status":"FDA-approved","Evidence":"consensus","Source":"FDA","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"irreversible EGFR TKIs","Association":"response","Status":"late trials","Evidence":"emerging","Source":"22753918","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"afatinib + cetuximab","Association":"response","Status":"early trials","Evidence":"emerging","Source":"Annals Oncol 2012;23(Suppl 9):1289","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"HSP90 inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"Annals Oncol 2012;23(Suppl 9):4380","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors (alone or in combination)","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23102728.0","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:10.950902	2016-05-18 21:41:46.962941
3574	2	226	244	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"erlotinib, afatinib","Association":"response","Status":"FDA-approved","Evidence":"consensus","Source":"FDA","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"irreversible EGFR TKIs","Association":"response","Status":"late trials","Evidence":"emerging","Source":"22753918","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"afatinib + cetuximab","Association":"response","Status":"early trials","Evidence":"emerging","Source":"Annals Oncol 2012;23(Suppl 9):1289","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"HSP90 inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"Annals Oncol 2012;23(Suppl 9):4380","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors (alone or in combination)","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23102728.0","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:11.569897	2016-05-18 21:41:47.099505
3575	2	227	244	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"erlotinib, afatinib","Association":"response","Status":"FDA-approved","Evidence":"consensus","Source":"FDA","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"irreversible EGFR TKIs","Association":"response","Status":"late trials","Evidence":"emerging","Source":"22753918","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"afatinib + cetuximab","Association":"response","Status":"early trials","Evidence":"emerging","Source":"Annals Oncol 2012;23(Suppl 9):1289","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"HSP90 inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"Annals Oncol 2012;23(Suppl 9):4380","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors (alone or in combination)","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23102728.0","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:11.658347	2016-05-18 21:41:47.133933
3576	2	228	244	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"erlotinib, afatinib","Association":"response","Status":"FDA-approved","Evidence":"consensus","Source":"FDA","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"irreversible EGFR TKIs","Association":"response","Status":"late trials","Evidence":"emerging","Source":"22753918","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"afatinib + cetuximab","Association":"response","Status":"early trials","Evidence":"emerging","Source":"Annals Oncol 2012;23(Suppl 9):1289","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"HSP90 inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"Annals Oncol 2012;23(Suppl 9):4380","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors (alone or in combination)","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23102728.0","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:11.741999	2016-05-18 21:41:47.148817
3577	2	229	244	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"erlotinib, afatinib","Association":"response","Status":"FDA-approved","Evidence":"consensus","Source":"FDA","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"irreversible EGFR TKIs","Association":"response","Status":"late trials","Evidence":"emerging","Source":"22753918","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"afatinib + cetuximab","Association":"response","Status":"early trials","Evidence":"emerging","Source":"Annals Oncol 2012;23(Suppl 9):1289","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"HSP90 inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"Annals Oncol 2012;23(Suppl 9):4380","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors (alone or in combination)","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23102728.0","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:11.801621	2016-05-18 21:41:47.165737
3573	2	225	244	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"erlotinib, afatinib","Association":"response","Status":"FDA-approved","Evidence":"consensus","Source":"FDA","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"irreversible EGFR TKIs","Association":"response","Status":"late trials","Evidence":"emerging","Source":"22753918","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"afatinib + cetuximab","Association":"response","Status":"early trials","Evidence":"emerging","Source":"Annals Oncol 2012;23(Suppl 9):1289","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"HSP90 inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"Annals Oncol 2012;23(Suppl 9):4380","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors (alone or in combination)","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23102728.0","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:11.487588	2016-05-18 21:41:47.084396
3580	2	222	245	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"erlotinib, afatinib","Association":"resistance","Status":"NCCN/ CAP guidelines","Evidence":"consensus","Source":"NCCN","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"afatinib + cetuximab","Association":"response","Status":"early trials","Evidence":"emerging","Source":"Annals Oncol 2012;23(Suppl 9):1289","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"HSP90 inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"Annals Oncol 2012;23(Suppl 9):4380","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"irreversible EGFR T790M inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"J Clin Oncol 2013;31: (suppl; abstr 2524), ASCO 2014; abstr 8009","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors (alone or in combination)","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23102728.0","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:12.069357	2016-05-18 21:41:47.231637
3581	2	223	245	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"erlotinib, afatinib","Association":"resistance","Status":"NCCN/ CAP guidelines","Evidence":"consensus","Source":"NCCN","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"afatinib + cetuximab","Association":"response","Status":"early trials","Evidence":"emerging","Source":"Annals Oncol 2012;23(Suppl 9):1289","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"HSP90 inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"Annals Oncol 2012;23(Suppl 9):4380","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"irreversible EGFR T790M inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"J Clin Oncol 2013;31: (suppl; abstr 2524), ASCO 2014; abstr 8009","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors (alone or in combination)","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23102728.0","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:12.158257	2016-05-18 21:41:47.24775
3582	2	231	245	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"erlotinib, afatinib","Association":"resistance","Status":"NCCN/ CAP guidelines","Evidence":"consensus","Source":"NCCN","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"afatinib + cetuximab","Association":"response","Status":"early trials","Evidence":"emerging","Source":"Annals Oncol 2012;23(Suppl 9):1289","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"HSP90 inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"Annals Oncol 2012;23(Suppl 9):4380","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"irreversible EGFR T790M inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"J Clin Oncol 2013;31: (suppl; abstr 2524), ASCO 2014; abstr 8009","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors (alone or in combination)","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23102728.0","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:12.245801	2016-05-18 21:41:47.268001
3625	24	273	356	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"dasatinib","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"22328973","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:15.968485	2016-05-18 21:41:47.278615
3579	2	221	245	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"erlotinib, afatinib","Association":"resistance","Status":"NCCN/ CAP guidelines","Evidence":"consensus","Source":"NCCN","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"afatinib + cetuximab","Association":"response","Status":"early trials","Evidence":"emerging","Source":"Annals Oncol 2012;23(Suppl 9):1289","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"HSP90 inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"Annals Oncol 2012;23(Suppl 9):4380","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"irreversible EGFR T790M inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"J Clin Oncol 2013;31: (suppl; abstr 2524), ASCO 2014; abstr 8009","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors (alone or in combination)","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23102728.0","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:11.970772	2016-05-18 21:41:47.200576
3645	12	286	170	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"imatinib","Association":"response","Status":"case report","Evidence":"emerging","Source":"15201427","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:17.951139	2016-05-18 21:41:47.289547
3585	2	234	245	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"erlotinib, afatinib","Association":"resistance","Status":"NCCN/ CAP guidelines","Evidence":"consensus","Source":"NCCN","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"afatinib + cetuximab","Association":"response","Status":"early trials","Evidence":"emerging","Source":"Annals Oncol 2012;23(Suppl 9):1289","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"HSP90 inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"Annals Oncol 2012;23(Suppl 9):4380","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"irreversible EGFR T790M inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"J Clin Oncol 2013;31: (suppl; abstr 2524), ASCO 2014; abstr 8009","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors (alone or in combination)","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23102728.0","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:12.464064	2016-05-18 21:41:47.338802
3586	2	235	245	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"erlotinib, afatinib","Association":"resistance","Status":"NCCN/ CAP guidelines","Evidence":"consensus","Source":"NCCN","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"afatinib + cetuximab","Association":"response","Status":"early trials","Evidence":"emerging","Source":"Annals Oncol 2012;23(Suppl 9):1289","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"HSP90 inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"Annals Oncol 2012;23(Suppl 9):4380","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"irreversible EGFR T790M inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"J Clin Oncol 2013;31: (suppl; abstr 2524), ASCO 2014; abstr 8009","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors (alone or in combination)","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23102728.0","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:12.547007	2016-05-18 21:41:47.356692
3587	2	236	245	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"erlotinib, afatinib","Association":"resistance","Status":"NCCN/ CAP guidelines","Evidence":"consensus","Source":"NCCN","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"afatinib + cetuximab","Association":"response","Status":"early trials","Evidence":"emerging","Source":"Annals Oncol 2012;23(Suppl 9):1289","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"HSP90 inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"Annals Oncol 2012;23(Suppl 9):4380","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"irreversible EGFR T790M inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"J Clin Oncol 2013;31: (suppl; abstr 2524), ASCO 2014; abstr 8009","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors (alone or in combination)","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23102728.0","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:12.638999	2016-05-18 21:41:47.393837
3641	12	281	153	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"imatinib","Association":"response","Status":"case report","Evidence":"emerging","Source":"21969494","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"sunitinib","Association":"response","Status":"case report","Evidence":"emerging","Source":"23375402","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:17.526033	2016-05-18 21:41:47.415697
4236	19	2	487	\N	\N	3	\N	5	2016-05-18 21:28:04.484958	2016-05-18 21:28:04.484958
4237	19	354	487	\N	\N	3	\N	5	2016-05-18 21:28:04.525442	2016-05-18 21:28:04.525442
4238	19	347	487	\N	\N	3	\N	5	2016-05-18 21:28:04.57355	2016-05-18 21:28:04.57355
4239	19	355	487	\N	\N	3	\N	5	2016-05-18 21:28:04.622909	2016-05-18 21:28:04.622909
3584	2	233	245	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"erlotinib, afatinib","Association":"resistance","Status":"NCCN/ CAP guidelines","Evidence":"consensus","Source":"NCCN","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"afatinib + cetuximab","Association":"response","Status":"early trials","Evidence":"emerging","Source":"Annals Oncol 2012;23(Suppl 9):1289","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"HSP90 inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"Annals Oncol 2012;23(Suppl 9):4380","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"irreversible EGFR T790M inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"J Clin Oncol 2013;31: (suppl; abstr 2524), ASCO 2014; abstr 8009","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors (alone or in combination)","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23102728.0","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:12.404763	2016-05-18 21:41:47.321387
3590	2	239	245	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"erlotinib, afatinib","Association":"resistance","Status":"NCCN/ CAP guidelines","Evidence":"consensus","Source":"NCCN","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"afatinib + cetuximab","Association":"response","Status":"early trials","Evidence":"emerging","Source":"Annals Oncol 2012;23(Suppl 9):1289","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"HSP90 inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"Annals Oncol 2012;23(Suppl 9):4380","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"irreversible EGFR T790M inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"J Clin Oncol 2013;31: (suppl; abstr 2524), ASCO 2014; abstr 8009","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors (alone or in combination)","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23102728.0","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:12.878684	2016-05-18 21:41:47.487173
3591	2	240	245	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"erlotinib, afatinib","Association":"resistance","Status":"NCCN/ CAP guidelines","Evidence":"consensus","Source":"NCCN","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"afatinib + cetuximab","Association":"response","Status":"early trials","Evidence":"emerging","Source":"Annals Oncol 2012;23(Suppl 9):1289","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"HSP90 inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"Annals Oncol 2012;23(Suppl 9):4380","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"irreversible EGFR T790M inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"J Clin Oncol 2013;31: (suppl; abstr 2524), ASCO 2014; abstr 8009","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors (alone or in combination)","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23102728.0","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:12.959504	2016-05-18 21:41:47.504942
3592	2	241	245	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"erlotinib, afatinib","Association":"resistance","Status":"NCCN/ CAP guidelines","Evidence":"consensus","Source":"NCCN","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"afatinib + cetuximab","Association":"response","Status":"early trials","Evidence":"emerging","Source":"Annals Oncol 2012;23(Suppl 9):1289","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"HSP90 inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"Annals Oncol 2012;23(Suppl 9):4380","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"irreversible EGFR T790M inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"J Clin Oncol 2013;31: (suppl; abstr 2524), ASCO 2014; abstr 8009","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors (alone or in combination)","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23102728.0","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:13.049047	2016-05-18 21:41:47.5258
3642	12	279	153	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"imatinib","Association":"response","Status":"case report","Evidence":"emerging","Source":"21969494","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"sunitinib","Association":"response","Status":"case report","Evidence":"emerging","Source":"23375402","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:17.623376	2016-05-18 21:41:47.540724
4240	19	356	487	\N	\N	3	\N	5	2016-05-18 21:28:04.668603	2016-05-18 21:28:04.668603
4241	19	3	487	\N	\N	3	\N	5	2016-05-18 21:28:04.732533	2016-05-18 21:28:04.732533
4242	19	173	488	\N	\N	3	\N	5	2016-05-18 21:28:04.80204	2016-05-18 21:28:04.80204
4243	19	188	488	\N	\N	3	\N	5	2016-05-18 21:28:04.86341	2016-05-18 21:28:04.86341
3589	2	238	245	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"erlotinib, afatinib","Association":"resistance","Status":"NCCN/ CAP guidelines","Evidence":"consensus","Source":"NCCN","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"afatinib + cetuximab","Association":"response","Status":"early trials","Evidence":"emerging","Source":"Annals Oncol 2012;23(Suppl 9):1289","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"HSP90 inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"Annals Oncol 2012;23(Suppl 9):4380","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"irreversible EGFR T790M inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"J Clin Oncol 2013;31: (suppl; abstr 2524), ASCO 2014; abstr 8009","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors (alone or in combination)","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23102728.0","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:12.798812	2016-05-18 21:41:47.465415
3595	2	221	246	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"erlotinib, afatinib","Association":"response","Status":"FDA-approved","Evidence":"consensus","Source":"FDA","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"irreversible EGFR TKIs","Association":"response","Status":"late trials","Evidence":"emerging","Source":"22753918","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"afatinib + cetuximab","Association":"response","Status":"early trials","Evidence":"emerging","Source":"Annals Oncol 2012;23(Suppl 9):1289","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"HSP90 inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"Annals Oncol 2012;23(Suppl 9):4380","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors (alone or in combination)","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23102728.0","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:13.28528	2016-05-18 21:41:47.596575
3596	2	222	246	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"erlotinib, afatinib","Association":"response","Status":"FDA-approved","Evidence":"consensus","Source":"FDA","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"irreversible EGFR TKIs","Association":"response","Status":"late trials","Evidence":"emerging","Source":"22753918","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"afatinib + cetuximab","Association":"response","Status":"early trials","Evidence":"emerging","Source":"Annals Oncol 2012;23(Suppl 9):1289","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"HSP90 inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"Annals Oncol 2012;23(Suppl 9):4380","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors (alone or in combination)","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23102728.0","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:13.370292	2016-05-18 21:41:47.615743
3597	2	223	246	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"erlotinib, afatinib","Association":"response","Status":"FDA-approved","Evidence":"consensus","Source":"FDA","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"irreversible EGFR TKIs","Association":"response","Status":"late trials","Evidence":"emerging","Source":"22753918","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"afatinib + cetuximab","Association":"response","Status":"early trials","Evidence":"emerging","Source":"Annals Oncol 2012;23(Suppl 9):1289","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"HSP90 inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"Annals Oncol 2012;23(Suppl 9):4380","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors (alone or in combination)","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23102728.0","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:13.449757	2016-05-18 21:41:47.636753
3643	12	282	153	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"imatinib","Association":"response","Status":"case report","Evidence":"emerging","Source":"21969494","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"sunitinib","Association":"response","Status":"case report","Evidence":"emerging","Source":"23375402","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:17.733804	2016-05-18 21:41:47.651933
3594	2	230	245	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"erlotinib, afatinib","Association":"resistance","Status":"NCCN/ CAP guidelines","Evidence":"consensus","Source":"NCCN","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"afatinib + cetuximab","Association":"response","Status":"early trials","Evidence":"emerging","Source":"Annals Oncol 2012;23(Suppl 9):1289","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"HSP90 inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"Annals Oncol 2012;23(Suppl 9):4380","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"irreversible EGFR T790M inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"J Clin Oncol 2013;31: (suppl; abstr 2524), ASCO 2014; abstr 8009","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors (alone or in combination)","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23102728.0","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:13.190357	2016-05-18 21:41:47.576995
3644	12	285	170	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"imatinib","Association":"response","Status":"case report","Evidence":"emerging","Source":"15201427","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:17.832685	2016-05-18 21:41:47.661543
3600	2	244	246	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"erlotinib, afatinib","Association":"response","Status":"FDA-approved","Evidence":"consensus","Source":"FDA","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"irreversible EGFR TKIs","Association":"response","Status":"late trials","Evidence":"emerging","Source":"22753918","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"afatinib + cetuximab","Association":"response","Status":"early trials","Evidence":"emerging","Source":"Annals Oncol 2012;23(Suppl 9):1289","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"HSP90 inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"Annals Oncol 2012;23(Suppl 9):4380","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors (alone or in combination)","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23102728.0","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:13.686925	2016-05-18 21:41:47.720998
3601	2	245	246	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"erlotinib, afatinib","Association":"response","Status":"FDA-approved","Evidence":"consensus","Source":"FDA","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"irreversible EGFR TKIs","Association":"response","Status":"late trials","Evidence":"emerging","Source":"22753918","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"afatinib + cetuximab","Association":"response","Status":"early trials","Evidence":"emerging","Source":"Annals Oncol 2012;23(Suppl 9):1289","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"HSP90 inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"Annals Oncol 2012;23(Suppl 9):4380","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors (alone or in combination)","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23102728.0","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:13.775404	2016-05-18 21:41:47.738495
3602	2	246	246	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"erlotinib, afatinib","Association":"response","Status":"FDA-approved","Evidence":"consensus","Source":"FDA","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"irreversible EGFR TKIs","Association":"response","Status":"late trials","Evidence":"emerging","Source":"22753918","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"afatinib + cetuximab","Association":"response","Status":"early trials","Evidence":"emerging","Source":"Annals Oncol 2012;23(Suppl 9):1289","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"HSP90 inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"Annals Oncol 2012;23(Suppl 9):4380","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors (alone or in combination)","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23102728.0","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:13.859435	2016-05-18 21:41:47.757622
3603	2	247	246	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"erlotinib, afatinib","Association":"response","Status":"FDA-approved","Evidence":"consensus","Source":"FDA","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"irreversible EGFR TKIs","Association":"response","Status":"late trials","Evidence":"emerging","Source":"22753918","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"afatinib + cetuximab","Association":"response","Status":"early trials","Evidence":"emerging","Source":"Annals Oncol 2012;23(Suppl 9):1289","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"HSP90 inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"Annals Oncol 2012;23(Suppl 9):4380","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors (alone or in combination)","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23102728.0","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:13.924136	2016-05-18 21:41:47.77759
3599	2	243	246	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"erlotinib, afatinib","Association":"response","Status":"FDA-approved","Evidence":"consensus","Source":"FDA","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"irreversible EGFR TKIs","Association":"response","Status":"late trials","Evidence":"emerging","Source":"22753918","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"afatinib + cetuximab","Association":"response","Status":"early trials","Evidence":"emerging","Source":"Annals Oncol 2012;23(Suppl 9):1289","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"HSP90 inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"Annals Oncol 2012;23(Suppl 9):4380","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors (alone or in combination)","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23102728.0","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:13.602499	2016-05-18 21:41:47.698312
3606	2	250	246	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"erlotinib, afatinib","Association":"response","Status":"FDA-approved","Evidence":"consensus","Source":"FDA","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"irreversible EGFR TKIs","Association":"response","Status":"late trials","Evidence":"emerging","Source":"22753918","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"afatinib + cetuximab","Association":"response","Status":"early trials","Evidence":"emerging","Source":"Annals Oncol 2012;23(Suppl 9):1289","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"HSP90 inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"Annals Oncol 2012;23(Suppl 9):4380","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors (alone or in combination)","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23102728.0","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:14.195075	2016-05-18 21:41:47.836756
3607	2	251	246	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"erlotinib, afatinib","Association":"response","Status":"FDA-approved","Evidence":"consensus","Source":"FDA","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"irreversible EGFR TKIs","Association":"response","Status":"late trials","Evidence":"emerging","Source":"22753918","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"afatinib + cetuximab","Association":"response","Status":"early trials","Evidence":"emerging","Source":"Annals Oncol 2012;23(Suppl 9):1289","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"HSP90 inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"Annals Oncol 2012;23(Suppl 9):4380","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors (alone or in combination)","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23102728.0","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:14.281536	2016-05-18 21:41:47.856607
3608	2	252	246	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"erlotinib, afatinib","Association":"response","Status":"FDA-approved","Evidence":"consensus","Source":"FDA","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"irreversible EGFR TKIs","Association":"response","Status":"late trials","Evidence":"emerging","Source":"22753918","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"afatinib + cetuximab","Association":"response","Status":"early trials","Evidence":"emerging","Source":"Annals Oncol 2012;23(Suppl 9):1289","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"HSP90 inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"Annals Oncol 2012;23(Suppl 9):4380","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors (alone or in combination)","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23102728.0","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:14.364859	2016-05-18 21:41:47.875231
3609	2	253	246	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"erlotinib, afatinib","Association":"response","Status":"FDA-approved","Evidence":"consensus","Source":"FDA","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"irreversible EGFR TKIs","Association":"response","Status":"late trials","Evidence":"emerging","Source":"22753918","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"afatinib + cetuximab","Association":"response","Status":"early trials","Evidence":"emerging","Source":"Annals Oncol 2012;23(Suppl 9):1289","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"HSP90 inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"Annals Oncol 2012;23(Suppl 9):4380","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors (alone or in combination)","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23102728.0","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:14.472915	2016-05-18 21:41:47.894986
3605	2	249	246	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"erlotinib, afatinib","Association":"response","Status":"FDA-approved","Evidence":"consensus","Source":"FDA","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"irreversible EGFR TKIs","Association":"response","Status":"late trials","Evidence":"emerging","Source":"22753918","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"afatinib + cetuximab","Association":"response","Status":"early trials","Evidence":"emerging","Source":"Annals Oncol 2012;23(Suppl 9):1289","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"HSP90 inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"Annals Oncol 2012;23(Suppl 9):4380","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors (alone or in combination)","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23102728.0","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:14.108991	2016-05-18 21:41:47.814718
3612	2	228	246	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"erlotinib, afatinib","Association":"response","Status":"FDA-approved","Evidence":"consensus","Source":"FDA","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"irreversible EGFR TKIs","Association":"response","Status":"late trials","Evidence":"emerging","Source":"22753918","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"afatinib + cetuximab","Association":"response","Status":"early trials","Evidence":"emerging","Source":"Annals Oncol 2012;23(Suppl 9):1289","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"HSP90 inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"Annals Oncol 2012;23(Suppl 9):4380","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors (alone or in combination)","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23102728.0","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:14.791146	2016-05-18 21:41:47.954226
3613	2	230	246	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"erlotinib, afatinib","Association":"response","Status":"FDA-approved","Evidence":"consensus","Source":"FDA","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"irreversible EGFR TKIs","Association":"response","Status":"late trials","Evidence":"emerging","Source":"22753918","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"afatinib + cetuximab","Association":"response","Status":"early trials","Evidence":"emerging","Source":"Annals Oncol 2012;23(Suppl 9):1289","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"HSP90 inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"Annals Oncol 2012;23(Suppl 9):4380","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors (alone or in combination)","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23102728.0","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:14.880259	2016-05-18 21:41:47.975923
3614	2	221	247	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"erlotinib, afatinib","Association":"response","Status":"FDA-approved","Evidence":"consensus","Source":"FDA","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"irreversible EGFR TKIs","Association":"response","Status":"late trials","Evidence":"emerging","Source":"22753918","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"afatinib + cetuximab","Association":"response","Status":"early trials","Evidence":"emerging","Source":"Annals Oncol 2012;23(Suppl 9):1289","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"HSP90 inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"Annals Oncol 2012;23(Suppl 9):4380","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors (alone or in combination)","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23102728.0","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:14.984161	2016-05-18 21:41:47.99341
3615	2	222	247	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"erlotinib, afatinib","Association":"response","Status":"FDA-approved","Evidence":"consensus","Source":"FDA","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"irreversible EGFR TKIs","Association":"response","Status":"late trials","Evidence":"emerging","Source":"22753918","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"afatinib + cetuximab","Association":"response","Status":"early trials","Evidence":"emerging","Source":"Annals Oncol 2012;23(Suppl 9):1289","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"HSP90 inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"Annals Oncol 2012;23(Suppl 9):4380","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors (alone or in combination)","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23102728.0","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:15.076261	2016-05-18 21:41:48.015716
3611	2	229	246	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"erlotinib, afatinib","Association":"response","Status":"FDA-approved","Evidence":"consensus","Source":"FDA","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"irreversible EGFR TKIs","Association":"response","Status":"late trials","Evidence":"emerging","Source":"22753918","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"afatinib + cetuximab","Association":"response","Status":"early trials","Evidence":"emerging","Source":"Annals Oncol 2012;23(Suppl 9):1289","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"HSP90 inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"Annals Oncol 2012;23(Suppl 9):4380","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors (alone or in combination)","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23102728.0","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:14.654768	2016-05-18 21:41:47.935368
3618	2	229	247	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"erlotinib, afatinib","Association":"response","Status":"FDA-approved","Evidence":"consensus","Source":"FDA","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"irreversible EGFR TKIs","Association":"response","Status":"late trials","Evidence":"emerging","Source":"22753918","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"afatinib + cetuximab","Association":"response","Status":"early trials","Evidence":"emerging","Source":"Annals Oncol 2012;23(Suppl 9):1289","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"HSP90 inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"Annals Oncol 2012;23(Suppl 9):4380","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors (alone or in combination)","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23102728.0","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:15.337974	2016-05-18 21:41:48.072493
3619	2	230	247	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"erlotinib, afatinib","Association":"response","Status":"FDA-approved","Evidence":"consensus","Source":"FDA","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"irreversible EGFR TKIs","Association":"response","Status":"late trials","Evidence":"emerging","Source":"22753918","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"afatinib + cetuximab","Association":"response","Status":"early trials","Evidence":"emerging","Source":"Annals Oncol 2012;23(Suppl 9):1289","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"HSP90 inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"Annals Oncol 2012;23(Suppl 9):4380","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors (alone or in combination)","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23102728.0","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:15.40105	2016-05-18 21:41:48.092027
3620	24	273	351	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"dasatinib","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"22328973","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:15.499056	2016-05-18 21:41:48.105347
3623	24	273	354	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"dasatinib","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"22328973","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:15.790473	2016-05-18 21:41:48.143657
3624	24	273	355	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"dasatinib","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"22328973","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:15.870297	2016-05-18 21:41:48.153378
4244	19	344	488	\N	\N	3	\N	5	2016-05-18 21:28:04.906283	2016-05-18 21:28:04.906283
4245	19	357	488	\N	\N	3	\N	5	2016-05-18 21:28:04.969714	2016-05-18 21:28:04.969714
3617	2	224	247	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"erlotinib, afatinib","Association":"response","Status":"FDA-approved","Evidence":"consensus","Source":"FDA","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"irreversible EGFR TKIs","Association":"response","Status":"late trials","Evidence":"emerging","Source":"22753918","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"afatinib + cetuximab","Association":"response","Status":"early trials","Evidence":"emerging","Source":"Annals Oncol 2012;23(Suppl 9):1289","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"HSP90 inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"Annals Oncol 2012;23(Suppl 9):4380","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors (alone or in combination)","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23102728.0","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:15.252092	2016-05-18 21:41:48.053718
3621	24	273	352	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"dasatinib","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"22328973","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:15.587803	2016-05-18 21:41:48.11539
3622	24	273	353	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"dasatinib","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"22328973","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:15.696671	2016-05-18 21:41:48.133338
3628	24	229	358	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"erlotinib, afatinib","Association":"response","Status":"FDA-approved","Evidence":"consensus","Source":"FDA","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"irreversible EGFR TKIs","Association":"response","Status":"late trials","Evidence":"emerging","Source":"22753918","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"afatinib + cetuximab","Association":"response","Status":"early trials","Evidence":"emerging","Source":"Annals Oncol 2012;23(Suppl 9):1289","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"HSP90 inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"Annals Oncol 2012;23(Suppl 9):4380","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors (alone or in combination)","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23102728.0","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:16.263892	2016-05-18 21:41:48.273868
3629	24	230	358	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"erlotinib, afatinib","Association":"response","Status":"FDA-approved","Evidence":"consensus","Source":"FDA","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"irreversible EGFR TKIs","Association":"response","Status":"late trials","Evidence":"emerging","Source":"22753918","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"afatinib + cetuximab","Association":"response","Status":"early trials","Evidence":"emerging","Source":"Annals Oncol 2012;23(Suppl 9):1289","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"HSP90 inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"Annals Oncol 2012;23(Suppl 9):4380","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors (alone or in combination)","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23102728.0","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:16.338949	2016-05-18 21:41:48.293444
3630	24	229	359	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"erlotinib, afatinib","Association":"response","Status":"FDA-approved","Evidence":"consensus","Source":"FDA","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"irreversible EGFR TKIs","Association":"response","Status":"late trials","Evidence":"emerging","Source":"22753918","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"afatinib + cetuximab","Association":"response","Status":"early trials","Evidence":"emerging","Source":"Annals Oncol 2012;23(Suppl 9):1289","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"HSP90 inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"Annals Oncol 2012;23(Suppl 9):4380","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors (alone or in combination)","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23102728.0","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:16.440885	2016-05-18 21:41:48.310692
3631	24	230	359	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"erlotinib, afatinib","Association":"response","Status":"FDA-approved","Evidence":"consensus","Source":"FDA","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"irreversible EGFR TKIs","Association":"response","Status":"late trials","Evidence":"emerging","Source":"22753918","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"afatinib + cetuximab","Association":"response","Status":"early trials","Evidence":"emerging","Source":"Annals Oncol 2012;23(Suppl 9):1289","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"HSP90 inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"Annals Oncol 2012;23(Suppl 9):4380","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors (alone or in combination)","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23102728.0","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:16.579156	2016-05-18 21:41:48.336607
3627	24	230	357	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"erlotinib, afatinib","Association":"response","Status":"FDA-approved","Evidence":"consensus","Source":"FDA","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"irreversible EGFR TKIs","Association":"response","Status":"late trials","Evidence":"emerging","Source":"22753918","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"afatinib + cetuximab","Association":"response","Status":"early trials","Evidence":"emerging","Source":"Annals Oncol 2012;23(Suppl 9):1289","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"HSP90 inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"Annals Oncol 2012;23(Suppl 9):4380","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors (alone or in combination)","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23102728.0","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:16.145699	2016-05-18 21:41:48.252347
3634	24	229	361	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"erlotinib, afatinib","Association":"response","Status":"FDA-approved","Evidence":"consensus","Source":"FDA","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"irreversible EGFR TKIs","Association":"response","Status":"late trials","Evidence":"emerging","Source":"22753918","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"afatinib + cetuximab","Association":"response","Status":"early trials","Evidence":"emerging","Source":"Annals Oncol 2012;23(Suppl 9):1289","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"HSP90 inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"Annals Oncol 2012;23(Suppl 9):4380","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors (alone or in combination)","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23102728.0","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:16.857976	2016-05-18 21:41:48.416581
3635	24	230	361	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"erlotinib, afatinib","Association":"response","Status":"FDA-approved","Evidence":"consensus","Source":"FDA","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"irreversible EGFR TKIs","Association":"response","Status":"late trials","Evidence":"emerging","Source":"22753918","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"afatinib + cetuximab","Association":"response","Status":"early trials","Evidence":"emerging","Source":"Annals Oncol 2012;23(Suppl 9):1289","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"HSP90 inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"Annals Oncol 2012;23(Suppl 9):4380","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors (alone or in combination)","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23102728.0","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:16.944694	2016-05-18 21:41:48.443028
3636	24	274	362	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"mTOR inhibitors, dasatinib","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"20360610","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:17.049972	2016-05-18 21:41:48.466742
3639	24	275	365	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"FGFR inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23786770","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:17.352612	2016-05-18 21:41:48.500473
3640	25	277	203	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"dasatinib","Association":"response","Status":"early trials","Evidence":"emerging","Source":"18559612","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:17.422458	2016-05-18 21:41:48.508828
4246	19	3	488	\N	\N	3	\N	5	2016-05-18 21:28:05.021347	2016-05-18 21:28:05.021347
3633	24	230	360	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"erlotinib, afatinib","Association":"response","Status":"FDA-approved","Evidence":"consensus","Source":"FDA","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"irreversible EGFR TKIs","Association":"response","Status":"late trials","Evidence":"emerging","Source":"22753918","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"afatinib + cetuximab","Association":"response","Status":"early trials","Evidence":"emerging","Source":"Annals Oncol 2012;23(Suppl 9):1289","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"HSP90 inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"Annals Oncol 2012;23(Suppl 9):4380","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors (alone or in combination)","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23102728.0","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:16.767094	2016-05-18 21:41:48.388523
3637	24	274	363	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"mTOR inhibitors, dasatinib","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"20360610","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:17.142669	2016-05-18 21:41:48.47885
3638	24	275	364	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"FGFR inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23786770","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:17.241097	2016-05-18 21:41:48.487144
3648	12	285	196	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"sunitinib","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"19861435","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:18.224347	2016-05-18 21:41:48.53801
3649	12	378	204	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"sorafenib","Association":"response","Status":"case report","Evidence":"emerging","Source":"19461405","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:18.301493	2016-05-18 21:41:48.54663
3650	12	279	204	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"sorafenib","Association":"response","Status":"case report","Evidence":"emerging","Source":"19461405","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:18.428614	2016-05-18 21:41:48.553708
3651	12	379	204	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"sorafenib","Association":"response","Status":"case report","Evidence":"emerging","Source":"19461405","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:18.536499	2016-05-18 21:41:48.566467
3652	10	290	366	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"FGFR inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"24124571","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:18.658258	2016-05-18 21:41:48.574593
3653	10	290	367	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"FGFR inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"24124571","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:18.740418	2016-05-18 21:41:48.583427
3654	10	290	368	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"FGFR inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"24124571","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:18.829918	2016-05-18 21:41:48.593086
3655	26	292	369	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"lapatinib","Association":"response","Status":"case report","Evidence":"emerging","Source":"22885469","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:18.926321	2016-05-18 21:41:48.600696
3656	26	293	370	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"dovitinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"23908597","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"ponatinib","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23908597","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:19.087946	2016-05-18 21:41:48.61174
3657	26	293	371	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"dovitinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"23908597","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"ponatinib","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23908597","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:19.224936	2016-05-18 21:41:48.622149
3658	26	293	372	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"dovitinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"23908597","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"ponatinib","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23908597","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:19.342178	2016-05-18 21:41:48.637958
3659	26	293	373	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"dovitinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"23908597","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"ponatinib","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23908597","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:19.454863	2016-05-18 21:41:48.647994
4247	19	358	300	\N	\N	3	\N	5	2016-05-18 21:28:05.06341	2016-05-18 21:28:05.06341
4248	19	359	300	\N	\N	3	\N	5	2016-05-18 21:28:05.113949	2016-05-18 21:28:05.113949
3646	12	287	170	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"imatinib","Association":"response","Status":"case report","Evidence":"emerging","Source":"15201427","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:18.046953	2016-05-18 21:41:48.517343
3647	12	288	170	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"imatinib","Association":"response","Status":"case report","Evidence":"emerging","Source":"15201427","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:18.138685	2016-05-18 21:41:48.526179
3662	26	296	374	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"FGFR inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"18552176, 22238366, 23002168","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:19.671945	2016-05-18 21:41:48.686307
3663	26	293	374	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"dovitinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"23908597","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"ponatinib","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23908597","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:19.737813	2016-05-18 21:41:48.698431
3664	26	294	375	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"FGFR inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"18552176, 22238366, 23002168","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:19.83449	2016-05-18 21:41:48.712286
3665	26	295	375	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"FGFR inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"18552176, 22238366, 23002168","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:19.901497	2016-05-18 21:41:48.722759
3666	26	296	375	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"FGFR inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"18552176, 22238366, 23002168","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:19.965726	2016-05-18 21:41:48.735402
3667	26	293	375	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"dovitinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"23908597","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"ponatinib","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23908597","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:20.044543	2016-05-18 21:41:48.750862
3668	26	293	376	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"dovitinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"23908597","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"ponatinib","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23908597","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:20.16612	2016-05-18 21:41:48.763706
3669	26	293	377	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"dovitinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"23908597","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"ponatinib","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23908597","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:20.292688	2016-05-18 21:41:48.771953
3670	26	293	378	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"dovitinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"23908597","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"ponatinib","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23908597","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:20.393989	2016-05-18 21:41:48.788632
3671	26	293	379	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"dovitinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"23908597","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"ponatinib","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23908597","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:20.479019	2016-05-18 21:41:48.80768
3672	26	293	380	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"dovitinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"23908597","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"ponatinib","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23908597","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:20.570027	2016-05-18 21:41:48.829598
3660	26	294	374	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"FGFR inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"18552176, 22238366, 23002168","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:19.545729	2016-05-18 21:41:48.661844
3661	26	295	374	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"FGFR inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"18552176, 22238366, 23002168","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:19.60197	2016-05-18 21:41:48.674803
3676	26	294	384	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"preclinical","Association":"FGFR inhibitors","Status":"emerging","Evidence":"18552176, 22238366, 23002168","Source":"nan","Effect":"gain-of-function","Pathway":"sensitivity"}]}]}}	4	2016-05-18 21:27:20.985219	2016-05-18 21:41:48.894157
3677	26	295	384	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"preclinical","Association":"FGFR inhibitors","Status":"emerging","Evidence":"18552176, 22238366, 23002168","Source":"nan","Effect":"gain-of-function","Pathway":"sensitivity"}]}]}}	4	2016-05-18 21:27:21.071437	2016-05-18 21:41:48.907886
3680	27	298	386	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"JAK inhibitors, dasatinib","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23696637","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:21.366327	2016-05-18 21:41:48.944077
3681	27	298	387	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"JAK inhibitors, dasatinib","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23696637","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:21.463771	2016-05-18 21:41:48.959706
3682	27	299	388	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"imatinib","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"18971950","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:21.555119	2016-05-18 21:41:48.980507
3683	27	300	389	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"JAK inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"16834459","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:21.647408	2016-05-18 21:41:48.996026
3673	26	293	381	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"dovitinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"23908597","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"ponatinib","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23908597","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:20.700557	2016-05-18 21:41:48.851082
3674	26	293	382	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"dovitinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"23908597","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"ponatinib","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23908597","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:20.795446	2016-05-18 21:41:48.861317
4249	19	185	300	\N	\N	3	\N	5	2016-05-18 21:28:05.164457	2016-05-18 21:28:05.164457
4250	19	360	300	\N	\N	3	\N	5	2016-05-18 21:28:05.217066	2016-05-18 21:28:05.217066
4251	19	361	300	\N	\N	3	\N	5	2016-05-18 21:28:05.256542	2016-05-18 21:28:05.256542
4252	19	173	300	\N	\N	3	\N	5	2016-05-18 21:28:05.303433	2016-05-18 21:28:05.303433
3675	26	293	383	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"dovitinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"23908597","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"ponatinib","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23908597","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:20.884113	2016-05-18 21:41:48.87195
3678	26	296	384	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"preclinical","Association":"FGFR inhibitors","Status":"emerging","Evidence":"18552176, 22238366, 23002168","Source":"nan","Effect":"gain-of-function","Pathway":"sensitivity"}]}]}}	4	2016-05-18 21:27:21.162271	2016-05-18 21:41:48.923583
3679	26	297	385	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"mTOR inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"21984976","Effect":"loss-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:21.266947	2016-05-18 21:41:48.934221
3690	6	307	226	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"BRAF inhibitors","Association":"response","Status":"case report","Evidence":"emerging","Source":"22608338","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"19018267","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:22.180525	2016-05-18 21:41:49.008707
3684	6	303	226	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"dabrafenib","Association":"response","Status":"case report","Evidence":"emerging","Source":"22608338","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:21.72618	2016-05-18 21:41:49.020582
3685	6	304	226	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"dabrafenib","Association":"response","Status":"case report","Evidence":"emerging","Source":"22608338","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:21.806552	2016-05-18 21:41:49.030847
3688	6	306	226	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"dabrafenib","Association":"response","Status":"case report","Evidence":"emerging","Source":"22608338","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:22.012419	2016-05-18 21:41:49.068256
3689	6	46	226	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"dabrafenib","Association":"response","Status":"case report","Evidence":"emerging","Source":"22608338","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:22.083514	2016-05-18 21:41:49.077838
3691	28	380	390	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"trastuzumab, pertuzumab, lapatinib, anti-HER3 mAbs, PI3K pathway inhibitors + MEK inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23680147","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:22.736351	2016-05-18 21:41:49.086681
4253	19	362	300	\N	\N	3	\N	5	2016-05-18 21:28:05.353731	2016-05-18 21:28:05.353731
4254	19	363	300	\N	\N	3	\N	5	2016-05-18 21:28:05.392744	2016-05-18 21:28:05.392744
4255	19	175	300	\N	\N	3	\N	5	2016-05-18 21:28:05.43325	2016-05-18 21:28:05.43325
3686	6	36	226	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"dabrafenib","Association":"response","Status":"case report","Evidence":"emerging","Source":"22608338","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:21.873912	2016-05-18 21:41:49.041826
3687	6	305	226	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"dabrafenib","Association":"response","Status":"case report","Evidence":"emerging","Source":"22608338","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:21.940835	2016-05-18 21:41:49.053388
3692	1	315	391	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"BRAF inhibitors","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"24265152","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:22.842479	2016-05-18 21:41:49.099843
3693	1	316	392	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"MEK inhibitors","Association":"response","Status":"case report","Evidence":"emerging","Source":"23248257","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:22.937218	2016-05-18 21:41:49.11174
3696	1	327	226	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"vemurafenib, dabrafenib, trametinib, dabrafenib + trametinib","Association":"response","Status":"FDA-approved","Evidence":"consensus","Source":"FDA","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"J Clin Oncol 2013;31 (suppl; abstr 9028)","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors + PI3K pathway inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"22389471, 21156289","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors + HSP90 inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"22351686","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors + CDK2/4 inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"22997239.0","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"preclinical","Association":"ERK inhibitors","Status":"preclinical","Evidence":"emerging","Source":"23614898, 22997239","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:23.177978	2016-05-18 21:41:49.175568
3697	1	323	226	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"vemurafenib, dabrafenib, trametinib, dabrafenib + trametinib","Association":"response","Status":"FDA-approved","Evidence":"consensus","Source":"FDA","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"J Clin Oncol 2013;31 (suppl; abstr 9028)","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors + PI3K pathway inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"22389471, 21156289","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors + HSP90 inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"22351686","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors + CDK2/4 inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"22997239.0","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"preclinical","Association":"ERK inhibitors","Status":"preclinical","Evidence":"emerging","Source":"23614898, 22997239","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:23.275749	2016-05-18 21:41:49.197297
3698	1	306	226	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"vemurafenib, dabrafenib, trametinib, dabrafenib + trametinib","Association":"response","Status":"FDA-approved","Evidence":"consensus","Source":"FDA","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"J Clin Oncol 2013;31 (suppl; abstr 9028)","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors + PI3K pathway inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"22389471, 21156289","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors + HSP90 inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"22351686","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors + CDK2/4 inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"22997239.0","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"preclinical","Association":"ERK inhibitors","Status":"preclinical","Evidence":"emerging","Source":"23614898, 22997239","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:23.356714	2016-05-18 21:41:49.224884
4256	19	172	300	\N	\N	3	\N	5	2016-05-18 21:28:05.48257	2016-05-18 21:28:05.48257
3695	1	317	226	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"vemurafenib, dabrafenib, trametinib, dabrafenib + trametinib","Association":"response","Status":"FDA-approved","Evidence":"consensus","Source":"FDA","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"J Clin Oncol 2013;31 (suppl; abstr 9028)","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors + PI3K pathway inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"22389471, 21156289","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors + HSP90 inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"22351686","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors + CDK2/4 inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"22997239.0","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"preclinical","Association":"ERK inhibitors","Status":"preclinical","Evidence":"emerging","Source":"23614898, 22997239","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:23.090746	2016-05-18 21:41:49.155691
3701	1	305	226	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"vemurafenib, dabrafenib, trametinib, dabrafenib + trametinib","Association":"response","Status":"FDA-approved","Evidence":"consensus","Source":"FDA","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"J Clin Oncol 2013;31 (suppl; abstr 9028)","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors + PI3K pathway inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"22389471, 21156289","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors + HSP90 inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"22351686","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors + CDK2/4 inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"22997239.0","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"preclinical","Association":"ERK inhibitors","Status":"preclinical","Evidence":"emerging","Source":"23614898, 22997239","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:23.625008	2016-05-18 21:41:49.297699
3702	1	325	226	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"vemurafenib, dabrafenib, trametinib, dabrafenib + trametinib","Association":"response","Status":"FDA-approved","Evidence":"consensus","Source":"FDA","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"J Clin Oncol 2013;31 (suppl; abstr 9028)","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors + PI3K pathway inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"22389471, 21156289","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors + HSP90 inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"22351686","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors + CDK2/4 inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"22997239.0","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"preclinical","Association":"ERK inhibitors","Status":"preclinical","Evidence":"emerging","Source":"23614898, 22997239","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:23.715986	2016-05-18 21:41:49.31137
3703	1	318	226	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"vemurafenib, dabrafenib, trametinib, dabrafenib + trametinib","Association":"response","Status":"FDA-approved","Evidence":"consensus","Source":"FDA","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"J Clin Oncol 2013;31 (suppl; abstr 9028)","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors + PI3K pathway inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"22389471, 21156289","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors + HSP90 inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"22351686","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors + CDK2/4 inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"22997239.0","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"preclinical","Association":"ERK inhibitors","Status":"preclinical","Evidence":"emerging","Source":"23614898, 22997239","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:23.803044	2016-05-18 21:41:49.356233
4257	19	188	300	\N	\N	3	\N	5	2016-05-18 21:28:05.533036	2016-05-18 21:28:05.533036
3700	1	324	226	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"vemurafenib, dabrafenib, trametinib, dabrafenib + trametinib","Association":"response","Status":"FDA-approved","Evidence":"consensus","Source":"FDA","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"J Clin Oncol 2013;31 (suppl; abstr 9028)","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors + PI3K pathway inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"22389471, 21156289","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors + HSP90 inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"22351686","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors + CDK2/4 inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"22997239.0","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"preclinical","Association":"ERK inhibitors","Status":"preclinical","Evidence":"emerging","Source":"23614898, 22997239","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:23.528472	2016-05-18 21:41:49.268499
3706	1	321	226	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"vemurafenib, dabrafenib, trametinib, dabrafenib + trametinib","Association":"response","Status":"FDA-approved","Evidence":"consensus","Source":"FDA","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"J Clin Oncol 2013;31 (suppl; abstr 9028)","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors + PI3K pathway inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"22389471, 21156289","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors + HSP90 inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"22351686","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors + CDK2/4 inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"22997239.0","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"preclinical","Association":"ERK inhibitors","Status":"preclinical","Evidence":"emerging","Source":"23614898, 22997239","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:24.13277	2016-05-18 21:41:49.468231
3707	1	322	226	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"vemurafenib, dabrafenib, trametinib, dabrafenib + trametinib","Association":"response","Status":"FDA-approved","Evidence":"consensus","Source":"FDA","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"J Clin Oncol 2013;31 (suppl; abstr 9028)","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors + PI3K pathway inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"22389471, 21156289","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors + HSP90 inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"22351686","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors + CDK2/4 inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"22997239.0","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"preclinical","Association":"ERK inhibitors","Status":"preclinical","Evidence":"emerging","Source":"23614898, 22997239","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:24.266668	2016-05-18 21:41:49.503408
3708	1	328	226	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"vemurafenib, dabrafenib, trametinib, dabrafenib + trametinib","Association":"response","Status":"FDA-approved","Evidence":"consensus","Source":"FDA","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"J Clin Oncol 2013;31 (suppl; abstr 9028)","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors + PI3K pathway inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"22389471, 21156289","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors + HSP90 inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"22351686","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors + CDK2/4 inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"22997239.0","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"preclinical","Association":"ERK inhibitors","Status":"preclinical","Evidence":"emerging","Source":"23614898, 22997239","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:24.359787	2016-05-18 21:41:49.524591
4258	19	177	300	\N	\N	3	\N	5	2016-05-18 21:28:05.596617	2016-05-18 21:28:05.596617
3705	1	320	226	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"vemurafenib, dabrafenib, trametinib, dabrafenib + trametinib","Association":"response","Status":"FDA-approved","Evidence":"consensus","Source":"FDA","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"J Clin Oncol 2013;31 (suppl; abstr 9028)","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors + PI3K pathway inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"22389471, 21156289","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors + HSP90 inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"22351686","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors + CDK2/4 inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"22997239.0","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"preclinical","Association":"ERK inhibitors","Status":"preclinical","Evidence":"emerging","Source":"23614898, 22997239","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:23.998367	2016-05-18 21:41:49.441709
3711	1	331	226	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"vemurafenib, dabrafenib, trametinib, dabrafenib + trametinib","Association":"response","Status":"FDA-approved","Evidence":"consensus","Source":"FDA","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"J Clin Oncol 2013;31 (suppl; abstr 9028)","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors + PI3K pathway inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"22389471, 21156289","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors + HSP90 inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"22351686","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors + CDK2/4 inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"22997239.0","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"preclinical","Association":"ERK inhibitors","Status":"preclinical","Evidence":"emerging","Source":"23614898, 22997239","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:24.654222	2016-05-18 21:41:49.5888
3712	1	332	226	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"vemurafenib, dabrafenib, trametinib, dabrafenib + trametinib","Association":"response","Status":"FDA-approved","Evidence":"consensus","Source":"FDA","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"J Clin Oncol 2013;31 (suppl; abstr 9028)","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors + PI3K pathway inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"22389471, 21156289","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors + HSP90 inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"22351686","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors + CDK2/4 inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"22997239.0","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"preclinical","Association":"ERK inhibitors","Status":"preclinical","Evidence":"emerging","Source":"23614898, 22997239","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:24.753603	2016-05-18 21:41:49.609204
3713	1	333	226	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"vemurafenib, dabrafenib, trametinib, dabrafenib + trametinib","Association":"response","Status":"FDA-approved","Evidence":"consensus","Source":"FDA","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"J Clin Oncol 2013;31 (suppl; abstr 9028)","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors + PI3K pathway inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"22389471, 21156289","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors + HSP90 inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"22351686","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors + CDK2/4 inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"22997239.0","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"preclinical","Association":"ERK inhibitors","Status":"preclinical","Evidence":"emerging","Source":"23614898, 22997239","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:24.817148	2016-05-18 21:41:49.625324
4259	19	179	300	\N	\N	3	\N	5	2016-05-18 21:28:05.653353	2016-05-18 21:28:05.653353
3710	1	330	226	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"vemurafenib, dabrafenib, trametinib, dabrafenib + trametinib","Association":"response","Status":"FDA-approved","Evidence":"consensus","Source":"FDA","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"J Clin Oncol 2013;31 (suppl; abstr 9028)","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors + PI3K pathway inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"22389471, 21156289","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors + HSP90 inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"22351686","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors + CDK2/4 inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"22997239.0","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"preclinical","Association":"ERK inhibitors","Status":"preclinical","Evidence":"emerging","Source":"23614898, 22997239","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:24.562915	2016-05-18 21:41:49.572615
3716	1	334	227	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"BRAF inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"23237741","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors","Association":"response","Status":"case report","Evidence":"emerging","Source":"23248257","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:25.109235	2016-05-18 21:41:49.666283
3717	1	326	227	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"BRAF inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"23237741","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors","Association":"response","Status":"case report","Evidence":"emerging","Source":"23248257","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:25.20963	2016-05-18 21:41:49.681798
3718	1	306	227	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"BRAF inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"23237741","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors","Association":"response","Status":"case report","Evidence":"emerging","Source":"23248257","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:25.28468	2016-05-18 21:41:49.691893
3719	1	46	227	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"BRAF inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"23237741","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors","Association":"response","Status":"case report","Evidence":"emerging","Source":"23248257","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:25.350583	2016-05-18 21:41:49.702995
3720	1	324	227	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"BRAF inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"23237741","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors","Association":"response","Status":"case report","Evidence":"emerging","Source":"23248257","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:25.459359	2016-05-18 21:41:49.715851
3721	1	305	227	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"BRAF inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"23237741","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors","Association":"response","Status":"case report","Evidence":"emerging","Source":"23248257","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:25.577438	2016-05-18 21:41:49.728587
3722	1	325	227	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"BRAF inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"23237741","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors","Association":"response","Status":"case report","Evidence":"emerging","Source":"23248257","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:25.678724	2016-05-18 21:41:49.737928
3723	1	318	227	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"BRAF inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"23237741","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors","Association":"response","Status":"case report","Evidence":"emerging","Source":"23248257","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:25.769285	2016-05-18 21:41:49.752284
3724	1	319	227	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"BRAF inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"23237741","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors","Association":"response","Status":"case report","Evidence":"emerging","Source":"23248257","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:25.83863	2016-05-18 21:41:49.764194
4260	19	2	300	\N	\N	3	\N	5	2016-05-18 21:28:05.705918	2016-05-18 21:28:05.705918
4261	19	347	300	\N	\N	3	\N	5	2016-05-18 21:28:05.816311	2016-05-18 21:28:05.816311
4262	19	184	300	\N	\N	3	\N	5	2016-05-18 21:28:05.872132	2016-05-18 21:28:05.872132
4263	19	364	300	\N	\N	3	\N	5	2016-05-18 21:28:05.917662	2016-05-18 21:28:05.917662
4264	19	350	300	\N	\N	3	\N	5	2016-05-18 21:28:05.973867	2016-05-18 21:28:05.973867
3714	1	36	227	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"BRAF inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"23237741","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors","Association":"response","Status":"case report","Evidence":"emerging","Source":"23248257","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:24.941939	2016-05-18 21:41:49.642698
3715	1	317	227	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"BRAF inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"23237741","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors","Association":"response","Status":"case report","Evidence":"emerging","Source":"23248257","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:25.045634	2016-05-18 21:41:49.654441
3727	1	322	227	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"BRAF inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"23237741","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors","Association":"response","Status":"case report","Evidence":"emerging","Source":"23248257","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:26.075731	2016-05-18 21:41:49.80211
3728	1	316	227	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"BRAF inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"23237741","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors","Association":"response","Status":"case report","Evidence":"emerging","Source":"23248257","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:26.138378	2016-05-18 21:41:49.813594
3729	1	36	228	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"trametinib, dabrafenib + trametinib","Association":"response","Status":"FDA-approved","Evidence":"consensus","Source":"FDA","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"vemurafenib","Association":"response","Status":"late trials","Evidence":"emerging","Source":"22356324","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:26.221598	2016-05-18 21:41:49.826791
3730	1	317	228	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"trametinib, dabrafenib + trametinib","Association":"response","Status":"FDA-approved","Evidence":"consensus","Source":"FDA","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"vemurafenib","Association":"response","Status":"late trials","Evidence":"emerging","Source":"22356324","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:26.28693	2016-05-18 21:41:49.839397
3731	1	327	228	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"trametinib, dabrafenib + trametinib","Association":"response","Status":"FDA-approved","Evidence":"consensus","Source":"FDA","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"vemurafenib","Association":"response","Status":"late trials","Evidence":"emerging","Source":"22356324","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:26.355357	2016-05-18 21:41:49.856743
3732	1	323	228	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"trametinib, dabrafenib + trametinib","Association":"response","Status":"FDA-approved","Evidence":"consensus","Source":"FDA","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"vemurafenib","Association":"response","Status":"late trials","Evidence":"emerging","Source":"22356324","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:26.426243	2016-05-18 21:41:49.869685
3733	1	46	228	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"trametinib, dabrafenib + trametinib","Association":"response","Status":"FDA-approved","Evidence":"consensus","Source":"FDA","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"vemurafenib","Association":"response","Status":"late trials","Evidence":"emerging","Source":"22356324","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:26.491387	2016-05-18 21:41:49.882931
3734	1	305	228	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"trametinib, dabrafenib + trametinib","Association":"response","Status":"FDA-approved","Evidence":"consensus","Source":"FDA","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"vemurafenib","Association":"response","Status":"late trials","Evidence":"emerging","Source":"22356324","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:26.575211	2016-05-18 21:41:49.897971
3735	1	325	228	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"trametinib, dabrafenib + trametinib","Association":"response","Status":"FDA-approved","Evidence":"consensus","Source":"FDA","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"vemurafenib","Association":"response","Status":"late trials","Evidence":"emerging","Source":"22356324","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:26.65499	2016-05-18 21:41:49.91233
4265	19	365	300	\N	\N	3	\N	5	2016-05-18 21:28:06.033394	2016-05-18 21:28:06.033394
4266	19	3	300	\N	\N	3	\N	5	2016-05-18 21:28:06.082505	2016-05-18 21:28:06.082505
4267	19	173	328	\N	\N	3	\N	5	2016-05-18 21:28:06.127949	2016-05-18 21:28:06.127949
4268	19	193	328	\N	\N	3	\N	5	2016-05-18 21:28:06.192474	2016-05-18 21:28:06.192474
3725	1	320	227	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"BRAF inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"23237741","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors","Association":"response","Status":"case report","Evidence":"emerging","Source":"23248257","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:25.921504	2016-05-18 21:41:49.77777
3726	1	321	227	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"BRAF inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"23237741","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors","Association":"response","Status":"case report","Evidence":"emerging","Source":"23248257","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:25.983759	2016-05-18 21:41:49.789598
3738	1	319	228	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"trametinib, dabrafenib + trametinib","Association":"response","Status":"FDA-approved","Evidence":"consensus","Source":"FDA","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"vemurafenib","Association":"response","Status":"late trials","Evidence":"emerging","Source":"22356324","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:26.88157	2016-05-18 21:41:49.950302
3739	1	320	228	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"trametinib, dabrafenib + trametinib","Association":"response","Status":"FDA-approved","Evidence":"consensus","Source":"FDA","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"vemurafenib","Association":"response","Status":"late trials","Evidence":"emerging","Source":"22356324","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:26.957053	2016-05-18 21:41:49.968548
3740	1	322	228	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"trametinib, dabrafenib + trametinib","Association":"response","Status":"FDA-approved","Evidence":"consensus","Source":"FDA","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"vemurafenib","Association":"response","Status":"late trials","Evidence":"emerging","Source":"22356324","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:27.039137	2016-05-18 21:41:49.979381
3741	1	321	228	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"trametinib, dabrafenib + trametinib","Association":"response","Status":"FDA-approved","Evidence":"consensus","Source":"FDA","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"vemurafenib","Association":"response","Status":"late trials","Evidence":"emerging","Source":"22356324","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:27.125129	2016-05-18 21:41:49.989261
3742	1	255	229	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"trametinib, MEK inhibitors","Association":"response","Status":"case report","Evidence":"emerging","Source":"22805292, 22798288","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors","Association":"response","Status":"case report","Evidence":"emerging","Source":"23715574","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:27.207476	2016-05-18 21:41:50.017077
3743	1	386	229	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"trametinib, MEK inhibitors","Association":"response","Status":"case report","Evidence":"emerging","Source":"22805292, 22798288","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors","Association":"response","Status":"case report","Evidence":"emerging","Source":"23715574","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:27.292565	2016-05-18 21:41:50.031563
3744	1	36	229	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"trametinib, MEK inhibitors","Association":"response","Status":"case report","Evidence":"emerging","Source":"22805292, 22798288","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors","Association":"response","Status":"case report","Evidence":"emerging","Source":"23715574","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:27.369938	2016-05-18 21:41:50.044979
3745	1	387	229	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"trametinib, MEK inhibitors","Association":"response","Status":"case report","Evidence":"emerging","Source":"22805292, 22798288","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors","Association":"response","Status":"case report","Evidence":"emerging","Source":"23715574","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:27.440308	2016-05-18 21:41:50.054742
3746	1	388	229	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"trametinib, MEK inhibitors","Association":"response","Status":"case report","Evidence":"emerging","Source":"22805292, 22798288","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors","Association":"response","Status":"case report","Evidence":"emerging","Source":"23715574","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:27.543286	2016-05-18 21:41:50.073208
4269	19	366	328	\N	\N	3	\N	5	2016-05-18 21:28:06.229292	2016-05-18 21:28:06.229292
4270	19	367	328	\N	\N	3	\N	5	2016-05-18 21:28:06.267945	2016-05-18 21:28:06.267945
3736	1	318	228	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"trametinib, dabrafenib + trametinib","Association":"response","Status":"FDA-approved","Evidence":"consensus","Source":"FDA","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"vemurafenib","Association":"response","Status":"late trials","Evidence":"emerging","Source":"22356324","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:26.720098	2016-05-18 21:41:49.926532
3737	1	306	228	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"trametinib, dabrafenib + trametinib","Association":"response","Status":"FDA-approved","Evidence":"consensus","Source":"FDA","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"vemurafenib","Association":"response","Status":"late trials","Evidence":"emerging","Source":"22356324","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:26.796153	2016-05-18 21:41:49.939137
3749	1	391	229	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"trametinib, MEK inhibitors","Association":"response","Status":"case report","Evidence":"emerging","Source":"22805292, 22798288","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors","Association":"response","Status":"case report","Evidence":"emerging","Source":"23715574","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:27.788171	2016-05-18 21:41:50.101853
3750	1	308	229	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"trametinib, MEK inhibitors","Association":"response","Status":"case report","Evidence":"emerging","Source":"22805292, 22798288","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors","Association":"response","Status":"case report","Evidence":"emerging","Source":"23715574","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:27.86183	2016-05-18 21:41:50.112117
3751	1	320	229	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"trametinib, MEK inhibitors","Association":"response","Status":"case report","Evidence":"emerging","Source":"22805292, 22798288","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors","Association":"response","Status":"case report","Evidence":"emerging","Source":"23715574","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:27.928885	2016-05-18 21:41:50.131762
3752	1	392	229	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"trametinib, MEK inhibitors","Association":"response","Status":"case report","Evidence":"emerging","Source":"22805292, 22798288","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors","Association":"response","Status":"case report","Evidence":"emerging","Source":"23715574","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:28.010229	2016-05-18 21:41:50.148898
3753	1	255	393	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"trametinib, MEK inhibitors","Association":"response","Status":"case report","Evidence":"emerging","Source":"22805292, 22798288","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors","Association":"response","Status":"case report","Evidence":"emerging","Source":"23715574","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:28.119021	2016-05-18 21:41:50.163439
3754	1	386	393	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"trametinib, MEK inhibitors","Association":"response","Status":"case report","Evidence":"emerging","Source":"22805292, 22798288","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors","Association":"response","Status":"case report","Evidence":"emerging","Source":"23715574","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:28.190237	2016-05-18 21:41:50.19375
3755	1	36	393	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"trametinib, MEK inhibitors","Association":"response","Status":"case report","Evidence":"emerging","Source":"22805292, 22798288","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors","Association":"response","Status":"case report","Evidence":"emerging","Source":"23715574","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:28.271193	2016-05-18 21:41:50.216322
3756	1	387	393	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"trametinib, MEK inhibitors","Association":"response","Status":"case report","Evidence":"emerging","Source":"22805292, 22798288","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors","Association":"response","Status":"case report","Evidence":"emerging","Source":"23715574","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:28.330033	2016-05-18 21:41:50.234847
3757	1	388	393	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"trametinib, MEK inhibitors","Association":"response","Status":"case report","Evidence":"emerging","Source":"22805292, 22798288","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors","Association":"response","Status":"case report","Evidence":"emerging","Source":"23715574","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:28.39042	2016-05-18 21:41:50.257564
4271	19	177	328	\N	\N	3	\N	5	2016-05-18 21:28:06.312457	2016-05-18 21:28:06.312457
4272	19	175	328	\N	\N	3	\N	5	2016-05-18 21:28:06.385482	2016-05-18 21:28:06.385482
3747	1	389	229	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"trametinib, MEK inhibitors","Association":"response","Status":"case report","Evidence":"emerging","Source":"22805292, 22798288","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors","Association":"response","Status":"case report","Evidence":"emerging","Source":"23715574","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:27.619566	2016-05-18 21:41:50.084758
3748	1	390	229	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"trametinib, MEK inhibitors","Association":"response","Status":"case report","Evidence":"emerging","Source":"22805292, 22798288","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors","Association":"response","Status":"case report","Evidence":"emerging","Source":"23715574","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:27.719647	2016-05-18 21:41:50.09409
3760	1	391	393	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"trametinib, MEK inhibitors","Association":"response","Status":"case report","Evidence":"emerging","Source":"22805292, 22798288","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors","Association":"response","Status":"case report","Evidence":"emerging","Source":"23715574","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:28.642855	2016-05-18 21:41:50.310916
3761	1	308	393	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"trametinib, MEK inhibitors","Association":"response","Status":"case report","Evidence":"emerging","Source":"22805292, 22798288","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors","Association":"response","Status":"case report","Evidence":"emerging","Source":"23715574","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:28.700961	2016-05-18 21:41:50.331859
3762	1	320	393	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"trametinib, MEK inhibitors","Association":"response","Status":"case report","Evidence":"emerging","Source":"22805292, 22798288","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors","Association":"response","Status":"case report","Evidence":"emerging","Source":"23715574","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:28.781632	2016-05-18 21:41:50.34749
3763	1	392	393	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"trametinib, MEK inhibitors","Association":"response","Status":"case report","Evidence":"emerging","Source":"22805292, 22798288","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors","Association":"response","Status":"case report","Evidence":"emerging","Source":"23715574","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:28.860679	2016-05-18 21:41:50.368333
3764	1	255	394	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"trametinib, MEK inhibitors","Association":"response","Status":"case report","Evidence":"emerging","Source":"22805292, 22798288","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors","Association":"response","Status":"case report","Evidence":"emerging","Source":"23715574","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:28.94925	2016-05-18 21:41:50.388607
3765	1	386	394	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"trametinib, MEK inhibitors","Association":"response","Status":"case report","Evidence":"emerging","Source":"22805292, 22798288","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors","Association":"response","Status":"case report","Evidence":"emerging","Source":"23715574","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:29.033966	2016-05-18 21:41:50.401406
3766	1	36	394	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"trametinib, MEK inhibitors","Association":"response","Status":"case report","Evidence":"emerging","Source":"22805292, 22798288","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors","Association":"response","Status":"case report","Evidence":"emerging","Source":"23715574","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:29.109245	2016-05-18 21:41:50.4127
3767	1	387	394	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"trametinib, MEK inhibitors","Association":"response","Status":"case report","Evidence":"emerging","Source":"22805292, 22798288","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors","Association":"response","Status":"case report","Evidence":"emerging","Source":"23715574","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:29.174548	2016-05-18 21:41:50.42489
3768	1	388	394	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"trametinib, MEK inhibitors","Association":"response","Status":"case report","Evidence":"emerging","Source":"22805292, 22798288","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors","Association":"response","Status":"case report","Evidence":"emerging","Source":"23715574","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:29.234943	2016-05-18 21:41:50.437966
4273	19	3	328	\N	\N	3	\N	5	2016-05-18 21:28:06.446551	2016-05-18 21:28:06.446551
4274	19	172	329	\N	\N	3	\N	5	2016-05-18 21:28:06.505445	2016-05-18 21:28:06.505445
3758	1	389	393	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"trametinib, MEK inhibitors","Association":"response","Status":"case report","Evidence":"emerging","Source":"22805292, 22798288","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors","Association":"response","Status":"case report","Evidence":"emerging","Source":"23715574","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:28.475305	2016-05-18 21:41:50.272692
3759	1	390	393	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"trametinib, MEK inhibitors","Association":"response","Status":"case report","Evidence":"emerging","Source":"22805292, 22798288","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors","Association":"response","Status":"case report","Evidence":"emerging","Source":"23715574","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:28.559012	2016-05-18 21:41:50.28934
3771	1	391	394	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"trametinib, MEK inhibitors","Association":"response","Status":"case report","Evidence":"emerging","Source":"22805292, 22798288","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors","Association":"response","Status":"case report","Evidence":"emerging","Source":"23715574","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:29.455992	2016-05-18 21:41:50.497338
3772	1	308	394	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"trametinib, MEK inhibitors","Association":"response","Status":"case report","Evidence":"emerging","Source":"22805292, 22798288","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors","Association":"response","Status":"case report","Evidence":"emerging","Source":"23715574","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:29.52177	2016-05-18 21:41:50.519835
3773	1	320	394	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"trametinib, MEK inhibitors","Association":"response","Status":"case report","Evidence":"emerging","Source":"22805292, 22798288","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors","Association":"response","Status":"case report","Evidence":"emerging","Source":"23715574","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:29.599856	2016-05-18 21:41:50.531746
3774	1	392	394	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"trametinib, MEK inhibitors","Association":"response","Status":"case report","Evidence":"emerging","Source":"22805292, 22798288","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors","Association":"response","Status":"case report","Evidence":"emerging","Source":"23715574","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:29.663536	2016-05-18 21:41:50.542595
3775	1	255	395	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"trametinib, MEK inhibitors","Association":"response","Status":"case report","Evidence":"emerging","Source":"22805292, 22798288","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors","Association":"response","Status":"case report","Evidence":"emerging","Source":"23715574","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:29.7736	2016-05-18 21:41:50.555782
3776	1	386	395	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"trametinib, MEK inhibitors","Association":"response","Status":"case report","Evidence":"emerging","Source":"22805292, 22798288","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors","Association":"response","Status":"case report","Evidence":"emerging","Source":"23715574","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:29.832092	2016-05-18 21:41:50.572453
3777	1	36	395	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"trametinib, MEK inhibitors","Association":"response","Status":"case report","Evidence":"emerging","Source":"22805292, 22798288","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors","Association":"response","Status":"case report","Evidence":"emerging","Source":"23715574","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:29.886709	2016-05-18 21:41:50.58445
3778	1	387	395	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"trametinib, MEK inhibitors","Association":"response","Status":"case report","Evidence":"emerging","Source":"22805292, 22798288","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors","Association":"response","Status":"case report","Evidence":"emerging","Source":"23715574","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:29.960474	2016-05-18 21:41:50.597107
3779	1	388	395	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"trametinib, MEK inhibitors","Association":"response","Status":"case report","Evidence":"emerging","Source":"22805292, 22798288","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors","Association":"response","Status":"case report","Evidence":"emerging","Source":"23715574","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:30.02779	2016-05-18 21:41:50.616066
4275	19	368	329	\N	\N	3	\N	5	2016-05-18 21:28:06.569171	2016-05-18 21:28:06.569171
4276	19	193	329	\N	\N	3	\N	5	2016-05-18 21:28:06.622223	2016-05-18 21:28:06.622223
3769	1	389	394	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"trametinib, MEK inhibitors","Association":"response","Status":"case report","Evidence":"emerging","Source":"22805292, 22798288","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors","Association":"response","Status":"case report","Evidence":"emerging","Source":"23715574","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:29.307528	2016-05-18 21:41:50.449607
3770	1	390	394	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"trametinib, MEK inhibitors","Association":"response","Status":"case report","Evidence":"emerging","Source":"22805292, 22798288","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors","Association":"response","Status":"case report","Evidence":"emerging","Source":"23715574","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:29.370422	2016-05-18 21:41:50.478368
3782	1	391	395	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"trametinib, MEK inhibitors","Association":"response","Status":"case report","Evidence":"emerging","Source":"22805292, 22798288","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors","Association":"response","Status":"case report","Evidence":"emerging","Source":"23715574","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:30.250267	2016-05-18 21:41:50.664159
3783	1	308	395	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"trametinib, MEK inhibitors","Association":"response","Status":"case report","Evidence":"emerging","Source":"22805292, 22798288","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors","Association":"response","Status":"case report","Evidence":"emerging","Source":"23715574","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:30.330086	2016-05-18 21:41:50.675208
3784	1	320	395	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"trametinib, MEK inhibitors","Association":"response","Status":"case report","Evidence":"emerging","Source":"22805292, 22798288","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors","Association":"response","Status":"case report","Evidence":"emerging","Source":"23715574","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:30.39036	2016-05-18 21:41:50.68986
3785	1	392	395	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"trametinib, MEK inhibitors","Association":"response","Status":"case report","Evidence":"emerging","Source":"22805292, 22798288","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors","Association":"response","Status":"case report","Evidence":"emerging","Source":"23715574","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:30.469737	2016-05-18 21:41:50.69905
2914	1	36	232	\N	\N	3	{"My Cancer Genome":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"sorafenib","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"18794803","Effect":"gain-of-function (low activity)","Pathway":"activation"}]}]}}	1	2016-05-18 21:26:40.825547	2016-05-18 21:41:50.706429
3787	1	393	232	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"sorafenib","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"18794803","Effect":"gain-of-function (low activity)","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:30.649697	2016-05-18 21:41:50.724901
3788	1	393	239	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"sorafenib","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"18794803","Effect":"gain-of-function (low activity)","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:30.727234	2016-05-18 21:41:50.734809
3789	1	394	396	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"lapatinib","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"19718025","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:30.819223	2016-05-18 21:41:50.744144
3790	1	394	397	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"lapatinib","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"19718025","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:30.907664	2016-05-18 21:41:50.75537
3791	1	394	398	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"lapatinib","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"19718025","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:30.99186	2016-05-18 21:41:50.765741
4277	19	175	329	\N	\N	3	\N	5	2016-05-18 21:28:06.69378	2016-05-18 21:28:06.69378
4278	19	177	329	\N	\N	3	\N	5	2016-05-18 21:28:06.737868	2016-05-18 21:28:06.737868
3780	1	389	395	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"trametinib, MEK inhibitors","Association":"response","Status":"case report","Evidence":"emerging","Source":"22805292, 22798288","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors","Association":"response","Status":"case report","Evidence":"emerging","Source":"23715574","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:30.109917	2016-05-18 21:41:50.641616
3781	1	390	395	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"trametinib, MEK inhibitors","Association":"response","Status":"case report","Evidence":"emerging","Source":"22805292, 22798288","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors","Association":"response","Status":"case report","Evidence":"emerging","Source":"23715574","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:30.188932	2016-05-18 21:41:50.653826
3786	1	317	232	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"sorafenib","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"18794803","Effect":"gain-of-function (low activity)","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:30.590584	2016-05-18 21:41:50.716947
3794	1	394	401	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"lapatinib","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"19718025","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:31.265436	2016-05-18 21:41:50.801882
3795	1	395	99	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"selumetinib","Association":"response","Status":"early trials","Evidence":"emerging","Source":"J Clin Oncol 2013;31: (suppl; abstr CRA9003)","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"PI3K pathway inhibitors + MEK inhibitors","Association":"response","Status":"preclinical","Evidence":"emerging","Source":"22733540, 22808163","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:31.32711	2016-05-18 21:41:50.814188
3796	1	396	99	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"selumetinib","Association":"response","Status":"early trials","Evidence":"emerging","Source":"J Clin Oncol 2013;31: (suppl; abstr CRA9003)","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"PI3K pathway inhibitors + MEK inhibitors","Association":"response","Status":"preclinical","Evidence":"emerging","Source":"22733540, 22808163","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:31.40599	2016-05-18 21:41:50.836827
3797	1	397	99	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"selumetinib","Association":"response","Status":"early trials","Evidence":"emerging","Source":"J Clin Oncol 2013;31: (suppl; abstr CRA9003)","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"PI3K pathway inhibitors + MEK inhibitors","Association":"response","Status":"preclinical","Evidence":"emerging","Source":"22733540, 22808163","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:31.467474	2016-05-18 21:41:50.858083
3798	1	398	99	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"selumetinib","Association":"response","Status":"early trials","Evidence":"emerging","Source":"J Clin Oncol 2013;31: (suppl; abstr CRA9003)","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"PI3K pathway inhibitors + MEK inhibitors","Association":"response","Status":"preclinical","Evidence":"emerging","Source":"22733540, 22808163","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:31.549597	2016-05-18 21:41:50.876811
3799	1	399	99	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"selumetinib","Association":"response","Status":"early trials","Evidence":"emerging","Source":"J Clin Oncol 2013;31: (suppl; abstr CRA9003)","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"PI3K pathway inhibitors + MEK inhibitors","Association":"response","Status":"preclinical","Evidence":"emerging","Source":"22733540, 22808163","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:31.637899	2016-05-18 21:41:50.89348
3800	1	395	100	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"selumetinib","Association":"response","Status":"early trials","Evidence":"emerging","Source":"J Clin Oncol 2013;31: (suppl; abstr CRA9003)","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"PI3K pathway inhibitors + MEK inhibitors","Association":"response","Status":"preclinical","Evidence":"emerging","Source":"22733540, 22808163","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:31.699867	2016-05-18 21:41:50.910929
3801	1	396	100	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"selumetinib","Association":"response","Status":"early trials","Evidence":"emerging","Source":"J Clin Oncol 2013;31: (suppl; abstr CRA9003)","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"PI3K pathway inhibitors + MEK inhibitors","Association":"response","Status":"preclinical","Evidence":"emerging","Source":"22733540, 22808163","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:31.782949	2016-05-18 21:41:50.922547
3802	1	397	100	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"selumetinib","Association":"response","Status":"early trials","Evidence":"emerging","Source":"J Clin Oncol 2013;31: (suppl; abstr CRA9003)","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"PI3K pathway inhibitors + MEK inhibitors","Association":"response","Status":"preclinical","Evidence":"emerging","Source":"22733540, 22808163","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:31.861061	2016-05-18 21:41:50.934346
4279	19	184	329	\N	\N	3	\N	5	2016-05-18 21:28:06.777335	2016-05-18 21:28:06.777335
4280	19	3	329	\N	\N	3	\N	5	2016-05-18 21:28:06.84451	2016-05-18 21:28:06.84451
4281	19	172	489	\N	\N	3	\N	5	2016-05-18 21:28:06.909117	2016-05-18 21:28:06.909117
4282	19	359	489	\N	\N	3	\N	5	2016-05-18 21:28:06.949512	2016-05-18 21:28:06.949512
4283	19	188	489	\N	\N	3	\N	5	2016-05-18 21:28:07.020307	2016-05-18 21:28:07.020307
3792	1	394	399	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"lapatinib","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"19718025","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:31.086949	2016-05-18 21:41:50.775429
3793	1	394	400	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"lapatinib","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"19718025","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:31.180404	2016-05-18 21:41:50.788622
3806	1	401	252	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"selumetinib","Association":"response","Status":"early trials","Evidence":"emerging","Source":"J Clin Oncol 2013;31: (suppl; abstr CRA9003)","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"PI3K pathway inhibitors + MEK inhibitors","Association":"response","Status":"preclinical","Evidence":"emerging","Source":"22733540, 22808163","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"PKC inhibitor","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"22653968, 22253748","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:32.130717	2016-05-18 21:41:51.021977
3807	1	395	252	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"selumetinib","Association":"response","Status":"early trials","Evidence":"emerging","Source":"J Clin Oncol 2013;31: (suppl; abstr CRA9003)","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"PI3K pathway inhibitors + MEK inhibitors","Association":"response","Status":"preclinical","Evidence":"emerging","Source":"22733540, 22808163","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"PKC inhibitor","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"22653968, 22253748","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:32.20681	2016-05-18 21:41:51.04143
3808	1	397	252	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"selumetinib","Association":"response","Status":"early trials","Evidence":"emerging","Source":"J Clin Oncol 2013;31: (suppl; abstr CRA9003)","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"PI3K pathway inhibitors + MEK inhibitors","Association":"response","Status":"preclinical","Evidence":"emerging","Source":"22733540, 22808163","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"PKC inhibitor","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"22653968, 22253748","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:32.27133	2016-05-18 21:41:51.095167
3809	1	396	252	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"selumetinib","Association":"response","Status":"early trials","Evidence":"emerging","Source":"J Clin Oncol 2013;31: (suppl; abstr CRA9003)","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"PI3K pathway inhibitors + MEK inhibitors","Association":"response","Status":"preclinical","Evidence":"emerging","Source":"22733540, 22808163","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"PKC inhibitor","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"22653968, 22253748","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:32.362483	2016-05-18 21:41:51.115008
3810	1	398	252	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"selumetinib","Association":"response","Status":"early trials","Evidence":"emerging","Source":"J Clin Oncol 2013;31: (suppl; abstr CRA9003)","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"PI3K pathway inhibitors + MEK inhibitors","Association":"response","Status":"preclinical","Evidence":"emerging","Source":"22733540, 22808163","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"PKC inhibitor","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"22653968, 22253748","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:32.448845	2016-05-18 21:41:51.130921
3837	1	407	402	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"vemurafenib","Association":"resistance","Status":"case report","Evidence":"emerging","Source":"23569304","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:34.481402	2016-05-18 21:41:51.143767
4284	19	177	489	\N	\N	3	\N	5	2016-05-18 21:28:07.073522	2016-05-18 21:28:07.073522
4285	19	184	489	\N	\N	3	\N	5	2016-05-18 21:28:07.122949	2016-05-18 21:28:07.122949
4286	19	179	489	\N	\N	3	\N	5	2016-05-18 21:28:07.18815	2016-05-18 21:28:07.18815
3803	1	398	100	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"selumetinib","Association":"response","Status":"early trials","Evidence":"emerging","Source":"J Clin Oncol 2013;31: (suppl; abstr CRA9003)","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"PI3K pathway inhibitors + MEK inhibitors","Association":"response","Status":"preclinical","Evidence":"emerging","Source":"22733540, 22808163","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:31.92254	2016-05-18 21:41:50.955715
3804	1	399	100	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"selumetinib","Association":"response","Status":"early trials","Evidence":"emerging","Source":"J Clin Oncol 2013;31: (suppl; abstr CRA9003)","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"PI3K pathway inhibitors + MEK inhibitors","Association":"response","Status":"preclinical","Evidence":"emerging","Source":"22733540, 22808163","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:31.987327	2016-05-18 21:41:50.975998
3813	1	403	252	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"selumetinib","Association":"response","Status":"early trials","Evidence":"emerging","Source":"J Clin Oncol 2013;31: (suppl; abstr CRA9003)","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"PI3K pathway inhibitors + MEK inhibitors","Association":"response","Status":"preclinical","Evidence":"emerging","Source":"22733540, 22808163","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"PKC inhibitor","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"22653968, 22253748","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:32.668958	2016-05-18 21:41:51.18207
3814	1	400	253	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"selumetinib","Association":"response","Status":"early trials","Evidence":"emerging","Source":"J Clin Oncol 2013;31: (suppl; abstr CRA9003)","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"PI3K pathway inhibitors + MEK inhibitors","Association":"response","Status":"preclinical","Evidence":"emerging","Source":"22733540, 22808163","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"PKC inhibitor","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"22653968, 22253748","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:32.725111	2016-05-18 21:41:51.211473
3815	1	401	253	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"selumetinib","Association":"response","Status":"early trials","Evidence":"emerging","Source":"J Clin Oncol 2013;31: (suppl; abstr CRA9003)","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"PI3K pathway inhibitors + MEK inhibitors","Association":"response","Status":"preclinical","Evidence":"emerging","Source":"22733540, 22808163","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"PKC inhibitor","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"22653968, 22253748","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:32.807016	2016-05-18 21:41:51.238447
3816	1	395	253	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"selumetinib","Association":"response","Status":"early trials","Evidence":"emerging","Source":"J Clin Oncol 2013;31: (suppl; abstr CRA9003)","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"PI3K pathway inhibitors + MEK inhibitors","Association":"response","Status":"preclinical","Evidence":"emerging","Source":"22733540, 22808163","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"PKC inhibitor","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"22653968, 22253748","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:32.890608	2016-05-18 21:41:51.268452
3817	1	397	253	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"selumetinib","Association":"response","Status":"early trials","Evidence":"emerging","Source":"J Clin Oncol 2013;31: (suppl; abstr CRA9003)","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"PI3K pathway inhibitors + MEK inhibitors","Association":"response","Status":"preclinical","Evidence":"emerging","Source":"22733540, 22808163","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"PKC inhibitor","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"22653968, 22253748","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:32.951149	2016-05-18 21:41:51.297493
3818	1	396	253	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"selumetinib","Association":"response","Status":"early trials","Evidence":"emerging","Source":"J Clin Oncol 2013;31: (suppl; abstr CRA9003)","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"PI3K pathway inhibitors + MEK inhibitors","Association":"response","Status":"preclinical","Evidence":"emerging","Source":"22733540, 22808163","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"PKC inhibitor","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"22653968, 22253748","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:33.029669	2016-05-18 21:41:51.325529
4287	19	364	489	\N	\N	3	\N	5	2016-05-18 21:28:07.234529	2016-05-18 21:28:07.234529
4288	19	191	489	\N	\N	3	\N	5	2016-05-18 21:28:07.27543	2016-05-18 21:28:07.27543
4289	19	369	489	\N	\N	3	\N	5	2016-05-18 21:28:07.324149	2016-05-18 21:28:07.324149
4290	19	370	489	\N	\N	3	\N	5	2016-05-18 21:28:07.364436	2016-05-18 21:28:07.364436
3812	1	402	252	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"selumetinib","Association":"response","Status":"early trials","Evidence":"emerging","Source":"J Clin Oncol 2013;31: (suppl; abstr CRA9003)","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"PI3K pathway inhibitors + MEK inhibitors","Association":"response","Status":"preclinical","Evidence":"emerging","Source":"22733540, 22808163","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"PKC inhibitor","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"22653968, 22253748","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:32.587896	2016-05-18 21:41:51.169619
3821	1	402	253	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"selumetinib","Association":"response","Status":"early trials","Evidence":"emerging","Source":"J Clin Oncol 2013;31: (suppl; abstr CRA9003)","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"PI3K pathway inhibitors + MEK inhibitors","Association":"response","Status":"preclinical","Evidence":"emerging","Source":"22733540, 22808163","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"PKC inhibitor","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"22653968, 22253748","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:33.243607	2016-05-18 21:41:51.401928
3822	1	403	253	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"selumetinib","Association":"response","Status":"early trials","Evidence":"emerging","Source":"J Clin Oncol 2013;31: (suppl; abstr CRA9003)","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"PI3K pathway inhibitors + MEK inhibitors","Association":"response","Status":"preclinical","Evidence":"emerging","Source":"22733540, 22808163","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"PKC inhibitor","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"22653968, 22253748","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:33.326626	2016-05-18 21:41:51.417142
3823	1	400	254	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"selumetinib","Association":"response","Status":"early trials","Evidence":"emerging","Source":"J Clin Oncol 2013;31: (suppl; abstr CRA9003)","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"PI3K pathway inhibitors + MEK inhibitors","Association":"response","Status":"preclinical","Evidence":"emerging","Source":"22733540, 22808163","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"PKC inhibitor","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"22653968, 22253748","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:33.405439	2016-05-18 21:41:51.436197
3824	1	401	254	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"selumetinib","Association":"response","Status":"early trials","Evidence":"emerging","Source":"J Clin Oncol 2013;31: (suppl; abstr CRA9003)","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"PI3K pathway inhibitors + MEK inhibitors","Association":"response","Status":"preclinical","Evidence":"emerging","Source":"22733540, 22808163","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"PKC inhibitor","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"22653968, 22253748","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:33.464602	2016-05-18 21:41:51.450112
3825	1	395	254	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"selumetinib","Association":"response","Status":"early trials","Evidence":"emerging","Source":"J Clin Oncol 2013;31: (suppl; abstr CRA9003)","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"PI3K pathway inhibitors + MEK inhibitors","Association":"response","Status":"preclinical","Evidence":"emerging","Source":"22733540, 22808163","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"PKC inhibitor","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"22653968, 22253748","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:33.548151	2016-05-18 21:41:51.464582
3826	1	397	254	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"selumetinib","Association":"response","Status":"early trials","Evidence":"emerging","Source":"J Clin Oncol 2013;31: (suppl; abstr CRA9003)","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"PI3K pathway inhibitors + MEK inhibitors","Association":"response","Status":"preclinical","Evidence":"emerging","Source":"22733540, 22808163","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"PKC inhibitor","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"22653968, 22253748","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:33.627757	2016-05-18 21:41:51.487278
4291	19	371	489	\N	\N	3	\N	5	2016-05-18 21:28:07.401057	2016-05-18 21:28:07.401057
4292	19	372	489	\N	\N	3	\N	5	2016-05-18 21:28:07.438296	2016-05-18 21:28:07.438296
4293	19	342	489	\N	\N	3	\N	5	2016-05-18 21:28:07.476813	2016-05-18 21:28:07.476813
4294	19	373	489	\N	\N	3	\N	5	2016-05-18 21:28:07.521787	2016-05-18 21:28:07.521787
4295	19	3	489	\N	\N	3	\N	5	2016-05-18 21:28:07.563045	2016-05-18 21:28:07.563045
3820	1	399	253	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"selumetinib","Association":"response","Status":"early trials","Evidence":"emerging","Source":"J Clin Oncol 2013;31: (suppl; abstr CRA9003)","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"PI3K pathway inhibitors + MEK inhibitors","Association":"response","Status":"preclinical","Evidence":"emerging","Source":"22733540, 22808163","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"PKC inhibitor","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"22653968, 22253748","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:33.179223	2016-05-18 21:41:51.38466
3829	1	399	254	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"selumetinib","Association":"response","Status":"early trials","Evidence":"emerging","Source":"J Clin Oncol 2013;31: (suppl; abstr CRA9003)","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"PI3K pathway inhibitors + MEK inhibitors","Association":"response","Status":"preclinical","Evidence":"emerging","Source":"22733540, 22808163","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"PKC inhibitor","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"22653968, 22253748","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:33.862957	2016-05-18 21:41:51.55328
3830	1	402	254	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"selumetinib","Association":"response","Status":"early trials","Evidence":"emerging","Source":"J Clin Oncol 2013;31: (suppl; abstr CRA9003)","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"PI3K pathway inhibitors + MEK inhibitors","Association":"response","Status":"preclinical","Evidence":"emerging","Source":"22733540, 22808163","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"PKC inhibitor","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"22653968, 22253748","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:33.95011	2016-05-18 21:41:51.563086
3831	1	403	254	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"selumetinib","Association":"response","Status":"early trials","Evidence":"emerging","Source":"J Clin Oncol 2013;31: (suppl; abstr CRA9003)","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"PI3K pathway inhibitors + MEK inhibitors","Association":"response","Status":"preclinical","Evidence":"emerging","Source":"22733540, 22808163","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"PKC inhibitor","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"22653968, 22253748","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:34.016235	2016-05-18 21:41:51.579562
3832	1	404	202	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"imatinib","Association":"response","Status":"case report","Evidence":"emerging","Source":"23775962","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:34.10876	2016-05-18 21:41:51.592527
3834	1	406	202	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"imatinib","Association":"response","Status":"case report","Evidence":"emerging","Source":"23775962","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:34.238702	2016-05-18 21:41:51.616014
3835	1	407	66	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"vemurafenib","Association":"resistance","Status":"case report","Evidence":"emerging","Source":"23569304","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors, MEK inhibitors","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"19915144","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:34.30406	2016-05-18 21:41:51.644402
3836	1	408	66	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"vemurafenib","Association":"resistance","Status":"case report","Evidence":"emerging","Source":"23569304","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors, MEK inhibitors","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"19915144","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:34.386733	2016-05-18 21:41:51.656574
4296	19	172	490	\N	\N	3	\N	5	2016-05-18 21:28:07.619378	2016-05-18 21:28:07.619378
4297	19	177	490	\N	\N	3	\N	5	2016-05-18 21:28:07.670512	2016-05-18 21:28:07.670512
4298	19	179	490	\N	\N	3	\N	5	2016-05-18 21:28:07.714041	2016-05-18 21:28:07.714041
4299	19	344	490	\N	\N	3	\N	5	2016-05-18 21:28:07.762761	2016-05-18 21:28:07.762761
3828	1	398	254	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"selumetinib","Association":"response","Status":"early trials","Evidence":"emerging","Source":"J Clin Oncol 2013;31: (suppl; abstr CRA9003)","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"PI3K pathway inhibitors + MEK inhibitors","Association":"response","Status":"preclinical","Evidence":"emerging","Source":"22733540, 22808163","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"PKC inhibitor","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"22653968, 22253748","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:33.778243	2016-05-18 21:41:51.537732
3833	1	405	202	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"imatinib","Association":"response","Status":"case report","Evidence":"emerging","Source":"23775962","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:34.183387	2016-05-18 21:41:51.608304
3840	1	410	69	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"BRAF inhibitors in BRAF mutant tumor","Association":"sensitivity","Status":"case report","Evidence":"emerging","Source":"22588879","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:34.686901	2016-05-18 21:41:51.690613
3841	1	411	69	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"BRAF inhibitors in BRAF mutant tumor","Association":"sensitivity","Status":"case report","Evidence":"emerging","Source":"22588879","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:34.754265	2016-05-18 21:41:51.703103
3842	1	410	70	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"BRAF inhibitors, MEK inhibitors","Association":"resistance","Status":"case report","Evidence":"emerging","Source":"21383288","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"novel MEK inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"24448821","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:34.80794	2016-05-18 21:41:51.710436
3843	1	412	70	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"BRAF inhibitors, MEK inhibitors","Association":"resistance","Status":"case report","Evidence":"emerging","Source":"21383288","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"novel MEK inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"24448821","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:34.877799	2016-05-18 21:41:51.721883
3844	1	411	70	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"BRAF inhibitors, MEK inhibitors","Association":"resistance","Status":"case report","Evidence":"emerging","Source":"21383288","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"novel MEK inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"24448821","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:34.971109	2016-05-18 21:41:51.734129
3845	1	413	70	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"BRAF inhibitors, MEK inhibitors","Association":"resistance","Status":"case report","Evidence":"emerging","Source":"21383288","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"novel MEK inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"24448821","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:35.062717	2016-05-18 21:41:51.745325
3846	1	410	71	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"BRAF inhibitors in BRAF mutant tumor","Association":"sensitivity","Status":"case report","Evidence":"emerging","Source":"22588879","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:35.122313	2016-05-18 21:41:51.756922
3847	1	411	71	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"BRAF inhibitors in BRAF mutant tumor","Association":"sensitivity","Status":"case report","Evidence":"emerging","Source":"22588879","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:35.195209	2016-05-18 21:41:51.769746
3848	1	410	72	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"BRAF inhibitors, MEK inhibitors","Association":"resistance","Status":"case report","Evidence":"emerging","Source":"19915144","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:35.36968	2016-05-18 21:41:51.779847
3849	1	408	72	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"BRAF inhibitors, MEK inhibitors","Association":"resistance","Status":"case report","Evidence":"emerging","Source":"19915144","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:35.416219	2016-05-18 21:41:51.794543
3850	1	414	72	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"BRAF inhibitors, MEK inhibitors","Association":"resistance","Status":"case report","Evidence":"emerging","Source":"19915144","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:35.479772	2016-05-18 21:41:51.802194
4300	19	374	490	\N	\N	3	\N	5	2016-05-18 21:28:07.801613	2016-05-18 21:28:07.801613
4301	19	375	490	\N	\N	3	\N	5	2016-05-18 21:28:07.842425	2016-05-18 21:28:07.842425
4302	19	372	490	\N	\N	3	\N	5	2016-05-18 21:28:07.890595	2016-05-18 21:28:07.890595
4303	19	3	490	\N	\N	3	\N	5	2016-05-18 21:28:07.927144	2016-05-18 21:28:07.927144
3838	1	409	403	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"MEK inhibitors","Association":"resistance","Status":"case report","Evidence":"emerging","Source":"23444215","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:34.559711	2016-05-18 21:41:51.668139
3839	1	409	67	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"MEK inhibitors","Association":"resistance","Status":"case report","Evidence":"emerging","Source":"23444215","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:34.63393	2016-05-18 21:41:51.675729
3853	1	333	405	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"MEK inhibitors","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"19915144","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"ERK inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23614898","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:35.712381	2016-05-18 21:41:51.835177
3854	1	410	73	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"vemurafenib","Association":"resistance","Status":"case report","Evidence":"emerging","Source":"23569304","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors, MEK inhibitors","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"19915144","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:35.787234	2016-05-18 21:41:51.847935
3855	1	407	73	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"vemurafenib","Association":"resistance","Status":"case report","Evidence":"emerging","Source":"23569304","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors, MEK inhibitors","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"19915144","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:35.84453	2016-05-18 21:41:51.863608
3856	1	408	73	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"vemurafenib","Association":"resistance","Status":"case report","Evidence":"emerging","Source":"23569304","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors, MEK inhibitors","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"19915144","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:35.923655	2016-05-18 21:41:51.87537
3857	1	415	406	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"BRAF inhibitors, MEK inhibitors","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"24265153","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"ERK inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"24265153","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:36.029134	2016-05-18 21:41:51.888892
3858	1	415	407	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"BRAF inhibitors, MEK inhibitors","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"24265153","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"ERK inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"24265153","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:36.127188	2016-05-18 21:41:51.909558
3859	1	416	408	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"BRAF + MEK inhibitors","Association":"resistance","Status":"case report","Evidence":"emerging","Source":"24265154","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"ERK inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"24265154","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:36.211681	2016-05-18 21:41:51.920275
3860	1	415	409	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"BRAF inhibitors, MEK inhibitors","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"24265153","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"ERK inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"24265153","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:36.298273	2016-05-18 21:41:51.93273
3861	1	415	410	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"BRAF inhibitors, MEK inhibitors","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"24265153","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"ERK inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"24265153","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:36.39501	2016-05-18 21:41:51.95677
4304	19	172	491	\N	\N	3	\N	5	2016-05-18 21:28:07.97521	2016-05-18 21:28:07.97521
4305	19	177	491	\N	\N	3	\N	5	2016-05-18 21:28:08.015314	2016-05-18 21:28:08.015314
4306	19	173	491	\N	\N	3	\N	5	2016-05-18 21:28:08.064263	2016-05-18 21:28:08.064263
4307	19	175	491	\N	\N	3	\N	5	2016-05-18 21:28:08.108315	2016-05-18 21:28:08.108315
4308	19	188	491	\N	\N	3	\N	5	2016-05-18 21:28:08.153267	2016-05-18 21:28:08.153267
3851	1	408	404	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"MEK inhibitors","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"19915144","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:35.566164	2016-05-18 21:41:51.809805
3852	1	408	405	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"MEK inhibitors","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"19915144","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"ERK inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23614898","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:35.656648	2016-05-18 21:41:51.824244
3864	1	419	1	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"MEK inhibitors","Association":"response","Status":"late trials","Evidence":"emerging","Source":"23414587","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"18390968, 22761467","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors + CDK4/6 inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"ASCO 2014; abstr 9009","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"HSP90 inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23538902","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors","Association":"resistance","Status":"case report","Evidence":"emerging","Source":"23569304.0","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"preclinical","Association":"ERK inhibitors","Status":"preclinical","Evidence":"emerging","Source":"23614898","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:36.628993	2016-05-18 21:41:52.041048
3865	1	420	1	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"MEK inhibitors","Association":"response","Status":"late trials","Evidence":"emerging","Source":"23414587","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"18390968, 22761467","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors + CDK4/6 inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"ASCO 2014; abstr 9009","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"HSP90 inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23538902","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors","Association":"resistance","Status":"case report","Evidence":"emerging","Source":"23569304.0","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"preclinical","Association":"ERK inhibitors","Status":"preclinical","Evidence":"emerging","Source":"23614898","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:36.709139	2016-05-18 21:41:52.059073
3866	1	421	1	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"MEK inhibitors","Association":"response","Status":"late trials","Evidence":"emerging","Source":"23414587","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"18390968, 22761467","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors + CDK4/6 inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"ASCO 2014; abstr 9009","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"HSP90 inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23538902","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors","Association":"resistance","Status":"case report","Evidence":"emerging","Source":"23569304.0","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"preclinical","Association":"ERK inhibitors","Status":"preclinical","Evidence":"emerging","Source":"23614898","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:36.785322	2016-05-18 21:41:52.080933
3998	5	445	16	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"dasatinib + erlotinib","Association":"response","Status":"case report","Evidence":"emerging","Source":"22328973","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"dasatinib","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"22328973","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:47.750098	2016-05-18 21:41:52.094755
3863	1	418	1	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"MEK inhibitors","Association":"response","Status":"late trials","Evidence":"emerging","Source":"23414587","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"18390968, 22761467","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors + CDK4/6 inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"ASCO 2014; abstr 9009","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"HSP90 inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23538902","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors","Association":"resistance","Status":"case report","Evidence":"emerging","Source":"23569304.0","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"preclinical","Association":"ERK inhibitors","Status":"preclinical","Evidence":"emerging","Source":"23614898","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:36.544612	2016-05-18 21:41:52.009172
3869	1	424	1	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"MEK inhibitors","Association":"response","Status":"late trials","Evidence":"emerging","Source":"23414587","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"18390968, 22761467","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors + CDK4/6 inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"ASCO 2014; abstr 9009","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"HSP90 inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23538902","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors","Association":"resistance","Status":"case report","Evidence":"emerging","Source":"23569304.0","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"preclinical","Association":"ERK inhibitors","Status":"preclinical","Evidence":"emerging","Source":"23614898","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:37.035047	2016-05-18 21:41:52.149416
3870	1	425	1	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"MEK inhibitors","Association":"response","Status":"late trials","Evidence":"emerging","Source":"23414587","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"18390968, 22761467","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors + CDK4/6 inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"ASCO 2014; abstr 9009","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"HSP90 inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23538902","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors","Association":"resistance","Status":"case report","Evidence":"emerging","Source":"23569304.0","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"preclinical","Association":"ERK inhibitors","Status":"preclinical","Evidence":"emerging","Source":"23614898","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:37.111409	2016-05-18 21:41:52.189347
3871	1	407	1	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"MEK inhibitors","Association":"response","Status":"late trials","Evidence":"emerging","Source":"23414587","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"18390968, 22761467","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors + CDK4/6 inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"ASCO 2014; abstr 9009","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"HSP90 inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23538902","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors","Association":"resistance","Status":"case report","Evidence":"emerging","Source":"23569304.0","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"preclinical","Association":"ERK inhibitors","Status":"preclinical","Evidence":"emerging","Source":"23614898","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:37.195457	2016-05-18 21:41:52.209567
3999	5	273	16	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"dasatinib + erlotinib","Association":"response","Status":"case report","Evidence":"emerging","Source":"22328973","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"dasatinib","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"22328973","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:47.822278	2016-05-18 21:41:52.224294
3868	1	423	1	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"MEK inhibitors","Association":"response","Status":"late trials","Evidence":"emerging","Source":"23414587","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"18390968, 22761467","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors + CDK4/6 inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"ASCO 2014; abstr 9009","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"HSP90 inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23538902","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors","Association":"resistance","Status":"case report","Evidence":"emerging","Source":"23569304.0","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"preclinical","Association":"ERK inhibitors","Status":"preclinical","Evidence":"emerging","Source":"23614898","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:36.954256	2016-05-18 21:41:52.135069
3874	1	418	411	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"MEK inhibitors","Association":"response","Status":"late trials","Evidence":"emerging","Source":"23414587","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"18390968, 22761467","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors + CDK4/6 inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"ASCO 2014; abstr 9009","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"HSP90 inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23538902","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors","Association":"resistance","Status":"case report","Evidence":"emerging","Source":"23569304.0","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"preclinical","Association":"ERK inhibitors","Status":"preclinical","Evidence":"emerging","Source":"23614898","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:37.450668	2016-05-18 21:41:52.289367
3875	1	419	411	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"MEK inhibitors","Association":"response","Status":"late trials","Evidence":"emerging","Source":"23414587","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"18390968, 22761467","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors + CDK4/6 inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"ASCO 2014; abstr 9009","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"HSP90 inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23538902","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors","Association":"resistance","Status":"case report","Evidence":"emerging","Source":"23569304.0","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"preclinical","Association":"ERK inhibitors","Status":"preclinical","Evidence":"emerging","Source":"23614898","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:37.534155	2016-05-18 21:41:52.318822
3876	1	420	411	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"MEK inhibitors","Association":"response","Status":"late trials","Evidence":"emerging","Source":"23414587","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"18390968, 22761467","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors + CDK4/6 inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"ASCO 2014; abstr 9009","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"HSP90 inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23538902","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors","Association":"resistance","Status":"case report","Evidence":"emerging","Source":"23569304.0","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"preclinical","Association":"ERK inhibitors","Status":"preclinical","Evidence":"emerging","Source":"23614898","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:37.611943	2016-05-18 21:41:52.340398
4000	30	214	426	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"ERBB2 TKIs, trastuzumab","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"22908275","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:47.933717	2016-05-18 21:41:52.35338
4309	19	189	491	\N	\N	3	\N	5	2016-05-18 21:28:08.210403	2016-05-18 21:28:08.210403
4310	19	190	491	\N	\N	3	\N	5	2016-05-18 21:28:08.251555	2016-05-18 21:28:08.251555
3873	1	417	411	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"MEK inhibitors","Association":"response","Status":"late trials","Evidence":"emerging","Source":"23414587","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"18390968, 22761467","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors + CDK4/6 inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"ASCO 2014; abstr 9009","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"HSP90 inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23538902","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors","Association":"resistance","Status":"case report","Evidence":"emerging","Source":"23569304.0","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"preclinical","Association":"ERK inhibitors","Status":"preclinical","Evidence":"emerging","Source":"23614898","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:37.366658	2016-05-18 21:41:52.268183
3879	1	423	411	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"MEK inhibitors","Association":"response","Status":"late trials","Evidence":"emerging","Source":"23414587","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"18390968, 22761467","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors + CDK4/6 inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"ASCO 2014; abstr 9009","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"HSP90 inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23538902","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors","Association":"resistance","Status":"case report","Evidence":"emerging","Source":"23569304.0","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"preclinical","Association":"ERK inhibitors","Status":"preclinical","Evidence":"emerging","Source":"23614898","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:37.839479	2016-05-18 21:41:52.401838
3880	1	424	411	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"MEK inhibitors","Association":"response","Status":"late trials","Evidence":"emerging","Source":"23414587","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"18390968, 22761467","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors + CDK4/6 inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"ASCO 2014; abstr 9009","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"HSP90 inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23538902","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors","Association":"resistance","Status":"case report","Evidence":"emerging","Source":"23569304.0","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"preclinical","Association":"ERK inhibitors","Status":"preclinical","Evidence":"emerging","Source":"23614898","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:37.919118	2016-05-18 21:41:52.418942
3881	1	425	411	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"MEK inhibitors","Association":"response","Status":"late trials","Evidence":"emerging","Source":"23414587","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"18390968, 22761467","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors + CDK4/6 inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"ASCO 2014; abstr 9009","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"HSP90 inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23538902","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors","Association":"resistance","Status":"case report","Evidence":"emerging","Source":"23569304.0","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"preclinical","Association":"ERK inhibitors","Status":"preclinical","Evidence":"emerging","Source":"23614898","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:38.009534	2016-05-18 21:41:52.446555
4001	30	214	427	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"ERBB2 TKIs, trastuzumab","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"22908275","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:48.056076	2016-05-18 21:41:52.463578
4311	19	191	491	\N	\N	3	\N	5	2016-05-18 21:28:08.318758	2016-05-18 21:28:08.318758
4312	19	192	491	\N	\N	3	\N	5	2016-05-18 21:28:08.362076	2016-05-18 21:28:08.362076
3878	1	422	411	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"MEK inhibitors","Association":"response","Status":"late trials","Evidence":"emerging","Source":"23414587","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"18390968, 22761467","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors + CDK4/6 inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"ASCO 2014; abstr 9009","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"HSP90 inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23538902","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors","Association":"resistance","Status":"case report","Evidence":"emerging","Source":"23569304.0","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"preclinical","Association":"ERK inhibitors","Status":"preclinical","Evidence":"emerging","Source":"23614898","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:37.752428	2016-05-18 21:41:52.382132
3884	1	417	412	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"MEK inhibitors","Association":"response","Status":"late trials","Evidence":"emerging","Source":"23414587","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"18390968, 22761467","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors + CDK4/6 inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"ASCO 2014; abstr 9009","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"HSP90 inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23538902","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors","Association":"resistance","Status":"case report","Evidence":"emerging","Source":"23569304.0","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"preclinical","Association":"ERK inhibitors","Status":"preclinical","Evidence":"emerging","Source":"23614898","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:38.278183	2016-05-18 21:41:52.518071
3885	1	418	412	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"MEK inhibitors","Association":"response","Status":"late trials","Evidence":"emerging","Source":"23414587","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"18390968, 22761467","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors + CDK4/6 inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"ASCO 2014; abstr 9009","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"HSP90 inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23538902","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors","Association":"resistance","Status":"case report","Evidence":"emerging","Source":"23569304.0","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"preclinical","Association":"ERK inhibitors","Status":"preclinical","Evidence":"emerging","Source":"23614898","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:38.346405	2016-05-18 21:41:52.53682
3886	1	419	412	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"MEK inhibitors","Association":"response","Status":"late trials","Evidence":"emerging","Source":"23414587","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"18390968, 22761467","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors + CDK4/6 inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"ASCO 2014; abstr 9009","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"HSP90 inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23538902","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors","Association":"resistance","Status":"case report","Evidence":"emerging","Source":"23569304.0","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"preclinical","Association":"ERK inhibitors","Status":"preclinical","Evidence":"emerging","Source":"23614898","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:38.424992	2016-05-18 21:41:52.557191
4002	30	380	428	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"trastuzumab, pertuzumab, lapatinib, anti-HER3 mAbs, PI3K pathway inhibitors + MEK inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23680147","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:48.260862	2016-05-18 21:41:52.571753
4313	19	3	491	\N	\N	3	\N	5	2016-05-18 21:28:08.402545	2016-05-18 21:28:08.402545
3883	1	333	411	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"MEK inhibitors","Association":"response","Status":"late trials","Evidence":"emerging","Source":"23414587","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"18390968, 22761467","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors + CDK4/6 inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"ASCO 2014; abstr 9009","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"HSP90 inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23538902","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors","Association":"resistance","Status":"case report","Evidence":"emerging","Source":"23569304.0","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"preclinical","Association":"ERK inhibitors","Status":"preclinical","Evidence":"emerging","Source":"23614898","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:38.176553	2016-05-18 21:41:52.497299
3889	1	422	412	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"MEK inhibitors","Association":"response","Status":"late trials","Evidence":"emerging","Source":"23414587","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"18390968, 22761467","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors + CDK4/6 inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"ASCO 2014; abstr 9009","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"HSP90 inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23538902","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors","Association":"resistance","Status":"case report","Evidence":"emerging","Source":"23569304.0","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"preclinical","Association":"ERK inhibitors","Status":"preclinical","Evidence":"emerging","Source":"23614898","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:38.655177	2016-05-18 21:41:52.630411
3890	1	423	412	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"MEK inhibitors","Association":"response","Status":"late trials","Evidence":"emerging","Source":"23414587","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"18390968, 22761467","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors + CDK4/6 inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"ASCO 2014; abstr 9009","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"HSP90 inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23538902","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors","Association":"resistance","Status":"case report","Evidence":"emerging","Source":"23569304.0","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"preclinical","Association":"ERK inhibitors","Status":"preclinical","Evidence":"emerging","Source":"23614898","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:38.738252	2016-05-18 21:41:52.65458
3891	1	424	412	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"MEK inhibitors","Association":"response","Status":"late trials","Evidence":"emerging","Source":"23414587","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"18390968, 22761467","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors + CDK4/6 inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"ASCO 2014; abstr 9009","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"HSP90 inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23538902","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors","Association":"resistance","Status":"case report","Evidence":"emerging","Source":"23569304.0","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"preclinical","Association":"ERK inhibitors","Status":"preclinical","Evidence":"emerging","Source":"23614898","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:38.834857	2016-05-18 21:41:52.678642
4003	30	380	429	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"trastuzumab, lapatinib, PI3K pathway inhibitors + MEK inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23680147","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:48.363476	2016-05-18 21:41:52.693264
4314	19	193	492	\N	\N	3	\N	5	2016-05-18 21:28:08.464503	2016-05-18 21:28:08.464503
4315	19	172	492	\N	\N	3	\N	5	2016-05-18 21:28:08.508454	2016-05-18 21:28:08.508454
3888	1	421	412	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"MEK inhibitors","Association":"response","Status":"late trials","Evidence":"emerging","Source":"23414587","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"18390968, 22761467","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors + CDK4/6 inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"ASCO 2014; abstr 9009","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"HSP90 inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23538902","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors","Association":"resistance","Status":"case report","Evidence":"emerging","Source":"23569304.0","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"preclinical","Association":"ERK inhibitors","Status":"preclinical","Evidence":"emerging","Source":"23614898","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:38.565218	2016-05-18 21:41:52.607426
3894	1	333	412	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"MEK inhibitors","Association":"response","Status":"late trials","Evidence":"emerging","Source":"23414587","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"18390968, 22761467","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors + CDK4/6 inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"ASCO 2014; abstr 9009","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"HSP90 inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23538902","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors","Association":"resistance","Status":"case report","Evidence":"emerging","Source":"23569304.0","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"preclinical","Association":"ERK inhibitors","Status":"preclinical","Evidence":"emerging","Source":"23614898","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:39.130428	2016-05-18 21:41:52.75621
3895	1	417	413	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"MEK inhibitors","Association":"response","Status":"late trials","Evidence":"emerging","Source":"23414587","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"18390968, 22761467","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors + CDK4/6 inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"ASCO 2014; abstr 9009","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"HSP90 inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23538902","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors","Association":"resistance","Status":"case report","Evidence":"emerging","Source":"23569304.0","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"preclinical","Association":"ERK inhibitors","Status":"preclinical","Evidence":"emerging","Source":"23614898","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:39.224151	2016-05-18 21:41:52.771301
3896	1	418	413	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"MEK inhibitors","Association":"response","Status":"late trials","Evidence":"emerging","Source":"23414587","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"18390968, 22761467","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors + CDK4/6 inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"ASCO 2014; abstr 9009","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"HSP90 inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23538902","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors","Association":"resistance","Status":"case report","Evidence":"emerging","Source":"23569304.0","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"preclinical","Association":"ERK inhibitors","Status":"preclinical","Evidence":"emerging","Source":"23614898","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:39.303497	2016-05-18 21:41:52.790972
4004	30	446	430	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"JAK inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"21835143","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:48.501901	2016-05-18 21:41:52.804186
4316	19	194	492	\N	\N	3	\N	5	2016-05-18 21:28:08.559929	2016-05-18 21:28:08.559929
4317	19	188	492	\N	\N	3	\N	5	2016-05-18 21:28:08.618605	2016-05-18 21:28:08.618605
3893	1	407	412	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"MEK inhibitors","Association":"response","Status":"late trials","Evidence":"emerging","Source":"23414587","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"18390968, 22761467","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors + CDK4/6 inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"ASCO 2014; abstr 9009","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"HSP90 inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23538902","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors","Association":"resistance","Status":"case report","Evidence":"emerging","Source":"23569304.0","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"preclinical","Association":"ERK inhibitors","Status":"preclinical","Evidence":"emerging","Source":"23614898","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:39.040903	2016-05-18 21:41:52.733116
3899	1	421	413	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"MEK inhibitors","Association":"response","Status":"late trials","Evidence":"emerging","Source":"23414587","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"18390968, 22761467","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors + CDK4/6 inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"ASCO 2014; abstr 9009","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"HSP90 inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23538902","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors","Association":"resistance","Status":"case report","Evidence":"emerging","Source":"23569304.0","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"preclinical","Association":"ERK inhibitors","Status":"preclinical","Evidence":"emerging","Source":"23614898","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:39.555669	2016-05-18 21:41:52.861914
3900	1	422	413	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"MEK inhibitors","Association":"response","Status":"late trials","Evidence":"emerging","Source":"23414587","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"18390968, 22761467","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors + CDK4/6 inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"ASCO 2014; abstr 9009","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"HSP90 inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23538902","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors","Association":"resistance","Status":"case report","Evidence":"emerging","Source":"23569304.0","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"preclinical","Association":"ERK inhibitors","Status":"preclinical","Evidence":"emerging","Source":"23614898","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:39.637654	2016-05-18 21:41:52.888787
3901	1	423	413	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"MEK inhibitors","Association":"response","Status":"late trials","Evidence":"emerging","Source":"23414587","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"18390968, 22761467","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors + CDK4/6 inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"ASCO 2014; abstr 9009","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"HSP90 inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23538902","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors","Association":"resistance","Status":"case report","Evidence":"emerging","Source":"23569304.0","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"preclinical","Association":"ERK inhibitors","Status":"preclinical","Evidence":"emerging","Source":"23614898","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:39.728633	2016-05-18 21:41:52.912522
4005	30	446	431	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"JAK inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"21835143","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:48.576217	2016-05-18 21:41:52.928847
4318	19	177	492	\N	\N	3	\N	5	2016-05-18 21:28:08.666216	2016-05-18 21:28:08.666216
4319	19	179	492	\N	\N	3	\N	5	2016-05-18 21:28:08.727873	2016-05-18 21:28:08.727873
3898	1	420	413	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"MEK inhibitors","Association":"response","Status":"late trials","Evidence":"emerging","Source":"23414587","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"18390968, 22761467","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors + CDK4/6 inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"ASCO 2014; abstr 9009","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"HSP90 inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23538902","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors","Association":"resistance","Status":"case report","Evidence":"emerging","Source":"23569304.0","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"preclinical","Association":"ERK inhibitors","Status":"preclinical","Evidence":"emerging","Source":"23614898","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:39.471681	2016-05-18 21:41:52.847876
3904	1	407	413	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"MEK inhibitors","Association":"response","Status":"late trials","Evidence":"emerging","Source":"23414587","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"18390968, 22761467","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors + CDK4/6 inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"ASCO 2014; abstr 9009","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"HSP90 inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23538902","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors","Association":"resistance","Status":"case report","Evidence":"emerging","Source":"23569304.0","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"preclinical","Association":"ERK inhibitors","Status":"preclinical","Evidence":"emerging","Source":"23614898","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:39.956871	2016-05-18 21:41:52.990891
3905	1	333	413	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"MEK inhibitors","Association":"response","Status":"late trials","Evidence":"emerging","Source":"23414587","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"18390968, 22761467","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors + CDK4/6 inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"ASCO 2014; abstr 9009","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"HSP90 inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23538902","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors","Association":"resistance","Status":"case report","Evidence":"emerging","Source":"23569304.0","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"preclinical","Association":"ERK inhibitors","Status":"preclinical","Evidence":"emerging","Source":"23614898","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:40.039782	2016-05-18 21:41:53.016521
3906	1	417	2	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"MEK inhibitors","Association":"response","Status":"late trials","Evidence":"emerging","Source":"23414587","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"18390968, 22761467","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors + CDK4/6 inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"ASCO 2014; abstr 9009","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"HSP90 inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23538902","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors","Association":"resistance","Status":"case report","Evidence":"emerging","Source":"23569304.0","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"preclinical","Association":"ERK inhibitors","Status":"preclinical","Evidence":"emerging","Source":"23614898","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:40.127228	2016-05-18 21:41:53.039978
4006	30	446	432	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"JAK inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"21835143","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:48.657432	2016-05-18 21:41:53.054937
4320	19	3	492	\N	\N	3	\N	5	2016-05-18 21:28:08.78554	2016-05-18 21:28:08.78554
4321	38	198	61	\N	\N	3	\N	5	2016-05-18 21:28:08.854667	2016-05-18 21:28:08.854667
3903	1	425	413	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"MEK inhibitors","Association":"response","Status":"late trials","Evidence":"emerging","Source":"23414587","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"18390968, 22761467","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors + CDK4/6 inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"ASCO 2014; abstr 9009","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"HSP90 inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23538902","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors","Association":"resistance","Status":"case report","Evidence":"emerging","Source":"23569304.0","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"preclinical","Association":"ERK inhibitors","Status":"preclinical","Evidence":"emerging","Source":"23614898","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:39.89223	2016-05-18 21:41:52.973515
3909	1	420	2	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"MEK inhibitors","Association":"response","Status":"late trials","Evidence":"emerging","Source":"23414587","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"18390968, 22761467","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors + CDK4/6 inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"ASCO 2014; abstr 9009","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"HSP90 inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23538902","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors","Association":"resistance","Status":"case report","Evidence":"emerging","Source":"23569304.0","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"preclinical","Association":"ERK inhibitors","Status":"preclinical","Evidence":"emerging","Source":"23614898","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:40.375761	2016-05-18 21:41:53.115412
3910	1	421	2	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"MEK inhibitors","Association":"response","Status":"late trials","Evidence":"emerging","Source":"23414587","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"18390968, 22761467","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors + CDK4/6 inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"ASCO 2014; abstr 9009","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"HSP90 inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23538902","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors","Association":"resistance","Status":"case report","Evidence":"emerging","Source":"23569304.0","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"preclinical","Association":"ERK inhibitors","Status":"preclinical","Evidence":"emerging","Source":"23614898","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:40.460636	2016-05-18 21:41:53.148493
3911	1	422	2	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"MEK inhibitors","Association":"response","Status":"late trials","Evidence":"emerging","Source":"23414587","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"18390968, 22761467","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors + CDK4/6 inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"ASCO 2014; abstr 9009","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"HSP90 inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23538902","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors","Association":"resistance","Status":"case report","Evidence":"emerging","Source":"23569304.0","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"preclinical","Association":"ERK inhibitors","Status":"preclinical","Evidence":"emerging","Source":"23614898","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:40.544346	2016-05-18 21:41:53.16575
4007	30	408	433	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"MEK inhibitors","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"19915144","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:48.746251	2016-05-18 21:41:53.183568
4322	38	3	61	\N	\N	3	\N	5	2016-05-18 21:28:08.916142	2016-05-18 21:28:08.916142
4323	23	207	61	\N	\N	3	\N	5	2016-05-18 21:28:08.965317	2016-05-18 21:28:08.965317
3908	1	419	2	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"MEK inhibitors","Association":"response","Status":"late trials","Evidence":"emerging","Source":"23414587","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"18390968, 22761467","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors + CDK4/6 inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"ASCO 2014; abstr 9009","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"HSP90 inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23538902","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors","Association":"resistance","Status":"case report","Evidence":"emerging","Source":"23569304.0","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"preclinical","Association":"ERK inhibitors","Status":"preclinical","Evidence":"emerging","Source":"23614898","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:40.294085	2016-05-18 21:41:53.096178
3914	1	425	2	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"MEK inhibitors","Association":"response","Status":"late trials","Evidence":"emerging","Source":"23414587","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"18390968, 22761467","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors + CDK4/6 inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"ASCO 2014; abstr 9009","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"HSP90 inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23538902","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors","Association":"resistance","Status":"case report","Evidence":"emerging","Source":"23569304.0","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"preclinical","Association":"ERK inhibitors","Status":"preclinical","Evidence":"emerging","Source":"23614898","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:40.769496	2016-05-18 21:41:53.231276
3915	1	407	2	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"MEK inhibitors","Association":"response","Status":"late trials","Evidence":"emerging","Source":"23414587","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"18390968, 22761467","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors + CDK4/6 inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"ASCO 2014; abstr 9009","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"HSP90 inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23538902","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors","Association":"resistance","Status":"case report","Evidence":"emerging","Source":"23569304.0","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"preclinical","Association":"ERK inhibitors","Status":"preclinical","Evidence":"emerging","Source":"23614898","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:40.865439	2016-05-18 21:41:53.246022
3916	1	333	2	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"MEK inhibitors","Association":"response","Status":"late trials","Evidence":"emerging","Source":"23414587","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"18390968, 22761467","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors + CDK4/6 inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"ASCO 2014; abstr 9009","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"HSP90 inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23538902","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors","Association":"resistance","Status":"case report","Evidence":"emerging","Source":"23569304.0","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"preclinical","Association":"ERK inhibitors","Status":"preclinical","Evidence":"emerging","Source":"23614898","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:40.948748	2016-05-18 21:41:53.261327
4008	30	408	434	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"MEK inhibitors","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"19915144","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"ERK inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23614898","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:48.830299	2016-05-18 21:41:53.274943
3913	1	424	2	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"MEK inhibitors","Association":"response","Status":"late trials","Evidence":"emerging","Source":"23414587","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"18390968, 22761467","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors + CDK4/6 inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"ASCO 2014; abstr 9009","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"HSP90 inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23538902","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors","Association":"resistance","Status":"case report","Evidence":"emerging","Source":"23569304.0","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"preclinical","Association":"ERK inhibitors","Status":"preclinical","Evidence":"emerging","Source":"23614898","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:40.680553	2016-05-18 21:41:53.214806
3919	1	418	414	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"MEK inhibitors","Association":"response","Status":"late trials","Evidence":"emerging","Source":"23414587","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"18390968, 22761467","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors + CDK4/6 inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"ASCO 2014; abstr 9009","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"HSP90 inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23538902","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors","Association":"resistance","Status":"case report","Evidence":"emerging","Source":"23569304.0","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"preclinical","Association":"ERK inhibitors","Status":"preclinical","Evidence":"emerging","Source":"23614898","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:41.216406	2016-05-18 21:41:53.317064
3920	1	419	414	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"MEK inhibitors","Association":"response","Status":"late trials","Evidence":"emerging","Source":"23414587","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"18390968, 22761467","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors + CDK4/6 inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"ASCO 2014; abstr 9009","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"HSP90 inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23538902","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors","Association":"resistance","Status":"case report","Evidence":"emerging","Source":"23569304.0","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"preclinical","Association":"ERK inhibitors","Status":"preclinical","Evidence":"emerging","Source":"23614898","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:41.297126	2016-05-18 21:41:53.339698
3921	1	420	414	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"MEK inhibitors","Association":"response","Status":"late trials","Evidence":"emerging","Source":"23414587","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"18390968, 22761467","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors + CDK4/6 inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"ASCO 2014; abstr 9009","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"HSP90 inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23538902","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors","Association":"resistance","Status":"case report","Evidence":"emerging","Source":"23569304.0","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"preclinical","Association":"ERK inhibitors","Status":"preclinical","Evidence":"emerging","Source":"23614898","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:41.355148	2016-05-18 21:41:53.359299
4009	30	333	434	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"MEK inhibitors","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"19915144","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"ERK inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23614898","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:48.900477	2016-05-18 21:41:53.37027
3918	1	417	414	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"MEK inhibitors","Association":"response","Status":"late trials","Evidence":"emerging","Source":"23414587","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"18390968, 22761467","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors + CDK4/6 inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"ASCO 2014; abstr 9009","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"HSP90 inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23538902","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors","Association":"resistance","Status":"case report","Evidence":"emerging","Source":"23569304.0","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"preclinical","Association":"ERK inhibitors","Status":"preclinical","Evidence":"emerging","Source":"23614898","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:41.135616	2016-05-18 21:41:53.304384
3924	1	423	414	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"MEK inhibitors","Association":"response","Status":"late trials","Evidence":"emerging","Source":"23414587","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"18390968, 22761467","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors + CDK4/6 inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"ASCO 2014; abstr 9009","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"HSP90 inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23538902","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors","Association":"resistance","Status":"case report","Evidence":"emerging","Source":"23569304.0","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"preclinical","Association":"ERK inhibitors","Status":"preclinical","Evidence":"emerging","Source":"23614898","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:41.600608	2016-05-18 21:41:53.422295
3925	1	424	414	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"MEK inhibitors","Association":"response","Status":"late trials","Evidence":"emerging","Source":"23414587","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"18390968, 22761467","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors + CDK4/6 inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"ASCO 2014; abstr 9009","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"HSP90 inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23538902","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors","Association":"resistance","Status":"case report","Evidence":"emerging","Source":"23569304.0","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"preclinical","Association":"ERK inhibitors","Status":"preclinical","Evidence":"emerging","Source":"23614898","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:41.694846	2016-05-18 21:41:53.435455
3926	1	425	414	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"MEK inhibitors","Association":"response","Status":"late trials","Evidence":"emerging","Source":"23414587","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"18390968, 22761467","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors + CDK4/6 inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"ASCO 2014; abstr 9009","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"HSP90 inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23538902","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors","Association":"resistance","Status":"case report","Evidence":"emerging","Source":"23569304.0","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"preclinical","Association":"ERK inhibitors","Status":"preclinical","Evidence":"emerging","Source":"23614898","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:41.770922	2016-05-18 21:41:53.451138
4010	30	408	435	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"MEK inhibitors","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"19915144","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:48.987475	2016-05-18 21:41:53.466916
4324	23	3	61	\N	\N	3	\N	5	2016-05-18 21:28:09.017797	2016-05-18 21:28:09.017797
4325	23	208	472	\N	\N	3	\N	5	2016-05-18 21:28:09.071998	2016-05-18 21:28:09.071998
3923	1	422	414	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"MEK inhibitors","Association":"response","Status":"late trials","Evidence":"emerging","Source":"23414587","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"18390968, 22761467","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors + CDK4/6 inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"ASCO 2014; abstr 9009","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"HSP90 inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23538902","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors","Association":"resistance","Status":"case report","Evidence":"emerging","Source":"23569304.0","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"preclinical","Association":"ERK inhibitors","Status":"preclinical","Evidence":"emerging","Source":"23614898","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:41.516264	2016-05-18 21:41:53.405223
3929	1	417	415	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"MEK inhibitors","Association":"response","Status":"late trials","Evidence":"emerging","Source":"23414587","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"18390968, 22761467","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors + CDK4/6 inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"ASCO 2014; abstr 9009","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"HSP90 inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23538902","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors","Association":"resistance","Status":"case report","Evidence":"emerging","Source":"23569304.0","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"preclinical","Association":"ERK inhibitors","Status":"preclinical","Evidence":"emerging","Source":"23614898","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:42.050719	2016-05-18 21:41:53.510961
3930	1	418	415	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"MEK inhibitors","Association":"response","Status":"late trials","Evidence":"emerging","Source":"23414587","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"18390968, 22761467","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors + CDK4/6 inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"ASCO 2014; abstr 9009","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"HSP90 inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23538902","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors","Association":"resistance","Status":"case report","Evidence":"emerging","Source":"23569304.0","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"preclinical","Association":"ERK inhibitors","Status":"preclinical","Evidence":"emerging","Source":"23614898","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:42.118774	2016-05-18 21:41:53.527169
3931	1	419	415	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"MEK inhibitors","Association":"response","Status":"late trials","Evidence":"emerging","Source":"23414587","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"18390968, 22761467","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors + CDK4/6 inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"ASCO 2014; abstr 9009","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"HSP90 inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23538902","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors","Association":"resistance","Status":"case report","Evidence":"emerging","Source":"23569304.0","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"preclinical","Association":"ERK inhibitors","Status":"preclinical","Evidence":"emerging","Source":"23614898","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:42.185693	2016-05-18 21:41:53.542501
4011	30	408	436	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"MEK inhibitors","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"19915144","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:49.077055	2016-05-18 21:41:53.55592
4326	23	3	472	\N	\N	3	\N	5	2016-05-18 21:28:09.133974	2016-05-18 21:28:09.133974
4327	2	30	61	\N	\N	3	\N	5	2016-05-18 21:28:09.185094	2016-05-18 21:28:09.185094
3928	1	333	414	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"MEK inhibitors","Association":"response","Status":"late trials","Evidence":"emerging","Source":"23414587","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"18390968, 22761467","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors + CDK4/6 inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"ASCO 2014; abstr 9009","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"HSP90 inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23538902","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors","Association":"resistance","Status":"case report","Evidence":"emerging","Source":"23569304.0","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"preclinical","Association":"ERK inhibitors","Status":"preclinical","Evidence":"emerging","Source":"23614898","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:41.957729	2016-05-18 21:41:53.495027
3934	1	422	415	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"MEK inhibitors","Association":"response","Status":"late trials","Evidence":"emerging","Source":"23414587","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"18390968, 22761467","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors + CDK4/6 inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"ASCO 2014; abstr 9009","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"HSP90 inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23538902","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors","Association":"resistance","Status":"case report","Evidence":"emerging","Source":"23569304.0","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"preclinical","Association":"ERK inhibitors","Status":"preclinical","Evidence":"emerging","Source":"23614898","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:42.430575	2016-05-18 21:41:53.603679
3935	1	423	415	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"MEK inhibitors","Association":"response","Status":"late trials","Evidence":"emerging","Source":"23414587","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"18390968, 22761467","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors + CDK4/6 inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"ASCO 2014; abstr 9009","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"HSP90 inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23538902","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors","Association":"resistance","Status":"case report","Evidence":"emerging","Source":"23569304.0","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"preclinical","Association":"ERK inhibitors","Status":"preclinical","Evidence":"emerging","Source":"23614898","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:42.513028	2016-05-18 21:41:53.620266
3936	1	424	415	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"MEK inhibitors","Association":"response","Status":"late trials","Evidence":"emerging","Source":"23414587","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"18390968, 22761467","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors + CDK4/6 inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"ASCO 2014; abstr 9009","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"HSP90 inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23538902","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors","Association":"resistance","Status":"case report","Evidence":"emerging","Source":"23569304.0","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"preclinical","Association":"ERK inhibitors","Status":"preclinical","Evidence":"emerging","Source":"23614898","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:42.598305	2016-05-18 21:41:53.633656
4012	30	408	437	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"MEK inhibitors","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"19915144","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:49.169536	2016-05-18 21:41:53.644664
4328	2	3	61	\N	\N	3	\N	5	2016-05-18 21:28:09.227867	2016-05-18 21:28:09.227867
4329	2	216	61	\N	\N	3	\N	5	2016-05-18 21:28:09.283415	2016-05-18 21:28:09.283415
3933	1	421	415	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"MEK inhibitors","Association":"response","Status":"late trials","Evidence":"emerging","Source":"23414587","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"18390968, 22761467","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors + CDK4/6 inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"ASCO 2014; abstr 9009","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"HSP90 inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23538902","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors","Association":"resistance","Status":"case report","Evidence":"emerging","Source":"23569304.0","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"preclinical","Association":"ERK inhibitors","Status":"preclinical","Evidence":"emerging","Source":"23614898","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:42.347583	2016-05-18 21:41:53.58176
3939	1	333	415	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"MEK inhibitors","Association":"response","Status":"late trials","Evidence":"emerging","Source":"23414587","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"18390968, 22761467","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors + CDK4/6 inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"ASCO 2014; abstr 9009","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"HSP90 inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23538902","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors","Association":"resistance","Status":"case report","Evidence":"emerging","Source":"23569304.0","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"preclinical","Association":"ERK inhibitors","Status":"preclinical","Evidence":"emerging","Source":"23614898","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:42.845694	2016-05-18 21:41:53.699625
3940	1	417	3	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"MEK inhibitors","Association":"response","Status":"late trials","Evidence":"emerging","Source":"23414587","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"18390968, 22761467","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors + CDK4/6 inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"ASCO 2014; abstr 9009","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"HSP90 inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23538902","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors","Association":"resistance","Status":"case report","Evidence":"emerging","Source":"23569304.0","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"preclinical","Association":"ERK inhibitors","Status":"preclinical","Evidence":"emerging","Source":"23614898","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:42.928389	2016-05-18 21:41:53.71953
3941	1	418	3	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"MEK inhibitors","Association":"response","Status":"late trials","Evidence":"emerging","Source":"23414587","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"18390968, 22761467","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors + CDK4/6 inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"ASCO 2014; abstr 9009","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"HSP90 inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23538902","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors","Association":"resistance","Status":"case report","Evidence":"emerging","Source":"23569304.0","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"preclinical","Association":"ERK inhibitors","Status":"preclinical","Evidence":"emerging","Source":"23614898","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:43.015371	2016-05-18 21:41:53.733666
4013	30	408	438	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"MEK inhibitors","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"19915144","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:49.257151	2016-05-18 21:41:53.744424
4330	2	217	493	\N	\N	3	\N	5	2016-05-18 21:28:09.346263	2016-05-18 21:28:09.346263
4331	2	3	493	\N	\N	3	\N	5	2016-05-18 21:28:09.385238	2016-05-18 21:28:09.385238
3938	1	407	415	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"MEK inhibitors","Association":"response","Status":"late trials","Evidence":"emerging","Source":"23414587","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"18390968, 22761467","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors + CDK4/6 inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"ASCO 2014; abstr 9009","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"HSP90 inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23538902","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors","Association":"resistance","Status":"case report","Evidence":"emerging","Source":"23569304.0","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"preclinical","Association":"ERK inhibitors","Status":"preclinical","Evidence":"emerging","Source":"23614898","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:42.765011	2016-05-18 21:41:53.683039
3944	1	421	3	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"MEK inhibitors","Association":"response","Status":"late trials","Evidence":"emerging","Source":"23414587","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"18390968, 22761467","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors + CDK4/6 inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"ASCO 2014; abstr 9009","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"HSP90 inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23538902","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors","Association":"resistance","Status":"case report","Evidence":"emerging","Source":"23569304.0","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"preclinical","Association":"ERK inhibitors","Status":"preclinical","Evidence":"emerging","Source":"23614898","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:43.257242	2016-05-18 21:41:53.804728
3945	1	422	3	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"MEK inhibitors","Association":"response","Status":"late trials","Evidence":"emerging","Source":"23414587","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"18390968, 22761467","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors + CDK4/6 inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"ASCO 2014; abstr 9009","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"HSP90 inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23538902","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors","Association":"resistance","Status":"case report","Evidence":"emerging","Source":"23569304.0","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"preclinical","Association":"ERK inhibitors","Status":"preclinical","Evidence":"emerging","Source":"23614898","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:43.335983	2016-05-18 21:41:53.824763
3946	1	423	3	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"MEK inhibitors","Association":"response","Status":"late trials","Evidence":"emerging","Source":"23414587","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"18390968, 22761467","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors + CDK4/6 inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"ASCO 2014; abstr 9009","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"HSP90 inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23538902","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors","Association":"resistance","Status":"case report","Evidence":"emerging","Source":"23569304.0","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"preclinical","Association":"ERK inhibitors","Status":"preclinical","Evidence":"emerging","Source":"23614898","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:43.423441	2016-05-18 21:41:53.839871
4014	30	408	439	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"MEK inhibitors","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"19915144","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:49.326079	2016-05-18 21:41:53.851361
4332	39	276	61	\N	\N	3	\N	5	2016-05-18 21:28:09.431413	2016-05-18 21:28:09.431413
4333	39	3	61	\N	\N	3	\N	5	2016-05-18 21:28:09.468756	2016-05-18 21:28:09.468756
3943	1	420	3	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"MEK inhibitors","Association":"response","Status":"late trials","Evidence":"emerging","Source":"23414587","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"18390968, 22761467","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors + CDK4/6 inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"ASCO 2014; abstr 9009","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"HSP90 inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23538902","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors","Association":"resistance","Status":"case report","Evidence":"emerging","Source":"23569304.0","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"preclinical","Association":"ERK inhibitors","Status":"preclinical","Evidence":"emerging","Source":"23614898","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:43.165927	2016-05-18 21:41:53.773491
3949	1	407	3	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"MEK inhibitors","Association":"response","Status":"late trials","Evidence":"emerging","Source":"23414587","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"18390968, 22761467","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors + CDK4/6 inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"ASCO 2014; abstr 9009","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"HSP90 inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23538902","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors","Association":"resistance","Status":"case report","Evidence":"emerging","Source":"23569304.0","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"preclinical","Association":"ERK inhibitors","Status":"preclinical","Evidence":"emerging","Source":"23614898","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:43.649796	2016-05-18 21:41:53.900479
3950	1	333	3	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"MEK inhibitors","Association":"response","Status":"late trials","Evidence":"emerging","Source":"23414587","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"18390968, 22761467","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors + CDK4/6 inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"ASCO 2014; abstr 9009","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"HSP90 inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23538902","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors","Association":"resistance","Status":"case report","Evidence":"emerging","Source":"23569304.0","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"preclinical","Association":"ERK inhibitors","Status":"preclinical","Evidence":"emerging","Source":"23614898","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:43.738669	2016-05-18 21:41:53.926439
3951	1	426	4	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"MEK inhibitors","Association":"response","Status":"late trials","Evidence":"emerging","Source":"23414587","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"18390968, 22761467","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors + CDK4/6 inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"ASCO 2014; abstr 9009","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"HSP90 inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23538902","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors","Association":"resistance","Status":"case report","Evidence":"emerging","Source":"23569304.0","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"preclinical","Association":"ERK inhibitors","Status":"preclinical","Evidence":"emerging","Source":"23614898","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:43.823823	2016-05-18 21:41:53.94938
4015	30	408	440	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"MEK inhibitors","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"19915144","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"ERK inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23614898","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:49.411514	2016-05-18 21:41:53.968947
3948	1	425	3	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"MEK inhibitors","Association":"response","Status":"late trials","Evidence":"emerging","Source":"23414587","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"18390968, 22761467","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors + CDK4/6 inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"ASCO 2014; abstr 9009","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"HSP90 inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23538902","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors","Association":"resistance","Status":"case report","Evidence":"emerging","Source":"23569304.0","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"preclinical","Association":"ERK inhibitors","Status":"preclinical","Evidence":"emerging","Source":"23614898","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:43.562989	2016-05-18 21:41:53.884687
3954	1	419	4	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"MEK inhibitors","Association":"response","Status":"late trials","Evidence":"emerging","Source":"23414587","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"18390968, 22761467","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors + CDK4/6 inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"ASCO 2014; abstr 9009","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"HSP90 inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23538902","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors","Association":"resistance","Status":"case report","Evidence":"emerging","Source":"23569304.0","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"preclinical","Association":"ERK inhibitors","Status":"preclinical","Evidence":"emerging","Source":"23614898","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:44.098177	2016-05-18 21:41:54.041908
3955	1	420	4	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"MEK inhibitors","Association":"response","Status":"late trials","Evidence":"emerging","Source":"23414587","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"18390968, 22761467","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors + CDK4/6 inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"ASCO 2014; abstr 9009","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"HSP90 inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23538902","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors","Association":"resistance","Status":"case report","Evidence":"emerging","Source":"23569304.0","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"preclinical","Association":"ERK inhibitors","Status":"preclinical","Evidence":"emerging","Source":"23614898","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:44.17588	2016-05-18 21:41:54.06517
3956	1	421	4	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"MEK inhibitors","Association":"response","Status":"late trials","Evidence":"emerging","Source":"23414587","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"18390968, 22761467","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors + CDK4/6 inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"ASCO 2014; abstr 9009","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"HSP90 inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23538902","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors","Association":"resistance","Status":"case report","Evidence":"emerging","Source":"23569304.0","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"preclinical","Association":"ERK inhibitors","Status":"preclinical","Evidence":"emerging","Source":"23614898","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:44.248048	2016-05-18 21:41:54.086892
4016	30	333	440	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"MEK inhibitors","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"19915144","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"ERK inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23614898","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:49.482782	2016-05-18 21:41:54.104747
3953	1	418	4	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"MEK inhibitors","Association":"response","Status":"late trials","Evidence":"emerging","Source":"23414587","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"18390968, 22761467","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors + CDK4/6 inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"ASCO 2014; abstr 9009","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"HSP90 inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23538902","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors","Association":"resistance","Status":"case report","Evidence":"emerging","Source":"23569304.0","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"preclinical","Association":"ERK inhibitors","Status":"preclinical","Evidence":"emerging","Source":"23614898","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:44.002985	2016-05-18 21:41:54.016046
3959	1	424	4	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"MEK inhibitors","Association":"response","Status":"late trials","Evidence":"emerging","Source":"23414587","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"18390968, 22761467","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors + CDK4/6 inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"ASCO 2014; abstr 9009","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"HSP90 inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23538902","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors","Association":"resistance","Status":"case report","Evidence":"emerging","Source":"23569304.0","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"preclinical","Association":"ERK inhibitors","Status":"preclinical","Evidence":"emerging","Source":"23614898","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:44.503028	2016-05-18 21:41:54.166239
3960	1	425	4	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"MEK inhibitors","Association":"response","Status":"late trials","Evidence":"emerging","Source":"23414587","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"18390968, 22761467","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors + CDK4/6 inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"ASCO 2014; abstr 9009","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"HSP90 inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23538902","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors","Association":"resistance","Status":"case report","Evidence":"emerging","Source":"23569304.0","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"preclinical","Association":"ERK inhibitors","Status":"preclinical","Evidence":"emerging","Source":"23614898","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:44.590296	2016-05-18 21:41:54.196314
3961	1	407	4	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"MEK inhibitors","Association":"response","Status":"late trials","Evidence":"emerging","Source":"23414587","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"18390968, 22761467","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors + CDK4/6 inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"ASCO 2014; abstr 9009","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"HSP90 inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23538902","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors","Association":"resistance","Status":"case report","Evidence":"emerging","Source":"23569304.0","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"preclinical","Association":"ERK inhibitors","Status":"preclinical","Evidence":"emerging","Source":"23614898","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:44.674977	2016-05-18 21:41:54.261221
4017	30	447	441	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"crizotinib","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"17483355","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:49.575863	2016-05-18 21:41:54.279452
4334	40	278	61	\N	\N	3	\N	5	2016-05-18 21:28:09.508909	2016-05-18 21:28:09.508909
4335	40	3	61	\N	\N	3	\N	5	2016-05-18 21:28:09.552774	2016-05-18 21:28:09.552774
3958	1	423	4	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"MEK inhibitors","Association":"response","Status":"late trials","Evidence":"emerging","Source":"23414587","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"18390968, 22761467","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors + CDK4/6 inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"ASCO 2014; abstr 9009","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"HSP90 inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23538902","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors","Association":"resistance","Status":"case report","Evidence":"emerging","Source":"23569304.0","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"preclinical","Association":"ERK inhibitors","Status":"preclinical","Evidence":"emerging","Source":"23614898","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:44.410633	2016-05-18 21:41:54.144293
3966	1	427	418	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"imatinib, crenolanib","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"24132921","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:45.088757	2016-05-18 21:41:54.384279
3967	1	427	419	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"imatinib, crenolanib","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"24132921","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:45.178906	2016-05-18 21:41:54.390601
3968	1	427	420	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"imatinib, crenolanib","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"24132921","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:45.257718	2016-05-18 21:41:54.399354
3970	1	428	422	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"BRAF inhibitors in BRAF mutant tumors","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"23737487","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:45.43604	2016-05-18 21:41:54.413658
3971	29	429	423	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"everolimus","Association":"response","Status":"case report","Evidence":"emerging","Source":"21189378","Effect":"loss-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:45.546082	2016-05-18 21:41:54.422537
3972	29	429	424	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"everolimus","Association":"response","Status":"case report","Evidence":"emerging","Source":"21189378","Effect":"loss-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:45.615324	2016-05-18 21:41:54.43
3963	1	333	13	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"ERK inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23614898","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:44.819514	2016-05-18 21:41:54.317516
3964	1	427	416	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"imatinib, crenolanib","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"24132921","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:44.928896	2016-05-18 21:41:54.367141
3965	1	427	417	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"crenolanib","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"24132921","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"imatinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"24132921","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:44.998804	2016-05-18 21:41:54.375357
3969	1	428	421	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"BRAF inhibitors in BRAF mutant tumors","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"23737487","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:45.348817	2016-05-18 21:41:54.406514
3976	3	36	226	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"vemurafenib, dabrafenib","Association":"response","Status":"early trials","Evidence":"emerging","Source":"22608338, 20818844, 23489023","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"22241789","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK-enhanced radioiodine uptake","Association":"response","Status":"early trials","Evidence":"emerging","Source":"23406027","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors + MEK inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"J Clin Oncol 2013;31(suppl; abstr 9029)","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:45.931051	2016-05-18 21:41:54.489305
3977	3	432	226	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"vemurafenib, dabrafenib","Association":"response","Status":"early trials","Evidence":"emerging","Source":"22608338, 20818844, 23489023","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"22241789","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK-enhanced radioiodine uptake","Association":"response","Status":"early trials","Evidence":"emerging","Source":"23406027","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors + MEK inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"J Clin Oncol 2013;31(suppl; abstr 9029)","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:46.019411	2016-05-18 21:41:54.514007
3978	3	433	226	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"vemurafenib, dabrafenib","Association":"response","Status":"early trials","Evidence":"emerging","Source":"22608338, 20818844, 23489023","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"22241789","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK-enhanced radioiodine uptake","Association":"response","Status":"early trials","Evidence":"emerging","Source":"23406027","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors + MEK inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"J Clin Oncol 2013;31(suppl; abstr 9029)","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:46.096399	2016-05-18 21:41:54.52512
3979	3	46	226	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"vemurafenib, dabrafenib","Association":"response","Status":"early trials","Evidence":"emerging","Source":"22608338, 20818844, 23489023","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"22241789","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK-enhanced radioiodine uptake","Association":"response","Status":"early trials","Evidence":"emerging","Source":"23406027","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors + MEK inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"J Clin Oncol 2013;31(suppl; abstr 9029)","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:46.184152	2016-05-18 21:41:54.538479
3980	3	434	226	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"vemurafenib, dabrafenib","Association":"response","Status":"early trials","Evidence":"emerging","Source":"22608338, 20818844, 23489023","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"22241789","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK-enhanced radioiodine uptake","Association":"response","Status":"early trials","Evidence":"emerging","Source":"23406027","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors + MEK inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"J Clin Oncol 2013;31(suppl; abstr 9029)","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:46.255916	2016-05-18 21:41:54.551137
3975	3	431	226	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"vemurafenib, dabrafenib","Association":"response","Status":"early trials","Evidence":"emerging","Source":"22608338, 20818844, 23489023","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"22241789","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK-enhanced radioiodine uptake","Association":"response","Status":"early trials","Evidence":"emerging","Source":"23406027","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors + MEK inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"J Clin Oncol 2013;31(suppl; abstr 9029)","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:45.827369	2016-05-18 21:41:54.474497
3983	3	437	425	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"vandetanib","Association":"response","Status":"FDA-approved","Evidence":"consensus","Source":"20065189, 22025146","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"cabozantinib, sunitinib","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"21470995","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"RET inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23056499","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:46.48477	2016-05-18 21:41:54.59947
3985	3	439	425	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"vandetanib","Association":"response","Status":"FDA-approved","Evidence":"consensus","Source":"20065189, 22025146","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"cabozantinib, sunitinib","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"21470995","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"RET inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23056499","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:46.621119	2016-05-18 21:41:54.620304
3986	3	440	425	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"vandetanib","Association":"response","Status":"FDA-approved","Evidence":"consensus","Source":"20065189, 22025146","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"cabozantinib, sunitinib","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"21470995","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"RET inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23056499","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:46.700221	2016-05-18 21:41:54.632644
3987	3	441	17	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"vandetanib","Association":"response","Status":"FDA-approved","Evidence":"consensus","Source":"20065189, 22025146","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"cabozantinib, sunitinib","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"21470995","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"RET inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23056499","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:46.781395	2016-05-18 21:41:54.643183
3988	3	432	17	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"vandetanib","Association":"response","Status":"FDA-approved","Evidence":"consensus","Source":"20065189, 22025146","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"cabozantinib, sunitinib","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"21470995","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"RET inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23056499","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:46.848584	2016-05-18 21:41:54.654842
4336	26	291	61	\N	\N	3	\N	5	2016-05-18 21:28:09.606971	2016-05-18 21:28:09.606971
4337	26	3	61	\N	\N	3	\N	5	2016-05-18 21:28:09.651645	2016-05-18 21:28:09.651645
4338	6	3	494	\N	\N	3	\N	5	2016-05-18 21:28:09.742498	2016-05-18 21:28:09.742498
4339	7	471	61	\N	\N	3	\N	5	2016-05-18 21:28:09.854593	2016-05-18 21:28:09.854593
3982	3	436	226	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"vemurafenib, dabrafenib","Association":"response","Status":"early trials","Evidence":"emerging","Source":"22608338, 20818844, 23489023","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"22241789","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK-enhanced radioiodine uptake","Association":"response","Status":"early trials","Evidence":"emerging","Source":"23406027","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors + MEK inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"J Clin Oncol 2013;31(suppl; abstr 9029)","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:46.382452	2016-05-18 21:41:54.58759
3984	3	438	425	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"vandetanib","Association":"response","Status":"FDA-approved","Evidence":"consensus","Source":"20065189, 22025146","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"cabozantinib, sunitinib","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"21470995","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"RET inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23056499","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:46.545214	2016-05-18 21:41:54.609442
3991	3	442	17	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"vandetanib","Association":"response","Status":"FDA-approved","Evidence":"consensus","Source":"20065189, 22025146","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"cabozantinib, sunitinib","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"21470995","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"RET inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23056499","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:47.169025	2016-05-18 21:41:54.692768
3992	3	437	17	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"vandetanib","Association":"response","Status":"FDA-approved","Evidence":"consensus","Source":"20065189, 22025146","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"cabozantinib, sunitinib","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"21470995","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"RET inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23056499","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:47.238477	2016-05-18 21:41:54.706777
3993	3	438	17	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"vandetanib","Association":"response","Status":"FDA-approved","Evidence":"consensus","Source":"20065189, 22025146","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"cabozantinib, sunitinib","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"21470995","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"RET inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23056499","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:47.296606	2016-05-18 21:41:54.721236
3994	3	443	17	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"vandetanib","Association":"response","Status":"FDA-approved","Evidence":"consensus","Source":"20065189, 22025146","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"cabozantinib, sunitinib","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"21470995","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"RET inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23056499","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:47.401264	2016-05-18 21:41:54.733857
3995	3	439	17	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"vandetanib","Association":"response","Status":"FDA-approved","Evidence":"consensus","Source":"20065189, 22025146","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"cabozantinib, sunitinib","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"21470995","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"RET inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23056499","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:47.51127	2016-05-18 21:41:54.745186
3996	3	440	17	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"vandetanib","Association":"response","Status":"FDA-approved","Evidence":"consensus","Source":"20065189, 22025146","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"cabozantinib, sunitinib","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"21470995","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"RET inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23056499","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:47.595205	2016-05-18 21:41:54.755981
3997	5	444	16	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"dasatinib + erlotinib","Association":"response","Status":"case report","Evidence":"emerging","Source":"22328973","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"dasatinib","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"22328973","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:47.674681	2016-05-18 21:41:54.776055
4340	7	472	61	\N	\N	3	\N	5	2016-05-18 21:28:09.925619	2016-05-18 21:28:09.925619
4341	7	473	61	\N	\N	3	\N	5	2016-05-18 21:28:09.986268	2016-05-18 21:28:09.986268
3990	3	433	17	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"vandetanib","Association":"response","Status":"FDA-approved","Evidence":"consensus","Source":"20065189, 22025146","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"cabozantinib, sunitinib","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"21470995","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"RET inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23056499","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:47.07219	2016-05-18 21:41:54.683243
4020	30	447	444	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"crizotinib","Association":"reduced sensitivity","Status":"preclinical","Evidence":"emerging","Source":"17483355","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:49.856128	2016-05-18 21:41:54.808631
4021	30	447	445	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"crizotinib","Association":"reduced sensitivity","Status":"preclinical","Evidence":"emerging","Source":"17483355","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:49.965333	2016-05-18 21:41:54.816183
4022	30	447	446	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"crizotinib","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"17483355","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:50.048092	2016-05-18 21:41:54.824987
4023	30	447	447	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"crizotinib","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"17483355","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:50.1241	2016-05-18 21:41:54.833137
4024	30	447	448	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"crizotinib","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"17483355","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:50.205654	2016-05-18 21:41:54.841215
4025	7	77	61	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"allosteric AKT inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"21464312, 17611497","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:50.273624	2016-05-18 21:41:54.84957
4026	7	30	61	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"allosteric AKT inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"21464312, 17611497","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:50.343314	2016-05-18 21:41:54.861093
4027	7	448	61	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"allosteric AKT inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"21464312, 17611497","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:50.41874	2016-05-18 21:41:54.876477
4028	7	449	449	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"ibrutinib","Association":"resistance","Status":"early trials","Evidence":"emerging","Source":"24869598","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:50.511308	2016-05-18 21:41:54.885116
4029	7	449	450	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"ibrutinib","Association":"resistance","Status":"early trials","Evidence":"emerging","Source":"24869598","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:50.594356	2016-05-18 21:41:54.894094
4030	7	450	82	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"lapatinib, neratinib","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23220880","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:50.654735	2016-05-18 21:41:54.905088
4031	7	450	85	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"trastuzumab, lapatinib, neratinib","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23220880","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:50.739198	2016-05-18 21:41:54.913618
4032	7	450	86	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"trastuzumab, lapatinib, neratinib","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23220880","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:50.806901	2016-05-18 21:41:54.923096
4342	7	474	61	\N	\N	3	\N	5	2016-05-18 21:28:10.063229	2016-05-18 21:28:10.063229
4343	7	475	61	\N	\N	3	\N	5	2016-05-18 21:28:10.118284	2016-05-18 21:28:10.118284
4018	30	447	442	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"crizotinib","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"17483355","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:49.671625	2016-05-18 21:41:54.784308
4019	30	447	443	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"crizotinib","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"17483355","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:49.763141	2016-05-18 21:41:54.792333
4035	7	450	89	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"lapatinib, neratinib","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23220880","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:51.018048	2016-05-18 21:41:54.948455
4036	7	451	89	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"lapatinib, neratinib","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23220880","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:51.090368	2016-05-18 21:41:54.956499
4037	7	450	90	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"trastuzumab, lapatinib, neratinib","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23220880","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:51.145276	2016-05-18 21:41:54.962514
4038	7	451	90	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"trastuzumab, lapatinib, neratinib","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23220880","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:51.213777	2016-05-18 21:41:54.971998
4039	7	452	451	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"anti-estrogens","Association":"resistance","Status":"early trials","Evidence":"emerging","Source":"24185512, 24185510, 24398047","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:51.305822	2016-05-18 21:41:54.979181
4040	7	453	451	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"anti-estrogens","Association":"resistance","Status":"early trials","Evidence":"emerging","Source":"24185512, 24185510, 24398047","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:51.363374	2016-05-18 21:41:54.988557
4041	7	454	451	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"anti-estrogens","Association":"resistance","Status":"early trials","Evidence":"emerging","Source":"24185512, 24185510, 24398047","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:51.436754	2016-05-18 21:41:54.995236
4042	7	450	63	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"neratinib","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23220880","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:51.511248	2016-05-18 21:41:55.004997
4044	15	386	226	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"EGFR TKIs","Association":"resistance","Status":"case report","Evidence":"emerging","Source":"22773810","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"dabrafenib","Association":"response","Status":"early trials","Evidence":"emerging","Source":"23524406, 22608338, J Clin Oncol 2013;31: (suppl; abstr 8009)","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"vemurafenib","Association":"response","Status":"case report","Evidence":"emerging","Source":"22743296","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors +/- MEK inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"19010912","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:51.634798	2016-05-18 21:41:55.035422
4064	15	386	241	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"dasatinib","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"22649091","Effect":"reduced kinase activity","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:53.089261	2016-05-18 21:41:55.044327
4033	7	450	87	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"lapatinib, neratinib","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23220880","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:50.8698	2016-05-18 21:41:54.933317
4034	7	451	87	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"lapatinib, neratinib","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23220880","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:50.94757	2016-05-18 21:41:54.940851
4047	15	388	226	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"EGFR TKIs","Association":"resistance","Status":"case report","Evidence":"emerging","Source":"22773810","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"dabrafenib","Association":"response","Status":"early trials","Evidence":"emerging","Source":"23524406, 22608338, J Clin Oncol 2013;31: (suppl; abstr 8009)","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"vemurafenib","Association":"response","Status":"case report","Evidence":"emerging","Source":"22743296","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors +/- MEK inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"19010912","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:51.868839	2016-05-18 21:41:55.09068
4048	15	389	226	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"EGFR TKIs","Association":"resistance","Status":"case report","Evidence":"emerging","Source":"22773810","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"dabrafenib","Association":"response","Status":"early trials","Evidence":"emerging","Source":"23524406, 22608338, J Clin Oncol 2013;31: (suppl; abstr 8009)","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"vemurafenib","Association":"response","Status":"case report","Evidence":"emerging","Source":"22743296","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors +/- MEK inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"19010912","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:51.960008	2016-05-18 21:41:55.112557
4049	15	390	226	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"EGFR TKIs","Association":"resistance","Status":"case report","Evidence":"emerging","Source":"22773810","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"dabrafenib","Association":"response","Status":"early trials","Evidence":"emerging","Source":"23524406, 22608338, J Clin Oncol 2013;31: (suppl; abstr 8009)","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"vemurafenib","Association":"response","Status":"case report","Evidence":"emerging","Source":"22743296","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors +/- MEK inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"19010912","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:52.056191	2016-05-18 21:41:55.125267
4050	15	391	226	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"EGFR TKIs","Association":"resistance","Status":"case report","Evidence":"emerging","Source":"22773810","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"dabrafenib","Association":"response","Status":"early trials","Evidence":"emerging","Source":"23524406, 22608338, J Clin Oncol 2013;31: (suppl; abstr 8009)","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"vemurafenib","Association":"response","Status":"case report","Evidence":"emerging","Source":"22743296","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors +/- MEK inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"19010912","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:52.132153	2016-05-18 21:41:55.138549
4051	15	455	226	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"EGFR TKIs","Association":"resistance","Status":"case report","Evidence":"emerging","Source":"22773810","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"dabrafenib","Association":"response","Status":"early trials","Evidence":"emerging","Source":"23524406, 22608338, J Clin Oncol 2013;31: (suppl; abstr 8009)","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"vemurafenib","Association":"response","Status":"case report","Evidence":"emerging","Source":"22743296","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors +/- MEK inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"19010912","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:52.193405	2016-05-18 21:41:55.15052
4344	7	476	61	\N	\N	3	\N	5	2016-05-18 21:28:10.176737	2016-05-18 21:28:10.176737
4046	15	387	226	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"EGFR TKIs","Association":"resistance","Status":"case report","Evidence":"emerging","Source":"22773810","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"dabrafenib","Association":"response","Status":"early trials","Evidence":"emerging","Source":"23524406, 22608338, J Clin Oncol 2013;31: (suppl; abstr 8009)","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"vemurafenib","Association":"response","Status":"case report","Evidence":"emerging","Source":"22743296","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors +/- MEK inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"19010912","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:51.779858	2016-05-18 21:41:55.078654
4055	15	255	236	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"dasatinib","Association":"response","Status":"case report","Evidence":"emerging","Source":"22649091","Effect":"reduced kinase activity","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:52.51964	2016-05-18 21:41:55.222236
4056	15	386	236	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"dasatinib","Association":"response","Status":"case report","Evidence":"emerging","Source":"22649091","Effect":"reduced kinase activity","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:52.568069	2016-05-18 21:41:55.229354
4060	15	389	236	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"dasatinib","Association":"response","Status":"case report","Evidence":"emerging","Source":"22649091","Effect":"reduced kinase activity","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:52.828231	2016-05-18 21:41:55.263487
4061	15	390	236	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"dasatinib","Association":"response","Status":"case report","Evidence":"emerging","Source":"22649091","Effect":"reduced kinase activity","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:52.884208	2016-05-18 21:41:55.277654
4062	15	391	236	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"dasatinib","Association":"response","Status":"case report","Evidence":"emerging","Source":"22649091","Effect":"reduced kinase activity","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:52.942896	2016-05-18 21:41:55.285475
4063	15	255	241	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"dasatinib","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"22649091","Effect":"reduced kinase activity","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:53.009841	2016-05-18 21:41:55.293891
4053	15	213	226	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"EGFR TKIs","Association":"resistance","Status":"case report","Evidence":"emerging","Source":"22773810","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"dabrafenib","Association":"response","Status":"early trials","Evidence":"emerging","Source":"23524406, 22608338, J Clin Oncol 2013;31: (suppl; abstr 8009)","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"vemurafenib","Association":"response","Status":"case report","Evidence":"emerging","Source":"22743296","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors +/- MEK inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"19010912","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:52.355733	2016-05-18 21:41:55.19337
4057	15	36	236	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"dasatinib","Association":"response","Status":"case report","Evidence":"emerging","Source":"22649091","Effect":"reduced kinase activity","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:52.631339	2016-05-18 21:41:55.238255
4058	15	387	236	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"dasatinib","Association":"response","Status":"case report","Evidence":"emerging","Source":"22649091","Effect":"reduced kinase activity","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:52.678392	2016-05-18 21:41:55.247019
4059	15	388	236	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"dasatinib","Association":"response","Status":"case report","Evidence":"emerging","Source":"22649091","Effect":"reduced kinase activity","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:52.753663	2016-05-18 21:41:55.255286
4067	15	388	241	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"dasatinib","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"22649091","Effect":"reduced kinase activity","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:53.318019	2016-05-18 21:41:55.316906
4068	15	389	241	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"dasatinib","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"22649091","Effect":"reduced kinase activity","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:53.374389	2016-05-18 21:41:55.324842
4069	15	390	241	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"dasatinib","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"22649091","Effect":"reduced kinase activity","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:53.449315	2016-05-18 21:41:55.331405
4070	15	391	241	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"dasatinib","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"22649091","Effect":"reduced kinase activity","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:53.535793	2016-05-18 21:41:55.341101
4071	31	196	114	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"crizotinib","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"22072639","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:53.589836	2016-05-18 21:41:55.3495
4072	31	196	452	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"crizotinib","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"22072639","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:53.67583	2016-05-18 21:41:55.357812
4073	31	196	453	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"crizotinib","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"22072639","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:53.747088	2016-05-18 21:41:55.365219
4074	31	457	226	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"BRAF inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"22038996, 22586120","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:53.832979	2016-05-18 21:41:55.381012
4075	31	458	226	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"BRAF inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"22038996, 22586120","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:54.013956	2016-05-18 21:41:55.388183
4076	31	459	454	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"erlotinib","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"17177598","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:54.206968	2016-05-18 21:41:55.396568
4077	31	459	455	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"erlotinib","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"17177598","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:54.294567	2016-05-18 21:41:55.406606
4078	31	459	456	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"erlotinib","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"17177598","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:54.391874	2016-05-18 21:41:55.413075
4079	31	459	457	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"erlotinib","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"17177598","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:54.467571	2016-05-18 21:41:55.420365
4185	19	172	482	\N	\N	3	\N	5	2016-05-18 21:28:01.688606	2016-05-18 21:28:01.688606
4186	19	3	482	\N	\N	3	\N	5	2016-05-18 21:28:01.734012	2016-05-18 21:28:01.734012
4187	19	186	483	\N	\N	3	\N	5	2016-05-18 21:28:01.820082	2016-05-18 21:28:01.820082
4065	15	36	241	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"dasatinib","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"22649091","Effect":"reduced kinase activity","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:53.152145	2016-05-18 21:41:55.303077
4066	15	387	241	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"dasatinib","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"22649091","Effect":"reduced kinase activity","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:53.219453	2016-05-18 21:41:55.309981
4082	32	462	459	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"cetuximab plus sirolimus","Association":"response","Status":"case report","Evidence":"emerging","Source":"24934779","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:54.797253	2016-05-18 21:41:55.444303
4083	32	463	460	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"gefitinib","Association":"no response","Status":"case report","Evidence":"emerging","Source":"21274259","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:54.884255	2016-05-18 21:41:55.452242
4084	32	275	461	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"pazopanib","Association":"response","Status":"case report","Evidence":"emerging","Source":"23786770","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:54.973231	2016-05-18 21:41:55.460348
4085	33	380	390	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"trastuzumab, pertuzumab, lapatinib, anti-HER3 mAbs, PI3K pathway inhibitors + MEK inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23680147","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:55.036334	2016-05-18 21:41:55.466829
4086	34	449	462	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"ibrutinib","Association":"resistance","Status":"early trials","Evidence":"emerging","Source":"24869598","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:55.119365	2016-05-18 21:41:55.480104
4087	34	449	463	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"ibrutinib","Association":"resistance","Status":"early trials","Evidence":"emerging","Source":"24869598","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:55.200693	2016-05-18 21:41:55.487233
4088	34	449	464	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"ibrutinib","Association":"resistance","Status":"early trials","Evidence":"emerging","Source":"24869598","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:55.283865	2016-05-18 21:41:55.496329
4089	36	468	465	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"EZH2 inhibitor","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23023262","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:55.371702	2016-05-18 21:41:55.504372
4090	36	468	466	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"EZH2 inhibitor","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23023262","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:55.457706	2016-05-18 21:41:55.513249
4091	36	468	467	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"EZH2 inhibitor","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23023262","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:55.550431	2016-05-18 21:41:55.521575
4092	36	468	468	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"EZH2 inhibitor","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23023262","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:55.641303	2016-05-18 21:41:55.530748
4093	36	468	469	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"EZH2 inhibitor","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23023262","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:55.738113	2016-05-18 21:41:55.538256
4094	36	469	467	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"EZH2 inhibitor","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"24563539","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:55.796465	2016-05-18 21:41:55.547595
4188	19	187	483	\N	\N	3	\N	5	2016-05-18 21:28:01.872768	2016-05-18 21:28:01.872768
4189	19	175	483	\N	\N	3	\N	5	2016-05-18 21:28:01.943213	2016-05-18 21:28:01.943213
4080	31	460	103	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"IDH inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23558169","Effect":"switch-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:54.537125	2016-05-18 21:41:55.428227
4081	32	461	458	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"cetuximab","Association":"response","Status":"case report","Evidence":"emerging","Source":"23578570","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:54.695889	2016-05-18 21:41:55.436994
4097	37	302	216	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"vismodegib","Association":"resistance","Status":"case report","Evidence":"emerging","Source":"19726788","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:56.033443	2016-05-18 21:41:55.573663
4098	17	1	322	\N	\N	3	\N	5	2016-05-18 21:27:56.087517	2016-05-18 21:27:56.087517
4099	17	2	322	\N	\N	3	\N	5	2016-05-18 21:27:56.152776	2016-05-18 21:27:56.152776
4100	17	3	322	\N	\N	3	\N	5	2016-05-18 21:27:56.205794	2016-05-18 21:27:56.205794
4101	17	335	300	\N	\N	3	\N	5	2016-05-18 21:27:56.277091	2016-05-18 21:27:56.277091
4102	17	3	300	\N	\N	3	\N	5	2016-05-18 21:27:56.333012	2016-05-18 21:27:56.333012
4103	4	17	61	\N	\N	3	\N	5	2016-05-18 21:27:56.396424	2016-05-18 21:27:56.396424
4104	4	336	61	\N	\N	3	\N	5	2016-05-18 21:27:56.45689	2016-05-18 21:27:56.45689
4105	4	30	61	\N	\N	3	\N	5	2016-05-18 21:27:56.509267	2016-05-18 21:27:56.509267
4106	4	3	61	\N	\N	3	\N	5	2016-05-18 21:27:56.595411	2016-05-18 21:27:56.595411
4107	4	14	471	\N	\N	3	\N	5	2016-05-18 21:27:56.730974	2016-05-18 21:27:56.730974
4108	4	15	471	\N	\N	3	\N	5	2016-05-18 21:27:56.812217	2016-05-18 21:27:56.812217
4109	4	16	471	\N	\N	3	\N	5	2016-05-18 21:27:56.881493	2016-05-18 21:27:56.881493
4110	4	3	471	\N	\N	3	\N	5	2016-05-18 21:27:56.965835	2016-05-18 21:27:56.965835
4111	4	17	472	\N	\N	3	\N	5	2016-05-18 21:27:57.056157	2016-05-18 21:27:57.056157
4112	4	18	472	\N	\N	3	\N	5	2016-05-18 21:27:57.108153	2016-05-18 21:27:57.108153
4113	4	19	472	\N	\N	3	\N	5	2016-05-18 21:27:57.187251	2016-05-18 21:27:57.187251
4114	4	15	472	\N	\N	3	\N	5	2016-05-18 21:27:57.237397	2016-05-18 21:27:57.237397
4115	4	3	472	\N	\N	3	\N	5	2016-05-18 21:27:57.291059	2016-05-18 21:27:57.291059
4116	4	15	473	\N	\N	3	\N	5	2016-05-18 21:27:57.37701	2016-05-18 21:27:57.37701
4117	4	16	473	\N	\N	3	\N	5	2016-05-18 21:27:57.431749	2016-05-18 21:27:57.431749
4118	4	20	473	\N	\N	3	\N	5	2016-05-18 21:27:57.498021	2016-05-18 21:27:57.498021
4119	4	3	473	\N	\N	3	\N	5	2016-05-18 21:27:57.550231	2016-05-18 21:27:57.550231
4120	4	15	474	\N	\N	3	\N	5	2016-05-18 21:27:57.630375	2016-05-18 21:27:57.630375
4121	4	16	474	\N	\N	3	\N	5	2016-05-18 21:27:57.676102	2016-05-18 21:27:57.676102
4122	4	20	474	\N	\N	3	\N	5	2016-05-18 21:27:57.738221	2016-05-18 21:27:57.738221
4123	4	21	474	\N	\N	3	\N	5	2016-05-18 21:27:57.785477	2016-05-18 21:27:57.785477
4124	4	22	474	\N	\N	3	\N	5	2016-05-18 21:27:57.846332	2016-05-18 21:27:57.846332
4125	4	23	474	\N	\N	3	\N	5	2016-05-18 21:27:57.89393	2016-05-18 21:27:57.89393
4126	4	24	474	\N	\N	3	\N	5	2016-05-18 21:27:57.946502	2016-05-18 21:27:57.946502
4127	4	3	474	\N	\N	3	\N	5	2016-05-18 21:27:58.006699	2016-05-18 21:27:58.006699
4128	4	16	475	\N	\N	3	\N	5	2016-05-18 21:27:58.069722	2016-05-18 21:27:58.069722
4129	4	20	475	\N	\N	3	\N	5	2016-05-18 21:27:58.140739	2016-05-18 21:27:58.140739
4130	4	25	475	\N	\N	3	\N	5	2016-05-18 21:27:58.189396	2016-05-18 21:27:58.189396
4131	4	23	475	\N	\N	3	\N	5	2016-05-18 21:27:58.261265	2016-05-18 21:27:58.261265
4132	4	24	475	\N	\N	3	\N	5	2016-05-18 21:27:58.328077	2016-05-18 21:27:58.328077
4133	4	21	475	\N	\N	3	\N	5	2016-05-18 21:27:58.390346	2016-05-18 21:27:58.390346
4134	4	3	475	\N	\N	3	\N	5	2016-05-18 21:27:58.438777	2016-05-18 21:27:58.438777
4135	4	15	476	\N	\N	3	\N	5	2016-05-18 21:27:58.541059	2016-05-18 21:27:58.541059
4136	4	17	476	\N	\N	3	\N	5	2016-05-18 21:27:58.597164	2016-05-18 21:27:58.597164
4137	4	26	476	\N	\N	3	\N	5	2016-05-18 21:27:58.667852	2016-05-18 21:27:58.667852
4138	4	27	476	\N	\N	3	\N	5	2016-05-18 21:27:58.721748	2016-05-18 21:27:58.721748
4139	4	3	476	\N	\N	3	\N	5	2016-05-18 21:27:58.775861	2016-05-18 21:27:58.775861
4140	4	15	477	\N	\N	3	\N	5	2016-05-18 21:27:58.853869	2016-05-18 21:27:58.853869
4141	4	16	477	\N	\N	3	\N	5	2016-05-18 21:27:58.919207	2016-05-18 21:27:58.919207
4142	4	20	477	\N	\N	3	\N	5	2016-05-18 21:27:58.977276	2016-05-18 21:27:58.977276
4143	4	21	477	\N	\N	3	\N	5	2016-05-18 21:27:59.02468	2016-05-18 21:27:59.02468
4144	4	3	477	\N	\N	3	\N	5	2016-05-18 21:27:59.093061	2016-05-18 21:27:59.093061
4145	4	15	478	\N	\N	3	\N	5	2016-05-18 21:27:59.180746	2016-05-18 21:27:59.180746
4146	4	16	478	\N	\N	3	\N	5	2016-05-18 21:27:59.236563	2016-05-18 21:27:59.236563
4147	4	21	478	\N	\N	3	\N	5	2016-05-18 21:27:59.299518	2016-05-18 21:27:59.299518
4148	4	28	478	\N	\N	3	\N	5	2016-05-18 21:27:59.355467	2016-05-18 21:27:59.355467
4149	4	29	478	\N	\N	3	\N	5	2016-05-18 21:27:59.407237	2016-05-18 21:27:59.407237
4150	4	24	478	\N	\N	3	\N	5	2016-05-18 21:27:59.472784	2016-05-18 21:27:59.472784
4151	4	3	478	\N	\N	3	\N	5	2016-05-18 21:27:59.516173	2016-05-18 21:27:59.516173
4152	4	15	479	\N	\N	3	\N	5	2016-05-18 21:27:59.606549	2016-05-18 21:27:59.606549
4153	4	16	479	\N	\N	3	\N	5	2016-05-18 21:27:59.673558	2016-05-18 21:27:59.673558
4154	4	20	479	\N	\N	3	\N	5	2016-05-18 21:27:59.744342	2016-05-18 21:27:59.744342
4155	4	21	479	\N	\N	3	\N	5	2016-05-18 21:27:59.81607	2016-05-18 21:27:59.81607
4156	4	22	479	\N	\N	3	\N	5	2016-05-18 21:27:59.863753	2016-05-18 21:27:59.863753
4157	4	19	479	\N	\N	3	\N	5	2016-05-18 21:27:59.927198	2016-05-18 21:27:59.927198
4158	4	23	479	\N	\N	3	\N	5	2016-05-18 21:27:59.987984	2016-05-18 21:27:59.987984
4159	4	24	479	\N	\N	3	\N	5	2016-05-18 21:28:00.062714	2016-05-18 21:28:00.062714
4160	4	27	479	\N	\N	3	\N	5	2016-05-18 21:28:00.152611	2016-05-18 21:28:00.152611
4161	4	29	479	\N	\N	3	\N	5	2016-05-18 21:28:00.211784	2016-05-18 21:28:00.211784
4162	4	17	479	\N	\N	3	\N	5	2016-05-18 21:28:00.268129	2016-05-18 21:28:00.268129
4163	4	3	479	\N	\N	3	\N	5	2016-05-18 21:28:00.330878	2016-05-18 21:28:00.330878
4164	19	172	480	\N	\N	3	\N	5	2016-05-18 21:28:00.412635	2016-05-18 21:28:00.412635
4165	19	173	480	\N	\N	3	\N	5	2016-05-18 21:28:00.460878	2016-05-18 21:28:00.460878
4166	19	174	480	\N	\N	3	\N	5	2016-05-18 21:28:00.530453	2016-05-18 21:28:00.530453
4167	19	175	480	\N	\N	3	\N	5	2016-05-18 21:28:00.582674	2016-05-18 21:28:00.582674
4168	19	176	480	\N	\N	3	\N	5	2016-05-18 21:28:00.64881	2016-05-18 21:28:00.64881
4169	19	177	480	\N	\N	3	\N	5	2016-05-18 21:28:00.6964	2016-05-18 21:28:00.6964
4170	19	178	480	\N	\N	3	\N	5	2016-05-18 21:28:00.750547	2016-05-18 21:28:00.750547
4171	19	179	480	\N	\N	3	\N	5	2016-05-18 21:28:00.826178	2016-05-18 21:28:00.826178
4172	19	3	480	\N	\N	3	\N	5	2016-05-18 21:28:00.875482	2016-05-18 21:28:00.875482
4173	19	180	481	\N	\N	3	\N	5	2016-05-18 21:28:00.95647	2016-05-18 21:28:00.95647
4174	19	181	481	\N	\N	3	\N	5	2016-05-18 21:28:01.021069	2016-05-18 21:28:01.021069
4175	19	182	481	\N	\N	3	\N	5	2016-05-18 21:28:01.086582	2016-05-18 21:28:01.086582
4176	19	177	481	\N	\N	3	\N	5	2016-05-18 21:28:01.13748	2016-05-18 21:28:01.13748
4177	19	175	481	\N	\N	3	\N	5	2016-05-18 21:28:01.183482	2016-05-18 21:28:01.183482
4178	19	3	481	\N	\N	3	\N	5	2016-05-18 21:28:01.254961	2016-05-18 21:28:01.254961
4179	19	183	482	\N	\N	3	\N	5	2016-05-18 21:28:01.338651	2016-05-18 21:28:01.338651
4180	19	184	482	\N	\N	3	\N	5	2016-05-18 21:28:01.391052	2016-05-18 21:28:01.391052
4181	19	177	482	\N	\N	3	\N	5	2016-05-18 21:28:01.443328	2016-05-18 21:28:01.443328
4182	19	175	482	\N	\N	3	\N	5	2016-05-18 21:28:01.523718	2016-05-18 21:28:01.523718
4183	19	173	482	\N	\N	3	\N	5	2016-05-18 21:28:01.58255	2016-05-18 21:28:01.58255
4184	19	185	482	\N	\N	3	\N	5	2016-05-18 21:28:01.638605	2016-05-18 21:28:01.638605
4096	37	301	216	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"vismodegib","Association":"resistance","Status":"case report","Evidence":"emerging","Source":"19726788","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:55.961747	2016-05-18 21:41:55.563252
4345	7	3	61	\N	\N	3	\N	5	2016-05-18 21:28:10.225987	2016-05-18 21:28:10.225987
4346	7	471	495	\N	\N	3	\N	5	2016-05-18 21:28:10.305916	2016-05-18 21:28:10.305916
4347	7	36	495	\N	\N	3	\N	5	2016-05-18 21:28:10.351443	2016-05-18 21:28:10.351443
4348	7	3	495	\N	\N	3	\N	5	2016-05-18 21:28:10.398333	2016-05-18 21:28:10.398333
4349	34	259	496	\N	\N	3	\N	5	2016-05-18 21:28:10.450299	2016-05-18 21:28:10.450299
4350	34	3	496	\N	\N	3	\N	5	2016-05-18 21:28:10.505945	2016-05-18 21:28:10.505945
4351	41	477	61	\N	\N	3	\N	5	2016-05-18 21:28:10.54455	2016-05-18 21:28:10.54455
4352	41	478	61	\N	\N	3	\N	5	2016-05-18 21:28:10.602986	2016-05-18 21:28:10.602986
4353	41	3	61	\N	\N	3	\N	5	2016-05-18 21:28:10.656817	2016-05-18 21:28:10.656817
4354	4	3	497	\N	\N	3	\N	5	2016-05-18 21:28:10.715894	2016-05-18 21:28:10.715894
4355	4	479	497	\N	\N	3	\N	5	2016-05-18 21:28:10.754486	2016-05-18 21:28:10.754486
4356	30	3	498	\N	\N	3	\N	5	2016-05-18 21:28:10.82491	2016-05-18 21:28:10.82491
4357	30	3	499	\N	\N	3	\N	5	2016-05-18 21:28:10.879422	2016-05-18 21:28:10.879422
4358	30	3	500	\N	\N	3	\N	5	2016-05-18 21:28:10.930273	2016-05-18 21:28:10.930273
4359	30	3	501	\N	\N	3	\N	5	2016-05-18 21:28:10.982451	2016-05-18 21:28:10.982451
4360	1	259	502	\N	\N	3	\N	5	2016-05-18 21:28:11.049507	2016-05-18 21:28:11.049507
4361	1	3	502	\N	\N	3	\N	5	2016-05-18 21:28:11.086172	2016-05-18 21:28:11.086172
4362	1	3	503	\N	\N	3	\N	5	2016-05-18 21:28:11.134737	2016-05-18 21:28:11.134737
4363	1	480	503	\N	\N	3	\N	5	2016-05-18 21:28:11.171568	2016-05-18 21:28:11.171568
4364	1	3	504	\N	\N	3	\N	5	2016-05-18 21:28:11.221142	2016-05-18 21:28:11.221142
4365	1	3	505	\N	\N	3	\N	5	2016-05-18 21:28:11.273412	2016-05-18 21:28:11.273412
4366	1	481	505	\N	\N	3	\N	5	2016-05-18 21:28:11.31626	2016-05-18 21:28:11.31626
4367	2	3	241	\N	\N	3	\N	5	2016-05-18 21:28:11.381605	2016-05-18 21:28:11.381605
4368	2	390	241	\N	\N	3	\N	5	2016-05-18 21:28:11.434766	2016-05-18 21:28:11.434766
4369	23	3	238	\N	\N	3	\N	5	2016-05-18 21:28:11.498413	2016-05-18 21:28:11.498413
4370	1	3	239	\N	\N	3	\N	5	2016-05-18 21:28:11.602669	2016-05-18 21:28:11.602669
4371	1	3	506	\N	\N	3	\N	5	2016-05-18 21:28:11.72599	2016-05-18 21:28:11.72599
4372	1	3	507	\N	\N	3	\N	5	2016-05-18 21:28:11.777428	2016-05-18 21:28:11.777428
4373	1	3	508	\N	\N	3	\N	5	2016-05-18 21:28:11.827969	2016-05-18 21:28:11.827969
4374	1	482	508	\N	\N	3	\N	5	2016-05-18 21:28:11.866762	2016-05-18 21:28:11.866762
4375	30	3	237	\N	\N	3	\N	5	2016-05-18 21:28:11.905403	2016-05-18 21:28:11.905403
4376	1	3	509	\N	\N	3	\N	5	2016-05-18 21:28:11.960603	2016-05-18 21:28:11.960603
4377	19	3	510	\N	\N	3	\N	5	2016-05-18 21:28:12.011751	2016-05-18 21:28:12.011751
4378	19	483	510	\N	\N	3	\N	5	2016-05-18 21:28:12.053996	2016-05-18 21:28:12.053996
4379	1	3	511	\N	\N	3	\N	5	2016-05-18 21:28:12.104709	2016-05-18 21:28:12.104709
4380	1	420	511	\N	\N	3	\N	5	2016-05-18 21:28:12.141287	2016-05-18 21:28:12.141287
4381	1	484	511	\N	\N	3	\N	5	2016-05-18 21:28:12.177566	2016-05-18 21:28:12.177566
4382	30	3	512	\N	\N	3	\N	5	2016-05-18 21:28:12.240683	2016-05-18 21:28:12.240683
4383	30	3	513	\N	\N	3	\N	5	2016-05-18 21:28:12.317979	2016-05-18 21:28:12.317979
4384	30	3	514	\N	\N	3	\N	5	2016-05-18 21:28:12.393734	2016-05-18 21:28:12.393734
4385	30	3	515	\N	\N	3	\N	5	2016-05-18 21:28:12.466107	2016-05-18 21:28:12.466107
4386	1	3	516	\N	\N	3	\N	5	2016-05-18 21:28:12.542342	2016-05-18 21:28:12.542342
4387	1	485	516	\N	\N	3	\N	5	2016-05-18 21:28:12.596717	2016-05-18 21:28:12.596717
4388	1	486	230	\N	\N	3	\N	5	2016-05-18 21:28:12.706487	2016-05-18 21:28:12.706487
4389	1	3	232	\N	\N	3	\N	5	2016-05-18 21:28:12.744356	2016-05-18 21:28:12.744356
4390	4	3	232	\N	\N	3	\N	5	2016-05-18 21:28:12.835972	2016-05-18 21:28:12.835972
4391	4	44	232	\N	\N	3	\N	5	2016-05-18 21:28:12.875514	2016-05-18 21:28:12.875514
4392	1	3	231	\N	\N	3	\N	5	2016-05-18 21:28:12.930552	2016-05-18 21:28:12.930552
4393	1	3	517	\N	\N	3	\N	5	2016-05-18 21:28:12.985705	2016-05-18 21:28:12.985705
4394	1	407	517	\N	\N	3	\N	5	2016-05-18 21:28:13.041079	2016-05-18 21:28:13.041079
4395	1	3	518	\N	\N	3	\N	5	2016-05-18 21:28:13.111053	2016-05-18 21:28:13.111053
4396	1	3	519	\N	\N	3	\N	5	2016-05-18 21:28:13.162876	2016-05-18 21:28:13.162876
4397	1	407	519	\N	\N	3	\N	5	2016-05-18 21:28:13.203669	2016-05-18 21:28:13.203669
4398	1	3	520	\N	\N	3	\N	5	2016-05-18 21:28:13.268661	2016-05-18 21:28:13.268661
4399	1	3	521	\N	\N	3	\N	5	2016-05-18 21:28:13.334068	2016-05-18 21:28:13.334068
4400	4	3	521	\N	\N	3	\N	5	2016-05-18 21:28:13.382275	2016-05-18 21:28:13.382275
4401	4	43	521	\N	\N	3	\N	5	2016-05-18 21:28:13.43741	2016-05-18 21:28:13.43741
4402	1	3	393	\N	\N	3	\N	5	2016-05-18 21:28:13.488395	2016-05-18 21:28:13.488395
4403	1	487	393	\N	\N	3	\N	5	2016-05-18 21:28:13.536045	2016-05-18 21:28:13.536045
4404	1	3	229	\N	\N	3	\N	5	2016-05-18 21:28:13.620725	2016-05-18 21:28:13.620725
4405	1	3	394	\N	\N	3	\N	5	2016-05-18 21:28:13.750684	2016-05-18 21:28:13.750684
4406	1	3	395	\N	\N	3	\N	5	2016-05-18 21:28:13.854948	2016-05-18 21:28:13.854948
4407	1	3	522	\N	\N	3	\N	5	2016-05-18 21:28:13.912631	2016-05-18 21:28:13.912631
4408	1	3	523	\N	\N	3	\N	5	2016-05-18 21:28:13.978935	2016-05-18 21:28:13.978935
4409	1	3	224	\N	\N	3	\N	5	2016-05-18 21:28:14.023427	2016-05-18 21:28:14.023427
4410	1	488	224	\N	\N	3	\N	5	2016-05-18 21:28:14.078633	2016-05-18 21:28:14.078633
4411	1	3	226	\N	\N	3	\N	5	2016-05-18 21:28:14.119668	2016-05-18 21:28:14.119668
4412	1	489	226	\N	\N	3	\N	5	2016-05-18 21:28:14.21146	2016-05-18 21:28:14.21146
4413	1	490	226	\N	\N	3	\N	5	2016-05-18 21:28:14.253013	2016-05-18 21:28:14.253013
4414	1	491	226	\N	\N	3	\N	5	2016-05-18 21:28:14.307173	2016-05-18 21:28:14.307173
4415	28	3	226	\N	\N	3	\N	5	2016-05-18 21:28:14.355292	2016-05-18 21:28:14.355292
4416	28	41	226	\N	\N	3	\N	5	2016-05-18 21:28:14.402916	2016-05-18 21:28:14.402916
4417	1	3	524	\N	\N	3	\N	5	2016-05-18 21:28:14.452728	2016-05-18 21:28:14.452728
4418	1	306	524	\N	\N	3	\N	5	2016-05-18 21:28:14.504765	2016-05-18 21:28:14.504765
4419	1	489	524	\N	\N	3	\N	5	2016-05-18 21:28:14.548862	2016-05-18 21:28:14.548862
4420	1	490	524	\N	\N	3	\N	5	2016-05-18 21:28:14.593953	2016-05-18 21:28:14.593953
4421	1	491	524	\N	\N	3	\N	5	2016-05-18 21:28:14.633208	2016-05-18 21:28:14.633208
4422	28	3	524	\N	\N	3	\N	5	2016-05-18 21:28:14.681973	2016-05-18 21:28:14.681973
4423	28	41	524	\N	\N	3	\N	5	2016-05-18 21:28:14.723384	2016-05-18 21:28:14.723384
4424	1	3	228	\N	\N	3	\N	5	2016-05-18 21:28:14.780721	2016-05-18 21:28:14.780721
4425	1	489	228	\N	\N	3	\N	5	2016-05-18 21:28:14.871461	2016-05-18 21:28:14.871461
4426	1	490	228	\N	\N	3	\N	5	2016-05-18 21:28:14.914994	2016-05-18 21:28:14.914994
4427	1	3	525	\N	\N	3	\N	5	2016-05-18 21:28:14.988133	2016-05-18 21:28:14.988133
4428	1	407	525	\N	\N	3	\N	5	2016-05-18 21:28:15.038954	2016-05-18 21:28:15.038954
4429	1	3	526	\N	\N	3	\N	5	2016-05-18 21:28:15.098639	2016-05-18 21:28:15.098639
4430	1	407	526	\N	\N	3	\N	5	2016-05-18 21:28:15.152237	2016-05-18 21:28:15.152237
4431	1	3	527	\N	\N	3	\N	5	2016-05-18 21:28:15.201071	2016-05-18 21:28:15.201071
4432	1	491	527	\N	\N	3	\N	5	2016-05-18 21:28:15.23679	2016-05-18 21:28:15.23679
4433	1	3	227	\N	\N	3	\N	5	2016-05-18 21:28:15.272201	2016-05-18 21:28:15.272201
4434	1	488	227	\N	\N	3	\N	5	2016-05-18 21:28:15.324327	2016-05-18 21:28:15.324327
4435	1	3	528	\N	\N	3	\N	5	2016-05-18 21:28:15.377228	2016-05-18 21:28:15.377228
4436	1	3	223	\N	\N	3	\N	5	2016-05-18 21:28:15.43739	2016-05-18 21:28:15.43739
4437	1	3	529	\N	\N	3	\N	5	2016-05-18 21:28:15.500263	2016-05-18 21:28:15.500263
4438	1	3	530	\N	\N	3	\N	5	2016-05-18 21:28:15.564473	2016-05-18 21:28:15.564473
4439	1	3	531	\N	\N	3	\N	5	2016-05-18 21:28:15.630626	2016-05-18 21:28:15.630626
4440	1	3	532	\N	\N	3	\N	5	2016-05-18 21:28:15.696544	2016-05-18 21:28:15.696544
4441	1	3	533	\N	\N	3	\N	5	2016-05-18 21:28:15.782031	2016-05-18 21:28:15.782031
4442	30	3	534	\N	\N	3	\N	5	2016-05-18 21:28:15.871788	2016-05-18 21:28:15.871788
4443	30	3	535	\N	\N	3	\N	5	2016-05-18 21:28:15.946421	2016-05-18 21:28:15.946421
4444	30	3	536	\N	\N	3	\N	5	2016-05-18 21:28:16.033577	2016-05-18 21:28:16.033577
4445	1	3	537	\N	\N	3	\N	5	2016-05-18 21:28:16.100986	2016-05-18 21:28:16.100986
4446	1	492	537	\N	\N	3	\N	5	2016-05-18 21:28:16.146418	2016-05-18 21:28:16.146418
4447	30	3	538	\N	\N	3	\N	5	2016-05-18 21:28:16.226292	2016-05-18 21:28:16.226292
4448	30	3	539	\N	\N	3	\N	5	2016-05-18 21:28:16.29603	2016-05-18 21:28:16.29603
4449	30	3	540	\N	\N	3	\N	5	2016-05-18 21:28:16.369554	2016-05-18 21:28:16.369554
4450	30	3	541	\N	\N	3	\N	5	2016-05-18 21:28:16.460442	2016-05-18 21:28:16.460442
4451	30	3	542	\N	\N	3	\N	5	2016-05-18 21:28:16.544136	2016-05-18 21:28:16.544136
4452	30	3	543	\N	\N	3	\N	5	2016-05-18 21:28:16.629831	2016-05-18 21:28:16.629831
4453	1	3	544	\N	\N	3	\N	5	2016-05-18 21:28:16.703224	2016-05-18 21:28:16.703224
4454	30	3	545	\N	\N	3	\N	5	2016-05-18 21:28:16.76826	2016-05-18 21:28:16.76826
4455	30	3	546	\N	\N	3	\N	5	2016-05-18 21:28:16.829275	2016-05-18 21:28:16.829275
4456	30	3	547	\N	\N	3	\N	5	2016-05-18 21:28:16.899837	2016-05-18 21:28:16.899837
4457	30	3	548	\N	\N	3	\N	5	2016-05-18 21:28:16.967638	2016-05-18 21:28:16.967638
4458	30	3	549	\N	\N	3	\N	5	2016-05-18 21:28:17.043373	2016-05-18 21:28:17.043373
4459	30	3	550	\N	\N	3	\N	5	2016-05-18 21:28:17.112173	2016-05-18 21:28:17.112173
4460	30	3	551	\N	\N	3	\N	5	2016-05-18 21:28:17.167963	2016-05-18 21:28:17.167963
4461	1	3	552	\N	\N	3	\N	5	2016-05-18 21:28:17.230283	2016-05-18 21:28:17.230283
4462	1	3	553	\N	\N	3	\N	5	2016-05-18 21:28:17.29956	2016-05-18 21:28:17.29956
4463	1	3	554	\N	\N	3	\N	5	2016-05-18 21:28:17.405746	2016-05-18 21:28:17.405746
4464	1	3	555	\N	\N	3	\N	5	2016-05-18 21:28:17.487293	2016-05-18 21:28:17.487293
4465	1	3	556	\N	\N	3	\N	5	2016-05-18 21:28:17.575666	2016-05-18 21:28:17.575666
4466	1	3	557	\N	\N	3	\N	5	2016-05-18 21:28:17.664518	2016-05-18 21:28:17.664518
4467	1	3	558	\N	\N	3	\N	5	2016-05-18 21:28:17.736731	2016-05-18 21:28:17.736731
4468	1	3	559	\N	\N	3	\N	5	2016-05-18 21:28:17.809441	2016-05-18 21:28:17.809441
4469	1	493	559	\N	\N	3	\N	5	2016-05-18 21:28:17.854949	2016-05-18 21:28:17.854949
4470	42	3	560	\N	\N	3	\N	5	2016-05-18 21:28:17.931239	2016-05-18 21:28:17.931239
4471	43	3	560	\N	\N	3	\N	5	2016-05-18 21:28:18.001492	2016-05-18 21:28:18.001492
4472	43	3	561	\N	\N	3	\N	5	2016-05-18 21:28:18.086846	2016-05-18 21:28:18.086846
4473	37	3	562	\N	\N	3	\N	5	2016-05-18 21:28:18.141407	2016-05-18 21:28:18.141407
4474	44	3	562	\N	\N	3	\N	5	2016-05-18 21:28:18.194894	2016-05-18 21:28:18.194894
4475	6	3	563	\N	\N	3	\N	5	2016-05-18 21:28:18.259157	2016-05-18 21:28:18.259157
4476	31	3	563	\N	\N	3	\N	5	2016-05-18 21:28:18.305484	2016-05-18 21:28:18.305484
4477	45	3	563	\N	\N	3	\N	5	2016-05-18 21:28:18.373074	2016-05-18 21:28:18.373074
4478	37	3	564	\N	\N	3	\N	5	2016-05-18 21:28:18.445644	2016-05-18 21:28:18.445644
4479	43	3	564	\N	\N	3	\N	5	2016-05-18 21:28:18.482922	2016-05-18 21:28:18.482922
4480	46	3	565	\N	\N	3	\N	5	2016-05-18 21:28:18.543128	2016-05-18 21:28:18.543128
4481	6	3	565	\N	\N	3	\N	5	2016-05-18 21:28:18.589605	2016-05-18 21:28:18.589605
4482	44	3	566	\N	\N	3	\N	5	2016-05-18 21:28:18.65363	2016-05-18 21:28:18.65363
4483	47	3	566	\N	\N	3	\N	5	2016-05-18 21:28:18.706605	2016-05-18 21:28:18.706605
4484	44	3	567	\N	\N	3	\N	5	2016-05-18 21:28:18.763271	2016-05-18 21:28:18.763271
4485	47	3	567	\N	\N	3	\N	5	2016-05-18 21:28:18.802966	2016-05-18 21:28:18.802966
4486	1	3	568	\N	\N	3	\N	5	2016-05-18 21:28:18.860451	2016-05-18 21:28:18.860451
4487	44	3	568	\N	\N	3	\N	5	2016-05-18 21:28:18.900065	2016-05-18 21:28:18.900065
4488	45	3	569	\N	\N	3	\N	5	2016-05-18 21:28:18.956336	2016-05-18 21:28:18.956336
4489	6	3	570	\N	\N	3	\N	5	2016-05-18 21:28:19.021756	2016-05-18 21:28:19.021756
4490	23	3	570	\N	\N	3	\N	5	2016-05-18 21:28:19.062931	2016-05-18 21:28:19.062931
4491	6	3	141	\N	\N	3	\N	5	2016-05-18 21:28:19.114742	2016-05-18 21:28:19.114742
4492	33	3	571	\N	\N	3	\N	5	2016-05-18 21:28:19.168461	2016-05-18 21:28:19.168461
4493	33	3	140	\N	\N	3	\N	5	2016-05-18 21:28:19.2096	2016-05-18 21:28:19.2096
4494	33	3	572	\N	\N	3	\N	5	2016-05-18 21:28:19.267935	2016-05-18 21:28:19.267935
4495	1	3	573	\N	\N	3	\N	5	2016-05-18 21:28:19.325435	2016-05-18 21:28:19.325435
4496	30	3	574	\N	\N	3	\N	5	2016-05-18 21:28:19.372897	2016-05-18 21:28:19.372897
4497	30	3	575	\N	\N	3	\N	5	2016-05-18 21:28:19.425248	2016-05-18 21:28:19.425248
4498	30	3	576	\N	\N	3	\N	5	2016-05-18 21:28:19.473425	2016-05-18 21:28:19.473425
4499	31	3	577	\N	\N	3	\N	5	2016-05-18 21:28:19.525466	2016-05-18 21:28:19.525466
4500	1	407	143	\N	\N	3	\N	5	2016-05-18 21:28:19.602022	2016-05-18 21:28:19.602022
4501	2	3	244	\N	\N	3	\N	5	2016-05-18 21:28:19.639142	2016-05-18 21:28:19.639142
4502	2	495	244	\N	\N	3	\N	5	2016-05-18 21:28:19.677868	2016-05-18 21:28:19.677868
4503	2	496	244	\N	\N	3	\N	5	2016-05-18 21:28:19.716473	2016-05-18 21:28:19.716473
4504	2	497	244	\N	\N	3	\N	5	2016-05-18 21:28:19.752258	2016-05-18 21:28:19.752258
4505	2	3	243	\N	\N	3	\N	5	2016-05-18 21:28:19.789645	2016-05-18 21:28:19.789645
4506	2	498	243	\N	\N	3	\N	5	2016-05-18 21:28:19.827303	2016-05-18 21:28:19.827303
4507	2	499	243	\N	\N	3	\N	5	2016-05-18 21:28:19.868828	2016-05-18 21:28:19.868828
4508	2	3	357	\N	\N	3	\N	5	2016-05-18 21:28:19.915702	2016-05-18 21:28:19.915702
4509	2	500	357	\N	\N	3	\N	5	2016-05-18 21:28:19.975785	2016-05-18 21:28:19.975785
4510	2	3	242	\N	\N	3	\N	5	2016-05-18 21:28:20.029858	2016-05-18 21:28:20.029858
4511	2	501	242	\N	\N	3	\N	5	2016-05-18 21:28:20.090761	2016-05-18 21:28:20.090761
4512	2	502	242	\N	\N	3	\N	5	2016-05-18 21:28:20.160013	2016-05-18 21:28:20.160013
4513	2	3	578	\N	\N	3	\N	5	2016-05-18 21:28:20.235712	2016-05-18 21:28:20.235712
4514	42	3	579	\N	\N	3	\N	5	2016-05-18 21:28:20.301376	2016-05-18 21:28:20.301376
4515	2	3	579	\N	\N	3	\N	5	2016-05-18 21:28:20.34913	2016-05-18 21:28:20.34913
4516	2	503	579	\N	\N	3	\N	5	2016-05-18 21:28:20.399856	2016-05-18 21:28:20.399856
4517	2	3	580	\N	\N	3	\N	5	2016-05-18 21:28:20.456666	2016-05-18 21:28:20.456666
4518	2	504	580	\N	\N	3	\N	5	2016-05-18 21:28:20.500168	2016-05-18 21:28:20.500168
4519	41	3	581	\N	\N	3	\N	5	2016-05-18 21:28:20.563298	2016-05-18 21:28:20.563298
4520	2	3	581	\N	\N	3	\N	5	2016-05-18 21:28:20.603915	2016-05-18 21:28:20.603915
4521	2	503	581	\N	\N	3	\N	5	2016-05-18 21:28:20.644975	2016-05-18 21:28:20.644975
4522	2	3	582	\N	\N	3	\N	5	2016-05-18 21:28:20.700266	2016-05-18 21:28:20.700266
4523	2	505	582	\N	\N	3	\N	5	2016-05-18 21:28:20.740252	2016-05-18 21:28:20.740252
4524	49	3	583	\N	\N	3	\N	5	2016-05-18 21:28:20.79371	2016-05-18 21:28:20.79371
4525	49	506	583	\N	\N	3	\N	5	2016-05-18 21:28:20.838505	2016-05-18 21:28:20.838505
4526	49	507	583	\N	\N	3	\N	5	2016-05-18 21:28:20.904812	2016-05-18 21:28:20.904812
4527	2	3	584	\N	\N	3	\N	5	2016-05-18 21:28:21.007651	2016-05-18 21:28:21.007651
4528	23	3	585	\N	\N	3	\N	5	2016-05-18 21:28:21.092078	2016-05-18 21:28:21.092078
4529	23	233	585	\N	\N	3	\N	5	2016-05-18 21:28:21.141385	2016-05-18 21:28:21.141385
4530	2	3	585	\N	\N	3	\N	5	2016-05-18 21:28:21.189235	2016-05-18 21:28:21.189235
4531	2	508	585	\N	\N	3	\N	5	2016-05-18 21:28:21.237866	2016-05-18 21:28:21.237866
4532	2	3	586	\N	\N	3	\N	5	2016-05-18 21:28:21.297697	2016-05-18 21:28:21.297697
4533	2	3	459	\N	\N	3	\N	5	2016-05-18 21:28:21.341391	2016-05-18 21:28:21.341391
4534	2	509	459	\N	\N	3	\N	5	2016-05-18 21:28:21.390376	2016-05-18 21:28:21.390376
4535	2	3	587	\N	\N	3	\N	5	2016-05-18 21:28:21.44305	2016-05-18 21:28:21.44305
4536	2	505	587	\N	\N	3	\N	5	2016-05-18 21:28:21.482539	2016-05-18 21:28:21.482539
4537	2	510	587	\N	\N	3	\N	5	2016-05-18 21:28:21.520409	2016-05-18 21:28:21.520409
4538	2	3	588	\N	\N	3	\N	5	2016-05-18 21:28:21.566137	2016-05-18 21:28:21.566137
4539	2	511	588	\N	\N	3	\N	5	2016-05-18 21:28:21.600891	2016-05-18 21:28:21.600891
4540	2	512	588	\N	\N	3	\N	5	2016-05-18 21:28:21.640437	2016-05-18 21:28:21.640437
4541	50	3	359	\N	\N	3	\N	5	2016-05-18 21:28:21.675856	2016-05-18 21:28:21.675856
4542	50	513	359	\N	\N	3	\N	5	2016-05-18 21:28:21.730324	2016-05-18 21:28:21.730324
4543	2	3	359	\N	\N	3	\N	5	2016-05-18 21:28:21.76514	2016-05-18 21:28:21.76514
4544	2	514	359	\N	\N	3	\N	5	2016-05-18 21:28:21.803884	2016-05-18 21:28:21.803884
4545	2	505	359	\N	\N	3	\N	5	2016-05-18 21:28:21.838974	2016-05-18 21:28:21.838974
4546	2	3	589	\N	\N	3	\N	5	2016-05-18 21:28:21.905727	2016-05-18 21:28:21.905727
4547	2	515	589	\N	\N	3	\N	5	2016-05-18 21:28:21.951904	2016-05-18 21:28:21.951904
4548	2	3	245	\N	\N	3	\N	5	2016-05-18 21:28:21.99226	2016-05-18 21:28:21.99226
4549	2	516	245	\N	\N	3	\N	5	2016-05-18 21:28:22.075486	2016-05-18 21:28:22.075486
4550	2	517	245	\N	\N	3	\N	5	2016-05-18 21:28:22.113435	2016-05-18 21:28:22.113435
4551	2	518	245	\N	\N	3	\N	5	2016-05-18 21:28:22.168276	2016-05-18 21:28:22.168276
4552	51	3	590	\N	\N	3	\N	5	2016-05-18 21:28:22.234878	2016-05-18 21:28:22.234878
4553	51	3	591	\N	\N	3	\N	5	2016-05-18 21:28:22.306847	2016-05-18 21:28:22.306847
4554	2	3	592	\N	\N	3	\N	5	2016-05-18 21:28:22.369829	2016-05-18 21:28:22.369829
4555	2	519	592	\N	\N	3	\N	5	2016-05-18 21:28:22.413755	2016-05-18 21:28:22.413755
4556	2	504	592	\N	\N	3	\N	5	2016-05-18 21:28:22.451103	2016-05-18 21:28:22.451103
4557	2	3	246	\N	\N	3	\N	5	2016-05-18 21:28:22.503445	2016-05-18 21:28:22.503445
4558	2	501	246	\N	\N	3	\N	5	2016-05-18 21:28:22.536913	2016-05-18 21:28:22.536913
4559	2	504	246	\N	\N	3	\N	5	2016-05-18 21:28:22.578682	2016-05-18 21:28:22.578682
4560	2	3	593	\N	\N	3	\N	5	2016-05-18 21:28:22.64094	2016-05-18 21:28:22.64094
4561	2	3	594	\N	\N	3	\N	5	2016-05-18 21:28:22.704337	2016-05-18 21:28:22.704337
4562	2	3	595	\N	\N	3	\N	5	2016-05-18 21:28:22.761418	2016-05-18 21:28:22.761418
4563	7	3	596	\N	\N	3	\N	5	2016-05-18 21:28:22.829387	2016-05-18 21:28:22.829387
4564	7	3	84	\N	\N	3	\N	5	2016-05-18 21:28:22.870886	2016-05-18 21:28:22.870886
4565	7	520	84	\N	\N	3	\N	5	2016-05-18 21:28:22.90844	2016-05-18 21:28:22.90844
4566	7	521	84	\N	\N	3	\N	5	2016-05-18 21:28:22.946244	2016-05-18 21:28:22.946244
4567	7	3	85	\N	\N	3	\N	5	2016-05-18 21:28:22.987274	2016-05-18 21:28:22.987274
4568	30	3	597	\N	\N	3	\N	5	2016-05-18 21:28:23.039555	2016-05-18 21:28:23.039555
4569	7	3	598	\N	\N	3	\N	5	2016-05-18 21:28:23.098253	2016-05-18 21:28:23.098253
4570	7	3	87	\N	\N	3	\N	5	2016-05-18 21:28:23.140593	2016-05-18 21:28:23.140593
4571	7	520	87	\N	\N	3	\N	5	2016-05-18 21:28:23.18503	2016-05-18 21:28:23.18503
4572	7	522	87	\N	\N	3	\N	5	2016-05-18 21:28:23.234261	2016-05-18 21:28:23.234261
4573	7	3	599	\N	\N	3	\N	5	2016-05-18 21:28:23.284282	2016-05-18 21:28:23.284282
4574	7	520	599	\N	\N	3	\N	5	2016-05-18 21:28:23.325221	2016-05-18 21:28:23.325221
4575	7	522	599	\N	\N	3	\N	5	2016-05-18 21:28:23.367425	2016-05-18 21:28:23.367425
4576	30	3	600	\N	\N	3	\N	5	2016-05-18 21:28:23.443433	2016-05-18 21:28:23.443433
4577	30	3	601	\N	\N	3	\N	5	2016-05-18 21:28:23.526554	2016-05-18 21:28:23.526554
4578	43	3	384	\N	\N	3	\N	5	2016-05-18 21:28:23.578984	2016-05-18 21:28:23.578984
4579	43	294	384	\N	\N	3	\N	5	2016-05-18 21:28:23.635418	2016-05-18 21:28:23.635418
4580	43	523	384	\N	\N	3	\N	5	2016-05-18 21:28:23.689135	2016-05-18 21:28:23.689135
4581	43	3	602	\N	\N	3	\N	5	2016-05-18 21:28:23.758072	2016-05-18 21:28:23.758072
4582	43	294	602	\N	\N	3	\N	5	2016-05-18 21:28:23.800161	2016-05-18 21:28:23.800161
4583	43	3	603	\N	\N	3	\N	5	2016-05-18 21:28:23.861842	2016-05-18 21:28:23.861842
4584	43	523	603	\N	\N	3	\N	5	2016-05-18 21:28:23.907644	2016-05-18 21:28:23.907644
4585	43	3	604	\N	\N	3	\N	5	2016-05-18 21:28:23.971902	2016-05-18 21:28:23.971902
4586	43	523	604	\N	\N	3	\N	5	2016-05-18 21:28:24.026192	2016-05-18 21:28:24.026192
4587	43	3	605	\N	\N	3	\N	5	2016-05-18 21:28:24.095985	2016-05-18 21:28:24.095985
4588	43	3	606	\N	\N	3	\N	5	2016-05-18 21:28:24.173702	2016-05-18 21:28:24.173702
4589	23	3	607	\N	\N	3	\N	5	2016-05-18 21:28:24.260521	2016-05-18 21:28:24.260521
4590	23	275	607	\N	\N	3	\N	5	2016-05-18 21:28:24.314704	2016-05-18 21:28:24.314704
4591	52	3	608	\N	\N	3	\N	5	2016-05-18 21:28:24.390793	2016-05-18 21:28:24.390793
4592	52	524	608	\N	\N	3	\N	5	2016-05-18 21:28:24.438218	2016-05-18 21:28:24.438218
4593	52	3	609	\N	\N	3	\N	5	2016-05-18 21:28:24.510152	2016-05-18 21:28:24.510152
4594	52	524	609	\N	\N	3	\N	5	2016-05-18 21:28:24.559667	2016-05-18 21:28:24.559667
4595	52	3	610	\N	\N	3	\N	5	2016-05-18 21:28:24.619714	2016-05-18 21:28:24.619714
4596	52	3	611	\N	\N	3	\N	5	2016-05-18 21:28:24.676956	2016-05-18 21:28:24.676956
4597	52	524	611	\N	\N	3	\N	5	2016-05-18 21:28:24.727708	2016-05-18 21:28:24.727708
4598	52	3	612	\N	\N	3	\N	5	2016-05-18 21:28:24.788417	2016-05-18 21:28:24.788417
4599	52	3	613	\N	\N	3	\N	5	2016-05-18 21:28:24.847682	2016-05-18 21:28:24.847682
4600	8	3	614	\N	\N	3	\N	5	2016-05-18 21:28:24.921134	2016-05-18 21:28:24.921134
4601	8	3	615	\N	\N	3	\N	5	2016-05-18 21:28:24.981658	2016-05-18 21:28:24.981658
4602	8	3	55	\N	\N	3	\N	5	2016-05-18 21:28:25.032837	2016-05-18 21:28:25.032837
4603	8	525	55	\N	\N	3	\N	5	2016-05-18 21:28:25.10659	2016-05-18 21:28:25.10659
4604	8	3	54	\N	\N	3	\N	5	2016-05-18 21:28:25.152758	2016-05-18 21:28:25.152758
4605	8	525	54	\N	\N	3	\N	5	2016-05-18 21:28:25.22794	2016-05-18 21:28:25.22794
4606	8	3	59	\N	\N	3	\N	5	2016-05-18 21:28:25.267785	2016-05-18 21:28:25.267785
4607	8	526	59	\N	\N	3	\N	5	2016-05-18 21:28:25.394377	2016-05-18 21:28:25.394377
4608	8	527	59	\N	\N	3	\N	5	2016-05-18 21:28:25.443449	2016-05-18 21:28:25.443449
4609	8	528	59	\N	\N	3	\N	5	2016-05-18 21:28:25.494336	2016-05-18 21:28:25.494336
4610	8	3	56	\N	\N	3	\N	5	2016-05-18 21:28:25.557783	2016-05-18 21:28:25.557783
4611	8	528	56	\N	\N	3	\N	5	2016-05-18 21:28:25.624241	2016-05-18 21:28:25.624241
4612	8	526	56	\N	\N	3	\N	5	2016-05-18 21:28:25.695187	2016-05-18 21:28:25.695187
4613	8	529	56	\N	\N	3	\N	5	2016-05-18 21:28:25.737208	2016-05-18 21:28:25.737208
4614	8	3	58	\N	\N	3	\N	5	2016-05-18 21:28:25.778669	2016-05-18 21:28:25.778669
4615	8	530	58	\N	\N	3	\N	5	2016-05-18 21:28:25.832255	2016-05-18 21:28:25.832255
4616	8	3	616	\N	\N	3	\N	5	2016-05-18 21:28:25.89483	2016-05-18 21:28:25.89483
4617	8	3	52	\N	\N	3	\N	5	2016-05-18 21:28:25.936004	2016-05-18 21:28:25.936004
4618	53	3	100	\N	\N	3	\N	5	2016-05-18 21:28:25.974868	2016-05-18 21:28:25.974868
4619	53	398	100	\N	\N	3	\N	5	2016-05-18 21:28:26.020561	2016-05-18 21:28:26.020561
4620	53	531	100	\N	\N	3	\N	5	2016-05-18 21:28:26.062671	2016-05-18 21:28:26.062671
4621	53	532	100	\N	\N	3	\N	5	2016-05-18 21:28:26.105606	2016-05-18 21:28:26.105606
4622	53	3	99	\N	\N	3	\N	5	2016-05-18 21:28:26.157964	2016-05-18 21:28:26.157964
4623	53	398	99	\N	\N	3	\N	5	2016-05-18 21:28:26.20384	2016-05-18 21:28:26.20384
4624	53	3	252	\N	\N	3	\N	5	2016-05-18 21:28:26.24373	2016-05-18 21:28:26.24373
4625	53	398	252	\N	\N	3	\N	5	2016-05-18 21:28:26.287096	2016-05-18 21:28:26.287096
4626	53	3	617	\N	\N	3	\N	5	2016-05-18 21:28:26.339086	2016-05-18 21:28:26.339086
4627	53	3	254	\N	\N	3	\N	5	2016-05-18 21:28:26.378349	2016-05-18 21:28:26.378349
4628	53	398	254	\N	\N	3	\N	5	2016-05-18 21:28:26.419577	2016-05-18 21:28:26.419577
4629	30	3	430	\N	\N	3	\N	5	2016-05-18 21:28:26.461741	2016-05-18 21:28:26.461741
4630	30	3	431	\N	\N	3	\N	5	2016-05-18 21:28:26.501944	2016-05-18 21:28:26.501944
4631	30	3	618	\N	\N	3	\N	5	2016-05-18 21:28:26.555311	2016-05-18 21:28:26.555311
4632	52	3	619	\N	\N	3	\N	5	2016-05-18 21:28:26.602838	2016-05-18 21:28:26.602838
4633	7	3	620	\N	\N	3	\N	5	2016-05-18 21:28:26.652321	2016-05-18 21:28:26.652321
4634	4	3	28	\N	\N	3	\N	5	2016-05-18 21:28:26.690875	2016-05-18 21:28:26.690875
4635	4	533	28	\N	\N	3	\N	5	2016-05-18 21:28:26.732197	2016-05-18 21:28:26.732197
4636	1	3	27	\N	\N	3	\N	5	2016-05-18 21:28:26.768585	2016-05-18 21:28:26.768585
4637	30	3	25	\N	\N	3	\N	5	2016-05-18 21:28:26.80685	2016-05-18 21:28:26.80685
4638	3	3	26	\N	\N	3	\N	5	2016-05-18 21:28:26.843526	2016-05-18 21:28:26.843526
4639	30	3	621	\N	\N	3	\N	5	2016-05-18 21:28:26.897602	2016-05-18 21:28:26.897602
4640	12	3	622	\N	\N	3	\N	5	2016-05-18 21:28:26.966774	2016-05-18 21:28:26.966774
4641	12	534	622	\N	\N	3	\N	5	2016-05-18 21:28:27.014988	2016-05-18 21:28:27.014988
4642	30	3	623	\N	\N	3	\N	5	2016-05-18 21:28:27.075402	2016-05-18 21:28:27.075402
4643	30	3	624	\N	\N	3	\N	5	2016-05-18 21:28:27.132653	2016-05-18 21:28:27.132653
4644	7	3	625	\N	\N	3	\N	5	2016-05-18 21:28:27.19574	2016-05-18 21:28:27.19574
4645	54	3	626	\N	\N	3	\N	5	2016-05-18 21:28:27.247941	2016-05-18 21:28:27.247941
4646	54	535	626	\N	\N	3	\N	5	2016-05-18 21:28:27.292631	2016-05-18 21:28:27.292631
4647	54	536	626	\N	\N	3	\N	5	2016-05-18 21:28:27.334994	2016-05-18 21:28:27.334994
4648	30	3	627	\N	\N	3	\N	5	2016-05-18 21:28:27.387461	2016-05-18 21:28:27.387461
4649	30	3	24	\N	\N	3	\N	5	2016-05-18 21:28:27.427939	2016-05-18 21:28:27.427939
4650	30	3	628	\N	\N	3	\N	5	2016-05-18 21:28:27.481129	2016-05-18 21:28:27.481129
4651	30	3	629	\N	\N	3	\N	5	2016-05-18 21:28:27.52851	2016-05-18 21:28:27.52851
4652	55	3	104	\N	\N	3	\N	5	2016-05-18 21:28:27.569444	2016-05-18 21:28:27.569444
4653	55	3	103	\N	\N	3	\N	5	2016-05-18 21:28:27.611101	2016-05-18 21:28:27.611101
4654	55	537	103	\N	\N	3	\N	5	2016-05-18 21:28:27.650522	2016-05-18 21:28:27.650522
4655	55	538	103	\N	\N	3	\N	5	2016-05-18 21:28:27.690217	2016-05-18 21:28:27.690217
4656	55	3	106	\N	\N	3	\N	5	2016-05-18 21:28:27.742012	2016-05-18 21:28:27.742012
4657	55	539	106	\N	\N	3	\N	5	2016-05-18 21:28:27.778815	2016-05-18 21:28:27.778815
4658	8	3	80	\N	\N	3	\N	5	2016-05-18 21:28:27.816833	2016-05-18 21:28:27.816833
4659	8	540	80	\N	\N	3	\N	5	2016-05-18 21:28:27.85687	2016-05-18 21:28:27.85687
4660	8	3	78	\N	\N	3	\N	5	2016-05-18 21:28:27.890405	2016-05-18 21:28:27.890405
4661	8	541	78	\N	\N	3	\N	5	2016-05-18 21:28:27.927463	2016-05-18 21:28:27.927463
4662	20	3	285	\N	\N	3	\N	5	2016-05-18 21:28:27.963398	2016-05-18 21:28:27.963398
4663	20	542	285	\N	\N	3	\N	5	2016-05-18 21:28:27.997922	2016-05-18 21:28:27.997922
4664	17	3	630	\N	\N	3	\N	5	2016-05-18 21:28:28.056516	2016-05-18 21:28:28.056516
4665	17	543	630	\N	\N	3	\N	5	2016-05-18 21:28:28.105456	2016-05-18 21:28:28.105456
4666	56	3	631	\N	\N	3	\N	5	2016-05-18 21:28:28.161184	2016-05-18 21:28:28.161184
4667	56	544	631	\N	\N	3	\N	5	2016-05-18 21:28:28.207943	2016-05-18 21:28:28.207943
4668	56	543	631	\N	\N	3	\N	5	2016-05-18 21:28:28.247927	2016-05-18 21:28:28.247927
4669	56	545	631	\N	\N	3	\N	5	2016-05-18 21:28:28.303181	2016-05-18 21:28:28.303181
4670	17	3	632	\N	\N	3	\N	5	2016-05-18 21:28:28.370839	2016-05-18 21:28:28.370839
4671	30	3	633	\N	\N	3	\N	5	2016-05-18 21:28:28.44055	2016-05-18 21:28:28.44055
4672	11	3	634	\N	\N	3	\N	5	2016-05-18 21:28:28.497868	2016-05-18 21:28:28.497868
4673	11	3	635	\N	\N	3	\N	5	2016-05-18 21:28:28.545969	2016-05-18 21:28:28.545969
4674	1	3	168	\N	\N	3	\N	5	2016-05-18 21:28:28.587336	2016-05-18 21:28:28.587336
4675	1	546	168	\N	\N	3	\N	5	2016-05-18 21:28:28.625177	2016-05-18 21:28:28.625177
4676	1	547	168	\N	\N	3	\N	5	2016-05-18 21:28:28.671066	2016-05-18 21:28:28.671066
4677	1	3	167	\N	\N	3	\N	5	2016-05-18 21:28:28.718722	2016-05-18 21:28:28.718722
4678	1	548	167	\N	\N	3	\N	5	2016-05-18 21:28:28.762126	2016-05-18 21:28:28.762126
4679	1	287	167	\N	\N	3	\N	5	2016-05-18 21:28:28.804685	2016-05-18 21:28:28.804685
4680	1	3	166	\N	\N	3	\N	5	2016-05-18 21:28:28.848241	2016-05-18 21:28:28.848241
4681	11	3	169	\N	\N	3	\N	5	2016-05-18 21:28:28.886202	2016-05-18 21:28:28.886202
4682	11	549	169	\N	\N	3	\N	5	2016-05-18 21:28:28.923535	2016-05-18 21:28:28.923535
4683	56	3	304	\N	\N	3	\N	5	2016-05-18 21:28:28.962707	2016-05-18 21:28:28.962707
4684	56	550	304	\N	\N	3	\N	5	2016-05-18 21:28:29.000325	2016-05-18 21:28:29.000325
4685	1	3	171	\N	\N	3	\N	5	2016-05-18 21:28:29.041116	2016-05-18 21:28:29.041116
4686	1	551	171	\N	\N	3	\N	5	2016-05-18 21:28:29.081839	2016-05-18 21:28:29.081839
4687	11	3	171	\N	\N	3	\N	5	2016-05-18 21:28:29.115933	2016-05-18 21:28:29.115933
4688	11	95	171	\N	\N	3	\N	5	2016-05-18 21:28:29.155094	2016-05-18 21:28:29.155094
4689	11	3	173	\N	\N	3	\N	5	2016-05-18 21:28:29.189702	2016-05-18 21:28:29.189702
4690	11	552	173	\N	\N	3	\N	5	2016-05-18 21:28:29.227595	2016-05-18 21:28:29.227595
4691	11	553	173	\N	\N	3	\N	5	2016-05-18 21:28:29.262867	2016-05-18 21:28:29.262867
4692	1	3	187	\N	\N	3	\N	5	2016-05-18 21:28:29.299949	2016-05-18 21:28:29.299949
4693	1	551	187	\N	\N	3	\N	5	2016-05-18 21:28:29.337578	2016-05-18 21:28:29.337578
4694	1	287	187	\N	\N	3	\N	5	2016-05-18 21:28:29.378974	2016-05-18 21:28:29.378974
4695	11	3	191	\N	\N	3	\N	5	2016-05-18 21:28:29.414888	2016-05-18 21:28:29.414888
4696	11	554	191	\N	\N	3	\N	5	2016-05-18 21:28:29.465722	2016-05-18 21:28:29.465722
4697	11	555	191	\N	\N	3	\N	5	2016-05-18 21:28:29.512292	2016-05-18 21:28:29.512292
4698	11	3	192	\N	\N	3	\N	5	2016-05-18 21:28:29.574859	2016-05-18 21:28:29.574859
4699	11	99	192	\N	\N	3	\N	5	2016-05-18 21:28:29.624883	2016-05-18 21:28:29.624883
4700	11	556	192	\N	\N	3	\N	5	2016-05-18 21:28:29.682673	2016-05-18 21:28:29.682673
4701	11	557	192	\N	\N	3	\N	5	2016-05-18 21:28:29.733555	2016-05-18 21:28:29.733555
4702	11	3	305	\N	\N	3	\N	5	2016-05-18 21:28:29.820333	2016-05-18 21:28:29.820333
4703	11	99	305	\N	\N	3	\N	5	2016-05-18 21:28:29.873342	2016-05-18 21:28:29.873342
4704	11	556	305	\N	\N	3	\N	5	2016-05-18 21:28:29.921807	2016-05-18 21:28:29.921807
4705	11	558	305	\N	\N	3	\N	5	2016-05-18 21:28:29.963109	2016-05-18 21:28:29.963109
4706	11	3	197	\N	\N	3	\N	5	2016-05-18 21:28:30.011359	2016-05-18 21:28:30.011359
4707	11	95	197	\N	\N	3	\N	5	2016-05-18 21:28:30.056133	2016-05-18 21:28:30.056133
4708	11	559	197	\N	\N	3	\N	5	2016-05-18 21:28:30.098532	2016-05-18 21:28:30.098532
4709	57	3	200	\N	\N	3	\N	5	2016-05-18 21:28:30.144363	2016-05-18 21:28:30.144363
4710	57	560	200	\N	\N	3	\N	5	2016-05-18 21:28:30.209056	2016-05-18 21:28:30.209056
4711	57	561	200	\N	\N	3	\N	5	2016-05-18 21:28:30.264128	2016-05-18 21:28:30.264128
4712	57	562	200	\N	\N	3	\N	5	2016-05-18 21:28:30.319499	2016-05-18 21:28:30.319499
4713	11	3	198	\N	\N	3	\N	5	2016-05-18 21:28:30.386415	2016-05-18 21:28:30.386415
4714	11	552	198	\N	\N	3	\N	5	2016-05-18 21:28:30.433331	2016-05-18 21:28:30.433331
4715	11	563	198	\N	\N	3	\N	5	2016-05-18 21:28:30.488599	2016-05-18 21:28:30.488599
4716	11	3	207	\N	\N	3	\N	5	2016-05-18 21:28:30.540882	2016-05-18 21:28:30.540882
4717	11	379	207	\N	\N	3	\N	5	2016-05-18 21:28:30.584458	2016-05-18 21:28:30.584458
4718	11	556	207	\N	\N	3	\N	5	2016-05-18 21:28:30.652396	2016-05-18 21:28:30.652396
4719	11	3	208	\N	\N	3	\N	5	2016-05-18 21:28:30.710479	2016-05-18 21:28:30.710479
4720	11	379	208	\N	\N	3	\N	5	2016-05-18 21:28:30.777248	2016-05-18 21:28:30.777248
4721	11	556	208	\N	\N	3	\N	5	2016-05-18 21:28:30.835648	2016-05-18 21:28:30.835648
4722	1	3	636	\N	\N	3	\N	5	2016-05-18 21:28:30.907743	2016-05-18 21:28:30.907743
4723	1	551	636	\N	\N	3	\N	5	2016-05-18 21:28:30.952854	2016-05-18 21:28:30.952854
4724	1	407	636	\N	\N	3	\N	5	2016-05-18 21:28:31.005876	2016-05-18 21:28:31.005876
4725	11	3	637	\N	\N	3	\N	5	2016-05-18 21:28:31.069088	2016-05-18 21:28:31.069088
4726	11	563	637	\N	\N	3	\N	5	2016-05-18 21:28:31.112418	2016-05-18 21:28:31.112418
4727	11	3	47	\N	\N	3	\N	5	2016-05-18 21:28:31.152893	2016-05-18 21:28:31.152893
4728	11	564	47	\N	\N	3	\N	5	2016-05-18 21:28:31.206589	2016-05-18 21:28:31.206589
4729	4	3	47	\N	\N	3	\N	5	2016-05-18 21:28:31.247143	2016-05-18 21:28:31.247143
4730	4	565	47	\N	\N	3	\N	5	2016-05-18 21:28:31.300824	2016-05-18 21:28:31.300824
4731	4	3	49	\N	\N	3	\N	5	2016-05-18 21:28:31.339553	2016-05-18 21:28:31.339553
4732	4	565	49	\N	\N	3	\N	5	2016-05-18 21:28:31.383557	2016-05-18 21:28:31.383557
4733	23	3	49	\N	\N	3	\N	5	2016-05-18 21:28:31.420545	2016-05-18 21:28:31.420545
4734	23	566	49	\N	\N	3	\N	5	2016-05-18 21:28:31.456673	2016-05-18 21:28:31.456673
4735	15	3	48	\N	\N	3	\N	5	2016-05-18 21:28:31.501561	2016-05-18 21:28:31.501561
4736	15	264	48	\N	\N	3	\N	5	2016-05-18 21:28:31.539635	2016-05-18 21:28:31.539635
4737	15	566	48	\N	\N	3	\N	5	2016-05-18 21:28:31.58531	2016-05-18 21:28:31.58531
4738	4	3	50	\N	\N	3	\N	5	2016-05-18 21:28:31.627867	2016-05-18 21:28:31.627867
4739	4	567	50	\N	\N	3	\N	5	2016-05-18 21:28:31.665953	2016-05-18 21:28:31.665953
4740	4	565	50	\N	\N	3	\N	5	2016-05-18 21:28:31.705786	2016-05-18 21:28:31.705786
4741	2	3	51	\N	\N	3	\N	5	2016-05-18 21:28:31.746174	2016-05-18 21:28:31.746174
4742	2	568	51	\N	\N	3	\N	5	2016-05-18 21:28:31.786072	2016-05-18 21:28:31.786072
4743	2	3	46	\N	\N	3	\N	5	2016-05-18 21:28:31.821714	2016-05-18 21:28:31.821714
4744	2	569	46	\N	\N	3	\N	5	2016-05-18 21:28:31.86043	2016-05-18 21:28:31.86043
4745	2	570	46	\N	\N	3	\N	5	2016-05-18 21:28:31.904154	2016-05-18 21:28:31.904154
4746	2	571	46	\N	\N	3	\N	5	2016-05-18 21:28:31.955495	2016-05-18 21:28:31.955495
4747	4	3	46	\N	\N	3	\N	5	2016-05-18 21:28:32.035467	2016-05-18 21:28:32.035467
4748	4	572	46	\N	\N	3	\N	5	2016-05-18 21:28:32.095922	2016-05-18 21:28:32.095922
4749	4	65	46	\N	\N	3	\N	5	2016-05-18 21:28:32.170188	2016-05-18 21:28:32.170188
4750	4	571	46	\N	\N	3	\N	5	2016-05-18 21:28:32.215082	2016-05-18 21:28:32.215082
4751	4	3	41	\N	\N	3	\N	5	2016-05-18 21:28:32.266777	2016-05-18 21:28:32.266777
4752	4	3	43	\N	\N	3	\N	5	2016-05-18 21:28:32.313489	2016-05-18 21:28:32.313489
4753	4	3	42	\N	\N	3	\N	5	2016-05-18 21:28:32.353295	2016-05-18 21:28:32.353295
4754	4	565	42	\N	\N	3	\N	5	2016-05-18 21:28:32.447108	2016-05-18 21:28:32.447108
4755	4	573	42	\N	\N	3	\N	5	2016-05-18 21:28:32.491657	2016-05-18 21:28:32.491657
4756	4	571	42	\N	\N	3	\N	5	2016-05-18 21:28:32.548683	2016-05-18 21:28:32.548683
4757	4	3	44	\N	\N	3	\N	5	2016-05-18 21:28:32.590489	2016-05-18 21:28:32.590489
4758	4	3	45	\N	\N	3	\N	5	2016-05-18 21:28:32.639632	2016-05-18 21:28:32.639632
4759	4	3	40	\N	\N	3	\N	5	2016-05-18 21:28:32.679656	2016-05-18 21:28:32.679656
4760	3	3	40	\N	\N	3	\N	5	2016-05-18 21:28:32.720459	2016-05-18 21:28:32.720459
4761	3	574	40	\N	\N	3	\N	5	2016-05-18 21:28:32.774458	2016-05-18 21:28:32.774458
4762	58	3	638	\N	\N	3	\N	5	2016-05-18 21:28:32.834012	2016-05-18 21:28:32.834012
4763	58	575	638	\N	\N	3	\N	5	2016-05-18 21:28:32.875418	2016-05-18 21:28:32.875418
4764	58	3	639	\N	\N	3	\N	5	2016-05-18 21:28:32.930844	2016-05-18 21:28:32.930844
4765	58	575	639	\N	\N	3	\N	5	2016-05-18 21:28:32.966172	2016-05-18 21:28:32.966172
4766	4	3	640	\N	\N	3	\N	5	2016-05-18 21:28:33.018248	2016-05-18 21:28:33.018248
4767	4	3	641	\N	\N	3	\N	5	2016-05-18 21:28:33.069716	2016-05-18 21:28:33.069716
4768	4	571	641	\N	\N	3	\N	5	2016-05-18 21:28:33.105679	2016-05-18 21:28:33.105679
4769	4	3	642	\N	\N	3	\N	5	2016-05-18 21:28:33.152766	2016-05-18 21:28:33.152766
4770	4	3	34	\N	\N	3	\N	5	2016-05-18 21:28:33.193388	2016-05-18 21:28:33.193388
4771	4	567	34	\N	\N	3	\N	5	2016-05-18 21:28:33.231387	2016-05-18 21:28:33.231387
4772	4	45	34	\N	\N	3	\N	5	2016-05-18 21:28:33.268574	2016-05-18 21:28:33.268574
4773	4	3	35	\N	\N	3	\N	5	2016-05-18 21:28:33.305447	2016-05-18 21:28:33.305447
4774	4	567	35	\N	\N	3	\N	5	2016-05-18 21:28:33.342012	2016-05-18 21:28:33.342012
4775	4	45	35	\N	\N	3	\N	5	2016-05-18 21:28:33.395682	2016-05-18 21:28:33.395682
4776	4	3	39	\N	\N	3	\N	5	2016-05-18 21:28:33.43482	2016-05-18 21:28:33.43482
4777	4	3	36	\N	\N	3	\N	5	2016-05-18 21:28:33.475469	2016-05-18 21:28:33.475469
4778	4	3	38	\N	\N	3	\N	5	2016-05-18 21:28:33.563553	2016-05-18 21:28:33.563553
4779	4	3	37	\N	\N	3	\N	5	2016-05-18 21:28:33.601794	2016-05-18 21:28:33.601794
4780	4	3	31	\N	\N	3	\N	5	2016-05-18 21:28:33.639396	2016-05-18 21:28:33.639396
4781	4	571	31	\N	\N	3	\N	5	2016-05-18 21:28:33.67863	2016-05-18 21:28:33.67863
4782	2	3	66	\N	\N	3	\N	5	2016-05-18 21:28:33.715241	2016-05-18 21:28:33.715241
4783	23	3	403	\N	\N	3	\N	5	2016-05-18 21:28:33.75246	2016-05-18 21:28:33.75246
4784	23	3	67	\N	\N	3	\N	5	2016-05-18 21:28:33.793602	2016-05-18 21:28:33.793602
4785	1	3	68	\N	\N	3	\N	5	2016-05-18 21:28:33.83194	2016-05-18 21:28:33.83194
4786	1	407	68	\N	\N	3	\N	5	2016-05-18 21:28:33.869796	2016-05-18 21:28:33.869796
4787	23	3	643	\N	\N	3	\N	5	2016-05-18 21:28:33.925564	2016-05-18 21:28:33.925564
4788	23	3	70	\N	\N	3	\N	5	2016-05-18 21:28:33.966934	2016-05-18 21:28:33.966934
4789	1	3	72	\N	\N	3	\N	5	2016-05-18 21:28:34.023386	2016-05-18 21:28:34.023386
4790	21	3	334	\N	\N	3	\N	5	2016-05-18 21:28:34.069953	2016-05-18 21:28:34.069953
4791	21	3	644	\N	\N	3	\N	5	2016-05-18 21:28:34.148626	2016-05-18 21:28:34.148626
4792	21	576	644	\N	\N	3	\N	5	2016-05-18 21:28:34.201451	2016-05-18 21:28:34.201451
4793	21	3	444	\N	\N	3	\N	5	2016-05-18 21:28:34.246684	2016-05-18 21:28:34.246684
4794	21	577	444	\N	\N	3	\N	5	2016-05-18 21:28:34.296769	2016-05-18 21:28:34.296769
4795	21	3	645	\N	\N	3	\N	5	2016-05-18 21:28:34.35328	2016-05-18 21:28:34.35328
4796	21	577	645	\N	\N	3	\N	5	2016-05-18 21:28:34.394762	2016-05-18 21:28:34.394762
4797	21	578	645	\N	\N	3	\N	5	2016-05-18 21:28:34.431444	2016-05-18 21:28:34.431444
4798	21	3	335	\N	\N	3	\N	5	2016-05-18 21:28:34.471912	2016-05-18 21:28:34.471912
4799	59	3	646	\N	\N	3	\N	5	2016-05-18 21:28:34.548104	2016-05-18 21:28:34.548104
4800	23	3	646	\N	\N	3	\N	5	2016-05-18 21:28:34.606723	2016-05-18 21:28:34.606723
4801	23	579	646	\N	\N	3	\N	5	2016-05-18 21:28:34.664079	2016-05-18 21:28:34.664079
4802	30	3	647	\N	\N	3	\N	5	2016-05-18 21:28:34.745083	2016-05-18 21:28:34.745083
4803	30	3	648	\N	\N	3	\N	5	2016-05-18 21:28:34.824073	2016-05-18 21:28:34.824073
4804	30	3	649	\N	\N	3	\N	5	2016-05-18 21:28:34.906342	2016-05-18 21:28:34.906342
4805	30	3	650	\N	\N	3	\N	5	2016-05-18 21:28:34.983561	2016-05-18 21:28:34.983561
4806	30	3	651	\N	\N	3	\N	5	2016-05-18 21:28:35.040683	2016-05-18 21:28:35.040683
4807	30	3	652	\N	\N	3	\N	5	2016-05-18 21:28:35.099568	2016-05-18 21:28:35.099568
4808	4	3	11	\N	\N	3	\N	5	2016-05-18 21:28:35.154297	2016-05-18 21:28:35.154297
4809	4	3	13	\N	\N	3	\N	5	2016-05-18 21:28:35.212292	2016-05-18 21:28:35.212292
4810	4	580	13	\N	\N	3	\N	5	2016-05-18 21:28:35.272814	2016-05-18 21:28:35.272814
4811	8	3	12	\N	\N	3	\N	5	2016-05-18 21:28:35.323255	2016-05-18 21:28:35.323255
4812	8	581	12	\N	\N	3	\N	5	2016-05-18 21:28:35.389922	2016-05-18 21:28:35.389922
4813	19	3	14	\N	\N	3	\N	5	2016-05-18 21:28:35.435345	2016-05-18 21:28:35.435345
4814	19	582	14	\N	\N	3	\N	5	2016-05-18 21:28:35.484187	2016-05-18 21:28:35.484187
4815	4	3	14	\N	\N	3	\N	5	2016-05-18 21:28:35.537459	2016-05-18 21:28:35.537459
4816	4	3	15	\N	\N	3	\N	5	2016-05-18 21:28:35.588772	2016-05-18 21:28:35.588772
4817	4	44	15	\N	\N	3	\N	5	2016-05-18 21:28:35.650521	2016-05-18 21:28:35.650521
4818	1	583	7	\N	\N	3	\N	5	2016-05-18 21:28:35.863106	2016-05-18 21:28:35.863106
4819	1	584	9	\N	\N	3	\N	5	2016-05-18 21:28:35.946377	2016-05-18 21:28:35.946377
4820	33	3	653	\N	\N	3	\N	5	2016-05-18 21:28:36.004999	2016-05-18 21:28:36.004999
4821	30	3	5	\N	\N	3	\N	5	2016-05-18 21:28:36.052673	2016-05-18 21:28:36.052673
4822	1	3	654	\N	\N	3	\N	5	2016-05-18 21:28:36.113114	2016-05-18 21:28:36.113114
4823	1	480	654	\N	\N	3	\N	5	2016-05-18 21:28:36.154221	2016-05-18 21:28:36.154221
4824	1	3	3	\N	\N	3	\N	5	2016-05-18 21:28:36.19665	2016-05-18 21:28:36.19665
4825	1	585	1	\N	\N	3	\N	5	2016-05-18 21:28:36.313402	2016-05-18 21:28:36.313402
4826	1	3	411	\N	\N	3	\N	5	2016-05-18 21:28:36.362107	2016-05-18 21:28:36.362107
4827	1	585	411	\N	\N	3	\N	5	2016-05-18 21:28:36.401131	2016-05-18 21:28:36.401131
4828	1	3	286	\N	\N	3	\N	5	2016-05-18 21:28:36.439327	2016-05-18 21:28:36.439327
4829	1	585	286	\N	\N	3	\N	5	2016-05-18 21:28:36.478916	2016-05-18 21:28:36.478916
4830	1	3	2	\N	\N	3	\N	5	2016-05-18 21:28:36.514743	2016-05-18 21:28:36.514743
4831	1	586	2	\N	\N	3	\N	5	2016-05-18 21:28:36.551348	2016-05-18 21:28:36.551348
4832	1	587	2	\N	\N	3	\N	5	2016-05-18 21:28:36.588307	2016-05-18 21:28:36.588307
4833	1	3	412	\N	\N	3	\N	5	2016-05-18 21:28:36.623924	2016-05-18 21:28:36.623924
4834	1	586	412	\N	\N	3	\N	5	2016-05-18 21:28:36.661619	2016-05-18 21:28:36.661619
4835	1	587	412	\N	\N	3	\N	5	2016-05-18 21:28:36.699974	2016-05-18 21:28:36.699974
4836	1	3	415	\N	\N	3	\N	5	2016-05-18 21:28:36.738272	2016-05-18 21:28:36.738272
4837	1	3	414	\N	\N	3	\N	5	2016-05-18 21:28:36.779099	2016-05-18 21:28:36.779099
4838	1	3	655	\N	\N	3	\N	5	2016-05-18 21:28:36.826782	2016-05-18 21:28:36.826782
4839	11	3	145	\N	\N	3	\N	5	2016-05-18 21:28:36.866366	2016-05-18 21:28:36.866366
4840	11	588	145	\N	\N	3	\N	5	2016-05-18 21:28:36.904137	2016-05-18 21:28:36.904137
4841	11	589	145	\N	\N	3	\N	5	2016-05-18 21:28:36.944253	2016-05-18 21:28:36.944253
4842	11	3	656	\N	\N	3	\N	5	2016-05-18 21:28:36.993442	2016-05-18 21:28:36.993442
4843	11	3	657	\N	\N	3	\N	5	2016-05-18 21:28:37.050175	2016-05-18 21:28:37.050175
4844	11	588	657	\N	\N	3	\N	5	2016-05-18 21:28:37.093345	2016-05-18 21:28:37.093345
4845	11	589	657	\N	\N	3	\N	5	2016-05-18 21:28:37.152896	2016-05-18 21:28:37.152896
4846	11	101	657	\N	\N	3	\N	5	2016-05-18 21:28:37.216148	2016-05-18 21:28:37.216148
4847	11	3	148	\N	\N	3	\N	5	2016-05-18 21:28:37.283121	2016-05-18 21:28:37.283121
4848	11	588	148	\N	\N	3	\N	5	2016-05-18 21:28:37.382001	2016-05-18 21:28:37.382001
4849	11	556	148	\N	\N	3	\N	5	2016-05-18 21:28:37.486472	2016-05-18 21:28:37.486472
4850	11	3	658	\N	\N	3	\N	5	2016-05-18 21:28:37.56135	2016-05-18 21:28:37.56135
4851	11	101	658	\N	\N	3	\N	5	2016-05-18 21:28:37.608456	2016-05-18 21:28:37.608456
4852	11	3	659	\N	\N	3	\N	5	2016-05-18 21:28:37.686862	2016-05-18 21:28:37.686862
4853	11	3	660	\N	\N	3	\N	5	2016-05-18 21:28:37.771624	2016-05-18 21:28:37.771624
4854	11	3	661	\N	\N	3	\N	5	2016-05-18 21:28:37.863818	2016-05-18 21:28:37.863818
4855	11	3	662	\N	\N	3	\N	5	2016-05-18 21:28:37.935146	2016-05-18 21:28:37.935146
4856	11	97	662	\N	\N	3	\N	5	2016-05-18 21:28:37.977194	2016-05-18 21:28:37.977194
4857	7	3	663	\N	\N	3	\N	5	2016-05-18 21:28:38.053319	2016-05-18 21:28:38.053319
4858	4	3	663	\N	\N	3	\N	5	2016-05-18 21:28:38.112389	2016-05-18 21:28:38.112389
4859	4	82	663	\N	\N	3	\N	5	2016-05-18 21:28:38.159405	2016-05-18 21:28:38.159405
4860	7	3	664	\N	\N	3	\N	5	2016-05-18 21:28:38.226184	2016-05-18 21:28:38.226184
4861	4	3	664	\N	\N	3	\N	5	2016-05-18 21:28:38.267801	2016-05-18 21:28:38.267801
4862	4	82	664	\N	\N	3	\N	5	2016-05-18 21:28:38.306392	2016-05-18 21:28:38.306392
4863	7	3	665	\N	\N	3	\N	5	2016-05-18 21:28:38.369102	2016-05-18 21:28:38.369102
4864	4	3	665	\N	\N	3	\N	5	2016-05-18 21:28:38.405503	2016-05-18 21:28:38.405503
4865	4	82	665	\N	\N	3	\N	5	2016-05-18 21:28:38.443141	2016-05-18 21:28:38.443141
4866	7	3	666	\N	\N	3	\N	5	2016-05-18 21:28:38.506454	2016-05-18 21:28:38.506454
4867	4	3	666	\N	\N	3	\N	5	2016-05-18 21:28:38.545007	2016-05-18 21:28:38.545007
4868	7	3	667	\N	\N	3	\N	5	2016-05-18 21:28:38.611604	2016-05-18 21:28:38.611604
4869	7	590	126	\N	\N	3	\N	5	2016-05-18 21:28:38.714126	2016-05-18 21:28:38.714126
4870	2	3	668	\N	\N	3	\N	5	2016-05-18 21:28:38.796348	2016-05-18 21:28:38.796348
4871	7	3	129	\N	\N	3	\N	5	2016-05-18 21:28:38.843858	2016-05-18 21:28:38.843858
4872	7	3	669	\N	\N	3	\N	5	2016-05-18 21:28:38.92973	2016-05-18 21:28:38.92973
4873	7	3	670	\N	\N	3	\N	5	2016-05-18 21:28:38.998379	2016-05-18 21:28:38.998379
4874	4	3	130	\N	\N	3	\N	5	2016-05-18 21:28:39.046415	2016-05-18 21:28:39.046415
4875	1	3	130	\N	\N	3	\N	5	2016-05-18 21:28:39.097035	2016-05-18 21:28:39.097035
4876	1	591	130	\N	\N	3	\N	5	2016-05-18 21:28:39.146943	2016-05-18 21:28:39.146943
4877	7	3	127	\N	\N	3	\N	5	2016-05-18 21:28:39.223933	2016-05-18 21:28:39.223933
4878	7	590	127	\N	\N	3	\N	5	2016-05-18 21:28:39.286285	2016-05-18 21:28:39.286285
4879	32	3	128	\N	\N	3	\N	5	2016-05-18 21:28:39.361271	2016-05-18 21:28:39.361271
4880	32	592	128	\N	\N	3	\N	5	2016-05-18 21:28:39.418715	2016-05-18 21:28:39.418715
4881	15	3	132	\N	\N	3	\N	5	2016-05-18 21:28:39.471269	2016-05-18 21:28:39.471269
4882	7	3	671	\N	\N	3	\N	5	2016-05-18 21:28:39.550805	2016-05-18 21:28:39.550805
4883	7	593	671	\N	\N	3	\N	5	2016-05-18 21:28:39.59571	2016-05-18 21:28:39.59571
4884	7	3	672	\N	\N	3	\N	5	2016-05-18 21:28:39.659038	2016-05-18 21:28:39.659038
4885	4	3	673	\N	\N	3	\N	5	2016-05-18 21:28:39.713432	2016-05-18 21:28:39.713432
4886	4	594	673	\N	\N	3	\N	5	2016-05-18 21:28:39.755601	2016-05-18 21:28:39.755601
4887	4	3	674	\N	\N	3	\N	5	2016-05-18 21:28:39.805348	2016-05-18 21:28:39.805348
4888	4	594	674	\N	\N	3	\N	5	2016-05-18 21:28:39.84429	2016-05-18 21:28:39.84429
4889	4	3	139	\N	\N	3	\N	5	2016-05-18 21:28:39.882831	2016-05-18 21:28:39.882831
4890	4	44	139	\N	\N	3	\N	5	2016-05-18 21:28:39.921997	2016-05-18 21:28:39.921997
4891	30	3	138	\N	\N	3	\N	5	2016-05-18 21:28:39.9708	2016-05-18 21:28:39.9708
4892	4	3	675	\N	\N	3	\N	5	2016-05-18 21:28:40.03356	2016-05-18 21:28:40.03356
4893	4	44	675	\N	\N	3	\N	5	2016-05-18 21:28:40.078742	2016-05-18 21:28:40.078742
4894	30	3	676	\N	\N	3	\N	5	2016-05-18 21:28:40.159212	2016-05-18 21:28:40.159212
4895	30	596	676	\N	\N	3	\N	5	2016-05-18 21:28:40.200097	2016-05-18 21:28:40.200097
4896	30	3	677	\N	\N	3	\N	5	2016-05-18 21:28:40.247236	2016-05-18 21:28:40.247236
4897	30	596	677	\N	\N	3	\N	5	2016-05-18 21:28:40.291931	2016-05-18 21:28:40.291931
4898	30	3	678	\N	\N	3	\N	5	2016-05-18 21:28:40.344424	2016-05-18 21:28:40.344424
4899	30	3	679	\N	\N	3	\N	5	2016-05-18 21:28:40.396504	2016-05-18 21:28:40.396504
4900	30	3	680	\N	\N	3	\N	5	2016-05-18 21:28:40.452097	2016-05-18 21:28:40.452097
4901	30	3	681	\N	\N	3	\N	5	2016-05-18 21:28:40.549135	2016-05-18 21:28:40.549135
4902	30	3	682	\N	\N	3	\N	5	2016-05-18 21:28:40.649081	2016-05-18 21:28:40.649081
4903	30	3	683	\N	\N	3	\N	5	2016-05-18 21:28:40.720537	2016-05-18 21:28:40.720537
4904	30	597	683	\N	\N	3	\N	5	2016-05-18 21:28:40.777636	2016-05-18 21:28:40.777636
4905	30	3	684	\N	\N	3	\N	5	2016-05-18 21:28:40.852746	2016-05-18 21:28:40.852746
4906	30	597	684	\N	\N	3	\N	5	2016-05-18 21:28:40.900836	2016-05-18 21:28:40.900836
4907	30	3	685	\N	\N	3	\N	5	2016-05-18 21:28:40.966294	2016-05-18 21:28:40.966294
4908	30	3	686	\N	\N	3	\N	5	2016-05-18 21:28:41.022964	2016-05-18 21:28:41.022964
4909	30	3	20	\N	\N	3	\N	5	2016-05-18 21:28:41.063787	2016-05-18 21:28:41.063787
4910	31	3	19	\N	\N	3	\N	5	2016-05-18 21:28:41.102202	2016-05-18 21:28:41.102202
4911	31	598	19	\N	\N	3	\N	5	2016-05-18 21:28:41.142809	2016-05-18 21:28:41.142809
4912	31	3	687	\N	\N	3	\N	5	2016-05-18 21:28:41.207498	2016-05-18 21:28:41.207498
4913	31	3	688	\N	\N	3	\N	5	2016-05-18 21:28:41.269491	2016-05-18 21:28:41.269491
4914	31	599	688	\N	\N	3	\N	5	2016-05-18 21:28:41.311839	2016-05-18 21:28:41.311839
4915	30	3	689	\N	\N	3	\N	5	2016-05-18 21:28:41.381275	2016-05-18 21:28:41.381275
4916	31	3	690	\N	\N	3	\N	5	2016-05-18 21:28:41.439786	2016-05-18 21:28:41.439786
4917	30	3	691	\N	\N	3	\N	5	2016-05-18 21:28:41.504117	2016-05-18 21:28:41.504117
4918	61	3	692	\N	\N	3	\N	5	2016-05-18 21:28:41.565597	2016-05-18 21:28:41.565597
4919	61	3	693	\N	\N	3	\N	5	2016-05-18 21:28:41.634017	2016-05-18 21:28:41.634017
4920	61	600	693	\N	\N	3	\N	5	2016-05-18 21:28:41.679978	2016-05-18 21:28:41.679978
4921	61	3	694	\N	\N	3	\N	5	2016-05-18 21:28:41.74873	2016-05-18 21:28:41.74873
4922	61	600	694	\N	\N	3	\N	5	2016-05-18 21:28:41.791356	2016-05-18 21:28:41.791356
4923	61	3	695	\N	\N	3	\N	5	2016-05-18 21:28:41.86527	2016-05-18 21:28:41.86527
4924	61	3	696	\N	\N	3	\N	5	2016-05-18 21:28:41.919642	2016-05-18 21:28:41.919642
4925	61	600	696	\N	\N	3	\N	5	2016-05-18 21:28:41.961754	2016-05-18 21:28:41.961754
4926	30	3	697	\N	\N	3	\N	5	2016-05-18 21:28:42.032064	2016-05-18 21:28:42.032064
4927	61	3	698	\N	\N	3	\N	5	2016-05-18 21:28:42.088615	2016-05-18 21:28:42.088615
4928	38	3	699	\N	\N	3	\N	5	2016-05-18 21:28:42.154557	2016-05-18 21:28:42.154557
4929	30	3	700	\N	\N	3	\N	5	2016-05-18 21:28:42.236924	2016-05-18 21:28:42.236924
4930	62	3	701	\N	\N	3	\N	5	2016-05-18 21:28:42.308667	2016-05-18 21:28:42.308667
4931	62	3	702	\N	\N	3	\N	5	2016-05-18 21:28:42.369603	2016-05-18 21:28:42.369603
4932	62	3	703	\N	\N	3	\N	5	2016-05-18 21:28:42.43928	2016-05-18 21:28:42.43928
4933	62	3	704	\N	\N	3	\N	5	2016-05-18 21:28:42.495865	2016-05-18 21:28:42.495865
4934	62	601	704	\N	\N	3	\N	5	2016-05-18 21:28:42.538223	2016-05-18 21:28:42.538223
4935	62	3	425	\N	\N	3	\N	5	2016-05-18 21:28:42.586741	2016-05-18 21:28:42.586741
4936	62	602	425	\N	\N	3	\N	5	2016-05-18 21:28:42.623577	2016-05-18 21:28:42.623577
4937	30	3	705	\N	\N	3	\N	5	2016-05-18 21:28:42.67609	2016-05-18 21:28:42.67609
4938	30	3	706	\N	\N	3	\N	5	2016-05-18 21:28:42.730623	2016-05-18 21:28:42.730623
4939	62	3	707	\N	\N	3	\N	5	2016-05-18 21:28:42.782689	2016-05-18 21:28:42.782689
4940	62	601	707	\N	\N	3	\N	5	2016-05-18 21:28:42.820308	2016-05-18 21:28:42.820308
4941	62	3	708	\N	\N	3	\N	5	2016-05-18 21:28:42.870662	2016-05-18 21:28:42.870662
4942	62	3	17	\N	\N	3	\N	5	2016-05-18 21:28:42.909277	2016-05-18 21:28:42.909277
4943	62	603	17	\N	\N	3	\N	5	2016-05-18 21:28:42.944955	2016-05-18 21:28:42.944955
4944	30	3	709	\N	\N	3	\N	5	2016-05-18 21:28:43.00009	2016-05-18 21:28:43.00009
4945	30	3	710	\N	\N	3	\N	5	2016-05-18 21:28:43.054999	2016-05-18 21:28:43.054999
4946	30	3	711	\N	\N	3	\N	5	2016-05-18 21:28:43.109502	2016-05-18 21:28:43.109502
4947	30	3	712	\N	\N	3	\N	5	2016-05-18 21:28:43.159747	2016-05-18 21:28:43.159747
4948	30	3	713	\N	\N	3	\N	5	2016-05-18 21:28:43.212096	2016-05-18 21:28:43.212096
4949	2	3	714	\N	\N	3	\N	5	2016-05-18 21:28:43.261644	2016-05-18 21:28:43.261644
4950	30	3	715	\N	\N	3	\N	5	2016-05-18 21:28:43.314399	2016-05-18 21:28:43.314399
4951	30	3	716	\N	\N	3	\N	5	2016-05-18 21:28:43.362222	2016-05-18 21:28:43.362222
4952	30	3	717	\N	\N	3	\N	5	2016-05-18 21:28:43.420066	2016-05-18 21:28:43.420066
4953	30	3	718	\N	\N	3	\N	5	2016-05-18 21:28:43.480853	2016-05-18 21:28:43.480853
4954	30	3	719	\N	\N	3	\N	5	2016-05-18 21:28:43.561937	2016-05-18 21:28:43.561937
4955	30	604	719	\N	\N	3	\N	5	2016-05-18 21:28:43.619359	2016-05-18 21:28:43.619359
4956	30	605	719	\N	\N	3	\N	5	2016-05-18 21:28:43.666191	2016-05-18 21:28:43.666191
4957	30	3	720	\N	\N	3	\N	5	2016-05-18 21:28:43.723752	2016-05-18 21:28:43.723752
4958	30	606	720	\N	\N	3	\N	5	2016-05-18 21:28:43.77861	2016-05-18 21:28:43.77861
4959	30	3	263	\N	\N	3	\N	5	2016-05-18 21:28:43.825584	2016-05-18 21:28:43.825584
4960	30	607	263	\N	\N	3	\N	5	2016-05-18 21:28:43.868079	2016-05-18 21:28:43.868079
4961	46	3	263	\N	\N	3	\N	5	2016-05-18 21:28:43.909547	2016-05-18 21:28:43.909547
4962	46	608	263	\N	\N	3	\N	5	2016-05-18 21:28:43.962097	2016-05-18 21:28:43.962097
4963	8	3	721	\N	\N	3	\N	5	2016-05-18 21:28:44.023438	2016-05-18 21:28:44.023438
4964	8	609	721	\N	\N	3	\N	5	2016-05-18 21:28:44.07823	2016-05-18 21:28:44.07823
4965	30	3	721	\N	\N	3	\N	5	2016-05-18 21:28:44.133548	2016-05-18 21:28:44.133548
4966	46	3	260	\N	\N	3	\N	5	2016-05-18 21:28:44.192864	2016-05-18 21:28:44.192864
4967	46	608	260	\N	\N	3	\N	5	2016-05-18 21:28:44.246282	2016-05-18 21:28:44.246282
4968	30	3	260	\N	\N	3	\N	5	2016-05-18 21:28:44.318301	2016-05-18 21:28:44.318301
4969	30	3	259	\N	\N	3	\N	5	2016-05-18 21:28:44.373076	2016-05-18 21:28:44.373076
4970	4	3	722	\N	\N	3	\N	5	2016-05-18 21:28:44.451661	2016-05-18 21:28:44.451661
4971	32	3	722	\N	\N	3	\N	5	2016-05-18 21:28:44.517314	2016-05-18 21:28:44.517314
4972	30	3	723	\N	\N	3	\N	5	2016-05-18 21:28:44.610883	2016-05-18 21:28:44.610883
4973	30	3	724	\N	\N	3	\N	5	2016-05-18 21:28:44.688351	2016-05-18 21:28:44.688351
4974	63	3	725	\N	\N	3	\N	5	2016-05-18 21:28:44.778301	2016-05-18 21:28:44.778301
4975	63	610	725	\N	\N	3	\N	5	2016-05-18 21:28:44.822497	2016-05-18 21:28:44.822497
4976	63	3	726	\N	\N	3	\N	5	2016-05-18 21:28:44.900609	2016-05-18 21:28:44.900609
4977	63	610	726	\N	\N	3	\N	5	2016-05-18 21:28:44.957978	2016-05-18 21:28:44.957978
4978	63	3	727	\N	\N	3	\N	5	2016-05-18 21:28:45.037852	2016-05-18 21:28:45.037852
4979	63	3	728	\N	\N	3	\N	5	2016-05-18 21:28:45.115065	2016-05-18 21:28:45.115065
4980	63	611	728	\N	\N	3	\N	5	2016-05-18 21:28:45.178118	2016-05-18 21:28:45.178118
4095	36	470	470	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"JAK inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"21179087","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:55.901955	2016-05-18 21:41:55.554324
3323	17	5	300	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"ponatinib","Association":"response","Status":"NCCN guidelines","Evidence":"consensus","Source":"NCCN","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"AURK inhibitors + BCR-ABL1 inhibitors","Association":"response","Status":"case report","Evidence":"emerging","Source":"22772060","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:26:47.19705	2016-05-18 21:41:43.233702
3343	4	33	226	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"cetuximab, panitumumab","Association":"resistance","Status":"late trials","Evidence":"emerging","Source":"20619739, 21163703, 23325582","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors +/- MEK inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"22608338, J Clin Oncol 2010;28:(suppl; abstr 3534), J Clin Oncol 2012;30:(suppl; abstr 3528)","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors + EGFR inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"22281684","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors + PI3K pathway inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23251002, 23549875","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"proteosome inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"24107445.0","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"preclinical","Association":"mTOR inhibitors + BH3 mimetics","Status":"preclinical","Evidence":"emerging","Source":"24163374","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:26:48.386172	2016-05-18 21:41:43.404052
3347	4	37	226	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"cetuximab, panitumumab","Association":"resistance","Status":"late trials","Evidence":"emerging","Source":"20619739, 21163703, 23325582","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors +/- MEK inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"22608338, J Clin Oncol 2010;28:(suppl; abstr 3534), J Clin Oncol 2012;30:(suppl; abstr 3528)","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors + EGFR inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"22281684","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors + PI3K pathway inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23251002, 23549875","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"proteosome inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"24107445.0","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"preclinical","Association":"mTOR inhibitors + BH3 mimetics","Status":"preclinical","Evidence":"emerging","Source":"24163374","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:26:48.592387	2016-05-18 21:41:43.485666
3351	4	41	226	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"cetuximab, panitumumab","Association":"resistance","Status":"late trials","Evidence":"emerging","Source":"20619739, 21163703, 23325582","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors +/- MEK inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"22608338, J Clin Oncol 2010;28:(suppl; abstr 3534), J Clin Oncol 2012;30:(suppl; abstr 3528)","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors + EGFR inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"22281684","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors + PI3K pathway inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23251002, 23549875","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"proteosome inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"24107445.0","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"preclinical","Association":"mTOR inhibitors + BH3 mimetics","Status":"preclinical","Evidence":"emerging","Source":"24163374","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:26:48.793905	2016-05-18 21:41:43.587303
3355	4	45	226	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"cetuximab, panitumumab","Association":"resistance","Status":"late trials","Evidence":"emerging","Source":"20619739, 21163703, 23325582","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors +/- MEK inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"22608338, J Clin Oncol 2010;28:(suppl; abstr 3534), J Clin Oncol 2012;30:(suppl; abstr 3528)","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors + EGFR inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"22281684","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors + PI3K pathway inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23251002, 23549875","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"proteosome inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"24107445.0","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"preclinical","Association":"mTOR inhibitors + BH3 mimetics","Status":"preclinical","Evidence":"emerging","Source":"24163374","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:26:49.005919	2016-05-18 21:41:43.675527
2312	8	115	56	\N	\N	3	{"My Cancer Genome":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"quizartinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"22504184","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"ponatinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"23430109","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"sorafenib","Association":"resistance","Status":"case report","Evidence":"emerging","Source":"22368270","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"midostaurin","Association":"response","Status":"case report","Evidence":"emerging","Source":"20733134","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"lestaurtinib","Association":"response","Status":"case report","Evidence":"emerging","Source":"16857985.0","Effect":"gain-of-function","Pathway":"activation"}]}]}}	1	2016-05-18 21:26:20.343663	2016-05-18 21:41:44.749975
3359	4	49	226	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"cetuximab, panitumumab","Association":"resistance","Status":"late trials","Evidence":"emerging","Source":"20619739, 21163703, 23325582","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors +/- MEK inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"22608338, J Clin Oncol 2010;28:(suppl; abstr 3534), J Clin Oncol 2012;30:(suppl; abstr 3528)","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors + EGFR inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"22281684","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors + PI3K pathway inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23251002, 23549875","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"proteosome inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"24107445.0","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"preclinical","Association":"mTOR inhibitors + BH3 mimetics","Status":"preclinical","Evidence":"emerging","Source":"24163374","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:26:49.204031	2016-05-18 21:41:43.771057
3405	11	96	148	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"imatinib, sunitinib","Association":"resistance","Status":"late trials, preclinical","Evidence":"emerging","Source":"22718859, 16638875","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"HSP90 inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"18794084","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"crenolanib","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"22745105","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"dasatinib","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"18794084","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:26:52.04505	2016-05-18 21:41:44.161212
3411	8	111	306	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"quizartinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"22504184","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"ponatinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"23430109","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"crenolanib, PKC412","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"24619500","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:26:52.527276	2016-05-18 21:41:44.262215
2303	8	117	54	\N	\N	3	{"My Cancer Genome":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"quizartinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"22504184","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"ponatinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"23430109","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"sorafenib","Association":"resistance","Status":"case report","Evidence":"emerging","Source":"22368270","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"midostaurin","Association":"response","Status":"case report","Evidence":"emerging","Source":"20733134","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"lestaurtinib","Association":"response","Status":"case report","Evidence":"emerging","Source":"16857985.0","Effect":"gain-of-function","Pathway":"activation"}]}]}}	1	2016-05-18 21:26:20.213032	2016-05-18 21:41:44.392038
3419	8	123	54	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"quizartinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"22504184","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"ponatinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"23430109","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"sorafenib","Association":"resistance","Status":"case report","Evidence":"emerging","Source":"22368270","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"midostaurin","Association":"response","Status":"case report","Evidence":"emerging","Source":"20733134","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"lestaurtinib","Association":"response","Status":"case report","Evidence":"emerging","Source":"16857985.0","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:26:53.476078	2016-05-18 21:41:44.480828
3421	8	116	55	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"quizartinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"22504184","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"ponatinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"23430109","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"sorafenib","Association":"resistance","Status":"case report","Evidence":"emerging","Source":"22368270","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"midostaurin","Association":"response","Status":"case report","Evidence":"emerging","Source":"20733134","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"lestaurtinib","Association":"response","Status":"case report","Evidence":"emerging","Source":"16857985.0","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:26:54.015962	2016-05-18 21:41:44.569979
3427	8	122	55	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"quizartinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"22504184","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"ponatinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"23430109","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"sorafenib","Association":"resistance","Status":"case report","Evidence":"emerging","Source":"22368270","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"midostaurin","Association":"response","Status":"case report","Evidence":"emerging","Source":"20733134","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"lestaurtinib","Association":"response","Status":"case report","Evidence":"emerging","Source":"16857985.0","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:26:54.483144	2016-05-18 21:41:44.659076
2317	8	120	56	\N	\N	3	{"My Cancer Genome":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"quizartinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"22504184","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"ponatinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"23430109","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"sorafenib","Association":"resistance","Status":"case report","Evidence":"emerging","Source":"22368270","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"midostaurin","Association":"response","Status":"case report","Evidence":"emerging","Source":"20733134","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"lestaurtinib","Association":"response","Status":"case report","Evidence":"emerging","Source":"16857985.0","Effect":"gain-of-function","Pathway":"activation"}]}]}}	1	2016-05-18 21:26:20.42592	2016-05-18 21:41:44.834082
3432	8	115	57	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"quizartinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"22504184","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"ponatinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"23430109","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"sorafenib","Association":"resistance","Status":"case report","Evidence":"emerging","Source":"22368270","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"midostaurin","Association":"response","Status":"case report","Evidence":"emerging","Source":"20733134","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"lestaurtinib","Association":"response","Status":"case report","Evidence":"emerging","Source":"16857985.0","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:26:56.238377	2016-05-18 21:41:44.952358
2325	8	111	57	\N	\N	3	{"My Cancer Genome":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"quizartinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"22504184","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"ponatinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"23430109","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"sorafenib","Association":"resistance","Status":"case report","Evidence":"emerging","Source":"22368270","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"midostaurin","Association":"response","Status":"case report","Evidence":"emerging","Source":"20733134","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"lestaurtinib","Association":"response","Status":"case report","Evidence":"emerging","Source":"16857985.0","Effect":"gain-of-function","Pathway":"activation"}]}]}}	1	2016-05-18 21:26:20.559161	2016-05-18 21:41:45.040707
2326	8	115	58	\N	\N	3	{"My Cancer Genome":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"quizartinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"22504184","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"ponatinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"23430109","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"sorafenib","Association":"resistance","Status":"case report","Evidence":"emerging","Source":"22368270","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"midostaurin","Association":"response","Status":"case report","Evidence":"emerging","Source":"20733134","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"lestaurtinib","Association":"response","Status":"case report","Evidence":"emerging","Source":"16857985.0","Effect":"gain-of-function","Pathway":"activation"}]}]}}	1	2016-05-18 21:26:20.574352	2016-05-18 21:41:45.108763
2328	8	117	58	\N	\N	3	{"My Cancer Genome":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"quizartinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"22504184","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"ponatinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"23430109","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"sorafenib","Association":"resistance","Status":"case report","Evidence":"emerging","Source":"22368270","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"midostaurin","Association":"response","Status":"case report","Evidence":"emerging","Source":"20733134","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"lestaurtinib","Association":"response","Status":"case report","Evidence":"emerging","Source":"16857985.0","Effect":"gain-of-function","Pathway":"activation"}]}]}}	1	2016-05-18 21:26:20.606398	2016-05-18 21:41:45.149642
2338	8	116	59	\N	\N	3	{"My Cancer Genome":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"quizartinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"22504184","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"ponatinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"23430109","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"sorafenib","Association":"resistance","Status":"case report","Evidence":"emerging","Source":"22368270","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"midostaurin","Association":"response","Status":"case report","Evidence":"emerging","Source":"20733134","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"lestaurtinib","Association":"response","Status":"case report","Evidence":"emerging","Source":"16857985.0","Effect":"gain-of-function","Pathway":"activation"}]}]}}	1	2016-05-18 21:26:20.777421	2016-05-18 21:41:45.321831
2343	8	121	59	\N	\N	3	{"My Cancer Genome":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"quizartinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"22504184","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"ponatinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"23430109","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"sorafenib","Association":"resistance","Status":"case report","Evidence":"emerging","Source":"22368270","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"midostaurin","Association":"response","Status":"case report","Evidence":"emerging","Source":"20733134","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"lestaurtinib","Association":"response","Status":"case report","Evidence":"emerging","Source":"16857985.0","Effect":"gain-of-function","Pathway":"activation"}]}]}}	1	2016-05-18 21:26:20.863983	2016-05-18 21:41:45.391978
2346	8	112	59	\N	\N	3	{"My Cancer Genome":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"quizartinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"22504184","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"ponatinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"23430109","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"sorafenib","Association":"resistance","Status":"case report","Evidence":"emerging","Source":"22368270","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"midostaurin","Association":"response","Status":"case report","Evidence":"emerging","Source":"20733134","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"lestaurtinib","Association":"response","Status":"case report","Evidence":"emerging","Source":"16857985.0","Effect":"gain-of-function","Pathway":"activation"}]}]}}	1	2016-05-18 21:26:20.911399	2016-05-18 21:41:45.440568
3447	8	12	60	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"quizartinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"22504184","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"ponatinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"23430109","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"sorafenib","Association":"resistance","Status":"case report","Evidence":"emerging","Source":"22368270","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"midostaurin","Association":"response","Status":"case report","Evidence":"emerging","Source":"20733134","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"lestaurtinib","Association":"response","Status":"case report","Evidence":"emerging","Source":"16857985.0","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:00.789825	2016-05-18 21:41:45.56156
3452	8	112	60	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"quizartinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"22504184","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"ponatinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"23430109","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"sorafenib","Association":"resistance","Status":"case report","Evidence":"emerging","Source":"22368270","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"midostaurin","Association":"response","Status":"case report","Evidence":"emerging","Source":"20733134","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"lestaurtinib","Association":"response","Status":"case report","Evidence":"emerging","Source":"16857985.0","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:01.202168	2016-05-18 21:41:45.672024
3467	8	111	315	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"quizartinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"22504184","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"ponatinib","Association":"resistance","Status":"preclinical","Evidence":"emerging","Source":"23430109","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"crenolanib, PKC412","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"24619500","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:02.437276	2016-05-18 21:41:45.792881
3549	2	221	242	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"erlotinib, afatinib","Association":"response","Status":"FDA-approved","Evidence":"consensus","Source":"FDA","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"irreversible EGFR TKIs","Association":"response","Status":"late trials","Evidence":"emerging","Source":"22753918","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"afatinib + cetuximab","Association":"response","Status":"early trials","Evidence":"emerging","Source":"Annals Oncol 2012;23(Suppl 9):1289","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"HSP90 inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"Annals Oncol 2012;23(Suppl 9):4380","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors (alone or in combination)","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23102728.0","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:09.477288	2016-05-18 21:41:46.644611
3554	2	226	242	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"erlotinib, afatinib","Association":"response","Status":"FDA-approved","Evidence":"consensus","Source":"FDA","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"irreversible EGFR TKIs","Association":"response","Status":"late trials","Evidence":"emerging","Source":"22753918","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"afatinib + cetuximab","Association":"response","Status":"early trials","Evidence":"emerging","Source":"Annals Oncol 2012;23(Suppl 9):1289","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"HSP90 inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"Annals Oncol 2012;23(Suppl 9):4380","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors (alone or in combination)","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23102728.0","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:09.878388	2016-05-18 21:41:46.715932
3560	2	222	243	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"erlotinib, afatinib","Association":"response","Status":"FDA-approved","Evidence":"consensus","Source":"FDA","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"irreversible EGFR TKIs","Association":"response","Status":"late trials","Evidence":"emerging","Source":"22753918","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"afatinib + cetuximab","Association":"response","Status":"early trials","Evidence":"emerging","Source":"Annals Oncol 2012;23(Suppl 9):1289","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"HSP90 inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"Annals Oncol 2012;23(Suppl 9):4380","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors (alone or in combination)","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23102728.0","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:10.347541	2016-05-18 21:41:46.827255
3566	2	228	243	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"erlotinib, afatinib","Association":"response","Status":"FDA-approved","Evidence":"consensus","Source":"FDA","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"irreversible EGFR TKIs","Association":"response","Status":"late trials","Evidence":"emerging","Source":"22753918","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"afatinib + cetuximab","Association":"response","Status":"early trials","Evidence":"emerging","Source":"Annals Oncol 2012;23(Suppl 9):1289","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"HSP90 inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"Annals Oncol 2012;23(Suppl 9):4380","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors (alone or in combination)","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23102728.0","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:10.881722	2016-05-18 21:41:46.940764
3572	2	224	244	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"erlotinib, afatinib","Association":"response","Status":"FDA-approved","Evidence":"consensus","Source":"FDA","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"irreversible EGFR TKIs","Association":"response","Status":"late trials","Evidence":"emerging","Source":"22753918","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"afatinib + cetuximab","Association":"response","Status":"early trials","Evidence":"emerging","Source":"Annals Oncol 2012;23(Suppl 9):1289","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"HSP90 inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"Annals Oncol 2012;23(Suppl 9):4380","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors (alone or in combination)","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23102728.0","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:11.404288	2016-05-18 21:41:47.053893
3578	2	230	244	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"erlotinib, afatinib","Association":"response","Status":"FDA-approved","Evidence":"consensus","Source":"FDA","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"irreversible EGFR TKIs","Association":"response","Status":"late trials","Evidence":"emerging","Source":"22753918","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"afatinib + cetuximab","Association":"response","Status":"early trials","Evidence":"emerging","Source":"Annals Oncol 2012;23(Suppl 9):1289","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"HSP90 inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"Annals Oncol 2012;23(Suppl 9):4380","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors (alone or in combination)","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23102728.0","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:11.882716	2016-05-18 21:41:47.179109
3583	2	232	245	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"erlotinib, afatinib","Association":"resistance","Status":"NCCN/ CAP guidelines","Evidence":"consensus","Source":"NCCN","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"afatinib + cetuximab","Association":"response","Status":"early trials","Evidence":"emerging","Source":"Annals Oncol 2012;23(Suppl 9):1289","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"HSP90 inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"Annals Oncol 2012;23(Suppl 9):4380","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"irreversible EGFR T790M inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"J Clin Oncol 2013;31: (suppl; abstr 2524), ASCO 2014; abstr 8009","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors (alone or in combination)","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23102728.0","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:12.321992	2016-05-18 21:41:47.303355
3588	2	237	245	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"erlotinib, afatinib","Association":"resistance","Status":"NCCN/ CAP guidelines","Evidence":"consensus","Source":"NCCN","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"afatinib + cetuximab","Association":"response","Status":"early trials","Evidence":"emerging","Source":"Annals Oncol 2012;23(Suppl 9):1289","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"HSP90 inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"Annals Oncol 2012;23(Suppl 9):4380","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"irreversible EGFR T790M inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"J Clin Oncol 2013;31: (suppl; abstr 2524), ASCO 2014; abstr 8009","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors (alone or in combination)","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23102728.0","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:12.707241	2016-05-18 21:41:47.431153
3593	2	242	245	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"erlotinib, afatinib","Association":"resistance","Status":"NCCN/ CAP guidelines","Evidence":"consensus","Source":"NCCN","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"afatinib + cetuximab","Association":"response","Status":"early trials","Evidence":"emerging","Source":"Annals Oncol 2012;23(Suppl 9):1289","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"HSP90 inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"Annals Oncol 2012;23(Suppl 9):4380","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"irreversible EGFR T790M inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"J Clin Oncol 2013;31: (suppl; abstr 2524), ASCO 2014; abstr 8009","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors (alone or in combination)","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23102728.0","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:13.12721	2016-05-18 21:41:47.556697
3598	2	224	246	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"erlotinib, afatinib","Association":"response","Status":"FDA-approved","Evidence":"consensus","Source":"FDA","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"irreversible EGFR TKIs","Association":"response","Status":"late trials","Evidence":"emerging","Source":"22753918","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"afatinib + cetuximab","Association":"response","Status":"early trials","Evidence":"emerging","Source":"Annals Oncol 2012;23(Suppl 9):1289","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"HSP90 inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"Annals Oncol 2012;23(Suppl 9):4380","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors (alone or in combination)","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23102728.0","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:13.516262	2016-05-18 21:41:47.678943
3604	2	248	246	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"erlotinib, afatinib","Association":"response","Status":"FDA-approved","Evidence":"consensus","Source":"FDA","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"irreversible EGFR TKIs","Association":"response","Status":"late trials","Evidence":"emerging","Source":"22753918","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"afatinib + cetuximab","Association":"response","Status":"early trials","Evidence":"emerging","Source":"Annals Oncol 2012;23(Suppl 9):1289","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"HSP90 inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"Annals Oncol 2012;23(Suppl 9):4380","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors (alone or in combination)","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23102728.0","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:14.016485	2016-05-18 21:41:47.79604
3610	2	254	246	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"erlotinib, afatinib","Association":"response","Status":"FDA-approved","Evidence":"consensus","Source":"FDA","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"irreversible EGFR TKIs","Association":"response","Status":"late trials","Evidence":"emerging","Source":"22753918","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"afatinib + cetuximab","Association":"response","Status":"early trials","Evidence":"emerging","Source":"Annals Oncol 2012;23(Suppl 9):1289","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"HSP90 inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"Annals Oncol 2012;23(Suppl 9):4380","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors (alone or in combination)","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23102728.0","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:14.562664	2016-05-18 21:41:47.915135
3616	2	223	247	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"erlotinib, afatinib","Association":"response","Status":"FDA-approved","Evidence":"consensus","Source":"FDA","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"irreversible EGFR TKIs","Association":"response","Status":"late trials","Evidence":"emerging","Source":"22753918","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"afatinib + cetuximab","Association":"response","Status":"early trials","Evidence":"emerging","Source":"Annals Oncol 2012;23(Suppl 9):1289","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"HSP90 inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"Annals Oncol 2012;23(Suppl 9):4380","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors (alone or in combination)","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23102728.0","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:15.162312	2016-05-18 21:41:48.032947
3626	24	229	357	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"erlotinib, afatinib","Association":"response","Status":"FDA-approved","Evidence":"consensus","Source":"FDA","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"irreversible EGFR TKIs","Association":"response","Status":"late trials","Evidence":"emerging","Source":"22753918","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"afatinib + cetuximab","Association":"response","Status":"early trials","Evidence":"emerging","Source":"Annals Oncol 2012;23(Suppl 9):1289","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"HSP90 inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"Annals Oncol 2012;23(Suppl 9):4380","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors (alone or in combination)","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23102728.0","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:16.067856	2016-05-18 21:41:48.19531
3632	24	229	360	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"erlotinib, afatinib","Association":"response","Status":"FDA-approved","Evidence":"consensus","Source":"FDA","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"irreversible EGFR TKIs","Association":"response","Status":"late trials","Evidence":"emerging","Source":"22753918","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"afatinib + cetuximab","Association":"response","Status":"early trials","Evidence":"emerging","Source":"Annals Oncol 2012;23(Suppl 9):1289","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"HSP90 inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"Annals Oncol 2012;23(Suppl 9):4380","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors (alone or in combination)","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23102728.0","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:16.693689	2016-05-18 21:41:48.365774
3694	1	36	226	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"vemurafenib, dabrafenib, trametinib, dabrafenib + trametinib","Association":"response","Status":"FDA-approved","Evidence":"consensus","Source":"FDA","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"J Clin Oncol 2013;31 (suppl; abstr 9028)","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors + PI3K pathway inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"22389471, 21156289","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors + HSP90 inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"22351686","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors + CDK2/4 inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"22997239.0","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"preclinical","Association":"ERK inhibitors","Status":"preclinical","Evidence":"emerging","Source":"23614898, 22997239","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:23.010006	2016-05-18 21:41:49.127905
3699	1	46	226	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"vemurafenib, dabrafenib, trametinib, dabrafenib + trametinib","Association":"response","Status":"FDA-approved","Evidence":"consensus","Source":"FDA","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"J Clin Oncol 2013;31 (suppl; abstr 9028)","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors + PI3K pathway inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"22389471, 21156289","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors + HSP90 inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"22351686","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors + CDK2/4 inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"22997239.0","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"preclinical","Association":"ERK inhibitors","Status":"preclinical","Evidence":"emerging","Source":"23614898, 22997239","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:23.437635	2016-05-18 21:41:49.251399
3704	1	319	226	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"vemurafenib, dabrafenib, trametinib, dabrafenib + trametinib","Association":"response","Status":"FDA-approved","Evidence":"consensus","Source":"FDA","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"J Clin Oncol 2013;31 (suppl; abstr 9028)","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors + PI3K pathway inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"22389471, 21156289","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors + HSP90 inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"22351686","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors + CDK2/4 inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"22997239.0","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"preclinical","Association":"ERK inhibitors","Status":"preclinical","Evidence":"emerging","Source":"23614898, 22997239","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:23.888872	2016-05-18 21:41:49.396294
3709	1	329	226	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"vemurafenib, dabrafenib, trametinib, dabrafenib + trametinib","Association":"response","Status":"FDA-approved","Evidence":"consensus","Source":"FDA","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"J Clin Oncol 2013;31 (suppl; abstr 9028)","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors + PI3K pathway inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"22389471, 21156289","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors + HSP90 inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"22351686","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors + CDK2/4 inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"22997239.0","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"preclinical","Association":"ERK inhibitors","Status":"preclinical","Evidence":"emerging","Source":"23614898, 22997239","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:24.464029	2016-05-18 21:41:49.550645
3805	1	400	252	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"selumetinib","Association":"response","Status":"early trials","Evidence":"emerging","Source":"J Clin Oncol 2013;31: (suppl; abstr CRA9003)","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"PI3K pathway inhibitors + MEK inhibitors","Association":"response","Status":"preclinical","Evidence":"emerging","Source":"22733540, 22808163","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"PKC inhibitor","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"22653968, 22253748","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:32.050489	2016-05-18 21:41:50.998877
3811	1	399	252	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"selumetinib","Association":"response","Status":"early trials","Evidence":"emerging","Source":"J Clin Oncol 2013;31: (suppl; abstr CRA9003)","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"PI3K pathway inhibitors + MEK inhibitors","Association":"response","Status":"preclinical","Evidence":"emerging","Source":"22733540, 22808163","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"PKC inhibitor","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"22653968, 22253748","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:32.528029	2016-05-18 21:41:51.154738
3819	1	398	253	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"selumetinib","Association":"response","Status":"early trials","Evidence":"emerging","Source":"J Clin Oncol 2013;31: (suppl; abstr CRA9003)","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"PI3K pathway inhibitors + MEK inhibitors","Association":"response","Status":"preclinical","Evidence":"emerging","Source":"22733540, 22808163","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"PKC inhibitor","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"22653968, 22253748","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:33.106586	2016-05-18 21:41:51.356899
3827	1	396	254	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"selumetinib","Association":"response","Status":"early trials","Evidence":"emerging","Source":"J Clin Oncol 2013;31: (suppl; abstr CRA9003)","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"PI3K pathway inhibitors + MEK inhibitors","Association":"response","Status":"preclinical","Evidence":"emerging","Source":"22733540, 22808163","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"PKC inhibitor","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"22653968, 22253748","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:33.696208	2016-05-18 21:41:51.51577
3862	1	417	1	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"MEK inhibitors","Association":"response","Status":"late trials","Evidence":"emerging","Source":"23414587","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"18390968, 22761467","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors + CDK4/6 inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"ASCO 2014; abstr 9009","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"HSP90 inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23538902","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors","Association":"resistance","Status":"case report","Evidence":"emerging","Source":"23569304.0","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"preclinical","Association":"ERK inhibitors","Status":"preclinical","Evidence":"emerging","Source":"23614898","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:36.466352	2016-05-18 21:41:51.977714
3867	1	422	1	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"MEK inhibitors","Association":"response","Status":"late trials","Evidence":"emerging","Source":"23414587","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"18390968, 22761467","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors + CDK4/6 inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"ASCO 2014; abstr 9009","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"HSP90 inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23538902","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors","Association":"resistance","Status":"case report","Evidence":"emerging","Source":"23569304.0","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"preclinical","Association":"ERK inhibitors","Status":"preclinical","Evidence":"emerging","Source":"23614898","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:36.870452	2016-05-18 21:41:52.110536
3872	1	333	1	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"MEK inhibitors","Association":"response","Status":"late trials","Evidence":"emerging","Source":"23414587","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"18390968, 22761467","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors + CDK4/6 inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"ASCO 2014; abstr 9009","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"HSP90 inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23538902","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors","Association":"resistance","Status":"case report","Evidence":"emerging","Source":"23569304.0","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"preclinical","Association":"ERK inhibitors","Status":"preclinical","Evidence":"emerging","Source":"23614898","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:37.273231	2016-05-18 21:41:52.241559
3877	1	421	411	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"MEK inhibitors","Association":"response","Status":"late trials","Evidence":"emerging","Source":"23414587","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"18390968, 22761467","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors + CDK4/6 inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"ASCO 2014; abstr 9009","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"HSP90 inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23538902","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors","Association":"resistance","Status":"case report","Evidence":"emerging","Source":"23569304.0","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"preclinical","Association":"ERK inhibitors","Status":"preclinical","Evidence":"emerging","Source":"23614898","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:37.689565	2016-05-18 21:41:52.363414
3882	1	407	411	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"MEK inhibitors","Association":"response","Status":"late trials","Evidence":"emerging","Source":"23414587","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"18390968, 22761467","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors + CDK4/6 inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"ASCO 2014; abstr 9009","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"HSP90 inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23538902","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors","Association":"resistance","Status":"case report","Evidence":"emerging","Source":"23569304.0","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"preclinical","Association":"ERK inhibitors","Status":"preclinical","Evidence":"emerging","Source":"23614898","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:38.098331	2016-05-18 21:41:52.480141
3887	1	420	412	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"MEK inhibitors","Association":"response","Status":"late trials","Evidence":"emerging","Source":"23414587","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"18390968, 22761467","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors + CDK4/6 inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"ASCO 2014; abstr 9009","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"HSP90 inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23538902","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors","Association":"resistance","Status":"case report","Evidence":"emerging","Source":"23569304.0","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"preclinical","Association":"ERK inhibitors","Status":"preclinical","Evidence":"emerging","Source":"23614898","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:38.48765	2016-05-18 21:41:52.583815
3892	1	425	412	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"MEK inhibitors","Association":"response","Status":"late trials","Evidence":"emerging","Source":"23414587","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"18390968, 22761467","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors + CDK4/6 inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"ASCO 2014; abstr 9009","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"HSP90 inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23538902","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors","Association":"resistance","Status":"case report","Evidence":"emerging","Source":"23569304.0","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"preclinical","Association":"ERK inhibitors","Status":"preclinical","Evidence":"emerging","Source":"23614898","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:38.940446	2016-05-18 21:41:52.713724
3897	1	419	413	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"MEK inhibitors","Association":"response","Status":"late trials","Evidence":"emerging","Source":"23414587","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"18390968, 22761467","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors + CDK4/6 inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"ASCO 2014; abstr 9009","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"HSP90 inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23538902","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors","Association":"resistance","Status":"case report","Evidence":"emerging","Source":"23569304.0","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"preclinical","Association":"ERK inhibitors","Status":"preclinical","Evidence":"emerging","Source":"23614898","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:39.388322	2016-05-18 21:41:52.819096
3902	1	424	413	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"MEK inhibitors","Association":"response","Status":"late trials","Evidence":"emerging","Source":"23414587","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"18390968, 22761467","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors + CDK4/6 inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"ASCO 2014; abstr 9009","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"HSP90 inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23538902","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors","Association":"resistance","Status":"case report","Evidence":"emerging","Source":"23569304.0","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"preclinical","Association":"ERK inhibitors","Status":"preclinical","Evidence":"emerging","Source":"23614898","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:39.805988	2016-05-18 21:41:52.943882
4045	15	36	226	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"EGFR TKIs","Association":"resistance","Status":"case report","Evidence":"emerging","Source":"22773810","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"dabrafenib","Association":"response","Status":"early trials","Evidence":"emerging","Source":"23524406, 22608338, J Clin Oncol 2013;31: (suppl; abstr 8009)","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"vemurafenib","Association":"response","Status":"case report","Evidence":"emerging","Source":"22743296","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors +/- MEK inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"19010912","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:51.708562	2016-05-18 21:41:55.054093
3907	1	418	2	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"MEK inhibitors","Association":"response","Status":"late trials","Evidence":"emerging","Source":"23414587","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"18390968, 22761467","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors + CDK4/6 inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"ASCO 2014; abstr 9009","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"HSP90 inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23538902","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors","Association":"resistance","Status":"case report","Evidence":"emerging","Source":"23569304.0","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"preclinical","Association":"ERK inhibitors","Status":"preclinical","Evidence":"emerging","Source":"23614898","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:40.208624	2016-05-18 21:41:53.06821
3912	1	423	2	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"MEK inhibitors","Association":"response","Status":"late trials","Evidence":"emerging","Source":"23414587","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"18390968, 22761467","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors + CDK4/6 inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"ASCO 2014; abstr 9009","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"HSP90 inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23538902","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors","Association":"resistance","Status":"case report","Evidence":"emerging","Source":"23569304.0","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"preclinical","Association":"ERK inhibitors","Status":"preclinical","Evidence":"emerging","Source":"23614898","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:40.611498	2016-05-18 21:41:53.19816
3917	1	426	414	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"MEK inhibitors","Association":"response","Status":"late trials","Evidence":"emerging","Source":"23414587","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"18390968, 22761467","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors + CDK4/6 inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"ASCO 2014; abstr 9009","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"HSP90 inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23538902","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors","Association":"resistance","Status":"case report","Evidence":"emerging","Source":"23569304.0","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"preclinical","Association":"ERK inhibitors","Status":"preclinical","Evidence":"emerging","Source":"23614898","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:41.061781	2016-05-18 21:41:53.290659
3922	1	421	414	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"MEK inhibitors","Association":"response","Status":"late trials","Evidence":"emerging","Source":"23414587","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"18390968, 22761467","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors + CDK4/6 inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"ASCO 2014; abstr 9009","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"HSP90 inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23538902","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors","Association":"resistance","Status":"case report","Evidence":"emerging","Source":"23569304.0","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"preclinical","Association":"ERK inhibitors","Status":"preclinical","Evidence":"emerging","Source":"23614898","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:41.434043	2016-05-18 21:41:53.384669
3927	1	407	414	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"MEK inhibitors","Association":"response","Status":"late trials","Evidence":"emerging","Source":"23414587","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"18390968, 22761467","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors + CDK4/6 inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"ASCO 2014; abstr 9009","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"HSP90 inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23538902","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors","Association":"resistance","Status":"case report","Evidence":"emerging","Source":"23569304.0","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"preclinical","Association":"ERK inhibitors","Status":"preclinical","Evidence":"emerging","Source":"23614898","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:41.880426	2016-05-18 21:41:53.479967
4052	15	456	226	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"EGFR TKIs","Association":"resistance","Status":"case report","Evidence":"emerging","Source":"22773810","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"dabrafenib","Association":"response","Status":"early trials","Evidence":"emerging","Source":"23524406, 22608338, J Clin Oncol 2013;31: (suppl; abstr 8009)","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"vemurafenib","Association":"response","Status":"case report","Evidence":"emerging","Source":"22743296","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors +/- MEK inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"19010912","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:52.27829	2016-05-18 21:41:55.179385
3932	1	420	415	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"MEK inhibitors","Association":"response","Status":"late trials","Evidence":"emerging","Source":"23414587","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"18390968, 22761467","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors + CDK4/6 inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"ASCO 2014; abstr 9009","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"HSP90 inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23538902","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors","Association":"resistance","Status":"case report","Evidence":"emerging","Source":"23569304.0","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"preclinical","Association":"ERK inhibitors","Status":"preclinical","Evidence":"emerging","Source":"23614898","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:42.265587	2016-05-18 21:41:53.566346
3937	1	425	415	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"MEK inhibitors","Association":"response","Status":"late trials","Evidence":"emerging","Source":"23414587","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"18390968, 22761467","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors + CDK4/6 inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"ASCO 2014; abstr 9009","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"HSP90 inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23538902","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors","Association":"resistance","Status":"case report","Evidence":"emerging","Source":"23569304.0","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"preclinical","Association":"ERK inhibitors","Status":"preclinical","Evidence":"emerging","Source":"23614898","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:42.684315	2016-05-18 21:41:53.666776
3942	1	419	3	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"MEK inhibitors","Association":"response","Status":"late trials","Evidence":"emerging","Source":"23414587","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"18390968, 22761467","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors + CDK4/6 inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"ASCO 2014; abstr 9009","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"HSP90 inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23538902","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors","Association":"resistance","Status":"case report","Evidence":"emerging","Source":"23569304.0","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"preclinical","Association":"ERK inhibitors","Status":"preclinical","Evidence":"emerging","Source":"23614898","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:43.095685	2016-05-18 21:41:53.754335
3947	1	424	3	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"MEK inhibitors","Association":"response","Status":"late trials","Evidence":"emerging","Source":"23414587","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"18390968, 22761467","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors + CDK4/6 inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"ASCO 2014; abstr 9009","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"HSP90 inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23538902","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors","Association":"resistance","Status":"case report","Evidence":"emerging","Source":"23569304.0","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"preclinical","Association":"ERK inhibitors","Status":"preclinical","Evidence":"emerging","Source":"23614898","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:43.501955	2016-05-18 21:41:53.868379
3952	1	417	4	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"MEK inhibitors","Association":"response","Status":"late trials","Evidence":"emerging","Source":"23414587","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"18390968, 22761467","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors + CDK4/6 inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"ASCO 2014; abstr 9009","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"HSP90 inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23538902","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors","Association":"resistance","Status":"case report","Evidence":"emerging","Source":"23569304.0","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"preclinical","Association":"ERK inhibitors","Status":"preclinical","Evidence":"emerging","Source":"23614898","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:43.918402	2016-05-18 21:41:53.989301
4054	15	46	226	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"EGFR TKIs","Association":"resistance","Status":"case report","Evidence":"emerging","Source":"22773810","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"dabrafenib","Association":"response","Status":"early trials","Evidence":"emerging","Source":"23524406, 22608338, J Clin Oncol 2013;31: (suppl; abstr 8009)","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"vemurafenib","Association":"response","Status":"case report","Evidence":"emerging","Source":"22743296","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors +/- MEK inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"19010912","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:52.442646	2016-05-18 21:41:55.211659
3957	1	422	4	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"MEK inhibitors","Association":"response","Status":"late trials","Evidence":"emerging","Source":"23414587","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"18390968, 22761467","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors + CDK4/6 inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"ASCO 2014; abstr 9009","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"HSP90 inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23538902","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors","Association":"resistance","Status":"case report","Evidence":"emerging","Source":"23569304.0","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"preclinical","Association":"ERK inhibitors","Status":"preclinical","Evidence":"emerging","Source":"23614898","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:44.331578	2016-05-18 21:41:54.121115
3962	1	333	4	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"MEK inhibitors","Association":"response","Status":"late trials","Evidence":"emerging","Source":"23414587","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"18390968, 22761467","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors + CDK4/6 inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"ASCO 2014; abstr 9009","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"HSP90 inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23538902","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors","Association":"resistance","Status":"case report","Evidence":"emerging","Source":"23569304.0","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"preclinical","Association":"ERK inhibitors","Status":"preclinical","Evidence":"emerging","Source":"23614898","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:44.760213	2016-05-18 21:41:54.299554
3973	3	305	226	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"vemurafenib, dabrafenib","Association":"response","Status":"early trials","Evidence":"emerging","Source":"22608338, 20818844, 23489023","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"22241789","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK-enhanced radioiodine uptake","Association":"response","Status":"early trials","Evidence":"emerging","Source":"23406027","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors + MEK inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"J Clin Oncol 2013;31(suppl; abstr 9029)","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:45.674435	2016-05-18 21:41:54.441575
3974	3	430	226	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"vemurafenib, dabrafenib","Association":"response","Status":"early trials","Evidence":"emerging","Source":"22608338, 20818844, 23489023","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"22241789","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK-enhanced radioiodine uptake","Association":"response","Status":"early trials","Evidence":"emerging","Source":"23406027","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors + MEK inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"J Clin Oncol 2013;31(suppl; abstr 9029)","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:45.744451	2016-05-18 21:41:54.453434
3981	3	435	226	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"vemurafenib, dabrafenib","Association":"response","Status":"early trials","Evidence":"emerging","Source":"22608338, 20818844, 23489023","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"22241789","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"MEK-enhanced radioiodine uptake","Association":"response","Status":"early trials","Evidence":"emerging","Source":"23406027","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors + MEK inhibitors","Association":"response","Status":"early trials","Evidence":"emerging","Source":"J Clin Oncol 2013;31(suppl; abstr 9029)","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:46.32745	2016-05-18 21:41:54.575325
3989	3	430	17	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"vandetanib","Association":"response","Status":"FDA-approved","Evidence":"consensus","Source":"20065189, 22025146","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"cabozantinib, sunitinib","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"21470995","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"RET inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"23056499","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:46.944271	2016-05-18 21:41:54.67168
4043	15	255	226	\N	\N	3	{"Drug Gene Knowledge Database":{"tables":[{"name":"Drug Interaction Data","columns":["Therapeutic Context","Pathway","Effect","Association","Status","Evidence","Source"],"rows":[{"Therapeutic Context":"EGFR TKIs","Association":"resistance","Status":"case report","Evidence":"emerging","Source":"22773810","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"dabrafenib","Association":"response","Status":"early trials","Evidence":"emerging","Source":"23524406, 22608338, J Clin Oncol 2013;31: (suppl; abstr 8009)","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"vemurafenib","Association":"response","Status":"case report","Evidence":"emerging","Source":"22743296","Effect":"gain-of-function","Pathway":"activation"},{"Therapeutic Context":"BRAF inhibitors +/- MEK inhibitors","Association":"sensitivity","Status":"preclinical","Evidence":"emerging","Source":"19010912","Effect":"gain-of-function","Pathway":"activation"}]}]}}	4	2016-05-18 21:27:51.562014	2016-05-18 21:41:55.016006
\.


--
-- Name: disease_source_variants_id_seq; Type: SEQUENCE SET; Schema: public; Owner: acoffman
--

SELECT pg_catalog.setval('disease_source_variants_id_seq', 4980, true);


--
-- Data for Name: tags; Type: TABLE DATA; Schema: public; Owner: acoffman
--

COPY tags (id, name, created_at, updated_at) FROM stdin;
1	pathogenic	2016-05-18 20:38:34.384151	2016-05-18 20:38:34.384151
2	likely pathogenic	2016-05-18 20:39:57.02121	2016-05-18 20:39:57.02121
\.


--
-- Data for Name: disease_source_variants_tags; Type: TABLE DATA; Schema: public; Owner: acoffman
--

COPY disease_source_variants_tags (tag_id, disease_source_variant_id) FROM stdin;
1	1
1	2
1	3
1	4
1	5
1	6
1	7
1	8
1	9
1	10
1	11
1	12
1	13
1	14
1	15
1	16
1	17
1	18
1	19
1	20
1	21
1	22
1	23
1	24
1	25
1	26
1	27
1	28
1	29
1	30
1	31
1	32
1	33
1	34
1	35
1	36
1	37
1	38
1	39
1	40
1	41
1	42
1	43
1	44
1	45
1	46
1	47
1	48
1	49
1	50
1	51
1	52
1	53
1	54
1	55
1	56
1	57
1	58
1	59
1	60
1	61
1	62
1	63
1	64
1	65
1	66
1	67
1	68
1	69
1	70
1	71
1	72
1	73
1	74
1	75
1	76
1	77
1	78
1	79
1	80
1	81
1	82
1	83
1	84
1	85
1	86
1	87
1	88
1	89
1	90
1	91
1	92
1	93
1	94
1	95
1	96
1	97
1	98
1	99
1	100
1	101
1	102
1	103
1	104
1	105
1	106
1	107
1	108
1	109
1	110
1	111
1	112
1	113
1	114
1	115
1	116
1	117
1	118
1	119
1	120
1	121
1	122
1	123
1	124
1	125
1	126
1	127
1	128
1	129
1	130
1	131
1	132
1	133
1	134
1	135
1	136
1	137
1	138
1	139
1	140
1	141
1	142
1	143
1	144
1	145
1	146
1	147
1	148
1	149
1	150
1	151
1	152
1	153
1	154
1	155
1	156
1	157
1	158
1	159
1	160
1	161
1	162
1	163
1	164
1	165
1	166
1	167
1	168
1	169
1	170
1	171
1	172
1	173
1	174
1	175
1	176
1	177
1	178
1	179
1	180
1	181
1	182
1	183
1	184
1	185
1	186
1	187
1	188
1	189
1	190
1	191
1	192
1	193
1	194
1	195
1	196
1	197
1	198
1	199
1	200
1	201
1	202
1	203
1	204
1	205
1	206
1	207
1	208
1	209
1	210
1	211
1	212
1	213
1	214
1	215
1	216
1	217
1	218
1	219
1	220
1	221
1	222
1	223
1	224
1	225
1	226
1	227
1	228
1	229
1	230
1	231
1	232
1	233
1	234
1	235
1	236
1	237
1	238
1	239
1	240
1	241
1	242
1	243
1	244
1	245
1	246
1	247
1	248
1	249
1	250
1	251
1	252
1	253
1	254
1	255
1	256
1	257
1	258
1	259
1	260
1	261
1	262
1	263
1	264
1	265
1	266
1	267
1	268
1	269
1	270
1	271
1	272
1	273
1	274
1	275
1	276
1	277
1	278
1	279
1	280
1	281
1	282
1	283
1	284
1	285
1	286
1	287
1	288
1	289
1	290
1	291
1	292
1	293
1	294
1	295
1	296
1	297
1	298
1	299
1	300
1	301
1	302
1	303
1	304
1	305
1	306
1	307
1	308
1	309
1	310
1	311
1	312
1	313
1	314
1	315
1	316
1	317
1	318
1	319
1	320
1	321
1	322
1	323
1	324
1	325
1	326
1	327
1	328
1	329
1	330
1	331
1	332
1	333
1	334
1	335
1	336
1	337
1	338
1	339
1	340
1	341
1	342
1	343
1	344
1	345
1	346
1	347
1	348
1	349
1	350
1	351
1	352
1	353
1	354
1	355
1	356
1	357
1	358
1	359
1	360
1	361
1	362
1	363
1	364
1	365
1	366
1	367
1	368
1	369
1	370
1	371
1	372
1	373
1	374
1	375
1	376
1	377
1	378
1	379
1	380
1	381
1	382
1	383
1	384
1	385
1	386
1	387
1	388
1	389
1	390
1	391
1	392
1	393
1	394
1	395
1	396
1	397
1	398
1	399
1	400
1	401
1	402
1	403
1	404
1	405
1	406
1	407
1	408
1	409
1	410
1	411
1	412
1	413
1	414
1	415
1	416
1	417
1	418
1	419
1	420
1	421
1	422
1	423
1	424
1	425
1	426
1	427
1	428
1	429
1	430
1	431
1	432
1	433
1	434
1	435
1	436
1	437
1	438
1	439
1	440
1	441
1	442
1	443
1	444
1	445
1	446
1	447
1	448
1	449
1	450
1	451
1	452
1	453
1	454
1	455
1	456
1	457
1	458
1	459
1	460
1	461
1	462
1	463
1	464
1	465
1	466
1	467
1	468
1	469
1	470
1	471
1	472
1	473
1	474
1	475
1	476
1	477
1	478
1	479
1	480
1	481
1	482
1	483
1	484
1	485
1	486
1	487
1	488
1	489
1	490
1	491
1	492
1	493
1	494
1	495
1	496
1	497
1	498
1	499
1	500
1	501
1	502
1	503
1	504
1	505
1	506
1	507
1	508
1	509
1	510
1	511
1	512
1	513
1	514
1	515
1	516
1	517
1	518
1	519
1	520
1	521
1	522
1	523
1	524
1	525
1	526
1	527
1	528
1	529
1	530
1	531
1	532
1	533
1	534
1	535
1	536
1	537
1	538
1	539
1	540
1	541
1	542
1	543
1	544
1	545
1	546
1	547
1	548
1	549
1	550
1	551
1	552
1	553
1	554
1	555
1	556
1	557
1	558
1	559
1	560
1	561
1	562
1	563
1	564
1	565
1	566
1	567
1	568
1	569
1	570
1	571
1	572
1	573
1	574
1	575
1	576
1	577
1	578
1	579
1	580
1	581
1	582
1	583
1	584
1	585
1	586
1	587
1	588
1	589
1	590
1	591
1	592
1	593
1	594
1	595
1	596
1	597
1	598
1	599
1	600
1	601
1	602
1	603
1	604
1	605
1	606
1	607
1	608
1	609
1	610
1	611
1	612
1	613
1	614
1	615
1	616
1	617
1	618
1	619
1	620
1	621
1	622
1	623
1	624
1	625
1	626
1	627
1	628
1	629
1	630
1	631
1	632
1	633
1	634
1	635
1	636
1	637
1	638
1	639
1	640
1	641
1	642
1	643
1	644
1	645
1	646
1	647
1	648
1	649
1	650
1	651
1	652
1	653
1	654
1	655
1	656
1	657
1	658
1	659
1	660
1	661
1	662
1	663
1	664
1	665
1	666
1	667
1	668
1	669
1	670
1	671
1	672
1	673
1	674
1	675
1	676
1	677
1	678
1	679
1	680
1	681
1	682
1	683
1	684
1	685
1	686
1	687
1	688
1	689
1	690
1	691
1	692
1	693
1	694
1	695
1	696
1	697
1	698
1	699
1	700
1	701
1	702
1	703
1	704
1	705
1	706
1	707
1	708
1	709
1	710
1	711
1	712
1	713
1	714
1	715
1	716
1	717
1	718
1	719
1	720
1	721
1	722
1	723
1	724
1	725
1	726
1	727
1	728
1	729
1	730
1	731
1	732
1	733
1	734
1	735
1	736
1	737
1	738
1	739
1	740
1	741
1	742
1	743
1	744
1	745
1	746
1	747
1	748
1	749
1	750
1	751
1	752
1	753
1	754
1	755
1	756
1	757
1	758
1	759
1	760
1	761
1	762
1	763
1	764
1	765
1	766
1	767
1	768
1	769
1	770
1	771
1	772
1	773
1	774
1	775
1	776
1	777
1	778
1	779
1	780
1	781
1	782
1	783
1	784
1	785
1	786
1	787
1	788
1	789
1	790
1	791
1	792
1	793
1	794
1	795
1	796
1	797
1	798
1	799
1	800
1	801
1	802
1	803
1	804
1	805
1	806
1	807
1	808
1	809
1	810
1	811
1	812
1	813
1	814
1	815
1	816
1	817
1	818
1	819
1	820
1	821
1	822
1	823
1	824
1	825
1	826
1	827
1	828
1	829
1	830
1	831
1	832
1	833
1	834
1	835
1	836
1	837
1	838
1	839
1	840
1	841
1	842
1	843
1	844
1	845
1	846
1	847
1	848
1	849
1	850
1	851
1	852
1	853
1	854
1	855
1	856
1	857
1	858
1	859
1	860
1	861
1	862
1	863
1	864
1	865
1	866
1	867
1	868
1	869
1	870
1	871
1	872
1	873
1	874
1	875
1	876
1	877
1	878
1	879
1	880
1	881
1	882
1	883
1	884
1	885
1	886
1	887
1	888
1	889
1	890
1	891
1	892
1	893
1	894
1	895
1	896
1	897
1	898
1	899
1	900
1	901
1	902
1	903
1	904
1	905
1	906
1	907
1	908
1	909
1	910
1	911
1	912
1	913
1	914
1	915
1	916
1	917
1	918
1	919
1	920
1	921
1	922
1	923
1	924
1	925
1	926
1	927
1	928
1	929
1	930
1	931
1	932
1	933
1	934
1	935
1	936
1	937
1	938
1	939
1	940
1	941
1	942
1	943
1	944
1	945
1	946
1	947
1	948
1	949
1	950
1	951
1	952
1	953
1	954
1	955
1	956
1	957
1	958
1	959
1	960
1	961
1	962
1	963
1	964
1	965
1	966
1	967
1	968
1	969
1	970
1	971
1	972
1	973
1	974
1	975
1	976
1	977
1	978
1	979
1	980
1	981
1	982
1	983
1	984
1	985
1	986
1	987
1	988
1	989
1	990
1	991
1	992
1	993
1	994
1	995
1	996
1	997
1	998
1	999
1	1000
1	1001
1	1002
1	1003
1	1004
1	1005
1	1006
1	1007
1	1008
1	1009
1	1010
1	1011
1	1012
1	1013
1	1014
1	1015
1	1016
1	1017
1	1018
1	1019
1	1020
1	1021
1	1022
1	1023
1	1024
1	1025
1	1026
1	1027
1	1028
1	1029
1	1030
1	1031
1	1032
1	1033
1	1034
1	1035
1	1036
1	1037
1	1038
1	1039
1	1040
1	1041
1	1042
1	1043
1	1044
1	1045
1	1046
1	1047
1	1048
1	1049
1	1050
1	1051
1	1052
1	1053
1	1054
1	1055
1	1056
1	1057
1	1058
1	1059
1	1060
1	1061
1	1062
1	1063
1	1064
1	1065
1	1066
1	1067
1	1068
1	1069
1	1070
1	1071
1	1072
1	1073
1	1074
1	1075
1	1076
1	1077
1	1078
1	1079
1	1080
1	1081
1	1082
1	1083
1	1084
1	1085
1	1086
1	1087
1	1088
1	1089
1	1090
1	1091
1	1092
1	1093
1	1094
1	1095
1	1096
1	1097
1	1098
1	1099
1	1100
1	1101
1	1102
1	1103
1	1104
1	1105
1	1106
1	1107
1	1108
1	1109
1	1110
1	1111
1	1112
1	1113
1	1114
1	1115
1	1116
1	1117
1	1118
1	1119
1	1120
1	1121
1	1122
1	1123
1	1124
1	1125
1	1126
1	1127
1	1128
1	1129
1	1130
1	1131
1	1132
1	1133
1	1134
1	1135
1	1136
1	1137
1	1138
1	1139
1	1140
1	1141
1	1142
1	1143
1	1144
1	1145
1	1146
1	1147
1	1148
1	1149
1	1150
1	1151
1	1152
1	1153
1	1154
1	1155
1	1156
1	1157
1	1158
1	1159
1	1160
1	1161
1	1162
1	1163
1	1164
1	1165
1	1166
1	1167
1	1168
1	1169
1	1170
1	1171
1	1172
1	1173
1	1174
1	1175
1	1176
1	1177
1	1178
1	1179
1	1180
1	1181
1	1182
1	1183
1	1184
1	1185
1	1186
1	1187
1	1188
1	1189
1	1190
1	1191
1	1192
1	1193
1	1194
1	1195
1	1196
1	1197
1	1198
1	1199
1	1200
1	1201
1	1202
1	1203
1	1204
1	1205
1	1206
1	1207
1	1208
1	1209
1	1210
1	1211
1	1212
1	1213
1	1214
1	1215
1	1216
1	1217
1	1218
1	1219
1	1220
1	1221
1	1222
1	1223
1	1224
1	1225
1	1226
1	1227
1	1228
1	1229
1	1230
1	1231
1	1232
1	1233
1	1234
1	1235
1	1236
1	1237
1	1238
1	1239
1	1240
1	1241
1	1242
1	1243
1	1244
1	1245
1	1246
1	1247
1	1248
1	1249
1	1250
1	1251
1	1252
1	1253
1	1254
1	1255
1	1256
1	1257
1	1258
1	1259
1	1260
1	1261
1	1262
1	1263
1	1264
1	1265
1	1266
1	1267
1	1268
1	1269
1	1270
1	1271
1	1272
1	1273
1	1274
1	1275
1	1276
1	1277
1	1278
1	1279
1	1280
1	1281
1	1282
1	1283
1	1284
1	1285
1	1286
1	1287
1	1288
1	1289
1	1290
1	1291
1	1292
1	1293
1	1294
1	1295
1	1296
1	1297
1	1298
1	1299
1	1300
1	1301
1	1302
1	1303
1	1304
1	1305
1	1306
1	1307
1	1308
1	1309
1	1310
1	1311
1	1312
1	1313
1	1314
1	1315
1	1316
1	1317
1	1318
1	1319
1	1320
1	1321
1	1322
1	1323
1	1324
1	1325
1	1326
1	1327
1	1328
1	1329
1	1330
1	1331
1	1332
1	1333
1	1334
1	1335
1	1336
1	1337
1	1338
1	1339
1	1340
1	1341
1	1342
1	1343
1	1344
1	1345
1	1346
1	1347
1	1348
1	1349
1	1350
1	1351
1	1352
1	1353
1	1354
1	1355
1	1356
1	1357
1	1358
1	1359
1	1360
1	1361
1	1362
1	1363
1	1364
1	1365
1	1366
1	1367
1	1368
1	1369
1	1370
1	1371
1	1372
1	1373
1	1374
1	1375
1	1376
1	1377
1	1378
1	1379
1	1380
1	1381
1	1382
1	1383
2	1384
2	1385
2	1386
2	1387
2	1388
2	1389
2	1390
2	1391
2	1392
2	1393
2	1394
2	1395
2	1396
2	1397
2	1398
2	1399
2	1400
2	1401
2	1402
2	1403
2	1404
2	1405
2	1406
2	1407
2	1408
2	1409
2	1410
2	1411
2	1412
2	1413
2	1414
2	1415
2	1416
2	1417
2	1418
2	1419
2	1420
2	1421
2	1422
2	1423
2	1424
2	1425
2	1426
2	1427
2	1428
2	1429
2	1430
2	1431
2	1432
2	1433
2	1434
2	1435
2	1436
2	1437
2	1438
2	1439
2	1440
2	1441
2	1442
2	1443
2	1444
2	1445
2	1446
2	1447
2	1448
2	1449
2	1450
2	1451
2	1452
2	1453
2	1454
2	1455
2	1456
2	1457
2	1458
2	1459
2	1460
2	1461
2	1462
2	1463
2	1464
2	1465
2	1466
2	1467
2	1468
2	1469
2	1470
2	1471
2	1472
2	1473
2	1474
2	1475
2	1476
2	1477
2	1478
2	1479
2	1480
2	1481
2	1482
2	1483
2	1484
2	1485
2	1486
2	1487
2	1488
2	1489
2	1490
2	1491
2	1492
2	1493
2	1494
2	1495
2	1496
2	1497
2	1498
2	1499
2	1500
2	1501
2	1502
2	1503
2	1504
2	1505
2	1506
2	1507
2	1508
2	1509
2	1510
2	1511
2	1512
2	1513
2	1514
2	1515
2	1516
2	1517
2	1518
2	1519
2	1520
2	1521
2	1522
2	1523
2	1524
2	1525
2	1526
2	1527
2	1528
2	1529
2	1530
2	1531
2	1532
2	1533
2	1534
2	1535
2	1536
2	1537
2	1538
2	1539
2	1540
2	1541
2	1542
2	1543
2	1544
2	1545
2	1546
2	1547
2	1548
2	1549
2	1550
2	1551
2	1552
2	1553
2	1554
2	1555
2	1556
2	1557
2	1558
2	1559
2	1560
2	1561
2	1562
2	1563
2	1564
2	1565
2	1566
2	1567
2	1568
2	1569
2	1570
2	1571
2	1572
2	1573
2	1574
2	1575
2	1576
2	1577
2	1578
2	1579
2	1580
2	1581
2	1582
2	1583
2	1584
2	1585
2	1586
2	1587
2	1588
2	1589
2	1590
2	1591
2	1592
2	1593
2	1594
2	1595
2	1596
2	1597
2	1598
2	1599
2	1600
2	1601
2	1602
2	1603
2	1604
2	1605
2	1606
2	1607
2	1608
2	1609
2	1610
2	1611
2	1612
2	1613
2	1614
2	1615
2	1616
2	1617
2	1618
2	1619
2	1620
1	1662
1	1663
1	1664
1	1665
1	1666
1	1667
1	1668
1	1669
1	1670
1	1671
1	1672
1	1673
1	1674
1	1675
1	1676
1	1677
1	1678
1	1679
1	1680
1	1681
1	1682
1	1683
1	1684
1	1685
1	1686
1	1687
1	1688
1	1689
1	1690
1	1691
1	1692
1	1693
1	1694
1	1695
1	1696
1	1697
1	1698
1	1699
1	1700
1	1701
1	1702
1	1703
1	1704
1	1705
1	1706
1	1707
1	1708
1	1709
1	1710
1	1711
1	1712
1	1713
1	1714
1	1715
1	1716
1	1717
1	1718
1	1719
1	1720
1	1721
1	1722
1	1723
1	1724
1	1725
1	1726
1	1727
1	1728
1	1729
1	1730
1	1731
1	1732
1	1733
1	1734
1	1735
1	1736
1	1737
1	1738
1	1739
1	1740
1	1741
1	1742
1	1743
1	1744
1	1745
1	1746
1	1747
1	1748
1	1749
1	1750
1	1751
1	1752
1	1753
1	1754
1	1755
1	1756
1	1757
1	1758
1	1759
1	1760
1	1761
1	1762
1	1763
1	1764
1	1765
1	1766
1	1767
1	1768
1	1769
1	1770
1	1771
1	1772
1	1773
1	1774
1	1775
1	1776
1	1777
1	1778
1	1779
1	1780
1	1781
1	1782
1	1783
1	1784
1	1785
1	1786
1	1787
1	1788
1	1789
1	1790
1	1791
1	1792
1	1793
1	1794
1	1795
1	1796
1	1797
1	1798
1	1799
1	1800
1	1801
1	1802
1	1803
1	1804
1	1805
1	1806
1	1807
1	1808
1	1809
1	1810
1	1811
1	1812
1	1813
1	1814
1	1815
1	1816
1	1817
1	1818
1	1819
1	1820
1	1821
1	1822
1	1823
1	1824
1	1825
1	1826
1	1827
1	1828
1	1829
1	1830
1	1831
1	1832
1	1833
1	1834
1	1835
1	1836
1	1837
1	1838
1	1839
1	1840
1	1841
1	1842
1	1843
1	1844
1	1845
1	1846
1	1847
1	1848
1	1849
1	1850
1	1851
1	1852
1	1853
1	1854
1	1855
1	1856
1	1857
1	1858
1	1859
1	1860
1	1861
1	1862
1	1863
1	1864
1	1865
1	1866
1	1867
1	1868
1	1869
1	1870
1	1871
1	1872
1	1873
1	1874
1	1875
1	1876
1	1877
1	1878
1	1879
1	1880
1	1881
1	1882
1	1883
1	1884
1	1885
1	1886
1	1887
1	1888
1	1889
1	1890
1	1891
1	1892
1	1893
1	1894
1	1895
1	1896
1	1897
1	1898
1	1899
1	1900
1	1901
1	1902
1	1903
1	1904
1	1905
1	1906
1	1907
1	1908
1	1909
1	1910
1	1911
1	1912
1	1913
1	1914
1	1915
1	1916
1	1917
1	1918
1	1919
1	1920
1	1921
1	1922
1	1923
1	1924
1	1925
1	1926
1	1927
1	1928
1	1929
1	1930
1	1931
1	1932
1	1933
1	1934
1	1935
1	1936
1	1937
1	1938
1	1939
1	1940
1	1941
1	1942
1	1943
1	1944
1	1945
1	1946
1	1947
1	1948
1	1949
1	1950
1	1951
1	1952
1	1953
1	1954
1	1955
1	1956
1	1957
1	1958
1	1959
1	1960
1	1961
1	1962
1	1963
1	1964
1	1965
1	1966
1	1967
1	1968
1	1969
1	1970
1	1971
1	1972
1	1973
1	1974
1	1975
1	1976
1	1977
1	1978
1	1979
1	1980
1	1981
1	1982
1	1983
1	1984
1	1985
1	1986
1	1987
1	1988
1	1989
1	1990
1	1991
1	1992
1	1993
1	1994
1	1995
1	1996
1	1997
1	1998
1	1999
1	2000
1	2001
1	2002
1	2003
1	2004
1	2005
1	2006
1	2007
1	2008
1	2009
1	2010
1	2011
1	2012
1	2013
1	2014
1	2015
1	2016
1	2017
1	2018
1	2019
1	2020
1	2021
1	2022
1	2023
1	2024
1	2025
1	2026
1	2027
1	2028
1	2029
1	2030
1	2031
1	2032
1	2033
1	2034
1	2035
1	2036
1	2037
1	2038
1	2039
1	2040
1	2041
1	2042
1	2043
1	2044
1	2045
1	2046
1	2047
1	2048
1	2049
1	2050
1	2051
1	2052
1	2053
1	2054
1	2055
1	2056
1	2057
1	2058
1	2059
1	2060
1	2061
1	2062
1	2063
1	2064
1	2065
1	2066
1	2067
1	2068
1	2069
1	2070
1	2071
1	2072
1	2073
1	2074
1	2075
1	2076
1	2077
1	2078
1	2079
1	2080
1	2081
1	2082
1	2083
1	2084
1	2085
1	2086
1	2087
1	2088
1	2089
1	2090
1	2091
1	2092
1	2093
1	2094
1	2095
1	2096
1	2097
1	2098
1	2099
1	2100
1	2101
1	2102
1	2103
1	2104
1	2105
1	2106
1	2107
1	2108
1	2109
1	2110
1	2111
1	2112
1	2113
1	2114
1	2115
1	2116
1	2117
1	2118
1	2119
1	2120
1	2121
1	2122
1	2123
1	2124
1	2125
1	2126
1	2127
1	2128
1	2129
1	2130
1	2131
1	2132
1	2133
1	2134
1	2135
1	2136
1	2137
1	2138
1	2139
1	2140
1	2141
1	2142
1	2143
1	2144
1	2145
1	2146
1	2147
1	2148
1	2149
1	2150
1	2151
1	2152
1	2153
1	2154
1	2155
1	2156
1	2157
1	2158
1	2159
1	2160
1	2161
1	2162
1	2163
1	2164
1	2165
1	2166
1	2167
1	2168
1	2169
1	2170
1	2171
1	2172
1	2173
1	2174
1	2175
1	2176
1	2177
1	2178
1	2179
1	2180
1	2181
1	2182
1	2183
1	2184
1	2185
1	2186
1	2187
1	2188
1	2189
1	2190
1	2191
1	2192
1	2193
1	2194
1	2195
1	2196
1	2197
1	2198
1	2199
1	2200
1	2201
1	2202
1	2203
1	2204
1	2205
1	2206
1	2207
1	2208
1	2209
1	2210
1	2211
1	2212
1	2213
1	2214
1	2215
1	2216
1	2217
1	2218
1	2219
1	2220
1	2221
1	2222
1	2223
1	2224
1	2225
1	2226
1	2227
1	2228
1	2229
1	2230
1	2231
1	2232
1	2233
1	2234
1	2235
1	2236
1	2237
1	2238
1	2239
1	2240
1	2241
1	2242
1	2243
1	2244
1	2245
1	2246
1	2247
1	2248
1	2249
1	2250
1	2251
1	2252
1	2253
1	2254
1	2255
1	2256
1	2257
1	2258
1	2259
1	2260
1	2261
1	2262
1	2263
1	2264
1	2265
1	2266
1	2267
1	2268
1	2269
1	2270
1	2271
1	2272
1	2273
1	2274
1	2275
1	2276
1	2277
1	2278
1	2279
1	2280
1	2281
1	2282
1	2283
1	2284
1	2285
1	2286
1	2287
1	2288
1	2289
1	2290
1	2291
1	2292
1	2293
1	2294
1	2295
1	2296
1	2297
1	2298
1	2299
1	2300
1	2301
1	2302
1	2303
1	2304
1	2305
1	2306
1	2307
1	2308
1	2309
1	2310
1	2311
1	2312
1	2313
1	2314
1	2315
1	2316
1	2317
1	2318
1	2319
1	2320
1	2321
1	2322
1	2323
1	2324
1	2325
1	2326
1	2327
1	2328
1	2329
1	2330
1	2331
1	2332
1	2333
1	2334
1	2335
1	2336
1	2337
1	2338
1	2339
1	2340
1	2341
1	2342
1	2343
1	2344
1	2345
1	2346
1	2347
1	2348
1	2349
1	2350
1	2351
1	2352
1	2353
1	2354
1	2355
1	2356
1	2357
1	2358
1	2359
1	2360
1	2361
1	2362
1	2363
1	2364
1	2365
1	2366
1	2367
1	2368
1	2369
1	2370
1	2371
1	2372
1	2373
1	2374
1	2375
1	2376
1	2377
1	2378
1	2379
1	2380
1	2381
1	2382
1	2383
1	2384
1	2385
1	2386
1	2387
1	2388
1	2389
1	2390
1	2391
1	2392
1	2393
1	2394
1	2395
1	2396
1	2397
1	2398
1	2399
1	2400
1	2401
1	2402
1	2403
1	2404
1	2405
1	2406
1	2407
1	2408
1	2409
1	2410
1	2411
1	2412
1	2413
1	2414
1	2415
1	2416
1	2417
1	2418
1	2419
1	2420
1	2421
1	2422
1	2423
1	2424
1	2425
1	2426
1	2427
1	2428
1	2429
1	2430
1	2431
1	2432
1	2433
1	2434
1	2435
1	2436
1	2437
1	2438
1	2439
1	2440
1	2441
1	2442
1	2443
1	2444
1	2445
1	2446
1	2447
1	2448
1	2449
1	2450
1	2451
1	2452
1	2453
1	2454
1	2455
1	2456
1	2457
1	2458
1	2459
1	2460
1	2461
1	2462
1	2463
1	2464
1	2465
1	2466
1	2467
1	2468
1	2469
1	2470
1	2471
1	2472
1	2473
1	2474
1	2475
1	2476
1	2477
1	2478
1	2479
1	2480
1	2481
1	2482
1	2483
1	2484
1	2485
1	2486
1	2487
1	2488
1	2489
1	2490
1	2491
1	2492
1	2493
1	2494
1	2495
1	2496
1	2497
1	2498
1	2499
1	2500
1	2501
1	2502
1	2503
1	2504
1	2505
1	2506
1	2507
1	2508
1	2509
1	2510
1	2511
1	2512
1	2513
1	2514
1	2515
1	2516
1	2517
1	2518
1	2519
1	2520
1	2521
1	2522
1	2523
1	2524
1	2525
1	2526
1	2527
1	2528
1	2529
1	2530
1	2531
1	2532
1	2533
1	2534
1	2535
1	2536
1	2537
1	2538
1	2539
1	2540
1	2541
1	2542
1	2543
1	2544
1	2545
1	2546
1	2547
1	2548
1	2549
1	2550
1	2551
1	2552
1	2553
1	2554
1	2555
1	2556
1	2557
1	2558
1	2559
1	2560
1	2561
1	2562
1	2563
1	2564
1	2565
1	2566
1	2567
1	2568
1	2569
1	2570
1	2571
1	2572
1	2573
1	2574
1	2575
1	2576
1	2577
1	2578
1	2579
1	2580
1	2581
1	2582
1	2583
1	2584
1	2585
1	2586
1	2587
1	2588
1	2589
1	2590
1	2591
1	2592
1	2593
1	2594
1	2595
1	2596
1	2597
1	2598
1	2599
1	2600
1	2601
1	2602
1	2603
1	2604
1	2605
1	2606
1	2607
1	2608
1	2609
1	2610
1	2611
1	2612
1	2613
1	2614
1	2615
1	2616
1	2617
1	2618
1	2619
1	2620
1	2621
1	2622
1	2623
1	2624
1	2625
1	2626
1	2627
1	2628
1	2629
1	2630
1	2631
1	2632
1	2633
1	2634
1	2635
1	2636
1	2637
1	2638
1	2639
1	2640
1	2641
1	2642
1	2643
1	2644
1	2645
1	2646
1	2647
1	2648
1	2649
1	2650
1	2651
1	2652
1	2653
1	2654
1	2655
1	2656
1	2657
1	2658
1	2659
1	2660
1	2661
1	2662
1	2663
1	2664
1	2665
1	2666
1	2667
1	2668
1	2669
1	2670
1	2671
1	2672
1	2673
1	2674
1	2675
1	2676
1	2677
1	2678
1	2679
1	2680
1	2681
1	2682
1	2683
1	2684
1	2685
1	2686
1	2687
1	2688
1	2689
1	2690
1	2691
1	2692
1	2693
1	2694
1	2695
1	2696
1	2697
1	2698
1	2699
1	2700
1	2701
1	2702
1	2703
1	2704
1	2705
1	2706
1	2707
1	2708
1	2709
1	2710
1	2711
1	2712
1	2713
1	2714
1	2715
1	2716
1	2717
1	2718
1	2719
1	2720
1	2721
1	2722
1	2723
1	2724
1	2725
1	2726
1	2727
1	2728
1	2729
1	2730
1	2731
1	2732
1	2733
1	2734
1	2735
1	2736
1	2737
1	2738
1	2739
1	2740
1	2741
1	2742
1	2743
1	2744
1	2745
1	2746
1	2747
1	2748
1	2749
1	2750
1	2751
1	2752
1	2753
1	2754
1	2755
1	2756
1	2757
1	2758
1	2759
1	2760
1	2761
1	2762
1	2763
1	2764
1	2765
1	2766
1	2767
1	2768
1	2769
1	2770
1	2771
1	2772
1	2773
1	2774
1	2775
1	2776
1	2777
1	2778
1	2779
1	2780
1	2781
1	2782
1	2783
1	2784
1	2785
1	2786
1	2787
1	2788
1	2789
1	2790
1	2791
1	2792
1	2793
1	2794
1	2795
1	2796
1	2797
1	2798
1	2799
1	2800
1	2801
1	2802
1	2803
1	2804
1	2805
1	2806
1	2807
1	2808
1	2809
1	2810
1	2811
1	2812
1	2813
1	2814
1	2815
1	2816
1	2817
1	2818
1	2819
1	2820
1	2821
1	2822
1	2823
1	2824
1	2825
1	2826
1	2827
1	2828
1	2829
1	2830
1	2831
1	2832
1	2833
1	2834
1	2835
1	2836
1	2837
1	2838
1	2839
1	2840
1	2841
1	2842
1	2843
1	2844
1	2845
1	2846
1	2847
1	2848
1	2849
1	2850
1	2851
1	2852
1	2853
1	2854
1	2855
1	2856
1	2857
1	2858
1	2859
1	2860
1	2861
1	2862
1	2863
1	2864
1	2865
1	2866
1	2867
1	2868
1	2869
1	2870
1	2871
1	2872
1	2873
1	2874
1	2875
1	2876
1	2877
1	2878
1	2879
1	2880
1	2881
1	2882
1	2883
1	2884
1	2885
1	2886
1	2887
1	2888
1	2889
1	2890
1	2891
1	2892
1	2893
1	2894
1	2895
1	2896
1	2897
1	2898
1	2899
1	2900
1	2901
1	2902
1	2903
1	2904
1	2905
1	2906
1	2907
1	2908
1	2909
1	2910
1	2911
1	2912
1	2913
1	2914
1	2915
1	2916
1	2917
1	2918
1	2919
1	2920
1	2921
1	2922
1	2923
1	2924
1	2925
1	2926
1	2927
1	2928
1	2929
1	2930
1	2931
1	2932
1	2933
1	2934
1	2935
1	2936
1	2937
1	2938
1	2939
1	2940
1	2941
1	2942
1	2943
1	2944
1	2945
1	2946
1	2947
1	2948
1	2949
1	2950
1	2951
1	2952
1	2953
1	2954
1	2955
1	2956
1	2957
1	2958
1	2959
1	2960
1	2961
1	2962
1	2963
1	2964
1	2965
1	2966
1	2967
1	2968
1	2969
1	2970
1	2971
1	2972
1	2973
1	2974
1	2975
1	2976
1	2977
1	2978
1	2979
1	2980
1	2981
1	2982
1	2983
1	2984
1	2985
1	2986
1	2987
1	2988
1	2989
1	2990
1	2991
1	2992
1	2993
1	2994
1	2995
1	2996
1	2997
1	2998
1	2999
1	3000
1	3001
1	3002
1	3003
1	3004
1	3005
1	3006
1	3007
1	3008
1	3009
1	3010
1	3011
1	3012
1	3013
1	3014
1	3015
1	3016
1	3017
1	3018
1	3019
1	3020
1	3021
1	3022
1	3023
1	3024
1	3025
1	3026
1	3027
1	3028
1	3029
1	3030
1	3031
1	3032
1	3033
1	3034
1	3035
1	3036
1	3037
1	3038
1	3039
1	3040
1	3041
1	3042
1	3043
1	3044
2	3045
2	3046
2	3047
2	3048
2	3049
2	3050
2	3051
2	3052
2	3053
2	3054
2	3055
2	3056
2	3057
2	3058
2	3059
2	3060
2	3061
2	3062
2	3063
2	3064
2	3065
2	3066
2	3067
2	3068
2	3069
2	3070
2	3071
2	3072
2	3073
2	3074
2	3075
2	3076
2	3077
2	3078
2	3079
2	3080
2	3081
2	3082
2	3083
2	3084
2	3085
2	3086
2	3087
2	3088
2	3089
2	3090
2	3091
2	3092
2	3093
2	3094
2	3095
2	3096
2	3097
2	3098
2	3099
2	3100
2	3101
2	3102
2	3103
2	3104
2	3105
2	3106
2	3107
2	3108
2	3109
2	3110
2	3111
2	3112
2	3113
2	3114
2	3115
2	3116
2	3117
2	3118
2	3119
2	3120
2	3121
2	3122
2	3123
2	3124
2	3125
2	3126
2	3127
2	3128
2	3129
2	3130
2	3131
2	3132
2	3133
2	3134
2	3135
2	3136
2	3137
2	3138
2	3139
2	3140
2	3141
2	3142
2	3143
2	3144
2	3145
2	3146
2	3147
2	3148
2	3149
2	3150
2	3151
2	3152
2	3153
2	3154
2	3155
2	3156
2	3157
2	3158
2	3159
2	3160
2	3161
2	3162
2	3163
2	3164
2	3165
2	3166
2	3167
2	3168
2	3169
2	3170
2	3171
2	3172
2	3173
2	3174
2	3175
2	3176
2	3177
2	3178
2	3179
2	3180
2	3181
2	3182
2	3183
2	3184
2	3185
2	3186
2	3187
2	3188
2	3189
2	3190
2	3191
2	3192
2	3193
2	3194
2	3195
2	3196
2	3197
2	3198
2	3199
2	3200
2	3201
2	3202
2	3203
2	3204
2	3205
2	3206
2	3207
2	3208
2	3209
2	3210
2	3211
2	3212
2	3213
2	3214
2	3215
2	3216
2	3217
2	3218
2	3219
2	3220
2	3221
2	3222
2	3223
2	3224
2	3225
2	3226
2	3227
2	3228
2	3229
2	3230
2	3231
2	3232
2	3233
2	3234
2	3235
2	3236
2	3237
2	3238
2	3239
2	3240
2	3241
2	3242
2	3243
2	3244
2	3245
2	3246
2	3247
2	3248
2	3249
2	3250
2	3251
2	3252
2	3253
2	3254
2	3255
2	3256
2	3257
2	3258
2	3259
2	3260
2	3261
2	3262
2	3263
2	3264
2	3265
2	3266
2	3267
2	3268
2	3269
2	3270
2	3271
2	3272
2	3273
2	3274
2	3275
2	3276
2	3277
2	3278
2	3279
2	3280
2	3281
2	3323
2	3324
2	3325
2	3326
2	3327
2	3328
2	3329
2	3330
2	3331
2	3332
2	3333
2	3334
2	3335
2	3336
2	3337
2	3338
2	3339
2	3340
2	3341
2	3342
2	3343
2	3344
2	3345
2	3346
2	3347
2	3348
2	3349
2	3350
2	3351
2	3352
2	3353
2	3354
2	3355
2	3356
2	3357
2	3358
2	3359
2	3360
2	3361
2	3362
2	3363
2	3364
2	3365
2	3366
2	3367
2	3368
2	3369
2	3370
2	3371
2	3372
2	3373
2	3374
2	3375
2	3376
2	3377
2	3378
2	3379
2	3380
2	3381
2	3382
2	3383
2	3384
2	3385
2	3386
2	3387
2	3388
2	3389
2	3390
2	3391
2	3392
2	3393
2	3394
2	3395
2	3396
2	3397
2	3398
2	3399
2	3400
2	3401
2	3402
2	3403
2	3404
2	3405
2	3406
2	3407
2	3408
2	3409
2	3410
2	3411
2	3412
2	3413
2	3414
2	3415
2	3416
2	2301
2	2302
2	2303
2	2304
2	2305
2	2306
2	3417
2	3418
2	3419
2	2307
2	2308
2	2309
2	2310
2	3420
2	3421
2	3422
2	3423
2	3424
2	3425
2	3426
2	3427
2	3428
2	2311
2	3429
2	3430
2	3431
2	2312
2	2313
2	2314
2	2315
2	2316
2	2317
2	2318
2	2319
2	2320
2	2321
2	2322
2	2323
2	2324
2	3432
2	3433
2	3434
2	3435
2	3436
2	3437
2	2325
2	3438
2	3439
2	3440
2	3441
2	2326
2	2327
2	2328
2	2329
2	2330
2	3442
2	2332
2	2333
2	3443
2	2331
2	2334
2	2335
2	2336
2	2337
2	2338
2	2339
2	2340
2	2341
2	2345
2	2343
2	2344
2	2346
2	2347
2	2348
2	3444
2	3445
2	3446
2	3447
2	3448
2	3449
2	3450
2	3451
2	2349
2	3452
2	3453
2	3454
2	3455
2	3456
2	3457
2	3458
2	3459
2	3460
2	3461
2	3462
2	3463
2	3464
2	3465
2	3466
2	3467
2	3468
2	3469
2	3470
2	3471
2	3472
2	2414
2	3473
2	2415
2	2416
2	2418
2	2419
2	3474
2	3475
2	3476
2	3477
2	3478
2	3479
2	3480
2	3481
2	3482
2	3483
2	3484
2	3485
2	3486
2	3487
2	3488
2	3489
2	3490
2	3491
2	3492
2	3493
2	3494
2	3495
2	3496
2	3497
2	3498
2	3499
2	3500
2	3501
2	3502
2	3503
2	3504
2	3505
2	3506
2	3507
2	3508
2	3509
2	3510
2	3511
2	3512
2	3513
2	3514
2	3515
2	3516
2	3517
2	3518
2	3519
2	3520
2	3521
2	3522
2	3523
2	3524
2	3525
2	3526
2	3527
2	3528
2	3529
2	3530
2	3531
2	3532
2	3533
2	3534
2	3535
2	3536
2	3537
2	3538
2	3539
2	3540
2	3541
2	3542
2	3543
2	3544
2	3545
2	3546
2	3547
2	3548
2	3549
2	3550
2	3551
2	3552
2	3553
2	3554
2	3555
2	3556
2	3557
2	3558
2	3559
2	3560
2	3561
2	3562
2	3563
2	3564
2	3565
2	3566
2	3567
2	3568
2	3569
2	3570
2	3571
2	3572
2	3573
2	3574
2	3575
2	3576
2	3577
2	3578
2	3579
2	3580
2	3581
2	3582
2	3583
2	3584
2	3585
2	3586
2	3587
2	3588
2	3589
2	3590
2	3591
2	3592
2	3593
2	3594
2	3595
2	3596
2	3597
2	3598
2	3599
2	3600
2	3601
2	3602
2	3603
2	3604
2	3605
2	3606
2	3607
2	3608
2	3609
2	3610
2	3611
2	3612
2	3613
2	3614
2	3615
2	3616
2	3617
2	3618
2	3619
2	3620
2	3621
2	3622
2	3623
2	3624
2	3625
2	3626
2	3627
2	3628
2	3629
2	3630
2	3631
2	3632
2	3633
2	3634
2	3635
2	3636
2	3637
2	3638
2	3639
2	3640
2	3641
2	3642
2	3643
2	3644
2	3645
2	3646
2	3647
2	3648
2	3649
2	3650
2	3651
2	3652
2	3653
2	3654
2	3655
2	3656
2	3657
2	3658
2	3659
2	3660
2	3661
2	3662
2	3663
2	3664
2	3665
2	3666
2	3667
2	3668
2	3669
2	3670
2	3671
2	3672
2	3673
2	3674
2	3675
2	3676
2	3677
2	3678
2	3679
2	3680
2	3681
2	3682
2	3683
2	3684
2	3685
2	3686
2	3687
2	3688
2	3689
2	3690
2	3691
2	3692
2	3693
2	3694
2	3695
2	3696
2	3697
2	3698
2	3699
2	3700
2	3701
2	3702
2	3703
2	3704
2	3705
2	3706
2	3707
2	3708
2	3709
2	3710
2	3711
2	3712
2	3713
2	3714
2	3715
2	3716
2	3717
2	3718
2	3719
2	3720
2	3721
2	3722
2	3723
2	3724
2	3725
2	3726
2	3727
2	3728
2	3729
2	3730
2	3731
2	3732
2	3733
2	3734
2	3735
2	3736
2	3737
2	3738
2	3739
2	3740
2	3741
2	3742
2	3743
2	3744
2	3745
2	3746
2	3747
2	3748
2	3749
2	3750
2	3751
2	3752
2	3753
2	3754
2	3755
2	3756
2	3757
2	3758
2	3759
2	3760
2	3761
2	3762
2	3763
2	3764
2	3765
2	3766
2	3767
2	3768
2	3769
2	3770
2	3771
2	3772
2	3773
2	3774
2	3775
2	3776
2	3777
2	3778
2	3779
2	3780
2	3781
2	3782
2	3783
2	3784
2	3785
2	2914
2	3786
2	3787
2	3788
2	3789
2	3790
2	3791
2	3792
2	3793
2	3794
2	3795
2	3796
2	3797
2	3798
2	3799
2	3800
2	3801
2	3802
2	3803
2	3804
2	3805
2	3806
2	3807
2	3808
2	3809
2	3810
2	3811
2	3812
2	3813
2	3814
2	3815
2	3816
2	3817
2	3818
2	3819
2	3820
2	3821
2	3822
2	3823
2	3824
2	3825
2	3826
2	3827
2	3828
2	3829
2	3830
2	3831
2	3832
2	3833
2	3834
2	3835
2	3836
2	3837
2	3838
2	3839
2	3840
2	3841
2	3842
2	3843
2	3844
2	3845
2	3846
2	3847
2	3848
2	3849
2	3850
2	3851
2	3852
2	3853
2	3854
2	3855
2	3856
2	3857
2	3858
2	3859
2	3860
2	3861
2	3862
2	3863
2	3864
2	3865
2	3866
2	3867
2	3868
2	3869
2	3870
2	3871
2	3872
2	3873
2	3874
2	3875
2	3876
2	3877
2	3878
2	3879
2	3880
2	3881
2	3882
2	3883
2	3884
2	3885
2	3886
2	3887
2	3888
2	3889
2	3890
2	3891
2	3892
2	3893
2	3894
2	3895
2	3896
2	3897
2	3898
2	3899
2	3900
2	3901
2	3902
2	3903
2	3904
2	3905
2	3906
2	3907
2	3908
2	3909
2	3910
2	3911
2	3912
2	3913
2	3914
2	3915
2	3916
2	3917
2	3918
2	3919
2	3920
2	3921
2	3922
2	3923
2	3924
2	3925
2	3926
2	3927
2	3928
2	3929
2	3930
2	3931
2	3932
2	3933
2	3934
2	3935
2	3936
2	3937
2	3938
2	3939
2	3940
2	3941
2	3942
2	3943
2	3944
2	3945
2	3946
2	3947
2	3948
2	3949
2	3950
2	3951
2	3952
2	3953
2	3954
2	3955
2	3956
2	3957
2	3958
2	3959
2	3960
2	3961
2	3962
2	3963
2	3964
2	3965
2	3966
2	3967
2	3968
2	3969
2	3970
2	3971
2	3972
2	3973
2	3974
2	3975
2	3976
2	3977
2	3978
2	3979
2	3980
2	3981
2	3982
2	3983
2	3984
2	3985
2	3986
2	3987
2	3988
2	3989
2	3990
2	3991
2	3992
2	3993
2	3994
2	3995
2	3996
2	3997
2	3998
2	3999
2	4000
2	4001
2	4002
2	4003
2	4004
2	4005
2	4006
2	4007
2	4008
2	4009
2	4010
2	4011
2	4012
2	4013
2	4014
2	4015
2	4016
2	4017
2	4018
2	4019
2	4020
2	4021
2	4022
2	4023
2	4024
2	4025
2	4026
2	4027
2	4028
2	4029
2	4030
2	4031
2	4032
2	4033
2	4034
2	4035
2	4036
2	4037
2	4038
2	4039
2	4040
2	4041
2	4042
2	4043
2	4044
2	4045
2	4046
2	4047
2	4048
2	4049
2	4050
2	4051
2	4052
2	4053
2	4054
2	4055
2	4056
2	4057
2	4058
2	4059
2	4060
2	4061
2	4062
2	4063
2	4064
2	4065
2	4066
2	4067
2	4068
2	4069
2	4070
2	4071
2	4072
2	4073
2	4074
2	4075
2	4076
2	4077
2	4078
2	4079
2	4080
2	4081
2	4082
2	4083
2	4084
2	4085
2	4086
2	4087
2	4088
2	4089
2	4090
2	4091
2	4092
2	4093
2	4094
2	4095
2	4096
2	4097
2	4098
2	4099
2	4100
2	4101
2	4102
2	4103
2	4104
2	4105
2	4106
2	4107
2	4108
2	4109
2	4110
2	4111
2	4112
2	4113
2	4114
2	4115
2	4116
2	4117
2	4118
2	4119
2	4120
2	4121
2	4122
2	4123
2	4124
2	4125
2	4126
2	4127
2	4128
2	4129
2	4130
2	4131
2	4132
2	4133
2	4134
2	4135
2	4136
2	4137
2	4138
2	4139
2	4140
2	4141
2	4142
2	4143
2	4144
2	4145
2	4146
2	4147
2	4148
2	4149
2	4150
2	4151
2	4152
2	4153
2	4154
2	4155
2	4156
2	4157
2	4158
2	4159
2	4160
2	4161
2	4162
2	4163
2	4164
2	4165
2	4166
2	4167
2	4168
2	4169
2	4170
2	4171
2	4172
2	4173
2	4174
2	4175
2	4176
2	4177
2	4178
2	4179
2	4180
2	4181
2	4182
2	4183
2	4184
2	4185
2	4186
2	4187
2	4188
2	4189
2	4190
2	4191
2	4192
2	4193
2	4194
2	4195
2	4196
2	4197
2	4198
2	4199
2	4200
2	4201
2	4202
2	4203
2	4204
2	4205
2	4206
2	4207
2	4208
2	4209
2	4210
2	4211
2	4212
2	4213
2	4214
2	4215
2	4216
2	4217
2	4218
2	4219
2	4220
2	4221
2	4222
2	4223
2	4224
2	4225
2	4226
2	4227
2	4228
2	4229
2	4230
2	4231
2	4232
2	4233
2	4234
2	4235
2	4236
2	4237
2	4238
2	4239
2	4240
2	4241
2	4242
2	4243
2	4244
2	4245
2	4246
2	4247
2	4248
2	4249
2	4250
2	4251
2	4252
2	4253
2	4254
2	4255
2	4256
2	4257
2	4258
2	4259
2	4260
2	4261
2	4262
2	4263
2	4264
2	4265
2	4266
2	4267
2	4268
2	4269
2	4270
2	4271
2	4272
2	4273
2	4274
2	4275
2	4276
2	4277
2	4278
2	4279
2	4280
2	4281
2	4282
2	4283
2	4284
2	4285
2	4286
2	4287
2	4288
2	4289
2	4290
2	4291
2	4292
2	4293
2	4294
2	4295
2	4296
2	4297
2	4298
2	4299
2	4300
2	4301
2	4302
2	4303
2	4304
2	4305
2	4306
2	4307
2	4308
2	4309
2	4310
2	4311
2	4312
2	4313
2	4314
2	4315
2	4316
2	4317
2	4318
2	4319
2	4320
2	4321
2	4322
2	4323
2	4324
2	4325
2	4326
2	4327
2	4328
2	4329
2	4330
2	4331
2	4332
2	4333
2	4334
2	4335
2	4336
2	4337
2	4338
2	4339
2	4340
2	4341
2	4342
2	4343
2	4344
2	4345
2	4346
2	4347
2	4348
2	4349
2	4350
2	4351
2	4352
2	4353
2	4354
2	4355
2	4356
2	4357
2	4358
2	4359
2	4360
2	4361
2	4362
2	4363
2	4364
2	4365
2	4366
2	4367
2	4368
2	4369
2	4370
2	4371
2	4372
2	4373
2	4374
2	4375
2	4376
2	4377
2	4378
2	4379
2	4380
2	4381
2	4382
2	4383
2	4384
2	4385
2	4386
2	4387
2	2904
2	4388
2	4389
2	4390
2	4391
2	4392
2	4393
2	4394
2	4395
2	4396
2	4397
2	4398
2	4399
2	4400
2	4401
2	4402
2	4403
2	4404
2	4405
2	4406
2	4407
2	4408
2	4409
2	4410
2	4411
2	4412
2	4413
2	4414
2	4415
2	4416
2	4417
2	4418
2	4419
2	4420
2	4421
2	4422
2	4423
2	4424
2	4425
2	4426
2	4427
2	4428
2	4429
2	4430
2	4431
2	4432
2	4433
2	4434
2	4435
2	4436
2	4437
2	4438
2	4439
2	4440
2	4441
2	4442
2	4443
2	4444
2	4445
2	4446
2	4447
2	4448
2	4449
2	4450
2	4451
2	4452
2	4453
2	4454
2	4455
2	4456
2	4457
2	4458
2	4459
2	4460
2	4461
2	4462
2	4463
2	4464
2	4465
2	4466
2	4467
2	4468
2	4469
2	4470
2	4471
2	4472
2	4473
2	4474
2	4475
2	4476
2	4477
2	4478
2	4479
2	4480
2	4481
2	4482
2	4483
2	4484
2	4485
2	4486
2	4487
2	4488
2	4489
2	4490
2	4491
2	4492
2	4493
2	4494
2	4495
2	4496
2	4497
2	4498
2	4499
2	2633
2	4500
2	4501
2	4502
2	4503
2	4504
2	4505
2	4506
2	4507
2	4508
2	4509
2	4510
2	4511
2	4512
2	4513
2	4514
2	4515
2	4516
2	4517
2	4518
2	4519
2	4520
2	4521
2	4522
2	4523
2	4524
2	4525
2	4526
2	4527
2	4528
2	4529
2	4530
2	4531
2	4532
2	4533
2	4534
2	4535
2	4536
2	4537
2	4538
2	4539
2	4540
2	4541
2	4542
2	4543
2	4544
2	4545
2	4546
2	4547
2	4548
2	4549
2	4550
2	4551
2	4552
2	4553
2	4554
2	4555
2	4556
2	4557
2	4558
2	4559
2	4560
2	4561
2	4562
2	4563
2	4564
2	4565
2	4566
2	4567
2	4568
2	4569
2	4570
2	4571
2	4572
2	4573
2	4574
2	4575
2	4576
2	4577
2	4578
2	4579
2	4580
2	4581
2	4582
2	4583
2	4584
2	4585
2	4586
2	4587
2	4588
2	4589
2	4590
2	4591
2	4592
2	4593
2	4594
2	4595
2	4596
2	4597
2	4598
2	4599
2	4600
2	4601
2	4602
2	4603
2	4604
2	4605
2	4606
2	4607
2	4608
2	4609
2	4610
2	4611
2	4612
2	4613
2	4614
2	4615
2	4616
2	4617
2	4618
2	4619
2	4620
2	4621
2	4622
2	4623
2	4624
2	4625
2	4626
2	4627
2	4628
2	4629
2	4630
2	4631
2	4632
2	4633
2	4634
2	4635
2	4636
2	4637
2	4638
2	4639
2	4640
2	4641
2	4642
2	4643
2	4644
2	4645
2	4646
2	4647
2	4648
2	4649
2	4650
2	4651
2	4652
2	4653
2	4654
2	4655
2	4656
2	4657
2	4658
2	4659
2	4660
2	4661
2	4662
2	4663
2	4664
2	4665
2	4666
2	4667
2	4668
2	4669
2	4670
2	4671
2	4672
2	4673
2	4674
2	4675
2	4676
2	4677
2	4678
2	4679
2	4680
2	4681
2	4682
2	4683
2	4684
2	4685
2	4686
2	4687
2	4688
2	4689
2	4690
2	4691
2	4692
2	4693
2	4694
2	4695
2	4696
2	4697
2	4698
2	4699
2	4700
2	4701
2	4702
2	4703
2	4704
2	4705
2	4706
2	4707
2	4708
2	4709
2	4710
2	4711
2	4712
2	4713
2	4714
2	4715
2	4716
2	4717
2	4718
2	4719
2	4720
2	4721
2	4722
2	4723
2	4724
2	4725
2	4726
2	4727
2	4728
2	4729
2	4730
2	4731
2	4732
2	4733
2	4734
2	4735
2	4736
2	4737
2	4738
2	4739
2	4740
2	4741
2	4742
2	4743
2	4744
2	4745
2	4746
2	4747
2	4748
2	4749
2	4750
2	4751
2	4752
2	4753
2	4754
2	4755
2	4756
2	4757
2	4758
2	4759
2	4760
2	4761
2	4762
2	4763
2	4764
2	4765
2	4766
2	4767
2	4768
2	4769
2	4770
2	4771
2	4772
2	4773
2	4774
2	4775
2	4776
2	4777
2	2078
2	4778
2	4779
2	4780
2	4781
2	4782
2	4783
2	4784
2	4785
2	4786
2	4787
2	4788
2	4789
2	4790
2	4791
2	4792
2	4793
2	4794
2	4795
2	4796
2	4797
2	4798
2	4799
2	4800
2	4801
2	4802
2	4803
2	4804
2	4805
2	4806
2	4807
2	4808
2	4809
2	4810
2	4811
2	4812
2	4813
2	4814
2	4815
2	4816
2	4817
2	1688
2	1701
2	1693
2	4818
2	1708
2	4819
2	4820
2	4821
2	4822
2	4823
2	4824
2	1664
2	4825
2	4826
2	4827
2	4828
2	4829
2	4830
2	4831
2	4832
2	4833
2	4834
2	4835
2	4836
2	4837
2	4838
2	4839
2	4840
2	4841
2	4842
2	4843
2	4844
2	4845
2	4846
2	4847
2	4848
2	4849
2	4850
2	4851
2	4852
2	4853
2	4854
2	4855
2	4856
2	4857
2	4858
2	4859
2	4860
2	4861
2	4862
2	4863
2	4864
2	4865
2	4866
2	4867
2	4868
2	2570
2	4869
2	4870
2	4871
2	4872
2	4873
2	4874
2	4875
2	4876
2	4877
2	4878
2	4879
2	4880
2	4881
2	4882
2	4883
2	4884
2	4885
2	4886
2	4887
2	4888
2	4889
2	4890
2	4891
2	4892
2	4893
2	4894
2	4895
2	4896
2	4897
2	4898
2	4899
2	4900
2	4901
2	4902
2	4903
2	4904
2	4905
2	4906
2	4907
2	4908
2	4909
2	4910
2	4911
2	4912
2	4913
2	4914
2	4915
2	4916
2	4917
2	4918
2	4919
2	4920
2	4921
2	4922
2	4923
2	4924
2	4925
2	4926
2	4927
2	4928
2	4929
2	4930
2	4931
2	4932
2	4933
2	4934
2	4935
2	4936
2	4937
2	4938
2	4939
2	4940
2	4941
2	4942
2	4943
2	4944
2	4945
2	4946
2	4947
2	4948
2	4949
2	4950
2	4951
2	4952
2	4953
2	4954
2	4955
2	4956
2	4957
2	4958
2	4959
2	4960
2	4961
2	4962
2	4963
2	4964
2	4965
2	4966
2	4967
2	4968
2	4969
2	4970
2	4971
2	4972
2	4973
2	4974
2	4975
2	4976
2	4977
2	4978
2	4979
2	4980
\.


--
-- Name: diseases_id_seq; Type: SEQUENCE SET; Schema: public; Owner: acoffman
--

SELECT pg_catalog.setval('diseases_id_seq', 63, true);


--
-- Data for Name: drug_interactions; Type: TABLE DATA; Schema: public; Owner: acoffman
--

COPY drug_interactions (id, effect, pathway, therapeutic_context, status, evidence, variant_id, source_id, clinical_association) FROM stdin;
\.


--
-- Name: drug_interactions_id_seq; Type: SEQUENCE SET; Schema: public; Owner: acoffman
--

SELECT pg_catalog.setval('drug_interactions_id_seq', 1, false);


--
-- Name: genes_id_seq; Type: SEQUENCE SET; Schema: public; Owner: acoffman
--

SELECT pg_catalog.setval('genes_id_seq', 73, true);


--
-- Name: locations_id_seq; Type: SEQUENCE SET; Schema: public; Owner: acoffman
--

SELECT pg_catalog.setval('locations_id_seq', 540, true);


--
-- Name: mutation_types_id_seq; Type: SEQUENCE SET; Schema: public; Owner: acoffman
--

SELECT pg_catalog.setval('mutation_types_id_seq', 5, true);


--
-- Data for Name: schema_migrations; Type: TABLE DATA; Schema: public; Owner: acoffman
--

COPY schema_migrations (version) FROM stdin;
20140224185736
20140307221921
20140328160937
20140328183844
20140401211108
20140402163345
20140709150748
20140908201835
20140909212322
20140910203359
20140917182544
20140917193015
20140917201703
20140924205020
20140925154732
20150206205847
20150617174045
20150715153937
20151209194223
20160203194352
20160203214847
20160209164657
20160309160747
20160419175927
20160419191118
20160419212717
20160427160413
20160427171018
20160428200903
20160428201207
20160428202128
20160503180826
20160504202856
20160506142500
20160506144358
20160506150717
20160506200403
\.


--
-- Name: sources_id_seq; Type: SEQUENCE SET; Schema: public; Owner: acoffman
--

SELECT pg_catalog.setval('sources_id_seq', 611, true);


--
-- Data for Name: submitted_variants; Type: TABLE DATA; Schema: public; Owner: acoffman
--

COPY submitted_variants (id, meta, tags, message, chromosome, start, stop, reference, variant, doid, pubmed_id, status, transcript, amino_acid_change, gene_symbol, strand, cdna_change, created_at, updated_at, batch_id, ensembl_gene_id, mutation_type) FROM stdin;
2552	\N	\N		5	112175390	112175390	C	T	DOID:9256	24518971	included	ENST00000257430	p.Q1367*	APC	1	c.4099	2016-05-18 21:06:54.757726	2016-05-18 21:27:58.200273	5	ENSG00000134982	stop
2553	\N	\N		5	112175390	112175390	C	T	DOID:9256	1338904	included	ENST00000257430	p.Q1367*	APC	1	c.4099	2016-05-18 21:06:54.766968	2016-05-18 21:27:58.272438	5	ENSG00000134982	stop
2	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/nras/81\\"}}"	\N		1	115256528	115256528	T	A	DOID:1909	11853795	included	ENST00000369535	p.Q61H	NRAS	-1	c.183	2016-05-18 19:53:30.456859	2016-05-18 20:38:34.731758	1	ENSG00000213281	missense
1689	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"ruxolitinib\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"18805579, 22955920\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		9	5078362	5078362	A	C	DOID:9952	22955920	included	ENST00000381652	p.R683S	JAK2	1	c.2049	2016-05-18 20:50:26.435387	2016-05-18 21:26:48.1276	4	ENSG00000096968	missense
1690	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"ruxolitinib\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"18805579, 22955920\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		9	5078362	5078362	A	T	DOID:9952	19470474	included	ENST00000381652	p.R683S	JAK2	1	c.2049	2016-05-18 20:50:26.451866	2016-05-18 21:26:48.194939	4	ENSG00000096968	missense
1691	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"ruxolitinib\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"18805579, 22955920\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		9	5078362	5078362	A	T	DOID:9952	22368270	included	ENST00000381652	p.R683S	JAK2	1	c.2049	2016-05-18 20:50:26.468038	2016-05-18 21:26:48.258511	4	ENSG00000096968	missense
2542	\N	\N		5	112175303	112175303	C	T	DOID:9256	8187091	included	ENST00000257430	p.Q1338*	APC	1	c.4012	2016-05-18 21:06:54.66259	2016-05-18 21:27:57.642245	5	ENSG00000134982	stop
34	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/nras/297\\"}}"	\N		1	115258745	115258745	C	A	DOID:1909	1528264	included	ENST00000369535	p.G13C	NRAS	-1	c.37	2016-05-18 19:53:30.9947	2016-05-18 20:38:36.460378	1	ENSG00000213281	missense
1674	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"ponatinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"NCCN guidelines\\",\\"Evidence\\":\\"consensus\\",\\"Source\\":\\"NCCN\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"AURK inhibitors + BCR-ABL1 inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22772060\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		9	133748283	133748283	C	T	DOID:9952	22772060	included	ENST00000372348	p.T334I	ABL1	1	c.1001	2016-05-18 20:50:26.142623	2016-05-18 21:26:47.216388	4	ENSG00000097007	missense
1675	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"ruxolitinib (in SH2B3 deleted)\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22897847, 22955920\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"mTOR inhibitors  (in SH2B3 deleted)\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22955920\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		5	35873597	35873597	A	T	DOID:9952	22897847	included	ENST00000303115	p.S185C	IL7R	1	c.553	2016-05-18 20:50:26.169407	2016-05-18 21:26:47.295101	4	ENSG00000168685	missense
1676	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"ruxolitinib (in SH2B3 deleted)\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22897847, 22955920\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"mTOR inhibitors  (in SH2B3 deleted)\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22955920\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		5	35873597	35873597	A	T	DOID:9952	22955920	included	ENST00000303115	p.S185C	IL7R	1	c.553	2016-05-18 20:50:26.213615	2016-05-18 21:26:47.362636	4	ENSG00000168685	missense
1677	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"ruxolitinib\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22955920\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		1	65312382	65312382	G	A	DOID:9952	22955920	included	ENST00000342505	p.S646F	JAK1	-1	c.1937	2016-05-18 20:50:26.234441	2016-05-18 21:26:47.436682	4	ENSG00000162434	missense
1678	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"ruxolitinib\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"18805579, 22955920\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		9	5078360	5078360	A	G	DOID:9952	19470474	included	ENST00000381652	p.R683G	JAK2	1	c.2047	2016-05-18 20:50:26.254473	2016-05-18 21:26:47.486993	4	ENSG00000096968	missense
1679	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"ruxolitinib\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"18805579, 22955920\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		9	5078360	5078360	A	G	DOID:9952	22368270	included	ENST00000381652	p.R683G	JAK2	1	c.2047	2016-05-18 20:50:26.27543	2016-05-18 21:26:47.546012	4	ENSG00000096968	missense
1680	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"ruxolitinib\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"18805579, 22955920\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		9	5078360	5078360	A	G	DOID:9952	18805579	included	ENST00000381652	p.R683G	JAK2	1	c.2047	2016-05-18 20:50:26.293072	2016-05-18 21:26:47.620942	4	ENSG00000096968	missense
2427	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"19915144\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		15	66729152	66729152	G	T	DOID:162	19915144	included	ENST00000307102	p.E120D	MAP2K1	1	c.360	2016-05-18 20:50:49.391905	2016-05-18 21:27:49.274697	4	ENSG00000169032	missense
65	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/nras/85\\"}}"	\N		1	115258747	115258747	C	G	DOID:1909	21901162	included	ENST00000369535	p.G12A	NRAS	-1	c.35	2016-05-18 19:53:31.536073	2016-05-18 20:38:38.030883	1	ENSG00000213281	missense
1681	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"ruxolitinib\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"18805579, 22955920\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		9	5078360	5078360	A	G	DOID:9952	22955920	included	ENST00000381652	p.R683G	JAK2	1	c.2047	2016-05-18 20:50:26.31076	2016-05-18 21:26:47.672093	4	ENSG00000096968	missense
1682	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"ruxolitinib\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"18805579, 22955920\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		9	5078361	5078361	G	C	DOID:9952	19470474	included	ENST00000381652	p.R683T	JAK2	1	c.2048	2016-05-18 20:50:26.328854	2016-05-18 21:26:47.735389	4	ENSG00000096968	missense
2554	\N	\N		5	112175390	112175390	C	T	DOID:9256	10737795	included	ENST00000257430	p.Q1367*	APC	1	c.4099	2016-05-18 21:06:54.775843	2016-05-18 21:27:58.350098	5	ENSG00000134982	stop
2555	\N	\N		5	112175390	112175390	C	T	DOID:9256	22810696	included	ENST00000257430	p.Q1367*	APC	1	c.4099	2016-05-18 21:06:54.785463	2016-05-18 21:27:58.401827	5	ENSG00000134982	stop
2556	\N	\N		5	112175390	112175390	C	T	DOID:9256	25157968	included	ENST00000257430	p.Q1367*	APC	1	c.4099	2016-05-18 21:06:54.797918	2016-05-18 21:27:58.452153	5	ENSG00000134982	stop
2557	\N	\N		5	112175423	112175423	C	T	DOID:9256	8187091	included	ENST00000257430	p.Q1378*	APC	1	c.4132	2016-05-18 21:06:54.807014	2016-05-18 21:27:58.565099	5	ENSG00000134982	stop
2558	\N	\N		5	112175423	112175423	C	T	DOID:9256	23700467	included	ENST00000257430	p.Q1378*	APC	1	c.4132	2016-05-18 21:06:54.816332	2016-05-18 21:27:58.624812	5	ENSG00000134982	stop
99	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/lung-cancer/nras/87\\"}}"	\N		1	115258747	115258747	C	T	DOID:3908	21129611	included	ENST00000369535	p.G12D	NRAS	-1	c.35	2016-05-18 19:53:32.115839	2016-05-18 20:38:39.661765	1	ENSG00000213281	missense
100	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/lung-cancer/nras/87\\"}}"	\N		1	115258747	115258747	C	T	DOID:3908	20350999	included	ENST00000369535	p.G12D	NRAS	-1	c.35	2016-05-18 19:53:32.145106	2016-05-18 20:38:39.715115	1	ENSG00000213281	missense
1683	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"ruxolitinib\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"18805579, 22955920\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		9	5078361	5078361	G	C	DOID:9952	22368270	included	ENST00000381652	p.R683T	JAK2	1	c.2048	2016-05-18 20:50:26.343786	2016-05-18 21:26:47.79238	4	ENSG00000096968	missense
2559	\N	\N		5	112175423	112175423	C	T	DOID:9256	17704924	included	ENST00000257430	p.Q1378*	APC	1	c.4132	2016-05-18 21:06:54.827837	2016-05-18 21:27:58.684549	5	ENSG00000134982	stop
2560	\N	\N		5	112175423	112175423	C	T	DOID:9256	18992635	included	ENST00000257430	p.Q1378*	APC	1	c.4132	2016-05-18 21:06:54.8367	2016-05-18 21:27:58.750079	5	ENSG00000134982	stop
2561	\N	\N		5	112175423	112175423	C	T	DOID:9256	25157968	included	ENST00000257430	p.Q1378*	APC	1	c.4132	2016-05-18 21:06:54.845375	2016-05-18 21:27:58.803231	5	ENSG00000134982	stop
2562	\N	\N		5	112175426	112175426	G	T	DOID:9256	8187091	included	ENST00000257430	p.E1379*	APC	1	c.4135	2016-05-18 21:06:54.856776	2016-05-18 21:27:58.87972	5	ENSG00000134982	stop
2563	\N	\N		5	112175426	112175426	G	T	DOID:9256	1528264	included	ENST00000257430	p.E1379*	APC	1	c.4135	2016-05-18 21:06:54.865099	2016-05-18 21:27:58.933428	5	ENSG00000134982	stop
2564	\N	\N		5	112175426	112175426	G	T	DOID:9256	24861525	included	ENST00000257430	p.E1379*	APC	1	c.4135	2016-05-18 21:06:54.874557	2016-05-18 21:27:58.988982	5	ENSG00000134982	stop
2565	\N	\N		5	112175426	112175426	G	T	DOID:9256	22810696	included	ENST00000257430	p.E1379*	APC	1	c.4135	2016-05-18 21:06:54.88676	2016-05-18 21:27:59.05173	5	ENSG00000134982	stop
2566	\N	\N		5	112175426	112175426	G	T	DOID:9256	25157968	included	ENST00000257430	p.E1379*	APC	1	c.4135	2016-05-18 21:06:54.895644	2016-05-18 21:27:59.104431	5	ENSG00000134982	stop
66	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/nras/85\\"}}"	\N		1	115258747	115258747	C	G	DOID:1909	1338904	included	ENST00000369535	p.G12A	NRAS	-1	c.35	2016-05-18 19:53:31.545164	2016-05-18 20:38:38.070891	1	ENSG00000213281	missense
1684	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"ruxolitinib\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"18805579, 22955920\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		9	5078361	5078361	G	C	DOID:9952	18805579	included	ENST00000381652	p.R683T	JAK2	1	c.2048	2016-05-18 20:50:26.359794	2016-05-18 21:26:47.845046	4	ENSG00000096968	missense
1685	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"ruxolitinib\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"18805579, 22955920\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		9	5078361	5078361	G	C	DOID:9952	22955920	included	ENST00000381652	p.R683T	JAK2	1	c.2048	2016-05-18 20:50:26.372351	2016-05-18 21:26:47.894971	4	ENSG00000096968	missense
1686	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"ruxolitinib\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"18805579, 22955920\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		9	5078362	5078362	A	C	DOID:9952	19470474	included	ENST00000381652	p.R683S	JAK2	1	c.2049	2016-05-18 20:50:26.386554	2016-05-18 21:26:47.952888	4	ENSG00000096968	missense
2610	\N	\N		9	133738356	133738356	G	C	DOID:8552	24109527	included	ENST00000372348	p.Q271H	ABL1	1	c.813	2016-05-18 21:06:55.320315	2016-05-18 21:28:01.89958	5	ENSG00000097007	missense
2612	\N	\N		9	133738356	133738356	G	C	DOID:8552	12623848	included	ENST00000372348	p.Q271H	ABL1	1	c.813	2016-05-18 21:06:55.337341	2016-05-18 21:28:02.013086	5	ENSG00000097007	missense
162	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/89\\"}}"	\N		1	115258748	115258748	C	T	DOID:9256	20921465	included	ENST00000369535	p.G12S	NRAS	-1	c.34	2016-05-18 19:53:33.230625	2016-05-18 20:38:42.766075	1	ENSG00000213281	missense
1433	\N	\N		1	115258748	115258748	C	T	DOID:9119	16618717	included	ENST00000369535	p.G12S	NRAS	-1	c.34	2016-05-18 20:26:14.730392	2016-05-18 20:39:58.9298	2	ENSG00000213281	missense
1688	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"ruxolitinib\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"18805579, 22955920\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		9	5078362	5078362	A	C	DOID:9952	18805579	included	ENST00000381652	p.R683S	JAK2	1	c.2049	2016-05-18 20:50:26.414481	2016-05-18 21:26:48.070694	4	ENSG00000096968	missense
2567	\N	\N		5	112175576	112175576	C	T	DOID:9256	8187091	included	ENST00000257430	p.Q1429*	APC	1	c.4285	2016-05-18 21:06:54.90432	2016-05-18 21:27:59.191548	5	ENSG00000134982	stop
2568	\N	\N		5	112175576	112175576	C	T	DOID:9256	1528264	included	ENST00000257430	p.Q1429*	APC	1	c.4285	2016-05-18 21:06:54.912454	2016-05-18 21:27:59.253126	5	ENSG00000134982	stop
2569	\N	\N		5	112175576	112175576	C	T	DOID:9256	22810696	included	ENST00000257430	p.Q1429*	APC	1	c.4285	2016-05-18 21:06:54.923924	2016-05-18 21:27:59.313484	5	ENSG00000134982	stop
2570	\N	\N		5	112175576	112175576	C	T	DOID:9256	22848674	included	ENST00000257430	p.Q1429*	APC	1	c.4285	2016-05-18 21:06:54.93311	2016-05-18 21:27:59.36842	5	ENSG00000134982	stop
97	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/nras/87\\"}}"	\N		1	115258747	115258747	C	T	DOID:1909	22310681	included	ENST00000369535	p.G12D	NRAS	-1	c.35	2016-05-18 19:53:32.091969	2016-05-18 20:38:39.55448	1	ENSG00000213281	missense
1692	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"ruxolitinib\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"18805579, 22955920\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		9	5078362	5078362	A	T	DOID:9952	18805579	included	ENST00000381652	p.R683S	JAK2	1	c.2049	2016-05-18 20:50:26.483538	2016-05-18 21:26:48.310427	4	ENSG00000096968	missense
1724	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"dabrafenib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23470635, 22608338\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	140453136	140453136	A	T	DOID:9253	19561230	included	ENST00000288602	p.V600E	BRAF	-1	c.1799	2016-05-18 20:50:27.340609	2016-05-18 21:26:49.975542	4	ENSG00000157764	missense
129	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/nras/88\\"}}"	\N		1	115258748	115258748	C	G	DOID:1909	21228335	included	ENST00000369535	p.G12R	NRAS	-1	c.34	2016-05-18 19:53:32.651993	2016-05-18 20:38:41.193809	1	ENSG00000213281	missense
1693	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"ruxolitinib\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"18805579, 22955920\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		9	5078362	5078362	A	T	DOID:9952	22955920	included	ENST00000381652	p.R683S	JAK2	1	c.2049	2016-05-18 20:50:26.499184	2016-05-18 21:26:48.354948	4	ENSG00000096968	missense
2571	\N	\N		5	112175576	112175576	C	T	DOID:9256	12374230	included	ENST00000257430	p.Q1429*	APC	1	c.4285	2016-05-18 21:06:54.942184	2016-05-18 21:27:59.431707	5	ENSG00000134982	stop
161	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/89\\"}}"	\N		1	115258748	115258748	C	T	DOID:9256	21228335	included	ENST00000369535	p.G12S	NRAS	-1	c.34	2016-05-18 19:53:33.220777	2016-05-18 20:38:42.725983	1	ENSG00000213281	missense
1747	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"imatinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23582185, 21689725, 17259998\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		4	55599339	55599339	A	T	DOID:9253	23582185	included	ENST00000288135	p.N822I	KIT	1	c.2465	2016-05-18 20:50:27.947434	2016-05-18 21:26:51.493532	4	ENSG00000157404	missense
2572	\N	\N		5	112175576	112175576	C	T	DOID:9256	10737795	included	ENST00000257430	p.Q1429*	APC	1	c.4285	2016-05-18 21:06:54.9523	2016-05-18 21:27:59.485435	5	ENSG00000134982	stop
192	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/ovarian-cancer/pten/137\\"}}"	\N		10	89692904	89692904	C	T	DOID:2394	19114683	included	ENST00000371953	p.R130*	PTEN	1	c.388	2016-05-18 19:53:33.727839	2016-05-18 20:38:44.258944	1	ENSG00000171862	stop
1694	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"cetuximab, panitumumab\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"late trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"20619739, 21163703, 23325582\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors +/- MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22608338, J Clin Oncol 2010;28:(suppl; abstr 3534), J Clin Oncol 2012;30:(suppl; abstr 3528)\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors + EGFR inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22281684\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors + PI3K pathway inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23251002, 23549875\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"proteosome inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"24107445.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"preclinical\\",\\"Assocation\\":\\"mTOR inhibitors + BH3 mimetics\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"24163374\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	140453136	140453136	A	T	DOID:9256	19537845	included	ENST00000288602	p.V600E	BRAF	-1	c.1799	2016-05-18 20:50:26.518684	2016-05-18 21:26:48.407119	4	ENSG00000157764	missense
1758	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"imatinib, sunitinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"late trials, preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22718859, 16638875\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"HSP90 inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"18794084\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"crenolanib\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22745105\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"dasatinib\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"18794084\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		4	55152093	55152093	A	T	DOID:9253	22718859	included	ENST00000257290	p.D842V	PDGFRA	1	c.2525	2016-05-18 20:50:28.283948	2016-05-18 21:26:52.234893	4	ENSG00000134853	missense
2573	\N	\N		5	112175576	112175576	C	T	DOID:9256	25157968	included	ENST00000257430	p.Q1429*	APC	1	c.4285	2016-05-18 21:06:54.962352	2016-05-18 21:27:59.543559	5	ENSG00000134982	stop
2574	\N	\N		5	112175639	112175639	C	T	DOID:9256	8187091	included	ENST00000257430	p.R1450*	APC	1	c.4348	2016-05-18 21:06:54.971454	2016-05-18 21:27:59.630542	5	ENSG00000134982	stop
206	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/breast-cancer/pten/24\\"}}"	\N		10	89692993	89692993	G	T	DOID:1612	19679400	included	ENST00000371953	p.R159S	PTEN	1	c.477	2016-05-18 19:53:33.939805	2016-05-18 20:38:45.015344	1	ENSG00000171862	missense
1695	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"cetuximab, panitumumab\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"late trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"20619739, 21163703, 23325582\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors +/- MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22608338, J Clin Oncol 2010;28:(suppl; abstr 3534), J Clin Oncol 2012;30:(suppl; abstr 3528)\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors + EGFR inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22281684\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors + PI3K pathway inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23251002, 23549875\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"proteosome inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"24107445.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"preclinical\\",\\"Assocation\\":\\"mTOR inhibitors + BH3 mimetics\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"24163374\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	140453136	140453136	A	T	DOID:9256	21129611	included	ENST00000288602	p.V600E	BRAF	-1	c.1799	2016-05-18 20:50:26.540247	2016-05-18 21:26:48.471762	4	ENSG00000157764	missense
1696	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"cetuximab, panitumumab\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"late trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"20619739, 21163703, 23325582\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors +/- MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22608338, J Clin Oncol 2010;28:(suppl; abstr 3534), J Clin Oncol 2012;30:(suppl; abstr 3528)\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors + EGFR inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22281684\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors + PI3K pathway inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23251002, 23549875\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"proteosome inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"24107445.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"preclinical\\",\\"Assocation\\":\\"mTOR inhibitors + BH3 mimetics\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"24163374\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	140453136	140453136	A	T	DOID:9256	20350999	included	ENST00000288602	p.V600E	BRAF	-1	c.1799	2016-05-18 20:50:26.565704	2016-05-18 21:26:48.523744	4	ENSG00000157764	missense
1939	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"crizotinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22277784\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"ceritinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"FDA-approved\\",\\"Evidence\\":\\"consensus\\",\\"Source\\":\\"24670165\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		2	29432682	29432682	C	G	DOID:3910	24670165	included	ENST00000389048	p.G1269A	ALK	-1	c.3806	2016-05-18 20:50:34.380854	2016-05-18 21:27:08.113321	4	ENSG00000171094	missense
347	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/160\\"}}"	\N		12	25378647	25378647	T	G	DOID:9256	20619739	included	ENST00000256078	p.K117N	KRAS	-1	c.351	2016-05-18 19:53:35.880382	2016-05-18 20:38:54.136503	1	ENSG00000133703	missense
1151	\N	\N		4	55594221	55594221	A	G	DOID:1909	19513541	included	ENST00000288135	p.K642E	KIT	1	c.1924	2016-05-18 19:53:48.647381	2016-05-18 20:39:42.798963	1	ENSG00000157404	missense
1773	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"quizartinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22504184\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"ponatinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23430109\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"sorafenib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22368270\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"midostaurin\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"20733134\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"lestaurtinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"16857985.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		13	28592640	28592640	A	C	DOID:9119	22504183	included	ENST00000380982	p.D835E	FLT3	-1	c.2505	2016-05-18 20:50:28.854471	2016-05-18 21:26:53.286301	4	ENSG00000122025	missense
378	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/lung-cancer/kras/30\\"}}"	\N		12	25380275	25380275	T	G	DOID:3908	19366826	included	ENST00000256078	p.Q61H	KRAS	-1	c.183	2016-05-18 19:53:36.42137	2016-05-18 20:38:55.783734	1	ENSG00000133703	missense
1778	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"quizartinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22504184\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"ponatinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23430109\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"sorafenib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22368270\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"midostaurin\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"20733134\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"lestaurtinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"16857985.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		13	28592640	28592640	A	C	DOID:9119	23430109	included	ENST00000380982	p.D835E	FLT3	-1	c.2505	2016-05-18 20:50:29.059703	2016-05-18 21:26:53.665962	4	ENSG00000122025	missense
419	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/43\\"}}"	\N		12	25380276	25380276	T	C	DOID:1781	15016963	included	ENST00000256078	p.Q61R	KRAS	-1	c.182	2016-05-18 19:53:37.121635	2016-05-18 20:38:57.907455	1	ENSG00000133703	missense
1783	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"quizartinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22504184\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"ponatinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23430109\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"sorafenib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22368270\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"midostaurin\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"20733134\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"lestaurtinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"16857985.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		13	28592640	28592640	A	T	DOID:9119	23321257	included	ENST00000380982	p.D835E	FLT3	-1	c.2505	2016-05-18 20:50:29.266263	2016-05-18 21:26:54.127086	4	ENSG00000122025	missense
223	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/pten/24\\"}}"	\N		10	89692993	89692993	G	T	DOID:9256	20921462	included	ENST00000371953	p.R159S	PTEN	1	c.477	2016-05-18 19:53:34.102494	2016-05-18 20:38:45.887708	1	ENSG00000171862	missense
1697	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"cetuximab, panitumumab\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"late trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"20619739, 21163703, 23325582\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors +/- MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22608338, J Clin Oncol 2010;28:(suppl; abstr 3534), J Clin Oncol 2012;30:(suppl; abstr 3528)\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors + EGFR inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22281684\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors + PI3K pathway inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23251002, 23549875\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"proteosome inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"24107445.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"preclinical\\",\\"Assocation\\":\\"mTOR inhibitors + BH3 mimetics\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"24163374\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	140453136	140453136	A	T	DOID:9256	12068308	included	ENST00000288602	p.V600E	BRAF	-1	c.1799	2016-05-18 20:50:26.584829	2016-05-18 21:26:48.56911	4	ENSG00000157764	missense
1698	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"cetuximab, panitumumab\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"late trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"20619739, 21163703, 23325582\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors +/- MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22608338, J Clin Oncol 2010;28:(suppl; abstr 3534), J Clin Oncol 2012;30:(suppl; abstr 3528)\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors + EGFR inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22281684\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors + PI3K pathway inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23251002, 23549875\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"proteosome inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"24107445.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"preclinical\\",\\"Assocation\\":\\"mTOR inhibitors + BH3 mimetics\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"24163374\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	140453136	140453136	A	T	DOID:9256	21163703	included	ENST00000288602	p.V600E	BRAF	-1	c.1799	2016-05-18 20:50:26.608398	2016-05-18 21:26:48.616179	4	ENSG00000157764	missense
2575	\N	\N		5	112175639	112175639	C	T	DOID:9256	1528264	included	ENST00000257430	p.R1450*	APC	1	c.4348	2016-05-18 21:06:54.982425	2016-05-18 21:27:59.698906	5	ENSG00000134982	stop
2576	\N	\N		5	112175639	112175639	C	T	DOID:9256	24861525	included	ENST00000257430	p.R1450*	APC	1	c.4348	2016-05-18 21:06:54.991364	2016-05-18 21:27:59.776941	5	ENSG00000134982	stop
471	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/lung-cancer/kras/41\\"}}"	\N		12	25380277	25380277	G	T	DOID:3908	12821112	included	ENST00000256078	p.Q61K	KRAS	-1	c.181	2016-05-18 19:53:38.055461	2016-05-18 20:39:00.963291	1	ENSG00000133703	missense
472	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/lung-cancer/kras/41\\"}}"	\N		12	25380277	25380277	G	T	DOID:3908	8898652	included	ENST00000256078	p.Q61K	KRAS	-1	c.181	2016-05-18 19:53:38.064548	2016-05-18 20:39:01.019894	1	ENSG00000133703	missense
1793	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"quizartinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22504184\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"ponatinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23430109\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"sorafenib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22368270\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"midostaurin\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"20733134\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"lestaurtinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"16857985.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		13	28592640	28592640	A	T	DOID:9119	16857985	included	ENST00000380982	p.D835E	FLT3	-1	c.2505	2016-05-18 20:50:29.728317	2016-05-18 21:26:54.939133	4	ENSG00000122025	missense
2698	\N	\N		9	133748290	133748290	C	G	DOID:8552	21489624	included	ENST00000372348	p.F336L	ABL1	1	c.1008	2016-05-18 21:06:56.726689	2016-05-18 21:28:06.63567	5	ENSG00000097007	missense
502	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/68\\"}}"	\N		12	25398281	25398281	C	G	DOID:9256	17994767	included	ENST00000256078	p.G13A	KRAS	-1	c.38	2016-05-18 19:53:38.589002	2016-05-18 20:39:02.813716	1	ENSG00000133703	missense
1417	\N	\N		1	115258747	115258747	C	T	DOID:9119	20350999	included	ENST00000369535	p.G12D	NRAS	-1	c.35	2016-05-18 20:26:14.564229	2016-05-18 20:39:58.085517	2	ENSG00000213281	missense
1700	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"cetuximab, panitumumab\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"late trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"20619739, 21163703, 23325582\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors +/- MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22608338, J Clin Oncol 2010;28:(suppl; abstr 3534), J Clin Oncol 2012;30:(suppl; abstr 3528)\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors + EGFR inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22281684\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors + PI3K pathway inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23251002, 23549875\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"proteosome inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"24107445.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"preclinical\\",\\"Assocation\\":\\"mTOR inhibitors + BH3 mimetics\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"24163374\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	140453136	140453136	A	T	DOID:9256	20413299	included	ENST00000288602	p.V600E	BRAF	-1	c.1799	2016-05-18 20:50:26.648624	2016-05-18 21:26:48.710579	4	ENSG00000157764	missense
1701	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"cetuximab, panitumumab\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"late trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"20619739, 21163703, 23325582\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors +/- MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22608338, J Clin Oncol 2010;28:(suppl; abstr 3534), J Clin Oncol 2012;30:(suppl; abstr 3528)\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors + EGFR inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22281684\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors + PI3K pathway inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23251002, 23549875\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"proteosome inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"24107445.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"preclinical\\",\\"Assocation\\":\\"mTOR inhibitors + BH3 mimetics\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"24163374\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	140453136	140453136	A	T	DOID:9256	21426297	included	ENST00000288602	p.V600E	BRAF	-1	c.1799	2016-05-18 20:50:26.674297	2016-05-18 21:26:48.769103	4	ENSG00000157764	missense
2577	\N	\N		5	112175639	112175639	C	T	DOID:9256	22810696	included	ENST00000257430	p.R1450*	APC	1	c.4348	2016-05-18 21:06:55.001638	2016-05-18 21:27:59.829445	5	ENSG00000134982	stop
533	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/38\\"}}"	\N		12	25398282	25398282	C	A	DOID:9256	17259998	included	ENST00000256078	p.G13C	KRAS	-1	c.37	2016-05-18 19:53:38.889006	2016-05-18 20:39:04.576002	1	ENSG00000133703	missense
534	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/40\\"}}"	\N		12	25398282	25398282	C	G	DOID:1781	23582185	included	ENST00000256078	p.G13R	KRAS	-1	c.37	2016-05-18 19:53:38.898842	2016-05-18 20:39:04.635491	1	ENSG00000133703	missense
1702	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"cetuximab, panitumumab\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"late trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"20619739, 21163703, 23325582\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors +/- MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22608338, J Clin Oncol 2010;28:(suppl; abstr 3534), J Clin Oncol 2012;30:(suppl; abstr 3528)\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors + EGFR inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22281684\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors + PI3K pathway inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23251002, 23549875\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"proteosome inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"24107445.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"preclinical\\",\\"Assocation\\":\\"mTOR inhibitors + BH3 mimetics\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"24163374\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	140453136	140453136	A	T	DOID:9256	22281684	included	ENST00000288602	p.V600E	BRAF	-1	c.1799	2016-05-18 20:50:26.698697	2016-05-18 21:26:48.827139	4	ENSG00000157764	missense
1703	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"cetuximab, panitumumab\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"late trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"20619739, 21163703, 23325582\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors +/- MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22608338, J Clin Oncol 2010;28:(suppl; abstr 3534), J Clin Oncol 2012;30:(suppl; abstr 3528)\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors + EGFR inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22281684\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors + PI3K pathway inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23251002, 23549875\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"proteosome inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"24107445.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"preclinical\\",\\"Assocation\\":\\"mTOR inhibitors + BH3 mimetics\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"24163374\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	140453136	140453136	A	T	DOID:9256	22448344	included	ENST00000288602	p.V600E	BRAF	-1	c.1799	2016-05-18 20:50:26.716617	2016-05-18 21:26:48.876156	4	ENSG00000157764	missense
2578	\N	\N		5	112175639	112175639	C	T	DOID:9256	23204322	included	ENST00000257430	p.R1450*	APC	1	c.4348	2016-05-18 21:06:55.01713	2016-05-18 21:27:59.878734	5	ENSG00000134982	stop
564	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/lung-cancer/kras/34\\"}}"	\N		12	25398284	25398284	C	T	DOID:3908	15928335	included	ENST00000256078	p.G12D	KRAS	-1	c.35	2016-05-18 19:53:39.204631	2016-05-18 20:39:06.267261	1	ENSG00000133703	missense
1423	\N	\N		1	115258748	115258748	C	A	DOID:9119	20350999	included	ENST00000369535	p.G12C	NRAS	-1	c.34	2016-05-18 20:26:14.627451	2016-05-18 20:39:58.429231	2	ENSG00000213281	missense
1704	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"cetuximab, panitumumab\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"late trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"20619739, 21163703, 23325582\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors +/- MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22608338, J Clin Oncol 2010;28:(suppl; abstr 3534), J Clin Oncol 2012;30:(suppl; abstr 3528)\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors + EGFR inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22281684\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors + PI3K pathway inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23251002, 23549875\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"proteosome inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"24107445.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"preclinical\\",\\"Assocation\\":\\"mTOR inhibitors + BH3 mimetics\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"24163374\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	140453136	140453136	A	T	DOID:9256	22180495	included	ENST00000288602	p.V600E	BRAF	-1	c.1799	2016-05-18 20:50:26.742117	2016-05-18 21:26:48.928098	4	ENSG00000157764	missense
1705	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"cetuximab, panitumumab\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"late trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"20619739, 21163703, 23325582\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors +/- MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22608338, J Clin Oncol 2010;28:(suppl; abstr 3534), J Clin Oncol 2012;30:(suppl; abstr 3528)\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors + EGFR inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22281684\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors + PI3K pathway inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23251002, 23549875\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"proteosome inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"24107445.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"preclinical\\",\\"Assocation\\":\\"mTOR inhibitors + BH3 mimetics\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"24163374\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	140453136	140453136	A	T	DOID:9256	20619739	included	ENST00000288602	p.V600E	BRAF	-1	c.1799	2016-05-18 20:50:26.766483	2016-05-18 21:26:48.977046	4	ENSG00000157764	missense
2579	\N	\N		5	112175639	112175639	C	T	DOID:9256	21901162	included	ENST00000257430	p.R1450*	APC	1	c.4348	2016-05-18 21:06:55.02685	2016-05-18 21:27:59.942811	5	ENSG00000134982	stop
2580	\N	\N		5	112175639	112175639	C	T	DOID:9256	1338904	included	ENST00000257430	p.R1450*	APC	1	c.4348	2016-05-18 21:06:55.035153	2016-05-18 21:28:00.003859	5	ENSG00000134982	stop
595	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/ovarian-cancer/kras/35\\"}}"	\N		12	25398285	25398285	C	G	DOID:2394	23430109	included	ENST00000256078	p.G12R	KRAS	-1	c.34	2016-05-18 19:53:39.537465	2016-05-18 20:39:07.901604	1	ENSG00000133703	missense
596	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/ovarian-cancer/kras/35\\"}}"	\N		12	25398285	25398285	C	G	DOID:2394	24619500	included	ENST00000256078	p.G12R	KRAS	-1	c.34	2016-05-18 19:53:39.563888	2016-05-18 20:39:07.963141	1	ENSG00000133703	missense
1814	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"quizartinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22504184\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"ponatinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23430109\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"sorafenib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22368270\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"midostaurin\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"20733134\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"lestaurtinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"16857985.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		13	28592641	28592641	T	G	DOID:9119	22504184	included	ENST00000380982	p.D835A	FLT3	-1	c.2504	2016-05-18 20:50:30.6672	2016-05-18 21:26:56.949063	4	ENSG00000122025	missense
626	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/290\\"}}"	\N		13	28592637	28592637	G	C	DOID:9119	23261068	included	ENST00000380982	p.I836M	FLT3	-1	c.2508	2016-05-18 19:53:40.06398	2016-05-18 20:39:09.727802	1	ENSG00000122025	missense
1429	\N	\N		1	115258748	115258748	C	T	DOID:9119	16361624	included	ENST00000369535	p.G12S	NRAS	-1	c.34	2016-05-18 20:26:14.695523	2016-05-18 20:39:58.727816	2	ENSG00000213281	missense
1706	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"cetuximab, panitumumab\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"late trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"20619739, 21163703, 23325582\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors +/- MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22608338, J Clin Oncol 2010;28:(suppl; abstr 3534), J Clin Oncol 2012;30:(suppl; abstr 3528)\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors + EGFR inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22281684\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors + PI3K pathway inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23251002, 23549875\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"proteosome inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"24107445.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"preclinical\\",\\"Assocation\\":\\"mTOR inhibitors + BH3 mimetics\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"24163374\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	140453136	140453136	A	T	DOID:9256	23325582	included	ENST00000288602	p.V600E	BRAF	-1	c.1799	2016-05-18 20:50:26.781486	2016-05-18 21:26:49.03013	4	ENSG00000157764	missense
1818	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"quizartinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22504184\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		13	28592641	28592642	TC	AA	DOID:9119	22504184	included	ENST00000380982	p.D835F	FLT3	-1	c.2503	2016-05-18 20:50:30.773289	2016-05-18 21:26:57.317176	4	ENSG00000122025	missense
2068	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"FGFR inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"18552176, 22238366, 23002168\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		10	123258034	123258034	A	C	DOID:2870	23002168	included	ENST00000457416	p.N550K	FGFR2	-1	c.1650	2016-05-18 20:50:38.564441	2016-05-18 21:27:19.692035	4	ENSG00000066468	missense
254	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/breast-cancer/pten/26\\"}}"	\N		10	89717775	89717775	A	-	DOID:1612	16618717	included	ENST00000371953	p.K267X	PTEN	1	c.800	2016-05-18 19:53:34.409159	2016-05-18 20:38:47.889339	1	ENSG00000171862	frameshift
1707	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"cetuximab, panitumumab\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"late trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"20619739, 21163703, 23325582\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors +/- MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22608338, J Clin Oncol 2010;28:(suppl; abstr 3534), J Clin Oncol 2012;30:(suppl; abstr 3528)\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors + EGFR inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22281684\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors + PI3K pathway inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23251002, 23549875\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"proteosome inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"24107445.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"preclinical\\",\\"Assocation\\":\\"mTOR inhibitors + BH3 mimetics\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"24163374\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	140453136	140453136	A	T	DOID:9256	22608338	included	ENST00000288602	p.V600E	BRAF	-1	c.1799	2016-05-18 20:50:26.808755	2016-05-18 21:26:49.07736	4	ENSG00000157764	missense
1709	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"cetuximab, panitumumab\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"late trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"20619739, 21163703, 23325582\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors +/- MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22608338, J Clin Oncol 2010;28:(suppl; abstr 3534), J Clin Oncol 2012;30:(suppl; abstr 3528)\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors + EGFR inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22281684\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors + PI3K pathway inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23251002, 23549875\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"proteosome inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"24107445.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"preclinical\\",\\"Assocation\\":\\"mTOR inhibitors + BH3 mimetics\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"24163374\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	140453136	140453136	A	T	DOID:9256	23549875	included	ENST00000288602	p.V600E	BRAF	-1	c.1799	2016-05-18 20:50:26.849222	2016-05-18 21:26:49.175934	4	ENSG00000157764	missense
2581	\N	\N		5	112175639	112175639	C	T	DOID:9256	10737795	included	ENST00000257430	p.R1450*	APC	1	c.4348	2016-05-18 21:06:55.044817	2016-05-18 21:28:00.088055	5	ENSG00000134982	stop
686	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/278\\"}}"	\N		13	28592642	28592642	C	G	DOID:9119	20733134	included	ENST00000380982	p.D835H	FLT3	-1	c.2503	2016-05-18 19:53:41.079542	2016-05-18 20:39:13.510762	1	ENSG00000122025	missense
690	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/lung-cancer/akt1/23\\"}}"	\N		14	105246551	105246551	C	T	DOID:3908	22504184	included	ENST00000349310	p.E17K	AKT1	-1	c.49	2016-05-18 19:53:41.148235	2016-05-18 20:39:13.798745	1	ENSG00000142208	missense
1830	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"quizartinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22504184\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"ponatinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23430109\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"sorafenib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22368270\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"midostaurin\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"20733134\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"lestaurtinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"16857985.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		13	28592642	28592642	C	A	DOID:9119	20733134	included	ENST00000380982	p.D835Y	FLT3	-1	c.2503	2016-05-18 20:50:31.031688	2016-05-18 21:26:58.51562	4	ENSG00000122025	missense
2582	\N	\N		5	112175639	112175639	C	T	DOID:9256	18992635	included	ENST00000257430	p.R1450*	APC	1	c.4348	2016-05-18 21:06:55.054776	2016-05-18 21:28:00.170709	5	ENSG00000134982	stop
285	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/306\\"}}"	\N		11	534286	534286	C	G	DOID:1781	17699718	included	ENST00000311189	p.G13R	HRAS	-1	c.37	2016-05-18 19:53:34.828301	2016-05-18 20:38:50.320964	1	ENSG00000174775	missense
1434	\N	\N		1	115258748	115258748	C	T	DOID:9119	20921462	included	ENST00000369535	p.G12S	NRAS	-1	c.34	2016-05-18 20:26:14.745202	2016-05-18 20:39:58.98014	2	ENSG00000213281	missense
1836	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"quizartinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22504184\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"ponatinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23430109\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"sorafenib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22368270\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"midostaurin\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"20733134\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"lestaurtinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"16857985.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		13	28592642	28592642	C	G	DOID:9119	22368270	included	ENST00000380982	p.D835H	FLT3	-1	c.2503	2016-05-18 20:50:31.172035	2016-05-18 21:26:59.816616	4	ENSG00000122025	missense
2750	\N	\N		14	105246551	105246551	C	T	DOID:3908	25157968	included	ENST00000349310	p.E17K	AKT1	-1	c.49	2016-05-18 21:06:58.010377	2016-05-18 21:28:09.24229	5	ENSG00000142208	missense
749	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh2/272\\"}}"	\N		15	90631837	90631837	C	G	DOID:9119	22397365	included	ENST00000330062	p.R172S	IDH2	-1	c.516	2016-05-18 19:53:42.183823	2016-05-18 20:39:17.210102	1	ENSG00000182054	missense
1435	\N	\N		1	36933434	36933434	G	A	DOID:9119	18316791	included	ENST00000373103	p.T618I	CSF3R	-1	c.1853	2016-05-18 20:26:14.757354	2016-05-18 20:39:59.057197	2	ENSG00000119535	missense
1840	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"quizartinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22504184\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"ponatinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23430109\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"sorafenib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22368270\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"midostaurin\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"20733134\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"lestaurtinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"16857985.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		13	28592642	28592642	C	G	DOID:9119	11290608	included	ENST00000380982	p.D835H	FLT3	-1	c.2503	2016-05-18 20:50:31.339559	2016-05-18 21:27:00.286044	4	ENSG00000122025	missense
2583	\N	\N		5	112175639	112175639	C	T	DOID:9256	12374230	included	ENST00000257430	p.R1450*	APC	1	c.4348	2016-05-18 21:06:55.063492	2016-05-18 21:28:00.227604	5	ENSG00000134982	stop
316	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/27\\"}}"	\N		12	25378562	25378562	C	G	DOID:9256	20736745	included	ENST00000256078	p.A146P	KRAS	-1	c.436	2016-05-18 19:53:35.366004	2016-05-18 20:38:52.469758	1	ENSG00000133703	missense
1846	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"quizartinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22504184\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"ponatinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23430109\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"sorafenib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22368270\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"midostaurin\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"20733134\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"lestaurtinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"16857985.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		13	28592642	28592642	C	T	DOID:9119	23321257	included	ENST00000380982	p.D835N	FLT3	-1	c.2503	2016-05-18 20:50:31.583379	2016-05-18 21:27:00.751797	4	ENSG00000122025	missense
810	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/157\\"}}"	\N		18	48591918	48591918	C	T	DOID:9256	19657110	included	ENST00000342988	p.R361C	SMAD4	1	c.1081	2016-05-18 19:53:43.09588	2016-05-18 20:39:21.050882	1	ENSG00000141646	missense
1851	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"quizartinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22504184\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"ponatinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23430109\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"sorafenib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22368270\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"midostaurin\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"20733134\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"lestaurtinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"16857985.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		13	28592642	28592642	C	T	DOID:9119	11290608	included	ENST00000380982	p.D835N	FLT3	-1	c.2503	2016-05-18 20:50:31.784455	2016-05-18 21:27:01.092976	4	ENSG00000122025	missense
345	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/160\\"}}"	\N		12	25378647	25378647	T	G	DOID:9256	22162582	included	ENST00000256078	p.K117N	KRAS	-1	c.351	2016-05-18 19:53:35.849875	2016-05-18 20:38:54.05681	1	ENSG00000133703	missense
1710	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"cetuximab, panitumumab\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"late trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"20619739, 21163703, 23325582\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors +/- MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22608338, J Clin Oncol 2010;28:(suppl; abstr 3534), J Clin Oncol 2012;30:(suppl; abstr 3528)\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors + EGFR inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22281684\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors + PI3K pathway inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23251002, 23549875\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"proteosome inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"24107445.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"preclinical\\",\\"Assocation\\":\\"mTOR inhibitors + BH3 mimetics\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"24163374\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	140453136	140453136	A	T	DOID:9256	24107445	included	ENST00000288602	p.V600E	BRAF	-1	c.1799	2016-05-18 20:50:26.873187	2016-05-18 21:26:49.225482	4	ENSG00000157764	missense
1856	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"quizartinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22504184\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		13	28601359	28601359	A	C	DOID:9119	22504184	included	ENST00000380982	p.F691L	FLT3	-1	c.2073	2016-05-18 20:50:31.98448	2016-05-18 21:27:01.499877	4	ENSG00000122025	missense
346	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/160\\"}}"	\N		12	25378647	25378647	T	G	DOID:9256	19903786	included	ENST00000256078	p.K117N	KRAS	-1	c.351	2016-05-18 19:53:35.870828	2016-05-18 20:38:54.103609	1	ENSG00000133703	missense
1436	\N	\N		1	36933434	36933434	G	A	DOID:9119	19679400	included	ENST00000373103	p.T618I	CSF3R	-1	c.1853	2016-05-18 20:26:14.7666	2016-05-18 20:39:59.098091	2	ENSG00000119535	missense
1861	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"quizartinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23878140\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"crenolanib, PKC412\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"24619500\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		13	28602340	28602340	G	C	DOID:9119	23878140	included	ENST00000380982	p.N676K	FLT3	-1	c.2028	2016-05-18 20:50:32.152298	2016-05-18 21:27:01.895193	4	ENSG00000122025	missense
1862	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"quizartinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23878140\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"crenolanib, PKC412\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"24619500\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		13	28602340	28602340	G	C	DOID:9119	24619500	included	ENST00000380982	p.N676K	FLT3	-1	c.2028	2016-05-18 20:50:32.177771	2016-05-18 21:27:01.974433	4	ENSG00000122025	missense
377	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/lung-cancer/kras/30\\"}}"	\N		12	25380275	25380275	T	G	DOID:3908	20619739	included	ENST00000256078	p.Q61H	KRAS	-1	c.183	2016-05-18 19:53:36.411818	2016-05-18 20:38:55.735771	1	ENSG00000133703	missense
1711	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"cetuximab, panitumumab\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"late trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"20619739, 21163703, 23325582\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors +/- MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22608338, J Clin Oncol 2010;28:(suppl; abstr 3534), J Clin Oncol 2012;30:(suppl; abstr 3528)\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors + EGFR inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22281684\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors + PI3K pathway inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23251002, 23549875\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"proteosome inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"24107445.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"preclinical\\",\\"Assocation\\":\\"mTOR inhibitors + BH3 mimetics\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"24163374\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	140453136	140453136	A	T	DOID:9256	24163374	included	ENST00000288602	p.V600E	BRAF	-1	c.1799	2016-05-18 20:50:26.9066	2016-05-18 21:26:49.280008	4	ENSG00000157764	missense
1713	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"panitumumab\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"FDA-rejected\\",\\"Evidence\\":\\"consensus\\",\\"Source\\":\\"FDA\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"cetuximab\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"late trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22734028, 20978259\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors + PI3K pathway inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22392911\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		12	25398281	25398281	C	T	DOID:9256	18316791	included	ENST00000256078	p.G13D	KRAS	-1	c.38	2016-05-18 20:50:26.946208	2016-05-18 21:26:49.380452	4	ENSG00000133703	missense
1874	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"IDH inhibitor\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"AACR 2014; abstr CT103\\",\\"Effect\\":\\"switch-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		15	90631838	90631838	C	T	DOID:9119	22160010	included	ENST00000330062	p.R172K	IDH2	-1	c.515	2016-05-18 20:50:32.575379	2016-05-18 21:27:02.917178	4	ENSG00000182054	missense
935	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/16\\"}}"	\N		3	178936094	178936094	C	A	DOID:1612	21838707	included	ENST00000263967	p.Q546K	PIK3CA	1	c.1636	2016-05-18 19:53:44.809566	2016-05-18 20:39:28.811987	1	ENSG00000121879	missense
936	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/ovarian-cancer/pik3ca/16\\"}}"	\N		3	178936094	178936094	C	A	DOID:2394	22072639	included	ENST00000263967	p.Q546K	PIK3CA	1	c.1636	2016-05-18 19:53:44.834685	2016-05-18 20:39:28.870449	1	ENSG00000121879	missense
1714	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"panitumumab\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"FDA-rejected\\",\\"Evidence\\":\\"consensus\\",\\"Source\\":\\"FDA\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"cetuximab\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"late trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22734028, 20978259\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors + PI3K pathway inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22392911\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		12	25398281	25398281	C	T	DOID:9256	19679400	included	ENST00000256078	p.G13D	KRAS	-1	c.38	2016-05-18 20:50:26.983719	2016-05-18 21:26:49.424313	4	ENSG00000133703	missense
2584	\N	\N		5	112175639	112175639	C	T	DOID:9256	23700467	included	ENST00000257430	p.R1450*	APC	1	c.4348	2016-05-18 21:06:55.072338	2016-05-18 21:28:00.286102	5	ENSG00000134982	stop
2585	\N	\N		5	112175639	112175639	C	T	DOID:9256	25157968	included	ENST00000257430	p.R1450*	APC	1	c.4348	2016-05-18 21:06:55.081805	2016-05-18 21:28:00.347983	5	ENSG00000134982	stop
408	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/lung-cancer/kras/42\\"}}"	\N		12	25380276	25380276	T	A	DOID:3908	19366826	included	ENST00000256078	p.Q61L	KRAS	-1	c.182	2016-05-18 19:53:36.952517	2016-05-18 20:38:57.343569	1	ENSG00000133703	missense
1437	\N	\N		1	36933434	36933434	G	A	DOID:9119	16361624	included	ENST00000373103	p.T618I	CSF3R	-1	c.1853	2016-05-18 20:26:14.774131	2016-05-18 20:39:59.160306	2	ENSG00000119535	missense
1715	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"panitumumab\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"FDA-rejected\\",\\"Evidence\\":\\"consensus\\",\\"Source\\":\\"FDA\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"cetuximab\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"late trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22734028, 20978259\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors + PI3K pathway inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22392911\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		12	25398281	25398281	C	T	DOID:9256	16361624	included	ENST00000256078	p.G13D	KRAS	-1	c.38	2016-05-18 20:50:27.016991	2016-05-18 21:26:49.472957	4	ENSG00000133703	missense
439	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/43\\"}}"	\N		12	25380276	25380276	T	C	DOID:9256	15016963	included	ENST00000256078	p.Q61R	KRAS	-1	c.182	2016-05-18 19:53:37.487967	2016-05-18 20:38:58.976339	1	ENSG00000133703	missense
997	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/kit/132\\"}}"	\N		4	55593600	55593601	-	CTC	DOID:1909	18611285	included	ENST00000288135	p.Q556LX	KIT	1	c.1666	2016-05-18 19:53:45.922378	2016-05-18 20:39:32.510521	1	ENSG00000157404	frameshift
1904	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"JAK inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"18397343\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		19	17945969	17945969	C	T	DOID:8761	18397343	included	ENST00000458235	p.R657Q	JAK3	-1	c.1970	2016-05-18 20:50:33.425968	2016-05-18 21:27:04.992165	4	ENSG00000105639	missense
2586	\N	\N		9	133738330	133738330	A	G	DOID:8552	23676790	included	ENST00000372348	p.M263V	ABL1	1	c.787	2016-05-18 21:06:55.091141	2016-05-18 21:28:00.42597	5	ENSG00000097007	missense
470	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/lung-cancer/kras/41\\"}}"	\N		12	25380277	25380277	G	T	DOID:3908	10479724	included	ENST00000256078	p.Q61K	KRAS	-1	c.181	2016-05-18 19:53:38.029427	2016-05-18 20:39:00.898809	1	ENSG00000133703	missense
1918	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"dasatinib, bosutinib, ponatinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"NCCN guidelines\\",\\"Evidence\\":\\"consensus\\",\\"Source\\":\\"21562040\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		9	133748414	133748414	T	A	DOID:8552	21562040	included	ENST00000372348	p.F378I	ABL1	1	c.1132	2016-05-18 20:50:33.797369	2016-05-18 21:27:06.411267	4	ENSG00000097007	missense
479	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/41\\"}}"	\N		12	25380277	25380277	G	T	DOID:9256	8898652	included	ENST00000256078	p.Q61K	KRAS	-1	c.181	2016-05-18 19:53:38.191863	2016-05-18 20:39:01.465309	1	ENSG00000133703	missense
1932	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"rapamycin\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"24631838\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		1	11169361	11169361	C	G	DOID:4451	24631838	included	ENST00000361445	p.R2505P	MTOR	-1	c.7514	2016-05-18 20:50:34.198567	2016-05-18 21:27:07.459535	4	ENSG00000198793	missense
2587	\N	\N		9	133738330	133738330	A	G	DOID:8552	21895409	included	ENST00000372348	p.M263V	ABL1	1	c.787	2016-05-18 21:06:55.100607	2016-05-18 21:28:00.492796	5	ENSG00000097007	missense
501	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/68\\"}}"	\N		12	25398281	25398281	C	G	DOID:9256	9679244	included	ENST00000256078	p.G13A	KRAS	-1	c.38	2016-05-18 19:53:38.564964	2016-05-18 20:39:02.757115	1	ENSG00000133703	missense
1438	\N	\N		1	36933434	36933434	G	A	DOID:9119	19114683	included	ENST00000373103	p.T618I	CSF3R	-1	c.1853	2016-05-18 20:26:14.78663	2016-05-18 20:39:59.198539	2	ENSG00000119535	missense
1940	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"crizotinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22277784\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"ceritinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"FDA-approved\\",\\"Evidence\\":\\"consensus\\",\\"Source\\":\\"24670165\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		2	29443600	29443600	G	T	DOID:3910	22277784	included	ENST00000389048	p.S1206Y	ALK	-1	c.3617	2016-05-18 20:50:34.408149	2016-05-18 21:27:08.198124	4	ENSG00000171094	missense
532	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/38\\"}}"	\N		12	25398282	25398282	C	A	DOID:9256	21689725	included	ENST00000256078	p.G13C	KRAS	-1	c.37	2016-05-18 19:53:38.877735	2016-05-18 20:39:04.530542	1	ENSG00000133703	missense
1126	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/thymic-carcinoma/kit/96\\"}}"	\N		4	55593661	55593661	T	C	DOID:3284	18948947	included	ENST00000288135	p.L576P	KIT	1	c.1727	2016-05-18 19:53:48.205252	2016-05-18 20:39:41.328356	1	ENSG00000157404	missense
1127	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/thymic-carcinoma/kit/96\\"}}"	\N		4	55593661	55593661	T	C	DOID:3284	23515407	included	ENST00000288135	p.L576P	KIT	1	c.1727	2016-05-18 19:53:48.227991	2016-05-18 20:39:41.389748	1	ENSG00000157404	missense
1128	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/thymic-carcinoma/kit/122\\"}}"	\N		4	55593664	55593664	CTTATGATC	-	DOID:3284	12460918	included	ENST00000288135	p.P577X	KIT	1	c.1730	2016-05-18 19:53:48.238314	2016-05-18 20:39:41.45592	1	ENSG00000157404	frameshift
1129	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/thymic-carcinoma/kit/122\\"}}"	\N		4	55593664	55593664	CTTATGATC	-	DOID:3284	18948947	included	ENST00000288135	p.P577X	KIT	1	c.1730	2016-05-18 19:53:48.258036	2016-05-18 20:39:41.523403	1	ENSG00000157404	frameshift
1130	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/thymic-carcinoma/kit/122\\"}}"	\N		4	55593664	55593664	CTTATGATC	-	DOID:3284	23515407	included	ENST00000288135	p.P577X	KIT	1	c.1730	2016-05-18 19:53:48.269138	2016-05-18 20:39:41.578913	1	ENSG00000157404	frameshift
1131	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/kit/132\\"}}"	\N		4	55593669	55593671	GAT	-	DOID:1909	12460918	included	ENST00000288135	p.D579-	KIT	1	c.1735	2016-05-18 19:53:48.313651	2016-05-18 20:39:41.660471	1	ENSG00000157404	inframe
563	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/lung-cancer/kras/34\\"}}"	\N		12	25398284	25398284	C	T	DOID:3908	14645423	included	ENST00000256078	p.G12D	KRAS	-1	c.35	2016-05-18 19:53:39.195443	2016-05-18 20:39:06.215565	1	ENSG00000133703	missense
1181	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/kit/132\\"}}"	\N		4	55594262	55594262	T	A	DOID:1909	20085938	included	ENST00000288135	p.N655K	KIT	1	c.1965	2016-05-18 19:53:49.183497	2016-05-18 20:39:44.486275	1	ENSG00000157404	missense
1183	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/kit/132\\"}}"	\N		4	55594262	55594262	T	A	DOID:1909	19351834	included	ENST00000288135	p.N655K	KIT	1	c.1965	2016-05-18 19:53:49.214857	2016-05-18 20:39:44.603063	1	ENSG00000157404	missense
1184	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/kit/132\\"}}"	\N		4	55594262	55594262	T	G	DOID:1909	22328973	included	ENST00000288135	p.N655K	KIT	1	c.1965	2016-05-18 19:53:49.224036	2016-05-18 20:39:44.688641	1	ENSG00000157404	missense
1185	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/thymic-carcinoma/kit/121\\"}}"	\N		4	55595599	55595599	C	T	DOID:3284	22328973	included	ENST00000288135	p.H697Y	KIT	1	c.2089	2016-05-18 19:53:49.25085	2016-05-18 20:39:44.755446	1	ENSG00000157404	missense
1186	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/kit/84\\"}}"	\N		4	55599320	55599320	G	C	DOID:1909	22328973	included	ENST00000288135	p.D816H	KIT	1	c.2446	2016-05-18 19:53:49.26148	2016-05-18 20:39:44.816337	1	ENSG00000157404	missense
1187	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/kit/274\\"}}"	\N		4	55599320	55599320	G	T	DOID:9119	22328973	included	ENST00000288135	p.D816Y	KIT	1	c.2446	2016-05-18 19:53:49.282981	2016-05-18 20:39:44.888308	1	ENSG00000157404	missense
1189	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/kit/276\\"}}"	\N		4	55599320	55599321	GA	AT	DOID:9119	23102728	included	ENST00000288135	p.D816I	KIT	1	c.2446	2016-05-18 19:53:49.314309	2016-05-18 20:39:45.016084	1	ENSG00000157404	missense
1190	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/kit/132\\"}}"	\N		4	55599321	55599321	A	T	DOID:1909	22753918	included	ENST00000288135	p.D816V	KIT	1	c.2447	2016-05-18 19:53:49.329979	2016-05-18 20:39:45.10476	1	ENSG00000157404	missense
1191	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/kit/132\\"}}"	\N		4	55599321	55599321	A	T	DOID:1909	23102728	included	ENST00000288135	p.D816V	KIT	1	c.2447	2016-05-18 19:53:49.350746	2016-05-18 20:39:45.199347	1	ENSG00000157404	missense
1953	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"ERBB2 TKIs, trastuzumab\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22908275\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		17	37868205	37868205	G	A	DOID:3910	22908275	included	ENST00000269571	p.G309E	ERBB2	1	c.926	2016-05-18 20:50:34.76433	2016-05-18 21:27:09.33637	4	ENSG00000141736	missense
1716	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"panitumumab\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"FDA-rejected\\",\\"Evidence\\":\\"consensus\\",\\"Source\\":\\"FDA\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"cetuximab\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"late trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22734028, 20978259\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors + PI3K pathway inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22392911\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		12	25398281	25398281	C	T	DOID:9256	19114683	included	ENST00000256078	p.G13D	KRAS	-1	c.38	2016-05-18 20:50:27.057571	2016-05-18 21:26:49.519595	4	ENSG00000133703	missense
1717	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"panitumumab\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"FDA-rejected\\",\\"Evidence\\":\\"consensus\\",\\"Source\\":\\"FDA\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"cetuximab\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"late trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22734028, 20978259\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors + PI3K pathway inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22392911\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		12	25398281	25398281	C	T	DOID:9256	21228335	included	ENST00000256078	p.G13D	KRAS	-1	c.38	2016-05-18 20:50:27.091813	2016-05-18 21:26:49.564151	4	ENSG00000133703	missense
1718	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"panitumumab\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"FDA-rejected\\",\\"Evidence\\":\\"consensus\\",\\"Source\\":\\"FDA\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"cetuximab\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"late trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22734028, 20978259\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors + PI3K pathway inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22392911\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		12	25398281	25398281	C	T	DOID:9256	20921465	included	ENST00000256078	p.G13D	KRAS	-1	c.38	2016-05-18 20:50:27.137458	2016-05-18 21:26:49.617191	4	ENSG00000133703	missense
1719	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"panitumumab\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"FDA-rejected\\",\\"Evidence\\":\\"consensus\\",\\"Source\\":\\"FDA\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"cetuximab\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"late trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22734028, 20978259\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors + PI3K pathway inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22392911\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		12	25398281	25398281	C	T	DOID:9256	16618717	included	ENST00000256078	p.G13D	KRAS	-1	c.38	2016-05-18 20:50:27.175778	2016-05-18 21:26:49.69407	4	ENSG00000133703	missense
2588	\N	\N		9	133738330	133738330	A	G	DOID:8552	21888027	included	ENST00000372348	p.M263V	ABL1	1	c.787	2016-05-18 21:06:55.109794	2016-05-18 21:28:00.545949	5	ENSG00000097007	missense
2589	\N	\N		9	133738330	133738330	A	G	DOID:8552	20367437	included	ENST00000372348	p.M263V	ABL1	1	c.787	2016-05-18 21:06:55.119596	2016-05-18 21:28:00.594965	5	ENSG00000097007	missense
1217	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/breast-cancer/er/314/\\"}}"	\N		6	152415537	152415537	T	C	DOID:0060077	22184391	invalid	ENST00000206249	p.S463P	ESR1	1	c.1387	2016-05-18 19:53:49.784007	2016-05-18 20:37:11.085785	1	ENSG00000091831	missense
1219	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/breast-cancer/er/314/\\"}}"	\N		6	152419917	152419917	C	A	DOID:0060077	24124571	invalid	ENST00000206249	p.P535H	ESR1	1	c.1604	2016-05-18 19:53:49.803974	2016-05-18 20:37:11.097203	1	ENSG00000091831	missense
1220	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/breast-cancer/er/314/\\"}}"	\N		6	152419920	152419920	T	G	DOID:0060077	24124571	invalid	ENST00000206249	p.L536R	ESR1	1	c.1607	2016-05-18 19:53:49.813136	2016-05-18 20:37:11.103147	1	ENSG00000091831	missense
1221	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/breast-cancer/er/314/\\"}}"	\N		6	152419922	152419922	T	A	DOID:0060077	19853286	invalid	ENST00000206249	p.Y537N	ESR1	1	c.1609	2016-05-18 19:53:49.825718	2016-05-18 20:37:11.109197	1	ENSG00000091831	missense
1223	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/breast-cancer/er/314/\\"}}"	\N		6	152419923	152419923	A	C	DOID:0060077	22885469	invalid	ENST00000206249	p.Y537S	ESR1	1	c.1610	2016-05-18 19:53:49.845711	2016-05-18 20:37:11.121901	1	ENSG00000091831	missense
593	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/35\\"}}"	\N		12	25398285	25398285	C	G	DOID:1781	21518476	included	ENST00000256078	p.G12R	KRAS	-1	c.34	2016-05-18 19:53:39.513515	2016-05-18 20:39:07.792032	1	ENSG00000133703	missense
1195	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/kit/132\\"}}"	\N		4	55599332	55599332	G	T	DOID:1909	20360610	included	ENST00000288135	p.D820Y	KIT	1	c.2458	2016-05-18 19:53:49.417803	2016-05-18 20:39:45.452866	1	ENSG00000157404	missense
1720	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"panitumumab\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"FDA-rejected\\",\\"Evidence\\":\\"consensus\\",\\"Source\\":\\"FDA\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"cetuximab\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"late trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22734028, 20978259\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors + PI3K pathway inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22392911\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		12	25398281	25398281	C	T	DOID:9256	20921462	included	ENST00000256078	p.G13D	KRAS	-1	c.38	2016-05-18 20:50:27.209293	2016-05-18 21:26:49.751034	4	ENSG00000133703	missense
2590	\N	\N		9	133738330	133738330	A	G	DOID:8552	18223278	included	ENST00000372348	p.M263V	ABL1	1	c.787	2016-05-18 21:06:55.128991	2016-05-18 21:28:00.663435	5	ENSG00000097007	missense
2591	\N	\N		9	133738330	133738330	A	G	DOID:8552	12623848	included	ENST00000372348	p.M263V	ABL1	1	c.787	2016-05-18 21:06:55.137601	2016-05-18 21:28:00.712345	5	ENSG00000097007	missense
2592	\N	\N		9	133738330	133738330	A	G	DOID:8552	12576318	included	ENST00000372348	p.M263V	ABL1	1	c.787	2016-05-18 21:06:55.146461	2016-05-18 21:28:00.783031	5	ENSG00000097007	missense
1232	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/medulloblastoma/smo/163\\"}}"	\N		7	128849189	128849189	G	C	DOID:3858	18552176	invalid	ENST00000249373	p.D473H	SMO	1	c.1417	2016-05-18 19:53:49.936031	2016-05-18 20:37:11.172895	1	ENSG00000128602	missense
2593	\N	\N		9	133738330	133738330	A	G	DOID:8552	12399961	included	ENST00000372348	p.M263V	ABL1	1	c.787	2016-05-18 21:06:55.156976	2016-05-18 21:28:00.840527	5	ENSG00000097007	missense
1234	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/medulloblastoma/smo/163\\"}}"	\N		7	128849189	128849189	G	C	DOID:3858	23002168	invalid	ENST00000249373	p.D473H	SMO	1	c.1417	2016-05-18 19:53:49.958646	2016-05-18 20:37:11.198752	1	ENSG00000128602	missense
1226	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/basal-cell-carcinoma/smo/164\\"}}"	\N		7	128829195	128829196	CC	TT	DOID:2513	23908597	included	ENST00000249373	p.A68V	SMO	1	c.203	2016-05-18 19:53:49.877315	2016-05-18 20:39:46.919984	1	ENSG00000128602	missense
1227	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/basal-cell-carcinoma/smo/165\\"}}"	\N		7	128845101	128845101	C	T	DOID:2513	23908597	included	ENST00000249373	p.R199W	SMO	1	c.595	2016-05-18 19:53:49.887787	2016-05-18 20:39:46.987394	1	ENSG00000128602	missense
1721	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"panitumumab\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"FDA-rejected\\",\\"Evidence\\":\\"consensus\\",\\"Source\\":\\"FDA\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"cetuximab\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"late trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22734028, 20978259\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors + PI3K pathway inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22392911\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		12	25398281	25398281	C	T	DOID:9256	22734028	included	ENST00000256078	p.G13D	KRAS	-1	c.38	2016-05-18 20:50:27.23936	2016-05-18 21:26:49.807585	4	ENSG00000133703	missense
2594	\N	\N		9	133738330	133738330	A	G	DOID:8552	25157968	included	ENST00000372348	p.M263V	ABL1	1	c.787	2016-05-18 21:06:55.166829	2016-05-18 21:28:00.90249	5	ENSG00000097007	missense
2595	\N	\N		9	133738342	133738342	C	G	DOID:8552	17008892	included	ENST00000372348	p.L267V	ABL1	1	c.799	2016-05-18 21:06:55.176448	2016-05-18 21:28:00.96958	5	ENSG00000097007	missense
2596	\N	\N		9	133738342	133738342	C	G	DOID:8552	21221851	included	ENST00000372348	p.L267V	ABL1	1	c.799	2016-05-18 21:06:55.186351	2016-05-18 21:28:01.035819	5	ENSG00000097007	missense
2597	\N	\N		9	133738342	133738342	C	G	DOID:8552	18354488	included	ENST00000372348	p.L267V	ABL1	1	c.799	2016-05-18 21:06:55.195711	2016-05-18 21:28:01.099892	5	ENSG00000097007	missense
1257	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/149\\"}}"	\N		7	140453154	140453154	T	A	DOID:9256	21975775	included	ENST00000288602	p.D594V	BRAF	-1	c.1781	2016-05-18 19:53:50.291602	2016-05-18 20:39:49.05022	1	ENSG00000157764	missense
1722	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"panitumumab\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"FDA-rejected\\",\\"Evidence\\":\\"consensus\\",\\"Source\\":\\"FDA\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"cetuximab\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"late trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22734028, 20978259\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors + PI3K pathway inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22392911\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		12	25398281	25398281	C	T	DOID:9256	20978259	included	ENST00000256078	p.G13D	KRAS	-1	c.38	2016-05-18 20:50:27.276452	2016-05-18 21:26:49.858322	4	ENSG00000133703	missense
2105	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23248257\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	140453133	140453133	T	C	DOID:1909	23248257	included	ENST00000288602	p.K601R	BRAF	-1	c.1802	2016-05-18 20:50:39.603549	2016-05-18 21:27:22.96815	4	ENSG00000157764	missense
2598	\N	\N		9	133738342	133738342	C	G	DOID:8552	12623848	included	ENST00000372348	p.L267V	ABL1	1	c.799	2016-05-18 21:06:55.204207	2016-05-18 21:28:01.148668	5	ENSG00000097007	missense
1288	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/146\\"}}"	\N		7	140481402	140481402	C	T	DOID:9256	22271473	included	ENST00000288602	p.G469E	BRAF	-1	c.1406	2016-05-18 19:53:50.669102	2016-05-18 20:39:50.972387	1	ENSG00000157764	missense
1439	\N	\N		1	36933434	36933434	G	A	DOID:9119	21228335	included	ENST00000373103	p.T618I	CSF3R	-1	c.1853	2016-05-18 20:26:14.799104	2016-05-18 20:39:59.241691	2	ENSG00000119535	missense
1723	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"panitumumab\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"FDA-rejected\\",\\"Evidence\\":\\"consensus\\",\\"Source\\":\\"FDA\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"cetuximab\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"late trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22734028, 20978259\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors + PI3K pathway inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22392911\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		12	25398281	25398281	C	T	DOID:9256	22392911	included	ENST00000256078	p.G13D	KRAS	-1	c.38	2016-05-18 20:50:27.311598	2016-05-18 21:26:49.926229	4	ENSG00000133703	missense
2599	\N	\N		9	133738342	133738342	C	G	DOID:8552	20367437	included	ENST00000372348	p.L267V	ABL1	1	c.799	2016-05-18 21:06:55.216059	2016-05-18 21:28:01.217296	5	ENSG00000097007	missense
2600	\N	\N		9	133738342	133738342	C	G	DOID:8552	25157968	included	ENST00000372348	p.L267V	ABL1	1	c.799	2016-05-18 21:06:55.225805	2016-05-18 21:28:01.271503	5	ENSG00000097007	missense
2601	\N	\N		9	133738349	133738349	G	A	DOID:8552	21505103	included	ENST00000372348	p.G269E	ABL1	1	c.806	2016-05-18 21:06:55.234076	2016-05-18 21:28:01.352626	5	ENSG00000097007	missense
2602	\N	\N		9	133738349	133738349	G	A	DOID:8552	11964322	included	ENST00000372348	p.G269E	ABL1	1	c.806	2016-05-18 21:06:55.24443	2016-05-18 21:28:01.403094	5	ENSG00000097007	missense
1319	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/jak2/202\\"}}"	\N		9	5078362	5078362	A	C	DOID:1037	22805292	included	ENST00000381652	p.R683S	JAK2	1	c.2049	2016-05-18 19:53:51.233018	2016-05-18 20:39:52.842565	1	ENSG00000096968	missense
1725	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"dabrafenib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23470635, 22608338\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	140453136	140453136	A	T	DOID:9253	12068308	included	ENST00000288602	p.V600E	BRAF	-1	c.1799	2016-05-18 20:50:27.378385	2016-05-18 21:26:50.025708	4	ENSG00000157764	missense
1726	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"dabrafenib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23470635, 22608338\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	140453136	140453136	A	T	DOID:9253	20818844	included	ENST00000288602	p.V600E	BRAF	-1	c.1799	2016-05-18 20:50:27.410743	2016-05-18 21:26:50.077962	4	ENSG00000157764	missense
2603	\N	\N		9	133738349	133738349	G	A	DOID:8552	12623848	included	ENST00000372348	p.G269E	ABL1	1	c.806	2016-05-18 21:06:55.254698	2016-05-18 21:28:01.471807	5	ENSG00000097007	missense
2604	\N	\N		9	133738349	133738349	G	A	DOID:8552	20367437	included	ENST00000372348	p.G269E	ABL1	1	c.806	2016-05-18 21:06:55.263315	2016-05-18 21:28:01.545725	5	ENSG00000097007	missense
2605	\N	\N		9	133738349	133738349	G	A	DOID:8552	21895409	included	ENST00000372348	p.G269E	ABL1	1	c.806	2016-05-18 21:06:55.272421	2016-05-18 21:28:01.605402	5	ENSG00000097007	missense
594	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/ovarian-cancer/kras/35\\"}}"	\N		12	25398285	25398285	C	G	DOID:2394	22504184	included	ENST00000256078	p.G12R	KRAS	-1	c.34	2016-05-18 19:53:39.528175	2016-05-18 20:39:07.847209	1	ENSG00000133703	missense
1727	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"dabrafenib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23470635, 22608338\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	140453136	140453136	A	T	DOID:9253	21639808	included	ENST00000288602	p.V600E	BRAF	-1	c.1799	2016-05-18 20:50:27.422675	2016-05-18 21:26:50.137034	4	ENSG00000157764	missense
1728	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"dabrafenib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23470635, 22608338\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	140453136	140453136	A	T	DOID:9253	23470635	included	ENST00000288602	p.V600E	BRAF	-1	c.1799	2016-05-18 20:50:27.445648	2016-05-18 21:26:50.2061	4	ENSG00000157764	missense
1729	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"dabrafenib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23470635, 22608338\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	140453136	140453136	A	T	DOID:9253	22608338	included	ENST00000288602	p.V600E	BRAF	-1	c.1799	2016-05-18 20:50:27.482892	2016-05-18 21:26:50.298272	4	ENSG00000157764	missense
1730	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"imatinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23582185, 21689725, 17259998\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		4	55593609	55593609	G	A	DOID:9253	23582185	included	ENST00000288135	p.V559I	KIT	1	c.1675	2016-05-18 20:50:27.510795	2016-05-18 21:26:50.405055	4	ENSG00000157404	missense
1731	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"imatinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23582185, 21689725, 17259998\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		4	55593609	55593609	G	A	DOID:9253	21689725	included	ENST00000288135	p.V559I	KIT	1	c.1675	2016-05-18 20:50:27.52144	2016-05-18 21:26:50.46523	4	ENSG00000157404	missense
1732	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"imatinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23582185, 21689725, 17259998\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		4	55593609	55593609	G	A	DOID:9253	17259998	included	ENST00000288135	p.V559I	KIT	1	c.1675	2016-05-18 20:50:27.551757	2016-05-18 21:26:50.543636	4	ENSG00000157404	missense
1733	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"imatinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23582185, 21689725, 17259998\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		4	55593610	55593610	T	A	DOID:9253	23582185	included	ENST00000288135	p.V559D	KIT	1	c.1676	2016-05-18 20:50:27.583235	2016-05-18 21:26:50.602606	4	ENSG00000157404	missense
1734	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"imatinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23582185, 21689725, 17259998\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		4	55593610	55593610	T	A	DOID:9253	21689725	included	ENST00000288135	p.V559D	KIT	1	c.1676	2016-05-18 20:50:27.620349	2016-05-18 21:26:50.665457	4	ENSG00000157404	missense
1735	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"imatinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23582185, 21689725, 17259998\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		4	55593610	55593610	T	A	DOID:9253	17259998	included	ENST00000288135	p.V559D	KIT	1	c.1676	2016-05-18 20:50:27.646586	2016-05-18 21:26:50.728259	4	ENSG00000157404	missense
1736	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"imatinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23582185, 21689725, 17259998\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		4	55594258	55594258	T	C	DOID:9253	23582185	included	ENST00000288135	p.V654A	KIT	1	c.1961	2016-05-18 20:50:27.658881	2016-05-18 21:26:50.787109	4	ENSG00000157404	missense
2606	\N	\N		9	133738349	133738349	G	A	DOID:8552	22870928	included	ENST00000372348	p.G269E	ABL1	1	c.806	2016-05-18 21:06:55.283094	2016-05-18 21:28:01.652712	5	ENSG00000097007	missense
2607	\N	\N		9	133738349	133738349	G	A	DOID:8552	23676790	included	ENST00000372348	p.G269E	ABL1	1	c.806	2016-05-18 21:06:55.29192	2016-05-18 21:28:01.699033	5	ENSG00000097007	missense
1	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/nras/81\\"}}"	\N		1	115256528	115256528	T	A	DOID:1909	18615627	included	ENST00000369535	p.Q61H	NRAS	-1	c.183	2016-05-18 19:53:30.436675	2016-05-18 20:38:34.682771	1	ENSG00000213281	missense
1738	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"imatinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23582185, 21689725, 17259998\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		4	55594258	55594258	T	C	DOID:9253	17259998	included	ENST00000288135	p.V654A	KIT	1	c.1961	2016-05-18 20:50:27.7214	2016-05-18 21:26:50.908219	4	ENSG00000157404	missense
1739	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"imatinib\\",\\"Assocation\\":\\"decreased sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"16751810\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		4	55594258	55594258	T	C	DOID:9253	16751810	included	ENST00000288135	p.V654A	KIT	1	c.1961	2016-05-18 20:50:27.753165	2016-05-18 21:26:50.968431	4	ENSG00000157404	missense
1740	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"imatinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"24687822\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		4	55595519	55595519	C	T	DOID:9253	24687822	included	ENST00000288135	p.T670I	KIT	1	c.2009	2016-05-18 20:50:27.776456	2016-05-18 21:26:51.047045	4	ENSG00000157404	missense
1741	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"imatinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23582185, 21689725, 17259998\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		4	55595519	55595519	C	T	DOID:9253	23582185	included	ENST00000288135	p.T670I	KIT	1	c.2009	2016-05-18 20:50:27.794439	2016-05-18 21:26:51.103041	4	ENSG00000157404	missense
1742	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"imatinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23582185, 21689725, 17259998\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		4	55595519	55595519	C	T	DOID:9253	21689725	included	ENST00000288135	p.T670I	KIT	1	c.2009	2016-05-18 20:50:27.818762	2016-05-18 21:26:51.167533	4	ENSG00000157404	missense
1743	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"imatinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23582185, 21689725, 17259998\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		4	55595519	55595519	C	T	DOID:9253	17259998	included	ENST00000288135	p.T670I	KIT	1	c.2009	2016-05-18 20:50:27.853357	2016-05-18 21:26:51.228788	4	ENSG00000157404	missense
1744	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"imatinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23582185, 21689725, 17259998\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		4	55599321	55599321	A	T	DOID:9253	23582185	included	ENST00000288135	p.D816V	KIT	1	c.2447	2016-05-18 20:50:27.88473	2016-05-18 21:26:51.300811	4	ENSG00000157404	missense
2608	\N	\N		9	133738349	133738349	G	A	DOID:8552	25157968	included	ENST00000372348	p.G269E	ABL1	1	c.806	2016-05-18 21:06:55.300077	2016-05-18 21:28:01.744629	5	ENSG00000097007	missense
2609	\N	\N		9	133738356	133738356	G	C	DOID:8552	15256422	included	ENST00000372348	p.Q271H	ABL1	1	c.813	2016-05-18 21:06:55.310181	2016-05-18 21:28:01.833847	5	ENSG00000097007	missense
2611	\N	\N		9	133738356	133738356	G	C	DOID:8552	20367437	included	ENST00000372348	p.Q271H	ABL1	1	c.813	2016-05-18 21:06:55.328545	2016-05-18 21:28:01.955796	5	ENSG00000097007	missense
70	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/nras/85\\"}}"	\N		1	115258747	115258747	C	G	DOID:1909	23700467	included	ENST00000369535	p.G12A	NRAS	-1	c.35	2016-05-18 19:53:31.611895	2016-05-18 20:38:38.239671	1	ENSG00000213281	missense
1746	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"imatinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23582185, 21689725, 17259998\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		4	55599321	55599321	A	T	DOID:9253	17259998	included	ENST00000288135	p.D816V	KIT	1	c.2447	2016-05-18 20:50:27.921112	2016-05-18 21:26:51.431108	4	ENSG00000157404	missense
1748	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"imatinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23582185, 21689725, 17259998\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		4	55599339	55599339	A	T	DOID:9253	21689725	included	ENST00000288135	p.N822I	KIT	1	c.2465	2016-05-18 20:50:27.989379	2016-05-18 21:26:51.548587	4	ENSG00000157404	missense
1749	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"imatinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23582185, 21689725, 17259998\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		4	55599339	55599339	A	T	DOID:9253	17259998	included	ENST00000288135	p.N822I	KIT	1	c.2465	2016-05-18 20:50:28.001582	2016-05-18 21:26:51.616616	4	ENSG00000157404	missense
1750	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"imatinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23582185, 21689725, 17259998\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		4	55599341	55599341	T	G	DOID:9253	23582185	included	ENST00000288135	p.Y823D	KIT	1	c.2467	2016-05-18 20:50:28.017822	2016-05-18 21:26:51.680113	4	ENSG00000157404	missense
1751	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"imatinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23582185, 21689725, 17259998\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		4	55599341	55599341	T	G	DOID:9253	21689725	included	ENST00000288135	p.Y823D	KIT	1	c.2467	2016-05-18 20:50:28.053355	2016-05-18 21:26:51.754008	4	ENSG00000157404	missense
212	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/breast-cancer/pten/24\\"}}"	\N		10	89692993	89692993	G	T	DOID:1612	20921462	included	ENST00000371953	p.R159S	PTEN	1	c.477	2016-05-18 19:53:33.999985	2016-05-18 20:38:45.317975	1	ENSG00000171862	missense
1752	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"imatinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23582185, 21689725, 17259998\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		4	55599341	55599341	T	G	DOID:9253	17259998	included	ENST00000288135	p.Y823D	KIT	1	c.2467	2016-05-18 20:50:28.081155	2016-05-18 21:26:51.826175	4	ENSG00000157404	missense
1753	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"imatinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23582185, 21689725, 17259998\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		4	55602664	55602664	G	C	DOID:9253	23582185	included	ENST00000288135	p.A829P	KIT	1	c.2485	2016-05-18 20:50:28.114769	2016-05-18 21:26:51.882184	4	ENSG00000157404	missense
1754	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"imatinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23582185, 21689725, 17259998\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		4	55602664	55602664	G	C	DOID:9253	21689725	included	ENST00000288135	p.A829P	KIT	1	c.2485	2016-05-18 20:50:28.125313	2016-05-18 21:26:51.943421	4	ENSG00000157404	missense
1755	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"imatinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23582185, 21689725, 17259998\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		4	55602664	55602664	G	C	DOID:9253	17259998	included	ENST00000288135	p.A829P	KIT	1	c.2485	2016-05-18 20:50:28.148996	2016-05-18 21:26:52.008359	4	ENSG00000157404	missense
2203	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"lapatinib\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"19718025\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		2	212295699	212295699	C	T	DOID:1909	19718025	included	ENST00000342788	p.E872K	ERBB4	-1	c.2614	2016-05-18 20:50:42.298751	2016-05-18 21:27:30.838896	4	ENSG00000178568	missense
350	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/lung-cancer/kras/31\\"}}"	\N		12	25380275	25380275	T	A	DOID:3908	15647370	included	ENST00000256078	p.Q61H	KRAS	-1	c.183	2016-05-18 19:53:35.936085	2016-05-18 20:38:54.289425	1	ENSG00000133703	missense
1440	\N	\N		1	36933434	36933434	G	A	DOID:9119	20921465	included	ENST00000373103	p.T618I	CSF3R	-1	c.1853	2016-05-18 20:26:14.806985	2016-05-18 20:39:59.302519	2	ENSG00000119535	missense
1941	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"crizotinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22277784\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"ceritinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"FDA-approved\\",\\"Evidence\\":\\"consensus\\",\\"Source\\":\\"24670165\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		2	29443600	29443600	G	T	DOID:3910	24670165	included	ENST00000389048	p.S1206Y	ALK	-1	c.3617	2016-05-18 20:50:34.433197	2016-05-18 21:27:08.297843	4	ENSG00000171094	missense
2613	\N	\N		9	133738356	133738356	G	C	DOID:8552	12399961	included	ENST00000372348	p.Q271H	ABL1	1	c.813	2016-05-18 21:06:55.347618	2016-05-18 21:28:02.08493	5	ENSG00000097007	missense
2614	\N	\N		9	133738356	133738356	G	C	DOID:8552	25157968	included	ENST00000372348	p.Q271H	ABL1	1	c.813	2016-05-18 21:06:55.359974	2016-05-18 21:28:02.140249	5	ENSG00000097007	missense
2615	\N	\N		9	133738356	133738356	G	T	DOID:8552	12623848	included	ENST00000372348	p.Q271H	ABL1	1	c.813	2016-05-18 21:06:55.369047	2016-05-18 21:28:02.22706	5	ENSG00000097007	missense
2616	\N	\N		9	133738356	133738356	G	T	DOID:8552	15256422	included	ENST00000372348	p.Q271H	ABL1	1	c.813	2016-05-18 21:06:55.379242	2016-05-18 21:28:02.285133	5	ENSG00000097007	missense
2617	\N	\N		9	133738356	133738356	G	T	DOID:8552	25157968	included	ENST00000372348	p.Q271H	ABL1	1	c.813	2016-05-18 21:06:55.390376	2016-05-18 21:28:02.354748	5	ENSG00000097007	missense
485	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/159\\"}}"	\N		12	25398281	25398281	C	A	DOID:9256	12821112	included	ENST00000256078	p.G13V	KRAS	-1	c.38	2016-05-18 19:53:38.297889	2016-05-18 20:39:01.820949	1	ENSG00000133703	missense
1943	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"crizotinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22277784\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"ceritinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"FDA-approved\\",\\"Evidence\\":\\"consensus\\",\\"Source\\":\\"24670165, 24327273\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		2	29443631	29443631	G	T	DOID:3910	22277784	included	ENST00000389048	p.L1196M	ALK	-1	c.3586	2016-05-18 20:50:34.473079	2016-05-18 21:27:08.506672	4	ENSG00000171094	missense
2618	\N	\N		9	133738358	133738358	A	T	DOID:8552	20367437	included	ENST00000372348	p.Y272F	ABL1	1	c.815	2016-05-18 21:06:55.400999	2016-05-18 21:28:02.43019	5	ENSG00000097007	missense
2619	\N	\N		9	133738358	133738358	A	T	DOID:8552	12623848	included	ENST00000372348	p.Y272F	ABL1	1	c.815	2016-05-18 21:06:55.410971	2016-05-18 21:28:02.474904	5	ENSG00000097007	missense
2620	\N	\N		9	133738358	133738358	A	T	DOID:8552	12399961	included	ENST00000372348	p.Y272F	ABL1	1	c.815	2016-05-18 21:06:55.421452	2016-05-18 21:28:02.538979	5	ENSG00000097007	missense
2621	\N	\N		9	133738358	133738358	A	T	DOID:8552	25157968	included	ENST00000372348	p.Y272F	ABL1	1	c.815	2016-05-18 21:06:55.430901	2016-05-18 21:28:02.58899	5	ENSG00000097007	missense
2622	\N	\N		9	133738357	133738357	T	C	DOID:8552	23676790	included	ENST00000372348	p.Y272H	ABL1	1	c.814	2016-05-18 21:06:55.439311	2016-05-18 21:28:02.642548	5	ENSG00000097007	missense
624	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/36\\"}}"	\N		12	25398285	25398285	C	T	DOID:9256	20733134	included	ENST00000256078	p.G12S	KRAS	-1	c.34	2016-05-18 19:53:40.033024	2016-05-18 20:39:09.582148	1	ENSG00000133703	missense
2934	\N	\N		3	41266137	41266137	C	G	DOID:0050891	25157968	invalid	ENST00000349496	p.S45C	CTNNB1	1	c.134	2016-05-18 21:07:00.216358	2016-05-18 21:25:20.507408	5	ENSG00000168036	missense
2936	\N	\N		3	41266137	41266137	C	T	DOID:0050891	24788118	invalid	ENST00000349496	p.S45F	CTNNB1	1	c.134	2016-05-18 21:07:00.235347	2016-05-18 21:25:20.518866	5	ENSG00000168036	missense
2937	\N	\N		3	41266136	41266136	T	C	DOID:0050891	25157968	invalid	ENST00000349496	p.S45P	CTNNB1	1	c.133	2016-05-18 21:07:00.243248	2016-05-18 21:25:20.524948	5	ENSG00000168036	missense
1756	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"imatinib, sunitinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"late trials, preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22718859, 16638875\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"HSP90 inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"18794084\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"crenolanib\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22745105\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"dasatinib\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"18794084\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		4	55152093	55152093	A	T	DOID:9253	14645423	included	ENST00000257290	p.D842V	PDGFRA	1	c.2525	2016-05-18 20:50:28.215225	2016-05-18 21:26:52.079492	4	ENSG00000134853	missense
2931	\N	\N		3	41266122	41266122	C	G	DOID:162	25157968	included	ENST00000349496	p.T40S	CTNNB1	1	c.119	2016-05-18 21:07:00.181997	2016-05-18 21:28:19.4859	5	ENSG00000168036	missense
2932	\N	\N		3	41266136	41266136	T	G	DOID:1319	25157968	included	ENST00000349496	p.S45A	CTNNB1	1	c.133	2016-05-18 21:07:00.192916	2016-05-18 21:28:19.535595	5	ENSG00000168036	missense
2939	\N	\N		3	41266137	41266137	C	A	DOID:1909	25157968	included	ENST00000349496	p.S45Y	CTNNB1	1	c.134	2016-05-18 21:07:00.265397	2016-05-18 21:28:19.571849	5	ENSG00000168036	missense
750	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh2/272\\"}}"	\N		15	90631837	90631837	C	G	DOID:9119	20946881	included	ENST00000330062	p.R172S	IDH2	-1	c.516	2016-05-18 19:53:42.193005	2016-05-18 20:39:17.256058	1	ENSG00000182054	missense
1944	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"crizotinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22277784\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"ceritinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"FDA-approved\\",\\"Evidence\\":\\"consensus\\",\\"Source\\":\\"24670165, 24327273\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		2	29443631	29443631	G	T	DOID:3910	24670165	included	ENST00000389048	p.L1196M	ALK	-1	c.3586	2016-05-18 20:50:34.499128	2016-05-18 21:27:08.573624	4	ENSG00000171094	missense
2623	\N	\N		9	133738357	133738357	T	C	DOID:8552	21895409	included	ENST00000372348	p.Y272H	ABL1	1	c.814	2016-05-18 21:06:55.452064	2016-05-18 21:28:02.716626	5	ENSG00000097007	missense
2624	\N	\N		9	133738357	133738357	T	C	DOID:8552	21505103	included	ENST00000372348	p.Y272H	ABL1	1	c.814	2016-05-18 21:06:55.460558	2016-05-18 21:28:02.767986	5	ENSG00000097007	missense
2625	\N	\N		9	133738357	133738357	T	C	DOID:8552	20367437	included	ENST00000372348	p.Y272H	ABL1	1	c.814	2016-05-18 21:06:55.470082	2016-05-18 21:28:02.819289	5	ENSG00000097007	missense
2626	\N	\N		9	133738357	133738357	T	C	DOID:8552	19652056	included	ENST00000372348	p.Y272H	ABL1	1	c.814	2016-05-18 21:06:55.480921	2016-05-18 21:28:02.887466	5	ENSG00000097007	missense
2627	\N	\N		9	133738357	133738357	T	C	DOID:8552	19466505	included	ENST00000372348	p.Y272H	ABL1	1	c.814	2016-05-18 21:06:55.523124	2016-05-18 21:28:02.928272	5	ENSG00000097007	missense
889	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/neuroblastoma/alk/174\\"}}"	\N		2	29445273	29445273	G	A	DOID:769	20367437	included	ENST00000389048	p.T1151M	ALK	-1	c.3452	2016-05-18 19:53:44.042684	2016-05-18 20:39:25.786951	1	ENSG00000171094	missense
1441	\N	\N		1	36933434	36933434	G	A	DOID:9119	16618717	included	ENST00000373103	p.T618I	CSF3R	-1	c.1853	2016-05-18 20:26:14.829405	2016-05-18 20:39:59.344007	2	ENSG00000119535	missense
1945	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"crizotinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22277784\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"ceritinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"FDA-approved\\",\\"Evidence\\":\\"consensus\\",\\"Source\\":\\"24670165, 24327273\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		2	29443631	29443631	G	T	DOID:3910	24327273	included	ENST00000389048	p.L1196M	ALK	-1	c.3586	2016-05-18 20:50:34.537884	2016-05-18 21:27:08.641714	4	ENSG00000171094	missense
2628	\N	\N		9	133738357	133738357	T	C	DOID:8552	15381060	included	ENST00000372348	p.Y272H	ABL1	1	c.814	2016-05-18 21:06:55.53134	2016-05-18 21:28:02.976253	5	ENSG00000097007	missense
2629	\N	\N		9	133738357	133738357	T	C	DOID:8552	15256422	included	ENST00000372348	p.Y272H	ABL1	1	c.814	2016-05-18 21:06:55.540992	2016-05-18 21:28:03.023028	5	ENSG00000097007	missense
2630	\N	\N		9	133738357	133738357	T	C	DOID:8552	14745431	included	ENST00000372348	p.Y272H	ABL1	1	c.814	2016-05-18 21:06:55.59141	2016-05-18 21:28:03.066692	5	ENSG00000097007	missense
2631	\N	\N		9	133738357	133738357	T	C	DOID:8552	14559829	included	ENST00000372348	p.Y272H	ABL1	1	c.814	2016-05-18 21:06:55.599928	2016-05-18 21:28:03.121497	5	ENSG00000097007	missense
2632	\N	\N		9	133738357	133738357	T	C	DOID:8552	12399961	included	ENST00000372348	p.Y272H	ABL1	1	c.814	2016-05-18 21:06:55.610796	2016-05-18 21:28:03.161536	5	ENSG00000097007	missense
1015	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/kit/132\\"}}"	\N		4	55593600	55593601	-	CTT	DOID:1909	16011858	included	ENST00000288135	p.Q556LX	KIT	1	c.1666	2016-05-18 19:53:46.22661	2016-05-18 20:39:33.938912	1	ENSG00000157404	frameshift
1218	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/breast-cancer/er/314/\\"}}"	\N		6	152419914	152419914	T	A	DOID:0060077	24124571	invalid	ENST00000206249	p.V534E	ESR1	1	c.1601	2016-05-18 19:53:49.794311	2016-05-18 20:37:11.091378	1	ENSG00000091831	missense
1222	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/breast-cancer/er/314/\\"}}"	\N		6	152419922	152419922	T	A	DOID:0060077	25157968	invalid	ENST00000206249	p.Y537N	ESR1	1	c.1609	2016-05-18 19:53:49.835892	2016-05-18 20:37:11.116007	1	ENSG00000091831	missense
1224	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/breast-cancer/er/314/\\"}}"	\N		6	152419923	152419923	A	G	DOID:0060077	23908597	invalid	ENST00000206249	p.Y537C	ESR1	1	c.1610	2016-05-18 19:53:49.857268	2016-05-18 20:37:11.128003	1	ENSG00000091831	missense
1233	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/medulloblastoma/smo/163\\"}}"	\N		7	128849189	128849189	G	C	DOID:3858	22238366	invalid	ENST00000249373	p.D473H	SMO	1	c.1417	2016-05-18 19:53:49.948367	2016-05-18 20:37:11.178978	1	ENSG00000128602	missense
2028	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"dasatinib\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22328973\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		1	162729671	162729671	G	T	DOID:3907	22328973	included	ENST00000367921	p.G253C	DDR2	1	c.757	2016-05-18 20:50:37.32008	2016-05-18 21:27:15.719254	4	ENSG00000162733	missense
1182	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/kit/132\\"}}"	\N		4	55594262	55594262	T	A	DOID:1909	11504908	included	ENST00000288135	p.N655K	KIT	1	c.1965	2016-05-18 19:53:49.193372	2016-05-18 20:39:44.543422	1	ENSG00000157404	missense
1188	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/kit/276\\"}}"	\N		4	55599320	55599321	GA	AT	DOID:9119	22753918	included	ENST00000288135	p.D816I	KIT	1	c.2446	2016-05-18 19:53:49.292212	2016-05-18 20:39:44.962311	1	ENSG00000157404	missense
1192	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/kit/275\\"}}"	\N		4	55599321	55599321	A	T	DOID:9119	22753918	included	ENST00000288135	p.D816V	KIT	1	c.2447	2016-05-18 19:53:49.360447	2016-05-18 20:39:45.262167	1	ENSG00000157404	missense
1194	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/kit/84\\"}}"	\N		4	55599332	55599332	G	C	DOID:1909	20360610	included	ENST00000288135	p.D820H	KIT	1	c.2458	2016-05-18 19:53:49.390061	2016-05-18 20:39:45.392595	1	ENSG00000157404	missense
1201	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/kit/132\\"}}"	\N		4	55599340	55599340	T	A	DOID:1909	24190505	included	ENST00000288135	p.N822K	KIT	1	c.2466	2016-05-18 19:53:49.520593	2016-05-18 20:39:45.850348	1	ENSG00000157404	missense
1207	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/kit/132\\"}}"	\N		4	55599341	55599341	T	G	DOID:1909	23375402	included	ENST00000288135	p.Y823D	KIT	1	c.2467	2016-05-18 19:53:49.629604	2016-05-18 20:39:46.307344	1	ENSG00000157404	missense
1442	\N	\N		1	36933434	36933434	G	A	DOID:9119	20921462	included	ENST00000373103	p.T618I	CSF3R	-1	c.1853	2016-05-18 20:26:14.837481	2016-05-18 20:39:59.388973	2	ENSG00000119535	missense
1946	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"crizotinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22277784\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"novel ALK inhibiors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"24327273\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		2	29443695	29443695	G	C	DOID:3910	22277784	included	ENST00000389048	p.F1174L	ALK	-1	c.3522	2016-05-18 20:50:34.566315	2016-05-18 21:27:08.727952	4	ENSG00000171094	missense
2982	\N	\N		7	55249005	55249005	G	T	DOID:1107	16707764	included	ENST00000275493	p.S768I	EGFR	1	c.2303	2016-05-18 21:07:00.954453	2016-05-18 21:28:21.740296	5	ENSG00000146648	missense
2983	\N	\N		7	55249005	55249005	G	T	DOID:3908	25157968	included	ENST00000275493	p.S768I	EGFR	1	c.2303	2016-05-18 21:07:00.972953	2016-05-18 21:28:21.777232	5	ENSG00000146648	missense
2985	\N	\N		7	55249005	55249005	G	T	DOID:3908	19147750	included	ENST00000275493	p.S768I	EGFR	1	c.2303	2016-05-18 21:07:01.008682	2016-05-18 21:28:21.863144	5	ENSG00000146648	missense
2986	\N	\N		7	55249020	55249020	A	G	DOID:3908	25157968	included	ENST00000275493	p.H773R	EGFR	1	c.2318	2016-05-18 21:07:01.02036	2016-05-18 21:28:21.918744	5	ENSG00000146648	missense
2987	\N	\N		7	55249020	55249020	A	G	DOID:3908	18628075	included	ENST00000275493	p.H773R	EGFR	1	c.2318	2016-05-18 21:07:01.050132	2016-05-18 21:28:21.965346	5	ENSG00000146648	missense
1286	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/71\\"}}"	\N		7	140481402	140481402	C	G	DOID:9256	22271473	included	ENST00000288602	p.G469A	BRAF	-1	c.1406	2016-05-18 19:53:50.640513	2016-05-18 20:39:50.850881	1	ENSG00000157764	missense
1759	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"imatinib, sunitinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"late trials, preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22718859, 16638875\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"HSP90 inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"18794084\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"crenolanib\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22745105\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"dasatinib\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"18794084\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		4	55152093	55152093	A	T	DOID:9253	16638875	included	ENST00000257290	p.D842V	PDGFRA	1	c.2525	2016-05-18 20:50:28.31217	2016-05-18 21:26:52.301608	4	ENSG00000134853	missense
1760	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"imatinib, sunitinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"late trials, preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22718859, 16638875\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"HSP90 inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"18794084\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"crenolanib\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22745105\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"dasatinib\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"18794084\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		4	55152093	55152093	A	T	DOID:9253	18794084	included	ENST00000257290	p.D842V	PDGFRA	1	c.2525	2016-05-18 20:50:28.350609	2016-05-18 21:26:52.377937	4	ENSG00000134853	missense
1761	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"imatinib, sunitinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"late trials, preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22718859, 16638875\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"HSP90 inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"18794084\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"crenolanib\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22745105\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"dasatinib\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"18794084\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		4	55152093	55152093	A	T	DOID:9253	22745105	included	ENST00000257290	p.D842V	PDGFRA	1	c.2525	2016-05-18 20:50:28.381193	2016-05-18 21:26:52.446354	4	ENSG00000134853	missense
2633	\N	\N		9	133738357	133738357	T	C	DOID:8552	11964322	included	ENST00000372348	p.Y272H	ABL1	1	c.814	2016-05-18 21:06:55.656029	2016-05-18 21:28:03.254853	5	ENSG00000097007	missense
2635	\N	\N		9	133738357	133738357	T	C	DOID:8552	20697894	included	ENST00000372348	p.Y272H	ABL1	1	c.814	2016-05-18 21:06:55.673695	2016-05-18 21:28:03.349433	5	ENSG00000097007	missense
2636	\N	\N		9	133738357	133738357	T	C	DOID:8552	25157968	included	ENST00000372348	p.Y272H	ABL1	1	c.814	2016-05-18 21:06:55.725363	2016-05-18 21:28:03.39877	5	ENSG00000097007	missense
1465	\N	\N		12	25380275	25380275	T	G	DOID:9119	18725974	included	ENST00000256078	p.Q61H	KRAS	-1	c.183	2016-05-18 20:26:15.144002	2016-05-18 20:40:00.543618	2	ENSG00000133703	missense
1466	\N	\N		12	25380275	25380275	T	G	DOID:9119	22162589	included	ENST00000256078	p.Q61H	KRAS	-1	c.183	2016-05-18 20:26:15.161016	2016-05-18 20:40:00.582328	2	ENSG00000133703	missense
2994	\N	\N		7	55249130	55249130	G	A	DOID:0050865	25157968	included	ENST00000275493	p.G810S	EGFR	1	c.2428	2016-05-18 21:07:01.162262	2016-05-18 21:28:22.31656	5	ENSG00000146648	missense
2996	\N	\N		7	55259514	55259514	C	A	DOID:3908	21718596	included	ENST00000275493	p.L858M	EGFR	1	c.2572	2016-05-18 21:07:01.306424	2016-05-18 21:28:22.422761	5	ENSG00000146648	missense
1762	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"quizartinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22504184\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"ponatinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23430109\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"crenolanib, PKC412\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"24619500\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		13	28592620	28592620	T	C	DOID:9119	22504184	included	ENST00000380982	p.Y842C	FLT3	-1	c.2525	2016-05-18 20:50:28.417828	2016-05-18 21:26:52.558629	4	ENSG00000122025	missense
1525	\N	\N		21	36252876	36252876	C	G	DOID:9119	19466505	included	ENST00000300305	p.R162S	RUNX1	-1	c.486	2016-05-18 20:26:15.759424	2016-05-18 20:40:03.238992	2	ENSG00000159216	missense
1947	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"crizotinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22277784\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"novel ALK inhibiors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"24327273\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		2	29443695	29443695	G	C	DOID:3910	24327273	included	ENST00000389048	p.F1174L	ALK	-1	c.3522	2016-05-18 20:50:34.602613	2016-05-18 21:27:08.798004	4	ENSG00000171094	missense
3001	\N	\N		7	55259515	55259516	TG	GT	DOID:3908	25157968	included	ENST00000275493	p.L858R	EGFR	1	c.2573	2016-05-18 21:07:01.359155	2016-05-18 21:28:22.651063	5	ENSG00000146648	missense
3002	\N	\N		7	55259514	55259515	CT	AG	DOID:3908	25157968	included	ENST00000275493	p.L858R	EGFR	1	c.2572	2016-05-18 21:07:01.368817	2016-05-18 21:28:22.715229	5	ENSG00000146648	missense
1396	\N	\N		1	115256528	115256528	T	A	DOID:9119	11861307	included	ENST00000369535	p.Q61H	NRAS	-1	c.183	2016-05-18 20:26:14.338529	2016-05-18 20:39:57.07728	2	ENSG00000213281	missense
1398	\N	\N		1	115256530	115256530	G	T	DOID:9119	19470474	included	ENST00000369535	p.Q61K	NRAS	-1	c.181	2016-05-18 20:26:14.362313	2016-05-18 20:39:57.160036	2	ENSG00000213281	missense
1764	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"quizartinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22504184\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"ponatinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23430109\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"crenolanib, PKC412\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"24619500\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		13	28592620	28592620	T	C	DOID:9119	24619500	included	ENST00000380982	p.Y842C	FLT3	-1	c.2525	2016-05-18 20:50:28.484819	2016-05-18 21:26:52.69865	4	ENSG00000122025	missense
1419	\N	\N		1	115258747	115258747	C	T	DOID:9119	22310681	included	ENST00000369535	p.G12D	NRAS	-1	c.35	2016-05-18 20:26:14.588751	2016-05-18 20:39:58.187784	2	ENSG00000213281	missense
1948	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"crizotinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22277784\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"novel ALK inhibiors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"24327273\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		2	29443695	29443695	G	T	DOID:3910	22277784	included	ENST00000389048	p.F1174L	ALK	-1	c.3522	2016-05-18 20:50:34.634323	2016-05-18 21:27:08.860601	4	ENSG00000171094	missense
3016	\N	\N		17	37881000	37881000	G	C	DOID:1612	24516025	included	ENST00000269571	p.V777L	ERBB2	1	c.2329	2016-05-18 21:07:01.605811	2016-05-18 21:28:23.381653	5	ENSG00000141736	missense
1443	\N	\N		11	32417909	32417910	-	ACCGTACA	DOID:9119	18316791	included	ENST00000332351	p.S381LYG	WT1	-1	c.1142	2016-05-18 20:26:14.863223	2016-05-18 20:39:59.469259	2	ENSG00000184937	protein
1444	\N	\N		11	32417909	32417910	-	ACCGTACA	DOID:9119	19679400	included	ENST00000332351	p.S381LYG	WT1	-1	c.1142	2016-05-18 20:26:14.871816	2016-05-18 20:39:59.518969	2	ENSG00000184937	protein
2637	\N	\N		9	133738363	133738363	G	A	DOID:8552	22210874	included	ENST00000372348	p.E274K	ABL1	1	c.820	2016-05-18 21:06:55.734623	2016-05-18 21:28:03.45325	5	ENSG00000097007	missense
2638	\N	\N		9	133738363	133738363	G	A	DOID:8552	24236021	included	ENST00000372348	p.E274K	ABL1	1	c.820	2016-05-18 21:06:55.755752	2016-05-18 21:28:03.493103	5	ENSG00000097007	missense
2639	\N	\N		9	133738363	133738363	G	A	DOID:8552	22912393	included	ENST00000372348	p.E274K	ABL1	1	c.820	2016-05-18 21:06:55.762777	2016-05-18 21:28:03.530766	5	ENSG00000097007	missense
622	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/36\\"}}"	\N		12	25398285	25398285	C	T	DOID:9256	22504184	included	ENST00000256078	p.G12S	KRAS	-1	c.34	2016-05-18 19:53:39.995971	2016-05-18 20:39:09.470732	1	ENSG00000133703	missense
1149	\N	\N		4	55594221	55594221	A	G	DOID:1909	18725974	included	ENST00000288135	p.K642E	KIT	1	c.1924	2016-05-18 19:53:48.61631	2016-05-18 20:39:42.693616	1	ENSG00000157404	missense
2640	\N	\N		9	133738363	133738363	G	A	DOID:8552	15194504	included	ENST00000372348	p.E274K	ABL1	1	c.820	2016-05-18 21:06:55.770473	2016-05-18 21:28:03.578715	5	ENSG00000097007	missense
2641	\N	\N		9	133738363	133738363	G	A	DOID:8552	21562040	included	ENST00000372348	p.E274K	ABL1	1	c.820	2016-05-18 21:06:55.779035	2016-05-18 21:28:03.630542	5	ENSG00000097007	missense
1225	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/breast-cancer/er/314/\\"}}"	\N		6	152419926	152419926	A	G	DOID:0060077	23908597	invalid	ENST00000206249	p.D538G	ESR1	1	c.1613	2016-05-18 19:53:49.867677	2016-05-18 20:37:11.133587	1	ENSG00000091831	missense
3	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/nras/81\\"}}"	\N		1	115256528	115256528	T	A	DOID:1909	25157968	included	ENST00000369535	p.Q61H	NRAS	-1	c.183	2016-05-18 19:53:30.468227	2016-05-18 20:38:34.786189	1	ENSG00000213281	missense
4	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/nras/76\\"}}"	\N		1	115256529	115256529	T	A	DOID:1909	22772060	included	ENST00000369535	p.Q61L	NRAS	-1	c.182	2016-05-18 19:53:30.498599	2016-05-18 20:38:34.847357	1	ENSG00000213281	missense
5	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/nras/97\\"}}"	\N		1	115256530	115256530	G	C	DOID:1909	22897847	included	ENST00000369535	p.Q61E	NRAS	-1	c.181	2016-05-18 19:53:30.543328	2016-05-18 20:38:34.912776	1	ENSG00000213281	missense
6	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/nras/97\\"}}"	\N		1	115256530	115256530	G	C	DOID:1909	22955920	included	ENST00000369535	p.Q61E	NRAS	-1	c.181	2016-05-18 19:53:30.553435	2016-05-18 20:38:34.963333	1	ENSG00000213281	missense
7	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/thyroid-cancer/nras/75\\"}}"	\N		1	115256530	115256530	G	T	DOID:1781	22955920	included	ENST00000369535	p.Q61K	NRAS	-1	c.181	2016-05-18 19:53:30.561159	2016-05-18 20:38:35.025732	1	ENSG00000213281	missense
8	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/nras/75\\"}}"	\N		1	115256530	115256530	G	T	DOID:1909	21680795	included	ENST00000369535	p.Q61K	NRAS	-1	c.181	2016-05-18 19:53:30.569218	2016-05-18 20:38:35.07475	1	ENSG00000213281	missense
9	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/nras/75\\"}}"	\N		1	115256530	115256530	G	T	DOID:1909	19470474	included	ENST00000369535	p.Q61K	NRAS	-1	c.181	2016-05-18 19:53:30.579525	2016-05-18 20:38:35.12201	1	ENSG00000213281	missense
1416	\N	\N		1	115258747	115258747	C	T	DOID:9119	21129611	included	ENST00000369535	p.G12D	NRAS	-1	c.35	2016-05-18 20:26:14.555092	2016-05-18 20:39:58.037162	2	ENSG00000213281	missense
1765	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"quizartinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22504184\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"ponatinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23430109\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"crenolanib, PKC412\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"24619500\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		13	28592621	28592621	A	G	DOID:9119	22504184	included	ENST00000380982	p.Y842H	FLT3	-1	c.2524	2016-05-18 20:50:28.518787	2016-05-18 21:26:52.771062	4	ENSG00000122025	missense
2642	\N	\N		9	133738363	133738363	G	A	DOID:8552	11423618	included	ENST00000372348	p.E274K	ABL1	1	c.820	2016-05-18 21:06:55.787289	2016-05-18 21:28:03.675135	5	ENSG00000097007	missense
10	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/nras/75\\"}}"	\N		1	115256530	115256530	G	T	DOID:1909	19838194	included	ENST00000369535	p.Q61K	NRAS	-1	c.181	2016-05-18 19:53:30.586818	2016-05-18 20:38:35.175214	1	ENSG00000213281	missense
11	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/nras/75\\"}}"	\N		1	115256530	115256530	G	T	DOID:1909	19139102	included	ENST00000369535	p.Q61K	NRAS	-1	c.181	2016-05-18 19:53:30.602393	2016-05-18 20:38:35.223495	1	ENSG00000213281	missense
12	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/lung-cancer/nras/75\\"}}"	\N		1	115256530	115256530	G	T	DOID:3908	19470474	included	ENST00000369535	p.Q61K	NRAS	-1	c.181	2016-05-18 19:53:30.627492	2016-05-18 20:38:35.27321	1	ENSG00000213281	missense
13	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/lung-cancer/nras/75\\"}}"	\N		1	115256530	115256530	G	T	DOID:3908	22368270	included	ENST00000369535	p.Q61K	NRAS	-1	c.181	2016-05-18 19:53:30.635824	2016-05-18 20:38:35.324149	1	ENSG00000213281	missense
14	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/lung-cancer/nras/75\\"}}"	\N		1	115256530	115256530	G	T	DOID:3908	18805579	included	ENST00000369535	p.Q61K	NRAS	-1	c.181	2016-05-18 19:53:30.660771	2016-05-18 20:38:35.373556	1	ENSG00000213281	missense
15	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/lung-cancer/nras/75\\"}}"	\N		1	115256530	115256530	G	T	DOID:3908	22955920	included	ENST00000369535	p.Q61K	NRAS	-1	c.181	2016-05-18 19:53:30.672648	2016-05-18 20:38:35.426014	1	ENSG00000213281	missense
16	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/75\\"}}"	\N		1	115256530	115256530	G	T	DOID:9256	19470474	included	ENST00000369535	p.Q61K	NRAS	-1	c.181	2016-05-18 19:53:30.682191	2016-05-18 20:38:35.476081	1	ENSG00000213281	missense
17	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/75\\"}}"	\N		1	115256530	115256530	G	T	DOID:9256	22368270	included	ENST00000369535	p.Q61K	NRAS	-1	c.181	2016-05-18 19:53:30.700598	2016-05-18 20:38:35.519993	1	ENSG00000213281	missense
18	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/75\\"}}"	\N		1	115256530	115256530	G	T	DOID:9256	18805579	included	ENST00000369535	p.Q61K	NRAS	-1	c.181	2016-05-18 19:53:30.709987	2016-05-18 20:38:35.561004	1	ENSG00000213281	missense
19	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/75\\"}}"	\N		1	115256530	115256530	G	T	DOID:9256	22955920	included	ENST00000369535	p.Q61K	NRAS	-1	c.181	2016-05-18 19:53:30.730204	2016-05-18 20:38:35.617285	1	ENSG00000213281	missense
20	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/nras/94\\"}}"	\N		1	115258744	115258744	C	A	DOID:1909	19470474	included	ENST00000369535	p.G13V	NRAS	-1	c.38	2016-05-18 19:53:30.739012	2016-05-18 20:38:35.689543	1	ENSG00000213281	missense
21	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/nras/94\\"}}"	\N		1	115258744	115258744	C	A	DOID:1909	22368270	included	ENST00000369535	p.G13V	NRAS	-1	c.38	2016-05-18 19:53:30.767512	2016-05-18 20:38:35.734813	1	ENSG00000213281	missense
22	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/nras/94\\"}}"	\N		1	115258744	115258744	C	A	DOID:1909	18805579	included	ENST00000369535	p.G13V	NRAS	-1	c.38	2016-05-18 19:53:30.776668	2016-05-18 20:38:35.794634	1	ENSG00000213281	missense
23	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/nras/94\\"}}"	\N		1	115258744	115258744	C	A	DOID:1909	22955920	included	ENST00000369535	p.G13V	NRAS	-1	c.38	2016-05-18 19:53:30.7975	2016-05-18 20:38:35.840149	1	ENSG00000213281	missense
24	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/nras/91\\"}}"	\N		1	115258744	115258744	C	G	DOID:1909	24651453	included	ENST00000369535	p.G13A	NRAS	-1	c.38	2016-05-18 19:53:30.806365	2016-05-18 20:38:35.907923	1	ENSG00000213281	missense
25	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/nras/91\\"}}"	\N		1	115258744	115258744	C	G	DOID:1909	8187091	included	ENST00000369535	p.G13A	NRAS	-1	c.38	2016-05-18 19:53:30.833232	2016-05-18 20:38:35.955685	1	ENSG00000213281	missense
26	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/nras/91\\"}}"	\N		1	115258744	115258744	C	G	DOID:1909	1528264	included	ENST00000369535	p.G13A	NRAS	-1	c.38	2016-05-18 19:53:30.841915	2016-05-18 20:38:36.019465	1	ENSG00000213281	missense
27	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/nras/91\\"}}"	\N		1	115258744	115258744	C	G	DOID:1909	25157968	included	ENST00000369535	p.G13A	NRAS	-1	c.38	2016-05-18 19:53:30.868086	2016-05-18 20:38:36.064468	1	ENSG00000213281	missense
28	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/nras/92\\"}}"	\N		1	115258744	115258744	C	T	DOID:1909	23700467	included	ENST00000369535	p.G13D	NRAS	-1	c.38	2016-05-18 19:53:30.877182	2016-05-18 20:38:36.131096	1	ENSG00000213281	missense
29	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/nras/92\\"}}"	\N		1	115258744	115258744	C	T	DOID:1909	2281069	included	ENST00000369535	p.G13D	NRAS	-1	c.38	2016-05-18 19:53:30.906399	2016-05-18 20:38:36.187473	1	ENSG00000213281	missense
30	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/nras/92\\"}}"	\N		1	115258744	115258744	C	T	DOID:1909	21901162	included	ENST00000369535	p.G13D	NRAS	-1	c.38	2016-05-18 19:53:30.919563	2016-05-18 20:38:36.22927	1	ENSG00000213281	missense
31	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/nras/92\\"}}"	\N		1	115258744	115258744	C	T	DOID:1909	8187091	included	ENST00000369535	p.G13D	NRAS	-1	c.38	2016-05-18 19:53:30.941324	2016-05-18 20:38:36.286147	1	ENSG00000213281	missense
32	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/nras/92\\"}}"	\N		1	115258744	115258744	C	T	DOID:1909	25157968	included	ENST00000369535	p.G13D	NRAS	-1	c.38	2016-05-18 19:53:30.953064	2016-05-18 20:38:36.328769	1	ENSG00000213281	missense
33	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/nras/297\\"}}"	\N		1	115258745	115258745	C	A	DOID:1909	8187091	included	ENST00000369535	p.G13C	NRAS	-1	c.37	2016-05-18 19:53:30.981908	2016-05-18 20:38:36.400758	1	ENSG00000213281	missense
35	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/nras/297\\"}}"	\N		1	115258745	115258745	C	A	DOID:1909	24861525	included	ENST00000369535	p.G13C	NRAS	-1	c.37	2016-05-18 19:53:31.03266	2016-05-18 20:38:36.519814	1	ENSG00000213281	missense
36	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/nras/297\\"}}"	\N		1	115258745	115258745	C	A	DOID:1909	22810696	included	ENST00000369535	p.G13C	NRAS	-1	c.37	2016-05-18 19:53:31.041859	2016-05-18 20:38:36.570095	1	ENSG00000213281	missense
37	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/nras/297\\"}}"	\N		1	115258745	115258745	C	A	DOID:1909	23204322	included	ENST00000369535	p.G13C	NRAS	-1	c.37	2016-05-18 19:53:31.068176	2016-05-18 20:38:36.615732	1	ENSG00000213281	missense
38	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/nras/297\\"}}"	\N		1	115258745	115258745	C	A	DOID:1909	1338904	included	ENST00000369535	p.G13C	NRAS	-1	c.37	2016-05-18 19:53:31.077867	2016-05-18 20:38:36.665087	1	ENSG00000213281	missense
39	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/nras/297\\"}}"	\N		1	115258745	115258745	C	A	DOID:1909	10737795	included	ENST00000369535	p.G13C	NRAS	-1	c.37	2016-05-18 19:53:31.084901	2016-05-18 20:38:36.711809	1	ENSG00000213281	missense
40	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/nras/297\\"}}"	\N		1	115258745	115258745	C	A	DOID:1909	25157968	included	ENST00000369535	p.G13C	NRAS	-1	c.37	2016-05-18 19:53:31.10196	2016-05-18 20:38:36.767218	1	ENSG00000213281	missense
41	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/nras/93\\"}}"	\N		1	115258745	115258745	C	G	DOID:1909	1528264	included	ENST00000369535	p.G13R	NRAS	-1	c.37	2016-05-18 19:53:31.110472	2016-05-18 20:38:36.833989	1	ENSG00000213281	missense
42	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/nras/93\\"}}"	\N		1	115258745	115258745	C	G	DOID:1909	24861525	included	ENST00000369535	p.G13R	NRAS	-1	c.37	2016-05-18 19:53:31.132955	2016-05-18 20:38:36.884241	1	ENSG00000213281	missense
43	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/nras/93\\"}}"	\N		1	115258745	115258745	C	G	DOID:1909	24518971	included	ENST00000369535	p.G13R	NRAS	-1	c.37	2016-05-18 19:53:31.141452	2016-05-18 20:38:36.927187	1	ENSG00000213281	missense
44	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/nras/93\\"}}"	\N		1	115258745	115258745	C	G	DOID:1909	1338904	included	ENST00000369535	p.G13R	NRAS	-1	c.37	2016-05-18 19:53:31.168764	2016-05-18 20:38:36.972777	1	ENSG00000213281	missense
45	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/nras/93\\"}}"	\N		1	115258745	115258745	C	G	DOID:1909	10737795	included	ENST00000369535	p.G13R	NRAS	-1	c.37	2016-05-18 19:53:31.177482	2016-05-18 20:38:37.025647	1	ENSG00000213281	missense
46	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/nras/93\\"}}"	\N		1	115258745	115258745	C	G	DOID:1909	22810696	included	ENST00000369535	p.G13R	NRAS	-1	c.37	2016-05-18 19:53:31.202026	2016-05-18 20:38:37.070049	1	ENSG00000213281	missense
47	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/nras/93\\"}}"	\N		1	115258745	115258745	C	G	DOID:1909	25157968	included	ENST00000369535	p.G13R	NRAS	-1	c.37	2016-05-18 19:53:31.210562	2016-05-18 20:38:37.124055	1	ENSG00000213281	missense
48	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/nras/90\\"}}"	\N		1	115258747	115258747	C	A	DOID:1909	8187091	included	ENST00000369535	p.G12V	NRAS	-1	c.35	2016-05-18 19:53:31.241574	2016-05-18 20:38:37.192075	1	ENSG00000213281	missense
49	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/nras/90\\"}}"	\N		1	115258747	115258747	C	A	DOID:1909	23700467	included	ENST00000369535	p.G12V	NRAS	-1	c.35	2016-05-18 19:53:31.2501	2016-05-18 20:38:37.23643	1	ENSG00000213281	missense
50	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/nras/90\\"}}"	\N		1	115258747	115258747	C	A	DOID:1909	17704924	included	ENST00000369535	p.G12V	NRAS	-1	c.35	2016-05-18 19:53:31.271122	2016-05-18 20:38:37.295028	1	ENSG00000213281	missense
51	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/nras/90\\"}}"	\N		1	115258747	115258747	C	A	DOID:1909	18992635	included	ENST00000369535	p.G12V	NRAS	-1	c.35	2016-05-18 19:53:31.302777	2016-05-18 20:38:37.342576	1	ENSG00000213281	missense
52	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/nras/90\\"}}"	\N		1	115258747	115258747	C	A	DOID:1909	25157968	included	ENST00000369535	p.G12V	NRAS	-1	c.35	2016-05-18 19:53:31.31322	2016-05-18 20:38:37.400958	1	ENSG00000213281	missense
53	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/90\\"}}"	\N		1	115258747	115258747	C	A	DOID:9256	8187091	included	ENST00000369535	p.G12V	NRAS	-1	c.35	2016-05-18 19:53:31.344571	2016-05-18 20:38:37.446318	1	ENSG00000213281	missense
54	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/90\\"}}"	\N		1	115258747	115258747	C	A	DOID:9256	1528264	included	ENST00000369535	p.G12V	NRAS	-1	c.35	2016-05-18 19:53:31.35457	2016-05-18 20:38:37.501073	1	ENSG00000213281	missense
55	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/90\\"}}"	\N		1	115258747	115258747	C	A	DOID:9256	22810696	included	ENST00000369535	p.G12V	NRAS	-1	c.35	2016-05-18 19:53:31.369313	2016-05-18 20:38:37.553407	1	ENSG00000213281	missense
56	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/90\\"}}"	\N		1	115258747	115258747	C	A	DOID:9256	22848674	included	ENST00000369535	p.G12V	NRAS	-1	c.35	2016-05-18 19:53:31.377736	2016-05-18 20:38:37.599877	1	ENSG00000213281	missense
57	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/90\\"}}"	\N		1	115258747	115258747	C	A	DOID:9256	12374230	included	ENST00000369535	p.G12V	NRAS	-1	c.35	2016-05-18 19:53:31.398736	2016-05-18 20:38:37.646282	1	ENSG00000213281	missense
58	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/90\\"}}"	\N		1	115258747	115258747	C	A	DOID:9256	10737795	included	ENST00000369535	p.G12V	NRAS	-1	c.35	2016-05-18 19:53:31.406713	2016-05-18 20:38:37.698062	1	ENSG00000213281	missense
59	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/90\\"}}"	\N		1	115258747	115258747	C	A	DOID:9256	25157968	included	ENST00000369535	p.G12V	NRAS	-1	c.35	2016-05-18 19:53:31.436568	2016-05-18 20:38:37.746883	1	ENSG00000213281	missense
60	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/nras/85\\"}}"	\N		1	115258747	115258747	C	G	DOID:1909	8187091	included	ENST00000369535	p.G12A	NRAS	-1	c.35	2016-05-18 19:53:31.458	2016-05-18 20:38:37.810336	1	ENSG00000213281	missense
61	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/nras/85\\"}}"	\N		1	115258747	115258747	C	G	DOID:1909	1528264	included	ENST00000369535	p.G12A	NRAS	-1	c.35	2016-05-18 19:53:31.46907	2016-05-18 20:38:37.854123	1	ENSG00000213281	missense
62	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/nras/85\\"}}"	\N		1	115258747	115258747	C	G	DOID:1909	24861525	included	ENST00000369535	p.G12A	NRAS	-1	c.35	2016-05-18 19:53:31.477167	2016-05-18 20:38:37.895538	1	ENSG00000213281	missense
63	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/nras/85\\"}}"	\N		1	115258747	115258747	C	G	DOID:1909	22810696	included	ENST00000369535	p.G12A	NRAS	-1	c.35	2016-05-18 19:53:31.504409	2016-05-18 20:38:37.939809	1	ENSG00000213281	missense
64	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/nras/85\\"}}"	\N		1	115258747	115258747	C	G	DOID:1909	23204322	included	ENST00000369535	p.G12A	NRAS	-1	c.35	2016-05-18 19:53:31.513347	2016-05-18 20:38:37.986998	1	ENSG00000213281	missense
1445	\N	\N		11	32417909	32417910	-	ACCGTACA	DOID:9119	16361624	included	ENST00000332351	p.S381LYG	WT1	-1	c.1142	2016-05-18 20:26:14.88615	2016-05-18 20:39:59.563119	2	ENSG00000184937	protein
67	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/nras/85\\"}}"	\N		1	115258747	115258747	C	G	DOID:1909	10737795	included	ENST00000369535	p.G12A	NRAS	-1	c.35	2016-05-18 19:53:31.572326	2016-05-18 20:38:38.112753	1	ENSG00000213281	missense
68	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/nras/85\\"}}"	\N		1	115258747	115258747	C	G	DOID:1909	18992635	included	ENST00000369535	p.G12A	NRAS	-1	c.35	2016-05-18 19:53:31.581081	2016-05-18 20:38:38.15093	1	ENSG00000213281	missense
69	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/nras/85\\"}}"	\N		1	115258747	115258747	C	G	DOID:1909	12374230	included	ENST00000369535	p.G12A	NRAS	-1	c.35	2016-05-18 19:53:31.603426	2016-05-18 20:38:38.19918	1	ENSG00000213281	missense
71	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/nras/85\\"}}"	\N		1	115258747	115258747	C	G	DOID:1909	25157968	included	ENST00000369535	p.G12A	NRAS	-1	c.35	2016-05-18 19:53:31.634224	2016-05-18 20:38:38.280838	1	ENSG00000213281	missense
72	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/lung-cancer/nras/85\\"}}"	\N		1	115258747	115258747	C	G	DOID:3908	17611497	included	ENST00000369535	p.G12A	NRAS	-1	c.35	2016-05-18 19:53:31.642489	2016-05-18 20:38:38.324354	1	ENSG00000213281	missense
73	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/lung-cancer/nras/85\\"}}"	\N		1	115258747	115258747	C	G	DOID:3908	20233444	included	ENST00000369535	p.G12A	NRAS	-1	c.35	2016-05-18 19:53:31.676976	2016-05-18 20:38:38.364396	1	ENSG00000213281	missense
74	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/lung-cancer/nras/85\\"}}"	\N		1	115258747	115258747	C	G	DOID:3908	18392055	included	ENST00000369535	p.G12A	NRAS	-1	c.35	2016-05-18 19:53:31.686848	2016-05-18 20:38:38.407249	1	ENSG00000213281	missense
75	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/85\\"}}"	\N		1	115258747	115258747	C	G	DOID:9256	19537845	included	ENST00000369535	p.G12A	NRAS	-1	c.35	2016-05-18 19:53:31.706595	2016-05-18 20:38:38.451682	1	ENSG00000213281	missense
76	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/85\\"}}"	\N		1	115258747	115258747	C	G	DOID:9256	21129611	included	ENST00000369535	p.G12A	NRAS	-1	c.35	2016-05-18 19:53:31.714963	2016-05-18 20:38:38.492451	1	ENSG00000213281	missense
77	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/85\\"}}"	\N		1	115258747	115258747	C	G	DOID:9256	20350999	included	ENST00000369535	p.G12A	NRAS	-1	c.35	2016-05-18 19:53:31.744586	2016-05-18 20:38:38.538831	1	ENSG00000213281	missense
78	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/85\\"}}"	\N		1	115258747	115258747	C	G	DOID:9256	12068308	included	ENST00000369535	p.G12A	NRAS	-1	c.35	2016-05-18 19:53:31.770051	2016-05-18 20:38:38.586037	1	ENSG00000213281	missense
79	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/85\\"}}"	\N		1	115258747	115258747	C	G	DOID:9256	21163703	included	ENST00000369535	p.G12A	NRAS	-1	c.35	2016-05-18 19:53:31.778232	2016-05-18 20:38:38.638942	1	ENSG00000213281	missense
80	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/85\\"}}"	\N		1	115258747	115258747	C	G	DOID:9256	20857202	included	ENST00000369535	p.G12A	NRAS	-1	c.35	2016-05-18 19:53:31.810725	2016-05-18 20:38:38.68156	1	ENSG00000213281	missense
81	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/85\\"}}"	\N		1	115258747	115258747	C	G	DOID:9256	20413299	included	ENST00000369535	p.G12A	NRAS	-1	c.35	2016-05-18 19:53:31.836306	2016-05-18 20:38:38.738517	1	ENSG00000213281	missense
82	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/85\\"}}"	\N		1	115258747	115258747	C	G	DOID:9256	21426297	included	ENST00000369535	p.G12A	NRAS	-1	c.35	2016-05-18 19:53:31.844955	2016-05-18 20:38:38.786962	1	ENSG00000213281	missense
83	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/85\\"}}"	\N		1	115258747	115258747	C	G	DOID:9256	22281684	included	ENST00000369535	p.G12A	NRAS	-1	c.35	2016-05-18 19:53:31.877641	2016-05-18 20:38:38.839194	1	ENSG00000213281	missense
84	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/85\\"}}"	\N		1	115258747	115258747	C	G	DOID:9256	22448344	included	ENST00000369535	p.G12A	NRAS	-1	c.35	2016-05-18 19:53:31.887076	2016-05-18 20:38:38.890072	1	ENSG00000213281	missense
85	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/85\\"}}"	\N		1	115258747	115258747	C	G	DOID:9256	22180495	included	ENST00000369535	p.G12A	NRAS	-1	c.35	2016-05-18 19:53:31.912704	2016-05-18 20:38:38.940634	1	ENSG00000213281	missense
86	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/85\\"}}"	\N		1	115258747	115258747	C	G	DOID:9256	20619739	included	ENST00000369535	p.G12A	NRAS	-1	c.35	2016-05-18 19:53:31.921651	2016-05-18 20:38:38.992624	1	ENSG00000213281	missense
87	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/85\\"}}"	\N		1	115258747	115258747	C	G	DOID:9256	23325582	included	ENST00000369535	p.G12A	NRAS	-1	c.35	2016-05-18 19:53:31.946216	2016-05-18 20:38:39.038953	1	ENSG00000213281	missense
88	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/85\\"}}"	\N		1	115258747	115258747	C	G	DOID:9256	22608338	included	ENST00000369535	p.G12A	NRAS	-1	c.35	2016-05-18 19:53:31.955327	2016-05-18 20:38:39.094761	1	ENSG00000213281	missense
89	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/85\\"}}"	\N		1	115258747	115258747	C	G	DOID:9256	23251002	included	ENST00000369535	p.G12A	NRAS	-1	c.35	2016-05-18 19:53:31.976225	2016-05-18 20:38:39.139691	1	ENSG00000213281	missense
90	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/85\\"}}"	\N		1	115258747	115258747	C	G	DOID:9256	23549875	included	ENST00000369535	p.G12A	NRAS	-1	c.35	2016-05-18 19:53:31.985094	2016-05-18 20:38:39.193716	1	ENSG00000213281	missense
91	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/85\\"}}"	\N		1	115258747	115258747	C	G	DOID:9256	24107445	included	ENST00000369535	p.G12A	NRAS	-1	c.35	2016-05-18 19:53:32.008275	2016-05-18 20:38:39.241763	1	ENSG00000213281	missense
92	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/85\\"}}"	\N		1	115258747	115258747	C	G	DOID:9256	24163374	included	ENST00000369535	p.G12A	NRAS	-1	c.35	2016-05-18 19:53:32.01668	2016-05-18 20:38:39.296114	1	ENSG00000213281	missense
93	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/nras/87\\"}}"	\N		1	115258747	115258747	C	T	DOID:1909	19537845	included	ENST00000369535	p.G12D	NRAS	-1	c.35	2016-05-18 19:53:32.045035	2016-05-18 20:38:39.353942	1	ENSG00000213281	missense
94	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/nras/87\\"}}"	\N		1	115258747	115258747	C	T	DOID:1909	21129611	included	ENST00000369535	p.G12D	NRAS	-1	c.35	2016-05-18 19:53:32.054419	2016-05-18 20:38:39.412317	1	ENSG00000213281	missense
95	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/nras/87\\"}}"	\N		1	115258747	115258747	C	T	DOID:1909	20350999	included	ENST00000369535	p.G12D	NRAS	-1	c.35	2016-05-18 19:53:32.074339	2016-05-18 20:38:39.454708	1	ENSG00000213281	missense
96	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/nras/87\\"}}"	\N		1	115258747	115258747	C	T	DOID:1909	12068308	included	ENST00000369535	p.G12D	NRAS	-1	c.35	2016-05-18 19:53:32.082321	2016-05-18 20:38:39.506797	1	ENSG00000213281	missense
98	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/lung-cancer/nras/87\\"}}"	\N		1	115258747	115258747	C	T	DOID:3908	19537845	included	ENST00000369535	p.G12D	NRAS	-1	c.35	2016-05-18 19:53:32.107808	2016-05-18 20:38:39.614413	1	ENSG00000213281	missense
101	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/lung-cancer/nras/87\\"}}"	\N		1	115258747	115258747	C	T	DOID:3908	12068308	included	ENST00000369535	p.G12D	NRAS	-1	c.35	2016-05-18 19:53:32.171779	2016-05-18 20:38:39.75778	1	ENSG00000213281	missense
102	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/lung-cancer/nras/87\\"}}"	\N		1	115258747	115258747	C	T	DOID:3908	14678966	included	ENST00000369535	p.G12D	NRAS	-1	c.35	2016-05-18 19:53:32.17966	2016-05-18 20:38:39.814479	1	ENSG00000213281	missense
103	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/lung-cancer/nras/87\\"}}"	\N		1	115258747	115258747	C	T	DOID:3908	15035987	included	ENST00000369535	p.G12D	NRAS	-1	c.35	2016-05-18 19:53:32.209586	2016-05-18 20:38:39.858299	1	ENSG00000213281	missense
104	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/lung-cancer/nras/87\\"}}"	\N		1	115258747	115258747	C	T	DOID:3908	12438234	included	ENST00000369535	p.G12D	NRAS	-1	c.35	2016-05-18 19:53:32.218884	2016-05-18 20:38:39.914207	1	ENSG00000213281	missense
105	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/lung-cancer/nras/87\\"}}"	\N		1	115258747	115258747	C	T	DOID:3908	22310681	included	ENST00000369535	p.G12D	NRAS	-1	c.35	2016-05-18 19:53:32.242759	2016-05-18 20:38:39.955453	1	ENSG00000213281	missense
106	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/87\\"}}"	\N		1	115258747	115258747	C	T	DOID:9256	19537845	included	ENST00000369535	p.G12D	NRAS	-1	c.35	2016-05-18 19:53:32.250964	2016-05-18 20:38:40.01326	1	ENSG00000213281	missense
107	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/87\\"}}"	\N		1	115258747	115258747	C	T	DOID:9256	21129611	included	ENST00000369535	p.G12D	NRAS	-1	c.35	2016-05-18 19:53:32.280927	2016-05-18 20:38:40.056332	1	ENSG00000213281	missense
108	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/87\\"}}"	\N		1	115258747	115258747	C	T	DOID:9256	20350999	included	ENST00000369535	p.G12D	NRAS	-1	c.35	2016-05-18 19:53:32.28868	2016-05-18 20:38:40.107577	1	ENSG00000213281	missense
109	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/87\\"}}"	\N		1	115258747	115258747	C	T	DOID:9256	18186519	included	ENST00000369535	p.G12D	NRAS	-1	c.35	2016-05-18 19:53:32.311489	2016-05-18 20:38:40.160544	1	ENSG00000213281	missense
110	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/87\\"}}"	\N		1	115258747	115258747	C	T	DOID:9256	12068308	included	ENST00000369535	p.G12D	NRAS	-1	c.35	2016-05-18 19:53:32.343233	2016-05-18 20:38:40.210423	1	ENSG00000213281	missense
111	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/87\\"}}"	\N		1	115258747	115258747	C	T	DOID:9256	22310681	included	ENST00000369535	p.G12D	NRAS	-1	c.35	2016-05-18 19:53:32.354346	2016-05-18 20:38:40.260613	1	ENSG00000213281	missense
112	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/nras/86\\"}}"	\N		1	115258748	115258748	C	A	DOID:1909	19537845	included	ENST00000369535	p.G12C	NRAS	-1	c.34	2016-05-18 19:53:32.373189	2016-05-18 20:38:40.323519	1	ENSG00000213281	missense
113	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/nras/86\\"}}"	\N		1	115258748	115258748	C	A	DOID:1909	21129611	included	ENST00000369535	p.G12C	NRAS	-1	c.34	2016-05-18 19:53:32.381298	2016-05-18 20:38:40.378857	1	ENSG00000213281	missense
114	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/nras/86\\"}}"	\N		1	115258748	115258748	C	A	DOID:1909	20350999	included	ENST00000369535	p.G12C	NRAS	-1	c.34	2016-05-18 19:53:32.410087	2016-05-18 20:38:40.42641	1	ENSG00000213281	missense
115	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/nras/86\\"}}"	\N		1	115258748	115258748	C	A	DOID:1909	18186519	included	ENST00000369535	p.G12C	NRAS	-1	c.34	2016-05-18 19:53:32.421997	2016-05-18 20:38:40.471969	1	ENSG00000213281	missense
116	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/nras/86\\"}}"	\N		1	115258748	115258748	C	A	DOID:1909	12068308	included	ENST00000369535	p.G12C	NRAS	-1	c.34	2016-05-18 19:53:32.44005	2016-05-18 20:38:40.525001	1	ENSG00000213281	missense
117	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/nras/86\\"}}"	\N		1	115258748	115258748	C	A	DOID:1909	22310681	included	ENST00000369535	p.G12C	NRAS	-1	c.34	2016-05-18 19:53:32.448374	2016-05-18 20:38:40.572954	1	ENSG00000213281	missense
118	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/lung-cancer/nras/86\\"}}"	\N		1	115258748	115258748	C	A	DOID:3908	19537845	included	ENST00000369535	p.G12C	NRAS	-1	c.34	2016-05-18 19:53:32.477361	2016-05-18 20:38:40.627506	1	ENSG00000213281	missense
119	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/lung-cancer/nras/86\\"}}"	\N		1	115258748	115258748	C	A	DOID:3908	21129611	included	ENST00000369535	p.G12C	NRAS	-1	c.34	2016-05-18 19:53:32.489523	2016-05-18 20:38:40.672549	1	ENSG00000213281	missense
120	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/lung-cancer/nras/86\\"}}"	\N		1	115258748	115258748	C	A	DOID:3908	20350999	included	ENST00000369535	p.G12C	NRAS	-1	c.34	2016-05-18 19:53:32.507383	2016-05-18 20:38:40.729446	1	ENSG00000213281	missense
121	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/lung-cancer/nras/86\\"}}"	\N		1	115258748	115258748	C	A	DOID:3908	18186519	included	ENST00000369535	p.G12C	NRAS	-1	c.34	2016-05-18 19:53:32.515338	2016-05-18 20:38:40.781471	1	ENSG00000213281	missense
122	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/lung-cancer/nras/86\\"}}"	\N		1	115258748	115258748	C	A	DOID:3908	12068308	included	ENST00000369535	p.G12C	NRAS	-1	c.34	2016-05-18 19:53:32.544125	2016-05-18 20:38:40.832038	1	ENSG00000213281	missense
123	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/lung-cancer/nras/86\\"}}"	\N		1	115258748	115258748	C	A	DOID:3908	22310681	included	ENST00000369535	p.G12C	NRAS	-1	c.34	2016-05-18 19:53:32.553603	2016-05-18 20:38:40.885242	1	ENSG00000213281	missense
124	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/86\\"}}"	\N		1	115258748	115258748	C	A	DOID:9256	22270724	included	ENST00000369535	p.G12C	NRAS	-1	c.34	2016-05-18 19:53:32.575423	2016-05-18 20:38:40.929498	1	ENSG00000213281	missense
1446	\N	\N		11	32417909	32417910	-	ACCGTACA	DOID:9119	19114683	included	ENST00000332351	p.S381LYG	WT1	-1	c.1142	2016-05-18 20:26:14.894653	2016-05-18 20:39:59.611078	2	ENSG00000184937	protein
125	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/nras/88\\"}}"	\N		1	115258748	115258748	C	G	DOID:1909	18316791	included	ENST00000369535	p.G12R	NRAS	-1	c.34	2016-05-18 19:53:32.583216	2016-05-18 20:38:40.995704	1	ENSG00000213281	missense
126	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/nras/88\\"}}"	\N		1	115258748	115258748	C	G	DOID:1909	19679400	included	ENST00000369535	p.G12R	NRAS	-1	c.34	2016-05-18 19:53:32.612257	2016-05-18 20:38:41.042901	1	ENSG00000213281	missense
127	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/nras/88\\"}}"	\N		1	115258748	115258748	C	G	DOID:1909	16361624	included	ENST00000369535	p.G12R	NRAS	-1	c.34	2016-05-18 19:53:32.620709	2016-05-18 20:38:41.099142	1	ENSG00000213281	missense
128	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/nras/88\\"}}"	\N		1	115258748	115258748	C	G	DOID:1909	19114683	included	ENST00000369535	p.G12R	NRAS	-1	c.34	2016-05-18 19:53:32.643652	2016-05-18 20:38:41.145432	1	ENSG00000213281	missense
130	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/nras/88\\"}}"	\N		1	115258748	115258748	C	G	DOID:1909	20921465	included	ENST00000369535	p.G12R	NRAS	-1	c.34	2016-05-18 19:53:32.684033	2016-05-18 20:38:41.247035	1	ENSG00000213281	missense
131	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/nras/88\\"}}"	\N		1	115258748	115258748	C	G	DOID:1909	16618717	included	ENST00000369535	p.G12R	NRAS	-1	c.34	2016-05-18 19:53:32.692391	2016-05-18 20:38:41.295812	1	ENSG00000213281	missense
132	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/nras/88\\"}}"	\N		1	115258748	115258748	C	G	DOID:1909	20921462	included	ENST00000369535	p.G12R	NRAS	-1	c.34	2016-05-18 19:53:32.715638	2016-05-18 20:38:41.347201	1	ENSG00000213281	missense
133	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/lung-cancer/nras/88\\"}}"	\N		1	115258748	115258748	C	G	DOID:3908	18316791	included	ENST00000369535	p.G12R	NRAS	-1	c.34	2016-05-18 19:53:32.724218	2016-05-18 20:38:41.402886	1	ENSG00000213281	missense
134	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/lung-cancer/nras/88\\"}}"	\N		1	115258748	115258748	C	G	DOID:3908	19679400	included	ENST00000369535	p.G12R	NRAS	-1	c.34	2016-05-18 19:53:32.74642	2016-05-18 20:38:41.453087	1	ENSG00000213281	missense
135	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/lung-cancer/nras/88\\"}}"	\N		1	115258748	115258748	C	G	DOID:3908	16361624	included	ENST00000369535	p.G12R	NRAS	-1	c.34	2016-05-18 19:53:32.754738	2016-05-18 20:38:41.504987	1	ENSG00000213281	missense
136	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/lung-cancer/nras/88\\"}}"	\N		1	115258748	115258748	C	G	DOID:3908	19114683	included	ENST00000369535	p.G12R	NRAS	-1	c.34	2016-05-18 19:53:32.782327	2016-05-18 20:38:41.554578	1	ENSG00000213281	missense
137	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/lung-cancer/nras/88\\"}}"	\N		1	115258748	115258748	C	G	DOID:3908	21228335	included	ENST00000369535	p.G12R	NRAS	-1	c.34	2016-05-18 19:53:32.792477	2016-05-18 20:38:41.606333	1	ENSG00000213281	missense
138	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/lung-cancer/nras/88\\"}}"	\N		1	115258748	115258748	C	G	DOID:3908	20921465	included	ENST00000369535	p.G12R	NRAS	-1	c.34	2016-05-18 19:53:32.802739	2016-05-18 20:38:41.656322	1	ENSG00000213281	missense
139	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/lung-cancer/nras/88\\"}}"	\N		1	115258748	115258748	C	G	DOID:3908	16618717	included	ENST00000369535	p.G12R	NRAS	-1	c.34	2016-05-18 19:53:32.817488	2016-05-18 20:38:41.713265	1	ENSG00000213281	missense
140	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/lung-cancer/nras/88\\"}}"	\N		1	115258748	115258748	C	G	DOID:3908	20921462	included	ENST00000369535	p.G12R	NRAS	-1	c.34	2016-05-18 19:53:32.827025	2016-05-18 20:38:41.761623	1	ENSG00000213281	missense
141	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/nras/89\\"}}"	\N		1	115258748	115258748	C	T	DOID:1909	18316791	included	ENST00000369535	p.G12S	NRAS	-1	c.34	2016-05-18 19:53:32.848433	2016-05-18 20:38:41.823072	1	ENSG00000213281	missense
142	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/nras/89\\"}}"	\N		1	115258748	115258748	C	T	DOID:1909	19679400	included	ENST00000369535	p.G12S	NRAS	-1	c.34	2016-05-18 19:53:32.857151	2016-05-18 20:38:41.863834	1	ENSG00000213281	missense
143	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/nras/89\\"}}"	\N		1	115258748	115258748	C	T	DOID:1909	16361624	included	ENST00000369535	p.G12S	NRAS	-1	c.34	2016-05-18 19:53:32.884153	2016-05-18 20:38:41.910375	1	ENSG00000213281	missense
144	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/nras/89\\"}}"	\N		1	115258748	115258748	C	T	DOID:1909	19114683	included	ENST00000369535	p.G12S	NRAS	-1	c.34	2016-05-18 19:53:32.892903	2016-05-18 20:38:41.967767	1	ENSG00000213281	missense
145	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/nras/89\\"}}"	\N		1	115258748	115258748	C	T	DOID:1909	21228335	included	ENST00000369535	p.G12S	NRAS	-1	c.34	2016-05-18 19:53:32.913751	2016-05-18 20:38:42.011496	1	ENSG00000213281	missense
146	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/nras/89\\"}}"	\N		1	115258748	115258748	C	T	DOID:1909	20921465	included	ENST00000369535	p.G12S	NRAS	-1	c.34	2016-05-18 19:53:32.948197	2016-05-18 20:38:42.066686	1	ENSG00000213281	missense
147	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/nras/89\\"}}"	\N		1	115258748	115258748	C	T	DOID:1909	16618717	included	ENST00000369535	p.G12S	NRAS	-1	c.34	2016-05-18 19:53:32.956566	2016-05-18 20:38:42.109285	1	ENSG00000213281	missense
148	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/nras/89\\"}}"	\N		1	115258748	115258748	C	T	DOID:1909	20921462	included	ENST00000369535	p.G12S	NRAS	-1	c.34	2016-05-18 19:53:32.977989	2016-05-18 20:38:42.164398	1	ENSG00000213281	missense
149	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/lung-cancer/kras/41\\"}}"	\N		1	115258748	115258748	C	T	DOID:3908	18316791	included	ENST00000369535	p.G12S	NRAS	-1	c.34	2016-05-18 19:53:32.985911	2016-05-18 20:38:42.208388	1	ENSG00000213281	missense
150	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/lung-cancer/kras/41\\"}}"	\N		1	115258748	115258748	C	T	DOID:3908	19679400	included	ENST00000369535	p.G12S	NRAS	-1	c.34	2016-05-18 19:53:33.015074	2016-05-18 20:38:42.264473	1	ENSG00000213281	missense
151	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/lung-cancer/kras/41\\"}}"	\N		1	115258748	115258748	C	T	DOID:3908	16361624	included	ENST00000369535	p.G12S	NRAS	-1	c.34	2016-05-18 19:53:33.023777	2016-05-18 20:38:42.305029	1	ENSG00000213281	missense
152	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/lung-cancer/kras/41\\"}}"	\N		1	115258748	115258748	C	T	DOID:3908	19114683	included	ENST00000369535	p.G12S	NRAS	-1	c.34	2016-05-18 19:53:33.045946	2016-05-18 20:38:42.346742	1	ENSG00000213281	missense
1447	\N	\N		11	32417909	32417910	-	ACCGTACA	DOID:9119	21228335	included	ENST00000332351	p.S381LYG	WT1	-1	c.1142	2016-05-18 20:26:14.914621	2016-05-18 20:39:59.662789	2	ENSG00000184937	protein
153	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/lung-cancer/kras/41\\"}}"	\N		1	115258748	115258748	C	T	DOID:3908	21228335	included	ENST00000369535	p.G12S	NRAS	-1	c.34	2016-05-18 19:53:33.054301	2016-05-18 20:38:42.391002	1	ENSG00000213281	missense
154	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/lung-cancer/kras/41\\"}}"	\N		1	115258748	115258748	C	T	DOID:3908	20921465	included	ENST00000369535	p.G12S	NRAS	-1	c.34	2016-05-18 19:53:33.081611	2016-05-18 20:38:42.438507	1	ENSG00000213281	missense
155	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/lung-cancer/kras/41\\"}}"	\N		1	115258748	115258748	C	T	DOID:3908	16618717	included	ENST00000369535	p.G12S	NRAS	-1	c.34	2016-05-18 19:53:33.090881	2016-05-18 20:38:42.479153	1	ENSG00000213281	missense
156	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/lung-cancer/kras/41\\"}}"	\N		1	115258748	115258748	C	T	DOID:3908	20921462	included	ENST00000369535	p.G12S	NRAS	-1	c.34	2016-05-18 19:53:33.115957	2016-05-18 20:38:42.520406	1	ENSG00000213281	missense
157	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/89\\"}}"	\N		1	115258748	115258748	C	T	DOID:9256	18316791	included	ENST00000369535	p.G12S	NRAS	-1	c.34	2016-05-18 19:53:33.124584	2016-05-18 20:38:42.560654	1	ENSG00000213281	missense
158	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/89\\"}}"	\N		1	115258748	115258748	C	T	DOID:9256	19679400	included	ENST00000369535	p.G12S	NRAS	-1	c.34	2016-05-18 19:53:33.15379	2016-05-18 20:38:42.601088	1	ENSG00000213281	missense
159	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/89\\"}}"	\N		1	115258748	115258748	C	T	DOID:9256	16361624	included	ENST00000369535	p.G12S	NRAS	-1	c.34	2016-05-18 19:53:33.179143	2016-05-18 20:38:42.64199	1	ENSG00000213281	missense
160	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/89\\"}}"	\N		1	115258748	115258748	C	T	DOID:9256	19114683	included	ENST00000369535	p.G12S	NRAS	-1	c.34	2016-05-18 19:53:33.187778	2016-05-18 20:38:42.684944	1	ENSG00000213281	missense
163	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/89\\"}}"	\N		1	115258748	115258748	C	T	DOID:9256	16618717	included	ENST00000369535	p.G12S	NRAS	-1	c.34	2016-05-18 19:53:33.251976	2016-05-18 20:38:42.801625	1	ENSG00000213281	missense
164	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/89\\"}}"	\N		1	115258748	115258748	C	T	DOID:9256	20921462	included	ENST00000369535	p.G12S	NRAS	-1	c.34	2016-05-18 19:53:33.262438	2016-05-18 20:38:42.834732	1	ENSG00000213281	missense
165	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/lung-cancer/ddr2/78\\"}}"	\N		1	162748390	162748390	T	A	DOID:1749	18316791	included	ENST00000367921	p.S768R	DDR2	1	c.2304	2016-05-18 19:53:33.288861	2016-05-18 20:38:42.890352	1	ENSG00000162733	missense
166	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/lung-cancer/ddr2/78\\"}}"	\N		1	162748390	162748390	T	A	DOID:1749	19679400	included	ENST00000367921	p.S768R	DDR2	1	c.2304	2016-05-18 19:53:33.298756	2016-05-18 20:38:42.936987	1	ENSG00000162733	missense
167	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/lung-cancer/ddr2/78\\"}}"	\N		1	162748390	162748390	T	A	DOID:1749	16361624	included	ENST00000367921	p.S768R	DDR2	1	c.2304	2016-05-18 19:53:33.324391	2016-05-18 20:38:42.978629	1	ENSG00000162733	missense
168	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/lung-cancer/ddr2/78\\"}}"	\N		1	162748390	162748390	T	A	DOID:1749	19114683	included	ENST00000367921	p.S768R	DDR2	1	c.2304	2016-05-18 19:53:33.334503	2016-05-18 20:38:43.019585	1	ENSG00000162733	missense
169	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/lung-cancer/ddr2/78\\"}}"	\N		1	162748390	162748390	T	A	DOID:1749	21228335	included	ENST00000367921	p.S768R	DDR2	1	c.2304	2016-05-18 19:53:33.356484	2016-05-18 20:38:43.071564	1	ENSG00000162733	missense
170	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/lung-cancer/ddr2/78\\"}}"	\N		1	162748390	162748390	T	A	DOID:1749	20921465	included	ENST00000367921	p.S768R	DDR2	1	c.2304	2016-05-18 19:53:33.36572	2016-05-18 20:38:43.115479	1	ENSG00000162733	missense
171	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/lung-cancer/ddr2/78\\"}}"	\N		1	162748390	162748390	T	A	DOID:1749	16618717	included	ENST00000367921	p.S768R	DDR2	1	c.2304	2016-05-18 19:53:33.387097	2016-05-18 20:38:43.170757	1	ENSG00000162733	missense
172	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/lung-cancer/ddr2/78\\"}}"	\N		1	162748390	162748390	T	A	DOID:1749	20921462	included	ENST00000367921	p.S768R	DDR2	1	c.2304	2016-05-18 19:53:33.396309	2016-05-18 20:38:43.220873	1	ENSG00000162733	missense
173	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/thyroid-cancer/ret/128\\"}}"	\N		10	43617416	43617416	T	C	DOID:1781	18316791	included	ENST00000355710	p.M918T	RET	1	c.2753	2016-05-18 19:53:33.41755	2016-05-18 20:38:43.292883	1	ENSG00000165731	missense
174	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/thyroid-cancer/ret/128\\"}}"	\N		10	43617416	43617416	T	C	DOID:1781	19679400	included	ENST00000355710	p.M918T	RET	1	c.2753	2016-05-18 19:53:33.426099	2016-05-18 20:38:43.336417	1	ENSG00000165731	missense
175	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/thyroid-cancer/ret/128\\"}}"	\N		10	43617416	43617416	T	C	DOID:1781	16361624	included	ENST00000355710	p.M918T	RET	1	c.2753	2016-05-18 19:53:33.456058	2016-05-18 20:38:43.37529	1	ENSG00000165731	missense
176	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/thyroid-cancer/ret/128\\"}}"	\N		10	43617416	43617416	T	C	DOID:1781	19114683	included	ENST00000355710	p.M918T	RET	1	c.2753	2016-05-18 19:53:33.465335	2016-05-18 20:38:43.413354	1	ENSG00000165731	missense
177	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/thyroid-cancer/ret/128\\"}}"	\N		10	43617416	43617416	T	C	DOID:1781	21228335	included	ENST00000355710	p.M918T	RET	1	c.2753	2016-05-18 19:53:33.484812	2016-05-18 20:38:43.46301	1	ENSG00000165731	missense
178	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/thyroid-cancer/ret/128\\"}}"	\N		10	43617416	43617416	T	C	DOID:1781	20921465	included	ENST00000355710	p.M918T	RET	1	c.2753	2016-05-18 19:53:33.49337	2016-05-18 20:38:43.519544	1	ENSG00000165731	missense
179	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/thyroid-cancer/ret/128\\"}}"	\N		10	43617416	43617416	T	C	DOID:1781	16618717	included	ENST00000355710	p.M918T	RET	1	c.2753	2016-05-18 19:53:33.510306	2016-05-18 20:38:43.563685	1	ENSG00000165731	missense
180	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/thyroid-cancer/ret/128\\"}}"	\N		10	43617416	43617416	T	C	DOID:1781	20921462	included	ENST00000355710	p.M918T	RET	1	c.2753	2016-05-18 19:53:33.518512	2016-05-18 20:38:43.61117	1	ENSG00000165731	missense
181	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/ovarian-cancer/pten/145\\"}}"	\N		10	89692904	89692904	C	G	DOID:2394	18316791	included	ENST00000371953	p.R130G	PTEN	1	c.388	2016-05-18 19:53:33.526577	2016-05-18 20:38:43.685286	1	ENSG00000171862	missense
182	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/ovarian-cancer/pten/145\\"}}"	\N		10	89692904	89692904	C	G	DOID:2394	19679400	included	ENST00000371953	p.R130G	PTEN	1	c.388	2016-05-18 19:53:33.557005	2016-05-18 20:38:43.744192	1	ENSG00000171862	missense
183	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/ovarian-cancer/pten/145\\"}}"	\N		10	89692904	89692904	C	G	DOID:2394	16361624	included	ENST00000371953	p.R130G	PTEN	1	c.388	2016-05-18 19:53:33.566879	2016-05-18 20:38:43.787495	1	ENSG00000171862	missense
184	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/ovarian-cancer/pten/145\\"}}"	\N		10	89692904	89692904	C	G	DOID:2394	19114683	included	ENST00000371953	p.R130G	PTEN	1	c.388	2016-05-18 19:53:33.586947	2016-05-18 20:38:43.843816	1	ENSG00000171862	missense
185	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/ovarian-cancer/pten/145\\"}}"	\N		10	89692904	89692904	C	G	DOID:2394	21228335	included	ENST00000371953	p.R130G	PTEN	1	c.388	2016-05-18 19:53:33.595021	2016-05-18 20:38:43.885091	1	ENSG00000171862	missense
186	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/ovarian-cancer/pten/145\\"}}"	\N		10	89692904	89692904	C	G	DOID:2394	20921465	included	ENST00000371953	p.R130G	PTEN	1	c.388	2016-05-18 19:53:33.618427	2016-05-18 20:38:43.945861	1	ENSG00000171862	missense
187	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/ovarian-cancer/pten/145\\"}}"	\N		10	89692904	89692904	C	G	DOID:2394	16618717	included	ENST00000371953	p.R130G	PTEN	1	c.388	2016-05-18 19:53:33.625547	2016-05-18 20:38:43.987573	1	ENSG00000171862	missense
188	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/ovarian-cancer/pten/145\\"}}"	\N		10	89692904	89692904	C	G	DOID:2394	20921462	included	ENST00000371953	p.R130G	PTEN	1	c.388	2016-05-18 19:53:33.657252	2016-05-18 20:38:44.045946	1	ENSG00000171862	missense
189	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/ovarian-cancer/pten/137\\"}}"	\N		10	89692904	89692904	C	T	DOID:2394	18316791	included	ENST00000371953	p.R130*	PTEN	1	c.388	2016-05-18 19:53:33.683297	2016-05-18 20:38:44.115923	1	ENSG00000171862	stop
190	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/ovarian-cancer/pten/137\\"}}"	\N		10	89692904	89692904	C	T	DOID:2394	19679400	included	ENST00000371953	p.R130*	PTEN	1	c.388	2016-05-18 19:53:33.69129	2016-05-18 20:38:44.161488	1	ENSG00000171862	stop
191	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/ovarian-cancer/pten/137\\"}}"	\N		10	89692904	89692904	C	T	DOID:2394	16361624	included	ENST00000371953	p.R130*	PTEN	1	c.388	2016-05-18 19:53:33.719638	2016-05-18 20:38:44.215397	1	ENSG00000171862	stop
193	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/ovarian-cancer/pten/137\\"}}"	\N		10	89692904	89692904	C	T	DOID:2394	21228335	included	ENST00000371953	p.R130*	PTEN	1	c.388	2016-05-18 19:53:33.75033	2016-05-18 20:38:44.316141	1	ENSG00000171862	stop
194	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/ovarian-cancer/pten/137\\"}}"	\N		10	89692904	89692904	C	T	DOID:2394	20921465	included	ENST00000371953	p.R130*	PTEN	1	c.388	2016-05-18 19:53:33.757261	2016-05-18 20:38:44.359309	1	ENSG00000171862	stop
195	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/ovarian-cancer/pten/137\\"}}"	\N		10	89692904	89692904	C	T	DOID:2394	16618717	included	ENST00000371953	p.R130*	PTEN	1	c.388	2016-05-18 19:53:33.786538	2016-05-18 20:38:44.413122	1	ENSG00000171862	stop
196	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/ovarian-cancer/pten/137\\"}}"	\N		10	89692904	89692904	C	T	DOID:2394	20921462	included	ENST00000371953	p.R130*	PTEN	1	c.388	2016-05-18 19:53:33.795574	2016-05-18 20:38:44.463462	1	ENSG00000171862	stop
197	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/ovarian-cancer/pten/144\\"}}"	\N		10	89692905	89692905	G	A	DOID:2394	18316791	included	ENST00000371953	p.R130Q	PTEN	1	c.389	2016-05-18 19:53:33.832211	2016-05-18 20:38:44.525944	1	ENSG00000171862	missense
198	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/ovarian-cancer/pten/144\\"}}"	\N		10	89692905	89692905	G	A	DOID:2394	19679400	included	ENST00000371953	p.R130Q	PTEN	1	c.389	2016-05-18 19:53:33.854935	2016-05-18 20:38:44.577885	1	ENSG00000171862	missense
199	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/ovarian-cancer/pten/144\\"}}"	\N		10	89692905	89692905	G	A	DOID:2394	16361624	included	ENST00000371953	p.R130Q	PTEN	1	c.389	2016-05-18 19:53:33.864409	2016-05-18 20:38:44.630281	1	ENSG00000171862	missense
200	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/ovarian-cancer/pten/144\\"}}"	\N		10	89692905	89692905	G	A	DOID:2394	19114683	included	ENST00000371953	p.R130Q	PTEN	1	c.389	2016-05-18 19:53:33.884227	2016-05-18 20:38:44.684587	1	ENSG00000171862	missense
201	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/ovarian-cancer/pten/144\\"}}"	\N		10	89692905	89692905	G	A	DOID:2394	21228335	included	ENST00000371953	p.R130Q	PTEN	1	c.389	2016-05-18 19:53:33.892806	2016-05-18 20:38:44.730205	1	ENSG00000171862	missense
202	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/ovarian-cancer/pten/144\\"}}"	\N		10	89692905	89692905	G	A	DOID:2394	20921465	included	ENST00000371953	p.R130Q	PTEN	1	c.389	2016-05-18 19:53:33.902261	2016-05-18 20:38:44.790966	1	ENSG00000171862	missense
203	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/ovarian-cancer/pten/144\\"}}"	\N		10	89692905	89692905	G	A	DOID:2394	16618717	included	ENST00000371953	p.R130Q	PTEN	1	c.389	2016-05-18 19:53:33.914008	2016-05-18 20:38:44.840008	1	ENSG00000171862	missense
204	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/ovarian-cancer/pten/144\\"}}"	\N		10	89692905	89692905	G	A	DOID:2394	20921462	included	ENST00000371953	p.R130Q	PTEN	1	c.389	2016-05-18 19:53:33.9217	2016-05-18 20:38:44.889237	1	ENSG00000171862	missense
205	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/breast-cancer/pten/24\\"}}"	\N		10	89692993	89692993	G	T	DOID:1612	18316791	included	ENST00000371953	p.R159S	PTEN	1	c.477	2016-05-18 19:53:33.930698	2016-05-18 20:38:44.960385	1	ENSG00000171862	missense
207	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/breast-cancer/pten/24\\"}}"	\N		10	89692993	89692993	G	T	DOID:1612	16361624	included	ENST00000371953	p.R159S	PTEN	1	c.477	2016-05-18 19:53:33.950444	2016-05-18 20:38:45.06021	1	ENSG00000171862	missense
208	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/breast-cancer/pten/24\\"}}"	\N		10	89692993	89692993	G	T	DOID:1612	19114683	included	ENST00000371953	p.R159S	PTEN	1	c.477	2016-05-18 19:53:33.959373	2016-05-18 20:38:45.117342	1	ENSG00000171862	missense
209	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/breast-cancer/pten/24\\"}}"	\N		10	89692993	89692993	G	T	DOID:1612	21228335	included	ENST00000371953	p.R159S	PTEN	1	c.477	2016-05-18 19:53:33.968282	2016-05-18 20:38:45.161733	1	ENSG00000171862	missense
210	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/breast-cancer/pten/24\\"}}"	\N		10	89692993	89692993	G	T	DOID:1612	20921465	included	ENST00000371953	p.R159S	PTEN	1	c.477	2016-05-18 19:53:33.97756	2016-05-18 20:38:45.213918	1	ENSG00000171862	missense
211	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/breast-cancer/pten/24\\"}}"	\N		10	89692993	89692993	G	T	DOID:1612	16618717	included	ENST00000371953	p.R159S	PTEN	1	c.477	2016-05-18 19:53:33.987843	2016-05-18 20:38:45.269869	1	ENSG00000171862	missense
213	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/breast-cancer/pten/24\\"}}"	\N		10	89692993	89692993	G	T	DOID:1612	22734028	included	ENST00000371953	p.R159S	PTEN	1	c.477	2016-05-18 19:53:34.009931	2016-05-18 20:38:45.372003	1	ENSG00000171862	missense
214	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/breast-cancer/pten/24\\"}}"	\N		10	89692993	89692993	G	T	DOID:1612	20978259	included	ENST00000371953	p.R159S	PTEN	1	c.477	2016-05-18 19:53:34.020263	2016-05-18 20:38:45.413782	1	ENSG00000171862	missense
215	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/breast-cancer/pten/24\\"}}"	\N		10	89692993	89692993	G	T	DOID:1612	22392911	included	ENST00000371953	p.R159S	PTEN	1	c.477	2016-05-18 19:53:34.028964	2016-05-18 20:38:45.466412	1	ENSG00000171862	missense
216	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/pten/24\\"}}"	\N		10	89692993	89692993	G	T	DOID:9256	18316791	included	ENST00000371953	p.R159S	PTEN	1	c.477	2016-05-18 19:53:34.037297	2016-05-18 20:38:45.51695	1	ENSG00000171862	missense
217	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/pten/24\\"}}"	\N		10	89692993	89692993	G	T	DOID:9256	19679400	included	ENST00000371953	p.R159S	PTEN	1	c.477	2016-05-18 19:53:34.04833	2016-05-18 20:38:45.566178	1	ENSG00000171862	missense
218	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/pten/24\\"}}"	\N		10	89692993	89692993	G	T	DOID:9256	16361624	included	ENST00000371953	p.R159S	PTEN	1	c.477	2016-05-18 19:53:34.056633	2016-05-18 20:38:45.617888	1	ENSG00000171862	missense
219	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/pten/24\\"}}"	\N		10	89692993	89692993	G	T	DOID:9256	19114683	included	ENST00000371953	p.R159S	PTEN	1	c.477	2016-05-18 19:53:34.064958	2016-05-18 20:38:45.672837	1	ENSG00000171862	missense
220	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/pten/24\\"}}"	\N		10	89692993	89692993	G	T	DOID:9256	21228335	included	ENST00000371953	p.R159S	PTEN	1	c.477	2016-05-18 19:53:34.074087	2016-05-18 20:38:45.72322	1	ENSG00000171862	missense
221	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/pten/24\\"}}"	\N		10	89692993	89692993	G	T	DOID:9256	20921465	included	ENST00000371953	p.R159S	PTEN	1	c.477	2016-05-18 19:53:34.084531	2016-05-18 20:38:45.776819	1	ENSG00000171862	missense
222	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/pten/24\\"}}"	\N		10	89692993	89692993	G	T	DOID:9256	16618717	included	ENST00000371953	p.R159S	PTEN	1	c.477	2016-05-18 19:53:34.09329	2016-05-18 20:38:45.834564	1	ENSG00000171862	missense
224	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/breast-cancer/pten/25\\"}}"	\N		10	89717672	89717672	C	T	DOID:1612	18316791	included	ENST00000371953	p.R233*	PTEN	1	c.697	2016-05-18 19:53:34.110928	2016-05-18 20:38:45.954639	1	ENSG00000171862	stop
225	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/breast-cancer/pten/25\\"}}"	\N		10	89717672	89717672	C	T	DOID:1612	19679400	included	ENST00000371953	p.R233*	PTEN	1	c.697	2016-05-18 19:53:34.121041	2016-05-18 20:38:46.004199	1	ENSG00000171862	stop
226	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/breast-cancer/pten/25\\"}}"	\N		10	89717672	89717672	C	T	DOID:1612	16361624	included	ENST00000371953	p.R233*	PTEN	1	c.697	2016-05-18 19:53:34.129542	2016-05-18 20:38:46.059795	1	ENSG00000171862	stop
227	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/breast-cancer/pten/25\\"}}"	\N		10	89717672	89717672	C	T	DOID:1612	19114683	included	ENST00000371953	p.R233*	PTEN	1	c.697	2016-05-18 19:53:34.137841	2016-05-18 20:38:46.104545	1	ENSG00000171862	stop
228	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/breast-cancer/pten/25\\"}}"	\N		10	89717672	89717672	C	T	DOID:1612	21228335	included	ENST00000371953	p.R233*	PTEN	1	c.697	2016-05-18 19:53:34.14948	2016-05-18 20:38:46.160634	1	ENSG00000171862	stop
229	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/breast-cancer/pten/25\\"}}"	\N		10	89717672	89717672	C	T	DOID:1612	20921465	included	ENST00000371953	p.R233*	PTEN	1	c.697	2016-05-18 19:53:34.157151	2016-05-18 20:38:46.20578	1	ENSG00000171862	stop
230	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/breast-cancer/pten/25\\"}}"	\N		10	89717672	89717672	C	T	DOID:1612	16618717	included	ENST00000371953	p.R233*	PTEN	1	c.697	2016-05-18 19:53:34.165541	2016-05-18 20:38:46.285606	1	ENSG00000171862	stop
231	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/breast-cancer/pten/25\\"}}"	\N		10	89717672	89717672	C	T	DOID:1612	20921462	included	ENST00000371953	p.R233*	PTEN	1	c.697	2016-05-18 19:53:34.175171	2016-05-18 20:38:46.335103	1	ENSG00000171862	stop
232	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/lung-cancer/pten/25\\"}}"	\N		10	89717672	89717672	C	T	DOID:3908	18316791	included	ENST00000371953	p.R233*	PTEN	1	c.697	2016-05-18 19:53:34.185208	2016-05-18 20:38:46.403023	1	ENSG00000171862	stop
233	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/lung-cancer/pten/25\\"}}"	\N		10	89717672	89717672	C	T	DOID:3908	19679400	included	ENST00000371953	p.R233*	PTEN	1	c.697	2016-05-18 19:53:34.192837	2016-05-18 20:38:46.452519	1	ENSG00000171862	stop
234	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/lung-cancer/pten/25\\"}}"	\N		10	89717672	89717672	C	T	DOID:3908	16361624	included	ENST00000371953	p.R233*	PTEN	1	c.697	2016-05-18 19:53:34.201109	2016-05-18 20:38:46.527881	1	ENSG00000171862	stop
235	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/lung-cancer/pten/25\\"}}"	\N		10	89717672	89717672	C	T	DOID:3908	19114683	included	ENST00000371953	p.R233*	PTEN	1	c.697	2016-05-18 19:53:34.210112	2016-05-18 20:38:46.578175	1	ENSG00000171862	stop
236	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/lung-cancer/pten/25\\"}}"	\N		10	89717672	89717672	C	T	DOID:3908	21228335	included	ENST00000371953	p.R233*	PTEN	1	c.697	2016-05-18 19:53:34.221328	2016-05-18 20:38:46.635711	1	ENSG00000171862	stop
237	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/lung-cancer/pten/25\\"}}"	\N		10	89717672	89717672	C	T	DOID:3908	20921465	included	ENST00000371953	p.R233*	PTEN	1	c.697	2016-05-18 19:53:34.230464	2016-05-18 20:38:46.686472	1	ENSG00000171862	stop
238	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/lung-cancer/pten/25\\"}}"	\N		10	89717672	89717672	C	T	DOID:3908	16618717	included	ENST00000371953	p.R233*	PTEN	1	c.697	2016-05-18 19:53:34.240461	2016-05-18 20:38:46.747745	1	ENSG00000171862	stop
239	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/lung-cancer/pten/25\\"}}"	\N		10	89717672	89717672	C	T	DOID:3908	20921462	included	ENST00000371953	p.R233*	PTEN	1	c.697	2016-05-18 19:53:34.251736	2016-05-18 20:38:46.811013	1	ENSG00000171862	stop
240	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/pten/25\\"}}"	\N		10	89717672	89717672	C	T	DOID:9256	18316791	included	ENST00000371953	p.R233*	PTEN	1	c.697	2016-05-18 19:53:34.259788	2016-05-18 20:38:46.856514	1	ENSG00000171862	stop
241	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/pten/25\\"}}"	\N		10	89717672	89717672	C	T	DOID:9256	19679400	included	ENST00000371953	p.R233*	PTEN	1	c.697	2016-05-18 19:53:34.268653	2016-05-18 20:38:46.907289	1	ENSG00000171862	stop
242	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/pten/25\\"}}"	\N		10	89717672	89717672	C	T	DOID:9256	16361624	included	ENST00000371953	p.R233*	PTEN	1	c.697	2016-05-18 19:53:34.277693	2016-05-18 20:38:46.972891	1	ENSG00000171862	stop
243	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/pten/25\\"}}"	\N		10	89717672	89717672	C	T	DOID:9256	19114683	included	ENST00000371953	p.R233*	PTEN	1	c.697	2016-05-18 19:53:34.288076	2016-05-18 20:38:47.027354	1	ENSG00000171862	stop
244	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/pten/25\\"}}"	\N		10	89717672	89717672	C	T	DOID:9256	21228335	included	ENST00000371953	p.R233*	PTEN	1	c.697	2016-05-18 19:53:34.296798	2016-05-18 20:38:47.092547	1	ENSG00000171862	stop
245	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/pten/25\\"}}"	\N		10	89717672	89717672	C	T	DOID:9256	20921465	included	ENST00000371953	p.R233*	PTEN	1	c.697	2016-05-18 19:53:34.306314	2016-05-18 20:38:47.147262	1	ENSG00000171862	stop
246	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/pten/25\\"}}"	\N		10	89717672	89717672	C	T	DOID:9256	16618717	included	ENST00000371953	p.R233*	PTEN	1	c.697	2016-05-18 19:53:34.314756	2016-05-18 20:38:47.224409	1	ENSG00000171862	stop
247	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/pten/25\\"}}"	\N		10	89717672	89717672	C	T	DOID:9256	20921462	included	ENST00000371953	p.R233*	PTEN	1	c.697	2016-05-18 19:53:34.32971	2016-05-18 20:38:47.284072	1	ENSG00000171862	stop
248	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/breast-cancer/pten/26\\"}}"	\N		10	89717775	89717775	A	-	DOID:1612	18316791	included	ENST00000371953	p.K267X	PTEN	1	c.800	2016-05-18 19:53:34.339123	2016-05-18 20:38:47.390272	1	ENSG00000171862	frameshift
249	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/breast-cancer/pten/26\\"}}"	\N		10	89717775	89717775	A	-	DOID:1612	19679400	included	ENST00000371953	p.K267X	PTEN	1	c.800	2016-05-18 19:53:34.358128	2016-05-18 20:38:47.47708	1	ENSG00000171862	frameshift
250	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/breast-cancer/pten/26\\"}}"	\N		10	89717775	89717775	A	-	DOID:1612	16361624	included	ENST00000371953	p.K267X	PTEN	1	c.800	2016-05-18 19:53:34.36614	2016-05-18 20:38:47.565659	1	ENSG00000171862	frameshift
251	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/breast-cancer/pten/26\\"}}"	\N		10	89717775	89717775	A	-	DOID:1612	19114683	included	ENST00000371953	p.K267X	PTEN	1	c.800	2016-05-18 19:53:34.375224	2016-05-18 20:38:47.666782	1	ENSG00000171862	frameshift
252	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/breast-cancer/pten/26\\"}}"	\N		10	89717775	89717775	A	-	DOID:1612	21228335	included	ENST00000371953	p.K267X	PTEN	1	c.800	2016-05-18 19:53:34.390868	2016-05-18 20:38:47.748389	1	ENSG00000171862	frameshift
253	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/breast-cancer/pten/26\\"}}"	\N		10	89717775	89717775	A	-	DOID:1612	20921465	included	ENST00000371953	p.K267X	PTEN	1	c.800	2016-05-18 19:53:34.399428	2016-05-18 20:38:47.811909	1	ENSG00000171862	frameshift
255	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/breast-cancer/pten/26\\"}}"	\N		10	89717775	89717775	A	-	DOID:1612	20921462	included	ENST00000371953	p.K267X	PTEN	1	c.800	2016-05-18 19:53:34.422612	2016-05-18 20:38:47.971662	1	ENSG00000171862	frameshift
256	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/pten/26\\"}}"	\N		10	89717775	89717775	A	-	DOID:9256	18316791	included	ENST00000371953	p.K267X	PTEN	1	c.800	2016-05-18 19:53:34.430754	2016-05-18 20:38:48.040651	1	ENSG00000171862	frameshift
257	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/pten/26\\"}}"	\N		10	89717775	89717775	A	-	DOID:9256	19679400	included	ENST00000371953	p.K267X	PTEN	1	c.800	2016-05-18 19:53:34.438782	2016-05-18 20:38:48.094432	1	ENSG00000171862	frameshift
258	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/pten/26\\"}}"	\N		10	89717775	89717775	A	-	DOID:9256	16361624	included	ENST00000371953	p.K267X	PTEN	1	c.800	2016-05-18 19:53:34.447489	2016-05-18 20:38:48.181191	1	ENSG00000171862	frameshift
259	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/pten/26\\"}}"	\N		10	89717775	89717775	A	-	DOID:9256	19114683	included	ENST00000371953	p.K267X	PTEN	1	c.800	2016-05-18 19:53:34.463333	2016-05-18 20:38:48.310186	1	ENSG00000171862	frameshift
260	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/pten/26\\"}}"	\N		10	89717775	89717775	A	-	DOID:9256	21228335	included	ENST00000371953	p.K267X	PTEN	1	c.800	2016-05-18 19:53:34.473012	2016-05-18 20:38:48.364378	1	ENSG00000171862	frameshift
261	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/pten/26\\"}}"	\N		10	89717775	89717775	A	-	DOID:9256	20921465	included	ENST00000371953	p.K267X	PTEN	1	c.800	2016-05-18 19:53:34.491457	2016-05-18 20:38:48.474802	1	ENSG00000171862	frameshift
262	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/pten/26\\"}}"	\N		10	89717775	89717775	A	-	DOID:9256	16618717	included	ENST00000371953	p.K267X	PTEN	1	c.800	2016-05-18 19:53:34.499483	2016-05-18 20:38:48.551443	1	ENSG00000171862	frameshift
263	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/pten/26\\"}}"	\N		10	89717775	89717775	A	-	DOID:9256	20921462	included	ENST00000371953	p.K267X	PTEN	1	c.800	2016-05-18 19:53:34.5086	2016-05-18 20:38:48.632904	1	ENSG00000171862	frameshift
264	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/307\\"}}"	\N		11	533874	533874	T	C	DOID:1781	18316791	included	ENST00000311189	p.Q61R	HRAS	-1	c.182	2016-05-18 19:53:34.521038	2016-05-18 20:38:48.761512	1	ENSG00000174775	missense
265	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/307\\"}}"	\N		11	533874	533874	T	C	DOID:1781	19679400	included	ENST00000311189	p.Q61R	HRAS	-1	c.182	2016-05-18 19:53:34.529679	2016-05-18 20:38:48.824867	1	ENSG00000174775	missense
1448	\N	\N		11	32417909	32417910	-	ACCGTACA	DOID:9119	20921465	included	ENST00000332351	p.S381LYG	WT1	-1	c.1142	2016-05-18 20:26:14.925272	2016-05-18 20:39:59.708342	2	ENSG00000184937	protein
266	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/307\\"}}"	\N		11	533874	533874	T	C	DOID:1781	16361624	included	ENST00000311189	p.Q61R	HRAS	-1	c.182	2016-05-18 19:53:34.537859	2016-05-18 20:38:48.901491	1	ENSG00000174775	missense
267	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/307\\"}}"	\N		11	533874	533874	T	C	DOID:1781	19114683	included	ENST00000311189	p.Q61R	HRAS	-1	c.182	2016-05-18 19:53:34.550258	2016-05-18 20:38:48.961157	1	ENSG00000174775	missense
268	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/307\\"}}"	\N		11	533874	533874	T	C	DOID:1781	21228335	included	ENST00000311189	p.Q61R	HRAS	-1	c.182	2016-05-18 19:53:34.558774	2016-05-18 20:38:49.02756	1	ENSG00000174775	missense
269	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/307\\"}}"	\N		11	533874	533874	T	C	DOID:1781	20921465	included	ENST00000311189	p.Q61R	HRAS	-1	c.182	2016-05-18 19:53:34.566443	2016-05-18 20:38:49.108714	1	ENSG00000174775	missense
270	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/307\\"}}"	\N		11	533874	533874	T	C	DOID:1781	16618717	included	ENST00000311189	p.Q61R	HRAS	-1	c.182	2016-05-18 19:53:34.575571	2016-05-18 20:38:49.166777	1	ENSG00000174775	missense
271	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/307\\"}}"	\N		11	533874	533874	T	C	DOID:1781	20921462	included	ENST00000311189	p.Q61R	HRAS	-1	c.182	2016-05-18 19:53:34.595675	2016-05-18 20:38:49.259192	1	ENSG00000174775	missense
272	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/305\\"}}"	\N		11	534286	534286	C	A	DOID:1781	18316791	included	ENST00000311189	p.G13C	HRAS	-1	c.37	2016-05-18 19:53:34.605348	2016-05-18 20:38:49.340432	1	ENSG00000174775	missense
273	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/305\\"}}"	\N		11	534286	534286	C	A	DOID:1781	19679400	included	ENST00000311189	p.G13C	HRAS	-1	c.37	2016-05-18 19:53:34.62458	2016-05-18 20:38:49.43383	1	ENSG00000174775	missense
274	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/305\\"}}"	\N		11	534286	534286	C	A	DOID:1781	16361624	included	ENST00000311189	p.G13C	HRAS	-1	c.37	2016-05-18 19:53:34.632539	2016-05-18 20:38:49.526051	1	ENSG00000174775	missense
275	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/305\\"}}"	\N		11	534286	534286	C	A	DOID:1781	19114683	included	ENST00000311189	p.G13C	HRAS	-1	c.37	2016-05-18 19:53:34.641236	2016-05-18 20:38:49.583545	1	ENSG00000174775	missense
276	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/305\\"}}"	\N		11	534286	534286	C	A	DOID:1781	21228335	included	ENST00000311189	p.G13C	HRAS	-1	c.37	2016-05-18 19:53:34.664719	2016-05-18 20:38:49.652271	1	ENSG00000174775	missense
277	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/305\\"}}"	\N		11	534286	534286	C	A	DOID:1781	20921465	included	ENST00000311189	p.G13C	HRAS	-1	c.37	2016-05-18 19:53:34.690285	2016-05-18 20:38:49.704713	1	ENSG00000174775	missense
278	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/305\\"}}"	\N		11	534286	534286	C	A	DOID:1781	16618717	included	ENST00000311189	p.G13C	HRAS	-1	c.37	2016-05-18 19:53:34.698326	2016-05-18 20:38:49.757277	1	ENSG00000174775	missense
279	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/305\\"}}"	\N		11	534286	534286	C	A	DOID:1781	20921462	included	ENST00000311189	p.G13C	HRAS	-1	c.37	2016-05-18 19:53:34.731086	2016-05-18 20:38:49.821043	1	ENSG00000174775	missense
280	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/306\\"}}"	\N		11	534286	534286	C	G	DOID:1781	20619739	included	ENST00000311189	p.G13R	HRAS	-1	c.37	2016-05-18 19:53:34.739914	2016-05-18 20:38:49.919772	1	ENSG00000174775	missense
281	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/306\\"}}"	\N		11	534286	534286	C	G	DOID:1781	20736745	included	ENST00000311189	p.G13R	HRAS	-1	c.37	2016-05-18 19:53:34.762411	2016-05-18 20:38:49.981178	1	ENSG00000174775	missense
282	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/306\\"}}"	\N		11	534286	534286	C	G	DOID:1781	21829508	included	ENST00000311189	p.G13R	HRAS	-1	c.37	2016-05-18 19:53:34.770991	2016-05-18 20:38:50.082169	1	ENSG00000174775	missense
283	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/306\\"}}"	\N		11	534286	534286	C	G	DOID:1781	21305640	included	ENST00000311189	p.G13R	HRAS	-1	c.37	2016-05-18 19:53:34.798595	2016-05-18 20:38:50.145801	1	ENSG00000174775	missense
284	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/306\\"}}"	\N		11	534286	534286	C	G	DOID:1781	21729679	included	ENST00000311189	p.G13R	HRAS	-1	c.37	2016-05-18 19:53:34.80819	2016-05-18 20:38:50.260745	1	ENSG00000174775	missense
286	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/306\\"}}"	\N		11	534286	534286	C	G	DOID:1781	16273091	included	ENST00000311189	p.G13R	HRAS	-1	c.37	2016-05-18 19:53:34.837135	2016-05-18 20:38:50.37556	1	ENSG00000174775	missense
287	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/304\\"}}"	\N		11	534288	534288	C	A	DOID:1781	20619739	included	ENST00000311189	p.G12V	HRAS	-1	c.35	2016-05-18 19:53:34.866471	2016-05-18 20:38:50.454106	1	ENSG00000174775	missense
288	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/304\\"}}"	\N		11	534288	534288	C	A	DOID:1781	20736745	included	ENST00000311189	p.G12V	HRAS	-1	c.35	2016-05-18 19:53:34.875558	2016-05-18 20:38:50.537565	1	ENSG00000174775	missense
289	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/304\\"}}"	\N		11	534288	534288	C	A	DOID:1781	21829508	included	ENST00000311189	p.G12V	HRAS	-1	c.35	2016-05-18 19:53:34.894247	2016-05-18 20:38:50.58838	1	ENSG00000174775	missense
290	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/304\\"}}"	\N		11	534288	534288	C	A	DOID:1781	21305640	included	ENST00000311189	p.G12V	HRAS	-1	c.35	2016-05-18 19:53:34.901815	2016-05-18 20:38:50.666596	1	ENSG00000174775	missense
291	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/304\\"}}"	\N		11	534288	534288	C	A	DOID:1781	21729679	included	ENST00000311189	p.G12V	HRAS	-1	c.35	2016-05-18 19:53:34.911041	2016-05-18 20:38:50.723916	1	ENSG00000174775	missense
292	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/304\\"}}"	\N		11	534288	534288	C	A	DOID:1781	17699718	included	ENST00000311189	p.G12V	HRAS	-1	c.35	2016-05-18 19:53:34.928105	2016-05-18 20:38:50.793565	1	ENSG00000174775	missense
293	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/304\\"}}"	\N		11	534288	534288	C	A	DOID:1781	16273091	included	ENST00000311189	p.G12V	HRAS	-1	c.35	2016-05-18 19:53:34.935935	2016-05-18 20:38:50.844625	1	ENSG00000174775	missense
294	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/303\\"}}"	\N		11	534289	534289	C	G	DOID:1781	20619739	included	ENST00000311189	p.G12R	HRAS	-1	c.34	2016-05-18 19:53:34.967787	2016-05-18 20:38:50.930249	1	ENSG00000174775	missense
295	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/303\\"}}"	\N		11	534289	534289	C	G	DOID:1781	20736745	included	ENST00000311189	p.G12R	HRAS	-1	c.34	2016-05-18 19:53:34.993505	2016-05-18 20:38:50.991656	1	ENSG00000174775	missense
296	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/303\\"}}"	\N		11	534289	534289	C	G	DOID:1781	21829508	included	ENST00000311189	p.G12R	HRAS	-1	c.34	2016-05-18 19:53:35.003	2016-05-18 20:38:51.05634	1	ENSG00000174775	missense
297	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/303\\"}}"	\N		11	534289	534289	C	G	DOID:1781	21305640	included	ENST00000311189	p.G12R	HRAS	-1	c.34	2016-05-18 19:53:35.033545	2016-05-18 20:38:51.138212	1	ENSG00000174775	missense
298	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/303\\"}}"	\N		11	534289	534289	C	G	DOID:1781	21729679	included	ENST00000311189	p.G12R	HRAS	-1	c.34	2016-05-18 19:53:35.042489	2016-05-18 20:38:51.184211	1	ENSG00000174775	missense
299	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/303\\"}}"	\N		11	534289	534289	C	G	DOID:1781	17699718	included	ENST00000311189	p.G12R	HRAS	-1	c.34	2016-05-18 19:53:35.063012	2016-05-18 20:38:51.248851	1	ENSG00000174775	missense
300	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/303\\"}}"	\N		11	534289	534289	C	G	DOID:1781	16273091	included	ENST00000311189	p.G12R	HRAS	-1	c.34	2016-05-18 19:53:35.071042	2016-05-18 20:38:51.3229	1	ENSG00000174775	missense
301	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/29\\"}}"	\N		12	25378561	25378561	G	A	DOID:1781	20619739	included	ENST00000256078	p.A146V	KRAS	-1	c.437	2016-05-18 19:53:35.102748	2016-05-18 20:38:51.43221	1	ENSG00000133703	missense
302	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/29\\"}}"	\N		12	25378561	25378561	G	A	DOID:1781	20736745	included	ENST00000256078	p.A146V	KRAS	-1	c.437	2016-05-18 19:53:35.111144	2016-05-18 20:38:51.505183	1	ENSG00000133703	missense
303	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/29\\"}}"	\N		12	25378561	25378561	G	A	DOID:1781	21829508	included	ENST00000256078	p.A146V	KRAS	-1	c.437	2016-05-18 19:53:35.133145	2016-05-18 20:38:51.567207	1	ENSG00000133703	missense
304	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/29\\"}}"	\N		12	25378561	25378561	G	A	DOID:1781	21305640	included	ENST00000256078	p.A146V	KRAS	-1	c.437	2016-05-18 19:53:35.141718	2016-05-18 20:38:51.663306	1	ENSG00000133703	missense
305	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/29\\"}}"	\N		12	25378561	25378561	G	A	DOID:1781	21729679	included	ENST00000256078	p.A146V	KRAS	-1	c.437	2016-05-18 19:53:35.169485	2016-05-18 20:38:51.722306	1	ENSG00000133703	missense
306	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/29\\"}}"	\N		12	25378561	25378561	G	A	DOID:1781	17699718	included	ENST00000256078	p.A146V	KRAS	-1	c.437	2016-05-18 19:53:35.178889	2016-05-18 20:38:51.791321	1	ENSG00000133703	missense
307	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/29\\"}}"	\N		12	25378561	25378561	G	A	DOID:1781	16273091	included	ENST00000256078	p.A146V	KRAS	-1	c.437	2016-05-18 19:53:35.199889	2016-05-18 20:38:51.849497	1	ENSG00000133703	missense
308	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/29\\"}}"	\N		12	25378561	25378561	G	A	DOID:9256	20619739	included	ENST00000256078	p.A146V	KRAS	-1	c.437	2016-05-18 19:53:35.208812	2016-05-18 20:38:51.915264	1	ENSG00000133703	missense
309	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/29\\"}}"	\N		12	25378561	25378561	G	A	DOID:9256	20736745	included	ENST00000256078	p.A146V	KRAS	-1	c.437	2016-05-18 19:53:35.236701	2016-05-18 20:38:51.986821	1	ENSG00000133703	missense
310	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/29\\"}}"	\N		12	25378561	25378561	G	A	DOID:9256	21829508	included	ENST00000256078	p.A146V	KRAS	-1	c.437	2016-05-18 19:53:35.245597	2016-05-18 20:38:52.036258	1	ENSG00000133703	missense
311	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/29\\"}}"	\N		12	25378561	25378561	G	A	DOID:9256	21305640	included	ENST00000256078	p.A146V	KRAS	-1	c.437	2016-05-18 19:53:35.266774	2016-05-18 20:38:52.10413	1	ENSG00000133703	missense
312	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/29\\"}}"	\N		12	25378561	25378561	G	A	DOID:9256	21729679	included	ENST00000256078	p.A146V	KRAS	-1	c.437	2016-05-18 19:53:35.275682	2016-05-18 20:38:52.169467	1	ENSG00000133703	missense
313	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/29\\"}}"	\N		12	25378561	25378561	G	A	DOID:9256	17699718	included	ENST00000256078	p.A146V	KRAS	-1	c.437	2016-05-18 19:53:35.302238	2016-05-18 20:38:52.272089	1	ENSG00000133703	missense
314	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/29\\"}}"	\N		12	25378561	25378561	G	A	DOID:9256	16273091	included	ENST00000256078	p.A146V	KRAS	-1	c.437	2016-05-18 19:53:35.328432	2016-05-18 20:38:52.330284	1	ENSG00000133703	missense
315	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/27\\"}}"	\N		12	25378562	25378562	C	G	DOID:9256	20619739	included	ENST00000256078	p.A146P	KRAS	-1	c.436	2016-05-18 19:53:35.33663	2016-05-18 20:38:52.411444	1	ENSG00000133703	missense
317	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/27\\"}}"	\N		12	25378562	25378562	C	G	DOID:9256	21829508	included	ENST00000256078	p.A146P	KRAS	-1	c.436	2016-05-18 19:53:35.375146	2016-05-18 20:38:52.52294	1	ENSG00000133703	missense
318	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/27\\"}}"	\N		12	25378562	25378562	C	G	DOID:9256	21305640	included	ENST00000256078	p.A146P	KRAS	-1	c.436	2016-05-18 19:53:35.400503	2016-05-18 20:38:52.577545	1	ENSG00000133703	missense
319	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/27\\"}}"	\N		12	25378562	25378562	C	G	DOID:9256	21729679	included	ENST00000256078	p.A146P	KRAS	-1	c.436	2016-05-18 19:53:35.409878	2016-05-18 20:38:52.626952	1	ENSG00000133703	missense
320	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/27\\"}}"	\N		12	25378562	25378562	C	G	DOID:9256	17699718	included	ENST00000256078	p.A146P	KRAS	-1	c.436	2016-05-18 19:53:35.43746	2016-05-18 20:38:52.689244	1	ENSG00000133703	missense
1449	\N	\N		11	32417909	32417910	-	ACCGTACA	DOID:9119	16618717	included	ENST00000332351	p.S381LYG	WT1	-1	c.1142	2016-05-18 20:26:14.93511	2016-05-18 20:39:59.761533	2	ENSG00000184937	protein
321	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/27\\"}}"	\N		12	25378562	25378562	C	G	DOID:9256	16273091	included	ENST00000256078	p.A146P	KRAS	-1	c.436	2016-05-18 19:53:35.446884	2016-05-18 20:38:52.760157	1	ENSG00000133703	missense
322	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/28\\"}}"	\N		12	25378562	25378562	C	T	DOID:9256	20619739	included	ENST00000256078	p.A146T	KRAS	-1	c.436	2016-05-18 19:53:35.468705	2016-05-18 20:38:52.841482	1	ENSG00000133703	missense
323	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/28\\"}}"	\N		12	25378562	25378562	C	T	DOID:9256	20736745	included	ENST00000256078	p.A146T	KRAS	-1	c.436	2016-05-18 19:53:35.500563	2016-05-18 20:38:52.90546	1	ENSG00000133703	missense
324	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/28\\"}}"	\N		12	25378562	25378562	C	T	DOID:9256	21829508	included	ENST00000256078	p.A146T	KRAS	-1	c.436	2016-05-18 19:53:35.509272	2016-05-18 20:38:52.983545	1	ENSG00000133703	missense
325	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/28\\"}}"	\N		12	25378562	25378562	C	T	DOID:9256	21305640	included	ENST00000256078	p.A146T	KRAS	-1	c.436	2016-05-18 19:53:35.531792	2016-05-18 20:38:53.032659	1	ENSG00000133703	missense
326	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/28\\"}}"	\N		12	25378562	25378562	C	T	DOID:9256	21729679	included	ENST00000256078	p.A146T	KRAS	-1	c.436	2016-05-18 19:53:35.53985	2016-05-18 20:38:53.091897	1	ENSG00000133703	missense
327	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/28\\"}}"	\N		12	25378562	25378562	C	T	DOID:9256	17699718	included	ENST00000256078	p.A146T	KRAS	-1	c.436	2016-05-18 19:53:35.567617	2016-05-18 20:38:53.14218	1	ENSG00000133703	missense
328	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/28\\"}}"	\N		12	25378562	25378562	C	T	DOID:9256	16273091	included	ENST00000256078	p.A146T	KRAS	-1	c.436	2016-05-18 19:53:35.576432	2016-05-18 20:38:53.192634	1	ENSG00000133703	missense
329	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/161\\"}}"	\N		12	25378647	25378647	T	A	DOID:9256	15016963	included	ENST00000256078	p.K117N	KRAS	-1	c.351	2016-05-18 19:53:35.598829	2016-05-18 20:38:53.266676	1	ENSG00000133703	missense
330	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/161\\"}}"	\N		12	25378647	25378647	T	A	DOID:9256	15647370	included	ENST00000256078	p.K117N	KRAS	-1	c.351	2016-05-18 19:53:35.608371	2016-05-18 20:38:53.311155	1	ENSG00000133703	missense
331	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/161\\"}}"	\N		12	25378647	25378647	T	A	DOID:9256	15254419	included	ENST00000256078	p.K117N	KRAS	-1	c.351	2016-05-18 19:53:35.618218	2016-05-18 20:38:53.364807	1	ENSG00000133703	missense
332	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/161\\"}}"	\N		12	25378647	25378647	T	A	DOID:9256	20453058	included	ENST00000256078	p.K117N	KRAS	-1	c.351	2016-05-18 19:53:35.63299	2016-05-18 20:38:53.410448	1	ENSG00000133703	missense
333	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/161\\"}}"	\N		12	25378647	25378647	T	A	DOID:9256	18725974	included	ENST00000256078	p.K117N	KRAS	-1	c.351	2016-05-18 19:53:35.641523	2016-05-18 20:38:53.453927	1	ENSG00000133703	missense
334	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/161\\"}}"	\N		12	25378647	25378647	T	A	DOID:9256	22162589	included	ENST00000256078	p.K117N	KRAS	-1	c.351	2016-05-18 19:53:35.66735	2016-05-18 20:38:53.498483	1	ENSG00000133703	missense
335	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/161\\"}}"	\N		12	25378647	25378647	T	A	DOID:9256	22162582	included	ENST00000256078	p.K117N	KRAS	-1	c.351	2016-05-18 19:53:35.675579	2016-05-18 20:38:53.541275	1	ENSG00000133703	missense
336	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/161\\"}}"	\N		12	25378647	25378647	T	A	DOID:9256	19903786	included	ENST00000256078	p.K117N	KRAS	-1	c.351	2016-05-18 19:53:35.706279	2016-05-18 20:38:53.596611	1	ENSG00000133703	missense
337	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/161\\"}}"	\N		12	25378647	25378647	T	A	DOID:9256	20619739	included	ENST00000256078	p.K117N	KRAS	-1	c.351	2016-05-18 19:53:35.715582	2016-05-18 20:38:53.658935	1	ENSG00000133703	missense
338	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/161\\"}}"	\N		12	25378647	25378647	T	A	DOID:9256	19366826	included	ENST00000256078	p.K117N	KRAS	-1	c.351	2016-05-18 19:53:35.735803	2016-05-18 20:38:53.71038	1	ENSG00000133703	missense
339	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/160\\"}}"	\N		12	25378647	25378647	T	G	DOID:9256	15016963	included	ENST00000256078	p.K117N	KRAS	-1	c.351	2016-05-18 19:53:35.744721	2016-05-18 20:38:53.777291	1	ENSG00000133703	missense
340	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/160\\"}}"	\N		12	25378647	25378647	T	G	DOID:9256	15647370	included	ENST00000256078	p.K117N	KRAS	-1	c.351	2016-05-18 19:53:35.77353	2016-05-18 20:38:53.841622	1	ENSG00000133703	missense
341	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/160\\"}}"	\N		12	25378647	25378647	T	G	DOID:9256	15254419	included	ENST00000256078	p.K117N	KRAS	-1	c.351	2016-05-18 19:53:35.783055	2016-05-18 20:38:53.889123	1	ENSG00000133703	missense
342	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/160\\"}}"	\N		12	25378647	25378647	T	G	DOID:9256	20453058	included	ENST00000256078	p.K117N	KRAS	-1	c.351	2016-05-18 19:53:35.803679	2016-05-18 20:38:53.938381	1	ENSG00000133703	missense
343	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/160\\"}}"	\N		12	25378647	25378647	T	G	DOID:9256	18725974	included	ENST00000256078	p.K117N	KRAS	-1	c.351	2016-05-18 19:53:35.812986	2016-05-18 20:38:53.979643	1	ENSG00000133703	missense
344	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/160\\"}}"	\N		12	25378647	25378647	T	G	DOID:9256	22162589	included	ENST00000256078	p.K117N	KRAS	-1	c.351	2016-05-18 19:53:35.839775	2016-05-18 20:38:54.016373	1	ENSG00000133703	missense
348	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/160\\"}}"	\N		12	25378647	25378647	T	G	DOID:9256	19366826	included	ENST00000256078	p.K117N	KRAS	-1	c.351	2016-05-18 19:53:35.906291	2016-05-18 20:38:54.173238	1	ENSG00000133703	missense
349	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/lung-cancer/kras/31\\"}}"	\N		12	25380275	25380275	T	A	DOID:3908	15016963	included	ENST00000256078	p.Q61H	KRAS	-1	c.183	2016-05-18 19:53:35.915635	2016-05-18 20:38:54.244612	1	ENSG00000133703	missense
351	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/lung-cancer/kras/31\\"}}"	\N		12	25380275	25380275	T	A	DOID:3908	15254419	included	ENST00000256078	p.Q61H	KRAS	-1	c.183	2016-05-18 19:53:35.970277	2016-05-18 20:38:54.348771	1	ENSG00000133703	missense
352	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/lung-cancer/kras/31\\"}}"	\N		12	25380275	25380275	T	A	DOID:3908	20453058	included	ENST00000256078	p.Q61H	KRAS	-1	c.183	2016-05-18 19:53:35.983936	2016-05-18 20:38:54.403256	1	ENSG00000133703	missense
353	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/lung-cancer/kras/31\\"}}"	\N		12	25380275	25380275	T	A	DOID:3908	18725974	included	ENST00000256078	p.Q61H	KRAS	-1	c.183	2016-05-18 19:53:36.000628	2016-05-18 20:38:54.485802	1	ENSG00000133703	missense
354	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/lung-cancer/kras/31\\"}}"	\N		12	25380275	25380275	T	A	DOID:3908	22162589	included	ENST00000256078	p.Q61H	KRAS	-1	c.183	2016-05-18 19:53:36.010719	2016-05-18 20:38:54.528338	1	ENSG00000133703	missense
355	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/lung-cancer/kras/31\\"}}"	\N		12	25380275	25380275	T	A	DOID:3908	22162582	included	ENST00000256078	p.Q61H	KRAS	-1	c.183	2016-05-18 19:53:36.033164	2016-05-18 20:38:54.594218	1	ENSG00000133703	missense
356	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/lung-cancer/kras/31\\"}}"	\N		12	25380275	25380275	T	A	DOID:3908	19903786	included	ENST00000256078	p.Q61H	KRAS	-1	c.183	2016-05-18 19:53:36.042548	2016-05-18 20:38:54.641075	1	ENSG00000133703	missense
357	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/lung-cancer/kras/31\\"}}"	\N		12	25380275	25380275	T	A	DOID:3908	20619739	included	ENST00000256078	p.Q61H	KRAS	-1	c.183	2016-05-18 19:53:36.069534	2016-05-18 20:38:54.694503	1	ENSG00000133703	missense
358	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/lung-cancer/kras/31\\"}}"	\N		12	25380275	25380275	T	A	DOID:3908	19366826	included	ENST00000256078	p.Q61H	KRAS	-1	c.183	2016-05-18 19:53:36.078581	2016-05-18 20:38:54.739633	1	ENSG00000133703	missense
359	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/31\\"}}"	\N		12	25380275	25380275	T	A	DOID:9256	15016963	included	ENST00000256078	p.Q61H	KRAS	-1	c.183	2016-05-18 19:53:36.118216	2016-05-18 20:38:54.822797	1	ENSG00000133703	missense
360	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/31\\"}}"	\N		12	25380275	25380275	T	A	DOID:9256	15647370	included	ENST00000256078	p.Q61H	KRAS	-1	c.183	2016-05-18 19:53:36.143858	2016-05-18 20:38:54.872093	1	ENSG00000133703	missense
361	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/31\\"}}"	\N		12	25380275	25380275	T	A	DOID:9256	15254419	included	ENST00000256078	p.Q61H	KRAS	-1	c.183	2016-05-18 19:53:36.153614	2016-05-18 20:38:54.940668	1	ENSG00000133703	missense
362	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/31\\"}}"	\N		12	25380275	25380275	T	A	DOID:9256	20453058	included	ENST00000256078	p.Q61H	KRAS	-1	c.183	2016-05-18 19:53:36.175106	2016-05-18 20:38:54.987969	1	ENSG00000133703	missense
363	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/31\\"}}"	\N		12	25380275	25380275	T	A	DOID:9256	18725974	included	ENST00000256078	p.Q61H	KRAS	-1	c.183	2016-05-18 19:53:36.184028	2016-05-18 20:38:55.032412	1	ENSG00000133703	missense
364	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/31\\"}}"	\N		12	25380275	25380275	T	A	DOID:9256	22162589	included	ENST00000256078	p.Q61H	KRAS	-1	c.183	2016-05-18 19:53:36.206275	2016-05-18 20:38:55.073954	1	ENSG00000133703	missense
365	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/31\\"}}"	\N		12	25380275	25380275	T	A	DOID:9256	22162582	included	ENST00000256078	p.Q61H	KRAS	-1	c.183	2016-05-18 19:53:36.216159	2016-05-18 20:38:55.11397	1	ENSG00000133703	missense
366	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/31\\"}}"	\N		12	25380275	25380275	T	A	DOID:9256	19903786	included	ENST00000256078	p.Q61H	KRAS	-1	c.183	2016-05-18 19:53:36.238302	2016-05-18 20:38:55.157641	1	ENSG00000133703	missense
367	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/31\\"}}"	\N		12	25380275	25380275	T	A	DOID:9256	20619739	included	ENST00000256078	p.Q61H	KRAS	-1	c.183	2016-05-18 19:53:36.246646	2016-05-18 20:38:55.212982	1	ENSG00000133703	missense
368	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/31\\"}}"	\N		12	25380275	25380275	T	A	DOID:9256	19366826	included	ENST00000256078	p.Q61H	KRAS	-1	c.183	2016-05-18 19:53:36.272919	2016-05-18 20:38:55.255472	1	ENSG00000133703	missense
369	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/lung-cancer/kras/30\\"}}"	\N		12	25380275	25380275	T	G	DOID:3908	15016963	included	ENST00000256078	p.Q61H	KRAS	-1	c.183	2016-05-18 19:53:36.282024	2016-05-18 20:38:55.3202	1	ENSG00000133703	missense
370	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/lung-cancer/kras/30\\"}}"	\N		12	25380275	25380275	T	G	DOID:3908	15647370	included	ENST00000256078	p.Q61H	KRAS	-1	c.183	2016-05-18 19:53:36.308939	2016-05-18 20:38:55.38142	1	ENSG00000133703	missense
371	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/lung-cancer/kras/30\\"}}"	\N		12	25380275	25380275	T	G	DOID:3908	15254419	included	ENST00000256078	p.Q61H	KRAS	-1	c.183	2016-05-18 19:53:36.3188	2016-05-18 20:38:55.431371	1	ENSG00000133703	missense
372	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/lung-cancer/kras/30\\"}}"	\N		12	25380275	25380275	T	G	DOID:3908	20453058	included	ENST00000256078	p.Q61H	KRAS	-1	c.183	2016-05-18 19:53:36.328511	2016-05-18 20:38:55.478075	1	ENSG00000133703	missense
373	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/lung-cancer/kras/30\\"}}"	\N		12	25380275	25380275	T	G	DOID:3908	18725974	included	ENST00000256078	p.Q61H	KRAS	-1	c.183	2016-05-18 19:53:36.342804	2016-05-18 20:38:55.524568	1	ENSG00000133703	missense
374	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/lung-cancer/kras/30\\"}}"	\N		12	25380275	25380275	T	G	DOID:3908	22162589	included	ENST00000256078	p.Q61H	KRAS	-1	c.183	2016-05-18 19:53:36.351963	2016-05-18 20:38:55.573352	1	ENSG00000133703	missense
375	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/lung-cancer/kras/30\\"}}"	\N		12	25380275	25380275	T	G	DOID:3908	22162582	included	ENST00000256078	p.Q61H	KRAS	-1	c.183	2016-05-18 19:53:36.374168	2016-05-18 20:38:55.624499	1	ENSG00000133703	missense
376	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/lung-cancer/kras/30\\"}}"	\N		12	25380275	25380275	T	G	DOID:3908	19903786	included	ENST00000256078	p.Q61H	KRAS	-1	c.183	2016-05-18 19:53:36.382694	2016-05-18 20:38:55.679864	1	ENSG00000133703	missense
1450	\N	\N		11	32417909	32417910	-	ACCGTACA	DOID:9119	20921462	included	ENST00000332351	p.S381LYG	WT1	-1	c.1142	2016-05-18 20:26:14.942669	2016-05-18 20:39:59.820935	2	ENSG00000184937	protein
379	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/30\\"}}"	\N		12	25380275	25380275	T	G	DOID:9256	15016963	included	ENST00000256078	p.Q61H	KRAS	-1	c.183	2016-05-18 19:53:36.44203	2016-05-18 20:38:55.839166	1	ENSG00000133703	missense
380	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/30\\"}}"	\N		12	25380275	25380275	T	G	DOID:9256	15647370	included	ENST00000256078	p.Q61H	KRAS	-1	c.183	2016-05-18 19:53:36.450815	2016-05-18 20:38:55.887469	1	ENSG00000133703	missense
381	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/30\\"}}"	\N		12	25380275	25380275	T	G	DOID:9256	15254419	included	ENST00000256078	p.Q61H	KRAS	-1	c.183	2016-05-18 19:53:36.473247	2016-05-18 20:38:55.950889	1	ENSG00000133703	missense
382	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/30\\"}}"	\N		12	25380275	25380275	T	G	DOID:9256	20453058	included	ENST00000256078	p.Q61H	KRAS	-1	c.183	2016-05-18 19:53:36.481435	2016-05-18 20:38:55.993226	1	ENSG00000133703	missense
383	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/30\\"}}"	\N		12	25380275	25380275	T	G	DOID:9256	18725974	included	ENST00000256078	p.Q61H	KRAS	-1	c.183	2016-05-18 19:53:36.511752	2016-05-18 20:38:56.047836	1	ENSG00000133703	missense
384	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/30\\"}}"	\N		12	25380275	25380275	T	G	DOID:9256	22162589	included	ENST00000256078	p.Q61H	KRAS	-1	c.183	2016-05-18 19:53:36.520518	2016-05-18 20:38:56.094326	1	ENSG00000133703	missense
385	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/30\\"}}"	\N		12	25380275	25380275	T	G	DOID:9256	22162582	included	ENST00000256078	p.Q61H	KRAS	-1	c.183	2016-05-18 19:53:36.541709	2016-05-18 20:38:56.145725	1	ENSG00000133703	missense
386	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/30\\"}}"	\N		12	25380275	25380275	T	G	DOID:9256	19903786	included	ENST00000256078	p.Q61H	KRAS	-1	c.183	2016-05-18 19:53:36.549988	2016-05-18 20:38:56.193987	1	ENSG00000133703	missense
387	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/30\\"}}"	\N		12	25380275	25380275	T	G	DOID:9256	20619739	included	ENST00000256078	p.Q61H	KRAS	-1	c.183	2016-05-18 19:53:36.577829	2016-05-18 20:38:56.240651	1	ENSG00000133703	missense
388	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/30\\"}}"	\N		12	25380275	25380275	T	G	DOID:9256	19366826	included	ENST00000256078	p.Q61H	KRAS	-1	c.183	2016-05-18 19:53:36.603274	2016-05-18 20:38:56.286783	1	ENSG00000133703	missense
389	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/42\\"}}"	\N		12	25380276	25380276	T	A	DOID:1781	15016963	included	ENST00000256078	p.Q61L	KRAS	-1	c.182	2016-05-18 19:53:36.610894	2016-05-18 20:38:56.35764	1	ENSG00000133703	missense
390	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/42\\"}}"	\N		12	25380276	25380276	T	A	DOID:1781	15647370	included	ENST00000256078	p.Q61L	KRAS	-1	c.182	2016-05-18 19:53:36.642155	2016-05-18 20:38:56.405562	1	ENSG00000133703	missense
391	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/42\\"}}"	\N		12	25380276	25380276	T	A	DOID:1781	15254419	included	ENST00000256078	p.Q61L	KRAS	-1	c.182	2016-05-18 19:53:36.650366	2016-05-18 20:38:56.454466	1	ENSG00000133703	missense
392	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/42\\"}}"	\N		12	25380276	25380276	T	A	DOID:1781	20453058	included	ENST00000256078	p.Q61L	KRAS	-1	c.182	2016-05-18 19:53:36.673494	2016-05-18 20:38:56.502157	1	ENSG00000133703	missense
393	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/42\\"}}"	\N		12	25380276	25380276	T	A	DOID:1781	18725974	included	ENST00000256078	p.Q61L	KRAS	-1	c.182	2016-05-18 19:53:36.682089	2016-05-18 20:38:56.557621	1	ENSG00000133703	missense
394	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/42\\"}}"	\N		12	25380276	25380276	T	A	DOID:1781	22162589	included	ENST00000256078	p.Q61L	KRAS	-1	c.182	2016-05-18 19:53:36.70908	2016-05-18 20:38:56.605829	1	ENSG00000133703	missense
395	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/42\\"}}"	\N		12	25380276	25380276	T	A	DOID:1781	22162582	included	ENST00000256078	p.Q61L	KRAS	-1	c.182	2016-05-18 19:53:36.718076	2016-05-18 20:38:56.6524	1	ENSG00000133703	missense
396	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/42\\"}}"	\N		12	25380276	25380276	T	A	DOID:1781	19903786	included	ENST00000256078	p.Q61L	KRAS	-1	c.182	2016-05-18 19:53:36.742901	2016-05-18 20:38:56.708067	1	ENSG00000133703	missense
397	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/42\\"}}"	\N		12	25380276	25380276	T	A	DOID:1781	20619739	included	ENST00000256078	p.Q61L	KRAS	-1	c.182	2016-05-18 19:53:36.776141	2016-05-18 20:38:56.761529	1	ENSG00000133703	missense
398	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/42\\"}}"	\N		12	25380276	25380276	T	A	DOID:1781	19366826	included	ENST00000256078	p.Q61L	KRAS	-1	c.182	2016-05-18 19:53:36.784473	2016-05-18 20:38:56.814849	1	ENSG00000133703	missense
399	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/lung-cancer/kras/42\\"}}"	\N		12	25380276	25380276	T	A	DOID:3908	15016963	included	ENST00000256078	p.Q61L	KRAS	-1	c.182	2016-05-18 19:53:36.807547	2016-05-18 20:38:56.866292	1	ENSG00000133703	missense
400	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/lung-cancer/kras/42\\"}}"	\N		12	25380276	25380276	T	A	DOID:3908	15647370	included	ENST00000256078	p.Q61L	KRAS	-1	c.182	2016-05-18 19:53:36.816134	2016-05-18 20:38:56.916689	1	ENSG00000133703	missense
401	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/lung-cancer/kras/42\\"}}"	\N		12	25380276	25380276	T	A	DOID:3908	15254419	included	ENST00000256078	p.Q61L	KRAS	-1	c.182	2016-05-18 19:53:36.838522	2016-05-18 20:38:56.966078	1	ENSG00000133703	missense
402	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/lung-cancer/kras/42\\"}}"	\N		12	25380276	25380276	T	A	DOID:3908	20453058	included	ENST00000256078	p.Q61L	KRAS	-1	c.182	2016-05-18 19:53:36.846008	2016-05-18 20:38:57.031541	1	ENSG00000133703	missense
403	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/lung-cancer/kras/42\\"}}"	\N		12	25380276	25380276	T	A	DOID:3908	18725974	included	ENST00000256078	p.Q61L	KRAS	-1	c.182	2016-05-18 19:53:36.876332	2016-05-18 20:38:57.078997	1	ENSG00000133703	missense
404	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/lung-cancer/kras/42\\"}}"	\N		12	25380276	25380276	T	A	DOID:3908	22162589	included	ENST00000256078	p.Q61L	KRAS	-1	c.182	2016-05-18 19:53:36.885169	2016-05-18 20:38:57.132831	1	ENSG00000133703	missense
1451	\N	\N		12	25380275	25380275	T	A	DOID:9119	15016963	included	ENST00000256078	p.Q61H	KRAS	-1	c.183	2016-05-18 20:26:14.964135	2016-05-18 20:39:59.858775	2	ENSG00000133703	missense
405	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/lung-cancer/kras/42\\"}}"	\N		12	25380276	25380276	T	A	DOID:3908	22162582	included	ENST00000256078	p.Q61L	KRAS	-1	c.182	2016-05-18 19:53:36.907007	2016-05-18 20:38:57.184222	1	ENSG00000133703	missense
406	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/lung-cancer/kras/42\\"}}"	\N		12	25380276	25380276	T	A	DOID:3908	19903786	included	ENST00000256078	p.Q61L	KRAS	-1	c.182	2016-05-18 19:53:36.915266	2016-05-18 20:38:57.241183	1	ENSG00000133703	missense
407	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/lung-cancer/kras/42\\"}}"	\N		12	25380276	25380276	T	A	DOID:3908	20619739	included	ENST00000256078	p.Q61L	KRAS	-1	c.182	2016-05-18 19:53:36.943778	2016-05-18 20:38:57.288945	1	ENSG00000133703	missense
409	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/42\\"}}"	\N		12	25380276	25380276	T	A	DOID:9256	15016963	included	ENST00000256078	p.Q61L	KRAS	-1	c.182	2016-05-18 19:53:36.974322	2016-05-18 20:38:57.388198	1	ENSG00000133703	missense
410	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/42\\"}}"	\N		12	25380276	25380276	T	A	DOID:9256	15647370	included	ENST00000256078	p.Q61L	KRAS	-1	c.182	2016-05-18 19:53:36.981862	2016-05-18 20:38:57.447776	1	ENSG00000133703	missense
411	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/42\\"}}"	\N		12	25380276	25380276	T	A	DOID:9256	15254419	included	ENST00000256078	p.Q61L	KRAS	-1	c.182	2016-05-18 19:53:37.008735	2016-05-18 20:38:57.511276	1	ENSG00000133703	missense
412	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/42\\"}}"	\N		12	25380276	25380276	T	A	DOID:9256	20453058	included	ENST00000256078	p.Q61L	KRAS	-1	c.182	2016-05-18 19:53:37.017787	2016-05-18 20:38:57.54967	1	ENSG00000133703	missense
413	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/42\\"}}"	\N		12	25380276	25380276	T	A	DOID:9256	18725974	included	ENST00000256078	p.Q61L	KRAS	-1	c.182	2016-05-18 19:53:37.028638	2016-05-18 20:38:57.591904	1	ENSG00000133703	missense
414	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/42\\"}}"	\N		12	25380276	25380276	T	A	DOID:9256	22162589	included	ENST00000256078	p.Q61L	KRAS	-1	c.182	2016-05-18 19:53:37.04261	2016-05-18 20:38:57.648613	1	ENSG00000133703	missense
415	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/42\\"}}"	\N		12	25380276	25380276	T	A	DOID:9256	22162582	included	ENST00000256078	p.Q61L	KRAS	-1	c.182	2016-05-18 19:53:37.05112	2016-05-18 20:38:57.694611	1	ENSG00000133703	missense
416	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/42\\"}}"	\N		12	25380276	25380276	T	A	DOID:9256	19903786	included	ENST00000256078	p.Q61L	KRAS	-1	c.182	2016-05-18 19:53:37.082034	2016-05-18 20:38:57.746718	1	ENSG00000133703	missense
417	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/42\\"}}"	\N		12	25380276	25380276	T	A	DOID:9256	20619739	included	ENST00000256078	p.Q61L	KRAS	-1	c.182	2016-05-18 19:53:37.091776	2016-05-18 20:38:57.797206	1	ENSG00000133703	missense
418	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/42\\"}}"	\N		12	25380276	25380276	T	A	DOID:9256	19366826	included	ENST00000256078	p.Q61L	KRAS	-1	c.182	2016-05-18 19:53:37.112606	2016-05-18 20:38:57.843588	1	ENSG00000133703	missense
420	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/43\\"}}"	\N		12	25380276	25380276	T	C	DOID:1781	15647370	included	ENST00000256078	p.Q61R	KRAS	-1	c.182	2016-05-18 19:53:37.149413	2016-05-18 20:38:57.959894	1	ENSG00000133703	missense
421	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/43\\"}}"	\N		12	25380276	25380276	T	C	DOID:1781	15254419	included	ENST00000256078	p.Q61R	KRAS	-1	c.182	2016-05-18 19:53:37.159159	2016-05-18 20:38:58.015983	1	ENSG00000133703	missense
422	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/43\\"}}"	\N		12	25380276	25380276	T	C	DOID:1781	20453058	included	ENST00000256078	p.Q61R	KRAS	-1	c.182	2016-05-18 19:53:37.179842	2016-05-18 20:38:58.066173	1	ENSG00000133703	missense
423	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/43\\"}}"	\N		12	25380276	25380276	T	C	DOID:1781	18725974	included	ENST00000256078	p.Q61R	KRAS	-1	c.182	2016-05-18 19:53:37.188186	2016-05-18 20:38:58.131114	1	ENSG00000133703	missense
424	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/43\\"}}"	\N		12	25380276	25380276	T	C	DOID:1781	22162589	included	ENST00000256078	p.Q61R	KRAS	-1	c.182	2016-05-18 19:53:37.216477	2016-05-18 20:38:58.197878	1	ENSG00000133703	missense
425	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/43\\"}}"	\N		12	25380276	25380276	T	C	DOID:1781	22162582	included	ENST00000256078	p.Q61R	KRAS	-1	c.182	2016-05-18 19:53:37.242387	2016-05-18 20:38:58.246465	1	ENSG00000133703	missense
426	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/43\\"}}"	\N		12	25380276	25380276	T	C	DOID:1781	19903786	included	ENST00000256078	p.Q61R	KRAS	-1	c.182	2016-05-18 19:53:37.25073	2016-05-18 20:38:58.29598	1	ENSG00000133703	missense
427	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/43\\"}}"	\N		12	25380276	25380276	T	C	DOID:1781	20619739	included	ENST00000256078	p.Q61R	KRAS	-1	c.182	2016-05-18 19:53:37.279438	2016-05-18 20:38:58.345987	1	ENSG00000133703	missense
428	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/43\\"}}"	\N		12	25380276	25380276	T	C	DOID:1781	19366826	included	ENST00000256078	p.Q61R	KRAS	-1	c.182	2016-05-18 19:53:37.289673	2016-05-18 20:38:58.390903	1	ENSG00000133703	missense
429	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/lung-cancer/kras/43\\"}}"	\N		12	25380276	25380276	T	C	DOID:3908	15016963	included	ENST00000256078	p.Q61R	KRAS	-1	c.182	2016-05-18 19:53:37.314022	2016-05-18 20:38:58.436981	1	ENSG00000133703	missense
430	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/lung-cancer/kras/43\\"}}"	\N		12	25380276	25380276	T	C	DOID:3908	15647370	included	ENST00000256078	p.Q61R	KRAS	-1	c.182	2016-05-18 19:53:37.322552	2016-05-18 20:38:58.495692	1	ENSG00000133703	missense
431	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/lung-cancer/kras/43\\"}}"	\N		12	25380276	25380276	T	C	DOID:3908	15254419	included	ENST00000256078	p.Q61R	KRAS	-1	c.182	2016-05-18 19:53:37.345516	2016-05-18 20:38:58.545638	1	ENSG00000133703	missense
432	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/lung-cancer/kras/43\\"}}"	\N		12	25380276	25380276	T	C	DOID:3908	20453058	included	ENST00000256078	p.Q61R	KRAS	-1	c.182	2016-05-18 19:53:37.354446	2016-05-18 20:38:58.599986	1	ENSG00000133703	missense
1452	\N	\N		12	25380275	25380275	T	A	DOID:9119	15647370	included	ENST00000256078	p.Q61H	KRAS	-1	c.183	2016-05-18 20:26:14.97199	2016-05-18 20:39:59.902001	2	ENSG00000133703	missense
433	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/lung-cancer/kras/43\\"}}"	\N		12	25380276	25380276	T	C	DOID:3908	18725974	included	ENST00000256078	p.Q61R	KRAS	-1	c.182	2016-05-18 19:53:37.38364	2016-05-18 20:38:58.666913	1	ENSG00000133703	missense
434	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/lung-cancer/kras/43\\"}}"	\N		12	25380276	25380276	T	C	DOID:3908	22162589	included	ENST00000256078	p.Q61R	KRAS	-1	c.182	2016-05-18 19:53:37.409393	2016-05-18 20:38:58.716009	1	ENSG00000133703	missense
435	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/lung-cancer/kras/43\\"}}"	\N		12	25380276	25380276	T	C	DOID:3908	22162582	included	ENST00000256078	p.Q61R	KRAS	-1	c.182	2016-05-18 19:53:37.417348	2016-05-18 20:38:58.768059	1	ENSG00000133703	missense
436	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/lung-cancer/kras/43\\"}}"	\N		12	25380276	25380276	T	C	DOID:3908	19903786	included	ENST00000256078	p.Q61R	KRAS	-1	c.182	2016-05-18 19:53:37.44796	2016-05-18 20:38:58.819673	1	ENSG00000133703	missense
437	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/lung-cancer/kras/43\\"}}"	\N		12	25380276	25380276	T	C	DOID:3908	20619739	included	ENST00000256078	p.Q61R	KRAS	-1	c.182	2016-05-18 19:53:37.457106	2016-05-18 20:38:58.86933	1	ENSG00000133703	missense
438	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/lung-cancer/kras/43\\"}}"	\N		12	25380276	25380276	T	C	DOID:3908	19366826	included	ENST00000256078	p.Q61R	KRAS	-1	c.182	2016-05-18 19:53:37.479048	2016-05-18 20:38:58.921023	1	ENSG00000133703	missense
440	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/43\\"}}"	\N		12	25380276	25380276	T	C	DOID:9256	15647370	included	ENST00000256078	p.Q61R	KRAS	-1	c.182	2016-05-18 19:53:37.520184	2016-05-18 20:38:59.034369	1	ENSG00000133703	missense
441	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/43\\"}}"	\N		12	25380276	25380276	T	C	DOID:9256	15254419	included	ENST00000256078	p.Q61R	KRAS	-1	c.182	2016-05-18 19:53:37.544941	2016-05-18 20:38:59.085231	1	ENSG00000133703	missense
442	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/43\\"}}"	\N		12	25380276	25380276	T	C	DOID:9256	20453058	included	ENST00000256078	p.Q61R	KRAS	-1	c.182	2016-05-18 19:53:37.553744	2016-05-18 20:38:59.15732	1	ENSG00000133703	missense
443	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/43\\"}}"	\N		12	25380276	25380276	T	C	DOID:9256	18725974	included	ENST00000256078	p.Q61R	KRAS	-1	c.182	2016-05-18 19:53:37.582485	2016-05-18 20:38:59.292979	1	ENSG00000133703	missense
444	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/43\\"}}"	\N		12	25380276	25380276	T	C	DOID:9256	22162589	included	ENST00000256078	p.Q61R	KRAS	-1	c.182	2016-05-18 19:53:37.591713	2016-05-18 20:38:59.390246	1	ENSG00000133703	missense
445	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/43\\"}}"	\N		12	25380276	25380276	T	C	DOID:9256	22162582	included	ENST00000256078	p.Q61R	KRAS	-1	c.182	2016-05-18 19:53:37.617802	2016-05-18 20:38:59.475991	1	ENSG00000133703	missense
446	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/43\\"}}"	\N		12	25380276	25380276	T	C	DOID:9256	19903786	included	ENST00000256078	p.Q61R	KRAS	-1	c.182	2016-05-18 19:53:37.627098	2016-05-18 20:38:59.538863	1	ENSG00000133703	missense
447	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/43\\"}}"	\N		12	25380276	25380276	T	C	DOID:9256	20619739	included	ENST00000256078	p.Q61R	KRAS	-1	c.182	2016-05-18 19:53:37.648606	2016-05-18 20:38:59.596837	1	ENSG00000133703	missense
448	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/43\\"}}"	\N		12	25380276	25380276	T	C	DOID:9256	19366826	included	ENST00000256078	p.Q61R	KRAS	-1	c.182	2016-05-18 19:53:37.656826	2016-05-18 20:38:59.660069	1	ENSG00000133703	missense
449	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/308\\"}}"	\N		12	25380276	25380276	T	G	DOID:1781	15016963	included	ENST00000256078	p.Q61P	KRAS	-1	c.182	2016-05-18 19:53:37.688019	2016-05-18 20:38:59.721411	1	ENSG00000133703	missense
450	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/308\\"}}"	\N		12	25380276	25380276	T	G	DOID:1781	15647370	included	ENST00000256078	p.Q61P	KRAS	-1	c.182	2016-05-18 19:53:37.697247	2016-05-18 20:38:59.772825	1	ENSG00000133703	missense
451	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/308\\"}}"	\N		12	25380276	25380276	T	G	DOID:1781	15254419	included	ENST00000256078	p.Q61P	KRAS	-1	c.182	2016-05-18 19:53:37.720182	2016-05-18 20:38:59.81888	1	ENSG00000133703	missense
452	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/308\\"}}"	\N		12	25380276	25380276	T	G	DOID:1781	20453058	included	ENST00000256078	p.Q61P	KRAS	-1	c.182	2016-05-18 19:53:37.729541	2016-05-18 20:38:59.855452	1	ENSG00000133703	missense
453	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/308\\"}}"	\N		12	25380276	25380276	T	G	DOID:1781	18725974	included	ENST00000256078	p.Q61P	KRAS	-1	c.182	2016-05-18 19:53:37.740343	2016-05-18 20:38:59.911751	1	ENSG00000133703	missense
454	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/308\\"}}"	\N		12	25380276	25380276	T	G	DOID:1781	22162589	included	ENST00000256078	p.Q61P	KRAS	-1	c.182	2016-05-18 19:53:37.753477	2016-05-18 20:38:59.956341	1	ENSG00000133703	missense
455	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/308\\"}}"	\N		12	25380276	25380276	T	G	DOID:1781	22162582	included	ENST00000256078	p.Q61P	KRAS	-1	c.182	2016-05-18 19:53:37.770979	2016-05-18 20:39:00.02287	1	ENSG00000133703	missense
456	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/308\\"}}"	\N		12	25380276	25380276	T	G	DOID:1781	19903786	included	ENST00000256078	p.Q61P	KRAS	-1	c.182	2016-05-18 19:53:37.784232	2016-05-18 20:39:00.06903	1	ENSG00000133703	missense
457	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/308\\"}}"	\N		12	25380276	25380276	T	G	DOID:1781	20619739	included	ENST00000256078	p.Q61P	KRAS	-1	c.182	2016-05-18 19:53:37.793214	2016-05-18 20:39:00.120894	1	ENSG00000133703	missense
458	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/308\\"}}"	\N		12	25380276	25380276	T	G	DOID:1781	19366826	included	ENST00000256078	p.Q61P	KRAS	-1	c.182	2016-05-18 19:53:37.822315	2016-05-18 20:39:00.169099	1	ENSG00000133703	missense
459	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/41\\"}}"	\N		12	25380277	25380277	G	T	DOID:1781	15016963	included	ENST00000256078	p.Q61K	KRAS	-1	c.181	2016-05-18 19:53:37.846285	2016-05-18 20:39:00.265992	1	ENSG00000133703	missense
1453	\N	\N		12	25380275	25380275	T	A	DOID:9119	15254419	included	ENST00000256078	p.Q61H	KRAS	-1	c.183	2016-05-18 20:26:14.997235	2016-05-18 20:39:59.957007	2	ENSG00000133703	missense
460	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/41\\"}}"	\N		12	25380277	25380277	G	T	DOID:1781	15647370	included	ENST00000256078	p.Q61K	KRAS	-1	c.181	2016-05-18 19:53:37.854114	2016-05-18 20:39:00.351591	1	ENSG00000133703	missense
461	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/41\\"}}"	\N		12	25380277	25380277	G	T	DOID:1781	15254419	included	ENST00000256078	p.Q61K	KRAS	-1	c.181	2016-05-18 19:53:37.883985	2016-05-18 20:39:00.410755	1	ENSG00000133703	missense
462	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/41\\"}}"	\N		12	25380277	25380277	G	T	DOID:1781	20453058	included	ENST00000256078	p.Q61K	KRAS	-1	c.181	2016-05-18 19:53:37.892957	2016-05-18 20:39:00.492492	1	ENSG00000133703	missense
463	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/41\\"}}"	\N		12	25380277	25380277	G	T	DOID:1781	18725974	included	ENST00000256078	p.Q61K	KRAS	-1	c.181	2016-05-18 19:53:37.914489	2016-05-18 20:39:00.538587	1	ENSG00000133703	missense
464	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/41\\"}}"	\N		12	25380277	25380277	G	T	DOID:1781	22162589	included	ENST00000256078	p.Q61K	KRAS	-1	c.181	2016-05-18 19:53:37.922664	2016-05-18 20:39:00.591211	1	ENSG00000133703	missense
465	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/41\\"}}"	\N		12	25380277	25380277	G	T	DOID:1781	22162582	included	ENST00000256078	p.Q61K	KRAS	-1	c.181	2016-05-18 19:53:37.949989	2016-05-18 20:39:00.638942	1	ENSG00000133703	missense
466	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/41\\"}}"	\N		12	25380277	25380277	G	T	DOID:1781	19903786	included	ENST00000256078	p.Q61K	KRAS	-1	c.181	2016-05-18 19:53:37.958298	2016-05-18 20:39:00.694573	1	ENSG00000133703	missense
467	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/41\\"}}"	\N		12	25380277	25380277	G	T	DOID:1781	20619739	included	ENST00000256078	p.Q61K	KRAS	-1	c.181	2016-05-18 19:53:37.98931	2016-05-18 20:39:00.749606	1	ENSG00000133703	missense
468	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/41\\"}}"	\N		12	25380277	25380277	G	T	DOID:1781	19366826	included	ENST00000256078	p.Q61K	KRAS	-1	c.181	2016-05-18 19:53:37.999495	2016-05-18 20:39:00.801287	1	ENSG00000133703	missense
469	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/lung-cancer/kras/41\\"}}"	\N		12	25380277	25380277	G	T	DOID:3908	14715079	included	ENST00000256078	p.Q61K	KRAS	-1	c.181	2016-05-18 19:53:38.020142	2016-05-18 20:39:00.85185	1	ENSG00000133703	missense
473	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/lung-cancer/kras/41\\"}}"	\N		12	25380277	25380277	G	T	DOID:3908	9679244	included	ENST00000256078	p.Q61K	KRAS	-1	c.181	2016-05-18 19:53:38.084921	2016-05-18 20:39:01.073671	1	ENSG00000133703	missense
474	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/lung-cancer/kras/41\\"}}"	\N		12	25380277	25380277	G	T	DOID:3908	17994767	included	ENST00000256078	p.Q61K	KRAS	-1	c.181	2016-05-18 19:53:38.093588	2016-05-18 20:39:01.124593	1	ENSG00000133703	missense
475	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/lung-cancer/kras/41\\"}}"	\N		12	25380277	25380277	G	T	DOID:3908	10775259	included	ENST00000256078	p.Q61K	KRAS	-1	c.181	2016-05-18 19:53:38.123822	2016-05-18 20:39:01.186929	1	ENSG00000133703	missense
476	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/41\\"}}"	\N		12	25380277	25380277	G	T	DOID:9256	14715079	included	ENST00000256078	p.Q61K	KRAS	-1	c.181	2016-05-18 19:53:38.133778	2016-05-18 20:39:01.24113	1	ENSG00000133703	missense
477	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/41\\"}}"	\N		12	25380277	25380277	G	T	DOID:9256	10479724	included	ENST00000256078	p.Q61K	KRAS	-1	c.181	2016-05-18 19:53:38.154022	2016-05-18 20:39:01.319268	1	ENSG00000133703	missense
478	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/41\\"}}"	\N		12	25380277	25380277	G	T	DOID:9256	12821112	included	ENST00000256078	p.Q61K	KRAS	-1	c.181	2016-05-18 19:53:38.16227	2016-05-18 20:39:01.385695	1	ENSG00000133703	missense
480	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/41\\"}}"	\N		12	25380277	25380277	G	T	DOID:9256	9679244	included	ENST00000256078	p.Q61K	KRAS	-1	c.181	2016-05-18 19:53:38.217215	2016-05-18 20:39:01.534444	1	ENSG00000133703	missense
481	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/41\\"}}"	\N		12	25380277	25380277	G	T	DOID:9256	17994767	included	ENST00000256078	p.Q61K	KRAS	-1	c.181	2016-05-18 19:53:38.226362	2016-05-18 20:39:01.589503	1	ENSG00000133703	missense
482	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/41\\"}}"	\N		12	25380277	25380277	G	T	DOID:9256	10775259	included	ENST00000256078	p.Q61K	KRAS	-1	c.181	2016-05-18 19:53:38.258514	2016-05-18 20:39:01.633571	1	ENSG00000133703	missense
483	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/159\\"}}"	\N		12	25398281	25398281	C	A	DOID:9256	14715079	included	ENST00000256078	p.G13V	KRAS	-1	c.38	2016-05-18 19:53:38.268222	2016-05-18 20:39:01.700712	1	ENSG00000133703	missense
484	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/159\\"}}"	\N		12	25398281	25398281	C	A	DOID:9256	10479724	included	ENST00000256078	p.G13V	KRAS	-1	c.38	2016-05-18 19:53:38.288957	2016-05-18 20:39:01.760754	1	ENSG00000133703	missense
486	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/159\\"}}"	\N		12	25398281	25398281	C	A	DOID:9256	8898652	included	ENST00000256078	p.G13V	KRAS	-1	c.38	2016-05-18 19:53:38.325177	2016-05-18 20:39:01.876164	1	ENSG00000133703	missense
487	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/159\\"}}"	\N		12	25398281	25398281	C	A	DOID:9256	9679244	included	ENST00000256078	p.G13V	KRAS	-1	c.38	2016-05-18 19:53:38.349711	2016-05-18 20:39:01.932847	1	ENSG00000133703	missense
488	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/159\\"}}"	\N		12	25398281	25398281	C	A	DOID:9256	17994767	included	ENST00000256078	p.G13V	KRAS	-1	c.38	2016-05-18 19:53:38.36469	2016-05-18 20:39:01.986066	1	ENSG00000133703	missense
489	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/159\\"}}"	\N		12	25398281	25398281	C	A	DOID:9256	10775259	included	ENST00000256078	p.G13V	KRAS	-1	c.38	2016-05-18 19:53:38.387194	2016-05-18 20:39:02.0604	1	ENSG00000133703	missense
490	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/lung-cancer/kras/68\\"}}"	\N		12	25398281	25398281	C	G	DOID:3908	14715079	included	ENST00000256078	p.G13A	KRAS	-1	c.38	2016-05-18 19:53:38.396244	2016-05-18 20:39:02.119056	1	ENSG00000133703	missense
1454	\N	\N		12	25380275	25380275	T	A	DOID:9119	20453058	included	ENST00000256078	p.Q61H	KRAS	-1	c.183	2016-05-18 20:26:15.005998	2016-05-18 20:39:59.992374	2	ENSG00000133703	missense
491	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/lung-cancer/kras/68\\"}}"	\N		12	25398281	25398281	C	G	DOID:3908	10479724	included	ENST00000256078	p.G13A	KRAS	-1	c.38	2016-05-18 19:53:38.417262	2016-05-18 20:39:02.184491	1	ENSG00000133703	missense
492	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/lung-cancer/kras/68\\"}}"	\N		12	25398281	25398281	C	G	DOID:3908	12821112	included	ENST00000256078	p.G13A	KRAS	-1	c.38	2016-05-18 19:53:38.425999	2016-05-18 20:39:02.226886	1	ENSG00000133703	missense
493	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/lung-cancer/kras/68\\"}}"	\N		12	25398281	25398281	C	G	DOID:3908	8898652	included	ENST00000256078	p.G13A	KRAS	-1	c.38	2016-05-18 19:53:38.434431	2016-05-18 20:39:02.308867	1	ENSG00000133703	missense
494	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/lung-cancer/kras/68\\"}}"	\N		12	25398281	25398281	C	G	DOID:3908	9679244	included	ENST00000256078	p.G13A	KRAS	-1	c.38	2016-05-18 19:53:38.45192	2016-05-18 20:39:02.361111	1	ENSG00000133703	missense
495	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/lung-cancer/kras/68\\"}}"	\N		12	25398281	25398281	C	G	DOID:3908	17994767	included	ENST00000256078	p.G13A	KRAS	-1	c.38	2016-05-18 19:53:38.460234	2016-05-18 20:39:02.435339	1	ENSG00000133703	missense
496	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/lung-cancer/kras/68\\"}}"	\N		12	25398281	25398281	C	G	DOID:3908	10775259	included	ENST00000256078	p.G13A	KRAS	-1	c.38	2016-05-18 19:53:38.487538	2016-05-18 20:39:02.484062	1	ENSG00000133703	missense
497	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/68\\"}}"	\N		12	25398281	25398281	C	G	DOID:9256	14715079	included	ENST00000256078	p.G13A	KRAS	-1	c.38	2016-05-18 19:53:38.496137	2016-05-18 20:39:02.548965	1	ENSG00000133703	missense
498	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/68\\"}}"	\N		12	25398281	25398281	C	G	DOID:9256	10479724	included	ENST00000256078	p.G13A	KRAS	-1	c.38	2016-05-18 19:53:38.519188	2016-05-18 20:39:02.601929	1	ENSG00000133703	missense
499	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/68\\"}}"	\N		12	25398281	25398281	C	G	DOID:9256	12821112	included	ENST00000256078	p.G13A	KRAS	-1	c.38	2016-05-18 19:53:38.527714	2016-05-18 20:39:02.6601	1	ENSG00000133703	missense
500	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/68\\"}}"	\N		12	25398281	25398281	C	G	DOID:9256	8898652	included	ENST00000256078	p.G13A	KRAS	-1	c.38	2016-05-18 19:53:38.555975	2016-05-18 20:39:02.707682	1	ENSG00000133703	missense
503	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/68\\"}}"	\N		12	25398281	25398281	C	G	DOID:9256	10775259	included	ENST00000256078	p.G13A	KRAS	-1	c.38	2016-05-18 19:53:38.597771	2016-05-18 20:39:02.87923	1	ENSG00000133703	missense
504	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/39\\"}}"	\N		12	25398281	25398281	C	T	DOID:1781	14715079	included	ENST00000256078	p.G13D	KRAS	-1	c.38	2016-05-18 19:53:38.607628	2016-05-18 20:39:02.937059	1	ENSG00000133703	missense
505	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/39\\"}}"	\N		12	25398281	25398281	C	T	DOID:1781	10479724	included	ENST00000256078	p.G13D	KRAS	-1	c.38	2016-05-18 19:53:38.618845	2016-05-18 20:39:03.005389	1	ENSG00000133703	missense
506	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/39\\"}}"	\N		12	25398281	25398281	C	T	DOID:1781	12821112	included	ENST00000256078	p.G13D	KRAS	-1	c.38	2016-05-18 19:53:38.627578	2016-05-18 20:39:03.053638	1	ENSG00000133703	missense
507	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/39\\"}}"	\N		12	25398281	25398281	C	T	DOID:1781	8898652	included	ENST00000256078	p.G13D	KRAS	-1	c.38	2016-05-18 19:53:38.637276	2016-05-18 20:39:03.117326	1	ENSG00000133703	missense
508	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/39\\"}}"	\N		12	25398281	25398281	C	T	DOID:1781	9679244	included	ENST00000256078	p.G13D	KRAS	-1	c.38	2016-05-18 19:53:38.648954	2016-05-18 20:39:03.183615	1	ENSG00000133703	missense
509	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/39\\"}}"	\N		12	25398281	25398281	C	T	DOID:1781	17994767	included	ENST00000256078	p.G13D	KRAS	-1	c.38	2016-05-18 19:53:38.657042	2016-05-18 20:39:03.235115	1	ENSG00000133703	missense
510	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/39\\"}}"	\N		12	25398281	25398281	C	T	DOID:1781	10775259	included	ENST00000256078	p.G13D	KRAS	-1	c.38	2016-05-18 19:53:38.665456	2016-05-18 20:39:03.302979	1	ENSG00000133703	missense
511	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/ovarian-cancer/kras/39\\"}}"	\N		12	25398281	25398281	C	T	DOID:2394	14715079	included	ENST00000256078	p.G13D	KRAS	-1	c.38	2016-05-18 19:53:38.674386	2016-05-18 20:39:03.353824	1	ENSG00000133703	missense
512	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/ovarian-cancer/kras/39\\"}}"	\N		12	25398281	25398281	C	T	DOID:2394	10479724	included	ENST00000256078	p.G13D	KRAS	-1	c.38	2016-05-18 19:53:38.685267	2016-05-18 20:39:03.434894	1	ENSG00000133703	missense
513	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/ovarian-cancer/kras/39\\"}}"	\N		12	25398281	25398281	C	T	DOID:2394	12821112	included	ENST00000256078	p.G13D	KRAS	-1	c.38	2016-05-18 19:53:38.694007	2016-05-18 20:39:03.491231	1	ENSG00000133703	missense
514	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/ovarian-cancer/kras/39\\"}}"	\N		12	25398281	25398281	C	T	DOID:2394	8898652	included	ENST00000256078	p.G13D	KRAS	-1	c.38	2016-05-18 19:53:38.703032	2016-05-18 20:39:03.549416	1	ENSG00000133703	missense
515	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/ovarian-cancer/kras/39\\"}}"	\N		12	25398281	25398281	C	T	DOID:2394	9679244	included	ENST00000256078	p.G13D	KRAS	-1	c.38	2016-05-18 19:53:38.715388	2016-05-18 20:39:03.60231	1	ENSG00000133703	missense
516	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/ovarian-cancer/kras/39\\"}}"	\N		12	25398281	25398281	C	T	DOID:2394	17994767	included	ENST00000256078	p.G13D	KRAS	-1	c.38	2016-05-18 19:53:38.722896	2016-05-18 20:39:03.651841	1	ENSG00000133703	missense
517	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/ovarian-cancer/kras/39\\"}}"	\N		12	25398281	25398281	C	T	DOID:2394	10775259	included	ENST00000256078	p.G13D	KRAS	-1	c.38	2016-05-18 19:53:38.734256	2016-05-18 20:39:03.725183	1	ENSG00000133703	missense
518	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/lung-cancer/kras/39\\"}}"	\N		12	25398281	25398281	C	T	DOID:3908	14715079	included	ENST00000256078	p.G13D	KRAS	-1	c.38	2016-05-18 19:53:38.74378	2016-05-18 20:39:03.77166	1	ENSG00000133703	missense
519	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/lung-cancer/kras/39\\"}}"	\N		12	25398281	25398281	C	T	DOID:3908	10479724	included	ENST00000256078	p.G13D	KRAS	-1	c.38	2016-05-18 19:53:38.753679	2016-05-18 20:39:03.83486	1	ENSG00000133703	missense
520	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/lung-cancer/kras/39\\"}}"	\N		12	25398281	25398281	C	T	DOID:3908	12821112	included	ENST00000256078	p.G13D	KRAS	-1	c.38	2016-05-18 19:53:38.762101	2016-05-18 20:39:03.883502	1	ENSG00000133703	missense
521	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/lung-cancer/kras/39\\"}}"	\N		12	25398281	25398281	C	T	DOID:3908	8898652	included	ENST00000256078	p.G13D	KRAS	-1	c.38	2016-05-18 19:53:38.770408	2016-05-18 20:39:03.940239	1	ENSG00000133703	missense
522	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/lung-cancer/kras/39\\"}}"	\N		12	25398281	25398281	C	T	DOID:3908	9679244	included	ENST00000256078	p.G13D	KRAS	-1	c.38	2016-05-18 19:53:38.782635	2016-05-18 20:39:03.98651	1	ENSG00000133703	missense
523	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/lung-cancer/kras/39\\"}}"	\N		12	25398281	25398281	C	T	DOID:3908	17994767	included	ENST00000256078	p.G13D	KRAS	-1	c.38	2016-05-18 19:53:38.790964	2016-05-18 20:39:04.038275	1	ENSG00000133703	missense
524	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/lung-cancer/kras/39\\"}}"	\N		12	25398281	25398281	C	T	DOID:3908	10775259	included	ENST00000256078	p.G13D	KRAS	-1	c.38	2016-05-18 19:53:38.800069	2016-05-18 20:39:04.087741	1	ENSG00000133703	missense
525	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/39\\"}}"	\N		12	25398281	25398281	C	T	DOID:9256	23582185	included	ENST00000256078	p.G13D	KRAS	-1	c.38	2016-05-18 19:53:38.809626	2016-05-18 20:39:04.143292	1	ENSG00000133703	missense
526	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/39\\"}}"	\N		12	25398281	25398281	C	T	DOID:9256	21689725	included	ENST00000256078	p.G13D	KRAS	-1	c.38	2016-05-18 19:53:38.81963	2016-05-18 20:39:04.192476	1	ENSG00000133703	missense
527	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/39\\"}}"	\N		12	25398281	25398281	C	T	DOID:9256	17259998	included	ENST00000256078	p.G13D	KRAS	-1	c.38	2016-05-18 19:53:38.830656	2016-05-18 20:39:04.2479	1	ENSG00000133703	missense
528	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/lung-cancer/kras/38\\"}}"	\N		12	25398282	25398282	C	A	DOID:3908	23582185	included	ENST00000256078	p.G13C	KRAS	-1	c.37	2016-05-18 19:53:38.839808	2016-05-18 20:39:04.314235	1	ENSG00000133703	missense
529	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/lung-cancer/kras/38\\"}}"	\N		12	25398282	25398282	C	A	DOID:3908	21689725	included	ENST00000256078	p.G13C	KRAS	-1	c.37	2016-05-18 19:53:38.849832	2016-05-18 20:39:04.367275	1	ENSG00000133703	missense
530	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/lung-cancer/kras/38\\"}}"	\N		12	25398282	25398282	C	A	DOID:3908	17259998	included	ENST00000256078	p.G13C	KRAS	-1	c.37	2016-05-18 19:53:38.857945	2016-05-18 20:39:04.437652	1	ENSG00000133703	missense
531	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/38\\"}}"	\N		12	25398282	25398282	C	A	DOID:9256	23582185	included	ENST00000256078	p.G13C	KRAS	-1	c.37	2016-05-18 19:53:38.868908	2016-05-18 20:39:04.475063	1	ENSG00000133703	missense
535	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/40\\"}}"	\N		12	25398282	25398282	C	G	DOID:1781	21689725	included	ENST00000256078	p.G13R	KRAS	-1	c.37	2016-05-18 19:53:38.906775	2016-05-18 20:39:04.700387	1	ENSG00000133703	missense
536	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/40\\"}}"	\N		12	25398282	25398282	C	G	DOID:1781	17259998	included	ENST00000256078	p.G13R	KRAS	-1	c.37	2016-05-18 19:53:38.917068	2016-05-18 20:39:04.747403	1	ENSG00000133703	missense
537	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/lung-cancer/kras/40\\"}}"	\N		12	25398282	25398282	C	G	DOID:3908	16751810	included	ENST00000256078	p.G13R	KRAS	-1	c.37	2016-05-18 19:53:38.926699	2016-05-18 20:39:04.79666	1	ENSG00000133703	missense
538	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/40\\"}}"	\N		12	25398282	25398282	C	G	DOID:9256	24687822	included	ENST00000256078	p.G13R	KRAS	-1	c.37	2016-05-18 19:53:38.936448	2016-05-18 20:39:04.8467	1	ENSG00000133703	missense
539	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/69\\"}}"	\N		12	25398282	25398282	C	T	DOID:1781	23582185	included	ENST00000256078	p.G13S	KRAS	-1	c.37	2016-05-18 19:53:38.944499	2016-05-18 20:39:04.904067	1	ENSG00000133703	missense
540	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/69\\"}}"	\N		12	25398282	25398282	C	T	DOID:1781	21689725	included	ENST00000256078	p.G13S	KRAS	-1	c.37	2016-05-18 19:53:38.954631	2016-05-18 20:39:04.944891	1	ENSG00000133703	missense
541	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/69\\"}}"	\N		12	25398282	25398282	C	T	DOID:1781	17259998	included	ENST00000256078	p.G13S	KRAS	-1	c.37	2016-05-18 19:53:38.96424	2016-05-18 20:39:04.997693	1	ENSG00000133703	missense
542	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/lung-cancer/kras/69\\"}}"	\N		12	25398282	25398282	C	T	DOID:3908	19164557	included	ENST00000256078	p.G13S	KRAS	-1	c.37	2016-05-18 19:53:38.974939	2016-05-18 20:39:05.052938	1	ENSG00000133703	missense
543	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/69\\"}}"	\N		12	25398282	25398282	C	T	DOID:9256	19164557	included	ENST00000256078	p.G13S	KRAS	-1	c.37	2016-05-18 19:53:38.985852	2016-05-18 20:39:05.104031	1	ENSG00000133703	missense
544	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/37\\"}}"	\N		12	25398284	25398284	C	A	DOID:1781	19164557	included	ENST00000256078	p.G12V	KRAS	-1	c.35	2016-05-18 19:53:38.995273	2016-05-18 20:39:05.175626	1	ENSG00000133703	missense
545	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/ovarian-cancer/kras/37\\"}}"	\N		12	25398284	25398284	C	A	DOID:2394	23582185	included	ENST00000256078	p.G12V	KRAS	-1	c.35	2016-05-18 19:53:39.004612	2016-05-18 20:39:05.230775	1	ENSG00000133703	missense
546	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/ovarian-cancer/kras/37\\"}}"	\N		12	25398284	25398284	C	A	DOID:2394	21689725	included	ENST00000256078	p.G12V	KRAS	-1	c.35	2016-05-18 19:53:39.01921	2016-05-18 20:39:05.289686	1	ENSG00000133703	missense
547	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/ovarian-cancer/kras/37\\"}}"	\N		12	25398284	25398284	C	A	DOID:2394	17259998	included	ENST00000256078	p.G12V	KRAS	-1	c.35	2016-05-18 19:53:39.028579	2016-05-18 20:39:05.341384	1	ENSG00000133703	missense
548	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/37\\"}}"	\N		12	25398284	25398284	C	A	DOID:9256	23582185	included	ENST00000256078	p.G12V	KRAS	-1	c.35	2016-05-18 19:53:39.039	2016-05-18 20:39:05.412709	1	ENSG00000133703	missense
549	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/37\\"}}"	\N		12	25398284	25398284	C	A	DOID:9256	21689725	included	ENST00000256078	p.G12V	KRAS	-1	c.35	2016-05-18 19:53:39.054364	2016-05-18 20:39:05.461078	1	ENSG00000133703	missense
550	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/37\\"}}"	\N		12	25398284	25398284	C	A	DOID:9256	17259998	included	ENST00000256078	p.G12V	KRAS	-1	c.35	2016-05-18 19:53:39.063266	2016-05-18 20:39:05.525822	1	ENSG00000133703	missense
551	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/ovarian-cancer/kras/32\\"}}"	\N		12	25398284	25398284	C	G	DOID:2394	23582185	included	ENST00000256078	p.G12A	KRAS	-1	c.35	2016-05-18 19:53:39.073686	2016-05-18 20:39:05.582013	1	ENSG00000133703	missense
552	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/ovarian-cancer/kras/32\\"}}"	\N		12	25398284	25398284	C	G	DOID:2394	21689725	included	ENST00000256078	p.G12A	KRAS	-1	c.35	2016-05-18 19:53:39.086696	2016-05-18 20:39:05.626558	1	ENSG00000133703	missense
553	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/ovarian-cancer/kras/32\\"}}"	\N		12	25398284	25398284	C	G	DOID:2394	17259998	included	ENST00000256078	p.G12A	KRAS	-1	c.35	2016-05-18 19:53:39.095461	2016-05-18 20:39:05.673213	1	ENSG00000133703	missense
554	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/lung-cancer/kras/32\\"}}"	\N		12	25398284	25398284	C	G	DOID:3908	23582185	included	ENST00000256078	p.G12A	KRAS	-1	c.35	2016-05-18 19:53:39.104572	2016-05-18 20:39:05.727075	1	ENSG00000133703	missense
555	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/lung-cancer/kras/32\\"}}"	\N		12	25398284	25398284	C	G	DOID:3908	21689725	included	ENST00000256078	p.G12A	KRAS	-1	c.35	2016-05-18 19:53:39.116365	2016-05-18 20:39:05.774634	1	ENSG00000133703	missense
556	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/lung-cancer/kras/32\\"}}"	\N		12	25398284	25398284	C	G	DOID:3908	17259998	included	ENST00000256078	p.G12A	KRAS	-1	c.35	2016-05-18 19:53:39.12544	2016-05-18 20:39:05.828147	1	ENSG00000133703	missense
557	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/32\\"}}"	\N		12	25398284	25398284	C	G	DOID:9256	14645423	included	ENST00000256078	p.G12A	KRAS	-1	c.35	2016-05-18 19:53:39.135044	2016-05-18 20:39:05.876282	1	ENSG00000133703	missense
558	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/32\\"}}"	\N		12	25398284	25398284	C	G	DOID:9256	15928335	included	ENST00000256078	p.G12A	KRAS	-1	c.35	2016-05-18 19:53:39.144628	2016-05-18 20:39:05.932042	1	ENSG00000133703	missense
559	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/34\\"}}"	\N		12	25398284	25398284	C	T	DOID:1781	14645423	included	ENST00000256078	p.G12D	KRAS	-1	c.35	2016-05-18 19:53:39.156047	2016-05-18 20:39:05.991562	1	ENSG00000133703	missense
560	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/34\\"}}"	\N		12	25398284	25398284	C	T	DOID:1781	15928335	included	ENST00000256078	p.G12D	KRAS	-1	c.35	2016-05-18 19:53:39.164554	2016-05-18 20:39:06.048153	1	ENSG00000133703	missense
561	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/ovarian-cancer/kras/34\\"}}"	\N		12	25398284	25398284	C	T	DOID:2394	14645423	included	ENST00000256078	p.G12D	KRAS	-1	c.35	2016-05-18 19:53:39.174698	2016-05-18 20:39:06.115189	1	ENSG00000133703	missense
562	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/ovarian-cancer/kras/34\\"}}"	\N		12	25398284	25398284	C	T	DOID:2394	15928335	included	ENST00000256078	p.G12D	KRAS	-1	c.35	2016-05-18 19:53:39.186349	2016-05-18 20:39:06.164433	1	ENSG00000133703	missense
565	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/lung-cancer/kras/34\\"}}"	\N		12	25398284	25398284	C	T	DOID:3908	22718859	included	ENST00000256078	p.G12D	KRAS	-1	c.35	2016-05-18 19:53:39.2171	2016-05-18 20:39:06.315937	1	ENSG00000133703	missense
566	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/lung-cancer/kras/34\\"}}"	\N		12	25398284	25398284	C	T	DOID:3908	16638875	included	ENST00000256078	p.G12D	KRAS	-1	c.35	2016-05-18 19:53:39.226909	2016-05-18 20:39:06.380428	1	ENSG00000133703	missense
567	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/lung-cancer/kras/34\\"}}"	\N		12	25398284	25398284	C	T	DOID:3908	18794084	included	ENST00000256078	p.G12D	KRAS	-1	c.35	2016-05-18 19:53:39.236438	2016-05-18 20:39:06.454425	1	ENSG00000133703	missense
568	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/lung-cancer/kras/34\\"}}"	\N		12	25398284	25398284	C	T	DOID:3908	22745105	included	ENST00000256078	p.G12D	KRAS	-1	c.35	2016-05-18 19:53:39.245848	2016-05-18 20:39:06.5148	1	ENSG00000133703	missense
569	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/34\\"}}"	\N		12	25398284	25398284	C	T	DOID:9256	22160010	included	ENST00000256078	p.G12D	KRAS	-1	c.35	2016-05-18 19:53:39.257558	2016-05-18 20:39:06.549325	1	ENSG00000133703	missense
570	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/34\\"}}"	\N		12	25398284	25398284	C	T	DOID:9256	22898540	included	ENST00000256078	p.G12D	KRAS	-1	c.35	2016-05-18 19:53:39.266065	2016-05-18 20:39:06.596915	1	ENSG00000133703	missense
571	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/33\\"}}"	\N		12	25398285	25398285	C	A	DOID:1781	21067377	included	ENST00000256078	p.G12C	KRAS	-1	c.34	2016-05-18 19:53:39.275916	2016-05-18 20:39:06.665882	1	ENSG00000133703	missense
572	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/33\\"}}"	\N		12	25398285	25398285	C	A	DOID:1781	22160010	included	ENST00000256078	p.G12C	KRAS	-1	c.34	2016-05-18 19:53:39.287103	2016-05-18 20:39:06.706004	1	ENSG00000133703	missense
573	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/33\\"}}"	\N		12	25398285	25398285	C	A	DOID:1781	22898541	included	ENST00000256078	p.G12C	KRAS	-1	c.34	2016-05-18 19:53:39.295969	2016-05-18 20:39:06.757766	1	ENSG00000133703	missense
574	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/ovarian-cancer/kras/33\\"}}"	\N		12	25398285	25398285	C	A	DOID:2394	21067377	included	ENST00000256078	p.G12C	KRAS	-1	c.34	2016-05-18 19:53:39.305728	2016-05-18 20:39:06.813226	1	ENSG00000133703	missense
575	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/ovarian-cancer/kras/33\\"}}"	\N		12	25398285	25398285	C	A	DOID:2394	22160010	included	ENST00000256078	p.G12C	KRAS	-1	c.34	2016-05-18 19:53:39.325724	2016-05-18 20:39:06.866707	1	ENSG00000133703	missense
576	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/ovarian-cancer/kras/33\\"}}"	\N		12	25398285	25398285	C	A	DOID:2394	22898539	included	ENST00000256078	p.G12C	KRAS	-1	c.34	2016-05-18 19:53:39.333802	2016-05-18 20:39:06.923875	1	ENSG00000133703	missense
577	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/ovarian-cancer/kras/33\\"}}"	\N		12	25398285	25398285	C	A	DOID:2394	24656771	included	ENST00000256078	p.G12C	KRAS	-1	c.34	2016-05-18 19:53:39.344132	2016-05-18 20:39:06.973931	1	ENSG00000133703	missense
578	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/ovarian-cancer/kras/33\\"}}"	\N		12	25398285	25398285	C	A	DOID:2394	24606448	included	ENST00000256078	p.G12C	KRAS	-1	c.34	2016-05-18 19:53:39.356095	2016-05-18 20:39:07.016624	1	ENSG00000133703	missense
579	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/ovarian-cancer/kras/33\\"}}"	\N		12	25398285	25398285	C	A	DOID:2394	22744846	included	ENST00000256078	p.G12C	KRAS	-1	c.34	2016-05-18 19:53:39.365216	2016-05-18 20:39:07.07111	1	ENSG00000133703	missense
580	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/ovarian-cancer/kras/33\\"}}"	\N		12	25398285	25398285	C	A	DOID:2394	21518476	included	ENST00000256078	p.G12C	KRAS	-1	c.34	2016-05-18 19:53:39.374675	2016-05-18 20:39:07.11255	1	ENSG00000133703	missense
581	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/lung-cancer/kras/33\\"}}"	\N		12	25398285	25398285	C	A	DOID:3908	21067377	included	ENST00000256078	p.G12C	KRAS	-1	c.34	2016-05-18 19:53:39.386715	2016-05-18 20:39:07.158647	1	ENSG00000133703	missense
582	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/lung-cancer/kras/33\\"}}"	\N		12	25398285	25398285	C	A	DOID:3908	22160010	included	ENST00000256078	p.G12C	KRAS	-1	c.34	2016-05-18 19:53:39.395308	2016-05-18 20:39:07.205469	1	ENSG00000133703	missense
583	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/lung-cancer/kras/33\\"}}"	\N		12	25398285	25398285	C	A	DOID:3908	22898539	included	ENST00000256078	p.G12C	KRAS	-1	c.34	2016-05-18 19:53:39.405108	2016-05-18 20:39:07.24958	1	ENSG00000133703	missense
584	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/lung-cancer/kras/33\\"}}"	\N		12	25398285	25398285	C	A	DOID:3908	24606448	included	ENST00000256078	p.G12C	KRAS	-1	c.34	2016-05-18 19:53:39.425319	2016-05-18 20:39:07.322075	1	ENSG00000133703	missense
585	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/lung-cancer/kras/33\\"}}"	\N		12	25398285	25398285	C	A	DOID:3908	22744846	included	ENST00000256078	p.G12C	KRAS	-1	c.34	2016-05-18 19:53:39.433672	2016-05-18 20:39:07.363725	1	ENSG00000133703	missense
586	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/lung-cancer/kras/33\\"}}"	\N		12	25398285	25398285	C	A	DOID:3908	21518476	included	ENST00000256078	p.G12C	KRAS	-1	c.34	2016-05-18 19:53:39.443312	2016-05-18 20:39:07.435535	1	ENSG00000133703	missense
587	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/33\\"}}"	\N		12	25398285	25398285	C	A	DOID:9256	22160010	included	ENST00000256078	p.G12C	KRAS	-1	c.34	2016-05-18 19:53:39.455366	2016-05-18 20:39:07.478538	1	ENSG00000133703	missense
588	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/33\\"}}"	\N		12	25398285	25398285	C	A	DOID:9256	22898539	included	ENST00000256078	p.G12C	KRAS	-1	c.34	2016-05-18 19:53:39.464091	2016-05-18 20:39:07.52916	1	ENSG00000133703	missense
589	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/35\\"}}"	\N		12	25398285	25398285	C	G	DOID:1781	21067377	included	ENST00000256078	p.G12R	KRAS	-1	c.34	2016-05-18 19:53:39.474328	2016-05-18 20:39:07.59153	1	ENSG00000133703	missense
590	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/35\\"}}"	\N		12	25398285	25398285	C	G	DOID:1781	22160010	included	ENST00000256078	p.G12R	KRAS	-1	c.34	2016-05-18 19:53:39.487495	2016-05-18 20:39:07.653146	1	ENSG00000133703	missense
591	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/35\\"}}"	\N		12	25398285	25398285	C	G	DOID:1781	22898540	included	ENST00000256078	p.G12R	KRAS	-1	c.34	2016-05-18 19:53:39.495763	2016-05-18 20:39:07.699271	1	ENSG00000133703	missense
592	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/35\\"}}"	\N		12	25398285	25398285	C	G	DOID:1781	22744846	included	ENST00000256078	p.G12R	KRAS	-1	c.34	2016-05-18 19:53:39.504476	2016-05-18 20:39:07.743129	1	ENSG00000133703	missense
597	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/lung-cancer/kras/35\\"}}"	\N		12	25398285	25398285	C	G	DOID:3908	22504184	included	ENST00000256078	p.G12R	KRAS	-1	c.34	2016-05-18 19:53:39.572993	2016-05-18 20:39:08.015947	1	ENSG00000133703	missense
598	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/lung-cancer/kras/35\\"}}"	\N		12	25398285	25398285	C	G	DOID:3908	23430109	included	ENST00000256078	p.G12R	KRAS	-1	c.34	2016-05-18 19:53:39.594899	2016-05-18 20:39:08.0702	1	ENSG00000133703	missense
599	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/lung-cancer/kras/35\\"}}"	\N		12	25398285	25398285	C	G	DOID:3908	24619500	included	ENST00000256078	p.G12R	KRAS	-1	c.34	2016-05-18 19:53:39.603591	2016-05-18 20:39:08.122243	1	ENSG00000133703	missense
600	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/35\\"}}"	\N		12	25398285	25398285	C	G	DOID:9256	15667533	included	ENST00000256078	p.G12R	KRAS	-1	c.34	2016-05-18 19:53:39.631136	2016-05-18 20:39:08.170269	1	ENSG00000133703	missense
601	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/36\\"}}"	\N		12	25398285	25398285	C	T	DOID:1781	23261068	included	ENST00000256078	p.G12S	KRAS	-1	c.34	2016-05-18 19:53:39.640486	2016-05-18 20:39:08.236304	1	ENSG00000133703	missense
602	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/36\\"}}"	\N		12	25398285	25398285	C	T	DOID:1781	23783394	included	ENST00000256078	p.G12S	KRAS	-1	c.34	2016-05-18 19:53:39.662062	2016-05-18 20:39:08.29013	1	ENSG00000133703	missense
603	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/36\\"}}"	\N		12	25398285	25398285	C	T	DOID:1781	23321257	included	ENST00000256078	p.G12S	KRAS	-1	c.34	2016-05-18 19:53:39.670651	2016-05-18 20:39:08.354403	1	ENSG00000133703	missense
604	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/36\\"}}"	\N		12	25398285	25398285	C	T	DOID:1781	22368270	included	ENST00000256078	p.G12S	KRAS	-1	c.34	2016-05-18 19:53:39.699388	2016-05-18 20:39:08.409292	1	ENSG00000133703	missense
605	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/36\\"}}"	\N		12	25398285	25398285	C	T	DOID:1781	23714533	included	ENST00000256078	p.G12S	KRAS	-1	c.34	2016-05-18 19:53:39.709325	2016-05-18 20:39:08.467434	1	ENSG00000133703	missense
606	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/36\\"}}"	\N		12	25398285	25398285	C	T	DOID:1781	22504186	included	ENST00000256078	p.G12S	KRAS	-1	c.34	2016-05-18 19:53:39.729545	2016-05-18 20:39:08.529972	1	ENSG00000133703	missense
607	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/lung-cancer/kras/36\\"}}"	\N		12	25398285	25398285	C	T	DOID:3908	23261068	included	ENST00000256078	p.G12S	KRAS	-1	c.34	2016-05-18 19:53:39.737911	2016-05-18 20:39:08.589997	1	ENSG00000133703	missense
608	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/lung-cancer/kras/36\\"}}"	\N		12	25398285	25398285	C	T	DOID:3908	23783394	included	ENST00000256078	p.G12S	KRAS	-1	c.34	2016-05-18 19:53:39.766879	2016-05-18 20:39:08.654395	1	ENSG00000133703	missense
609	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/lung-cancer/kras/36\\"}}"	\N		12	25398285	25398285	C	T	DOID:3908	23321257	included	ENST00000256078	p.G12S	KRAS	-1	c.34	2016-05-18 19:53:39.77648	2016-05-18 20:39:08.713746	1	ENSG00000133703	missense
610	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/lung-cancer/kras/36\\"}}"	\N		12	25398285	25398285	C	T	DOID:3908	22368270	included	ENST00000256078	p.G12S	KRAS	-1	c.34	2016-05-18 19:53:39.796883	2016-05-18 20:39:08.767299	1	ENSG00000133703	missense
611	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/lung-cancer/kras/36\\"}}"	\N		12	25398285	25398285	C	T	DOID:3908	23714533	included	ENST00000256078	p.G12S	KRAS	-1	c.34	2016-05-18 19:53:39.805694	2016-05-18 20:39:08.823404	1	ENSG00000133703	missense
612	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/lung-cancer/kras/36\\"}}"	\N		12	25398285	25398285	C	T	DOID:3908	22504186	included	ENST00000256078	p.G12S	KRAS	-1	c.34	2016-05-18 19:53:39.831183	2016-05-18 20:39:08.902787	1	ENSG00000133703	missense
613	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/36\\"}}"	\N		12	25398285	25398285	C	T	DOID:9256	23261068	included	ENST00000256078	p.G12S	KRAS	-1	c.34	2016-05-18 19:53:39.839381	2016-05-18 20:39:08.947892	1	ENSG00000133703	missense
614	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/36\\"}}"	\N		12	25398285	25398285	C	T	DOID:9256	23783394	included	ENST00000256078	p.G12S	KRAS	-1	c.34	2016-05-18 19:53:39.849579	2016-05-18 20:39:09.020982	1	ENSG00000133703	missense
615	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/36\\"}}"	\N		12	25398285	25398285	C	T	DOID:9256	23321257	included	ENST00000256078	p.G12S	KRAS	-1	c.34	2016-05-18 19:53:39.865011	2016-05-18 20:39:09.081987	1	ENSG00000133703	missense
616	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/36\\"}}"	\N		12	25398285	25398285	C	T	DOID:9256	22368270	included	ENST00000256078	p.G12S	KRAS	-1	c.34	2016-05-18 19:53:39.87445	2016-05-18 20:39:09.132641	1	ENSG00000133703	missense
617	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/36\\"}}"	\N		12	25398285	25398285	C	T	DOID:9256	23714533	included	ENST00000256078	p.G12S	KRAS	-1	c.34	2016-05-18 19:53:39.903648	2016-05-18 20:39:09.176995	1	ENSG00000133703	missense
618	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/36\\"}}"	\N		12	25398285	25398285	C	T	DOID:9256	22504183	included	ENST00000256078	p.G12S	KRAS	-1	c.34	2016-05-18 19:53:39.929342	2016-05-18 20:39:09.240184	1	ENSG00000133703	missense
619	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/36\\"}}"	\N		12	25398285	25398285	C	T	DOID:9256	15256420	included	ENST00000256078	p.G12S	KRAS	-1	c.34	2016-05-18 19:53:39.937616	2016-05-18 20:39:09.29204	1	ENSG00000133703	missense
620	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/36\\"}}"	\N		12	25398285	25398285	C	T	DOID:9256	11290608	included	ENST00000256078	p.G12S	KRAS	-1	c.34	2016-05-18 19:53:39.965052	2016-05-18 20:39:09.361093	1	ENSG00000133703	missense
621	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/36\\"}}"	\N		12	25398285	25398285	C	T	DOID:9256	19657110	included	ENST00000256078	p.G12S	KRAS	-1	c.34	2016-05-18 19:53:39.973988	2016-05-18 20:39:09.414491	1	ENSG00000133703	missense
623	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/36\\"}}"	\N		12	25398285	25398285	C	T	DOID:9256	23430109	included	ENST00000256078	p.G12S	KRAS	-1	c.34	2016-05-18 19:53:40.005892	2016-05-18 20:39:09.524926	1	ENSG00000133703	missense
625	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/36\\"}}"	\N		12	25398285	25398285	C	T	DOID:9256	16857985	included	ENST00000256078	p.G12S	KRAS	-1	c.34	2016-05-18 19:53:40.042289	2016-05-18 20:39:09.649772	1	ENSG00000133703	missense
627	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/290\\"}}"	\N		13	28592637	28592637	G	C	DOID:9119	23783394	included	ENST00000380982	p.I836M	FLT3	-1	c.2508	2016-05-18 19:53:40.073224	2016-05-18 20:39:09.7765	1	ENSG00000122025	missense
628	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/290\\"}}"	\N		13	28592637	28592637	G	C	DOID:9119	23321257	included	ENST00000380982	p.I836M	FLT3	-1	c.2508	2016-05-18 19:53:40.101223	2016-05-18 20:39:09.843363	1	ENSG00000122025	missense
629	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/290\\"}}"	\N		13	28592637	28592637	G	C	DOID:9119	22368270	included	ENST00000380982	p.I836M	FLT3	-1	c.2508	2016-05-18 19:53:40.109893	2016-05-18 20:39:09.890513	1	ENSG00000122025	missense
630	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/290\\"}}"	\N		13	28592637	28592637	G	C	DOID:9119	23714533	included	ENST00000380982	p.I836M	FLT3	-1	c.2508	2016-05-18 19:53:40.1358	2016-05-18 20:39:09.968097	1	ENSG00000122025	missense
631	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/290\\"}}"	\N		13	28592637	28592637	G	C	DOID:9119	22504183	included	ENST00000380982	p.I836M	FLT3	-1	c.2508	2016-05-18 19:53:40.144492	2016-05-18 20:39:10.020485	1	ENSG00000122025	missense
632	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/290\\"}}"	\N		13	28592637	28592637	G	C	DOID:9119	15256420	included	ENST00000380982	p.I836M	FLT3	-1	c.2508	2016-05-18 19:53:40.167071	2016-05-18 20:39:10.11477	1	ENSG00000122025	missense
633	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/290\\"}}"	\N		13	28592637	28592637	G	C	DOID:9119	11290608	included	ENST00000380982	p.I836M	FLT3	-1	c.2508	2016-05-18 19:53:40.17601	2016-05-18 20:39:10.174564	1	ENSG00000122025	missense
634	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/290\\"}}"	\N		13	28592637	28592637	G	C	DOID:9119	19657110	included	ENST00000380982	p.I836M	FLT3	-1	c.2508	2016-05-18 19:53:40.20591	2016-05-18 20:39:10.238053	1	ENSG00000122025	missense
635	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/290\\"}}"	\N		13	28592637	28592637	G	C	DOID:9119	22504184	included	ENST00000380982	p.I836M	FLT3	-1	c.2508	2016-05-18 19:53:40.214986	2016-05-18 20:39:10.290072	1	ENSG00000122025	missense
636	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/290\\"}}"	\N		13	28592637	28592637	G	C	DOID:9119	23430109	included	ENST00000380982	p.I836M	FLT3	-1	c.2508	2016-05-18 19:53:40.236734	2016-05-18 20:39:10.344224	1	ENSG00000122025	missense
637	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/290\\"}}"	\N		13	28592637	28592637	G	C	DOID:9119	20733134	included	ENST00000380982	p.I836M	FLT3	-1	c.2508	2016-05-18 19:53:40.249806	2016-05-18 20:39:10.393314	1	ENSG00000122025	missense
638	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/290\\"}}"	\N		13	28592637	28592637	G	C	DOID:9119	16857985	included	ENST00000380982	p.I836M	FLT3	-1	c.2508	2016-05-18 19:53:40.269095	2016-05-18 20:39:10.442247	1	ENSG00000122025	missense
639	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/284\\"}}"	\N		13	28592639	28592639	T	G	DOID:9119	22504184	included	ENST00000380982	p.I836L	FLT3	-1	c.2506	2016-05-18 19:53:40.277587	2016-05-18 20:39:10.526047	1	ENSG00000122025	missense
640	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/283\\"}}"	\N		13	28592640	28592640	A	C	DOID:9119	23261068	included	ENST00000380982	p.D835E	FLT3	-1	c.2505	2016-05-18 19:53:40.305427	2016-05-18 20:39:10.602957	1	ENSG00000122025	missense
641	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/283\\"}}"	\N		13	28592640	28592640	A	C	DOID:9119	23783394	included	ENST00000380982	p.D835E	FLT3	-1	c.2505	2016-05-18 19:53:40.331879	2016-05-18 20:39:10.671628	1	ENSG00000122025	missense
642	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/283\\"}}"	\N		13	28592640	28592640	A	C	DOID:9119	23321257	included	ENST00000380982	p.D835E	FLT3	-1	c.2505	2016-05-18 19:53:40.340537	2016-05-18 20:39:10.717123	1	ENSG00000122025	missense
643	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/283\\"}}"	\N		13	28592640	28592640	A	C	DOID:9119	22368270	included	ENST00000380982	p.D835E	FLT3	-1	c.2505	2016-05-18 19:53:40.373767	2016-05-18 20:39:10.760947	1	ENSG00000122025	missense
644	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/283\\"}}"	\N		13	28592640	28592640	A	C	DOID:9119	23714533	included	ENST00000380982	p.D835E	FLT3	-1	c.2505	2016-05-18 19:53:40.382726	2016-05-18 20:39:10.82234	1	ENSG00000122025	missense
645	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/283\\"}}"	\N		13	28592640	28592640	A	C	DOID:9119	22504183	included	ENST00000380982	p.D835E	FLT3	-1	c.2505	2016-05-18 19:53:40.405365	2016-05-18 20:39:10.886622	1	ENSG00000122025	missense
646	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/283\\"}}"	\N		13	28592640	28592640	A	C	DOID:9119	22504184	included	ENST00000380982	p.D835E	FLT3	-1	c.2505	2016-05-18 19:53:40.421348	2016-05-18 20:39:10.934629	1	ENSG00000122025	missense
647	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/283\\"}}"	\N		13	28592640	28592640	A	C	DOID:9119	23430109	included	ENST00000380982	p.D835E	FLT3	-1	c.2505	2016-05-18 19:53:40.435957	2016-05-18 20:39:11.018632	1	ENSG00000122025	missense
648	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/283\\"}}"	\N		13	28592640	28592640	A	C	DOID:9119	20733134	included	ENST00000380982	p.D835E	FLT3	-1	c.2505	2016-05-18 19:53:40.444573	2016-05-18 20:39:11.062891	1	ENSG00000122025	missense
649	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/283\\"}}"	\N		13	28592640	28592640	A	C	DOID:9119	16857985	included	ENST00000380982	p.D835E	FLT3	-1	c.2505	2016-05-18 19:53:40.475305	2016-05-18 20:39:11.12076	1	ENSG00000122025	missense
650	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/288\\"}}"	\N		13	28592640	28592640	A	T	DOID:9119	22504184	included	ENST00000380982	p.D835E	FLT3	-1	c.2505	2016-05-18 19:53:40.485741	2016-05-18 20:39:11.184612	1	ENSG00000122025	missense
651	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/282\\"}}"	\N		13	28592641	28592641	T	A	DOID:9119	23261068	included	ENST00000380982	p.D835V	FLT3	-1	c.2504	2016-05-18 19:53:40.506799	2016-05-18 20:39:11.258318	1	ENSG00000122025	missense
652	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/282\\"}}"	\N		13	28592641	28592641	T	A	DOID:9119	23783394	included	ENST00000380982	p.D835V	FLT3	-1	c.2504	2016-05-18 19:53:40.516246	2016-05-18 20:39:11.354433	1	ENSG00000122025	missense
653	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/282\\"}}"	\N		13	28592641	28592641	T	A	DOID:9119	23321257	included	ENST00000380982	p.D835V	FLT3	-1	c.2504	2016-05-18 19:53:40.535568	2016-05-18 20:39:11.403176	1	ENSG00000122025	missense
654	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/282\\"}}"	\N		13	28592641	28592641	T	A	DOID:9119	22368270	included	ENST00000380982	p.D835V	FLT3	-1	c.2504	2016-05-18 19:53:40.543717	2016-05-18 20:39:11.468588	1	ENSG00000122025	missense
655	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/282\\"}}"	\N		13	28592641	28592641	T	A	DOID:9119	23714533	included	ENST00000380982	p.D835V	FLT3	-1	c.2504	2016-05-18 19:53:40.55316	2016-05-18 20:39:11.522723	1	ENSG00000122025	missense
656	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/282\\"}}"	\N		13	28592641	28592641	T	A	DOID:9119	22504183	included	ENST00000380982	p.D835V	FLT3	-1	c.2504	2016-05-18 19:53:40.569525	2016-05-18 20:39:11.567527	1	ENSG00000122025	missense
657	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/282\\"}}"	\N		13	28592641	28592641	T	A	DOID:9119	15256420	included	ENST00000380982	p.D835V	FLT3	-1	c.2504	2016-05-18 19:53:40.577886	2016-05-18 20:39:11.648263	1	ENSG00000122025	missense
658	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/282\\"}}"	\N		13	28592641	28592641	T	A	DOID:9119	11290608	included	ENST00000380982	p.D835V	FLT3	-1	c.2504	2016-05-18 19:53:40.608125	2016-05-18 20:39:11.705988	1	ENSG00000122025	missense
659	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/282\\"}}"	\N		13	28592641	28592641	T	A	DOID:9119	19657110	included	ENST00000380982	p.D835V	FLT3	-1	c.2504	2016-05-18 19:53:40.618286	2016-05-18 20:39:11.767499	1	ENSG00000122025	missense
660	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/282\\"}}"	\N		13	28592641	28592641	T	A	DOID:9119	22504184	included	ENST00000380982	p.D835V	FLT3	-1	c.2504	2016-05-18 19:53:40.638273	2016-05-18 20:39:11.830656	1	ENSG00000122025	missense
661	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/282\\"}}"	\N		13	28592641	28592641	T	A	DOID:9119	23430109	included	ENST00000380982	p.D835V	FLT3	-1	c.2504	2016-05-18 19:53:40.647069	2016-05-18 20:39:11.881584	1	ENSG00000122025	missense
662	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/282\\"}}"	\N		13	28592641	28592641	T	A	DOID:9119	20733134	included	ENST00000380982	p.D835V	FLT3	-1	c.2504	2016-05-18 19:53:40.67579	2016-05-18 20:39:11.937352	1	ENSG00000122025	missense
663	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/282\\"}}"	\N		13	28592641	28592641	T	A	DOID:9119	16857985	included	ENST00000380982	p.D835V	FLT3	-1	c.2504	2016-05-18 19:53:40.700056	2016-05-18 20:39:11.994013	1	ENSG00000122025	missense
1455	\N	\N		12	25380275	25380275	T	A	DOID:9119	18725974	included	ENST00000256078	p.Q61H	KRAS	-1	c.183	2016-05-18 20:26:15.021592	2016-05-18 20:40:00.039559	2	ENSG00000133703	missense
664	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/281\\"}}"	\N		13	28592641	28592641	T	G	DOID:9119	22504184	included	ENST00000380982	p.D835A	FLT3	-1	c.2504	2016-05-18 19:53:40.707918	2016-05-18 20:39:12.060792	1	ENSG00000122025	missense
665	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/280\\"}}"	\N		13	28592642	28592642	C	A	DOID:9119	23261068	included	ENST00000380982	p.D835Y	FLT3	-1	c.2503	2016-05-18 19:53:40.738232	2016-05-18 20:39:12.129002	1	ENSG00000122025	missense
666	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/280\\"}}"	\N		13	28592642	28592642	C	A	DOID:9119	23783394	included	ENST00000380982	p.D835Y	FLT3	-1	c.2503	2016-05-18 19:53:40.747221	2016-05-18 20:39:12.175574	1	ENSG00000122025	missense
667	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/280\\"}}"	\N		13	28592642	28592642	C	A	DOID:9119	23321257	included	ENST00000380982	p.D835Y	FLT3	-1	c.2503	2016-05-18 19:53:40.770707	2016-05-18 20:39:12.231382	1	ENSG00000122025	missense
668	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/280\\"}}"	\N		13	28592642	28592642	C	A	DOID:9119	22368270	included	ENST00000380982	p.D835Y	FLT3	-1	c.2503	2016-05-18 19:53:40.779663	2016-05-18 20:39:12.282222	1	ENSG00000122025	missense
669	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/280\\"}}"	\N		13	28592642	28592642	C	A	DOID:9119	23714533	included	ENST00000380982	p.D835Y	FLT3	-1	c.2503	2016-05-18 19:53:40.802204	2016-05-18 20:39:12.340447	1	ENSG00000122025	missense
670	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/280\\"}}"	\N		13	28592642	28592642	C	A	DOID:9119	22504184	included	ENST00000380982	p.D835Y	FLT3	-1	c.2503	2016-05-18 19:53:40.810822	2016-05-18 20:39:12.393675	1	ENSG00000122025	missense
671	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/280\\"}}"	\N		13	28592642	28592642	C	A	DOID:9119	15256420	included	ENST00000380982	p.D835Y	FLT3	-1	c.2503	2016-05-18 19:53:40.838672	2016-05-18 20:39:12.464493	1	ENSG00000122025	missense
672	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/280\\"}}"	\N		13	28592642	28592642	C	A	DOID:9119	11290608	included	ENST00000380982	p.D835Y	FLT3	-1	c.2503	2016-05-18 19:53:40.847734	2016-05-18 20:39:12.515297	1	ENSG00000122025	missense
673	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/280\\"}}"	\N		13	28592642	28592642	C	A	DOID:9119	23430109	included	ENST00000380982	p.D835Y	FLT3	-1	c.2503	2016-05-18 19:53:40.869989	2016-05-18 20:39:12.585818	1	ENSG00000122025	missense
674	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/280\\"}}"	\N		13	28592642	28592642	C	A	DOID:9119	20733134	included	ENST00000380982	p.D835Y	FLT3	-1	c.2503	2016-05-18 19:53:40.878806	2016-05-18 20:39:12.812303	1	ENSG00000122025	missense
675	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/280\\"}}"	\N		13	28592642	28592642	C	A	DOID:9119	16857985	included	ENST00000380982	p.D835Y	FLT3	-1	c.2503	2016-05-18 19:53:40.901817	2016-05-18 20:39:12.850502	1	ENSG00000122025	missense
676	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/278\\"}}"	\N		13	28592642	28592642	C	G	DOID:9119	23261068	included	ENST00000380982	p.D835H	FLT3	-1	c.2503	2016-05-18 19:53:40.910258	2016-05-18 20:39:12.912828	1	ENSG00000122025	missense
677	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/278\\"}}"	\N		13	28592642	28592642	C	G	DOID:9119	23783394	included	ENST00000380982	p.D835H	FLT3	-1	c.2503	2016-05-18 19:53:40.939984	2016-05-18 20:39:12.964546	1	ENSG00000122025	missense
678	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/278\\"}}"	\N		13	28592642	28592642	C	G	DOID:9119	23321257	included	ENST00000380982	p.D835H	FLT3	-1	c.2503	2016-05-18 19:53:40.949506	2016-05-18 20:39:13.026071	1	ENSG00000122025	missense
679	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/278\\"}}"	\N		13	28592642	28592642	C	G	DOID:9119	22368270	included	ENST00000380982	p.D835H	FLT3	-1	c.2503	2016-05-18 19:53:40.971668	2016-05-18 20:39:13.099657	1	ENSG00000122025	missense
680	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/278\\"}}"	\N		13	28592642	28592642	C	G	DOID:9119	23714533	included	ENST00000380982	p.D835H	FLT3	-1	c.2503	2016-05-18 19:53:40.980407	2016-05-18 20:39:13.142145	1	ENSG00000122025	missense
681	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/278\\"}}"	\N		13	28592642	28592642	C	G	DOID:9119	22504185	included	ENST00000380982	p.D835H	FLT3	-1	c.2503	2016-05-18 19:53:41.003822	2016-05-18 20:39:13.183875	1	ENSG00000122025	missense
682	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/278\\"}}"	\N		13	28592642	28592642	C	G	DOID:9119	15256420	included	ENST00000380982	p.D835H	FLT3	-1	c.2503	2016-05-18 19:53:41.012335	2016-05-18 20:39:13.239565	1	ENSG00000122025	missense
683	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/278\\"}}"	\N		13	28592642	28592642	C	G	DOID:9119	11290608	included	ENST00000380982	p.D835H	FLT3	-1	c.2503	2016-05-18 19:53:41.040174	2016-05-18 20:39:13.29567	1	ENSG00000122025	missense
684	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/278\\"}}"	\N		13	28592642	28592642	C	G	DOID:9119	22504184	included	ENST00000380982	p.D835H	FLT3	-1	c.2503	2016-05-18 19:53:41.048903	2016-05-18 20:39:13.349253	1	ENSG00000122025	missense
685	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/278\\"}}"	\N		13	28592642	28592642	C	G	DOID:9119	23430109	included	ENST00000380982	p.D835H	FLT3	-1	c.2503	2016-05-18 19:53:41.070925	2016-05-18 20:39:13.451745	1	ENSG00000122025	missense
687	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/278\\"}}"	\N		13	28592642	28592642	C	G	DOID:9119	16857985	included	ENST00000380982	p.D835H	FLT3	-1	c.2503	2016-05-18 19:53:41.10773	2016-05-18 20:39:13.560556	1	ENSG00000122025	missense
688	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/279\\"}}"	\N		13	28592642	28592642	C	T	DOID:9119	22504184	included	ENST00000380982	p.D835N	FLT3	-1	c.2503	2016-05-18 19:53:41.116976	2016-05-18 20:39:13.643788	1	ENSG00000122025	missense
689	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/breast-cancer/akt1/23\\"}}"	\N		14	105246551	105246551	C	T	DOID:1612	22504184	included	ENST00000349310	p.E17K	AKT1	-1	c.49	2016-05-18 19:53:41.139738	2016-05-18 20:39:13.725724	1	ENSG00000142208	missense
1456	\N	\N		12	25380275	25380275	T	A	DOID:9119	22162589	included	ENST00000256078	p.Q61H	KRAS	-1	c.183	2016-05-18 20:26:15.029966	2016-05-18 20:40:00.077571	2	ENSG00000133703	missense
691	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/lung-cancer/akt1/23\\"}}"	\N		14	105246551	105246551	C	T	DOID:3908	23430109	included	ENST00000349310	p.E17K	AKT1	-1	c.49	2016-05-18 19:53:41.170862	2016-05-18 20:39:13.839038	1	ENSG00000142208	missense
692	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/lung-cancer/akt1/23\\"}}"	\N		14	105246551	105246551	C	T	DOID:3908	24619500	included	ENST00000349310	p.E17K	AKT1	-1	c.49	2016-05-18 19:53:41.178919	2016-05-18 20:39:13.93047	1	ENSG00000142208	missense
693	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/akt1/23\\"}}"	\N		14	105246551	105246551	C	T	DOID:9256	23878140	included	ENST00000349310	p.E17K	AKT1	-1	c.49	2016-05-18 19:53:41.209032	2016-05-18 20:39:13.983561	1	ENSG00000142208	missense
694	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/akt1/23\\"}}"	\N		14	105246551	105246551	C	T	DOID:9256	24619500	included	ENST00000349310	p.E17K	AKT1	-1	c.49	2016-05-18 19:53:41.218361	2016-05-18 20:39:14.04374	1	ENSG00000142208	missense
695	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/breast-cancer/her2/242\\"}}"	\N		15	28505962	28505962	CAGGTCAGGACCGTT	-	DOID:1612	23878140	included	ENST00000261609	p.D759X	HERC2	-1	c.2277	2016-05-18 19:53:41.239194	2016-05-18 20:39:14.190017	1	ENSG00000128731	frameshift
696	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/breast-cancer/her2/242\\"}}"	\N		15	28505962	28505962	CAGGTCAGGACCGTT	-	DOID:1612	24619500	included	ENST00000261609	p.D759X	HERC2	-1	c.2277	2016-05-18 19:53:41.248073	2016-05-18 20:39:14.253364	1	ENSG00000128731	frameshift
697	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/breast-cancer/her2/246\\"}}"	\N		15	28505975	28505975	A	G	DOID:1612	22504184	included	ENST00000261609	p.L755S	HERC2	-1	c.2264	2016-05-18 19:53:41.257463	2016-05-18 20:39:14.351155	1	ENSG00000128731	missense
698	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/breast-cancer/her2/246\\"}}"	\N		15	28505975	28505975	A	G	DOID:1612	23430109	included	ENST00000261609	p.L755S	HERC2	-1	c.2264	2016-05-18 19:53:41.273691	2016-05-18 20:39:14.394826	1	ENSG00000128731	missense
699	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/breast-cancer/her2/246\\"}}"	\N		15	28505975	28505975	A	G	DOID:1612	24619500	included	ENST00000261609	p.L755S	HERC2	-1	c.2264	2016-05-18 19:53:41.281762	2016-05-18 20:39:14.452687	1	ENSG00000128731	missense
700	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/breast-cancer/her2/239\\"}}"	\N		15	28517518	28517518	G	C	DOID:1612	22504184	included	ENST00000261609	p.A309G	HERC2	-1	c.926	2016-05-18 19:53:41.313772	2016-05-18 20:39:14.519623	1	ENSG00000128731	missense
701	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/breast-cancer/her2/239\\"}}"	\N		15	28517518	28517518	G	C	DOID:1612	23430109	included	ENST00000261609	p.A309G	HERC2	-1	c.926	2016-05-18 19:53:41.323076	2016-05-18 20:39:14.574202	1	ENSG00000128731	missense
702	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/breast-cancer/her2/239\\"}}"	\N		15	28517518	28517518	G	C	DOID:1612	24619500	included	ENST00000261609	p.A309G	HERC2	-1	c.926	2016-05-18 19:53:41.345006	2016-05-18 20:39:14.621377	1	ENSG00000128731	missense
703	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/mek1/210\\"}}"	\N		15	66727441	66727441	T	C	DOID:1909	22504184	included	ENST00000307102	p.F53L	MAP2K1	1	c.157	2016-05-18 19:53:41.371004	2016-05-18 20:39:14.697266	1	ENSG00000169032	missense
704	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/mek1/210\\"}}"	\N		15	66727441	66727441	T	C	DOID:1909	23430109	included	ENST00000307102	p.F53L	MAP2K1	1	c.157	2016-05-18 19:53:41.379155	2016-05-18 20:39:14.748996	1	ENSG00000169032	missense
705	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/mek1/210\\"}}"	\N		15	66727441	66727441	T	C	DOID:1909	24619500	included	ENST00000307102	p.F53L	MAP2K1	1	c.157	2016-05-18 19:53:41.409918	2016-05-18 20:39:14.794334	1	ENSG00000169032	missense
706	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/lung-cancer/mek1/74\\"}}"	\N		15	66727451	66727451	A	C	DOID:3908	22147895	included	ENST00000307102	p.Q56P	MAP2K1	1	c.167	2016-05-18 19:53:41.418965	2016-05-18 20:39:14.866239	1	ENSG00000169032	missense
707	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/lung-cancer/mek1/74\\"}}"	\N		15	66727451	66727451	A	C	DOID:3908	21765025	included	ENST00000307102	p.Q56P	MAP2K1	1	c.167	2016-05-18 19:53:41.440331	2016-05-18 20:39:14.920481	1	ENSG00000169032	missense
708	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/lung-cancer/mek1/72\\"}}"	\N		15	66727455	66727455	G	T	DOID:3908	22147895	included	ENST00000307102	p.K57N	MAP2K1	1	c.171	2016-05-18 19:53:41.448911	2016-05-18 20:39:14.988257	1	ENSG00000169032	missense
709	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/lung-cancer/mek1/72\\"}}"	\N		15	66727455	66727455	G	T	DOID:3908	21765025	included	ENST00000307102	p.K57N	MAP2K1	1	c.171	2016-05-18 19:53:41.476846	2016-05-18 20:39:15.038673	1	ENSG00000169032	missense
710	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/lung-cancer/mek1/60\\"}}"	\N		15	66727483	66727483	G	A	DOID:3908	22160010	included	ENST00000307102	p.D67N	MAP2K1	1	c.199	2016-05-18 19:53:41.485575	2016-05-18 20:39:15.105942	1	ENSG00000169032	missense
711	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/lung-cancer/mek1/60\\"}}"	\N		15	66727483	66727483	G	A	DOID:3908	22898539	included	ENST00000307102	p.D67N	MAP2K1	1	c.199	2016-05-18 19:53:41.507227	2016-05-18 20:39:15.157896	1	ENSG00000169032	missense
712	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/lung-cancer/mek1/60\\"}}"	\N		15	66727483	66727483	G	A	DOID:3908	22417203	included	ENST00000307102	p.D67N	MAP2K1	1	c.199	2016-05-18 19:53:41.515684	2016-05-18 20:39:15.213555	1	ENSG00000169032	missense
713	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/lung-cancer/mek1/60\\"}}"	\N		15	66727483	66727483	G	A	DOID:3908	22397365	included	ENST00000307102	p.D67N	MAP2K1	1	c.199	2016-05-18 19:53:41.543716	2016-05-18 20:39:15.259988	1	ENSG00000169032	missense
714	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/mek1/211\\"}}"	\N		15	66729124	66729124	T	G	DOID:1909	22160010	included	ENST00000307102	p.I111S	MAP2K1	1	c.332	2016-05-18 19:53:41.552867	2016-05-18 20:39:15.329653	1	ENSG00000169032	missense
715	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/mek1/211\\"}}"	\N		15	66729124	66729124	T	G	DOID:1909	22898539	included	ENST00000307102	p.I111S	MAP2K1	1	c.332	2016-05-18 19:53:41.574824	2016-05-18 20:39:15.378244	1	ENSG00000169032	missense
716	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/mek1/211\\"}}"	\N		15	66729124	66729124	T	G	DOID:1909	22417203	included	ENST00000307102	p.I111S	MAP2K1	1	c.332	2016-05-18 19:53:41.583551	2016-05-18 20:39:15.431263	1	ENSG00000169032	missense
717	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/mek1/212\\"}}"	\N		15	66729154	66729154	G	C	DOID:1909	19657110	included	ENST00000307102	p.C121S	MAP2K1	1	c.362	2016-05-18 19:53:41.610043	2016-05-18 20:39:15.497635	1	ENSG00000169032	missense
718	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/mek1/212\\"}}"	\N		15	66729154	66729154	G	C	DOID:1909	22160010	included	ENST00000307102	p.C121S	MAP2K1	1	c.362	2016-05-18 19:53:41.619202	2016-05-18 20:39:15.550921	1	ENSG00000169032	missense
719	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/mek1/212\\"}}"	\N		15	66729154	66729154	G	C	DOID:1909	22898539	included	ENST00000307102	p.C121S	MAP2K1	1	c.362	2016-05-18 19:53:41.644654	2016-05-18 20:39:15.595714	1	ENSG00000169032	missense
720	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/mek1/212\\"}}"	\N		15	66729154	66729154	G	C	DOID:1909	22417203	included	ENST00000307102	p.C121S	MAP2K1	1	c.362	2016-05-18 19:53:41.653755	2016-05-18 20:39:15.644399	1	ENSG00000169032	missense
721	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/mek1/212\\"}}"	\N		15	66729154	66729154	G	C	DOID:1909	24606448	included	ENST00000307102	p.C121S	MAP2K1	1	c.362	2016-05-18 19:53:41.683281	2016-05-18 20:39:15.687905	1	ENSG00000169032	missense
722	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/mek1/212\\"}}"	\N		15	66729154	66729154	G	C	DOID:1909	22397365	included	ENST00000307102	p.C121S	MAP2K1	1	c.362	2016-05-18 19:53:41.709032	2016-05-18 20:39:15.747768	1	ENSG00000169032	missense
723	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/mek1/214\\"}}"	\N		15	66729162	66729162	C	T	DOID:1909	19657110	included	ENST00000307102	p.P124S	MAP2K1	1	c.370	2016-05-18 19:53:41.7177	2016-05-18 20:39:15.816583	1	ENSG00000169032	missense
724	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/mek1/214\\"}}"	\N		15	66729162	66729162	C	T	DOID:1909	22160010	included	ENST00000307102	p.P124S	MAP2K1	1	c.370	2016-05-18 19:53:41.745494	2016-05-18 20:39:15.862434	1	ENSG00000169032	missense
725	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/mek1/214\\"}}"	\N		15	66729162	66729162	C	T	DOID:1909	22898539	included	ENST00000307102	p.P124S	MAP2K1	1	c.370	2016-05-18 19:53:41.754801	2016-05-18 20:39:15.919818	1	ENSG00000169032	missense
726	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/mek1/214\\"}}"	\N		15	66729162	66729162	C	T	DOID:1909	22417203	included	ENST00000307102	p.P124S	MAP2K1	1	c.370	2016-05-18 19:53:41.77691	2016-05-18 20:39:15.969213	1	ENSG00000169032	missense
727	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/mek1/214\\"}}"	\N		15	66729162	66729162	C	T	DOID:1909	22397365	included	ENST00000307102	p.P124S	MAP2K1	1	c.370	2016-05-18 19:53:41.785457	2016-05-18 20:39:16.024333	1	ENSG00000169032	missense
728	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/mek1/214\\"}}"	\N		15	66729162	66729162	C	T	DOID:1909	20946881	included	ENST00000307102	p.P124S	MAP2K1	1	c.370	2016-05-18 19:53:41.812727	2016-05-18 20:39:16.069118	1	ENSG00000169032	missense
729	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/mek1/213\\"}}"	\N		15	66729163	66729163	C	T	DOID:1909	22160010	included	ENST00000307102	p.P124L	MAP2K1	1	c.371	2016-05-18 19:53:41.822225	2016-05-18 20:39:16.133554	1	ENSG00000169032	missense
730	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/mek1/213\\"}}"	\N		15	66729163	66729163	C	T	DOID:1909	22898539	included	ENST00000307102	p.P124L	MAP2K1	1	c.371	2016-05-18 19:53:41.846835	2016-05-18 20:39:16.187799	1	ENSG00000169032	missense
731	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/mek1/213\\"}}"	\N		15	66729163	66729163	C	T	DOID:1909	22417203	included	ENST00000307102	p.P124L	MAP2K1	1	c.371	2016-05-18 19:53:41.85615	2016-05-18 20:39:16.245055	1	ENSG00000169032	missense
732	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/mek1/213\\"}}"	\N		15	66729163	66729163	C	T	DOID:1909	22397365	included	ENST00000307102	p.P124L	MAP2K1	1	c.371	2016-05-18 19:53:41.884093	2016-05-18 20:39:16.293741	1	ENSG00000169032	missense
733	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/mek1/213\\"}}"	\N		15	66729163	66729163	C	T	DOID:1909	20946881	included	ENST00000307102	p.P124L	MAP2K1	1	c.371	2016-05-18 19:53:41.893815	2016-05-18 20:39:16.341988	1	ENSG00000169032	missense
734	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/mek1/215\\"}}"	\N		15	66774131	66774131	G	A	DOID:1909	19657110	included	ENST00000307102	p.E203K	MAP2K1	1	c.607	2016-05-18 19:53:41.914271	2016-05-18 20:39:16.404327	1	ENSG00000169032	missense
735	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/mek1/215\\"}}"	\N		15	66774131	66774131	G	A	DOID:1909	22160010	included	ENST00000307102	p.E203K	MAP2K1	1	c.607	2016-05-18 19:53:41.923451	2016-05-18 20:39:16.454881	1	ENSG00000169032	missense
736	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/mek1/215\\"}}"	\N		15	66774131	66774131	G	A	DOID:1909	22898539	included	ENST00000307102	p.E203K	MAP2K1	1	c.607	2016-05-18 19:53:41.950321	2016-05-18 20:39:16.512316	1	ENSG00000169032	missense
737	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/mek1/215\\"}}"	\N		15	66774131	66774131	G	A	DOID:1909	22417203	included	ENST00000307102	p.E203K	MAP2K1	1	c.607	2016-05-18 19:53:41.959005	2016-05-18 20:39:16.556386	1	ENSG00000169032	missense
738	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/mek1/216\\"}}"	\N		15	66777424	66777424	C	T	DOID:1909	22160010	included	ENST00000307102	p.P264S	MAP2K1	1	c.790	2016-05-18 19:53:41.9692	2016-05-18 20:39:16.62548	1	ENSG00000169032	missense
739	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/mek1/216\\"}}"	\N		15	66777424	66777424	C	T	DOID:1909	22898539	included	ENST00000307102	p.P264S	MAP2K1	1	c.790	2016-05-18 19:53:41.98388	2016-05-18 20:39:16.682208	1	ENSG00000169032	missense
740	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/mek1/216\\"}}"	\N		15	66777424	66777424	C	T	DOID:1909	22417203	included	ENST00000307102	p.P264S	MAP2K1	1	c.790	2016-05-18 19:53:41.993117	2016-05-18 20:39:16.720278	1	ENSG00000169032	missense
741	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/mek1/216\\"}}"	\N		15	66777424	66777424	C	T	DOID:1909	24606448	included	ENST00000307102	p.P264S	MAP2K1	1	c.790	2016-05-18 19:53:42.015053	2016-05-18 20:39:16.783894	1	ENSG00000169032	missense
742	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/mek1/217\\"}}"	\N		15	66782915	66782915	A	C	DOID:1909	22160010	included	ENST00000307102	p.N382H	MAP2K1	1	c.1144	2016-05-18 19:53:42.047919	2016-05-18 20:39:16.84806	1	ENSG00000169032	missense
743	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/mek1/217\\"}}"	\N		15	66782915	66782915	A	C	DOID:1909	22898539	included	ENST00000307102	p.N382H	MAP2K1	1	c.1144	2016-05-18 19:53:42.057561	2016-05-18 20:39:16.894721	1	ENSG00000169032	missense
744	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/mek1/217\\"}}"	\N		15	66782915	66782915	A	C	DOID:1909	22417203	included	ENST00000307102	p.N382H	MAP2K1	1	c.1144	2016-05-18 19:53:42.081786	2016-05-18 20:39:16.948378	1	ENSG00000169032	missense
745	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh2/272\\"}}"	\N		15	90631837	90631837	C	G	DOID:9119	22160010	included	ENST00000330062	p.R172S	IDH2	-1	c.516	2016-05-18 19:53:42.090669	2016-05-18 20:39:17.025578	1	ENSG00000182054	missense
746	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh2/272\\"}}"	\N		15	90631837	90631837	C	G	DOID:9119	22417203	included	ENST00000330062	p.R172S	IDH2	-1	c.516	2016-05-18 19:53:42.118008	2016-05-18 20:39:17.071842	1	ENSG00000182054	missense
747	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh2/272\\"}}"	\N		15	90631837	90631837	C	G	DOID:9119	24606448	included	ENST00000330062	p.R172S	IDH2	-1	c.516	2016-05-18 19:53:42.148528	2016-05-18 20:39:17.130745	1	ENSG00000182054	missense
748	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh2/272\\"}}"	\N		15	90631837	90631837	C	G	DOID:9119	23949315	included	ENST00000330062	p.R172S	IDH2	-1	c.516	2016-05-18 19:53:42.15768	2016-05-18 20:39:17.166173	1	ENSG00000182054	missense
751	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh2/271\\"}}"	\N		15	90631838	90631838	C	A	DOID:9119	22160010	included	ENST00000330062	p.R172M	IDH2	-1	c.515	2016-05-18 19:53:42.214674	2016-05-18 20:39:17.3147	1	ENSG00000182054	missense
752	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh2/271\\"}}"	\N		15	90631838	90631838	C	A	DOID:9119	22417203	included	ENST00000330062	p.R172M	IDH2	-1	c.515	2016-05-18 19:53:42.222708	2016-05-18 20:39:17.37712	1	ENSG00000182054	missense
753	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh2/270\\"}}"	\N		15	90631838	90631838	C	T	DOID:9119	22160010	included	ENST00000330062	p.R172K	IDH2	-1	c.515	2016-05-18 19:53:42.254752	2016-05-18 20:39:17.450686	1	ENSG00000182054	missense
754	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh2/270\\"}}"	\N		15	90631838	90631838	C	T	DOID:9119	24606448	included	ENST00000330062	p.R172K	IDH2	-1	c.515	2016-05-18 19:53:42.264542	2016-05-18 20:39:17.514655	1	ENSG00000182054	missense
755	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh2/270\\"}}"	\N		15	90631838	90631838	C	T	DOID:9119	23949315	included	ENST00000330062	p.R172K	IDH2	-1	c.515	2016-05-18 19:53:42.287053	2016-05-18 20:39:17.564718	1	ENSG00000182054	missense
756	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh2/270\\"}}"	\N		15	90631838	90631838	C	T	DOID:9119	23815907	included	ENST00000330062	p.R172K	IDH2	-1	c.515	2016-05-18 19:53:42.297182	2016-05-18 20:39:17.629331	1	ENSG00000182054	missense
757	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh2/270\\"}}"	\N		15	90631838	90631838	C	T	DOID:9119	22397365	included	ENST00000330062	p.R172K	IDH2	-1	c.515	2016-05-18 19:53:42.317473	2016-05-18 20:39:17.694671	1	ENSG00000182054	missense
758	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh2/270\\"}}"	\N		15	90631838	90631838	C	T	DOID:9119	20946881	included	ENST00000330062	p.R172K	IDH2	-1	c.515	2016-05-18 19:53:42.326215	2016-05-18 20:39:17.747388	1	ENSG00000182054	missense
759	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh2/268\\"}}"	\N		15	90631934	90631934	C	A	DOID:9119	22160010	included	ENST00000330062	p.R140L	IDH2	-1	c.419	2016-05-18 19:53:42.354242	2016-05-18 20:39:17.828469	1	ENSG00000182054	missense
760	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh2/268\\"}}"	\N		15	90631934	90631934	C	A	DOID:9119	22898539	included	ENST00000330062	p.R140L	IDH2	-1	c.419	2016-05-18 19:53:42.363926	2016-05-18 20:39:17.880605	1	ENSG00000182054	missense
761	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh2/268\\"}}"	\N		15	90631934	90631934	C	A	DOID:9119	22417203	included	ENST00000330062	p.R140L	IDH2	-1	c.419	2016-05-18 19:53:42.384836	2016-05-18 20:39:17.96992	1	ENSG00000182054	missense
762	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh2/266\\"}}"	\N		15	90631934	90631934	C	T	DOID:9119	21680795	included	ENST00000330062	p.R140Q	IDH2	-1	c.419	2016-05-18 19:53:42.394939	2016-05-18 20:39:18.047576	1	ENSG00000182054	missense
763	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh2/266\\"}}"	\N		15	90631934	90631934	C	T	DOID:9119	21436584	included	ENST00000330062	p.R140Q	IDH2	-1	c.419	2016-05-18 19:53:42.416804	2016-05-18 20:39:18.109378	1	ENSG00000182054	missense
764	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh2/267\\"}}"	\N		15	90631935	90631935	G	A	DOID:9119	24404189	included	ENST00000330062	p.R140W	IDH2	-1	c.418	2016-05-18 19:53:42.425691	2016-05-18 20:39:18.214625	1	ENSG00000182054	missense
765	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh2/267\\"}}"	\N		15	90631935	90631935	G	A	DOID:9119	23115274	included	ENST00000330062	p.R140W	IDH2	-1	c.418	2016-05-18 19:53:42.45503	2016-05-18 20:39:18.286858	1	ENSG00000182054	missense
766	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh2/267\\"}}"	\N		15	90631935	90631935	G	A	DOID:9119	22829971	included	ENST00000330062	p.R140W	IDH2	-1	c.418	2016-05-18 19:53:42.464542	2016-05-18 20:39:18.371059	1	ENSG00000182054	missense
767	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh2/267\\"}}"	\N		15	90631935	90631935	G	A	DOID:9119	22818858	included	ENST00000330062	p.R140W	IDH2	-1	c.418	2016-05-18 19:53:42.484515	2016-05-18 20:39:18.423127	1	ENSG00000182054	missense
768	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh2/267\\"}}"	\N		15	90631935	90631935	G	A	DOID:9119	22571758	included	ENST00000330062	p.R140W	IDH2	-1	c.418	2016-05-18 19:53:42.492992	2016-05-18 20:39:18.502808	1	ENSG00000182054	missense
769	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh2/267\\"}}"	\N		15	90631935	90631935	G	A	DOID:9119	22041374	included	ENST00000330062	p.R140W	IDH2	-1	c.418	2016-05-18 19:53:42.52195	2016-05-18 20:39:18.545776	1	ENSG00000182054	missense
770	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh2/267\\"}}"	\N		15	90631935	90631935	G	A	DOID:9119	21689158	included	ENST00000330062	p.R140W	IDH2	-1	c.418	2016-05-18 19:53:42.546921	2016-05-18 20:39:18.592104	1	ENSG00000182054	missense
771	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh2/267\\"}}"	\N		15	90631935	90631935	G	A	DOID:9119	21120162	included	ENST00000330062	p.R140W	IDH2	-1	c.418	2016-05-18 19:53:42.554276	2016-05-18 20:39:18.659894	1	ENSG00000182054	missense
1457	\N	\N		12	25380275	25380275	T	A	DOID:9119	22162582	included	ENST00000256078	p.Q61H	KRAS	-1	c.183	2016-05-18 20:26:15.041873	2016-05-18 20:40:00.118496	2	ENSG00000133703	missense
772	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh2/267\\"}}"	\N		15	90631935	90631935	G	A	DOID:9119	20339092	included	ENST00000330062	p.R140W	IDH2	-1	c.418	2016-05-18 19:53:42.584949	2016-05-18 20:39:18.725698	1	ENSG00000182054	missense
773	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh2/267\\"}}"	\N		15	90631935	90631935	G	A	DOID:9119	20631743	included	ENST00000330062	p.R140W	IDH2	-1	c.418	2016-05-18 19:53:42.594084	2016-05-18 20:39:18.770537	1	ENSG00000182054	missense
774	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh2/267\\"}}"	\N		15	90631935	90631935	G	A	DOID:9119	22422826	included	ENST00000330062	p.R140W	IDH2	-1	c.418	2016-05-18 19:53:42.616484	2016-05-18 20:39:18.817439	1	ENSG00000182054	missense
775	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/breast-cancer/her2/239/\\"}}"	\N		17	37868205	37868205	G	C	DOID:1612	19164557	included	ENST00000269571	p.G309A	ERBB2	1	c.926	2016-05-18 19:53:42.625582	2016-05-18 20:39:18.889977	1	ENSG00000141736	missense
776	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/breast-cancer/her2/239/\\"}}"	\N		17	37868205	37868205	G	C	DOID:1612	23714533	included	ENST00000269571	p.G309A	ERBB2	1	c.926	2016-05-18 19:53:42.650851	2016-05-18 20:39:18.964714	1	ENSG00000141736	missense
777	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/breast-cancer/her2/242/\\"}}"	\N		17	37880219	37880219	TTGAGGGAAAACACA	-	DOID:1612	23714533	included	ENST00000269571	p.L755X	ERBB2	1	c.2263	2016-05-18 19:53:42.659966	2016-05-18 20:39:19.039191	1	ENSG00000141736	frameshift
778	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/breast-cancer/her2/242/\\"}}"	\N		17	37880219	37880219	TTGAGGGAAAACACA	-	DOID:1612	19164557	included	ENST00000269571	p.L755X	ERBB2	1	c.2263	2016-05-18 19:53:42.671532	2016-05-18 20:39:19.082409	1	ENSG00000141736	frameshift
779	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/breast-cancer/her2/246/\\"}}"	\N		17	37880220	37880220	T	C	DOID:1612	19164557	included	ENST00000269571	p.L755S	ERBB2	1	c.2264	2016-05-18 19:53:42.685343	2016-05-18 20:39:19.146569	1	ENSG00000141736	missense
780	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/breast-cancer/her2/246/\\"}}"	\N		17	37880220	37880220	T	C	DOID:1612	23714533	included	ENST00000269571	p.L755S	ERBB2	1	c.2264	2016-05-18 19:53:42.694662	2016-05-18 20:39:19.205112	1	ENSG00000141736	missense
781	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/breast-cancer/her2/246/\\"}}"	\N		17	37880220	37880220	T	C	DOID:1612	24045550	included	ENST00000269571	p.L755S	ERBB2	1	c.2264	2016-05-18 19:53:42.716174	2016-05-18 20:39:19.242152	1	ENSG00000141736	missense
782	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/breast-cancer/her2/246/\\"}}"	\N		17	37880220	37880220	T	C	DOID:1612	18986703	included	ENST00000269571	p.L755S	ERBB2	1	c.2264	2016-05-18 19:53:42.724762	2016-05-18 20:39:19.293141	1	ENSG00000141736	missense
783	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/breast-cancer/her2/240\\"}}"	\N		17	37880261	37880261	G	C	DOID:1612	22504184	included	ENST00000269571	p.D769H	ERBB2	1	c.2305	2016-05-18 19:53:42.751691	2016-05-18 20:39:19.397895	1	ENSG00000141736	missense
784	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/breast-cancer/her2/241\\"}}"	\N		17	37880261	37880261	G	T	DOID:1612	23149070	included	ENST00000269571	p.D769Y	ERBB2	1	c.2305	2016-05-18 19:53:42.76081	2016-05-18 20:39:19.459033	1	ENSG00000141736	missense
785	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/breast-cancer/her2/247\\"}}"	\N		17	37881000	37881000	G	T	DOID:1612	23149070	included	ENST00000269571	p.V777L	ERBB2	1	c.2329	2016-05-18 19:53:42.793091	2016-05-18 20:39:19.528216	1	ENSG00000141736	missense
786	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/breast-cancer/her2/243/\\"}}"	\N		17	37881003	37881004	-	GGCTCCCCA	DOID:1612	22407852	included	ENST00000269571	p.G778GSPX	ERBB2	1	c.2332	2016-05-18 19:53:42.816953	2016-05-18 20:39:19.600177	1	ENSG00000141736	frameshift
787	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/breast-cancer/her2/243/\\"}}"	\N		17	37881003	37881004	-	GGCTCCCCA	DOID:1612	19075190	included	ENST00000269571	p.G778GSPX	ERBB2	1	c.2332	2016-05-18 19:53:42.826163	2016-05-18 20:39:19.672093	1	ENSG00000141736	frameshift
788	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/breast-cancer/her2/243/\\"}}"	\N		17	37881003	37881004	-	GGCTCCCCA	DOID:1612	16434492	included	ENST00000269571	p.G778GSPX	ERBB2	1	c.2332	2016-05-18 19:53:42.834952	2016-05-18 20:39:19.733052	1	ENSG00000141736	frameshift
789	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/breast-cancer/her2/243/\\"}}"	\N		17	37881003	37881004	-	GGCTCCCCA	DOID:1612	2278970	included	ENST00000269571	p.G778GSPX	ERBB2	1	c.2332	2016-05-18 19:53:42.844298	2016-05-18 20:39:19.807193	1	ENSG00000141736	frameshift
790	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/breast-cancer/her2/243/\\"}}"	\N		17	37881003	37881004	-	GGCTCCCCA	DOID:1612	3122217	included	ENST00000269571	p.G778GSPX	ERBB2	1	c.2332	2016-05-18 19:53:42.854454	2016-05-18 20:39:19.866437	1	ENSG00000141736	frameshift
791	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/breast-cancer/her2/244\\"}}"	\N		17	37881332	37881332	G	A	DOID:1612	22407852	included	ENST00000269571	p.V842I	ERBB2	1	c.2524	2016-05-18 19:53:42.86395	2016-05-18 20:39:19.94728	1	ENSG00000141736	missense
792	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/breast-cancer/her2/244\\"}}"	\N		17	37881332	37881332	G	A	DOID:1612	19075190	included	ENST00000269571	p.V842I	ERBB2	1	c.2524	2016-05-18 19:53:42.873899	2016-05-18 20:39:19.995935	1	ENSG00000141736	missense
793	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/breast-cancer/her2/244\\"}}"	\N		17	37881332	37881332	G	A	DOID:1612	16434492	included	ENST00000269571	p.V842I	ERBB2	1	c.2524	2016-05-18 19:53:42.884725	2016-05-18 20:39:20.051555	1	ENSG00000141736	missense
794	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/breast-cancer/her2/244\\"}}"	\N		17	37881332	37881332	G	A	DOID:1612	2278970	included	ENST00000269571	p.V842I	ERBB2	1	c.2524	2016-05-18 19:53:42.894094	2016-05-18 20:39:20.093659	1	ENSG00000141736	missense
795	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/breast-cancer/her2/244\\"}}"	\N		17	37881332	37881332	G	A	DOID:1612	3122217	included	ENST00000269571	p.V842I	ERBB2	1	c.2524	2016-05-18 19:53:42.903427	2016-05-18 20:39:20.157887	1	ENSG00000141736	missense
796	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/breast-cancer/her2/245\\"}}"	\N		17	37881616	37881616	C	T	DOID:1612	22407852	included	ENST00000269571	p.R896C	ERBB2	1	c.2686	2016-05-18 19:53:42.912625	2016-05-18 20:39:20.229822	1	ENSG00000141736	missense
797	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/breast-cancer/her2/245\\"}}"	\N		17	37881616	37881616	C	T	DOID:1612	19075190	included	ENST00000269571	p.R896C	ERBB2	1	c.2686	2016-05-18 19:53:42.92468	2016-05-18 20:39:20.280108	1	ENSG00000141736	missense
798	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/breast-cancer/her2/245\\"}}"	\N		17	37881616	37881616	C	T	DOID:1612	16434492	included	ENST00000269571	p.R896C	ERBB2	1	c.2686	2016-05-18 19:53:42.942121	2016-05-18 20:39:20.332904	1	ENSG00000141736	missense
799	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/breast-cancer/her2/245\\"}}"	\N		17	37881616	37881616	C	T	DOID:1612	2278970	included	ENST00000269571	p.R896C	ERBB2	1	c.2686	2016-05-18 19:53:42.954486	2016-05-18 20:39:20.381217	1	ENSG00000141736	missense
800	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/breast-cancer/her2/245\\"}}"	\N		17	37881616	37881616	C	T	DOID:1612	3122217	included	ENST00000269571	p.R896C	ERBB2	1	c.2686	2016-05-18 19:53:42.963846	2016-05-18 20:39:20.440002	1	ENSG00000141736	missense
801	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/151\\"}}"	\N		18	48591826	48591826	A	C	DOID:9256	22407852	included	ENST00000342988	p.E330A	SMAD4	1	c.989	2016-05-18 19:53:42.974249	2016-05-18 20:39:20.516557	1	ENSG00000141646	missense
802	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/151\\"}}"	\N		18	48591826	48591826	A	C	DOID:9256	19075190	included	ENST00000342988	p.E330A	SMAD4	1	c.989	2016-05-18 19:53:42.988277	2016-05-18 20:39:20.569307	1	ENSG00000141646	missense
803	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/151\\"}}"	\N		18	48591826	48591826	A	C	DOID:9256	16434492	included	ENST00000342988	p.E330A	SMAD4	1	c.989	2016-05-18 19:53:42.997759	2016-05-18 20:39:20.610709	1	ENSG00000141646	missense
804	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/151\\"}}"	\N		18	48591826	48591826	A	C	DOID:9256	2278970	included	ENST00000342988	p.E330A	SMAD4	1	c.989	2016-05-18 19:53:43.00787	2016-05-18 20:39:20.651453	1	ENSG00000141646	missense
805	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/151\\"}}"	\N		18	48591826	48591826	A	C	DOID:9256	3122217	included	ENST00000342988	p.E330A	SMAD4	1	c.989	2016-05-18 19:53:43.02621	2016-05-18 20:39:20.711141	1	ENSG00000141646	missense
806	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/154\\"}}"	\N		18	48591888	48591888	G	A	DOID:9256	19657110	included	ENST00000342988	p.D351N	SMAD4	1	c.1051	2016-05-18 19:53:43.03577	2016-05-18 20:39:20.777461	1	ENSG00000141646	missense
807	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/152\\"}}"	\N		18	48591888	48591888	G	C	DOID:9256	19657110	included	ENST00000342988	p.D351H	SMAD4	1	c.1051	2016-05-18 19:53:43.056574	2016-05-18 20:39:20.846459	1	ENSG00000141646	missense
808	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/155\\"}}"	\N		18	48591902	48591902	C	A	DOID:9256	19657110	included	ENST00000342988	p.D355E	SMAD4	1	c.1065	2016-05-18 19:53:43.066092	2016-05-18 20:39:20.913294	1	ENSG00000141646	missense
809	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/156\\"}}"	\N		18	48591918	48591918	C	A	DOID:9256	19657110	included	ENST00000342988	p.R361S	SMAD4	1	c.1081	2016-05-18 19:53:43.086722	2016-05-18 20:39:20.981631	1	ENSG00000141646	missense
811	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/157\\"}}"	\N		18	48591918	48591918	C	T	DOID:9256	22407852	included	ENST00000342988	p.R361C	SMAD4	1	c.1081	2016-05-18 19:53:43.105306	2016-05-18 20:39:21.097819	1	ENSG00000141646	missense
812	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/157\\"}}"	\N		18	48591918	48591918	C	T	DOID:9256	19075190	included	ENST00000342988	p.R361C	SMAD4	1	c.1081	2016-05-18 19:53:43.116996	2016-05-18 20:39:21.14525	1	ENSG00000141646	missense
813	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/157\\"}}"	\N		18	48591918	48591918	C	T	DOID:9256	16434492	included	ENST00000342988	p.R361C	SMAD4	1	c.1081	2016-05-18 19:53:43.126108	2016-05-18 20:39:21.236776	1	ENSG00000141646	missense
814	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/157\\"}}"	\N		18	48591918	48591918	C	T	DOID:9256	2278970	included	ENST00000342988	p.R361C	SMAD4	1	c.1081	2016-05-18 19:53:43.135764	2016-05-18 20:39:21.276616	1	ENSG00000141646	missense
815	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/157\\"}}"	\N		18	48591918	48591918	C	T	DOID:9256	3122217	included	ENST00000342988	p.R361C	SMAD4	1	c.1081	2016-05-18 19:53:43.144996	2016-05-18 20:39:21.341143	1	ENSG00000141646	missense
816	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/158\\"}}"	\N		18	48591919	48591919	G	A	DOID:9256	19657110	included	ENST00000342988	p.R361H	SMAD4	1	c.1082	2016-05-18 19:53:43.158604	2016-05-18 20:39:21.417294	1	ENSG00000141646	missense
817	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/158\\"}}"	\N		18	48591919	48591919	G	A	DOID:9256	22407852	included	ENST00000342988	p.R361H	SMAD4	1	c.1082	2016-05-18 19:53:43.16696	2016-05-18 20:39:21.471831	1	ENSG00000141646	missense
818	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/158\\"}}"	\N		18	48591919	48591919	G	A	DOID:9256	19075190	included	ENST00000342988	p.R361H	SMAD4	1	c.1082	2016-05-18 19:53:43.17621	2016-05-18 20:39:21.537236	1	ENSG00000141646	missense
819	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/158\\"}}"	\N		18	48591919	48591919	G	A	DOID:9256	16434492	included	ENST00000342988	p.R361H	SMAD4	1	c.1082	2016-05-18 19:53:43.187283	2016-05-18 20:39:21.597027	1	ENSG00000141646	missense
820	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/158\\"}}"	\N		18	48591919	48591919	G	A	DOID:9256	2278970	included	ENST00000342988	p.R361H	SMAD4	1	c.1082	2016-05-18 19:53:43.196676	2016-05-18 20:39:21.642868	1	ENSG00000141646	missense
821	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/158\\"}}"	\N		18	48591919	48591919	G	A	DOID:9256	3122217	included	ENST00000342988	p.R361H	SMAD4	1	c.1082	2016-05-18 19:53:43.205932	2016-05-18 20:39:21.687815	1	ENSG00000141646	missense
822	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/153\\"}}"	\N		18	48604787	48604787	G	T	DOID:9256	19657110	included	ENST00000342988	p.D537Y	SMAD4	1	c.1609	2016-05-18 19:53:43.22059	2016-05-18 20:39:21.758514	1	ENSG00000141646	missense
823	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/gna11/101\\"}}"	\N		19	3118942	3118942	A	C	DOID:1909	10508512	included	ENST00000078429	p.Q209P	GNA11	1	c.626	2016-05-18 19:53:43.230305	2016-05-18 20:39:21.836615	1	ENSG00000088256	missense
824	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/gna11/99\\"}}"	\N		19	3118942	3118942	A	T	DOID:1909	24659740	included	ENST00000078429	p.Q209L	GNA11	1	c.626	2016-05-18 19:53:43.240678	2016-05-18 20:39:21.893507	1	ENSG00000088256	missense
1458	\N	\N		12	25380275	25380275	T	A	DOID:9119	19903786	included	ENST00000256078	p.Q61H	KRAS	-1	c.183	2016-05-18 20:26:15.063672	2016-05-18 20:40:00.175076	2	ENSG00000133703	missense
825	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/gna11/99\\"}}"	\N		19	3118942	3118942	A	T	DOID:1909	24616160	included	ENST00000078429	p.Q209L	GNA11	1	c.626	2016-05-18 19:53:43.256092	2016-05-18 20:39:21.945944	1	ENSG00000088256	missense
826	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/gna11/99\\"}}"	\N		19	3118942	3118942	A	T	DOID:1909	24374719	included	ENST00000078429	p.Q209L	GNA11	1	c.626	2016-05-18 19:53:43.265423	2016-05-18 20:39:22.007284	1	ENSG00000088256	missense
827	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh1/264\\"}}"	\N		2	209113112	209113112	C	A	DOID:9119	23634996	included	ENST00000345146	p.R132L	IDH1	-1	c.395	2016-05-18 19:53:43.276247	2016-05-18 20:39:22.103419	1	ENSG00000138413	missense
828	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh1/265\\"}}"	\N		2	209113112	209113112	C	G	DOID:9119	23634996	included	ENST00000345146	p.R132P	IDH1	-1	c.395	2016-05-18 19:53:43.290395	2016-05-18 20:39:22.178265	1	ENSG00000138413	missense
829	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh1/263\\"}}"	\N		2	209113112	209113112	C	T	DOID:9119	23634996	included	ENST00000345146	p.R132H	IDH1	-1	c.395	2016-05-18 19:53:43.299173	2016-05-18 20:39:22.239331	1	ENSG00000138413	missense
830	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh1/260\\"}}"	\N		2	209113113	209113113	G	A	DOID:9119	24641375	included	ENST00000345146	p.R132C	IDH1	-1	c.394	2016-05-18 19:53:43.318701	2016-05-18 20:39:22.302177	1	ENSG00000138413	missense
831	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh1/260\\"}}"	\N		2	209113113	209113113	G	A	DOID:9119	24487413	included	ENST00000345146	p.R132C	IDH1	-1	c.394	2016-05-18 19:53:43.32762	2016-05-18 20:39:22.35039	1	ENSG00000138413	missense
832	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh1/260\\"}}"	\N		2	209113113	209113113	G	A	DOID:9119	24381225	included	ENST00000345146	p.R132C	IDH1	-1	c.394	2016-05-18 19:53:43.336256	2016-05-18 20:39:22.400694	1	ENSG00000138413	missense
833	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh1/261\\"}}"	\N		2	209113113	209113113	G	C	DOID:9119	24641375	included	ENST00000345146	p.R132G	IDH1	-1	c.394	2016-05-18 19:53:43.345425	2016-05-18 20:39:22.465625	1	ENSG00000138413	missense
834	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh1/261\\"}}"	\N		2	209113113	209113113	G	C	DOID:9119	24487413	included	ENST00000345146	p.R132G	IDH1	-1	c.394	2016-05-18 19:53:43.355809	2016-05-18 20:39:22.524607	1	ENSG00000138413	missense
835	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh1/261\\"}}"	\N		2	209113113	209113113	G	C	DOID:9119	24381225	included	ENST00000345146	p.R132G	IDH1	-1	c.394	2016-05-18 19:53:43.364657	2016-05-18 20:39:22.572854	1	ENSG00000138413	missense
836	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh1/262\\"}}"	\N		2	209113113	209113113	G	T	DOID:9119	24641375	included	ENST00000345146	p.R132S	IDH1	-1	c.394	2016-05-18 19:53:43.374344	2016-05-18 20:39:22.636973	1	ENSG00000138413	missense
837	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh1/262\\"}}"	\N		2	209113113	209113113	G	T	DOID:9119	24487413	included	ENST00000345146	p.R132S	IDH1	-1	c.394	2016-05-18 19:53:43.385456	2016-05-18 20:39:22.681932	1	ENSG00000138413	missense
838	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh1/262\\"}}"	\N		2	209113113	209113113	G	T	DOID:9119	24381225	included	ENST00000345146	p.R132S	IDH1	-1	c.394	2016-05-18 19:53:43.394311	2016-05-18 20:39:22.73627	1	ENSG00000138413	missense
839	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/dnmt3a/296\\"}}"	\N		2	25457242	25457242	C	A	DOID:9119	24641375	included	ENST00000264709	p.R882L	DNMT3A	-1	c.2645	2016-05-18 19:53:43.404434	2016-05-18 20:39:22.800451	1	ENSG00000119772	missense
840	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/dnmt3a/296\\"}}"	\N		2	25457242	25457242	C	A	DOID:9119	24487413	included	ENST00000264709	p.R882L	DNMT3A	-1	c.2645	2016-05-18 19:53:43.41561	2016-05-18 20:39:22.84676	1	ENSG00000119772	missense
841	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/dnmt3a/296\\"}}"	\N		2	25457242	25457242	C	A	DOID:9119	24381225	included	ENST00000264709	p.R882L	DNMT3A	-1	c.2645	2016-05-18 19:53:43.424345	2016-05-18 20:39:22.906659	1	ENSG00000119772	missense
842	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/dnmt3a/294\\"}}"	\N		2	25457242	25457242	C	G	DOID:9119	24641375	included	ENST00000264709	p.R882P	DNMT3A	-1	c.2645	2016-05-18 19:53:43.432956	2016-05-18 20:39:22.971796	1	ENSG00000119772	missense
843	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/dnmt3a/294\\"}}"	\N		2	25457242	25457242	C	G	DOID:9119	24487413	included	ENST00000264709	p.R882P	DNMT3A	-1	c.2645	2016-05-18 19:53:43.442094	2016-05-18 20:39:23.024372	1	ENSG00000119772	missense
844	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/dnmt3a/294\\"}}"	\N		2	25457242	25457242	C	G	DOID:9119	24381225	included	ENST00000264709	p.R882P	DNMT3A	-1	c.2645	2016-05-18 19:53:43.452818	2016-05-18 20:39:23.077727	1	ENSG00000119772	missense
845	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/dnmt3a/293\\"}}"	\N		2	25457242	25457242	C	T	DOID:9119	24641375	included	ENST00000264709	p.R882H	DNMT3A	-1	c.2645	2016-05-18 19:53:43.461687	2016-05-18 20:39:23.138277	1	ENSG00000119772	missense
846	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/dnmt3a/293\\"}}"	\N		2	25457242	25457242	C	T	DOID:9119	24487413	included	ENST00000264709	p.R882H	DNMT3A	-1	c.2645	2016-05-18 19:53:43.471183	2016-05-18 20:39:23.184107	1	ENSG00000119772	missense
847	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/dnmt3a/293\\"}}"	\N		2	25457242	25457242	C	T	DOID:9119	24381225	included	ENST00000264709	p.R882H	DNMT3A	-1	c.2645	2016-05-18 19:53:43.483302	2016-05-18 20:39:23.242338	1	ENSG00000119772	missense
848	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/dnmt3a/291\\"}}"	\N		2	25457243	25457243	G	A	DOID:9119	24641375	included	ENST00000264709	p.R882C	DNMT3A	-1	c.2644	2016-05-18 19:53:43.49172	2016-05-18 20:39:23.308151	1	ENSG00000119772	missense
849	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/dnmt3a/291\\"}}"	\N		2	25457243	25457243	G	A	DOID:9119	24487413	included	ENST00000264709	p.R882C	DNMT3A	-1	c.2644	2016-05-18 19:53:43.499818	2016-05-18 20:39:23.353108	1	ENSG00000119772	missense
985	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/kit/132\\"}}"	\N		4	55592186	55592186	T	C	DOID:1909	22277784	included	ENST00000288135	p.F504L	KIT	1	c.1510	2016-05-18 19:53:45.720393	2016-05-18 20:39:31.677266	1	ENSG00000157404	missense
850	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/dnmt3a/291\\"}}"	\N		2	25457243	25457243	G	A	DOID:9119	24381225	included	ENST00000264709	p.R882C	DNMT3A	-1	c.2644	2016-05-18 19:53:43.509934	2016-05-18 20:39:23.408523	1	ENSG00000119772	missense
851	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/dnmt3a/295\\"}}"	\N		2	25457243	25457243	G	C	DOID:9119	24641375	included	ENST00000264709	p.R882G	DNMT3A	-1	c.2644	2016-05-18 19:53:43.523326	2016-05-18 20:39:23.469991	1	ENSG00000119772	missense
852	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/dnmt3a/295\\"}}"	\N		2	25457243	25457243	G	C	DOID:9119	24487413	included	ENST00000264709	p.R882G	DNMT3A	-1	c.2644	2016-05-18 19:53:43.530959	2016-05-18 20:39:23.517385	1	ENSG00000119772	missense
853	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/dnmt3a/295\\"}}"	\N		2	25457243	25457243	G	C	DOID:9119	24381225	included	ENST00000264709	p.R882G	DNMT3A	-1	c.2644	2016-05-18 19:53:43.53972	2016-05-18 20:39:23.568205	1	ENSG00000119772	missense
854	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/dnmt3a/292\\"}}"	\N		2	25457243	25457243	G	T	DOID:9119	22158538	included	ENST00000264709	p.R882S	DNMT3A	-1	c.2644	2016-05-18 19:53:43.547529	2016-05-18 20:39:23.645567	1	ENSG00000119772	missense
855	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/neuroblastoma/alk/184\\"}}"	\N		2	29432655	29432655	T	G	DOID:769	22158538	included	ENST00000389048	p.Y1278S	ALK	-1	c.3833	2016-05-18 19:53:43.554282	2016-05-18 20:39:23.722849	1	ENSG00000171094	missense
856	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/neuroblastoma/alk/183\\"}}"	\N		2	29432664	29432664	C	T	DOID:769	22158538	included	ENST00000389048	p.R1275Q	ALK	-1	c.3824	2016-05-18 19:53:43.562311	2016-05-18 20:39:23.788576	1	ENSG00000171094	missense
857	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/neuroblastoma/alk/183\\"}}"	\N		2	29432664	29432664	C	T	DOID:769	24498085	included	ENST00000389048	p.R1275Q	ALK	-1	c.3824	2016-05-18 19:53:43.569461	2016-05-18 20:39:23.842822	1	ENSG00000171094	missense
858	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/neuroblastoma/alk/181\\"}}"	\N		2	29436858	29436858	G	C	DOID:769	22158538	included	ENST00000389048	p.F1245L	ALK	-1	c.3735	2016-05-18 19:53:43.580158	2016-05-18 20:39:23.91255	1	ENSG00000171094	missense
859	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/neuroblastoma/alk/181\\"}}"	\N		2	29436858	29436858	G	C	DOID:769	24498085	included	ENST00000389048	p.F1245L	ALK	-1	c.3735	2016-05-18 19:53:43.588255	2016-05-18 20:39:23.969184	1	ENSG00000171094	missense
860	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/neuroblastoma/alk/180\\"}}"	\N		2	29436859	29436859	A	C	DOID:769	24659740	included	ENST00000389048	p.F1245C	ALK	-1	c.3734	2016-05-18 19:53:43.596974	2016-05-18 20:39:24.038093	1	ENSG00000171094	missense
861	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/neuroblastoma/alk/180\\"}}"	\N		2	29436859	29436859	A	C	DOID:769	24671364	included	ENST00000389048	p.F1245C	ALK	-1	c.3734	2016-05-18 19:53:43.605251	2016-05-18 20:39:24.091403	1	ENSG00000171094	missense
862	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/neuroblastoma/alk/180\\"}}"	\N		2	29436859	29436859	A	C	DOID:769	24667279	included	ENST00000389048	p.F1245C	ALK	-1	c.3734	2016-05-18 19:53:43.612398	2016-05-18 20:39:24.142576	1	ENSG00000171094	missense
863	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/neuroblastoma/alk/180\\"}}"	\N		2	29436859	29436859	A	C	DOID:769	24521058	included	ENST00000389048	p.F1245C	ALK	-1	c.3734	2016-05-18 19:53:43.622353	2016-05-18 20:39:24.194507	1	ENSG00000171094	missense
864	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/neuroblastoma/alk/180\\"}}"	\N		2	29436859	29436859	A	C	DOID:769	24422723	included	ENST00000389048	p.F1245C	ALK	-1	c.3734	2016-05-18 19:53:43.631429	2016-05-18 20:39:24.243925	1	ENSG00000171094	missense
865	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/neuroblastoma/alk/180\\"}}"	\N		2	29436859	29436859	A	C	DOID:769	24374862	included	ENST00000389048	p.F1245C	ALK	-1	c.3734	2016-05-18 19:53:43.656932	2016-05-18 20:39:24.301198	1	ENSG00000171094	missense
866	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/neuroblastoma/alk/182\\"}}"	\N		2	29436860	29436860	A	C	DOID:769	16239216	included	ENST00000389048	p.F1245V	ALK	-1	c.3733	2016-05-18 19:53:43.665481	2016-05-18 20:39:24.380099	1	ENSG00000171094	missense
867	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/rhabdomyosarcoma/alk/187\\"}}"	\N		2	29436920	29436920	C	T	DOID:3247	18397343	included	ENST00000389048	p.D1225N	ALK	-1	c.3673	2016-05-18 19:53:43.692393	2016-05-18 20:39:24.448056	1	ENSG00000171094	missense
868	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/neuroblastoma/alk/178\\"}}"	\N		2	29443695	29443695	G	T	DOID:769	18397343	included	ENST00000389048	p.F1174L	ALK	-1	c.3522	2016-05-18 19:53:43.701141	2016-05-18 20:39:24.514434	1	ENSG00000171094	missense
869	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/neuroblastoma/alk/176\\"}}"	\N		2	29443696	29443696	A	C	DOID:769	18397343	included	ENST00000389048	p.F1174C	ALK	-1	c.3521	2016-05-18 19:53:43.724077	2016-05-18 20:39:24.582058	1	ENSG00000171094	missense
870	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/neuroblastoma/alk/179\\"}}"	\N		2	29443697	29443697	A	C	DOID:769	18397343	included	ENST00000389048	p.F1174V	ALK	-1	c.3520	2016-05-18 19:53:43.732652	2016-05-18 20:39:24.650015	1	ENSG00000171094	missense
871	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/neuroblastoma/alk/177\\"}}"	\N		2	29443697	29443697	A	T	DOID:769	23676790	included	ENST00000389048	p.F1174I	ALK	-1	c.3520	2016-05-18 19:53:43.760063	2016-05-18 20:39:24.728882	1	ENSG00000171094	missense
872	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/neuroblastoma/alk/177\\"}}"	\N		2	29443697	29443697	A	T	DOID:769	21895409	included	ENST00000389048	p.F1174I	ALK	-1	c.3520	2016-05-18 19:53:43.768978	2016-05-18 20:39:24.788183	1	ENSG00000171094	missense
873	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/neuroblastoma/alk/177\\"}}"	\N		2	29443697	29443697	A	T	DOID:769	21888027	included	ENST00000389048	p.F1174I	ALK	-1	c.3520	2016-05-18 19:53:43.791189	2016-05-18 20:39:24.841507	1	ENSG00000171094	missense
874	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/neuroblastoma/alk/177\\"}}"	\N		2	29443697	29443697	A	T	DOID:769	20367437	included	ENST00000389048	p.F1174I	ALK	-1	c.3520	2016-05-18 19:53:43.800178	2016-05-18 20:39:24.902647	1	ENSG00000171094	missense
875	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/neuroblastoma/alk/177\\"}}"	\N		2	29443697	29443697	A	T	DOID:769	18223278	included	ENST00000389048	p.F1174I	ALK	-1	c.3520	2016-05-18 19:53:43.826232	2016-05-18 20:39:24.949856	1	ENSG00000171094	missense
1422	\N	\N		1	115258748	115258748	C	A	DOID:9119	21129611	included	ENST00000369535	p.G12C	NRAS	-1	c.34	2016-05-18 20:26:14.619035	2016-05-18 20:39:58.381004	2	ENSG00000213281	missense
876	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/neuroblastoma/alk/177\\"}}"	\N		2	29443697	29443697	A	T	DOID:769	12623848	included	ENST00000389048	p.F1174I	ALK	-1	c.3520	2016-05-18 19:53:43.83494	2016-05-18 20:39:24.998845	1	ENSG00000171094	missense
877	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/neuroblastoma/alk/177\\"}}"	\N		2	29443697	29443697	A	T	DOID:769	12576318	included	ENST00000389048	p.F1174I	ALK	-1	c.3520	2016-05-18 19:53:43.858589	2016-05-18 20:39:25.056371	1	ENSG00000171094	missense
878	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/neuroblastoma/alk/177\\"}}"	\N		2	29443697	29443697	A	T	DOID:769	12399961	included	ENST00000389048	p.F1174I	ALK	-1	c.3520	2016-05-18 19:53:43.866613	2016-05-18 20:39:25.105273	1	ENSG00000171094	missense
879	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/neuroblastoma/alk/177\\"}}"	\N		2	29443697	29443697	A	T	DOID:769	25157968	included	ENST00000389048	p.F1174I	ALK	-1	c.3520	2016-05-18 19:53:43.87582	2016-05-18 20:39:25.156125	1	ENSG00000171094	missense
880	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/neuroblastoma/alk/175\\"}}"	\N		2	29445213	29445213	A	T	DOID:769	17008892	included	ENST00000389048	p.I1171N	ALK	-1	c.3512	2016-05-18 19:53:43.898708	2016-05-18 20:39:25.229824	1	ENSG00000171094	missense
881	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/neuroblastoma/alk/175\\"}}"	\N		2	29445213	29445213	A	T	DOID:769	21221851	included	ENST00000389048	p.I1171N	ALK	-1	c.3512	2016-05-18 19:53:43.908427	2016-05-18 20:39:25.293012	1	ENSG00000171094	missense
882	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/neuroblastoma/alk/175\\"}}"	\N		2	29445213	29445213	A	T	DOID:769	18354488	included	ENST00000389048	p.I1171N	ALK	-1	c.3512	2016-05-18 19:53:43.931222	2016-05-18 20:39:25.367946	1	ENSG00000171094	missense
883	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/neuroblastoma/alk/175\\"}}"	\N		2	29445213	29445213	A	T	DOID:769	12623848	included	ENST00000389048	p.I1171N	ALK	-1	c.3512	2016-05-18 19:53:43.940322	2016-05-18 20:39:25.425825	1	ENSG00000171094	missense
884	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/neuroblastoma/alk/175\\"}}"	\N		2	29445213	29445213	A	T	DOID:769	20367437	included	ENST00000389048	p.I1171N	ALK	-1	c.3512	2016-05-18 19:53:43.96156	2016-05-18 20:39:25.494799	1	ENSG00000171094	missense
885	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/neuroblastoma/alk/175\\"}}"	\N		2	29445213	29445213	A	T	DOID:769	25157968	included	ENST00000389048	p.I1171N	ALK	-1	c.3512	2016-05-18 19:53:43.970289	2016-05-18 20:39:25.560116	1	ENSG00000171094	missense
886	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/neuroblastoma/alk/174\\"}}"	\N		2	29445273	29445273	G	A	DOID:769	21505103	included	ENST00000389048	p.T1151M	ALK	-1	c.3452	2016-05-18 19:53:44.0018	2016-05-18 20:39:25.629652	1	ENSG00000171094	missense
887	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/neuroblastoma/alk/174\\"}}"	\N		2	29445273	29445273	G	A	DOID:769	11964322	included	ENST00000389048	p.T1151M	ALK	-1	c.3452	2016-05-18 19:53:44.012397	2016-05-18 20:39:25.691926	1	ENSG00000171094	missense
888	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/neuroblastoma/alk/174\\"}}"	\N		2	29445273	29445273	G	A	DOID:769	12623848	included	ENST00000389048	p.T1151M	ALK	-1	c.3452	2016-05-18 19:53:44.033172	2016-05-18 20:39:25.741749	1	ENSG00000171094	missense
890	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/neuroblastoma/alk/174\\"}}"	\N		2	29445273	29445273	G	A	DOID:769	21895409	included	ENST00000389048	p.T1151M	ALK	-1	c.3452	2016-05-18 19:53:44.06228	2016-05-18 20:39:25.849986	1	ENSG00000171094	missense
891	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/neuroblastoma/alk/174\\"}}"	\N		2	29445273	29445273	G	A	DOID:769	22870928	included	ENST00000389048	p.T1151M	ALK	-1	c.3452	2016-05-18 19:53:44.070556	2016-05-18 20:39:25.897583	1	ENSG00000171094	missense
892	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/neuroblastoma/alk/174\\"}}"	\N		2	29445273	29445273	G	A	DOID:769	23676790	included	ENST00000389048	p.T1151M	ALK	-1	c.3452	2016-05-18 19:53:44.080182	2016-05-18 20:39:25.966648	1	ENSG00000171094	missense
893	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/neuroblastoma/alk/174\\"}}"	\N		2	29445273	29445273	G	A	DOID:769	25157968	included	ENST00000389048	p.T1151M	ALK	-1	c.3452	2016-05-18 19:53:44.095713	2016-05-18 20:39:26.031809	1	ENSG00000171094	missense
894	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/neuroblastoma/alk/173\\"}}"	\N		2	29446296	29446296	C	T	DOID:769	15256422	included	ENST00000389048	p.D1091N	ALK	-1	c.3271	2016-05-18 19:53:44.104844	2016-05-18 20:39:26.124962	1	ENSG00000171094	missense
895	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/neuroblastoma/alk/173\\"}}"	\N		2	29446296	29446296	C	T	DOID:769	24109527	included	ENST00000389048	p.D1091N	ALK	-1	c.3271	2016-05-18 19:53:44.134483	2016-05-18 20:39:26.189077	1	ENSG00000171094	missense
896	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/neuroblastoma/alk/173\\"}}"	\N		2	29446296	29446296	C	T	DOID:769	20367437	included	ENST00000389048	p.D1091N	ALK	-1	c.3271	2016-05-18 19:53:44.144409	2016-05-18 20:39:26.238519	1	ENSG00000171094	missense
897	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/neuroblastoma/alk/173\\"}}"	\N		2	29446296	29446296	C	T	DOID:769	12623848	included	ENST00000389048	p.D1091N	ALK	-1	c.3271	2016-05-18 19:53:44.163958	2016-05-18 20:39:26.304785	1	ENSG00000171094	missense
898	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/neuroblastoma/alk/173\\"}}"	\N		2	29446296	29446296	C	T	DOID:769	12399961	included	ENST00000389048	p.D1091N	ALK	-1	c.3271	2016-05-18 19:53:44.172821	2016-05-18 20:39:26.353659	1	ENSG00000171094	missense
899	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/neuroblastoma/alk/173\\"}}"	\N		2	29446296	29446296	C	T	DOID:769	25157968	included	ENST00000389048	p.D1091N	ALK	-1	c.3271	2016-05-18 19:53:44.201056	2016-05-18 20:39:26.406618	1	ENSG00000171094	missense
900	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/7\\"}}"	\N		3	178936082	178936082	G	A	DOID:1612	23676790	included	ENST00000263967	p.E542K	PIK3CA	1	c.1624	2016-05-18 19:53:44.225015	2016-05-18 20:39:26.505241	1	ENSG00000121879	missense
901	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/7\\"}}"	\N		3	178936082	178936082	G	A	DOID:1612	12623848	included	ENST00000263967	p.E542K	PIK3CA	1	c.1624	2016-05-18 19:53:44.23312	2016-05-18 20:39:26.570027	1	ENSG00000121879	missense
902	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/7\\"}}"	\N		3	178936082	178936082	G	A	DOID:1612	21895409	included	ENST00000263967	p.E542K	PIK3CA	1	c.1624	2016-05-18 19:53:44.264464	2016-05-18 20:39:26.651418	1	ENSG00000121879	missense
903	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/7\\"}}"	\N		3	178936082	178936082	G	A	DOID:1612	20367437	included	ENST00000263967	p.E542K	PIK3CA	1	c.1624	2016-05-18 19:53:44.282008	2016-05-18 20:39:26.735138	1	ENSG00000121879	missense
904	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/7\\"}}"	\N		3	178936082	178936082	G	A	DOID:1612	14745431	included	ENST00000263967	p.E542K	PIK3CA	1	c.1624	2016-05-18 19:53:44.29543	2016-05-18 20:39:26.815815	1	ENSG00000121879	missense
905	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/7\\"}}"	\N		3	178936082	178936082	G	A	DOID:1612	21562040	included	ENST00000263967	p.E542K	PIK3CA	1	c.1624	2016-05-18 19:53:44.304266	2016-05-18 20:39:26.897615	1	ENSG00000121879	missense
906	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/7\\"}}"	\N		3	178936082	178936082	G	A	DOID:1612	25152116	included	ENST00000263967	p.E542K	PIK3CA	1	c.1624	2016-05-18 19:53:44.327593	2016-05-18 20:39:26.964779	1	ENSG00000121879	missense
907	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/7\\"}}"	\N		3	178936082	178936082	G	A	DOID:1612	19768693	included	ENST00000263967	p.E542K	PIK3CA	1	c.1624	2016-05-18 19:53:44.336457	2016-05-18 20:39:27.063072	1	ENSG00000121879	missense
908	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/7\\"}}"	\N		3	178936082	178936082	G	A	DOID:1612	23575252	included	ENST00000263967	p.E542K	PIK3CA	1	c.1624	2016-05-18 19:53:44.364968	2016-05-18 20:39:27.134574	1	ENSG00000121879	missense
909	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/7\\"}}"	\N		3	178936082	178936082	G	A	DOID:1612	25157968	included	ENST00000263967	p.E542K	PIK3CA	1	c.1624	2016-05-18 19:53:44.374408	2016-05-18 20:39:27.196055	1	ENSG00000121879	missense
910	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/ovarian-cancer/pik3ca/7\\"}}"	\N		3	178936082	178936082	G	A	DOID:2394	21489624	included	ENST00000263967	p.E542K	PIK3CA	1	c.1624	2016-05-18 19:53:44.395884	2016-05-18 20:39:27.269974	1	ENSG00000121879	missense
911	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/ovarian-cancer/pik3ca/7\\"}}"	\N		3	178936082	178936082	G	A	DOID:2394	23676790	included	ENST00000263967	p.E542K	PIK3CA	1	c.1624	2016-05-18 19:53:44.40457	2016-05-18 20:39:27.331554	1	ENSG00000121879	missense
912	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/ovarian-cancer/pik3ca/7\\"}}"	\N		3	178936082	178936082	G	A	DOID:2394	19811824	included	ENST00000263967	p.E542K	PIK3CA	1	c.1624	2016-05-18 19:53:44.427365	2016-05-18 20:39:27.403038	1	ENSG00000121879	missense
913	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/ovarian-cancer/pik3ca/7\\"}}"	\N		3	178936082	178936082	G	A	DOID:2394	14745431	included	ENST00000263967	p.E542K	PIK3CA	1	c.1624	2016-05-18 19:53:44.435701	2016-05-18 20:39:27.46909	1	ENSG00000121879	missense
914	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/ovarian-cancer/pik3ca/7\\"}}"	\N		3	178936082	178936082	G	A	DOID:2394	12623848	included	ENST00000263967	p.E542K	PIK3CA	1	c.1624	2016-05-18 19:53:44.469742	2016-05-18 20:39:27.532667	1	ENSG00000121879	missense
915	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/ovarian-cancer/pik3ca/7\\"}}"	\N		3	178936082	178936082	G	A	DOID:2394	12399961	included	ENST00000263967	p.E542K	PIK3CA	1	c.1624	2016-05-18 19:53:44.478626	2016-05-18 20:39:27.593641	1	ENSG00000121879	missense
916	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/ovarian-cancer/pik3ca/7\\"}}"	\N		3	178936082	178936082	G	A	DOID:2394	25157968	included	ENST00000263967	p.E542K	PIK3CA	1	c.1624	2016-05-18 19:53:44.500265	2016-05-18 20:39:27.656514	1	ENSG00000121879	missense
917	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/lung-cancer/pik3ca/7\\"}}"	\N		3	178936082	178936082	G	A	DOID:3908	21562040	included	ENST00000263967	p.E542K	PIK3CA	1	c.1624	2016-05-18 19:53:44.509403	2016-05-18 20:39:27.711244	1	ENSG00000121879	missense
918	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/7\\"}}"	\N		3	178936082	178936082	G	A	DOID:9256	21562040	included	ENST00000263967	p.E542K	PIK3CA	1	c.1624	2016-05-18 19:53:44.536841	2016-05-18 20:39:27.772028	1	ENSG00000121879	missense
919	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/8\\"}}"	\N		3	178936091	178936091	G	A	DOID:1612	21562040	included	ENST00000263967	p.E545K	PIK3CA	1	c.1633	2016-05-18 19:53:44.546133	2016-05-18 20:39:27.843932	1	ENSG00000121879	missense
920	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/ovarian-cancer/pik3ca/8\\"}}"	\N		3	178936091	178936091	G	A	DOID:2394	21562040	included	ENST00000263967	p.E545K	PIK3CA	1	c.1633	2016-05-18 19:53:44.566378	2016-05-18 20:39:27.894107	1	ENSG00000121879	missense
921	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/lung-cancer/pik3ca/8\\"}}"	\N		3	178936091	178936091	G	A	DOID:3908	21562040	included	ENST00000263967	p.E545K	PIK3CA	1	c.1633	2016-05-18 19:53:44.575497	2016-05-18 20:39:27.958244	1	ENSG00000121879	missense
922	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/8\\"}}"	\N		3	178936091	178936091	G	A	DOID:9256	21562040	included	ENST00000263967	p.E545K	PIK3CA	1	c.1633	2016-05-18 19:53:44.605199	2016-05-18 20:39:28.010986	1	ENSG00000121879	missense
923	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/9\\"}}"	\N		3	178936091	178936091	G	C	DOID:1612	21562040	included	ENST00000263967	p.E545Q	PIK3CA	1	c.1633	2016-05-18 19:53:44.614942	2016-05-18 20:39:28.074106	1	ENSG00000121879	missense
924	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/lung-cancer/pik3ca/9\\"}}"	\N		3	178936091	178936091	G	C	DOID:3908	21562040	included	ENST00000263967	p.E545Q	PIK3CA	1	c.1633	2016-05-18 19:53:44.634204	2016-05-18 20:39:28.122323	1	ENSG00000121879	missense
925	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/9\\"}}"	\N		3	178936091	178936091	G	C	DOID:9256	21562040	included	ENST00000263967	p.E545Q	PIK3CA	1	c.1633	2016-05-18 19:53:44.642595	2016-05-18 20:39:28.185879	1	ENSG00000121879	missense
926	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/12\\"}}"	\N		3	178936092	178936092	A	C	DOID:1612	21562040	included	ENST00000263967	p.E545A	PIK3CA	1	c.1634	2016-05-18 19:53:44.665622	2016-05-18 20:39:28.271239	1	ENSG00000121879	missense
927	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/ovarian-cancer/pik3ca/12\\"}}"	\N		3	178936092	178936092	A	C	DOID:2394	21562040	included	ENST00000263967	p.E545A	PIK3CA	1	c.1634	2016-05-18 19:53:44.673986	2016-05-18 20:39:28.337159	1	ENSG00000121879	missense
928	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/12\\"}}"	\N		3	178936092	178936092	A	C	DOID:9256	21562040	included	ENST00000263967	p.E545A	PIK3CA	1	c.1634	2016-05-18 19:53:44.706083	2016-05-18 20:39:28.405328	1	ENSG00000121879	missense
929	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/13\\"}}"	\N		3	178936092	178936092	A	G	DOID:1612	21562040	included	ENST00000263967	p.E545G	PIK3CA	1	c.1634	2016-05-18 19:53:44.729965	2016-05-18 20:39:28.476855	1	ENSG00000121879	missense
1424	\N	\N		1	115258748	115258748	C	A	DOID:9119	18186519	included	ENST00000369535	p.G12C	NRAS	-1	c.34	2016-05-18 20:26:14.644618	2016-05-18 20:39:58.492924	2	ENSG00000213281	missense
930	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/13\\"}}"	\N		3	178936092	178936092	A	G	DOID:9256	23656643	included	ENST00000263967	p.E545G	PIK3CA	1	c.1634	2016-05-18 19:53:44.737798	2016-05-18 20:39:28.528678	1	ENSG00000121879	missense
931	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/14\\"}}"	\N		3	178936092	178936092	A	T	DOID:1612	23656643	included	ENST00000263967	p.E545V	PIK3CA	1	c.1634	2016-05-18 19:53:44.766011	2016-05-18 20:39:28.60478	1	ENSG00000121879	missense
932	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/14\\"}}"	\N		3	178936092	178936092	A	T	DOID:9256	22072639	included	ENST00000263967	p.E545V	PIK3CA	1	c.1634	2016-05-18 19:53:44.776108	2016-05-18 20:39:28.650712	1	ENSG00000121879	missense
933	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/14\\"}}"	\N		3	178936092	178936092	A	T	DOID:9256	21838707	included	ENST00000263967	p.E545V	PIK3CA	1	c.1634	2016-05-18 19:53:44.787013	2016-05-18 20:39:28.699402	1	ENSG00000121879	missense
934	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/16\\"}}"	\N		3	178936094	178936094	C	A	DOID:1612	22072639	included	ENST00000263967	p.Q546K	PIK3CA	1	c.1636	2016-05-18 19:53:44.800849	2016-05-18 20:39:28.762522	1	ENSG00000121879	missense
937	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/ovarian-cancer/pik3ca/16\\"}}"	\N		3	178936094	178936094	C	A	DOID:2394	21838707	included	ENST00000263967	p.Q546K	PIK3CA	1	c.1636	2016-05-18 19:53:44.843874	2016-05-18 20:39:28.912583	1	ENSG00000121879	missense
938	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/16\\"}}"	\N		3	178936094	178936094	C	A	DOID:9256	21838707	included	ENST00000263967	p.Q546K	PIK3CA	1	c.1636	2016-05-18 19:53:44.874094	2016-05-18 20:39:28.963584	1	ENSG00000121879	missense
939	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/16\\"}}"	\N		3	178936094	178936094	C	A	DOID:9256	22072639	included	ENST00000263967	p.Q546K	PIK3CA	1	c.1636	2016-05-18 19:53:44.899415	2016-05-18 20:39:29.007761	1	ENSG00000121879	missense
940	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/15\\"}}"	\N		3	178936094	178936094	C	G	DOID:1612	22072639	included	ENST00000263967	p.Q546E	PIK3CA	1	c.1636	2016-05-18 19:53:44.907941	2016-05-18 20:39:29.065036	1	ENSG00000121879	missense
941	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/15\\"}}"	\N		3	178936094	178936094	C	G	DOID:1612	21838707	included	ENST00000263967	p.Q546E	PIK3CA	1	c.1636	2016-05-18 19:53:44.935371	2016-05-18 20:39:29.11067	1	ENSG00000121879	missense
942	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/15\\"}}"	\N		3	178936094	178936094	C	G	DOID:9256	22072639	included	ENST00000263967	p.Q546E	PIK3CA	1	c.1636	2016-05-18 19:53:44.944778	2016-05-18 20:39:29.156882	1	ENSG00000121879	missense
943	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/15\\"}}"	\N		3	178936094	178936094	C	G	DOID:9256	21838707	included	ENST00000263967	p.Q546E	PIK3CA	1	c.1636	2016-05-18 19:53:44.966536	2016-05-18 20:39:29.199841	1	ENSG00000121879	missense
944	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/18\\"}}"	\N		3	178936095	178936095	A	C	DOID:1612	22072639	included	ENST00000263967	p.Q546P	PIK3CA	1	c.1637	2016-05-18 19:53:44.975108	2016-05-18 20:39:29.279491	1	ENSG00000121879	missense
945	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/18\\"}}"	\N		3	178936095	178936095	A	C	DOID:1612	21838707	included	ENST00000263967	p.Q546P	PIK3CA	1	c.1637	2016-05-18 19:53:45.003538	2016-05-18 20:39:29.33036	1	ENSG00000121879	missense
946	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/18\\"}}"	\N		3	178936095	178936095	A	C	DOID:9256	22072639	included	ENST00000263967	p.Q546P	PIK3CA	1	c.1637	2016-05-18 19:53:45.014456	2016-05-18 20:39:29.387135	1	ENSG00000121879	missense
947	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/18\\"}}"	\N		3	178936095	178936095	A	C	DOID:9256	21838707	included	ENST00000263967	p.Q546P	PIK3CA	1	c.1637	2016-05-18 19:53:45.039087	2016-05-18 20:39:29.43131	1	ENSG00000121879	missense
948	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/19\\"}}"	\N		3	178936095	178936095	A	G	DOID:1612	22072639	included	ENST00000263967	p.Q546R	PIK3CA	1	c.1637	2016-05-18 19:53:45.047439	2016-05-18 20:39:29.502446	1	ENSG00000121879	missense
949	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/19\\"}}"	\N		3	178936095	178936095	A	G	DOID:1612	21838707	included	ENST00000263967	p.Q546R	PIK3CA	1	c.1637	2016-05-18 19:53:45.069889	2016-05-18 20:39:29.555051	1	ENSG00000121879	missense
950	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/19\\"}}"	\N		3	178936095	178936095	A	G	DOID:9256	21838707	included	ENST00000263967	p.Q546R	PIK3CA	1	c.1637	2016-05-18 19:53:45.079223	2016-05-18 20:39:29.610203	1	ENSG00000121879	missense
951	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/19\\"}}"	\N		3	178936095	178936095	A	G	DOID:9256	22072639	included	ENST00000263967	p.Q546R	PIK3CA	1	c.1637	2016-05-18 19:53:45.108889	2016-05-18 20:39:29.673377	1	ENSG00000121879	missense
952	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/17\\"}}"	\N		3	178936095	178936095	A	T	DOID:1612	22072639	included	ENST00000263967	p.Q546L	PIK3CA	1	c.1637	2016-05-18 19:53:45.118663	2016-05-18 20:39:29.736704	1	ENSG00000121879	missense
953	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/17\\"}}"	\N		3	178936095	178936095	A	T	DOID:1612	21838707	included	ENST00000263967	p.Q546L	PIK3CA	1	c.1637	2016-05-18 19:53:45.139975	2016-05-18 20:39:29.782443	1	ENSG00000121879	missense
954	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/20\\"}}"	\N		3	178936103	178936103	G	A	DOID:1612	22072639	included	ENST00000263967	p.D549N	PIK3CA	1	c.1645	2016-05-18 19:53:45.149577	2016-05-18 20:39:29.855795	1	ENSG00000121879	missense
955	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/20\\"}}"	\N		3	178936103	178936103	G	A	DOID:1612	21838707	included	ENST00000263967	p.D549N	PIK3CA	1	c.1645	2016-05-18 19:53:45.171005	2016-05-18 20:39:29.899636	1	ENSG00000121879	missense
956	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/20\\"}}"	\N		3	178936103	178936103	G	A	DOID:9256	24657128	included	ENST00000263967	p.D549N	PIK3CA	1	c.1645	2016-05-18 19:53:45.204817	2016-05-18 20:39:29.938653	1	ENSG00000121879	missense
957	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/20\\"}}"	\N		3	178936103	178936103	G	A	DOID:9256	25157968	included	ENST00000263967	p.D549N	PIK3CA	1	c.1645	2016-05-18 19:53:45.214583	2016-05-18 20:39:29.993036	1	ENSG00000121879	missense
958	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/11\\"}}"	\N		3	178952085	178952085	A	G	DOID:1612	24986690	included	ENST00000263967	p.H1047R	PIK3CA	1	c.3140	2016-05-18 19:53:45.238998	2016-05-18 20:39:30.052248	1	ENSG00000121879	missense
959	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/ovarian-cancer/pik3ca/11\\"}}"	\N		3	178952085	178952085	A	G	DOID:2394	20151976	included	ENST00000263967	p.H1047R	PIK3CA	1	c.3140	2016-05-18 19:53:45.249009	2016-05-18 20:39:30.110426	1	ENSG00000121879	missense
960	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/ovarian-cancer/pik3ca/11\\"}}"	\N		3	178952085	178952085	A	G	DOID:2394	18528423	included	ENST00000263967	p.H1047R	PIK3CA	1	c.3140	2016-05-18 19:53:45.276034	2016-05-18 20:39:30.156413	1	ENSG00000121879	missense
961	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/lung-cancer/pik3ca/11\\"}}"	\N		3	178952085	178952085	A	G	DOID:3908	23213094	included	ENST00000263967	p.H1047R	PIK3CA	1	c.3140	2016-05-18 19:53:45.285641	2016-05-18 20:39:30.2101	1	ENSG00000121879	missense
962	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/10\\"}}"	\N		3	178952085	178952085	A	G	DOID:9256	23610116	included	ENST00000263967	p.H1047R	PIK3CA	1	c.3140	2016-05-18 19:53:45.306002	2016-05-18 20:39:30.255654	1	ENSG00000121879	missense
963	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/10\\"}}"	\N		3	178952085	178952085	A	T	DOID:1612	24631838	included	ENST00000263967	p.H1047L	PIK3CA	1	c.3140	2016-05-18 19:53:45.314926	2016-05-18 20:39:30.329944	1	ENSG00000121879	missense
964	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/ovarian-cancer/pik3ca/10\\"}}"	\N		3	178952085	178952085	A	T	DOID:2394	24622468	included	ENST00000263967	p.H1047L	PIK3CA	1	c.3140	2016-05-18 19:53:45.343788	2016-05-18 20:39:30.386789	1	ENSG00000121879	missense
965	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/lung-cancer/pik3ca/10\\"}}"	\N		3	178952085	178952085	A	T	DOID:3908	24631838	included	ENST00000263967	p.H1047L	PIK3CA	1	c.3140	2016-05-18 19:53:45.367909	2016-05-18 20:39:30.434037	1	ENSG00000121879	missense
966	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/10\\"}}"	\N		3	178952085	178952085	A	T	DOID:9256	24631838	included	ENST00000263967	p.H1047L	PIK3CA	1	c.3140	2016-05-18 19:53:45.376186	2016-05-18 20:39:30.486429	1	ENSG00000121879	missense
967	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/ctnnb1/105\\"}}"	\N		3	41266113	41266113	C	A	DOID:1909	24625776	included	ENST00000349496	p.S37Y	CTNNB1	1	c.110	2016-05-18 19:53:45.411098	2016-05-18 20:39:30.557679	1	ENSG00000168036	missense
968	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/ctnnb1/104\\"}}"	\N		3	41266113	41266113	C	T	DOID:1909	24625776	included	ENST00000349496	p.S37F	CTNNB1	1	c.110	2016-05-18 19:53:45.436449	2016-05-18 20:39:30.62223	1	ENSG00000168036	missense
969	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/ctnnb1/107\\"}}"	\N		3	41266136	41266136	T	C	DOID:1909	22980975	included	ENST00000349496	p.S45P	CTNNB1	1	c.133	2016-05-18 19:53:45.445046	2016-05-18 20:39:30.696628	1	ENSG00000168036	missense
970	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/ctnnb1/107\\"}}"	\N		3	41266136	41266136	T	C	DOID:1909	25157968	included	ENST00000349496	p.S45P	CTNNB1	1	c.133	2016-05-18 19:53:45.47118	2016-05-18 20:39:30.744008	1	ENSG00000168036	missense
971	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/ctnnb1/108\\"}}"	\N		3	41266137	41266137	C	A	DOID:1909	18948947	included	ENST00000349496	p.S45Y	CTNNB1	1	c.134	2016-05-18 19:53:45.480583	2016-05-18 20:39:30.812174	1	ENSG00000168036	missense
972	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/ctnnb1/108\\"}}"	\N		3	41266137	41266137	C	A	DOID:1909	25157968	included	ENST00000349496	p.S45Y	CTNNB1	1	c.134	2016-05-18 19:53:45.490845	2016-05-18 20:39:30.876458	1	ENSG00000168036	missense
973	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/ctnnb1/106\\"}}"	\N		3	41266137	41266137	C	T	DOID:1909	22277784	included	ENST00000349496	p.S45F	CTNNB1	1	c.134	2016-05-18 19:53:45.505913	2016-05-18 20:39:30.942604	1	ENSG00000168036	missense
974	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/ctnnb1/106\\"}}"	\N		3	41266137	41266137	C	T	DOID:1909	24670165	included	ENST00000349496	p.S45F	CTNNB1	1	c.134	2016-05-18 19:53:45.514904	2016-05-18 20:39:30.989931	1	ENSG00000168036	missense
975	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/gist/pdgfra/48\\"}}"	\N		4	55141036	55141036	T	A	DOID:9253	22277784	included	ENST00000257290	p.V561D	PDGFRA	1	c.1682	2016-05-18 19:53:45.535817	2016-05-18 20:39:31.063927	1	ENSG00000134853	missense
976	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/gist/pdgfra/48\\"}}"	\N		4	55141036	55141036	T	A	DOID:9253	24670165	included	ENST00000257290	p.V561D	PDGFRA	1	c.1682	2016-05-18 19:53:45.544085	2016-05-18 20:39:31.121308	1	ENSG00000134853	missense
977	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/gist/pdgfra/51\\"}}"	\N		4	55144148	55144148	C	A	DOID:9253	22277784	included	ENST00000257290	p.N659K	PDGFRA	1	c.1977	2016-05-18 19:53:45.572927	2016-05-18 20:39:31.186019	1	ENSG00000134853	missense
978	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/gist/pdgfra/51\\"}}"	\N		4	55144148	55144148	C	G	DOID:9253	22277784	included	ENST00000257290	p.N659K	PDGFRA	1	c.1977	2016-05-18 19:53:45.581789	2016-05-18 20:39:31.243742	1	ENSG00000134853	missense
979	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/gist/pdgfra/51\\"}}"	\N		4	55144148	55144148	C	G	DOID:9253	24670165	included	ENST00000257290	p.N659K	PDGFRA	1	c.1977	2016-05-18 19:53:45.60658	2016-05-18 20:39:31.291939	1	ENSG00000134853	missense
980	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/gist/pdgfra/51\\"}}"	\N		4	55144148	55144148	C	G	DOID:9253	24327273	included	ENST00000257290	p.N659K	PDGFRA	1	c.1977	2016-05-18 19:53:45.615596	2016-05-18 20:39:31.342403	1	ENSG00000134853	missense
981	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/gist/pdgfra/45\\"}}"	\N		4	55152093	55152093	A	T	DOID:9253	22277784	included	ENST00000257290	p.D842V	PDGFRA	1	c.2525	2016-05-18 19:53:45.645884	2016-05-18 20:39:31.415711	1	ENSG00000134853	missense
982	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/gist/pdgfra/45\\"}}"	\N		4	55152093	55152093	A	T	DOID:9253	24327273	included	ENST00000257290	p.D842V	PDGFRA	1	c.2525	2016-05-18 19:53:45.671171	2016-05-18 20:39:31.460228	1	ENSG00000134853	missense
983	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/thymic-carcinoma/kit/218\\"}}"	\N		4	55592144	55592144	G	A	DOID:3284	22277784	included	ENST00000288135	p.E490K	KIT	1	c.1468	2016-05-18 19:53:45.679784	2016-05-18 20:39:31.541634	1	ENSG00000157404	missense
984	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/thymic-carcinoma/kit/218\\"}}"	\N		4	55592144	55592144	G	A	DOID:3284	24327273	included	ENST00000288135	p.E490K	KIT	1	c.1468	2016-05-18 19:53:45.711011	2016-05-18 20:39:31.595412	1	ENSG00000157404	missense
986	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/kit/132\\"}}"	\N		4	55593584	55593584	A	C	DOID:1909	24569458	included	ENST00000288135	p.K550N	KIT	1	c.1650	2016-05-18 19:53:45.741033	2016-05-18 20:39:31.763467	1	ENSG00000157404	missense
987	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/kit/132\\"}}"	\N		4	55593584	55593584	A	T	DOID:1909	22773810	included	ENST00000288135	p.K550N	KIT	1	c.1650	2016-05-18 19:53:45.750257	2016-05-18 20:39:31.832036	1	ENSG00000157404	missense
988	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/kit/132\\"}}"	\N		4	55593591	55593591	T	A	DOID:1909	22908275	included	ENST00000288135	p.Y553N	KIT	1	c.1657	2016-05-18 19:53:45.780591	2016-05-18 20:39:31.923531	1	ENSG00000157404	missense
989	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/thymic-carcinoma/kit/124\\"}}"	\N		4	55593591	55593591	T	A	DOID:3284	23724914	included	ENST00000288135	p.Y553N	KIT	1	c.1657	2016-05-18 19:53:45.79066	2016-05-18 20:39:31.989996	1	ENSG00000157404	missense
990	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/kit/132\\"}}"	\N		4	55593594	55593594	GAAGTACAGTGGAAG	-	DOID:1909	17611497	included	ENST00000288135	p.E554X	KIT	1	c.1660	2016-05-18 19:53:45.811229	2016-05-18 20:39:32.059929	1	ENSG00000157404	frameshift
991	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/kit/132\\"}}"	\N		4	55593594	55593594	GAAGTACAGTGGAAG	-	DOID:1909	25157968	included	ENST00000288135	p.E554X	KIT	1	c.1660	2016-05-18 19:53:45.82122	2016-05-18 20:39:32.103291	1	ENSG00000157404	frameshift
992	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/kit/132\\"}}"	\N		4	55593594	55593594	GAAGTACAGTGGAAGGTT	-	DOID:1909	23728071	included	ENST00000288135	p.E554X	KIT	1	c.1660	2016-05-18 19:53:45.84145	2016-05-18 20:39:32.171116	1	ENSG00000157404	frameshift
993	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/kit/132\\"}}"	\N		4	55593594	55593594	GAAGTACAGTGGAAGGTT	-	DOID:1909	25157968	included	ENST00000288135	p.E554X	KIT	1	c.1660	2016-05-18 19:53:45.850501	2016-05-18 20:39:32.220961	1	ENSG00000157404	frameshift
994	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/kit/132\\"}}"	\N		4	55593600	55593601	-	CTA	DOID:1909	21479466	included	ENST00000288135	p.Q556LX	KIT	1	c.1666	2016-05-18 19:53:45.881606	2016-05-18 20:39:32.306093	1	ENSG00000157404	frameshift
995	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/kit/132\\"}}"	\N		4	55593600	55593601	-	CTA	DOID:1909	25157968	included	ENST00000288135	p.Q556LX	KIT	1	c.1666	2016-05-18 19:53:45.892011	2016-05-18 20:39:32.369098	1	ENSG00000157404	frameshift
996	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/kit/132\\"}}"	\N		4	55593600	55593601	-	CTC	DOID:1909	18504432	included	ENST00000288135	p.Q556LX	KIT	1	c.1666	2016-05-18 19:53:45.911955	2016-05-18 20:39:32.443309	1	ENSG00000157404	frameshift
998	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/kit/132\\"}}"	\N		4	55593600	55593601	-	CTC	DOID:1909	18256540	included	ENST00000288135	p.Q556LX	KIT	1	c.1666	2016-05-18 19:53:45.943847	2016-05-18 20:39:32.560401	1	ENSG00000157404	frameshift
999	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/kit/132\\"}}"	\N		4	55593600	55593601	-	CTC	DOID:1909	17611497	included	ENST00000288135	p.Q556LX	KIT	1	c.1666	2016-05-18 19:53:45.953573	2016-05-18 20:39:32.612296	1	ENSG00000157404	frameshift
1000	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/kit/132\\"}}"	\N		4	55593600	55593601	-	CTG	DOID:1909	15118073	included	ENST00000288135	p.Q556LX	KIT	1	c.1666	2016-05-18 19:53:45.982023	2016-05-18 20:39:32.677743	1	ENSG00000157404	frameshift
1001	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/kit/132\\"}}"	\N		4	55593600	55593601	-	CTG	DOID:1909	15118125	included	ENST00000288135	p.Q556LX	KIT	1	c.1666	2016-05-18 19:53:46.009229	2016-05-18 20:39:32.76478	1	ENSG00000157404	frameshift
1002	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/kit/132\\"}}"	\N		4	55593600	55593601	-	CTG	DOID:1909	15329413	included	ENST00000288135	p.Q556LX	KIT	1	c.1666	2016-05-18 19:53:46.01845	2016-05-18 20:39:32.822111	1	ENSG00000157404	frameshift
1003	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/kit/132\\"}}"	\N		4	55593600	55593601	-	CTG	DOID:1909	19922469	included	ENST00000288135	p.Q556LX	KIT	1	c.1666	2016-05-18 19:53:46.040496	2016-05-18 20:39:33.024184	1	ENSG00000157404	frameshift
1004	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/kit/132\\"}}"	\N		4	55593600	55593601	-	CTG	DOID:1909	15710947	included	ENST00000288135	p.Q556LX	KIT	1	c.1666	2016-05-18 19:53:46.049461	2016-05-18 20:39:33.072452	1	ENSG00000157404	frameshift
1005	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/kit/132\\"}}"	\N		4	55593600	55593601	-	CTG	DOID:1909	16011858	included	ENST00000288135	p.Q556LX	KIT	1	c.1666	2016-05-18 19:53:46.07623	2016-05-18 20:39:33.133864	1	ENSG00000157404	frameshift
1006	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/kit/132\\"}}"	\N		4	55593600	55593601	-	CTG	DOID:1909	16115929	included	ENST00000288135	p.Q556LX	KIT	1	c.1666	2016-05-18 19:53:46.085326	2016-05-18 20:39:33.199071	1	ENSG00000157404	frameshift
1007	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/kit/132\\"}}"	\N		4	55593600	55593601	-	CTG	DOID:1909	20479403	included	ENST00000288135	p.Q556LX	KIT	1	c.1666	2016-05-18 19:53:46.106906	2016-05-18 20:39:33.256892	1	ENSG00000157404	frameshift
1008	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/kit/132\\"}}"	\N		4	55593600	55593601	-	CTG	DOID:1909	22753918	included	ENST00000288135	p.Q556LX	KIT	1	c.1666	2016-05-18 19:53:46.115292	2016-05-18 20:39:33.33377	1	ENSG00000157404	frameshift
1009	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/kit/132\\"}}"	\N		4	55593600	55593601	-	CTG	DOID:1909	23102728	included	ENST00000288135	p.Q556LX	KIT	1	c.1666	2016-05-18 19:53:46.143596	2016-05-18 20:39:33.407067	1	ENSG00000157404	frameshift
1010	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/kit/132\\"}}"	\N		4	55593600	55593601	-	CTT	DOID:1909	15118073	included	ENST00000288135	p.Q556LX	KIT	1	c.1666	2016-05-18 19:53:46.15259	2016-05-18 20:39:33.507024	1	ENSG00000157404	frameshift
1011	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/kit/132\\"}}"	\N		4	55593600	55593601	-	CTT	DOID:1909	15118125	included	ENST00000288135	p.Q556LX	KIT	1	c.1666	2016-05-18 19:53:46.176528	2016-05-18 20:39:33.583301	1	ENSG00000157404	frameshift
1012	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/kit/132\\"}}"	\N		4	55593600	55593601	-	CTT	DOID:1909	15329413	included	ENST00000288135	p.Q556LX	KIT	1	c.1666	2016-05-18 19:53:46.184753	2016-05-18 20:39:33.646277	1	ENSG00000157404	frameshift
1013	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/kit/132\\"}}"	\N		4	55593600	55593601	-	CTT	DOID:1909	19922469	included	ENST00000288135	p.Q556LX	KIT	1	c.1666	2016-05-18 19:53:46.194309	2016-05-18 20:39:33.733245	1	ENSG00000157404	frameshift
1425	\N	\N		1	115258748	115258748	C	A	DOID:9119	12068308	included	ENST00000369535	p.G12C	NRAS	-1	c.34	2016-05-18 20:26:14.655872	2016-05-18 20:39:58.5335	2	ENSG00000213281	missense
1014	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/kit/132\\"}}"	\N		4	55593600	55593601	-	CTT	DOID:1909	15710947	included	ENST00000288135	p.Q556LX	KIT	1	c.1666	2016-05-18 19:53:46.217021	2016-05-18 20:39:33.857028	1	ENSG00000157404	frameshift
1016	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/kit/132\\"}}"	\N		4	55593600	55593601	-	CTT	DOID:1909	16115929	included	ENST00000288135	p.Q556LX	KIT	1	c.1666	2016-05-18 19:53:46.247104	2016-05-18 20:39:34.017511	1	ENSG00000157404	frameshift
1017	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/kit/132\\"}}"	\N		4	55593600	55593601	-	CTT	DOID:1909	20479403	included	ENST00000288135	p.Q556LX	KIT	1	c.1666	2016-05-18 19:53:46.256018	2016-05-18 20:39:34.104258	1	ENSG00000157404	frameshift
1018	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/kit/132\\"}}"	\N		4	55593600	55593601	-	CTT	DOID:1909	22753918	included	ENST00000288135	p.Q556LX	KIT	1	c.1666	2016-05-18 19:53:46.279004	2016-05-18 20:39:34.188242	1	ENSG00000157404	frameshift
1019	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/kit/132\\"}}"	\N		4	55593600	55593601	-	CTT	DOID:1909	23102728	included	ENST00000288135	p.Q556LX	KIT	1	c.1666	2016-05-18 19:53:46.312634	2016-05-18 20:39:34.246839	1	ENSG00000157404	frameshift
1020	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/kit/132\\"}}"	\N		4	55593600	55593601	-	TTA	DOID:1909	15118073	included	ENST00000288135	p.Q556LX	KIT	1	c.1666	2016-05-18 19:53:46.321708	2016-05-18 20:39:34.329467	1	ENSG00000157404	frameshift
1021	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/kit/132\\"}}"	\N		4	55593600	55593601	-	TTA	DOID:1909	15118125	included	ENST00000288135	p.Q556LX	KIT	1	c.1666	2016-05-18 19:53:46.344211	2016-05-18 20:39:34.4159	1	ENSG00000157404	frameshift
1022	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/kit/132\\"}}"	\N		4	55593600	55593601	-	TTA	DOID:1909	15329413	included	ENST00000288135	p.Q556LX	KIT	1	c.1666	2016-05-18 19:53:46.353825	2016-05-18 20:39:34.482463	1	ENSG00000157404	frameshift
1023	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/kit/132\\"}}"	\N		4	55593600	55593601	-	TTA	DOID:1909	19922469	included	ENST00000288135	p.Q556LX	KIT	1	c.1666	2016-05-18 19:53:46.374925	2016-05-18 20:39:34.565182	1	ENSG00000157404	frameshift
1024	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/kit/132\\"}}"	\N		4	55593600	55593601	-	TTA	DOID:1909	15710947	included	ENST00000288135	p.Q556LX	KIT	1	c.1666	2016-05-18 19:53:46.383271	2016-05-18 20:39:34.631743	1	ENSG00000157404	frameshift
1025	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/kit/132\\"}}"	\N		4	55593600	55593601	-	TTA	DOID:1909	16011858	included	ENST00000288135	p.Q556LX	KIT	1	c.1666	2016-05-18 19:53:46.412891	2016-05-18 20:39:34.708474	1	ENSG00000157404	frameshift
1026	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/kit/132\\"}}"	\N		4	55593600	55593601	-	TTA	DOID:1909	16115929	included	ENST00000288135	p.Q556LX	KIT	1	c.1666	2016-05-18 19:53:46.423038	2016-05-18 20:39:34.772733	1	ENSG00000157404	frameshift
1027	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/kit/132\\"}}"	\N		4	55593600	55593601	-	TTA	DOID:1909	20479403	included	ENST00000288135	p.Q556LX	KIT	1	c.1666	2016-05-18 19:53:46.444495	2016-05-18 20:39:34.838122	1	ENSG00000157404	frameshift
1028	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/kit/132\\"}}"	\N		4	55593600	55593601	-	TTA	DOID:1909	22753918	included	ENST00000288135	p.Q556LX	KIT	1	c.1666	2016-05-18 19:53:46.453495	2016-05-18 20:39:34.900148	1	ENSG00000157404	frameshift
1029	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/kit/132\\"}}"	\N		4	55593600	55593601	-	TTA	DOID:1909	23102728	included	ENST00000288135	p.Q556LX	KIT	1	c.1666	2016-05-18 19:53:46.479695	2016-05-18 20:39:34.97384	1	ENSG00000157404	frameshift
1030	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/kit/132\\"}}"	\N		4	55593600	55593601	-	TTG	DOID:1909	15118073	included	ENST00000288135	p.Q556LX	KIT	1	c.1666	2016-05-18 19:53:46.488969	2016-05-18 20:39:35.07311	1	ENSG00000157404	frameshift
1031	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/kit/132\\"}}"	\N		4	55593600	55593601	-	TTG	DOID:1909	15118125	included	ENST00000288135	p.Q556LX	KIT	1	c.1666	2016-05-18 19:53:46.511023	2016-05-18 20:39:35.168002	1	ENSG00000157404	frameshift
1032	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/kit/132\\"}}"	\N		4	55593600	55593601	-	TTG	DOID:1909	15329413	included	ENST00000288135	p.Q556LX	KIT	1	c.1666	2016-05-18 19:53:46.519638	2016-05-18 20:39:35.265268	1	ENSG00000157404	frameshift
1033	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/kit/132\\"}}"	\N		4	55593600	55593601	-	TTG	DOID:1909	16912157	included	ENST00000288135	p.Q556LX	KIT	1	c.1666	2016-05-18 19:53:46.547577	2016-05-18 20:39:35.357619	1	ENSG00000157404	frameshift
1034	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/kit/132\\"}}"	\N		4	55593600	55593601	-	TTG	DOID:1909	15728811	included	ENST00000288135	p.Q556LX	KIT	1	c.1666	2016-05-18 19:53:46.556904	2016-05-18 20:39:35.420799	1	ENSG00000157404	frameshift
1035	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/kit/132\\"}}"	\N		4	55593600	55593601	-	TTG	DOID:1909	15737014	included	ENST00000288135	p.Q556LX	KIT	1	c.1666	2016-05-18 19:53:46.578863	2016-05-18 20:39:35.497342	1	ENSG00000157404	frameshift
1036	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/kit/132\\"}}"	\N		4	55593600	55593601	-	TTG	DOID:1909	21430269	included	ENST00000288135	p.Q556LX	KIT	1	c.1666	2016-05-18 19:53:46.587411	2016-05-18 20:39:35.558228	1	ENSG00000157404	frameshift
1037	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/kit/132\\"}}"	\N		4	55593600	55593601	-	TTG	DOID:1909	21194487	included	ENST00000288135	p.Q556LX	KIT	1	c.1666	2016-05-18 19:53:46.6097	2016-05-18 20:39:35.634774	1	ENSG00000157404	frameshift
1038	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/kit/132\\"}}"	\N		4	55593600	55593601	-	TTG	DOID:1909	21531810	included	ENST00000288135	p.Q556LX	KIT	1	c.1666	2016-05-18 19:53:46.61781	2016-05-18 20:39:35.690015	1	ENSG00000157404	frameshift
1039	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/kit/132\\"}}"	\N		4	55593600	55593601	-	TTG	DOID:1909	20068085	included	ENST00000288135	p.Q556LX	KIT	1	c.1666	2016-05-18 19:53:46.647937	2016-05-18 20:39:35.741348	1	ENSG00000157404	frameshift
1040	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/kit/132\\"}}"	\N		4	55593600	55593601	-	TTG	DOID:1909	16258541	included	ENST00000288135	p.Q556LX	KIT	1	c.1666	2016-05-18 19:53:46.657109	2016-05-18 20:39:35.808928	1	ENSG00000157404	frameshift
1041	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/kit/132\\"}}"	\N		4	55593600	55593601	-	TTG	DOID:1909	22588155	included	ENST00000288135	p.Q556LX	KIT	1	c.1666	2016-05-18 19:53:46.678826	2016-05-18 20:39:35.872955	1	ENSG00000157404	frameshift
1426	\N	\N		1	115258748	115258748	C	A	DOID:9119	22310681	included	ENST00000369535	p.G12C	NRAS	-1	c.34	2016-05-18 20:26:14.665298	2016-05-18 20:39:58.581207	2	ENSG00000213281	missense
1042	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/kit/132\\"}}"	\N		4	55593600	55593601	-	TTG	DOID:1909	22452896	included	ENST00000288135	p.Q556LX	KIT	1	c.1666	2016-05-18 19:53:46.687347	2016-05-18 20:39:35.946561	1	ENSG00000157404	frameshift
1043	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/kit/132\\"}}"	\N		4	55593600	55593601	-	TTG	DOID:1909	23816963	included	ENST00000288135	p.Q556LX	KIT	1	c.1666	2016-05-18 19:53:46.71487	2016-05-18 20:39:36.026615	1	ENSG00000157404	frameshift
1044	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/kit/132\\"}}"	\N		4	55593600	55593601	-	TTG	DOID:1909	24729716	included	ENST00000288135	p.Q556LX	KIT	1	c.1666	2016-05-18 19:53:46.723639	2016-05-18 20:39:36.109796	1	ENSG00000157404	frameshift
1045	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/kit/132\\"}}"	\N		4	55593600	55593601	-	TTG	DOID:1909	23102728	included	ENST00000288135	p.Q556LX	KIT	1	c.1666	2016-05-18 19:53:46.745555	2016-05-18 20:39:36.162959	1	ENSG00000157404	frameshift
1046	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/kit/132\\"}}"	\N		4	55593603	55593603	T	A	DOID:1909	15118073	included	ENST00000288135	p.W557R	KIT	1	c.1669	2016-05-18 19:53:46.753839	2016-05-18 20:39:36.257621	1	ENSG00000157404	missense
1047	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/kit/132\\"}}"	\N		4	55593603	55593603	T	A	DOID:1909	15118125	included	ENST00000288135	p.W557R	KIT	1	c.1669	2016-05-18 19:53:46.781899	2016-05-18 20:39:36.34137	1	ENSG00000157404	missense
1048	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/kit/132\\"}}"	\N		4	55593603	55593603	T	A	DOID:1909	15329413	included	ENST00000288135	p.W557R	KIT	1	c.1669	2016-05-18 19:53:46.790593	2016-05-18 20:39:36.39713	1	ENSG00000157404	missense
1049	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/kit/132\\"}}"	\N		4	55593603	55593603	T	A	DOID:1909	19922469	included	ENST00000288135	p.W557R	KIT	1	c.1669	2016-05-18 19:53:46.812684	2016-05-18 20:39:36.449851	1	ENSG00000157404	missense
1050	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/kit/132\\"}}"	\N		4	55593603	55593603	T	A	DOID:1909	21670455	included	ENST00000288135	p.W557R	KIT	1	c.1669	2016-05-18 19:53:46.821324	2016-05-18 20:39:36.524318	1	ENSG00000157404	missense
1051	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/kit/132\\"}}"	\N		4	55593603	55593603	T	A	DOID:1909	20573926	included	ENST00000288135	p.W557R	KIT	1	c.1669	2016-05-18 19:53:46.848764	2016-05-18 20:39:36.581102	1	ENSG00000157404	missense
1052	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/kit/132\\"}}"	\N		4	55593603	55593603	T	A	DOID:1909	20022809	included	ENST00000288135	p.W557R	KIT	1	c.1669	2016-05-18 19:53:46.857879	2016-05-18 20:39:36.703641	1	ENSG00000157404	missense
1053	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/kit/132\\"}}"	\N		4	55593603	55593603	T	A	DOID:1909	19692680	included	ENST00000288135	p.W557R	KIT	1	c.1669	2016-05-18 19:53:46.878385	2016-05-18 20:39:36.760134	1	ENSG00000157404	missense
1054	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/kit/132\\"}}"	\N		4	55593603	55593603	T	A	DOID:1909	19692684	included	ENST00000288135	p.W557R	KIT	1	c.1669	2016-05-18 19:53:46.886739	2016-05-18 20:39:36.859366	1	ENSG00000157404	missense
1055	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/kit/132\\"}}"	\N		4	55593603	55593603	T	A	DOID:1909	22285168	included	ENST00000288135	p.W557R	KIT	1	c.1669	2016-05-18 19:53:46.896754	2016-05-18 20:39:36.925663	1	ENSG00000157404	missense
1056	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/kit/132\\"}}"	\N		4	55593603	55593603	T	A	DOID:1909	23816960	included	ENST00000288135	p.W557R	KIT	1	c.1669	2016-05-18 19:53:46.913499	2016-05-18 20:39:37.014427	1	ENSG00000157404	missense
1057	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/kit/132\\"}}"	\N		4	55593603	55593603	T	A	DOID:1909	22452895	included	ENST00000288135	p.W557R	KIT	1	c.1669	2016-05-18 19:53:46.922324	2016-05-18 20:39:37.076917	1	ENSG00000157404	missense
1058	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/kit/132\\"}}"	\N		4	55593603	55593603	T	A	DOID:1909	21783417	included	ENST00000288135	p.W557R	KIT	1	c.1669	2016-05-18 19:53:46.945523	2016-05-18 20:39:37.126203	1	ENSG00000157404	missense
1059	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/kit/132\\"}}"	\N		4	55593603	55593603	T	A	DOID:1909	19096302	included	ENST00000288135	p.W557R	KIT	1	c.1669	2016-05-18 19:53:46.954292	2016-05-18 20:39:37.173226	1	ENSG00000157404	missense
1060	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/kit/132\\"}}"	\N		4	55593603	55593603	T	A	DOID:1909	18303429	included	ENST00000288135	p.W557R	KIT	1	c.1669	2016-05-18 19:53:46.983503	2016-05-18 20:39:37.228734	1	ENSG00000157404	missense
1061	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/kit/132\\"}}"	\N		4	55593603	55593603	T	A	DOID:1909	23948351	included	ENST00000288135	p.W557R	KIT	1	c.1669	2016-05-18 19:53:46.993324	2016-05-18 20:39:37.280367	1	ENSG00000157404	missense
1062	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/kit/132\\"}}"	\N		4	55593603	55593603	T	A	DOID:1909	22753918	included	ENST00000288135	p.W557R	KIT	1	c.1669	2016-05-18 19:53:47.018036	2016-05-18 20:39:37.32508	1	ENSG00000157404	missense
1063	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/kit/132\\"}}"	\N		4	55593603	55593603	T	A	DOID:1909	20479403	included	ENST00000288135	p.W557R	KIT	1	c.1669	2016-05-18 19:53:47.027012	2016-05-18 20:39:37.372048	1	ENSG00000157404	missense
1064	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/kit/132\\"}}"	\N		4	55593603	55593603	T	A	DOID:1909	23102728	included	ENST00000288135	p.W557R	KIT	1	c.1669	2016-05-18 19:53:47.05411	2016-05-18 20:39:37.427786	1	ENSG00000157404	missense
1065	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/kit/132\\"}}"	\N		4	55593603	55593603	T	C	DOID:1909	15118073	included	ENST00000288135	p.W557R	KIT	1	c.1669	2016-05-18 19:53:47.063488	2016-05-18 20:39:37.501202	1	ENSG00000157404	missense
1066	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/kit/132\\"}}"	\N		4	55593603	55593603	T	C	DOID:1909	15118125	included	ENST00000288135	p.W557R	KIT	1	c.1669	2016-05-18 19:53:47.085345	2016-05-18 20:39:37.550833	1	ENSG00000157404	missense
1067	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/kit/132\\"}}"	\N		4	55593603	55593603	T	C	DOID:1909	15329413	included	ENST00000288135	p.W557R	KIT	1	c.1669	2016-05-18 19:53:47.095096	2016-05-18 20:39:37.62518	1	ENSG00000157404	missense
1068	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/kit/132\\"}}"	\N		4	55593603	55593603	T	C	DOID:1909	19922469	included	ENST00000288135	p.W557R	KIT	1	c.1669	2016-05-18 19:53:47.116705	2016-05-18 20:39:37.708598	1	ENSG00000157404	missense
1427	\N	\N		1	115258748	115258748	C	T	DOID:9119	18316791	included	ENST00000369535	p.G12S	NRAS	-1	c.34	2016-05-18 20:26:14.672523	2016-05-18 20:39:58.621736	2	ENSG00000213281	missense
1069	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/kit/132\\"}}"	\N		4	55593603	55593603	T	C	DOID:1909	22753918	included	ENST00000288135	p.W557R	KIT	1	c.1669	2016-05-18 19:53:47.151277	2016-05-18 20:39:37.797374	1	ENSG00000157404	missense
1070	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/kit/132\\"}}"	\N		4	55593603	55593603	T	C	DOID:1909	23102728	included	ENST00000288135	p.W557R	KIT	1	c.1669	2016-05-18 19:53:47.160822	2016-05-18 20:39:37.891946	1	ENSG00000157404	missense
1071	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/thymic-carcinoma/kit/110\\"}}"	\N		4	55593603	55593603	T	C	DOID:3284	12460918	included	ENST00000288135	p.W557R	KIT	1	c.1669	2016-05-18 19:53:47.181615	2016-05-18 20:39:37.961727	1	ENSG00000157404	missense
1072	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/thymic-carcinoma/kit/110\\"}}"	\N		4	55593603	55593603	T	C	DOID:3284	18794081	included	ENST00000288135	p.W557R	KIT	1	c.1669	2016-05-18 19:53:47.190059	2016-05-18 20:39:38.008368	1	ENSG00000157404	missense
1073	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/kit/132\\"}}"	\N		4	55593608	55593608	G	C	DOID:1909	12460918	included	ENST00000288135	p.K558N	KIT	1	c.1674	2016-05-18 19:53:47.218378	2016-05-18 20:39:38.084847	1	ENSG00000157404	missense
1074	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/kit/132\\"}}"	\N		4	55593608	55593608	G	C	DOID:1909	18794081	included	ENST00000288135	p.K558N	KIT	1	c.1674	2016-05-18 19:53:47.227517	2016-05-18 20:39:38.140161	1	ENSG00000157404	missense
1075	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/kit/132\\"}}"	\N		4	55593608	55593608	G	T	DOID:1909	12460918	included	ENST00000288135	p.K558N	KIT	1	c.1674	2016-05-18 19:53:47.254307	2016-05-18 20:39:38.195643	1	ENSG00000157404	missense
1076	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/kit/132\\"}}"	\N		4	55593608	55593608	G	T	DOID:1909	18794081	included	ENST00000288135	p.K558N	KIT	1	c.1674	2016-05-18 19:53:47.262986	2016-05-18 20:39:38.242487	1	ENSG00000157404	missense
1077	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/kit/132\\"}}"	\N		4	55593609	55593611	GTT	-	DOID:1909	12460918	included	ENST00000288135	p.V559-	KIT	1	c.1675	2016-05-18 19:53:47.290706	2016-05-18 20:39:38.300308	1	ENSG00000157404	inframe
1078	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/kit/132\\"}}"	\N		4	55593609	55593611	GTT	-	DOID:1909	18794081	included	ENST00000288135	p.V559-	KIT	1	c.1675	2016-05-18 19:53:47.301433	2016-05-18 20:39:38.345007	1	ENSG00000157404	inframe
1079	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/kit/132\\"}}"	\N		4	55593610	55593610	T	A	DOID:1909	12460918	included	ENST00000288135	p.V559D	KIT	1	c.1676	2016-05-18 19:53:47.321215	2016-05-18 20:39:38.40884	1	ENSG00000157404	missense
1080	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/kit/132\\"}}"	\N		4	55593610	55593610	T	A	DOID:1909	18794081	included	ENST00000288135	p.V559D	KIT	1	c.1676	2016-05-18 19:53:47.329915	2016-05-18 20:39:38.455834	1	ENSG00000157404	missense
1081	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/thymic-carcinoma/kit/112\\"}}"	\N		4	55593610	55593610	T	C	DOID:3284	12460918	included	ENST00000288135	p.V559A	KIT	1	c.1676	2016-05-18 19:53:47.357361	2016-05-18 20:39:38.524984	1	ENSG00000157404	missense
1082	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/thymic-carcinoma/kit/112\\"}}"	\N		4	55593610	55593610	T	C	DOID:3284	18794081	included	ENST00000288135	p.V559A	KIT	1	c.1676	2016-05-18 19:53:47.367361	2016-05-18 20:39:38.58562	1	ENSG00000157404	missense
1083	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/kit/132\\"}}"	\N		4	55593610	55593610	T	G	DOID:1909	12460918	included	ENST00000288135	p.V559G	KIT	1	c.1676	2016-05-18 19:53:47.38785	2016-05-18 20:39:38.683213	1	ENSG00000157404	missense
1084	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/kit/132\\"}}"	\N		4	55593610	55593610	T	G	DOID:1909	18794081	included	ENST00000288135	p.V559G	KIT	1	c.1676	2016-05-18 19:53:47.420588	2016-05-18 20:39:38.74519	1	ENSG00000157404	missense
1085	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/thymic-carcinoma/kit/123\\"}}"	\N		4	55593612	55593612	GTT	-	DOID:3284	12460918	included	ENST00000288135	p.V560X	KIT	1	c.1678	2016-05-18 19:53:47.429711	2016-05-18 20:39:38.820925	1	ENSG00000157404	frameshift
1086	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/thymic-carcinoma/kit/123\\"}}"	\N		4	55593612	55593612	GTT	-	DOID:3284	18794081	included	ENST00000288135	p.V560X	KIT	1	c.1678	2016-05-18 19:53:47.453615	2016-05-18 20:39:38.88048	1	ENSG00000157404	frameshift
1087	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/kit/132\\"}}"	\N		4	55593613	55593613	T	A	DOID:1909	12460918	included	ENST00000288135	p.V560D	KIT	1	c.1679	2016-05-18 19:53:47.463118	2016-05-18 20:39:38.958895	1	ENSG00000157404	missense
1088	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/kit/132\\"}}"	\N		4	55593613	55593613	T	A	DOID:1909	18794081	included	ENST00000288135	p.V560D	KIT	1	c.1679	2016-05-18 19:53:47.48464	2016-05-18 20:39:39.004365	1	ENSG00000157404	missense
1089	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/kit/132\\"}}"	\N		4	55593613	55593613	T	C	DOID:1909	12460918	included	ENST00000288135	p.V560A	KIT	1	c.1679	2016-05-18 19:53:47.493185	2016-05-18 20:39:39.071825	1	ENSG00000157404	missense
1090	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/kit/132\\"}}"	\N		4	55593613	55593613	T	C	DOID:1909	18794081	included	ENST00000288135	p.V560A	KIT	1	c.1679	2016-05-18 19:53:47.515344	2016-05-18 20:39:39.126417	1	ENSG00000157404	missense
1091	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/kit/132\\"}}"	\N		4	55593613	55593613	T	G	DOID:1909	12460918	included	ENST00000288135	p.V560G	KIT	1	c.1679	2016-05-18 19:53:47.523653	2016-05-18 20:39:39.189894	1	ENSG00000157404	missense
1092	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/kit/132\\"}}"	\N		4	55593613	55593613	T	G	DOID:1909	18794081	included	ENST00000288135	p.V560G	KIT	1	c.1679	2016-05-18 19:53:47.554544	2016-05-18 20:39:39.250935	1	ENSG00000157404	missense
1093	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/kit/132\\"}}"	\N		4	55593628	55593628	G	T	DOID:1909	12460918	included	ENST00000288135	p.G565V	KIT	1	c.1694	2016-05-18 19:53:47.565076	2016-05-18 20:39:39.328242	1	ENSG00000157404	missense
1094	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/kit/132\\"}}"	\N		4	55593628	55593628	G	T	DOID:1909	18794081	included	ENST00000288135	p.G565V	KIT	1	c.1694	2016-05-18 19:53:47.589541	2016-05-18 20:39:39.383839	1	ENSG00000157404	missense
1095	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/kit/132\\"}}"	\N		4	55593630	55593630	A	G	DOID:1909	12460918	included	ENST00000288135	p.N566D	KIT	1	c.1696	2016-05-18 19:53:47.614437	2016-05-18 20:39:39.500511	1	ENSG00000157404	missense
1096	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/kit/132\\"}}"	\N		4	55593630	55593630	A	G	DOID:1909	18794081	included	ENST00000288135	p.N566D	KIT	1	c.1696	2016-05-18 19:53:47.635816	2016-05-18 20:39:39.56359	1	ENSG00000157404	missense
1097	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/kit/132\\"}}"	\N		4	55593630	55593647	AACAATTATGTTACAGAC	-	DOID:1909	12460918	included	ENST00000288135	p.NNYVYI566-	KIT	1	c.1696	2016-05-18 19:53:47.649891	2016-05-18 20:39:39.644649	1	ENSG00000157404	inframe
1098	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/kit/132\\"}}"	\N		4	55593630	55593647	AACAATTATGTTACAGAC	-	DOID:1909	18794081	included	ENST00000288135	p.NNYVYI566-	KIT	1	c.1696	2016-05-18 19:53:47.665367	2016-05-18 20:39:39.708599	1	ENSG00000157404	inframe
1099	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/kit/132\\"}}"	\N		4	55593630	55593656	AACAATTATGTTACAGACCCAACA	-	DOID:1909	18632602	included	ENST00000288135	p.NNYVYIDPT566-	KIT	1	c.1696	2016-05-18 19:53:47.689908	2016-05-18 20:39:39.779119	1	ENSG00000157404	inframe
1100	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/kit/132\\"}}"	\N		4	55593630	55593656	AACAATTATGTTACAGACCCAACA	-	DOID:1909	7651428	included	ENST00000288135	p.NNYVYIDPT566-	KIT	1	c.1696	2016-05-18 19:53:47.701017	2016-05-18 20:39:39.836748	1	ENSG00000157404	inframe
1101	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/kit/132\\"}}"	\N		4	55593640	55593640	T	G	DOID:1909	18632602	included	ENST00000288135	p.V569G	KIT	1	c.1706	2016-05-18 19:53:47.729555	2016-05-18 20:39:39.929928	1	ENSG00000157404	missense
1102	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/kit/132\\"}}"	\N		4	55593657	55593658	-	CCAGAA	DOID:1909	18060073	included	ENST00000288135	p.Q575PEX	KIT	1	c.1723	2016-05-18 19:53:47.73978	2016-05-18 20:39:40.005018	1	ENSG00000157404	frameshift
1103	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/kit/132\\"}}"	\N		4	55593657	55593658	-	CCAGAA	DOID:1909	18632602	included	ENST00000288135	p.Q575PEX	KIT	1	c.1723	2016-05-18 19:53:47.764101	2016-05-18 20:39:40.085678	1	ENSG00000157404	frameshift
1104	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/kit/132\\"}}"	\N		4	55593657	55593658	-	CCAGAG	DOID:1909	12460918	included	ENST00000288135	p.Q575PEX	KIT	1	c.1723	2016-05-18 19:53:47.776326	2016-05-18 20:39:40.16515	1	ENSG00000157404	frameshift
1105	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/kit/132\\"}}"	\N		4	55593657	55593658	-	CCAGAG	DOID:1909	18948947	included	ENST00000288135	p.Q575PEX	KIT	1	c.1723	2016-05-18 19:53:47.799536	2016-05-18 20:39:40.216373	1	ENSG00000157404	frameshift
1106	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/kit/132\\"}}"	\N		4	55593657	55593658	-	CCAGAG	DOID:1909	23515407	included	ENST00000288135	p.Q575PEX	KIT	1	c.1723	2016-05-18 19:53:47.812542	2016-05-18 20:39:40.279153	1	ENSG00000157404	frameshift
1107	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/kit/132\\"}}"	\N		4	55593657	55593658	-	CCCGAA	DOID:1909	12460918	included	ENST00000288135	p.Q575PEX	KIT	1	c.1723	2016-05-18 19:53:47.836388	2016-05-18 20:39:40.336628	1	ENSG00000157404	frameshift
1108	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/kit/132\\"}}"	\N		4	55593657	55593658	-	CCCGAA	DOID:1909	18948947	included	ENST00000288135	p.Q575PEX	KIT	1	c.1723	2016-05-18 19:53:47.848148	2016-05-18 20:39:40.38809	1	ENSG00000157404	frameshift
1109	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/kit/132\\"}}"	\N		4	55593657	55593658	-	CCCGAA	DOID:1909	23515407	included	ENST00000288135	p.Q575PEX	KIT	1	c.1723	2016-05-18 19:53:47.891337	2016-05-18 20:39:40.431415	1	ENSG00000157404	frameshift
1110	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/kit/132\\"}}"	\N		4	55593657	55593658	-	CCCGAG	DOID:1909	12460918	included	ENST00000288135	p.Q575PEX	KIT	1	c.1723	2016-05-18 19:53:47.901561	2016-05-18 20:39:40.493943	1	ENSG00000157404	frameshift
1111	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/kit/132\\"}}"	\N		4	55593657	55593658	-	CCCGAG	DOID:1909	18948947	included	ENST00000288135	p.Q575PEX	KIT	1	c.1723	2016-05-18 19:53:47.92609	2016-05-18 20:39:40.550028	1	ENSG00000157404	frameshift
1112	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/kit/132\\"}}"	\N		4	55593657	55593658	-	CCCGAG	DOID:1909	23515407	included	ENST00000288135	p.Q575PEX	KIT	1	c.1723	2016-05-18 19:53:47.94304	2016-05-18 20:39:40.592712	1	ENSG00000157404	frameshift
1113	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/kit/132\\"}}"	\N		4	55593657	55593658	-	CCGGAA	DOID:1909	24370118	included	ENST00000288135	p.Q575PEX	KIT	1	c.1723	2016-05-18 19:53:47.958092	2016-05-18 20:39:40.652588	1	ENSG00000157404	frameshift
1114	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/kit/132\\"}}"	\N		4	55593657	55593658	-	CCGGAA	DOID:1909	23515407	included	ENST00000288135	p.Q575PEX	KIT	1	c.1723	2016-05-18 19:53:47.97537	2016-05-18 20:39:40.69389	1	ENSG00000157404	frameshift
1115	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/kit/132\\"}}"	\N		4	55593657	55593658	-	CCGGAG	DOID:1909	23515407	included	ENST00000288135	p.Q575PEX	KIT	1	c.1723	2016-05-18 19:53:47.994487	2016-05-18 20:39:40.749142	1	ENSG00000157404	frameshift
1116	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/kit/132\\"}}"	\N		4	55593657	55593658	-	CCTGAA	DOID:1909	12460918	included	ENST00000288135	p.Q575PEX	KIT	1	c.1723	2016-05-18 19:53:48.006392	2016-05-18 20:39:40.81408	1	ENSG00000157404	frameshift
1117	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/kit/132\\"}}"	\N		4	55593657	55593658	-	CCTGAA	DOID:1909	18948947	included	ENST00000288135	p.Q575PEX	KIT	1	c.1723	2016-05-18 19:53:48.033077	2016-05-18 20:39:40.855648	1	ENSG00000157404	frameshift
1118	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/kit/132\\"}}"	\N		4	55593657	55593658	-	CCTGAA	DOID:1909	23515407	included	ENST00000288135	p.Q575PEX	KIT	1	c.1723	2016-05-18 19:53:48.044437	2016-05-18 20:39:40.902992	1	ENSG00000157404	frameshift
1119	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/kit/132\\"}}"	\N		4	55593657	55593658	-	CCTGAG	DOID:1909	12460918	included	ENST00000288135	p.Q575PEX	KIT	1	c.1723	2016-05-18 19:53:48.07086	2016-05-18 20:39:40.94814	1	ENSG00000157404	frameshift
1120	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/kit/132\\"}}"	\N		4	55593657	55593658	-	CCTGAG	DOID:1909	18948947	included	ENST00000288135	p.Q575PEX	KIT	1	c.1723	2016-05-18 19:53:48.082686	2016-05-18 20:39:40.99036	1	ENSG00000157404	frameshift
1121	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/kit/132\\"}}"	\N		4	55593657	55593658	-	CCTGAG	DOID:1909	23515407	included	ENST00000288135	p.Q575PEX	KIT	1	c.1723	2016-05-18 19:53:48.105385	2016-05-18 20:39:41.045998	1	ENSG00000157404	frameshift
1122	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/kit/96\\"}}"	\N		4	55593661	55593661	T	C	DOID:1909	12460918	included	ENST00000288135	p.L576P	KIT	1	c.1727	2016-05-18 19:53:48.117418	2016-05-18 20:39:41.108684	1	ENSG00000157404	missense
1123	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/kit/96\\"}}"	\N		4	55593661	55593661	T	C	DOID:1909	18948947	included	ENST00000288135	p.L576P	KIT	1	c.1727	2016-05-18 19:53:48.1449	2016-05-18 20:39:41.158321	1	ENSG00000157404	missense
1124	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/kit/96\\"}}"	\N		4	55593661	55593661	T	C	DOID:1909	23515407	included	ENST00000288135	p.L576P	KIT	1	c.1727	2016-05-18 19:53:48.156402	2016-05-18 20:39:41.208768	1	ENSG00000157404	missense
1125	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/thymic-carcinoma/kit/96\\"}}"	\N		4	55593661	55593661	T	C	DOID:3284	12460918	included	ENST00000288135	p.L576P	KIT	1	c.1727	2016-05-18 19:53:48.195304	2016-05-18 20:39:41.255556	1	ENSG00000157404	missense
1132	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/kit/132\\"}}"	\N		4	55593669	55593671	GAT	-	DOID:1909	18794081	included	ENST00000288135	p.D579-	KIT	1	c.1735	2016-05-18 19:53:48.322525	2016-05-18 20:39:41.7108	1	ENSG00000157404	inframe
1133	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/kit/132\\"}}"	\N		4	55594197	55594197	C	T	DOID:1909	16930767	included	ENST00000288135	p.R634W	KIT	1	c.1900	2016-05-18 19:53:48.34491	2016-05-18 20:39:41.779244	1	ENSG00000157404	missense
1134	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/kit/132\\"}}"	\N		4	55594197	55594197	C	T	DOID:1909	15016963	included	ENST00000288135	p.R634W	KIT	1	c.1900	2016-05-18 19:53:48.357119	2016-05-18 20:39:41.824427	1	ENSG00000157404	missense
1135	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/kit/132\\"}}"	\N		4	55594197	55594197	C	T	DOID:1909	15647370	included	ENST00000288135	p.R634W	KIT	1	c.1900	2016-05-18 19:53:48.366669	2016-05-18 20:39:41.877319	1	ENSG00000157404	missense
1136	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/kit/132\\"}}"	\N		4	55594197	55594197	C	T	DOID:1909	15254419	included	ENST00000288135	p.R634W	KIT	1	c.1900	2016-05-18 19:53:48.402198	2016-05-18 20:39:41.9299	1	ENSG00000157404	missense
1137	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/kit/132\\"}}"	\N		4	55594197	55594197	C	T	DOID:1909	20453058	included	ENST00000288135	p.R634W	KIT	1	c.1900	2016-05-18 19:53:48.411501	2016-05-18 20:39:42.015124	1	ENSG00000157404	missense
1138	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/kit/132\\"}}"	\N		4	55594197	55594197	C	T	DOID:1909	18725974	included	ENST00000288135	p.R634W	KIT	1	c.1900	2016-05-18 19:53:48.43704	2016-05-18 20:39:42.075698	1	ENSG00000157404	missense
1139	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/kit/132\\"}}"	\N		4	55594197	55594197	C	T	DOID:1909	22162589	included	ENST00000288135	p.R634W	KIT	1	c.1900	2016-05-18 19:53:48.449727	2016-05-18 20:39:42.137696	1	ENSG00000157404	missense
1140	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/kit/132\\"}}"	\N		4	55594197	55594197	C	T	DOID:1909	19513541	included	ENST00000288135	p.R634W	KIT	1	c.1900	2016-05-18 19:53:48.472289	2016-05-18 20:39:42.212909	1	ENSG00000157404	missense
1141	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/kit/132\\"}}"	\N		4	55594197	55594197	C	T	DOID:1909	19029981	included	ENST00000288135	p.R634W	KIT	1	c.1900	2016-05-18 19:53:48.480894	2016-05-18 20:39:42.268294	1	ENSG00000157404	missense
1142	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/kit/132\\"}}"	\N		4	55594197	55594197	C	T	DOID:1909	16906227	included	ENST00000288135	p.R634W	KIT	1	c.1900	2016-05-18 19:53:48.504364	2016-05-18 20:39:42.33143	1	ENSG00000157404	missense
1143	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/kit/132\\"}}"	\N		4	55594197	55594197	C	T	DOID:1909	21430269	included	ENST00000288135	p.R634W	KIT	1	c.1900	2016-05-18 19:53:48.513539	2016-05-18 20:39:42.391648	1	ENSG00000157404	missense
1144	\N	\N		4	55594221	55594221	A	G	DOID:1909	16930767	included	ENST00000288135	p.K642E	KIT	1	c.1924	2016-05-18 19:53:48.54202	2016-05-18 20:39:42.453626	1	ENSG00000157404	missense
1145	\N	\N		4	55594221	55594221	A	G	DOID:1909	15016963	included	ENST00000288135	p.K642E	KIT	1	c.1924	2016-05-18 19:53:48.550943	2016-05-18 20:39:42.514583	1	ENSG00000157404	missense
1146	\N	\N		4	55594221	55594221	A	G	DOID:1909	15647370	included	ENST00000288135	p.K642E	KIT	1	c.1924	2016-05-18 19:53:48.573162	2016-05-18 20:39:42.555239	1	ENSG00000157404	missense
1147	\N	\N		4	55594221	55594221	A	G	DOID:1909	15254419	included	ENST00000288135	p.K642E	KIT	1	c.1924	2016-05-18 19:53:48.581694	2016-05-18 20:39:42.598514	1	ENSG00000157404	missense
1148	\N	\N		4	55594221	55594221	A	G	DOID:1909	20453058	included	ENST00000288135	p.K642E	KIT	1	c.1924	2016-05-18 19:53:48.608097	2016-05-18 20:39:42.656211	1	ENSG00000157404	missense
1150	\N	\N		4	55594221	55594221	A	G	DOID:1909	22162589	included	ENST00000288135	p.K642E	KIT	1	c.1924	2016-05-18 19:53:48.639833	2016-05-18 20:39:42.734794	1	ENSG00000157404	missense
1152	\N	\N		4	55594221	55594221	A	G	DOID:1909	19029981	included	ENST00000288135	p.K642E	KIT	1	c.1924	2016-05-18 19:53:48.676416	2016-05-18 20:39:42.838717	1	ENSG00000157404	missense
1153	\N	\N		4	55594221	55594221	A	G	DOID:1909	16906227	included	ENST00000288135	p.K642E	KIT	1	c.1924	2016-05-18 19:53:48.684847	2016-05-18 20:39:42.886406	1	ENSG00000157404	missense
1154	\N	\N		4	55594221	55594221	A	G	DOID:1909	21430269	included	ENST00000288135	p.K642E	KIT	1	c.1924	2016-05-18 19:53:48.707186	2016-05-18 20:39:42.935084	1	ENSG00000157404	missense
1155	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/kit/132\\"}}"	\N		4	55594258	55594258	T	C	DOID:1909	16930767	included	ENST00000288135	p.V654A	KIT	1	c.1961	2016-05-18 19:53:48.715163	2016-05-18 20:39:43.006467	1	ENSG00000157404	missense
1156	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/kit/132\\"}}"	\N		4	55594258	55594258	T	C	DOID:1909	15016963	included	ENST00000288135	p.V654A	KIT	1	c.1961	2016-05-18 19:53:48.744762	2016-05-18 20:39:43.048795	1	ENSG00000157404	missense
1157	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/kit/132\\"}}"	\N		4	55594258	55594258	T	C	DOID:1909	15647370	included	ENST00000288135	p.V654A	KIT	1	c.1961	2016-05-18 19:53:48.754382	2016-05-18 20:39:43.114192	1	ENSG00000157404	missense
1158	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/kit/132\\"}}"	\N		4	55594258	55594258	T	C	DOID:1909	15254419	included	ENST00000288135	p.V654A	KIT	1	c.1961	2016-05-18 19:53:48.775326	2016-05-18 20:39:43.159759	1	ENSG00000157404	missense
1159	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/kit/132\\"}}"	\N		4	55594258	55594258	T	C	DOID:1909	20453058	included	ENST00000288135	p.V654A	KIT	1	c.1961	2016-05-18 19:53:48.783881	2016-05-18 20:39:43.211454	1	ENSG00000157404	missense
1160	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/kit/132\\"}}"	\N		4	55594258	55594258	T	C	DOID:1909	18725974	included	ENST00000288135	p.V654A	KIT	1	c.1961	2016-05-18 19:53:48.811808	2016-05-18 20:39:43.263761	1	ENSG00000157404	missense
1161	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/kit/132\\"}}"	\N		4	55594258	55594258	T	C	DOID:1909	22162589	included	ENST00000288135	p.V654A	KIT	1	c.1961	2016-05-18 19:53:48.820524	2016-05-18 20:39:43.317453	1	ENSG00000157404	missense
1162	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/kit/132\\"}}"	\N		4	55594258	55594258	T	C	DOID:1909	19513541	included	ENST00000288135	p.V654A	KIT	1	c.1961	2016-05-18 19:53:48.842163	2016-05-18 20:39:43.370238	1	ENSG00000157404	missense
1163	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/kit/132\\"}}"	\N		4	55594258	55594258	T	C	DOID:1909	19029981	included	ENST00000288135	p.V654A	KIT	1	c.1961	2016-05-18 19:53:48.850462	2016-05-18 20:39:43.427497	1	ENSG00000157404	missense
1164	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/kit/132\\"}}"	\N		4	55594258	55594258	T	C	DOID:1909	16906227	included	ENST00000288135	p.V654A	KIT	1	c.1961	2016-05-18 19:53:48.884712	2016-05-18 20:39:43.470837	1	ENSG00000157404	missense
1165	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/kit/132\\"}}"	\N		4	55594258	55594258	T	C	DOID:1909	21430269	included	ENST00000288135	p.V654A	KIT	1	c.1961	2016-05-18 19:53:48.910842	2016-05-18 20:39:43.545744	1	ENSG00000157404	missense
1166	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/kit/132\\"}}"	\N		4	55594261	55594261	A	G	DOID:1909	16930767	included	ENST00000288135	p.N655S	KIT	1	c.1964	2016-05-18 19:53:48.919498	2016-05-18 20:39:43.612479	1	ENSG00000157404	missense
1167	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/kit/132\\"}}"	\N		4	55594261	55594261	A	G	DOID:1909	15016963	included	ENST00000288135	p.N655S	KIT	1	c.1964	2016-05-18 19:53:48.948026	2016-05-18 20:39:43.660611	1	ENSG00000157404	missense
1168	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/kit/132\\"}}"	\N		4	55594261	55594261	A	G	DOID:1909	15647370	included	ENST00000288135	p.N655S	KIT	1	c.1964	2016-05-18 19:53:48.956805	2016-05-18 20:39:43.727399	1	ENSG00000157404	missense
1169	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/kit/132\\"}}"	\N		4	55594261	55594261	A	G	DOID:1909	15254419	included	ENST00000288135	p.N655S	KIT	1	c.1964	2016-05-18 19:53:48.982987	2016-05-18 20:39:43.772693	1	ENSG00000157404	missense
1170	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/kit/132\\"}}"	\N		4	55594261	55594261	A	G	DOID:1909	20453058	included	ENST00000288135	p.N655S	KIT	1	c.1964	2016-05-18 19:53:48.991743	2016-05-18 20:39:43.849863	1	ENSG00000157404	missense
1171	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/kit/132\\"}}"	\N		4	55594261	55594261	A	G	DOID:1909	18725974	included	ENST00000288135	p.N655S	KIT	1	c.1964	2016-05-18 19:53:49.020172	2016-05-18 20:39:43.909788	1	ENSG00000157404	missense
1172	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/kit/132\\"}}"	\N		4	55594261	55594261	A	G	DOID:1909	22162589	included	ENST00000288135	p.N655S	KIT	1	c.1964	2016-05-18 19:53:49.04254	2016-05-18 20:39:43.969743	1	ENSG00000157404	missense
1173	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/kit/132\\"}}"	\N		4	55594261	55594261	A	G	DOID:1909	19513541	included	ENST00000288135	p.N655S	KIT	1	c.1964	2016-05-18 19:53:49.050661	2016-05-18 20:39:44.014634	1	ENSG00000157404	missense
1174	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/kit/132\\"}}"	\N		4	55594261	55594261	A	G	DOID:1909	19029981	included	ENST00000288135	p.N655S	KIT	1	c.1964	2016-05-18 19:53:49.060186	2016-05-18 20:39:44.053792	1	ENSG00000157404	missense
1175	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/kit/132\\"}}"	\N		4	55594261	55594261	A	G	DOID:1909	16906227	included	ENST00000288135	p.N655S	KIT	1	c.1964	2016-05-18 19:53:49.082907	2016-05-18 20:39:44.101637	1	ENSG00000157404	missense
1176	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/kit/132\\"}}"	\N		4	55594261	55594261	A	G	DOID:1909	21430269	included	ENST00000288135	p.N655S	KIT	1	c.1964	2016-05-18 19:53:49.092691	2016-05-18 20:39:44.146532	1	ENSG00000157404	missense
1177	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/kit/132\\"}}"	\N		4	55594262	55594262	T	A	DOID:1909	20018398	included	ENST00000288135	p.N655K	KIT	1	c.1965	2016-05-18 19:53:49.114517	2016-05-18 20:39:44.217567	1	ENSG00000157404	missense
1178	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/kit/132\\"}}"	\N		4	55594262	55594262	T	A	DOID:1909	9598803	included	ENST00000288135	p.N655K	KIT	1	c.1965	2016-05-18 19:53:49.123473	2016-05-18 20:39:44.286548	1	ENSG00000157404	missense
1179	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/kit/132\\"}}"	\N		4	55594262	55594262	T	A	DOID:1909	20881644	included	ENST00000288135	p.N655K	KIT	1	c.1965	2016-05-18 19:53:49.145672	2016-05-18 20:39:44.349833	1	ENSG00000157404	missense
1180	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/kit/132\\"}}"	\N		4	55594262	55594262	T	A	DOID:1909	10555148	included	ENST00000288135	p.N655K	KIT	1	c.1965	2016-05-18 19:53:49.154241	2016-05-18 20:39:44.422632	1	ENSG00000157404	missense
1193	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/kit/275\\"}}"	\N		4	55599321	55599321	A	T	DOID:9119	23102728	included	ENST00000288135	p.D816V	KIT	1	c.2447	2016-05-18 19:53:49.381475	2016-05-18 20:39:45.334745	1	ENSG00000157404	missense
1196	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/kit/132\\"}}"	\N		4	55599333	55599333	A	T	DOID:1909	23786770	included	ENST00000288135	p.D820V	KIT	1	c.2459	2016-05-18 19:53:49.42713	2016-05-18 20:39:45.518928	1	ENSG00000157404	missense
1197	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/thymic-carcinoma/kit/120\\"}}"	\N		4	55599334	55599334	T	A	DOID:3284	23786770	included	ENST00000288135	p.D820E	KIT	1	c.2460	2016-05-18 19:53:49.452289	2016-05-18 20:39:45.585214	1	ENSG00000157404	missense
1198	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/kit/132\\"}}"	\N		4	55599338	55599338	A	T	DOID:1909	23348505	included	ENST00000288135	p.N822Y	KIT	1	c.2464	2016-05-18 19:53:49.461057	2016-05-18 20:39:45.652681	1	ENSG00000157404	missense
1199	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/kit/132\\"}}"	\N		4	55599338	55599338	A	T	DOID:1909	25157968	included	ENST00000288135	p.N822Y	KIT	1	c.2464	2016-05-18 19:53:49.489047	2016-05-18 20:39:45.698898	1	ENSG00000157404	missense
1200	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/kit/132\\"}}"	\N		4	55599339	55599339	A	T	DOID:1909	18559612	included	ENST00000288135	p.N822I	KIT	1	c.2465	2016-05-18 19:53:49.499015	2016-05-18 20:39:45.766375	1	ENSG00000157404	missense
1202	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/kit/132\\"}}"	\N		4	55599340	55599340	T	A	DOID:1909	25157968	included	ENST00000288135	p.N822K	KIT	1	c.2466	2016-05-18 19:53:49.552839	2016-05-18 20:39:45.915428	1	ENSG00000157404	missense
1203	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/kit/132\\"}}"	\N		4	55599340	55599340	T	G	DOID:1909	22357254	included	ENST00000288135	p.N822K	KIT	1	c.2466	2016-05-18 19:53:49.562187	2016-05-18 20:39:46.035843	1	ENSG00000157404	missense
1428	\N	\N		1	115258748	115258748	C	T	DOID:9119	19679400	included	ENST00000369535	p.G12S	NRAS	-1	c.34	2016-05-18 20:26:14.684383	2016-05-18 20:39:58.677037	2	ENSG00000213281	missense
1204	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/kit/132\\"}}"	\N		4	55599340	55599340	T	G	DOID:1909	21325067	included	ENST00000288135	p.N822K	KIT	1	c.2466	2016-05-18 19:53:49.583488	2016-05-18 20:39:46.104517	1	ENSG00000157404	missense
1205	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/kit/132\\"}}"	\N		4	55599341	55599341	T	G	DOID:1909	21969494	included	ENST00000288135	p.Y823D	KIT	1	c.2467	2016-05-18 19:53:49.591809	2016-05-18 20:39:46.202173	1	ENSG00000157404	missense
1206	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/kit/132\\"}}"	\N		4	55599341	55599341	T	G	DOID:1909	22357254	included	ENST00000288135	p.Y823D	KIT	1	c.2467	2016-05-18 19:53:49.620115	2016-05-18 20:39:46.255227	1	ENSG00000157404	missense
1208	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/kit/132\\"}}"	\N		4	55602664	55602664	G	C	DOID:1909	12960119	included	ENST00000288135	p.A829P	KIT	1	c.2485	2016-05-18 19:53:49.651508	2016-05-18 20:39:46.379232	1	ENSG00000157404	missense
1209	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/kit/132\\"}}"	\N		4	55602664	55602664	G	C	DOID:1909	22357254	included	ENST00000288135	p.A829P	KIT	1	c.2485	2016-05-18 19:53:49.661026	2016-05-18 20:39:46.432636	1	ENSG00000157404	missense
1210	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/kit/132\\"}}"	\N		4	55602700	55602700	A	G	DOID:1909	20736294	included	ENST00000288135	p.I841V	KIT	1	c.2521	2016-05-18 19:53:49.682887	2016-05-18 20:39:46.516996	1	ENSG00000157404	missense
1211	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/kit/132\\"}}"	\N		4	55602700	55602700	A	G	DOID:1909	12960119	included	ENST00000288135	p.I841V	KIT	1	c.2521	2016-05-18 19:53:49.691843	2016-05-18 20:39:46.581472	1	ENSG00000157404	missense
1212	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/kit/132\\"}}"	\N		4	55602700	55602700	A	G	DOID:1909	22357254	included	ENST00000288135	p.I841V	KIT	1	c.2521	2016-05-18 19:53:49.721302	2016-05-18 20:39:46.631196	1	ENSG00000157404	missense
1213	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/kit/132\\"}}"	\N		4	55602770	55602770	C	T	DOID:1909	19861435	included	ENST00000288135	p.S864F	KIT	1	c.2591	2016-05-18 19:53:49.731146	2016-05-18 20:39:46.706705	1	ENSG00000157404	missense
1214	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/kit/132\\"}}"	\N		4	55602770	55602770	C	T	DOID:1909	15201427	included	ENST00000288135	p.S864F	KIT	1	c.2591	2016-05-18 19:53:49.752723	2016-05-18 20:39:46.750342	1	ENSG00000157404	missense
1215	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/kit/132\\"}}"	\N		4	55602770	55602770	C	T	DOID:1909	17372901	included	ENST00000288135	p.S864F	KIT	1	c.2591	2016-05-18 19:53:49.762557	2016-05-18 20:39:46.806805	1	ENSG00000157404	missense
1216	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/kit/132\\"}}"	\N		4	55602770	55602770	C	T	DOID:1909	15930355	included	ENST00000288135	p.S864F	KIT	1	c.2591	2016-05-18 19:53:49.772732	2016-05-18 20:39:46.853494	1	ENSG00000157404	missense
1228	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/basal-cell-carcinoma/smo/166\\"}}"	\N		7	128846116	128846117	CC	TT	DOID:2513	18552176	included	ENST00000249373	p.T349I	SMO	1	c.1046	2016-05-18 19:53:49.897139	2016-05-18 20:39:47.050138	1	ENSG00000128602	missense
1229	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/basal-cell-carcinoma/smo/166\\"}}"	\N		7	128846116	128846117	CC	TT	DOID:2513	22238366	included	ENST00000249373	p.T349I	SMO	1	c.1046	2016-05-18 19:53:49.906912	2016-05-18 20:39:47.111615	1	ENSG00000128602	missense
1230	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/basal-cell-carcinoma/smo/166\\"}}"	\N		7	128846116	128846117	CC	TT	DOID:2513	23002168	included	ENST00000249373	p.T349I	SMO	1	c.1046	2016-05-18 19:53:49.917963	2016-05-18 20:39:47.154459	1	ENSG00000128602	missense
1231	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/basal-cell-carcinoma/smo/163\\"}}"	\N		7	128849189	128849189	G	C	DOID:2513	23908597	included	ENST00000249373	p.D473H	SMO	1	c.1417	2016-05-18 19:53:49.927154	2016-05-18 20:39:47.224154	1	ENSG00000128602	missense
1235	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/basal-cell-carcinoma/smo/167\\"}}"	\N		7	128849224	128849225	CC	TT	DOID:2513	23908597	included	ENST00000249373	p.FR484FW	SMO	1	c.1452	2016-05-18 19:53:49.968259	2016-05-18 20:39:47.282454	1	ENSG00000128602	missense
1236	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/basal-cell-carcinoma/smo/168\\"}}"	\N		7	128850279	128850280	CC	TT	DOID:2513	23908597	included	ENST00000249373	p.SL514SF	SMO	1	c.1542	2016-05-18 19:53:49.977569	2016-05-18 20:39:47.338772	1	ENSG00000128602	missense
1237	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/basal-cell-carcinoma/smo/169\\"}}"	\N		7	128850341	128850341	G	T	DOID:2513	23908597	included	ENST00000249373	p.W535L	SMO	1	c.1604	2016-05-18 19:53:49.988187	2016-05-18 20:39:47.39483	1	ENSG00000128602	missense
1238	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/basal-cell-carcinoma/smo/170\\"}}"	\N		7	128850838	128850838	G	A	DOID:2513	23908597	included	ENST00000249373	p.R562Q	SMO	1	c.1685	2016-05-18 19:53:49.997286	2016-05-18 20:39:47.465412	1	ENSG00000128602	missense
1239	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/basal-cell-carcinoma/smo/171\\"}}"	\N		7	128851883	128851883	C	T	DOID:2513	23908597	included	ENST00000249373	p.A652V	SMO	1	c.1955	2016-05-18 19:53:50.006628	2016-05-18 20:39:47.552956	1	ENSG00000128602	missense
1240	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/basal-cell-carcinoma/smo/172\\"}}"	\N		7	128852191	128852192	CC	TT	DOID:2513	23908597	included	ENST00000249373	p.P755F	SMO	1	c.2263	2016-05-18 19:53:50.0183	2016-05-18 20:39:47.628891	1	ENSG00000128602	missense
1241	\N	\N		7	140453134	140453134	T	C	DOID:1909	23908597	included	ENST00000288602	p.K601E	BRAF	-1	c.1801	2016-05-18 19:53:50.027009	2016-05-18 20:39:47.725042	1	ENSG00000157764	missense
1242	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/braf/114\\"}}"	\N		7	140453135	140453136	CA	AT	DOID:1909	23908597	included	ENST00000288602	p.V600D	BRAF	-1	c.1799	2016-05-18 19:53:50.036184	2016-05-18 20:39:47.824123	1	ENSG00000157764	missense
1243	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/braf/115\\"}}"	\N		7	140453136	140453136	A	C	DOID:1909	23908597	included	ENST00000288602	p.V600G	BRAF	-1	c.1799	2016-05-18 19:53:50.045252	2016-05-18 20:39:47.940973	1	ENSG00000157764	missense
1244	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/lung-cancer/braf/54\\"}}"	\N		7	140453136	140453136	A	T	DOID:1324	23908597	included	ENST00000288602	p.V600E	BRAF	-1	c.1799	2016-05-18 19:53:50.05876	2016-05-18 20:39:48.089379	1	ENSG00000157764	missense
1245	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/thyroid-cancer/braf/54\\"}}"	\N		7	140453136	140453136	A	T	DOID:1781	18552176	included	ENST00000288602	p.V600E	BRAF	-1	c.1799	2016-05-18 19:53:50.067856	2016-05-18 20:39:48.18581	1	ENSG00000157764	missense
1430	\N	\N		1	115258748	115258748	C	T	DOID:9119	19114683	included	ENST00000369535	p.G12S	NRAS	-1	c.34	2016-05-18 20:26:14.703175	2016-05-18 20:39:58.775123	2	ENSG00000213281	missense
1246	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/thyroid-cancer/braf/54\\"}}"	\N		7	140453136	140453136	A	T	DOID:1781	22238366	included	ENST00000288602	p.V600E	BRAF	-1	c.1799	2016-05-18 19:53:50.077678	2016-05-18 20:39:48.271416	1	ENSG00000157764	missense
1247	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/thyroid-cancer/braf/54\\"}}"	\N		7	140453136	140453136	A	T	DOID:1781	23002168	included	ENST00000288602	p.V600E	BRAF	-1	c.1799	2016-05-18 19:53:50.090739	2016-05-18 20:39:48.348596	1	ENSG00000157764	missense
1248	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/ovarian-cancer/braf/54\\"}}"	\N		7	140453136	140453136	A	T	DOID:2394	21984976	included	ENST00000288602	p.V600E	BRAF	-1	c.1799	2016-05-18 19:53:50.109669	2016-05-18 20:39:48.402081	1	ENSG00000157764	missense
1249	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/gist/braf/54\\"}}"	\N		7	140453136	140453136	A	T	DOID:9253	23696637	included	ENST00000288602	p.V600E	BRAF	-1	c.1799	2016-05-18 19:53:50.125144	2016-05-18 20:39:48.473146	1	ENSG00000157764	missense
1250	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/54\\"}}"	\N		7	140453136	140453136	A	T	DOID:9256	23696637	included	ENST00000288602	p.V600E	BRAF	-1	c.1799	2016-05-18 19:53:50.134073	2016-05-18 20:39:48.52597	1	ENSG00000157764	missense
1251	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/braf/118\\"}}"	\N		7	140453136	140453137	AC	CT	DOID:1909	18971950	included	ENST00000288602	p.V600R	BRAF	-1	c.1798	2016-05-18 19:53:50.144582	2016-05-18 20:39:48.620491	1	ENSG00000157764	missense
1252	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/braf/116\\"}}"	\N		7	140453136	140453137	AC	TT	DOID:1909	16834459	included	ENST00000288602	p.V600K	BRAF	-1	c.1798	2016-05-18 19:53:50.156315	2016-05-18 20:39:48.702727	1	ENSG00000157764	missense
1253	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/ovarian-cancer/braf/138\\"}}"	\N		7	140453145	140453145	A	C	DOID:2394	19726788	included	ENST00000288602	p.L597R	BRAF	-1	c.1790	2016-05-18 19:53:50.179363	2016-05-18 20:39:48.787827	1	ENSG00000157764	missense
1254	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/ovarian-cancer/braf/138\\"}}"	\N		7	140453145	140453145	A	C	DOID:2394	22679179	included	ENST00000288602	p.L597R	BRAF	-1	c.1790	2016-05-18 19:53:50.189304	2016-05-18 20:39:48.865011	1	ENSG00000157764	missense
1255	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/braf/301\\"}}"	\N		7	140453153	140453153	A	T	DOID:1909	25157968	included	ENST00000288602	p.D594E	BRAF	-1	c.1782	2016-05-18 19:53:50.246463	2016-05-18 20:39:48.941295	1	ENSG00000157764	missense
1256	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/149\\"}}"	\N		7	140453154	140453154	T	A	DOID:9256	21683865	included	ENST00000288602	p.D594V	BRAF	-1	c.1781	2016-05-18 19:53:50.273591	2016-05-18 20:39:49.007341	1	ENSG00000157764	missense
1258	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/149\\"}}"	\N		7	140453154	140453154	T	A	DOID:9256	12068308	included	ENST00000288602	p.D594V	BRAF	-1	c.1781	2016-05-18 19:53:50.300982	2016-05-18 20:39:49.104957	1	ENSG00000157764	missense
1259	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/149\\"}}"	\N		7	140453154	140453154	T	A	DOID:9256	20818844	included	ENST00000288602	p.D594V	BRAF	-1	c.1781	2016-05-18 19:53:50.320075	2016-05-18 20:39:49.151394	1	ENSG00000157764	missense
1260	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/149\\"}}"	\N		7	140453154	140453154	T	A	DOID:9256	21639808	included	ENST00000288602	p.D594V	BRAF	-1	c.1781	2016-05-18 19:53:50.328926	2016-05-18 20:39:49.220377	1	ENSG00000157764	missense
1261	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/149\\"}}"	\N		7	140453154	140453154	T	A	DOID:9256	22608338	included	ENST00000288602	p.D594V	BRAF	-1	c.1781	2016-05-18 19:53:50.338282	2016-05-18 20:39:49.284153	1	ENSG00000157764	missense
1262	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/149\\"}}"	\N		7	140453154	140453154	T	A	DOID:9256	19018267	included	ENST00000288602	p.D594V	BRAF	-1	c.1781	2016-05-18 19:53:50.351825	2016-05-18 20:39:49.350514	1	ENSG00000157764	missense
1263	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/braf/148\\"}}"	\N		7	140453154	140453154	T	C	DOID:1909	21683865	included	ENST00000288602	p.D594G	BRAF	-1	c.1781	2016-05-18 19:53:50.360233	2016-05-18 20:39:49.452297	1	ENSG00000157764	missense
1264	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/braf/148\\"}}"	\N		7	140453154	140453154	T	C	DOID:1909	21975775	included	ENST00000288602	p.D594G	BRAF	-1	c.1781	2016-05-18 19:53:50.375858	2016-05-18 20:39:49.509855	1	ENSG00000157764	missense
1265	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/braf/148\\"}}"	\N		7	140453154	140453154	T	C	DOID:1909	12068308	included	ENST00000288602	p.D594G	BRAF	-1	c.1781	2016-05-18 19:53:50.385159	2016-05-18 20:39:49.569683	1	ENSG00000157764	missense
1266	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/braf/148\\"}}"	\N		7	140453154	140453154	T	C	DOID:1909	20818844	included	ENST00000288602	p.D594G	BRAF	-1	c.1781	2016-05-18 19:53:50.394593	2016-05-18 20:39:49.612669	1	ENSG00000157764	missense
1267	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/braf/148\\"}}"	\N		7	140453154	140453154	T	C	DOID:1909	21639808	included	ENST00000288602	p.D594G	BRAF	-1	c.1781	2016-05-18 19:53:50.404738	2016-05-18 20:39:49.667786	1	ENSG00000157764	missense
1268	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/braf/148\\"}}"	\N		7	140453154	140453154	T	C	DOID:1909	22608338	included	ENST00000288602	p.D594G	BRAF	-1	c.1781	2016-05-18 19:53:50.421782	2016-05-18 20:39:49.73023	1	ENSG00000157764	missense
1269	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/148\\"}}"	\N		7	140453154	140453154	T	C	DOID:9256	21683865	included	ENST00000288602	p.D594G	BRAF	-1	c.1781	2016-05-18 19:53:50.437226	2016-05-18 20:39:49.784851	1	ENSG00000157764	missense
1270	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/148\\"}}"	\N		7	140453154	140453154	T	C	DOID:9256	21975775	included	ENST00000288602	p.D594G	BRAF	-1	c.1781	2016-05-18 19:53:50.452149	2016-05-18 20:39:49.830883	1	ENSG00000157764	missense
1271	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/148\\"}}"	\N		7	140453154	140453154	T	C	DOID:9256	12068308	included	ENST00000288602	p.D594G	BRAF	-1	c.1781	2016-05-18 19:53:50.460458	2016-05-18 20:39:49.885118	1	ENSG00000157764	missense
1272	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/148\\"}}"	\N		7	140453154	140453154	T	C	DOID:9256	22798288	included	ENST00000288602	p.D594G	BRAF	-1	c.1781	2016-05-18 19:53:50.47101	2016-05-18 20:39:49.926903	1	ENSG00000157764	missense
1431	\N	\N		1	115258748	115258748	C	T	DOID:9119	21228335	included	ENST00000369535	p.G12S	NRAS	-1	c.34	2016-05-18 20:26:14.71341	2016-05-18 20:39:58.825279	2	ENSG00000213281	missense
1273	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/braf/300\\"}}"	\N		7	140453155	140453155	C	G	DOID:1909	21975775	included	ENST00000288602	p.D594H	BRAF	-1	c.1780	2016-05-18 19:53:50.480749	2016-05-18 20:39:49.998721	1	ENSG00000157764	missense
1274	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/braf/300\\"}}"	\N		7	140453155	140453155	C	G	DOID:1909	19018267	included	ENST00000288602	p.D594H	BRAF	-1	c.1780	2016-05-18 19:53:50.492899	2016-05-18 20:39:50.047865	1	ENSG00000157764	missense
1275	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/braf/298\\"}}"	\N		7	140453155	140453155	C	T	DOID:1909	21975775	included	ENST00000288602	p.D594N	BRAF	-1	c.1780	2016-05-18 19:53:50.503357	2016-05-18 20:39:50.098852	1	ENSG00000157764	missense
1276	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/braf/298\\"}}"	\N		7	140453155	140453155	C	T	DOID:1909	19018267	included	ENST00000288602	p.D594N	BRAF	-1	c.1780	2016-05-18 19:53:50.523857	2016-05-18 20:39:50.150556	1	ENSG00000157764	missense
1277	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/braf/299\\"}}"	\N		7	140453155	140453156	CA	TC	DOID:1909	21975775	included	ENST00000288602	p.GD593GN	BRAF	-1	c.1779	2016-05-18 19:53:50.532523	2016-05-18 20:39:50.218523	1	ENSG00000157764	missense
1278	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/braf/299\\"}}"	\N		7	140453155	140453156	CA	TC	DOID:1909	19018267	included	ENST00000288602	p.GD593GN	BRAF	-1	c.1779	2016-05-18 19:53:50.553612	2016-05-18 20:39:50.270577	1	ENSG00000157764	missense
1279	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/lung-cancer/braf/209\\"}}"	\N		7	140481393	140481393	T	C	DOID:1324	21975775	included	ENST00000288602	p.Y472C	BRAF	-1	c.1415	2016-05-18 19:53:50.562055	2016-05-18 20:39:50.338741	1	ENSG00000157764	missense
1280	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/lung-cancer/braf/209\\"}}"	\N		7	140481393	140481393	T	C	DOID:1324	19018267	included	ENST00000288602	p.Y472C	BRAF	-1	c.1415	2016-05-18 19:53:50.571527	2016-05-18 20:39:50.405462	1	ENSG00000157764	missense
1281	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/147\\"}}"	\N		7	140481402	140481402	C	A	DOID:9256	15647370	included	ENST00000496384	p.G77V	BRAF	-1	c.230	2016-05-18 19:53:50.584054	2016-05-18 20:39:50.483747	1	ENSG00000157764	missense
1282	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/147\\"}}"	\N		7	140481402	140481402	C	A	DOID:9256	22271473	included	ENST00000496384	p.G77V	BRAF	-1	c.230	2016-05-18 19:53:50.593072	2016-05-18 20:39:50.556896	1	ENSG00000157764	missense
1283	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/lung-cancer/braf/71\\"}}"	\N		7	140481402	140481402	C	G	DOID:1324	15647370	included	ENST00000288602	p.G469A	BRAF	-1	c.1406	2016-05-18 19:53:50.601269	2016-05-18 20:39:50.653368	1	ENSG00000157764	missense
1284	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/lung-cancer/braf/71\\"}}"	\N		7	140481402	140481402	C	G	DOID:1324	22271473	included	ENST00000288602	p.G469A	BRAF	-1	c.1406	2016-05-18 19:53:50.611018	2016-05-18 20:39:50.720284	1	ENSG00000157764	missense
1285	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/71\\"}}"	\N		7	140481402	140481402	C	G	DOID:9256	15647370	included	ENST00000288602	p.G469A	BRAF	-1	c.1406	2016-05-18 19:53:50.630861	2016-05-18 20:39:50.788544	1	ENSG00000157764	missense
1287	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/146\\"}}"	\N		7	140481402	140481402	C	T	DOID:9256	15647370	included	ENST00000288602	p.G469E	BRAF	-1	c.1406	2016-05-18 19:53:50.660282	2016-05-18 20:39:50.928355	1	ENSG00000157764	missense
1289	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/lung-cancer/braf/310\\"}}"	\N		7	140481402	140481403	CC	AA	DOID:1324	15647370	included	ENST00000496384	p.G77L	BRAF	-1	c.229	2016-05-18 19:53:50.69971	2016-05-18 20:39:51.042519	1	ENSG00000157764	missense
1290	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/lung-cancer/braf/310\\"}}"	\N		7	140481402	140481403	CC	AA	DOID:1324	22271473	included	ENST00000496384	p.G77L	BRAF	-1	c.229	2016-05-18 19:53:50.710032	2016-05-18 20:39:51.082872	1	ENSG00000157764	missense
1291	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/lung-cancer/braf/70\\"}}"	\N		7	140481411	140481411	C	A	DOID:1324	15647370	included	ENST00000288602	p.G466V	BRAF	-1	c.1397	2016-05-18 19:53:50.730998	2016-05-18 20:39:51.144062	1	ENSG00000157764	missense
1292	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/lung-cancer/braf/70\\"}}"	\N		7	140481411	140481411	C	A	DOID:1324	22271473	included	ENST00000288602	p.G466V	BRAF	-1	c.1397	2016-05-18 19:53:50.756499	2016-05-18 20:39:51.187634	1	ENSG00000157764	missense
1293	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/70\\"}}"	\N		7	140481411	140481411	C	A	DOID:9256	18767981	included	ENST00000288602	p.G466V	BRAF	-1	c.1397	2016-05-18 19:53:50.764346	2016-05-18 20:39:51.23485	1	ENSG00000157764	missense
1294	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/70\\"}}"	\N		7	140481411	140481411	C	A	DOID:9256	20085938	included	ENST00000288602	p.G466V	BRAF	-1	c.1397	2016-05-18 19:53:50.799222	2016-05-18 20:39:51.271374	1	ENSG00000157764	missense
1295	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/70\\"}}"	\N		7	140481411	140481411	C	A	DOID:9256	11504908	included	ENST00000288602	p.G466V	BRAF	-1	c.1397	2016-05-18 19:53:50.808556	2016-05-18 20:39:51.315308	1	ENSG00000157764	missense
1296	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/lung-cancer/egfr/3\\"}}"	\N		7	55241707	55241707	G	A	DOID:3908	18767981	included	ENST00000275493	p.G719S	EGFR	1	c.2155	2016-05-18 19:53:50.829735	2016-05-18 20:39:51.385972	1	ENSG00000146648	missense
1297	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/lung-cancer/egfr/3\\"}}"	\N		7	55241707	55241707	G	A	DOID:3908	20085938	included	ENST00000275493	p.G719S	EGFR	1	c.2155	2016-05-18 19:53:50.83902	2016-05-18 20:39:51.428762	1	ENSG00000146648	missense
1298	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/lung-cancer/egfr/3\\"}}"	\N		7	55241707	55241707	G	A	DOID:3908	11504908	included	ENST00000275493	p.G719S	EGFR	1	c.2155	2016-05-18 19:53:50.867311	2016-05-18 20:39:51.46747	1	ENSG00000146648	missense
1299	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/lung-cancer/egfr/2\\"}}"	\N		7	55241707	55241707	G	T	DOID:3908	18767981	included	ENST00000275493	p.G719C	EGFR	1	c.2155	2016-05-18 19:53:50.877028	2016-05-18 20:39:51.529185	1	ENSG00000146648	missense
1300	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/lung-cancer/egfr/2\\"}}"	\N		7	55241707	55241707	G	T	DOID:3908	20085938	included	ENST00000275493	p.G719C	EGFR	1	c.2155	2016-05-18 19:53:50.898276	2016-05-18 20:39:51.587017	1	ENSG00000146648	missense
1301	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/lung-cancer/egfr/2\\"}}"	\N		7	55241707	55241707	G	T	DOID:3908	11504908	included	ENST00000275493	p.G719C	EGFR	1	c.2155	2016-05-18 19:53:50.908212	2016-05-18 20:39:51.642177	1	ENSG00000146648	missense
1302	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/lung-cancer/egfr/1\\"}}"	\N		7	55241708	55241708	G	C	DOID:3908	18528423	included	ENST00000275493	p.G719A	EGFR	1	c.2156	2016-05-18 19:53:50.929182	2016-05-18 20:39:51.721664	1	ENSG00000146648	missense
1303	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/lung-cancer/egfr/1\\"}}"	\N		7	55241708	55241708	G	C	DOID:3908	18451306	included	ENST00000275493	p.G719A	EGFR	1	c.2156	2016-05-18 19:53:50.961932	2016-05-18 20:39:51.764512	1	ENSG00000146648	missense
1304	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/lung-cancer/egfr/1\\"}}"	\N		7	55241708	55241708	G	C	DOID:3908	23970983	included	ENST00000275493	p.G719A	EGFR	1	c.2156	2016-05-18 19:53:50.972704	2016-05-18 20:39:51.826303	1	ENSG00000146648	missense
1305	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/lung-cancer/egfr/4\\"}}"	\N		7	55249071	55249071	C	T	DOID:3908	21228032	included	ENST00000275493	p.T790M	EGFR	1	c.2369	2016-05-18 19:53:50.992416	2016-05-18 20:39:51.882583	1	ENSG00000146648	missense
1306	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/lung-cancer/egfr/5\\"}}"	\N		7	55259515	55259515	T	G	DOID:3908	20151976	included	ENST00000275493	p.L858R	EGFR	1	c.2573	2016-05-18 19:53:51.000779	2016-05-18 20:39:51.942477	1	ENSG00000146648	missense
1307	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/lung-cancer/egfr/5\\"}}"	\N		7	55259515	55259515	T	G	DOID:3908	18451306	included	ENST00000275493	p.L858R	EGFR	1	c.2573	2016-05-18 19:53:51.028369	2016-05-18 20:39:51.999934	1	ENSG00000146648	missense
1308	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/lung-cancer/egfr/5\\"}}"	\N		7	55259515	55259515	T	G	DOID:3908	18528423	included	ENST00000275493	p.L858R	EGFR	1	c.2573	2016-05-18 19:53:51.03766	2016-05-18 20:39:52.069717	1	ENSG00000146648	missense
1309	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/lung-cancer/egfr/6\\"}}"	\N		7	55259524	55259524	T	A	DOID:3908	19608689	included	ENST00000275493	p.L861Q	EGFR	1	c.2582	2016-05-18 19:53:51.058797	2016-05-18 20:39:52.152399	1	ENSG00000146648	missense
1310	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/jak2/200\\"}}"	\N		9	5078360	5078360	A	G	DOID:1037	24265152	included	ENST00000381652	p.R683G	JAK2	1	c.2047	2016-05-18 19:53:51.067334	2016-05-18 20:39:52.231686	1	ENSG00000096968	missense
1311	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/jak2/203\\"}}"	\N		9	5078361	5078361	G	C	DOID:1037	23248257	included	ENST00000381652	p.R683T	JAK2	1	c.2048	2016-05-18 19:53:51.102442	2016-05-18 20:39:52.31033	1	ENSG00000096968	missense
1312	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/jak2/202\\"}}"	\N		9	5078362	5078362	A	C	DOID:1037	14679157	included	ENST00000381652	p.R683S	JAK2	1	c.2049	2016-05-18 19:53:51.126702	2016-05-18 20:39:52.418518	1	ENSG00000096968	missense
1313	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/jak2/202\\"}}"	\N		9	5078362	5078362	A	C	DOID:1037	12068308	included	ENST00000381652	p.R683S	JAK2	1	c.2049	2016-05-18 19:53:51.135522	2016-05-18 20:39:52.478579	1	ENSG00000096968	missense
1314	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/jak2/202\\"}}"	\N		9	5078362	5078362	A	C	DOID:1037	22798288	included	ENST00000381652	p.R683S	JAK2	1	c.2049	2016-05-18 19:53:51.163195	2016-05-18 20:39:52.548859	1	ENSG00000096968	missense
1315	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/jak2/202\\"}}"	\N		9	5078362	5078362	A	C	DOID:1037	20818844	included	ENST00000381652	p.R683S	JAK2	1	c.2049	2016-05-18 19:53:51.173949	2016-05-18 20:39:52.618316	1	ENSG00000096968	missense
1316	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/jak2/202\\"}}"	\N		9	5078362	5078362	A	C	DOID:1037	21639808	included	ENST00000381652	p.R683S	JAK2	1	c.2049	2016-05-18 19:53:51.184665	2016-05-18 20:39:52.684851	1	ENSG00000096968	missense
1317	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/jak2/202\\"}}"	\N		9	5078362	5078362	A	C	DOID:1037	22356324	included	ENST00000381652	p.R683S	JAK2	1	c.2049	2016-05-18 19:53:51.198342	2016-05-18 20:39:52.744671	1	ENSG00000096968	missense
1318	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/jak2/202\\"}}"	\N		9	5078362	5078362	A	C	DOID:1037	22663011	included	ENST00000381652	p.R683S	JAK2	1	c.2049	2016-05-18 19:53:51.20859	2016-05-18 20:39:52.792196	1	ENSG00000096968	missense
1320	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/jak2/202\\"}}"	\N		9	5078362	5078362	A	C	DOID:1037	22048237	included	ENST00000381652	p.R683S	JAK2	1	c.2049	2016-05-18 19:53:51.242359	2016-05-18 20:39:52.883064	1	ENSG00000096968	missense
1321	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/jak2/202\\"}}"	\N		9	5078362	5078362	A	C	DOID:1037	22972589	included	ENST00000381652	p.R683S	JAK2	1	c.2049	2016-05-18 19:53:51.270854	2016-05-18 20:39:52.937906	1	ENSG00000096968	missense
1322	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/jak2/201\\"}}"	\N		9	5078362	5078362	A	T	DOID:1037	12068308	included	ENST00000381652	p.R683S	JAK2	1	c.2049	2016-05-18 19:53:51.295553	2016-05-18 20:39:52.996635	1	ENSG00000096968	missense
1323	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/jak2/201\\"}}"	\N		9	5078362	5078362	A	T	DOID:1037	14679157	included	ENST00000381652	p.R683S	JAK2	1	c.2049	2016-05-18 19:53:51.304262	2016-05-18 20:39:53.040962	1	ENSG00000096968	missense
1324	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/jak2/201\\"}}"	\N		9	5078362	5078362	A	T	DOID:1037	22048237	included	ENST00000381652	p.R683S	JAK2	1	c.2049	2016-05-18 19:53:51.326518	2016-05-18 20:39:53.088415	1	ENSG00000096968	missense
1325	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/jak2/201\\"}}"	\N		9	5078362	5078362	A	T	DOID:1037	22972589	included	ENST00000381652	p.R683S	JAK2	1	c.2049	2016-05-18 19:53:51.334732	2016-05-18 20:39:53.149408	1	ENSG00000096968	missense
1326	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/jak2/201\\"}}"	\N		9	5078362	5078362	A	T	DOID:1037	22663011	included	ENST00000381652	p.R683S	JAK2	1	c.2049	2016-05-18 19:53:51.367041	2016-05-18 20:39:53.194536	1	ENSG00000096968	missense
1327	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/jak2/201\\"}}"	\N		9	5078362	5078362	A	T	DOID:1037	22805292	included	ENST00000381652	p.R683S	JAK2	1	c.2049	2016-05-18 19:53:51.377295	2016-05-18 20:39:53.2471	1	ENSG00000096968	missense
1328	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/jak2/201\\"}}"	\N		9	5078362	5078362	A	T	DOID:1037	20630094	included	ENST00000381652	p.R683S	JAK2	1	c.2049	2016-05-18 19:53:51.398682	2016-05-18 20:39:53.299206	1	ENSG00000096968	missense
1329	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/jak2/201\\"}}"	\N		9	5078362	5078362	A	T	DOID:1037	21639808	included	ENST00000381652	p.R683S	JAK2	1	c.2049	2016-05-18 19:53:51.407714	2016-05-18 20:39:53.348884	1	ENSG00000096968	missense
1330	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/jak2/201\\"}}"	\N		9	5078362	5078362	A	T	DOID:1037	22608338	included	ENST00000381652	p.R683S	JAK2	1	c.2049	2016-05-18 19:53:51.429915	2016-05-18 20:39:53.396967	1	ENSG00000096968	missense
1331	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/jak2/201\\"}}"	\N		9	5078362	5078362	A	T	DOID:1037	23020132	included	ENST00000381652	p.R683S	JAK2	1	c.2049	2016-05-18 19:53:51.438876	2016-05-18 20:39:53.444552	1	ENSG00000096968	missense
1332	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/jak2/201\\"}}"	\N		9	5078362	5078362	A	T	DOID:1037	20818844	included	ENST00000381652	p.R683S	JAK2	1	c.2049	2016-05-18 19:53:51.470752	2016-05-18 20:39:53.501492	1	ENSG00000096968	missense
1333	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/jak2/201\\"}}"	\N		9	5078362	5078362	A	T	DOID:1037	22735384	included	ENST00000381652	p.R683S	JAK2	1	c.2049	2016-05-18 19:53:51.481377	2016-05-18 20:39:53.544231	1	ENSG00000096968	missense
1334	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/jak2/201\\"}}"	\N		9	5078362	5078362	A	T	DOID:1037	22356324	included	ENST00000381652	p.R683S	JAK2	1	c.2049	2016-05-18 19:53:51.500653	2016-05-18 20:39:53.588359	1	ENSG00000096968	missense
1335	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/jak2/201\\"}}"	\N		9	5078362	5078362	A	T	DOID:1037	20551065	included	ENST00000381652	p.R683S	JAK2	1	c.2049	2016-05-18 19:53:51.509302	2016-05-18 20:39:53.627374	1	ENSG00000096968	missense
1336	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/gnaq/100\\"}}"	\N		9	80409488	80409488	T	A	DOID:1909	12068308	included	ENST00000286548	p.Q209L	GNAQ	-1	c.626	2016-05-18 19:53:51.538422	2016-05-18 20:39:53.687362	1	ENSG00000156052	missense
1337	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/gnaq/100\\"}}"	\N		9	80409488	80409488	T	A	DOID:1909	14679157	included	ENST00000286548	p.Q209L	GNAQ	-1	c.626	2016-05-18 19:53:51.563174	2016-05-18 20:39:53.727014	1	ENSG00000156052	missense
1338	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/gnaq/100\\"}}"	\N		9	80409488	80409488	T	A	DOID:1909	21639808	included	ENST00000286548	p.Q209L	GNAQ	-1	c.626	2016-05-18 19:53:51.571314	2016-05-18 20:39:53.769505	1	ENSG00000156052	missense
1339	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/gnaq/100\\"}}"	\N		9	80409488	80409488	T	A	DOID:1909	22608338	included	ENST00000286548	p.Q209L	GNAQ	-1	c.626	2016-05-18 19:53:51.600332	2016-05-18 20:39:53.814164	1	ENSG00000156052	missense
1340	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/gnaq/100\\"}}"	\N		9	80409488	80409488	T	A	DOID:1909	23020132	included	ENST00000286548	p.Q209L	GNAQ	-1	c.626	2016-05-18 19:53:51.61002	2016-05-18 20:39:53.854063	1	ENSG00000156052	missense
1341	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/gnaq/100\\"}}"	\N		9	80409488	80409488	T	A	DOID:1909	20818844	included	ENST00000286548	p.Q209L	GNAQ	-1	c.626	2016-05-18 19:53:51.631637	2016-05-18 20:39:53.897099	1	ENSG00000156052	missense
1342	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/gnaq/100\\"}}"	\N		9	80409488	80409488	T	A	DOID:1909	22735384	included	ENST00000286548	p.Q209L	GNAQ	-1	c.626	2016-05-18 19:53:51.640286	2016-05-18 20:39:53.934704	1	ENSG00000156052	missense
1343	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/gnaq/100\\"}}"	\N		9	80409488	80409488	T	A	DOID:1909	22356324	included	ENST00000286548	p.Q209L	GNAQ	-1	c.626	2016-05-18 19:53:51.667619	2016-05-18 20:39:53.976235	1	ENSG00000156052	missense
1344	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/gnaq/100\\"}}"	\N		9	80409488	80409488	T	A	DOID:1909	22663011	included	ENST00000286548	p.Q209L	GNAQ	-1	c.626	2016-05-18 19:53:51.677159	2016-05-18 20:39:54.019776	1	ENSG00000156052	missense
1345	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/gnaq/100\\"}}"	\N		9	80409488	80409488	T	A	DOID:1909	22805292	included	ENST00000286548	p.Q209L	GNAQ	-1	c.626	2016-05-18 19:53:51.698332	2016-05-18 20:39:54.062877	1	ENSG00000156052	missense
1346	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/gnaq/100\\"}}"	\N		9	80409488	80409488	T	A	DOID:1909	22048237	included	ENST00000286548	p.Q209L	GNAQ	-1	c.626	2016-05-18 19:53:51.707373	2016-05-18 20:39:54.104812	1	ENSG00000156052	missense
1347	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/gnaq/100\\"}}"	\N		9	80409488	80409488	T	A	DOID:1909	22972589	included	ENST00000286548	p.Q209L	GNAQ	-1	c.626	2016-05-18 19:53:51.734849	2016-05-18 20:39:54.14576	1	ENSG00000156052	missense
1348	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/gnaq/103\\"}}"	\N		9	80409488	80409488	T	C	DOID:1909	12068308	included	ENST00000286548	p.Q209R	GNAQ	-1	c.626	2016-05-18 19:53:51.753919	2016-05-18 20:39:54.213247	1	ENSG00000156052	missense
1349	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/gnaq/103\\"}}"	\N		9	80409488	80409488	T	C	DOID:1909	14679157	included	ENST00000286548	p.Q209R	GNAQ	-1	c.626	2016-05-18 19:53:51.764876	2016-05-18 20:39:54.258073	1	ENSG00000156052	missense
1350	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/gnaq/103\\"}}"	\N		9	80409488	80409488	T	C	DOID:1909	22536370	included	ENST00000286548	p.Q209R	GNAQ	-1	c.626	2016-05-18 19:53:51.773583	2016-05-18 20:39:54.313993	1	ENSG00000156052	missense
1351	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/gnaq/103\\"}}"	\N		9	80409488	80409488	T	C	DOID:1909	20630094	included	ENST00000286548	p.Q209R	GNAQ	-1	c.626	2016-05-18 19:53:51.802801	2016-05-18 20:39:54.366221	1	ENSG00000156052	missense
1352	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/gnaq/103\\"}}"	\N		9	80409488	80409488	T	C	DOID:1909	21639808	included	ENST00000286548	p.Q209R	GNAQ	-1	c.626	2016-05-18 19:53:51.812116	2016-05-18 20:39:54.412091	1	ENSG00000156052	missense
1353	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/gnaq/103\\"}}"	\N		9	80409488	80409488	T	C	DOID:1909	22608338	included	ENST00000286548	p.Q209R	GNAQ	-1	c.626	2016-05-18 19:53:51.834342	2016-05-18 20:39:54.462976	1	ENSG00000156052	missense
1354	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/gnaq/103\\"}}"	\N		9	80409488	80409488	T	C	DOID:1909	23020132	included	ENST00000286548	p.Q209R	GNAQ	-1	c.626	2016-05-18 19:53:51.846024	2016-05-18 20:39:54.512923	1	ENSG00000156052	missense
1432	\N	\N		1	115258748	115258748	C	T	DOID:9119	20921465	included	ENST00000369535	p.G12S	NRAS	-1	c.34	2016-05-18 20:26:14.722149	2016-05-18 20:39:58.873385	2	ENSG00000213281	missense
1355	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/gnaq/103\\"}}"	\N		9	80409488	80409488	T	C	DOID:1909	20818844	included	ENST00000286548	p.Q209R	GNAQ	-1	c.626	2016-05-18 19:53:51.862356	2016-05-18 20:39:54.560484	1	ENSG00000156052	missense
1356	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/gnaq/103\\"}}"	\N		9	80409488	80409488	T	C	DOID:1909	22735384	included	ENST00000286548	p.Q209R	GNAQ	-1	c.626	2016-05-18 19:53:51.870683	2016-05-18 20:39:54.611435	1	ENSG00000156052	missense
1357	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/gnaq/103\\"}}"	\N		9	80409488	80409488	T	C	DOID:1909	22356324	included	ENST00000286548	p.Q209R	GNAQ	-1	c.626	2016-05-18 19:53:51.881073	2016-05-18 20:39:54.661117	1	ENSG00000156052	missense
1358	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/gnaq/103\\"}}"	\N		9	80409488	80409488	T	C	DOID:1909	22663011	included	ENST00000286548	p.Q209R	GNAQ	-1	c.626	2016-05-18 19:53:51.901237	2016-05-18 20:39:54.71189	1	ENSG00000156052	missense
1359	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/gnaq/103\\"}}"	\N		9	80409488	80409488	T	C	DOID:1909	22805292	included	ENST00000286548	p.Q209R	GNAQ	-1	c.626	2016-05-18 19:53:51.910835	2016-05-18 20:39:54.769344	1	ENSG00000156052	missense
1360	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/gnaq/103\\"}}"	\N		9	80409488	80409488	T	C	DOID:1909	22048237	included	ENST00000286548	p.Q209R	GNAQ	-1	c.626	2016-05-18 19:53:51.94031	2016-05-18 20:39:54.810222	1	ENSG00000156052	missense
1361	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/gnaq/103\\"}}"	\N		9	80409488	80409488	T	C	DOID:1909	22972589	included	ENST00000286548	p.Q209R	GNAQ	-1	c.626	2016-05-18 19:53:51.95083	2016-05-18 20:39:54.865099	1	ENSG00000156052	missense
1362	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/gnaq/103\\"}}"	\N		9	80409488	80409488	T	C	DOID:1909	19404918	included	ENST00000286548	p.Q209R	GNAQ	-1	c.626	2016-05-18 19:53:51.970758	2016-05-18 20:39:54.915307	1	ENSG00000156052	missense
1363	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/gnaq/103\\"}}"	\N		9	80409488	80409488	T	C	DOID:1909	22389471	included	ENST00000286548	p.Q209R	GNAQ	-1	c.626	2016-05-18 19:53:51.982096	2016-05-18 20:39:54.972146	1	ENSG00000156052	missense
1364	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/gnaq/103\\"}}"	\N		9	80409488	80409488	T	C	DOID:1909	21156289	included	ENST00000286548	p.Q209R	GNAQ	-1	c.626	2016-05-18 19:53:52.010611	2016-05-18 20:39:55.017425	1	ENSG00000156052	missense
1365	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/gnaq/103\\"}}"	\N		9	80409488	80409488	T	C	DOID:1909	22351686	included	ENST00000286548	p.Q209R	GNAQ	-1	c.626	2016-05-18 19:53:52.021906	2016-05-18 20:39:55.085208	1	ENSG00000156052	missense
1366	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/gnaq/103\\"}}"	\N		9	80409488	80409488	T	C	DOID:1909	22997239	included	ENST00000286548	p.Q209R	GNAQ	-1	c.626	2016-05-18 19:53:52.040503	2016-05-18 20:39:55.143945	1	ENSG00000156052	missense
1367	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/gnaq/103\\"}}"	\N		9	80409488	80409488	T	C	DOID:1909	23614898	included	ENST00000286548	p.Q209R	GNAQ	-1	c.626	2016-05-18 19:53:52.049627	2016-05-18 20:39:55.221071	1	ENSG00000156052	missense
1368	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/gnaq/102\\"}}"	\N		9	80409488	80409488	T	G	DOID:1909	12068308	included	ENST00000286548	p.Q209P	GNAQ	-1	c.626	2016-05-18 19:53:52.070872	2016-05-18 20:39:55.308421	1	ENSG00000156052	missense
1369	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/gnaq/102\\"}}"	\N		9	80409488	80409488	T	G	DOID:1909	14679157	included	ENST00000286548	p.Q209P	GNAQ	-1	c.626	2016-05-18 19:53:52.079344	2016-05-18 20:39:55.371944	1	ENSG00000156052	missense
1370	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/gnaq/102\\"}}"	\N		9	80409488	80409488	T	G	DOID:1909	23237741	included	ENST00000286548	p.Q209P	GNAQ	-1	c.626	2016-05-18 19:53:52.110308	2016-05-18 20:39:55.444853	1	ENSG00000156052	missense
1371	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/gnaq/102\\"}}"	\N		9	80409488	80409488	T	G	DOID:1909	20551065	included	ENST00000286548	p.Q209P	GNAQ	-1	c.626	2016-05-18 19:53:52.133881	2016-05-18 20:39:55.4926	1	ENSG00000156052	missense
1372	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/gnaq/102\\"}}"	\N		9	80409488	80409488	T	G	DOID:1909	21639808	included	ENST00000286548	p.Q209P	GNAQ	-1	c.626	2016-05-18 19:53:52.142125	2016-05-18 20:39:55.555124	1	ENSG00000156052	missense
1373	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/gnaq/102\\"}}"	\N		9	80409488	80409488	T	G	DOID:1909	22608338	included	ENST00000286548	p.Q209P	GNAQ	-1	c.626	2016-05-18 19:53:52.17175	2016-05-18 20:39:55.602737	1	ENSG00000156052	missense
1374	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/gnaq/102\\"}}"	\N		9	80409488	80409488	T	G	DOID:1909	23020132	included	ENST00000286548	p.Q209P	GNAQ	-1	c.626	2016-05-18 19:53:52.18131	2016-05-18 20:39:55.662247	1	ENSG00000156052	missense
1375	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/gnaq/102\\"}}"	\N		9	80409488	80409488	T	G	DOID:1909	20818844	included	ENST00000286548	p.Q209P	GNAQ	-1	c.626	2016-05-18 19:53:52.203295	2016-05-18 20:39:55.711021	1	ENSG00000156052	missense
1376	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/gnaq/102\\"}}"	\N		9	80409488	80409488	T	G	DOID:1909	22735384	included	ENST00000286548	p.Q209P	GNAQ	-1	c.626	2016-05-18 19:53:52.211204	2016-05-18 20:39:55.802076	1	ENSG00000156052	missense
1377	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/gnaq/102\\"}}"	\N		9	80409488	80409488	T	G	DOID:1909	22356324	included	ENST00000286548	p.Q209P	GNAQ	-1	c.626	2016-05-18 19:53:52.23837	2016-05-18 20:39:55.865798	1	ENSG00000156052	missense
1378	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/gnaq/102\\"}}"	\N		9	80409488	80409488	T	G	DOID:1909	22663011	included	ENST00000286548	p.Q209P	GNAQ	-1	c.626	2016-05-18 19:53:52.247325	2016-05-18 20:39:55.935432	1	ENSG00000156052	missense
1379	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/gnaq/102\\"}}"	\N		9	80409488	80409488	T	G	DOID:1909	22805292	included	ENST00000286548	p.Q209P	GNAQ	-1	c.626	2016-05-18 19:53:52.275502	2016-05-18 20:39:56.031818	1	ENSG00000156052	missense
1380	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/gnaq/102\\"}}"	\N		9	80409488	80409488	T	G	DOID:1909	22048237	included	ENST00000286548	p.Q209P	GNAQ	-1	c.626	2016-05-18 19:53:52.285185	2016-05-18 20:39:56.081775	1	ENSG00000156052	missense
1381	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/gnaq/102\\"}}"	\N		9	80409488	80409488	T	G	DOID:1909	22972589	included	ENST00000286548	p.Q209P	GNAQ	-1	c.626	2016-05-18 19:53:52.307264	2016-05-18 20:39:56.141267	1	ENSG00000156052	missense
1382	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/melanoma/gnaq/102\\"}}"	\N		9	80409488	80409488	T	G	DOID:1909	23248257	included	ENST00000286548	p.Q209P	GNAQ	-1	c.626	2016-05-18 19:53:52.339745	2016-05-18 20:39:56.195283	1	ENSG00000156052	missense
1383	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/crlf2/199\\"}}"	\N		X	1314966	1314966	A	C	DOID:1037	12068308	included	ENST00000381567	p.F232C	CRLF2	-1	c.695	2016-05-18 19:53:52.353671	2016-05-18 20:39:56.274714	1	ENSG00000205755	missense
1384	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/crlf2/199\\"}}"	\N		X	1314966	1314966	A	C	DOID:1037	14679157	included	ENST00000381567	p.F232C	CRLF2	-1	c.695	2016-05-18 19:53:52.369023	2016-05-18 20:39:56.321129	1	ENSG00000205755	missense
1385	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/crlf2/199\\"}}"	\N		X	1314966	1314966	A	C	DOID:1037	22536370	included	ENST00000381567	p.F232C	CRLF2	-1	c.695	2016-05-18 19:53:52.377475	2016-05-18 20:39:56.39987	1	ENSG00000205755	missense
1386	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/crlf2/199\\"}}"	\N		X	1314966	1314966	A	C	DOID:1037	20630094	included	ENST00000381567	p.F232C	CRLF2	-1	c.695	2016-05-18 19:53:52.407214	2016-05-18 20:39:56.453089	1	ENSG00000205755	missense
1387	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/crlf2/199\\"}}"	\N		X	1314966	1314966	A	C	DOID:1037	22608338	included	ENST00000381567	p.F232C	CRLF2	-1	c.695	2016-05-18 19:53:52.424054	2016-05-18 20:39:56.526608	1	ENSG00000205755	missense
1388	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/crlf2/199\\"}}"	\N		X	1314966	1314966	A	C	DOID:1037	20818844	included	ENST00000381567	p.F232C	CRLF2	-1	c.695	2016-05-18 19:53:52.452325	2016-05-18 20:39:56.587068	1	ENSG00000205755	missense
1389	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/crlf2/199\\"}}"	\N		X	1314966	1314966	A	C	DOID:1037	22735384	included	ENST00000381567	p.F232C	CRLF2	-1	c.695	2016-05-18 19:53:52.462358	2016-05-18 20:39:56.658869	1	ENSG00000205755	missense
1390	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/crlf2/199\\"}}"	\N		X	1314966	1314966	A	C	DOID:1037	22356324	included	ENST00000381567	p.F232C	CRLF2	-1	c.695	2016-05-18 19:53:52.476372	2016-05-18 20:39:56.719352	1	ENSG00000205755	missense
1391	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/crlf2/199\\"}}"	\N		X	1314966	1314966	A	C	DOID:1037	21639808	included	ENST00000381567	p.F232C	CRLF2	-1	c.695	2016-05-18 19:53:52.487452	2016-05-18 20:39:56.789221	1	ENSG00000205755	missense
1392	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/crlf2/199\\"}}"	\N		X	1314966	1314966	A	C	DOID:1037	22663011	included	ENST00000381567	p.F232C	CRLF2	-1	c.695	2016-05-18 19:53:52.508741	2016-05-18 20:39:56.840178	1	ENSG00000205755	missense
1393	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/crlf2/199\\"}}"	\N		X	1314966	1314966	A	C	DOID:1037	22805292	included	ENST00000381567	p.F232C	CRLF2	-1	c.695	2016-05-18 19:53:52.540699	2016-05-18 20:39:56.896878	1	ENSG00000205755	missense
1394	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/crlf2/199\\"}}"	\N		X	1314966	1314966	A	C	DOID:1037	22972589	included	ENST00000381567	p.F232C	CRLF2	-1	c.695	2016-05-18 19:53:52.549857	2016-05-18 20:39:56.948778	1	ENSG00000205755	missense
1395	"{\\"urls\\":{\\"name\\":\\"My Cancer Genome\\",\\"path\\":\\"http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/crlf2/199\\"}}"	\N		X	1314966	1314966	A	C	DOID:1037	22048237	included	ENST00000381567	p.F232C	CRLF2	-1	c.695	2016-05-18 19:53:52.568903	2016-05-18 20:39:57.008859	1	ENSG00000205755	missense
1397	\N	\N		1	115256528	115256528	T	A	DOID:9119	25157968	included	ENST00000369535	p.Q61H	NRAS	-1	c.183	2016-05-18 20:26:14.352548	2016-05-18 20:39:57.116057	2	ENSG00000213281	missense
1399	\N	\N		1	115256530	115256530	G	T	DOID:9119	22368270	included	ENST00000369535	p.Q61K	NRAS	-1	c.181	2016-05-18 20:26:14.373938	2016-05-18 20:39:57.214082	2	ENSG00000213281	missense
1400	\N	\N		1	115256530	115256530	G	T	DOID:9119	18805579	included	ENST00000369535	p.Q61K	NRAS	-1	c.181	2016-05-18 20:26:14.386412	2016-05-18 20:39:57.279185	2	ENSG00000213281	missense
1401	\N	\N		1	115256530	115256530	G	T	DOID:9119	22955920	included	ENST00000369535	p.Q61K	NRAS	-1	c.181	2016-05-18 20:26:14.396909	2016-05-18 20:39:57.331097	2	ENSG00000213281	missense
1402	\N	\N		1	115258744	115258744	C	A	DOID:9119	23700467	included	ENST00000369535	p.G13V	NRAS	-1	c.38	2016-05-18 20:26:14.408542	2016-05-18 20:39:57.387493	2	ENSG00000213281	missense
1403	\N	\N		1	115258744	115258744	C	A	DOID:9119	23934607	included	ENST00000369535	p.G13V	NRAS	-1	c.38	2016-05-18 20:26:14.420977	2016-05-18 20:39:57.44451	2	ENSG00000213281	missense
1404	\N	\N		1	115258744	115258744	C	A	DOID:9119	17611497	included	ENST00000369535	p.G13V	NRAS	-1	c.38	2016-05-18 20:26:14.430921	2016-05-18 20:39:57.484961	2	ENSG00000213281	missense
1405	\N	\N		1	115258744	115258744	C	A	DOID:9119	25157968	included	ENST00000369535	p.G13V	NRAS	-1	c.38	2016-05-18 20:26:14.438331	2016-05-18 20:39:57.540833	2	ENSG00000213281	missense
1406	\N	\N		1	115258744	115258744	C	T	DOID:9119	8187091	included	ENST00000369535	p.G13D	NRAS	-1	c.38	2016-05-18 20:26:14.449684	2016-05-18 20:39:57.579657	2	ENSG00000213281	missense
1407	\N	\N		1	115258744	115258744	C	T	DOID:9119	1528264	included	ENST00000369535	p.G13D	NRAS	-1	c.38	2016-05-18 20:26:14.462236	2016-05-18 20:39:57.624638	2	ENSG00000213281	missense
1408	\N	\N		1	115258744	115258744	C	T	DOID:9119	24861525	included	ENST00000369535	p.G13D	NRAS	-1	c.38	2016-05-18 20:26:14.471489	2016-05-18 20:39:57.678679	2	ENSG00000213281	missense
1409	\N	\N		1	115258744	115258744	C	T	DOID:9119	25157968	included	ENST00000369535	p.G13D	NRAS	-1	c.38	2016-05-18 20:26:14.482413	2016-05-18 20:39:57.722191	2	ENSG00000213281	missense
1410	\N	\N		1	115258747	115258747	C	A	DOID:9119	8187091	included	ENST00000369535	p.G12V	NRAS	-1	c.35	2016-05-18 20:26:14.490892	2016-05-18 20:39:57.783125	2	ENSG00000213281	missense
1411	\N	\N		1	115258747	115258747	C	A	DOID:9119	1528264	included	ENST00000369535	p.G12V	NRAS	-1	c.35	2016-05-18 20:26:14.501916	2016-05-18 20:39:57.822008	2	ENSG00000213281	missense
1412	\N	\N		1	115258747	115258747	C	A	DOID:9119	24861525	included	ENST00000369535	p.G12V	NRAS	-1	c.35	2016-05-18 20:26:14.514278	2016-05-18 20:39:57.85905	2	ENSG00000213281	missense
1413	\N	\N		1	115258747	115258747	C	A	DOID:9119	22810696	included	ENST00000369535	p.G12V	NRAS	-1	c.35	2016-05-18 20:26:14.525144	2016-05-18 20:39:57.90052	2	ENSG00000213281	missense
1414	\N	\N		1	115258747	115258747	C	A	DOID:9119	25157968	included	ENST00000369535	p.G12V	NRAS	-1	c.35	2016-05-18 20:26:14.535371	2016-05-18 20:39:57.949323	2	ENSG00000213281	missense
1415	\N	\N		1	115258747	115258747	C	T	DOID:9119	19537845	included	ENST00000369535	p.G12D	NRAS	-1	c.35	2016-05-18 20:26:14.545487	2016-05-18 20:39:57.989851	2	ENSG00000213281	missense
1418	\N	\N		1	115258747	115258747	C	T	DOID:9119	12068308	included	ENST00000369535	p.G12D	NRAS	-1	c.35	2016-05-18 20:26:14.577988	2016-05-18 20:39:58.137028	2	ENSG00000213281	missense
1420	\N	\N		1	115258747	115258747	C	T	DOID:9119	20619739	included	ENST00000369535	p.G12D	NRAS	-1	c.35	2016-05-18 20:26:14.600189	2016-05-18 20:39:58.265805	2	ENSG00000213281	missense
1421	\N	\N		1	115258748	115258748	C	A	DOID:9119	19537845	included	ENST00000369535	p.G12C	NRAS	-1	c.34	2016-05-18 20:26:14.607961	2016-05-18 20:39:58.322038	2	ENSG00000213281	missense
1459	\N	\N		12	25380275	25380275	T	A	DOID:9119	20619739	included	ENST00000256078	p.Q61H	KRAS	-1	c.183	2016-05-18 20:26:15.071747	2016-05-18 20:40:00.2355	2	ENSG00000133703	missense
1460	\N	\N		12	25380275	25380275	T	A	DOID:9119	19366826	included	ENST00000256078	p.Q61H	KRAS	-1	c.183	2016-05-18 20:26:15.086928	2016-05-18 20:40:00.285816	2	ENSG00000133703	missense
1461	\N	\N		12	25380275	25380275	T	G	DOID:9119	15016963	included	ENST00000256078	p.Q61H	KRAS	-1	c.183	2016-05-18 20:26:15.099437	2016-05-18 20:40:00.328605	2	ENSG00000133703	missense
1462	\N	\N		12	25380275	25380275	T	G	DOID:9119	15647370	included	ENST00000256078	p.Q61H	KRAS	-1	c.183	2016-05-18 20:26:15.111408	2016-05-18 20:40:00.389001	2	ENSG00000133703	missense
1463	\N	\N		12	25380275	25380275	T	G	DOID:9119	15254419	included	ENST00000256078	p.Q61H	KRAS	-1	c.183	2016-05-18 20:26:15.1212	2016-05-18 20:40:00.429011	2	ENSG00000133703	missense
1464	\N	\N		12	25380275	25380275	T	G	DOID:9119	20453058	included	ENST00000256078	p.Q61H	KRAS	-1	c.183	2016-05-18 20:26:15.131683	2016-05-18 20:40:00.493321	2	ENSG00000133703	missense
1467	\N	\N		12	25380275	25380275	T	G	DOID:9119	22162582	included	ENST00000256078	p.Q61H	KRAS	-1	c.183	2016-05-18 20:26:15.168886	2016-05-18 20:40:00.639053	2	ENSG00000133703	missense
1468	\N	\N		12	25380275	25380275	T	G	DOID:9119	19903786	included	ENST00000256078	p.Q61H	KRAS	-1	c.183	2016-05-18 20:26:15.178463	2016-05-18 20:40:00.675555	2	ENSG00000133703	missense
1469	\N	\N		12	25380275	25380275	T	G	DOID:9119	20619739	included	ENST00000256078	p.Q61H	KRAS	-1	c.183	2016-05-18 20:26:15.188241	2016-05-18 20:40:00.714771	2	ENSG00000133703	missense
1470	\N	\N		12	25380275	25380275	T	G	DOID:9119	19366826	included	ENST00000256078	p.Q61H	KRAS	-1	c.183	2016-05-18 20:26:15.19885	2016-05-18 20:40:00.758444	2	ENSG00000133703	missense
1471	\N	\N		12	25398281	25398281	C	T	DOID:9119	19561230	included	ENST00000256078	p.G13D	KRAS	-1	c.38	2016-05-18 20:26:15.208764	2016-05-18 20:40:00.804533	2	ENSG00000133703	missense
1472	\N	\N		12	25398281	25398281	C	T	DOID:9119	12068308	included	ENST00000256078	p.G13D	KRAS	-1	c.38	2016-05-18 20:26:15.21691	2016-05-18 20:40:00.84921	2	ENSG00000133703	missense
1473	\N	\N		12	25398281	25398281	C	T	DOID:9119	20818844	included	ENST00000256078	p.G13D	KRAS	-1	c.38	2016-05-18 20:26:15.229366	2016-05-18 20:40:00.893783	2	ENSG00000133703	missense
1474	\N	\N		12	25398281	25398281	C	T	DOID:9119	21639808	included	ENST00000256078	p.G13D	KRAS	-1	c.38	2016-05-18 20:26:15.239265	2016-05-18 20:40:00.941875	2	ENSG00000133703	missense
1475	\N	\N		12	25398281	25398281	C	T	DOID:9119	23470635	included	ENST00000256078	p.G13D	KRAS	-1	c.38	2016-05-18 20:26:15.246351	2016-05-18 20:40:00.980046	2	ENSG00000133703	missense
1476	\N	\N		12	25398281	25398281	C	T	DOID:9119	22608338	included	ENST00000256078	p.G13D	KRAS	-1	c.38	2016-05-18 20:26:15.258874	2016-05-18 20:40:01.025496	2	ENSG00000133703	missense
1477	\N	\N		12	25398284	25398284	C	A	DOID:9119	23582185	included	ENST00000256078	p.G12V	KRAS	-1	c.35	2016-05-18 20:26:15.270321	2016-05-18 20:40:01.074446	2	ENSG00000133703	missense
1478	\N	\N		12	25398284	25398284	C	A	DOID:9119	21689725	included	ENST00000256078	p.G12V	KRAS	-1	c.35	2016-05-18 20:26:15.277792	2016-05-18 20:40:01.113373	2	ENSG00000133703	missense
1479	\N	\N		12	25398284	25398284	C	A	DOID:9119	17259998	included	ENST00000256078	p.G12V	KRAS	-1	c.35	2016-05-18 20:26:15.286161	2016-05-18 20:40:01.165921	2	ENSG00000133703	missense
1480	\N	\N		12	25398284	25398284	C	T	DOID:9119	23634996	included	ENST00000256078	p.G12D	KRAS	-1	c.35	2016-05-18 20:26:15.30593	2016-05-18 20:40:01.210447	2	ENSG00000133703	missense
1481	\N	\N		13	28592629	28592629	T	C	DOID:9119	23261068	included	ENST00000380982	p.D839G	FLT3	-1	c.2516	2016-05-18 20:26:15.32198	2016-05-18 20:40:01.265696	2	ENSG00000122025	missense
1482	\N	\N		13	28592629	28592629	T	C	DOID:9119	23783394	included	ENST00000380982	p.D839G	FLT3	-1	c.2516	2016-05-18 20:26:15.332832	2016-05-18 20:40:01.303695	2	ENSG00000122025	missense
1483	\N	\N		13	28592629	28592629	T	C	DOID:9119	23321257	included	ENST00000380982	p.D839G	FLT3	-1	c.2516	2016-05-18 20:26:15.343121	2016-05-18 20:40:01.34536	2	ENSG00000122025	missense
1484	\N	\N		13	28592629	28592629	T	C	DOID:9119	22368270	included	ENST00000380982	p.D839G	FLT3	-1	c.2516	2016-05-18 20:26:15.352278	2016-05-18 20:40:01.387663	2	ENSG00000122025	missense
1485	\N	\N		13	28592629	28592629	T	C	DOID:9119	23714533	included	ENST00000380982	p.D839G	FLT3	-1	c.2516	2016-05-18 20:26:15.363601	2016-05-18 20:40:01.432963	2	ENSG00000122025	missense
1486	\N	\N		13	28592629	28592629	T	C	DOID:9119	22504183	included	ENST00000380982	p.D839G	FLT3	-1	c.2516	2016-05-18 20:26:15.37401	2016-05-18 20:40:01.476448	2	ENSG00000122025	missense
1487	\N	\N		13	28592629	28592629	T	C	DOID:9119	15256420	included	ENST00000380982	p.D839G	FLT3	-1	c.2516	2016-05-18 20:26:15.381284	2016-05-18 20:40:01.516121	2	ENSG00000122025	missense
1488	\N	\N		13	28592629	28592629	T	C	DOID:9119	11290608	included	ENST00000380982	p.D839G	FLT3	-1	c.2516	2016-05-18 20:26:15.391728	2016-05-18 20:40:01.57466	2	ENSG00000122025	missense
1489	\N	\N		13	28592629	28592629	T	C	DOID:9119	19657110	included	ENST00000380982	p.D839G	FLT3	-1	c.2516	2016-05-18 20:26:15.403849	2016-05-18 20:40:01.615718	2	ENSG00000122025	missense
1490	\N	\N		13	28592629	28592629	T	C	DOID:9119	22504184	included	ENST00000380982	p.D839G	FLT3	-1	c.2516	2016-05-18 20:26:15.410674	2016-05-18 20:40:01.67087	2	ENSG00000122025	missense
1491	\N	\N		13	28592629	28592629	T	C	DOID:9119	23430109	included	ENST00000380982	p.D839G	FLT3	-1	c.2516	2016-05-18 20:26:15.420559	2016-05-18 20:40:01.708045	2	ENSG00000122025	missense
1492	\N	\N		13	28592629	28592629	T	C	DOID:9119	20733134	included	ENST00000380982	p.D839G	FLT3	-1	c.2516	2016-05-18 20:26:15.431871	2016-05-18 20:40:01.746699	2	ENSG00000122025	missense
1493	\N	\N		13	28592629	28592629	T	C	DOID:9119	16857985	included	ENST00000380982	p.D839G	FLT3	-1	c.2516	2016-05-18 20:26:15.441929	2016-05-18 20:40:01.788698	2	ENSG00000122025	missense
1494	\N	\N		17	7577120	7577120	C	T	DOID:9119	22407852	included	ENST00000269305	p.R273H	TP53	-1	c.818	2016-05-18 20:26:15.451002	2016-05-18 20:40:01.844484	2	ENSG00000141510	missense
1495	\N	\N		17	7577120	7577120	C	T	DOID:9119	19075190	included	ENST00000269305	p.R273H	TP53	-1	c.818	2016-05-18 20:26:15.46352	2016-05-18 20:40:01.882975	2	ENSG00000141510	missense
1496	\N	\N		17	7577120	7577120	C	T	DOID:9119	16434492	included	ENST00000269305	p.R273H	TP53	-1	c.818	2016-05-18 20:26:15.475796	2016-05-18 20:40:01.915276	2	ENSG00000141510	missense
1497	\N	\N		17	7577120	7577120	C	T	DOID:9119	2278970	included	ENST00000269305	p.R273H	TP53	-1	c.818	2016-05-18 20:26:15.484265	2016-05-18 20:40:01.959172	2	ENSG00000141510	missense
1498	\N	\N		17	7577120	7577120	C	T	DOID:9119	3122217	included	ENST00000269305	p.R273H	TP53	-1	c.818	2016-05-18 20:26:15.49692	2016-05-18 20:40:01.997743	2	ENSG00000141510	missense
1499	\N	\N		17	7577121	7577121	G	A	DOID:9119	22407852	included	ENST00000269305	p.R273C	TP53	-1	c.817	2016-05-18 20:26:15.509597	2016-05-18 20:40:02.052569	2	ENSG00000141510	missense
1500	\N	\N		17	7577121	7577121	G	A	DOID:9119	19075190	included	ENST00000269305	p.R273C	TP53	-1	c.817	2016-05-18 20:26:15.52015	2016-05-18 20:40:02.09954	2	ENSG00000141510	missense
1501	\N	\N		17	7577121	7577121	G	A	DOID:9119	16434492	included	ENST00000269305	p.R273C	TP53	-1	c.817	2016-05-18 20:26:15.52774	2016-05-18 20:40:02.135245	2	ENSG00000141510	missense
1502	\N	\N		17	7577121	7577121	G	A	DOID:9119	2278970	included	ENST00000269305	p.R273C	TP53	-1	c.817	2016-05-18 20:26:15.536665	2016-05-18 20:40:02.175466	2	ENSG00000141510	missense
1503	\N	\N		17	7577121	7577121	G	A	DOID:9119	3122217	included	ENST00000269305	p.R273C	TP53	-1	c.817	2016-05-18 20:26:15.547259	2016-05-18 20:40:02.223125	2	ENSG00000141510	missense
1504	\N	\N		17	7577535	7577535	C	G	DOID:9119	19657110	included	ENST00000269305	p.R249T	TP53	-1	c.746	2016-05-18 20:26:15.556807	2016-05-18 20:40:02.275627	2	ENSG00000141510	missense
1505	\N	\N		17	7577536	7577536	T	A	DOID:9119	19657110	included	ENST00000269305	p.R249W	TP53	-1	c.745	2016-05-18 20:26:15.564202	2016-05-18 20:40:02.331947	2	ENSG00000141510	missense
1506	\N	\N		17	7577538	7577538	C	T	DOID:9119	19657110	included	ENST00000269305	p.R248Q	TP53	-1	c.743	2016-05-18 20:26:15.575623	2016-05-18 20:40:02.386274	2	ENSG00000141510	missense
1507	\N	\N		17	7578190	7578190	T	C	DOID:9119	19657110	included	ENST00000269305	p.Y220C	TP53	-1	c.659	2016-05-18 20:26:15.586546	2016-05-18 20:40:02.438782	2	ENSG00000141510	missense
1508	\N	\N		17	7578412	7578412	A	C	DOID:9119	19657110	included	ENST00000269305	p.V173G	TP53	-1	c.518	2016-05-18 20:26:15.596066	2016-05-18 20:40:02.494041	2	ENSG00000141510	missense
1509	\N	\N		17	7578412	7578412	A	G	DOID:9119	19657110	included	ENST00000269305	p.V173A	TP53	-1	c.518	2016-05-18 20:26:15.606007	2016-05-18 20:40:02.547056	2	ENSG00000141510	missense
1510	\N	\N		2	198266834	198266834	T	C	DOID:9119	23395771	included	ENST00000335508	p.K700E	SF3B1	-1	c.2098	2016-05-18 20:26:15.616694	2016-05-18 20:40:02.605888	2	ENSG00000115524	missense
1511	\N	\N		2	198267359	198267359	C	A	DOID:9119	23395771	included	ENST00000335508	p.K666N	SF3B1	-1	c.1998	2016-05-18 20:26:15.625797	2016-05-18 20:40:02.658707	2	ENSG00000115524	missense
1512	\N	\N		2	198267359	198267359	C	G	DOID:9119	23395771	included	ENST00000335508	p.K666N	SF3B1	-1	c.1998	2016-05-18 20:26:15.633179	2016-05-18 20:40:02.704147	2	ENSG00000115524	missense
1513	\N	\N		21	36231783	36231783	G	A	DOID:9119	12623848	included	ENST00000300305	p.R201*	RUNX1	-1	c.601	2016-05-18 20:26:15.64495	2016-05-18 20:40:02.759998	2	ENSG00000159216	stop
1514	\N	\N		21	36231783	36231783	G	A	DOID:9119	15256422	included	ENST00000300305	p.R201*	RUNX1	-1	c.601	2016-05-18 20:26:15.655436	2016-05-18 20:40:02.797484	2	ENSG00000159216	stop
1515	\N	\N		21	36231783	36231783	G	A	DOID:9119	25157968	included	ENST00000300305	p.R201*	RUNX1	-1	c.601	2016-05-18 20:26:15.663432	2016-05-18 20:40:02.835318	2	ENSG00000159216	stop
1516	\N	\N		21	36252876	36252876	C	A	DOID:9119	20367437	included	ENST00000300305	p.R162S	RUNX1	-1	c.486	2016-05-18 20:26:15.672612	2016-05-18 20:40:02.885417	2	ENSG00000159216	missense
1517	\N	\N		21	36252876	36252876	C	A	DOID:9119	12623848	included	ENST00000300305	p.R162S	RUNX1	-1	c.486	2016-05-18 20:26:15.683664	2016-05-18 20:40:02.9245	2	ENSG00000159216	missense
1518	\N	\N		21	36252876	36252876	C	A	DOID:9119	12399961	included	ENST00000300305	p.R162S	RUNX1	-1	c.486	2016-05-18 20:26:15.692506	2016-05-18 20:40:02.958418	2	ENSG00000159216	missense
1519	\N	\N		21	36252876	36252876	C	A	DOID:9119	25157968	included	ENST00000300305	p.R162S	RUNX1	-1	c.486	2016-05-18 20:26:15.699449	2016-05-18 20:40:02.99739	2	ENSG00000159216	missense
1520	\N	\N		21	36252876	36252876	C	G	DOID:9119	23676790	included	ENST00000300305	p.R162S	RUNX1	-1	c.486	2016-05-18 20:26:15.710149	2016-05-18 20:40:03.046583	2	ENSG00000159216	missense
1521	\N	\N		21	36252876	36252876	C	G	DOID:9119	21895409	included	ENST00000300305	p.R162S	RUNX1	-1	c.486	2016-05-18 20:26:15.721419	2016-05-18 20:40:03.084979	2	ENSG00000159216	missense
1522	\N	\N		21	36252876	36252876	C	G	DOID:9119	21505103	included	ENST00000300305	p.R162S	RUNX1	-1	c.486	2016-05-18 20:26:15.729115	2016-05-18 20:40:03.125779	2	ENSG00000159216	missense
1523	\N	\N		21	36252876	36252876	C	G	DOID:9119	20367437	included	ENST00000300305	p.R162S	RUNX1	-1	c.486	2016-05-18 20:26:15.737231	2016-05-18 20:40:03.160706	2	ENSG00000159216	missense
1524	\N	\N		21	36252876	36252876	C	G	DOID:9119	19652056	included	ENST00000300305	p.R162S	RUNX1	-1	c.486	2016-05-18 20:26:15.750259	2016-05-18 20:40:03.202375	2	ENSG00000159216	missense
1526	\N	\N		21	36252876	36252876	C	G	DOID:9119	15381060	included	ENST00000300305	p.R162S	RUNX1	-1	c.486	2016-05-18 20:26:15.767489	2016-05-18 20:40:03.281265	2	ENSG00000159216	missense
1527	\N	\N		21	36252876	36252876	C	G	DOID:9119	15256422	included	ENST00000300305	p.R162S	RUNX1	-1	c.486	2016-05-18 20:26:15.778554	2016-05-18 20:40:03.321415	2	ENSG00000159216	missense
1528	\N	\N		21	36252876	36252876	C	G	DOID:9119	14745431	included	ENST00000300305	p.R162S	RUNX1	-1	c.486	2016-05-18 20:26:15.789049	2016-05-18 20:40:03.372657	2	ENSG00000159216	missense
1529	\N	\N		21	36252876	36252876	C	G	DOID:9119	14559829	included	ENST00000300305	p.R162S	RUNX1	-1	c.486	2016-05-18 20:26:15.79712	2016-05-18 20:40:03.408849	2	ENSG00000159216	missense
1530	\N	\N		21	36252876	36252876	C	G	DOID:9119	12399961	included	ENST00000300305	p.R162S	RUNX1	-1	c.486	2016-05-18 20:26:15.804927	2016-05-18 20:40:03.448957	2	ENSG00000159216	missense
1531	\N	\N		21	36252876	36252876	C	G	DOID:9119	11964322	included	ENST00000300305	p.R162S	RUNX1	-1	c.486	2016-05-18 20:26:15.819168	2016-05-18 20:40:03.484577	2	ENSG00000159216	missense
1532	\N	\N		21	36252876	36252876	C	G	DOID:9119	24456693	included	ENST00000300305	p.R162S	RUNX1	-1	c.486	2016-05-18 20:26:15.827618	2016-05-18 20:40:03.520824	2	ENSG00000159216	missense
1533	\N	\N		21	36252876	36252876	C	G	DOID:9119	20697894	included	ENST00000300305	p.R162S	RUNX1	-1	c.486	2016-05-18 20:26:15.834772	2016-05-18 20:40:03.559478	2	ENSG00000159216	missense
1534	\N	\N		21	36252876	36252876	C	G	DOID:9119	25157968	included	ENST00000300305	p.R162S	RUNX1	-1	c.486	2016-05-18 20:26:15.845982	2016-05-18 20:40:03.602136	2	ENSG00000159216	missense
1535	\N	\N		21	36252877	36252877	C	T	DOID:9119	22210874	included	ENST00000300305	p.R162K	RUNX1	-1	c.485	2016-05-18 20:26:15.856778	2016-05-18 20:40:03.657335	2	ENSG00000159216	missense
1536	\N	\N		21	36252877	36252877	C	T	DOID:9119	24236021	included	ENST00000300305	p.R162K	RUNX1	-1	c.485	2016-05-18 20:26:15.864374	2016-05-18 20:40:03.704883	2	ENSG00000159216	missense
1537	\N	\N		21	36252877	36252877	C	T	DOID:9119	22912393	included	ENST00000300305	p.R162K	RUNX1	-1	c.485	2016-05-18 20:26:15.871997	2016-05-18 20:40:03.752889	2	ENSG00000159216	missense
1538	\N	\N		21	36252877	36252877	C	T	DOID:9119	15194504	included	ENST00000300305	p.R162K	RUNX1	-1	c.485	2016-05-18 20:26:15.885162	2016-05-18 20:40:03.797254	2	ENSG00000159216	missense
1539	\N	\N		21	36252877	36252877	C	T	DOID:9119	21562040	included	ENST00000300305	p.R162K	RUNX1	-1	c.485	2016-05-18 20:26:15.894088	2016-05-18 20:40:03.848406	2	ENSG00000159216	missense
1540	\N	\N		21	36252877	36252877	C	T	DOID:9119	11423618	included	ENST00000300305	p.R162K	RUNX1	-1	c.485	2016-05-18 20:26:15.901287	2016-05-18 20:40:03.889258	2	ENSG00000159216	missense
1541	\N	\N		21	36252877	36252877	C	T	DOID:9119	14745431	included	ENST00000300305	p.R162K	RUNX1	-1	c.485	2016-05-18 20:26:15.912102	2016-05-18 20:40:03.942573	2	ENSG00000159216	missense
1542	\N	\N		21	36252877	36252877	C	T	DOID:9119	12623848	included	ENST00000300305	p.R162K	RUNX1	-1	c.485	2016-05-18 20:26:15.922243	2016-05-18 20:40:03.982272	2	ENSG00000159216	missense
1543	\N	\N		21	36252877	36252877	C	T	DOID:9119	11964322	included	ENST00000300305	p.R162K	RUNX1	-1	c.485	2016-05-18 20:26:15.93039	2016-05-18 20:40:04.037239	2	ENSG00000159216	missense
1544	\N	\N		21	36252877	36252877	C	T	DOID:9119	12399961	included	ENST00000300305	p.R162K	RUNX1	-1	c.485	2016-05-18 20:26:15.937927	2016-05-18 20:40:04.078191	2	ENSG00000159216	missense
1545	\N	\N		21	36252877	36252877	C	T	DOID:9119	11861307	included	ENST00000300305	p.R162K	RUNX1	-1	c.485	2016-05-18 20:26:15.949382	2016-05-18 20:40:04.119221	2	ENSG00000159216	missense
1546	\N	\N		21	36252877	36252877	C	T	DOID:9119	11853795	included	ENST00000300305	p.R162K	RUNX1	-1	c.485	2016-05-18 20:26:15.959075	2016-05-18 20:40:04.178589	2	ENSG00000159216	missense
1547	\N	\N		21	36252877	36252877	C	T	DOID:9119	23676790	included	ENST00000300305	p.R162K	RUNX1	-1	c.485	2016-05-18 20:26:15.96654	2016-05-18 20:40:04.223214	2	ENSG00000159216	missense
1548	\N	\N		21	36252877	36252877	C	T	DOID:9119	11567109	included	ENST00000300305	p.R162K	RUNX1	-1	c.485	2016-05-18 20:26:15.977148	2016-05-18 20:40:04.272748	2	ENSG00000159216	missense
1549	\N	\N		21	36252877	36252877	C	T	DOID:9119	21509757	included	ENST00000300305	p.R162K	RUNX1	-1	c.485	2016-05-18 20:26:15.988294	2016-05-18 20:40:04.312327	2	ENSG00000159216	missense
1550	\N	\N		21	36252877	36252877	C	T	DOID:9119	18757400	included	ENST00000300305	p.R162K	RUNX1	-1	c.485	2016-05-18 20:26:15.996115	2016-05-18 20:40:04.353997	2	ENSG00000159216	missense
1551	\N	\N		21	36252877	36252877	C	T	DOID:9119	25157968	included	ENST00000300305	p.R162K	RUNX1	-1	c.485	2016-05-18 20:26:16.004474	2016-05-18 20:40:04.394452	2	ENSG00000159216	missense
1552	\N	\N		21	36252878	36252878	T	C	DOID:9119	23676790	included	ENST00000300305	p.R162G	RUNX1	-1	c.484	2016-05-18 20:26:16.014984	2016-05-18 20:40:04.444871	2	ENSG00000159216	missense
1553	\N	\N		21	36252878	36252878	T	C	DOID:9119	14745431	included	ENST00000300305	p.R162G	RUNX1	-1	c.484	2016-05-18 20:26:16.024091	2016-05-18 20:40:04.483019	2	ENSG00000159216	missense
1554	\N	\N		21	36252878	36252878	T	C	DOID:9119	12623848	included	ENST00000300305	p.R162G	RUNX1	-1	c.484	2016-05-18 20:26:16.034692	2016-05-18 20:40:04.541995	2	ENSG00000159216	missense
1555	\N	\N		21	36252878	36252878	T	C	DOID:9119	12399961	included	ENST00000300305	p.R162G	RUNX1	-1	c.484	2016-05-18 20:26:16.045877	2016-05-18 20:40:04.603108	2	ENSG00000159216	missense
1556	\N	\N		21	36252878	36252878	T	C	DOID:9119	11853795	included	ENST00000300305	p.R162G	RUNX1	-1	c.484	2016-05-18 20:26:16.056208	2016-05-18 20:40:04.64877	2	ENSG00000159216	missense
1557	\N	\N		21	36252878	36252878	T	C	DOID:9119	11569495	included	ENST00000300305	p.R162G	RUNX1	-1	c.484	2016-05-18 20:26:16.064348	2016-05-18 20:40:04.71883	2	ENSG00000159216	missense
1558	\N	\N		21	36252878	36252878	T	C	DOID:9119	24236021	included	ENST00000300305	p.R162G	RUNX1	-1	c.484	2016-05-18 20:26:16.072536	2016-05-18 20:40:04.771462	2	ENSG00000159216	missense
1559	\N	\N		21	36252878	36252878	T	C	DOID:9119	19264234	included	ENST00000300305	p.R162G	RUNX1	-1	c.484	2016-05-18 20:26:16.094533	2016-05-18 20:40:04.825955	2	ENSG00000159216	missense
1560	\N	\N		21	36252878	36252878	T	C	DOID:9119	19164531	included	ENST00000300305	p.R162G	RUNX1	-1	c.484	2016-05-18 20:26:16.107508	2016-05-18 20:40:04.865081	2	ENSG00000159216	missense
1561	\N	\N		21	36252878	36252878	T	C	DOID:9119	25157968	included	ENST00000300305	p.R162G	RUNX1	-1	c.484	2016-05-18 20:26:16.12931	2016-05-18 20:40:04.903845	2	ENSG00000159216	missense
1562	\N	\N		21	44514777	44514777	T	C	DOID:9119	21895409	included	ENST00000291552	p.Q157R	U2AF1	-1	c.470	2016-05-18 20:26:16.13893	2016-05-18 20:40:04.962547	2	ENSG00000160201	missense
1563	\N	\N		21	44514777	44514777	T	C	DOID:9119	14745431	included	ENST00000291552	p.Q157R	U2AF1	-1	c.470	2016-05-18 20:26:16.150171	2016-05-18 20:40:04.99974	2	ENSG00000160201	missense
1564	\N	\N		21	44514777	44514777	T	C	DOID:9119	24456693	included	ENST00000291552	p.Q157R	U2AF1	-1	c.470	2016-05-18 20:26:16.161464	2016-05-18 20:40:05.038777	2	ENSG00000160201	missense
1565	\N	\N		21	44514777	44514777	T	C	DOID:9119	15510211	included	ENST00000291552	p.Q157R	U2AF1	-1	c.470	2016-05-18 20:26:16.168724	2016-05-18 20:40:05.080952	2	ENSG00000160201	missense
1566	\N	\N		21	44514777	44514777	T	C	DOID:9119	25157968	included	ENST00000291552	p.Q157R	U2AF1	-1	c.470	2016-05-18 20:26:16.180052	2016-05-18 20:40:05.128351	2	ENSG00000160201	missense
1567	\N	\N		21	44514777	44514777	T	G	DOID:9119	23540562	included	ENST00000291552	p.Q157P	U2AF1	-1	c.470	2016-05-18 20:26:16.193168	2016-05-18 20:40:05.195139	2	ENSG00000160201	missense
1568	\N	\N		21	44514777	44514777	T	G	DOID:9119	23355941	included	ENST00000291552	p.Q157P	U2AF1	-1	c.470	2016-05-18 20:26:16.20108	2016-05-18 20:40:05.262778	2	ENSG00000160201	missense
1569	\N	\N		21	44514777	44514777	T	G	DOID:9119	22870928	included	ENST00000291552	p.Q157P	U2AF1	-1	c.470	2016-05-18 20:26:16.216027	2016-05-18 20:40:05.311666	2	ENSG00000160201	missense
1570	\N	\N		21	44514777	44514777	T	G	DOID:9119	22306673	included	ENST00000291552	p.Q157P	U2AF1	-1	c.470	2016-05-18 20:26:16.226244	2016-05-18 20:40:05.36437	2	ENSG00000160201	missense
1571	\N	\N		21	44514777	44514777	T	G	DOID:9119	21762985	included	ENST00000291552	p.Q157P	U2AF1	-1	c.470	2016-05-18 20:26:16.234348	2016-05-18 20:40:05.436911	2	ENSG00000160201	missense
1572	\N	\N		21	44514777	44514777	T	G	DOID:9119	21895409	included	ENST00000291552	p.Q157P	U2AF1	-1	c.470	2016-05-18 20:26:16.245219	2016-05-18 20:40:05.497182	2	ENSG00000160201	missense
1573	\N	\N		21	44514777	44514777	T	G	DOID:9119	20512393	included	ENST00000291552	p.Q157P	U2AF1	-1	c.470	2016-05-18 20:26:16.279344	2016-05-18 20:40:05.557985	2	ENSG00000160201	missense
1574	\N	\N		21	44514777	44514777	T	G	DOID:9119	20963643	included	ENST00000291552	p.Q157P	U2AF1	-1	c.470	2016-05-18 20:26:16.292285	2016-05-18 20:40:05.628704	2	ENSG00000160201	missense
1575	\N	\N		21	44514777	44514777	T	G	DOID:9119	20367437	included	ENST00000291552	p.Q157P	U2AF1	-1	c.470	2016-05-18 20:26:16.320679	2016-05-18 20:40:05.685177	2	ENSG00000160201	missense
1576	\N	\N		21	44514777	44514777	T	G	DOID:9119	23676790	included	ENST00000291552	p.Q157P	U2AF1	-1	c.470	2016-05-18 20:26:16.329942	2016-05-18 20:40:05.737443	2	ENSG00000160201	missense
1577	\N	\N		21	44514777	44514777	T	G	DOID:9119	14745431	included	ENST00000291552	p.Q157P	U2AF1	-1	c.470	2016-05-18 20:26:16.33758	2016-05-18 20:40:05.813228	2	ENSG00000160201	missense
1578	\N	\N		21	44514777	44514777	T	G	DOID:9119	12623848	included	ENST00000291552	p.Q157P	U2AF1	-1	c.470	2016-05-18 20:26:16.34709	2016-05-18 20:40:05.851942	2	ENSG00000160201	missense
1579	\N	\N		21	44514777	44514777	T	G	DOID:9119	12399961	included	ENST00000291552	p.Q157P	U2AF1	-1	c.470	2016-05-18 20:26:16.3612	2016-05-18 20:40:05.892847	2	ENSG00000160201	missense
1580	\N	\N		21	44514777	44514777	T	G	DOID:9119	11853795	included	ENST00000291552	p.Q157P	U2AF1	-1	c.470	2016-05-18 20:26:16.371594	2016-05-18 20:40:05.934536	2	ENSG00000160201	missense
1581	\N	\N		21	44514777	44514777	T	G	DOID:9119	24236021	included	ENST00000291552	p.Q157P	U2AF1	-1	c.470	2016-05-18 20:26:16.384352	2016-05-18 20:40:05.979968	2	ENSG00000160201	missense
1582	\N	\N		21	44514777	44514777	T	G	DOID:9119	11964322	included	ENST00000291552	p.Q157P	U2AF1	-1	c.470	2016-05-18 20:26:16.396143	2016-05-18 20:40:06.032427	2	ENSG00000160201	missense
1583	\N	\N		21	44514777	44514777	T	G	DOID:9119	12130516	included	ENST00000291552	p.Q157P	U2AF1	-1	c.470	2016-05-18 20:26:16.404653	2016-05-18 20:40:06.078089	2	ENSG00000160201	missense
1584	\N	\N		21	44514777	44514777	T	G	DOID:9119	11423618	included	ENST00000291552	p.Q157P	U2AF1	-1	c.470	2016-05-18 20:26:16.41505	2016-05-18 20:40:06.132288	2	ENSG00000160201	missense
1585	\N	\N		21	44514777	44514777	T	G	DOID:9119	21872826	included	ENST00000291552	p.Q157P	U2AF1	-1	c.470	2016-05-18 20:26:16.428453	2016-05-18 20:40:06.181353	2	ENSG00000160201	missense
1586	\N	\N		21	44514777	44514777	T	G	DOID:9119	25157968	included	ENST00000291552	p.Q157P	U2AF1	-1	c.470	2016-05-18 20:26:16.43852	2016-05-18 20:40:06.23282	2	ENSG00000160201	missense
1587	\N	\N		21	44524456	44524456	G	A	DOID:9119	21895409	included	ENST00000291552	p.S34F	U2AF1	-1	c.101	2016-05-18 20:26:16.448872	2016-05-18 20:40:06.286063	2	ENSG00000160201	missense
1588	\N	\N		21	44524456	44524456	G	A	DOID:9119	21489624	included	ENST00000291552	p.S34F	U2AF1	-1	c.101	2016-05-18 20:26:16.45917	2016-05-18 20:40:06.325623	2	ENSG00000160201	missense
1589	\N	\N		21	44524456	44524456	G	A	DOID:9119	17114651	included	ENST00000291552	p.S34F	U2AF1	-1	c.101	2016-05-18 20:26:16.46609	2016-05-18 20:40:06.362435	2	ENSG00000160201	missense
1590	\N	\N		21	44524456	44524456	G	A	DOID:9119	18828913	included	ENST00000291552	p.S34F	U2AF1	-1	c.101	2016-05-18 20:26:16.477123	2016-05-18 20:40:06.40642	2	ENSG00000160201	missense
1591	\N	\N		21	44524456	44524456	G	A	DOID:9119	12623848	included	ENST00000291552	p.S34F	U2AF1	-1	c.101	2016-05-18 20:26:16.487985	2016-05-18 20:40:06.443699	2	ENSG00000160201	missense
1592	\N	\N		21	44524456	44524456	G	A	DOID:9119	20367437	included	ENST00000291552	p.S34F	U2AF1	-1	c.101	2016-05-18 20:26:16.49747	2016-05-18 20:40:06.483928	2	ENSG00000160201	missense
1593	\N	\N		21	44524456	44524456	G	A	DOID:9119	25157968	included	ENST00000291552	p.S34F	U2AF1	-1	c.101	2016-05-18 20:26:16.504697	2016-05-18 20:40:06.524379	2	ENSG00000160201	missense
1594	\N	\N		21	44524456	44524456	G	T	DOID:9119	23676790	included	ENST00000291552	p.S34Y	U2AF1	-1	c.101	2016-05-18 20:26:16.515618	2016-05-18 20:40:06.577892	2	ENSG00000160201	missense
1595	\N	\N		21	44524456	44524456	G	T	DOID:9119	21605905	included	ENST00000291552	p.S34Y	U2AF1	-1	c.101	2016-05-18 20:26:16.52573	2016-05-18 20:40:06.633554	2	ENSG00000160201	missense
1596	\N	\N		21	44524456	44524456	G	T	DOID:9119	21489624	included	ENST00000291552	p.S34Y	U2AF1	-1	c.101	2016-05-18 20:26:16.537394	2016-05-18 20:40:06.699279	2	ENSG00000160201	missense
1597	\N	\N		21	44524456	44524456	G	T	DOID:9119	20367437	included	ENST00000291552	p.S34Y	U2AF1	-1	c.101	2016-05-18 20:26:16.555253	2016-05-18 20:40:06.758684	2	ENSG00000160201	missense
1598	\N	\N		21	44524456	44524456	G	T	DOID:9119	12623848	included	ENST00000291552	p.S34Y	U2AF1	-1	c.101	2016-05-18 20:26:16.563352	2016-05-18 20:40:06.820767	2	ENSG00000160201	missense
1599	\N	\N		21	44524456	44524456	G	T	DOID:9119	11964322	included	ENST00000291552	p.S34Y	U2AF1	-1	c.101	2016-05-18 20:26:16.569776	2016-05-18 20:40:06.882483	2	ENSG00000160201	missense
1600	\N	\N		21	44524456	44524456	G	T	DOID:9119	25157968	included	ENST00000291552	p.S34Y	U2AF1	-1	c.101	2016-05-18 20:26:16.581778	2016-05-18 20:40:06.945919	2	ENSG00000160201	missense
1601	\N	\N		3	128200113	128200113	G	A	DOID:9119	23676790	included	ENST00000341105	p.R398W	GATA2	-1	c.1192	2016-05-18 20:26:16.591911	2016-05-18 20:40:07.052731	2	ENSG00000179348	missense
1602	\N	\N		3	128200113	128200113	G	A	DOID:9119	23355941	included	ENST00000341105	p.R398W	GATA2	-1	c.1192	2016-05-18 20:26:16.599044	2016-05-18 20:40:07.116402	2	ENSG00000179348	missense
1603	\N	\N		3	128200113	128200113	G	A	DOID:9119	14745431	included	ENST00000341105	p.R398W	GATA2	-1	c.1192	2016-05-18 20:26:16.60548	2016-05-18 20:40:07.172127	2	ENSG00000179348	missense
1604	\N	\N		3	128200113	128200113	G	A	DOID:9119	12623848	included	ENST00000341105	p.R398W	GATA2	-1	c.1192	2016-05-18 20:26:16.611951	2016-05-18 20:40:07.235802	2	ENSG00000179348	missense
1605	\N	\N		3	128200113	128200113	G	A	DOID:9119	11964322	included	ENST00000341105	p.R398W	GATA2	-1	c.1192	2016-05-18 20:26:16.624429	2016-05-18 20:40:07.280509	2	ENSG00000179348	missense
1606	\N	\N		3	128200113	128200113	G	A	DOID:9119	12399961	included	ENST00000341105	p.R398W	GATA2	-1	c.1192	2016-05-18 20:26:16.636871	2016-05-18 20:40:07.324412	2	ENSG00000179348	missense
1607	\N	\N		3	128200113	128200113	G	A	DOID:9119	12130516	included	ENST00000341105	p.R398W	GATA2	-1	c.1192	2016-05-18 20:26:16.650088	2016-05-18 20:40:07.378281	2	ENSG00000179348	missense
1608	\N	\N		3	128200113	128200113	G	A	DOID:9119	19768693	included	ENST00000341105	p.R398W	GATA2	-1	c.1192	2016-05-18 20:26:16.657814	2016-05-18 20:40:07.421699	2	ENSG00000179348	missense
1609	\N	\N		3	128200113	128200113	G	A	DOID:9119	19557636	included	ENST00000341105	p.R398W	GATA2	-1	c.1192	2016-05-18 20:26:16.66863	2016-05-18 20:40:07.473618	2	ENSG00000179348	missense
1610	\N	\N		3	128200113	128200113	G	A	DOID:9119	20607847	included	ENST00000341105	p.R398W	GATA2	-1	c.1192	2016-05-18 20:26:16.678298	2016-05-18 20:40:07.521483	2	ENSG00000179348	missense
1611	\N	\N		3	128200113	128200113	G	A	DOID:9119	20557306	included	ENST00000341105	p.R398W	GATA2	-1	c.1192	2016-05-18 20:26:16.684351	2016-05-18 20:40:07.563105	2	ENSG00000179348	missense
1612	\N	\N		3	128200113	128200113	G	A	DOID:9119	12783380	included	ENST00000341105	p.R398W	GATA2	-1	c.1192	2016-05-18 20:26:16.690207	2016-05-18 20:40:07.617321	2	ENSG00000179348	missense
1613	\N	\N		3	128200113	128200113	G	A	DOID:9119	15381060	included	ENST00000341105	p.R398W	GATA2	-1	c.1192	2016-05-18 20:26:16.696155	2016-05-18 20:40:07.657632	2	ENSG00000179348	missense
1614	\N	\N		3	128200113	128200113	G	A	DOID:9119	17189410	included	ENST00000341105	p.R398W	GATA2	-1	c.1192	2016-05-18 20:26:16.702735	2016-05-18 20:40:07.709233	2	ENSG00000179348	missense
1615	\N	\N		3	128200113	128200113	G	A	DOID:9119	25157968	included	ENST00000341105	p.R398W	GATA2	-1	c.1192	2016-05-18 20:26:16.708469	2016-05-18 20:40:07.775563	2	ENSG00000179348	missense
1616	\N	\N		3	128200744	128200744	G	A	DOID:9119	23676790	included	ENST00000341105	p.T354M	GATA2	-1	c.1061	2016-05-18 20:26:16.714613	2016-05-18 20:40:07.859175	2	ENSG00000179348	missense
1617	\N	\N		3	128200744	128200744	G	A	DOID:9119	12623848	included	ENST00000341105	p.T354M	GATA2	-1	c.1061	2016-05-18 20:26:16.720305	2016-05-18 20:40:07.913676	2	ENSG00000179348	missense
1618	\N	\N		3	128200744	128200744	G	A	DOID:9119	12399961	included	ENST00000341105	p.T354M	GATA2	-1	c.1061	2016-05-18 20:26:16.726076	2016-05-18 20:40:07.978651	2	ENSG00000179348	missense
1619	\N	\N		3	128200744	128200744	G	A	DOID:9119	24456693	included	ENST00000341105	p.T354M	GATA2	-1	c.1061	2016-05-18 20:26:16.732072	2016-05-18 20:40:08.041536	2	ENSG00000179348	missense
1620	\N	\N		3	128200744	128200744	G	A	DOID:9119	20702476	included	ENST00000341105	p.T354M	GATA2	-1	c.1061	2016-05-18 20:26:16.738078	2016-05-18 20:40:08.096161	2	ENSG00000179348	missense
1621	\N	\N		3	128200744	128200744	G	A	DOID:9119	20010464	included	ENST00000341105	p.T354M	GATA2	-1	c.1061	2016-05-18 20:26:16.744097	2016-05-18 20:40:08.152897	2	ENSG00000179348	missense
1622	\N	\N		3	128200744	128200744	G	A	DOID:9119	12783380	included	ENST00000341105	p.T354M	GATA2	-1	c.1061	2016-05-18 20:26:16.750169	2016-05-18 20:40:08.196836	2	ENSG00000179348	missense
1623	\N	\N		3	128200744	128200744	G	A	DOID:9119	25157968	included	ENST00000341105	p.T354M	GATA2	-1	c.1061	2016-05-18 20:26:16.75595	2016-05-18 20:40:08.241036	2	ENSG00000179348	missense
1624	\N	\N		5	170837546	170837547	-	CATG	DOID:9119	22357254	included	ENST00000296930	p.W288HX	NPM1	1	c.862	2016-05-18 20:26:16.761891	2016-05-18 20:40:08.308886	2	ENSG00000181163	frameshift
1625	\N	\N		5	170837546	170837547	-	CATG	DOID:9119	17372901	included	ENST00000296930	p.W288HX	NPM1	1	c.862	2016-05-18 20:26:16.767729	2016-05-18 20:40:08.366363	2	ENSG00000181163	frameshift
1626	\N	\N		5	170837546	170837547	-	CATG	DOID:9119	18448188	included	ENST00000296930	p.W288HX	NPM1	1	c.862	2016-05-18 20:26:16.77361	2016-05-18 20:40:08.408231	2	ENSG00000181163	frameshift
1627	\N	\N		5	170837546	170837547	-	CCTG	DOID:9119	20970876	included	ENST00000296930	p.W288PX	NPM1	1	c.862	2016-05-18 20:26:16.779553	2016-05-18 20:40:08.492677	2	ENSG00000181163	frameshift
1628	\N	\N		5	170837546	170837547	-	TCAG	DOID:9119	19861435	included	ENST00000296930	p.W288SX	NPM1	1	c.862	2016-05-18 20:26:16.785373	2016-05-18 20:40:08.580919	2	ENSG00000181163	frameshift
1629	\N	\N		5	170837546	170837547	-	TCTG	DOID:9119	19461405	included	ENST00000296930	p.W288SX	NPM1	1	c.862	2016-05-18 20:26:16.791039	2016-05-18 20:40:08.632068	2	ENSG00000181163	frameshift
1630	\N	\N		5	170837546	170837547	-	TCTG	DOID:9119	22357254	included	ENST00000296930	p.W288SX	NPM1	1	c.862	2016-05-18 20:26:16.796968	2016-05-18 20:40:08.694687	2	ENSG00000181163	frameshift
1631	\N	\N		5	170837546	170837547	-	TCTG	DOID:9119	17699867	included	ENST00000296930	p.W288SX	NPM1	1	c.862	2016-05-18 20:26:16.80253	2016-05-18 20:40:08.747249	2	ENSG00000181163	frameshift
1632	\N	\N		9	5073770	5073770	G	T	DOID:9119	23680147	included	ENST00000381652	p.V617F	JAK2	1	c.1849	2016-05-18 20:26:16.807935	2016-05-18 20:40:08.819527	2	ENSG00000096968	missense
1633	\N	\N		1	115256530	115256530	G	A	DOID:3908	19907440	included	ENST00000369535	p.Q61*	NRAS	-1	c.181	2016-05-18 20:32:57.604319	2016-05-18 20:40:08.880822	3	ENSG00000213281	stop
1634	\N	\N		1	115256530	115256530	G	A	DOID:3908	19965641	included	ENST00000369535	p.Q61*	NRAS	-1	c.181	2016-05-18 20:32:57.618007	2016-05-18 20:40:08.935386	3	ENSG00000213281	stop
1635	\N	\N		1	115256530	115256530	G	A	DOID:3908	20018760	included	ENST00000369535	p.Q61*	NRAS	-1	c.181	2016-05-18 20:32:57.627307	2016-05-18 20:40:09.000688	3	ENSG00000213281	stop
1636	\N	\N		1	115256530	115256530	G	A	DOID:3908	22368272	included	ENST00000369535	p.Q61*	NRAS	-1	c.181	2016-05-18 20:32:57.635406	2016-05-18 20:40:09.065523	3	ENSG00000213281	stop
1637	\N	\N		2	198266832	198266832	T	A	DOID:9119	24659740	included	ENST00000335508	p.K700N	SF3B1	-1	c.2100	2016-05-18 20:32:57.645921	2016-05-18 20:40:09.123666	3	ENSG00000115524	missense
1638	\N	\N		2	198266832	198266832	T	A	DOID:9119	24616160	included	ENST00000335508	p.K700N	SF3B1	-1	c.2100	2016-05-18 20:32:57.655339	2016-05-18 20:40:09.188792	3	ENSG00000115524	missense
1639	\N	\N		2	198266832	198266832	T	A	DOID:9119	24374719	included	ENST00000335508	p.K700N	SF3B1	-1	c.2100	2016-05-18 20:32:57.665237	2016-05-18 20:40:09.235368	3	ENSG00000115524	missense
1640	\N	\N		2	198266832	198266832	T	G	DOID:9119	24659740	included	ENST00000335508	p.K700N	SF3B1	-1	c.2100	2016-05-18 20:32:57.672921	2016-05-18 20:40:09.284398	3	ENSG00000115524	missense
1641	\N	\N		2	198266832	198266832	T	G	DOID:9119	19357396	included	ENST00000335508	p.K700N	SF3B1	-1	c.2100	2016-05-18 20:32:57.680321	2016-05-18 20:40:09.322634	3	ENSG00000115524	missense
1642	\N	\N		2	198266833	198266833	T	A	DOID:9119	24659740	included	ENST00000335508	p.K700I	SF3B1	-1	c.2099	2016-05-18 20:32:57.691337	2016-05-18 20:40:09.388375	3	ENSG00000115524	missense
1643	\N	\N		2	198266833	198266833	T	A	DOID:9119	19357396	included	ENST00000335508	p.K700I	SF3B1	-1	c.2099	2016-05-18 20:32:57.700121	2016-05-18 20:40:09.427409	3	ENSG00000115524	missense
1644	\N	\N		2	198266833	198266833	T	C	DOID:9119	23395771	included	ENST00000335508	p.K700R	SF3B1	-1	c.2099	2016-05-18 20:32:57.710836	2016-05-18 20:40:09.491982	3	ENSG00000115524	missense
1645	\N	\N		2	198266833	198266833	T	G	DOID:9119	23395771	included	ENST00000335508	p.K700T	SF3B1	-1	c.2099	2016-05-18 20:32:57.724393	2016-05-18 20:40:09.552947	3	ENSG00000115524	missense
1646	\N	\N		2	198266834	198266834	T	A	DOID:9119	23395771	included	ENST00000335508	p.K700*	SF3B1	-1	c.2098	2016-05-18 20:32:57.734177	2016-05-18 20:40:09.60494	3	ENSG00000115524	stop
1647	\N	\N		2	198266834	198266834	T	G	DOID:9119	23395771	included	ENST00000335508	p.K700Q	SF3B1	-1	c.2098	2016-05-18 20:32:57.745312	2016-05-18 20:40:09.651246	3	ENSG00000115524	missense
1648	\N	\N		2	198267360	198267360	T	C	DOID:9119	23395771	included	ENST00000335508	p.K666R	SF3B1	-1	c.1997	2016-05-18 20:32:57.757507	2016-05-18 20:40:09.710614	3	ENSG00000115524	missense
1649	\N	\N		2	198267360	198267360	T	G	DOID:9119	23395771	included	ENST00000335508	p.K666T	SF3B1	-1	c.1997	2016-05-18 20:32:57.767107	2016-05-18 20:40:09.759622	3	ENSG00000115524	missense
1650	\N	\N		2	198267361	198267361	T	C	DOID:9119	23395771	included	ENST00000335508	p.K666E	SF3B1	-1	c.1996	2016-05-18 20:32:57.777923	2016-05-18 20:40:09.824456	3	ENSG00000115524	missense
1651	\N	\N		4	55593610	55593610	T	C	DOID:1909	12460918	included	ENST00000288135	p.V559A	KIT	1	c.1676	2016-05-18 20:32:57.791118	2016-05-18 20:40:09.880195	3	ENSG00000157404	missense
1652	\N	\N		4	55593610	55593610	T	C	DOID:1909	18794081	included	ENST00000288135	p.V559A	KIT	1	c.1676	2016-05-18 20:32:57.799989	2016-05-18 20:40:09.933503	3	ENSG00000157404	missense
1653	\N	\N		4	55594258	55594258	T	A	DOID:1909	16930767	included	ENST00000288135	p.V654E	KIT	1	c.1961	2016-05-18 20:32:57.811565	2016-05-18 20:40:10.01181	3	ENSG00000157404	missense
1654	\N	\N		4	55594258	55594258	T	A	DOID:1909	15016963	included	ENST00000288135	p.V654E	KIT	1	c.1961	2016-05-18 20:32:57.823895	2016-05-18 20:40:10.055028	3	ENSG00000157404	missense
1655	\N	\N		4	55594258	55594258	T	A	DOID:1909	15647370	included	ENST00000288135	p.V654E	KIT	1	c.1961	2016-05-18 20:32:57.835248	2016-05-18 20:40:10.099937	3	ENSG00000157404	missense
1656	\N	\N		4	55594258	55594258	T	A	DOID:1909	15254419	included	ENST00000288135	p.V654E	KIT	1	c.1961	2016-05-18 20:32:57.846778	2016-05-18 20:40:10.134523	3	ENSG00000157404	missense
1657	\N	\N		4	55594258	55594258	T	A	DOID:1909	20453058	included	ENST00000288135	p.V654E	KIT	1	c.1961	2016-05-18 20:32:57.857671	2016-05-18 20:40:10.166972	3	ENSG00000157404	missense
1658	\N	\N		4	55594258	55594258	T	A	DOID:1909	18725974	included	ENST00000288135	p.V654E	KIT	1	c.1961	2016-05-18 20:32:57.867787	2016-05-18 20:40:10.200373	3	ENSG00000157404	missense
1659	\N	\N		4	55594258	55594258	T	A	DOID:1909	22162589	included	ENST00000288135	p.V654E	KIT	1	c.1961	2016-05-18 20:32:57.879063	2016-05-18 20:40:10.233385	3	ENSG00000157404	missense
1660	\N	\N		4	55594258	55594258	T	A	DOID:1909	19513541	included	ENST00000288135	p.V654E	KIT	1	c.1961	2016-05-18 20:32:57.893265	2016-05-18 20:40:10.265502	3	ENSG00000157404	missense
1661	\N	\N		4	55594258	55594258	T	A	DOID:1909	19029981	included	ENST00000288135	p.V654E	KIT	1	c.1961	2016-05-18 20:32:57.901485	2016-05-18 20:40:10.297777	3	ENSG00000157404	missense
1662	\N	\N		4	55594258	55594258	T	A	DOID:1909	16906227	included	ENST00000288135	p.V654E	KIT	1	c.1961	2016-05-18 20:32:57.912035	2016-05-18 20:40:10.33192	3	ENSG00000157404	missense
1663	\N	\N		4	55594258	55594258	T	A	DOID:1909	21430269	included	ENST00000288135	p.V654E	KIT	1	c.1961	2016-05-18 20:32:57.923902	2016-05-18 20:40:10.363692	3	ENSG00000157404	missense
1664	\N	\N		4	55599320	55599320	G	C	DOID:9119	22328973	included	ENST00000288135	p.D816H	KIT	1	c.2446	2016-05-18 20:32:57.932266	2016-05-18 20:40:10.398499	3	ENSG00000157404	missense
1665	\N	\N		4	55599320	55599320	G	T	DOID:1909	22328973	included	ENST00000288135	p.D816Y	KIT	1	c.2446	2016-05-18 20:32:57.941946	2016-05-18 20:40:10.435786	3	ENSG00000157404	missense
1666	\N	\N		4	55599320	55599320	G	T	DOID:9253	22753918	included	ENST00000288135	p.D816Y	KIT	1	c.2446	2016-05-18 20:32:57.9503	2016-05-18 20:40:10.470945	3	ENSG00000157404	missense
1667	\N	\N		4	55599320	55599320	G	T	DOID:9253	23102728	included	ENST00000288135	p.D816Y	KIT	1	c.2446	2016-05-18 20:32:57.963573	2016-05-18 20:40:10.503927	3	ENSG00000157404	missense
1668	\N	\N		4	55599321	55599321	A	T	DOID:9253	22753918	included	ENST00000288135	p.D816V	KIT	1	c.2447	2016-05-18 20:32:57.97261	2016-05-18 20:40:10.537366	3	ENSG00000157404	missense
1669	\N	\N		4	55599321	55599321	A	T	DOID:9253	23102728	included	ENST00000288135	p.D816V	KIT	1	c.2447	2016-05-18 20:32:57.993328	2016-05-18 20:40:10.571971	3	ENSG00000157404	missense
1670	\N	\N		7	140453154	140453154	T	G	DOID:1909	21975775	included	ENST00000288602	p.D594A	BRAF	-1	c.1781	2016-05-18 20:32:58.003278	2016-05-18 20:40:10.623205	3	ENSG00000157764	missense
1671	\N	\N		7	140453154	140453154	T	G	DOID:1909	19018267	included	ENST00000288602	p.D594A	BRAF	-1	c.1781	2016-05-18 20:32:58.014441	2016-05-18 20:40:10.661876	3	ENSG00000157764	missense
1672	\N	\N		7	140453155	140453155	C	A	DOID:1909	21975775	included	ENST00000288602	p.D594Y	BRAF	-1	c.1780	2016-05-18 20:32:58.02892	2016-05-18 20:40:10.713437	3	ENSG00000157764	missense
1673	\N	\N		7	140453155	140453155	C	A	DOID:1909	19018267	included	ENST00000288602	p.D594Y	BRAF	-1	c.1780	2016-05-18 20:32:58.037358	2016-05-18 20:40:10.750026	3	ENSG00000157764	missense
1766	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"quizartinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22504184\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"ponatinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23430109\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"crenolanib, PKC412\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"24619500\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		13	28592621	28592621	A	G	DOID:9119	23430109	included	ENST00000380982	p.Y842H	FLT3	-1	c.2524	2016-05-18 20:50:28.547769	2016-05-18 21:26:52.842057	4	ENSG00000122025	missense
1767	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"quizartinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22504184\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"ponatinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23430109\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"crenolanib, PKC412\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"24619500\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		13	28592621	28592621	A	G	DOID:9119	24619500	included	ENST00000380982	p.Y842H	FLT3	-1	c.2524	2016-05-18 20:50:28.587757	2016-05-18 21:26:52.899829	4	ENSG00000122025	missense
1768	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"quizartinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22504184\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"ponatinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23430109\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"sorafenib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22368270\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"midostaurin\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"20733134\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"lestaurtinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"16857985.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		13	28592640	28592640	A	C	DOID:9119	23261068	included	ENST00000380982	p.D835E	FLT3	-1	c.2505	2016-05-18 20:50:28.616343	2016-05-18 21:26:52.969406	4	ENSG00000122025	missense
1949	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"crizotinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22277784\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"novel ALK inhibiors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"24327273\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		2	29443695	29443695	G	T	DOID:3910	24327273	included	ENST00000389048	p.F1174L	ALK	-1	c.3522	2016-05-18 20:50:34.667595	2016-05-18 21:27:08.950602	4	ENSG00000171094	missense
2643	\N	\N		9	133738363	133738363	G	A	DOID:8552	14745431	included	ENST00000372348	p.E274K	ABL1	1	c.820	2016-05-18 21:06:55.794856	2016-05-18 21:28:03.729007	5	ENSG00000097007	missense
2644	\N	\N		9	133738363	133738363	G	A	DOID:8552	12623848	included	ENST00000372348	p.E274K	ABL1	1	c.820	2016-05-18 21:06:55.801876	2016-05-18 21:28:03.782108	5	ENSG00000097007	missense
1950	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"crizotinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22277784\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		2	29445270	29445270	A	C	DOID:3910	22277784	included	ENST00000389048	p.L1152R	ALK	-1	c.3455	2016-05-18 20:50:34.699855	2016-05-18 21:27:09.053257	4	ENSG00000171094	missense
2645	\N	\N		9	133738363	133738363	G	A	DOID:8552	11964322	included	ENST00000372348	p.E274K	ABL1	1	c.820	2016-05-18 21:06:55.811626	2016-05-18 21:28:03.835611	5	ENSG00000097007	missense
2646	\N	\N		9	133738363	133738363	G	A	DOID:8552	12399961	included	ENST00000372348	p.E274K	ABL1	1	c.820	2016-05-18 21:06:55.819621	2016-05-18 21:28:03.908967	5	ENSG00000097007	missense
2647	\N	\N		9	133738363	133738363	G	A	DOID:8552	11861307	included	ENST00000372348	p.E274K	ABL1	1	c.820	2016-05-18 21:06:55.827336	2016-05-18 21:28:03.961941	5	ENSG00000097007	missense
1769	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"quizartinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22504184\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"ponatinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23430109\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"sorafenib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22368270\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"midostaurin\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"20733134\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"lestaurtinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"16857985.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		13	28592640	28592640	A	C	DOID:9119	23783394	included	ENST00000380982	p.D835E	FLT3	-1	c.2505	2016-05-18 20:50:28.658077	2016-05-18 21:26:53.039253	4	ENSG00000122025	missense
1770	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"quizartinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22504184\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"ponatinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23430109\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"sorafenib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22368270\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"midostaurin\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"20733134\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"lestaurtinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"16857985.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		13	28592640	28592640	A	C	DOID:9119	23321257	included	ENST00000380982	p.D835E	FLT3	-1	c.2505	2016-05-18 20:50:28.718402	2016-05-18 21:26:53.111618	4	ENSG00000122025	missense
1771	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"quizartinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22504184\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"ponatinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23430109\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"sorafenib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22368270\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"midostaurin\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"20733134\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"lestaurtinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"16857985.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		13	28592640	28592640	A	C	DOID:9119	22368270	included	ENST00000380982	p.D835E	FLT3	-1	c.2505	2016-05-18 20:50:28.754251	2016-05-18 21:26:53.16792	4	ENSG00000122025	missense
1951	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"sorafenib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"24569458\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		X	47426121	47426121	C	G	DOID:3910	24569458	included	ENST00000377045	p.S214C	ARAF	1	c.641	2016-05-18 20:50:34.710311	2016-05-18 21:27:09.165944	4	ENSG00000078061	missense
2648	\N	\N		9	133738363	133738363	G	A	DOID:8552	11853795	included	ENST00000372348	p.E274K	ABL1	1	c.820	2016-05-18 21:06:55.835778	2016-05-18 21:28:04.012042	5	ENSG00000097007	missense
1952	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"EGFR TKIs\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22773810\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"EGFR TKIs + MEK inhibitors in EGFR mutant\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22773810\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	140481402	140481402	C	G	DOID:3910	22773810	included	ENST00000288602	p.G469A	BRAF	-1	c.1406	2016-05-18 20:50:34.727498	2016-05-18 21:27:09.236443	4	ENSG00000157764	missense
2649	\N	\N		9	133738363	133738363	G	A	DOID:8552	23676790	included	ENST00000372348	p.E274K	ABL1	1	c.820	2016-05-18 21:06:55.843169	2016-05-18 21:28:04.070791	5	ENSG00000097007	missense
2154	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"trametinib, dabrafenib + trametinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"FDA-approved\\",\\"Evidence\\":\\"consensus\\",\\"Source\\":\\"FDA\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"vemurafenib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"late trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22356324\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	140453136	140453137	AC	TT	DOID:1909	FDA	invalid	ENST00000288602	p.V600K	BRAF	-1	c.1798	2016-05-18 20:50:40.608003	2016-05-18 21:14:34.164945	4	ENSG00000157764	missense
2650	\N	\N		9	133738363	133738363	G	A	DOID:8552	11567109	included	ENST00000372348	p.E274K	ABL1	1	c.820	2016-05-18 21:06:55.865554	2016-05-18 21:28:04.110796	5	ENSG00000097007	missense
2651	\N	\N		9	133738363	133738363	G	A	DOID:8552	21509757	included	ENST00000372348	p.E274K	ABL1	1	c.820	2016-05-18 21:06:55.874079	2016-05-18 21:28:04.151832	5	ENSG00000097007	missense
2652	\N	\N		9	133738363	133738363	G	A	DOID:8552	18757400	included	ENST00000372348	p.E274K	ABL1	1	c.820	2016-05-18 21:06:55.887937	2016-05-18 21:28:04.195984	5	ENSG00000097007	missense
2653	\N	\N		9	133738363	133738363	G	A	DOID:8552	25157968	included	ENST00000372348	p.E274K	ABL1	1	c.820	2016-05-18 21:06:55.900266	2016-05-18 21:28:04.243799	5	ENSG00000097007	missense
2654	\N	\N		9	133738364	133738364	A	T	DOID:8552	23676790	included	ENST00000372348	p.E274V	ABL1	1	c.821	2016-05-18 21:06:55.909812	2016-05-18 21:28:04.309601	5	ENSG00000097007	missense
2655	\N	\N		9	133738364	133738364	A	T	DOID:8552	14745431	included	ENST00000372348	p.E274V	ABL1	1	c.821	2016-05-18 21:06:55.918097	2016-05-18 21:28:04.358876	5	ENSG00000097007	missense
2656	\N	\N		9	133738364	133738364	A	T	DOID:8552	12623848	included	ENST00000372348	p.E274V	ABL1	1	c.821	2016-05-18 21:06:55.926698	2016-05-18 21:28:04.402953	5	ENSG00000097007	missense
2657	\N	\N		9	133738364	133738364	A	T	DOID:8552	12399961	included	ENST00000372348	p.E274V	ABL1	1	c.821	2016-05-18 21:06:55.935424	2016-05-18 21:28:04.451878	5	ENSG00000097007	missense
2658	\N	\N		9	133738364	133738364	A	T	DOID:8552	11853795	included	ENST00000372348	p.E274V	ABL1	1	c.821	2016-05-18 21:06:55.943285	2016-05-18 21:28:04.495481	5	ENSG00000097007	missense
2659	\N	\N		9	133738364	133738364	A	T	DOID:8552	11569495	included	ENST00000372348	p.E274V	ABL1	1	c.821	2016-05-18 21:06:55.963014	2016-05-18 21:28:04.545069	5	ENSG00000097007	missense
2660	\N	\N		9	133738364	133738364	A	T	DOID:8552	24236021	included	ENST00000372348	p.E274V	ABL1	1	c.821	2016-05-18 21:06:55.970673	2016-05-18 21:28:04.588316	5	ENSG00000097007	missense
2661	\N	\N		9	133738364	133738364	A	T	DOID:8552	19264234	included	ENST00000372348	p.E274V	ABL1	1	c.821	2016-05-18 21:06:55.97968	2016-05-18 21:28:04.634444	5	ENSG00000097007	missense
1772	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"quizartinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22504184\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"ponatinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23430109\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"sorafenib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22368270\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"midostaurin\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"20733134\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"lestaurtinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"16857985.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		13	28592640	28592640	A	C	DOID:9119	23714533	included	ENST00000380982	p.D835E	FLT3	-1	c.2505	2016-05-18 20:50:28.788074	2016-05-18 21:26:53.226096	4	ENSG00000122025	missense
2662	\N	\N		9	133738364	133738364	A	T	DOID:8552	19164531	included	ENST00000372348	p.E274V	ABL1	1	c.821	2016-05-18 21:06:55.988176	2016-05-18 21:28:04.67965	5	ENSG00000097007	missense
2663	\N	\N		9	133738364	133738364	A	T	DOID:8552	25157968	included	ENST00000372348	p.E274V	ABL1	1	c.821	2016-05-18 21:06:55.995866	2016-05-18 21:28:04.746964	5	ENSG00000097007	missense
1774	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"quizartinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22504184\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"ponatinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23430109\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"sorafenib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22368270\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"midostaurin\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"20733134\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"lestaurtinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"16857985.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		13	28592640	28592640	A	C	DOID:9119	15256420	included	ENST00000380982	p.D835E	FLT3	-1	c.2505	2016-05-18 20:50:28.885012	2016-05-18 21:26:53.368015	4	ENSG00000122025	missense
1776	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"quizartinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22504184\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"ponatinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23430109\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"sorafenib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22368270\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"midostaurin\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"20733134\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"lestaurtinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"16857985.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		13	28592640	28592640	A	C	DOID:9119	19657110	included	ENST00000380982	p.D835E	FLT3	-1	c.2505	2016-05-18 20:50:28.987996	2016-05-18 21:26:53.52274	4	ENSG00000122025	missense
1954	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"crizotinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23724914\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		6	117638347	117638347	C	T	DOID:3910	23724914	included	ENST00000368508	p.G2032R	ROS1	-1	c.6094	2016-05-18 20:50:34.776467	2016-05-18 21:27:09.435647	4	ENSG00000047936	missense
2664	\N	\N		9	133747540	133747540	A	G	DOID:8552	21895409	included	ENST00000372348	p.F302V	ABL1	1	c.904	2016-05-18 21:06:56.003809	2016-05-18 21:28:04.8254	5	ENSG00000097007	missense
2665	\N	\N		9	133747540	133747540	A	G	DOID:8552	14745431	included	ENST00000372348	p.F302V	ABL1	1	c.904	2016-05-18 21:06:56.013995	2016-05-18 21:28:04.875946	5	ENSG00000097007	missense
2666	\N	\N		9	133747540	133747540	A	G	DOID:8552	24456693	included	ENST00000372348	p.F302V	ABL1	1	c.904	2016-05-18 21:06:56.022339	2016-05-18 21:28:04.919865	5	ENSG00000097007	missense
1777	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"quizartinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22504184\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"ponatinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23430109\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"sorafenib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22368270\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"midostaurin\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"20733134\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"lestaurtinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"16857985.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		13	28592640	28592640	A	C	DOID:9119	22504184	included	ENST00000380982	p.D835E	FLT3	-1	c.2505	2016-05-18 20:50:29.021667	2016-05-18 21:26:53.594051	4	ENSG00000122025	missense
1779	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"quizartinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22504184\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"ponatinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23430109\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"sorafenib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22368270\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"midostaurin\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"20733134\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"lestaurtinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"16857985.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		13	28592640	28592640	A	C	DOID:9119	20733134	included	ENST00000380982	p.D835E	FLT3	-1	c.2505	2016-05-18 20:50:29.08627	2016-05-18 21:26:53.762132	4	ENSG00000122025	missense
2048	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"imatinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"21969494\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"sunitinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23375402\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		4	55593591	55593591	T	A	DOID:3284	22357254	included	ENST00000288135	p.Y553N	KIT	1	c.1657	2016-05-18 20:50:38.053743	2016-05-18 21:27:17.67428	4	ENSG00000157404	missense
2667	\N	\N		9	133747540	133747540	A	G	DOID:8552	15510211	included	ENST00000372348	p.F302V	ABL1	1	c.904	2016-05-18 21:06:56.030081	2016-05-18 21:28:04.981298	5	ENSG00000097007	missense
2668	\N	\N		9	133747540	133747540	A	G	DOID:8552	25157968	included	ENST00000372348	p.F302V	ABL1	1	c.904	2016-05-18 21:06:56.038694	2016-05-18 21:28:05.032149	5	ENSG00000097007	missense
1780	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"quizartinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22504184\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"ponatinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23430109\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"sorafenib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22368270\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"midostaurin\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"20733134\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"lestaurtinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"16857985.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		13	28592640	28592640	A	C	DOID:9119	16857985	included	ENST00000380982	p.D835E	FLT3	-1	c.2505	2016-05-18 20:50:29.127074	2016-05-18 21:26:53.886016	4	ENSG00000122025	missense
1781	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"quizartinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22504184\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"ponatinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23430109\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"sorafenib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22368270\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"midostaurin\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"20733134\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"lestaurtinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"16857985.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		13	28592640	28592640	A	T	DOID:9119	23261068	included	ENST00000380982	p.D835E	FLT3	-1	c.2505	2016-05-18 20:50:29.18831	2016-05-18 21:26:53.967104	4	ENSG00000122025	missense
2049	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"imatinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"21969494\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"sunitinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23375402\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		4	55593591	55593591	T	A	DOID:3284	23375402	included	ENST00000288135	p.Y553N	KIT	1	c.1657	2016-05-18 20:50:38.087896	2016-05-18 21:27:17.786957	4	ENSG00000157404	missense
2669	\N	\N		9	133748283	133748283	C	T	DOID:8552	23540562	included	ENST00000372348	p.T334I	ABL1	1	c.1001	2016-05-18 21:06:56.064353	2016-05-18 21:28:05.087169	5	ENSG00000097007	missense
2670	\N	\N		9	133748283	133748283	C	T	DOID:8552	23355941	included	ENST00000372348	p.T334I	ABL1	1	c.1001	2016-05-18 21:06:56.081174	2016-05-18 21:28:05.127749	5	ENSG00000097007	missense
2050	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"imatinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"15201427\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		4	55593612	55593612	GTT	-	DOID:3284	19861435	included	ENST00000288135	p.V560X	KIT	1	c.1678	2016-05-18 20:50:38.097631	2016-05-18 21:27:17.877288	4	ENSG00000157404	frameshift
2671	\N	\N		9	133748283	133748283	C	T	DOID:8552	22870928	included	ENST00000372348	p.T334I	ABL1	1	c.1001	2016-05-18 21:06:56.101284	2016-05-18 21:28:05.187784	5	ENSG00000097007	missense
2672	\N	\N		9	133748283	133748283	C	T	DOID:8552	22306673	included	ENST00000372348	p.T334I	ABL1	1	c.1001	2016-05-18 21:06:56.142472	2016-05-18 21:28:05.229416	5	ENSG00000097007	missense
2673	\N	\N		9	133748283	133748283	C	T	DOID:8552	21762985	included	ENST00000372348	p.T334I	ABL1	1	c.1001	2016-05-18 21:06:56.156276	2016-05-18 21:28:05.268423	5	ENSG00000097007	missense
1782	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"quizartinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22504184\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"ponatinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23430109\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"sorafenib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22368270\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"midostaurin\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"20733134\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"lestaurtinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"16857985.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		13	28592640	28592640	A	T	DOID:9119	23783394	included	ENST00000380982	p.D835E	FLT3	-1	c.2505	2016-05-18 20:50:29.223591	2016-05-18 21:26:54.047052	4	ENSG00000122025	missense
1784	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"quizartinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22504184\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"ponatinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23430109\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"sorafenib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22368270\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"midostaurin\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"20733134\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"lestaurtinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"16857985.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		13	28592640	28592640	A	T	DOID:9119	22368270	included	ENST00000380982	p.D835E	FLT3	-1	c.2505	2016-05-18 20:50:29.324823	2016-05-18 21:26:54.213064	4	ENSG00000122025	missense
1785	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"quizartinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22504184\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"ponatinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23430109\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"sorafenib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22368270\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"midostaurin\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"20733134\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"lestaurtinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"16857985.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		13	28592640	28592640	A	T	DOID:9119	23714533	included	ENST00000380982	p.D835E	FLT3	-1	c.2505	2016-05-18 20:50:29.354085	2016-05-18 21:26:54.308554	4	ENSG00000122025	missense
2051	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"imatinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"15201427\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		4	55593612	55593612	GTT	-	DOID:3284	15201427	included	ENST00000288135	p.V560X	KIT	1	c.1678	2016-05-18 20:50:38.128474	2016-05-18 21:27:17.978569	4	ENSG00000157404	frameshift
1786	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"quizartinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22504184\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"ponatinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23430109\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"sorafenib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22368270\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"midostaurin\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"20733134\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"lestaurtinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"16857985.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		13	28592640	28592640	A	T	DOID:9119	22504183	included	ENST00000380982	p.D835E	FLT3	-1	c.2505	2016-05-18 20:50:29.398253	2016-05-18 21:26:54.374809	4	ENSG00000122025	missense
1787	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"quizartinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22504184\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"ponatinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23430109\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"sorafenib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22368270\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"midostaurin\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"20733134\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"lestaurtinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"16857985.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		13	28592640	28592640	A	T	DOID:9119	15256420	included	ENST00000380982	p.D835E	FLT3	-1	c.2505	2016-05-18 20:50:29.453505	2016-05-18 21:26:54.444444	4	ENSG00000122025	missense
1788	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"quizartinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22504184\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"ponatinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23430109\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"sorafenib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22368270\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"midostaurin\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"20733134\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"lestaurtinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"16857985.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		13	28592640	28592640	A	T	DOID:9119	11290608	included	ENST00000380982	p.D835E	FLT3	-1	c.2505	2016-05-18 20:50:29.496777	2016-05-18 21:26:54.517689	4	ENSG00000122025	missense
2052	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"imatinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"15201427\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		4	55593612	55593612	GTT	-	DOID:3284	17372901	included	ENST00000288135	p.V560X	KIT	1	c.1678	2016-05-18 20:50:38.154827	2016-05-18 21:27:18.070299	4	ENSG00000157404	frameshift
1789	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"quizartinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22504184\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"ponatinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23430109\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"sorafenib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22368270\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"midostaurin\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"20733134\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"lestaurtinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"16857985.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		13	28592640	28592640	A	T	DOID:9119	19657110	included	ENST00000380982	p.D835E	FLT3	-1	c.2505	2016-05-18 20:50:29.527771	2016-05-18 21:26:54.598184	4	ENSG00000122025	missense
1790	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"quizartinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22504184\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"ponatinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23430109\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"sorafenib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22368270\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"midostaurin\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"20733134\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"lestaurtinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"16857985.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		13	28592640	28592640	A	T	DOID:9119	22504184	included	ENST00000380982	p.D835E	FLT3	-1	c.2505	2016-05-18 20:50:29.589325	2016-05-18 21:26:54.691703	4	ENSG00000122025	missense
1791	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"quizartinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22504184\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"ponatinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23430109\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"sorafenib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22368270\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"midostaurin\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"20733134\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"lestaurtinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"16857985.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		13	28592640	28592640	A	T	DOID:9119	23430109	included	ENST00000380982	p.D835E	FLT3	-1	c.2505	2016-05-18 20:50:29.633439	2016-05-18 21:26:54.778754	4	ENSG00000122025	missense
2053	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"imatinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"15201427\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		4	55593612	55593612	GTT	-	DOID:3284	15930355	included	ENST00000288135	p.V560X	KIT	1	c.1678	2016-05-18 20:50:38.189815	2016-05-18 21:27:18.1803	4	ENSG00000157404	frameshift
1792	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"quizartinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22504184\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"ponatinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23430109\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"sorafenib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22368270\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"midostaurin\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"20733134\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"lestaurtinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"16857985.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		13	28592640	28592640	A	T	DOID:9119	20733134	included	ENST00000380982	p.D835E	FLT3	-1	c.2505	2016-05-18 20:50:29.692738	2016-05-18 21:26:54.866867	4	ENSG00000122025	missense
1794	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"quizartinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22504184\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"ponatinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23430109\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"sorafenib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22368270\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"midostaurin\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"20733134\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"lestaurtinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"16857985.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		13	28592641	28592641	T	A	DOID:9119	23261068	included	ENST00000380982	p.D835V	FLT3	-1	c.2504	2016-05-18 20:50:29.760048	2016-05-18 21:26:55.018715	4	ENSG00000122025	missense
1795	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"quizartinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22504184\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"ponatinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23430109\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"sorafenib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22368270\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"midostaurin\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"20733134\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"lestaurtinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"16857985.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		13	28592641	28592641	T	A	DOID:9119	23783394	included	ENST00000380982	p.D835V	FLT3	-1	c.2504	2016-05-18 20:50:29.826809	2016-05-18 21:26:55.089793	4	ENSG00000122025	missense
2054	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"sunitinib\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"19861435\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		4	55595599	55595599	C	T	DOID:3284	19861435	included	ENST00000288135	p.H697Y	KIT	1	c.2089	2016-05-18 20:50:38.200195	2016-05-18 21:27:18.247126	4	ENSG00000157404	missense
1796	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"quizartinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22504184\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"ponatinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23430109\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"sorafenib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22368270\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"midostaurin\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"20733134\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"lestaurtinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"16857985.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		13	28592641	28592641	T	A	DOID:9119	23321257	included	ENST00000380982	p.D835V	FLT3	-1	c.2504	2016-05-18 20:50:29.862562	2016-05-18 21:26:55.150069	4	ENSG00000122025	missense
1797	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"quizartinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22504184\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"ponatinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23430109\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"sorafenib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22368270\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"midostaurin\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"20733134\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"lestaurtinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"16857985.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		13	28592641	28592641	T	A	DOID:9119	22368270	included	ENST00000380982	p.D835V	FLT3	-1	c.2504	2016-05-18 20:50:29.927937	2016-05-18 21:26:55.215866	4	ENSG00000122025	missense
1798	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"quizartinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22504184\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"ponatinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23430109\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"sorafenib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22368270\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"midostaurin\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"20733134\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"lestaurtinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"16857985.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		13	28592641	28592641	T	A	DOID:9119	23714533	included	ENST00000380982	p.D835V	FLT3	-1	c.2504	2016-05-18 20:50:29.962431	2016-05-18 21:26:55.308537	4	ENSG00000122025	missense
2055	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"sorafenib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"19461405\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		4	55599334	55599334	T	A	DOID:3284	19461405	included	ENST00000288135	p.D820E	KIT	1	c.2460	2016-05-18 20:50:38.22205	2016-05-18 21:27:18.341332	4	ENSG00000157404	missense
1799	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"quizartinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22504184\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"ponatinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23430109\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"sorafenib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22368270\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"midostaurin\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"20733134\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"lestaurtinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"16857985.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		13	28592641	28592641	T	A	DOID:9119	22504183	included	ENST00000380982	p.D835V	FLT3	-1	c.2504	2016-05-18 20:50:30.002227	2016-05-18 21:26:55.383902	4	ENSG00000122025	missense
1800	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"quizartinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22504184\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"ponatinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23430109\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"sorafenib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22368270\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"midostaurin\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"20733134\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"lestaurtinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"16857985.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		13	28592641	28592641	T	A	DOID:9119	15256420	included	ENST00000380982	p.D835V	FLT3	-1	c.2504	2016-05-18 20:50:30.062408	2016-05-18 21:26:55.572857	4	ENSG00000122025	missense
1801	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"quizartinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22504184\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"ponatinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23430109\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"sorafenib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22368270\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"midostaurin\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"20733134\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"lestaurtinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"16857985.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		13	28592641	28592641	T	A	DOID:9119	11290608	included	ENST00000380982	p.D835V	FLT3	-1	c.2504	2016-05-18 20:50:30.092123	2016-05-18 21:26:55.700145	4	ENSG00000122025	missense
2056	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"sorafenib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"19461405\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		4	55599334	55599334	T	A	DOID:3284	22357254	included	ENST00000288135	p.D820E	KIT	1	c.2460	2016-05-18 20:50:38.233961	2016-05-18 21:27:18.466627	4	ENSG00000157404	missense
1802	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"quizartinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22504184\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"ponatinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23430109\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"sorafenib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22368270\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"midostaurin\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"20733134\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"lestaurtinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"16857985.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		13	28592641	28592641	T	A	DOID:9119	19657110	included	ENST00000380982	p.D835V	FLT3	-1	c.2504	2016-05-18 20:50:30.136505	2016-05-18 21:26:55.800846	4	ENSG00000122025	missense
1803	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"quizartinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22504184\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"ponatinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23430109\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"sorafenib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22368270\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"midostaurin\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"20733134\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"lestaurtinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"16857985.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		13	28592641	28592641	T	A	DOID:9119	22504184	included	ENST00000380982	p.D835V	FLT3	-1	c.2504	2016-05-18 20:50:30.196847	2016-05-18 21:26:55.883628	4	ENSG00000122025	missense
1804	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"quizartinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22504184\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"ponatinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23430109\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"sorafenib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22368270\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"midostaurin\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"20733134\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"lestaurtinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"16857985.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		13	28592641	28592641	T	A	DOID:9119	23430109	included	ENST00000380982	p.D835V	FLT3	-1	c.2504	2016-05-18 20:50:30.231695	2016-05-18 21:26:55.961619	4	ENSG00000122025	missense
2057	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"sorafenib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"19461405\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		4	55599334	55599334	T	A	DOID:3284	17699867	included	ENST00000288135	p.D820E	KIT	1	c.2460	2016-05-18 20:50:38.258982	2016-05-18 21:27:18.577532	4	ENSG00000157404	missense
1805	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"quizartinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22504184\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"ponatinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23430109\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"sorafenib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22368270\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"midostaurin\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"20733134\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"lestaurtinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"16857985.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		13	28592641	28592641	T	A	DOID:9119	20733134	included	ENST00000380982	p.D835V	FLT3	-1	c.2504	2016-05-18 20:50:30.270485	2016-05-18 21:26:56.041908	4	ENSG00000122025	missense
1806	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"quizartinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22504184\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"ponatinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23430109\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"sorafenib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22368270\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"midostaurin\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"20733134\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"lestaurtinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"16857985.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		13	28592641	28592641	T	A	DOID:9119	16857985	included	ENST00000380982	p.D835V	FLT3	-1	c.2504	2016-05-18 20:50:30.332818	2016-05-18 21:26:56.131935	4	ENSG00000122025	missense
1807	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"quizartinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22504184\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		13	28592641	28592641	T	A	DOID:9119	22504184	included	ENST00000380982	p.D835V	FLT3	-1	c.2504	2016-05-18 20:50:30.364138	2016-05-18 21:26:56.196708	4	ENSG00000122025	missense
1808	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"quizartinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22504184\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"ponatinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23430109\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"sorafenib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22368270\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"midostaurin\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"20733134\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"lestaurtinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"16857985.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		13	28592641	28592641	T	G	DOID:9119	23261068	included	ENST00000380982	p.D835A	FLT3	-1	c.2504	2016-05-18 20:50:30.399662	2016-05-18 21:26:56.276168	4	ENSG00000122025	missense
1809	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"quizartinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22504184\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"ponatinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23430109\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"sorafenib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22368270\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"midostaurin\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"20733134\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"lestaurtinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"16857985.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		13	28592641	28592641	T	G	DOID:9119	23783394	included	ENST00000380982	p.D835A	FLT3	-1	c.2504	2016-05-18 20:50:30.43191	2016-05-18 21:26:56.36599	4	ENSG00000122025	missense
1810	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"quizartinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22504184\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"ponatinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23430109\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"sorafenib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22368270\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"midostaurin\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"20733134\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"lestaurtinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"16857985.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		13	28592641	28592641	T	G	DOID:9119	23321257	included	ENST00000380982	p.D835A	FLT3	-1	c.2504	2016-05-18 20:50:30.472045	2016-05-18 21:26:56.442892	4	ENSG00000122025	missense
1811	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"quizartinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22504184\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"ponatinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23430109\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"sorafenib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22368270\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"midostaurin\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"20733134\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"lestaurtinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"16857985.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		13	28592641	28592641	T	G	DOID:9119	22368270	included	ENST00000380982	p.D835A	FLT3	-1	c.2504	2016-05-18 20:50:30.531859	2016-05-18 21:26:56.605283	4	ENSG00000122025	missense
2059	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"FGFR inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"24124571\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		5	176522416	176522416	C	G	DOID:3247	24124571	included	ENST00000292408	p.N535K	FGFR4	1	c.1605	2016-05-18 20:50:38.329102	2016-05-18 21:27:18.760905	4	ENSG00000160867	missense
1812	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"quizartinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22504184\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"ponatinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23430109\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"sorafenib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22368270\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"midostaurin\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"20733134\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"lestaurtinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"16857985.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		13	28592641	28592641	T	G	DOID:9119	23714533	included	ENST00000380982	p.D835A	FLT3	-1	c.2504	2016-05-18 20:50:30.568129	2016-05-18 21:26:56.706042	4	ENSG00000122025	missense
1813	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"quizartinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22504184\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"ponatinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23430109\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"sorafenib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22368270\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"midostaurin\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"20733134\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"lestaurtinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"16857985.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		13	28592641	28592641	T	G	DOID:9119	22504183	included	ENST00000380982	p.D835A	FLT3	-1	c.2504	2016-05-18 20:50:30.605603	2016-05-18 21:26:56.821883	4	ENSG00000122025	missense
1815	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"quizartinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22504184\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"ponatinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23430109\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"sorafenib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22368270\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"midostaurin\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"20733134\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"lestaurtinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"16857985.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		13	28592641	28592641	T	G	DOID:9119	23430109	included	ENST00000380982	p.D835A	FLT3	-1	c.2504	2016-05-18 20:50:30.70156	2016-05-18 21:26:57.051513	4	ENSG00000122025	missense
2060	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"FGFR inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"24124571\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		5	176522552	176522552	T	A	DOID:3247	24124571	included	ENST00000292408	p.V550E	FGFR4	1	c.1649	2016-05-18 20:50:38.356565	2016-05-18 21:27:18.856853	4	ENSG00000160867	missense
1817	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"quizartinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22504184\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"ponatinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23430109\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"sorafenib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22368270\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"midostaurin\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"20733134\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"lestaurtinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"16857985.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		13	28592641	28592641	T	G	DOID:9119	16857985	included	ENST00000380982	p.D835A	FLT3	-1	c.2504	2016-05-18 20:50:30.753796	2016-05-18 21:26:57.22764	4	ENSG00000122025	missense
1819	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"quizartinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22504184\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"ponatinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23430109\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"sorafenib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22368270\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"midostaurin\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"20733134\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"lestaurtinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"16857985.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		13	28592642	28592642	C	A	DOID:9119	23261068	included	ENST00000380982	p.D835Y	FLT3	-1	c.2503	2016-05-18 20:50:30.785957	2016-05-18 21:26:57.38979	4	ENSG00000122025	missense
1820	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"quizartinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22504184\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"ponatinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23430109\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"sorafenib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22368270\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"midostaurin\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"20733134\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"lestaurtinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"16857985.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		13	28592642	28592642	C	A	DOID:9119	23783394	included	ENST00000380982	p.D835Y	FLT3	-1	c.2503	2016-05-18 20:50:30.805402	2016-05-18 21:26:57.491678	4	ENSG00000122025	missense
2061	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"lapatinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22885469\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	55241620	55241620	G	A	DOID:2870	22885469	included	ENST00000275493	p.E690K	EGFR	1	c.2068	2016-05-18 20:50:38.366303	2016-05-18 21:27:18.957435	4	ENSG00000146648	missense
1821	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"quizartinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22504184\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"ponatinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23430109\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"sorafenib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22368270\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"midostaurin\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"20733134\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"lestaurtinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"16857985.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		13	28592642	28592642	C	A	DOID:9119	23321257	included	ENST00000380982	p.D835Y	FLT3	-1	c.2503	2016-05-18 20:50:30.829427	2016-05-18 21:26:57.566175	4	ENSG00000122025	missense
1822	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"quizartinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22504184\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"ponatinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23430109\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"sorafenib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22368270\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"midostaurin\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"20733134\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"lestaurtinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"16857985.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		13	28592642	28592642	C	A	DOID:9119	22368270	included	ENST00000380982	p.D835Y	FLT3	-1	c.2503	2016-05-18 20:50:30.842898	2016-05-18 21:26:57.654938	4	ENSG00000122025	missense
1823	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"quizartinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22504184\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"ponatinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23430109\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"sorafenib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22368270\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"midostaurin\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"20733134\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"lestaurtinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"16857985.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		13	28592642	28592642	C	A	DOID:9119	23714533	included	ENST00000380982	p.D835Y	FLT3	-1	c.2503	2016-05-18 20:50:30.868625	2016-05-18 21:26:57.819348	4	ENSG00000122025	missense
2204	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"lapatinib\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"19718025\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		2	212537975	212537975	G	A	DOID:1909	19718025	included	ENST00000342788	p.R544W	ERBB4	-1	c.1630	2016-05-18 20:50:42.313385	2016-05-18 21:27:30.928291	4	ENSG00000178568	missense
1824	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"quizartinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22504184\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"ponatinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23430109\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"sorafenib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22368270\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"midostaurin\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"20733134\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"lestaurtinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"16857985.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		13	28592642	28592642	C	A	DOID:9119	22504183	included	ENST00000380982	p.D835Y	FLT3	-1	c.2503	2016-05-18 20:50:30.900536	2016-05-18 21:26:57.899276	4	ENSG00000122025	missense
1825	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"quizartinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22504184\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"ponatinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23430109\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"sorafenib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22368270\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"midostaurin\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"20733134\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"lestaurtinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"16857985.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		13	28592642	28592642	C	A	DOID:9119	15256420	included	ENST00000380982	p.D835Y	FLT3	-1	c.2503	2016-05-18 20:50:30.913041	2016-05-18 21:26:57.963386	4	ENSG00000122025	missense
1826	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"quizartinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22504184\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"ponatinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23430109\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"sorafenib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22368270\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"midostaurin\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"20733134\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"lestaurtinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"16857985.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		13	28592642	28592642	C	A	DOID:9119	11290608	included	ENST00000380982	p.D835Y	FLT3	-1	c.2503	2016-05-18 20:50:30.942161	2016-05-18 21:26:58.038414	4	ENSG00000122025	missense
2205	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"lapatinib\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"19718025\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		2	212537981	212537981	C	T	DOID:1909	19718025	included	ENST00000342788	p.E542K	ERBB4	-1	c.1624	2016-05-18 20:50:42.329587	2016-05-18 21:27:31.011576	4	ENSG00000178568	missense
1828	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"quizartinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22504184\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"ponatinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23430109\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"sorafenib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22368270\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"midostaurin\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"20733134\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"lestaurtinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"16857985.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		13	28592642	28592642	C	A	DOID:9119	22504184	included	ENST00000380982	p.D835Y	FLT3	-1	c.2503	2016-05-18 20:50:30.987469	2016-05-18 21:26:58.287713	4	ENSG00000122025	missense
1829	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"quizartinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22504184\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"ponatinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23430109\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"sorafenib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22368270\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"midostaurin\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"20733134\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"lestaurtinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"16857985.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		13	28592642	28592642	C	A	DOID:9119	23430109	included	ENST00000380982	p.D835Y	FLT3	-1	c.2503	2016-05-18 20:50:31.01123	2016-05-18 21:26:58.395296	4	ENSG00000122025	missense
1831	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"quizartinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22504184\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"ponatinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23430109\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"sorafenib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22368270\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"midostaurin\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"20733134\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"lestaurtinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"16857985.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		13	28592642	28592642	C	A	DOID:9119	16857985	included	ENST00000380982	p.D835Y	FLT3	-1	c.2503	2016-05-18 20:50:31.044789	2016-05-18 21:26:58.738155	4	ENSG00000122025	missense
1832	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"quizartinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22504184\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		13	28592642	28592642	C	A	DOID:9119	22504184	included	ENST00000380982	p.D835Y	FLT3	-1	c.2503	2016-05-18 20:50:31.063404	2016-05-18 21:26:58.997198	4	ENSG00000122025	missense
1833	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"quizartinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22504184\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"ponatinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23430109\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"sorafenib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22368270\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"midostaurin\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"20733134\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"lestaurtinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"16857985.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		13	28592642	28592642	C	G	DOID:9119	23261068	included	ENST00000380982	p.D835H	FLT3	-1	c.2503	2016-05-18 20:50:31.075958	2016-05-18 21:26:59.311964	4	ENSG00000122025	missense
1834	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"quizartinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22504184\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"ponatinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23430109\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"sorafenib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22368270\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"midostaurin\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"20733134\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"lestaurtinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"16857985.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		13	28592642	28592642	C	G	DOID:9119	23783394	included	ENST00000380982	p.D835H	FLT3	-1	c.2503	2016-05-18 20:50:31.104763	2016-05-18 21:26:59.413842	4	ENSG00000122025	missense
1835	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"quizartinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22504184\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"ponatinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23430109\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"sorafenib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22368270\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"midostaurin\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"20733134\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"lestaurtinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"16857985.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		13	28592642	28592642	C	G	DOID:9119	23321257	included	ENST00000380982	p.D835H	FLT3	-1	c.2503	2016-05-18 20:50:31.14423	2016-05-18 21:26:59.568717	4	ENSG00000122025	missense
2206	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"lapatinib\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"19718025\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		2	212566827	212566827	C	T	DOID:1909	19718025	included	ENST00000342788	p.E452K	ERBB4	-1	c.1354	2016-05-18 20:50:42.34331	2016-05-18 21:27:31.104033	4	ENSG00000178568	missense
1837	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"quizartinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22504184\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"ponatinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23430109\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"sorafenib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22368270\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"midostaurin\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"20733134\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"lestaurtinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"16857985.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		13	28592642	28592642	C	G	DOID:9119	23714533	included	ENST00000380982	p.D835H	FLT3	-1	c.2503	2016-05-18 20:50:31.2035	2016-05-18 21:26:59.943362	4	ENSG00000122025	missense
1838	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"quizartinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22504184\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"ponatinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23430109\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"sorafenib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22368270\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"midostaurin\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"20733134\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"lestaurtinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"16857985.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		13	28592642	28592642	C	G	DOID:9119	22504184	included	ENST00000380982	p.D835H	FLT3	-1	c.2503	2016-05-18 20:50:31.243072	2016-05-18 21:27:00.068515	4	ENSG00000122025	missense
1839	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"quizartinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22504184\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"ponatinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23430109\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"sorafenib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22368270\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"midostaurin\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"20733134\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"lestaurtinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"16857985.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		13	28592642	28592642	C	G	DOID:9119	15256420	included	ENST00000380982	p.D835H	FLT3	-1	c.2503	2016-05-18 20:50:31.304661	2016-05-18 21:27:00.225778	4	ENSG00000122025	missense
2207	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"lapatinib\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"19718025\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		2	212570064	212570064	G	A	DOID:1909	19718025	included	ENST00000342788	p.R393W	ERBB4	-1	c.1177	2016-05-18 20:50:42.357451	2016-05-18 21:27:31.197985	4	ENSG00000178568	missense
1841	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"quizartinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22504184\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"ponatinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23430109\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"sorafenib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22368270\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"midostaurin\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"20733134\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"lestaurtinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"16857985.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		13	28592642	28592642	C	G	DOID:9119	23430109	included	ENST00000380982	p.D835H	FLT3	-1	c.2503	2016-05-18 20:50:31.407849	2016-05-18 21:27:00.371954	4	ENSG00000122025	missense
1842	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"quizartinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22504184\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"ponatinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23430109\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"sorafenib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22368270\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"midostaurin\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"20733134\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"lestaurtinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"16857985.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		13	28592642	28592642	C	G	DOID:9119	20733134	included	ENST00000380982	p.D835H	FLT3	-1	c.2503	2016-05-18 20:50:31.438406	2016-05-18 21:27:00.459174	4	ENSG00000122025	missense
1843	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"quizartinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22504184\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"ponatinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23430109\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"sorafenib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22368270\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"midostaurin\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"20733134\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"lestaurtinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"16857985.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		13	28592642	28592642	C	G	DOID:9119	16857985	included	ENST00000380982	p.D835H	FLT3	-1	c.2503	2016-05-18 20:50:31.482876	2016-05-18 21:27:00.538614	4	ENSG00000122025	missense
2208	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"lapatinib\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"19718025\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		2	212578308	212578308	C	T	DOID:1909	19718025	included	ENST00000342788	p.E317K	ERBB4	-1	c.949	2016-05-18 20:50:42.383051	2016-05-18 21:27:31.281878	4	ENSG00000178568	missense
1844	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"quizartinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22504184\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"ponatinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23430109\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"sorafenib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22368270\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"midostaurin\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"20733134\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"lestaurtinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"16857985.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		13	28592642	28592642	C	T	DOID:9119	23261068	included	ENST00000380982	p.D835N	FLT3	-1	c.2503	2016-05-18 20:50:31.507696	2016-05-18 21:27:00.601657	4	ENSG00000122025	missense
1845	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"quizartinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22504184\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"ponatinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23430109\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"sorafenib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22368270\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"midostaurin\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"20733134\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"lestaurtinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"16857985.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		13	28592642	28592642	C	T	DOID:9119	23783394	included	ENST00000380982	p.D835N	FLT3	-1	c.2503	2016-05-18 20:50:31.5388	2016-05-18 21:27:00.674334	4	ENSG00000122025	missense
1847	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"quizartinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22504184\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"ponatinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23430109\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"sorafenib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22368270\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"midostaurin\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"20733134\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"lestaurtinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"16857985.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		13	28592642	28592642	C	T	DOID:9119	22368270	included	ENST00000380982	p.D835N	FLT3	-1	c.2503	2016-05-18 20:50:31.640735	2016-05-18 21:27:00.824386	4	ENSG00000122025	missense
2247	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"imatinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23775962\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		4	55599332	55599332	G	T	DOID:1909	21642685	included	ENST00000288135	p.D820Y	KIT	1	c.2458	2016-05-18 20:50:43.186149	2016-05-18 21:27:34.20231	4	ENSG00000157404	missense
1848	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"quizartinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22504184\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"ponatinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23430109\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"sorafenib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22368270\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"midostaurin\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"20733134\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"lestaurtinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"16857985.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		13	28592642	28592642	C	T	DOID:9119	23714533	included	ENST00000380982	p.D835N	FLT3	-1	c.2503	2016-05-18 20:50:31.668535	2016-05-18 21:27:00.888882	4	ENSG00000122025	missense
1849	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"quizartinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22504184\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"ponatinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23430109\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"sorafenib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22368270\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"midostaurin\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"20733134\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"lestaurtinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"16857985.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		13	28592642	28592642	C	T	DOID:9119	22504185	included	ENST00000380982	p.D835N	FLT3	-1	c.2503	2016-05-18 20:50:31.70796	2016-05-18 21:27:00.949027	4	ENSG00000122025	missense
1850	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"quizartinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22504184\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"ponatinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23430109\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"sorafenib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22368270\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"midostaurin\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"20733134\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"lestaurtinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"16857985.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		13	28592642	28592642	C	T	DOID:9119	15256420	included	ENST00000380982	p.D835N	FLT3	-1	c.2503	2016-05-18 20:50:31.737547	2016-05-18 21:27:01.025669	4	ENSG00000122025	missense
2248	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"imatinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23775962\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		4	55599332	55599332	G	T	DOID:1909	23775962	included	ENST00000288135	p.D820Y	KIT	1	c.2458	2016-05-18 20:50:43.20586	2016-05-18 21:27:34.261338	4	ENSG00000157404	missense
1852	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"quizartinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22504184\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"ponatinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23430109\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"sorafenib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22368270\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"midostaurin\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"20733134\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"lestaurtinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"16857985.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		13	28592642	28592642	C	T	DOID:9119	22504184	included	ENST00000380982	p.D835N	FLT3	-1	c.2503	2016-05-18 20:50:31.841316	2016-05-18 21:27:01.164009	4	ENSG00000122025	missense
1854	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"quizartinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22504184\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"ponatinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23430109\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"sorafenib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22368270\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"midostaurin\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"20733134\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"lestaurtinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"16857985.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		13	28592642	28592642	C	T	DOID:9119	20733134	included	ENST00000380982	p.D835N	FLT3	-1	c.2503	2016-05-18 20:50:31.909427	2016-05-18 21:27:01.315111	4	ENSG00000122025	missense
1855	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"quizartinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22504184\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"ponatinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23430109\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"sorafenib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22368270\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"midostaurin\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"20733134\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"lestaurtinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"16857985.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		13	28592642	28592642	C	T	DOID:9119	16857985	included	ENST00000380982	p.D835N	FLT3	-1	c.2503	2016-05-18 20:50:31.94621	2016-05-18 21:27:01.410422	4	ENSG00000122025	missense
1857	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"quizartinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22504184\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		13	28601359	28601359	A	T	DOID:9119	22504184	included	ENST00000380982	p.F691L	FLT3	-1	c.2073	2016-05-18 20:50:32.016428	2016-05-18 21:27:01.574308	4	ENSG00000122025	missense
1858	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"quizartinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22504184\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"ponatinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23430109\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"crenolanib, PKC412\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"24619500\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		13	28601373	28601373	T	A	DOID:9119	22504184	included	ENST00000380982	p.I687F	FLT3	-1	c.2059	2016-05-18 20:50:32.047054	2016-05-18 21:27:01.668344	4	ENSG00000122025	missense
1859	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"quizartinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22504184\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"ponatinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23430109\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"crenolanib, PKC412\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"24619500\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		13	28601373	28601373	T	A	DOID:9119	23430109	included	ENST00000380982	p.I687F	FLT3	-1	c.2059	2016-05-18 20:50:32.085662	2016-05-18 21:27:01.74603	4	ENSG00000122025	missense
1860	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"quizartinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22504184\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"ponatinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23430109\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"crenolanib, PKC412\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"24619500\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		13	28601373	28601373	T	A	DOID:9119	24619500	included	ENST00000380982	p.I687F	FLT3	-1	c.2059	2016-05-18 20:50:32.121402	2016-05-18 21:27:01.801723	4	ENSG00000122025	missense
2674	\N	\N		9	133748283	133748283	C	T	DOID:8552	21895409	included	ENST00000372348	p.T334I	ABL1	1	c.1001	2016-05-18 21:06:56.169015	2016-05-18 21:28:05.312567	5	ENSG00000097007	missense
2675	\N	\N		9	133748283	133748283	C	T	DOID:8552	20512393	included	ENST00000372348	p.T334I	ABL1	1	c.1001	2016-05-18 21:06:56.211549	2016-05-18 21:28:05.365729	5	ENSG00000097007	missense
2676	\N	\N		9	133748283	133748283	C	T	DOID:8552	20963643	included	ENST00000372348	p.T334I	ABL1	1	c.1001	2016-05-18 21:06:56.220701	2016-05-18 21:28:05.402939	5	ENSG00000097007	missense
2677	\N	\N		9	133748283	133748283	C	T	DOID:8552	20367437	included	ENST00000372348	p.T334I	ABL1	1	c.1001	2016-05-18 21:06:56.230287	2016-05-18 21:28:05.447599	5	ENSG00000097007	missense
2678	\N	\N		9	133748283	133748283	C	T	DOID:8552	23676790	included	ENST00000372348	p.T334I	ABL1	1	c.1001	2016-05-18 21:06:56.277947	2016-05-18 21:28:05.494464	5	ENSG00000097007	missense
2264	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"BRAF inhibitors, MEK inhibitors\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"19915144\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		15	66729163	66729163	C	T	DOID:1909	21107320	included	ENST00000307102	p.P124L	MAP2K1	1	c.371	2016-05-18 20:50:43.434313	2016-05-18 21:27:35.498806	4	ENSG00000169032	missense
2679	\N	\N		9	133748283	133748283	C	T	DOID:8552	14745431	included	ENST00000372348	p.T334I	ABL1	1	c.1001	2016-05-18 21:06:56.288963	2016-05-18 21:28:05.544937	5	ENSG00000097007	missense
2680	\N	\N		9	133748283	133748283	C	T	DOID:8552	12623848	included	ENST00000372348	p.T334I	ABL1	1	c.1001	2016-05-18 21:06:56.298413	2016-05-18 21:28:05.61172	5	ENSG00000097007	missense
2681	\N	\N		9	133748283	133748283	C	T	DOID:8552	12399961	included	ENST00000372348	p.T334I	ABL1	1	c.1001	2016-05-18 21:06:56.34755	2016-05-18 21:28:05.668315	5	ENSG00000097007	missense
2682	\N	\N		9	133748283	133748283	C	T	DOID:8552	11853795	included	ENST00000372348	p.T334I	ABL1	1	c.1001	2016-05-18 21:06:56.361968	2016-05-18 21:28:05.721955	5	ENSG00000097007	missense
1863	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"quizartinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23878140\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"crenolanib, PKC412\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"24619500\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		13	28602340	28602340	G	T	DOID:9119	23878140	included	ENST00000380982	p.N676K	FLT3	-1	c.2028	2016-05-18 20:50:32.207219	2016-05-18 21:27:02.069275	4	ENSG00000122025	missense
1864	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"quizartinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23878140\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"crenolanib, PKC412\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"24619500\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		13	28602340	28602340	G	T	DOID:9119	24619500	included	ENST00000380982	p.N676K	FLT3	-1	c.2028	2016-05-18 20:50:32.247137	2016-05-18 21:27:02.139198	4	ENSG00000122025	missense
1865	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"quizartinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22504184\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"ponatinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23430109\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"crenolanib, PKC412\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"24619500\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		13	28602342	28602342	T	C	DOID:9119	22504184	included	ENST00000380982	p.N676D	FLT3	-1	c.2026	2016-05-18 20:50:32.282812	2016-05-18 21:27:02.232801	4	ENSG00000122025	missense
2265	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"19915144\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		15	66729175	66729175	G	A	DOID:1909	19915144	included	ENST00000307102	p.G128D	MAP2K1	1	c.383	2016-05-18 20:50:43.443038	2016-05-18 21:27:35.584606	4	ENSG00000169032	missense
2062	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"dovitinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23908597\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"ponatinib\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23908597\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		10	123247516	123247516	T	C	DOID:2870	23908597	included	ENST00000457416	p.K660E	FGFR2	-1	c.1978	2016-05-18 20:50:38.396719	2016-05-18 21:27:19.125153	4	ENSG00000066468	missense
3267	\N	\N		1	115258744	115258744	C	T	DOID:1909	23431193	included	ENST00000369535	p.G13D	NRAS	-1	c.38	2016-05-18 21:07:04.299676	2016-05-18 21:28:35.876046	5	ENSG00000213281	missense
2683	\N	\N		9	133748283	133748283	C	T	DOID:8552	24236021	included	ENST00000372348	p.T334I	ABL1	1	c.1001	2016-05-18 21:06:56.373135	2016-05-18 21:28:05.8408	5	ENSG00000097007	missense
2684	\N	\N		9	133748283	133748283	C	T	DOID:8552	11964322	included	ENST00000372348	p.T334I	ABL1	1	c.1001	2016-05-18 21:06:56.510091	2016-05-18 21:28:05.885385	5	ENSG00000097007	missense
2063	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"dovitinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23908597\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"ponatinib\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23908597\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		10	123256060	123256060	A	T	DOID:2870	23908597	included	ENST00000457416	p.L618M	FGFR2	-1	c.1852	2016-05-18 20:50:38.429418	2016-05-18 21:27:19.272049	4	ENSG00000066468	missense
2503	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"vemurafenib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23612012\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	140453136	140453136	A	T	DOID:0070004	23612012	invalid	ENST00000288602	p.V600E	BRAF	-1	c.1799	2016-05-18 20:50:50.987634	2016-05-18 21:14:36.294585	4	ENSG00000157764	missense
2506	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"bortezomib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"19331127, 21273588\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"FGFR inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22869148\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		4	1806099	1806099	A	G	DOID:0070004	22869148	invalid	ENST00000340107	p.Y375C	FGFR3	1	c.1124	2016-05-18 20:50:51.031769	2016-05-18 21:14:36.314065	4	ENSG00000068078	missense
2507	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"FGFR inhibitors\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22869148\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		4	1807488	1807488	G	A	DOID:0070004	22869148	invalid	ENST00000340107	p.V555M	FGFR3	1	c.1663	2016-05-18 20:50:51.045264	2016-05-18 21:14:36.32008	4	ENSG00000068078	missense
2508	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"anti-estrogens\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"24185512\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		6	152419917	152419917	C	A	DOID:0060077	24185512	invalid	ENST00000206249	p.P535H	ESR1	1	c.1604	2016-05-18 20:50:51.054821	2016-05-18 21:14:36.326037	4	ENSG00000091831	missense
2509	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"anti-estrogens\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"24185512, 24185510\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		6	152419920	152419920	T	G	DOID:0060077	24185512	invalid	ENST00000206249	p.L536R	ESR1	1	c.1607	2016-05-18 20:50:51.068697	2016-05-18 21:14:36.331343	4	ENSG00000091831	missense
2510	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"anti-estrogens\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"24185512, 24185510\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		6	152419920	152419920	T	G	DOID:0060077	24185510	invalid	ENST00000206249	p.L536R	ESR1	1	c.1607	2016-05-18 20:50:51.07923	2016-05-18 21:14:36.33762	4	ENSG00000091831	missense
1866	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"quizartinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22504184\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"ponatinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23430109\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"crenolanib, PKC412\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"24619500\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		13	28602342	28602342	T	C	DOID:9119	23430109	included	ENST00000380982	p.N676D	FLT3	-1	c.2026	2016-05-18 20:50:32.311978	2016-05-18 21:27:02.301169	4	ENSG00000122025	missense
3286	\N	\N		1	115256528	115256529	TT	CA	DOID:1909	20406486	included	ENST00000369535	p.Q61L	NRAS	-1	c.182	2016-05-18 21:07:04.506482	2016-05-18 21:28:36.672844	5	ENSG00000213281	missense
3287	\N	\N		1	115256528	115256529	TT	CA	DOID:1909	20149136	included	ENST00000369535	p.Q61L	NRAS	-1	c.182	2016-05-18 21:07:04.515248	2016-05-18 21:28:36.713151	5	ENSG00000213281	missense
3288	\N	\N		1	115256529	115256529	T	G	DOID:1909	25157968	included	ENST00000369535	p.Q61P	NRAS	-1	c.182	2016-05-18 21:07:04.522761	2016-05-18 21:28:36.751122	5	ENSG00000213281	missense
2516	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"EZH2 inhibitor\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"24563539\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	148508727	148508727	T	A	DOID:0060058	24563539	included	ENST00000320356	p.Y646F	EZH2	-1	c.1937	2016-05-18 20:50:51.158437	2016-05-18 21:27:55.827654	4	ENSG00000106462	missense
3293	\N	\N		4	55141036	55141036	T	A	DOID:9253	17087936	included	ENST00000257290	p.V561D	PDGFRA	1	c.1682	2016-05-18 21:07:04.571835	2016-05-18 21:28:36.956297	5	ENSG00000134853	missense
1687	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"ruxolitinib\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"18805579, 22955920\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		9	5078362	5078362	A	C	DOID:9952	22368270	included	ENST00000381652	p.R683S	JAK2	1	c.2049	2016-05-18 20:50:26.400077	2016-05-18 21:26:48.013674	4	ENSG00000096968	missense
1737	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"imatinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23582185, 21689725, 17259998\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		4	55594258	55594258	T	C	DOID:9253	21689725	included	ENST00000288135	p.V654A	KIT	1	c.1961	2016-05-18 20:50:27.685673	2016-05-18 21:26:50.848272	4	ENSG00000157404	missense
1745	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"imatinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23582185, 21689725, 17259998\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		4	55599321	55599321	A	T	DOID:9253	21689725	included	ENST00000288135	p.D816V	KIT	1	c.2447	2016-05-18 20:50:27.896847	2016-05-18 21:26:51.352667	4	ENSG00000157404	missense
2444	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"lapatinib, neratinib\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23220880\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		17	37868205	37868205	G	C	DOID:1612	23220880	included	ENST00000269571	p.G309A	ERBB2	1	c.926	2016-05-18 20:50:49.778169	2016-05-18 21:27:50.69755	4	ENSG00000141736	missense
1699	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"cetuximab, panitumumab\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"late trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"20619739, 21163703, 23325582\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors +/- MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22608338, J Clin Oncol 2010;28:(suppl; abstr 3534), J Clin Oncol 2012;30:(suppl; abstr 3528)\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors + EGFR inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22281684\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors + PI3K pathway inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23251002, 23549875\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"proteosome inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"24107445.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"preclinical\\",\\"Assocation\\":\\"mTOR inhibitors + BH3 mimetics\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"24163374\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	140453136	140453136	A	T	DOID:9256	20857202	included	ENST00000288602	p.V600E	BRAF	-1	c.1799	2016-05-18 20:50:26.631414	2016-05-18 21:26:48.666761	4	ENSG00000157764	missense
1708	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"cetuximab, panitumumab\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"late trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"20619739, 21163703, 23325582\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors +/- MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22608338, J Clin Oncol 2010;28:(suppl; abstr 3534), J Clin Oncol 2012;30:(suppl; abstr 3528)\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors + EGFR inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22281684\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors + PI3K pathway inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23251002, 23549875\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"proteosome inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"24107445.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"preclinical\\",\\"Assocation\\":\\"mTOR inhibitors + BH3 mimetics\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"24163374\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	140453136	140453136	A	T	DOID:9256	23251002	included	ENST00000288602	p.V600E	BRAF	-1	c.1799	2016-05-18 20:50:26.833342	2016-05-18 21:26:49.126521	4	ENSG00000157764	missense
1712	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"cetuximab\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22270724\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"panitumumab\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22270724\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	55228007	55228007	A	G	DOID:9256	22270724	included	ENST00000275493	p.S492G	EGFR	1	c.1474	2016-05-18 20:50:26.93498	2016-05-18 21:26:49.335511	4	ENSG00000146648	missense
2685	\N	\N		9	133748283	133748283	C	T	DOID:8552	12130516	included	ENST00000372348	p.T334I	ABL1	1	c.1001	2016-05-18 21:06:56.519936	2016-05-18 21:28:05.938117	5	ENSG00000097007	missense
2686	\N	\N		9	133748283	133748283	C	T	DOID:8552	11423618	included	ENST00000372348	p.T334I	ABL1	1	c.1001	2016-05-18 21:06:56.528988	2016-05-18 21:28:05.994167	5	ENSG00000097007	missense
1757	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"imatinib, sunitinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"late trials, preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22718859, 16638875\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"HSP90 inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"18794084\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"crenolanib\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22745105\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"dasatinib\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"18794084\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		4	55152093	55152093	A	T	DOID:9253	15928335	included	ENST00000257290	p.D842V	PDGFRA	1	c.2525	2016-05-18 20:50:28.249663	2016-05-18 21:26:52.15954	4	ENSG00000134853	missense
1763	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"quizartinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22504184\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"ponatinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23430109\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"crenolanib, PKC412\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"24619500\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		13	28592620	28592620	T	C	DOID:9119	23430109	included	ENST00000380982	p.Y842C	FLT3	-1	c.2525	2016-05-18 20:50:28.44713	2016-05-18 21:26:52.634046	4	ENSG00000122025	missense
2687	\N	\N		9	133748283	133748283	C	T	DOID:8552	21872826	included	ENST00000372348	p.T334I	ABL1	1	c.1001	2016-05-18 21:06:56.547393	2016-05-18 21:28:06.04755	5	ENSG00000097007	missense
2688	\N	\N		9	133748283	133748283	C	T	DOID:8552	25157968	included	ENST00000372348	p.T334I	ABL1	1	c.1001	2016-05-18 21:06:56.557859	2016-05-18 21:28:06.096745	5	ENSG00000097007	missense
1775	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"quizartinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22504184\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"ponatinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23430109\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"sorafenib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22368270\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"midostaurin\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"20733134\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"lestaurtinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"16857985.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		13	28592640	28592640	A	C	DOID:9119	11290608	included	ENST00000380982	p.D835E	FLT3	-1	c.2505	2016-05-18 20:50:28.930694	2016-05-18 21:26:53.440022	4	ENSG00000122025	missense
1867	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"quizartinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22504184\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"ponatinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23430109\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"crenolanib, PKC412\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"24619500\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		13	28602342	28602342	T	C	DOID:9119	24619500	included	ENST00000380982	p.N676D	FLT3	-1	c.2026	2016-05-18 20:50:32.345389	2016-05-18 21:27:02.364532	4	ENSG00000122025	missense
2689	\N	\N		9	133748290	133748290	C	A	DOID:8552	21895409	included	ENST00000372348	p.F336L	ABL1	1	c.1008	2016-05-18 21:06:56.56793	2016-05-18 21:28:06.154898	5	ENSG00000097007	missense
1868	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"quizartinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22504184\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"ponatinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23430109\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"crenolanib, PKC412\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"24619500\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		13	28602416	28602416	T	C	DOID:9119	22504184	included	ENST00000380982	p.D651G	FLT3	-1	c.1952	2016-05-18 20:50:32.380103	2016-05-18 21:27:02.474906	4	ENSG00000122025	missense
2690	\N	\N		9	133748290	133748290	C	A	DOID:8552	21489624	included	ENST00000372348	p.F336L	ABL1	1	c.1008	2016-05-18 21:06:56.582631	2016-05-18 21:28:06.202528	5	ENSG00000097007	missense
1816	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"quizartinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22504184\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"ponatinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23430109\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"sorafenib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22368270\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"midostaurin\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"20733134\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"lestaurtinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"16857985.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		13	28592641	28592641	T	G	DOID:9119	20733134	included	ENST00000380982	p.D835A	FLT3	-1	c.2504	2016-05-18 20:50:30.739685	2016-05-18 21:26:57.14357	4	ENSG00000122025	missense
1827	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"quizartinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22504184\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"ponatinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23430109\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"sorafenib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22368270\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"midostaurin\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"20733134\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"lestaurtinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"16857985.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		13	28592642	28592642	C	A	DOID:9119	19657110	included	ENST00000380982	p.D835Y	FLT3	-1	c.2503	2016-05-18 20:50:30.966288	2016-05-18 21:26:58.203782	4	ENSG00000122025	missense
1853	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"quizartinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22504184\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"ponatinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23430109\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"sorafenib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22368270\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"midostaurin\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"20733134\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"lestaurtinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"16857985.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		13	28592642	28592642	C	T	DOID:9119	23430109	included	ENST00000380982	p.D835N	FLT3	-1	c.2503	2016-05-18 20:50:31.871337	2016-05-18 21:27:01.244922	4	ENSG00000122025	missense
1869	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"quizartinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22504184\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"ponatinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23430109\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"crenolanib, PKC412\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"24619500\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		13	28602416	28602416	T	C	DOID:9119	23430109	included	ENST00000380982	p.D651G	FLT3	-1	c.1952	2016-05-18 20:50:32.413064	2016-05-18 21:27:02.541635	4	ENSG00000122025	missense
1942	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"crizotinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22277784\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		2	29443613	29443613	C	T	DOID:3910	22277784	included	ENST00000389048	p.G1202R	ALK	-1	c.3604	2016-05-18 20:50:34.461905	2016-05-18 21:27:08.391532	4	ENSG00000171094	missense
2691	\N	\N		9	133748290	133748290	C	A	DOID:8552	17114651	included	ENST00000372348	p.F336L	ABL1	1	c.1008	2016-05-18 21:06:56.59178	2016-05-18 21:28:06.239089	5	ENSG00000097007	missense
1870	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"quizartinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22504184\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"ponatinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23430109\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"crenolanib, PKC412\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"24619500\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		13	28602416	28602416	T	C	DOID:9119	24619500	included	ENST00000380982	p.D651G	FLT3	-1	c.1952	2016-05-18 20:50:32.443414	2016-05-18 21:27:02.617187	4	ENSG00000122025	missense
1871	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"quizartinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22504184\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"ponatinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23430109\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"crenolanib, PKC412\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"24619500\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		13	28608111	28608111	C	A	DOID:9119	22504184	included	ENST00000380982	p.G619C	FLT3	-1	c.1855	2016-05-18 20:50:32.481888	2016-05-18 21:27:02.71397	4	ENSG00000122025	missense
2058	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"FGFR inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"24124571\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		5	176522416	176522416	C	A	DOID:3247	24124571	included	ENST00000292408	p.N535K	FGFR4	1	c.1605	2016-05-18 20:50:38.295909	2016-05-18 21:27:18.683134	4	ENSG00000160867	missense
2692	\N	\N		9	133748290	133748290	C	A	DOID:8552	18828913	included	ENST00000372348	p.F336L	ABL1	1	c.1008	2016-05-18 21:06:56.614583	2016-05-18 21:28:06.278761	5	ENSG00000097007	missense
2693	\N	\N		9	133748290	133748290	C	A	DOID:8552	12623848	included	ENST00000372348	p.F336L	ABL1	1	c.1008	2016-05-18 21:06:56.624907	2016-05-18 21:28:06.323473	5	ENSG00000097007	missense
2694	\N	\N		9	133748290	133748290	C	A	DOID:8552	20367437	included	ENST00000372348	p.F336L	ABL1	1	c.1008	2016-05-18 21:06:56.655026	2016-05-18 21:28:06.396748	5	ENSG00000097007	missense
1872	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"quizartinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22504184\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"ponatinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23430109\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"crenolanib, PKC412\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"24619500\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		13	28608111	28608111	C	A	DOID:9119	23430109	included	ENST00000380982	p.G619C	FLT3	-1	c.1855	2016-05-18 20:50:32.513354	2016-05-18 21:27:02.785737	4	ENSG00000122025	missense
1873	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"quizartinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22504184\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"ponatinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23430109\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"crenolanib, PKC412\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"24619500\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		13	28608111	28608111	C	A	DOID:9119	24619500	included	ENST00000380982	p.G619C	FLT3	-1	c.1855	2016-05-18 20:50:32.545658	2016-05-18 21:27:02.850617	4	ENSG00000122025	missense
1875	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"IDH inhibitor\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"AACR 2014; abstr CT103\\",\\"Effect\\":\\"switch-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		15	90631838	90631838	C	T	DOID:9119	22417203	included	ENST00000330062	p.R172K	IDH2	-1	c.515	2016-05-18 20:50:32.585836	2016-05-18 21:27:02.982561	4	ENSG00000182054	missense
1876	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"IDH inhibitor\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"AACR 2014; abstr CT103\\",\\"Effect\\":\\"switch-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		15	90631838	90631838	C	T	DOID:9119	24606448	included	ENST00000330062	p.R172K	IDH2	-1	c.515	2016-05-18 20:50:32.619988	2016-05-18 21:27:03.044621	4	ENSG00000182054	missense
1877	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"IDH inhibitor\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"AACR 2014; abstr CT103\\",\\"Effect\\":\\"switch-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		15	90631838	90631838	C	T	DOID:9119	23949315	included	ENST00000330062	p.R172K	IDH2	-1	c.515	2016-05-18 20:50:32.643351	2016-05-18 21:27:03.118515	4	ENSG00000182054	missense
2695	\N	\N		9	133748290	133748290	C	A	DOID:8552	25157968	included	ENST00000372348	p.F336L	ABL1	1	c.1008	2016-05-18 21:06:56.670291	2016-05-18 21:28:06.458142	5	ENSG00000097007	missense
1878	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"IDH inhibitor\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"AACR 2014; abstr CT103\\",\\"Effect\\":\\"switch-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		15	90631838	90631838	C	T	DOID:9119	22397365	included	ENST00000330062	p.R172K	IDH2	-1	c.515	2016-05-18 20:50:32.65346	2016-05-18 21:27:03.178319	4	ENSG00000182054	missense
2696	\N	\N		9	133748290	133748290	C	G	DOID:8552	23676790	included	ENST00000372348	p.F336L	ABL1	1	c.1008	2016-05-18 21:06:56.68148	2016-05-18 21:28:06.522829	5	ENSG00000097007	missense
2697	\N	\N		9	133748290	133748290	C	G	DOID:8552	21605905	included	ENST00000372348	p.F336L	ABL1	1	c.1008	2016-05-18 21:06:56.708295	2016-05-18 21:28:06.583384	5	ENSG00000097007	missense
1879	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"IDH inhibitor\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"AACR 2014; abstr CT103\\",\\"Effect\\":\\"switch-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		15	90631838	90631838	C	T	DOID:9119	20946881	included	ENST00000330062	p.R172K	IDH2	-1	c.515	2016-05-18 20:50:32.692183	2016-05-18 21:27:03.241896	4	ENSG00000182054	missense
1880	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"IDH inhibitor\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"AACR 2014; abstr CT103\\",\\"Effect\\":\\"switch-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		15	90631934	90631934	C	T	DOID:9119	22160010	included	ENST00000330062	p.R140Q	IDH2	-1	c.419	2016-05-18 20:50:32.720033	2016-05-18 21:27:03.301974	4	ENSG00000182054	missense
1881	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"IDH inhibitor\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"AACR 2014; abstr CT103\\",\\"Effect\\":\\"switch-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		15	90631934	90631934	C	T	DOID:9119	24606448	included	ENST00000330062	p.R140Q	IDH2	-1	c.419	2016-05-18 20:50:32.755159	2016-05-18 21:27:03.374818	4	ENSG00000182054	missense
1882	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"IDH inhibitor\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"AACR 2014; abstr CT103\\",\\"Effect\\":\\"switch-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		15	90631934	90631934	C	T	DOID:9119	23949315	included	ENST00000330062	p.R140Q	IDH2	-1	c.419	2016-05-18 20:50:32.778475	2016-05-18 21:27:03.433575	4	ENSG00000182054	missense
1883	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"IDH inhibitor\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"AACR 2014; abstr CT103\\",\\"Effect\\":\\"switch-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		15	90631934	90631934	C	T	DOID:9119	23815907	included	ENST00000330062	p.R140Q	IDH2	-1	c.419	2016-05-18 20:50:32.789375	2016-05-18 21:27:03.510191	4	ENSG00000182054	missense
1884	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"IDH inhibitor\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"AACR 2014; abstr CT103\\",\\"Effect\\":\\"switch-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		15	90631934	90631934	C	T	DOID:9119	22397365	included	ENST00000330062	p.R140Q	IDH2	-1	c.419	2016-05-18 20:50:32.825849	2016-05-18 21:27:03.569269	4	ENSG00000182054	missense
2699	\N	\N		9	133748290	133748290	C	G	DOID:8552	20367437	included	ENST00000372348	p.F336L	ABL1	1	c.1008	2016-05-18 21:06:56.737807	2016-05-18 21:28:06.708772	5	ENSG00000097007	missense
1885	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"IDH inhibitor\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"AACR 2014; abstr CT103\\",\\"Effect\\":\\"switch-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		15	90631934	90631934	C	T	DOID:9119	20946881	included	ENST00000330062	p.R140Q	IDH2	-1	c.419	2016-05-18 20:50:32.856845	2016-05-18 21:27:03.646299	4	ENSG00000182054	missense
1886	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"ruxolitinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22422826\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"JAK inhibitors (alone or in combination)\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22829971\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		9	5073770	5073770	G	T	DOID:9119	24404189	included	ENST00000381652	p.V617F	JAK2	1	c.1849	2016-05-18 20:50:32.880294	2016-05-18 21:27:03.72805	4	ENSG00000096968	missense
2700	\N	\N		9	133748290	133748290	C	G	DOID:8552	12623848	included	ENST00000372348	p.F336L	ABL1	1	c.1008	2016-05-18 21:06:56.749136	2016-05-18 21:28:06.748008	5	ENSG00000097007	missense
1887	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"ruxolitinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22422826\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"JAK inhibitors (alone or in combination)\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22829971\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		9	5073770	5073770	G	T	DOID:9119	23115274	included	ENST00000381652	p.V617F	JAK2	1	c.1849	2016-05-18 20:50:32.916442	2016-05-18 21:27:03.784301	4	ENSG00000096968	missense
2045	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"FGFR inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23786770\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		10	123279562	123279562	C	G	DOID:3907	23786770	included	ENST00000457416	p.W290C	FGFR2	-1	c.870	2016-05-18 20:50:37.957566	2016-05-18 21:27:17.380795	4	ENSG00000066468	missense
2701	\N	\N		9	133748290	133748290	C	G	DOID:8552	11964322	included	ENST00000372348	p.F336L	ABL1	1	c.1008	2016-05-18 21:06:56.771814	2016-05-18 21:28:06.800294	5	ENSG00000097007	missense
2070	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"FGFR inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"18552176, 22238366, 23002168\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		10	123258034	123258034	A	T	DOID:2870	18552176	included	ENST00000457416	p.N550K	FGFR2	-1	c.1650	2016-05-18 20:50:38.624704	2016-05-18 21:27:19.861774	4	ENSG00000066468	missense
3313	\N	\N		3	178916876	178916876	G	A	DOID:9256	19366826	included	ENST00000263967	p.R88Q	PIK3CA	1	c.263	2016-05-18 21:07:04.77362	2016-05-18 21:28:38.181297	5	ENSG00000121879	missense
1888	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"ruxolitinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22422826\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"JAK inhibitors (alone or in combination)\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22829971\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		9	5073770	5073770	G	T	DOID:9119	22829971	included	ENST00000381652	p.V617F	JAK2	1	c.1849	2016-05-18 20:50:32.945455	2016-05-18 21:27:03.857994	4	ENSG00000096968	missense
1889	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"ruxolitinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22422826\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"JAK inhibitors (alone or in combination)\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22829971\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		9	5073770	5073770	G	T	DOID:9119	22818858	included	ENST00000381652	p.V617F	JAK2	1	c.1849	2016-05-18 20:50:32.985042	2016-05-18 21:27:03.916157	4	ENSG00000096968	missense
3317	\N	\N		3	178921553	178921553	T	G	DOID:1612	25157968	included	ENST00000263967	p.N345K	PIK3CA	1	c.1035	2016-05-18 21:07:04.814993	2016-05-18 21:28:38.382076	5	ENSG00000121879	missense
1890	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"ruxolitinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22422826\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"JAK inhibitors (alone or in combination)\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22829971\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		9	5073770	5073770	G	T	DOID:9119	22571758	included	ENST00000381652	p.V617F	JAK2	1	c.1849	2016-05-18 20:50:33.016157	2016-05-18 21:27:03.98976	4	ENSG00000096968	missense
1891	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"ruxolitinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22422826\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"JAK inhibitors (alone or in combination)\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22829971\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		9	5073770	5073770	G	T	DOID:9119	22041374	included	ENST00000381652	p.V617F	JAK2	1	c.1849	2016-05-18 20:50:33.050333	2016-05-18 21:27:04.071703	4	ENSG00000096968	missense
3318	\N	\N		3	178921553	178921553	T	G	DOID:9256	25157968	included	ENST00000263967	p.N345K	PIK3CA	1	c.1035	2016-05-18 21:07:04.825211	2016-05-18 21:28:38.418324	5	ENSG00000121879	missense
1892	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"ruxolitinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22422826\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"JAK inhibitors (alone or in combination)\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22829971\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		9	5073770	5073770	G	T	DOID:9119	21689158	included	ENST00000381652	p.V617F	JAK2	1	c.1849	2016-05-18 20:50:33.086167	2016-05-18 21:27:04.14169	4	ENSG00000096968	missense
1893	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"ruxolitinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22422826\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"JAK inhibitors (alone or in combination)\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22829971\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		9	5073770	5073770	G	T	DOID:9119	21120162	included	ENST00000381652	p.V617F	JAK2	1	c.1849	2016-05-18 20:50:33.116144	2016-05-18 21:27:04.224037	4	ENSG00000096968	missense
2064	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"dovitinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23908597\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"ponatinib\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23908597\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		10	123256215	123256215	T	C	DOID:2870	23908597	included	ENST00000457416	p.E566G	FGFR2	-1	c.1697	2016-05-18 20:50:38.457608	2016-05-18 21:27:19.366011	4	ENSG00000066468	missense
1894	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"ruxolitinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22422826\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"JAK inhibitors (alone or in combination)\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22829971\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		9	5073770	5073770	G	T	DOID:9119	20339092	included	ENST00000381652	p.V617F	JAK2	1	c.1849	2016-05-18 20:50:33.149164	2016-05-18 21:27:04.291033	4	ENSG00000096968	missense
1895	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"ruxolitinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22422826\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"JAK inhibitors (alone or in combination)\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22829971\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		9	5073770	5073770	G	T	DOID:9119	20631743	included	ENST00000381652	p.V617F	JAK2	1	c.1849	2016-05-18 20:50:33.185793	2016-05-18 21:27:04.353993	4	ENSG00000096968	missense
1896	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"ruxolitinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22422826\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"JAK inhibitors (alone or in combination)\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22829971\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		9	5073770	5073770	G	T	DOID:9119	22422826	included	ENST00000381652	p.V617F	JAK2	1	c.1849	2016-05-18 20:50:33.213708	2016-05-18 21:27:04.431733	4	ENSG00000096968	missense
2702	\N	\N		9	133748290	133748290	C	G	DOID:8552	25157968	included	ENST00000372348	p.F336L	ABL1	1	c.1008	2016-05-18 21:06:56.807696	2016-05-18 21:28:06.855993	5	ENSG00000097007	missense
1897	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"dasatinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"18986703\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		4	55599321	55599321	A	T	DOID:9119	19164557	included	ENST00000288135	p.D816V	KIT	1	c.2447	2016-05-18 20:50:33.224202	2016-05-18 21:27:04.489706	4	ENSG00000157404	missense
1898	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"dasatinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"18986703\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		4	55599321	55599321	A	T	DOID:9119	23714533	included	ENST00000288135	p.D816V	KIT	1	c.2447	2016-05-18 20:50:33.260562	2016-05-18 21:27:04.543315	4	ENSG00000157404	missense
2703	\N	\N		9	133748391	133748391	T	C	DOID:8552	23676790	included	ENST00000372348	p.M370T	ABL1	1	c.1109	2016-05-18 21:06:56.815699	2016-05-18 21:28:06.921552	5	ENSG00000097007	missense
1899	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"dasatinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"18986703\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		4	55599321	55599321	A	T	DOID:9119	24045550	included	ENST00000288135	p.D816V	KIT	1	c.2447	2016-05-18 20:50:33.292075	2016-05-18 21:27:04.629969	4	ENSG00000157404	missense
2704	\N	\N		9	133748391	133748391	T	C	DOID:8552	23355941	included	ENST00000372348	p.M370T	ABL1	1	c.1109	2016-05-18 21:06:56.843525	2016-05-18 21:28:06.96674	5	ENSG00000097007	missense
2705	\N	\N		9	133748391	133748391	T	C	DOID:8552	14745431	included	ENST00000372348	p.M370T	ABL1	1	c.1109	2016-05-18 21:06:56.863677	2016-05-18 21:28:07.035594	5	ENSG00000097007	missense
2275	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"BRAF inhibitors, MEK inhibitors\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"24265153\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"ERK inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"24265153\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		19	4117617	4117617	C	T	DOID:1909	24265153	included	ENST00000262948	p.V35M	MAP2K2	-1	c.103	2016-05-18 20:50:43.569684	2016-05-18 21:27:36.425344	4	ENSG00000126934	missense
3327	\N	\N		3	178936093	178936093	G	T	DOID:1612	25157968	included	ENST00000263967	p.E545D	PIK3CA	1	c.1635	2016-05-18 21:07:04.935704	2016-05-18 21:28:38.942663	5	ENSG00000121879	missense
3328	\N	\N		3	178936093	178936093	G	C	DOID:1612	25157968	included	ENST00000263967	p.E545D	PIK3CA	1	c.1635	2016-05-18 21:07:04.9474	2016-05-18 21:28:39.012009	5	ENSG00000121879	missense
1900	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"dasatinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"18986703\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		4	55599321	55599321	A	T	DOID:9119	18986703	included	ENST00000288135	p.D816V	KIT	1	c.2447	2016-05-18 20:50:33.303556	2016-05-18 21:27:04.690885	4	ENSG00000157404	missense
1901	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"quizartinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22504184\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		4	55599321	55599321	A	T	DOID:9119	22504184	included	ENST00000288135	p.D816V	KIT	1	c.2447	2016-05-18 20:50:33.322013	2016-05-18 21:27:04.763802	4	ENSG00000157404	missense
1902	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"dasatinib\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23149070\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		4	55599340	55599340	T	A	DOID:9119	23149070	included	ENST00000288135	p.N822K	KIT	1	c.2466	2016-05-18 20:50:33.359205	2016-05-18 21:27:04.817555	4	ENSG00000157404	missense
1905	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"JAK inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"18397343\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		19	17949138	17949138	C	A	DOID:8761	18397343	included	ENST00000458235	p.Q501H	JAK3	-1	c.1503	2016-05-18 20:50:33.459695	2016-05-18 21:27:05.101407	4	ENSG00000105639	missense
1906	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"JAK inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"18397343\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		19	17949138	17949138	C	G	DOID:8761	18397343	included	ENST00000458235	p.Q501H	JAK3	-1	c.1503	2016-05-18 20:50:33.492241	2016-05-18 21:27:05.213877	4	ENSG00000105639	missense
1907	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"JAK inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"18397343\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		19	17954634	17954634	A	G	DOID:8761	18397343	included	ENST00000458235	p.I87T	JAK3	-1	c.260	2016-05-18 20:50:33.524555	2016-05-18 21:27:05.316505	4	ENSG00000105639	missense
2706	\N	\N		9	133748391	133748391	T	C	DOID:8552	12623848	included	ENST00000372348	p.M370T	ABL1	1	c.1109	2016-05-18 21:06:56.904411	2016-05-18 21:28:07.085524	5	ENSG00000097007	missense
1908	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"dasatinib, bosutinib, ponatinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"NCCN guidelines\\",\\"Evidence\\":\\"consensus\\",\\"Source\\":\\"21562040\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		9	133738306	133738306	G	A	DOID:8552	21562040	included	ENST00000372348	p.E255K	ABL1	1	c.763	2016-05-18 20:50:33.551509	2016-05-18 21:27:05.40749	4	ENSG00000097007	missense
1909	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"dasatinib, bosutinib, ponatinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"NCCN guidelines\\",\\"Evidence\\":\\"consensus\\",\\"Source\\":\\"21562040\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		9	133738357	133738357	T	C	DOID:8552	21562040	included	ENST00000372348	p.Y272H	ABL1	1	c.814	2016-05-18 20:50:33.562997	2016-05-18 21:27:05.501077	4	ENSG00000097007	missense
2707	\N	\N		9	133748391	133748391	T	C	DOID:8552	11964322	included	ENST00000372348	p.M370T	ABL1	1	c.1109	2016-05-18 21:06:56.938792	2016-05-18 21:28:07.138262	5	ENSG00000097007	missense
2708	\N	\N		9	133748391	133748391	T	C	DOID:8552	12399961	included	ENST00000372348	p.M370T	ABL1	1	c.1109	2016-05-18 21:06:56.96837	2016-05-18 21:28:07.199511	5	ENSG00000097007	missense
1910	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"nilotinib, ponatinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"NCCN guidelines\\",\\"Evidence\\":\\"consensus\\",\\"Source\\":\\"21562040\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		9	133747588	133747588	G	C	DOID:8552	21562040	included	ENST00000372348	p.V318L	ABL1	1	c.952	2016-05-18 20:50:33.593947	2016-05-18 21:27:05.723185	4	ENSG00000097007	missense
1911	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"nilotinib, bosutinib, ponatinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"NCCN guidelines\\",\\"Evidence\\":\\"consensus\\",\\"Source\\":\\"21562040\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		9	133748282	133748282	A	G	DOID:8552	21562040	included	ENST00000372348	p.T334A	ABL1	1	c.1000	2016-05-18 20:50:33.626849	2016-05-18 21:27:05.795395	4	ENSG00000097007	missense
2709	\N	\N		9	133748391	133748391	T	C	DOID:8552	12130516	included	ENST00000372348	p.M370T	ABL1	1	c.1109	2016-05-18 21:06:57.01264	2016-05-18 21:28:07.245708	5	ENSG00000097007	missense
2710	\N	\N		9	133748391	133748391	T	C	DOID:8552	19768693	included	ENST00000372348	p.M370T	ABL1	1	c.1109	2016-05-18 21:06:57.044572	2016-05-18 21:28:07.296713	5	ENSG00000097007	missense
2711	\N	\N		9	133748391	133748391	T	C	DOID:8552	19557636	included	ENST00000372348	p.M370T	ABL1	1	c.1109	2016-05-18 21:06:57.064587	2016-05-18 21:28:07.335777	5	ENSG00000097007	missense
1912	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"ponatinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"NCCN guidelines\\",\\"Evidence\\":\\"consensus\\",\\"Source\\":\\"21562040\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		9	133748283	133748283	C	T	DOID:8552	21562040	included	ENST00000372348	p.T334I	ABL1	1	c.1001	2016-05-18 20:50:33.650269	2016-05-18 21:27:05.873019	4	ENSG00000097007	missense
1913	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"nilotinib, bosutinib, ponatinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"NCCN guidelines\\",\\"Evidence\\":\\"consensus\\",\\"Source\\":\\"21562040\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		9	133748288	133748288	T	A	DOID:8552	21562040	included	ENST00000372348	p.F336I	ABL1	1	c.1006	2016-05-18 20:50:33.66005	2016-05-18 21:27:05.974634	4	ENSG00000097007	missense
2712	\N	\N		9	133748391	133748391	T	C	DOID:8552	20607847	included	ENST00000372348	p.M370T	ABL1	1	c.1109	2016-05-18 21:06:57.100086	2016-05-18 21:28:07.373579	5	ENSG00000097007	missense
2713	\N	\N		9	133748391	133748391	T	C	DOID:8552	20557306	included	ENST00000372348	p.M370T	ABL1	1	c.1109	2016-05-18 21:06:57.118528	2016-05-18 21:28:07.414851	5	ENSG00000097007	missense
2714	\N	\N		9	133748391	133748391	T	C	DOID:8552	12783380	included	ENST00000372348	p.M370T	ABL1	1	c.1109	2016-05-18 21:06:57.129582	2016-05-18 21:28:07.450872	5	ENSG00000097007	missense
1914	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"nilotinib, bosutinib, ponatinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"NCCN guidelines\\",\\"Evidence\\":\\"consensus\\",\\"Source\\":\\"21562040\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		9	133748288	133748288	T	G	DOID:8552	21562040	included	ENST00000372348	p.F336V	ABL1	1	c.1006	2016-05-18 20:50:33.696902	2016-05-18 21:27:06.040011	4	ENSG00000097007	missense
1915	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"nilotinib, bosutinib, ponatinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"NCCN guidelines\\",\\"Evidence\\":\\"consensus\\",\\"Source\\":\\"21562040\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		9	133748289	133748289	T	G	DOID:8552	21562040	included	ENST00000372348	p.F336C	ABL1	1	c.1007	2016-05-18 20:50:33.724976	2016-05-18 21:27:06.150962	4	ENSG00000097007	missense
2715	\N	\N		9	133748391	133748391	T	C	DOID:8552	15381060	included	ENST00000372348	p.M370T	ABL1	1	c.1109	2016-05-18 21:06:57.164688	2016-05-18 21:28:07.489684	5	ENSG00000097007	missense
2404	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"vandetanib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"FDA-approved\\",\\"Evidence\\":\\"consensus\\",\\"Source\\":\\"20065189, 22025146\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"cabozantinib, sunitinib\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"21470995\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"RET inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23056499\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		10	43617416	43617416	T	C	DOID:1781	20368568	included	ENST00000355710	p.M918T	RET	1	c.2753	2016-05-18 20:50:48.921358	2016-05-18 21:27:47.104457	4	ENSG00000165731	missense
1916	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"nilotinib, bosutinib, ponatinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"NCCN guidelines\\",\\"Evidence\\":\\"consensus\\",\\"Source\\":\\"21562040\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		9	133748290	133748290	C	A	DOID:8552	21562040	included	ENST00000372348	p.F336L	ABL1	1	c.1008	2016-05-18 20:50:33.755813	2016-05-18 21:27:06.245094	4	ENSG00000097007	missense
2716	\N	\N		9	133748391	133748391	T	C	DOID:8552	17189410	included	ENST00000372348	p.M370T	ABL1	1	c.1109	2016-05-18 21:06:57.174488	2016-05-18 21:28:07.532433	5	ENSG00000097007	missense
2717	\N	\N		9	133748391	133748391	T	C	DOID:8552	25157968	included	ENST00000372348	p.M370T	ABL1	1	c.1109	2016-05-18 21:06:57.194888	2016-05-18 21:28:07.573299	5	ENSG00000097007	missense
2718	\N	\N		9	133748403	133748403	A	G	DOID:8552	23676790	included	ENST00000372348	p.E374G	ABL1	1	c.1121	2016-05-18 21:06:57.206603	2016-05-18 21:28:07.64217	5	ENSG00000097007	missense
1917	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"nilotinib, bosutinib, ponatinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"NCCN guidelines\\",\\"Evidence\\":\\"consensus\\",\\"Source\\":\\"21562040\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		9	133748290	133748290	C	G	DOID:8552	21562040	included	ENST00000372348	p.F336L	ABL1	1	c.1008	2016-05-18 20:50:33.787218	2016-05-18 21:27:06.324007	4	ENSG00000097007	missense
2719	\N	\N		9	133748403	133748403	A	G	DOID:8552	12623848	included	ENST00000372348	p.E374G	ABL1	1	c.1121	2016-05-18 21:06:57.230123	2016-05-18 21:28:07.684634	5	ENSG00000097007	missense
2720	\N	\N		9	133748403	133748403	A	G	DOID:8552	12399961	included	ENST00000372348	p.E374G	ABL1	1	c.1121	2016-05-18 21:06:57.238427	2016-05-18 21:28:07.727575	5	ENSG00000097007	missense
2721	\N	\N		9	133748403	133748403	A	G	DOID:8552	24456693	included	ENST00000372348	p.E374G	ABL1	1	c.1121	2016-05-18 21:06:57.275828	2016-05-18 21:28:07.775583	5	ENSG00000097007	missense
2722	\N	\N		9	133748403	133748403	A	G	DOID:8552	20702476	included	ENST00000372348	p.E374G	ABL1	1	c.1121	2016-05-18 21:06:57.298328	2016-05-18 21:28:07.812618	5	ENSG00000097007	missense
2723	\N	\N		9	133748403	133748403	A	G	DOID:8552	20010464	included	ENST00000372348	p.E374G	ABL1	1	c.1121	2016-05-18 21:06:57.325606	2016-05-18 21:28:07.864331	5	ENSG00000097007	missense
1919	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"dasatinib, bosutinib, ponatinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"NCCN guidelines\\",\\"Evidence\\":\\"consensus\\",\\"Source\\":\\"21562040\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		9	133748414	133748414	T	C	DOID:8552	21562040	included	ENST00000372348	p.F378L	ABL1	1	c.1132	2016-05-18 20:50:33.831995	2016-05-18 21:27:06.496313	4	ENSG00000097007	missense
2724	\N	\N		9	133748403	133748403	A	G	DOID:8552	12783380	included	ENST00000372348	p.E374G	ABL1	1	c.1121	2016-05-18 21:06:57.334156	2016-05-18 21:28:07.901047	5	ENSG00000097007	missense
2725	\N	\N		9	133748403	133748403	A	G	DOID:8552	25157968	included	ENST00000372348	p.E374G	ABL1	1	c.1121	2016-05-18 21:06:57.367056	2016-05-18 21:28:07.938492	5	ENSG00000097007	missense
1920	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"dasatinib, bosutinib, ponatinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"NCCN guidelines\\",\\"Evidence\\":\\"consensus\\",\\"Source\\":\\"21562040\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		9	133748415	133748415	T	G	DOID:8552	21562040	included	ENST00000372348	p.F378C	ABL1	1	c.1133	2016-05-18 20:50:33.862751	2016-05-18 21:27:06.590301	4	ENSG00000097007	missense
2412	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"dasatinib + erlotinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22328973\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"dasatinib\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22328973\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		1	162748390	162748390	T	A	DOID:1749	18938156	included	ENST00000367921	p.S768R	DDR2	1	c.2304	2016-05-18 20:50:49.167756	2016-05-18 21:27:47.78497	4	ENSG00000162733	missense
3347	\N	\N		3	178952084	178952084	C	T	DOID:0050866	25157968	invalid	ENST00000263967	p.H1047Y	PIK3CA	1	c.3139	2016-05-18 21:07:05.171902	2016-05-18 21:25:22.866435	5	ENSG00000121879	missense
3348	\N	\N		3	178952084	178952084	C	T	DOID:0050866	21824802	invalid	ENST00000263967	p.H1047Y	PIK3CA	1	c.3139	2016-05-18 21:07:05.179112	2016-05-18 21:25:22.871588	5	ENSG00000121879	missense
3351	\N	\N		3	178952090	178952090	G	C	DOID:0050866	25157968	invalid	ENST00000263967	p.G1049R	PIK3CA	1	c.3145	2016-05-18 21:07:05.211062	2016-05-18 21:25:22.886823	5	ENSG00000121879	missense
1921	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"ruxolitinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23656643\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		1	36933434	36933434	G	A	DOID:8552	23656643	included	ENST00000373103	p.T618I	CSF3R	-1	c.1853	2016-05-18 20:50:33.895768	2016-05-18 21:27:06.648911	4	ENSG00000119535	missense
1922	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"ruxolitinib\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23656643\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		1	36933444	36933444	T	C	DOID:8552	23656643	included	ENST00000373103	p.T615A	CSF3R	-1	c.1843	2016-05-18 20:50:33.907433	2016-05-18 21:27:06.726661	4	ENSG00000119535	missense
3353	\N	\N		5	67589138	67589138	G	A	DOID:162	25157968	included	ENST00000396611	p.G376R	PIK3R1	1	c.1126	2016-05-18 21:07:05.229834	2016-05-18 21:28:40.169219	5	ENSG00000145675	missense
3352	\N	\N		3	178952090	178952090	G	C	DOID:0050866	21824802	invalid	ENST00000263967	p.G1049R	PIK3CA	1	c.3145	2016-05-18 21:07:05.22031	2016-05-18 21:25:22.892156	5	ENSG00000121879	missense
1923	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"crizotinib\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22072639\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		2	29436859	29436859	A	C	DOID:769	21838707	included	ENST00000389048	p.F1245C	ALK	-1	c.3734	2016-05-18 20:50:33.92649	2016-05-18 21:27:06.784678	4	ENSG00000171094	missense
1924	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"crizotinib\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22072639\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		2	29436859	29436859	A	C	DOID:769	22072639	included	ENST00000389048	p.F1245C	ALK	-1	c.3734	2016-05-18 20:50:33.978941	2016-05-18 21:27:06.865683	4	ENSG00000171094	missense
1925	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"crizotinib\\",\\"Assocation\\":\\"reduced sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22072639\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		2	29443695	29443695	G	T	DOID:769	22072639	included	ENST00000389048	p.F1174L	ALK	-1	c.3522	2016-05-18 20:50:34.018407	2016-05-18 21:27:06.919505	4	ENSG00000171094	missense
3356	\N	\N		5	67589138	67589138	G	C	DOID:162	19962457	included	ENST00000396611	p.G376R	PIK3R1	1	c.1126	2016-05-18 21:07:05.257831	2016-05-18 21:28:40.301651	5	ENSG00000145675	missense
3357	\N	\N		5	67589552	67589552	GAA	-	DOID:162	25157968	included	ENST00000396611	p.E439X	PIK3R1	1	c.1315	2016-05-18 21:07:05.267087	2016-05-18 21:28:40.354988	5	ENSG00000145675	frameshift
1926	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"crizotinib\\",\\"Assocation\\":\\"reduced sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22072639\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		2	29443695	29443695	G	T	DOID:769	21838707	included	ENST00000389048	p.F1174L	ALK	-1	c.3522	2016-05-18 20:50:34.037283	2016-05-18 21:27:06.995076	4	ENSG00000171094	missense
1927	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"crizotinib\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22072639\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		2	29445213	29445213	A	T	DOID:769	21838707	included	ENST00000389048	p.I1171N	ALK	-1	c.3512	2016-05-18 20:50:34.069603	2016-05-18 21:27:07.053384	4	ENSG00000171094	missense
2726	\N	\N		9	133748414	133748414	T	G	DOID:8552	23676790	included	ENST00000372348	p.F378V	ABL1	1	c.1132	2016-05-18 21:06:57.376184	2016-05-18 21:28:07.98875	5	ENSG00000097007	missense
1928	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"crizotinib\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22072639\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		2	29445213	29445213	A	T	DOID:769	22072639	included	ENST00000389048	p.I1171N	ALK	-1	c.3512	2016-05-18 20:50:34.090439	2016-05-18 21:27:07.133	4	ENSG00000171094	missense
1929	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"ruxolitinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"FDA-approved\\",\\"Evidence\\":\\"consensus\\",\\"Source\\":\\"FDA\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		9	5073770	5073770	G	T	DOID:4971	24986690	included	ENST00000381652	p.V617F	JAK2	1	c.1849	2016-05-18 20:50:34.11338	2016-05-18 21:27:07.186705	4	ENSG00000096968	missense
2727	\N	\N		9	133748414	133748414	T	G	DOID:8552	12623848	included	ENST00000372348	p.F378V	ABL1	1	c.1132	2016-05-18 21:06:57.415031	2016-05-18 21:28:08.035196	5	ENSG00000097007	missense
2728	\N	\N		9	133748414	133748414	T	G	DOID:8552	21895409	included	ENST00000372348	p.F378V	ABL1	1	c.1132	2016-05-18 21:06:57.425185	2016-05-18 21:28:08.076168	5	ENSG00000097007	missense
2729	\N	\N		9	133748414	133748414	T	G	DOID:8552	20367437	included	ENST00000372348	p.F378V	ABL1	1	c.1132	2016-05-18 21:06:57.458519	2016-05-18 21:28:08.123751	5	ENSG00000097007	missense
1930	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"MET inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23213094\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	116417464	116417464	A	G	DOID:4451	23213094	included	ENST00000318493	p.H1112R	MET	1	c.3335	2016-05-18 20:50:34.134253	2016-05-18 21:27:07.280356	4	ENSG00000105976	missense
1931	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"MET inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23610116\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	116423474	116423474	T	C	DOID:4451	23610116	included	ENST00000318493	p.M1268T	MET	1	c.3803	2016-05-18 20:50:34.170406	2016-05-18 21:27:07.372392	4	ENSG00000105976	missense
2730	\N	\N		9	133748414	133748414	T	G	DOID:8552	14745431	included	ENST00000372348	p.F378V	ABL1	1	c.1132	2016-05-18 21:06:57.475647	2016-05-18 21:28:08.175441	5	ENSG00000097007	missense
2731	\N	\N		9	133748414	133748414	T	G	DOID:8552	21562040	included	ENST00000372348	p.F378V	ABL1	1	c.1132	2016-05-18 21:06:57.510563	2016-05-18 21:28:08.220993	5	ENSG00000097007	missense
2732	\N	\N		9	133748414	133748414	T	G	DOID:8552	25152116	included	ENST00000372348	p.F378V	ABL1	1	c.1132	2016-05-18 21:06:57.528607	2016-05-18 21:28:08.281283	5	ENSG00000097007	missense
1933	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"everolimus\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"24622468\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		1	11182179	11182179	G	T	DOID:4451	24622468	included	ENST00000361445	p.Q2223K	MTOR	-1	c.6667	2016-05-18 20:50:34.216523	2016-05-18 21:27:07.550711	4	ENSG00000198793	missense
1934	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"rapamycin\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"24631838\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		1	11184573	11184573	G	T	DOID:4451	24631838	included	ENST00000361445	p.S2215Y	MTOR	-1	c.6644	2016-05-18 20:50:34.238436	2016-05-18 21:27:07.64699	4	ENSG00000198793	missense
2733	\N	\N		9	133748414	133748414	T	G	DOID:8552	19768693	included	ENST00000372348	p.F378V	ABL1	1	c.1132	2016-05-18 21:06:57.550086	2016-05-18 21:28:08.334993	5	ENSG00000097007	missense
2734	\N	\N		9	133748414	133748414	T	G	DOID:8552	23575252	included	ENST00000372348	p.F378V	ABL1	1	c.1132	2016-05-18 21:06:57.574808	2016-05-18 21:28:08.37475	5	ENSG00000097007	missense
1935	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"rapamycin\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"24631838\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		1	11217299	11217299	A	G	DOID:4451	24631838	included	ENST00000361445	p.L1460P	MTOR	-1	c.4379	2016-05-18 20:50:34.262822	2016-05-18 21:27:07.749591	4	ENSG00000198793	missense
1936	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"everolimus\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"24625776\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		1	11174420	11174420	C	T	DOID:4006	24625776	included	ENST00000361445	p.E2419K	MTOR	-1	c.7255	2016-05-18 20:50:34.273969	2016-05-18 21:27:07.836054	4	ENSG00000198793	missense
2384	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"BRAF inhibitors in BRAF mutant tumors\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23737487\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		3	12645700	12645700	A	G	DOID:1909	23737487	included	ENST00000442415	p.S257P	RAF1	-1	c.769	2016-05-18 20:50:48.321016	2016-05-18 21:27:45.467748	4	ENSG00000132155	missense
2545	\N	\N		5	112175303	112175303	C	T	DOID:9256	22810696	included	ENST00000257430	p.Q1338*	APC	1	c.4012	2016-05-18 21:06:54.690802	2016-05-18 21:27:57.795696	5	ENSG00000134982	stop
1937	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"everolimus\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"24625776\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		1	11187857	11187857	C	T	DOID:4006	24625776	included	ENST00000361445	p.E2014K	MTOR	-1	c.6040	2016-05-18 20:50:34.299159	2016-05-18 21:27:07.933186	4	ENSG00000198793	missense
2470	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"dasatinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22649091\\",\\"Effect\\":\\"reduced kinase activity\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	140481393	140481393	T	C	DOID:1324	23833300	included	ENST00000288602	p.Y472C	BRAF	-1	c.1415	2016-05-18 20:50:50.3519	2016-05-18 21:27:52.598749	4	ENSG00000157764	missense
2521	\N	\N		9	133738357	133738357	T	C	DOID:9952	11853795	included	ENST00000372348	p.Y272H	ABL1	1	c.814	2016-05-18 21:06:54.45732	2016-05-18 21:27:56.167924	5	ENSG00000097007	missense
2522	\N	\N		9	133738357	133738357	T	C	DOID:9952	25157968	included	ENST00000372348	p.Y272H	ABL1	1	c.814	2016-05-18 21:06:54.466018	2016-05-18 21:27:56.238377	5	ENSG00000097007	missense
2504	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"bortezomib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"19331127, 21273588\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"FGFR inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22869148\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		4	1806099	1806099	A	G	DOID:0070004	19331127	invalid	ENST00000340107	p.Y375C	FGFR3	1	c.1124	2016-05-18 20:50:51.00337	2016-05-18 21:14:36.302002	4	ENSG00000068078	missense
3369	\N	\N		10	89692904	89692904	C	G	DOID:0050866	21824802	invalid	ENST00000371953	p.R130G	PTEN	1	c.388	2016-05-18 21:07:05.385389	2016-05-18 21:25:22.990272	5	ENSG00000171862	missense
2735	\N	\N		9	133748414	133748414	T	G	DOID:8552	25157968	included	ENST00000372348	p.F378V	ABL1	1	c.1132	2016-05-18 21:06:57.586819	2016-05-18 21:28:08.414653	5	ENSG00000097007	missense
2520	\N	\N		9	133738357	133738357	T	C	DOID:9952	18615627	included	ENST00000372348	p.Y272H	ABL1	1	c.814	2016-05-18 21:06:54.442455	2016-05-18 21:27:56.117034	5	ENSG00000097007	missense
2634	\N	\N		9	133738357	133738357	T	C	DOID:8552	24456693	included	ENST00000372348	p.Y272H	ABL1	1	c.814	2016-05-18 21:06:55.665108	2016-05-18 21:28:03.309015	5	ENSG00000097007	missense
2784	\N	\N		7	140481478	140481478	G	A	DOID:1909	25157968	included	ENST00000288602	p.R444W	BRAF	-1	c.1330	2016-05-18 21:06:58.559414	2016-05-18 21:28:11.096548	5	ENSG00000157764	missense
2933	\N	\N		3	41266136	41266136	T	G	DOID:0050891	25157968	invalid	ENST00000349496	p.S45A	CTNNB1	1	c.133	2016-05-18 21:07:00.201308	2016-05-18 21:25:20.502194	5	ENSG00000168036	missense
2935	\N	\N		3	41266137	41266137	C	T	DOID:0050891	25157968	invalid	ENST00000349496	p.S45F	CTNNB1	1	c.134	2016-05-18 21:07:00.225878	2016-05-18 21:25:20.513412	5	ENSG00000168036	missense
2938	\N	\N		3	41266136	41266136	T	C	DOID:0050891	24788118	invalid	ENST00000349496	p.S45P	CTNNB1	1	c.133	2016-05-18 21:07:00.254379	2016-05-18 21:25:20.530242	5	ENSG00000168036	missense
2736	\N	\N		9	133750356	133750356	A	G	DOID:8552	21489624	included	ENST00000372348	p.H415R	ABL1	1	c.1244	2016-05-18 21:06:57.662579	2016-05-18 21:28:08.478504	5	ENSG00000097007	missense
2737	\N	\N		9	133750356	133750356	A	G	DOID:8552	23676790	included	ENST00000372348	p.H415R	ABL1	1	c.1244	2016-05-18 21:06:57.672221	2016-05-18 21:28:08.528426	5	ENSG00000097007	missense
2738	\N	\N		9	133750356	133750356	A	G	DOID:8552	19811824	included	ENST00000372348	p.H415R	ABL1	1	c.1244	2016-05-18 21:06:57.708499	2016-05-18 21:28:08.576023	5	ENSG00000097007	missense
2739	\N	\N		9	133750356	133750356	A	G	DOID:8552	14745431	included	ENST00000372348	p.H415R	ABL1	1	c.1244	2016-05-18 21:06:57.724131	2016-05-18 21:28:08.632591	5	ENSG00000097007	missense
2740	\N	\N		9	133750356	133750356	A	G	DOID:8552	12623848	included	ENST00000372348	p.H415R	ABL1	1	c.1244	2016-05-18 21:06:57.748563	2016-05-18 21:28:08.68805	5	ENSG00000097007	missense
2741	\N	\N		9	133750356	133750356	A	G	DOID:8552	12399961	included	ENST00000372348	p.H415R	ABL1	1	c.1244	2016-05-18 21:06:57.76243	2016-05-18 21:28:08.744474	5	ENSG00000097007	missense
1903	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"dasatinib\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23149070\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		4	55599340	55599340	T	G	DOID:9119	23149070	included	ENST00000288135	p.N822K	KIT	1	c.2466	2016-05-18 20:50:33.396244	2016-05-18 21:27:04.896577	4	ENSG00000157404	missense
2471	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"dasatinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22649091\\",\\"Effect\\":\\"reduced kinase activity\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	140481393	140481393	T	C	DOID:1324	12068308	included	ENST00000288602	p.Y472C	BRAF	-1	c.1415	2016-05-18 20:50:50.373489	2016-05-18 21:27:52.651196	4	ENSG00000157764	missense
2742	\N	\N		9	133750356	133750356	A	G	DOID:8552	25157968	included	ENST00000372348	p.H415R	ABL1	1	c.1244	2016-05-18 21:06:57.791452	2016-05-18 21:28:08.818275	5	ENSG00000097007	missense
2472	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"dasatinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22649091\\",\\"Effect\\":\\"reduced kinase activity\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	140481393	140481393	T	C	DOID:1324	12460919	included	ENST00000288602	p.Y472C	BRAF	-1	c.1415	2016-05-18 20:50:50.385974	2016-05-18 21:27:52.708763	4	ENSG00000157764	missense
2743	\N	\N		14	105246551	105246551	C	T	DOID:5409	24657128	included	ENST00000349310	p.E17K	AKT1	-1	c.49	2016-05-18 21:06:57.803089	2016-05-18 21:28:08.869197	5	ENSG00000142208	missense
2744	\N	\N		14	105246551	105246551	C	T	DOID:5409	25157968	included	ENST00000349310	p.E17K	AKT1	-1	c.49	2016-05-18 21:06:57.842335	2016-05-18 21:28:08.92973	5	ENSG00000142208	missense
2745	\N	\N		14	105246551	105246551	C	T	DOID:3910	22980975	included	ENST00000349310	p.E17K	AKT1	-1	c.49	2016-05-18 21:06:57.855316	2016-05-18 21:28:08.986791	5	ENSG00000142208	missense
2746	\N	\N		14	105246551	105246551	C	T	DOID:3910	25157968	included	ENST00000349310	p.E17K	AKT1	-1	c.49	2016-05-18 21:06:57.912227	2016-05-18 21:28:09.032363	5	ENSG00000142208	missense
2747	\N	\N		5	112174631	112174631	C	T	DOID:3910	18948947	included	ENST00000257430	p.R1114*	APC	1	c.3340	2016-05-18 21:06:57.920919	2016-05-18 21:28:09.083237	5	ENSG00000134982	stop
2748	\N	\N		5	112174631	112174631	C	T	DOID:3910	25157968	included	ENST00000257430	p.R1114*	APC	1	c.3340	2016-05-18 21:06:57.961957	2016-05-18 21:28:09.147451	5	ENSG00000134982	stop
2749	\N	\N		14	105246551	105246551	C	T	DOID:3908	17611497	included	ENST00000349310	p.E17K	AKT1	-1	c.49	2016-05-18 21:06:57.971452	2016-05-18 21:28:09.197423	5	ENSG00000142208	missense
2751	\N	\N		14	105246551	105246551	C	T	DOID:3908	23728071	included	ENST00000349310	p.E17K	AKT1	-1	c.49	2016-05-18 21:06:58.018118	2016-05-18 21:28:09.29727	5	ENSG00000142208	missense
2752	\N	\N		19	40741870	40741870	C	T	DOID:3908	21479466	included	ENST00000392038	p.R368S	AKT2	-1	c.1102	2016-05-18 21:06:58.046521	2016-05-18 21:28:09.35674	5	ENSG00000105221	missense
2416	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"trastuzumab, pertuzumab, lapatinib, anti-HER3 mAbs, PI3K pathway inhibitors + MEK inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23680147\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		12	56481857	56481857	C	A	DOID:162	23680147	included	ENST00000267101	p.P262H	ERBB3	1	c.785	2016-05-18 20:50:49.219466	2016-05-18 21:27:48.290483	4	ENSG00000065361	missense
2753	\N	\N		19	40741870	40741870	C	T	DOID:3908	25157968	included	ENST00000392038	p.R368S	AKT2	-1	c.1102	2016-05-18 21:06:58.057081	2016-05-18 21:28:09.39989	5	ENSG00000105221	missense
2754	\N	\N		14	105246551	105246551	C	T	DOID:3565	23348505	included	ENST00000349310	p.E17K	AKT1	-1	c.49	2016-05-18 21:06:58.077575	2016-05-18 21:28:09.441554	5	ENSG00000142208	missense
2505	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"bortezomib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"19331127, 21273588\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"FGFR inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22869148\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		4	1806099	1806099	A	G	DOID:0070004	21273588	invalid	ENST00000340107	p.Y375C	FGFR3	1	c.1124	2016-05-18 20:50:51.014583	2016-05-18 21:14:36.307766	4	ENSG00000068078	missense
3368	\N	\N		10	89692904	89692904	C	G	DOID:0050866	25157968	invalid	ENST00000371953	p.R130G	PTEN	1	c.388	2016-05-18 21:07:05.374958	2016-05-18 21:25:22.978955	5	ENSG00000171862	missense
1938	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"crizotinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22277784\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"ceritinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"FDA-approved\\",\\"Evidence\\":\\"consensus\\",\\"Source\\":\\"24670165\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		2	29432682	29432682	C	G	DOID:3910	22277784	included	ENST00000389048	p.G1269A	ALK	-1	c.3806	2016-05-18 20:50:34.345887	2016-05-18 21:27:08.032085	4	ENSG00000171094	missense
2755	\N	\N		14	105246551	105246551	C	T	DOID:3565	25157968	included	ENST00000349310	p.E17K	AKT1	-1	c.49	2016-05-18 21:06:58.088454	2016-05-18 21:28:09.481689	5	ENSG00000142208	missense
2756	\N	\N		14	105246551	105246551	C	T	DOID:3347	24190505	included	ENST00000349310	p.E17K	AKT1	-1	c.49	2016-05-18 21:06:58.10458	2016-05-18 21:28:09.521566	5	ENSG00000142208	missense
2757	\N	\N		14	105246551	105246551	C	T	DOID:3347	25157968	included	ENST00000349310	p.E17K	AKT1	-1	c.49	2016-05-18 21:06:58.11585	2016-05-18 21:28:09.565434	5	ENSG00000142208	missense
2758	\N	\N		14	105246551	105246551	C	T	DOID:2870	19853286	included	ENST00000349310	p.E17K	AKT1	-1	c.49	2016-05-18 21:06:58.1383	2016-05-18 21:28:09.6168	5	ENSG00000142208	missense
1955	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"erlotinib, afatinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"FDA-approved\\",\\"Evidence\\":\\"consensus\\",\\"Source\\":\\"FDA\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"irreversible EGFR TKIs\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"late trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22753918\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"afatinib + cetuximab\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"Annals Oncol 2012;23(Suppl 9):1289\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"HSP90 inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"Annals Oncol 2012;23(Suppl 9):4380\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors (alone or in combination)\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23102728.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	55241707	55241707	G	A	DOID:3908	15118073	included	ENST00000275493	p.G719S	EGFR	1	c.2155	2016-05-18 20:50:34.800511	2016-05-18 21:27:09.526213	4	ENSG00000146648	missense
1956	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"erlotinib, afatinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"FDA-approved\\",\\"Evidence\\":\\"consensus\\",\\"Source\\":\\"FDA\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"irreversible EGFR TKIs\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"late trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22753918\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"afatinib + cetuximab\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"Annals Oncol 2012;23(Suppl 9):1289\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"HSP90 inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"Annals Oncol 2012;23(Suppl 9):4380\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors (alone or in combination)\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23102728.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	55241707	55241707	G	A	DOID:3908	15118125	included	ENST00000275493	p.G719S	EGFR	1	c.2155	2016-05-18 20:50:34.86431	2016-05-18 21:27:09.603277	4	ENSG00000146648	missense
1957	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"erlotinib, afatinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"FDA-approved\\",\\"Evidence\\":\\"consensus\\",\\"Source\\":\\"FDA\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"irreversible EGFR TKIs\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"late trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22753918\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"afatinib + cetuximab\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"Annals Oncol 2012;23(Suppl 9):1289\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"HSP90 inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"Annals Oncol 2012;23(Suppl 9):4380\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors (alone or in combination)\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23102728.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	55241707	55241707	G	A	DOID:3908	15329413	included	ENST00000275493	p.G719S	EGFR	1	c.2155	2016-05-18 20:50:34.894719	2016-05-18 21:27:09.68574	4	ENSG00000146648	missense
1958	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"erlotinib, afatinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"FDA-approved\\",\\"Evidence\\":\\"consensus\\",\\"Source\\":\\"FDA\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"irreversible EGFR TKIs\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"late trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22753918\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"afatinib + cetuximab\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"Annals Oncol 2012;23(Suppl 9):1289\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"HSP90 inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"Annals Oncol 2012;23(Suppl 9):4380\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors (alone or in combination)\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23102728.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	55241707	55241707	G	A	DOID:3908	19922469	included	ENST00000275493	p.G719S	EGFR	1	c.2155	2016-05-18 20:50:34.94052	2016-05-18 21:27:09.757723	4	ENSG00000146648	missense
1959	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"erlotinib, afatinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"FDA-approved\\",\\"Evidence\\":\\"consensus\\",\\"Source\\":\\"FDA\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"irreversible EGFR TKIs\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"late trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22753918\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"afatinib + cetuximab\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"Annals Oncol 2012;23(Suppl 9):1289\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"HSP90 inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"Annals Oncol 2012;23(Suppl 9):4380\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors (alone or in combination)\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23102728.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	55241707	55241707	G	A	DOID:3908	15710947	included	ENST00000275493	p.G719S	EGFR	1	c.2155	2016-05-18 20:50:34.995532	2016-05-18 21:27:09.831239	4	ENSG00000146648	missense
2417	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"trastuzumab, lapatinib, PI3K pathway inhibitors + MEK inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23680147\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		12	56490980	56490980	A	G	DOID:162	23680147	included	ENST00000267101	p.Q809R	ERBB3	1	c.2426	2016-05-18 20:50:49.237806	2016-05-18 21:27:48.402312	4	ENSG00000065361	missense
1960	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"erlotinib, afatinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"FDA-approved\\",\\"Evidence\\":\\"consensus\\",\\"Source\\":\\"FDA\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"irreversible EGFR TKIs\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"late trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22753918\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"afatinib + cetuximab\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"Annals Oncol 2012;23(Suppl 9):1289\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"HSP90 inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"Annals Oncol 2012;23(Suppl 9):4380\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors (alone or in combination)\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23102728.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	55241707	55241707	G	A	DOID:3908	16011858	included	ENST00000275493	p.G719S	EGFR	1	c.2155	2016-05-18 20:50:35.03268	2016-05-18 21:27:09.91939	4	ENSG00000146648	missense
1961	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"erlotinib, afatinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"FDA-approved\\",\\"Evidence\\":\\"consensus\\",\\"Source\\":\\"FDA\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"irreversible EGFR TKIs\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"late trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22753918\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"afatinib + cetuximab\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"Annals Oncol 2012;23(Suppl 9):1289\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"HSP90 inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"Annals Oncol 2012;23(Suppl 9):4380\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors (alone or in combination)\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23102728.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	55241707	55241707	G	A	DOID:3908	16115929	included	ENST00000275493	p.G719S	EGFR	1	c.2155	2016-05-18 20:50:35.069369	2016-05-18 21:27:09.989578	4	ENSG00000146648	missense
1962	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"erlotinib, afatinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"FDA-approved\\",\\"Evidence\\":\\"consensus\\",\\"Source\\":\\"FDA\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"irreversible EGFR TKIs\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"late trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22753918\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"afatinib + cetuximab\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"Annals Oncol 2012;23(Suppl 9):1289\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"HSP90 inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"Annals Oncol 2012;23(Suppl 9):4380\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors (alone or in combination)\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23102728.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	55241707	55241707	G	A	DOID:3908	20479403	included	ENST00000275493	p.G719S	EGFR	1	c.2155	2016-05-18 20:50:35.127397	2016-05-18 21:27:10.082023	4	ENSG00000146648	missense
1963	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"erlotinib, afatinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"FDA-approved\\",\\"Evidence\\":\\"consensus\\",\\"Source\\":\\"FDA\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"irreversible EGFR TKIs\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"late trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22753918\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"afatinib + cetuximab\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"Annals Oncol 2012;23(Suppl 9):1289\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"HSP90 inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"Annals Oncol 2012;23(Suppl 9):4380\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors (alone or in combination)\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23102728.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	55241707	55241707	G	A	DOID:3908	22753918	included	ENST00000275493	p.G719S	EGFR	1	c.2155	2016-05-18 20:50:35.140868	2016-05-18 21:27:10.165454	4	ENSG00000146648	missense
1964	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"erlotinib, afatinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"FDA-approved\\",\\"Evidence\\":\\"consensus\\",\\"Source\\":\\"FDA\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"irreversible EGFR TKIs\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"late trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22753918\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"afatinib + cetuximab\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"Annals Oncol 2012;23(Suppl 9):1289\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"HSP90 inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"Annals Oncol 2012;23(Suppl 9):4380\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors (alone or in combination)\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23102728.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	55241707	55241707	G	A	DOID:3908	23102728	included	ENST00000275493	p.G719S	EGFR	1	c.2155	2016-05-18 20:50:35.163812	2016-05-18 21:27:10.235535	4	ENSG00000146648	missense
2418	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"JAK inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"21835143\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		20	57484420	57484420	C	T	DOID:162	21835143	included	ENST00000354359	p.R202C	GNAS	1	c.604	2016-05-18 20:50:49.248261	2016-05-18 21:27:48.517687	4	ENSG00000087460	missense
1965	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"erlotinib, afatinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"FDA-approved\\",\\"Evidence\\":\\"consensus\\",\\"Source\\":\\"FDA\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"irreversible EGFR TKIs\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"late trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22753918\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"afatinib + cetuximab\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"Annals Oncol 2012;23(Suppl 9):1289\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"HSP90 inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"Annals Oncol 2012;23(Suppl 9):4380\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors (alone or in combination)\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23102728.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	55241707	55241707	G	T	DOID:3908	15118073	included	ENST00000275493	p.G719C	EGFR	1	c.2155	2016-05-18 20:50:35.180199	2016-05-18 21:27:10.314879	4	ENSG00000146648	missense
1966	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"erlotinib, afatinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"FDA-approved\\",\\"Evidence\\":\\"consensus\\",\\"Source\\":\\"FDA\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"irreversible EGFR TKIs\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"late trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22753918\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"afatinib + cetuximab\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"Annals Oncol 2012;23(Suppl 9):1289\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"HSP90 inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"Annals Oncol 2012;23(Suppl 9):4380\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors (alone or in combination)\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23102728.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	55241707	55241707	G	T	DOID:3908	15118125	included	ENST00000275493	p.G719C	EGFR	1	c.2155	2016-05-18 20:50:35.204128	2016-05-18 21:27:10.39667	4	ENSG00000146648	missense
1967	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"erlotinib, afatinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"FDA-approved\\",\\"Evidence\\":\\"consensus\\",\\"Source\\":\\"FDA\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"irreversible EGFR TKIs\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"late trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22753918\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"afatinib + cetuximab\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"Annals Oncol 2012;23(Suppl 9):1289\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"HSP90 inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"Annals Oncol 2012;23(Suppl 9):4380\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors (alone or in combination)\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23102728.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	55241707	55241707	G	T	DOID:3908	15329413	included	ENST00000275493	p.G719C	EGFR	1	c.2155	2016-05-18 20:50:35.218029	2016-05-18 21:27:10.493503	4	ENSG00000146648	missense
1968	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"erlotinib, afatinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"FDA-approved\\",\\"Evidence\\":\\"consensus\\",\\"Source\\":\\"FDA\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"irreversible EGFR TKIs\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"late trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22753918\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"afatinib + cetuximab\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"Annals Oncol 2012;23(Suppl 9):1289\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"HSP90 inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"Annals Oncol 2012;23(Suppl 9):4380\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors (alone or in combination)\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23102728.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	55241707	55241707	G	T	DOID:3908	19922469	included	ENST00000275493	p.G719C	EGFR	1	c.2155	2016-05-18 20:50:35.240697	2016-05-18 21:27:10.571678	4	ENSG00000146648	missense
1969	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"erlotinib, afatinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"FDA-approved\\",\\"Evidence\\":\\"consensus\\",\\"Source\\":\\"FDA\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"irreversible EGFR TKIs\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"late trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22753918\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"afatinib + cetuximab\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"Annals Oncol 2012;23(Suppl 9):1289\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"HSP90 inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"Annals Oncol 2012;23(Suppl 9):4380\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors (alone or in combination)\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23102728.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	55241707	55241707	G	T	DOID:3908	15710947	included	ENST00000275493	p.G719C	EGFR	1	c.2155	2016-05-18 20:50:35.264791	2016-05-18 21:27:10.652072	4	ENSG00000146648	missense
2419	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"JAK inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"21835143\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		20	57484421	57484421	G	A	DOID:162	21835143	included	ENST00000354359	p.R202H	GNAS	1	c.605	2016-05-18 20:50:49.269816	2016-05-18 21:27:48.595472	4	ENSG00000087460	missense
1970	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"erlotinib, afatinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"FDA-approved\\",\\"Evidence\\":\\"consensus\\",\\"Source\\":\\"FDA\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"irreversible EGFR TKIs\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"late trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22753918\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"afatinib + cetuximab\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"Annals Oncol 2012;23(Suppl 9):1289\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"HSP90 inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"Annals Oncol 2012;23(Suppl 9):4380\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors (alone or in combination)\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23102728.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	55241707	55241707	G	T	DOID:3908	16011858	included	ENST00000275493	p.G719C	EGFR	1	c.2155	2016-05-18 20:50:35.278567	2016-05-18 21:27:10.74743	4	ENSG00000146648	missense
1971	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"erlotinib, afatinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"FDA-approved\\",\\"Evidence\\":\\"consensus\\",\\"Source\\":\\"FDA\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"irreversible EGFR TKIs\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"late trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22753918\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"afatinib + cetuximab\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"Annals Oncol 2012;23(Suppl 9):1289\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"HSP90 inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"Annals Oncol 2012;23(Suppl 9):4380\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors (alone or in combination)\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23102728.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	55241707	55241707	G	T	DOID:3908	16115929	included	ENST00000275493	p.G719C	EGFR	1	c.2155	2016-05-18 20:50:35.300357	2016-05-18 21:27:10.833683	4	ENSG00000146648	missense
1972	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"erlotinib, afatinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"FDA-approved\\",\\"Evidence\\":\\"consensus\\",\\"Source\\":\\"FDA\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"irreversible EGFR TKIs\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"late trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22753918\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"afatinib + cetuximab\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"Annals Oncol 2012;23(Suppl 9):1289\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"HSP90 inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"Annals Oncol 2012;23(Suppl 9):4380\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors (alone or in combination)\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23102728.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	55241707	55241707	G	T	DOID:3908	20479403	included	ENST00000275493	p.G719C	EGFR	1	c.2155	2016-05-18 20:50:35.313958	2016-05-18 21:27:10.905855	4	ENSG00000146648	missense
1973	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"erlotinib, afatinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"FDA-approved\\",\\"Evidence\\":\\"consensus\\",\\"Source\\":\\"FDA\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"irreversible EGFR TKIs\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"late trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22753918\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"afatinib + cetuximab\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"Annals Oncol 2012;23(Suppl 9):1289\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"HSP90 inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"Annals Oncol 2012;23(Suppl 9):4380\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors (alone or in combination)\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23102728.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	55241707	55241707	G	T	DOID:3908	22753918	included	ENST00000275493	p.G719C	EGFR	1	c.2155	2016-05-18 20:50:35.337015	2016-05-18 21:27:10.995222	4	ENSG00000146648	missense
1974	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"erlotinib, afatinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"FDA-approved\\",\\"Evidence\\":\\"consensus\\",\\"Source\\":\\"FDA\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"irreversible EGFR TKIs\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"late trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22753918\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"afatinib + cetuximab\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"Annals Oncol 2012;23(Suppl 9):1289\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"HSP90 inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"Annals Oncol 2012;23(Suppl 9):4380\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors (alone or in combination)\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23102728.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	55241707	55241707	G	T	DOID:3908	23102728	included	ENST00000275493	p.G719C	EGFR	1	c.2155	2016-05-18 20:50:35.352403	2016-05-18 21:27:11.067496	4	ENSG00000146648	missense
2420	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"JAK inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"21835143\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		20	57484421	57484421	G	T	DOID:162	21835143	included	ENST00000354359	p.R202L	GNAS	1	c.605	2016-05-18 20:50:49.279613	2016-05-18 21:27:48.676158	4	ENSG00000087460	missense
1975	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"erlotinib, afatinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"FDA-approved\\",\\"Evidence\\":\\"consensus\\",\\"Source\\":\\"FDA\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"irreversible EGFR TKIs\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"late trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22753918\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"afatinib + cetuximab\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"Annals Oncol 2012;23(Suppl 9):1289\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"HSP90 inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"Annals Oncol 2012;23(Suppl 9):4380\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors (alone or in combination)\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23102728.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	55241708	55241708	G	C	DOID:3908	15118073	included	ENST00000275493	p.G719A	EGFR	1	c.2156	2016-05-18 20:50:35.369179	2016-05-18 21:27:11.168951	4	ENSG00000146648	missense
1976	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"erlotinib, afatinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"FDA-approved\\",\\"Evidence\\":\\"consensus\\",\\"Source\\":\\"FDA\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"irreversible EGFR TKIs\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"late trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22753918\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"afatinib + cetuximab\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"Annals Oncol 2012;23(Suppl 9):1289\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"HSP90 inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"Annals Oncol 2012;23(Suppl 9):4380\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors (alone or in combination)\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23102728.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	55241708	55241708	G	C	DOID:3908	15118125	included	ENST00000275493	p.G719A	EGFR	1	c.2156	2016-05-18 20:50:35.39778	2016-05-18 21:27:11.262416	4	ENSG00000146648	missense
1977	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"erlotinib, afatinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"FDA-approved\\",\\"Evidence\\":\\"consensus\\",\\"Source\\":\\"FDA\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"irreversible EGFR TKIs\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"late trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22753918\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"afatinib + cetuximab\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"Annals Oncol 2012;23(Suppl 9):1289\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"HSP90 inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"Annals Oncol 2012;23(Suppl 9):4380\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors (alone or in combination)\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23102728.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	55241708	55241708	G	C	DOID:3908	15329413	included	ENST00000275493	p.G719A	EGFR	1	c.2156	2016-05-18 20:50:35.410554	2016-05-18 21:27:11.354943	4	ENSG00000146648	missense
1978	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"erlotinib, afatinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"FDA-approved\\",\\"Evidence\\":\\"consensus\\",\\"Source\\":\\"FDA\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"irreversible EGFR TKIs\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"late trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22753918\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"afatinib + cetuximab\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"Annals Oncol 2012;23(Suppl 9):1289\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"HSP90 inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"Annals Oncol 2012;23(Suppl 9):4380\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors (alone or in combination)\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23102728.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	55241708	55241708	G	C	DOID:3908	19922469	included	ENST00000275493	p.G719A	EGFR	1	c.2156	2016-05-18 20:50:35.439437	2016-05-18 21:27:11.441614	4	ENSG00000146648	missense
1979	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"erlotinib, afatinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"FDA-approved\\",\\"Evidence\\":\\"consensus\\",\\"Source\\":\\"FDA\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"irreversible EGFR TKIs\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"late trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22753918\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"afatinib + cetuximab\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"Annals Oncol 2012;23(Suppl 9):1289\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"HSP90 inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"Annals Oncol 2012;23(Suppl 9):4380\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors (alone or in combination)\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23102728.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	55241708	55241708	G	C	DOID:3908	15710947	included	ENST00000275493	p.G719A	EGFR	1	c.2156	2016-05-18 20:50:35.452853	2016-05-18 21:27:11.524846	4	ENSG00000146648	missense
2421	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"19915144\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		15	66729088	66729088	T	C	DOID:162	19915144	included	ENST00000307102	p.I99T	MAP2K1	1	c.296	2016-05-18 20:50:49.302046	2016-05-18 21:27:48.760982	4	ENSG00000169032	missense
1980	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"erlotinib, afatinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"FDA-approved\\",\\"Evidence\\":\\"consensus\\",\\"Source\\":\\"FDA\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"irreversible EGFR TKIs\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"late trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22753918\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"afatinib + cetuximab\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"Annals Oncol 2012;23(Suppl 9):1289\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"HSP90 inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"Annals Oncol 2012;23(Suppl 9):4380\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors (alone or in combination)\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23102728.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	55241708	55241708	G	C	DOID:3908	16011858	included	ENST00000275493	p.G719A	EGFR	1	c.2156	2016-05-18 20:50:35.472762	2016-05-18 21:27:11.609134	4	ENSG00000146648	missense
1981	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"erlotinib, afatinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"FDA-approved\\",\\"Evidence\\":\\"consensus\\",\\"Source\\":\\"FDA\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"irreversible EGFR TKIs\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"late trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22753918\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"afatinib + cetuximab\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"Annals Oncol 2012;23(Suppl 9):1289\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"HSP90 inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"Annals Oncol 2012;23(Suppl 9):4380\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors (alone or in combination)\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23102728.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	55241708	55241708	G	C	DOID:3908	16115929	included	ENST00000275493	p.G719A	EGFR	1	c.2156	2016-05-18 20:50:35.497109	2016-05-18 21:27:11.696429	4	ENSG00000146648	missense
1982	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"erlotinib, afatinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"FDA-approved\\",\\"Evidence\\":\\"consensus\\",\\"Source\\":\\"FDA\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"irreversible EGFR TKIs\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"late trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22753918\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"afatinib + cetuximab\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"Annals Oncol 2012;23(Suppl 9):1289\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"HSP90 inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"Annals Oncol 2012;23(Suppl 9):4380\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors (alone or in combination)\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23102728.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	55241708	55241708	G	C	DOID:3908	20479403	included	ENST00000275493	p.G719A	EGFR	1	c.2156	2016-05-18 20:50:35.511564	2016-05-18 21:27:11.763585	4	ENSG00000146648	missense
1983	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"erlotinib, afatinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"FDA-approved\\",\\"Evidence\\":\\"consensus\\",\\"Source\\":\\"FDA\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"irreversible EGFR TKIs\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"late trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22753918\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"afatinib + cetuximab\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"Annals Oncol 2012;23(Suppl 9):1289\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"HSP90 inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"Annals Oncol 2012;23(Suppl 9):4380\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors (alone or in combination)\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23102728.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	55241708	55241708	G	C	DOID:3908	22753918	included	ENST00000275493	p.G719A	EGFR	1	c.2156	2016-05-18 20:50:35.543475	2016-05-18 21:27:11.835585	4	ENSG00000146648	missense
1984	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"erlotinib, afatinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"FDA-approved\\",\\"Evidence\\":\\"consensus\\",\\"Source\\":\\"FDA\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"irreversible EGFR TKIs\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"late trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22753918\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"afatinib + cetuximab\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"Annals Oncol 2012;23(Suppl 9):1289\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"HSP90 inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"Annals Oncol 2012;23(Suppl 9):4380\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors (alone or in combination)\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23102728.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	55241708	55241708	G	C	DOID:3908	23102728	included	ENST00000275493	p.G719A	EGFR	1	c.2156	2016-05-18 20:50:35.571318	2016-05-18 21:27:11.920673	4	ENSG00000146648	missense
2439	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"allosteric AKT inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"21464312, 17611497\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		14	105246551	105246551	C	T	DOID:1612	20453058	included	ENST00000349310	p.E17K	AKT1	-1	c.49	2016-05-18 20:50:49.663534	2016-05-18 21:27:50.303749	4	ENSG00000142208	missense
1985	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"erlotinib, afatinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"NCCN/ CAP guidelines\\",\\"Evidence\\":\\"consensus\\",\\"Source\\":\\"NCCN\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"afatinib + cetuximab\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"Annals Oncol 2012;23(Suppl 9):1289\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"HSP90 inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"Annals Oncol 2012;23(Suppl 9):4380\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"irreversible EGFR T790M inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"J Clin Oncol 2013;31: (suppl; abstr 2524), ASCO 2014; abstr 8009\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors (alone or in combination)\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23102728.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	55249071	55249071	C	T	DOID:3908	15118073	included	ENST00000275493	p.T790M	EGFR	1	c.2369	2016-05-18 20:50:35.601786	2016-05-18 21:27:12.007443	4	ENSG00000146648	missense
1986	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"erlotinib, afatinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"NCCN/ CAP guidelines\\",\\"Evidence\\":\\"consensus\\",\\"Source\\":\\"NCCN\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"afatinib + cetuximab\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"Annals Oncol 2012;23(Suppl 9):1289\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"HSP90 inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"Annals Oncol 2012;23(Suppl 9):4380\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"irreversible EGFR T790M inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"J Clin Oncol 2013;31: (suppl; abstr 2524), ASCO 2014; abstr 8009\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors (alone or in combination)\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23102728.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	55249071	55249071	C	T	DOID:3908	15118125	included	ENST00000275493	p.T790M	EGFR	1	c.2369	2016-05-18 20:50:35.631705	2016-05-18 21:27:12.105233	4	ENSG00000146648	missense
1987	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"erlotinib, afatinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"NCCN/ CAP guidelines\\",\\"Evidence\\":\\"consensus\\",\\"Source\\":\\"NCCN\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"afatinib + cetuximab\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"Annals Oncol 2012;23(Suppl 9):1289\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"HSP90 inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"Annals Oncol 2012;23(Suppl 9):4380\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"irreversible EGFR T790M inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"J Clin Oncol 2013;31: (suppl; abstr 2524), ASCO 2014; abstr 8009\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors (alone or in combination)\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23102728.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	55249071	55249071	C	T	DOID:3908	15329413	included	ENST00000275493	p.T790M	EGFR	1	c.2369	2016-05-18 20:50:35.645208	2016-05-18 21:27:12.196035	4	ENSG00000146648	missense
1988	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"erlotinib, afatinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"NCCN/ CAP guidelines\\",\\"Evidence\\":\\"consensus\\",\\"Source\\":\\"NCCN\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"afatinib + cetuximab\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"Annals Oncol 2012;23(Suppl 9):1289\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"HSP90 inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"Annals Oncol 2012;23(Suppl 9):4380\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"irreversible EGFR T790M inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"J Clin Oncol 2013;31: (suppl; abstr 2524), ASCO 2014; abstr 8009\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors (alone or in combination)\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23102728.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	55249071	55249071	C	T	DOID:3908	16912157	included	ENST00000275493	p.T790M	EGFR	1	c.2369	2016-05-18 20:50:35.676645	2016-05-18 21:27:12.282796	4	ENSG00000146648	missense
1989	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"erlotinib, afatinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"NCCN/ CAP guidelines\\",\\"Evidence\\":\\"consensus\\",\\"Source\\":\\"NCCN\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"afatinib + cetuximab\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"Annals Oncol 2012;23(Suppl 9):1289\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"HSP90 inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"Annals Oncol 2012;23(Suppl 9):4380\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"irreversible EGFR T790M inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"J Clin Oncol 2013;31: (suppl; abstr 2524), ASCO 2014; abstr 8009\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors (alone or in combination)\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23102728.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	55249071	55249071	C	T	DOID:3908	15728811	included	ENST00000275493	p.T790M	EGFR	1	c.2369	2016-05-18 20:50:35.706115	2016-05-18 21:27:12.363918	4	ENSG00000146648	missense
2759	\N	\N		14	105246551	105246551	C	T	DOID:2870	25157968	included	ENST00000349310	p.E17K	AKT1	-1	c.49	2016-05-18 21:06:58.149399	2016-05-18 21:28:09.66781	5	ENSG00000142208	missense
1990	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"erlotinib, afatinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"NCCN/ CAP guidelines\\",\\"Evidence\\":\\"consensus\\",\\"Source\\":\\"NCCN\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"afatinib + cetuximab\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"Annals Oncol 2012;23(Suppl 9):1289\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"HSP90 inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"Annals Oncol 2012;23(Suppl 9):4380\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"irreversible EGFR T790M inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"J Clin Oncol 2013;31: (suppl; abstr 2524), ASCO 2014; abstr 8009\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors (alone or in combination)\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23102728.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	55249071	55249071	C	T	DOID:3908	15737014	included	ENST00000275493	p.T790M	EGFR	1	c.2369	2016-05-18 20:50:35.737646	2016-05-18 21:27:12.428181	4	ENSG00000146648	missense
1991	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"erlotinib, afatinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"NCCN/ CAP guidelines\\",\\"Evidence\\":\\"consensus\\",\\"Source\\":\\"NCCN\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"afatinib + cetuximab\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"Annals Oncol 2012;23(Suppl 9):1289\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"HSP90 inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"Annals Oncol 2012;23(Suppl 9):4380\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"irreversible EGFR T790M inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"J Clin Oncol 2013;31: (suppl; abstr 2524), ASCO 2014; abstr 8009\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors (alone or in combination)\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23102728.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	55249071	55249071	C	T	DOID:3908	21430269	included	ENST00000275493	p.T790M	EGFR	1	c.2369	2016-05-18 20:50:35.770037	2016-05-18 21:27:12.501805	4	ENSG00000146648	missense
1992	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"erlotinib, afatinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"NCCN/ CAP guidelines\\",\\"Evidence\\":\\"consensus\\",\\"Source\\":\\"NCCN\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"afatinib + cetuximab\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"Annals Oncol 2012;23(Suppl 9):1289\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"HSP90 inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"Annals Oncol 2012;23(Suppl 9):4380\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"irreversible EGFR T790M inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"J Clin Oncol 2013;31: (suppl; abstr 2524), ASCO 2014; abstr 8009\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors (alone or in combination)\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23102728.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	55249071	55249071	C	T	DOID:3908	21194487	included	ENST00000275493	p.T790M	EGFR	1	c.2369	2016-05-18 20:50:35.805313	2016-05-18 21:27:12.595715	4	ENSG00000146648	missense
1993	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"erlotinib, afatinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"NCCN/ CAP guidelines\\",\\"Evidence\\":\\"consensus\\",\\"Source\\":\\"NCCN\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"afatinib + cetuximab\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"Annals Oncol 2012;23(Suppl 9):1289\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"HSP90 inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"Annals Oncol 2012;23(Suppl 9):4380\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"irreversible EGFR T790M inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"J Clin Oncol 2013;31: (suppl; abstr 2524), ASCO 2014; abstr 8009\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors (alone or in combination)\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23102728.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	55249071	55249071	C	T	DOID:3908	21531810	included	ENST00000275493	p.T790M	EGFR	1	c.2369	2016-05-18 20:50:35.847245	2016-05-18 21:27:12.66524	4	ENSG00000146648	missense
1994	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"erlotinib, afatinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"NCCN/ CAP guidelines\\",\\"Evidence\\":\\"consensus\\",\\"Source\\":\\"NCCN\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"afatinib + cetuximab\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"Annals Oncol 2012;23(Suppl 9):1289\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"HSP90 inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"Annals Oncol 2012;23(Suppl 9):4380\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"irreversible EGFR T790M inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"J Clin Oncol 2013;31: (suppl; abstr 2524), ASCO 2014; abstr 8009\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors (alone or in combination)\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23102728.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	55249071	55249071	C	T	DOID:3908	20068085	included	ENST00000275493	p.T790M	EGFR	1	c.2369	2016-05-18 20:50:35.900123	2016-05-18 21:27:12.763133	4	ENSG00000146648	missense
2760	\N	\N		7	140481412	140481412	C	T	DOID:2394	25157968	included	ENST00000288602	p.G466R	BRAF	-1	c.1396	2016-05-18 21:06:58.175967	2016-05-18 21:28:09.760535	5	ENSG00000157764	missense
1995	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"erlotinib, afatinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"NCCN/ CAP guidelines\\",\\"Evidence\\":\\"consensus\\",\\"Source\\":\\"NCCN\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"afatinib + cetuximab\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"Annals Oncol 2012;23(Suppl 9):1289\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"HSP90 inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"Annals Oncol 2012;23(Suppl 9):4380\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"irreversible EGFR T790M inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"J Clin Oncol 2013;31: (suppl; abstr 2524), ASCO 2014; abstr 8009\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors (alone or in combination)\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23102728.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	55249071	55249071	C	T	DOID:3908	16258541	included	ENST00000275493	p.T790M	EGFR	1	c.2369	2016-05-18 20:50:35.913763	2016-05-18 21:27:12.835219	4	ENSG00000146648	missense
1996	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"erlotinib, afatinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"NCCN/ CAP guidelines\\",\\"Evidence\\":\\"consensus\\",\\"Source\\":\\"NCCN\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"afatinib + cetuximab\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"Annals Oncol 2012;23(Suppl 9):1289\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"HSP90 inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"Annals Oncol 2012;23(Suppl 9):4380\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"irreversible EGFR T790M inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"J Clin Oncol 2013;31: (suppl; abstr 2524), ASCO 2014; abstr 8009\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors (alone or in combination)\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23102728.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	55249071	55249071	C	T	DOID:3908	22588155	included	ENST00000275493	p.T790M	EGFR	1	c.2369	2016-05-18 20:50:35.967128	2016-05-18 21:27:12.919945	4	ENSG00000146648	missense
1997	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"erlotinib, afatinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"NCCN/ CAP guidelines\\",\\"Evidence\\":\\"consensus\\",\\"Source\\":\\"NCCN\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"afatinib + cetuximab\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"Annals Oncol 2012;23(Suppl 9):1289\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"HSP90 inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"Annals Oncol 2012;23(Suppl 9):4380\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"irreversible EGFR T790M inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"J Clin Oncol 2013;31: (suppl; abstr 2524), ASCO 2014; abstr 8009\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors (alone or in combination)\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23102728.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	55249071	55249071	C	T	DOID:3908	22452896	included	ENST00000275493	p.T790M	EGFR	1	c.2369	2016-05-18 20:50:35.980498	2016-05-18 21:27:12.993591	4	ENSG00000146648	missense
1998	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"erlotinib, afatinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"NCCN/ CAP guidelines\\",\\"Evidence\\":\\"consensus\\",\\"Source\\":\\"NCCN\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"afatinib + cetuximab\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"Annals Oncol 2012;23(Suppl 9):1289\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"HSP90 inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"Annals Oncol 2012;23(Suppl 9):4380\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"irreversible EGFR T790M inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"J Clin Oncol 2013;31: (suppl; abstr 2524), ASCO 2014; abstr 8009\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors (alone or in combination)\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23102728.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	55249071	55249071	C	T	DOID:3908	23816963	included	ENST00000275493	p.T790M	EGFR	1	c.2369	2016-05-18 20:50:36.037222	2016-05-18 21:27:13.084172	4	ENSG00000146648	missense
1999	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"erlotinib, afatinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"NCCN/ CAP guidelines\\",\\"Evidence\\":\\"consensus\\",\\"Source\\":\\"NCCN\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"afatinib + cetuximab\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"Annals Oncol 2012;23(Suppl 9):1289\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"HSP90 inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"Annals Oncol 2012;23(Suppl 9):4380\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"irreversible EGFR T790M inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"J Clin Oncol 2013;31: (suppl; abstr 2524), ASCO 2014; abstr 8009\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors (alone or in combination)\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23102728.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	55249071	55249071	C	T	DOID:3908	24729716	included	ENST00000275493	p.T790M	EGFR	1	c.2369	2016-05-18 20:50:36.08244	2016-05-18 21:27:13.153123	4	ENSG00000146648	missense
2761	\N	\N		14	105246551	105246551	C	T	DOID:1612	17611497	included	ENST00000349310	p.E17K	AKT1	-1	c.49	2016-05-18 21:06:58.18775	2016-05-18 21:28:09.812419	5	ENSG00000142208	missense
2000	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"erlotinib, afatinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"NCCN/ CAP guidelines\\",\\"Evidence\\":\\"consensus\\",\\"Source\\":\\"NCCN\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"afatinib + cetuximab\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"Annals Oncol 2012;23(Suppl 9):1289\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"HSP90 inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"Annals Oncol 2012;23(Suppl 9):4380\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"irreversible EGFR T790M inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"J Clin Oncol 2013;31: (suppl; abstr 2524), ASCO 2014; abstr 8009\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors (alone or in combination)\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23102728.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	55249071	55249071	C	T	DOID:3908	23102728	included	ENST00000275493	p.T790M	EGFR	1	c.2369	2016-05-18 20:50:36.112149	2016-05-18 21:27:13.236291	4	ENSG00000146648	missense
2001	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"erlotinib, afatinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"FDA-approved\\",\\"Evidence\\":\\"consensus\\",\\"Source\\":\\"FDA\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"irreversible EGFR TKIs\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"late trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22753918\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"afatinib + cetuximab\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"Annals Oncol 2012;23(Suppl 9):1289\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"HSP90 inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"Annals Oncol 2012;23(Suppl 9):4380\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors (alone or in combination)\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23102728.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	55259515	55259515	T	G	DOID:3908	15118073	included	ENST00000275493	p.L858R	EGFR	1	c.2573	2016-05-18 20:50:36.141651	2016-05-18 21:27:13.326573	4	ENSG00000146648	missense
2002	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"erlotinib, afatinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"FDA-approved\\",\\"Evidence\\":\\"consensus\\",\\"Source\\":\\"FDA\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"irreversible EGFR TKIs\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"late trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22753918\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"afatinib + cetuximab\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"Annals Oncol 2012;23(Suppl 9):1289\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"HSP90 inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"Annals Oncol 2012;23(Suppl 9):4380\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors (alone or in combination)\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23102728.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	55259515	55259515	T	G	DOID:3908	15118125	included	ENST00000275493	p.L858R	EGFR	1	c.2573	2016-05-18 20:50:36.207705	2016-05-18 21:27:13.409783	4	ENSG00000146648	missense
2003	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"erlotinib, afatinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"FDA-approved\\",\\"Evidence\\":\\"consensus\\",\\"Source\\":\\"FDA\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"irreversible EGFR TKIs\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"late trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22753918\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"afatinib + cetuximab\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"Annals Oncol 2012;23(Suppl 9):1289\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"HSP90 inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"Annals Oncol 2012;23(Suppl 9):4380\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors (alone or in combination)\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23102728.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	55259515	55259515	T	G	DOID:3908	15329413	included	ENST00000275493	p.L858R	EGFR	1	c.2573	2016-05-18 20:50:36.238322	2016-05-18 21:27:13.476189	4	ENSG00000146648	missense
2004	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"erlotinib, afatinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"FDA-approved\\",\\"Evidence\\":\\"consensus\\",\\"Source\\":\\"FDA\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"irreversible EGFR TKIs\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"late trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22753918\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"afatinib + cetuximab\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"Annals Oncol 2012;23(Suppl 9):1289\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"HSP90 inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"Annals Oncol 2012;23(Suppl 9):4380\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors (alone or in combination)\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23102728.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	55259515	55259515	T	G	DOID:3908	19922469	included	ENST00000275493	p.L858R	EGFR	1	c.2573	2016-05-18 20:50:36.284805	2016-05-18 21:27:13.561319	4	ENSG00000146648	missense
2473	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"dasatinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22649091\\",\\"Effect\\":\\"reduced kinase activity\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	140481393	140481393	T	C	DOID:1324	21483012	included	ENST00000288602	p.Y472C	BRAF	-1	c.1415	2016-05-18 20:50:50.408864	2016-05-18 21:27:52.783706	4	ENSG00000157764	missense
2005	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"erlotinib, afatinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"FDA-approved\\",\\"Evidence\\":\\"consensus\\",\\"Source\\":\\"FDA\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"irreversible EGFR TKIs\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"late trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22753918\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"afatinib + cetuximab\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"Annals Oncol 2012;23(Suppl 9):1289\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"HSP90 inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"Annals Oncol 2012;23(Suppl 9):4380\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors (alone or in combination)\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23102728.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	55259515	55259515	T	G	DOID:3908	21670455	included	ENST00000275493	p.L858R	EGFR	1	c.2573	2016-05-18 20:50:36.34185	2016-05-18 21:27:13.635921	4	ENSG00000146648	missense
2006	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"erlotinib, afatinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"FDA-approved\\",\\"Evidence\\":\\"consensus\\",\\"Source\\":\\"FDA\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"irreversible EGFR TKIs\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"late trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22753918\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"afatinib + cetuximab\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"Annals Oncol 2012;23(Suppl 9):1289\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"HSP90 inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"Annals Oncol 2012;23(Suppl 9):4380\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors (alone or in combination)\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23102728.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	55259515	55259515	T	G	DOID:3908	20573926	included	ENST00000275493	p.L858R	EGFR	1	c.2573	2016-05-18 20:50:36.371401	2016-05-18 21:27:13.725462	4	ENSG00000146648	missense
2007	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"erlotinib, afatinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"FDA-approved\\",\\"Evidence\\":\\"consensus\\",\\"Source\\":\\"FDA\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"irreversible EGFR TKIs\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"late trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22753918\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"afatinib + cetuximab\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"Annals Oncol 2012;23(Suppl 9):1289\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"HSP90 inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"Annals Oncol 2012;23(Suppl 9):4380\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors (alone or in combination)\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23102728.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	55259515	55259515	T	G	DOID:3908	20022809	included	ENST00000275493	p.L858R	EGFR	1	c.2573	2016-05-18 20:50:36.44392	2016-05-18 21:27:13.822148	4	ENSG00000146648	missense
2008	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"erlotinib, afatinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"FDA-approved\\",\\"Evidence\\":\\"consensus\\",\\"Source\\":\\"FDA\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"irreversible EGFR TKIs\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"late trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22753918\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"afatinib + cetuximab\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"Annals Oncol 2012;23(Suppl 9):1289\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"HSP90 inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"Annals Oncol 2012;23(Suppl 9):4380\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors (alone or in combination)\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23102728.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	55259515	55259515	T	G	DOID:3908	19692680	included	ENST00000275493	p.L858R	EGFR	1	c.2573	2016-05-18 20:50:36.47645	2016-05-18 21:27:13.886925	4	ENSG00000146648	missense
2009	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"erlotinib, afatinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"FDA-approved\\",\\"Evidence\\":\\"consensus\\",\\"Source\\":\\"FDA\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"irreversible EGFR TKIs\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"late trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22753918\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"afatinib + cetuximab\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"Annals Oncol 2012;23(Suppl 9):1289\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"HSP90 inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"Annals Oncol 2012;23(Suppl 9):4380\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors (alone or in combination)\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23102728.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	55259515	55259515	T	G	DOID:3908	19692684	included	ENST00000275493	p.L858R	EGFR	1	c.2573	2016-05-18 20:50:36.520055	2016-05-18 21:27:13.957534	4	ENSG00000146648	missense
2440	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"allosteric AKT inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"21464312, 17611497\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		14	105246551	105246551	C	T	DOID:1612	17611497	included	ENST00000349310	p.E17K	AKT1	-1	c.49	2016-05-18 20:50:49.679085	2016-05-18 21:27:50.359816	4	ENSG00000142208	missense
2010	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"erlotinib, afatinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"FDA-approved\\",\\"Evidence\\":\\"consensus\\",\\"Source\\":\\"FDA\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"irreversible EGFR TKIs\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"late trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22753918\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"afatinib + cetuximab\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"Annals Oncol 2012;23(Suppl 9):1289\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"HSP90 inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"Annals Oncol 2012;23(Suppl 9):4380\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors (alone or in combination)\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23102728.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	55259515	55259515	T	G	DOID:3908	22285168	included	ENST00000275493	p.L858R	EGFR	1	c.2573	2016-05-18 20:50:36.576272	2016-05-18 21:27:14.056947	4	ENSG00000146648	missense
2011	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"erlotinib, afatinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"FDA-approved\\",\\"Evidence\\":\\"consensus\\",\\"Source\\":\\"FDA\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"irreversible EGFR TKIs\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"late trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22753918\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"afatinib + cetuximab\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"Annals Oncol 2012;23(Suppl 9):1289\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"HSP90 inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"Annals Oncol 2012;23(Suppl 9):4380\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors (alone or in combination)\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23102728.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	55259515	55259515	T	G	DOID:3908	23816960	included	ENST00000275493	p.L858R	EGFR	1	c.2573	2016-05-18 20:50:36.608742	2016-05-18 21:27:14.150142	4	ENSG00000146648	missense
2012	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"erlotinib, afatinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"FDA-approved\\",\\"Evidence\\":\\"consensus\\",\\"Source\\":\\"FDA\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"irreversible EGFR TKIs\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"late trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22753918\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"afatinib + cetuximab\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"Annals Oncol 2012;23(Suppl 9):1289\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"HSP90 inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"Annals Oncol 2012;23(Suppl 9):4380\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors (alone or in combination)\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23102728.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	55259515	55259515	T	G	DOID:3908	22452895	included	ENST00000275493	p.L858R	EGFR	1	c.2573	2016-05-18 20:50:36.652937	2016-05-18 21:27:14.236234	4	ENSG00000146648	missense
2013	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"erlotinib, afatinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"FDA-approved\\",\\"Evidence\\":\\"consensus\\",\\"Source\\":\\"FDA\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"irreversible EGFR TKIs\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"late trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22753918\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"afatinib + cetuximab\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"Annals Oncol 2012;23(Suppl 9):1289\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"HSP90 inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"Annals Oncol 2012;23(Suppl 9):4380\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors (alone or in combination)\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23102728.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	55259515	55259515	T	G	DOID:3908	21783417	included	ENST00000275493	p.L858R	EGFR	1	c.2573	2016-05-18 20:50:36.7127	2016-05-18 21:27:14.326289	4	ENSG00000146648	missense
2014	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"erlotinib, afatinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"FDA-approved\\",\\"Evidence\\":\\"consensus\\",\\"Source\\":\\"FDA\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"irreversible EGFR TKIs\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"late trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22753918\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"afatinib + cetuximab\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"Annals Oncol 2012;23(Suppl 9):1289\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"HSP90 inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"Annals Oncol 2012;23(Suppl 9):4380\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors (alone or in combination)\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23102728.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	55259515	55259515	T	G	DOID:3908	19096302	included	ENST00000275493	p.L858R	EGFR	1	c.2573	2016-05-18 20:50:36.741537	2016-05-18 21:27:14.420033	4	ENSG00000146648	missense
2441	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"allosteric AKT inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"21464312, 17611497\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		14	105246551	105246551	C	T	DOID:1612	21464312	included	ENST00000349310	p.E17K	AKT1	-1	c.49	2016-05-18 20:50:49.689073	2016-05-18 21:27:50.442238	4	ENSG00000142208	missense
2015	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"erlotinib, afatinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"FDA-approved\\",\\"Evidence\\":\\"consensus\\",\\"Source\\":\\"FDA\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"irreversible EGFR TKIs\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"late trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22753918\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"afatinib + cetuximab\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"Annals Oncol 2012;23(Suppl 9):1289\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"HSP90 inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"Annals Oncol 2012;23(Suppl 9):4380\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors (alone or in combination)\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23102728.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	55259515	55259515	T	G	DOID:3908	18303429	included	ENST00000275493	p.L858R	EGFR	1	c.2573	2016-05-18 20:50:36.78879	2016-05-18 21:27:14.511124	4	ENSG00000146648	missense
2016	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"erlotinib, afatinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"FDA-approved\\",\\"Evidence\\":\\"consensus\\",\\"Source\\":\\"FDA\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"irreversible EGFR TKIs\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"late trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22753918\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"afatinib + cetuximab\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"Annals Oncol 2012;23(Suppl 9):1289\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"HSP90 inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"Annals Oncol 2012;23(Suppl 9):4380\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors (alone or in combination)\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23102728.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	55259515	55259515	T	G	DOID:3908	23948351	included	ENST00000275493	p.L858R	EGFR	1	c.2573	2016-05-18 20:50:36.818223	2016-05-18 21:27:14.605758	4	ENSG00000146648	missense
2017	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"erlotinib, afatinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"FDA-approved\\",\\"Evidence\\":\\"consensus\\",\\"Source\\":\\"FDA\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"irreversible EGFR TKIs\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"late trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22753918\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"afatinib + cetuximab\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"Annals Oncol 2012;23(Suppl 9):1289\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"HSP90 inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"Annals Oncol 2012;23(Suppl 9):4380\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors (alone or in combination)\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23102728.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	55259515	55259515	T	G	DOID:3908	22753918	included	ENST00000275493	p.L858R	EGFR	1	c.2573	2016-05-18 20:50:36.850107	2016-05-18 21:27:14.701468	4	ENSG00000146648	missense
2018	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"erlotinib, afatinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"FDA-approved\\",\\"Evidence\\":\\"consensus\\",\\"Source\\":\\"FDA\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"irreversible EGFR TKIs\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"late trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22753918\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"afatinib + cetuximab\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"Annals Oncol 2012;23(Suppl 9):1289\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"HSP90 inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"Annals Oncol 2012;23(Suppl 9):4380\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors (alone or in combination)\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23102728.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	55259515	55259515	T	G	DOID:3908	20479403	included	ENST00000275493	p.L858R	EGFR	1	c.2573	2016-05-18 20:50:36.911124	2016-05-18 21:27:14.83519	4	ENSG00000146648	missense
2019	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"erlotinib, afatinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"FDA-approved\\",\\"Evidence\\":\\"consensus\\",\\"Source\\":\\"FDA\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"irreversible EGFR TKIs\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"late trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22753918\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"afatinib + cetuximab\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"Annals Oncol 2012;23(Suppl 9):1289\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"HSP90 inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"Annals Oncol 2012;23(Suppl 9):4380\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors (alone or in combination)\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23102728.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	55259515	55259515	T	G	DOID:3908	23102728	included	ENST00000275493	p.L858R	EGFR	1	c.2573	2016-05-18 20:50:36.947659	2016-05-18 21:27:14.924122	4	ENSG00000146648	missense
2442	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"ibrutinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"24869598\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		X	100611164	100611164	C	G	DOID:1612	24869598	included	ENST00000308731	p.C481S	BTK	-1	c.1442	2016-05-18 20:50:49.714893	2016-05-18 21:27:50.526756	4	ENSG00000010671	missense
2020	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"erlotinib, afatinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"FDA-approved\\",\\"Evidence\\":\\"consensus\\",\\"Source\\":\\"FDA\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"irreversible EGFR TKIs\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"late trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22753918\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"afatinib + cetuximab\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"Annals Oncol 2012;23(Suppl 9):1289\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"HSP90 inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"Annals Oncol 2012;23(Suppl 9):4380\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors (alone or in combination)\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23102728.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	55259524	55259524	T	A	DOID:3908	15118073	included	ENST00000275493	p.L861Q	EGFR	1	c.2582	2016-05-18 20:50:36.985362	2016-05-18 21:27:15.025863	4	ENSG00000146648	missense
2021	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"erlotinib, afatinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"FDA-approved\\",\\"Evidence\\":\\"consensus\\",\\"Source\\":\\"FDA\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"irreversible EGFR TKIs\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"late trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22753918\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"afatinib + cetuximab\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"Annals Oncol 2012;23(Suppl 9):1289\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"HSP90 inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"Annals Oncol 2012;23(Suppl 9):4380\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors (alone or in combination)\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23102728.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	55259524	55259524	T	A	DOID:3908	15118125	included	ENST00000275493	p.L861Q	EGFR	1	c.2582	2016-05-18 20:50:37.046792	2016-05-18 21:27:15.111239	4	ENSG00000146648	missense
2022	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"erlotinib, afatinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"FDA-approved\\",\\"Evidence\\":\\"consensus\\",\\"Source\\":\\"FDA\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"irreversible EGFR TKIs\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"late trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22753918\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"afatinib + cetuximab\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"Annals Oncol 2012;23(Suppl 9):1289\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"HSP90 inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"Annals Oncol 2012;23(Suppl 9):4380\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors (alone or in combination)\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23102728.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	55259524	55259524	T	A	DOID:3908	15329413	included	ENST00000275493	p.L861Q	EGFR	1	c.2582	2016-05-18 20:50:37.07671	2016-05-18 21:27:15.208925	4	ENSG00000146648	missense
2023	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"erlotinib, afatinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"FDA-approved\\",\\"Evidence\\":\\"consensus\\",\\"Source\\":\\"FDA\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"irreversible EGFR TKIs\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"late trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22753918\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"afatinib + cetuximab\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"Annals Oncol 2012;23(Suppl 9):1289\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"HSP90 inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"Annals Oncol 2012;23(Suppl 9):4380\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors (alone or in combination)\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23102728.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	55259524	55259524	T	A	DOID:3908	19922469	included	ENST00000275493	p.L861Q	EGFR	1	c.2582	2016-05-18 20:50:37.123021	2016-05-18 21:27:15.295494	4	ENSG00000146648	missense
2024	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"erlotinib, afatinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"FDA-approved\\",\\"Evidence\\":\\"consensus\\",\\"Source\\":\\"FDA\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"irreversible EGFR TKIs\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"late trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22753918\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"afatinib + cetuximab\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"Annals Oncol 2012;23(Suppl 9):1289\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"HSP90 inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"Annals Oncol 2012;23(Suppl 9):4380\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors (alone or in combination)\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23102728.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	55259524	55259524	T	A	DOID:3908	22753918	included	ENST00000275493	p.L861Q	EGFR	1	c.2582	2016-05-18 20:50:37.17998	2016-05-18 21:27:15.361489	4	ENSG00000146648	missense
2443	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"ibrutinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"24869598\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		X	100611165	100611165	A	T	DOID:1612	24869598	included	ENST00000308731	p.C481S	BTK	-1	c.1441	2016-05-18 20:50:49.755738	2016-05-18 21:27:50.615079	4	ENSG00000010671	missense
2025	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"erlotinib, afatinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"FDA-approved\\",\\"Evidence\\":\\"consensus\\",\\"Source\\":\\"FDA\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"irreversible EGFR TKIs\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"late trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22753918\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"afatinib + cetuximab\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"Annals Oncol 2012;23(Suppl 9):1289\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"HSP90 inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"Annals Oncol 2012;23(Suppl 9):4380\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors (alone or in combination)\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23102728.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	55259524	55259524	T	A	DOID:3908	23102728	included	ENST00000275493	p.L861Q	EGFR	1	c.2582	2016-05-18 20:50:37.21888	2016-05-18 21:27:15.431232	4	ENSG00000146648	missense
2026	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"dasatinib\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22328973\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		1	162724415	162724415	C	G	DOID:3907	22328973	included	ENST00000367921	p.L63V	DDR2	1	c.187	2016-05-18 20:50:37.276848	2016-05-18 21:27:15.532555	4	ENSG00000162733	missense
2027	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"dasatinib\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22328973\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		1	162729630	162729630	T	G	DOID:3907	22328973	included	ENST00000367921	p.L239R	DDR2	1	c.716	2016-05-18 20:50:37.285343	2016-05-18 21:27:15.621367	4	ENSG00000162733	missense
2029	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"dasatinib\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22328973\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		1	162741822	162741822	G	A	DOID:3907	22328973	included	ENST00000367921	p.G505S	DDR2	1	c.1513	2016-05-18 20:50:37.348823	2016-05-18 21:27:15.80584	4	ENSG00000162733	missense
2030	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"dasatinib\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22328973\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		1	162745497	162745497	A	T	DOID:3907	22328973	included	ENST00000367921	p.I638F	DDR2	1	c.1912	2016-05-18 20:50:37.359109	2016-05-18 21:27:15.900434	4	ENSG00000162733	missense
2031	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"dasatinib\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22328973\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		1	162748407	162748407	G	T	DOID:3907	22328973	included	ENST00000367921	p.G774V	DDR2	1	c.2321	2016-05-18 20:50:37.382228	2016-05-18 21:27:15.993928	4	ENSG00000162733	missense
2032	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"erlotinib, afatinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"FDA-approved\\",\\"Evidence\\":\\"consensus\\",\\"Source\\":\\"FDA\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"irreversible EGFR TKIs\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"late trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22753918\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"afatinib + cetuximab\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"Annals Oncol 2012;23(Suppl 9):1289\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"HSP90 inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"Annals Oncol 2012;23(Suppl 9):4380\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors (alone or in combination)\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23102728.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	55241708	55241708	G	A	DOID:3907	22753918	included	ENST00000275493	p.G719D	EGFR	1	c.2156	2016-05-18 20:50:37.42243	2016-05-18 21:27:16.099107	4	ENSG00000146648	missense
2033	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"erlotinib, afatinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"FDA-approved\\",\\"Evidence\\":\\"consensus\\",\\"Source\\":\\"FDA\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"irreversible EGFR TKIs\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"late trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22753918\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"afatinib + cetuximab\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"Annals Oncol 2012;23(Suppl 9):1289\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"HSP90 inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"Annals Oncol 2012;23(Suppl 9):4380\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors (alone or in combination)\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23102728.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	55241708	55241708	G	A	DOID:3907	23102728	included	ENST00000275493	p.G719D	EGFR	1	c.2156	2016-05-18 20:50:37.482982	2016-05-18 21:27:16.195308	4	ENSG00000146648	missense
2065	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"dovitinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23908597\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"ponatinib\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23908597\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		10	123256219	123256219	C	T	DOID:2870	23908597	included	ENST00000457416	p.V565I	FGFR2	-1	c.1693	2016-05-18 20:50:38.497292	2016-05-18 21:27:19.475439	4	ENSG00000066468	missense
2034	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"erlotinib, afatinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"FDA-approved\\",\\"Evidence\\":\\"consensus\\",\\"Source\\":\\"FDA\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"irreversible EGFR TKIs\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"late trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22753918\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"afatinib + cetuximab\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"Annals Oncol 2012;23(Suppl 9):1289\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"HSP90 inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"Annals Oncol 2012;23(Suppl 9):4380\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors (alone or in combination)\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23102728.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	55242470	55242470	T	C	DOID:3907	22753918	included	ENST00000275493	p.L747S	EGFR	1	c.2240	2016-05-18 20:50:37.523223	2016-05-18 21:27:16.299399	4	ENSG00000146648	missense
2035	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"erlotinib, afatinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"FDA-approved\\",\\"Evidence\\":\\"consensus\\",\\"Source\\":\\"FDA\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"irreversible EGFR TKIs\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"late trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22753918\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"afatinib + cetuximab\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"Annals Oncol 2012;23(Suppl 9):1289\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"HSP90 inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"Annals Oncol 2012;23(Suppl 9):4380\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors (alone or in combination)\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23102728.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	55242470	55242470	T	C	DOID:3907	23102728	included	ENST00000275493	p.L747S	EGFR	1	c.2240	2016-05-18 20:50:37.555468	2016-05-18 21:27:16.375151	4	ENSG00000146648	missense
2036	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"erlotinib, afatinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"FDA-approved\\",\\"Evidence\\":\\"consensus\\",\\"Source\\":\\"FDA\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"irreversible EGFR TKIs\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"late trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22753918\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"afatinib + cetuximab\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"Annals Oncol 2012;23(Suppl 9):1289\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"HSP90 inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"Annals Oncol 2012;23(Suppl 9):4380\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors (alone or in combination)\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23102728.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	55249005	55249005	G	T	DOID:3907	22753918	included	ENST00000275493	p.S768I	EGFR	1	c.2303	2016-05-18 20:50:37.61675	2016-05-18 21:27:16.507216	4	ENSG00000146648	missense
2037	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"erlotinib, afatinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"FDA-approved\\",\\"Evidence\\":\\"consensus\\",\\"Source\\":\\"FDA\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"irreversible EGFR TKIs\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"late trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22753918\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"afatinib + cetuximab\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"Annals Oncol 2012;23(Suppl 9):1289\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"HSP90 inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"Annals Oncol 2012;23(Suppl 9):4380\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors (alone or in combination)\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23102728.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	55249005	55249005	G	T	DOID:3907	23102728	included	ENST00000275493	p.S768I	EGFR	1	c.2303	2016-05-18 20:50:37.652992	2016-05-18 21:27:16.622704	4	ENSG00000146648	missense
2038	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"erlotinib, afatinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"FDA-approved\\",\\"Evidence\\":\\"consensus\\",\\"Source\\":\\"FDA\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"irreversible EGFR TKIs\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"late trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22753918\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"afatinib + cetuximab\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"Annals Oncol 2012;23(Suppl 9):1289\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"HSP90 inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"Annals Oncol 2012;23(Suppl 9):4380\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors (alone or in combination)\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23102728.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	55259524	55259524	T	C	DOID:3907	22753918	included	ENST00000275493	p.L861P	EGFR	1	c.2582	2016-05-18 20:50:37.685105	2016-05-18 21:27:16.730511	4	ENSG00000146648	missense
2066	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"FGFR inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"18552176, 22238366, 23002168\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		10	123258034	123258034	A	C	DOID:2870	18552176	included	ENST00000457416	p.N550K	FGFR2	-1	c.1650	2016-05-18 20:50:38.519815	2016-05-18 21:27:19.564165	4	ENSG00000066468	missense
2039	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"erlotinib, afatinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"FDA-approved\\",\\"Evidence\\":\\"consensus\\",\\"Source\\":\\"FDA\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"irreversible EGFR TKIs\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"late trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22753918\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"afatinib + cetuximab\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"Annals Oncol 2012;23(Suppl 9):1289\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"HSP90 inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"Annals Oncol 2012;23(Suppl 9):4380\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors (alone or in combination)\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23102728.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	55259524	55259524	T	C	DOID:3907	23102728	included	ENST00000275493	p.L861P	EGFR	1	c.2582	2016-05-18 20:50:37.747458	2016-05-18 21:27:16.801824	4	ENSG00000146648	missense
2040	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"erlotinib, afatinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"FDA-approved\\",\\"Evidence\\":\\"consensus\\",\\"Source\\":\\"FDA\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"irreversible EGFR TKIs\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"late trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22753918\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"afatinib + cetuximab\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"Annals Oncol 2012;23(Suppl 9):1289\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"HSP90 inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"Annals Oncol 2012;23(Suppl 9):4380\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors (alone or in combination)\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23102728.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	55259524	55259524	T	G	DOID:3907	22753918	included	ENST00000275493	p.L861R	EGFR	1	c.2582	2016-05-18 20:50:37.787003	2016-05-18 21:27:16.897068	4	ENSG00000146648	missense
2041	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"erlotinib, afatinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"FDA-approved\\",\\"Evidence\\":\\"consensus\\",\\"Source\\":\\"FDA\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"irreversible EGFR TKIs\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"late trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22753918\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"afatinib + cetuximab\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"Annals Oncol 2012;23(Suppl 9):1289\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"HSP90 inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"Annals Oncol 2012;23(Suppl 9):4380\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors (alone or in combination)\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23102728.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	55259524	55259524	T	G	DOID:3907	23102728	included	ENST00000275493	p.L861R	EGFR	1	c.2582	2016-05-18 20:50:37.822119	2016-05-18 21:27:16.977962	4	ENSG00000146648	missense
2042	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"mTOR inhibitors, dasatinib\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"20360610\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		1	16464489	16464489	C	G	DOID:3907	20360610	included	ENST00000358432	p.G391R	EPHA2	-1	c.1171	2016-05-18 20:50:37.885326	2016-05-18 21:27:17.085585	4	ENSG00000142627	missense
2043	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"mTOR inhibitors, dasatinib\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"20360610\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		1	16464489	16464489	C	T	DOID:3907	20360610	included	ENST00000358432	p.G391R	EPHA2	-1	c.1171	2016-05-18 20:50:37.894803	2016-05-18 21:27:17.181634	4	ENSG00000142627	missense
2044	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"FGFR inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23786770\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		10	123278324	123278324	G	C	DOID:3907	23786770	included	ENST00000457416	p.S320C	FGFR2	-1	c.959	2016-05-18 20:50:37.919382	2016-05-18 21:27:17.27246	4	ENSG00000066468	missense
2046	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"dasatinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"18559612\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		4	55599333	55599333	A	T	DOID:349	18559612	included	ENST00000288135	p.D820V	KIT	1	c.2459	2016-05-18 20:50:37.992681	2016-05-18 21:27:17.467193	4	ENSG00000157404	missense
2047	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"imatinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"21969494\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"sunitinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23375402\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		4	55593591	55593591	T	A	DOID:3284	21969494	included	ENST00000288135	p.Y553N	KIT	1	c.1657	2016-05-18 20:50:38.018386	2016-05-18 21:27:17.562424	4	ENSG00000157404	missense
2067	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"FGFR inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"18552176, 22238366, 23002168\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		10	123258034	123258034	A	C	DOID:2870	22238366	included	ENST00000457416	p.N550K	FGFR2	-1	c.1650	2016-05-18 20:50:38.528794	2016-05-18 21:27:19.63512	4	ENSG00000066468	missense
2069	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"dovitinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23908597\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"ponatinib\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23908597\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		10	123258034	123258034	A	C	DOID:2870	23908597	included	ENST00000457416	p.N550K	FGFR2	-1	c.1650	2016-05-18 20:50:38.592044	2016-05-18 21:27:19.772215	4	ENSG00000066468	missense
2071	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"FGFR inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"18552176, 22238366, 23002168\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		10	123258034	123258034	A	T	DOID:2870	22238366	included	ENST00000457416	p.N550K	FGFR2	-1	c.1650	2016-05-18 20:50:38.634548	2016-05-18 21:27:19.924023	4	ENSG00000066468	missense
2072	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"FGFR inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"18552176, 22238366, 23002168\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		10	123258034	123258034	A	T	DOID:2870	23002168	included	ENST00000457416	p.N550K	FGFR2	-1	c.1650	2016-05-18 20:50:38.65887	2016-05-18 21:27:19.997645	4	ENSG00000066468	missense
2073	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"dovitinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23908597\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"ponatinib\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23908597\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		10	123258034	123258034	A	T	DOID:2870	23908597	included	ENST00000457416	p.N550K	FGFR2	-1	c.1650	2016-05-18 20:50:38.696546	2016-05-18 21:27:20.064204	4	ENSG00000066468	missense
2074	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"dovitinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23908597\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"ponatinib\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23908597\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		10	123258036	123258036	T	G	DOID:2870	23908597	included	ENST00000457416	p.N550H	FGFR2	-1	c.1648	2016-05-18 20:50:38.725084	2016-05-18 21:27:20.208012	4	ENSG00000066468	missense
2075	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"dovitinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23908597\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"ponatinib\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23908597\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		10	123258042	123258042	T	C	DOID:2870	23908597	included	ENST00000457416	p.I548V	FGFR2	-1	c.1642	2016-05-18 20:50:38.759374	2016-05-18 21:27:20.311684	4	ENSG00000066468	missense
2076	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"dovitinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23908597\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"ponatinib\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23908597\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		10	123258070	123258070	C	A	DOID:2870	23908597	included	ENST00000457416	p.M538I	FGFR2	-1	c.1614	2016-05-18 20:50:38.792885	2016-05-18 21:27:20.423079	4	ENSG00000066468	missense
2077	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"dovitinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23908597\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"ponatinib\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23908597\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		10	123258070	123258070	C	G	DOID:2870	23908597	included	ENST00000457416	p.M538I	FGFR2	-1	c.1614	2016-05-18 20:50:38.826654	2016-05-18 21:27:20.504813	4	ENSG00000066468	missense
2078	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"dovitinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23908597\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"ponatinib\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23908597\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		10	123258070	123258070	C	T	DOID:2870	23908597	included	ENST00000457416	p.M538I	FGFR2	-1	c.1614	2016-05-18 20:50:38.85658	2016-05-18 21:27:20.627794	4	ENSG00000066468	missense
2079	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"dovitinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23908597\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"ponatinib\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23908597\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		10	123258076	123258076	C	A	DOID:2870	23908597	included	ENST00000457416	p.M536I	FGFR2	-1	c.1608	2016-05-18 20:50:38.892481	2016-05-18 21:27:20.740862	4	ENSG00000066468	missense
2080	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"dovitinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23908597\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"ponatinib\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23908597\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		10	123258076	123258076	C	G	DOID:2870	23908597	included	ENST00000457416	p.M536I	FGFR2	-1	c.1608	2016-05-18 20:50:38.92539	2016-05-18 21:27:20.826113	4	ENSG00000066468	missense
2081	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"dovitinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23908597\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"ponatinib\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23908597\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		10	123258076	123258076	C	T	DOID:2870	23908597	included	ENST00000457416	p.M536I	FGFR2	-1	c.1608	2016-05-18 20:50:38.935697	2016-05-18 21:27:20.91543	4	ENSG00000066468	missense
2082	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"preclinical\\",\\"Assocation\\":\\"FGFR inhibitors\\",\\"Status\\":\\"emerging\\",\\"Evidence\\":\\"18552176, 22238366, 23002168\\",\\"Source\\":\\"nan\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"sensitivity\\"}]}]}"	\N		10	123279677	123279677	G	C	DOID:2870	18552176	included	ENST00000457416	p.S252W	FGFR2	-1	c.755	2016-05-18 20:50:38.963074	2016-05-18 21:27:21.023383	4	ENSG00000066468	missense
2083	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"preclinical\\",\\"Assocation\\":\\"FGFR inhibitors\\",\\"Status\\":\\"emerging\\",\\"Evidence\\":\\"18552176, 22238366, 23002168\\",\\"Source\\":\\"nan\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"sensitivity\\"}]}]}"	\N		10	123279677	123279677	G	C	DOID:2870	22238366	included	ENST00000457416	p.S252W	FGFR2	-1	c.755	2016-05-18 20:50:39.000762	2016-05-18 21:27:21.12257	4	ENSG00000066468	missense
2084	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"preclinical\\",\\"Assocation\\":\\"FGFR inhibitors\\",\\"Status\\":\\"emerging\\",\\"Evidence\\":\\"18552176, 22238366, 23002168\\",\\"Source\\":\\"nan\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"sensitivity\\"}]}]}"	\N		10	123279677	123279677	G	C	DOID:2870	23002168	included	ENST00000457416	p.S252W	FGFR2	-1	c.755	2016-05-18 20:50:39.028623	2016-05-18 21:27:21.181251	4	ENSG00000066468	missense
2085	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"mTOR inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"21984976\\",\\"Effect\\":\\"loss-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		19	18278061	18278061	A	G	DOID:2870	21984976	included	ENST00000222254	p.N561D	PIK3R2	1	c.1681	2016-05-18 20:50:39.037942	2016-05-18 21:27:21.287122	4	ENSG00000105647	missense
2086	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"JAK inhibitors, dasatinib\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23696637\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		11	119148891	119148891	T	C	DOID:2531	23696637	included	ENST00000264033	p.Y371H	CBL	1	c.1111	2016-05-18 20:50:39.067969	2016-05-18 21:27:21.388863	4	ENSG00000110395	missense
2087	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"JAK inhibitors, dasatinib\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23696637\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		11	119148930	119148930	T	C	DOID:2531	23696637	included	ENST00000264033	p.C384R	CBL	1	c.1150	2016-05-18 20:50:39.096321	2016-05-18 21:27:21.489888	4	ENSG00000110395	missense
2088	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"imatinib\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"18971950\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		5	149441328	149441328	A	C	DOID:2531	18971950	included	ENST00000286301	p.Y571D	CSF1R	-1	c.1711	2016-05-18 20:50:39.133995	2016-05-18 21:27:21.583942	4	ENSG00000182578	missense
2089	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"JAK inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"16834459\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		1	43815009	43815009	G	T	DOID:2531	16834459	included	ENST00000372470	p.W515L	MPL	1	c.1544	2016-05-18 20:50:39.157483	2016-05-18 21:27:21.69043	4	ENSG00000117400	missense
2090	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"BRAF inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22608338\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"19018267\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	140453136	140453136	A	T	DOID:2394	21683865	included	ENST00000288602	p.V600E	BRAF	-1	c.1799	2016-05-18 20:50:39.166354	2016-05-18 21:27:21.752239	4	ENSG00000157764	missense
2091	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"BRAF inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22608338\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"19018267\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	140453136	140453136	A	T	DOID:2394	21975775	included	ENST00000288602	p.V600E	BRAF	-1	c.1799	2016-05-18 20:50:39.200989	2016-05-18 21:27:21.833162	4	ENSG00000157764	missense
2092	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"BRAF inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22608338\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"19018267\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	140453136	140453136	A	T	DOID:2394	12068308	included	ENST00000288602	p.V600E	BRAF	-1	c.1799	2016-05-18 20:50:39.235597	2016-05-18 21:27:21.894828	4	ENSG00000157764	missense
2762	\N	\N		14	105246551	105246551	C	T	DOID:1612	22538770	included	ENST00000349310	p.E17K	AKT1	-1	c.49	2016-05-18 21:06:58.20433	2016-05-18 21:28:09.880293	5	ENSG00000142208	missense
2763	\N	\N		14	105246551	105246551	C	T	DOID:1612	22722201	included	ENST00000349310	p.E17K	AKT1	-1	c.49	2016-05-18 21:06:58.21654	2016-05-18 21:28:09.940181	5	ENSG00000142208	missense
2093	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"BRAF inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22608338\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"19018267\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	140453136	140453136	A	T	DOID:2394	20818844	included	ENST00000288602	p.V600E	BRAF	-1	c.1799	2016-05-18 20:50:39.268095	2016-05-18 21:27:21.969364	4	ENSG00000157764	missense
2094	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"BRAF inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22608338\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"19018267\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	140453136	140453136	A	T	DOID:2394	21639808	included	ENST00000288602	p.V600E	BRAF	-1	c.1799	2016-05-18 20:50:39.296888	2016-05-18 21:27:22.049483	4	ENSG00000157764	missense
2095	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"BRAF inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22608338\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"19018267\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	140453136	140453136	A	T	DOID:2394	22608338	included	ENST00000288602	p.V600E	BRAF	-1	c.1799	2016-05-18 20:50:39.334828	2016-05-18 21:27:22.120918	4	ENSG00000157764	missense
2096	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"BRAF inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22608338\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"19018267\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	140453136	140453136	A	T	DOID:2394	19018267	included	ENST00000288602	p.V600E	BRAF	-1	c.1799	2016-05-18 20:50:39.362906	2016-05-18 21:27:22.212757	4	ENSG00000157764	missense
2097	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"dabrafenib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22608338\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	140453136	140453136	A	T	DOID:2394	21683865	included	ENST00000288602	p.V600E	BRAF	-1	c.1799	2016-05-18 20:50:39.397242	2016-05-18 21:27:22.290688	4	ENSG00000157764	missense
2098	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"dabrafenib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22608338\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	140453136	140453136	A	T	DOID:2394	21975775	included	ENST00000288602	p.V600E	BRAF	-1	c.1799	2016-05-18 20:50:39.406991	2016-05-18 21:27:22.367481	4	ENSG00000157764	missense
2099	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"dabrafenib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22608338\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	140453136	140453136	A	T	DOID:2394	12068308	included	ENST00000288602	p.V600E	BRAF	-1	c.1799	2016-05-18 20:50:39.431088	2016-05-18 21:27:22.463117	4	ENSG00000157764	missense
2100	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"dabrafenib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22608338\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	140453136	140453136	A	T	DOID:2394	20818844	included	ENST00000288602	p.V600E	BRAF	-1	c.1799	2016-05-18 20:50:39.46854	2016-05-18 21:27:22.52337	4	ENSG00000157764	missense
2101	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"dabrafenib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22608338\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	140453136	140453136	A	T	DOID:2394	21639808	included	ENST00000288602	p.V600E	BRAF	-1	c.1799	2016-05-18 20:50:39.496583	2016-05-18 21:27:22.573743	4	ENSG00000157764	missense
2102	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"dabrafenib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22608338\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	140453136	140453136	A	T	DOID:2394	22608338	included	ENST00000288602	p.V600E	BRAF	-1	c.1799	2016-05-18 20:50:39.505983	2016-05-18 21:27:22.654439	4	ENSG00000157764	missense
2103	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"trastuzumab, pertuzumab, lapatinib, anti-HER3 mAbs, PI3K pathway inhibitors + MEK inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23680147\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		12	56481922	56481922	G	A	DOID:219	23680147	included	ENST00000267101	p.G284R	ERBB3	1	c.850	2016-05-18 20:50:39.535985	2016-05-18 21:27:22.765599	4	ENSG00000065361	missense
2104	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"BRAF inhibitors\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"24265152\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		14	105243048	105243048	G	T	DOID:1909	24265152	included	ENST00000349310	p.Q79K	AKT1	-1	c.235	2016-05-18 20:50:39.568876	2016-05-18 21:27:22.87149	4	ENSG00000142208	missense
2764	\N	\N		14	105246551	105246551	C	T	DOID:1612	21512767	included	ENST00000349310	p.E17K	AKT1	-1	c.49	2016-05-18 21:06:58.22688	2016-05-18 21:28:10.016936	5	ENSG00000142208	missense
2765	\N	\N		14	105246551	105246551	C	T	DOID:1612	19487299	included	ENST00000349310	p.E17K	AKT1	-1	c.49	2016-05-18 21:06:58.239895	2016-05-18 21:28:10.07825	5	ENSG00000142208	missense
2106	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"vemurafenib, dabrafenib, trametinib, dabrafenib + trametinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"FDA-approved\\",\\"Evidence\\":\\"consensus\\",\\"Source\\":\\"FDA\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"J Clin Oncol 2013;31 (suppl; abstr 9028)\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors + PI3K pathway inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22389471, 21156289\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors + HSP90 inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22351686\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors + CDK2/4 inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22997239.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"preclinical\\",\\"Assocation\\":\\"ERK inhibitors\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23614898, 22997239\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	140453136	140453136	A	T	DOID:1909	12068308	included	ENST00000288602	p.V600E	BRAF	-1	c.1799	2016-05-18 20:50:39.632203	2016-05-18 21:27:23.049428	4	ENSG00000157764	missense
2107	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"vemurafenib, dabrafenib, trametinib, dabrafenib + trametinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"FDA-approved\\",\\"Evidence\\":\\"consensus\\",\\"Source\\":\\"FDA\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"J Clin Oncol 2013;31 (suppl; abstr 9028)\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors + PI3K pathway inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22389471, 21156289\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors + HSP90 inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22351686\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors + CDK2/4 inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22997239.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"preclinical\\",\\"Assocation\\":\\"ERK inhibitors\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23614898, 22997239\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	140453136	140453136	A	T	DOID:1909	14679157	included	ENST00000288602	p.V600E	BRAF	-1	c.1799	2016-05-18 20:50:39.660315	2016-05-18 21:27:23.136983	4	ENSG00000157764	missense
2108	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"vemurafenib, dabrafenib, trametinib, dabrafenib + trametinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"FDA-approved\\",\\"Evidence\\":\\"consensus\\",\\"Source\\":\\"FDA\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"J Clin Oncol 2013;31 (suppl; abstr 9028)\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors + PI3K pathway inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22389471, 21156289\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors + HSP90 inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22351686\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors + CDK2/4 inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22997239.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"preclinical\\",\\"Assocation\\":\\"ERK inhibitors\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23614898, 22997239\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	140453136	140453136	A	T	DOID:1909	22536370	included	ENST00000288602	p.V600E	BRAF	-1	c.1799	2016-05-18 20:50:39.673345	2016-05-18 21:27:23.218637	4	ENSG00000157764	missense
2109	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"vemurafenib, dabrafenib, trametinib, dabrafenib + trametinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"FDA-approved\\",\\"Evidence\\":\\"consensus\\",\\"Source\\":\\"FDA\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"J Clin Oncol 2013;31 (suppl; abstr 9028)\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors + PI3K pathway inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22389471, 21156289\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors + HSP90 inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22351686\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors + CDK2/4 inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22997239.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"preclinical\\",\\"Assocation\\":\\"ERK inhibitors\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23614898, 22997239\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	140453136	140453136	A	T	DOID:1909	20630094	included	ENST00000288602	p.V600E	BRAF	-1	c.1799	2016-05-18 20:50:39.697136	2016-05-18 21:27:23.318424	4	ENSG00000157764	missense
2127	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"BRAF inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23237741\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23248257\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	140453136	140453137	AC	CT	DOID:1909	14679157	included	ENST00000288602	p.V600R	BRAF	-1	c.1798	2016-05-18 20:50:40.080883	2016-05-18 21:27:25.073091	4	ENSG00000157764	missense
2766	\N	\N		14	105246551	105246551	C	T	DOID:1612	19418217	included	ENST00000349310	p.E17K	AKT1	-1	c.49	2016-05-18 21:06:58.251073	2016-05-18 21:28:10.143668	5	ENSG00000142208	missense
2110	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"vemurafenib, dabrafenib, trametinib, dabrafenib + trametinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"FDA-approved\\",\\"Evidence\\":\\"consensus\\",\\"Source\\":\\"FDA\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"J Clin Oncol 2013;31 (suppl; abstr 9028)\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors + PI3K pathway inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22389471, 21156289\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors + HSP90 inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22351686\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors + CDK2/4 inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22997239.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"preclinical\\",\\"Assocation\\":\\"ERK inhibitors\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23614898, 22997239\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	140453136	140453136	A	T	DOID:1909	21639808	included	ENST00000288602	p.V600E	BRAF	-1	c.1799	2016-05-18 20:50:39.713374	2016-05-18 21:27:23.39481	4	ENSG00000157764	missense
2111	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"vemurafenib, dabrafenib, trametinib, dabrafenib + trametinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"FDA-approved\\",\\"Evidence\\":\\"consensus\\",\\"Source\\":\\"FDA\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"J Clin Oncol 2013;31 (suppl; abstr 9028)\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors + PI3K pathway inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22389471, 21156289\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors + HSP90 inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22351686\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors + CDK2/4 inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22997239.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"preclinical\\",\\"Assocation\\":\\"ERK inhibitors\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23614898, 22997239\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	140453136	140453136	A	T	DOID:1909	22608338	included	ENST00000288602	p.V600E	BRAF	-1	c.1799	2016-05-18 20:50:39.73745	2016-05-18 21:27:23.480023	4	ENSG00000157764	missense
2112	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"vemurafenib, dabrafenib, trametinib, dabrafenib + trametinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"FDA-approved\\",\\"Evidence\\":\\"consensus\\",\\"Source\\":\\"FDA\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"J Clin Oncol 2013;31 (suppl; abstr 9028)\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors + PI3K pathway inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22389471, 21156289\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors + HSP90 inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22351686\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors + CDK2/4 inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22997239.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"preclinical\\",\\"Assocation\\":\\"ERK inhibitors\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23614898, 22997239\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	140453136	140453136	A	T	DOID:1909	23020132	included	ENST00000288602	p.V600E	BRAF	-1	c.1799	2016-05-18 20:50:39.76384	2016-05-18 21:27:23.57792	4	ENSG00000157764	missense
2113	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"vemurafenib, dabrafenib, trametinib, dabrafenib + trametinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"FDA-approved\\",\\"Evidence\\":\\"consensus\\",\\"Source\\":\\"FDA\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"J Clin Oncol 2013;31 (suppl; abstr 9028)\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors + PI3K pathway inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22389471, 21156289\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors + HSP90 inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22351686\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors + CDK2/4 inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22997239.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"preclinical\\",\\"Assocation\\":\\"ERK inhibitors\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23614898, 22997239\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	140453136	140453136	A	T	DOID:1909	20818844	included	ENST00000288602	p.V600E	BRAF	-1	c.1799	2016-05-18 20:50:39.776684	2016-05-18 21:27:23.66849	4	ENSG00000157764	missense
2128	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"BRAF inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23237741\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23248257\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	140453136	140453137	AC	CT	DOID:1909	23237741	included	ENST00000288602	p.V600R	BRAF	-1	c.1798	2016-05-18 20:50:40.097266	2016-05-18 21:27:25.155022	4	ENSG00000157764	missense
2767	\N	\N		14	105246551	105246551	C	T	DOID:1612	23237847	included	ENST00000349310	p.E17K	AKT1	-1	c.49	2016-05-18 21:06:58.284041	2016-05-18 21:28:10.188026	5	ENSG00000142208	missense
2114	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"vemurafenib, dabrafenib, trametinib, dabrafenib + trametinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"FDA-approved\\",\\"Evidence\\":\\"consensus\\",\\"Source\\":\\"FDA\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"J Clin Oncol 2013;31 (suppl; abstr 9028)\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors + PI3K pathway inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22389471, 21156289\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors + HSP90 inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22351686\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors + CDK2/4 inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22997239.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"preclinical\\",\\"Assocation\\":\\"ERK inhibitors\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23614898, 22997239\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	140453136	140453136	A	T	DOID:1909	22735384	included	ENST00000288602	p.V600E	BRAF	-1	c.1799	2016-05-18 20:50:39.806114	2016-05-18 21:27:23.757044	4	ENSG00000157764	missense
2115	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"vemurafenib, dabrafenib, trametinib, dabrafenib + trametinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"FDA-approved\\",\\"Evidence\\":\\"consensus\\",\\"Source\\":\\"FDA\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"J Clin Oncol 2013;31 (suppl; abstr 9028)\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors + PI3K pathway inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22389471, 21156289\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors + HSP90 inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22351686\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors + CDK2/4 inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22997239.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"preclinical\\",\\"Assocation\\":\\"ERK inhibitors\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23614898, 22997239\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	140453136	140453136	A	T	DOID:1909	22356324	included	ENST00000288602	p.V600E	BRAF	-1	c.1799	2016-05-18 20:50:39.831261	2016-05-18 21:27:23.841456	4	ENSG00000157764	missense
2116	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"vemurafenib, dabrafenib, trametinib, dabrafenib + trametinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"FDA-approved\\",\\"Evidence\\":\\"consensus\\",\\"Source\\":\\"FDA\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"J Clin Oncol 2013;31 (suppl; abstr 9028)\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors + PI3K pathway inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22389471, 21156289\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors + HSP90 inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22351686\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors + CDK2/4 inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22997239.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"preclinical\\",\\"Assocation\\":\\"ERK inhibitors\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23614898, 22997239\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	140453136	140453136	A	T	DOID:1909	22663011	included	ENST00000288602	p.V600E	BRAF	-1	c.1799	2016-05-18 20:50:39.861467	2016-05-18 21:27:23.93095	4	ENSG00000157764	missense
2117	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"vemurafenib, dabrafenib, trametinib, dabrafenib + trametinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"FDA-approved\\",\\"Evidence\\":\\"consensus\\",\\"Source\\":\\"FDA\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"J Clin Oncol 2013;31 (suppl; abstr 9028)\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors + PI3K pathway inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22389471, 21156289\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors + HSP90 inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22351686\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors + CDK2/4 inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22997239.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"preclinical\\",\\"Assocation\\":\\"ERK inhibitors\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23614898, 22997239\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	140453136	140453136	A	T	DOID:1909	22805292	included	ENST00000288602	p.V600E	BRAF	-1	c.1799	2016-05-18 20:50:39.874154	2016-05-18 21:27:24.07012	4	ENSG00000157764	missense
2129	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"BRAF inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23237741\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23248257\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	140453136	140453137	AC	CT	DOID:1909	20551065	included	ENST00000288602	p.V600R	BRAF	-1	c.1798	2016-05-18 20:50:40.107314	2016-05-18 21:27:25.239333	4	ENSG00000157764	missense
2768	\N	\N		14	105246551	105246551	C	T	DOID:1612	25157968	included	ENST00000349310	p.E17K	AKT1	-1	c.49	2016-05-18 21:06:58.292595	2016-05-18 21:28:10.253664	5	ENSG00000142208	missense
2118	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"vemurafenib, dabrafenib, trametinib, dabrafenib + trametinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"FDA-approved\\",\\"Evidence\\":\\"consensus\\",\\"Source\\":\\"FDA\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"J Clin Oncol 2013;31 (suppl; abstr 9028)\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors + PI3K pathway inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22389471, 21156289\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors + HSP90 inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22351686\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors + CDK2/4 inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22997239.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"preclinical\\",\\"Assocation\\":\\"ERK inhibitors\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23614898, 22997239\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	140453136	140453136	A	T	DOID:1909	22048237	included	ENST00000288602	p.V600E	BRAF	-1	c.1799	2016-05-18 20:50:39.899347	2016-05-18 21:27:24.194344	4	ENSG00000157764	missense
2119	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"vemurafenib, dabrafenib, trametinib, dabrafenib + trametinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"FDA-approved\\",\\"Evidence\\":\\"consensus\\",\\"Source\\":\\"FDA\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"J Clin Oncol 2013;31 (suppl; abstr 9028)\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors + PI3K pathway inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22389471, 21156289\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors + HSP90 inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22351686\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors + CDK2/4 inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22997239.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"preclinical\\",\\"Assocation\\":\\"ERK inhibitors\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23614898, 22997239\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	140453136	140453136	A	T	DOID:1909	22972589	included	ENST00000288602	p.V600E	BRAF	-1	c.1799	2016-05-18 20:50:39.914043	2016-05-18 21:27:24.309321	4	ENSG00000157764	missense
2120	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"vemurafenib, dabrafenib, trametinib, dabrafenib + trametinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"FDA-approved\\",\\"Evidence\\":\\"consensus\\",\\"Source\\":\\"FDA\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"J Clin Oncol 2013;31 (suppl; abstr 9028)\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors + PI3K pathway inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22389471, 21156289\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors + HSP90 inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22351686\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors + CDK2/4 inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22997239.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"preclinical\\",\\"Assocation\\":\\"ERK inhibitors\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23614898, 22997239\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	140453136	140453136	A	T	DOID:1909	19404918	included	ENST00000288602	p.V600E	BRAF	-1	c.1799	2016-05-18 20:50:39.937352	2016-05-18 21:27:24.406257	4	ENSG00000157764	missense
2121	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"vemurafenib, dabrafenib, trametinib, dabrafenib + trametinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"FDA-approved\\",\\"Evidence\\":\\"consensus\\",\\"Source\\":\\"FDA\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"J Clin Oncol 2013;31 (suppl; abstr 9028)\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors + PI3K pathway inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22389471, 21156289\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors + HSP90 inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22351686\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors + CDK2/4 inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22997239.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"preclinical\\",\\"Assocation\\":\\"ERK inhibitors\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23614898, 22997239\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	140453136	140453136	A	T	DOID:1909	22389471	included	ENST00000288602	p.V600E	BRAF	-1	c.1799	2016-05-18 20:50:39.962998	2016-05-18 21:27:24.500695	4	ENSG00000157764	missense
2130	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"BRAF inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23237741\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23248257\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	140453136	140453137	AC	CT	DOID:1909	21639808	included	ENST00000288602	p.V600R	BRAF	-1	c.1798	2016-05-18 20:50:40.118668	2016-05-18 21:27:25.308103	4	ENSG00000157764	missense
2769	\N	\N		7	140481417	140481417	C	A	DOID:1612	22538770	included	ENST00000288602	p.G464V	BRAF	-1	c.1391	2016-05-18 21:06:58.316917	2016-05-18 21:28:10.317819	5	ENSG00000157764	missense
2122	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"vemurafenib, dabrafenib, trametinib, dabrafenib + trametinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"FDA-approved\\",\\"Evidence\\":\\"consensus\\",\\"Source\\":\\"FDA\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"J Clin Oncol 2013;31 (suppl; abstr 9028)\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors + PI3K pathway inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22389471, 21156289\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors + HSP90 inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22351686\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors + CDK2/4 inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22997239.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"preclinical\\",\\"Assocation\\":\\"ERK inhibitors\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23614898, 22997239\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	140453136	140453136	A	T	DOID:1909	21156289	included	ENST00000288602	p.V600E	BRAF	-1	c.1799	2016-05-18 20:50:39.975704	2016-05-18 21:27:24.612855	4	ENSG00000157764	missense
2123	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"vemurafenib, dabrafenib, trametinib, dabrafenib + trametinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"FDA-approved\\",\\"Evidence\\":\\"consensus\\",\\"Source\\":\\"FDA\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"J Clin Oncol 2013;31 (suppl; abstr 9028)\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors + PI3K pathway inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22389471, 21156289\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors + HSP90 inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22351686\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors + CDK2/4 inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22997239.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"preclinical\\",\\"Assocation\\":\\"ERK inhibitors\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23614898, 22997239\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	140453136	140453136	A	T	DOID:1909	22351686	included	ENST00000288602	p.V600E	BRAF	-1	c.1799	2016-05-18 20:50:40.004107	2016-05-18 21:27:24.69833	4	ENSG00000157764	missense
2124	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"vemurafenib, dabrafenib, trametinib, dabrafenib + trametinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"FDA-approved\\",\\"Evidence\\":\\"consensus\\",\\"Source\\":\\"FDA\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"J Clin Oncol 2013;31 (suppl; abstr 9028)\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors + PI3K pathway inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22389471, 21156289\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors + HSP90 inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22351686\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors + CDK2/4 inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22997239.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"preclinical\\",\\"Assocation\\":\\"ERK inhibitors\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23614898, 22997239\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	140453136	140453136	A	T	DOID:1909	22997239	included	ENST00000288602	p.V600E	BRAF	-1	c.1799	2016-05-18 20:50:40.03098	2016-05-18 21:27:24.781497	4	ENSG00000157764	missense
2125	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"vemurafenib, dabrafenib, trametinib, dabrafenib + trametinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"FDA-approved\\",\\"Evidence\\":\\"consensus\\",\\"Source\\":\\"FDA\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"J Clin Oncol 2013;31 (suppl; abstr 9028)\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors + PI3K pathway inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22389471, 21156289\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors + HSP90 inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22351686\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors + CDK2/4 inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22997239.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"preclinical\\",\\"Assocation\\":\\"ERK inhibitors\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23614898, 22997239\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	140453136	140453136	A	T	DOID:1909	23614898	included	ENST00000288602	p.V600E	BRAF	-1	c.1799	2016-05-18 20:50:40.045079	2016-05-18 21:27:24.866354	4	ENSG00000157764	missense
2126	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"BRAF inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23237741\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23248257\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	140453136	140453137	AC	CT	DOID:1909	12068308	included	ENST00000288602	p.V600R	BRAF	-1	c.1798	2016-05-18 20:50:40.066838	2016-05-18 21:27:24.983782	4	ENSG00000157764	missense
2770	\N	\N		7	140481417	140481417	C	A	DOID:1612	12068308	included	ENST00000288602	p.G464V	BRAF	-1	c.1391	2016-05-18 21:06:58.32713	2016-05-18 21:28:10.364788	5	ENSG00000157764	missense
2131	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"BRAF inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23237741\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23248257\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	140453136	140453137	AC	CT	DOID:1909	22608338	included	ENST00000288602	p.V600R	BRAF	-1	c.1798	2016-05-18 20:50:40.133563	2016-05-18 21:27:25.390781	4	ENSG00000157764	missense
2132	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"BRAF inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23237741\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23248257\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	140453136	140453137	AC	CT	DOID:1909	23020132	included	ENST00000288602	p.V600R	BRAF	-1	c.1798	2016-05-18 20:50:40.143186	2016-05-18 21:27:25.508512	4	ENSG00000157764	missense
2133	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"BRAF inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23237741\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23248257\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	140453136	140453137	AC	CT	DOID:1909	20818844	included	ENST00000288602	p.V600R	BRAF	-1	c.1798	2016-05-18 20:50:40.168583	2016-05-18 21:27:25.620529	4	ENSG00000157764	missense
2134	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"BRAF inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23237741\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23248257\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	140453136	140453137	AC	CT	DOID:1909	22735384	included	ENST00000288602	p.V600R	BRAF	-1	c.1798	2016-05-18 20:50:40.177437	2016-05-18 21:27:25.722133	4	ENSG00000157764	missense
2135	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"BRAF inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23237741\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23248257\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	140453136	140453137	AC	CT	DOID:1909	22356324	included	ENST00000288602	p.V600R	BRAF	-1	c.1798	2016-05-18 20:50:40.187846	2016-05-18 21:27:25.803564	4	ENSG00000157764	missense
2136	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"BRAF inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23237741\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23248257\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	140453136	140453137	AC	CT	DOID:1909	22663011	included	ENST00000288602	p.V600R	BRAF	-1	c.1798	2016-05-18 20:50:40.195599	2016-05-18 21:27:25.870591	4	ENSG00000157764	missense
2137	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"BRAF inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23237741\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23248257\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	140453136	140453137	AC	CT	DOID:1909	22805292	included	ENST00000288602	p.V600R	BRAF	-1	c.1798	2016-05-18 20:50:40.204889	2016-05-18 21:27:25.947395	4	ENSG00000157764	missense
2138	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"BRAF inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23237741\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23248257\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	140453136	140453137	AC	CT	DOID:1909	22048237	included	ENST00000288602	p.V600R	BRAF	-1	c.1798	2016-05-18 20:50:40.223764	2016-05-18 21:27:26.034577	4	ENSG00000157764	missense
2139	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"BRAF inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23237741\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23248257\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	140453136	140453137	AC	CT	DOID:1909	22972589	included	ENST00000288602	p.V600R	BRAF	-1	c.1798	2016-05-18 20:50:40.233527	2016-05-18 21:27:26.098523	4	ENSG00000157764	missense
2140	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"BRAF inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23237741\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23248257\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	140453136	140453137	AC	CT	DOID:1909	23248257	included	ENST00000288602	p.V600R	BRAF	-1	c.1798	2016-05-18 20:50:40.243039	2016-05-18 21:27:26.174635	4	ENSG00000157764	missense
2771	\N	\N		7	140481417	140481417	C	A	DOID:1612	25157968	included	ENST00000288602	p.G464V	BRAF	-1	c.1391	2016-05-18 21:06:58.347777	2016-05-18 21:28:10.411347	5	ENSG00000157764	missense
2772	\N	\N		7	140481417	140481417	C	T	DOID:1040	18060073	included	ENST00000288602	p.G464E	BRAF	-1	c.1391	2016-05-18 21:06:58.360053	2016-05-18 21:28:10.464179	5	ENSG00000157764	missense
2141	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"trametinib, dabrafenib + trametinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"FDA-approved\\",\\"Evidence\\":\\"consensus\\",\\"Source\\":\\"FDA\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"vemurafenib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"late trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22356324\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	140453136	140453137	AC	TT	DOID:1909	12068308	included	ENST00000288602	p.V600K	BRAF	-1	c.1798	2016-05-18 20:50:40.252131	2016-05-18 21:27:26.248684	4	ENSG00000157764	missense
2142	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"trametinib, dabrafenib + trametinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"FDA-approved\\",\\"Evidence\\":\\"consensus\\",\\"Source\\":\\"FDA\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"vemurafenib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"late trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22356324\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	140453136	140453137	AC	TT	DOID:1909	14679157	included	ENST00000288602	p.V600K	BRAF	-1	c.1798	2016-05-18 20:50:40.274299	2016-05-18 21:27:26.314819	4	ENSG00000157764	missense
2143	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"trametinib, dabrafenib + trametinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"FDA-approved\\",\\"Evidence\\":\\"consensus\\",\\"Source\\":\\"FDA\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"vemurafenib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"late trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22356324\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	140453136	140453137	AC	TT	DOID:1909	22536370	included	ENST00000288602	p.V600K	BRAF	-1	c.1798	2016-05-18 20:50:40.308059	2016-05-18 21:27:26.387526	4	ENSG00000157764	missense
2144	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"trametinib, dabrafenib + trametinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"FDA-approved\\",\\"Evidence\\":\\"consensus\\",\\"Source\\":\\"FDA\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"vemurafenib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"late trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22356324\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	140453136	140453137	AC	TT	DOID:1909	20630094	included	ENST00000288602	p.V600K	BRAF	-1	c.1798	2016-05-18 20:50:40.34192	2016-05-18 21:27:26.448154	4	ENSG00000157764	missense
2145	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"trametinib, dabrafenib + trametinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"FDA-approved\\",\\"Evidence\\":\\"consensus\\",\\"Source\\":\\"FDA\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"vemurafenib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"late trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22356324\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	140453136	140453137	AC	TT	DOID:1909	22608338	included	ENST00000288602	p.V600K	BRAF	-1	c.1798	2016-05-18 20:50:40.372317	2016-05-18 21:27:26.53452	4	ENSG00000157764	missense
2146	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"trametinib, dabrafenib + trametinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"FDA-approved\\",\\"Evidence\\":\\"consensus\\",\\"Source\\":\\"FDA\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"vemurafenib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"late trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22356324\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	140453136	140453137	AC	TT	DOID:1909	20818844	included	ENST00000288602	p.V600K	BRAF	-1	c.1798	2016-05-18 20:50:40.409773	2016-05-18 21:27:26.61033	4	ENSG00000157764	missense
2147	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"trametinib, dabrafenib + trametinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"FDA-approved\\",\\"Evidence\\":\\"consensus\\",\\"Source\\":\\"FDA\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"vemurafenib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"late trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22356324\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	140453136	140453137	AC	TT	DOID:1909	22735384	included	ENST00000288602	p.V600K	BRAF	-1	c.1798	2016-05-18 20:50:40.432416	2016-05-18 21:27:26.678432	4	ENSG00000157764	missense
2148	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"trametinib, dabrafenib + trametinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"FDA-approved\\",\\"Evidence\\":\\"consensus\\",\\"Source\\":\\"FDA\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"vemurafenib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"late trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22356324\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	140453136	140453137	AC	TT	DOID:1909	22356324	included	ENST00000288602	p.V600K	BRAF	-1	c.1798	2016-05-18 20:50:40.444488	2016-05-18 21:27:26.757458	4	ENSG00000157764	missense
2149	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"trametinib, dabrafenib + trametinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"FDA-approved\\",\\"Evidence\\":\\"consensus\\",\\"Source\\":\\"FDA\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"vemurafenib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"late trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22356324\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	140453136	140453137	AC	TT	DOID:1909	21639808	included	ENST00000288602	p.V600K	BRAF	-1	c.1798	2016-05-18 20:50:40.456669	2016-05-18 21:27:26.83391	4	ENSG00000157764	missense
2150	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"trametinib, dabrafenib + trametinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"FDA-approved\\",\\"Evidence\\":\\"consensus\\",\\"Source\\":\\"FDA\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"vemurafenib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"late trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22356324\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	140453136	140453137	AC	TT	DOID:1909	22663011	included	ENST00000288602	p.V600K	BRAF	-1	c.1798	2016-05-18 20:50:40.484229	2016-05-18 21:27:26.916636	4	ENSG00000157764	missense
2773	\N	\N		7	140481417	140481417	C	T	DOID:1040	25157968	included	ENST00000288602	p.G464E	BRAF	-1	c.1391	2016-05-18 21:06:58.380566	2016-05-18 21:28:10.516172	5	ENSG00000157764	missense
2151	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"trametinib, dabrafenib + trametinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"FDA-approved\\",\\"Evidence\\":\\"consensus\\",\\"Source\\":\\"FDA\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"vemurafenib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"late trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22356324\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	140453136	140453137	AC	TT	DOID:1909	22805292	included	ENST00000288602	p.V600K	BRAF	-1	c.1798	2016-05-18 20:50:40.516064	2016-05-18 21:27:26.999562	4	ENSG00000157764	missense
2152	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"trametinib, dabrafenib + trametinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"FDA-approved\\",\\"Evidence\\":\\"consensus\\",\\"Source\\":\\"FDA\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"vemurafenib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"late trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22356324\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	140453136	140453137	AC	TT	DOID:1909	22972589	included	ENST00000288602	p.V600K	BRAF	-1	c.1798	2016-05-18 20:50:40.547227	2016-05-18 21:27:27.07566	4	ENSG00000157764	missense
2153	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"trametinib, dabrafenib + trametinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"FDA-approved\\",\\"Evidence\\":\\"consensus\\",\\"Source\\":\\"FDA\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"vemurafenib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"late trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22356324\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	140453136	140453137	AC	TT	DOID:1909	22048237	included	ENST00000288602	p.V600K	BRAF	-1	c.1798	2016-05-18 20:50:40.577921	2016-05-18 21:27:27.160073	4	ENSG00000157764	missense
2155	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"trametinib, MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22805292, 22798288\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23715574\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	140453145	140453145	A	C	DOID:1909	12460918	included	ENST00000288602	p.L597R	BRAF	-1	c.1790	2016-05-18 20:50:40.669407	2016-05-18 21:27:27.24455	4	ENSG00000157764	missense
2156	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"trametinib, MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22805292, 22798288\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23715574\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	140453145	140453145	A	C	DOID:1909	23833300	included	ENST00000288602	p.L597R	BRAF	-1	c.1790	2016-05-18 20:50:40.705721	2016-05-18 21:27:27.325561	4	ENSG00000157764	missense
2157	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"trametinib, MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22805292, 22798288\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23715574\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	140453145	140453145	A	C	DOID:1909	12068308	included	ENST00000288602	p.L597R	BRAF	-1	c.1790	2016-05-18 20:50:40.735645	2016-05-18 21:27:27.39537	4	ENSG00000157764	missense
2158	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"trametinib, MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22805292, 22798288\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23715574\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	140453145	140453145	A	C	DOID:1909	12460919	included	ENST00000288602	p.L597R	BRAF	-1	c.1790	2016-05-18 20:50:40.774726	2016-05-18 21:27:27.48299	4	ENSG00000157764	missense
2159	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"trametinib, MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22805292, 22798288\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23715574\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	140453145	140453145	A	C	DOID:1909	21483012	included	ENST00000288602	p.L597R	BRAF	-1	c.1790	2016-05-18 20:50:40.806335	2016-05-18 21:27:27.570163	4	ENSG00000157764	missense
2160	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"trametinib, MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22805292, 22798288\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23715574\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	140453145	140453145	A	C	DOID:1909	19010912	included	ENST00000288602	p.L597R	BRAF	-1	c.1790	2016-05-18 20:50:40.841644	2016-05-18 21:27:27.655304	4	ENSG00000157764	missense
2161	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"trametinib, MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22805292, 22798288\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23715574\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	140453145	140453145	A	C	DOID:1909	22649091	included	ENST00000288602	p.L597R	BRAF	-1	c.1790	2016-05-18 20:50:40.8529	2016-05-18 21:27:27.747935	4	ENSG00000157764	missense
2774	\N	\N		14	105246551	105246551	C	T	DOID:10283	22722839	included	ENST00000349310	p.E17K	AKT1	-1	c.49	2016-05-18 21:06:58.392993	2016-05-18 21:28:10.560567	5	ENSG00000142208	missense
2162	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"trametinib, MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22805292, 22798288\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23715574\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	140453145	140453145	A	C	DOID:1909	19238210	included	ENST00000288602	p.L597R	BRAF	-1	c.1790	2016-05-18 20:50:40.875991	2016-05-18 21:27:27.81654	4	ENSG00000157764	missense
2163	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"trametinib, MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22805292, 22798288\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23715574\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	140453145	140453145	A	C	DOID:1909	22798288	included	ENST00000288602	p.L597R	BRAF	-1	c.1790	2016-05-18 20:50:40.915173	2016-05-18 21:27:27.886995	4	ENSG00000157764	missense
2164	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"trametinib, MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22805292, 22798288\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23715574\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	140453145	140453145	A	C	DOID:1909	22805292	included	ENST00000288602	p.L597R	BRAF	-1	c.1790	2016-05-18 20:50:40.944158	2016-05-18 21:27:27.958228	4	ENSG00000157764	missense
2165	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"trametinib, MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22805292, 22798288\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23715574\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	140453145	140453145	A	C	DOID:1909	23715574	included	ENST00000288602	p.L597R	BRAF	-1	c.1790	2016-05-18 20:50:40.980994	2016-05-18 21:27:28.055049	4	ENSG00000157764	missense
2166	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"trametinib, MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22805292, 22798288\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23715574\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	140453145	140453145	A	T	DOID:1909	12460918	included	ENST00000288602	p.L597Q	BRAF	-1	c.1790	2016-05-18 20:50:41.015339	2016-05-18 21:27:28.150408	4	ENSG00000157764	missense
2167	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"trametinib, MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22805292, 22798288\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23715574\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	140453145	140453145	A	T	DOID:1909	23833300	included	ENST00000288602	p.L597Q	BRAF	-1	c.1790	2016-05-18 20:50:41.038331	2016-05-18 21:27:28.222602	4	ENSG00000157764	missense
2168	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"trametinib, MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22805292, 22798288\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23715574\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	140453145	140453145	A	T	DOID:1909	12068308	included	ENST00000288602	p.L597Q	BRAF	-1	c.1790	2016-05-18 20:50:41.055116	2016-05-18 21:27:28.292692	4	ENSG00000157764	missense
2169	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"trametinib, MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22805292, 22798288\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23715574\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	140453145	140453145	A	T	DOID:1909	12460919	included	ENST00000288602	p.L597Q	BRAF	-1	c.1790	2016-05-18 20:50:41.110487	2016-05-18 21:27:28.362912	4	ENSG00000157764	missense
2170	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"trametinib, MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22805292, 22798288\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23715574\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	140453145	140453145	A	T	DOID:1909	21483012	included	ENST00000288602	p.L597Q	BRAF	-1	c.1790	2016-05-18 20:50:41.130842	2016-05-18 21:27:28.427625	4	ENSG00000157764	missense
2171	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"trametinib, MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22805292, 22798288\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23715574\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	140453145	140453145	A	T	DOID:1909	19010912	included	ENST00000288602	p.L597Q	BRAF	-1	c.1790	2016-05-18 20:50:41.142519	2016-05-18 21:27:28.508318	4	ENSG00000157764	missense
2775	\N	\N		14	105246551	105246551	C	T	DOID:10283	22610119	included	ENST00000349310	p.E17K	AKT1	-1	c.49	2016-05-18 21:06:58.410288	2016-05-18 21:28:10.616592	5	ENSG00000142208	missense
2172	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"trametinib, MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22805292, 22798288\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23715574\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	140453145	140453145	A	T	DOID:1909	22649091	included	ENST00000288602	p.L597Q	BRAF	-1	c.1790	2016-05-18 20:50:41.177131	2016-05-18 21:27:28.592973	4	ENSG00000157764	missense
2173	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"trametinib, MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22805292, 22798288\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23715574\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	140453145	140453145	A	T	DOID:1909	19238210	included	ENST00000288602	p.L597Q	BRAF	-1	c.1790	2016-05-18 20:50:41.213466	2016-05-18 21:27:28.662003	4	ENSG00000157764	missense
2174	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"trametinib, MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22805292, 22798288\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23715574\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	140453145	140453145	A	T	DOID:1909	22798288	included	ENST00000288602	p.L597Q	BRAF	-1	c.1790	2016-05-18 20:50:41.272758	2016-05-18 21:27:28.74129	4	ENSG00000157764	missense
2175	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"trametinib, MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22805292, 22798288\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23715574\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	140453145	140453145	A	T	DOID:1909	22805292	included	ENST00000288602	p.L597Q	BRAF	-1	c.1790	2016-05-18 20:50:41.282923	2016-05-18 21:27:28.812128	4	ENSG00000157764	missense
2176	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"trametinib, MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22805292, 22798288\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23715574\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	140453145	140453145	A	T	DOID:1909	23715574	included	ENST00000288602	p.L597Q	BRAF	-1	c.1790	2016-05-18 20:50:41.308517	2016-05-18 21:27:28.882704	4	ENSG00000157764	missense
2177	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"trametinib, MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22805292, 22798288\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23715574\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	140453145	140453146	AG	GA	DOID:1909	12460918	included	ENST00000288602	p.L597S	BRAF	-1	c.1789	2016-05-18 20:50:41.342428	2016-05-18 21:27:28.980504	4	ENSG00000157764	missense
2178	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"trametinib, MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22805292, 22798288\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23715574\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	140453145	140453146	AG	GA	DOID:1909	23833300	included	ENST00000288602	p.L597S	BRAF	-1	c.1789	2016-05-18 20:50:41.376042	2016-05-18 21:27:29.053851	4	ENSG00000157764	missense
2179	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"trametinib, MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22805292, 22798288\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23715574\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	140453145	140453146	AG	GA	DOID:1909	12068308	included	ENST00000288602	p.L597S	BRAF	-1	c.1789	2016-05-18 20:50:41.40831	2016-05-18 21:27:29.144688	4	ENSG00000157764	missense
2180	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"trametinib, MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22805292, 22798288\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23715574\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	140453145	140453146	AG	GA	DOID:1909	12460919	included	ENST00000288602	p.L597S	BRAF	-1	c.1789	2016-05-18 20:50:41.441784	2016-05-18 21:27:29.205654	4	ENSG00000157764	missense
2181	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"trametinib, MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22805292, 22798288\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23715574\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	140453145	140453146	AG	GA	DOID:1909	21483012	included	ENST00000288602	p.L597S	BRAF	-1	c.1789	2016-05-18 20:50:41.477875	2016-05-18 21:27:29.26349	4	ENSG00000157764	missense
2776	\N	\N		14	105246551	105246551	C	T	DOID:10283	25157968	included	ENST00000349310	p.E17K	AKT1	-1	c.49	2016-05-18 21:06:58.420329	2016-05-18 21:28:10.667206	5	ENSG00000142208	missense
2182	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"trametinib, MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22805292, 22798288\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23715574\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	140453145	140453146	AG	GA	DOID:1909	19010912	included	ENST00000288602	p.L597S	BRAF	-1	c.1789	2016-05-18 20:50:41.513086	2016-05-18 21:27:29.331095	4	ENSG00000157764	missense
2183	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"trametinib, MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22805292, 22798288\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23715574\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	140453145	140453146	AG	GA	DOID:1909	22649091	included	ENST00000288602	p.L597S	BRAF	-1	c.1789	2016-05-18 20:50:41.54378	2016-05-18 21:27:29.40199	4	ENSG00000157764	missense
2184	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"trametinib, MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22805292, 22798288\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23715574\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	140453145	140453146	AG	GA	DOID:1909	19238210	included	ENST00000288602	p.L597S	BRAF	-1	c.1789	2016-05-18 20:50:41.577335	2016-05-18 21:27:29.474501	4	ENSG00000157764	missense
2185	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"trametinib, MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22805292, 22798288\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23715574\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	140453145	140453146	AG	GA	DOID:1909	22798288	included	ENST00000288602	p.L597S	BRAF	-1	c.1789	2016-05-18 20:50:41.588402	2016-05-18 21:27:29.560215	4	ENSG00000157764	missense
2186	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"trametinib, MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22805292, 22798288\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23715574\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	140453145	140453146	AG	GA	DOID:1909	22805292	included	ENST00000288602	p.L597S	BRAF	-1	c.1789	2016-05-18 20:50:41.614797	2016-05-18 21:27:29.617954	4	ENSG00000157764	missense
2187	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"trametinib, MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22805292, 22798288\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23715574\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	140453145	140453146	AG	GA	DOID:1909	23715574	included	ENST00000288602	p.L597S	BRAF	-1	c.1789	2016-05-18 20:50:41.650133	2016-05-18 21:27:29.701936	4	ENSG00000157764	missense
2188	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"trametinib, MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22805292, 22798288\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23715574\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	140453146	140453146	G	C	DOID:1909	12460918	included	ENST00000288602	p.L597V	BRAF	-1	c.1789	2016-05-18 20:50:41.685087	2016-05-18 21:27:29.792189	4	ENSG00000157764	missense
2189	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"trametinib, MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22805292, 22798288\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23715574\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	140453146	140453146	G	C	DOID:1909	23833300	included	ENST00000288602	p.L597V	BRAF	-1	c.1789	2016-05-18 20:50:41.722671	2016-05-18 21:27:29.851115	4	ENSG00000157764	missense
2190	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"trametinib, MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22805292, 22798288\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23715574\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	140453146	140453146	G	C	DOID:1909	12068308	included	ENST00000288602	p.L597V	BRAF	-1	c.1789	2016-05-18 20:50:41.752788	2016-05-18 21:27:29.9263	4	ENSG00000157764	missense
2191	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"trametinib, MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22805292, 22798288\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23715574\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	140453146	140453146	G	C	DOID:1909	12460919	included	ENST00000288602	p.L597V	BRAF	-1	c.1789	2016-05-18 20:50:41.773324	2016-05-18 21:27:29.979533	4	ENSG00000157764	missense
2777	\N	\N		19	40742220	40742220	T	C	DOID:9256	25157968	included	ENST00000392038	p.S302G	AKT2	-1	c.904	2016-05-18 21:06:58.447351	2016-05-18 21:28:10.725815	5	ENSG00000105221	missense
2192	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"trametinib, MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22805292, 22798288\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23715574\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	140453146	140453146	G	C	DOID:1909	21483012	included	ENST00000288602	p.L597V	BRAF	-1	c.1789	2016-05-18 20:50:41.801283	2016-05-18 21:27:30.063893	4	ENSG00000157764	missense
2193	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"trametinib, MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22805292, 22798288\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23715574\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	140453146	140453146	G	C	DOID:1909	19010912	included	ENST00000288602	p.L597V	BRAF	-1	c.1789	2016-05-18 20:50:41.824656	2016-05-18 21:27:30.135751	4	ENSG00000157764	missense
2194	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"trametinib, MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22805292, 22798288\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23715574\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	140453146	140453146	G	C	DOID:1909	22649091	included	ENST00000288602	p.L597V	BRAF	-1	c.1789	2016-05-18 20:50:41.855839	2016-05-18 21:27:30.208503	4	ENSG00000157764	missense
2195	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"trametinib, MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22805292, 22798288\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23715574\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	140453146	140453146	G	C	DOID:1909	19238210	included	ENST00000288602	p.L597V	BRAF	-1	c.1789	2016-05-18 20:50:41.88487	2016-05-18 21:27:30.28564	4	ENSG00000157764	missense
2196	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"trametinib, MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22805292, 22798288\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23715574\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	140453146	140453146	G	C	DOID:1909	22798288	included	ENST00000288602	p.L597V	BRAF	-1	c.1789	2016-05-18 20:50:41.923084	2016-05-18 21:27:30.350686	4	ENSG00000157764	missense
2197	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"trametinib, MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22805292, 22798288\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23715574\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	140453146	140453146	G	C	DOID:1909	22805292	included	ENST00000288602	p.L597V	BRAF	-1	c.1789	2016-05-18 20:50:41.951352	2016-05-18 21:27:30.426905	4	ENSG00000157764	missense
2198	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"trametinib, MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22805292, 22798288\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23715574\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	140453146	140453146	G	C	DOID:1909	23715574	included	ENST00000288602	p.L597V	BRAF	-1	c.1789	2016-05-18 20:50:42.004941	2016-05-18 21:27:30.495649	4	ENSG00000157764	missense
2199	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"sorafenib\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"18794803\\",\\"Effect\\":\\"gain-of-function (low activity)\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	140453154	140453154	T	C	DOID:1909	12068308	included	ENST00000288602	p.D594G	BRAF	-1	c.1781	2016-05-18 20:50:42.231697	2016-05-18 21:27:30.553262	4	ENSG00000157764	missense
2200	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"sorafenib\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"18794803\\",\\"Effect\\":\\"gain-of-function (low activity)\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	140453154	140453154	T	C	DOID:1909	14679157	included	ENST00000288602	p.D594G	BRAF	-1	c.1781	2016-05-18 20:50:42.250956	2016-05-18 21:27:30.610546	4	ENSG00000157764	missense
2201	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"sorafenib\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"18794803\\",\\"Effect\\":\\"gain-of-function (low activity)\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	140453154	140453154	T	C	DOID:1909	18794803	included	ENST00000288602	p.D594G	BRAF	-1	c.1781	2016-05-18 20:50:42.266583	2016-05-18 21:27:30.69089	4	ENSG00000157764	missense
2202	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"sorafenib\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"18794803\\",\\"Effect\\":\\"gain-of-function (low activity)\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	140481402	140481402	C	T	DOID:1909	18794803	included	ENST00000288602	p.G469E	BRAF	-1	c.1406	2016-05-18 20:50:42.281267	2016-05-18 21:27:30.747982	4	ENSG00000157764	missense
2778	\N	\N		19	40742220	40742220	T	C	DOID:9256	16094359	included	ENST00000392038	p.S302G	AKT2	-1	c.904	2016-05-18 21:06:58.458558	2016-05-18 21:28:10.776175	5	ENSG00000105221	missense
2209	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"selumetinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"J Clin Oncol 2013;31: (suppl; abstr CRA9003)\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"PI3K pathway inhibitors + MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22733540, 22808163\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		19	3118942	3118942	A	C	DOID:1909	21083380	included	ENST00000078429	p.Q209P	GNA11	1	c.626	2016-05-18 20:50:42.413928	2016-05-18 21:27:31.361358	4	ENSG00000088256	missense
2210	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"selumetinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"J Clin Oncol 2013;31: (suppl; abstr CRA9003)\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"PI3K pathway inhibitors + MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22733540, 22808163\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		19	3118942	3118942	A	C	DOID:1909	2549426	included	ENST00000078429	p.Q209P	GNA11	1	c.626	2016-05-18 20:50:42.448654	2016-05-18 21:27:31.424111	4	ENSG00000088256	missense
2211	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"selumetinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"J Clin Oncol 2013;31: (suppl; abstr CRA9003)\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"PI3K pathway inhibitors + MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22733540, 22808163\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		19	3118942	3118942	A	C	DOID:1909	1328859	included	ENST00000078429	p.Q209P	GNA11	1	c.626	2016-05-18 20:50:42.481582	2016-05-18 21:27:31.504571	4	ENSG00000088256	missense
2212	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"selumetinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"J Clin Oncol 2013;31: (suppl; abstr CRA9003)\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"PI3K pathway inhibitors + MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22733540, 22808163\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		19	3118942	3118942	A	C	DOID:1909	22733540	included	ENST00000078429	p.Q209P	GNA11	1	c.626	2016-05-18 20:50:42.492572	2016-05-18 21:27:31.587703	4	ENSG00000088256	missense
2213	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"selumetinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"J Clin Oncol 2013;31: (suppl; abstr CRA9003)\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"PI3K pathway inhibitors + MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22733540, 22808163\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		19	3118942	3118942	A	C	DOID:1909	22808163	included	ENST00000078429	p.Q209P	GNA11	1	c.626	2016-05-18 20:50:42.545976	2016-05-18 21:27:31.659472	4	ENSG00000088256	missense
2214	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"selumetinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"J Clin Oncol 2013;31: (suppl; abstr CRA9003)\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"PI3K pathway inhibitors + MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22733540, 22808163\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		19	3118942	3118942	A	T	DOID:1909	21083380	included	ENST00000078429	p.Q209L	GNA11	1	c.626	2016-05-18 20:50:42.555154	2016-05-18 21:27:31.736871	4	ENSG00000088256	missense
2215	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"selumetinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"J Clin Oncol 2013;31: (suppl; abstr CRA9003)\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"PI3K pathway inhibitors + MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22733540, 22808163\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		19	3118942	3118942	A	T	DOID:1909	2549426	included	ENST00000078429	p.Q209L	GNA11	1	c.626	2016-05-18 20:50:42.585428	2016-05-18 21:27:31.825308	4	ENSG00000088256	missense
2216	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"selumetinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"J Clin Oncol 2013;31: (suppl; abstr CRA9003)\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"PI3K pathway inhibitors + MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22733540, 22808163\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		19	3118942	3118942	A	T	DOID:1909	1328859	included	ENST00000078429	p.Q209L	GNA11	1	c.626	2016-05-18 20:50:42.612043	2016-05-18 21:27:31.882903	4	ENSG00000088256	missense
2217	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"selumetinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"J Clin Oncol 2013;31: (suppl; abstr CRA9003)\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"PI3K pathway inhibitors + MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22733540, 22808163\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		19	3118942	3118942	A	T	DOID:1909	22733540	included	ENST00000078429	p.Q209L	GNA11	1	c.626	2016-05-18 20:50:42.63722	2016-05-18 21:27:31.955603	4	ENSG00000088256	missense
2779	\N	\N		5	112175219	112175229	AAGATTGGAAC	-	DOID:162	25157968	included	ENST00000257430	p.KIGT1310X	APC	1	c.3928	2016-05-18 21:06:58.480409	2016-05-18 21:28:10.837398	5	ENSG00000134982	frameshift
2780	\N	\N		5	112175219	112175238	AAGATTGGAACTAGGTCAGC	-	DOID:162	25157968	included	ENST00000257430	p.KIGTRSA1310X	APC	1	c.3928	2016-05-18 21:06:58.492811	2016-05-18 21:28:10.889602	5	ENSG00000134982	frameshift
2781	\N	\N		5	112175687	112175691	GGACC	-	DOID:162	25157968	included	ENST00000257430	p.GP1466X	APC	1	c.4396	2016-05-18 21:06:58.514556	2016-05-18 21:28:10.939197	5	ENSG00000134982	frameshift
2218	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"selumetinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"J Clin Oncol 2013;31: (suppl; abstr CRA9003)\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"PI3K pathway inhibitors + MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22733540, 22808163\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		19	3118942	3118942	A	T	DOID:1909	22808163	included	ENST00000078429	p.Q209L	GNA11	1	c.626	2016-05-18 20:50:42.647609	2016-05-18 21:27:32.014132	4	ENSG00000088256	missense
2219	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"selumetinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"J Clin Oncol 2013;31: (suppl; abstr CRA9003)\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"PI3K pathway inhibitors + MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22733540, 22808163\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"PKC inhibitor\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22653968, 22253748\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		9	80409488	80409488	T	A	DOID:1909	18719078	included	ENST00000286548	p.Q209L	GNAQ	-1	c.626	2016-05-18 20:50:42.668347	2016-05-18 21:27:32.081872	4	ENSG00000156052	missense
2220	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"selumetinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"J Clin Oncol 2013;31: (suppl; abstr CRA9003)\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"PI3K pathway inhibitors + MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22733540, 22808163\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"PKC inhibitor\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22653968, 22253748\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		9	80409488	80409488	T	A	DOID:1909	19078957	included	ENST00000286548	p.Q209L	GNAQ	-1	c.626	2016-05-18 20:50:42.678247	2016-05-18 21:27:32.166023	4	ENSG00000156052	missense
2221	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"selumetinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"J Clin Oncol 2013;31: (suppl; abstr CRA9003)\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"PI3K pathway inhibitors + MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22733540, 22808163\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"PKC inhibitor\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22653968, 22253748\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		9	80409488	80409488	T	A	DOID:1909	21083380	included	ENST00000286548	p.Q209L	GNAQ	-1	c.626	2016-05-18 20:50:42.697219	2016-05-18 21:27:32.237788	4	ENSG00000156052	missense
2222	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"selumetinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"J Clin Oncol 2013;31: (suppl; abstr CRA9003)\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"PI3K pathway inhibitors + MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22733540, 22808163\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"PKC inhibitor\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22653968, 22253748\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		9	80409488	80409488	T	A	DOID:1909	1328859	included	ENST00000286548	p.Q209L	GNAQ	-1	c.626	2016-05-18 20:50:42.706836	2016-05-18 21:27:32.315677	4	ENSG00000156052	missense
2223	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"selumetinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"J Clin Oncol 2013;31: (suppl; abstr CRA9003)\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"PI3K pathway inhibitors + MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22733540, 22808163\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"PKC inhibitor\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22653968, 22253748\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		9	80409488	80409488	T	A	DOID:1909	2549426	included	ENST00000286548	p.Q209L	GNAQ	-1	c.626	2016-05-18 20:50:42.730615	2016-05-18 21:27:32.406223	4	ENSG00000156052	missense
2224	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"selumetinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"J Clin Oncol 2013;31: (suppl; abstr CRA9003)\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"PI3K pathway inhibitors + MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22733540, 22808163\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"PKC inhibitor\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22653968, 22253748\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		9	80409488	80409488	T	A	DOID:1909	22733540	included	ENST00000286548	p.Q209L	GNAQ	-1	c.626	2016-05-18 20:50:42.740229	2016-05-18 21:27:32.489439	4	ENSG00000156052	missense
2249	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"vemurafenib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23569304\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors, MEK inhibitors\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"19915144\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		15	66727451	66727451	A	C	DOID:1909	23569304	included	ENST00000307102	p.Q56P	MAP2K1	1	c.167	2016-05-18 20:50:43.215834	2016-05-18 21:27:34.341825	4	ENSG00000169032	missense
2225	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"selumetinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"J Clin Oncol 2013;31: (suppl; abstr CRA9003)\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"PI3K pathway inhibitors + MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22733540, 22808163\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"PKC inhibitor\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22653968, 22253748\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		9	80409488	80409488	T	A	DOID:1909	22808163	included	ENST00000286548	p.Q209L	GNAQ	-1	c.626	2016-05-18 20:50:42.750254	2016-05-18 21:27:32.547493	4	ENSG00000156052	missense
2226	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"selumetinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"J Clin Oncol 2013;31: (suppl; abstr CRA9003)\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"PI3K pathway inhibitors + MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22733540, 22808163\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"PKC inhibitor\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22653968, 22253748\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		9	80409488	80409488	T	A	DOID:1909	22653968	included	ENST00000286548	p.Q209L	GNAQ	-1	c.626	2016-05-18 20:50:42.772887	2016-05-18 21:27:32.627669	4	ENSG00000156052	missense
2227	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"selumetinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"J Clin Oncol 2013;31: (suppl; abstr CRA9003)\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"PI3K pathway inhibitors + MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22733540, 22808163\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"PKC inhibitor\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22653968, 22253748\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		9	80409488	80409488	T	A	DOID:1909	22253748	included	ENST00000286548	p.Q209L	GNAQ	-1	c.626	2016-05-18 20:50:42.799786	2016-05-18 21:27:32.695625	4	ENSG00000156052	missense
2228	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"selumetinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"J Clin Oncol 2013;31: (suppl; abstr CRA9003)\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"PI3K pathway inhibitors + MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22733540, 22808163\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"PKC inhibitor\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22653968, 22253748\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		9	80409488	80409488	T	C	DOID:1909	18719078	included	ENST00000286548	p.Q209R	GNAQ	-1	c.626	2016-05-18 20:50:42.811092	2016-05-18 21:27:32.756164	4	ENSG00000156052	missense
2229	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"selumetinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"J Clin Oncol 2013;31: (suppl; abstr CRA9003)\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"PI3K pathway inhibitors + MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22733540, 22808163\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"PKC inhibitor\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22653968, 22253748\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		9	80409488	80409488	T	C	DOID:1909	19078957	included	ENST00000286548	p.Q209R	GNAQ	-1	c.626	2016-05-18 20:50:42.832322	2016-05-18 21:27:32.84514	4	ENSG00000156052	missense
2230	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"selumetinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"J Clin Oncol 2013;31: (suppl; abstr CRA9003)\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"PI3K pathway inhibitors + MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22733540, 22808163\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"PKC inhibitor\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22653968, 22253748\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		9	80409488	80409488	T	C	DOID:1909	21083380	included	ENST00000286548	p.Q209R	GNAQ	-1	c.626	2016-05-18 20:50:42.842057	2016-05-18 21:27:32.912473	4	ENSG00000156052	missense
2231	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"selumetinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"J Clin Oncol 2013;31: (suppl; abstr CRA9003)\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"PI3K pathway inhibitors + MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22733540, 22808163\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"PKC inhibitor\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22653968, 22253748\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		9	80409488	80409488	T	C	DOID:1909	1328859	included	ENST00000286548	p.Q209R	GNAQ	-1	c.626	2016-05-18 20:50:42.852274	2016-05-18 21:27:32.989451	4	ENSG00000156052	missense
2262	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"BRAF inhibitors, MEK inhibitors\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"19915144\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		15	66729163	66729163	C	T	DOID:1909	22197931	included	ENST00000307102	p.P124L	MAP2K1	1	c.371	2016-05-18 20:50:43.417528	2016-05-18 21:27:35.385355	4	ENSG00000169032	missense
2232	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"selumetinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"J Clin Oncol 2013;31: (suppl; abstr CRA9003)\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"PI3K pathway inhibitors + MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22733540, 22808163\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"PKC inhibitor\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22653968, 22253748\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		9	80409488	80409488	T	C	DOID:1909	2549426	included	ENST00000286548	p.Q209R	GNAQ	-1	c.626	2016-05-18 20:50:42.87659	2016-05-18 21:27:33.060173	4	ENSG00000156052	missense
2233	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"selumetinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"J Clin Oncol 2013;31: (suppl; abstr CRA9003)\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"PI3K pathway inhibitors + MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22733540, 22808163\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"PKC inhibitor\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22653968, 22253748\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		9	80409488	80409488	T	C	DOID:1909	22733540	included	ENST00000286548	p.Q209R	GNAQ	-1	c.626	2016-05-18 20:50:42.905236	2016-05-18 21:27:33.136992	4	ENSG00000156052	missense
2234	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"selumetinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"J Clin Oncol 2013;31: (suppl; abstr CRA9003)\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"PI3K pathway inhibitors + MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22733540, 22808163\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"PKC inhibitor\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22653968, 22253748\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		9	80409488	80409488	T	C	DOID:1909	22808163	included	ENST00000286548	p.Q209R	GNAQ	-1	c.626	2016-05-18 20:50:42.933013	2016-05-18 21:27:33.213288	4	ENSG00000156052	missense
2235	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"selumetinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"J Clin Oncol 2013;31: (suppl; abstr CRA9003)\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"PI3K pathway inhibitors + MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22733540, 22808163\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"PKC inhibitor\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22653968, 22253748\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		9	80409488	80409488	T	C	DOID:1909	22653968	included	ENST00000286548	p.Q209R	GNAQ	-1	c.626	2016-05-18 20:50:42.944433	2016-05-18 21:27:33.278492	4	ENSG00000156052	missense
2236	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"selumetinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"J Clin Oncol 2013;31: (suppl; abstr CRA9003)\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"PI3K pathway inhibitors + MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22733540, 22808163\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"PKC inhibitor\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22653968, 22253748\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		9	80409488	80409488	T	C	DOID:1909	22253748	included	ENST00000286548	p.Q209R	GNAQ	-1	c.626	2016-05-18 20:50:42.954867	2016-05-18 21:27:33.366197	4	ENSG00000156052	missense
2237	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"selumetinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"J Clin Oncol 2013;31: (suppl; abstr CRA9003)\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"PI3K pathway inhibitors + MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22733540, 22808163\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"PKC inhibitor\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22653968, 22253748\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		9	80409488	80409488	T	G	DOID:1909	18719078	included	ENST00000286548	p.Q209P	GNAQ	-1	c.626	2016-05-18 20:50:42.98074	2016-05-18 21:27:33.431077	4	ENSG00000156052	missense
2238	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"selumetinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"J Clin Oncol 2013;31: (suppl; abstr CRA9003)\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"PI3K pathway inhibitors + MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22733540, 22808163\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"PKC inhibitor\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22653968, 22253748\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		9	80409488	80409488	T	G	DOID:1909	19078957	included	ENST00000286548	p.Q209P	GNAQ	-1	c.626	2016-05-18 20:50:43.004415	2016-05-18 21:27:33.494416	4	ENSG00000156052	missense
2263	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"BRAF inhibitors, MEK inhibitors\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"19915144\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		15	66729163	66729163	C	T	DOID:1909	19915144	included	ENST00000307102	p.P124L	MAP2K1	1	c.371	2016-05-18 20:50:43.425494	2016-05-18 21:27:35.432782	4	ENSG00000169032	missense
2239	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"selumetinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"J Clin Oncol 2013;31: (suppl; abstr CRA9003)\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"PI3K pathway inhibitors + MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22733540, 22808163\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"PKC inhibitor\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22653968, 22253748\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		9	80409488	80409488	T	G	DOID:1909	21083380	included	ENST00000286548	p.Q209P	GNAQ	-1	c.626	2016-05-18 20:50:43.022805	2016-05-18 21:27:33.580253	4	ENSG00000156052	missense
2240	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"selumetinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"J Clin Oncol 2013;31: (suppl; abstr CRA9003)\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"PI3K pathway inhibitors + MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22733540, 22808163\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"PKC inhibitor\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22653968, 22253748\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		9	80409488	80409488	T	G	DOID:1909	1328859	included	ENST00000286548	p.Q209P	GNAQ	-1	c.626	2016-05-18 20:50:43.049111	2016-05-18 21:27:33.645251	4	ENSG00000156052	missense
2241	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"selumetinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"J Clin Oncol 2013;31: (suppl; abstr CRA9003)\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"PI3K pathway inhibitors + MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22733540, 22808163\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"PKC inhibitor\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22653968, 22253748\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		9	80409488	80409488	T	G	DOID:1909	2549426	included	ENST00000286548	p.Q209P	GNAQ	-1	c.626	2016-05-18 20:50:43.105074	2016-05-18 21:27:33.739141	4	ENSG00000156052	missense
2242	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"selumetinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"J Clin Oncol 2013;31: (suppl; abstr CRA9003)\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"PI3K pathway inhibitors + MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22733540, 22808163\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"PKC inhibitor\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22653968, 22253748\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		9	80409488	80409488	T	G	DOID:1909	22733540	included	ENST00000286548	p.Q209P	GNAQ	-1	c.626	2016-05-18 20:50:43.116516	2016-05-18 21:27:33.816559	4	ENSG00000156052	missense
2243	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"selumetinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"J Clin Oncol 2013;31: (suppl; abstr CRA9003)\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"PI3K pathway inhibitors + MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22733540, 22808163\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"PKC inhibitor\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22653968, 22253748\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		9	80409488	80409488	T	G	DOID:1909	22808163	included	ENST00000286548	p.Q209P	GNAQ	-1	c.626	2016-05-18 20:50:43.137379	2016-05-18 21:27:33.899942	4	ENSG00000156052	missense
2244	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"selumetinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"J Clin Oncol 2013;31: (suppl; abstr CRA9003)\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"PI3K pathway inhibitors + MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22733540, 22808163\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"PKC inhibitor\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22653968, 22253748\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		9	80409488	80409488	T	G	DOID:1909	22653968	included	ENST00000286548	p.Q209P	GNAQ	-1	c.626	2016-05-18 20:50:43.150065	2016-05-18 21:27:33.970654	4	ENSG00000156052	missense
2245	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"selumetinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"J Clin Oncol 2013;31: (suppl; abstr CRA9003)\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"PI3K pathway inhibitors + MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22733540, 22808163\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"PKC inhibitor\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22653968, 22253748\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		9	80409488	80409488	T	G	DOID:1909	22253748	included	ENST00000286548	p.Q209P	GNAQ	-1	c.626	2016-05-18 20:50:43.167386	2016-05-18 21:27:34.055767	4	ENSG00000156052	missense
2246	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"imatinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23775962\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		4	55599332	55599332	G	T	DOID:1909	20088873	included	ENST00000288135	p.D820Y	KIT	1	c.2458	2016-05-18 20:50:43.177297	2016-05-18 21:27:34.144181	4	ENSG00000157404	missense
2250	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"vemurafenib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23569304\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors, MEK inhibitors\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"19915144\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		15	66727451	66727451	A	C	DOID:1909	19915144	included	ENST00000307102	p.Q56P	MAP2K1	1	c.167	2016-05-18 20:50:43.244161	2016-05-18 21:27:34.427072	4	ENSG00000169032	missense
2251	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"vemurafenib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23569304\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		15	66727453	66727453	A	G	DOID:1909	23569304	included	ENST00000307102	p.K57E	MAP2K1	1	c.169	2016-05-18 20:50:43.267834	2016-05-18 21:27:34.511796	4	ENSG00000169032	missense
2252	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23444215\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		15	66727455	66727455	G	C	DOID:1909	23444215	included	ENST00000307102	p.K57N	MAP2K1	1	c.171	2016-05-18 20:50:43.278292	2016-05-18 21:27:34.591655	4	ENSG00000169032	missense
2253	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23444215\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		15	66727455	66727455	G	T	DOID:1909	23444215	included	ENST00000307102	p.K57N	MAP2K1	1	c.171	2016-05-18 20:50:43.310113	2016-05-18 21:27:34.649058	4	ENSG00000169032	missense
2254	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"BRAF inhibitors in BRAF mutant tumor\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22588879\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		15	66729124	66729124	T	G	DOID:1909	22197931	included	ENST00000307102	p.I111S	MAP2K1	1	c.332	2016-05-18 20:50:43.319222	2016-05-18 21:27:34.718715	4	ENSG00000169032	missense
2255	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"BRAF inhibitors in BRAF mutant tumor\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22588879\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		15	66729124	66729124	T	G	DOID:1909	22588879	included	ENST00000307102	p.I111S	MAP2K1	1	c.332	2016-05-18 20:50:43.327306	2016-05-18 21:27:34.770666	4	ENSG00000169032	missense
2256	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"BRAF inhibitors, MEK inhibitors\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"21383288\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"novel MEK inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"24448821\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		15	66729154	66729154	G	C	DOID:1909	22197931	included	ENST00000307102	p.C121S	MAP2K1	1	c.362	2016-05-18 20:50:43.33594	2016-05-18 21:27:34.844305	4	ENSG00000169032	missense
2257	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"BRAF inhibitors, MEK inhibitors\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"21383288\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"novel MEK inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"24448821\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		15	66729154	66729154	G	C	DOID:1909	21383288	included	ENST00000307102	p.C121S	MAP2K1	1	c.362	2016-05-18 20:50:43.34501	2016-05-18 21:27:34.920799	4	ENSG00000169032	missense
2258	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"BRAF inhibitors, MEK inhibitors\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"21383288\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"novel MEK inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"24448821\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		15	66729154	66729154	G	C	DOID:1909	22588879	included	ENST00000307102	p.C121S	MAP2K1	1	c.362	2016-05-18 20:50:43.359476	2016-05-18 21:27:34.997231	4	ENSG00000169032	missense
2259	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"BRAF inhibitors, MEK inhibitors\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"21383288\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"novel MEK inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"24448821\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		15	66729154	66729154	G	C	DOID:1909	24448821	included	ENST00000307102	p.C121S	MAP2K1	1	c.362	2016-05-18 20:50:43.368651	2016-05-18 21:27:35.079549	4	ENSG00000169032	missense
2260	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"BRAF inhibitors in BRAF mutant tumor\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22588879\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		15	66729162	66729162	C	T	DOID:1909	22197931	included	ENST00000307102	p.P124S	MAP2K1	1	c.370	2016-05-18 20:50:43.380478	2016-05-18 21:27:35.151655	4	ENSG00000169032	missense
2261	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"BRAF inhibitors in BRAF mutant tumor\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22588879\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		15	66729162	66729162	C	T	DOID:1909	22588879	included	ENST00000307102	p.P124S	MAP2K1	1	c.370	2016-05-18 20:50:43.407544	2016-05-18 21:27:35.226565	4	ENSG00000169032	missense
2266	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"19915144\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"ERK inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23614898\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		15	66729177	66729177	T	C	DOID:1909	19915144	included	ENST00000307102	p.F129L	MAP2K1	1	c.385	2016-05-18 20:50:43.451099	2016-05-18 21:27:35.676061	4	ENSG00000169032	missense
2267	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"19915144\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"ERK inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23614898\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		15	66729177	66729177	T	C	DOID:1909	23614898	included	ENST00000307102	p.F129L	MAP2K1	1	c.385	2016-05-18 20:50:43.465514	2016-05-18 21:27:35.740478	4	ENSG00000169032	missense
2268	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"vemurafenib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23569304\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors, MEK inhibitors\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"19915144\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		15	66774131	66774131	G	A	DOID:1909	22197931	included	ENST00000307102	p.E203K	MAP2K1	1	c.607	2016-05-18 20:50:43.474856	2016-05-18 21:27:35.80651	4	ENSG00000169032	missense
2269	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"vemurafenib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23569304\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors, MEK inhibitors\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"19915144\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		15	66774131	66774131	G	A	DOID:1909	23569304	included	ENST00000307102	p.E203K	MAP2K1	1	c.607	2016-05-18 20:50:43.508216	2016-05-18 21:27:35.885386	4	ENSG00000169032	missense
2270	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"vemurafenib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23569304\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors, MEK inhibitors\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"19915144\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		15	66774131	66774131	G	A	DOID:1909	19915144	included	ENST00000307102	p.E203K	MAP2K1	1	c.607	2016-05-18 20:50:43.51904	2016-05-18 21:27:35.942992	4	ENSG00000169032	missense
2271	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"BRAF inhibitors, MEK inhibitors\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"24265153\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"ERK inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"24265153\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		19	4110581	4110581	T	C	DOID:1909	24265153	included	ENST00000262948	p.N126D	MAP2K2	-1	c.376	2016-05-18 20:50:43.526868	2016-05-18 21:27:36.066602	4	ENSG00000126934	missense
2272	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"BRAF inhibitors, MEK inhibitors\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"24265153\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"ERK inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"24265153\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		19	4110584	4110584	A	T	DOID:1909	24265153	included	ENST00000262948	p.C125S	MAP2K2	-1	c.373	2016-05-18 20:50:43.536664	2016-05-18 21:27:36.154441	4	ENSG00000126934	missense
2273	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"BRAF + MEK inhibitors\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"24265154\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"ERK inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"24265154\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		19	4117541	4117541	T	G	DOID:1909	24265154	included	ENST00000262948	p.Q60P	MAP2K2	-1	c.179	2016-05-18 20:50:43.545605	2016-05-18 21:27:36.248993	4	ENSG00000126934	missense
2274	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"BRAF inhibitors, MEK inhibitors\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"24265153\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"ERK inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"24265153\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		19	4117584	4117584	G	A	DOID:1909	24265153	included	ENST00000262948	p.L46F	MAP2K2	-1	c.136	2016-05-18 20:50:43.560433	2016-05-18 21:27:36.331353	4	ENSG00000126934	missense
2422	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"19915144\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"ERK inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23614898\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		15	66729100	66729100	T	A	DOID:162	19915144	included	ENST00000307102	p.I103N	MAP2K1	1	c.308	2016-05-18 20:50:49.311885	2016-05-18 21:27:48.857557	4	ENSG00000169032	missense
2782	\N	\N		5	112175960	112175967	ATTGATTC	-	DOID:162	25157968	included	ENST00000257430	p.IDS1557X	APC	1	c.4669	2016-05-18 21:06:58.526796	2016-05-18 21:28:11.007728	5	ENSG00000134982	frameshift
2276	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"late trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23414587\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"18390968, 22761467\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors + CDK4/6 inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"ASCO 2014; abstr 9009\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"HSP90 inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23538902\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23569304.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"preclinical\\",\\"Assocation\\":\\"ERK inhibitors\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23614898\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		1	115256528	115256528	T	A	DOID:1909	8120410	included	ENST00000369535	p.Q61H	NRAS	-1	c.183	2016-05-18 20:50:43.581547	2016-05-18 21:27:36.497481	4	ENSG00000213281	missense
2277	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"late trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23414587\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"18390968, 22761467\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors + CDK4/6 inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"ASCO 2014; abstr 9009\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"HSP90 inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23538902\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23569304.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"preclinical\\",\\"Assocation\\":\\"ERK inhibitors\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23614898\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		1	115256528	115256528	T	A	DOID:1909	16291983	included	ENST00000369535	p.Q61H	NRAS	-1	c.183	2016-05-18 20:50:43.615441	2016-05-18 21:27:36.587883	4	ENSG00000213281	missense
2278	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"late trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23414587\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"18390968, 22761467\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors + CDK4/6 inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"ASCO 2014; abstr 9009\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"HSP90 inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23538902\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23569304.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"preclinical\\",\\"Assocation\\":\\"ERK inhibitors\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23614898\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		1	115256528	115256528	T	A	DOID:1909	2674680	included	ENST00000369535	p.Q61H	NRAS	-1	c.183	2016-05-18 20:50:43.637591	2016-05-18 21:27:36.670219	4	ENSG00000213281	missense
2279	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"late trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23414587\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"18390968, 22761467\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors + CDK4/6 inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"ASCO 2014; abstr 9009\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"HSP90 inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23538902\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23569304.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"preclinical\\",\\"Assocation\\":\\"ERK inhibitors\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23614898\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		1	115256528	115256528	T	A	DOID:1909	20130576	included	ENST00000369535	p.Q61H	NRAS	-1	c.183	2016-05-18 20:50:43.650427	2016-05-18 21:27:36.746477	4	ENSG00000213281	missense
2387	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"vemurafenib, dabrafenib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22608338, 20818844, 23489023\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22241789\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK-enhanced radioiodine uptake\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23406027\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors + MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"J Clin Oncol 2013;31(suppl; abstr 9029)\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	140453136	140453136	A	T	DOID:1781	20818844	included	ENST00000288602	p.V600E	BRAF	-1	c.1799	2016-05-18 20:50:48.41386	2016-05-18 21:27:45.699873	4	ENSG00000157764	missense
2783	\N	\N		7	140481478	140481478	G	A	DOID:1909	18060073	included	ENST00000288602	p.R444W	BRAF	-1	c.1330	2016-05-18 21:06:58.547659	2016-05-18 21:28:11.06125	5	ENSG00000157764	missense
2280	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"late trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23414587\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"18390968, 22761467\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors + CDK4/6 inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"ASCO 2014; abstr 9009\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"HSP90 inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23538902\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23569304.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"preclinical\\",\\"Assocation\\":\\"ERK inhibitors\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23614898\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		1	115256528	115256528	T	A	DOID:1909	20179705	included	ENST00000369535	p.Q61H	NRAS	-1	c.183	2016-05-18 20:50:43.700192	2016-05-18 21:27:36.822828	4	ENSG00000213281	missense
2281	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"late trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23414587\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"18390968, 22761467\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors + CDK4/6 inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"ASCO 2014; abstr 9009\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"HSP90 inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23538902\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23569304.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"preclinical\\",\\"Assocation\\":\\"ERK inhibitors\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23614898\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		1	115256528	115256528	T	A	DOID:1909	23414587	included	ENST00000369535	p.Q61H	NRAS	-1	c.183	2016-05-18 20:50:43.720452	2016-05-18 21:27:36.915532	4	ENSG00000213281	missense
2282	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"late trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23414587\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"18390968, 22761467\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors + CDK4/6 inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"ASCO 2014; abstr 9009\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"HSP90 inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23538902\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23569304.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"preclinical\\",\\"Assocation\\":\\"ERK inhibitors\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23614898\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		1	115256528	115256528	T	A	DOID:1909	18390968	included	ENST00000369535	p.Q61H	NRAS	-1	c.183	2016-05-18 20:50:43.774294	2016-05-18 21:27:36.983098	4	ENSG00000213281	missense
2283	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"late trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23414587\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"18390968, 22761467\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors + CDK4/6 inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"ASCO 2014; abstr 9009\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"HSP90 inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23538902\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23569304.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"preclinical\\",\\"Assocation\\":\\"ERK inhibitors\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23614898\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		1	115256528	115256528	T	A	DOID:1909	22761467	included	ENST00000369535	p.Q61H	NRAS	-1	c.183	2016-05-18 20:50:43.8084	2016-05-18 21:27:37.07031	4	ENSG00000213281	missense
2388	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"vemurafenib, dabrafenib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22608338, 20818844, 23489023\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22241789\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK-enhanced radioiodine uptake\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23406027\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors + MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"J Clin Oncol 2013;31(suppl; abstr 9029)\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	140453136	140453136	A	T	DOID:1781	19255327	included	ENST00000288602	p.V600E	BRAF	-1	c.1799	2016-05-18 20:50:48.447646	2016-05-18 21:27:45.790751	4	ENSG00000157764	missense
2785	\N	\N		7	140481418	140481418	C	T	DOID:1909	25157968	included	ENST00000288602	p.G464R	BRAF	-1	c.1390	2016-05-18 21:06:58.582075	2016-05-18 21:28:11.146678	5	ENSG00000157764	missense
2284	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"late trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23414587\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"18390968, 22761467\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors + CDK4/6 inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"ASCO 2014; abstr 9009\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"HSP90 inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23538902\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23569304.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"preclinical\\",\\"Assocation\\":\\"ERK inhibitors\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23614898\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		1	115256528	115256528	T	A	DOID:1909	23538902	included	ENST00000369535	p.Q61H	NRAS	-1	c.183	2016-05-18 20:50:43.881752	2016-05-18 21:27:37.150626	4	ENSG00000213281	missense
2285	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"late trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23414587\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"18390968, 22761467\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors + CDK4/6 inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"ASCO 2014; abstr 9009\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"HSP90 inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23538902\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23569304.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"preclinical\\",\\"Assocation\\":\\"ERK inhibitors\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23614898\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		1	115256528	115256528	T	A	DOID:1909	23569304	included	ENST00000369535	p.Q61H	NRAS	-1	c.183	2016-05-18 20:50:43.944742	2016-05-18 21:27:37.23517	4	ENSG00000213281	missense
2286	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"late trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23414587\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"18390968, 22761467\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors + CDK4/6 inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"ASCO 2014; abstr 9009\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"HSP90 inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23538902\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23569304.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"preclinical\\",\\"Assocation\\":\\"ERK inhibitors\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23614898\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		1	115256528	115256528	T	A	DOID:1909	23614898	included	ENST00000369535	p.Q61H	NRAS	-1	c.183	2016-05-18 20:50:44.027885	2016-05-18 21:27:37.31326	4	ENSG00000213281	missense
2287	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"late trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23414587\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"18390968, 22761467\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors + CDK4/6 inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"ASCO 2014; abstr 9009\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"HSP90 inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23538902\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23569304.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"preclinical\\",\\"Assocation\\":\\"ERK inhibitors\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23614898\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		1	115256528	115256528	T	G	DOID:1909	8120410	included	ENST00000369535	p.Q61H	NRAS	-1	c.183	2016-05-18 20:50:44.067906	2016-05-18 21:27:37.404121	4	ENSG00000213281	missense
2389	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"vemurafenib, dabrafenib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22608338, 20818844, 23489023\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22241789\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK-enhanced radioiodine uptake\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23406027\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors + MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"J Clin Oncol 2013;31(suppl; abstr 9029)\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	140453136	140453136	A	T	DOID:1781	19773371	included	ENST00000288602	p.V600E	BRAF	-1	c.1799	2016-05-18 20:50:48.507411	2016-05-18 21:27:45.891858	4	ENSG00000157764	missense
2786	\N	\N		7	140481418	140481418	C	T	DOID:1909	24918823	included	ENST00000288602	p.G464R	BRAF	-1	c.1390	2016-05-18 21:06:58.592734	2016-05-18 21:28:11.184772	5	ENSG00000157764	missense
2288	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"late trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23414587\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"18390968, 22761467\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors + CDK4/6 inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"ASCO 2014; abstr 9009\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"HSP90 inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23538902\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23569304.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"preclinical\\",\\"Assocation\\":\\"ERK inhibitors\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23614898\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		1	115256528	115256528	T	G	DOID:1909	16291983	included	ENST00000369535	p.Q61H	NRAS	-1	c.183	2016-05-18 20:50:44.116577	2016-05-18 21:27:37.48663	4	ENSG00000213281	missense
2289	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"late trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23414587\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"18390968, 22761467\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors + CDK4/6 inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"ASCO 2014; abstr 9009\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"HSP90 inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23538902\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23569304.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"preclinical\\",\\"Assocation\\":\\"ERK inhibitors\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23614898\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		1	115256528	115256528	T	G	DOID:1909	2674680	included	ENST00000369535	p.Q61H	NRAS	-1	c.183	2016-05-18 20:50:44.193997	2016-05-18 21:27:37.570801	4	ENSG00000213281	missense
2290	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"late trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23414587\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"18390968, 22761467\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors + CDK4/6 inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"ASCO 2014; abstr 9009\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"HSP90 inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23538902\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23569304.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"preclinical\\",\\"Assocation\\":\\"ERK inhibitors\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23614898\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		1	115256528	115256528	T	G	DOID:1909	20130576	included	ENST00000369535	p.Q61H	NRAS	-1	c.183	2016-05-18 20:50:44.243102	2016-05-18 21:27:37.647901	4	ENSG00000213281	missense
2291	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"late trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23414587\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"18390968, 22761467\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors + CDK4/6 inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"ASCO 2014; abstr 9009\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"HSP90 inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23538902\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23569304.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"preclinical\\",\\"Assocation\\":\\"ERK inhibitors\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23614898\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		1	115256528	115256528	T	G	DOID:1909	20179705	included	ENST00000369535	p.Q61H	NRAS	-1	c.183	2016-05-18 20:50:44.278717	2016-05-18 21:27:37.715698	4	ENSG00000213281	missense
2390	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"vemurafenib, dabrafenib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22608338, 20818844, 23489023\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22241789\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK-enhanced radioiodine uptake\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23406027\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors + MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"J Clin Oncol 2013;31(suppl; abstr 9029)\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	140453136	140453136	A	T	DOID:1781	12068308	included	ENST00000288602	p.V600E	BRAF	-1	c.1799	2016-05-18 20:50:48.542507	2016-05-18 21:27:45.972044	4	ENSG00000157764	missense
2787	\N	\N		7	140481411	140481411	C	G	DOID:1909	25157968	included	ENST00000288602	p.G466A	BRAF	-1	c.1397	2016-05-18 21:06:58.615168	2016-05-18 21:28:11.231535	5	ENSG00000157764	missense
2292	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"late trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23414587\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"18390968, 22761467\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors + CDK4/6 inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"ASCO 2014; abstr 9009\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"HSP90 inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23538902\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23569304.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"preclinical\\",\\"Assocation\\":\\"ERK inhibitors\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23614898\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		1	115256528	115256528	T	G	DOID:1909	23414587	included	ENST00000369535	p.Q61H	NRAS	-1	c.183	2016-05-18 20:50:44.334657	2016-05-18 21:27:37.798526	4	ENSG00000213281	missense
2293	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"late trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23414587\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"18390968, 22761467\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors + CDK4/6 inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"ASCO 2014; abstr 9009\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"HSP90 inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23538902\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23569304.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"preclinical\\",\\"Assocation\\":\\"ERK inhibitors\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23614898\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		1	115256528	115256528	T	G	DOID:1909	18390968	included	ENST00000369535	p.Q61H	NRAS	-1	c.183	2016-05-18 20:50:44.407079	2016-05-18 21:27:37.881808	4	ENSG00000213281	missense
2294	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"late trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23414587\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"18390968, 22761467\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors + CDK4/6 inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"ASCO 2014; abstr 9009\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"HSP90 inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23538902\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23569304.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"preclinical\\",\\"Assocation\\":\\"ERK inhibitors\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23614898\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		1	115256528	115256528	T	G	DOID:1909	22761467	included	ENST00000369535	p.Q61H	NRAS	-1	c.183	2016-05-18 20:50:44.468585	2016-05-18 21:27:37.965016	4	ENSG00000213281	missense
2295	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"late trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23414587\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"18390968, 22761467\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors + CDK4/6 inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"ASCO 2014; abstr 9009\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"HSP90 inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23538902\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23569304.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"preclinical\\",\\"Assocation\\":\\"ERK inhibitors\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23614898\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		1	115256528	115256528	T	G	DOID:1909	23538902	included	ENST00000369535	p.Q61H	NRAS	-1	c.183	2016-05-18 20:50:44.507127	2016-05-18 21:27:38.046838	4	ENSG00000213281	missense
2391	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"vemurafenib, dabrafenib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22608338, 20818844, 23489023\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22241789\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK-enhanced radioiodine uptake\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23406027\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors + MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"J Clin Oncol 2013;31(suppl; abstr 9029)\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	140453136	140453136	A	T	DOID:1781	18541894	included	ENST00000288602	p.V600E	BRAF	-1	c.1799	2016-05-18 20:50:48.585472	2016-05-18 21:27:46.052102	4	ENSG00000157764	missense
2788	\N	\N		7	140481411	140481411	C	T	DOID:1909	25157968	included	ENST00000288602	p.G466E	BRAF	-1	c.1397	2016-05-18 21:06:58.627737	2016-05-18 21:28:11.285666	5	ENSG00000157764	missense
2296	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"late trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23414587\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"18390968, 22761467\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors + CDK4/6 inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"ASCO 2014; abstr 9009\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"HSP90 inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23538902\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23569304.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"preclinical\\",\\"Assocation\\":\\"ERK inhibitors\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23614898\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		1	115256528	115256528	T	G	DOID:1909	23569304	included	ENST00000369535	p.Q61H	NRAS	-1	c.183	2016-05-18 20:50:44.538975	2016-05-18 21:27:38.131055	4	ENSG00000213281	missense
2297	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"late trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23414587\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"18390968, 22761467\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors + CDK4/6 inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"ASCO 2014; abstr 9009\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"HSP90 inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23538902\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23569304.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"preclinical\\",\\"Assocation\\":\\"ERK inhibitors\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23614898\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		1	115256528	115256528	T	G	DOID:1909	23614898	included	ENST00000369535	p.Q61H	NRAS	-1	c.183	2016-05-18 20:50:44.566449	2016-05-18 21:27:38.210577	4	ENSG00000213281	missense
2298	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"late trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23414587\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"18390968, 22761467\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors + CDK4/6 inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"ASCO 2014; abstr 9009\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"HSP90 inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23538902\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23569304.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"preclinical\\",\\"Assocation\\":\\"ERK inhibitors\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23614898\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		1	115256528	115256529	TT	CA	DOID:1909	8120410	included	ENST00000369535	p.Q61L	NRAS	-1	c.182	2016-05-18 20:50:44.581809	2016-05-18 21:27:38.307975	4	ENSG00000213281	missense
2299	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"late trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23414587\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"18390968, 22761467\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors + CDK4/6 inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"ASCO 2014; abstr 9009\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"HSP90 inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23538902\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23569304.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"preclinical\\",\\"Assocation\\":\\"ERK inhibitors\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23614898\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		1	115256528	115256529	TT	CA	DOID:1909	16291983	included	ENST00000369535	p.Q61L	NRAS	-1	c.182	2016-05-18 20:50:44.605619	2016-05-18 21:27:38.385551	4	ENSG00000213281	missense
2392	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"vemurafenib, dabrafenib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22608338, 20818844, 23489023\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22241789\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK-enhanced radioiodine uptake\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23406027\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors + MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"J Clin Oncol 2013;31(suppl; abstr 9029)\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	140453136	140453136	A	T	DOID:1781	20368568	included	ENST00000288602	p.V600E	BRAF	-1	c.1799	2016-05-18 20:50:48.616631	2016-05-18 21:27:46.138697	4	ENSG00000157764	missense
2789	\N	\N		7	140481411	140481411	C	T	DOID:1909	23273605	included	ENST00000288602	p.G466E	BRAF	-1	c.1397	2016-05-18 21:06:58.642973	2016-05-18 21:28:11.34369	5	ENSG00000157764	missense
2300	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"late trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23414587\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"18390968, 22761467\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors + CDK4/6 inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"ASCO 2014; abstr 9009\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"HSP90 inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23538902\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23569304.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"preclinical\\",\\"Assocation\\":\\"ERK inhibitors\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23614898\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		1	115256528	115256529	TT	CA	DOID:1909	2674680	included	ENST00000369535	p.Q61L	NRAS	-1	c.182	2016-05-18 20:50:44.63065	2016-05-18 21:27:38.446452	4	ENSG00000213281	missense
2301	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"late trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23414587\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"18390968, 22761467\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors + CDK4/6 inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"ASCO 2014; abstr 9009\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"HSP90 inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23538902\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23569304.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"preclinical\\",\\"Assocation\\":\\"ERK inhibitors\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23614898\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		1	115256528	115256529	TT	CA	DOID:1909	20130576	included	ENST00000369535	p.Q61L	NRAS	-1	c.182	2016-05-18 20:50:44.674918	2016-05-18 21:27:38.52284	4	ENSG00000213281	missense
2302	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"late trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23414587\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"18390968, 22761467\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors + CDK4/6 inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"ASCO 2014; abstr 9009\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"HSP90 inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23538902\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23569304.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"preclinical\\",\\"Assocation\\":\\"ERK inhibitors\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23614898\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		1	115256528	115256529	TT	CA	DOID:1909	20179705	included	ENST00000369535	p.Q61L	NRAS	-1	c.182	2016-05-18 20:50:44.712021	2016-05-18 21:27:38.605325	4	ENSG00000213281	missense
2303	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"late trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23414587\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"18390968, 22761467\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors + CDK4/6 inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"ASCO 2014; abstr 9009\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"HSP90 inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23538902\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23569304.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"preclinical\\",\\"Assocation\\":\\"ERK inhibitors\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23614898\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		1	115256528	115256529	TT	CA	DOID:1909	23414587	included	ENST00000369535	p.Q61L	NRAS	-1	c.182	2016-05-18 20:50:44.750106	2016-05-18 21:27:38.694366	4	ENSG00000213281	missense
2393	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"vemurafenib, dabrafenib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22608338, 20818844, 23489023\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22241789\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK-enhanced radioiodine uptake\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23406027\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors + MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"J Clin Oncol 2013;31(suppl; abstr 9029)\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	140453136	140453136	A	T	DOID:1781	22608338	included	ENST00000288602	p.V600E	BRAF	-1	c.1799	2016-05-18 20:50:48.664287	2016-05-18 21:27:46.217445	4	ENSG00000157764	missense
2790	\N	\N		7	140481411	140481411	C	A	DOID:3908	25157968	included	ENST00000288602	p.G466V	BRAF	-1	c.1397	2016-05-18 21:06:58.652236	2016-05-18 21:28:11.395249	5	ENSG00000157764	missense
2304	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"late trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23414587\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"18390968, 22761467\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors + CDK4/6 inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"ASCO 2014; abstr 9009\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"HSP90 inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23538902\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23569304.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"preclinical\\",\\"Assocation\\":\\"ERK inhibitors\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23614898\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		1	115256528	115256529	TT	CA	DOID:1909	18390968	included	ENST00000369535	p.Q61L	NRAS	-1	c.182	2016-05-18 20:50:44.804313	2016-05-18 21:27:38.780816	4	ENSG00000213281	missense
2305	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"late trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23414587\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"18390968, 22761467\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors + CDK4/6 inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"ASCO 2014; abstr 9009\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"HSP90 inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23538902\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23569304.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"preclinical\\",\\"Assocation\\":\\"ERK inhibitors\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23614898\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		1	115256528	115256529	TT	CA	DOID:1909	22761467	included	ENST00000369535	p.Q61L	NRAS	-1	c.182	2016-05-18 20:50:44.836822	2016-05-18 21:27:38.891386	4	ENSG00000213281	missense
2306	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"late trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23414587\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"18390968, 22761467\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors + CDK4/6 inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"ASCO 2014; abstr 9009\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"HSP90 inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23538902\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23569304.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"preclinical\\",\\"Assocation\\":\\"ERK inhibitors\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23614898\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		1	115256528	115256529	TT	CA	DOID:1909	23538902	included	ENST00000369535	p.Q61L	NRAS	-1	c.182	2016-05-18 20:50:44.864051	2016-05-18 21:27:38.98709	4	ENSG00000213281	missense
2307	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"late trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23414587\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"18390968, 22761467\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors + CDK4/6 inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"ASCO 2014; abstr 9009\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"HSP90 inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23538902\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23569304.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"preclinical\\",\\"Assocation\\":\\"ERK inhibitors\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23614898\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		1	115256528	115256529	TT	CA	DOID:1909	23569304	included	ENST00000369535	p.Q61L	NRAS	-1	c.182	2016-05-18 20:50:44.876348	2016-05-18 21:27:39.085416	4	ENSG00000213281	missense
2394	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"vemurafenib, dabrafenib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22608338, 20818844, 23489023\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22241789\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK-enhanced radioiodine uptake\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23406027\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors + MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"J Clin Oncol 2013;31(suppl; abstr 9029)\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	140453136	140453136	A	T	DOID:1781	23489023	included	ENST00000288602	p.V600E	BRAF	-1	c.1799	2016-05-18 20:50:48.685141	2016-05-18 21:27:46.291048	4	ENSG00000157764	missense
2791	\N	\N		7	140481411	140481411	C	A	DOID:3908	22649091	included	ENST00000288602	p.G466V	BRAF	-1	c.1397	2016-05-18 21:06:58.673433	2016-05-18 21:28:11.448997	5	ENSG00000157764	missense
2308	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"late trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23414587\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"18390968, 22761467\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors + CDK4/6 inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"ASCO 2014; abstr 9009\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"HSP90 inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23538902\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23569304.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"preclinical\\",\\"Assocation\\":\\"ERK inhibitors\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23614898\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		1	115256528	115256529	TT	CA	DOID:1909	23614898	included	ENST00000369535	p.Q61L	NRAS	-1	c.182	2016-05-18 20:50:44.902057	2016-05-18 21:27:39.152438	4	ENSG00000213281	missense
2309	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"late trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23414587\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"18390968, 22761467\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors + CDK4/6 inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"ASCO 2014; abstr 9009\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"HSP90 inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23538902\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23569304.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"preclinical\\",\\"Assocation\\":\\"ERK inhibitors\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23614898\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		1	115256528	115256529	TT	CC	DOID:1909	8120410	included	ENST00000369535	p.Q61R	NRAS	-1	c.182	2016-05-18 20:50:44.932485	2016-05-18 21:27:39.263117	4	ENSG00000213281	missense
2310	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"late trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23414587\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"18390968, 22761467\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors + CDK4/6 inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"ASCO 2014; abstr 9009\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"HSP90 inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23538902\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23569304.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"preclinical\\",\\"Assocation\\":\\"ERK inhibitors\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23614898\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		1	115256528	115256529	TT	CC	DOID:1909	16291983	included	ENST00000369535	p.Q61R	NRAS	-1	c.182	2016-05-18 20:50:44.946256	2016-05-18 21:27:39.345647	4	ENSG00000213281	missense
2311	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"late trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23414587\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"18390968, 22761467\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors + CDK4/6 inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"ASCO 2014; abstr 9009\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"HSP90 inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23538902\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23569304.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"preclinical\\",\\"Assocation\\":\\"ERK inhibitors\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23614898\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		1	115256528	115256529	TT	CC	DOID:1909	2674680	included	ENST00000369535	p.Q61R	NRAS	-1	c.182	2016-05-18 20:50:44.972429	2016-05-18 21:27:39.43127	4	ENSG00000213281	missense
2395	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"vemurafenib, dabrafenib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22608338, 20818844, 23489023\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22241789\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK-enhanced radioiodine uptake\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23406027\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors + MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"J Clin Oncol 2013;31(suppl; abstr 9029)\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	140453136	140453136	A	T	DOID:1781	22241789	included	ENST00000288602	p.V600E	BRAF	-1	c.1799	2016-05-18 20:50:48.708235	2016-05-18 21:27:46.350523	4	ENSG00000157764	missense
2792	\N	\N		7	140481402	140481402	C	G	DOID:3910	25157968	included	ENST00000288602	p.G469A	BRAF	-1	c.1406	2016-05-18 21:06:58.685189	2016-05-18 21:28:11.512433	5	ENSG00000157764	missense
2312	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"late trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23414587\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"18390968, 22761467\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors + CDK4/6 inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"ASCO 2014; abstr 9009\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"HSP90 inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23538902\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23569304.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"preclinical\\",\\"Assocation\\":\\"ERK inhibitors\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23614898\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		1	115256528	115256529	TT	CC	DOID:1909	20130576	included	ENST00000369535	p.Q61R	NRAS	-1	c.182	2016-05-18 20:50:45.000783	2016-05-18 21:27:39.510297	4	ENSG00000213281	missense
2313	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"late trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23414587\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"18390968, 22761467\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors + CDK4/6 inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"ASCO 2014; abstr 9009\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"HSP90 inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23538902\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23569304.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"preclinical\\",\\"Assocation\\":\\"ERK inhibitors\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23614898\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		1	115256528	115256529	TT	CC	DOID:1909	20179705	included	ENST00000369535	p.Q61R	NRAS	-1	c.182	2016-05-18 20:50:45.017077	2016-05-18 21:27:39.596516	4	ENSG00000213281	missense
2314	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"late trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23414587\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"18390968, 22761467\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors + CDK4/6 inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"ASCO 2014; abstr 9009\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"HSP90 inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23538902\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23569304.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"preclinical\\",\\"Assocation\\":\\"ERK inhibitors\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23614898\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		1	115256528	115256529	TT	CC	DOID:1909	23414587	included	ENST00000369535	p.Q61R	NRAS	-1	c.182	2016-05-18 20:50:45.041571	2016-05-18 21:27:39.67701	4	ENSG00000213281	missense
2315	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"late trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23414587\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"18390968, 22761467\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors + CDK4/6 inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"ASCO 2014; abstr 9009\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"HSP90 inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23538902\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23569304.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"preclinical\\",\\"Assocation\\":\\"ERK inhibitors\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23614898\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		1	115256528	115256529	TT	CC	DOID:1909	18390968	included	ENST00000369535	p.Q61R	NRAS	-1	c.182	2016-05-18 20:50:45.071065	2016-05-18 21:27:39.766731	4	ENSG00000213281	missense
2396	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"vemurafenib, dabrafenib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22608338, 20818844, 23489023\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22241789\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK-enhanced radioiodine uptake\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23406027\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors + MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"J Clin Oncol 2013;31(suppl; abstr 9029)\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	140453136	140453136	A	T	DOID:1781	23406027	included	ENST00000288602	p.V600E	BRAF	-1	c.1799	2016-05-18 20:50:48.739526	2016-05-18 21:27:46.407557	4	ENSG00000157764	missense
2793	\N	\N		7	140481402	140481402	C	G	DOID:3910	22773810	included	ENST00000288602	p.G469A	BRAF	-1	c.1406	2016-05-18 21:06:58.700154	2016-05-18 21:28:11.562698	5	ENSG00000157764	missense
2316	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"late trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23414587\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"18390968, 22761467\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors + CDK4/6 inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"ASCO 2014; abstr 9009\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"HSP90 inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23538902\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23569304.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"preclinical\\",\\"Assocation\\":\\"ERK inhibitors\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23614898\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		1	115256528	115256529	TT	CC	DOID:1909	22761467	included	ENST00000369535	p.Q61R	NRAS	-1	c.182	2016-05-18 20:50:45.09878	2016-05-18 21:27:39.847396	4	ENSG00000213281	missense
2317	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"late trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23414587\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"18390968, 22761467\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors + CDK4/6 inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"ASCO 2014; abstr 9009\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"HSP90 inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23538902\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23569304.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"preclinical\\",\\"Assocation\\":\\"ERK inhibitors\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23614898\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		1	115256528	115256529	TT	CC	DOID:1909	23538902	included	ENST00000369535	p.Q61R	NRAS	-1	c.182	2016-05-18 20:50:45.111988	2016-05-18 21:27:39.921833	4	ENSG00000213281	missense
2318	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"late trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23414587\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"18390968, 22761467\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors + CDK4/6 inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"ASCO 2014; abstr 9009\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"HSP90 inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23538902\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23569304.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"preclinical\\",\\"Assocation\\":\\"ERK inhibitors\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23614898\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		1	115256528	115256529	TT	CC	DOID:1909	23569304	included	ENST00000369535	p.Q61R	NRAS	-1	c.182	2016-05-18 20:50:45.13972	2016-05-18 21:27:39.992698	4	ENSG00000213281	missense
2319	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"late trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23414587\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"18390968, 22761467\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors + CDK4/6 inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"ASCO 2014; abstr 9009\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"HSP90 inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23538902\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23569304.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"preclinical\\",\\"Assocation\\":\\"ERK inhibitors\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23614898\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		1	115256528	115256529	TT	CC	DOID:1909	23614898	included	ENST00000369535	p.Q61R	NRAS	-1	c.182	2016-05-18 20:50:45.181087	2016-05-18 21:27:40.074361	4	ENSG00000213281	missense
2397	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"vandetanib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"FDA-approved\\",\\"Evidence\\":\\"consensus\\",\\"Source\\":\\"20065189, 22025146\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"cabozantinib, sunitinib\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"21470995\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"RET inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23056499\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		10	43609950	43609950	C	G	DOID:1781	20065189	included	ENST00000355710	p.C634W	RET	1	c.1902	2016-05-18 20:50:48.751102	2016-05-18 21:27:46.506581	4	ENSG00000165731	missense
2794	\N	\N		7	140481402	140481402	C	T	DOID:1909	25157968	included	ENST00000288602	p.G469E	BRAF	-1	c.1406	2016-05-18 21:06:58.713118	2016-05-18 21:28:11.616879	5	ENSG00000157764	missense
2795	\N	\N		7	140481402	140481402	C	T	DOID:1909	18794803	included	ENST00000288602	p.G469E	BRAF	-1	c.1406	2016-05-18 21:06:58.728161	2016-05-18 21:28:11.662218	5	ENSG00000157764	missense
2320	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"late trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23414587\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"18390968, 22761467\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors + CDK4/6 inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"ASCO 2014; abstr 9009\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"HSP90 inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23538902\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23569304.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"preclinical\\",\\"Assocation\\":\\"ERK inhibitors\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23614898\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		1	115256529	115256529	T	A	DOID:1909	8120410	included	ENST00000369535	p.Q61L	NRAS	-1	c.182	2016-05-18 20:50:45.248867	2016-05-18 21:27:40.163501	4	ENSG00000213281	missense
2321	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"late trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23414587\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"18390968, 22761467\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors + CDK4/6 inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"ASCO 2014; abstr 9009\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"HSP90 inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23538902\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23569304.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"preclinical\\",\\"Assocation\\":\\"ERK inhibitors\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23614898\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		1	115256529	115256529	T	A	DOID:1909	16291983	included	ENST00000369535	p.Q61L	NRAS	-1	c.182	2016-05-18 20:50:45.295679	2016-05-18 21:27:40.246416	4	ENSG00000213281	missense
2322	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"late trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23414587\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"18390968, 22761467\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors + CDK4/6 inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"ASCO 2014; abstr 9009\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"HSP90 inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23538902\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23569304.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"preclinical\\",\\"Assocation\\":\\"ERK inhibitors\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23614898\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		1	115256529	115256529	T	A	DOID:1909	2674680	included	ENST00000369535	p.Q61L	NRAS	-1	c.182	2016-05-18 20:50:45.33326	2016-05-18 21:27:40.330323	4	ENSG00000213281	missense
2323	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"late trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23414587\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"18390968, 22761467\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors + CDK4/6 inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"ASCO 2014; abstr 9009\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"HSP90 inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23538902\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23569304.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"preclinical\\",\\"Assocation\\":\\"ERK inhibitors\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23614898\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		1	115256529	115256529	T	A	DOID:1909	20130576	included	ENST00000369535	p.Q61L	NRAS	-1	c.182	2016-05-18 20:50:45.396973	2016-05-18 21:27:40.4133	4	ENSG00000213281	missense
2398	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"vandetanib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"FDA-approved\\",\\"Evidence\\":\\"consensus\\",\\"Source\\":\\"20065189, 22025146\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"cabozantinib, sunitinib\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"21470995\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"RET inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23056499\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		10	43609950	43609950	C	G	DOID:1781	22025146	included	ENST00000355710	p.C634W	RET	1	c.1902	2016-05-18 20:50:48.77379	2016-05-18 21:27:46.586685	4	ENSG00000165731	missense
2796	\N	\N		7	140481403	140481403	C	T	DOID:1909	25157968	included	ENST00000288602	p.G469R	BRAF	-1	c.1405	2016-05-18 21:06:58.739986	2016-05-18 21:28:11.737271	5	ENSG00000157764	missense
2797	\N	\N		7	140481403	140481403	C	G	DOID:1909	25157968	included	ENST00000288602	p.G469R	BRAF	-1	c.1405	2016-05-18 21:06:58.754336	2016-05-18 21:28:11.789125	5	ENSG00000157764	missense
2324	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"late trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23414587\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"18390968, 22761467\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors + CDK4/6 inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"ASCO 2014; abstr 9009\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"HSP90 inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23538902\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23569304.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"preclinical\\",\\"Assocation\\":\\"ERK inhibitors\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23614898\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		1	115256529	115256529	T	A	DOID:1909	20179705	included	ENST00000369535	p.Q61L	NRAS	-1	c.182	2016-05-18 20:50:45.450107	2016-05-18 21:27:40.496689	4	ENSG00000213281	missense
2325	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"late trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23414587\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"18390968, 22761467\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors + CDK4/6 inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"ASCO 2014; abstr 9009\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"HSP90 inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23538902\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23569304.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"preclinical\\",\\"Assocation\\":\\"ERK inhibitors\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23614898\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		1	115256529	115256529	T	A	DOID:1909	23414587	included	ENST00000369535	p.Q61L	NRAS	-1	c.182	2016-05-18 20:50:45.526765	2016-05-18 21:27:40.579432	4	ENSG00000213281	missense
2326	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"late trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23414587\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"18390968, 22761467\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors + CDK4/6 inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"ASCO 2014; abstr 9009\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"HSP90 inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23538902\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23569304.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"preclinical\\",\\"Assocation\\":\\"ERK inhibitors\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23614898\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		1	115256529	115256529	T	A	DOID:1909	18390968	included	ENST00000369535	p.Q61L	NRAS	-1	c.182	2016-05-18 20:50:45.570555	2016-05-18 21:27:40.642852	4	ENSG00000213281	missense
2327	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"late trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23414587\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"18390968, 22761467\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors + CDK4/6 inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"ASCO 2014; abstr 9009\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"HSP90 inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23538902\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23569304.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"preclinical\\",\\"Assocation\\":\\"ERK inhibitors\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23614898\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		1	115256529	115256529	T	A	DOID:1909	22761467	included	ENST00000369535	p.Q61L	NRAS	-1	c.182	2016-05-18 20:50:45.641384	2016-05-18 21:27:40.719913	4	ENSG00000213281	missense
2399	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"vandetanib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"FDA-approved\\",\\"Evidence\\":\\"consensus\\",\\"Source\\":\\"20065189, 22025146\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"cabozantinib, sunitinib\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"21470995\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"RET inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23056499\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		10	43609950	43609950	C	G	DOID:1781	21470995	included	ENST00000355710	p.C634W	RET	1	c.1902	2016-05-18 20:50:48.785494	2016-05-18 21:27:46.65684	4	ENSG00000165731	missense
2798	\N	\N		7	140481402	140481403	CC	GA	DOID:1909	25157968	included	ENST00000288602	p.G469S	BRAF	-1	c.1405	2016-05-18 21:06:58.764495	2016-05-18 21:28:11.838028	5	ENSG00000157764	missense
2799	\N	\N		7	140481402	140481403	CC	GA	DOID:1909	16096377	included	ENST00000288602	p.G469S	BRAF	-1	c.1405	2016-05-18 21:06:58.773647	2016-05-18 21:28:11.879623	5	ENSG00000157764	missense
2328	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"late trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23414587\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"18390968, 22761467\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors + CDK4/6 inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"ASCO 2014; abstr 9009\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"HSP90 inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23538902\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23569304.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"preclinical\\",\\"Assocation\\":\\"ERK inhibitors\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23614898\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		1	115256529	115256529	T	A	DOID:1909	23538902	included	ENST00000369535	p.Q61L	NRAS	-1	c.182	2016-05-18 20:50:45.694046	2016-05-18 21:27:40.809078	4	ENSG00000213281	missense
2329	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"late trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23414587\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"18390968, 22761467\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors + CDK4/6 inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"ASCO 2014; abstr 9009\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"HSP90 inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23538902\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23569304.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"preclinical\\",\\"Assocation\\":\\"ERK inhibitors\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23614898\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		1	115256529	115256529	T	A	DOID:1909	23569304	included	ENST00000369535	p.Q61L	NRAS	-1	c.182	2016-05-18 20:50:45.733816	2016-05-18 21:27:40.900514	4	ENSG00000213281	missense
2330	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"late trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23414587\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"18390968, 22761467\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors + CDK4/6 inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"ASCO 2014; abstr 9009\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"HSP90 inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23538902\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23569304.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"preclinical\\",\\"Assocation\\":\\"ERK inhibitors\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23614898\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		1	115256529	115256529	T	A	DOID:1909	23614898	included	ENST00000369535	p.Q61L	NRAS	-1	c.182	2016-05-18 20:50:45.800025	2016-05-18 21:27:40.989551	4	ENSG00000213281	missense
2331	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"late trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23414587\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"18390968, 22761467\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors + CDK4/6 inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"ASCO 2014; abstr 9009\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"HSP90 inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23538902\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23569304.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"preclinical\\",\\"Assocation\\":\\"ERK inhibitors\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23614898\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		1	115256529	115256529	T	C	DOID:1909	21107323	included	ENST00000369535	p.Q61R	NRAS	-1	c.182	2016-05-18 20:50:45.843272	2016-05-18 21:27:41.101022	4	ENSG00000213281	missense
2400	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"vandetanib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"FDA-approved\\",\\"Evidence\\":\\"consensus\\",\\"Source\\":\\"20065189, 22025146\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"cabozantinib, sunitinib\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"21470995\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"RET inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23056499\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		10	43609950	43609950	C	G	DOID:1781	23056499	included	ENST00000355710	p.C634W	RET	1	c.1902	2016-05-18 20:50:48.811618	2016-05-18 21:27:46.737983	4	ENSG00000165731	missense
2800	\N	\N		7	140481402	140481402	C	A	DOID:162	25157968	included	ENST00000496384	p.G77V	BRAF	-1	c.230	2016-05-18 21:06:58.781759	2016-05-18 21:28:11.918029	5	ENSG00000157764	missense
2801	\N	\N		7	140481397	140481397	C	A	DOID:1909	25157968	included	ENST00000288602	p.V471F	BRAF	-1	c.1411	2016-05-18 21:06:58.793431	2016-05-18 21:28:11.971451	5	ENSG00000157764	missense
2332	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"late trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23414587\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"18390968, 22761467\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors + CDK4/6 inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"ASCO 2014; abstr 9009\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"HSP90 inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23538902\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23569304.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"preclinical\\",\\"Assocation\\":\\"ERK inhibitors\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23614898\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		1	115256529	115256529	T	C	DOID:1909	8120410	included	ENST00000369535	p.Q61R	NRAS	-1	c.182	2016-05-18 20:50:45.906962	2016-05-18 21:27:41.174523	4	ENSG00000213281	missense
2333	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"late trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23414587\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"18390968, 22761467\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors + CDK4/6 inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"ASCO 2014; abstr 9009\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"HSP90 inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23538902\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23569304.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"preclinical\\",\\"Assocation\\":\\"ERK inhibitors\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23614898\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		1	115256529	115256529	T	C	DOID:1909	16291983	included	ENST00000369535	p.Q61R	NRAS	-1	c.182	2016-05-18 20:50:45.945484	2016-05-18 21:27:41.253972	4	ENSG00000213281	missense
2334	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"late trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23414587\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"18390968, 22761467\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors + CDK4/6 inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"ASCO 2014; abstr 9009\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"HSP90 inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23538902\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23569304.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"preclinical\\",\\"Assocation\\":\\"ERK inhibitors\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23614898\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		1	115256529	115256529	T	C	DOID:1909	2674680	included	ENST00000369535	p.Q61R	NRAS	-1	c.182	2016-05-18 20:50:45.999489	2016-05-18 21:27:41.328786	4	ENSG00000213281	missense
2335	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"late trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23414587\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"18390968, 22761467\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors + CDK4/6 inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"ASCO 2014; abstr 9009\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"HSP90 inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23538902\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23569304.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"preclinical\\",\\"Assocation\\":\\"ERK inhibitors\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23614898\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		1	115256529	115256529	T	C	DOID:1909	20130576	included	ENST00000369535	p.Q61R	NRAS	-1	c.182	2016-05-18 20:50:46.018599	2016-05-18 21:27:41.397002	4	ENSG00000213281	missense
2401	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"vandetanib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"FDA-approved\\",\\"Evidence\\":\\"consensus\\",\\"Source\\":\\"20065189, 22025146\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"cabozantinib, sunitinib\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"21470995\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"RET inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23056499\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		10	43617416	43617416	T	C	DOID:1781	9681850	included	ENST00000355710	p.M918T	RET	1	c.2753	2016-05-18 20:50:48.845444	2016-05-18 21:27:46.806334	4	ENSG00000165731	missense
2802	\N	\N		7	140453193	140453193	T	C	DOID:8552	25157968	included	ENST00000288602	p.N581S	BRAF	-1	c.1742	2016-05-18 21:06:58.803692	2016-05-18 21:28:12.024343	5	ENSG00000157764	missense
2803	\N	\N		7	140453193	140453193	T	C	DOID:8552	24446311	included	ENST00000288602	p.N581S	BRAF	-1	c.1742	2016-05-18 21:06:58.821039	2016-05-18 21:28:12.064257	5	ENSG00000157764	missense
2336	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"late trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23414587\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"18390968, 22761467\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors + CDK4/6 inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"ASCO 2014; abstr 9009\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"HSP90 inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23538902\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23569304.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"preclinical\\",\\"Assocation\\":\\"ERK inhibitors\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23614898\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		1	115256529	115256529	T	C	DOID:1909	20179705	included	ENST00000369535	p.Q61R	NRAS	-1	c.182	2016-05-18 20:50:46.046422	2016-05-18 21:27:41.478604	4	ENSG00000213281	missense
2337	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"late trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23414587\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"18390968, 22761467\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors + CDK4/6 inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"ASCO 2014; abstr 9009\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"HSP90 inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23538902\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23569304.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"preclinical\\",\\"Assocation\\":\\"ERK inhibitors\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23614898\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		1	115256529	115256529	T	C	DOID:1909	23414587	included	ENST00000369535	p.Q61R	NRAS	-1	c.182	2016-05-18 20:50:46.0838	2016-05-18 21:27:41.547393	4	ENSG00000213281	missense
2338	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"late trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23414587\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"18390968, 22761467\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors + CDK4/6 inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"ASCO 2014; abstr 9009\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"HSP90 inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23538902\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23569304.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"preclinical\\",\\"Assocation\\":\\"ERK inhibitors\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23614898\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		1	115256529	115256529	T	C	DOID:1909	18390968	included	ENST00000369535	p.Q61R	NRAS	-1	c.182	2016-05-18 20:50:46.148639	2016-05-18 21:27:41.642739	4	ENSG00000213281	missense
2339	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"late trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23414587\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"18390968, 22761467\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors + CDK4/6 inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"ASCO 2014; abstr 9009\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"HSP90 inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23538902\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23569304.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"preclinical\\",\\"Assocation\\":\\"ERK inhibitors\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23614898\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		1	115256529	115256529	T	C	DOID:1909	22761467	included	ENST00000369535	p.Q61R	NRAS	-1	c.182	2016-05-18 20:50:46.187375	2016-05-18 21:27:41.731755	4	ENSG00000213281	missense
2402	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"vandetanib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"FDA-approved\\",\\"Evidence\\":\\"consensus\\",\\"Source\\":\\"20065189, 22025146\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"cabozantinib, sunitinib\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"21470995\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"RET inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23056499\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		10	43617416	43617416	T	C	DOID:1781	18541894	included	ENST00000355710	p.M918T	RET	1	c.2753	2016-05-18 20:50:48.879269	2016-05-18 21:27:46.887732	4	ENSG00000165731	missense
2804	\N	\N		7	140453179	140453179	C	T	DOID:1909	25157968	included	ENST00000288602	p.E586K	BRAF	-1	c.1756	2016-05-18 21:06:58.830829	2016-05-18 21:28:12.116577	5	ENSG00000157764	missense
2805	\N	\N		7	140453179	140453179	C	T	DOID:1909	20130576	included	ENST00000288602	p.E586K	BRAF	-1	c.1756	2016-05-18 21:06:58.841272	2016-05-18 21:28:12.155088	5	ENSG00000157764	missense
2340	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"late trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23414587\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"18390968, 22761467\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors + CDK4/6 inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"ASCO 2014; abstr 9009\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"HSP90 inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23538902\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23569304.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"preclinical\\",\\"Assocation\\":\\"ERK inhibitors\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23614898\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		1	115256529	115256529	T	C	DOID:1909	23538902	included	ENST00000369535	p.Q61R	NRAS	-1	c.182	2016-05-18 20:50:46.230852	2016-05-18 21:27:41.851227	4	ENSG00000213281	missense
2341	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"late trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23414587\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"18390968, 22761467\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors + CDK4/6 inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"ASCO 2014; abstr 9009\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"HSP90 inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23538902\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23569304.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"preclinical\\",\\"Assocation\\":\\"ERK inhibitors\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23614898\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		1	115256529	115256529	T	C	DOID:1909	23569304	included	ENST00000369535	p.Q61R	NRAS	-1	c.182	2016-05-18 20:50:46.307106	2016-05-18 21:27:41.91579	4	ENSG00000213281	missense
2342	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"late trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23414587\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"18390968, 22761467\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors + CDK4/6 inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"ASCO 2014; abstr 9009\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"HSP90 inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23538902\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23569304.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"preclinical\\",\\"Assocation\\":\\"ERK inhibitors\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23614898\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		1	115256529	115256529	T	C	DOID:1909	23614898	included	ENST00000369535	p.Q61R	NRAS	-1	c.182	2016-05-18 20:50:46.348887	2016-05-18 21:27:41.991184	4	ENSG00000213281	missense
2343	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"late trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23414587\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"18390968, 22761467\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors + CDK4/6 inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"ASCO 2014; abstr 9009\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"HSP90 inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23538902\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23569304.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"preclinical\\",\\"Assocation\\":\\"ERK inhibitors\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23614898\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		1	115256529	115256529	T	G	DOID:1909	8120410	included	ENST00000369535	p.Q61P	NRAS	-1	c.182	2016-05-18 20:50:46.411379	2016-05-18 21:27:42.086378	4	ENSG00000213281	missense
2403	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"vandetanib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"FDA-approved\\",\\"Evidence\\":\\"consensus\\",\\"Source\\":\\"20065189, 22025146\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"cabozantinib, sunitinib\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"21470995\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"RET inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23056499\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		10	43617416	43617416	T	C	DOID:1781	19255327	included	ENST00000355710	p.M918T	RET	1	c.2753	2016-05-18 20:50:48.91084	2016-05-18 21:27:46.996841	4	ENSG00000165731	missense
2806	\N	\N		7	140453179	140453179	C	T	DOID:1909	24926260	included	ENST00000288602	p.E586K	BRAF	-1	c.1756	2016-05-18 21:06:58.849666	2016-05-18 21:28:12.190858	5	ENSG00000157764	missense
2807	\N	\N		7	140453175	140453175	T	G	DOID:162	25157968	included	ENST00000288602	p.D587A	BRAF	-1	c.1760	2016-05-18 21:06:58.868224	2016-05-18 21:28:12.255618	5	ENSG00000157764	missense
2344	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"late trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23414587\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"18390968, 22761467\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors + CDK4/6 inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"ASCO 2014; abstr 9009\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"HSP90 inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23538902\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23569304.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"preclinical\\",\\"Assocation\\":\\"ERK inhibitors\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23614898\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		1	115256529	115256529	T	G	DOID:1909	16291983	included	ENST00000369535	p.Q61P	NRAS	-1	c.182	2016-05-18 20:50:46.446156	2016-05-18 21:27:42.144164	4	ENSG00000213281	missense
2345	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"late trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23414587\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"18390968, 22761467\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors + CDK4/6 inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"ASCO 2014; abstr 9009\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"HSP90 inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23538902\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23569304.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"preclinical\\",\\"Assocation\\":\\"ERK inhibitors\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23614898\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		1	115256529	115256529	T	G	DOID:1909	2674680	included	ENST00000369535	p.Q61P	NRAS	-1	c.182	2016-05-18 20:50:46.507802	2016-05-18 21:27:42.228699	4	ENSG00000213281	missense
2346	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"late trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23414587\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"18390968, 22761467\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors + CDK4/6 inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"ASCO 2014; abstr 9009\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"HSP90 inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23538902\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23569304.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"preclinical\\",\\"Assocation\\":\\"ERK inhibitors\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23614898\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		1	115256529	115256529	T	G	DOID:1909	20130576	included	ENST00000369535	p.Q61P	NRAS	-1	c.182	2016-05-18 20:50:46.571777	2016-05-18 21:27:42.306763	4	ENSG00000213281	missense
2347	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"late trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23414587\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"18390968, 22761467\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors + CDK4/6 inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"ASCO 2014; abstr 9009\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"HSP90 inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23538902\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23569304.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"preclinical\\",\\"Assocation\\":\\"ERK inhibitors\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23614898\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		1	115256529	115256529	T	G	DOID:1909	20179705	included	ENST00000369535	p.Q61P	NRAS	-1	c.182	2016-05-18 20:50:46.627251	2016-05-18 21:27:42.387089	4	ENSG00000213281	missense
2405	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"vandetanib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"FDA-approved\\",\\"Evidence\\":\\"consensus\\",\\"Source\\":\\"20065189, 22025146\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"cabozantinib, sunitinib\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"21470995\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"RET inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23056499\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		10	43617416	43617416	T	C	DOID:1781	20847059	included	ENST00000355710	p.M918T	RET	1	c.2753	2016-05-18 20:50:48.953962	2016-05-18 21:27:47.192088	4	ENSG00000165731	missense
2808	\N	\N		7	140453174	140453174	G	T	DOID:162	25157968	included	ENST00000288602	p.D587E	BRAF	-1	c.1761	2016-05-18 21:06:58.880315	2016-05-18 21:28:12.334111	5	ENSG00000157764	missense
2809	\N	\N		7	140453174	140453174	G	C	DOID:162	25157968	included	ENST00000288602	p.D587E	BRAF	-1	c.1761	2016-05-18 21:06:58.8945	2016-05-18 21:28:12.411358	5	ENSG00000157764	missense
2348	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"late trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23414587\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"18390968, 22761467\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors + CDK4/6 inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"ASCO 2014; abstr 9009\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"HSP90 inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23538902\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23569304.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"preclinical\\",\\"Assocation\\":\\"ERK inhibitors\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23614898\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		1	115256529	115256529	T	G	DOID:1909	23414587	included	ENST00000369535	p.Q61P	NRAS	-1	c.182	2016-05-18 20:50:46.674229	2016-05-18 21:27:42.47	4	ENSG00000213281	missense
2349	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"late trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23414587\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"18390968, 22761467\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors + CDK4/6 inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"ASCO 2014; abstr 9009\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"HSP90 inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23538902\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23569304.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"preclinical\\",\\"Assocation\\":\\"ERK inhibitors\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23614898\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		1	115256529	115256529	T	G	DOID:1909	18390968	included	ENST00000369535	p.Q61P	NRAS	-1	c.182	2016-05-18 20:50:46.711129	2016-05-18 21:27:42.554571	4	ENSG00000213281	missense
2350	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"late trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23414587\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"18390968, 22761467\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors + CDK4/6 inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"ASCO 2014; abstr 9009\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"HSP90 inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23538902\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23569304.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"preclinical\\",\\"Assocation\\":\\"ERK inhibitors\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23614898\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		1	115256529	115256529	T	G	DOID:1909	22761467	included	ENST00000369535	p.Q61P	NRAS	-1	c.182	2016-05-18 20:50:46.745843	2016-05-18 21:27:42.639352	4	ENSG00000213281	missense
2351	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"late trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23414587\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"18390968, 22761467\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors + CDK4/6 inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"ASCO 2014; abstr 9009\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"HSP90 inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23538902\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23569304.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"preclinical\\",\\"Assocation\\":\\"ERK inhibitors\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23614898\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		1	115256529	115256529	T	G	DOID:1909	23538902	included	ENST00000369535	p.Q61P	NRAS	-1	c.182	2016-05-18 20:50:46.789169	2016-05-18 21:27:42.723325	4	ENSG00000213281	missense
2406	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"vandetanib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"FDA-approved\\",\\"Evidence\\":\\"consensus\\",\\"Source\\":\\"20065189, 22025146\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"cabozantinib, sunitinib\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"21470995\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"RET inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23056499\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		10	43617416	43617416	T	C	DOID:1781	20065189	included	ENST00000355710	p.M918T	RET	1	c.2753	2016-05-18 20:50:48.984946	2016-05-18 21:27:47.260835	4	ENSG00000165731	missense
2810	\N	\N		7	140453159	140453159	T	C	DOID:162	25157968	included	ENST00000288602	p.I592M	BRAF	-1	c.1776	2016-05-18 21:06:58.903578	2016-05-18 21:28:12.485561	5	ENSG00000157764	missense
2811	\N	\N		7	140453161	140453161	T	C	DOID:1909	25157968	included	ENST00000288602	p.I592V	BRAF	-1	c.1774	2016-05-18 21:06:58.920891	2016-05-18 21:28:12.55889	5	ENSG00000157764	missense
2352	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"late trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23414587\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"18390968, 22761467\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors + CDK4/6 inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"ASCO 2014; abstr 9009\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"HSP90 inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23538902\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23569304.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"preclinical\\",\\"Assocation\\":\\"ERK inhibitors\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23614898\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		1	115256529	115256529	T	G	DOID:1909	23569304	included	ENST00000369535	p.Q61P	NRAS	-1	c.182	2016-05-18 20:50:46.853007	2016-05-18 21:27:42.802897	4	ENSG00000213281	missense
2353	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"late trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23414587\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"18390968, 22761467\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors + CDK4/6 inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"ASCO 2014; abstr 9009\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"HSP90 inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23538902\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23569304.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"preclinical\\",\\"Assocation\\":\\"ERK inhibitors\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23614898\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		1	115256529	115256529	T	G	DOID:1909	23614898	included	ENST00000369535	p.Q61P	NRAS	-1	c.182	2016-05-18 20:50:46.885762	2016-05-18 21:27:42.882781	4	ENSG00000213281	missense
2354	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"late trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23414587\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"18390968, 22761467\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors + CDK4/6 inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"ASCO 2014; abstr 9009\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"HSP90 inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23538902\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23569304.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"preclinical\\",\\"Assocation\\":\\"ERK inhibitors\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23614898\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		1	115256530	115256530	G	C	DOID:1909	8120410	included	ENST00000369535	p.Q61E	NRAS	-1	c.181	2016-05-18 20:50:46.917998	2016-05-18 21:27:42.966227	4	ENSG00000213281	missense
2355	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"late trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23414587\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"18390968, 22761467\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors + CDK4/6 inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"ASCO 2014; abstr 9009\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"HSP90 inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23538902\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23569304.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"preclinical\\",\\"Assocation\\":\\"ERK inhibitors\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23614898\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		1	115256530	115256530	G	C	DOID:1909	16291983	included	ENST00000369535	p.Q61E	NRAS	-1	c.181	2016-05-18 20:50:46.984882	2016-05-18 21:27:43.057704	4	ENSG00000213281	missense
2407	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"vandetanib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"FDA-approved\\",\\"Evidence\\":\\"consensus\\",\\"Source\\":\\"20065189, 22025146\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"cabozantinib, sunitinib\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"21470995\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"RET inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23056499\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		10	43617416	43617416	T	C	DOID:1781	22025146	included	ENST00000355710	p.M918T	RET	1	c.2753	2016-05-18 20:50:49.015978	2016-05-18 21:27:47.356611	4	ENSG00000165731	missense
2812	\N	\N		7	140453161	140453161	T	C	DOID:1909	24710085	included	ENST00000288602	p.I592V	BRAF	-1	c.1774	2016-05-18 21:06:58.932943	2016-05-18 21:28:12.609249	5	ENSG00000157764	missense
2813	\N	\N		7	140453153	140453153	A	T	DOID:1909	25157968	included	ENST00000288602	p.D594E	BRAF	-1	c.1782	2016-05-18 21:06:58.94201	2016-05-18 21:28:12.67426	5	ENSG00000157764	missense
2356	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"late trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23414587\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"18390968, 22761467\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors + CDK4/6 inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"ASCO 2014; abstr 9009\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"HSP90 inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23538902\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23569304.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"preclinical\\",\\"Assocation\\":\\"ERK inhibitors\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23614898\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		1	115256530	115256530	G	C	DOID:1909	2674680	included	ENST00000369535	p.Q61E	NRAS	-1	c.181	2016-05-18 20:50:47.020554	2016-05-18 21:27:43.136483	4	ENSG00000213281	missense
2357	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"late trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23414587\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"18390968, 22761467\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors + CDK4/6 inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"ASCO 2014; abstr 9009\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"HSP90 inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23538902\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23569304.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"preclinical\\",\\"Assocation\\":\\"ERK inhibitors\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23614898\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		1	115256530	115256530	G	C	DOID:1909	20130576	included	ENST00000369535	p.Q61E	NRAS	-1	c.181	2016-05-18 20:50:47.054865	2016-05-18 21:27:43.207623	4	ENSG00000213281	missense
2358	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"late trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23414587\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"18390968, 22761467\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors + CDK4/6 inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"ASCO 2014; abstr 9009\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"HSP90 inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23538902\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23569304.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"preclinical\\",\\"Assocation\\":\\"ERK inhibitors\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23614898\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		1	115256530	115256530	G	C	DOID:1909	20179705	included	ENST00000369535	p.Q61E	NRAS	-1	c.181	2016-05-18 20:50:47.124244	2016-05-18 21:27:43.294513	4	ENSG00000213281	missense
2359	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"late trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23414587\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"18390968, 22761467\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors + CDK4/6 inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"ASCO 2014; abstr 9009\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"HSP90 inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23538902\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23569304.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"preclinical\\",\\"Assocation\\":\\"ERK inhibitors\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23614898\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		1	115256530	115256530	G	C	DOID:1909	23414587	included	ENST00000369535	p.Q61E	NRAS	-1	c.181	2016-05-18 20:50:47.162522	2016-05-18 21:27:43.374188	4	ENSG00000213281	missense
2408	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"vandetanib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"FDA-approved\\",\\"Evidence\\":\\"consensus\\",\\"Source\\":\\"20065189, 22025146\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"cabozantinib, sunitinib\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"21470995\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"RET inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23056499\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		10	43617416	43617416	T	C	DOID:1781	21455200	included	ENST00000355710	p.M918T	RET	1	c.2753	2016-05-18 20:50:49.049561	2016-05-18 21:27:47.455602	4	ENSG00000165731	missense
2814	\N	\N		7	140453153	140453153	A	T	DOID:1909	24345920	included	ENST00000288602	p.D594E	BRAF	-1	c.1782	2016-05-18 21:06:58.952642	2016-05-18 21:28:12.716391	5	ENSG00000157764	missense
2815	\N	\N		7	140453154	140453154	T	C	DOID:1909	25157968	included	ENST00000288602	p.D594G	BRAF	-1	c.1781	2016-05-18 21:06:58.963204	2016-05-18 21:28:12.757474	5	ENSG00000157764	missense
2360	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"late trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23414587\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"18390968, 22761467\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors + CDK4/6 inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"ASCO 2014; abstr 9009\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"HSP90 inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23538902\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23569304.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"preclinical\\",\\"Assocation\\":\\"ERK inhibitors\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23614898\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		1	115256530	115256530	G	C	DOID:1909	18390968	included	ENST00000369535	p.Q61E	NRAS	-1	c.181	2016-05-18 20:50:47.218955	2016-05-18 21:27:43.462593	4	ENSG00000213281	missense
2361	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"late trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23414587\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"18390968, 22761467\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors + CDK4/6 inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"ASCO 2014; abstr 9009\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"HSP90 inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23538902\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23569304.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"preclinical\\",\\"Assocation\\":\\"ERK inhibitors\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23614898\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		1	115256530	115256530	G	C	DOID:1909	22761467	included	ENST00000369535	p.Q61E	NRAS	-1	c.181	2016-05-18 20:50:47.257565	2016-05-18 21:27:43.527535	4	ENSG00000213281	missense
2362	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"late trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23414587\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"18390968, 22761467\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors + CDK4/6 inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"ASCO 2014; abstr 9009\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"HSP90 inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23538902\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23569304.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"preclinical\\",\\"Assocation\\":\\"ERK inhibitors\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23614898\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		1	115256530	115256530	G	C	DOID:1909	23538902	included	ENST00000369535	p.Q61E	NRAS	-1	c.181	2016-05-18 20:50:47.342518	2016-05-18 21:27:43.610546	4	ENSG00000213281	missense
2363	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"late trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23414587\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"18390968, 22761467\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors + CDK4/6 inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"ASCO 2014; abstr 9009\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"HSP90 inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23538902\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23569304.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"preclinical\\",\\"Assocation\\":\\"ERK inhibitors\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23614898\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		1	115256530	115256530	G	C	DOID:1909	23569304	included	ENST00000369535	p.Q61E	NRAS	-1	c.181	2016-05-18 20:50:47.384763	2016-05-18 21:27:43.69673	4	ENSG00000213281	missense
2409	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"vandetanib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"FDA-approved\\",\\"Evidence\\":\\"consensus\\",\\"Source\\":\\"20065189, 22025146\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"cabozantinib, sunitinib\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"21470995\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"RET inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23056499\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		10	43617416	43617416	T	C	DOID:1781	21470995	included	ENST00000355710	p.M918T	RET	1	c.2753	2016-05-18 20:50:49.079352	2016-05-18 21:27:47.549223	4	ENSG00000165731	missense
2816	\N	\N		7	140453154	140453154	T	C	DOID:1909	18794803	included	ENST00000288602	p.D594G	BRAF	-1	c.1781	2016-05-18 21:06:58.973523	2016-05-18 21:28:12.799845	5	ENSG00000157764	missense
2817	\N	\N		7	140453154	140453154	T	C	DOID:9256	25157968	included	ENST00000288602	p.D594G	BRAF	-1	c.1781	2016-05-18 21:06:58.981032	2016-05-18 21:28:12.846378	5	ENSG00000157764	missense
2364	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"late trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23414587\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"18390968, 22761467\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors + CDK4/6 inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"ASCO 2014; abstr 9009\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"HSP90 inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23538902\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23569304.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"preclinical\\",\\"Assocation\\":\\"ERK inhibitors\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23614898\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		1	115256530	115256530	G	C	DOID:1909	23614898	included	ENST00000369535	p.Q61E	NRAS	-1	c.181	2016-05-18 20:50:47.43922	2016-05-18 21:27:43.779173	4	ENSG00000213281	missense
2365	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"late trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23414587\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"18390968, 22761467\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors + CDK4/6 inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"ASCO 2014; abstr 9009\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"HSP90 inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23538902\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23569304.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"preclinical\\",\\"Assocation\\":\\"ERK inhibitors\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23614898\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		1	115256530	115256530	G	T	DOID:1909	21107323	included	ENST00000369535	p.Q61K	NRAS	-1	c.181	2016-05-18 20:50:47.478484	2016-05-18 21:27:43.863573	4	ENSG00000213281	missense
2366	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"late trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23414587\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"18390968, 22761467\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors + CDK4/6 inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"ASCO 2014; abstr 9009\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"HSP90 inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23538902\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23569304.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"preclinical\\",\\"Assocation\\":\\"ERK inhibitors\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23614898\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		1	115256530	115256530	G	T	DOID:1909	8120410	included	ENST00000369535	p.Q61K	NRAS	-1	c.181	2016-05-18 20:50:47.515732	2016-05-18 21:27:43.960895	4	ENSG00000213281	missense
2367	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"late trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23414587\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"18390968, 22761467\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors + CDK4/6 inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"ASCO 2014; abstr 9009\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"HSP90 inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23538902\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23569304.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"preclinical\\",\\"Assocation\\":\\"ERK inhibitors\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23614898\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		1	115256530	115256530	G	T	DOID:1909	16291983	included	ENST00000369535	p.Q61K	NRAS	-1	c.181	2016-05-18 20:50:47.588797	2016-05-18 21:27:44.049376	4	ENSG00000213281	missense
2410	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"vandetanib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"FDA-approved\\",\\"Evidence\\":\\"consensus\\",\\"Source\\":\\"20065189, 22025146\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"cabozantinib, sunitinib\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"21470995\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"RET inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23056499\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		10	43617416	43617416	T	C	DOID:1781	23056499	included	ENST00000355710	p.M918T	RET	1	c.2753	2016-05-18 20:50:49.109756	2016-05-18 21:27:47.638022	4	ENSG00000165731	missense
2818	\N	\N		7	140453154	140453154	T	C	DOID:9256	20619739	included	ENST00000288602	p.D594G	BRAF	-1	c.1781	2016-05-18 21:06:58.99179	2016-05-18 21:28:12.887871	5	ENSG00000157764	missense
2819	\N	\N		7	140453154	140453154	T	A	DOID:1909	25157968	included	ENST00000288602	p.D594V	BRAF	-1	c.1781	2016-05-18 21:06:59.000416	2016-05-18 21:28:12.940658	5	ENSG00000157764	missense
2368	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"late trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23414587\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"18390968, 22761467\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors + CDK4/6 inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"ASCO 2014; abstr 9009\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"HSP90 inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23538902\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23569304.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"preclinical\\",\\"Assocation\\":\\"ERK inhibitors\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23614898\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		1	115256530	115256530	G	T	DOID:1909	2674680	included	ENST00000369535	p.Q61K	NRAS	-1	c.181	2016-05-18 20:50:47.647651	2016-05-18 21:27:44.136756	4	ENSG00000213281	missense
2369	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"late trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23414587\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"18390968, 22761467\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors + CDK4/6 inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"ASCO 2014; abstr 9009\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"HSP90 inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23538902\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23569304.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"preclinical\\",\\"Assocation\\":\\"ERK inhibitors\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23614898\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		1	115256530	115256530	G	T	DOID:1909	20130576	included	ENST00000369535	p.Q61K	NRAS	-1	c.181	2016-05-18 20:50:47.707399	2016-05-18 21:27:44.212728	4	ENSG00000213281	missense
2370	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"late trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23414587\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"18390968, 22761467\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors + CDK4/6 inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"ASCO 2014; abstr 9009\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"HSP90 inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23538902\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23569304.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"preclinical\\",\\"Assocation\\":\\"ERK inhibitors\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23614898\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		1	115256530	115256530	G	T	DOID:1909	20179705	included	ENST00000369535	p.Q61K	NRAS	-1	c.181	2016-05-18 20:50:47.76224	2016-05-18 21:27:44.285992	4	ENSG00000213281	missense
2371	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"late trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23414587\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"18390968, 22761467\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors + CDK4/6 inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"ASCO 2014; abstr 9009\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"HSP90 inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23538902\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23569304.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"preclinical\\",\\"Assocation\\":\\"ERK inhibitors\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23614898\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		1	115256530	115256530	G	T	DOID:1909	23414587	included	ENST00000369535	p.Q61K	NRAS	-1	c.181	2016-05-18 20:50:47.855542	2016-05-18 21:27:44.370129	4	ENSG00000213281	missense
2411	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"dasatinib + erlotinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22328973\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"dasatinib\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22328973\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		1	162748390	162748390	T	A	DOID:1749	23932362	included	ENST00000367921	p.S768R	DDR2	1	c.2304	2016-05-18 20:50:49.140381	2016-05-18 21:27:47.701186	4	ENSG00000162733	missense
2437	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"crizotinib\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"17483355\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	116423475	116423475	G	C	DOID:162	17483355	included	ENST00000318493	p.M1268I	MET	1	c.3804	2016-05-18 20:50:49.624542	2016-05-18 21:27:50.144762	4	ENSG00000105976	missense
2372	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"late trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23414587\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"18390968, 22761467\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors + CDK4/6 inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"ASCO 2014; abstr 9009\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"HSP90 inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23538902\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23569304.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"preclinical\\",\\"Assocation\\":\\"ERK inhibitors\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23614898\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		1	115256530	115256530	G	T	DOID:1909	18390968	included	ENST00000369535	p.Q61K	NRAS	-1	c.181	2016-05-18 20:50:47.90585	2016-05-18 21:27:44.447298	4	ENSG00000213281	missense
2373	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"late trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23414587\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"18390968, 22761467\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors + CDK4/6 inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"ASCO 2014; abstr 9009\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"HSP90 inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23538902\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23569304.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"preclinical\\",\\"Assocation\\":\\"ERK inhibitors\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23614898\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		1	115256530	115256530	G	T	DOID:1909	22761467	included	ENST00000369535	p.Q61K	NRAS	-1	c.181	2016-05-18 20:50:47.98353	2016-05-18 21:27:44.545366	4	ENSG00000213281	missense
2374	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"late trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23414587\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"18390968, 22761467\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors + CDK4/6 inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"ASCO 2014; abstr 9009\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"HSP90 inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23538902\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23569304.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"preclinical\\",\\"Assocation\\":\\"ERK inhibitors\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23614898\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		1	115256530	115256530	G	T	DOID:1909	23538902	included	ENST00000369535	p.Q61K	NRAS	-1	c.181	2016-05-18 20:50:48.022074	2016-05-18 21:27:44.631632	4	ENSG00000213281	missense
2375	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"late trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23414587\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"18390968, 22761467\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors + CDK4/6 inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"ASCO 2014; abstr 9009\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"HSP90 inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23538902\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23569304.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"preclinical\\",\\"Assocation\\":\\"ERK inhibitors\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23614898\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		1	115256530	115256530	G	T	DOID:1909	23569304	included	ENST00000369535	p.Q61K	NRAS	-1	c.181	2016-05-18 20:50:48.079938	2016-05-18 21:27:44.716347	4	ENSG00000213281	missense
2413	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"dasatinib + erlotinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22328973\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"dasatinib\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22328973\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		1	162748390	162748390	T	A	DOID:1749	22328973	included	ENST00000367921	p.S768R	DDR2	1	c.2304	2016-05-18 20:50:49.178293	2016-05-18 21:27:47.864521	4	ENSG00000162733	missense
2414	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"ERBB2 TKIs, trastuzumab\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22908275\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		17	37868208	37868208	C	A	DOID:162	22908275	included	ENST00000269571	p.S310Y	ERBB2	1	c.929	2016-05-18 20:50:49.198901	2016-05-18 21:27:47.966494	4	ENSG00000141736	missense
2376	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"late trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23414587\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"18390968, 22761467\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"MEK inhibitors + CDK4/6 inhibitors\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"ASCO 2014; abstr 9009\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"HSP90 inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23538902\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23569304.0\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"preclinical\\",\\"Assocation\\":\\"ERK inhibitors\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23614898\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		1	115256530	115256530	G	T	DOID:1909	23614898	included	ENST00000369535	p.Q61K	NRAS	-1	c.181	2016-05-18 20:50:48.116859	2016-05-18 21:27:44.781166	4	ENSG00000213281	missense
2377	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"ERK inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23614898\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		1	115258748	115258748	C	A	DOID:1909	23614898	included	ENST00000369535	p.G12C	NRAS	-1	c.34	2016-05-18 20:50:48.150355	2016-05-18 21:27:44.853427	4	ENSG00000213281	missense
2378	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"imatinib, crenolanib\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"24132921\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		4	55141083	55141083	C	T	DOID:1909	24132921	included	ENST00000257290	p.P577S	PDGFRA	1	c.1729	2016-05-18 20:50:48.179656	2016-05-18 21:27:44.947163	4	ENSG00000134853	missense
2379	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"crenolanib\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"24132921\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"imatinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"24132921\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		4	55144144	55144144	T	C	DOID:1909	24132921	included	ENST00000257290	p.V658A	PDGFRA	1	c.1973	2016-05-18 20:50:48.192919	2016-05-18 21:27:45.024503	4	ENSG00000134853	missense
2380	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"imatinib, crenolanib\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"24132921\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		4	55152090	55152090	G	A	DOID:1909	24132921	included	ENST00000257290	p.R841K	PDGFRA	1	c.2522	2016-05-18 20:50:48.21872	2016-05-18 21:27:45.126195	4	ENSG00000134853	missense
2381	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"imatinib, crenolanib\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"24132921\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		4	55152101	55152101	C	T	DOID:1909	24132921	included	ENST00000257290	p.H845Y	PDGFRA	1	c.2533	2016-05-18 20:50:48.255102	2016-05-18 21:27:45.20125	4	ENSG00000134853	missense
2382	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"imatinib, crenolanib\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"24132921\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		4	55152126	55152126	G	A	DOID:1909	24132921	included	ENST00000257290	p.G853D	PDGFRA	1	c.2558	2016-05-18 20:50:48.281358	2016-05-18 21:27:45.289073	4	ENSG00000134853	missense
2383	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"BRAF inhibitors in BRAF mutant tumors\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23737487\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		3	12641195	12641195	C	G	DOID:1909	23737487	included	ENST00000442415	p.W388S	RAF1	-1	c.1163	2016-05-18 20:50:48.296458	2016-05-18 21:27:45.377344	4	ENSG00000132155	missense
2385	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"everolimus\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"21189378\\",\\"Effect\\":\\"loss-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		19	1220489	1220489	C	A	DOID:1793	21189378	included	ENST00000326873	p.D194E	STK11	1	c.582	2016-05-18 20:50:48.351926	2016-05-18 21:27:45.567701	4	ENSG00000118046	missense
2386	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"everolimus\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"21189378\\",\\"Effect\\":\\"loss-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		19	1220489	1220489	C	G	DOID:1793	21189378	included	ENST00000326873	p.D194E	STK11	1	c.582	2016-05-18 20:50:48.377499	2016-05-18 21:27:45.642484	4	ENSG00000118046	missense
2415	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"ERBB2 TKIs, trastuzumab\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22908275\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		17	37868208	37868208	C	T	DOID:162	22908275	included	ENST00000269571	p.S310F	ERBB2	1	c.929	2016-05-18 20:50:49.20884	2016-05-18 21:27:48.119652	4	ENSG00000141736	missense
2438	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"crizotinib\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"17483355\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	116423475	116423475	G	T	DOID:162	17483355	included	ENST00000318493	p.M1268I	MET	1	c.3804	2016-05-18 20:50:49.642625	2016-05-18 21:27:50.224304	4	ENSG00000105976	missense
2423	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"19915144\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"ERK inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23614898\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		15	66729100	66729100	T	A	DOID:162	23614898	included	ENST00000307102	p.I103N	MAP2K1	1	c.308	2016-05-18 20:50:49.338164	2016-05-18 21:27:48.923304	4	ENSG00000169032	missense
2424	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"19915144\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		15	66729124	66729124	T	A	DOID:162	19915144	included	ENST00000307102	p.I111N	MAP2K1	1	c.332	2016-05-18 20:50:49.364372	2016-05-18 21:27:49.014669	4	ENSG00000169032	missense
2425	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"19915144\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		15	66729148	66729148	A	C	DOID:162	19915144	included	ENST00000307102	p.H119P	MAP2K1	1	c.356	2016-05-18 20:50:49.373344	2016-05-18 21:27:49.099202	4	ENSG00000169032	missense
2426	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"19915144\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		15	66729152	66729152	G	C	DOID:162	19915144	included	ENST00000307102	p.E120D	MAP2K1	1	c.360	2016-05-18 20:50:49.383862	2016-05-18 21:27:49.198708	4	ENSG00000169032	missense
2428	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"19915144\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		15	66774156	66774156	T	A	DOID:162	19915144	included	ENST00000307102	p.V211D	MAP2K1	1	c.632	2016-05-18 20:50:49.418058	2016-05-18 21:27:49.352049	4	ENSG00000169032	missense
2429	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"19915144\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"ERK inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23614898\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		15	66774168	66774168	T	C	DOID:162	19915144	included	ENST00000307102	p.L215P	MAP2K1	1	c.644	2016-05-18 20:50:49.448281	2016-05-18 21:27:49.444528	4	ENSG00000169032	missense
2430	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"MEK inhibitors\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"19915144\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"ERK inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23614898\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		15	66774168	66774168	T	C	DOID:162	23614898	included	ENST00000307102	p.L215P	MAP2K1	1	c.644	2016-05-18 20:50:49.479075	2016-05-18 21:27:49.503323	4	ENSG00000169032	missense
2431	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"crizotinib\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"17483355\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	116411923	116411923	C	T	DOID:162	17483355	included	ENST00000318493	p.R988C	MET	1	c.2962	2016-05-18 20:50:49.508401	2016-05-18 21:27:49.593978	4	ENSG00000105976	missense
2432	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"crizotinib\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"17483355\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	116411990	116411990	C	T	DOID:162	17483355	included	ENST00000318493	p.T1010I	MET	1	c.3029	2016-05-18 20:50:49.535122	2016-05-18 21:27:49.692249	4	ENSG00000105976	missense
2433	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"crizotinib\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"17483355\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	116417457	116417457	G	A	DOID:162	17483355	included	ENST00000318493	p.V1110I	MET	1	c.3328	2016-05-18 20:50:49.544988	2016-05-18 21:27:49.782612	4	ENSG00000105976	missense
2434	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"crizotinib\\",\\"Assocation\\":\\"reduced sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"17483355\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	116423414	116423414	A	G	DOID:162	17483355	included	ENST00000318493	p.Y1248C	MET	1	c.3743	2016-05-18 20:50:49.57507	2016-05-18 21:27:49.884076	4	ENSG00000105976	missense
2435	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"crizotinib\\",\\"Assocation\\":\\"reduced sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"17483355\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	116423428	116423428	T	G	DOID:162	17483355	included	ENST00000318493	p.Y1253D	MET	1	c.3757	2016-05-18 20:50:49.585748	2016-05-18 21:27:49.987806	4	ENSG00000105976	missense
2436	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"crizotinib\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"17483355\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	116423475	116423475	G	A	DOID:162	17483355	included	ENST00000318493	p.M1268I	MET	1	c.3804	2016-05-18 20:50:49.614125	2016-05-18 21:27:50.064328	4	ENSG00000105976	missense
2445	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"trastuzumab, lapatinib, neratinib\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23220880\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		17	37880261	37880261	G	C	DOID:1612	23220880	included	ENST00000269571	p.D769H	ERBB2	1	c.2305	2016-05-18 20:50:49.789873	2016-05-18 21:27:50.766597	4	ENSG00000141736	missense
2446	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"trastuzumab, lapatinib, neratinib\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23220880\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		17	37880261	37880261	G	T	DOID:1612	23220880	included	ENST00000269571	p.D769Y	ERBB2	1	c.2305	2016-05-18 20:50:49.812824	2016-05-18 21:27:50.829545	4	ENSG00000141736	missense
2447	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"lapatinib, neratinib\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23220880\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		17	37881000	37881000	G	T	DOID:1612	23220880	included	ENST00000269571	p.V777L	ERBB2	1	c.2329	2016-05-18 20:50:49.857078	2016-05-18 21:27:50.907041	4	ENSG00000141736	missense
2448	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"lapatinib, neratinib\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23220880\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		17	37881000	37881000	G	T	DOID:1612	16397024	included	ENST00000269571	p.V777L	ERBB2	1	c.2329	2016-05-18 20:50:49.879034	2016-05-18 21:27:50.969077	4	ENSG00000141736	missense
2449	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"lapatinib, neratinib\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23220880\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		17	37881332	37881332	G	A	DOID:1612	23220880	included	ENST00000269571	p.V842I	ERBB2	1	c.2524	2016-05-18 20:50:49.890877	2016-05-18 21:27:51.038887	4	ENSG00000141736	missense
2450	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"lapatinib, neratinib\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23220880\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		17	37881332	37881332	G	A	DOID:1612	16397024	included	ENST00000269571	p.V842I	ERBB2	1	c.2524	2016-05-18 20:50:49.913985	2016-05-18 21:27:51.111513	4	ENSG00000141736	missense
2451	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"trastuzumab, lapatinib, neratinib\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23220880\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		17	37881616	37881616	C	T	DOID:1612	23220880	included	ENST00000269571	p.R896C	ERBB2	1	c.2686	2016-05-18 20:50:49.947339	2016-05-18 21:27:51.176626	4	ENSG00000141736	missense
2452	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"trastuzumab, lapatinib, neratinib\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23220880\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		17	37881616	37881616	C	T	DOID:1612	16397024	included	ENST00000269571	p.R896C	ERBB2	1	c.2686	2016-05-18 20:50:49.981553	2016-05-18 21:27:51.238635	4	ENSG00000141736	missense
2453	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"anti-estrogens\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"24185512, 24185510, 24398047\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		6	152332832	152332832	G	C	DOID:1612	24185512	included	ENST00000206249	p.E380Q	ESR1	1	c.1138	2016-05-18 20:50:49.998531	2016-05-18 21:27:51.329143	4	ENSG00000091831	missense
2454	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"anti-estrogens\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"24185512, 24185510, 24398047\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		6	152332832	152332832	G	C	DOID:1612	24185510	included	ENST00000206249	p.E380Q	ESR1	1	c.1138	2016-05-18 20:50:50.00857	2016-05-18 21:27:51.389575	4	ENSG00000091831	missense
2455	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"anti-estrogens\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"24185512, 24185510, 24398047\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		6	152332832	152332832	G	C	DOID:1612	24398047	included	ENST00000206249	p.E380Q	ESR1	1	c.1138	2016-05-18 20:50:50.036505	2016-05-18 21:27:51.469834	4	ENSG00000091831	missense
2456	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"neratinib\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23220880\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		15	28505975	28505975	A	G	DOID:1612	23220880	included	ENST00000261609	p.L755S	HERC2	-1	c.2264	2016-05-18 20:50:50.04719	2016-05-18 21:27:51.528745	4	ENSG00000128731	missense
2474	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"dasatinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22649091\\",\\"Effect\\":\\"reduced kinase activity\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	140481393	140481393	T	C	DOID:1324	19010912	included	ENST00000288602	p.Y472C	BRAF	-1	c.1415	2016-05-18 20:50:50.4376	2016-05-18 21:27:52.847909	4	ENSG00000157764	missense
2475	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"dasatinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22649091\\",\\"Effect\\":\\"reduced kinase activity\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	140481393	140481393	T	C	DOID:1324	22649091	included	ENST00000288602	p.Y472C	BRAF	-1	c.1415	2016-05-18 20:50:50.453255	2016-05-18 21:27:52.909025	4	ENSG00000157764	missense
2457	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"EGFR TKIs\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22773810\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"dabrafenib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23524406, 22608338, J Clin Oncol 2013;31: (suppl; abstr 8009)\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"vemurafenib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22743296\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors +/- MEK inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"19010912\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	140453136	140453136	A	T	DOID:1324	12460918	included	ENST00000288602	p.V600E	BRAF	-1	c.1799	2016-05-18 20:50:50.064294	2016-05-18 21:27:51.586394	4	ENSG00000157764	missense
2458	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"EGFR TKIs\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22773810\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"dabrafenib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23524406, 22608338, J Clin Oncol 2013;31: (suppl; abstr 8009)\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"vemurafenib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22743296\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors +/- MEK inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"19010912\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	140453136	140453136	A	T	DOID:1324	23833300	included	ENST00000288602	p.V600E	BRAF	-1	c.1799	2016-05-18 20:50:50.075105	2016-05-18 21:27:51.660379	4	ENSG00000157764	missense
2459	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"EGFR TKIs\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22773810\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"dabrafenib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23524406, 22608338, J Clin Oncol 2013;31: (suppl; abstr 8009)\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"vemurafenib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22743296\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors +/- MEK inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"19010912\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	140453136	140453136	A	T	DOID:1324	12068308	included	ENST00000288602	p.V600E	BRAF	-1	c.1799	2016-05-18 20:50:50.103641	2016-05-18 21:27:51.739306	4	ENSG00000157764	missense
2460	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"EGFR TKIs\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22773810\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"dabrafenib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23524406, 22608338, J Clin Oncol 2013;31: (suppl; abstr 8009)\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"vemurafenib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22743296\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors +/- MEK inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"19010912\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	140453136	140453136	A	T	DOID:1324	12460919	included	ENST00000288602	p.V600E	BRAF	-1	c.1799	2016-05-18 20:50:50.13218	2016-05-18 21:27:51.816313	4	ENSG00000157764	missense
2461	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"EGFR TKIs\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22773810\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"dabrafenib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23524406, 22608338, J Clin Oncol 2013;31: (suppl; abstr 8009)\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"vemurafenib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22743296\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors +/- MEK inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"19010912\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	140453136	140453136	A	T	DOID:1324	21483012	included	ENST00000288602	p.V600E	BRAF	-1	c.1799	2016-05-18 20:50:50.142844	2016-05-18 21:27:51.915743	4	ENSG00000157764	missense
2462	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"EGFR TKIs\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22773810\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"dabrafenib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23524406, 22608338, J Clin Oncol 2013;31: (suppl; abstr 8009)\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"vemurafenib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22743296\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors +/- MEK inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"19010912\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	140453136	140453136	A	T	DOID:1324	19010912	included	ENST00000288602	p.V600E	BRAF	-1	c.1799	2016-05-18 20:50:50.171978	2016-05-18 21:27:51.998222	4	ENSG00000157764	missense
2476	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"dasatinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22649091\\",\\"Effect\\":\\"reduced kinase activity\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	140481393	140481393	T	C	DOID:1324	19238210	included	ENST00000288602	p.Y472C	BRAF	-1	c.1415	2016-05-18 20:50:50.479335	2016-05-18 21:27:52.973004	4	ENSG00000157764	missense
2463	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"EGFR TKIs\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22773810\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"dabrafenib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23524406, 22608338, J Clin Oncol 2013;31: (suppl; abstr 8009)\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"vemurafenib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22743296\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors +/- MEK inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"19010912\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	140453136	140453136	A	T	DOID:1324	22649091	included	ENST00000288602	p.V600E	BRAF	-1	c.1799	2016-05-18 20:50:50.20372	2016-05-18 21:27:52.098737	4	ENSG00000157764	missense
2464	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"EGFR TKIs\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22773810\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"dabrafenib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23524406, 22608338, J Clin Oncol 2013;31: (suppl; abstr 8009)\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"vemurafenib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22743296\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors +/- MEK inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"19010912\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	140453136	140453136	A	T	DOID:1324	19238210	included	ENST00000288602	p.V600E	BRAF	-1	c.1799	2016-05-18 20:50:50.233111	2016-05-18 21:27:52.157563	4	ENSG00000157764	missense
2465	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"EGFR TKIs\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22773810\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"dabrafenib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23524406, 22608338, J Clin Oncol 2013;31: (suppl; abstr 8009)\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"vemurafenib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22743296\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors +/- MEK inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"19010912\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	140453136	140453136	A	T	DOID:1324	22743296	included	ENST00000288602	p.V600E	BRAF	-1	c.1799	2016-05-18 20:50:50.2437	2016-05-18 21:27:52.228155	4	ENSG00000157764	missense
2466	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"EGFR TKIs\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22773810\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"dabrafenib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23524406, 22608338, J Clin Oncol 2013;31: (suppl; abstr 8009)\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"vemurafenib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22743296\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors +/- MEK inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"19010912\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	140453136	140453136	A	T	DOID:1324	23524406	included	ENST00000288602	p.V600E	BRAF	-1	c.1799	2016-05-18 20:50:50.273911	2016-05-18 21:27:52.313233	4	ENSG00000157764	missense
2467	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"EGFR TKIs\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22773810\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"dabrafenib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23524406, 22608338, J Clin Oncol 2013;31: (suppl; abstr 8009)\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"vemurafenib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22743296\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors +/- MEK inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"19010912\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	140453136	140453136	A	T	DOID:1324	22773810	included	ENST00000288602	p.V600E	BRAF	-1	c.1799	2016-05-18 20:50:50.305231	2016-05-18 21:27:52.392656	4	ENSG00000157764	missense
2468	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"EGFR TKIs\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22773810\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"dabrafenib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23524406, 22608338, J Clin Oncol 2013;31: (suppl; abstr 8009)\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"vemurafenib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22743296\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"},{\\"Therapeutic Context\\":\\"BRAF inhibitors +/- MEK inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"19010912\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	140453136	140453136	A	T	DOID:1324	22608338	included	ENST00000288602	p.V600E	BRAF	-1	c.1799	2016-05-18 20:50:50.332262	2016-05-18 21:27:52.475023	4	ENSG00000157764	missense
2469	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"dasatinib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22649091\\",\\"Effect\\":\\"reduced kinase activity\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	140481393	140481393	T	C	DOID:1324	12460918	included	ENST00000288602	p.Y472C	BRAF	-1	c.1415	2016-05-18 20:50:50.34183	2016-05-18 21:27:52.536129	4	ENSG00000157764	missense
2477	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"dasatinib\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22649091\\",\\"Effect\\":\\"reduced kinase activity\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	140481411	140481411	C	A	DOID:1324	12460918	included	ENST00000288602	p.G466V	BRAF	-1	c.1397	2016-05-18 20:50:50.50505	2016-05-18 21:27:53.030744	4	ENSG00000157764	missense
2478	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"dasatinib\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22649091\\",\\"Effect\\":\\"reduced kinase activity\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	140481411	140481411	C	A	DOID:1324	23833300	included	ENST00000288602	p.G466V	BRAF	-1	c.1397	2016-05-18 20:50:50.51433	2016-05-18 21:27:53.11139	4	ENSG00000157764	missense
2479	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"dasatinib\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22649091\\",\\"Effect\\":\\"reduced kinase activity\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	140481411	140481411	C	A	DOID:1324	12068308	included	ENST00000288602	p.G466V	BRAF	-1	c.1397	2016-05-18 20:50:50.553632	2016-05-18 21:27:53.180998	4	ENSG00000157764	missense
2480	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"dasatinib\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22649091\\",\\"Effect\\":\\"reduced kinase activity\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	140481411	140481411	C	A	DOID:1324	12460919	included	ENST00000288602	p.G466V	BRAF	-1	c.1397	2016-05-18 20:50:50.580139	2016-05-18 21:27:53.24338	4	ENSG00000157764	missense
2481	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"dasatinib\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22649091\\",\\"Effect\\":\\"reduced kinase activity\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	140481411	140481411	C	A	DOID:1324	21483012	included	ENST00000288602	p.G466V	BRAF	-1	c.1397	2016-05-18 20:50:50.605649	2016-05-18 21:27:53.343885	4	ENSG00000157764	missense
2482	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"dasatinib\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22649091\\",\\"Effect\\":\\"reduced kinase activity\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	140481411	140481411	C	A	DOID:1324	19010912	included	ENST00000288602	p.G466V	BRAF	-1	c.1397	2016-05-18 20:50:50.61579	2016-05-18 21:27:53.409293	4	ENSG00000157764	missense
2483	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"dasatinib\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22649091\\",\\"Effect\\":\\"reduced kinase activity\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	140481411	140481411	C	A	DOID:1324	22649091	included	ENST00000288602	p.G466V	BRAF	-1	c.1397	2016-05-18 20:50:50.637798	2016-05-18 21:27:53.482859	4	ENSG00000157764	missense
2484	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"dasatinib\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22649091\\",\\"Effect\\":\\"reduced kinase activity\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	140481411	140481411	C	A	DOID:1324	19238210	included	ENST00000288602	p.G466V	BRAF	-1	c.1397	2016-05-18 20:50:50.653836	2016-05-18 21:27:53.553226	4	ENSG00000157764	missense
2485	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"crizotinib\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22072639\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		2	29432664	29432664	C	T	DOID:1319	22072639	included	ENST00000389048	p.R1275Q	ALK	-1	c.3824	2016-05-18 20:50:50.67603	2016-05-18 21:27:53.62248	4	ENSG00000171094	missense
2486	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"crizotinib\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22072639\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		2	29443642	29443642	C	G	DOID:1319	22072639	included	ENST00000389048	p.R1192P	ALK	-1	c.3575	2016-05-18 20:50:50.685958	2016-05-18 21:27:53.694874	4	ENSG00000171094	missense
2487	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"crizotinib\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22072639\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		2	29445450	29445450	C	G	DOID:1319	22072639	included	ENST00000389048	p.G1128A	ALK	-1	c.3383	2016-05-18 20:50:50.710757	2016-05-18 21:27:53.766681	4	ENSG00000171094	missense
2488	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"BRAF inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22038996, 22586120\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	140453136	140453136	A	T	DOID:1319	22038996	included	ENST00000288602	p.V600E	BRAF	-1	c.1799	2016-05-18 20:50:50.737669	2016-05-18 21:27:53.950901	4	ENSG00000157764	missense
2489	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"BRAF inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"22038996, 22586120\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	140453136	140453136	A	T	DOID:1319	22586120	included	ENST00000288602	p.V600E	BRAF	-1	c.1799	2016-05-18 20:50:50.746655	2016-05-18 21:27:54.14312	4	ENSG00000157764	missense
2490	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"erlotinib\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"17177598\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	55211080	55211080	G	A	DOID:1319	17177598	included	ENST00000275493	p.R108K	EGFR	1	c.323	2016-05-18 20:50:50.756035	2016-05-18 21:27:54.236325	4	ENSG00000146648	missense
2491	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"erlotinib\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"17177598\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	55221743	55221743	A	C	DOID:1319	17177598	included	ENST00000275493	p.T263P	EGFR	1	c.787	2016-05-18 20:50:50.779946	2016-05-18 21:27:54.324593	4	ENSG00000146648	missense
2492	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"erlotinib\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"17177598\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	55221822	55221822	C	T	DOID:1319	17177598	included	ENST00000275493	p.A289V	EGFR	1	c.866	2016-05-18 20:50:50.804642	2016-05-18 21:27:54.416081	4	ENSG00000146648	missense
2493	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"erlotinib\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"17177598\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	55233043	55233043	G	T	DOID:1319	17177598	included	ENST00000275493	p.G598V	EGFR	1	c.1793	2016-05-18 20:50:50.813422	2016-05-18 21:27:54.491934	4	ENSG00000146648	missense
2494	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"IDH inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23558169\\",\\"Effect\\":\\"switch-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		2	209113112	209113112	C	T	DOID:1319	23558169	included	ENST00000345146	p.R132H	IDH1	-1	c.395	2016-05-18 20:50:50.845607	2016-05-18 21:27:54.581984	4	ENSG00000138413	missense
2495	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"cetuximab\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23578570\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	55231430	55231430	C	T	DOID:11934	23578570	included	ENST00000275493	p.P546S	EGFR	1	c.1636	2016-05-18 20:50:50.87779	2016-05-18 21:27:54.735148	4	ENSG00000146648	missense
2496	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"cetuximab plus sirolimus\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"24934779\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	55242487	55242487	C	T	DOID:11934	24934779	included	ENST00000275493	p.P753S	EGFR	1	c.2257	2016-05-18 20:50:50.903663	2016-05-18 21:27:54.827894	4	ENSG00000146648	missense
2497	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"gefitinib\\",\\"Assocation\\":\\"no response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"21274259\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	55259469	55259469	G	A	DOID:11934	21274259	included	ENST00000275493	p.V843I	EGFR	1	c.2527	2016-05-18 20:50:50.915084	2016-05-18 21:27:54.916081	4	ENSG00000146648	missense
2498	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"pazopanib\\",\\"Assocation\\":\\"response\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23786770\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		10	123279674	123279674	G	C	DOID:11934	23786770	included	ENST00000457416	p.P253R	FGFR2	-1	c.758	2016-05-18 20:50:50.926058	2016-05-18 21:27:55.000244	4	ENSG00000066468	missense
2499	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"trastuzumab, pertuzumab, lapatinib, anti-HER3 mAbs, PI3K pathway inhibitors + MEK inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23680147\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		12	56481922	56481922	G	A	DOID:10534	23680147	included	ENST00000267101	p.G284R	ERBB3	1	c.850	2016-05-18 20:50:50.935738	2016-05-18 21:27:55.05592	4	ENSG00000065361	missense
2500	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"ibrutinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"24869598\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		16	81946260	81946260	C	T	DOID:1040	24869598	included	ENST00000359376	p.R665W	PLCG2	1	c.1993	2016-05-18 20:50:50.947527	2016-05-18 21:27:55.139056	4	ENSG00000197943	missense
2501	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"ibrutinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"24869598\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		16	81962183	81962183	A	C	DOID:1040	24869598	included	ENST00000359376	p.L845F	PLCG2	1	c.2535	2016-05-18 20:50:50.966897	2016-05-18 21:27:55.221098	4	ENSG00000197943	missense
2502	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"ibrutinib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"early trials\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"24869598\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		16	81962183	81962183	A	T	DOID:1040	24869598	included	ENST00000359376	p.L845F	PLCG2	1	c.2535	2016-05-18 20:50:50.977954	2016-05-18 21:27:55.302586	4	ENSG00000197943	missense
2511	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"EZH2 inhibitor\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23023262\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	148508728	148508728	A	G	DOID:0060058	23023262	included	ENST00000320356	p.Y646H	EZH2	-1	c.1936	2016-05-18 20:50:51.097954	2016-05-18 21:27:55.392169	4	ENSG00000106462	missense
2512	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"EZH2 inhibitor\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23023262\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	148508728	148508728	A	T	DOID:0060058	23023262	included	ENST00000320356	p.Y646N	EZH2	-1	c.1936	2016-05-18 20:50:51.108046	2016-05-18 21:27:55.473201	4	ENSG00000106462	missense
2513	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"EZH2 inhibitor\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23023262\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	148508727	148508727	T	A	DOID:0060058	23023262	included	ENST00000320356	p.Y646F	EZH2	-1	c.1937	2016-05-18 20:50:51.118631	2016-05-18 21:27:55.579014	4	ENSG00000106462	missense
2514	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"EZH2 inhibitor\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23023262\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	148508727	148508727	T	G	DOID:0060058	23023262	included	ENST00000320356	p.Y646S	EZH2	-1	c.1937	2016-05-18 20:50:51.136179	2016-05-18 21:27:55.659041	4	ENSG00000106462	missense
2515	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"EZH2 inhibitor\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"23023262\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	148506467	148506467	G	C	DOID:0060058	23023262	included	ENST00000320356	p.A682G	EZH2	-1	c.2045	2016-05-18 20:50:51.146635	2016-05-18 21:27:55.761283	4	ENSG00000106462	missense
2517	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"JAK inhibitors\\",\\"Assocation\\":\\"sensitivity\\",\\"Status\\":\\"preclinical\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"21179087\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		3	38182641	38182641	T	C	DOID:0060058	21179087	included	ENST00000417037	p.L273P	MYD88	1	c.818	2016-05-18 20:50:51.168943	2016-05-18 21:27:55.918301	4	ENSG00000172936	missense
2518	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"vismodegib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"19726788\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	128849189	128849189	G	C	DOID:0050902	19726788	included	ENST00000249373	p.D473H	SMO	1	c.1417	2016-05-18 20:50:51.187081	2016-05-18 21:27:55.99423	4	ENSG00000128602	missense
2519	"{\\"tables\\":[{\\"name\\":\\"Drug Interaction Data\\",\\"columns\\":[\\"Therapeutic Context\\",\\"Pathway\\",\\"Effect\\",\\"Association\\",\\"Status\\",\\"Evidence\\",\\"Source\\"],\\"rows\\":[{\\"Therapeutic Context\\":\\"vismodegib\\",\\"Assocation\\":\\"resistance\\",\\"Status\\":\\"case report\\",\\"Evidence\\":\\"emerging\\",\\"Source\\":\\"19726788\\",\\"Effect\\":\\"gain-of-function\\",\\"Pathway\\":\\"activation\\"}]}]}"	\N		7	128849189	128849189	G	C	DOID:0050902	22679179	included	ENST00000249373	p.D473H	SMO	1	c.1417	2016-05-18 20:50:51.201618	2016-05-18 21:27:56.051727	4	ENSG00000128602	missense
2523	\N	\N		9	133748283	133748283	C	T	DOID:9952	11861307	included	ENST00000372348	p.T334I	ABL1	1	c.1001	2016-05-18 21:06:54.473934	2016-05-18 21:27:56.289377	5	ENSG00000097007	missense
2524	\N	\N		9	133748283	133748283	C	T	DOID:9952	25157968	included	ENST00000372348	p.T334I	ABL1	1	c.1001	2016-05-18 21:06:54.48383	2016-05-18 21:27:56.343431	5	ENSG00000097007	missense
2525	\N	\N		14	105246551	105246551	C	T	DOID:9256	23700467	included	ENST00000349310	p.E17K	AKT1	-1	c.49	2016-05-18 21:06:54.493775	2016-05-18 21:27:56.411757	5	ENSG00000142208	missense
2526	\N	\N		14	105246551	105246551	C	T	DOID:9256	23934607	included	ENST00000349310	p.E17K	AKT1	-1	c.49	2016-05-18 21:06:54.502826	2016-05-18 21:27:56.473812	5	ENSG00000142208	missense
2527	\N	\N		14	105246551	105246551	C	T	DOID:9256	17611497	included	ENST00000349310	p.E17K	AKT1	-1	c.49	2016-05-18 21:06:54.514057	2016-05-18 21:27:56.536251	5	ENSG00000142208	missense
2528	\N	\N		14	105246551	105246551	C	T	DOID:9256	25157968	included	ENST00000349310	p.E17K	AKT1	-1	c.49	2016-05-18 21:06:54.522385	2016-05-18 21:27:56.622905	5	ENSG00000142208	missense
2529	\N	\N		5	112173917	112173917	C	T	DOID:9256	24651453	included	ENST00000257430	p.R876*	APC	1	c.2626	2016-05-18 21:06:54.531152	2016-05-18 21:27:56.751972	5	ENSG00000134982	stop
2530	\N	\N		5	112173917	112173917	C	T	DOID:9256	8187091	included	ENST00000257430	p.R876*	APC	1	c.2626	2016-05-18 21:06:54.540657	2016-05-18 21:27:56.842636	5	ENSG00000134982	stop
2531	\N	\N		5	112173917	112173917	C	T	DOID:9256	1528264	included	ENST00000257430	p.R876*	APC	1	c.2626	2016-05-18 21:06:54.551126	2016-05-18 21:27:56.917764	5	ENSG00000134982	stop
2532	\N	\N		5	112173917	112173917	C	T	DOID:9256	25157968	included	ENST00000257430	p.R876*	APC	1	c.2626	2016-05-18 21:06:54.565378	2016-05-18 21:27:56.987645	5	ENSG00000134982	stop
2533	\N	\N		5	112174631	112174631	C	T	DOID:9256	23700467	included	ENST00000257430	p.R1114*	APC	1	c.3340	2016-05-18 21:06:54.575542	2016-05-18 21:27:57.06898	5	ENSG00000134982	stop
2534	\N	\N		5	112174631	112174631	C	T	DOID:9256	2281069	included	ENST00000257430	p.R1114*	APC	1	c.3340	2016-05-18 21:06:54.585613	2016-05-18 21:27:57.124352	5	ENSG00000134982	stop
2535	\N	\N		5	112174631	112174631	C	T	DOID:9256	21901162	included	ENST00000257430	p.R1114*	APC	1	c.3340	2016-05-18 21:06:54.594737	2016-05-18 21:27:57.199951	5	ENSG00000134982	stop
2536	\N	\N		5	112174631	112174631	C	T	DOID:9256	8187091	included	ENST00000257430	p.R1114*	APC	1	c.3340	2016-05-18 21:06:54.603965	2016-05-18 21:27:57.250776	5	ENSG00000134982	stop
2537	\N	\N		5	112174631	112174631	C	T	DOID:9256	25157968	included	ENST00000257430	p.R1114*	APC	1	c.3340	2016-05-18 21:06:54.614485	2016-05-18 21:27:57.31557	5	ENSG00000134982	stop
2538	\N	\N		5	112175207	112175207	G	T	DOID:9256	8187091	included	ENST00000257430	p.E1306*	APC	1	c.3916	2016-05-18 21:06:54.623332	2016-05-18 21:27:57.389757	5	ENSG00000134982	stop
2539	\N	\N		5	112175207	112175207	G	T	DOID:9256	1528264	included	ENST00000257430	p.E1306*	APC	1	c.3916	2016-05-18 21:06:54.632283	2016-05-18 21:27:57.458395	5	ENSG00000134982	stop
2540	\N	\N		5	112175207	112175207	G	T	DOID:9256	24861525	included	ENST00000257430	p.E1306*	APC	1	c.3916	2016-05-18 21:06:54.641648	2016-05-18 21:27:57.51048	5	ENSG00000134982	stop
2541	\N	\N		5	112175207	112175207	G	T	DOID:9256	25157968	included	ENST00000257430	p.E1306*	APC	1	c.3916	2016-05-18 21:06:54.651978	2016-05-18 21:27:57.567387	5	ENSG00000134982	stop
2543	\N	\N		5	112175303	112175303	C	T	DOID:9256	1528264	included	ENST00000257430	p.Q1338*	APC	1	c.4012	2016-05-18 21:06:54.671348	2016-05-18 21:27:57.704569	5	ENSG00000134982	stop
2544	\N	\N		5	112175303	112175303	C	T	DOID:9256	24861525	included	ENST00000257430	p.Q1338*	APC	1	c.4012	2016-05-18 21:06:54.682523	2016-05-18 21:27:57.752617	5	ENSG00000134982	stop
2546	\N	\N		5	112175303	112175303	C	T	DOID:9256	23204322	included	ENST00000257430	p.Q1338*	APC	1	c.4012	2016-05-18 21:06:54.700977	2016-05-18 21:27:57.859051	5	ENSG00000134982	stop
2547	\N	\N		5	112175303	112175303	C	T	DOID:9256	1338904	included	ENST00000257430	p.Q1338*	APC	1	c.4012	2016-05-18 21:06:54.71042	2016-05-18 21:27:57.907554	5	ENSG00000134982	stop
2548	\N	\N		5	112175303	112175303	C	T	DOID:9256	10737795	included	ENST00000257430	p.Q1338*	APC	1	c.4012	2016-05-18 21:06:54.720776	2016-05-18 21:27:57.960007	5	ENSG00000134982	stop
2549	\N	\N		5	112175303	112175303	C	T	DOID:9256	25157968	included	ENST00000257430	p.Q1338*	APC	1	c.4012	2016-05-18 21:06:54.730077	2016-05-18 21:27:58.022945	5	ENSG00000134982	stop
2550	\N	\N		5	112175390	112175390	C	T	DOID:9256	1528264	included	ENST00000257430	p.Q1367*	APC	1	c.4099	2016-05-18 21:06:54.738902	2016-05-18 21:27:58.098581	5	ENSG00000134982	stop
2551	\N	\N		5	112175390	112175390	C	T	DOID:9256	24861525	included	ENST00000257430	p.Q1367*	APC	1	c.4099	2016-05-18 21:06:54.749031	2016-05-18 21:27:58.151302	5	ENSG00000134982	stop
2820	\N	\N		7	140453152	140453152	A	G	DOID:1909	25157968	included	ENST00000288602	p.F595L	BRAF	-1	c.1783	2016-05-18 21:06:59.010928	2016-05-18 21:28:13.000614	5	ENSG00000157764	missense
2821	\N	\N		7	140453152	140453152	A	G	DOID:1909	23569304	included	ENST00000288602	p.F595L	BRAF	-1	c.1783	2016-05-18 21:06:59.029978	2016-05-18 21:28:13.05293	5	ENSG00000157764	missense
2822	\N	\N		7	140453150	140453150	A	T	DOID:1909	25157968	included	ENST00000496384	p.F203L	BRAF	-1	c.609	2016-05-18 21:06:59.040845	2016-05-18 21:28:13.122256	5	ENSG00000157764	missense
2823	\N	\N		7	140453150	140453150	A	C	DOID:1909	25157968	included	ENST00000288602	p.F595L	BRAF	-1	c.1785	2016-05-18 21:06:59.051044	2016-05-18 21:28:13.173622	5	ENSG00000157764	missense
2824	\N	\N		7	140453150	140453150	A	C	DOID:1909	23569304	included	ENST00000288602	p.F595L	BRAF	-1	c.1785	2016-05-18 21:06:59.061434	2016-05-18 21:28:13.217839	5	ENSG00000157764	missense
2825	\N	\N		7	140453151	140453151	A	G	DOID:1909	25157968	included	ENST00000288602	p.F595S	BRAF	-1	c.1784	2016-05-18 21:06:59.070688	2016-05-18 21:28:13.281891	5	ENSG00000157764	missense
2826	\N	\N		7	140453149	140453149	C	G	DOID:1909	25157968	included	ENST00000288602	p.G596R	BRAF	-1	c.1786	2016-05-18 21:06:59.078671	2016-05-18 21:28:13.345524	5	ENSG00000157764	missense
2827	\N	\N		7	140453149	140453149	C	G	DOID:9256	25157968	included	ENST00000288602	p.G596R	BRAF	-1	c.1786	2016-05-18 21:06:59.089064	2016-05-18 21:28:13.395589	5	ENSG00000157764	missense
2828	\N	\N		7	140453149	140453149	C	G	DOID:9256	22180495	included	ENST00000288602	p.G596R	BRAF	-1	c.1786	2016-05-18 21:06:59.097013	2016-05-18 21:28:13.447551	5	ENSG00000157764	missense
2829	\N	\N		7	140453145	140453145	A	T	DOID:1909	25157968	included	ENST00000288602	p.L597Q	BRAF	-1	c.1790	2016-05-18 21:06:59.105312	2016-05-18 21:28:13.499535	5	ENSG00000157764	missense
2830	\N	\N		7	140453145	140453145	A	T	DOID:1909	2493360	included	ENST00000288602	p.L597Q	BRAF	-1	c.1790	2016-05-18 21:06:59.122685	2016-05-18 21:28:13.548693	5	ENSG00000157764	missense
2831	\N	\N		7	140453145	140453145	A	T	DOID:1909	22798288	included	ENST00000288602	p.L597Q	BRAF	-1	c.1790	2016-05-18 21:06:59.134504	2016-05-18 21:28:13.5847	5	ENSG00000157764	missense
2832	\N	\N		7	140453145	140453145	A	C	DOID:1909	25157968	included	ENST00000288602	p.L597R	BRAF	-1	c.1790	2016-05-18 21:06:59.143467	2016-05-18 21:28:13.631622	5	ENSG00000157764	missense
2833	\N	\N		7	140453145	140453145	A	C	DOID:1909	23715574	included	ENST00000288602	p.L597R	BRAF	-1	c.1790	2016-05-18 21:06:59.153964	2016-05-18 21:28:13.682899	5	ENSG00000157764	missense
2834	\N	\N		7	140453145	140453145	A	C	DOID:1909	22798288	included	ENST00000288602	p.L597R	BRAF	-1	c.1790	2016-05-18 21:06:59.162485	2016-05-18 21:28:13.716938	5	ENSG00000157764	missense
2835	\N	\N		7	140453145	140453146	AG	GA	DOID:1909	25157968	included	ENST00000288602	p.L597S	BRAF	-1	c.1789	2016-05-18 21:06:59.172828	2016-05-18 21:28:13.765156	5	ENSG00000157764	missense
2836	\N	\N		7	140453145	140453146	AG	GA	DOID:1909	22798288	included	ENST00000288602	p.L597S	BRAF	-1	c.1789	2016-05-18 21:06:59.180728	2016-05-18 21:28:13.813478	5	ENSG00000157764	missense
2837	\N	\N		7	140453146	140453146	G	C	DOID:1909	25157968	included	ENST00000288602	p.L597V	BRAF	-1	c.1789	2016-05-18 21:06:59.191984	2016-05-18 21:28:13.868679	5	ENSG00000157764	missense
2838	\N	\N		7	140453139	140453139	G	A	DOID:1909	25157968	included	ENST00000496384	p.T207I	BRAF	-1	c.620	2016-05-18 21:06:59.212803	2016-05-18 21:28:13.937609	5	ENSG00000157764	missense
2839	\N	\N		7	140453136	140453136	A	G	DOID:1909	25157968	included	ENST00000288602	p.V600A	BRAF	-1	c.1799	2016-05-18 21:06:59.220385	2016-05-18 21:28:13.992035	5	ENSG00000157764	missense
2840	\N	\N		7	140453135	140453136	CA	AT	DOID:1909	25157968	included	ENST00000288602	p.V600D	BRAF	-1	c.1799	2016-05-18 21:06:59.231083	2016-05-18 21:28:14.03832	5	ENSG00000157764	missense
2841	\N	\N		7	140453135	140453136	CA	AT	DOID:1909	23317446	included	ENST00000288602	p.V600D	BRAF	-1	c.1799	2016-05-18 21:06:59.239792	2016-05-18 21:28:14.093649	5	ENSG00000157764	missense
2842	\N	\N		7	140453136	140453136	A	T	DOID:1909	25157968	included	ENST00000288602	p.V600E	BRAF	-1	c.1799	2016-05-18 21:06:59.260541	2016-05-18 21:28:14.141387	5	ENSG00000157764	missense
2843	\N	\N		7	140453136	140453136	A	T	DOID:1909	21639808	included	ENST00000288602	p.V600E	BRAF	-1	c.1799	2016-05-18 21:06:59.27294	2016-05-18 21:28:14.175238	5	ENSG00000157764	missense
2844	\N	\N		7	140453136	140453136	A	T	DOID:1909	23918947	included	ENST00000288602	p.V600E	BRAF	-1	c.1799	2016-05-18 21:06:59.28425	2016-05-18 21:28:14.222707	5	ENSG00000157764	missense
2845	\N	\N		7	140453136	140453136	A	T	DOID:1909	24508103	included	ENST00000288602	p.V600E	BRAF	-1	c.1799	2016-05-18 21:06:59.293732	2016-05-18 21:28:14.280556	5	ENSG00000157764	missense
2846	\N	\N		7	140453136	140453136	A	T	DOID:1909	23031422	included	ENST00000288602	p.V600E	BRAF	-1	c.1799	2016-05-18 21:06:59.303742	2016-05-18 21:28:14.319684	5	ENSG00000157764	missense
2847	\N	\N		7	140453136	140453136	A	T	DOID:219	25157968	included	ENST00000288602	p.V600E	BRAF	-1	c.1799	2016-05-18 21:06:59.313787	2016-05-18 21:28:14.368358	5	ENSG00000157764	missense
2848	\N	\N		7	140453136	140453136	A	T	DOID:219	22281684	included	ENST00000288602	p.V600E	BRAF	-1	c.1799	2016-05-18 21:06:59.32105	2016-05-18 21:28:14.415317	5	ENSG00000157764	missense
2849	\N	\N		7	140453135	140453136	CA	TT	DOID:1909	25157968	included	ENST00000288602	p.V600E	BRAF	-1	c.1799	2016-05-18 21:06:59.333262	2016-05-18 21:28:14.46855	5	ENSG00000157764	missense
2850	\N	\N		7	140453135	140453136	CA	TT	DOID:1909	21639808	included	ENST00000288602	p.V600E	BRAF	-1	c.1799	2016-05-18 21:06:59.345232	2016-05-18 21:28:14.519552	5	ENSG00000157764	missense
2851	\N	\N		7	140453135	140453136	CA	TT	DOID:1909	23918947	included	ENST00000288602	p.V600E	BRAF	-1	c.1799	2016-05-18 21:06:59.353241	2016-05-18 21:28:14.561685	5	ENSG00000157764	missense
2852	\N	\N		7	140453135	140453136	CA	TT	DOID:1909	24508103	included	ENST00000288602	p.V600E	BRAF	-1	c.1799	2016-05-18 21:06:59.362564	2016-05-18 21:28:14.60777	5	ENSG00000157764	missense
2853	\N	\N		7	140453135	140453136	CA	TT	DOID:1909	23031422	included	ENST00000288602	p.V600E	BRAF	-1	c.1799	2016-05-18 21:06:59.373324	2016-05-18 21:28:14.654377	5	ENSG00000157764	missense
2854	\N	\N		7	140453135	140453136	CA	TT	DOID:219	25157968	included	ENST00000288602	p.V600E	BRAF	-1	c.1799	2016-05-18 21:06:59.382996	2016-05-18 21:28:14.694224	5	ENSG00000157764	missense
2855	\N	\N		7	140453135	140453136	CA	TT	DOID:219	22281684	included	ENST00000288602	p.V600E	BRAF	-1	c.1799	2016-05-18 21:06:59.391805	2016-05-18 21:28:14.737068	5	ENSG00000157764	missense
2856	\N	\N		7	140453136	140453137	AC	TT	DOID:1909	25157968	included	ENST00000288602	p.V600K	BRAF	-1	c.1798	2016-05-18 21:06:59.404078	2016-05-18 21:28:14.802388	5	ENSG00000157764	missense
2857	\N	\N		7	140453136	140453137	AC	TT	DOID:1909	20630094	included	ENST00000288602	p.V600K	BRAF	-1	c.1798	2016-05-18 21:06:59.414241	2016-05-18 21:28:14.840501	5	ENSG00000157764	missense
2858	\N	\N		7	140453136	140453137	AC	TT	DOID:1909	23918947	included	ENST00000288602	p.V600K	BRAF	-1	c.1798	2016-05-18 21:06:59.422157	2016-05-18 21:28:14.885808	5	ENSG00000157764	missense
2859	\N	\N		7	140453136	140453137	AC	TT	DOID:1909	24508103	included	ENST00000288602	p.V600K	BRAF	-1	c.1798	2016-05-18 21:06:59.432586	2016-05-18 21:28:14.942936	5	ENSG00000157764	missense
2860	\N	\N		7	140453137	140453137	C	G	DOID:1909	25157968	included	ENST00000288602	p.V600L	BRAF	-1	c.1798	2016-05-18 21:06:59.445658	2016-05-18 21:28:15.011084	5	ENSG00000157764	missense
2861	\N	\N		7	140453137	140453137	C	G	DOID:1909	23569304	included	ENST00000288602	p.V600L	BRAF	-1	c.1798	2016-05-18 21:06:59.452703	2016-05-18 21:28:15.049189	5	ENSG00000157764	missense
2862	\N	\N		7	140453137	140453137	C	A	DOID:1909	25157968	included	ENST00000288602	p.V600L	BRAF	-1	c.1798	2016-05-18 21:06:59.461665	2016-05-18 21:28:15.119595	5	ENSG00000157764	missense
2863	\N	\N		7	140453137	140453137	C	A	DOID:1909	23569304	included	ENST00000288602	p.V600L	BRAF	-1	c.1798	2016-05-18 21:06:59.473767	2016-05-18 21:28:15.164395	5	ENSG00000157764	missense
2864	\N	\N		7	140453137	140453137	C	T	DOID:1909	25157968	included	ENST00000288602	p.V600M	BRAF	-1	c.1798	2016-05-18 21:06:59.483186	2016-05-18 21:28:15.210476	5	ENSG00000157764	missense
2865	\N	\N		7	140453137	140453137	C	T	DOID:1909	23031422	included	ENST00000288602	p.V600M	BRAF	-1	c.1798	2016-05-18 21:06:59.491627	2016-05-18 21:28:15.246807	5	ENSG00000157764	missense
2866	\N	\N		7	140453136	140453137	AC	CT	DOID:1909	25157968	included	ENST00000288602	p.V600R	BRAF	-1	c.1798	2016-05-18 21:06:59.502325	2016-05-18 21:28:15.286524	5	ENSG00000157764	missense
2867	\N	\N		7	140453136	140453137	AC	CT	DOID:1909	23317446	included	ENST00000288602	p.V600R	BRAF	-1	c.1798	2016-05-18 21:06:59.513146	2016-05-18 21:28:15.335269	5	ENSG00000157764	missense
2868	\N	\N		7	140453132	140453134	TTT	-	DOID:1909	25157968	included	ENST00000288602	p.K601-	BRAF	-1	c.1801	2016-05-18 21:06:59.521105	2016-05-18 21:28:15.39149	5	ENSG00000157764	inframe
2869	\N	\N		7	140453134	140453134	T	C	DOID:1909	25157968	included	ENST00000288602	p.K601E	BRAF	-1	c.1801	2016-05-18 21:06:59.530313	2016-05-18 21:28:15.447262	5	ENSG00000157764	missense
2870	\N	\N		7	140453132	140453132	T	A	DOID:1909	25157968	included	ENST00000288602	p.K601N	BRAF	-1	c.1803	2016-05-18 21:06:59.542023	2016-05-18 21:28:15.513897	5	ENSG00000157764	missense
2871	\N	\N		7	140453132	140453132	T	G	DOID:1909	25157968	included	ENST00000288602	p.K601N	BRAF	-1	c.1803	2016-05-18 21:06:59.552211	2016-05-18 21:28:15.584839	5	ENSG00000157764	missense
2872	\N	\N		7	140453121	140453122	CT	AA	DOID:1909	25157968	included	ENST00000288602	p.S605F	BRAF	-1	c.1813	2016-05-18 21:06:59.562064	2016-05-18 21:28:15.640528	5	ENSG00000157764	missense
2873	\N	\N		7	140453121	140453121	C	T	DOID:1909	25157968	included	ENST00000288602	p.S605N	BRAF	-1	c.1814	2016-05-18 21:06:59.572795	2016-05-18 21:28:15.719063	5	ENSG00000157764	missense
2874	\N	\N		12	58145430	58145430	C	T	DOID:1909	25157968	included	ENST00000257904	p.R24H	CDK4	-1	c.71	2016-05-18 21:06:59.582121	2016-05-18 21:28:15.806181	5	ENSG00000135446	missense
2875	\N	\N		9	21971186	21971186	G	A	DOID:162	25157968	included	ENST00000446177	p.R58*	CDKN2A	-1	c.172	2016-05-18 21:06:59.589774	2016-05-18 21:28:15.891293	5	ENSG00000147889	stop
2876	\N	\N		9	21971177	21971177	C	A	DOID:162	25157968	included	ENST00000446177	p.E61*	CDKN2A	-1	c.181	2016-05-18 21:06:59.599278	2016-05-18 21:28:15.97397	5	ENSG00000147889	stop
2877	\N	\N		9	21971153	21971153	C	A	DOID:162	25157968	included	ENST00000446177	p.E69*	CDKN2A	-1	c.205	2016-05-18 21:06:59.610995	2016-05-18 21:28:16.051481	5	ENSG00000147889	stop
2878	\N	\N		9	21971120	21971120	G	A	DOID:1909	25157968	included	ENST00000446177	p.R80*	CDKN2A	-1	c.238	2016-05-18 21:06:59.618333	2016-05-18 21:28:16.116489	5	ENSG00000147889	stop
2879	\N	\N		9	21971120	21971120	G	A	DOID:1909	21609436	included	ENST00000446177	p.R80*	CDKN2A	-1	c.238	2016-05-18 21:06:59.627331	2016-05-18 21:28:16.166447	5	ENSG00000147889	stop
2880	\N	\N		9	21971111	21971111	G	A	DOID:162	25157968	included	ENST00000361570	p.A138V	CDKN2A	-1	c.413	2016-05-18 21:06:59.638309	2016-05-18 21:28:16.241317	5	ENSG00000147889	missense
2881	\N	\N		9	21971108	21971108	C	A	DOID:162	25157968	included	ENST00000361570	p.R139L	CDKN2A	-1	c.416	2016-05-18 21:06:59.648459	2016-05-18 21:28:16.315683	5	ENSG00000147889	missense
2882	\N	\N		9	21971096	21971096	C	A	DOID:162	25157968	included	ENST00000446177	p.E88*	CDKN2A	-1	c.262	2016-05-18 21:06:59.656299	2016-05-18 21:28:16.391667	5	ENSG00000147889	stop
2883	\N	\N		9	21971036	21971036	C	A	DOID:162	25157968	included	ENST00000361570	p.R163L	CDKN2A	-1	c.488	2016-05-18 21:06:59.665693	2016-05-18 21:28:16.474522	5	ENSG00000147889	missense
2884	\N	\N		9	21971029	21971029	C	T	DOID:162	25157968	included	ENST00000446177	p.W110*	CDKN2A	-1	c.329	2016-05-18 21:06:59.678735	2016-05-18 21:28:16.558598	5	ENSG00000147889	stop
2885	\N	\N		9	21971028	21971028	C	T	DOID:162	25157968	included	ENST00000446177	p.W110*	CDKN2A	-1	c.330	2016-05-18 21:06:59.685689	2016-05-18 21:28:16.641785	5	ENSG00000147889	stop
2886	\N	\N		9	21971017	21971017	G	A	DOID:1909	25157968	included	ENST00000446177	p.P114L	CDKN2A	-1	c.341	2016-05-18 21:06:59.697924	2016-05-18 21:28:16.721768	5	ENSG00000147889	missense
2887	\N	\N		5	149453044	149453044	A	G	DOID:162	25157968	included	ENST00000286301	p.L301S	CSF1R	-1	c.902	2016-05-18 21:06:59.707505	2016-05-18 21:28:16.783155	5	ENSG00000182578	missense
2888	\N	\N		5	149453044	149453044	A	T	DOID:162	25157968	included	ENST00000286301	p.L301*	CSF1R	-1	c.902	2016-05-18 21:06:59.717419	2016-05-18 21:28:16.840677	5	ENSG00000182578	stop
2889	\N	\N		5	149433645	149433645	T	C	DOID:162	25157968	included	ENST00000286301	p.Y969C	CSF1R	-1	c.2906	2016-05-18 21:06:59.725926	2016-05-18 21:28:16.91408	5	ENSG00000182578	missense
2890	\N	\N		5	149433645	149433645	T	A	DOID:162	25157968	included	ENST00000286301	p.Y969F	CSF1R	-1	c.2906	2016-05-18 21:06:59.736006	2016-05-18 21:28:16.98056	5	ENSG00000182578	missense
2891	\N	\N		5	149433646	149433646	A	G	DOID:162	25157968	included	ENST00000286301	p.Y969H	CSF1R	-1	c.2905	2016-05-18 21:06:59.748381	2016-05-18 21:28:17.056298	5	ENSG00000182578	missense
2892	\N	\N		5	149433644	149433644	A	T	DOID:162	25157968	included	ENST00000286301	p.Y969*	CSF1R	-1	c.2907	2016-05-18 21:06:59.756083	2016-05-18 21:28:17.124189	5	ENSG00000182578	stop
2893	\N	\N		5	149433644	149433644	A	C	DOID:162	25157968	included	ENST00000286301	p.Y969*	CSF1R	-1	c.2907	2016-05-18 21:06:59.765014	2016-05-18 21:28:17.177437	5	ENSG00000182578	stop
2894	\N	\N		3	41266040	41266040	G	A	DOID:1909	25157968	included	ENST00000349496	p.A13T	CTNNB1	1	c.37	2016-05-18 21:06:59.778457	2016-05-18 21:28:17.24121	5	ENSG00000168036	missense
2895	\N	\N		3	41266064	41266064	G	A	DOID:1909	25157968	included	ENST00000349496	p.A21T	CTNNB1	1	c.61	2016-05-18 21:06:59.786693	2016-05-18 21:28:17.327483	5	ENSG00000168036	missense
2896	\N	\N		3	41266068	41266068	T	C	DOID:1909	25157968	included	ENST00000349496	p.V22A	CTNNB1	1	c.65	2016-05-18 21:06:59.797091	2016-05-18 21:28:17.423058	5	ENSG00000168036	missense
2897	\N	\N		3	41266067	41266117	GTTAGTCACTGGCAGCAACAGTCTTACCTGGACTCTGGAATCCATTCTGGT	-	DOID:1909	25157968	included	ENST00000349496	p.VSHWQQQSYLDSGIHSG22-	CTNNB1	1	c.64	2016-05-18 21:06:59.809155	2016-05-18 21:28:17.511443	5	ENSG00000168036	inframe
2898	\N	\N		3	41266076	41266099	TGGCAGCAACAGTCTTACCTGGAC	-	DOID:1909	25157968	included	ENST00000349496	p.WQQQSYLD25-	CTNNB1	1	c.73	2016-05-18 21:06:59.818774	2016-05-18 21:28:17.598336	5	ENSG00000168036	inframe
2899	\N	\N		3	41266098	41266098	A	C	DOID:1909	25157968	included	ENST00000349496	p.D32A	CTNNB1	1	c.95	2016-05-18 21:06:59.828922	2016-05-18 21:28:17.68151	5	ENSG00000168036	missense
2900	\N	\N		3	41266098	41266098	A	G	DOID:1909	25157968	included	ENST00000349496	p.D32G	CTNNB1	1	c.95	2016-05-18 21:06:59.840682	2016-05-18 21:28:17.753887	5	ENSG00000168036	missense
2901	\N	\N		3	41266097	41266097	G	C	DOID:1909	25157968	included	ENST00000349496	p.D32H	CTNNB1	1	c.94	2016-05-18 21:06:59.851872	2016-05-18 21:28:17.818939	5	ENSG00000168036	missense
2902	\N	\N		3	41266097	41266097	G	C	DOID:1909	19234609	included	ENST00000349496	p.D32H	CTNNB1	1	c.94	2016-05-18 21:06:59.860542	2016-05-18 21:28:17.88174	5	ENSG00000168036	missense
2903	\N	\N		3	41266097	41266097	G	A	DOID:3748	25157968	included	ENST00000349496	p.D32N	CTNNB1	1	c.94	2016-05-18 21:06:59.871337	2016-05-18 21:28:17.957995	5	ENSG00000168036	missense
2904	\N	\N		3	41266097	41266097	G	A	DOID:2871	25157968	included	ENST00000349496	p.D32N	CTNNB1	1	c.94	2016-05-18 21:06:59.883083	2016-05-18 21:28:18.015542	5	ENSG00000168036	missense
2905	\N	\N		3	41266098	41266098	A	T	DOID:2871	25157968	included	ENST00000349496	p.D32V	CTNNB1	1	c.95	2016-05-18 21:06:59.891472	2016-05-18 21:28:18.10234	5	ENSG00000168036	missense
2906	\N	\N		3	41266097	41266097	G	T	DOID:0050902	25157968	included	ENST00000349496	p.D32Y	CTNNB1	1	c.94	2016-05-18 21:06:59.908871	2016-05-18 21:28:18.161805	5	ENSG00000168036	missense
2907	\N	\N		3	41266097	41266097	G	T	DOID:3840	25157968	included	ENST00000349496	p.D32Y	CTNNB1	1	c.94	2016-05-18 21:06:59.918219	2016-05-18 21:28:18.206125	5	ENSG00000168036	missense
2908	\N	\N		3	41266101	41266101	C	G	DOID:2394	25157968	included	ENST00000349496	p.S33C	CTNNB1	1	c.98	2016-05-18 21:06:59.928338	2016-05-18 21:28:18.276019	5	ENSG00000168036	missense
2909	\N	\N		3	41266101	41266101	C	G	DOID:1319	25157968	included	ENST00000349496	p.S33C	CTNNB1	1	c.98	2016-05-18 21:06:59.936654	2016-05-18 21:28:18.336271	5	ENSG00000168036	missense
2910	\N	\N		3	41266101	41266101	C	G	DOID:1540	25157968	included	ENST00000349496	p.S33C	CTNNB1	1	c.98	2016-05-18 21:06:59.945539	2016-05-18 21:28:18.386617	5	ENSG00000168036	missense
2911	\N	\N		3	41266101	41266101	C	A	DOID:0050902	25157968	included	ENST00000349496	p.S33Y	CTNNB1	1	c.98	2016-05-18 21:06:59.955195	2016-05-18 21:28:18.454636	5	ENSG00000168036	missense
2912	\N	\N		3	41266101	41266101	C	A	DOID:2871	25157968	included	ENST00000349496	p.S33Y	CTNNB1	1	c.98	2016-05-18 21:06:59.964779	2016-05-18 21:28:18.495202	5	ENSG00000168036	missense
2913	\N	\N		3	41266104	41266104	G	A	DOID:684	25157968	included	ENST00000349496	p.G34E	CTNNB1	1	c.101	2016-05-18 21:06:59.972719	2016-05-18 21:28:18.55936	5	ENSG00000168036	missense
2914	\N	\N		3	41266104	41266104	G	A	DOID:2394	25157968	included	ENST00000349496	p.G34E	CTNNB1	1	c.101	2016-05-18 21:06:59.982714	2016-05-18 21:28:18.607327	5	ENSG00000168036	missense
2915	\N	\N		3	41266103	41266103	G	A	DOID:3840	25157968	included	ENST00000349496	p.G34R	CTNNB1	1	c.100	2016-05-18 21:06:59.99089	2016-05-18 21:28:18.667842	5	ENSG00000168036	missense
2916	\N	\N		3	41266103	41266103	G	A	DOID:5374	25157968	included	ENST00000349496	p.G34R	CTNNB1	1	c.100	2016-05-18 21:07:00.000555	2016-05-18 21:28:18.716814	5	ENSG00000168036	missense
2917	\N	\N		3	41266103	41266103	G	C	DOID:3840	25157968	included	ENST00000349496	p.G34R	CTNNB1	1	c.100	2016-05-18 21:07:00.016782	2016-05-18 21:28:18.775609	5	ENSG00000168036	missense
2918	\N	\N		3	41266103	41266103	G	C	DOID:5374	25157968	included	ENST00000349496	p.G34R	CTNNB1	1	c.100	2016-05-18 21:07:00.026436	2016-05-18 21:28:18.813769	5	ENSG00000168036	missense
2919	\N	\N		3	41266104	41266104	G	T	DOID:1909	25157968	included	ENST00000349496	p.G34V	CTNNB1	1	c.101	2016-05-18 21:07:00.04108	2016-05-18 21:28:18.873132	5	ENSG00000168036	missense
2920	\N	\N		3	41266104	41266104	G	T	DOID:3840	25157968	included	ENST00000349496	p.G34V	CTNNB1	1	c.101	2016-05-18 21:07:00.051717	2016-05-18 21:28:18.914633	5	ENSG00000168036	missense
2921	\N	\N		3	41266112	41266112	T	G	DOID:1540	25157968	included	ENST00000349496	p.S37A	CTNNB1	1	c.109	2016-05-18 21:07:00.062505	2016-05-18 21:28:18.974745	5	ENSG00000168036	missense
2922	\N	\N		3	41266113	41266113	C	G	DOID:2394	25157968	included	ENST00000349496	p.S37C	CTNNB1	1	c.110	2016-05-18 21:07:00.080358	2016-05-18 21:28:19.037062	5	ENSG00000168036	missense
2923	\N	\N		3	41266113	41266113	C	G	DOID:3910	25157968	included	ENST00000349496	p.S37C	CTNNB1	1	c.110	2016-05-18 21:07:00.090796	2016-05-18 21:28:19.078244	5	ENSG00000168036	missense
2924	\N	\N		3	41266113	41266113	C	T	DOID:2394	25157968	included	ENST00000349496	p.S37F	CTNNB1	1	c.110	2016-05-18 21:07:00.101888	2016-05-18 21:28:19.124439	5	ENSG00000168036	missense
2925	\N	\N		3	41266112	41266112	T	C	DOID:10534	25157968	included	ENST00000349496	p.S37P	CTNNB1	1	c.109	2016-05-18 21:07:00.112937	2016-05-18 21:28:19.18101	5	ENSG00000168036	missense
2926	\N	\N		3	41266113	41266113	C	A	DOID:10534	25157968	included	ENST00000349496	p.S37Y	CTNNB1	1	c.110	2016-05-18 21:07:00.129486	2016-05-18 21:28:19.221859	5	ENSG00000168036	missense
2927	\N	\N		3	41266121	41266121	A	G	DOID:10534	25157968	included	ENST00000349496	p.T40A	CTNNB1	1	c.118	2016-05-18 21:07:00.140052	2016-05-18 21:28:19.283678	5	ENSG00000168036	missense
2928	\N	\N		3	41266122	41266122	C	T	DOID:1909	25157968	included	ENST00000349496	p.T40I	CTNNB1	1	c.119	2016-05-18 21:07:00.156007	2016-05-18 21:28:19.335575	5	ENSG00000168036	missense
2929	\N	\N		3	41266121	41266121	A	C	DOID:162	25157968	included	ENST00000349496	p.T40P	CTNNB1	1	c.118	2016-05-18 21:07:00.165548	2016-05-18 21:28:19.385642	5	ENSG00000168036	missense
2930	\N	\N		3	41266121	41266121	A	T	DOID:162	25157968	included	ENST00000349496	p.T40S	CTNNB1	1	c.118	2016-05-18 21:07:00.174203	2016-05-18 21:28:19.436396	5	ENSG00000168036	missense
2940	\N	\N		3	41266137	41266137	C	A	DOID:1909	23569304	included	ENST00000349496	p.S45Y	CTNNB1	1	c.134	2016-05-18 21:07:00.279235	2016-05-18 21:28:19.614421	5	ENSG00000168036	missense
2941	\N	\N		7	55241708	55241708	G	C	DOID:3908	25157968	included	ENST00000275493	p.G719A	EGFR	1	c.2156	2016-05-18 21:07:00.297023	2016-05-18 21:28:19.651496	5	ENSG00000146648	missense
2942	\N	\N		7	55241708	55241708	G	C	DOID:3908	2302402	included	ENST00000275493	p.G719A	EGFR	1	c.2156	2016-05-18 21:07:00.310593	2016-05-18 21:28:19.688632	5	ENSG00000146648	missense
2943	\N	\N		7	55241708	55241708	G	C	DOID:3908	23242437	included	ENST00000275493	p.G719A	EGFR	1	c.2156	2016-05-18 21:07:00.328315	2016-05-18 21:28:19.729254	5	ENSG00000146648	missense
2944	\N	\N		7	55241708	55241708	G	C	DOID:3908	18458038	included	ENST00000275493	p.G719A	EGFR	1	c.2156	2016-05-18 21:07:00.343503	2016-05-18 21:28:19.764836	5	ENSG00000146648	missense
2945	\N	\N		7	55241707	55241707	G	T	DOID:3908	25157968	included	ENST00000275493	p.G719C	EGFR	1	c.2155	2016-05-18 21:07:00.37232	2016-05-18 21:28:19.800762	5	ENSG00000146648	missense
2946	\N	\N		7	55241707	55241707	G	T	DOID:3908	18199554	included	ENST00000275493	p.G719C	EGFR	1	c.2155	2016-05-18 21:07:00.382477	2016-05-18 21:28:19.837813	5	ENSG00000146648	missense
2947	\N	\N		7	55241707	55241707	G	T	DOID:3908	19671738	included	ENST00000275493	p.G719C	EGFR	1	c.2155	2016-05-18 21:07:00.420859	2016-05-18 21:28:19.878828	5	ENSG00000146648	missense
2948	\N	\N		7	55241708	55241708	G	A	DOID:3908	25157968	included	ENST00000275493	p.G719D	EGFR	1	c.2156	2016-05-18 21:07:00.443089	2016-05-18 21:28:19.929626	5	ENSG00000146648	missense
2949	\N	\N		7	55241708	55241708	G	A	DOID:3908	23945392	included	ENST00000275493	p.G719D	EGFR	1	c.2156	2016-05-18 21:07:00.460437	2016-05-18 21:28:19.99142	5	ENSG00000146648	missense
2950	\N	\N		7	55241707	55241707	G	A	DOID:3908	25157968	included	ENST00000275493	p.G719S	EGFR	1	c.2155	2016-05-18 21:07:00.470332	2016-05-18 21:28:20.047642	5	ENSG00000146648	missense
2951	\N	\N		7	55241707	55241707	G	A	DOID:3908	16204070	included	ENST00000275493	p.G719S	EGFR	1	c.2155	2016-05-18 21:07:00.509806	2016-05-18 21:28:20.106444	5	ENSG00000146648	missense
2952	\N	\N		7	55241707	55241707	G	A	DOID:3908	16187797	included	ENST00000275493	p.G719S	EGFR	1	c.2155	2016-05-18 21:07:00.52203	2016-05-18 21:28:20.177427	5	ENSG00000146648	missense
2953	\N	\N		7	55242423	55242423	G	A	DOID:3908	25157968	included	ENST00000275493	p.W731*	EGFR	1	c.2193	2016-05-18 21:07:00.54545	2016-05-18 21:28:20.249496	5	ENSG00000146648	stop
2954	\N	\N		7	55242428	55242428	C	T	DOID:3748	25157968	included	ENST00000275493	p.P733L	EGFR	1	c.2198	2016-05-18 21:07:00.558572	2016-05-18 21:28:20.314885	5	ENSG00000146648	missense
2955	\N	\N		7	55242428	55242428	C	T	DOID:3908	25157968	included	ENST00000275493	p.P733L	EGFR	1	c.2198	2016-05-18 21:07:00.613954	2016-05-18 21:28:20.3684	5	ENSG00000146648	missense
2956	\N	\N		7	55242428	55242428	C	T	DOID:3908	23485129	included	ENST00000275493	p.P733L	EGFR	1	c.2198	2016-05-18 21:07:00.632221	2016-05-18 21:28:20.41173	5	ENSG00000146648	missense
2957	\N	\N		7	55242430	55242430	G	A	DOID:3908	25157968	included	ENST00000275493	p.E734K	EGFR	1	c.2200	2016-05-18 21:07:00.662421	2016-05-18 21:28:20.472307	5	ENSG00000146648	missense
2958	\N	\N		7	55242430	55242430	G	A	DOID:3908	19455431	included	ENST00000275493	p.E734K	EGFR	1	c.2200	2016-05-18 21:07:00.67592	2016-05-18 21:28:20.513689	5	ENSG00000146648	missense
2959	\N	\N		7	55242433	55242433	G	A	DOID:10283	25157968	included	ENST00000275493	p.G735S	EGFR	1	c.2203	2016-05-18 21:07:00.695313	2016-05-18 21:28:20.574741	5	ENSG00000146648	missense
2960	\N	\N		7	55242433	55242433	G	A	DOID:3908	25157968	included	ENST00000275493	p.G735S	EGFR	1	c.2203	2016-05-18 21:07:00.705448	2016-05-18 21:28:20.616955	5	ENSG00000146648	missense
2961	\N	\N		7	55242433	55242433	G	A	DOID:3908	23485129	included	ENST00000275493	p.G735S	EGFR	1	c.2203	2016-05-18 21:07:00.724695	2016-05-18 21:28:20.656049	5	ENSG00000146648	missense
2962	\N	\N		7	55242455	55242455	T	C	DOID:3908	25157968	included	ENST00000275493	p.V742A	EGFR	1	c.2225	2016-05-18 21:07:00.737278	2016-05-18 21:28:20.713505	5	ENSG00000146648	missense
2963	\N	\N		7	55242455	55242455	T	C	DOID:3908	19147750	included	ENST00000275493	p.V742A	EGFR	1	c.2225	2016-05-18 21:07:00.749107	2016-05-18 21:28:20.753606	5	ENSG00000146648	missense
2964	\N	\N		7	55242464	55242464	A	G	DOID:5520	25157968	included	ENST00000275493	p.K745R	EGFR	1	c.2234	2016-05-18 21:07:00.75784	2016-05-18 21:28:20.805727	5	ENSG00000146648	missense
2965	\N	\N		7	55242464	55242464	A	G	DOID:5520	21531084	included	ENST00000275493	p.K745R	EGFR	1	c.2234	2016-05-18 21:07:00.768421	2016-05-18 21:28:20.858191	5	ENSG00000146648	missense
2966	\N	\N		7	55242464	55242464	A	G	DOID:5520	20415598	included	ENST00000275493	p.K745R	EGFR	1	c.2234	2016-05-18 21:07:00.77631	2016-05-18 21:28:20.9364	5	ENSG00000146648	missense
2967	\N	\N		7	55242466	55242466	G	A	DOID:3908	25157968	included	ENST00000275493	p.E746K	EGFR	1	c.2236	2016-05-18 21:07:00.787118	2016-05-18 21:28:21.033679	5	ENSG00000146648	missense
2968	\N	\N		7	55242478	55242478	G	C	DOID:3910	25157968	included	ENST00000275493	p.A750P	EGFR	1	c.2248	2016-05-18 21:07:00.801105	2016-05-18 21:28:21.108093	5	ENSG00000146648	missense
2969	\N	\N		7	55242478	55242478	G	C	DOID:3910	15737014	included	ENST00000275493	p.A750P	EGFR	1	c.2248	2016-05-18 21:07:00.811058	2016-05-18 21:28:21.155957	5	ENSG00000146648	missense
2970	\N	\N		7	55242478	55242478	G	C	DOID:3908	25157968	included	ENST00000275493	p.A750P	EGFR	1	c.2248	2016-05-18 21:07:00.82947	2016-05-18 21:28:21.203975	5	ENSG00000146648	missense
2971	\N	\N		7	55242478	55242478	G	C	DOID:3908	22622260	included	ENST00000275493	p.A750P	EGFR	1	c.2248	2016-05-18 21:07:00.841506	2016-05-18 21:28:21.248809	5	ENSG00000146648	missense
2972	\N	\N		7	55242485	55242485	C	A	DOID:3908	25157968	included	ENST00000275493	p.S752Y	EGFR	1	c.2255	2016-05-18 21:07:00.853608	2016-05-18 21:28:21.311099	5	ENSG00000146648	missense
2973	\N	\N		7	55242487	55242487	C	T	DOID:3908	25157968	included	ENST00000275493	p.P753S	EGFR	1	c.2257	2016-05-18 21:07:00.862921	2016-05-18 21:28:21.36085	5	ENSG00000146648	missense
2974	\N	\N		7	55242487	55242487	C	T	DOID:3908	18089823	included	ENST00000275493	p.P753S	EGFR	1	c.2257	2016-05-18 21:07:00.871893	2016-05-18 21:28:21.401022	5	ENSG00000146648	missense
2975	\N	\N		7	55242511	55242511	G	A	DOID:3908	25157968	included	ENST00000275493	p.D761N	EGFR	1	c.2281	2016-05-18 21:07:00.879945	2016-05-18 21:28:21.457927	5	ENSG00000146648	missense
2976	\N	\N		7	55242511	55242511	G	A	DOID:3908	19147750	included	ENST00000275493	p.D761N	EGFR	1	c.2281	2016-05-18 21:07:00.891449	2016-05-18 21:28:21.492578	5	ENSG00000146648	missense
2977	\N	\N		7	55242511	55242511	G	A	DOID:3908	23800712	included	ENST00000275493	p.D761N	EGFR	1	c.2281	2016-05-18 21:07:00.903922	2016-05-18 21:28:21.530956	5	ENSG00000146648	missense
2978	\N	\N		7	55242511	55242511	G	T	DOID:3908	25157968	included	ENST00000275493	p.D761Y	EGFR	1	c.2281	2016-05-18 21:07:00.91578	2016-05-18 21:28:21.575143	5	ENSG00000146648	missense
2979	\N	\N		7	55242511	55242511	G	T	DOID:3908	17545553	included	ENST00000275493	p.D761Y	EGFR	1	c.2281	2016-05-18 21:07:00.924805	2016-05-18 21:28:21.616919	5	ENSG00000146648	missense
2980	\N	\N		7	55242511	55242511	G	T	DOID:3908	16730855	included	ENST00000275493	p.D761Y	EGFR	1	c.2281	2016-05-18 21:07:00.937964	2016-05-18 21:28:21.651304	5	ENSG00000146648	missense
2981	\N	\N		7	55249005	55249005	G	T	DOID:1107	25157968	included	ENST00000275493	p.S768I	EGFR	1	c.2303	2016-05-18 21:07:00.946086	2016-05-18 21:28:21.68779	5	ENSG00000146648	missense
2984	\N	\N		7	55249005	55249005	G	T	DOID:3908	17653080	included	ENST00000275493	p.S768I	EGFR	1	c.2303	2016-05-18 21:07:00.986046	2016-05-18 21:28:21.813292	5	ENSG00000146648	missense
2988	\N	\N		7	55249071	55249071	C	T	DOID:3908	25157968	included	ENST00000275493	p.T790M	EGFR	1	c.2369	2016-05-18 21:07:01.065023	2016-05-18 21:28:22.00335	5	ENSG00000146648	missense
2989	\N	\N		7	55249071	55249071	C	T	DOID:3908	16258541	included	ENST00000275493	p.T790M	EGFR	1	c.2369	2016-05-18 21:07:01.080625	2016-05-18 21:28:22.038443	5	ENSG00000146648	missense
2990	\N	\N		7	55249071	55249071	C	T	DOID:3908	20033049	included	ENST00000275493	p.T790M	EGFR	1	c.2369	2016-05-18 21:07:01.092639	2016-05-18 21:28:22.085082	5	ENSG00000146648	missense
2991	\N	\N		7	55249071	55249071	C	T	DOID:3908	22215752	included	ENST00000275493	p.T790M	EGFR	1	c.2369	2016-05-18 21:07:01.111546	2016-05-18 21:28:22.142716	5	ENSG00000146648	missense
2992	\N	\N		7	55249071	55249071	C	T	DOID:3908	21233402	included	ENST00000275493	p.T790M	EGFR	1	c.2369	2016-05-18 21:07:01.12356	2016-05-18 21:28:22.180551	5	ENSG00000146648	missense
2993	\N	\N		7	55249131	55249131	G	A	DOID:0050865	25157968	included	ENST00000275493	p.G810D	EGFR	1	c.2429	2016-05-18 21:07:01.152281	2016-05-18 21:28:22.249619	5	ENSG00000146648	missense
2995	\N	\N		7	55259514	55259514	C	A	DOID:3908	25157968	included	ENST00000275493	p.L858M	EGFR	1	c.2572	2016-05-18 21:07:01.290057	2016-05-18 21:28:22.382737	5	ENSG00000146648	missense
2997	\N	\N		7	55259514	55259514	C	A	DOID:3908	19455431	included	ENST00000275493	p.L858M	EGFR	1	c.2572	2016-05-18 21:07:01.319177	2016-05-18 21:28:22.472907	5	ENSG00000146648	missense
2998	\N	\N		7	55259515	55259515	T	G	DOID:3908	25157968	included	ENST00000275493	p.L858R	EGFR	1	c.2573	2016-05-18 21:07:01.326869	2016-05-18 21:28:22.51341	5	ENSG00000146648	missense
2999	\N	\N		7	55259515	55259515	T	G	DOID:3908	16204070	included	ENST00000275493	p.L858R	EGFR	1	c.2573	2016-05-18 21:07:01.335203	2016-05-18 21:28:22.549533	5	ENSG00000146648	missense
3000	\N	\N		7	55259515	55259515	T	G	DOID:3908	19455431	included	ENST00000275493	p.L858R	EGFR	1	c.2573	2016-05-18 21:07:01.347546	2016-05-18 21:28:22.590276	5	ENSG00000146648	missense
3003	\N	\N		7	55259515	55259515	T	A	DOID:3908	25157968	included	ENST00000275493	p.L858Q	EGFR	1	c.2573	2016-05-18 21:07:01.390993	2016-05-18 21:28:22.775837	5	ENSG00000146648	missense
3004	\N	\N		17	37881025	37881025	T	C	DOID:1612	25157968	included	ENST00000269571	p.L785P	ERBB2	1	c.2354	2016-05-18 21:07:01.40262	2016-05-18 21:28:22.842413	5	ENSG00000141736	missense
3005	\N	\N		17	37880220	37880220	T	C	DOID:1612	25157968	included	ENST00000269571	p.L755S	ERBB2	1	c.2264	2016-05-18 21:07:01.447282	2016-05-18 21:28:22.882949	5	ENSG00000141736	missense
3006	\N	\N		17	37880220	37880220	T	C	DOID:1612	22046346	included	ENST00000269571	p.L755S	ERBB2	1	c.2264	2016-05-18 21:07:01.463603	2016-05-18 21:28:22.923967	5	ENSG00000141736	missense
3007	\N	\N		17	37880220	37880220	T	C	DOID:1612	18413839	included	ENST00000269571	p.L755S	ERBB2	1	c.2264	2016-05-18 21:07:01.473554	2016-05-18 21:28:22.958831	5	ENSG00000141736	missense
3008	\N	\N		17	37880261	37880261	G	C	DOID:1612	25157968	included	ENST00000269571	p.D769H	ERBB2	1	c.2305	2016-05-18 21:07:01.518069	2016-05-18 21:28:22.998386	5	ENSG00000141736	missense
3009	\N	\N		17	37880997	37880997	G	A	DOID:162	25157968	included	ENST00000269571	p.G776S	ERBB2	1	c.2326	2016-05-18 21:07:01.528378	2016-05-18 21:28:23.054621	5	ENSG00000141736	missense
3010	\N	\N		17	37880997	37880998	-	TGT	DOID:1612	25157968	included	ENST00000269571	p.G776CX	ERBB2	1	c.2326	2016-05-18 21:07:01.540114	2016-05-18 21:28:23.107971	5	ENSG00000141736	frameshift
3011	\N	\N		17	37881000	37881000	G	T	DOID:1612	25157968	included	ENST00000269571	p.V777L	ERBB2	1	c.2329	2016-05-18 21:07:01.550082	2016-05-18 21:28:23.156114	5	ENSG00000141736	missense
3012	\N	\N		17	37881000	37881000	G	T	DOID:1612	22046346	included	ENST00000269571	p.V777L	ERBB2	1	c.2329	2016-05-18 21:07:01.559948	2016-05-18 21:28:23.205775	5	ENSG00000141736	missense
3013	\N	\N		17	37881000	37881000	G	T	DOID:1612	24516025	included	ENST00000269571	p.V777L	ERBB2	1	c.2329	2016-05-18 21:07:01.568687	2016-05-18 21:28:23.247167	5	ENSG00000141736	missense
3014	\N	\N		17	37881000	37881000	G	C	DOID:1612	25157968	included	ENST00000269571	p.V777L	ERBB2	1	c.2329	2016-05-18 21:07:01.577102	2016-05-18 21:28:23.297498	5	ENSG00000141736	missense
3015	\N	\N		17	37881000	37881000	G	C	DOID:1612	22046346	included	ENST00000269571	p.V777L	ERBB2	1	c.2329	2016-05-18 21:07:01.592016	2016-05-18 21:28:23.33731	5	ENSG00000141736	missense
3017	\N	\N		8	38285938	38285938	G	A	DOID:162	25157968	included	ENST00000425967	p.S158L	FGFR1	-1	c.473	2016-05-18 21:07:01.614464	2016-05-18 21:28:23.455734	5	ENSG00000077782	missense
3018	\N	\N		8	38282209	38282209	G	T	DOID:162	25157968	included	ENST00000425967	p.P283T	FGFR1	-1	c.847	2016-05-18 21:07:01.653478	2016-05-18 21:28:23.540909	5	ENSG00000077782	missense
3019	\N	\N		10	123279677	123279677	G	C	DOID:2871	25157968	included	ENST00000457416	p.S252W	FGFR2	-1	c.755	2016-05-18 21:07:01.663218	2016-05-18 21:28:23.602971	5	ENSG00000066468	missense
3020	\N	\N		10	123279677	123279677	G	C	DOID:2871	18552176	included	ENST00000457416	p.S252W	FGFR2	-1	c.755	2016-05-18 21:07:01.670899	2016-05-18 21:28:23.658771	5	ENSG00000066468	missense
3021	\N	\N		10	123279677	123279677	G	C	DOID:2871	21367659	included	ENST00000457416	p.S252W	FGFR2	-1	c.755	2016-05-18 21:07:01.67908	2016-05-18 21:28:23.699753	5	ENSG00000066468	missense
3022	\N	\N		10	123279503	123279503	T	C	DOID:2871	25157968	included	ENST00000457416	p.K310R	FGFR2	-1	c.929	2016-05-18 21:07:01.689968	2016-05-18 21:28:23.771568	5	ENSG00000066468	missense
3023	\N	\N		10	123279503	123279503	T	C	DOID:2871	18552176	included	ENST00000457416	p.K310R	FGFR2	-1	c.929	2016-05-18 21:07:01.706418	2016-05-18 21:28:23.812346	5	ENSG00000066468	missense
3024	\N	\N		10	123274803	123274803	G	C	DOID:2871	25157968	included	ENST00000457416	p.S373C	FGFR2	-1	c.1118	2016-05-18 21:07:01.714867	2016-05-18 21:28:23.876457	5	ENSG00000066468	missense
3025	\N	\N		10	123274803	123274803	G	C	DOID:2871	21367659	included	ENST00000457416	p.S373C	FGFR2	-1	c.1118	2016-05-18 21:07:01.731346	2016-05-18 21:28:23.927346	5	ENSG00000066468	missense
3026	\N	\N		10	123274794	123274794	T	C	DOID:2871	25157968	included	ENST00000457416	p.Y376C	FGFR2	-1	c.1127	2016-05-18 21:07:01.741897	2016-05-18 21:28:23.985946	5	ENSG00000066468	missense
3027	\N	\N		10	123274794	123274794	T	C	DOID:2871	21367659	included	ENST00000457416	p.Y376C	FGFR2	-1	c.1127	2016-05-18 21:07:01.77434	2016-05-18 21:28:24.041141	5	ENSG00000066468	missense
3028	\N	\N		10	123274777	123274777	A	G	DOID:2871	25157968	included	ENST00000457416	p.Y382H	FGFR2	-1	c.1144	2016-05-18 21:07:01.78226	2016-05-18 21:28:24.112407	5	ENSG00000066468	missense
3029	\N	\N		10	123247577	123247577	A	T	DOID:2871	25157968	included	ENST00000457416	p.N639K	FGFR2	-1	c.1917	2016-05-18 21:07:01.794755	2016-05-18 21:28:24.187713	5	ENSG00000066468	missense
3030	\N	\N		4	1803564	1803564	C	T	DOID:3910	25157968	included	ENST00000340107	p.R248C	FGFR3	1	c.742	2016-05-18 21:07:01.802911	2016-05-18 21:28:24.273827	5	ENSG00000068078	missense
3031	\N	\N		4	1803564	1803564	C	T	DOID:3910	23786770	included	ENST00000340107	p.R248C	FGFR3	1	c.742	2016-05-18 21:07:01.814102	2016-05-18 21:28:24.330376	5	ENSG00000068078	missense
3032	\N	\N		4	1803568	1803568	C	G	DOID:4007	25157968	included	ENST00000340107	p.S249C	FGFR3	1	c.746	2016-05-18 21:07:01.827721	2016-05-18 21:28:24.407148	5	ENSG00000068078	missense
3033	\N	\N		4	1803568	1803568	C	G	DOID:4007	19381019	included	ENST00000340107	p.S249C	FGFR3	1	c.746	2016-05-18 21:07:01.840577	2016-05-18 21:28:24.456459	5	ENSG00000068078	missense
3034	\N	\N		4	1806089	1806089	G	T	DOID:4007	25157968	included	ENST00000340107	p.G372C	FGFR3	1	c.1114	2016-05-18 21:07:01.856893	2016-05-18 21:28:24.527771	5	ENSG00000068078	missense
3035	\N	\N		4	1806089	1806089	G	T	DOID:4007	19381019	included	ENST00000340107	p.G372C	FGFR3	1	c.1114	2016-05-18 21:07:01.868667	2016-05-18 21:28:24.570218	5	ENSG00000068078	missense
3036	\N	\N		4	1806092	1806092	A	T	DOID:4007	25157968	included	ENST00000340107	p.S373C	FGFR3	1	c.1117	2016-05-18 21:07:01.888373	2016-05-18 21:28:24.633889	5	ENSG00000068078	missense
3037	\N	\N		4	1806099	1806099	A	G	DOID:4007	25157968	included	ENST00000340107	p.Y375C	FGFR3	1	c.1124	2016-05-18 21:07:01.902827	2016-05-18 21:28:24.69113	5	ENSG00000068078	missense
3038	\N	\N		4	1806099	1806099	A	G	DOID:4007	19381019	included	ENST00000340107	p.Y375C	FGFR3	1	c.1124	2016-05-18 21:07:01.910598	2016-05-18 21:28:24.737882	5	ENSG00000068078	missense
3039	\N	\N		4	1807889	1807889	A	C	DOID:4007	25157968	included	ENST00000340107	p.K652Q	FGFR3	1	c.1954	2016-05-18 21:07:01.921162	2016-05-18 21:28:24.805688	5	ENSG00000068078	missense
3040	\N	\N		4	1808331	1808331	G	T	DOID:4007	25157968	included	ENST00000340107	p.G699C	FGFR3	1	c.2095	2016-05-18 21:07:01.932935	2016-05-18 21:28:24.872044	5	ENSG00000068078	missense
3041	\N	\N		13	28608341	28608341	T	C	DOID:9119	25157968	included	ENST00000380982	p.Y572C	FLT3	-1	c.1715	2016-05-18 21:07:01.944469	2016-05-18 21:28:24.934332	5	ENSG00000122025	missense
3042	\N	\N		13	28592640	28592642	ATC	-	DOID:9119	25157968	included	ENST00000380982	p.D835-	FLT3	-1	c.2503	2016-05-18 21:07:01.95118	2016-05-18 21:28:24.996408	5	ENSG00000122025	inframe
3043	\N	\N		13	28592640	28592640	A	T	DOID:9119	25157968	included	ENST00000380982	p.D835E	FLT3	-1	c.2505	2016-05-18 21:07:01.960357	2016-05-18 21:28:25.04292	5	ENSG00000122025	missense
3044	\N	\N		13	28592640	28592640	A	T	DOID:9119	15256420	included	ENST00000380982	p.D835E	FLT3	-1	c.2505	2016-05-18 21:07:01.971165	2016-05-18 21:28:25.076711	5	ENSG00000122025	missense
3045	\N	\N		13	28592640	28592640	A	T	DOID:9119	15374878	included	ENST00000380982	p.D835E	FLT3	-1	c.2505	2016-05-18 21:07:01.988921	2016-05-18 21:28:25.12085	5	ENSG00000122025	missense
3046	\N	\N		13	28592640	28592640	A	C	DOID:9119	25157968	included	ENST00000380982	p.D835E	FLT3	-1	c.2505	2016-05-18 21:07:02.00192	2016-05-18 21:28:25.168602	5	ENSG00000122025	missense
3047	\N	\N		13	28592640	28592640	A	C	DOID:9119	15256420	included	ENST00000380982	p.D835E	FLT3	-1	c.2505	2016-05-18 21:07:02.017328	2016-05-18 21:28:25.202011	5	ENSG00000122025	missense
3048	\N	\N		13	28592640	28592640	A	C	DOID:9119	15374878	included	ENST00000380982	p.D835E	FLT3	-1	c.2505	2016-05-18 21:07:02.029853	2016-05-18 21:28:25.239892	5	ENSG00000122025	missense
3049	\N	\N		13	28592642	28592642	C	G	DOID:9119	25157968	included	ENST00000380982	p.D835H	FLT3	-1	c.2503	2016-05-18 21:07:02.043711	2016-05-18 21:28:25.279222	5	ENSG00000122025	missense
3050	\N	\N		13	28592642	28592642	C	G	DOID:9119	14604974	included	ENST00000380982	p.D835H	FLT3	-1	c.2503	2016-05-18 21:07:02.054917	2016-05-18 21:28:25.405155	5	ENSG00000122025	missense
3051	\N	\N		13	28592642	28592642	C	G	DOID:9119	17047150	included	ENST00000380982	p.D835H	FLT3	-1	c.2503	2016-05-18 21:07:02.068571	2016-05-18 21:28:25.456312	5	ENSG00000122025	missense
3052	\N	\N		13	28592642	28592642	C	G	DOID:9119	24046014	included	ENST00000380982	p.D835H	FLT3	-1	c.2503	2016-05-18 21:07:02.079676	2016-05-18 21:28:25.513033	5	ENSG00000122025	missense
3053	\N	\N		13	28592641	28592641	T	A	DOID:9119	25157968	included	ENST00000380982	p.D835V	FLT3	-1	c.2504	2016-05-18 21:07:02.08832	2016-05-18 21:28:25.578572	5	ENSG00000122025	missense
3054	\N	\N		13	28592641	28592641	T	A	DOID:9119	24046014	included	ENST00000380982	p.D835V	FLT3	-1	c.2504	2016-05-18 21:07:02.101735	2016-05-18 21:28:25.63729	5	ENSG00000122025	missense
3055	\N	\N		13	28592641	28592641	T	A	DOID:9119	14604974	included	ENST00000380982	p.D835V	FLT3	-1	c.2504	2016-05-18 21:07:02.113511	2016-05-18 21:28:25.706469	5	ENSG00000122025	missense
3056	\N	\N		13	28592641	28592641	T	A	DOID:9119	17606455	included	ENST00000380982	p.D835V	FLT3	-1	c.2504	2016-05-18 21:07:02.121179	2016-05-18 21:28:25.747931	5	ENSG00000122025	missense
3057	\N	\N		13	28592642	28592642	C	A	DOID:9119	25157968	included	ENST00000380982	p.D835Y	FLT3	-1	c.2503	2016-05-18 21:07:02.134989	2016-05-18 21:28:25.791825	5	ENSG00000122025	missense
3058	\N	\N		13	28592642	28592642	C	A	DOID:9119	17889720	included	ENST00000380982	p.D835Y	FLT3	-1	c.2503	2016-05-18 21:07:02.146654	2016-05-18 21:28:25.843571	5	ENSG00000122025	missense
3059	\N	\N		13	28592637	28592639	GAT	-	DOID:9119	25157968	included	ENST00000380982	p.I836-	FLT3	-1	c.2506	2016-05-18 21:07:02.160433	2016-05-18 21:28:25.90816	5	ENSG00000122025	inframe
3060	\N	\N		13	28592637	28592637	G	C	DOID:9119	25157968	included	ENST00000380982	p.I836M	FLT3	-1	c.2508	2016-05-18 21:07:02.169826	2016-05-18 21:28:25.946922	5	ENSG00000122025	missense
3061	\N	\N		19	3118942	3118942	A	T	DOID:6039	25157968	included	ENST00000078429	p.Q209L	GNA11	1	c.626	2016-05-18 21:07:02.177803	2016-05-18 21:28:25.988622	5	ENSG00000088256	missense
3062	\N	\N		19	3118942	3118942	A	T	DOID:6039	22733540	included	ENST00000078429	p.Q209L	GNA11	1	c.626	2016-05-18 21:07:02.186088	2016-05-18 21:28:26.034021	5	ENSG00000088256	missense
3063	\N	\N		19	3118942	3118942	A	T	DOID:6039	24141786	included	ENST00000078429	p.Q209L	GNA11	1	c.626	2016-05-18 21:07:02.231673	2016-05-18 21:28:26.072856	5	ENSG00000088256	missense
3064	\N	\N		19	3118942	3118942	A	T	DOID:6039	21444680	included	ENST00000078429	p.Q209L	GNA11	1	c.626	2016-05-18 21:07:02.242631	2016-05-18 21:28:26.121877	5	ENSG00000088256	missense
3065	\N	\N		19	3118942	3118942	A	C	DOID:6039	25157968	included	ENST00000078429	p.Q209P	GNA11	1	c.626	2016-05-18 21:07:02.254088	2016-05-18 21:28:26.172168	5	ENSG00000088256	missense
3066	\N	\N		19	3118942	3118942	A	C	DOID:6039	22733540	included	ENST00000078429	p.Q209P	GNA11	1	c.626	2016-05-18 21:07:02.263816	2016-05-18 21:28:26.21698	5	ENSG00000088256	missense
3067	\N	\N		9	80409488	80409488	T	A	DOID:6039	25157968	included	ENST00000286548	p.Q209L	GNAQ	-1	c.626	2016-05-18 21:07:02.275767	2016-05-18 21:28:26.260943	5	ENSG00000156052	missense
3068	\N	\N		9	80409488	80409488	T	A	DOID:6039	22733540	included	ENST00000286548	p.Q209L	GNAQ	-1	c.626	2016-05-18 21:07:02.288244	2016-05-18 21:28:26.299287	5	ENSG00000156052	missense
3069	\N	\N		9	80409488	80409489	TG	AA	DOID:6039	25157968	included	ENST00000286548	p.Q209L	GNAQ	-1	c.625	2016-05-18 21:07:02.297436	2016-05-18 21:28:26.352325	5	ENSG00000156052	missense
3070	\N	\N		9	80409488	80409488	T	G	DOID:6039	25157968	included	ENST00000286548	p.Q209P	GNAQ	-1	c.626	2016-05-18 21:07:02.312986	2016-05-18 21:28:26.393831	5	ENSG00000156052	missense
3071	\N	\N		9	80409488	80409488	T	G	DOID:6039	22733540	included	ENST00000286548	p.Q209P	GNAQ	-1	c.626	2016-05-18 21:07:02.323341	2016-05-18 21:28:26.431166	5	ENSG00000156052	missense
3072	\N	\N		20	57484420	57484420	C	T	DOID:162	25157968	included	ENST00000354359	p.R202C	GNAS	1	c.604	2016-05-18 21:07:02.394815	2016-05-18 21:28:26.472471	5	ENSG00000087460	missense
3073	\N	\N		20	57484421	57484421	G	A	DOID:162	25157968	included	ENST00000354359	p.R202H	GNAS	1	c.605	2016-05-18 21:07:02.406068	2016-05-18 21:28:26.514643	5	ENSG00000087460	missense
3074	\N	\N		20	57484596	57484596	A	T	DOID:162	25157968	included	ENST00000354359	p.Q228L	GNAS	1	c.683	2016-05-18 21:07:02.414581	2016-05-18 21:28:26.566959	5	ENSG00000087460	missense
3075	\N	\N		11	534289	534289	C	A	DOID:4007	25157968	included	ENST00000311189	p.G12C	HRAS	-1	c.34	2016-05-18 21:07:02.423629	2016-05-18 21:28:26.615028	5	ENSG00000174775	missense
3076	\N	\N		11	534288	534288	C	T	DOID:1612	25157968	included	ENST00000311189	p.G12D	HRAS	-1	c.35	2016-05-18 21:07:02.431094	2016-05-18 21:28:26.663703	5	ENSG00000174775	missense
3077	\N	\N		11	534289	534289	C	G	DOID:9256	25157968	included	ENST00000311189	p.G12R	HRAS	-1	c.34	2016-05-18 21:07:02.440048	2016-05-18 21:28:26.704724	5	ENSG00000174775	missense
3078	\N	\N		11	534289	534289	C	G	DOID:9256	16478791	included	ENST00000311189	p.G12R	HRAS	-1	c.34	2016-05-18 21:07:02.448047	2016-05-18 21:28:26.741318	5	ENSG00000174775	missense
3079	\N	\N		11	534288	534288	C	A	DOID:1909	25157968	included	ENST00000311189	p.G12V	HRAS	-1	c.35	2016-05-18 21:07:02.458495	2016-05-18 21:28:26.778219	5	ENSG00000174775	missense
3080	\N	\N		11	534286	534286	C	A	DOID:162	25157968	included	ENST00000311189	p.G13C	HRAS	-1	c.37	2016-05-18 21:07:02.468439	2016-05-18 21:28:26.81981	5	ENSG00000174775	missense
3081	\N	\N		11	534286	534286	C	G	DOID:1781	25157968	included	ENST00000311189	p.G13R	HRAS	-1	c.37	2016-05-18 21:07:02.476905	2016-05-18 21:28:26.857067	5	ENSG00000174775	missense
3082	\N	\N		11	534286	534286	C	T	DOID:162	25157968	included	ENST00000311189	p.G13S	HRAS	-1	c.37	2016-05-18 21:07:02.490588	2016-05-18 21:28:26.911551	5	ENSG00000174775	missense
3083	\N	\N		11	534285	534285	C	A	DOID:3284	25157968	included	ENST00000311189	p.G13V	HRAS	-1	c.38	2016-05-18 21:07:02.498982	2016-05-18 21:28:26.982433	5	ENSG00000174775	missense
3084	\N	\N		11	534285	534285	C	A	DOID:3284	20859122	included	ENST00000311189	p.G13V	HRAS	-1	c.38	2016-05-18 21:07:02.514848	2016-05-18 21:28:27.032359	5	ENSG00000174775	missense
3085	\N	\N		11	533873	533873	C	G	DOID:162	25157968	included	ENST00000311189	p.Q61H	HRAS	-1	c.183	2016-05-18 21:07:02.525236	2016-05-18 21:28:27.087185	5	ENSG00000174775	missense
3086	\N	\N		11	533873	533873	C	A	DOID:162	25157968	included	ENST00000311189	p.Q61H	HRAS	-1	c.183	2016-05-18 21:07:02.533189	2016-05-18 21:28:27.146543	5	ENSG00000174775	missense
3087	\N	\N		11	533875	533875	G	T	DOID:1612	25157968	included	ENST00000311189	p.Q61K	HRAS	-1	c.181	2016-05-18 21:07:02.543285	2016-05-18 21:28:27.205667	5	ENSG00000174775	missense
3088	\N	\N		11	533874	533874	T	A	DOID:3151	25157968	included	ENST00000311189	p.Q61L	HRAS	-1	c.182	2016-05-18 21:07:02.555873	2016-05-18 21:28:27.260842	5	ENSG00000174775	missense
3089	\N	\N		11	533874	533874	T	A	DOID:3151	22256804	included	ENST00000311189	p.Q61L	HRAS	-1	c.182	2016-05-18 21:07:02.567448	2016-05-18 21:28:27.30658	5	ENSG00000174775	missense
3090	\N	\N		11	533874	533874	T	A	DOID:3151	22726224	included	ENST00000311189	p.Q61L	HRAS	-1	c.182	2016-05-18 21:07:02.579256	2016-05-18 21:28:27.345269	5	ENSG00000174775	missense
3091	\N	\N		11	533874	533874	T	G	DOID:162	25157968	included	ENST00000311189	p.Q61P	HRAS	-1	c.182	2016-05-18 21:07:02.590185	2016-05-18 21:28:27.400788	5	ENSG00000174775	missense
3092	\N	\N		11	533874	533874	T	C	DOID:162	25157968	included	ENST00000311189	p.Q61R	HRAS	-1	c.182	2016-05-18 21:07:02.597798	2016-05-18 21:28:27.439065	5	ENSG00000174775	missense
3093	\N	\N		11	533873	533874	CT	TC	DOID:162	25157968	included	ENST00000311189	p.Q61R	HRAS	-1	c.182	2016-05-18 21:07:02.610995	2016-05-18 21:28:27.491937	5	ENSG00000174775	missense
3094	\N	\N		11	533873	533874	CT	AC	DOID:162	25157968	included	ENST00000311189	p.Q61R	HRAS	-1	c.182	2016-05-18 21:07:02.620938	2016-05-18 21:28:27.539637	5	ENSG00000174775	missense
3095	\N	\N		2	209113113	209113113	G	A	DOID:3069	25157968	included	ENST00000345146	p.R132C	IDH1	-1	c.394	2016-05-18 21:07:02.632613	2016-05-18 21:28:27.582219	5	ENSG00000138413	missense
3096	\N	\N		2	209113112	209113112	C	T	DOID:3069	25157968	included	ENST00000345146	p.R132H	IDH1	-1	c.395	2016-05-18 21:07:02.640166	2016-05-18 21:28:27.621811	5	ENSG00000138413	missense
3097	\N	\N		2	209113112	209113112	C	T	DOID:3069	19798509	included	ENST00000345146	p.R132H	IDH1	-1	c.395	2016-05-18 21:07:02.649006	2016-05-18 21:28:27.661723	5	ENSG00000138413	missense
3098	\N	\N		2	209113112	209113112	C	T	DOID:3069	19818334	included	ENST00000345146	p.R132H	IDH1	-1	c.395	2016-05-18 21:07:02.656942	2016-05-18 21:28:27.702143	5	ENSG00000138413	missense
3099	\N	\N		2	209113113	209113113	G	T	DOID:3069	25157968	included	ENST00000345146	p.R132S	IDH1	-1	c.394	2016-05-18 21:07:02.664681	2016-05-18 21:28:27.75445	5	ENSG00000138413	missense
3100	\N	\N		2	209113113	209113113	G	T	DOID:3069	21352804	included	ENST00000345146	p.R132S	IDH1	-1	c.394	2016-05-18 21:07:02.677605	2016-05-18 21:28:27.788722	5	ENSG00000138413	missense
3101	\N	\N		15	90631934	90631934	C	T	DOID:9119	25157968	included	ENST00000330062	p.R140Q	IDH2	-1	c.419	2016-05-18 21:07:02.687564	2016-05-18 21:28:27.82834	5	ENSG00000182054	missense
3102	\N	\N		15	90631934	90631934	C	T	DOID:9119	23558173	included	ENST00000330062	p.R140Q	IDH2	-1	c.419	2016-05-18 21:07:02.697407	2016-05-18 21:28:27.86655	5	ENSG00000182054	missense
3103	\N	\N		15	90631838	90631838	C	T	DOID:9119	25157968	included	ENST00000330062	p.R172K	IDH2	-1	c.515	2016-05-18 21:07:02.705105	2016-05-18 21:28:27.901128	5	ENSG00000182054	missense
3104	\N	\N		15	90631838	90631838	C	T	DOID:9119	21250968	included	ENST00000330062	p.R172K	IDH2	-1	c.515	2016-05-18 21:07:02.714741	2016-05-18 21:28:27.937143	5	ENSG00000182054	missense
3105	\N	\N		9	5073770	5073770	G	T	DOID:4971	25157968	included	ENST00000381652	p.V617F	JAK2	1	c.1849	2016-05-18 21:07:02.725921	2016-05-18 21:28:27.972587	5	ENSG00000096968	missense
3106	\N	\N		9	5073770	5073770	G	T	DOID:4971	16293597	included	ENST00000381652	p.V617F	JAK2	1	c.1849	2016-05-18 21:07:02.734862	2016-05-18 21:28:28.0147	5	ENSG00000096968	missense
3107	\N	\N		19	17954215	17954215	G	T	DOID:9952	25157968	included	ENST00000458235	p.P132T	JAK3	-1	c.394	2016-05-18 21:07:02.742257	2016-05-18 21:28:28.069774	5	ENSG00000105639	missense
3108	\N	\N		19	17954215	17954215	G	T	DOID:9952	20372971	included	ENST00000458235	p.P132T	JAK3	-1	c.394	2016-05-18 21:07:02.753223	2016-05-18 21:28:28.118324	5	ENSG00000105639	missense
3109	\N	\N		19	17948009	17948009	G	A	DOID:2226	25157968	included	ENST00000458235	p.A572V	JAK3	-1	c.1715	2016-05-18 21:07:02.763279	2016-05-18 21:28:28.175401	5	ENSG00000105639	missense
3110	\N	\N		19	17948009	17948009	G	A	DOID:2226	22271575	included	ENST00000458235	p.A572V	JAK3	-1	c.1715	2016-05-18 21:07:02.771746	2016-05-18 21:28:28.221677	5	ENSG00000105639	missense
3111	\N	\N		19	17948009	17948009	G	A	DOID:2226	20372971	included	ENST00000458235	p.A572V	JAK3	-1	c.1715	2016-05-18 21:07:02.778922	2016-05-18 21:28:28.263915	5	ENSG00000105639	missense
3112	\N	\N		19	17948009	17948009	G	A	DOID:2226	20385788	included	ENST00000458235	p.A572V	JAK3	-1	c.1715	2016-05-18 21:07:02.789021	2016-05-18 21:28:28.313027	5	ENSG00000105639	missense
3113	\N	\N		19	17945696	17945696	C	T	DOID:9952	25157968	included	ENST00000458235	p.V722I	JAK3	-1	c.2164	2016-05-18 21:07:02.797034	2016-05-18 21:28:28.380104	5	ENSG00000105639	missense
3114	\N	\N		4	55561764	55561764	G	A	DOID:162	25157968	included	ENST00000288135	p.D52N	KIT	1	c.154	2016-05-18 21:07:02.812098	2016-05-18 21:28:28.4513	5	ENSG00000157404	missense
3115	\N	\N		4	55593603	55593603	G	A	DOID:9253	25157968	included	ENST00000288135	p.W557R	KIT	1	c.1669	2016-05-18 21:07:02.821888	2016-05-18 21:28:28.514851	5	ENSG00000157404	missense
3116	\N	\N		4	55593603	55593603	G	C	DOID:9253	25157968	included	ENST00000288135	p.W557R	KIT	1	c.1669	2016-05-18 21:07:02.832085	2016-05-18 21:28:28.563085	5	ENSG00000157404	missense
3117	\N	\N		4	55593610	55593610	T	C	DOID:1909	25157968	included	ENST00000288135	p.V559A	KIT	1	c.1676	2016-05-18 21:07:02.840612	2016-05-18 21:28:28.599251	5	ENSG00000157404	missense
3118	\N	\N		4	55593610	55593610	T	C	DOID:1909	19812602	included	ENST00000288135	p.V559A	KIT	1	c.1676	2016-05-18 21:07:02.850009	2016-05-18 21:28:28.638654	5	ENSG00000157404	missense
3119	\N	\N		4	55593610	55593610	T	C	DOID:1909	21159146	included	ENST00000288135	p.V559A	KIT	1	c.1676	2016-05-18 21:07:02.858467	2016-05-18 21:28:28.681931	5	ENSG00000157404	missense
3120	\N	\N		4	55593610	55593610	T	A	DOID:1909	25157968	included	ENST00000288135	p.V559D	KIT	1	c.1676	2016-05-18 21:07:02.86602	2016-05-18 21:28:28.733044	5	ENSG00000157404	missense
3121	\N	\N		4	55593610	55593610	T	A	DOID:1909	16046538	included	ENST00000288135	p.V559D	KIT	1	c.1676	2016-05-18 21:07:02.87557	2016-05-18 21:28:28.774676	5	ENSG00000157404	missense
3122	\N	\N		4	55593610	55593610	T	A	DOID:1909	17372901	included	ENST00000288135	p.V559D	KIT	1	c.1676	2016-05-18 21:07:02.887053	2016-05-18 21:28:28.81938	5	ENSG00000157404	missense
3123	\N	\N		4	55593609	55593611	GTT	-	DOID:1909	25157968	included	ENST00000288135	p.V559-	KIT	1	c.1675	2016-05-18 21:07:02.897143	2016-05-18 21:28:28.86076	5	ENSG00000157404	inframe
3124	\N	\N		4	55593610	55593610	T	G	DOID:9253	25157968	included	ENST00000288135	p.V559G	KIT	1	c.1676	2016-05-18 21:07:02.905682	2016-05-18 21:28:28.897356	5	ENSG00000157404	missense
3125	\N	\N		4	55593610	55593610	T	G	DOID:9253	16624552	included	ENST00000288135	p.V559G	KIT	1	c.1676	2016-05-18 21:07:02.915155	2016-05-18 21:28:28.935426	5	ENSG00000157404	missense
3126	\N	\N		4	55593609	55593609	G	A	DOID:2226	25157968	included	ENST00000288135	p.V559I	KIT	1	c.1675	2016-05-18 21:07:02.924854	2016-05-18 21:28:28.972297	5	ENSG00000157404	missense
3127	\N	\N		4	55593609	55593609	G	A	DOID:2226	19175693	included	ENST00000288135	p.V559I	KIT	1	c.1675	2016-05-18 21:07:02.935362	2016-05-18 21:28:29.014391	5	ENSG00000157404	missense
3128	\N	\N		4	55593613	55593613	T	A	DOID:1909	25157968	included	ENST00000288135	p.V560D	KIT	1	c.1679	2016-05-18 21:07:02.943216	2016-05-18 21:28:29.055625	5	ENSG00000157404	missense
3129	\N	\N		4	55593613	55593613	T	A	DOID:1909	19671763	included	ENST00000288135	p.V560D	KIT	1	c.1679	2016-05-18 21:07:02.951862	2016-05-18 21:28:29.092677	5	ENSG00000157404	missense
3130	\N	\N		4	55593613	55593613	T	A	DOID:9253	25157968	included	ENST00000288135	p.V560D	KIT	1	c.1679	2016-05-18 21:07:02.960511	2016-05-18 21:28:29.128698	5	ENSG00000157404	missense
3131	\N	\N		4	55593613	55593613	T	A	DOID:9253	19164557	included	ENST00000288135	p.V560D	KIT	1	c.1679	2016-05-18 21:07:02.968184	2016-05-18 21:28:29.164963	5	ENSG00000157404	missense
3132	\N	\N		4	55593613	55593613	T	G	DOID:9253	25157968	included	ENST00000288135	p.V560G	KIT	1	c.1679	2016-05-18 21:07:02.986664	2016-05-18 21:28:29.201447	5	ENSG00000157404	missense
3133	\N	\N		4	55593613	55593613	T	G	DOID:9253	16397263	included	ENST00000288135	p.V560G	KIT	1	c.1679	2016-05-18 21:07:02.996717	2016-05-18 21:28:29.236656	5	ENSG00000157404	missense
3134	\N	\N		4	55593613	55593613	T	G	DOID:9253	19737976	included	ENST00000288135	p.V560G	KIT	1	c.1679	2016-05-18 21:07:03.007075	2016-05-18 21:28:29.272151	5	ENSG00000157404	missense
3135	\N	\N		4	55593661	55593661	T	C	DOID:1909	25157968	included	ENST00000288135	p.L576P	KIT	1	c.1727	2016-05-18 21:07:03.014163	2016-05-18 21:28:29.31218	5	ENSG00000157404	missense
3136	\N	\N		4	55593661	55593661	T	C	DOID:1909	19671763	included	ENST00000288135	p.L576P	KIT	1	c.1727	2016-05-18 21:07:03.02409	2016-05-18 21:28:29.35025	5	ENSG00000157404	missense
3137	\N	\N		4	55593661	55593661	T	C	DOID:1909	17372901	included	ENST00000288135	p.L576P	KIT	1	c.1727	2016-05-18 21:07:03.032147	2016-05-18 21:28:29.390978	5	ENSG00000157404	missense
3138	\N	\N		4	55594221	55594221	A	G	DOID:9253	25157968	included	ENST00000288135	p.K642E	KIT	1	c.1924	2016-05-18 21:07:03.052265	2016-05-18 21:28:29.432102	5	ENSG00000157404	missense
3139	\N	\N		4	55594221	55594221	A	G	DOID:9253	17824795	included	ENST00000288135	p.K642E	KIT	1	c.1924	2016-05-18 21:07:03.062891	2016-05-18 21:28:29.47835	5	ENSG00000157404	missense
3140	\N	\N		4	55594221	55594221	A	G	DOID:9253	11526490	included	ENST00000288135	p.K642E	KIT	1	c.1924	2016-05-18 21:07:03.072472	2016-05-18 21:28:29.527845	5	ENSG00000157404	missense
3141	\N	\N		4	55594258	55594258	T	C	DOID:9253	25157968	included	ENST00000288135	p.V654A	KIT	1	c.1961	2016-05-18 21:07:03.079533	2016-05-18 21:28:29.589523	5	ENSG00000157404	missense
3142	\N	\N		4	55594258	55594258	T	C	DOID:9253	16638875	included	ENST00000288135	p.V654A	KIT	1	c.1961	2016-05-18 21:07:03.088799	2016-05-18 21:28:29.638607	5	ENSG00000157404	missense
3143	\N	\N		4	55594258	55594258	T	C	DOID:9253	15685537	included	ENST00000288135	p.V654A	KIT	1	c.1961	2016-05-18 21:07:03.097403	2016-05-18 21:28:29.700238	5	ENSG00000157404	missense
3144	\N	\N		4	55594258	55594258	T	C	DOID:9253	17363509	included	ENST00000288135	p.V654A	KIT	1	c.1961	2016-05-18 21:07:03.105698	2016-05-18 21:28:29.777239	5	ENSG00000157404	missense
3145	\N	\N		4	55595519	55595519	C	T	DOID:9253	25157968	included	ENST00000288135	p.T670I	KIT	1	c.2009	2016-05-18 21:07:03.119644	2016-05-18 21:28:29.842276	5	ENSG00000157404	missense
3146	\N	\N		4	55595519	55595519	C	T	DOID:9253	16638875	included	ENST00000288135	p.T670I	KIT	1	c.2009	2016-05-18 21:07:03.12978	2016-05-18 21:28:29.886768	5	ENSG00000157404	missense
3147	\N	\N		4	55595519	55595519	C	T	DOID:9253	15685537	included	ENST00000288135	p.T670I	KIT	1	c.2009	2016-05-18 21:07:03.138938	2016-05-18 21:28:29.935483	5	ENSG00000157404	missense
3148	\N	\N		4	55595519	55595519	C	T	DOID:9253	15236194	included	ENST00000288135	p.T670I	KIT	1	c.2009	2016-05-18 21:07:03.146115	2016-05-18 21:28:29.973799	5	ENSG00000157404	missense
3149	\N	\N		4	55599320	55599320	G	C	DOID:9253	25157968	included	ENST00000288135	p.D816H	KIT	1	c.2446	2016-05-18 21:07:03.157131	2016-05-18 21:28:30.025768	5	ENSG00000157404	missense
3150	\N	\N		4	55599320	55599320	G	C	DOID:9253	19164557	included	ENST00000288135	p.D816H	KIT	1	c.2446	2016-05-18 21:07:03.170131	2016-05-18 21:28:30.069307	5	ENSG00000157404	missense
3151	\N	\N		4	55599320	55599320	G	C	DOID:9253	20147452	included	ENST00000288135	p.D816H	KIT	1	c.2446	2016-05-18 21:07:03.180024	2016-05-18 21:28:30.10949	5	ENSG00000157404	missense
3152	\N	\N		4	55599321	55599321	A	T	DOID:9254	25157968	included	ENST00000288135	p.D816V	KIT	1	c.2447	2016-05-18 21:07:03.188543	2016-05-18 21:28:30.163739	5	ENSG00000157404	missense
3153	\N	\N		4	55599321	55599321	A	T	DOID:9254	15972446	included	ENST00000288135	p.D816V	KIT	1	c.2447	2016-05-18 21:07:03.199438	2016-05-18 21:28:30.224112	5	ENSG00000157404	missense
3154	\N	\N		4	55599321	55599321	A	T	DOID:9254	18024392	included	ENST00000288135	p.D816V	KIT	1	c.2447	2016-05-18 21:07:03.208315	2016-05-18 21:28:30.281573	5	ENSG00000157404	missense
3155	\N	\N		4	55599321	55599321	A	T	DOID:9254	16912224	included	ENST00000288135	p.D816V	KIT	1	c.2447	2016-05-18 21:07:03.21769	2016-05-18 21:28:30.340695	5	ENSG00000157404	missense
3156	\N	\N		4	55599320	55599320	G	T	DOID:9253	25157968	included	ENST00000288135	p.D816Y	KIT	1	c.2446	2016-05-18 21:07:03.228384	2016-05-18 21:28:30.400433	5	ENSG00000157404	missense
3157	\N	\N		4	55599320	55599320	G	T	DOID:9253	16397263	included	ENST00000288135	p.D816Y	KIT	1	c.2446	2016-05-18 21:07:03.238732	2016-05-18 21:28:30.448299	5	ENSG00000157404	missense
3158	\N	\N		4	55599320	55599320	G	T	DOID:9253	15790786	included	ENST00000288135	p.D816Y	KIT	1	c.2446	2016-05-18 21:07:03.248655	2016-05-18 21:28:30.502946	5	ENSG00000157404	missense
3159	\N	\N		4	55599340	55599340	T	A	DOID:9253	25157968	included	ENST00000288135	p.N822K	KIT	1	c.2466	2016-05-18 21:07:03.256691	2016-05-18 21:28:30.553234	5	ENSG00000157404	missense
3160	\N	\N		4	55599340	55599340	T	A	DOID:9253	17699867	included	ENST00000288135	p.N822K	KIT	1	c.2466	2016-05-18 21:07:03.267389	2016-05-18 21:28:30.609648	5	ENSG00000157404	missense
3161	\N	\N		4	55599340	55599340	T	A	DOID:9253	15685537	included	ENST00000288135	p.N822K	KIT	1	c.2466	2016-05-18 21:07:03.275795	2016-05-18 21:28:30.669817	5	ENSG00000157404	missense
3162	\N	\N		4	55599340	55599340	T	G	DOID:9253	25157968	included	ENST00000288135	p.N822K	KIT	1	c.2466	2016-05-18 21:07:03.285704	2016-05-18 21:28:30.728268	5	ENSG00000157404	missense
3163	\N	\N		4	55599340	55599340	T	G	DOID:9253	17699867	included	ENST00000288135	p.N822K	KIT	1	c.2466	2016-05-18 21:07:03.296262	2016-05-18 21:28:30.790115	5	ENSG00000157404	missense
3164	\N	\N		4	55599340	55599340	T	G	DOID:9253	15685537	included	ENST00000288135	p.N822K	KIT	1	c.2466	2016-05-18 21:07:03.306326	2016-05-18 21:28:30.853924	5	ENSG00000157404	missense
3165	\N	\N		4	55599348	55599348	T	C	DOID:1909	25157968	included	ENST00000288135	p.V825A	KIT	1	c.2474	2016-05-18 21:07:03.316749	2016-05-18 21:28:30.921519	5	ENSG00000157404	missense
3166	\N	\N		4	55599348	55599348	T	C	DOID:1909	19671763	included	ENST00000288135	p.V825A	KIT	1	c.2474	2016-05-18 21:07:03.327586	2016-05-18 21:28:30.974968	5	ENSG00000157404	missense
3167	\N	\N		4	55599348	55599348	T	C	DOID:1909	23569304	included	ENST00000288135	p.V825A	KIT	1	c.2474	2016-05-18 21:07:03.339492	2016-05-18 21:28:31.020013	5	ENSG00000157404	missense
3168	\N	\N		4	55602694	55602694	G	A	DOID:9253	25157968	included	ENST00000288135	p.E839K	KIT	1	c.2515	2016-05-18 21:07:03.347186	2016-05-18 21:28:31.081852	5	ENSG00000157404	missense
3169	\N	\N		4	55602694	55602694	G	A	DOID:9253	15790786	included	ENST00000288135	p.E839K	KIT	1	c.2515	2016-05-18 21:07:03.357879	2016-05-18 21:28:31.1269	5	ENSG00000157404	missense
3170	\N	\N		12	25398284	25398284	C	G	DOID:9253	25157968	included	ENST00000256078	p.G12A	KRAS	-1	c.35	2016-05-18 21:07:03.369868	2016-05-18 21:28:31.169047	5	ENSG00000133703	missense
3171	\N	\N		12	25398284	25398284	C	G	DOID:9253	22282465	included	ENST00000256078	p.G12A	KRAS	-1	c.35	2016-05-18 21:07:03.380753	2016-05-18 21:28:31.217881	5	ENSG00000133703	missense
3172	\N	\N		12	25398284	25398284	C	G	DOID:9256	25157968	included	ENST00000256078	p.G12A	KRAS	-1	c.35	2016-05-18 21:07:03.389431	2016-05-18 21:28:31.267423	5	ENSG00000133703	missense
3173	\N	\N		12	25398284	25398284	C	G	DOID:9256	23182985	included	ENST00000256078	p.G12A	KRAS	-1	c.35	2016-05-18 21:07:03.399409	2016-05-18 21:28:31.3108	5	ENSG00000133703	missense
3174	\N	\N		12	25398285	25398285	C	A	DOID:9256	25157968	included	ENST00000256078	p.G12C	KRAS	-1	c.34	2016-05-18 21:07:03.408177	2016-05-18 21:28:31.360713	5	ENSG00000133703	missense
3175	\N	\N		12	25398285	25398285	C	A	DOID:9256	23182985	included	ENST00000256078	p.G12C	KRAS	-1	c.34	2016-05-18 21:07:03.415442	2016-05-18 21:28:31.396742	5	ENSG00000133703	missense
3176	\N	\N		12	25398285	25398285	C	A	DOID:3910	25157968	included	ENST00000256078	p.G12C	KRAS	-1	c.34	2016-05-18 21:07:03.426432	2016-05-18 21:28:31.432799	5	ENSG00000133703	missense
3177	\N	\N		12	25398285	25398285	C	A	DOID:3910	25044103	included	ENST00000256078	p.G12C	KRAS	-1	c.34	2016-05-18 21:07:03.436545	2016-05-18 21:28:31.471025	5	ENSG00000133703	missense
3178	\N	\N		12	25398284	25398284	C	T	DOID:1324	25157968	included	ENST00000256078	p.G12D	KRAS	-1	c.35	2016-05-18 21:07:03.444374	2016-05-18 21:28:31.512264	5	ENSG00000133703	missense
3179	\N	\N		12	25398284	25398284	C	T	DOID:1324	19029981	included	ENST00000256078	p.G12D	KRAS	-1	c.35	2016-05-18 21:07:03.45365	2016-05-18 21:28:31.558414	5	ENSG00000133703	missense
3180	\N	\N		12	25398284	25398284	C	T	DOID:1324	25044103	included	ENST00000256078	p.G12D	KRAS	-1	c.35	2016-05-18 21:07:03.464131	2016-05-18 21:28:31.599259	5	ENSG00000133703	missense
3181	\N	\N		12	25398285	25398285	C	G	DOID:9256	25157968	included	ENST00000256078	p.G12R	KRAS	-1	c.34	2016-05-18 21:07:03.474979	2016-05-18 21:28:31.637353	5	ENSG00000133703	missense
3182	\N	\N		12	25398285	25398285	C	G	DOID:9256	22722830	included	ENST00000256078	p.G12R	KRAS	-1	c.34	2016-05-18 21:07:03.490389	2016-05-18 21:28:31.679445	5	ENSG00000133703	missense
3183	\N	\N		12	25398285	25398285	C	G	DOID:9256	23182985	included	ENST00000256078	p.G12R	KRAS	-1	c.34	2016-05-18 21:07:03.500882	2016-05-18 21:28:31.720877	5	ENSG00000133703	missense
3184	\N	\N		12	25398285	25398285	C	T	DOID:3908	25157968	included	ENST00000256078	p.G12S	KRAS	-1	c.34	2016-05-18 21:07:03.510701	2016-05-18 21:28:31.757718	5	ENSG00000133703	missense
3185	\N	\N		12	25398285	25398285	C	T	DOID:3908	18594010	included	ENST00000256078	p.G12S	KRAS	-1	c.34	2016-05-18 21:07:03.517785	2016-05-18 21:28:31.796955	5	ENSG00000133703	missense
3186	\N	\N		12	25398284	25398284	C	A	DOID:3908	25157968	included	ENST00000256078	p.G12V	KRAS	-1	c.35	2016-05-18 21:07:03.532143	2016-05-18 21:28:31.83346	5	ENSG00000133703	missense
3187	\N	\N		12	25398284	25398284	C	A	DOID:3908	22897852	included	ENST00000256078	p.G12V	KRAS	-1	c.35	2016-05-18 21:07:03.540136	2016-05-18 21:28:31.870618	5	ENSG00000133703	missense
3188	\N	\N		12	25398284	25398284	C	A	DOID:3908	22235099	included	ENST00000256078	p.G12V	KRAS	-1	c.35	2016-05-18 21:07:03.549224	2016-05-18 21:28:31.915143	5	ENSG00000133703	missense
3189	\N	\N		12	25398284	25398284	C	A	DOID:3908	21398618	included	ENST00000256078	p.G12V	KRAS	-1	c.35	2016-05-18 21:07:03.557571	2016-05-18 21:28:31.97899	5	ENSG00000133703	missense
3190	\N	\N		12	25398284	25398284	C	A	DOID:9256	25157968	included	ENST00000256078	p.G12V	KRAS	-1	c.35	2016-05-18 21:07:03.568474	2016-05-18 21:28:32.0529	5	ENSG00000133703	missense
3191	\N	\N		12	25398284	25398284	C	A	DOID:9256	19881948	included	ENST00000256078	p.G12V	KRAS	-1	c.35	2016-05-18 21:07:03.577196	2016-05-18 21:28:32.12066	5	ENSG00000133703	missense
3192	\N	\N		12	25398284	25398284	C	A	DOID:9256	22734028	included	ENST00000256078	p.G12V	KRAS	-1	c.35	2016-05-18 21:07:03.587525	2016-05-18 21:28:32.183612	5	ENSG00000133703	missense
3193	\N	\N		12	25398284	25398284	C	A	DOID:9256	21398618	included	ENST00000256078	p.G12V	KRAS	-1	c.35	2016-05-18 21:07:03.59726	2016-05-18 21:28:32.227835	5	ENSG00000133703	missense
3194	\N	\N		12	25398281	25398281	C	G	DOID:9256	25157968	included	ENST00000256078	p.G13A	KRAS	-1	c.38	2016-05-18 21:07:03.609357	2016-05-18 21:28:32.281337	5	ENSG00000133703	missense
3195	\N	\N		12	25398282	25398282	C	A	DOID:9256	25157968	included	ENST00000256078	p.G13C	KRAS	-1	c.37	2016-05-18 21:07:03.619966	2016-05-18 21:28:32.324074	5	ENSG00000133703	missense
3196	\N	\N		12	25398281	25398281	C	T	DOID:9256	25157968	included	ENST00000256078	p.G13D	KRAS	-1	c.38	2016-05-18 21:07:03.631063	2016-05-18 21:28:32.3815	5	ENSG00000133703	missense
3197	\N	\N		12	25398281	25398281	C	T	DOID:9256	22734028	included	ENST00000256078	p.G13D	KRAS	-1	c.38	2016-05-18 21:07:03.640226	2016-05-18 21:28:32.417785	5	ENSG00000133703	missense
3198	\N	\N		12	25398281	25398281	C	T	DOID:9256	23182985	included	ENST00000256078	p.G13D	KRAS	-1	c.38	2016-05-18 21:07:03.649939	2016-05-18 21:28:32.457191	5	ENSG00000133703	missense
3199	\N	\N		12	25398281	25398281	C	T	DOID:9256	24558511	included	ENST00000256078	p.G13D	KRAS	-1	c.38	2016-05-18 21:07:03.659721	2016-05-18 21:28:32.51849	5	ENSG00000133703	missense
3200	\N	\N		12	25398281	25398281	C	T	DOID:9256	21398618	included	ENST00000256078	p.G13D	KRAS	-1	c.38	2016-05-18 21:07:03.669952	2016-05-18 21:28:32.559881	5	ENSG00000133703	missense
3201	\N	\N		12	25398282	25398282	C	G	DOID:9256	25157968	included	ENST00000256078	p.G13R	KRAS	-1	c.37	2016-05-18 21:07:03.680962	2016-05-18 21:28:32.603966	5	ENSG00000133703	missense
3202	\N	\N		12	25398282	25398282	C	T	DOID:9256	25157968	included	ENST00000256078	p.G13S	KRAS	-1	c.37	2016-05-18 21:07:03.690372	2016-05-18 21:28:32.649808	5	ENSG00000133703	missense
3203	\N	\N		12	25398281	25398281	C	A	DOID:9256	25157968	included	ENST00000256078	p.G13V	KRAS	-1	c.38	2016-05-18 21:07:03.698172	2016-05-18 21:28:32.693982	5	ENSG00000133703	missense
3204	\N	\N		12	25398281	25398281	C	A	DOID:1781	25157968	included	ENST00000256078	p.G13V	KRAS	-1	c.38	2016-05-18 21:07:03.706036	2016-05-18 21:28:32.743108	5	ENSG00000133703	missense
3205	\N	\N		12	25398281	25398281	C	A	DOID:1781	24628546	included	ENST00000256078	p.G13V	KRAS	-1	c.38	2016-05-18 21:07:03.715692	2016-05-18 21:28:32.785091	5	ENSG00000133703	missense
3206	\N	\N		12	25398262	25398262	C	A	DOID:0001816	25157968	included	ENST00000256078	p.L19F	KRAS	-1	c.57	2016-05-18 21:07:03.723727	2016-05-18 21:28:32.84504	5	ENSG00000133703	missense
3207	\N	\N		12	25398262	25398262	C	A	DOID:0001816	24740626	included	ENST00000256078	p.L19F	KRAS	-1	c.57	2016-05-18 21:07:03.73607	2016-05-18 21:28:32.893307	5	ENSG00000133703	missense
3208	\N	\N		12	25398262	25398262	C	G	DOID:0001816	25157968	included	ENST00000256078	p.L19F	KRAS	-1	c.57	2016-05-18 21:07:03.746621	2016-05-18 21:28:32.940009	5	ENSG00000133703	missense
3209	\N	\N		12	25398262	25398262	C	G	DOID:0001816	24740626	included	ENST00000256078	p.L19F	KRAS	-1	c.57	2016-05-18 21:07:03.756779	2016-05-18 21:28:32.97561	5	ENSG00000133703	missense
3210	\N	\N		12	25398255	25398255	G	T	DOID:9256	25157968	included	ENST00000256078	p.Q22K	KRAS	-1	c.64	2016-05-18 21:07:03.764811	2016-05-18 21:28:33.028112	5	ENSG00000133703	missense
3211	\N	\N		12	25380283	25380283	C	T	DOID:9256	25157968	included	ENST00000256078	p.A59T	KRAS	-1	c.175	2016-05-18 21:07:03.772488	2016-05-18 21:28:33.081686	5	ENSG00000133703	missense
3212	\N	\N		12	25380283	25380283	C	T	DOID:9256	21398618	included	ENST00000256078	p.A59T	KRAS	-1	c.175	2016-05-18 21:07:03.781931	2016-05-18 21:28:33.117715	5	ENSG00000133703	missense
3213	\N	\N		12	25380277	25380277	G	C	DOID:9256	25157968	included	ENST00000256078	p.Q61E	KRAS	-1	c.181	2016-05-18 21:07:03.789378	2016-05-18 21:28:33.163821	5	ENSG00000133703	missense
3214	\N	\N		12	25380275	25380275	T	A	DOID:9256	25157968	included	ENST00000256078	p.Q61H	KRAS	-1	c.183	2016-05-18 21:07:03.800179	2016-05-18 21:28:33.203378	5	ENSG00000133703	missense
3215	\N	\N		12	25380275	25380275	T	A	DOID:9256	22722830	included	ENST00000256078	p.Q61H	KRAS	-1	c.183	2016-05-18 21:07:03.811128	2016-05-18 21:28:33.244135	5	ENSG00000133703	missense
3216	\N	\N		12	25380275	25380275	T	A	DOID:9256	23325582	included	ENST00000256078	p.Q61H	KRAS	-1	c.183	2016-05-18 21:07:03.82079	2016-05-18 21:28:33.278293	5	ENSG00000133703	missense
3217	\N	\N		12	25380275	25380275	T	G	DOID:9256	25157968	included	ENST00000256078	p.Q61H	KRAS	-1	c.183	2016-05-18 21:07:03.829805	2016-05-18 21:28:33.318756	5	ENSG00000133703	missense
3218	\N	\N		12	25380275	25380275	T	G	DOID:9256	22722830	included	ENST00000256078	p.Q61H	KRAS	-1	c.183	2016-05-18 21:07:03.837574	2016-05-18 21:28:33.356111	5	ENSG00000133703	missense
3219	\N	\N		12	25380275	25380275	T	G	DOID:9256	23325582	included	ENST00000256078	p.Q61H	KRAS	-1	c.183	2016-05-18 21:07:03.846415	2016-05-18 21:28:33.405423	5	ENSG00000133703	missense
3220	\N	\N		12	25380277	25380277	G	T	DOID:9256	25157968	included	ENST00000256078	p.Q61K	KRAS	-1	c.181	2016-05-18 21:07:03.857937	2016-05-18 21:28:33.445084	5	ENSG00000133703	missense
3221	\N	\N		12	25380276	25380276	T	A	DOID:9256	25157968	included	ENST00000256078	p.Q61L	KRAS	-1	c.182	2016-05-18 21:07:03.868565	2016-05-18 21:28:33.489132	5	ENSG00000133703	missense
3222	\N	\N		12	25380276	25380276	T	A	DOID:9256	20619739	included	ENST00000256078	p.Q61L	KRAS	-1	c.182	2016-05-18 21:07:03.878868	2016-05-18 21:28:33.52935	5	ENSG00000133703	missense
3223	\N	\N		12	25380276	25380276	T	G	DOID:9256	25157968	included	ENST00000256078	p.Q61P	KRAS	-1	c.182	2016-05-18 21:07:03.887871	2016-05-18 21:28:33.573829	5	ENSG00000133703	missense
3224	\N	\N		12	25380276	25380276	T	C	DOID:9256	25157968	included	ENST00000256078	p.Q61R	KRAS	-1	c.182	2016-05-18 21:07:03.89673	2016-05-18 21:28:33.613896	5	ENSG00000133703	missense
3225	\N	\N		12	25378562	25378562	C	T	DOID:9256	25157968	included	ENST00000256078	p.A146T	KRAS	-1	c.436	2016-05-18 21:07:03.904416	2016-05-18 21:28:33.651771	5	ENSG00000133703	missense
3226	\N	\N		12	25378562	25378562	C	T	DOID:9256	21398618	included	ENST00000256078	p.A146T	KRAS	-1	c.436	2016-05-18 21:07:03.913967	2016-05-18 21:28:33.689066	5	ENSG00000133703	missense
3227	\N	\N		15	66727451	66727451	A	C	DOID:3908	25157968	included	ENST00000307102	p.Q56P	MAP2K1	1	c.167	2016-05-18 21:07:03.921832	2016-05-18 21:28:33.728755	5	ENSG00000169032	missense
3228	\N	\N		15	66727455	66727455	G	C	DOID:3910	25157968	included	ENST00000307102	p.K57N	MAP2K1	1	c.171	2016-05-18 21:07:03.931767	2016-05-18 21:28:33.767675	5	ENSG00000169032	missense
3229	\N	\N		15	66727455	66727455	G	T	DOID:3910	25157968	included	ENST00000307102	p.K57N	MAP2K1	1	c.171	2016-05-18 21:07:03.942986	2016-05-18 21:28:33.803988	5	ENSG00000169032	missense
3230	\N	\N		15	66727483	66727483	G	A	DOID:1909	25157968	included	ENST00000307102	p.D67N	MAP2K1	1	c.199	2016-05-18 21:07:03.951509	2016-05-18 21:28:33.844214	5	ENSG00000169032	missense
3231	\N	\N		15	66727483	66727483	G	A	DOID:1909	23569304	included	ENST00000307102	p.D67N	MAP2K1	1	c.199	2016-05-18 21:07:03.961188	2016-05-18 21:28:33.883524	5	ENSG00000169032	missense
3232	\N	\N		15	66729153	66729153	T	A	DOID:3910	25157968	included	ENST00000307102	p.C121S	MAP2K1	1	c.361	2016-05-18 21:07:03.969227	2016-05-18 21:28:33.938016	5	ENSG00000169032	missense
3233	\N	\N		15	66729154	66729154	G	C	DOID:3910	25157968	included	ENST00000307102	p.C121S	MAP2K1	1	c.362	2016-05-18 21:07:03.976942	2016-05-18 21:28:33.979853	5	ENSG00000169032	missense
3234	\N	\N		15	66729163	66729163	C	T	DOID:1909	25157968	included	ENST00000307102	p.P124L	MAP2K1	1	c.371	2016-05-18 21:07:03.988158	2016-05-18 21:28:34.035544	5	ENSG00000169032	missense
3235	\N	\N		7	116417464	116417464	A	G	DOID:4451	25157968	included	ENST00000318493	p.H1112R	MET	1	c.3335	2016-05-18 21:07:03.99705	2016-05-18 21:28:34.082726	5	ENSG00000105976	missense
3236	\N	\N		7	116417463	116417463	C	T	DOID:4451	25157968	included	ENST00000318493	p.H1112Y	MET	1	c.3334	2016-05-18 21:07:04.005311	2016-05-18 21:28:34.159868	5	ENSG00000105976	missense
3237	\N	\N		7	116417463	116417463	C	T	DOID:4451	18829470	included	ENST00000318493	p.H1112Y	MET	1	c.3334	2016-05-18 21:07:04.01331	2016-05-18 21:28:34.217001	5	ENSG00000105976	missense
3238	\N	\N		7	116423414	116423414	A	G	DOID:4451	25157968	included	ENST00000318493	p.Y1248C	MET	1	c.3743	2016-05-18 21:07:04.023711	2016-05-18 21:28:34.266174	5	ENSG00000105976	missense
3239	\N	\N		7	116423414	116423414	A	G	DOID:4451	11750879	included	ENST00000318493	p.Y1248C	MET	1	c.3743	2016-05-18 21:07:04.034769	2016-05-18 21:28:34.308653	5	ENSG00000105976	missense
3240	\N	\N		7	116423413	116423413	T	C	DOID:4451	25157968	included	ENST00000318493	p.Y1248H	MET	1	c.3742	2016-05-18 21:07:04.046206	2016-05-18 21:28:34.367355	5	ENSG00000105976	missense
3241	\N	\N		7	116423413	116423413	T	C	DOID:4451	11750879	included	ENST00000318493	p.Y1248H	MET	1	c.3742	2016-05-18 21:07:04.054599	2016-05-18 21:28:34.404465	5	ENSG00000105976	missense
3242	\N	\N		7	116423413	116423413	T	C	DOID:4451	24121490	included	ENST00000318493	p.Y1248H	MET	1	c.3742	2016-05-18 21:07:04.063714	2016-05-18 21:28:34.44654	5	ENSG00000105976	missense
3243	\N	\N		7	116423474	116423474	T	C	DOID:4451	25157968	included	ENST00000318493	p.M1268T	MET	1	c.3803	2016-05-18 21:07:04.0717	2016-05-18 21:28:34.48686	5	ENSG00000105976	missense
3244	\N	\N		3	37067240	37067240	T	A	DOID:3717	25157968	included	ENST00000231790	p.V384D	MLH1	1	c.1151	2016-05-18 21:07:04.081771	2016-05-18 21:28:34.564025	5	ENSG00000076242	missense
3245	\N	\N		3	37067240	37067240	T	A	DOID:3910	25157968	included	ENST00000231790	p.V384D	MLH1	1	c.1151	2016-05-18 21:07:04.090976	2016-05-18 21:28:34.624486	5	ENSG00000076242	missense
3246	\N	\N		3	37067240	37067240	T	A	DOID:3910	25823662	included	ENST00000231790	p.V384D	MLH1	1	c.1151	2016-05-18 21:07:04.100718	2016-05-18 21:28:34.679022	5	ENSG00000076242	missense
3247	\N	\N		8	128750632	128750632	C	T	DOID:162	25157968	included	ENST00000377970	p.P57S	MYC	1	c.169	2016-05-18 21:07:04.108886	2016-05-18 21:28:34.759885	5	ENSG00000136997	missense
3248	\N	\N		8	128750639	128750639	C	T	DOID:162	25157968	included	ENST00000377970	p.A59V	MYC	1	c.176	2016-05-18 21:07:04.120453	2016-05-18 21:28:34.84748	5	ENSG00000136997	missense
3249	\N	\N		8	128750681	128750681	C	T	DOID:162	25157968	included	ENST00000377970	p.T73I	MYC	1	c.218	2016-05-18 21:07:04.129472	2016-05-18 21:28:34.920539	5	ENSG00000136997	missense
3250	\N	\N		8	128750693	128750693	C	T	DOID:162	25157968	included	ENST00000377970	p.S77F	MYC	1	c.230	2016-05-18 21:07:04.141169	2016-05-18 21:28:34.995983	5	ENSG00000136997	missense
3251	\N	\N		8	128750765	128750765	A	C	DOID:162	25157968	included	ENST00000377970	p.N101T	MYC	1	c.302	2016-05-18 21:07:04.151577	2016-05-18 21:28:35.053571	5	ENSG00000136997	missense
3252	\N	\N		8	128751241	128751241	C	G	DOID:162	25157968	included	ENST00000377970	p.P260A	MYC	1	c.778	2016-05-18 21:07:04.161275	2016-05-18 21:28:35.116493	5	ENSG00000136997	missense
3253	\N	\N		1	115258747	115258747	C	G	DOID:9256	25157968	included	ENST00000369535	p.G12A	NRAS	-1	c.35	2016-05-18 21:07:04.169694	2016-05-18 21:28:35.169973	5	ENSG00000213281	missense
3254	\N	\N		1	115258748	115258748	C	A	DOID:9256	25157968	included	ENST00000369535	p.G12C	NRAS	-1	c.34	2016-05-18 21:07:04.177471	2016-05-18 21:28:35.23619	5	ENSG00000213281	missense
3255	\N	\N		1	115258748	115258748	C	A	DOID:9256	24553387	included	ENST00000369535	p.G12C	NRAS	-1	c.34	2016-05-18 21:07:04.187583	2016-05-18 21:28:35.29111	5	ENSG00000213281	missense
3256	\N	\N		1	115258747	115258747	C	T	DOID:9119	25157968	included	ENST00000369535	p.G12D	NRAS	-1	c.35	2016-05-18 21:07:04.197497	2016-05-18 21:28:35.346999	5	ENSG00000213281	missense
3257	\N	\N		1	115258747	115258747	C	T	DOID:9119	22144181	included	ENST00000369535	p.G12D	NRAS	-1	c.35	2016-05-18 21:07:04.205477	2016-05-18 21:28:35.404396	5	ENSG00000213281	missense
3258	\N	\N		1	115258748	115258748	C	G	DOID:8552	25157968	included	ENST00000369535	p.G12R	NRAS	-1	c.34	2016-05-18 21:07:04.213153	2016-05-18 21:28:35.455623	5	ENSG00000213281	missense
3259	\N	\N		1	115258748	115258748	C	G	DOID:8552	23134356	included	ENST00000369535	p.G12R	NRAS	-1	c.34	2016-05-18 21:07:04.224193	2016-05-18 21:28:35.499356	5	ENSG00000213281	missense
3260	\N	\N		1	115258748	115258748	C	G	DOID:9256	25157968	included	ENST00000369535	p.G12R	NRAS	-1	c.34	2016-05-18 21:07:04.235468	2016-05-18 21:28:35.549478	5	ENSG00000213281	missense
3261	\N	\N		1	115258748	115258748	C	T	DOID:9256	25157968	included	ENST00000369535	p.G12S	NRAS	-1	c.34	2016-05-18 21:07:04.247235	2016-05-18 21:28:35.60537	5	ENSG00000213281	missense
3262	\N	\N		1	115258748	115258748	C	T	DOID:9256	20619739	included	ENST00000369535	p.G12S	NRAS	-1	c.34	2016-05-18 21:07:04.254599	2016-05-18 21:28:35.664554	5	ENSG00000213281	missense
3263	\N	\N		1	115258747	115258747	C	A	DOID:9119	25157968	included	ENST00000369535	p.G12V	NRAS	-1	c.35	2016-05-18 21:07:04.264643	2016-05-18 21:28:35.70372	5	ENSG00000213281	missense
3264	\N	\N		1	115258744	115258744	C	G	DOID:1909	25157968	included	ENST00000369535	p.G13A	NRAS	-1	c.38	2016-05-18 21:07:04.272627	2016-05-18 21:28:35.752182	5	ENSG00000213281	missense
3265	\N	\N		1	115258745	115258745	C	A	DOID:1909	25157968	included	ENST00000369535	p.G13C	NRAS	-1	c.37	2016-05-18 21:07:04.280187	2016-05-18 21:28:35.794351	5	ENSG00000213281	missense
3266	\N	\N		1	115258744	115258744	C	T	DOID:1909	25157968	included	ENST00000369535	p.G13D	NRAS	-1	c.38	2016-05-18 21:07:04.290401	2016-05-18 21:28:35.833372	5	ENSG00000213281	missense
3268	\N	\N		1	115258745	115258745	C	G	DOID:1909	25157968	included	ENST00000369535	p.G13R	NRAS	-1	c.37	2016-05-18 21:07:04.307882	2016-05-18 21:28:35.917982	5	ENSG00000213281	missense
3269	\N	\N		1	115258745	115258745	C	G	DOID:1909	22962325	included	ENST00000369535	p.G13R	NRAS	-1	c.37	2016-05-18 21:07:04.318128	2016-05-18 21:28:35.96803	5	ENSG00000213281	missense
3270	\N	\N		1	115258745	115258745	C	T	DOID:10534	25157968	included	ENST00000369535	p.G13S	NRAS	-1	c.37	2016-05-18 21:07:04.340207	2016-05-18 21:28:36.02026	5	ENSG00000213281	missense
3271	\N	\N		1	115258744	115258744	C	A	DOID:162	25157968	included	ENST00000369535	p.G13V	NRAS	-1	c.38	2016-05-18 21:07:04.349018	2016-05-18 21:28:36.066874	5	ENSG00000213281	missense
3272	\N	\N		1	115258730	115258730	C	T	DOID:1909	25157968	included	ENST00000369535	p.A18T	NRAS	-1	c.52	2016-05-18 21:07:04.361545	2016-05-18 21:28:36.127266	5	ENSG00000213281	missense
3273	\N	\N		1	115258730	115258730	C	T	DOID:1909	24918823	included	ENST00000369535	p.A18T	NRAS	-1	c.52	2016-05-18 21:07:04.373206	2016-05-18 21:28:36.167604	5	ENSG00000213281	missense
3274	\N	\N		1	115256530	115256530	G	C	DOID:1909	25157968	included	ENST00000369535	p.Q61E	NRAS	-1	c.181	2016-05-18 21:07:04.387557	2016-05-18 21:28:36.207935	5	ENSG00000213281	missense
3275	\N	\N		1	115256530	115256530	G	C	DOID:1909	23569304	included	ENST00000369535	p.Q61E	NRAS	-1	c.181	2016-05-18 21:07:04.399956	2016-05-18 21:28:36.238945	5	ENSG00000213281	missense
3276	\N	\N		1	115256528	115256528	T	A	DOID:1909	25157968	included	ENST00000369535	p.Q61H	NRAS	-1	c.183	2016-05-18 21:07:04.40801	2016-05-18 21:28:36.285246	5	ENSG00000213281	missense
3277	\N	\N		1	115256528	115256528	T	A	DOID:1909	23076151	included	ENST00000369535	p.Q61H	NRAS	-1	c.183	2016-05-18 21:07:04.41834	2016-05-18 21:28:36.333315	5	ENSG00000213281	missense
3278	\N	\N		1	115256528	115256528	T	G	DOID:1909	25157968	included	ENST00000369535	p.Q61H	NRAS	-1	c.183	2016-05-18 21:07:04.428403	2016-05-18 21:28:36.373044	5	ENSG00000213281	missense
3279	\N	\N		1	115256528	115256528	T	G	DOID:1909	23076151	included	ENST00000369535	p.Q61H	NRAS	-1	c.183	2016-05-18 21:07:04.438444	2016-05-18 21:28:36.413636	5	ENSG00000213281	missense
3280	\N	\N		1	115256530	115256530	G	A	DOID:1909	25157968	included	ENST00000369535	p.Q61*	NRAS	-1	c.181	2016-05-18 21:07:04.449459	2016-05-18 21:28:36.451502	5	ENSG00000213281	stop
3281	\N	\N		1	115256530	115256530	G	A	DOID:1909	23076151	included	ENST00000369535	p.Q61*	NRAS	-1	c.181	2016-05-18 21:07:04.458497	2016-05-18 21:28:36.488825	5	ENSG00000213281	stop
3282	\N	\N		1	115256529	115256529	T	A	DOID:1909	25157968	included	ENST00000369535	p.Q61L	NRAS	-1	c.182	2016-05-18 21:07:04.469536	2016-05-18 21:28:36.525724	5	ENSG00000213281	missense
3283	\N	\N		1	115256529	115256529	T	A	DOID:1909	20406486	included	ENST00000369535	p.Q61L	NRAS	-1	c.182	2016-05-18 21:07:04.480456	2016-05-18 21:28:36.562777	5	ENSG00000213281	missense
3284	\N	\N		1	115256529	115256529	T	A	DOID:1909	20149136	included	ENST00000369535	p.Q61L	NRAS	-1	c.182	2016-05-18 21:07:04.490473	2016-05-18 21:28:36.599894	5	ENSG00000213281	missense
3285	\N	\N		1	115256528	115256529	TT	CA	DOID:1909	25157968	included	ENST00000369535	p.Q61L	NRAS	-1	c.182	2016-05-18 21:07:04.499262	2016-05-18 21:28:36.636418	5	ENSG00000213281	missense
3289	\N	\N		1	115256529	115256529	T	C	DOID:1909	25157968	included	ENST00000369535	p.Q61R	NRAS	-1	c.182	2016-05-18 21:07:04.53322	2016-05-18 21:28:36.789398	5	ENSG00000213281	missense
3290	\N	\N		1	115256529	115256530	TG	CT	DOID:1909	25157968	included	ENST00000369535	p.Q61R	NRAS	-1	c.181	2016-05-18 21:07:04.544165	2016-05-18 21:28:36.839053	5	ENSG00000213281	missense
3291	\N	\N		4	55141036	55141036	T	A	DOID:9253	25157968	included	ENST00000257290	p.V561D	PDGFRA	1	c.1682	2016-05-18 21:07:04.555316	2016-05-18 21:28:36.880143	5	ENSG00000134853	missense
3292	\N	\N		4	55141036	55141036	T	A	DOID:9253	16954519	included	ENST00000257290	p.V561D	PDGFRA	1	c.1682	2016-05-18 21:07:04.564472	2016-05-18 21:28:36.916323	5	ENSG00000134853	missense
3294	\N	\N		4	55152089	55152094	AGAGAC	-	DOID:9253	25157968	included	ENST00000257290	p.RD841-	PDGFRA	1	c.2521	2016-05-18 21:07:04.581957	2016-05-18 21:28:37.006662	5	ENSG00000134853	inframe
3295	\N	\N		4	55152092	55152093	GA	AT	DOID:9253	25157968	included	ENST00000257290	p.D842I	PDGFRA	1	c.2524	2016-05-18 21:07:04.58933	2016-05-18 21:28:37.060526	5	ENSG00000134853	missense
3296	\N	\N		4	55152092	55152093	GA	AT	DOID:9253	16954519	included	ENST00000257290	p.D842I	PDGFRA	1	c.2524	2016-05-18 21:07:04.602128	2016-05-18 21:28:37.108897	5	ENSG00000134853	missense
3297	\N	\N		4	55152092	55152093	GA	AT	DOID:9253	17087936	included	ENST00000257290	p.D842I	PDGFRA	1	c.2524	2016-05-18 21:07:04.613754	2016-05-18 21:28:37.166724	5	ENSG00000134853	missense
3298	\N	\N		4	55152092	55152093	GA	AT	DOID:9253	22745105	included	ENST00000257290	p.D842I	PDGFRA	1	c.2524	2016-05-18 21:07:04.621887	2016-05-18 21:28:37.234376	5	ENSG00000134853	missense
3299	\N	\N		4	55152093	55152093	A	T	DOID:9253	25157968	included	ENST00000257290	p.D842V	PDGFRA	1	c.2525	2016-05-18 21:07:04.633074	2016-05-18 21:28:37.296284	5	ENSG00000134853	missense
3300	\N	\N		4	55152093	55152093	A	T	DOID:9253	22745105	included	ENST00000257290	p.D842V	PDGFRA	1	c.2525	2016-05-18 21:07:04.641699	2016-05-18 21:28:37.344185	5	ENSG00000134853	missense
3301	\N	\N		4	55152093	55152093	A	T	DOID:9253	16954519	included	ENST00000257290	p.D842V	PDGFRA	1	c.2525	2016-05-18 21:07:04.65297	2016-05-18 21:28:37.410955	5	ENSG00000134853	missense
3302	\N	\N		4	55152093	55152093	A	T	DOID:9253	16638875	included	ENST00000257290	p.D842V	PDGFRA	1	c.2525	2016-05-18 21:07:04.662513	2016-05-18 21:28:37.451606	5	ENSG00000134853	missense
3303	\N	\N		4	55152093	55152093	A	T	DOID:9253	15685537	included	ENST00000257290	p.D842V	PDGFRA	1	c.2525	2016-05-18 21:07:04.673404	2016-05-18 21:28:37.50477	5	ENSG00000134853	missense
3304	\N	\N		4	55152092	55152092	G	T	DOID:9253	25157968	included	ENST00000257290	p.D842Y	PDGFRA	1	c.2524	2016-05-18 21:07:04.687239	2016-05-18 21:28:37.575791	5	ENSG00000134853	missense
3305	\N	\N		4	55152092	55152092	G	T	DOID:9253	22745105	included	ENST00000257290	p.D842Y	PDGFRA	1	c.2524	2016-05-18 21:07:04.698085	2016-05-18 21:28:37.625951	5	ENSG00000134853	missense
3306	\N	\N		4	55152092	55152100	GACATCATG	-	DOID:9253	25157968	included	ENST00000257290	p.DIM842-	PDGFRA	1	c.2524	2016-05-18 21:07:04.705825	2016-05-18 21:28:37.700861	5	ENSG00000134853	inframe
3307	\N	\N		4	55152092	55152103	GACATCATGCAT	-	DOID:9253	25157968	included	ENST00000257290	p.DIMH842-	PDGFRA	1	c.2524	2016-05-18 21:07:04.715779	2016-05-18 21:28:37.78945	5	ENSG00000134853	inframe
3308	\N	\N		4	55152095	55152106	ATCATGCATGAT	-	DOID:9253	25157968	included	ENST00000257290	p.IMHD843-	PDGFRA	1	c.2527	2016-05-18 21:07:04.724233	2016-05-18 21:28:37.877346	5	ENSG00000134853	inframe
3309	\N	\N		4	55152104	55152104	G	T	DOID:9253	25157968	included	ENST00000257290	p.D846Y	PDGFRA	1	c.2536	2016-05-18 21:07:04.734675	2016-05-18 21:28:37.945764	5	ENSG00000134853	missense
3310	\N	\N		4	55152104	55152104	G	T	DOID:9253	15928335	included	ENST00000257290	p.D846Y	PDGFRA	1	c.2536	2016-05-18 21:07:04.74736	2016-05-18 21:28:38.006371	5	ENSG00000134853	missense
3311	\N	\N		3	178916876	178916876	G	A	DOID:1612	25157968	included	ENST00000263967	p.R88Q	PIK3CA	1	c.263	2016-05-18 21:07:04.757488	2016-05-18 21:28:38.069195	5	ENSG00000121879	missense
3312	\N	\N		3	178916876	178916876	G	A	DOID:9256	25157968	included	ENST00000263967	p.R88Q	PIK3CA	1	c.263	2016-05-18 21:07:04.766602	2016-05-18 21:28:38.126229	5	ENSG00000121879	missense
3314	\N	\N		3	178921553	178921553	T	A	DOID:1612	25157968	included	ENST00000263967	p.N345K	PIK3CA	1	c.1035	2016-05-18 21:07:04.78355	2016-05-18 21:28:38.240592	5	ENSG00000121879	missense
3315	\N	\N		3	178921553	178921553	T	A	DOID:9256	25157968	included	ENST00000263967	p.N345K	PIK3CA	1	c.1035	2016-05-18 21:07:04.791664	2016-05-18 21:28:38.279003	5	ENSG00000121879	missense
3316	\N	\N		3	178921553	178921553	T	A	DOID:9256	19366826	included	ENST00000263967	p.N345K	PIK3CA	1	c.1035	2016-05-18 21:07:04.803278	2016-05-18 21:28:38.316843	5	ENSG00000121879	missense
3319	\N	\N		3	178921553	178921553	T	G	DOID:9256	19366826	included	ENST00000263967	p.N345K	PIK3CA	1	c.1035	2016-05-18 21:07:04.834594	2016-05-18 21:28:38.456664	5	ENSG00000121879	missense
3320	\N	\N		3	178927980	178927980	T	C	DOID:1612	25157968	included	ENST00000263967	p.C420R	PIK3CA	1	c.1258	2016-05-18 21:07:04.8429	2016-05-18 21:28:38.516053	5	ENSG00000121879	missense
3321	\N	\N		3	178927980	178927980	T	C	DOID:9256	25157968	included	ENST00000263967	p.C420R	PIK3CA	1	c.1258	2016-05-18 21:07:04.854166	2016-05-18 21:28:38.568468	5	ENSG00000121879	missense
3322	\N	\N		3	178936074	178936074	C	G	DOID:1612	25157968	included	ENST00000263967	p.P539R	PIK3CA	1	c.1616	2016-05-18 21:07:04.865555	2016-05-18 21:28:38.629446	5	ENSG00000121879	missense
3323	\N	\N		3	178936082	178936082	G	A	DOID:1612	25157968	included	ENST00000263967	p.E542K	PIK3CA	1	c.1624	2016-05-18 21:07:04.877255	2016-05-18 21:28:38.678908	5	ENSG00000121879	missense
3324	\N	\N		3	178936082	178936082	G	A	DOID:1612	23066039	included	ENST00000263967	p.E542K	PIK3CA	1	c.1624	2016-05-18 21:07:04.890691	2016-05-18 21:28:38.726532	5	ENSG00000121879	missense
3325	\N	\N		3	178936082	178936082	G	C	DOID:3908	25157968	included	ENST00000263967	p.E542Q	PIK3CA	1	c.1624	2016-05-18 21:07:04.899345	2016-05-18 21:28:38.8061	5	ENSG00000121879	missense
3326	\N	\N		3	178936092	178936092	A	C	DOID:1612	25157968	included	ENST00000263967	p.E545A	PIK3CA	1	c.1634	2016-05-18 21:07:04.907165	2016-05-18 21:28:38.875334	5	ENSG00000121879	missense
3329	\N	\N		3	178936092	178936092	A	G	DOID:9256	25157968	included	ENST00000263967	p.E545G	PIK3CA	1	c.1634	2016-05-18 21:07:04.965233	2016-05-18 21:28:39.056858	5	ENSG00000121879	missense
3330	\N	\N		3	178936092	178936092	A	G	DOID:1909	25157968	included	ENST00000263967	p.E545G	PIK3CA	1	c.1634	2016-05-18 21:07:04.977333	2016-05-18 21:28:39.10787	5	ENSG00000121879	missense
3331	\N	\N		3	178936092	178936092	A	G	DOID:1909	24265155	included	ENST00000263967	p.E545G	PIK3CA	1	c.1634	2016-05-18 21:07:04.997072	2016-05-18 21:28:39.181288	5	ENSG00000121879	missense
3332	\N	\N		3	178936091	178936091	G	A	DOID:1612	25157968	included	ENST00000263967	p.E545K	PIK3CA	1	c.1633	2016-05-18 21:07:05.008468	2016-05-18 21:28:39.239463	5	ENSG00000121879	missense
3333	\N	\N		3	178936091	178936091	G	A	DOID:1612	23066039	included	ENST00000263967	p.E545K	PIK3CA	1	c.1633	2016-05-18 21:07:05.025518	2016-05-18 21:28:39.304135	5	ENSG00000121879	missense
3334	\N	\N		3	178936091	178936091	G	C	DOID:11934	25157968	included	ENST00000263967	p.E545Q	PIK3CA	1	c.1633	2016-05-18 21:07:05.038021	2016-05-18 21:28:39.377301	5	ENSG00000121879	missense
3335	\N	\N		3	178936091	178936091	G	C	DOID:11934	23408298	included	ENST00000263967	p.E545Q	PIK3CA	1	c.1633	2016-05-18 21:07:05.053689	2016-05-18 21:28:39.435425	5	ENSG00000121879	missense
3336	\N	\N		3	178936094	178936094	C	A	DOID:1324	25157968	included	ENST00000263967	p.Q546K	PIK3CA	1	c.1636	2016-05-18 21:07:05.062277	2016-05-18 21:28:39.501185	5	ENSG00000121879	missense
3337	\N	\N		3	178938860	178938860	A	C	DOID:1612	25157968	included	ENST00000263967	p.H701P	PIK3CA	1	c.2102	2016-05-18 21:07:05.073104	2016-05-18 21:28:39.564763	5	ENSG00000121879	missense
3338	\N	\N		3	178938860	178938860	A	C	DOID:1612	15805248	included	ENST00000263967	p.H701P	PIK3CA	1	c.2102	2016-05-18 21:07:05.085002	2016-05-18 21:28:39.609325	5	ENSG00000121879	missense
3339	\N	\N		3	178952007	178952007	A	G	DOID:1612	25157968	included	ENST00000263967	p.Y1021C	PIK3CA	1	c.3062	2016-05-18 21:07:05.09543	2016-05-18 21:28:39.671528	5	ENSG00000121879	missense
3340	\N	\N		3	178952074	178952074	G	T	DOID:9256	25157968	included	ENST00000263967	p.M1043I	PIK3CA	1	c.3129	2016-05-18 21:07:05.104371	2016-05-18 21:28:39.727174	5	ENSG00000121879	missense
3341	\N	\N		3	178952074	178952074	G	T	DOID:9256	15930273	included	ENST00000263967	p.M1043I	PIK3CA	1	c.3129	2016-05-18 21:07:05.111907	2016-05-18 21:28:39.766827	5	ENSG00000121879	missense
3342	\N	\N		3	178952074	178952074	G	A	DOID:9256	25157968	included	ENST00000263967	p.M1043I	PIK3CA	1	c.3129	2016-05-18 21:07:05.122595	2016-05-18 21:28:39.820292	5	ENSG00000121879	missense
3343	\N	\N		3	178952074	178952074	G	A	DOID:9256	15930273	included	ENST00000263967	p.M1043I	PIK3CA	1	c.3129	2016-05-18 21:07:05.130273	2016-05-18 21:28:39.858504	5	ENSG00000121879	missense
3344	\N	\N		3	178952085	178952085	A	T	DOID:9256	25157968	included	ENST00000263967	p.H1047L	PIK3CA	1	c.3140	2016-05-18 21:07:05.144144	2016-05-18 21:28:39.895562	5	ENSG00000121879	missense
3345	\N	\N		3	178952085	178952085	A	T	DOID:9256	20619739	included	ENST00000263967	p.H1047L	PIK3CA	1	c.3140	2016-05-18 21:07:05.153183	2016-05-18 21:28:39.934039	5	ENSG00000121879	missense
3346	\N	\N		3	178952085	178952085	A	G	DOID:162	25157968	included	ENST00000263967	p.H1047R	PIK3CA	1	c.3140	2016-05-18 21:07:05.162723	2016-05-18 21:28:39.982667	5	ENSG00000121879	missense
3349	\N	\N		3	178952090	178952090	G	A	DOID:9256	25157968	included	ENST00000263967	p.G1049S	PIK3CA	1	c.3145	2016-05-18 21:07:05.189432	2016-05-18 21:28:40.04775	5	ENSG00000121879	missense
3350	\N	\N		3	178952090	178952090	G	A	DOID:9256	20619739	included	ENST00000263967	p.G1049S	PIK3CA	1	c.3145	2016-05-18 21:07:05.197273	2016-05-18 21:28:40.104524	5	ENSG00000121879	missense
3354	\N	\N		5	67589138	67589138	G	A	DOID:162	19962457	included	ENST00000396611	p.G376R	PIK3R1	1	c.1126	2016-05-18 21:07:05.239094	2016-05-18 21:28:40.210654	5	ENSG00000145675	missense
3355	\N	\N		5	67589138	67589138	G	C	DOID:162	25157968	included	ENST00000396611	p.G376R	PIK3R1	1	c.1126	2016-05-18 21:07:05.246775	2016-05-18 21:28:40.265362	5	ENSG00000145675	missense
3358	\N	\N		5	67589618	67589618	C	T	DOID:162	25157968	included	ENST00000396611	p.R461*	PIK3R1	1	c.1381	2016-05-18 21:07:05.279949	2016-05-18 21:28:40.408444	5	ENSG00000145675	stop
3359	\N	\N		5	67591085	67591085	G	T	DOID:162	25157968	included	ENST00000396611	p.D560Y	PIK3R1	1	c.1678	2016-05-18 21:07:05.291266	2016-05-18 21:28:40.475306	5	ENSG00000145675	missense
3360	\N	\N		5	67591085	67591102	GACAAACGTATGAACAGC	-	DOID:162	25157968	included	ENST00000396611	p.DKRMNS560-	PIK3R1	1	c.1678	2016-05-18 21:07:05.301004	2016-05-18 21:28:40.57098	5	ENSG00000145675	inframe
3361	\N	\N		5	67591097	67591097	A	G	DOID:162	25157968	included	ENST00000396611	p.N564D	PIK3R1	1	c.1690	2016-05-18 21:07:05.308584	2016-05-18 21:28:40.665492	5	ENSG00000145675	missense
3362	\N	\N		5	67591099	67591099	C	A	DOID:162	25157968	included	ENST00000396611	p.N564K	PIK3R1	1	c.1692	2016-05-18 21:07:05.318757	2016-05-18 21:28:40.734171	5	ENSG00000145675	missense
3363	\N	\N		5	67591099	67591099	C	A	DOID:162	24459181	included	ENST00000396611	p.N564K	PIK3R1	1	c.1692	2016-05-18 21:07:05.326983	2016-05-18 21:28:40.799414	5	ENSG00000145675	missense
3364	\N	\N		5	67591099	67591099	C	G	DOID:162	25157968	included	ENST00000396611	p.N564K	PIK3R1	1	c.1692	2016-05-18 21:07:05.334866	2016-05-18 21:28:40.868486	5	ENSG00000145675	missense
3365	\N	\N		5	67591099	67591099	C	G	DOID:162	24459181	included	ENST00000396611	p.N564K	PIK3R1	1	c.1692	2016-05-18 21:07:05.348037	2016-05-18 21:28:40.91204	5	ENSG00000145675	missense
3366	\N	\N		5	67591133	67591135	ACG	-	DOID:162	25157968	included	ENST00000396611	p.T576-	PIK3R1	1	c.1726	2016-05-18 21:07:05.357128	2016-05-18 21:28:40.979966	5	ENSG00000145675	inframe
3367	\N	\N		5	67591249	67591249	TGG	-	DOID:162	25157968	included	ENST00000396611	p.W583X	PIK3R1	1	c.1747	2016-05-18 21:07:05.36703	2016-05-18 21:28:41.036065	5	ENSG00000145675	frameshift
3370	\N	\N		10	89692905	89692905	G	A	DOID:162	25157968	included	ENST00000371953	p.R130Q	PTEN	1	c.389	2016-05-18 21:07:05.393823	2016-05-18 21:28:41.073829	5	ENSG00000171862	missense
3371	\N	\N		10	89692904	89692904	C	T	DOID:1319	25157968	included	ENST00000371953	p.R130*	PTEN	1	c.388	2016-05-18 21:07:05.405571	2016-05-18 21:28:41.115123	5	ENSG00000171862	stop
3372	\N	\N		10	89692904	89692904	C	T	DOID:1319	11274365	included	ENST00000371953	p.R130*	PTEN	1	c.388	2016-05-18 21:07:05.416914	2016-05-18 21:28:41.156999	5	ENSG00000171862	stop
3373	\N	\N		10	89711899	89711899	C	T	DOID:1319	25157968	included	ENST00000371953	p.R173C	PTEN	1	c.517	2016-05-18 21:07:05.440388	2016-05-18 21:28:41.2204	5	ENSG00000171862	missense
3374	\N	\N		10	89711900	89711900	G	A	DOID:1319	25157968	included	ENST00000371953	p.R173H	PTEN	1	c.518	2016-05-18 21:07:05.447993	2016-05-18 21:28:41.281174	5	ENSG00000171862	missense
3375	\N	\N		10	89711900	89711900	G	A	DOID:1319	24721394	included	ENST00000371953	p.R173H	PTEN	1	c.518	2016-05-18 21:07:05.458648	2016-05-18 21:28:41.333046	5	ENSG00000171862	missense
3376	\N	\N		10	89717675	89717675	C	T	DOID:162	25157968	included	ENST00000371953	p.R234W	PTEN	1	c.700	2016-05-18 21:07:05.465898	2016-05-18 21:28:41.394718	5	ENSG00000171862	missense
3377	\N	\N		10	89720852	89720852	C	T	DOID:1319	25157968	included	ENST00000371953	p.R335*	PTEN	1	c.1003	2016-05-18 21:07:05.475893	2016-05-18 21:28:41.455074	5	ENSG00000171862	stop
3378	\N	\N		13	48919244	48919244	G	T	DOID:162	25157968	included	ENST00000267163	p.E137*	RB1	1	c.409	2016-05-18 21:07:05.487561	2016-05-18 21:28:41.518425	5	ENSG00000139687	stop
3379	\N	\N		13	48923148	48923148	T	A	DOID:768	25157968	included	ENST00000267163	p.L199*	RB1	1	c.596	2016-05-18 21:07:05.49726	2016-05-18 21:28:41.578814	5	ENSG00000139687	stop
3380	\N	\N		13	48941648	48941648	C	T	DOID:768	25157968	included	ENST00000267163	p.R320*	RB1	1	c.958	2016-05-18 21:07:05.505857	2016-05-18 21:28:41.646249	5	ENSG00000139687	stop
3381	\N	\N		13	48941648	48941648	C	T	DOID:768	25754945	included	ENST00000267163	p.R320*	RB1	1	c.958	2016-05-18 21:07:05.513018	2016-05-18 21:28:41.696932	5	ENSG00000139687	stop
3382	\N	\N		13	48942685	48942685	C	T	DOID:768	25157968	included	ENST00000267163	p.R358*	RB1	1	c.1072	2016-05-18 21:07:05.523728	2016-05-18 21:28:41.764218	5	ENSG00000139687	stop
3383	\N	\N		13	48942685	48942685	C	T	DOID:768	25754945	included	ENST00000267163	p.R358*	RB1	1	c.1072	2016-05-18 21:07:05.531274	2016-05-18 21:28:41.809893	5	ENSG00000139687	stop
3384	\N	\N		13	48953760	48953760	C	T	DOID:768	25157968	included	ENST00000267163	p.R455*	RB1	1	c.1363	2016-05-18 21:07:05.539694	2016-05-18 21:28:41.878478	5	ENSG00000139687	stop
3385	\N	\N		13	48955538	48955538	C	T	DOID:768	25157968	included	ENST00000267163	p.R552*	RB1	1	c.1654	2016-05-18 21:07:05.560071	2016-05-18 21:28:41.934631	5	ENSG00000139687	stop
3386	\N	\N		13	48955538	48955538	C	T	DOID:768	25754945	included	ENST00000267163	p.R552*	RB1	1	c.1654	2016-05-18 21:07:05.569429	2016-05-18 21:28:41.977904	5	ENSG00000139687	stop
3387	\N	\N		13	48955550	48955550	C	T	DOID:162	25157968	included	ENST00000267163	p.R556*	RB1	1	c.1666	2016-05-18 21:07:05.577232	2016-05-18 21:28:42.045208	5	ENSG00000139687	stop
3388	\N	\N		13	49027168	49027168	C	T	DOID:768	25157968	included	ENST00000267163	p.R579*	RB1	1	c.1735	2016-05-18 21:07:05.587163	2016-05-18 21:28:42.102514	5	ENSG00000139687	stop
3389	\N	\N		13	49037877	49037877	G	T	DOID:5409	25157968	included	ENST00000267163	p.C706F	RB1	1	c.2117	2016-05-18 21:07:05.595929	2016-05-18 21:28:42.177482	5	ENSG00000139687	missense
3390	\N	\N		13	49039164	49039164	G	T	DOID:162	25157968	included	ENST00000267163	p.E748*	RB1	1	c.2242	2016-05-18 21:07:05.604123	2016-05-18 21:28:42.250504	5	ENSG00000139687	stop
3391	\N	\N		10	43609078	43609104	TTCCCTGAGGAGGAGAAGTGCTTCTGC	-	DOID:3973	25157968	included	ENST00000355710	p.FPEEEKCFC612-	RET	1	c.1834	2016-05-18 21:07:05.620085	2016-05-18 21:28:42.320797	5	ENSG00000165731	inframe
3392	\N	\N		10	43609940	43609940	A	G	DOID:3973	25157968	included	ENST00000355710	p.D631G	RET	1	c.1892	2016-05-18 21:07:05.62932	2016-05-18 21:28:42.382749	5	ENSG00000165731	missense
3393	\N	\N		10	43609942	43609947	GAGCTG	-	DOID:3973	25157968	included	ENST00000355710	p.EL632-	RET	1	c.1894	2016-05-18 21:07:05.638603	2016-05-18 21:28:42.452432	5	ENSG00000165731	inframe
3394	\N	\N		10	43609948	43609948	T	C	DOID:3973	25157968	included	ENST00000355710	p.C634R	RET	1	c.1900	2016-05-18 21:07:05.64595	2016-05-18 21:28:42.509003	5	ENSG00000165731	missense
3395	\N	\N		10	43609948	43609948	T	C	DOID:3973	15184865	included	ENST00000355710	p.C634R	RET	1	c.1900	2016-05-18 21:07:05.670882	2016-05-18 21:28:42.550964	5	ENSG00000165731	missense
3396	\N	\N		10	43609950	43609950	C	G	DOID:3973	25157968	included	ENST00000355710	p.C634W	RET	1	c.1902	2016-05-18 21:07:05.678929	2016-05-18 21:28:42.597807	5	ENSG00000165731	missense
3397	\N	\N		10	43609950	43609950	C	G	DOID:3973	20943719	included	ENST00000355710	p.C634W	RET	1	c.1902	2016-05-18 21:07:05.693059	2016-05-18 21:28:42.634282	5	ENSG00000165731	missense
3398	\N	\N		10	43609949	43609949	G	A	DOID:162	25157968	included	ENST00000355710	p.C634Y	RET	1	c.1901	2016-05-18 21:07:05.701165	2016-05-18 21:28:42.686297	5	ENSG00000165731	missense
3399	\N	\N		10	43613840	43613840	G	C	DOID:162	25157968	included	ENST00000355710	p.E768D	RET	1	c.2304	2016-05-18 21:07:05.737467	2016-05-18 21:28:42.739952	5	ENSG00000165731	missense
3400	\N	\N		10	43615568	43615569	GC	TT	DOID:3973	25157968	included	ENST00000355710	p.A883F	RET	1	c.2647	2016-05-18 21:07:05.745683	2016-05-18 21:28:42.796451	5	ENSG00000165731	missense
3401	\N	\N		10	43615568	43615569	GC	TT	DOID:3973	15184865	included	ENST00000355710	p.A883F	RET	1	c.2647	2016-05-18 21:07:05.759535	2016-05-18 21:28:42.832865	5	ENSG00000165731	missense
3402	\N	\N		10	43615613	43615624	GATGTTTATGAA	-	DOID:3973	25157968	included	ENST00000355710	p.DVYE898-	RET	1	c.2692	2016-05-18 21:07:05.767755	2016-05-18 21:28:42.882528	5	ENSG00000165731	inframe
3403	\N	\N		10	43617416	43617416	T	C	DOID:3973	25157968	included	ENST00000355710	p.M918T	RET	1	c.2753	2016-05-18 21:07:05.805116	2016-05-18 21:28:42.91903	5	ENSG00000165731	missense
3404	\N	\N		10	43617416	43617416	T	C	DOID:3973	11351254	included	ENST00000355710	p.M918T	RET	1	c.2753	2016-05-18 21:07:05.813179	2016-05-18 21:28:42.955102	5	ENSG00000165731	missense
3405	\N	\N		20	36031762	36031762	C	T	DOID:162	25157968	included	ENST00000360723	p.Q537*	SRC	1	c.1609	2016-05-18 21:07:05.828288	2016-05-18 21:28:43.014538	5	ENSG00000197122	stop
3406	\N	\N		19	1207021	1207021	C	T	DOID:162	25157968	included	ENST00000326873	p.Q37*	STK11	1	c.109	2016-05-18 21:07:05.836463	2016-05-18 21:28:43.066732	5	ENSG00000118046	stop
3407	\N	\N		19	1220415	1220415	C	T	DOID:162	25157968	included	ENST00000326873	p.Q170*	STK11	1	c.508	2016-05-18 21:07:05.860823	2016-05-18 21:28:43.118877	5	ENSG00000118046	stop
3408	\N	\N		19	1220487	1220487	G	A	DOID:162	25157968	included	ENST00000326873	p.D194N	STK11	1	c.580	2016-05-18 21:07:05.872408	2016-05-18 21:28:43.170224	5	ENSG00000118046	missense
3409	\N	\N		19	1220488	1220488	A	T	DOID:162	25157968	included	ENST00000326873	p.D194V	STK11	1	c.581	2016-05-18 21:07:05.884765	2016-05-18 21:28:43.224257	5	ENSG00000118046	missense
3410	\N	\N		19	1220494	1220494	G	T	DOID:3908	25157968	included	ENST00000326873	p.G196V	STK11	1	c.587	2016-05-18 21:07:05.894447	2016-05-18 21:28:43.271713	5	ENSG00000118046	missense
3411	\N	\N		19	1220502	1220502	G	A	DOID:162	25157968	included	ENST00000326873	p.E199K	STK11	1	c.595	2016-05-18 21:07:05.904511	2016-05-18 21:28:43.326121	5	ENSG00000118046	missense
3412	\N	\N		19	1220502	1220502	G	T	DOID:162	25157968	included	ENST00000326873	p.E199*	STK11	1	c.595	2016-05-18 21:07:05.914002	2016-05-18 21:28:43.37642	5	ENSG00000118046	stop
3413	\N	\N		19	1221319	1221319	C	T	DOID:162	25157968	included	ENST00000326873	p.P281L	STK11	1	c.842	2016-05-18 21:07:05.921659	2016-05-18 21:28:43.435397	5	ENSG00000118046	missense
3414	\N	\N		19	1223059	1223059	G	A	DOID:162	25157968	included	ENST00000326873	p.W332*	STK11	1	c.996	2016-05-18 21:07:05.933907	2016-05-18 21:28:43.510369	5	ENSG00000118046	stop
3415	\N	\N		17	7578406	7578406	C	T	DOID:162	25157968	included	ENST00000269305	p.R175H	TP53	-1	c.524	2016-05-18 21:07:05.944616	2016-05-18 21:28:43.584965	5	ENSG00000141510	missense
3416	\N	\N		17	7578406	7578406	C	T	DOID:162	11101847	included	ENST00000269305	p.R175H	TP53	-1	c.524	2016-05-18 21:07:05.951597	2016-05-18 21:28:43.632018	5	ENSG00000141510	missense
3417	\N	\N		17	7578406	7578406	C	T	DOID:162	18391940	included	ENST00000269305	p.R175H	TP53	-1	c.524	2016-05-18 21:07:05.961145	2016-05-18 21:28:43.68059	5	ENSG00000141510	missense
3418	\N	\N		17	7577548	7577548	C	T	DOID:162	25157968	included	ENST00000269305	p.G245S	TP53	-1	c.733	2016-05-18 21:07:05.971541	2016-05-18 21:28:43.738214	5	ENSG00000141510	missense
3419	\N	\N		17	7577548	7577548	C	T	DOID:162	17015838	included	ENST00000269305	p.G245S	TP53	-1	c.733	2016-05-18 21:07:05.981406	2016-05-18 21:28:43.792409	5	ENSG00000141510	missense
3420	\N	\N		17	7577538	7577538	C	T	DOID:162	25157968	included	ENST00000269305	p.R248Q	TP53	-1	c.743	2016-05-18 21:07:05.98962	2016-05-18 21:28:43.839709	5	ENSG00000141510	missense
3421	\N	\N		17	7577538	7577538	C	T	DOID:162	24651012	included	ENST00000269305	p.R248Q	TP53	-1	c.743	2016-05-18 21:07:06.002284	2016-05-18 21:28:43.88061	5	ENSG00000141510	missense
3422	\N	\N		17	7577538	7577538	C	T	DOID:684	25157968	included	ENST00000269305	p.R248Q	TP53	-1	c.743	2016-05-18 21:07:06.01129	2016-05-18 21:28:43.923843	5	ENSG00000141510	missense
3423	\N	\N		17	7577538	7577538	C	T	DOID:684	15004724	included	ENST00000269305	p.R248Q	TP53	-1	c.743	2016-05-18 21:07:06.020859	2016-05-18 21:28:43.975817	5	ENSG00000141510	missense
3424	\N	\N		17	7577539	7577539	G	A	DOID:9119	25157968	included	ENST00000269305	p.R248W	TP53	-1	c.742	2016-05-18 21:07:06.032969	2016-05-18 21:28:44.038754	5	ENSG00000141510	missense
3425	\N	\N		17	7577539	7577539	G	A	DOID:9119	20013323	included	ENST00000269305	p.R248W	TP53	-1	c.742	2016-05-18 21:07:06.043298	2016-05-18 21:28:44.088786	5	ENSG00000141510	missense
3426	\N	\N		17	7577539	7577539	G	A	DOID:162	25157968	included	ENST00000269305	p.R248W	TP53	-1	c.742	2016-05-18 21:07:06.051747	2016-05-18 21:28:44.144725	5	ENSG00000141510	missense
3427	\N	\N		17	7577121	7577121	G	A	DOID:684	25157968	included	ENST00000269305	p.R273C	TP53	-1	c.817	2016-05-18 21:07:06.06048	2016-05-18 21:28:44.207107	5	ENSG00000141510	missense
3428	\N	\N		17	7577121	7577121	G	A	DOID:684	15004724	included	ENST00000269305	p.R273C	TP53	-1	c.817	2016-05-18 21:07:06.070298	2016-05-18 21:28:44.280345	5	ENSG00000141510	missense
3429	\N	\N		17	7577121	7577121	G	A	DOID:162	25157968	included	ENST00000269305	p.R273C	TP53	-1	c.817	2016-05-18 21:07:06.079981	2016-05-18 21:28:44.33128	5	ENSG00000141510	missense
3430	\N	\N		17	7577120	7577120	C	T	DOID:162	25157968	included	ENST00000269305	p.R273H	TP53	-1	c.818	2016-05-18 21:07:06.086696	2016-05-18 21:28:44.39376	5	ENSG00000141510	missense
3431	\N	\N		17	7577022	7577022	G	A	DOID:9256	25157968	included	ENST00000269305	p.R306*	TP53	-1	c.916	2016-05-18 21:07:06.100894	2016-05-18 21:28:44.465252	5	ENSG00000141510	stop
3432	\N	\N		17	7577022	7577022	G	A	DOID:11934	25157968	included	ENST00000269305	p.R306*	TP53	-1	c.916	2016-05-18 21:07:06.111302	2016-05-18 21:28:44.53867	5	ENSG00000141510	stop
3433	\N	\N		3	10183772	10183772	C	T	DOID:162	25157968	included	ENST00000256474	p.P81S	VHL	1	c.241	2016-05-18 21:07:06.117952	2016-05-18 21:28:44.632342	5	ENSG00000134086	missense
3434	\N	\N		3	10183785	10183785	T	C	DOID:162	25157968	included	ENST00000256474	p.L85P	VHL	1	c.254	2016-05-18 21:07:06.127889	2016-05-18 21:28:44.71925	5	ENSG00000134086	missense
3435	\N	\N		3	10183797	10183797	T	A	DOID:4467	25157968	included	ENST00000256474	p.L89H	VHL	1	c.266	2016-05-18 21:07:06.138296	2016-05-18 21:28:44.793405	5	ENSG00000134086	missense
3436	\N	\N		3	10183797	10183797	T	A	DOID:4467	11921283	included	ENST00000256474	p.L89H	VHL	1	c.266	2016-05-18 21:07:06.148995	2016-05-18 21:28:44.835126	5	ENSG00000134086	missense
3437	\N	\N		3	10191480	10191480	T	A	DOID:4467	25157968	included	ENST00000256474	p.L158Q	VHL	1	c.473	2016-05-18 21:07:06.157093	2016-05-18 21:28:44.914487	5	ENSG00000134086	missense
3438	\N	\N		3	10191480	10191480	T	A	DOID:4467	11921283	included	ENST00000256474	p.L158Q	VHL	1	c.473	2016-05-18 21:07:06.168378	2016-05-18 21:28:44.969629	5	ENSG00000134086	missense
3439	\N	\N		3	10191488	10191488	C	T	DOID:4467	25157968	included	ENST00000256474	p.R161*	VHL	1	c.481	2016-05-18 21:07:06.178891	2016-05-18 21:28:45.048749	5	ENSG00000134086	stop
3440	\N	\N		3	10191506	10191506	C	T	DOID:4467	25157968	included	ENST00000256474	p.R167W	VHL	1	c.499	2016-05-18 21:07:06.185572	2016-05-18 21:28:45.125274	5	ENSG00000134086	missense
3441	\N	\N		3	10191506	10191506	C	T	DOID:4467	7660122	included	ENST00000256474	p.R167W	VHL	1	c.499	2016-05-18 21:07:06.195469	2016-05-18 21:28:45.198033	5	ENSG00000134086	missense
\.


--
-- Name: submitted_variants_id_seq; Type: SEQUENCE SET; Schema: public; Owner: acoffman
--

SELECT pg_catalog.setval('submitted_variants_id_seq', 3441, true);


--
-- Name: tags_id_seq; Type: SEQUENCE SET; Schema: public; Owner: acoffman
--

SELECT pg_catalog.setval('tags_id_seq', 2, true);


--
-- Name: transcripts_id_seq; Type: SEQUENCE SET; Schema: public; Owner: acoffman
--

SELECT pg_catalog.setval('transcripts_id_seq', 75, true);


--
-- Name: variant_types_id_seq; Type: SEQUENCE SET; Schema: public; Owner: acoffman
--

SELECT pg_catalog.setval('variant_types_id_seq', 4, true);


--
-- Name: variants_id_seq; Type: SEQUENCE SET; Schema: public; Owner: acoffman
--

SELECT pg_catalog.setval('variants_id_seq', 728, true);


--
-- Name: versions_id_seq; Type: SEQUENCE SET; Schema: public; Owner: acoffman
--

SELECT pg_catalog.setval('versions_id_seq', 3, true);


--
-- PostgreSQL database dump complete
--

